ࡱ> S                    U WY[]_acegikmoqsuw|r p!!n""l##j$$h%%f&&d''b((` bjbj   2Tiiil{#-&:ZF&$< +++++++$o0h2f+u"+-yyy_+y+yyL.bԟ Wi0x. & symbol that appears in Courier font, no larger than 10 points, and bolded. Example: Tab Symbol - User response to computer dialogue is followed by the symbol that appears in Courier font, no larger than 10 points, and bolded. Example: References Please review the following guide and manual prior to installing and implementing the VistA Laboratory EPI Rollup Modifications Patch LR*5.2*281: Kernel Systems Manual V. 8.0 VA FileMan V. 21.0 VA Mailman V. 7.1 EPI Roll Up Modifications Software Phased Installation and Implementation Instructions Due to extensive historical data transmission requirements and mandated setups required for such, a phased installation and implementation of this patch (LR*5.2*281) is utilized for releasing this patch. The software download information is made available to sites attending one of the following national audio conference training calls: Tuesday, June 8 at 1:00 - 3:00 PM EST for VISNs 1-2-3-4-5-6 Thursday, June 10 at 3:00 - 5:00 PM EST for VISNs 7-8-9-10-11 Tuesday, June 15 at 4:00 - 6:00 PM EST for VISNs 12-15-16-16-23 Wednesday, June 16 at 2:00 - 4:00 PM EST for VISNs 18-19-20-21-22 Thursday, June 17 at 2:00 - 4:00 PM EST for those unable to attend the other calls. The VANTS telephone number is 1 800 767-1750 and the access code for all calls is 13143. This patch will involve reseeding of the EPI databases for each site to allow the new data created by this patch to be captured. It is imperative that each site attend an audio conference prior to installation and implementation of the EPI patch LR*5.2*281. Instructions for Seeding EPI Historical Data: EPI historical data must be gathered from October 1, 2000 through June 14, 2004. Use the Lab EPI Manual Run (Enhanced) [LREPI ENHANCE MANUAL RUN] option to extract and transmit 6 manual runs (consecutive runs) at a time. WARNING: SITES - DO NOT transmit the EPI historical data reports on June 16 or July 4, 2004 to avoid Austin Automation Center (AAC) capacity limitations. Batch #1: October 1, 2000 -March 31, 2001 Batch #2: April 1, 2001 - September 30, 2001 Batch #3: October 1, 2001 - March 31, 2002 Batch #4: April 1, 2002 - September 30, 2002 Batch #5: October 1, 2002 - March 31, 2003 Batch #6: April 1, 2003 - September 30, 2003 Batch #7: October 1, 2003 - March 31, 2004 Batch #8: April 1, 2004 - June 14, 2004 Sites will run 8 batches of EPI historical data reports. Each batch should contain 6 separate monthly extracts which are tasked separately by month, (i.e., OCT 2000, NOV 2000, DEC 2000, JAN 2001, FEB 2001, MAR 2001 = 1 batch) and will generate six separate processing reports back to the station and transmit them over a five week period June 10, 2004 July 12, 2004. You do not have to wait for one monthly extract to run before starting the next in a batch. You do not have to wait for one batch to complete running before queuing the next batch. If you receive any fatal errors and the monthly extract is rejected, you will need to fix the error and retransmit that month. Austin Automation Center (AAC) Schedule for Transmitting EPI Historical Data: WARNING: SITES - DO NOT transmit the EPI historical data reports on June 16 or July 4, 2004 to avoid Austin Automation Center (AAC) capacity limitations. Sites may transmit EPI historical data reports to AAC on evenings and weekends following this schedule: 1. VISNs with odd numbers are asked to transmit batches on Tuesday & Thursday during the PM hours and Saturdays. 2. VISNs with even numbers are asked to transmit on Monday & Friday during the PM hours and Sundays. EPI Roll Up Modifications Manual Retrieval The VistA Laboratory EPI Rollup Modifications Technical and User Manual (i.e., LR_52_281_EPI_TUM.PDF) file is available for retrieval via the File Transfer Protocol (FTP). All VA medical centers are encouraged to use the Transmission Control Protocol/Internet Protocol (TCP/IP) FTP functionality to obtain the documentation file at the following Office of Information Field Offices (OIFOs) ANONYMOUS SOFTWARE directories: OIFOs FTP ADDRESS DIRECTORY Albany  HYPERLINK "ftp://ftp.fo-albany.med.va.gov" ftp.fo-albany.med.va.gov [ANONYMOUS.SOFTWARE] Hines  HYPERLINK "ftp://ftp.fo-hines.med.va.gov" ftp.fo-hines.med.va.gov [ANONYMOUS.SOFTWARE] Salt Lake City  HYPERLINK "ftp://ftp.fo-slc.med.va.gov" ftp.fo-slc.med.va.gov [ANONYMOUS.SOFTWARE] VistA Download Site download.vista.med.va.gov EPI Roll Up Modifications Manual Formats VistA Laboratory EPI Rollup Modifications Technical and User Manual is exported as part of Patch LR*52*281 in the following file name and retrieval format: FILE NAME RETRIEVAL FORMATS LR_52_281_EPI_TUM.PDF LR EPI Technical and User Manual Website Locations: The VistA Laboratory EPI Rollup Modifications Patch LR*5.2*281 Technical and User Manual is available in MS Word (i.e., LR_52_281_EPI_TUM.DOC) format and Portable Document Format (PDF) (i.e., LR_52_281_EPI_TUM.PDF) at the following website locations: Laboratory Version 5.2 Home Page  HYPERLINK "http://vista.med.va.gov/ClinicalSpecialties/lab/" http://vista.med.va.gov/ClinicalSpecialties/lab/ VistA Documentation Library (VDL)  HYPERLINK "http://www.va.gov/vdl/" http://www.va.gov/vdl/ Table of Contents  TOC \o "1-8" \h \z  HYPERLINK \l "_Toc76869005" Preface  PAGEREF _Toc76869005 \h i  HYPERLINK \l "_Toc76869006" Intended Audience  PAGEREF _Toc76869006 \h i  HYPERLINK \l "_Toc76869007" Orientation  PAGEREF _Toc76869007 \h iii  HYPERLINK \l "_Toc76869008" EPI Roll Up Modifications Technical and User Manual  PAGEREF _Toc76869008 \h iii  HYPERLINK \l "_Toc76869009" Screen Dialogue  PAGEREF _Toc76869009 \h iv  HYPERLINK \l "_Toc76869010" References  PAGEREF _Toc76869010 \h iv  HYPERLINK \l "_Toc76869011" EPI Roll Up Modifications Software Phased Installation and Implementation Instructions  PAGEREF _Toc76869011 \h iv  HYPERLINK \l "_Toc76869012" Instructions for Seeding EPI Historical Data:  PAGEREF _Toc76869012 \h v  HYPERLINK \l "_Toc76869013" Austin Automation Center (AAC) Schedule for Transmitting EPI Historical Data:  PAGEREF _Toc76869013 \h v  HYPERLINK \l "_Toc76869014" EPI Roll Up Modifications Manual Retrieval  PAGEREF _Toc76869014 \h vi  HYPERLINK \l "_Toc76869015" EPI Roll Up Modifications Manual Formats  PAGEREF _Toc76869015 \h vi  HYPERLINK \l "_Toc76869016" Website Locations:  PAGEREF _Toc76869016 \h vi  HYPERLINK \l "_Toc76869017" Table of Contents  PAGEREF _Toc76869017 \h vii  HYPERLINK \l "_Toc76869018" Introduction  PAGEREF _Toc76869018 \h 15  HYPERLINK \l "_Toc76869019" Overview  PAGEREF _Toc76869019 \h 15  HYPERLINK \l "_Toc76869020" Enhancements and Modifications  PAGEREF _Toc76869020 \h 21  HYPERLINK \l "_Toc76869021" Enhancements:  PAGEREF _Toc76869021 \h 21  HYPERLINK \l "_Toc76869022" Renamed EPI Menu/Options  PAGEREF _Toc76869022 \h 21  HYPERLINK \l "_Toc76869023" Lab Search Extract Primary [LREPI SEARCH EXTRACT MENU] menu RENAMED to Lab EPI Primary [LREPI SEARCH EXTRACT MENU] menu:  PAGEREF _Toc76869023 \h 21  HYPERLINK \l "_Toc76869024" Lab Search/Extract Manual Run (Enhanced) [LREPI SEARCH/EXTRACT ENHANCED MANUAL RUN] option RENAMED Lab EPI Manual Run (Enhanced) [LREPI ENHANCE MANUAL RUN] option:  PAGEREF _Toc76869024 \h 21  HYPERLINK \l "_Toc76869025" Modified Lab EPI Primary [LREPI SEARCH EXTRACT MENU] menu options:  PAGEREF _Toc76869025 \h 22  HYPERLINK \l "_Toc76869026" Lab EPI Parameter Setup [LREPI (EPI) PARAMETER SETUP] option:  PAGEREF _Toc76869026 \h 22  HYPERLINK \l "_Toc76869027" New Lab EPI Primary [LREPI SEARCH EXTRACT MENU] menu options  PAGEREF _Toc76869027 \h 22  HYPERLINK \l "_Toc76869028" Print Detailed Verification Report [LREPI VERIFICATION REPORT] option:  PAGEREF _Toc76869028 \h 22  HYPERLINK \l "_Toc76869029" Pathogen Inquiry [LREPI PATHOGEN INQUIRY] option:  PAGEREF _Toc76869029 \h 22  HYPERLINK \l "_Toc76869030" New Local Pathogen Submenu and Options:  PAGEREF _Toc76869030 \h 22  HYPERLINK \l "_Toc76869031" Local Pathogen [LREPI LOCAL PATHOGEN MENU] Submenu:  PAGEREF _Toc76869031 \h 22  HYPERLINK \l "_Toc76869032" Enter/Edit Local Pathogens [LREPI ENTER/EDIT LOCAL PATH] option:  PAGEREF _Toc76869032 \h 23  HYPERLINK \l "_Toc76869033" Lab EPI Generate Report/Spreadsheet [LREPI GENERATE REPORT/SP] option:  PAGEREF _Toc76869033 \h 23  HYPERLINK \l "_Toc76869034" Lab EPI Print Local Report/Spreadsheet [LREPI PRINT REPORT/SPSHT] option:  PAGEREF _Toc76869034 \h 23  HYPERLINK \l "_Toc76869035" Delete Local Pathogen [LREPI DELETE LOCAL PATHOGEN] option  PAGEREF _Toc76869035 \h 23  HYPERLINK \l "_Toc76869036" Delete Local Report or Spreadsheet [LREPI DELETE LOCAL REPORT] option  PAGEREF _Toc76869036 \h 23  HYPERLINK \l "_Toc76869037" New EPI Reports  PAGEREF _Toc76869037 \h 24  HYPERLINK \l "_Toc76869038" New EPI Summary Verification Report of EPI Extracted Data from Site for Nationally Rolled-Up Emerging Pathogens:  PAGEREF _Toc76869038 \h 24  HYPERLINK \l "_Toc76869039" New Detailed Verification Report of EPI Extracted Data from Site for Nationally Rolled-Up Emerging Pathogens:  PAGEREF _Toc76869039 \h 24  HYPERLINK \l "_Toc76869040" New EPI Processing/Error Report Mailman Message sent from Austin  PAGEREF _Toc76869040 \h 25  HYPERLINK \l "_Toc76869041" New EPI Data Extracted:  PAGEREF _Toc76869041 \h 25  HYPERLINK \l "_Toc76869042" Logical Observation, Identifiers, Name, and Codes (LOINC)  PAGEREF _Toc76869042 \h 25  HYPERLINK \l "_Toc76869043" Master Patient Index (MPI)  PAGEREF _Toc76869043 \h 25  HYPERLINK \l "_Toc76869044" Susceptibility Results MIC Values  PAGEREF _Toc76869044 \h 25  HYPERLINK \l "_Toc76869045" Site Institution/Division Number  PAGEREF _Toc76869045 \h 25  HYPERLINK \l "_Toc76869046" Patient Demographics  PAGEREF _Toc76869046 \h 25  HYPERLINK \l "_Toc76869047" Race and Ethnicity  PAGEREF _Toc76869047 \h 25  HYPERLINK \l "_Toc76869048" Six New Emerging Pathogens  PAGEREF _Toc76869048 \h 26  HYPERLINK \l "_Toc76869049" New Legionella Urinary Antigen Test  PAGEREF _Toc76869049 \h 26  HYPERLINK \l "_Toc76869050" New EPI Informational Alert  PAGEREF _Toc76869050 \h 26  HYPERLINK \l "_Toc76869051" Modifications  PAGEREF _Toc76869051 \h 27  HYPERLINK \l "_Toc76869052" EPI Single Day Transmissions:  PAGEREF _Toc76869052 \h 27  HYPERLINK \l "_Toc76869053" LAB EPI Search Criteria  PAGEREF _Toc76869053 \h 27  HYPERLINK \l "_Toc76869054" National Center for Health (NCH) Data Screening No Longer Required:  PAGEREF _Toc76869054 \h 27  HYPERLINK \l "_Toc76869055" Deletion of National Center for Health (NCH) Protocol  PAGEREF _Toc76869055 \h 27  HYPERLINK \l "_Toc76869056" Lab EPI Nightly Task [LREPI NIGHTLY TASK] option  PAGEREF _Toc76869056 \h 27  HYPERLINK \l "_Toc76869057" Austin Automation Center Database Processing  PAGEREF _Toc76869057 \h 29  HYPERLINK \l "_Toc76869058" Numerator Files:  PAGEREF _Toc76869058 \h 29  HYPERLINK \l "_Toc76869059" Denominator File:  PAGEREF _Toc76869059 \h 29  HYPERLINK \l "_Toc76869060" AAC EPI Data Transmission  PAGEREF _Toc76869060 \h 30  HYPERLINK \l "_Toc76869061" AAC Transmission Reports  PAGEREF _Toc76869061 \h 30  HYPERLINK \l "_Toc76869062" EPI Confirmation Mailman Message sent from AAC  PAGEREF _Toc76869062 \h 30  HYPERLINK \l "_Toc76869063" New EPI Processing (Error) Report Mailman Message from Austin  PAGEREF _Toc76869063 \h 30  HYPERLINK \l "_Toc76869064" Security Information  PAGEREF _Toc76869064 \h 31  HYPERLINK \l "_Toc76869065" Security Management:  PAGEREF _Toc76869065 \h 31  HYPERLINK \l "_Toc76869066" Security Features:  PAGEREF _Toc76869066 \h 31  HYPERLINK \l "_Toc76869067" EPI Mail Groups  PAGEREF _Toc76869067 \h 31  HYPERLINK \l "_Toc76869068" EPI mail group:  PAGEREF _Toc76869068 \h 31  HYPERLINK \l "_Toc76869069" EPI-Report mail group:  PAGEREF _Toc76869069 \h 31  HYPERLINK \l "_Toc76869070" New EPI Informational Alert  PAGEREF _Toc76869070 \h 31  HYPERLINK \l "_Toc76869071" Remote Systems  PAGEREF _Toc76869071 \h 32  HYPERLINK \l "_Toc76869072" Archiving/Purging  PAGEREF _Toc76869072 \h 32  HYPERLINK \l "_Toc76869073" Contingency Planning  PAGEREF _Toc76869073 \h 32  HYPERLINK \l "_Toc76869074" Interfacing  PAGEREF _Toc76869074 \h 32  HYPERLINK \l "_Toc76869075" Electronic Signatures  PAGEREF _Toc76869075 \h 32  HYPERLINK \l "_Toc76869076" Menus  PAGEREF _Toc76869076 \h 32  HYPERLINK \l "_Toc76869077" Security Keys  PAGEREF _Toc76869077 \h 32  HYPERLINK \l "_Toc76869078" File Security  PAGEREF _Toc76869078 \h 32  HYPERLINK \l "_Toc76869079" References  PAGEREF _Toc76869079 \h 32  HYPERLINK \l "_Toc76869080" Official Policies  PAGEREF _Toc76869080 \h 32  HYPERLINK \l "_Toc76869081" Pre-Installation Information  PAGEREF _Toc76869081 \h 33  HYPERLINK \l "_Toc76869082" EPI Phased Installation and Implementation  PAGEREF _Toc76869082 \h 33  HYPERLINK \l "_Toc76869083" Intended Audience  PAGEREF _Toc76869083 \h 33  HYPERLINK \l "_Toc76869084" IRM Staff:  PAGEREF _Toc76869084 \h 33  HYPERLINK \l "_Toc76869085" Laboratory Staff:  PAGEREF _Toc76869085 \h 33  HYPERLINK \l "_Toc76869086" Quality Management Staff:  PAGEREF _Toc76869086 \h 34  HYPERLINK \l "_Toc76869087" Other Staff:  PAGEREF _Toc76869087 \h 34  HYPERLINK \l "_Toc76869088" Test Sites:  PAGEREF _Toc76869088 \h 34  HYPERLINK \l "_Toc76869089" Hardware and Operating System Requirements:  PAGEREF _Toc76869089 \h 34  HYPERLINK \l "_Toc76869090" Digital Equipment Corporation (DEC) Alpha Series:  PAGEREF _Toc76869090 \h 34  HYPERLINK \l "_Toc76869091" System Performance Capacity:  PAGEREF _Toc76869091 \h 35  HYPERLINK \l "_Toc76869092" Memory Constraints:  PAGEREF _Toc76869092 \h 35  HYPERLINK \l "_Toc76869093" Installation Time:  PAGEREF _Toc76869093 \h 35  HYPERLINK \l "_Toc76869094" Disabling EPI Menus Not Required:  PAGEREF _Toc76869094 \h 35  HYPERLINK \l "_Toc76869095" Users on the System:  PAGEREF _Toc76869095 \h 35  HYPERLINK \l "_Toc76869096" Backup Routines:  PAGEREF _Toc76869096 \h 35  HYPERLINK \l "_Toc76869097" Namespace:  PAGEREF _Toc76869097 \h 35  HYPERLINK \l "_Toc76869098" Software Requirements:  PAGEREF _Toc76869098 \h 36  HYPERLINK \l "_Toc76869099" Required Patches:  PAGEREF _Toc76869099 \h 36  HYPERLINK \l "_Toc76869100" Health Level Seven (HL7):  PAGEREF _Toc76869100 \h 36  HYPERLINK \l "_Toc76869101" Protocols:  PAGEREF _Toc76869101 \h 36  HYPERLINK \l "_Toc76869102" Domain  PAGEREF _Toc76869102 \h 36  HYPERLINK \l "_Toc76869103" Database Integration Agreements (DBIAs)  PAGEREF _Toc76869103 \h 37  HYPERLINK \l "_Toc76869104" 1. DBIA #418  PAGEREF _Toc76869104 \h 37  HYPERLINK \l "_Toc76869105" 2. DBIA #3018  PAGEREF _Toc76869105 \h 37  HYPERLINK \l "_Toc76869106" 3. DBIA #3094:  PAGEREF _Toc76869106 \h 37  HYPERLINK \l "_Toc76869107" 4. DBIA #3530  PAGEREF _Toc76869107 \h 38  HYPERLINK \l "_Toc76869108" 5. DBIA 4280  PAGEREF _Toc76869108 \h 38  HYPERLINK \l "_Toc76869109" Data Dictionary Changes  PAGEREF _Toc76869109 \h 39  HYPERLINK \l "_Toc76869110" LAB SEARCH/EXTRACT file (#69.5)  PAGEREF _Toc76869110 \h 39  HYPERLINK \l "_Toc76869111" Modified Fields:  PAGEREF _Toc76869111 \h 39  HYPERLINK \l "_Toc76869112" NAME field (#69.5.,01)  PAGEREF _Toc76869112 \h 39  HYPERLINK \l "_Toc76869113" INACTIVE field (#69.5,1)  PAGEREF _Toc76869113 \h 40  HYPERLINK \l "_Toc76869114" PROTOCOL field (#69.55,12):  PAGEREF _Toc76869114 \h 40  HYPERLINK \l "_Toc76869115" NEW Fields:  PAGEREF _Toc76869115 \h 41  HYPERLINK \l "_Toc76869116" PREVIOUS CYCLE field (69.5,19)  PAGEREF _Toc76869116 \h 41  HYPERLINK \l "_Toc76869117" INDICATOR field (#69.55,1):  PAGEREF _Toc76869117 \h 41  HYPERLINK \l "_Toc76869118" INDICATED VALUE field (#69.55,2):  PAGEREF _Toc76869118 \h 42  HYPERLINK \l "_Toc76869119" PROTOCOL file (#101)  PAGEREF _Toc76869119 \h 42  HYPERLINK \l "_Toc76869120" Modified Field  PAGEREF _Toc76869120 \h 42  HYPERLINK \l "_Toc76869121" Processing Routine field (#771):  PAGEREF _Toc76869121 \h 42  HYPERLINK \l "_Toc76869122" Routine Summary  PAGEREF _Toc76869122 \h 43  HYPERLINK \l "_Toc76869123" Installation Instructions  PAGEREF _Toc76869123 \h 45  HYPERLINK \l "_Toc76869124" Installation Example:  PAGEREF _Toc76869124 \h 47  HYPERLINK \l "_Toc76869125" Post Installation and Implementation Instructions  PAGEREF _Toc76869125 \h 49  HYPERLINK \l "_Toc76869126" IRM Post Installation Instructions:  PAGEREF _Toc76869126 \h 49  HYPERLINK \l "_Toc76869127" IRM - Step 1: Verify Lower Level Protocol of the HL7 V. 1.6 background job for EPI LAB  PAGEREF _Toc76869127 \h 49  HYPERLINK \l "_Toc76869128" IRM - Step 2: Verify Lab EPI Nightly Task [LREPI NIGHTLY TASK] Option Nightly Run  PAGEREF _Toc76869128 \h 51  HYPERLINK \l "_Toc76869129" Example: How to schedule the Lab EPI Nightly Task [LREPI NIGHTLY TASK] option to run nightly.  PAGEREF _Toc76869129 \h 51  HYPERLINK \l "_Toc76869130" Example: How to schedule the Lab EPI Nightly Task [LREPI NIGHTLY TASK] option to run nightly continued.  PAGEREF _Toc76869130 \h 52  HYPERLINK \l "_Toc76869131" IRM - Step 3: Verify EPI mail group setup entries  PAGEREF _Toc76869131 \h 53  HYPERLINK \l "_Toc76869132" Example: How to verify existing EPI mail group setup entries  PAGEREF _Toc76869132 \h 53  HYPERLINK \l "_Toc76869133" IRM Step 4: Verify EPI-REPORT mail group setup entries  PAGEREF _Toc76869133 \h 54  HYPERLINK \l "_Toc76869134" Example: How to verify EPI-REPORT mail group setup entries  PAGEREF _Toc76869134 \h 54  HYPERLINK \l "_Toc76869135" IRM Step 5: Verify XXX@Q-EPI.MED.VA.GOV Remote Member Entries  PAGEREF _Toc76869135 \h 55  HYPERLINK \l "_Toc76869136" IRM Step 6: Verify Lab EPI Primary [LREPI SEARCH EXTRACT MENU] menu assignment to all designated users  PAGEREF _Toc76869136 \h 56  HYPERLINK \l "_Toc76869137" Example: Lab EPI Primary [LREPI SEARCH EXTRACT MENU] menu  PAGEREF _Toc76869137 \h 56  HYPERLINK \l "_Toc76869138" Example: Local Pathogen [LREPI LOCAL PATHOGEN MENU] Menu  PAGEREF _Toc76869138 \h 56  HYPERLINK \l "_Toc76869139" LIM Implementation Instructions  PAGEREF _Toc76869139 \h 57  HYPERLINK \l "_Toc76869140" LIM - Step 1: Review new EPI Descriptions and Input Screens Examples  PAGEREF _Toc76869140 \h 57  HYPERLINK \l "_Toc76869141" LIM - Step 2: Setup new EPI Parameter Descriptions  PAGEREF _Toc76869141 \h 58  HYPERLINK \l "_Toc76869142" LIM - Step 3: Link the Logical Observations, Identifiers, Names, and Codes (LOINC)  PAGEREF _Toc76869142 \h 58  HYPERLINK \l "_Toc76869143" Office of Director (00) Designated Staff Implementation Instructions:  PAGEREF _Toc76869143 \h 59  HYPERLINK \l "_Toc76869144" (00) Designated Staff - Step 1: Review new EPI Descriptions and Input Screens Examples  PAGEREF _Toc76869144 \h 59  HYPERLINK \l "_Toc76869145" (00) Designated Staff - Step 2: Setup new EPI Parameter Descriptions  PAGEREF _Toc76869145 \h 60  HYPERLINK \l "_Toc76869146" Instructions for Seeding EPI Historical Data:  PAGEREF _Toc76869146 \h 61  HYPERLINK \l "_Toc76869147" Austin Automation Center (AAC) Schedule for Transmitting EPI Historical Data:  PAGEREF _Toc76869147 \h 61  HYPERLINK \l "_Toc76869148" Use of the Software  PAGEREF _Toc76869148 \h 65  HYPERLINK \l "_Toc76869149" EPI Review Requirements:  PAGEREF _Toc76869149 \h 65  HYPERLINK \l "_Toc76869150" Six New Emerging Pathogens:  PAGEREF _Toc76869150 \h 66  HYPERLINK \l "_Toc76869151" New Legionella Urinary Antigen Test:  PAGEREF _Toc76869151 \h 66  HYPERLINK \l "_Toc76869152" New Local Pathogen [LREPI LOCAL PATHOGEN MENU] Menu  PAGEREF _Toc76869152 \h 66  HYPERLINK \l "_Toc76869153" Lab EPI Primary (LREPI SEARCH EXTRACT MENU) Menu Diagram  PAGEREF _Toc76869153 \h 67  HYPERLINK \l "_Toc76869154" Lab EPI Primary [LREPI SEARCH EXTRACT MENU] Menu  PAGEREF _Toc76869154 \h 68  HYPERLINK \l "_Toc76869155" Lab EPI Manual Run (Enhanced) [LREPI ENHANCE MANUAL RUN] option:  PAGEREF _Toc76869155 \h 68  HYPERLINK \l "_Toc76869156" Print Detailed Verification Report [LREPI VERIFICATION REPORT] option:  PAGEREF _Toc76869156 \h 70  HYPERLINK \l "_Toc76869157" Local Pathogen [LREPI LOCAL PATHOGEN MENU] Menu:  PAGEREF _Toc76869157 \h 72  HYPERLINK \l "_Toc76869158" Enter/Edit Local Pathogens [LREPI ENTER/EDIT LOCAL PATH] option:  PAGEREF _Toc76869158 \h 72  HYPERLINK \l "_Toc76869159" How to use the Enter/Edit Local Pathogens [LREPI ENTER/EDIT LOCAL PATH] option  PAGEREF _Toc76869159 \h 76  HYPERLINK \l "_Toc76869160" Lab EPI Generate Local Report/Spreadsheet [LREPI GENERATE REPORT/SP] option:  PAGEREF _Toc76869160 \h 80  HYPERLINK \l "_Toc76869161" Lab EPI Print Local Report/Spreadsheet [LREPI PRINT] option:  PAGEREF _Toc76869161 \h 86  HYPERLINK \l "_Toc76869162" How to ENTER local SPREADSHEET captures to a TEXT FILE or EXCEL spreadsheet software:  PAGEREF _Toc76869162 \h 97  HYPERLINK \l "_Toc76869163" Delete Local Pathogen [LREPI DELETE LOCAL PATHOGEN] option  PAGEREF _Toc76869163 \h 107  HYPERLINK \l "_Toc76869164" Delete Local Report or Spreadsheet [LREPI DELETE LOCAL REPORT] option  PAGEREF _Toc76869164 \h 108  HYPERLINK \l "_Toc76869165" Pathogen Inquiry [LREPI PATHOGEN INQUIRY] option:  PAGEREF _Toc76869165 \h 109  HYPERLINK \l "_Toc76869166" Lab EPI Parameter Setup [LREPI (EPI) PARAMETER SETUP] option:  PAGEREF _Toc76869166 \h 110  HYPERLINK \l "_Toc76869167" Lab EPI Protocol Edit [LREPI PROTOCOL EDIT] option  PAGEREF _Toc76869167 \h 111  HYPERLINK \l "_Toc76869168" Antimicrobial Link Update [LREPILK] option:  PAGEREF _Toc76869168 \h 111  HYPERLINK \l "_Toc76869169" Emerging Pathogens Names and Reference Numbers  PAGEREF _Toc76869169 \h 112  HYPERLINK \l "_Toc76869170" Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option Input Screen Definitions  PAGEREF _Toc76869170 \h 113  HYPERLINK \l "_Toc76869171" Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option Input Screen Definitions (continued)  PAGEREF _Toc76869171 \h 114  HYPERLINK \l "_Toc76869172" Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option Input Screen Definitions (continued)  PAGEREF _Toc76869172 \h 115  HYPERLINK \l "_Toc76869173" Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option  PAGEREF _Toc76869173 \h 116  HYPERLINK \l "_Toc76869174" New Legionella Urinary Antigen Test  PAGEREF _Toc76869174 \h 117  HYPERLINK \l "_Toc76869175" LAB SEARCH/EXTRACT file (#69.5) Entries and Parameter Setup Examples  PAGEREF _Toc76869175 \h 118  HYPERLINK \l "_Toc76869176" All Enterococci (Reference #23)  PAGEREF _Toc76869176 \h 119  HYPERLINK \l "_Toc76869177" Example: Lab EPI Parameter Setup for All Enterococci  PAGEREF _Toc76869177 \h 120  HYPERLINK \l "_Toc76869178" All Staphylococcus aureus (Reference #18)  PAGEREF _Toc76869178 \h 124  HYPERLINK \l "_Toc76869179" Lab EPI Parameter setup for All Staphylococcus aureus (Reference #18)  PAGEREF _Toc76869179 \h 125  HYPERLINK \l "_Toc76869180" All Streptococcus pneumoniae (Reference #22)  PAGEREF _Toc76869180 \h 128  HYPERLINK \l "_Toc76869181" Lab EPI Parameter setup for All Streptococcus pneumoniae (Reference #22)  PAGEREF _Toc76869181 \h 129  HYPERLINK \l "_Toc76869182" Candida (Reference #8)  PAGEREF _Toc76869182 \h 132  HYPERLINK \l "_Toc76869183" Lab EPI Parameter Setup for CANDIDA  PAGEREF _Toc76869183 \h 133  HYPERLINK \l "_Toc76869184" Clostridium difficile (Reference #4)  PAGEREF _Toc76869184 \h 136  HYPERLINK \l "_Toc76869185" Lab EPI Parameter Setup for CLOSTRIDIUM DIFFICILE  PAGEREF _Toc76869185 \h 137  HYPERLINK \l "_Toc76869186" Creutzfeldt-Jakob Disease (CJD) (Reference #13  PAGEREF _Toc76869186 \h 140  HYPERLINK \l "_Toc76869187" Example: Lab EPI Parameter Setup for CREUTZFELDT-JAKOB DISEASE  PAGEREF _Toc76869187 \h 140  HYPERLINK \l "_Toc76869188" Cryptosporidium (Reference #9)  PAGEREF _Toc76869188 \h 143  HYPERLINK \l "_Toc76869189" Example: Lab EPI Parameter Setup for CRYPTOSPORIDIUM  PAGEREF _Toc76869189 \h 144  HYPERLINK \l "_Toc76869190" Dengue (Reference #12)  PAGEREF _Toc76869190 \h 147  HYPERLINK \l "_Toc76869191" Example: Lab EPI Parameter Setup for DENGUE  PAGEREF _Toc76869191 \h 147  HYPERLINK \l "_Toc76869192" E. coli O157:H7 (Reference #10)  PAGEREF _Toc76869192 \h 150  HYPERLINK \l "_Toc76869193" Example: Lab EPI Parameter Setup for E. COLI 0157:H7  PAGEREF _Toc76869193 \h 151  HYPERLINK \l "_Toc76869194" Hepatitis A Antibody Positive (Reference #16)  PAGEREF _Toc76869194 \h 154  HYPERLINK \l "_Toc76869195" Example: Lab EPI Parameter Setup for HEPATITIS A ANTIBODY POS  PAGEREF _Toc76869195 \h 155  HYPERLINK \l "_Toc76869196" Hepatitis B Positive (Reference #17)  PAGEREF _Toc76869196 \h 158  HYPERLINK \l "_Toc76869197" Example: Lab EPI Parameter Setup for HEPATITIS B POS  PAGEREF _Toc76869197 \h 159  HYPERLINK \l "_Toc76869198" Not Positive for Hepatitis C Antibody OR Hepatitis C Antibody Neg (Reference #15)  PAGEREF _Toc76869198 \h 163  HYPERLINK \l "_Toc76869199" Example: Lab EPI Parameter Setup for HEPATITIS C ANTIBODY NEG  PAGEREF _Toc76869199 \h 164  HYPERLINK \l "_Toc76869200" Hepatitis C Antibody Positive (Reference #2)  PAGEREF _Toc76869200 \h 167  HYPERLINK \l "_Toc76869201" Example: Lab EPI Parameter Setup for Hepatitis C Antibody POS  PAGEREF _Toc76869201 \h 168  HYPERLINK \l "_Toc76869202" Legionella (Reference #7)  PAGEREF _Toc76869202 \h 171  HYPERLINK \l "_Toc76869203" Example: Lab EPI Parameter Setup for LEGIONELLA  PAGEREF _Toc76869203 \h 172  HYPERLINK \l "_Toc76869204" Leishmaniasis (Reference #14)  PAGEREF _Toc76869204 \h 175  HYPERLINK \l "_Toc76869205" Example: Lab EPI Parameter Setup for Leishmaniasis  PAGEREF _Toc76869205 \h 175  HYPERLINK \l "_Toc76869206" Malaria (Reference #11)  PAGEREF _Toc76869206 \h 178  HYPERLINK \l "_Toc76869207" Example: Lab EPI Parameter Setup for Malaria  PAGEREF _Toc76869207 \h 178  HYPERLINK \l "_Toc76869208" Methicillin-Resistant Staphylococcus aureus (MRSA) (Reference #19)  PAGEREF _Toc76869208 \h 181  HYPERLINK \l "_Toc76869209" Example: Lab EPI Parameter Setup for METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA)  PAGEREF _Toc76869209 \h 182  HYPERLINK \l "_Toc76869210" Penicillin - Resistant Pneumococcus (Reference #3)  PAGEREF _Toc76869210 \h 185  HYPERLINK \l "_Toc76869211" Example: Lab EPI Parameter Setup for Penicillin - Resistant Pneumococcus  PAGEREF _Toc76869211 \h 185  HYPERLINK \l "_Toc76869212" Streptococcus-Group A (Reference #6)  PAGEREF _Toc76869212 \h 188  HYPERLINK \l "_Toc76869213" Example: Lab EPI Parameter Setup for Streptococcus-Group A  PAGEREF _Toc76869213 \h 188  HYPERLINK \l "_Toc76869214" Tuberculosis (TB) (Reference #5)  PAGEREF _Toc76869214 \h 191  HYPERLINK \l "_Toc76869215" Example: Lab EPI Parameter Setup for Tuberculosis (TB)  PAGEREF _Toc76869215 \h 192  HYPERLINK \l "_Toc76869216" Vancomycin-Resistant Coagulase Negative Staphylcocci/Staph epi (VRSE) (Reference #21)  PAGEREF _Toc76869216 \h 195  HYPERLINK \l "_Toc76869217" Example: Lab EPI Parameter Setup for Vancomycin-Resistant Coagulase Negative Staphylococci/Staph epi (VRSE) (Reference #21)  PAGEREF _Toc76869217 \h 196  HYPERLINK \l "_Toc76869218" Vancomycin-Resistant Enterococcus (VRE) (Reference #1)  PAGEREF _Toc76869218 \h 199  HYPERLINK \l "_Toc76869219" Example: Lab EPI Parameter Setup for Vancomycin-Resistant Enterococcus (VRE) (Reference #1)  PAGEREF _Toc76869219 \h 200  HYPERLINK \l "_Toc76869220" Vancomycin-Resistant Staphylococcus Aureus (VRSA) (Reference #20)  PAGEREF _Toc76869220 \h 203  HYPERLINK \l "_Toc76869221" Example: Lab EPI Parameter Setup for Vancomycin-Resistant Staphylococcus aureus (VRSA) (Reference #20)  PAGEREF _Toc76869221 \h 204  HYPERLINK \l "_Toc76869222" Conclusion  PAGEREF _Toc76869222 \h 207  HYPERLINK \l "_Toc76869223" Appendix A  PAGEREF _Toc76869223 \h 210  HYPERLINK \l "_Toc76869224" Editing/Printing Files, Linking Data, and Editing Input Screens  PAGEREF _Toc76869224 \h 210  HYPERLINK \l "_Toc76869225" Editing/Printing Files, Screens, Linking Data, Request Form  PAGEREF _Toc76869225 \h 211  HYPERLINK \l "_Toc76869226" Editing TOPOGRAPHY file (#61):  PAGEREF _Toc76869226 \h 211  HYPERLINK \l "_Toc76869227" Printing LAB SEARCH/EXTRACT file (#69.5) Definitions:  PAGEREF _Toc76869227 \h 212  HYPERLINK \l "_Toc76869228" How to Link Antimicrobial Entries to Workload Codes Entries:  PAGEREF _Toc76869228 \h 214  HYPERLINK \l "_Toc76869229" AUTO function  PAGEREF _Toc76869229 \h 214  HYPERLINK \l "_Toc76869230" MANUAL function  PAGEREF _Toc76869230 \h 215  HYPERLINK \l "_Toc76869231" SEMI-AUTO function  PAGEREF _Toc76869231 \h 215  HYPERLINK \l "_Toc76869232" Delete Entry from Laboratory EPI Parameters Input Screen  PAGEREF _Toc76869232 \h 216  HYPERLINK \l "_Toc76869233" How to add an entry to the Laboratory EPI Parameters Input Screen  PAGEREF _Toc76869233 \h 217  HYPERLINK \l "_Toc76869234" Lab EPI Generate Local Report/Spreadsheet [LREPI GENERATE REPORT/SP] option Field Definitions:  PAGEREF _Toc76869234 \h 218  HYPERLINK \l "_Toc76869235" Appendix B Helpful Hints  PAGEREF _Toc76869235 \h 224  HYPERLINK \l "_Toc76869236" Preferred Methods for Clostridium difficile Data Capture  PAGEREF _Toc76869236 \h 224  HYPERLINK \l "_Toc76869237" Preferred Method #1:  PAGEREF _Toc76869237 \h 224  HYPERLINK \l "_Toc76869238" Preferred Method #2:  PAGEREF _Toc76869238 \h 225  HYPERLINK \l "_Toc76869239" Validating EPI Data Captures  PAGEREF _Toc76869239 \h 225  HYPERLINK \l "_Toc76869240" Required EPI Mail Groups and Descriptions  PAGEREF _Toc76869240 \h 227  HYPERLINK \l "_Toc76869241" EPI Mail Group Description  PAGEREF _Toc76869241 \h 227  HYPERLINK \l "_Toc76869242" EPI-REPORT Mail Group Description  PAGEREF _Toc76869242 \h 227  HYPERLINK \l "_Toc76869243" EPI Data Processing Cycles  PAGEREF _Toc76869243 \h 228  HYPERLINK \l "_Toc76869244" EPI HL7 Format Mailman Message  PAGEREF _Toc76869244 \h 229  HYPERLINK \l "_Toc76869245" EPI Confirmation Mailman Message  PAGEREF _Toc76869245 \h 231  HYPERLINK \l "_Toc76869246" New EPI Summary Verification Report of EPI Extracted Data from Site HL7 Mailman Message  PAGEREF _Toc76869246 \h 232  HYPERLINK \l "_Toc76869247" New EPI Summary Verification Report for prior month - TB only  PAGEREF _Toc76869247 \h 237  HYPERLINK \l "_Toc76869248" New Detailed Verification Report of EPI Extracted Data from Site Mailman Message  PAGEREF _Toc76869248 \h 240  HYPERLINK \l "_Toc76869249" New EPI Processing Error Report Mailman Message sent from Austin  PAGEREF _Toc76869249 \h 267  HYPERLINK \l "_Toc76869250" Table of Reject and Errors and/or Warning Codes  PAGEREF _Toc76869250 \h 269  HYPERLINK \l "_Toc76869251" National Laboratory Test (NLT) List  PAGEREF _Toc76869251 \h 275  HYPERLINK \l "_Toc76869252" Health Level Seven (HL7) Protocol  PAGEREF _Toc76869252 \h 361  HYPERLINK \l "_Toc76869253" 3. General Specifications  PAGEREF _Toc76869253 \h 361  HYPERLINK \l "_Toc76869254" Definitions from Austin  PAGEREF _Toc76869254 \h 366  HYPERLINK \l "_Toc76869255" 4.0 Transaction Specifications  PAGEREF _Toc76869255 \h 370  HYPERLINK \l "_Toc76869256" Table VA011 - Period of Service  PAGEREF _Toc76869256 \h 371  HYPERLINK \l "_Toc76869257" Table 0070 - Specimen Source Codes (continued)  PAGEREF _Toc76869257 \h 372  HYPERLINK \l "_Toc76869258" Table 0070 - Specimen Source Codes (continued)  PAGEREF _Toc76869258 \h 373  HYPERLINK \l "_Toc76869259" Table 0005 Race:  PAGEREF _Toc76869259 \h 374  HYPERLINK \l "_Toc76869260" Table CDC Race:  PAGEREF _Toc76869260 \h 374  HYPERLINK \l "_Toc76869261" Table 0189 - Ethnic Group  PAGEREF _Toc76869261 \h 375  HYPERLINK \l "_Toc76869262" Table CDC - Ethnic Group  PAGEREF _Toc76869262 \h 375  HYPERLINK \l "_Toc76869263" Table 0001 - Sex  PAGEREF _Toc76869263 \h 375  HYPERLINK \l "_Toc76869264" Table 0078 - Abnormal flags  PAGEREF _Toc76869264 \h 376  HYPERLINK \l "_Toc76869265" Table Specimen Source ID Code  PAGEREF _Toc76869265 \h 376  HYPERLINK \l "_Toc76869266" Table Hepatitis Risk Assessment Resolutions  PAGEREF _Toc76869266 \h 376  HYPERLINK \l "_Toc76869267" APPENDIX D  PAGEREF _Toc76869267 \h 379  HYPERLINK \l "_Toc76869268" IMPLEMENTATION OF LOGICAL OBSERVATION IDENTIFIERS NAMES AND CODES (LOINC) FOR LABORATORY DATA  PAGEREF _Toc76869268 \h 379  Introduction Overview The Infectious Diseases Program Office was tasked by the Under Secretary for Health to retrieve tracking and trending information about emerging and re-emerging infectious diseases (including antibiotic resistance) that are important to VHA. Data would be used for tracking and trending of specified infectious diseases entities, policy decision-making, and resource allocation at the national level. To accomplish this, the VistA Laboratory Emerging Pathogens Initiatives (EPI) software was initially installed at all VAMC facilities in February 1997 via VistA EPI Patch LR*5.2*132, with modifications occurring by means of the VistA Laboratory Search/Extract Patch LR*5.2*175 in March 1998. This software was originally developed by the CIOFO-Dallas in conjunction with the Infectious Diseases Program Office. As this proved to be a successful and beneficial endeavor, the Under Secretary for Health further tasked the Infectious Diseases program Office to retrieve Hepatitis C antibody testing data for a one-day survey nationwide, Hepatitis C Surveillance Day (March 17, 1999). The EPI software application was selected to accomplish this task because data were already stored in the standard VistA data set and linked to patient identifiers. Information retrieved from both the routine running of the EPI, as well as Hepatitis C Surveillance Day was an extremely important component that resulted in the VHA obtaining additional Congressional funding for hepatitis C disease care. Information obtained from the EPI assisted in determining the importance of the emerging pathogen, hepatitis C, as a significant issue for VHA. Data from EPI have been used by the Allocation Resource Center (ARC) in determinations for Veterans Equitable Resource Allocation (VERA) hepatitis C resource allocation to local facilities; EPI data are still provided to ARC for this purpose. For Hepatitis C Surveillance Day, temporary modifications were necessary to achieve prompt data acquisition. More lasting modifications/enhancements were to occur with the release of the combined process from VistA Laboratory EPI Hepatitis Extract Patch LR*5.2*260, Patch PXRM*1.5*1, PSJ*5*48, and Patch PSO*7*45 in August 2000. However, due to significant pressures and time constraints applied to this project to produce the National Hepatitis C Risk Assessment portion of the requests, the Infectious Diseases Program Office agreed to delay the below-listed components of that approved request until this time; one of the key functionalities that was delayed was the ability of local facilities to use the software to extract locally-relevant data. The following delayed enhancement components were requested and have been addressed with the release of VistA Laboratory Emerging Pathogens Rollup Modifications Patch LR*5.2*281 (note that due to systems constraints and set-ups, not all requested components are deliverable with this patch): New EPI Summary Verification Report of EPI-extracted data from site in plain text (human-readable) format for nationally rolled-up pathogen information New EPI Detailed Verification Report of EPI-extracted data from site in plain text (human-readable) format for nationally rolled-up pathogen information New EPI Processing Report (error report) concerning data processed at the central data repository for the EPI delivered to site in plain text (human-readable) format containing only patients with error/warning codes or indicating that the data were processed into the central data repository without any errors New Local Pathogen Menu [LREPI LOCAL PATHOGEN MENU] New EPI option to add locally-relevant pathogens using the EPI search/extract backbone, without altering nationally rolled-up pathogen information Improvement of the extraction tool to capture and report tuberculosis (due to constraints of long incubation periods in the results reporting, embedded within an accessioning acquisition framework of the EPI extracts) Ability to capture and report International Classification of Diseases, ICD-9-CM, codes in association with outpatients who have a reported EPI pathogen (system constraints will not allow this requested component to be completed for this release) Ability to capture and report Logical Observations, Identifiers, Names and Codes (LOINC) information along with laboratory-based testing information acquired by EPI (system constraints will not allow this requested component to be fully realized for this release; partial realization will occur for CH-subscripted laboratory tests) Ability to capture and report Master Patient Index codes for patients identified as meeting an EPI pathogen parameter Ability to capture and report antibiotic susceptibility MIC values Ability to use antibiotic susceptibility MIC values as an identification parameter for either national or locally-relevant pathogens (system constraints will not allow this requested component to be completed for this release) Ability to capture and report actual site/location (institution and division designations) in which the patient actually received care associated with the EPI pathogen trigger for data acquisition (not just the reporting site) in order to accurately assess where the pathogens are occurring (system constraints will not allow this requested component to be completed for this release) Ability to capture and report county and state information from patients identified by the EPI process Ability to capture and report the newly implemented race and ethnicity coding, along with the prior race/ethnicity coding Ability to capture and report the actual station location (unit) of care for a patient at the time of EPI pathogen data acquisition (this currently only applies to inpatient information and only for information that is CH-subscripted) Six new national EPI Emerging Pathogens to be added for national roll-up New documentation of the prior Legionella pathogen to provided guidance for use of recently FDA-approved Legionella Urinary Antigen test that can be used for diagnosis  EMBED Visio.Drawing.11   SHAPE \* MERGEFORMAT  VistA Blood Bank Software Version 5.2 EFFECT ON BLOOD BANK FUNCTIONAL REQUIREMENTS: Patch LR*5.2*281 does not contain any changes to the VISTA BLOOD BANK Software as defined by VHA DIRECTIVE 99-053 titled VISTA BLOOD BANK SOFTWARE VERSION 5.2. EFFECT ON BLOOD BANK FUNCTIONAL REQUIREMENTS: Patch LR*5.2*281 does not alter or modify any software design safeguards or safety critical elements functions. RISK ANALYSIS: Changes made by patch LR*5.2*281 have no effect on Blood Bank software functionality, therefore RISK is none. VALIDATION REQUIREMENTS BY OPTION: Because of the nature of the changes made, no specific validation requirements exist as a result of installation of this patch. NOTE: As with previous Lab EPI patches, it is highly recommended that the Office of the Director (00) at each facility designate a person or persons to be responsible for the routine implementation of this patch (both at the time of this installation and afterwards) and to take the lead in trouble-shooting issues that arise with the routine functioning of the process Enhancements and Modifications VistA Laboratory EPI Rollup Modification patch LR*5.2*281 contain the following software enhancements and modifications: Enhancements: Renamed EPI Menu/Options Lab Search Extract Primary [LREPI SEARCH EXTRACT MENU] menu RENAMED to Lab EPI Primary [LREPI SEARCH EXTRACT MENU] menu: For consistency of this software release, the Lab Search Extract Primary [LREPI SEARCH EXTRACT MENU] menu is RENAMED Lab EPI Primary [LREPI SEARCH EXTRACT MENU] menu. This is the main EPI menu containing four existing options, two new options, and one new submenu containing 4 new options. This new submenu may be assigned to users without the Lab EPI Primary [LREPI SEARCH EXTRACT MENU] menu. Lab Search/Extract Manual Run (Enhanced) [LREPI SEARCH/EXTRACT ENHANCED MANUAL RUN] option RENAMED Lab EPI Manual Run (Enhanced) [LREPI ENHANCE MANUAL RUN] option: For consistency of this software release, the Lab Search/Extract Manual Run (Enhanced) [LREPI SEARCH/EXTRACT ENHANCED MANUAL RUN] is RENAMED Lab EPI Manual Run (Enhanced) [LREPI ENHANCE MANUAL RUN] option. This option is used ONLY to manually extract National EPI data, transmit the manually extracted data to the Austin Automation Center (AAC), and to generate the new EPI Summary Verification Report. This new EPI Summary Verification Report is automatically sent to the EPI-Report mail group after being generated. This option has been enhanced to generate the new Detailed Verification Report which can be printed using the new Print Detailed Verification Report [LREPI VERIFICATION REPORT] option. NOTE: ONLY national emerging pathogens extract data are transmitted to the AAC, local emerging pathogens extract data will NOT be transmitted. Modified Lab EPI Primary [LREPI SEARCH EXTRACT MENU] menu options: Lab EPI Parameter Setup [LREPI (EPI) PARAMETER SETUP] option: The Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option is used to define the search criteria associated with the National Emerging Pathogen Initiative extract data. This option only allows editing of the EPI Parameter Setup input screens. Local pathogens CANNOT be added using this option. This option has been enhanced by adding the new PREVIOUS CYCLE field which is automatically defined as 1 for TB ONLY and CANNOT be edit. For all other emerging pathogens the new PREVIOUS CYCLE field is blank and CANNOT be EDITED. The existing PROTOCOL field can no longer be EDITED. The ACTIVE: YES has been changed to display INACTIVE: NO, and Lag Days for the six new EPIs have been defined as 15 with the release of the new EPI enhancement software. New Lab EPI Primary [LREPI SEARCH EXTRACT MENU] menu options Print Detailed Verification Report [LREPI VERIFICATION REPORT] option: This new option is use to print the new Detailed Verification Report mailman message. Pathogen Inquiry [LREPI PATHOGEN INQUIRY] option: This new option is used to inquire into the LAB SEARCH/EXTRACT file (#69.5) parameter description fields (i.e., INACTIVE: NO, LAG DAYS: 15, RUN DATE: OCT 07, 2003, CYCLE: MONTHLY, PROTOCOL: LREPI, FOLLOW PTF: YES, REFERENCE NUMBER: 23, and ETIOLOGIES) for defined emerging pathogen. New Local Pathogen Submenu and Options: Local Pathogen [LREPI LOCAL PATHOGEN MENU] Submenu: This new submenu contains four new options use to enter/edit local pathogens, generate and print local EPI reports and spreadsheets, and delete local pathogens. Example: New Local Pathogen [LREPI LOCAL PATHOGEN MENU] Menu Local Pathogen Menu ENT Enter/Edit Local Pathogens GEN Lab EPI Generate Local Report/Spreadsheet PRT Lab EPI Print Local Report/Spreadsheet DEL Delete Local Pathogen DRS Delete Local Report or Spreadsheet Enter/Edit Local Pathogens [LREPI ENTER/EDIT LOCAL PATH] option: This new option is use to enter or edit local pathogens into LAB SEARCH/EXTRACT file (#69.5). Lab EPI Generate Report/Spreadsheet [LREPI GENERATE REPORT/SP] option: This new option is used to generate Lab EPI reports or spreadsheets for national and local emerging pathogens extract data. After selecting national or local emerging pathogens, time period, segments and fields, report or spreadsheet, the job is automatically tasked. The tasked job will take approximately 2-3 hours to generate. An alert is automatically sent to the requester/user after the tasked job has finished generating. The Lab EPI report or spreadsheet can then be viewed on the screen or printed using the new Lab EPI Print Local Report/Spreadsheet [LREPI PRINT] option. NOTE: NO data will be transmitted to AAC when using this option. Lab EPI Print Local Report/Spreadsheet [LREPI PRINT REPORT/SPSHT] option: This new option is used to print a report or spreadsheet that was generated with the Lab EPI Generate Local Report/Spreadsheet [LREPI GENERATE REPORT/SP] option. Delete Local Pathogen [LREPI DELETE LOCAL PATHOGEN] option This new option is use to delete local pathogens entries ONLY. NOTE: National emerging pathogens entries CANNOT be deleted. Delete Local Report or Spreadsheet [LREPI DELETE LOCAL REPORT] option This new option is use to delete local reports or local spreadsheets. New EPI Reports New EPI Summary Verification Report of EPI Extracted Data from Site for Nationally Rolled-Up Emerging Pathogens: The new Summary Verification Report of EPI Extracted Data from Site contains the following new functionality: Automatically sent to EPI-REPORT mail group after EPI extract data transmissions to AAC on the 15th each month Displays in a human readable format used for quick reviewing Displays reporting site name and station number Displays emerging pathogens total number of occurrences during the monthly processing cycle Displays emerging pathogens total number of persons with occurrences during the monthly processing cycle Displays number of persons with the nationally rolled-up resolutions for the National Hepatitis C Risk Assessment Clinical Reminder that occurred during the monthly processing cycle Displays report in several pages ENHANCE MANUAL RUN] option (Note that each manual run generates HL7 message transmission to the central data repository [AAC]) Automatically sent to EPI-REPORT mail group after manual generation New Detailed Verification Report of EPI Extracted Data from Site for Nationally Rolled-Up Emerging Pathogens: The new Detailed Verification Report of EPI Extracted Data from Site contains the following new functionality: Displays reporting site station number with Notes and Comment Segments (NTE) findings in a human readable format Displays the site reporting NTE findings of 1, 2, 323, starting with a new page for each NTE findings. Displays listing by emerging pathogens Recreation of the report on demand using the Lab EPI Manual Run (Enhanced) [LREPI ENHANCE MANUAL RUN] option Recreation of the manually generated EPI extract data is automatically sent to Austin Automation Center. Displays Clinical Reminder data transmitted to EPI data stream regarding nationally rolled-up data about Hepatitis C Risk Assessment and associated hepatitis laboratory data. New EPI Processing/Error Report Mailman Message sent from Austin The new EPI Processing (Error) Report mailman message itemizes all transmissions received by AAC and document the records status as either being accepted or rejected (with the reason and reject code identified). This report will be sent to EPI mail group. (Examples of the new EPI Processing/Error Report mailman message and Tables of Rejects and Errors and/or Warning Codes are located in the Appendix - B section of this manual). New EPI Data Extracted: Logical Observation, Identifiers, Name, and Codes (LOINC) EPI Roll up Modifications software provides the ability to automatically extract LOINC data, transmit the data to the AAC, and display the data on the new Verification Detailed Report of EPI Extracted Data from Site. Master Patient Index (MPI) EPI Roll Up Modifications software provides the ability to automatically extract MPI values and transmit the data to AAC. Susceptibility Results MIC Values EPI Roll Up Modifications software provides the ability to automatically extract Susceptibility Results MIC values from the ANTIMICROBIAL SUSCEPTIBILITY file (#62.06), Susceptibility Result field (#.01), Susceptibility Result subfile (#2), and transmit the data to AAC. These MIC values can be displayed via the new Verification Detailed Report of EPI Extracted Data from Site. Site Institution/Division Number EPI Rollup Modifications software release provides the ability to automatically capture the patients site division number during an encounter. Patient Demographics EPI Roll Up Modifications software release provides the ability to extract patients demographics county and state data, transmit data to the AAC, and display the demographic data on the new Verification Detailed Report of EPI Extracted Data From Site. Race and Ethnicity EPI Roll Up modifications software release provide the ability to capture patients race and ethnicity data using the new race/ethnicity protocols, transmit data to AAC, and display the data on the new Verification Detailed Report of EPI Extracted Data from Site. Six New Emerging Pathogens EPI Roll-Up Modifications software provides the ability to automatically extract data for the following six new emerging pathogens without the necessity of any manual data entry once the parameter descriptions are set up using the Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option: All Staphylococcus aureus (Reference #18) Methicillin-Resistant Staphylococcus aureus (MRSA) (Reference #19) Vancomycin-Resistant Staphylococcus aureus (VRSA) (Reference #20) Vancomycin-Resistant Coagulase Negative Staphylococci/Staph epi (VRSE) (Reference #21) All Streptococcus pneumoniae (Reference #22) All Enterococci (Reference #23) New Legionella Urinary Antigen Test The Legionella Urinary Antigen test is FDA-approved and available clinical use. Suggestions will be provided for updating parameter setups to capture the results of this testing in the already existent Legionella (Reference #7) EPI national pathogen and allow for national roll-up. This newer test must be added for LEGIONELLA using the Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option. The preferred Lab EPI parameter setup for etiology for the newer Legionella Urinary Antigen test is POSITIVE FOR LEGIONELLA PNEUMOPHILA. New EPI Informational Alert This alert is created when the new Lab EPI Generate Local Report/Spreadsheet [LREPI GENERATE REPORT/SP] option is accessed. This alert is sent to the user who generated the report or spreadsheet when the report or spreadsheet is finished generating. Modifications VistA Laboratory EPI Roll-Up Modification Patch LR*5.2*281 software contains the following modifications: EPI Single Day Transmissions: Date handling for start and stop date was modified because it created a problem with EPI single day transmissions. It showed the beginning date and time to be 10:00 a.m. yesterday. The end time is (in effect) midnight tonight. This was corrected by creating a beginning time of one tenth of a second after midnight and the end time is the following midnight. LAB EPI Search Criteria Currently, some TB cultures are not being captured because it can require up to six weeks for TB cultures to grow and obtain the results. This delay causes the result to be overlooked in the subsequent EPI reporting. A new search criterion has been added to the Lab EPI engine. The LAB SEARCH/EXTRACT file (#69.5), contains the new PREVIOUS CYCLE field (# 19), which is a numeric value of 1, automatically set by the EPI software. This new field instructs the LAB SEARCH EXTRACT engine to also look for TB pathogen(s) in previous cycles. Note: The new PREVIOUS CYCLE field (# 19), is used for the automated run (i.e., 15th day of the month) ONLY. This field CANNOT be EDITED. National Center for Health (NCH) Data Screening No Longer Required: NCH data screening is no longer required and NCH transmissions to AAC have been terminated. NCH Cholesterol and NCH Pap smear entries has been removed from the Lab EPI Parameter Setup entries. Deletion of National Center for Health (NCH) Protocol The LRNCH AAC and LRNCH SEND CLIENT protocols have been deleted since the NCH data screening is no longer required. Lab EPI Nightly Task [LREPI NIGHTLY TASK] option The Lab Search/Extract Nightly Task [LREPI SEARCH/EXTRACT NIGHTLY TASK] option is renamed to Lab EPI Nightly Task [LREPI NIGHTLY TASK]. This option builds a HL7 message and sends it to the defined location specified in the EPI Protocols. The EPI Nightly Task [LREPI NIGHTLY TASK] option must be scheduled to run each night by TaskMan. Austin Automation Center Database Processing The Austin Automation Center (AAC) serves as the central data repository for the national EPI pathogen data that is rolled-up from sites. AAC creates two file structures, both in Statistical Analysis System (SAS) file format. These two file structures are used as a source of data for the VHA Headquarters Infectious Disease Program Office. The data are available to the VA Central Office Infectious Diseases Program Office to be used for analysis and reporting. The two file structures are referred to as the Numerator Files and Denominator File because of their planned utilization. Numerator Files: The Numerator files contain accumulated data sent by all VHA facilities. The Numerator file information is specific to unique patients with a VA Central Office Infectious Diseases Program Office designated national emerging pathogen. Emerging pathogen data entries are flagged through the VistA Laboratory EPI software process. Numerator files data are collected and transmitted to AAC monthly by VHA facilities. Denominator File: The Denominator file provides the VHA Headquarters Infectious Diseases Program Office total and unique counts of patients each VHA facility. The individual files that these data elements are extracted from are the National Patient Care (NPC), Inpatient Treatment File (PTF), VHA Work Measurement (VWM), and Cost Distribution Report (CDR) systems. The data elements are: * Unique SSN served (inpatient and outpatient together) * Total # of discharges * Total unique SSN discharges * Inpatient hospital days * Inpatient ICU days * Unique SSN encounters for both inpatient and outpatient Unique and total counts are available for the individual months, current month, and previous eleven months for a year's set of totals, current month, and previous three month periods for a quarter's set of totals. AAC EPI Data Transmission National emerging Pathogens, as defined by VA Central Office, act as triggers for data acquisition for Patch LR*5.2*281. The software then retrieves relevant, predetermined, and patient-specific data for transmission to the EPI central data repository at the AAC. Once at that location, the data are uploaded into Statistical Analysis System (SAS)-based statistical software accessible files. VA Central Office reports may then be generated for appropriate use and distribution at the national level. With the installation of patch LR*5.2*281, automated data transmissions will occur. Receipt of this transmission at the AAC queue will trigger a confirmation message back to the originating site to confirm that data has been sent. Then at the next processing cycle (~25th of the month), a processing/error report will also be generated and sent back to the originating site. This processing/error report will serve as the definitive confirmation that data has been accepted. If there is a fatal error in any segment of the message, the entire message will be rejected and must be resent manually. Warning codes/errors are accepted into the data set, but serve to remind the originating site that a correction of the process generating the error may be needed. AAC Transmission Reports EPI Confirmation Mailman Message sent from AAC An EPI Confirmation mailman message is sent from the AAC upon receipt of the VHA facilities EPI monthly transmission via the EPI mail group. The EPI mail group members are notified that the original EPI HL7 format mailman message data transmission has been received by AAC for processing. NOTE: This EPI Confirmation mailman message ONLY means that the sending VHA facility data transmission has been received by the AAC for processing. New EPI Processing (Error) Report Mailman Message from Austin The new EPI Processing Error Report mailman message itemizes all transmissions received by AAC and document the records status as either being accepted or rejected (with the reason and reject code identified). This report will be sent to the EPI mail group. (Examples of the Table of Rejects and Errors and/or Warning Codes are located in the Appendix - B section of this manual). Security Information This section addresses any legal requirements pertaining to the EPI Patch LR*5.2*281, software product and identifies any security measures necessary to protect the integrity of the product and database. Security Management: According to VA Directive 6214, the existing Laboratory EPI software meets the requirements for VA IT Security Certification and Accreditation Program. The Lab EPI Enhancement software (LR*5.2*281) does not constitute a major change that requires new risk assessment and re-accreditation of the Laboratory system. Lab EPI security is maintained through menu assignment and VA FileMan protection. Security Features: EPI Mail Groups EPI mail group: This mail group is used by the VHA facilities to transmit EPI HL7 format mailman messages to AAC and for AAC to transmit EPI Confirmation mailman messages back to the sending VHA facilities once the EPI HL7 format mailman messages data transmission has been received by AAC. EPI-Report mail group: This mail group is used to receive the Emerging Pathogens Verification Report and the EPI Processing Report mailman messages sent from AAC. The members of this mail group will assist in the EPI data validation and corrections process. New EPI Informational Alert An alert is created by the Lab EPI Generate Local Report/Spreadsheet [LREPI GENERATE REPORT/SP] option. This alert is sent to the user who generated the report or spreadsheet when the report or spreadsheet is finished generating. Example: Alert Display The local report/spreadsheet finished generating at JAN 23, 2004@18:45:00 Enter "VA to jump to VIEW ALERTS option Remote Systems The EPI software retrieves relevant, predetermined patient-specific data for transmission to the Austin Automation Center database repository. Archiving/Purging Archiving and Purging utilities are not provided with this software release. Contingency Planning Each facility using the VISTA Laboratory EPI software application must develop a local contingency plan to be used in the event of application problems in a live environment. The facility contingency plan must identify procedures used for maintaining the functionality provided by the software in the event of a system outage. Interfacing No specialized (not VA-produced) products (hardware and/or software) are embedded within or required by the EPI software product. Electronic Signatures There is no electronic signature utilized in the VistA EPI software application. Menus The Lab EPI Primary [LREPI SEARCH EXTRACT MENU] menu contains six options. IRM staff assigns the menu to have access to all options and the new submenu [Local Pathogen Menu] that has 4 options. The new [Local Pathogen Menu] submenu may be assigned independent from the Lab EPI Primary [LREPI SEARCH EXTRACT MENU] menu; this will allow only access to the submenu options. Security Keys There are no locks or security keys associated with the EPI Lab EPI Primary [LREPI SEARCH EXTRACT MENU] menu or options. File Security EPI changes and enhancements do not modify any existing file security schemes. New files exported by the patch installation have no file security applied. However, VA FileMan security access Ll code is recommended if file security is deemed necessary by the facilities. References Please review the following guide and manual prior to installing and implementing the Laboratory EPI Rollup Modifications Patch LR*5.2*281: Kernel Systems Manual V. 8.0 VA FileMan V. 21.0 VA Mailman V. 7.1 Official Policies EPI software release reference no official policy unique to the product regarding the modification of software and distribution of the product. Pre-Installation Information The following information contain recommendations and requirements that should be acknowledged prior to installing the VistA Laboratory EPI Rollup Modifications patch LR*5.2*281. EPI Phased Installation and Implementation NOTE: Due to extensive historical data transmission requirements and mandated setups required for such, a phased installation and implementation of this patch will be utilized for release of this patch. The software download information will be made available to sites attending one of the following national audio conference training calls: Tuesday, June 8 at 1:00 - 3:00 PM EST for VISNs 1-2-3-4-5-6 Thursday, June 10 at 3:00 - 5:00 PM EST for VISNs 7-8-9-10-11 Tuesday, June 15 at 4:00 - 6:00 PM EST for VISNs 12-15-16-16-23 Wednesday, June 16 at 2:00 - 4:00 PM EST for VISNs 18-19-20-21-22 Thursday, June 17 at 2:00 - 4:00 PM EST for those unable to attend the other calls. The VANTS telephone number is 1 800 767-1750 and the access code for all calls is 13143. This patch will involve reseeding of the EPI databases for each site to allow the new data created by this patch to be captured. It is imperative each site attend an audio conference prior to installation and implementation of LR*5.2*281. Intended Audience IRM Staff: IRM staff is required for the installation, post installation, assignment of mail groups, and menu options for the EPI Rollup Modifications patch LR*5.2*281. Laboratory Staff: It is highly recommended that the following person(s) jointly participate in reviewing the national EPI pathogen parameter descriptions and set-ups: Laboratory Information Manager (LIM) Representative from the Microbiology section for the Emerging Pathogens Initiative (i.e., director, supervisor, or technologist) Quality Management Staff: It is highly recommended that the following person(s) jointly participate in reviewing the national EPI pathogen parameter descriptions and set-ups: Total Quality Improvement/Quality Improvement/Quality Assurance (TQI/QI/QA) staff (or person at the facility with similar function) Other Staff: It may also be beneficial to have Infection Control Personnel involved in national EPI pathogen parameter set-ups. Test Sites: The VistA Laboratory EPI Rollup Modifications patch LR*5.2*281, has been tested at the following VAMCs: EPI Test SitesOperating SystemBoston, MA HCS (Beta Test)ALPHA/Digital Standard Mumps (DSM) Oct 2003 DSM VMS - May 15, 2004Cincinnati, OH VAMC (Alpha/Beta Test)OS V7.2-1 DSM V7.2.1, June 2003Detroit, MI VAMC (Beta Test)OS V7.3 DSM V7.2.1, June 2003Durham, NC VAMC (Beta Test)OS V7.2-1 DSM V7.2.1, March 2003:Manchester, NH VAMC (Beta Test)Windows NT 3.2, June 2003Togus, ME VAMC (Beta Test)CACHE V7.3 - DSM V7.2.1, October 2003 Hardware and Operating System Requirements: VistA software operates on two hardware platforms. The hardware platforms are listed in the mini-computer category, which provides multi-tasking and multi-user capabilities. The hardware platforms systems used are: Digital Equipment Corporation (DEC) Alpha Series: Digital Equipment Corporation (DEC) Alpha series is using the DEC Open Virtual Memory System (VMS), Version 6.1 or greater, operating system. This platform uses the DEC System Mumps (DSM), Version 6.3 or greater, of American National Standards Institutes (ANSI) of Massachusetts General Hospital Utility Multi-Programming System (MUMPS) also known as M language. MUMPS is a Federal Information Processing Standard (FIPS) language. System Performance Capacity: There are no significant changes in the performance capacity of the VistA operating system once the Lab EPI Roll Up Modification Enhancement patch LR*5.2*281 is installed. The software application should not create any appreciable global growth or network transmission problems. There are no memory constraints. Memory Constraints: Sufficient memory is required by sites to maintain the growth of the EPI globals. Installation Time: Installation time for the VistA Laboratory EPI Rollup Modifications patch LR*5.2*281 is less than 2 minutes during off peak hours and less than 5 minutes during peak hours. Disabling EPI Menus Not Required: The Lab EPI Primary (LREPI SEARCH EXTRACT MENU) menu and options are NOT required to be disabled during the EPI installation process. Users on the System: Users may remain on system during the installation of patch LR*5.2*281 and all options may remain in service. Backup Routines: It is highly recommended that a backup of the transport global be performed before installing patch LR*5.2*281. Namespace: The VistA Laboratory EPI Rollup Modifications Patch LR*5.2*281, uses the Laboratorys LR namespace. Software Requirements: The following software applications are must be installed prior to the installation of Laboratory EPI Rollup Modifications patch LR*5.2*281: Software Applications Versions (or Greater) VA FileMan v. 21 (with patches installed) Kernel v. 8.0 (with patches installed) Laboratory v.5.2 (with patches installed) PIMS v. 5.3 (with patches installed) HL7 v.1.6 (with patches installed) Social Work v.3.0 (with patches installed) Mailman v.7.1 (with patches installed) Clinical Reminder v.1.5 (with patches installed) Required Patches: Prior to the installation of Laboratory EPI Rollup Modifications patch LR*5.2*281, the following patches MUST be installed: Software Applications Patches Laboratory V. 5.2 LR*5.2*175 LR*5.2*242 LR*5.2*260 Clinical Reminder V. 1.5 PXRM*1.5*1 Health Level Seven (HL7): Laboratory EPI Rollup Modifications patch LR*5.2*281 uses the VistA HL7 V. 1.6 software application to transmit EPI data to the AAC. Protocols: LREPI: This event driver protocol defines the associated parameters required for building HL7 messages that are used to transmit EPI data to the AAC. LREPI CLIENT: This subscriber protocol defines the parameter required by the HL7 application that determines where to send the HL7 formatted message containing the emerging pathogens data. Domain The Q-EPI-MED.GOV domain is used for transmitting EPI data to AAC. Database Integration Agreements (DBIAs) The following DBIAs were approved for VistA Laboratory EPI Rollup Modifications patch LR*5.2*281: 1. DBIA #418 Laboratory EPI software has been approved to look at the discharge date x-ref in the PTF file (#45). The EPI software gathers lab data to send to Austin. FILE: 45 ROOT: DGPT( DESCRIPTION: TYPE: File #45 PTF file ^DGPT("ADS", cross-reference: The routine LREPI5 searches a date range for discharge dates in that range to gather Lab EPI data to send to Austin. 2. DBIA #3018 Laboratory EPI software approved to call the $$IN^VAFHLPV1 to create a PV1 segment to send to the Austin Automation Center. 3. DBIA #3094: AUPNVPOV (PCE PATIENT CARE ENCOUNTER DESCRIPTION: TYPE: File V POV diagnoses are used as a finding in Clinical Reminders. Therefore, Clinical Reminders needs to read the following fields: GLOBAL REFERENCE: ^AUPNVPOV('AA', GLOBAL REFERENCE: ^AUPNVPOV(D0,0) .01 POV 0;1 Direct Global Read .03 VISIT 0;3 Direct Global Read .04 PROVIDER NARRATIVE 0;4 Direct Global Read .12 PRIMARY/SECONDARY 0;12 Direct Global Read KEYWORDS: CLINICAL REMINDERS V POV 4. DBIA #3530 Laboratory EPI software approved to reference ^AUPNVSIT. 3530 NAME: DBIA3530 CUSTODIAL PACKAGE: PCE PATIENT CARE ENCOUNTER Albany SUBSCRIBING PACKAGE: INTEGRATED BILLING Albany USAGE: Private ENTERED: FEB 27, 2002 STATUS: Active EXPIRES: DURATION: Till Otherwise Agr VERSION: FILE: 9000010 ROOT: AUPNVSIT( DESCRIPTION: TYPE: File Integrated Billing receives encounters from PCE but screens out many based on certain criteria. One of these criteria is the Data Source of the encounter. The following reference is needed to identify the Data Source of an encounter to determine if the encounter should pass to Integrated Billing. GLOBAL REFERENCE: ^AUPNVSIT(D0 81203 DATA SOURCE 812;3 Direct Global Read Visit's Data Source, pointer to file 839.7 KEYWORDS: 5. DBIA 4280 LAB EPI software approved to do a direct read of the global $P(^DIC(21,D0,0),U,3) and a direct global read of the "D" cross reference ^DIC(21,"D". NAME: DIC(21 CUSTODIAL PACKAGE: REGISTRATION Albany SUBSCRIBING PACKAGE: LAB SERVICE Dallas USAGE: Private ENTERED: MAY 27,2004 STATUS: EXPIRES: DURATION: Till Otherwise Agr VERSION: FILE: 21 ROOT: DIC(21 DESCRIPTION: TYPE: File LAB EPI software does a direct read of the global $P(^DIC(21,D0,0),U,3) and a direct global read of the "D" cross reference ^DIC(21,"D" The software gathers EPI data for transmission to Austin. GLOBAL REFERENCE: ^DIC(21 Data Dictionary Changes The following data dictionary changes are required for the EPI Roll-Up Modifications Patch LR*5.2*281 software release: LAB SEARCH/EXTRACT file (#69.5) This file contains search criteria used by the Laboratory EPI software. This file should ONLY be edited using the EPI Parameter Setup [LREPI PARAMETER SETUP] option provided with this software. This file contains the following changes: Modified Fields: NAME field (#69.5.,01) The Search/Extract parameter name is converted to upper case and stored in the D x-ref for easier lookup (i.e., enter a Name (3 to 30 characters) for the Search/Extract parameter you are defining). 69.5,.01 NAME 0;1 FREE TEXT (Required) INPUT TRANSFORM: K:$L(X)>30!($L(X)<3)!'(X'?1P.E)!(X'?.ANP) X LAST EDITED: MAR 16, 2004 HELP-PROMPT: Enter a Name (3 to 30 characters) for the Search/Extract parameter you are defining. DESCRIPTION: This is the name of the Search/Extract parameter you are defining. NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER CROSS-REFERENCE: 69.5^B 1)= S ^LAB(69.5,"B",$E(X,1,30),DA)="" 2)= K ^LAB(69.5,"B",$E(X,1,30),DA) CROSS-REFERENCE: 69.5^D^MUMPS 1)= D UP^LRXREF S ^LAB(69.5,"D",X,DA)="" 2)= D UP^LRXREF K ^LAB(69.5,"D",X,DA) The name is converted to upper case and stored in the "D" x-ref for easier lookup. ^LAB(69.5,"D",UPPERCASE NAME, IEN) This field has also been modified to add the following 6 new emerging pathogens entries: All Staphylococcus aureus (Reference #18) Methicillin-Resistant Staphylococcus aureus (MRSA) (Reference #19) Vancomycin-Resistant Staphylococcus aureus (VRSA) (Reference #20) Vancomycin-Resistant Coagulase Negative Staphylococci/Staph epi (VRSE) (Reference #21) All Streptococcus pneumoniae (Reference #22) All Enterococci (Reference #23) INACTIVE field (#69.5,1) This field has been renamed from ACTIVE to INACTIVE. Example: 69.5,1 INACTIVE 0;2 SET '1' FOR YES; '0' FOR NO; LAST EDITED: JUN 19, 2002 HELP-PROMPT: '1' or 'YES' indicates that this is an inactive entry. '0' or 'NO' indicates that this is an active entry. DESCRIPTION: This defines if this entry is active or not. PROTOCOL field (#69.55,12): This field defines the protocol associated with the parameters. This field has been changed to UNEDITABLE. Example: 69.5,12 PROTOCOL 0;7 POINTER TO LAB SEARCH/EXTRACT PROTOCOL FILE (#69.4) LAST EDITED: NOV 06, 2003 HELP-PROMPT: Select the Protocol to be used to define the output messages. DESCRIPTION: This defines what protocol is associated with the parameters. UNEDITABLE NEW Fields: PREVIOUS CYCLE field (69.5,19) This new field is defined as a numeric field, (type a number between 1 and 99). By entering a number here the Lab search engine knows to look at a previous cycle for updates to data. How far back it looks is based on the cycle and number entered. For example if the cycle is monthly and the previous cycle is 1, then the search engine will also search 1 month back for data. This new field is UNEDITABLE. Example: 69.5,19 PREVIOUS CYCLE 0;13 NUMBER INPUT TRANSFORM: K:+X'=X!(X>99)!(X<1)!(X?.E1"."1.N) X LAST EDITED: SEP 09, 2003 HELP-PROMPT: Type a number between 1 and 99. DESCRIPTION: By entering a number here the Lab search engine knows to look at a previous cycle for updates to data. How far back it looks is based on the cycle and number entered. For example if the cycle is monthly and the previous cycle is 1 then the search engine will also search 1 month back for data. UNEDITABLE INDICATOR field (#69.55,1): NOTE: The new INDICATOR field (#69.55,1) located under ANTIMICROBIL SUSCEPTIBILITY sub-field (#69.55) is NOT being used in this release of the EPI software. This new INDICATOR field (#69.55,1) is defined as a SET of CODES. Select the code that will determine how to match lab results. This indicates if the search for the lab test is conditional. Example: 69.55,1 INDICATOR 0;2 SET '1' FOR Use Reference Ranges; '2' FOR Contains; '3' FOR Greater Than; '4' FOR Less Than; '5' FOR Equal To; LAST EDITED: MAR 24, 2004 HELP-PROMPT: Select the code that will determine how to match lab results. DESCRIPTION: This indicates if the search for the lab test is conditional. INDICATED VALUE field (#69.55,2): NOTE: The new INDICATED VALUE field (#69.55,2) located under ANTIMICROBIL SUSCEPTIBILITY sub-field (#69.55) is NOT being used in this release of the EPI software. The new INDICATED VALUE field (#69.55,2) is defined as FREE TEXT. When the search indicator is used then use this field to define the criteria. Answer must be 1-30 characters in length. Example: 69.55,2 INDICATED VALUE 0;3 FREE TEXT INPUT TRANSFORM: K:$L(X)>30!($L(X)<1) X LAST EDITED: MAR 24, 2004 HELP-PROMPT: Enter the data to be compared using the INDICATOR field. DESCRIPTION: If the search is conditional this defines the criteria. PROTOCOL file (#101) Modified Field Processing Routine field (#771): Entry in the Processing Routine field (#771) for the Protocol LREPI CLIENT was changed from PROCESS^LREPIRP to a NULL entry. NOTE: In the LAB SEARCH/EXTRACT file (#69.5), the PROTOCOL field (#101) and PREVIOUS CYCLE field (69.5, 19) has been changed to be UNEDITABLE. Routine Summary Example: Checksum The following routines are included in this patch. The second line of each of these routines now looks like: ;;5.2;LAB SERVICE;;Sep 27, 1994 Checksum Checksum Routine Name Before Patch After Patch Patch List ------------ ------------ ----------- ------------ LR281 N/A 4418686 281(Deleted by KIDS) LREPI 14217525 14182167 132,175,260,281 LREPI1 10654552 11822436 132,157,175,260,281 LREPI2 7199135 8491199 132,157,175,242,260,281 LREPI2A NEW 7574864 281 LREPI3 5462995 9184652 132,175,260,281 LREPI5 NEW 2408593 281 LREPIPH 5818757 6144410 260,281 LREPIPI NEW 5220624 281 LREPIRM 5260075 7566388 175,281 LREPIRP 5973015 20442264 132,157,175,260,281 LREPIRP1 NEW 15133552 281 LREPIRP2 NEW 3729823 281 LREPIRP3 NEW 29061422 281 LREPIRP4 NEW 1812384 281 LREPIRP5 NEW 11788836 281 LREPIRP6 NEW 25502070 281 LREPIRP7 NEW 17171829 281 LREPIRP8 NEW 8376752 281 LREPIRP9 NEW 4718 281 LREPIRS NEW 8576522 281 LREPIRS1 NEW 16664999 281 LREPIRS2 NEW 22133542 281 LREPIRS3 NEW 16290972 281 LREPISRV 12552990 15211664 260,281 LREPISV1 NEW 4805594 281 Installation Instructions VistA Laboratory EPI Rollup Modifications patch LR*5.2*281 uses the Kernel Installation and Distribution System (KIDS). For further instructions on using KIDS, please refer to the Kernel V. 8.0 Systems Manual. The install time for this patch is less than 2 minutes. This patch can be installed when Laboratory users are on the system. NOTE: Kernel patches must be current on the target system to avoid problems loading and/or installing this patch. 1. If any of the above routines are mapped, disable mapping for them. 2. Use the 'Load a Distribution' option to load the Host file onto your system. 3. The patch has now been loaded into a Transport global on your system. You now need to use KIDS to install the transport global. 4. On the 'Kernel Installation & Distribution System' Menu (KIDS), select the 'Installation' menu. 5. Use the 'Verify Checksum in Transport Global' option and verify that all routines have the correct checksums. 6. On the KIDS menu, under the 'Installation' menu, use the following options: Print Transport Global Compare Transport Global to Current System Backup a Transport Global If you wish to preserve a copy of the routines exported in this patch prior to installation, you should use the 'Backup a Transport Global' option at this time. You may also compare the routines in your production account to the routines in the patch by using the 'Compare a Transport Global to Current System' option. 7. Use the 'Install Package(s)' option under the 'Installation' menu and select the package 'LR*5.2*281'. If prompted ' Want KIDS to Rebuild Menu Trees Upon Completion of Install? YES//' choose 'NO'. If prompted ' Want KIDS to INHIBIT LOGONs during the install? YES// ' choose 'NO'. If prompted 'Want to DISABLE Scheduled Options, Menu Options, and Protocols? YES//', choose 'NO'. 8. On a mapped system, rebuild your map set. 9. Routine LR281 will be deleted after successful patch installation. Installation Example: Select Kernel Installation & Distribution System Option: INSTallation Select Installation Option: 6 Install Package(s) Select INSTALL NAME: LR*5.2*281 Loaded from Distribution 5/24/04@14:18:24 => LR*5.2*281 This Distribution was loaded on May 24, 2004@14:18:24 with header of LR*5.2*281 It consisted of the following Install(s): LR*5.2*281 Checking Install for Package LR*5.2*281 Will first run the Environment Check Routine, LR281 --- Environment Check is Ok --- Install Questions for LR*5.2*281 Incoming Files: 69.5 LAB SEARCH/EXTRACT (including data) Note: You already have the 'LAB SEARCH/EXTRACT' File. I will MERGE your data with mine. Want KIDS to Rebuild Menu Trees Upon Completion of Install? YES// NO Want KIDS to INHIBIT LOGONs during the install? YES// NO Want to DISABLE Scheduled Options, Menu Options, and Protocols? YES// NO Enter the Device you want to print the Install messages. You can queue the install by enter a 'Q' at the device prompt. Enter a '^' to abort the install. DEVICE: HOME// UCX/TELNET Install Started for LR*5.2*281 : May 24, 2004@14:19:41 Build Distribution Date: May 20, 2004 Installing Routines: May 24, 2004@14:19:41 Running Pre-Install Routine: PRE^LR281 Deleting NCH entries from LAB/SEARCH EXTRACT file (#69.5) *** Preinstall completed *** Installing Data Dictionaries: May 24, 2004@14:19:42 Installing Data: May 24, 2004@14:19:43 Installing PACKAGE COMPONENTS: Installing FORM LR*5.2*281 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% Installing PROTOCOL Installing OPTION May 24, 2004@14:19:46 Running Post-Install Routine: POST^LR281 Updating Routine file... Updating KIDS files... LR*5.2*281 Installed. May 24, 2004@14:19:47 Install Message sent #10960 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 100% % 25 50 75 % Complete %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% Install Completed Post Installation and Implementation Instructions The following post installation and implementation instructions must be completed to ensure a successful performance of the EPI Roll up Modification software enhancements: IRM Post Installation Instructions: IRM - Step 1: Verify Lower Level Protocol of the HL7 V. 1.6 background job for EPI LAB Example: How to verify that the Lower Level Protocol of the HL7 V. 1.6 background job EPI LAB is running. Select HL7 Main Menu Option: ? Event monitoring menu ... Systems Link Monitor Filer and Link Management Options ... Message Management Options ... Interface Developer Options ... Site Parameter Edit Enter ?? for more options, ??? for brief descriptions, ?OPTION for help text. Select HL7 Main Menu Option: FILER and Link Management Options Select Filer and Link Management Options Option: ? SM Systems Link Monitor FM Monitor, Start, Stop Filers LM TCP Link Manager Start/Stop SA Stop All Messaging Background Processes RA Restart/Start All Links and Filers DF Default Filers Startup SL Start/Stop Links PI Ping (TCP Only) ED Link Edit ER Link Errors ... Enter ?? for more options, ??? for brief descriptions, ?OPTION for help text. Select HL7 Main Menu Option: FILER and Link Management Options Select Filer and Link Management Options Option: START/Stop Links This option is used to launch the lower level protocol for the appropriate device. Please select the node with which you want to communicate Select HL LOGICAL LINK NODE: EPI-LAB The LLP was last shutdown on JUL 14, 2000 08:52:58. Select one of the following: F FOREGROUND B BACKGROUND Q QUIT Method for running the receiver: B// ACKGROUND Job was queued as 130212. IRM - Step 2: Verify Lab EPI Nightly Task [LREPI NIGHTLY TASK] Option Nightly Run The Lab EPI Nightly Task [LREPI NIGHTLY TASK] option must be scheduled to run nightly. This option will build HL7 messages and send them to the defined locations specified by the LREPI protocol. Example: How to schedule the Lab EPI Nightly Task [LREPI NIGHTLY TASK] option to run nightly. Select Systems Manager Menu Core Applications ... Device Management ... FM VA FileMan ... Manage Mailman ... Menu Management ... Programmer Options ... Operations Management ... Spool Management ... Information Security Officer Menu ... Taskman Management ... User Management ... Application Utilities ... Capacity Management ... HL7 Main Menu ... You have 89 new messages. (Last arrival: 03/17/04@15:30) Select Systems Manager Menu Option: TASKman Management Schedule/Unschedule Options One-time Option Queue Taskman Management Utilities ... List Tasks Dequeue Tasks Requeue Tasks Delete Tasks Print Options that are Scheduled to run Cleanup Task List Print Options Recommended for Queueing Select Taskman Management Option: SCHEDULE/UnscheduleOptions Select OPTION to schedule or reschedule: LREPI NIGHTLY TASK Example: How to schedule the Lab EPI Nightly Task [LREPI NIGHTLY TASK] option to run nightly continued.  INCLUDEPICTURE "cid:image001.jpg@01C40CEA.F23F93F0" \* MERGEFORMATINET  IRM - Step 3: Verify EPI mail group setup entries This mail group is used by VHA facilities to transmit EPI HL7 format mailman messages to Austin Automation Center (AAC) and for AAC to transmit EPI Confirmation mailman messages back to the sending VHA facilities once the EPI HL7 format mailman messages data transmission has been received by AAC. The Office of Director (00)-designated staff for EPI process implementation should be assigned to this mail group and kept current as personnel assume this responsibility. This/these staff member(s) is/are responsible for that the monthly EPI process has run and generated the appropriately formatted HL7 messages that are transmitted to the AAC. Receipt of the HL7 message series by this mail group is a means of ascertaining that this process has occurred. Installation of this patch provides opportunity to review this EPI mail group and update as needed. NOTE: It is highly recommended that the Office of the Director (00) at each facility initially designate the member(s) responsible for overseeing the EPI mail group data. Example: How to verify existing EPI mail group setup entries OUTPUT FROM WHAT FILE: LAB EPI// MAIL GROUP (1441 entries) Select MAIL GROUP NAME: EPI ANOTHER ONE: STANDARD CAPTIONED OUTPUT? Yes// (Yes) Include COMPUTED fields: (N/Y/R/B): NO// - No record number (IEN), no Computed Fields NAME: EPI TYPE: public ALLOW SELF ENROLLMENT?: NO REFERENCE COUNT: 8499 LAST REFERENCED: AUG 15, 2000 RESTRICTIONS: UNRESTRICTED MEMBER: EPI, USER DESCRIPTION: This mail group is used to deliver a formatted report taken from the HL7 message that is created to assist in the verification of data. IRM Step 4: Verify EPI-REPORT mail group setup entries This mail group receives the new EPI Summary Verification Report that is automatically generated on the 15th day of each month at each VHA facility. The Office of Director (00)-designated staff for EPI process implementation should be assigned to this mail group and kept current as personnel assume this responsibility. Other members of this mail group should be personnel who can assist the Office of Director-designated staff validate that the data contained in the new EPI Summary Verification Report accurately reflect what has occurred at the facility during the prior month. If the data do no accurately reflect facility activity regarding the national EPI Pathogens, corrections should be undertaken and coordinated by the Office of Director-designated staff; once the corrections are made, it is the responsibility of this designated staff to re-transmit the EPI data to the AAC using the Lab EPI Manual Run (Enhanced) option. Other personnel at the site may have interest in this summary overview of occurrences at the local site and should be permitted to join this mail groupthese personnel may include the Infection Control Practitioners, Infectious Diseases physicians, hospital epidemiologists and Quality Managers. Installation of this patch provides opportunity to review this EPI-REPORT mail group and update as needed. Example: How to verify EPI-REPORT mail group setup entries OUTPUT FROM WHAT FILE: LAB EPI// MAIL GROUP (1441 entries) Select MAIL GROUP NAME: EPI-REPORT ANOTHER ONE: STANDARD CAPTIONED OUTPUT? Yes// (Yes) Include COMPUTED fields: (N/Y/R/B): NO// - No record number (IEN), no Computed Fields NAME: EPI-REPORT TYPE: public ALLOW SELF ENROLLMENT?: NO REFERENCE COUNT: 8499 LAST REFERENCED: AUG 15, 2000 RESTRICTIONS: UNRESTRICTED MEMBER: EPI, USER DESCRIPTION: This mail group is used to deliver a formatted report taken from the HL7 message that is created to assist in the verification of data. IRM Step 5: Verify XXX@Q-EPI.MED.VA.GOV Remote Member Entries Verify designated remote members entries in the MAIL GROUP file (#3.8), MEMBERS - REMOTE field (#12), for the EPI mail group. Example: How to verify EPI mail groups remote member  HYPERLINK "mailto:XXX@Q-EPI.MED.VA.GOV" XXX@Q-EPI.MED.VA.GOV entries: Select VA FileMan 22.0 Select OPTION: 1ENTER OR EDIT FILE ENTRIES INPUT TO WHAT FILE: MAIL GROUP// EDIT WHICH FIELD: ALL// MEMBERS - REMOTE (multiple) EDIT WHICH MEMBERS - REMOTE SUB-FIELD: ALL// THEN EDIT FIELD: Select MAIL GROUP NAME: EPI 1 EPI 2 EPI-REPORT CHOOSE 1-2: 1 EPI Select REMOTE MEMBER: S.HL V16 SERVER@DEV// XXX@Q-EPI.MED.VA.GOV Are you adding 'XXX@Q-EPI.MED.VA.GOV' as a new REMOTE MEMBER (the2ND for this MAIL GROUP)? No// Y(Yes) IRM Step 6: Verify Lab EPI Primary [LREPI SEARCH EXTRACT MENU] menu assignment to all designated users NOTE: The Office of Director (00)-designated staff for EPI process implementation should be assigned to the EPI mail group and kept current as personnel assume this responsibility. It is highly recommended that the Laboratory Information Manager (LIM), a representative from the Microbiology section (director, supervisor, or technologist) and a Total Quality Improvement/Quality Improvement/Quality Assurance (TQI/QI/QA) staff (or person at the facility with similar function) also be assigned the Lab EPI Primary Menu [LREPI SEARCH EXTRACT MENU]. These will be the individual(s) responsible for initially setting the national Lab EPI parameters descriptions and doing periodic reviews of the parameters descriptions to assure they are current. Example: Lab EPI Primary [LREPI SEARCH EXTRACT MENU] menu Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Example: Local Pathogen [LREPI LOCAL PATHOGEN MENU] Menu ENT...Enter/Edit Local Pathogens GEN Lab EPI Generate Local Report/Spreadsheet PRT Lab EPI Print Local Report/Spreadsheet DEL Delete Local Pathogen DRS Delete Local Report or Spreadsheet NOTE: Assignment of the Local Pathogen [LREPI Local Pathogen Menu] submenu is automatic with assignment of the Lab EPI Primary Menu. However, this submenu may be assigned independent of the primary menu; this independent assignment allows only access to the local pathogen menu functions. This provides one way of limiting access to functionality to only those personnel truly needing access and preventing personnel from inadvertently changing national EPI pathogen parameters. LIM Implementation Instructions The following implementation instructions must be completed to achieve a successful performance of the EPI Roll up Modification software enhancements: NOTE: It is highly recommended that the Laboratory Information Manager (LIM), a representative from the Microbiology section (director, supervisor, or technologist) and a Total Quality Improvement/Quality Improvement/Quality Assurance (TQI/QI/QA) staff (or person at the facility with similar function) be assigned the Lab EPI Primary Menu [LREPI SEARCH EXTRACT MENU]. These will be the individual(s) responsible for initially setting the national Lab EPI parameters descriptions and doing periodic reviews of the parameters descriptions to assure they are current. LIM - Step 1: Review new EPI Descriptions and Input Screens Examples Review the following 6 new emerging pathogens descriptions and input screens examples prior to setting up the Lab EPI parameters. Also review the exiting Legionella (Reference #7) pathogen regarding descriptions and input screen examples to capture the Legionella Urinary Antigen) (i.e., Descriptions and input screens examples are located in the EPI Roll-Up Modifications User Manual Use of the Software section of this manual): All Staphylococcus aureus (Reference #18) Methicillin-Resistant Staphylococcus aureus (MRSA) (Reference #19) Vancomycin-Resistant Staphylococcus aureus (VRSA) (Reference #20) Vancomycin-Resistant Coagulase Negative Staphylococci/Staph epi (VRSE) (Reference #21) All Streptococcus pneumoniae (Reference #22) All Enterococci (Reference #23) LIM - Step 2: Setup new EPI Parameter Descriptions Use the Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option to setup the 6 new emerging pathogens parameter descriptions (i.e., as specified by the VAHQ Infectious Disease Program Office). (See the EPI Roll Up Modifications User Manual section of this manual for examples on setting up the six new EPI parameters). NOTE: Take this opportunity to perform the expected annual review of the already existing EPI parameter set-ups for the other 17 pathogens to assure that they are up-to-date and correct. Should there be corrections that need to be made, they should be made at this time with the following exception: the 4 hepatitis pathogens (Hepatitis C Antibody Positive, Hepatitis C Antibody Negative, Hepatitis A Antibody Positive and Hepatitis B Positive) are tightly integrated with the Clinical Reminder data stream that the EPI national roll-up accomplishes (see combined products VistA Laboratory EPI Hepatitis Extract Patch LR*5.2*260, PXRM*1.5*1, PSJ*5*48 and Patch PSO*7*45) and changes in the EPI parameters may need to have concomitant changes in the Clinical Reminder data being passed over to the EPI national roll-upconcurrent review (and changes, if necessary), should be undertaken in conjunction with the local Clinical Applications Coordinator for the Clinical Reminder package to assure that appropriate mapping of Health factors to the national pathogens has occurred. NOTE: LAG DAYS must be set at 15 for all EPI-defined pathogens, including the 6 new EPI. LIM - Step 3: Link the Logical Observations, Identifiers, Names, and Codes (LOINC) For instructions on linking LOINC please refer to the following web site to obtain a copy of the VistA NLT Mapping to LOINC Technical, Installation, and User Guide.  HYPERLINK "http://www.va.gov/vdl/Clinical.asp?appID=119" http://www.va.gov/vdl/Clinical.asp?appID=119 Office of Director (00) Designated Staff Implementation Instructions: The following implementation instructions must be completed to achieve a successful performance of the EPI Roll up Modification software enhancements: NOTE: It is highly recommended that the Laboratory Information Manager (LIM), a representative from the Microbiology section (director, supervisor, or technologist), and a Total Quality Improvement/Quality Improvement/Quality Assurance (TQI/QI/QA) staff (or person at the facility with similar function) be assigned the Lab EPI Primary Menu [LREPI SEARCH EXTRACT MENU]. These will be the individual(s) responsible for initially setting the national Lab EPI parameters descriptions and doing periodic reviews of the parameters descriptions to assure they are current. (00) Designated Staff - Step 1: Review new EPI Descriptions and Input Screens Examples Review the following 6 new emerging pathogens descriptions and input screens examples prior to setting up the Lab EPI parameters. Also review the exiting Legionella (Reference #7) pathogen regarding descriptions and input screen examples to capture the Legionella Urinary Antigen) (i.e., Descriptions and input screens examples are located in the EPI Roll Up Modifications User Manual Use of the Software section of this manual): All Staphylococcus aureus (Reference #18) Methicillin-Resistant Staphylococcus aureus (MRSA) (Reference #19) Vancomycin-Resistant Staphylococcus aureus (VRSA) (Reference #20) Vancomycin-Resistant Coagulase Negative Staphylococci/Staph epi (VRSE) (Reference #21) All Streptococcus pneumoniae (Reference #22) All Enterococci (Reference #23) (00) Designated Staff - Step 2: Setup new EPI Parameter Descriptions Use the Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option to setup the 6 new emerging pathogens parameter descriptions (i.e., as specified by the VAHQ Infectious Disease Program Office). (See the EPI Roll Up Modifications User Manual section of this manual for examples on setting up the 6 new EPI parameters). NOTE: Take this opportunity to perform the expected annual review of the already existing EPI parameter set-ups for the other 17 pathogens to assure that they are up-to-date and correct. Should there be corrections that need to be made, they should be made at this time with the following exception: the 4 hepatitis pathogens (Hepatitis C Antibody Positive, Hepatitis C Antibody Negative, Hepatitis A Antibody Positive and Hepatitis B Positive) are tightly integrated with the Clinical Reminder data stream that the EPI national roll-up accomplishes (see combined products VistA Laboratory EPI Hepatitis Extract Patch LR*5.2*260, PXRM*1.5*1, PSJ*5*48 and Patch PSO*7*45) and changes in the EPI parameters may need to have concomitant changes in the Clinical Reminder data being passed over to the EPI national roll-upconcurrent review (and changes, if necessary), should be undertaken in conjunction with the local Clinical Applications Coordinator for the Clinical Reminder package to assure that appropriate mapping of Health factors to the national pathogens has occurred. NOTE: LAG DAYS must be set at 15 for all EPI-defined pathogens, including the 6 new EPI. Instructions for Seeding EPI Historical Data: EPI historical data must be gathered from October 1, 2000 through June 14, 2004. Use the Lab EPI Manual Run (Enhanced) [LREPI ENHANCE MANUAL RUN] option to extract and transmit 6 manual runs (consecutive runs) at a time. WARNING: SITES - DO NOT transmit the EPI historical data reports on June 16 or July 4, 2004 to avoid Austin Automation Center (AAC) capacity limitations. Batch #1: October 1, 2000 -March 31, 2001 Batch #2: April 1, 2001 - September 30, 2001 Batch #3: October 1, 2001 - March 31, 2002 Batch #4: April 1, 2002 - September 30, 2002 Batch #5: October 1, 2002 - March 31, 2003 Batch #6: April 1, 2003 - September 30, 2003 Batch #7: October 1, 2003 - March 31, 2004 Batch #8: April 1, 2004 - June 14, 2004 Sites will run 8 batches of EPI historical data reports. Each batch should contain 6 separate monthly extracts which are tasked separately by month, (i.e., OCT 2000, NOV 2000, DEC 2000, JAN 2001, FEB 2001, MAR 2001 = 1 batch) and will generate six separate processing reports back to the station and transmit them over a five week period June 10, 2004 July 12, 2004. You do not have to wait for one monthly extract to run before starting the next in a batch. You do not have to wait for one batch to complete running before queuing the next batch. If you receive any fatal errors and the monthly extract is rejected, you will need to fix the error and retransmit that month. Austin Automation Center (AAC) Schedule for Transmitting EPI Historical Data: WARNING: SITES - DO NOT transmit the EPI historical data reports on June 16 or July 4, 2004 to avoid Austin Automation Center (AAC) capacity limitations. Sites may transmit EPI historical data reports to AAC on evenings and weekends following this schedule: 1. VISNs with odd numbers are asked to transmit batches on Tuesday & Thursday during the PM hours and Saturdays. 2. VISNs with even numbers are asked to transmit on Monday & Friday during the PM hours and Sundays. VistA LABORATORY EPI ROLLUP MODIFICATIONS USER MANUAL Use of the Software VistA Laboratory Emerging Pathogens Initiative (EPI) Rollup Modifications User Manual (Patch LR*5.2*281) section provides all the necessary information, instructions, illustrations, and examples required for the EPI coordinators, Laboratory personnel, and other users to implement and maintain the 23 emerging pathogens parameter descriptions: NOTE: It is highly recommended that the following person(s) jointly participate in the review and parameter descriptions setup process for the 23 EPI descriptions at the time of this installation and at least once annually thereafter: Laboratory Information Manager (LIM) Total Quality Improvement/Quality Improvement/Quality Assurance (TQI/QI/QA) staff (e.g., or person at the facility with similar function) Representative from the Microbiology (i.e., director, supervisor, or technologist) EPI Review Requirements: The 23 emerging pathogens will require an ongoing review process (i.e., as specified by the VA Central Office Infectious Disease Program Office). The expected minimum for review is once annually. The person(s) participating in the ongoing review process is(are) responsible for ensuring the following requirements are kept current. Periodic reviews of the ICDM-9 codes. Periodic reviews of the Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option for the defined EPI parameter description setups. NOTE: Remember that if the parameter set up needs to be changed for any of the four hepatitis entities, that a concomitant change needs to be made in the corresponding Reminder logic. Annual review of the national EPI pathogen descriptions (i.e., as specified by the VA Central Office Infectious Disease Program Office). NOTE: To request additional LOINC, Workload, and Suffixes codes access the VistA Laboratory website, National Lab Tests (NLT) Documentation Set and LOINC Request Forms link:  HYPERLINK "http://vista.med.va.gov/ClinicalSpecialties/lab/" http://vista.med.va.gov/ClinicalSpecialties/lab/ Six New Emerging Pathogens: The EPI Roll-Up Modifications software release exports the following 6 new Emerging Pathogens Initiative and parameter descriptions: All Staphylococcus aureus (Reference #18) Methicillin - resistant Staphylococcus aureus (MRSA) (Reference #19) Vancomycin-Resistant Staphylococcus aureus (VRSA) (Reference #20) Vancomycin-Resistant Coagulase Negative Staphylococci/Staph epi (VRSE) (Reference #21) All Streptococcus pneumoniae (Reference #22) All Enterococci (Reference #23) New Legionella Urinary Antigen Test: The new Food and Drug Administration (FDA)-approved Legionella Urinary Antigen test may be added to the existing Legionella pathogen criteria. New Local Pathogen [LREPI LOCAL PATHOGEN MENU] Menu The new submenu contains four new options use to enter/edit local pathogens, generate and print local EPI reports and spreadsheets, and delete local pathogens Lab EPI Primary (LREPI SEARCH EXTRACT MENU) Menu Diagram Example: Lab EPI Primary [LREPI SEARCH EXTRACT MENU] menu diagram Lab EPI Primary Menu (LREPI SEARCH EXTRACT MENU) | | ------------------------------------------ENH Lab EPI Manual Run (Enhanced) [LREPI ENHANCE MANUAL RUN] -------------------------------------------VR Print Detailed Verification Report [LREPI VERIFICATION REPORT] ---LO Local Pathogen Menu [LREPI ------------ Enter/Edit Local Pathogens LOCAL PATHOGEN MENU] [LREPI ENTER/EDIT LOCAL PATH] | |-------------------------------GEN Lab EPI Generate Local | Report/Spreadsheet [LREPI | GENERATE REPORT/SP] | |-------------------------------PRT Lab EPI Print Local | Report/Spreadsheet [LREPI | PRINT REPORT/SPSHT] | |-------------------------------DEL Delete Local Pathogen [LREPI | DELETE LOCAL PATHOGEN] | DRS Delete Local Report or Spreadsheet [LREPI DELETE LOCAL REPORT] -------------------------------------------PI Pathogen Inquiry [LREPI PATHOGEN INQUIRY] -------------------------------------------UP Lab EPI Parameter Setup [LREPI PARAMETER SETUP] --------------------------------------------- Lab EPI Protocol Edit [LREPI PROTOCOL EDIT] -------------------------------------------LK Antimicrobial Link Update [LREPILK] Lab EPI Primary [LREPI SEARCH EXTRACT MENU] Menu For consistency of this software release, the Lab Search Extract Primary [LREPI SEARCH EXTRACT MENU] menu is RENAMED Lab EPI Primary [LREPI SEARCH EXTRACT MENU] menu. This is the main EPI menu containing four existing options, two new options, and one new submenu containing four new options. Example: Lab Search Extract Primary [LREPI SEARCH EXTRACT MENU] menu screen Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Lab EPI Manual Run (Enhanced) [LREPI ENHANCE MANUAL RUN] option: This option is used ONLY to manually extract National EPI data, transmit manually extracted data to the Austin Automation Center (AAC), and to generate the new EPI Summary Verification Report. The new EPI Summary Verification Report is automatically sent to the EPI-Report mail group after being generated. This option has been enhanced to generate the new Detailed Verification Report which can be printed using the new Print Detailed Verification Report [LREPI VERIFICATION REPORT] option. NOTES: ONLY national emerging pathogens extract data are transmitted to the AAC, local pathogens extract data will NOT be transmitted. Lab EPI Transmissions to AAC after 6:00 p.m. are processed the next day. DO NOT use the Lab EPI Manual Run (Enhanced) [LREPI ENHANCED MANUAL RUN] option to transmit EPI data on Wednesdays of PAY ROLL weeks. These transmissions may cause a delay in processing PAY ROLL data. Example: How to use the Lab EPI Manual Run (Enhanced) [LREPI ENHANCE MANUAL RUN] option. NOTES: In the following Laboratory Search rerun option example Override Any Inactive indicators: ? NO//' prompt requires a YES or NO answer. However, ALL National Emerging Pathogens are automatically set by the EPI software as ACTIVE, so either answer is correct. THIS PROMPT WILL BE REMOVED IN A FUTURE PATCH. At the Select Search Date prompt choose the month/date/year that you wish to manually re-submit and press ENTER. At this point you should get a message regarding queuing of the task that will run at the queued time. Laboratory Search rerun option Select Protocol: LREPI EMERGING PATHOGEN Emerging Pathogens Initiative (EPI) Override Any Inactive indicators: ? NO// Include All Search Parameters? YES// Select Search Date: 1/15/04 Requested Start Time: NOW// (JAN 27, 2004@12:08:10) The Task has been queued Task # 54381 Print Detailed Verification Report [LREPI VERIFICATION REPORT] option: This new option is use to print the new Detailed Verification Report. Example: How to use the Print Detailed Verification Report [LREPI VERIFICATION REPORT] option Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary Menu Option: VR Print Detailed Verification Report Print Detailed Verification Report Option 1 JAN 15,2004@16:07:41 2 JAN 16,2004@01:23:25 3 JAN 17,2004@17:19:28 4 JAN 18,2004@19:36:33 5 JAN 22,2004@22:42:01 6 JAN 23,2004@13:01:50 7 JAN 23,2004@16:15:31 8 JAN 23,2004@20:27:36 9 JAN 24,2004@17:56:01 10 JAN 30,2004@21:27:40 11 FEB 4,2004@01:49:41 12 FEB 4,2004@11:07:52 13 FEB 4,2004@11:59:16 14 FEB 4,2004@15:27 15 FEB 4,2004@18:16:41 16 FEB 8,2004@21:32:11 Choose the number for the report you wish to print: (1-16): 16 This report will contain Confidential Information. Do you wish to continue/proceed? NO// y YES Include All Pathogens? NO// y YES DEVICE: HOME// WAN PAGE 1 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (your site station number and name will be displayed) PROCESSING PERIOD: 01-01-2003 through 01-31-2003 NTE~1-Report of Vancomycin-resistant Enterococcus These data note persons at your facility during the month that had a positive result for Vancomycin-resistant Enterococcus. Identifying information, along with specimen and culture results has been provided. PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT~ONE 0001 02-05-1949 M VIETNAM ERA Outpatient Accession Date: 01-09-2003@1600 01-09-2003@1600 BACT 03 275 MICRO CULTURE URINE 1 01-12-2003 ENTEROCOCCUS FAECIUM ORG # 1 01-09-2003@1600 ANTIBIOTIC MIC URINE PENICILLIN R R VANCOMYCIN R R NITROFURANTOIN S S CIPROFLOXACIN R R LEVOFLOXACIN R R GENTAMICIN HP SYN-R SYN-R STREPTOMYCIN HP SYN-R SYN-R PAGE 2 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (your site station number and name will be displayed) PROCESSING PERIOD: 01-01-2003 through 01-31-2003 NTE~2 Report of Hepatitis C antibody positive This represents a line listing of persons reported during the month who had a positive test for hepatitis C antibody (based on accession date and not results reported date). Definitions for data to be extracted are provided in Technical and User Manual documentation for Laboratory EPI LR*5.2*281. Name LAST 4 Accession Date Test Name Test Result ______________________________________________________________________________ LABPATIENT~TWO 0002 01-16-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT~THREE 0003 01-14-2003@0909 HEP C ANTIBODY STRONG POSITIVE LABPATIENT~FOUR 0004 01-22-2003@1833 HEP C ANTIBODY STRONG POSITIVE LABPATIENT~FIVE 0005 01-30-2003@1137 HEP C ANTIBODY STRONG POSITIVE LABPATIENT~SIX 0006 01-13-2003@1653 HEP C ANTIBODY STRONG POSITIVE LABPATIENT~SEVEN 0007 01-17-2003@0941 HEP C ANTIBODY STRONG POSITIVE LABPATIENT~EIGHT 0008 01-30-2003@1246 HEP C ANTIBODY STRONG POSITIVE LABPATIENT~NINE 0009 01-13-2003@1516 HEP C ANTIBODY STRONG POSITIVE LABPATIENT~TEN 0010 01-23-2003@1153 HEP C ANTIBODY STRONG POSITIVE LABPATIENT1~ONE 0011 01-16-2003@1147 HEP C ANTIBODY STRONG POSITIVE LAPPATIENT1~TWO 0012 01-16-2003@1317 HEP C ANTIBODY STRONG POSITIVE LABPATIENT1~THREE 0013 01-29-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT1~THREE 0013 01-15-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT1~FOUR 0014 01-06-2003@0725 HEP C ANTIBODY STRONG POSITIVE LABPATIENT1~FIVE 0015 01-24-2003@1433 HEP C ANTIBODY STRONG POSITIVE LABPATIENT1~SIX 0016 01-01-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT1~SEVEN 0017 01-08-2003@1334 HEP C ANTIBODY STRONG POSITIVE LABPATIENT1~EIGHT 0018 01-08-2003@0901 HEP C ANTIBODY STRONG POSITIVE LABPATIENT1~NINE 0019 01-21-2003@1708 HEP C ANTIBODY STRONG POSITIVE LABPATIENT1~TEN 0110 01-28-2003@1618 HEP C ANTIBODY STRONG POSITIVE LABPATIENT2~ONE 0021 01-13-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT2~TWO 0022 01-30-2003@1108 HEP C ANTIBODY STRONG POSITIVE LABPATIENT2~THREE 0023 01-15-2003@1653 HEP C ANTIBODY STRONG POSITIVE NOTE: This Detailed Verification Report will include a subsequent page for each national pathogen as well as one for each National Hepatitis C Risk Assessment Clinical Reminder Data element that is integrated into the EPI data stream. Local Pathogen [LREPI LOCAL PATHOGEN MENU] Menu: This new submenu contains 5 new options used to enter/edit local pathogens, generate and print local reports and spreadsheets, and delete local pathogens. Example: New Local Pathogen [LREPI LOCAL PATHOGEN MENU] Menu Local Pathogen Menu ENT Enter/Edit Local Pathogens GEN Lab EPI Generate Local Report/Spreadsheet PRT Lab EPI Print Local Report/Spreadsheet DEL Delete Local Pathogen DRS Delete Local Report or Spreadsheet Enter/Edit Local Pathogens [LREPI ENTER/EDIT LOCAL PATH] option: This new option is use to enter or edit local pathogens into LAB SEARCH/EXTRACT file (#69.5). Example: How to use the Enter/Edit Local Pathogens [LREPI ENTER/EDIT LOCAL PATH] option to ENTER local pathogens. NOTE: The following LABORATORY EPI PARAMETERS INPUT SCREEN under the Topography Selection screen, Include, Exclude, and Sex prompts are FOR FUTURE USE ONLY. Select Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary Menu Option: lo Local Pathogen Menu ENT Enter/Edit Local Pathogens GEN Lab EPI Generate Local Report/Spreadsheet PRT Lab EPI Print Local Report/Spreadsheet DEL Delete Local Pathogen DRS Delete Local Report or Spreadsheet Select Local Pathogen Menu Option: Enter/Edit Local Pathogens< Example: How to use the Enter/Edit Local Pathogens [LREPI ENTER/EDIT LOCAL PATH] option to ENTER local pathogens continued. LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: Herpes virus539 INACTIVE: NO _____________________________________________________________________________ Laboratory Test(s) Indicator Value < > ICDM-9 ICDM-9 Description < > _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: n Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: Herpes virus539 INACTIVE: NO _____________________________________________________________________________ Selected Etiology Selected Snomed Codes HERPES SIMPLEX VIRUS 1 HERPES SIMPLEX VIRUS 2 < > Antimicrobial Susceptibility NLT Code NLT Description < > ____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: n Press H for help Insert Example: How to use the Enter/Edit Local Pathogens [LREPI ENTER/EDIT LOCAL PATH] option to ENTER local pathogens continued. NOTE: The following LABORATORY EPI PARAMETERS INPUT SCREEN under the Topography Selection screen, Include, Exclude, and Sex prompts are FOR FUTURE USE ONLY. LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: Herpes virus539 INACTIVE: NO ____________________________________________________________________________ Topography Selection Include Exclude < > < > _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: n Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: Herpes virus539 INACTIVE: NO ____________________________________________________________________________ FIRST ENCOUNTER: < > FOLLOW PTF: < > BEFORE DATE OF BIRTH: < > AFTER DATE OF BIRTH: < > Select SEX: < > ____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: n Press H for help Insert Example: How to use the Enter/Edit Local Pathogens [LREPI ENTER/EDIT LOCAL PATH] option to ENTER local pathogens continued. LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: Herpes virus539 INACTIVE: NO ____________________________________________________________________________ Run Date: < > Protocol: LREPI < > Run Cycle: < > Lag Days: < > Previous Cycle: < > General Description: < > ______________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: n Press H for help Insert How to use the Enter/Edit Local Pathogens [LREPI ENTER/EDIT LOCAL PATH] option Example: How to use the Enter/Edit Local Pathogens [LREPI ENTER/EDIT LOCAL PATH] option to EDIT LOCAL pathogens. NOTE: The following LABORATORY EPI PARAMETERS INPUT SCREEN under the Topography Selection screen, Include, Exclude, and Sex prompt will NOT be used in this release. Select Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary Menu Option: lo Local Pathogen Menu ENT Enter/Edit Local Pathogens GEN Lab EPI Generate Local Report/Spreadsheet PRT Lab EPI Print Local Report/Spreadsheet DEL Delete Local Pathogen DRS Delete Local Report or Spreadsheet Select Local Pathogen Menu Option: Enter/Edit Local Pathogens< Example: How to use the Enter/Edit Local Pathogens [LREPI ENTER/EDIT LOCAL PATH] option to EDIT local pathogens continued. LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: Herpes virus539 INACTIVE: NO ___________________________________________________________________________ Laboratory Test(s) Indicator Value < > ICDM-9 ICDM-9 Description < > _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: n Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: Herpes virus539 INACTIVE: NO ____________________________________________________________________________ Selected Etiology Selected Snomed Codes HERPES SIMPLEX VIRUS 1 HERPES SIMPLEX VIRUS 2 < > Antimicrobial Susceptibility NLT Code NLT Description < > _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: n Press H for help Insert Example: How to use the Enter/Edit Local Pathogens [LREPI ENTER/EDIT LOCAL PATH] option to EDIT local pathogens continued. NOTE: The following LABORATORY EPI PARAMETERS INPUT SCREEN under the Topography Selection screen, Include, Exclude, and Sex prompts are for FUTURE USE. LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: Herpes virus539 INACTIVE: NO ____________________________________________________________________________ Topography Selection Include Exclude SKIN < > SKIN APPENDAGE < > URETHRA < > ____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: n Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: Herpes virus539 INACTIVE: NO ______________________________________________________________________________ FIRST ENCOUNTER: < > FOLLOW PTF: < > BEFORE DATE OF BIRTH: < > AFTER DATE OF BIRTH: < > Select SEX: < > ____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: n Press H for help Insert Example: How to use the Enter/Edit Local Pathogens [LREPI ENTER/EDIT LOCAL PATH] option to EDIT local pathogens continued. LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: Herpes virus539 INACTIVE: NO ____________________________________________________________________________ Run Date: < > Protocol: LREPI < > Run Cycle: < > Lag Days: < > Previous Cycle: < > General Description: < > ___________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. Lab EPI Generate Local Report/Spreadsheet [LREPI GENERATE REPORT/SP] option: This new option is used to generate Lab EPI reports or spreadsheets for national and local emerging pathogens extract data. After selecting national or local emerging pathogens, time period, segments and fields, report or spreadsheet, the job is automatically tasked. The tasked job will take approximately 2-3 hours to generate. An alert is automatically sent to the requester/user after the tasked job has finished generating. The Lab EPI report or spreadsheet can then be viewed on the screen or printed using the new Lab EPI Print Local Report/Spreadsheet [LREPI PRINT] option. NOTE: NO data will be transmitted to AAC when using this option. (See the EPI Roll Up Modifications User Manual Appendix-A section of this manual for the local Report/Spreadsheet field definitions). Example: How to use the new Lab EPI Generate Local Report/Spreadsheet [LREPI GENERATE REORT/SP] option to GENERATE a local REPORT. NOTE: In the following Lab EPI Generate Local Report/Spreadsheet [LREPI GENERATE REORT/SP] option, the prompt 'Include All Pathogens?' when answered "YES" will generate ALL NATIONAL and LOCAL Pathogens. Select Lab EPI Primary Menu Option: lo Local Pathogen Menu ENT Enter/Edit Local Pathogens GEN Lab EPI Generate Local Report/Spreadsheet PRT Lab EPI Print Local Report/Spreadsheet DEL Delete Local Pathogen DRS Delete Local Report or Spreadsheet Select Local Pathogen Menu Option: gen Lab EPI Generate Local Report/Spreadsheet Laboratory Generate Local Report/Spreadsheet option Include All Pathogens? NO// Include All Local Pathogens? NO// Select Pathogens: ? Answer with LAB SEARCH/EXTRACT NAME, or REFERENCE NUMBER Do you want the entire LAB SEARCH/EXTRACT List? y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPH AUREUS ALL STREP PNEUMO CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 Gonorrhea539 HCV Genotype539 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS Hepatitis C RNA tests539 Herpes virus539 Influenza A isolates539 LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS MRSA Bloodstream isolates539 Mycobacterium avium Mycobacterium fortuitum PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A Salmonella539 TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS Select Pathogens: sal Answer with LAB SEARCH/EXTRACT NAME, or REFERENCE NUMBER Do you want the entire LAB SEARCH/EXTRACT List? n (No) Select Pathogens: salm Answer with LAB SEARCH/EXTRACT NAME, or REFERENCE NUMBER Do you want the entire LAB SEARCH/EXTRACT List? n (No) Select Pathogens: S 1 STREPTOCOCCUS GROUP A 2 Salmonella539 CHOOSE 1-2: 2 Salmonella539 Select Pathogens: Select Start Date: 1/1/1995 Select End Date: 12/31/2003 Select one of the following: 1 REPORT 2 SPREADSHEET Enter response: 1 REPORT Choose the segments to capture for report. 1-PID 2-PV1 3-DG1 4-NTE 5-OBR 6-OBX Enter a list or range of numbers (1-7): 1,2,6,7 Choose the fields from the PID segment to capture for report. 1-Set Id 2-SSN 3-MPI 4-Patient Name 5-Date of Birth 6-Sex 7-Race 8-Homeless 9-State 10-Zip Code 11-County 12-Ethnicity 13-Period of Service Enter a list or range of numbers (1-13): 1,2,4 Choose the fields from the PV1 segment to capture for report. 1-Set Id 2-Patient Class 3-Hospital Location 4-Discharge Disposition 5-Facility 6-Admit Date/Time 7-Discharge Date/Time Enter a list or range of numbers (1-7): 1,2,3,5 Choose the fields from the OBR segment to capture for report. 1-Set Id 2-Test Name 3-Accession Date 4-Specimen 5-Accession Number Enter a list or range of numbers (1-5): 1,2,3,4 Choose the fields from the OBX segment to capture for report. 1-Set Id 2-Value Type 3-Test Name 4-LOINC Code 5-LOINC Name 6-Test Result 7-Units 8-Abnormal Flags 9-Verified Date/Time Enter a list or range of numbers (1-9): 1,3,6,9 DOCUMENT TITLE: Sam+Ella 1995 thru 2003 Requested Start Time: NOW//(MAR 08, 2004@10:39:54) The Task has been queued Task # 75028 Example: How to use the new Lab EPI Generate Report/Spreadsheet [LREPI GENERATE REORT/SP] option to GENERATE a local SPREADSHEET. NOTE: In the following Lab EPI Generate Local Report/Spreadsheet [LREPI GENERATE REORT/SP] option, a 'YES' response at the 'Include All Pathogens? NO//' prompt will include ALL NATIONAL and LOCAL Pathogens. ENT Enter/Edit Local Pathogens GEN Lab EPI Generate Local Report/Spreadsheet PRT Lab EPI Print Local Report/Spreadsheet DEL Delete Local Pathogen DRS Delete Local Report or Spreadsheet Select Local Pathogen Menu Option: gen Lab EPI Generate Local Report/Spreadsheet Laboratory Generate Local Report/Spreadsheet option Include All Pathogens? NO// Include All Local Pathogens? NO// Select Pathogens: S 1 STREPTOCOCCUS GROUP A 2 Salmonella539 CHOOSE 1-2: 2 Salmonella539 Select Pathogens: Select Start Date: 1/1/1995 Select End Date: 12/31/2003 Select one of the following: 1 REPORT 2 SPREADSHEET Enter response: 2 SPREADSHEET Choose the segments to capture for spreadsheet. 1-PID 2-PV1 3-DG1 4-DSP 5-NTE 6-OBR 7-OBX Enter a list or range of numbers (1-7): 1,2,6,7 Choose the fields from the PID segment to capture for spreadsheet. 1-Set Id 2-SSN 3-MPI 4-Patient Name 5-Date of Birth 6-Sex 7-Race 8-Homeless 9-State 10-Zip Code 11-County 12-Ethnicity 13-Period of Service Enter a list or range of numbers (1-13): 1,2,4 Choose the fields from the PV1 segment to capture for spreadsheet. 1-Set Id 2-Patient Class 3-Hospital Location 4-Discharge Disposition 5-Facility 6-Admit Date/Time 7-Discharge Date/Time Enter a list or range of numbers (1-7): 1,2,3,5 Choose the fields from the OBR segment to capture for spreadsheet. 1-Set Id 2-Test Name 3-Accession Date 4-Specimen 5-Accession Number Enter a list or range of numbers (1-5): 1,2,3,4 Choose the fields from the OBX segment to capture for spreadsheet. 1-Set Id 2-Value Type 3-Test Name 4-LOINC Code 5-LOINC Name 6-Test Result 7-Units 8-Abnormal Flags 9-Verified Date/Time Enter a list or range of numbers (1-9): 1,3,6,9 DOCUMENT TITLE: Sam+Ella 1995 thru 2003 Requested Start Time: NOW// (MAR 08, 2004@10:41:29) The Task has been queued Task # 75030 Lab EPI Print Local Report/Spreadsheet [LREPI PRINT] option: This new option is used to PRINT a report or spreadsheet which has been generated using the new Lab EPI Generate Local Report/Spreadsheet [LREPI GENERATE REPORT/SP] option. Example: How to use the new Lab EPI Print Local Report/Spreadsheet [LREPI PRINT] option to PRINT a local REPORT. Select Lab EPI Primary Menu Option: lo Local Pathogen Menu ENT Enter/Edit Local Pathogens GEN Lab EPI Generate Local Report/Spreadsheet PRT Lab EPI Print Local Report/Spreadsheet DEL Delete Local Pathogen DRS Delete Local Report or Spreadsheet Select Local Pathogen Menu Option: prt Lab EPI Print Local Report/Spreadsheet Print Local Report/Spreadsheet Option Select one of the following: 1 REPORT 2 SPREADSHEET Which one do you wish to print: 1 REPORT 1 JAN 14,2004@14:50:29 Locl EPI 1-09 thru 12-02 2 JAN 14,2004@15:02:02 Cipro Res 1995 thru 2002 3 JAN 14,2004@20:38:46 Histoplasma Jan 90 - Dec 99 4 JAN 14,2004@20:40:58 CiprResPseud 1-99 - 12-02 5 JAN 14,2004@20:43:25 Mfortuitum 01-85 - 12-02 6 JAN 24,2004@15:08:06 TEST REPORT 7 FEB 4,2004@20:56:48 Gonorrhea report 8 FEB 9,2004@11:15:52 Influenza A 1995 thru 2003 9 FEB 11,2004@13:51:27 Flu A 1995 thru 2003 10 FEB 15,2004@14:33:30 HCV Genotyping 11 FEB 26,2004@23:52:09 HCV RNA Jan 96 thru Dec 02 12 MAR 8,2004@10:37:31 Sam+Ella 1995 thru 2003 Choose the number for the report you wish to print: (1-12): 12 This report will contain Confidential Information. Do you wish to continue/proceed? NO// y YES DEVICE: HOME// WAN ***THIS REPORT CONTAINS CONFIDENTIAL INFORMATION*** EMERGING PATHOGENS LOCAL REPORT MAR 8,2004 PAGE 1 FROM STATION (Your station number is displayed) PROCESSING PERIOD FROM 01-01-1995 THROUGH 12-31-2003 Reported Local Pathogens:Salmonella539 Set Id SSN Patient Name Set Id Patient Class Hospital Location Facility Set ID Test Name Accession Date Specimen Set Id Test Name Test Result Verified Date/Time *************************************************************************** 1 000000024 LABPATIENT2, FOUR 1 Outpatient 1 MICRO CULTURE 04-25-2002@0041 BLOOD 1 SALMONELLA SP 05-08-2002 2 ANTIBIOTIC MIC 04-25-2002@0041 BLOOD 1 AMPICILLIN R 2 TRIMETHOPRIM+SULFAMETHOXAZOLE S 3 CEFOTAXIME S Enter RETURN to continue or '^' to exit: ***THIS REPORT CONTAINS CONFIDENTIAL INFORMATION*** EMERGING PATHOGENS LOCAL REPORT MAR 8,2004 PAGE 2 FROM STATION (Your station number is displayed here) PROCESSING PERIOD FROM 01-01-1995 THROUGH 12-31-2003 Reported Local Pathogens:Salmonella539 Set Id SSN Patient Name Set Id Patient Class Hospital Location Facility Set ID Test Name Accession Date Specimen Set Id Test Name Test Result Verified Date/Time 4 LEVOFLOXACIN S 2 Inpatient 6 NORTH~A612~1 539 1 MICRO CULTURE 05-01-2002@0000 FECES 1 SALMONELLA SP 05-08-2002 **************************************************************************** 2 000000025 LABPATIENT2, FIVE 1 Outpatient 1 MICRO CULTURE 12-30-2002@0000 BLOOD 1 SALMONELLA SP 01-13-2003 ***THIS REPORT CONTAINS CONFIDENTIAL INFORMATION.*** EMERGING PATHOGENS LOCAL REPORT MAR 8,2004 PAGE 3 FROM STATION (Your station number is displayed) PROCESSING PERIOD FROM 01-01-1995 THROUGH 12-31-2003 Reported Local Pathogens: Salmonella539 Set Id SSN Patient Name Set Id Patient Class Hospital Location Facility Set ID Test Name Accession Date Specimen Set Id Test Name Test Result Verified Date/Time 2 ANTIBIOTIC MIC 12-30-2002@0000 BLOOD 1 AMPICILLIN S 2 TRIMETHOPRIM+SULFAMETHOXAZOLE S 3 CEFOTAXIME S 4 LEVOFLOXACIN S 2 Inpatient 6 SOUTH~A667~1 539 1 MICRO CULTURE 12-31-2002@0000 FECES 1 SALMONELLA SP 01-03-2003 **************************************************************************** ***THIS REPORT CONTAINS CONFIDENTIAL INFORMATION.*** EMERGING PATHOGENS LOCAL REPORT MAR 8,2004 PAGE 4 FROM STATION (Your station number is displayed here) PROCESSING PERIOD FROM 01-01-1995 THROUGH 12-31-2003 Reported Local Pathogens:Salmonella539 Set Id SSN Patient Name Set Id Patient Class Hospital Location Facility Set ID Test Name Accession Date Specimen Set Id Test Name Test Result Verified Date/Time 3 000000026 LABPATIENT2, SIX 1 Inpatient MICU/CCU~B608~8 539 1 MICRO CULTURE 05-06-2002@0220 BLOOD 1 SALMONELLA SP 05-24-2002 2 ANTIBIOTIC MIC 05-06-2002@0220 BLOOD 1 AMPICILLIN S 2 TRIMETHOPRIM+SULFAMETHOXAZOLE S 3 CEFOTAXIME S 4 LEVOFLOXACIN S ***THIS REPORT CONTAINS CONFIDENTIAL INFORMATION.*** EMERGING PATHOGENS LOCAL REPORT MAR 8,2004 PAGE 5 FROM STATION (Your station number is displayed here) PROCESSING PERIOD FROM 01-01-1995 THROUGH 12-31-2003 Reported Local Pathogens:Salmonella539 Set Id SSN Patient Name Set Id Patient Class Hospital Location Facility Set ID Test Name Accession Date Specimen Set Id Test Name Test Result Verified Date/Time *************************************************************************** 4 000000027 LABPATIENT2, SEVEN 1 Outpatient 1 MICRO CULTURE 11-03-2000@0000 FECES 1 SALMONELLA SP 11-22-2000 2 ANTIBIOTIC MIC 11-03-2000@0000 FECES 1 AMPICILLIN S 2 TRIMETHOPRIM+SULFAMETHOXAZOLE S 3 LEVOFLOXACIN S ***THIS REPORT CONTAINS CONFIDENTIAL INFORMATION.*** EMERGING PATHOGENS LOCAL REPORT MAR 8,2004 PAGE 6 FROM STATION (Your station number is displayed here) PROCESSING PERIOD FROM 01-01-1995 THROUGH 12-31-2003 Reported Local Pathogens:Salmonella539 Set Id SSN Patient Name Set Id Patient Class Hospital Location Facility Set ID Test Name Accession Date Specimen Set Id Test Name Test Result Verified Date/Time 2 Outpatient 1 MICRO CULTURE 12-29-2000@1400 FECES 1 SALMONELLA SP 01-03-2001 2 ANTIBIOTIC MIC 12-29-2000@1400 FECES 1 GENTAMICIN 2 CEFAZOLIN 3 AMPICILLIN S 4 POLYMIXIN B 5 TRIMETHOPRIM+SULFAMETHOXAZOLE S ***THIS REPORT CONTAINS CONFIDENTIAL INFORMATION.*** EMERGING PATHOGENS LOCAL REPORT MAR 8,2004 PAGE 7 FROM STATION (Your station number is displayed here) PROCESSING PERIOD FROM 01-01-1995 THROUGH 12-31-2003 Reported Local Pathogens:Salmonella539 Set Id SSN Patient Name Set Id Patient Class Hospital Location Facility Set ID Test Name Accession Date Specimen Set Id Test Name Test Result Verified Date/Time 6 PIPERACILLIN 7 CEFOTAXIME 8 CIPROFLOXACIN 9 IMIPENUM 10 CEFTAZIDIME 11 TIMENTIN 12 AMPICILLIN+SULBACTAM 13 CEFOTETAN 14 CEFTRIAXONE ***THIS REPORT CONTAINS CONFIDENTIAL INFORMATION.*** EMERGING PATHOGENS LOCAL REPORT MAR 8,2004 PAGE 8 FROM STATION (Your station number is displayed here) PROCESSING PERIOD FROM 01-01-1995 THROUGH 12-31-2003 Reported Local Pathogens:Salmonella539 Set Id SSN Patient Name Set Id Patient Class Hospital Location Facility Set ID Test Name Accession Date Specimen Set Id Test Name Test Result Verified Date/Time 15 CEFUROXIME-SODIUM 16 CEFUROXIME-AXETIL 17 LEVOFLOXACIN S *************************************************************************** 5 000000028 LABPATIENT2, EIGHT 1 Outpatient 1 MICRO CULTURE 06-18-1997 FECES 1 SALMONELLA SP 06-23-1997 2 ANTIBIOTIC MIC 06-18-1997 FECES ***THIS REPORT CONTAINS CONFIDENTIAL INFORMATION.*** EMERGING PATHOGENS LOCAL REPORT MAR 8,2004 PAGE 9 FROM STATION (Your station number is displayed here) PROCESSING PERIOD FROM 01-01-1995 THROUGH 12-31-2003 Reported Local Pathogens:Salmonella539 Set Id SSN Patient Name Set Id Patient Class Hospital Location Facility Set ID Test Name Accession Date Specimen Set Id Test Name Test Result Verified Date/Time 1 GENTAMICIN 2 CEFAZOLIN 3 AMPICILLIN S 4 POLYMIXIN B 5 TRIMETHOPRIM+SULFAMETHOXAZOLE S 6 AMIKACIN 7 CEFOXITIN 8 PIPERACILLIN 9 CEFOTAXIME ***THIS REPORT CONTAINS CONFIDENTIAL INFORMATION.*** EMERGING PATHOGENS LOCAL REPORT MAR 8,2004 PAGE 10 FROM STATION (Your station number is displayed here) PROCESSING PERIOD FROM 01-01-1995 THROUGH 12-31-2003 Reported Local Pathogens:Salmonella539 Set Id SSN Patient Name Set Id Patient Class Hospital Location Facility Set ID Test Name Accession Date Specimen Set Id Test Name Test Result Verified Date/Time 10 NITROFURANTOIN 11 CEFOPERAZONE 12 MEZLOCILLIN 13 CEPHALOTHIN 14 CEFUROXIME 15 TICARCILLIN 16 CIPROFLOXACIN S 17 AZTREONAM 18 IMIPENUM ***THIS REPORT CONTAINS CONFIDENTIAL INFORMATION.*** EMERGING PATHOGENS LOCAL REPORT MAR 8,2004 PAGE 11 FROM STATION (Your station number is displayed here) PROCESSING PERIOD FROM 01-01-1995 THROUGH 12-31-2003 Reported Local Pathogens:Salmonella539 Set Id SSN Patient Name Set Id Patient Class Hospital Location Facility Set ID Test Name Accession Date Specimen Set Id Test Name Test Result Verified Date/Time 19 CEFTAZIDIME 20 TIMENTIN 21 AMPICILLIN+SULBACTAM 22 NORFLOXACIN *************************************************************************** 6 000000029 LABPATIENT2, NINE 1 Inpatient 6 NORTH~A624~1 539 1 MICRO CULTURE 01-23-2003@0000 FECES 1 SALMONELLA SP 02-07-2003 ***THIS REPORT CONTAINS CONFIDENTIAL INFORMATION.*** EMERGING PATHOGENS LOCAL REPORT MAR 8,2004 PAGE 12 FROM STATION (Your station number is displayed here) PROCESSING PERIOD FROM 01-01-1995 THROUGH 12-31-2003 Reported Local Pathogens:Salmonella539 Set Id SSN Patient Name Set Id Patient Class Hospital Location Facility Set ID Test Name Accession Date Specimen Set Id Test Name Test Result Verified Date/Time 2 ANTIBIOTIC MIC 01-23-2003@0000 FECES 1 AMPICILLIN S 2 TRIMETHOPRIM+SULFAMETHOXAZOLE S 3 LEVOFLOXACIN S ************************************************************************** 7 000000210 LABPATIENT2, TEN 1 Outpatient 1 MICRO CULTURE 04-03-1996@0000 FECES 1 SALMONELLA SP 04-07-1996 ***THIS REPORT CONTAINS CONFIDENTIAL INFORMATION.*** EMERGING PATHOGENS LOCAL REPORT MAR 8, 2004 PAGE 13 FROM STATION (Your station number is displayed here) PROCESSING PERIOD FROM 01-01-1995 THROUGH 12-31-2003 Reported Local Pathogens:Salmonella539 Set Id SSN Patient Name Set Id Patient Class Hospital Location Facility Set ID Test Name Accession Date Specimen Set Id Test Name Test Result Verified Date/Time 2 ANTIBIOTIC MIC 04-03-1996@0000 FECES 1 AMPICILLIN S 2 TRIMETHOPRIM+SULFAMETHOXAZOLE S 3 CIPROFLOXACIN S ***************************************************************************** 8 000000031 LABPATIENT3, ONE 1 Outpatient 1 MICRO CULTURE 06-27-2002@0000 FECES 1 SALMONELLA SP 07-24-2002 ***THIS REPORT CONTAINS CONFIDENTIAL INFORMATION.*** EMERGING PATHOGENS LOCAL REPORT MAR 8, 2004 PAGE 14 FROM STATION (Your station number is displayed here) PROCESSING PERIOD FROM 01-01-1995 THROUGH 12-31-2003 Reported Local Pathogens:Salmonella539 Set Id SSN Patient Name Set Id Patient Class Hospital Location Facility Set ID Test Name Accession Date Specimen Set Id Test Name Test Result Verified Date/Time 2 ANTIBIOTIC MIC 06-27-2002@0000 FECES 1 AMPICILLIN S 2 TRIMETHOPRIM+SULFAMETHOXAZOLE S 3 LEVOFLOXACIN S ENT Enter/Edit Local Pathogens GEN Lab EPI Generate Local Report/Spreadsheet PRT Lab EPI Print Local Report/Spreadsheet DEL Delete Local Pathogen DRS Delete Local Report or Spreadsheet Example: How to use the new Lab EPI Print Local Report/Spreadsheet [LREPI PRINT] option to PRINT a local SPREADSHEET. ENT Enter/Edit Local Pathogens GEN Lab EPI Generate Local Report/Spreadsheet PRT Lab EPI Print Local Report/Spreadsheet DEL Delete Local Pathogen DRS Delete Local Report or Spreadsheet Select Local Pathogen Menu Option: prt Lab EPI Print Local Report/Spreadsheet Print Local Report/Spreadsheet Option Select one of the following: 1 REPORT 2 SPREADSHEET Which one do you wish to print: 2 SPREADSHEET 1 JAN 16,2004@16:31:40 Mfortuitum 1-97 thru 12-02 2 JAN 24,2004@15:09:13 TEST SPSHT 3 FEB 4,2004@20:59:04 Myfortuitum report 4 FEB 26,2004@23:49:13 MRSA BSI Jan 00 thru Dec 02 5 FEB 29,2004@14:29:54 Sam+Ella 4 subfield results 6 MAR 8,2004@10:40:05 Sam+Ella 1995 thru 2003 Choose the number for the spreadsheet you wish to print: (1-6): 6 This option will print the selected fields. You will need to capture this printout in a text document. Using a text editor, remove any extraneous lines from the beginning and the end of the file so that only the data to be imported remains. Save the edited file. Use this file in the import function of your spreadsheet program. This report will contain Confidential Information. Do you wish to continue/proceed? NO// y YES Ready to Capture? y YES Set Id|SSN|Patient Name| Set Id|Patient Class|Hospital Location|Facility| Set ID|Test Name|Accession Date/Time|Specimen| Set Id|Test Name|Test Result|Verified Date/Time| ***************************************************************************** 1|000000024|LABPATIENT2, FOUR| 1|Outpatient||| 1|MICRO CULTURE|04-25-2002@0041|BLOOD| 1||SALMONELLA SP|05-08-2002| 2|ANTIBIOTIC MIC|04-25-2002@0041|BLOOD| 1|AMPICILLIN|R|| 2|TRIMETHOPRIM+SULFAMETHOXAZOLE|S|| 3|CEFOTAXIME|S|| 4|LEVOFLOXACIN|S|| 2|Inpatient|6 NORTH~A612~1|539| 1|MICRO CULTURE|05-01-2002@0000|FECES| 1||SALMONELLA SP|05-08-2002| ***************************************************************************** 2|000000025|LABPATIENT2, FIVE| 1|Outpatient||| 1|MICRO CULTURE|12-30-2002@0000|BLOOD| 1||SALMONELLA SP|01-13-2003| 2|ANTIBIOTIC MIC|12-30-2002@0000|BLOOD| 1|AMPICILLIN|S|| 2|TRIMETHOPRIM+SULFAMETHOXAZOLE|S|| 3|CEFOTAXIME|S|| 4|LEVOFLOXACIN|S|| 2|Inpatient|6 SOUTH~A667~1|539| 1|MICRO CULTURE|12-31-2002@0000|FECES| 1||SALMONELLA SP|01-03-2003| **************************************************************************** 3|000000026|LABPATIENT2, SIX| 1|Inpatient|MICU/CCU~B608~8|539| 1|MICRO CULTURE|05-06-2002@0220|BLOOD| 1||SALMONELLA SP|05-24-2002| 2|ANTIBIOTIC MIC|05-06-2002@0220|BLOOD| 1|AMPICILLIN|S|| 2|TRIMETHOPRIM+SULFAMETHOXAZOLE|S|| 3|CEFOTAXIME|S|| 4|LEVOFLOXACIN|S|| **************************************************************************** 4|000000027|LABPATIENT2, SEVEN| 1|Outpatient||| 1|MICRO CULTURE|11-03-2000@0000|FECES| 1||SALMONELLA SP|11-22-2000| 2|ANTIBIOTIC MIC|11-03-2000@0000|FECES| 1|AMPICILLIN|S|| 2|TRIMETHOPRIM+SULFAMETHOXAZOLE|S|| 3|LEVOFLOXACIN|S|| 2|Outpatient||| 1|MICRO CULTURE|12-29-2000@1400|FECES| 1||SALMONELLA SP|01-03-2001| 2|ANTIBIOTIC MIC|12-29-2000@1400|FECES| 1|GENTAMICIN||| 2|CEFAZOLIN||| 3|AMPICILLIN|S|| 4|POLYMIXIN B||| 5|TRIMETHOPRIM+SULFAMETHOXAZOLE|S|| 6|PIPERACILLIN||| 7|CEFOTAXIME||| 8|CIPROFLOXACIN||| 9|IMIPENUM||| 10|CEFTAZIDIME||| 11|TIMENTIN||| 12|AMPICILLIN+SULBACTAM||| 13|CEFOTETAN||| 14|CEFTRIAXONE||| 15|CEFUROXIME-SODIUM||| 16|CEFUROXIME-AXETIL||| 17|LEVOFLOXACIN|S|| *************************************************************************** 5|000000028|LABPATIENT2, EIGHT| 1|Outpatient||| 1|MICRO CULTURE|06-18-1997|FECES| 1||SALMONELLA SP|06-23-1997| 2|ANTIBIOTIC MIC|06-18-1997|FECES| 1|GENTAMICIN||| 2|CEFAZOLIN||| 3|AMPICILLIN|S|| 4|POLYMIXIN B||| 5|TRIMETHOPRIM+SULFAMETHOXAZOLE|S|| 6|AMIKACIN||| 7|CEFOXITIN||| 8|PIPERACILLIN||| 9|CEFOTAXIME||| 10|NITROFURANTOIN||| 11|CEFOPERAZONE||| 12|MEZLOCILLIN||| 13|CEPHALOTHIN||| 14|CEFUROXIME||| 15|TICARCILLIN||| 16|CIPROFLOXACIN|S|| 17|AZTREONAM||| 18|IMIPENUM||| 19|CEFTAZIDIME||| 20|TIMENTIN||| 21|AMPICILLIN+SULBACTAM||| 22|NORFLOXACIN||| **************************************************************************** 6|000000029|LABPATIENT2, NINE| 1|Inpatient|6 NORTH~A624~1|539| 1|MICRO CULTURE|01-23-2003@0000|FECES| 1||SALMONELLA SP|02-07-2003| 2|ANTIBIOTIC MIC|01-23-2003@0000|FECES| 1|AMPICILLIN|S|| 2|TRIMETHOPRIM+SULFAMETHOXAZOLE|S|| 3|LEVOFLOXACIN|S|| **************************************************************************** 7|000000210|LABPATIENT2, TEN| 1|Outpatient||| 1|MICRO CULTURE|04-03-1996@0000|FECES| 1||SALMONELLA SP|04-07-1996| 2|ANTIBIOTIC MIC|04-03-1996@0000|FECES| 1|AMPICILLIN|S|| 2|TRIMETHOPRIM+SULFAMETHOXAZOLE|S|| 3|CIPROFLOXACIN|S|| ***************************************************************************** 8|000000031|LABPATIENT3, ONE| 1|Outpatient||| 1|MICRO CULTURE|06-27-2002@0000|FECES| 1||SALMONELLA SP|07-24-2002| 2|ANTIBIOTIC MIC|06-27-2002@0000|FECES| 1|AMPICILLIN|S|| 2|TRIMETHOPRIM+SULFAMETHOXAZOLE|S|| 3|LEVOFLOXACIN|S|| How to ENTER local SPREADSHEET captures to a TEXT FILE or EXCEL spreadsheet software: 1. Start the KEA Emulator. From the menu bar, click on the Tools menu, and select the Capture Incoming Data command. NOTE: Other emulators will have similar menu options that will provide the same functionality. Example: KEA emulator setup for screen capture.  How to ENTER local SPREADSHEET captures to a TEXT FILE or EXCEL spreadsheet software continued. 2. After indicating the preferred capture, you must define the location you want the capture file to be stored in (important remember where you indicated). Note: It may be a good idea to create a special folder for this purpose and always route the captured data to this particular folder. Name the capture file something that will be meaningful to you later on). From the Save as type: command to be a Text Files (*.TXT) AND checkmark the Save as text box at the bottom, uncheck the Append data to existing file if it is checked. Example: Saving local SPREADSHEET captures as a Text Files (*.TXT).  How to ENTER local SPREADSHEET captures to a TEXT FILE or EXCEL spreadsheet software continued: Example: Captured data folder location. Note: It may be helpful to see the full folder location path in order to find it again.  How to ENTER local SPREADSHEET captures to a TEXT FILE or EXCEL spreadsheet software continued: 3. After the data capture has finished scrolling to the screen, from the KEA emulator menu bar, click on the Tools menu, and select the End Capture command to decrease the amount of unwanted text that will appear in the saved file. NOTE: The data capture will need to be edited prior to opening the TEXT file in your spreadsheet program. Use the wizard to finish importing the data into a spreadsheet format.  How to ENTER local SPREADSHEET captures to a TEXT FILE or EXCEL spreadsheet software continued. 4. Select the basic Notepad program to open the saved text file folder (remember the location of the saved text file folder). Navigate to the folder via the Notepad program and then open saved text file. Do any required editing and resave the edited text file under the same file name.  How to ENTER local SPREADSHEET captures to a TEXT FILE or EXCEL spreadsheet software continued. Example: This is an example of the saved text file folder location where the particular screen captures were stored in this example. NOTE: This will be different on your system; therefore, it is a good idea to establish a known, standard downloading folder where you can easily find your downloaded text files.  How to ENTER local SPREADSHEET captures to a TEXT FILE or EXCEL spreadsheet software continued. Example: A unique file name in a specific download folder  How to ENTER local SPREADSHEET captures to a TEXT FILE or EXCEL spreadsheet software continued. 5. The saved text file may look similar to the following example. Edit the beginning and end of the captured text so that only text with the bar delimiters are left. NOTE: If the text download wrapped (lines at 80 columns), edit the lines to unwrap the text. Usually this can be done via Notepad by putting the curser at the end of the first line that is wrapped and press delete once or twice to get the next line down that is wrapped. The text must appear as one continuous line for the spreadsheet import to work correctly. Example: Saved Text File Download  How to ENTER local SPREADSHEET captures to a TEXT FILE or EXCEL spreadsheet software continued. Example: This is screen capture example of how the text file should appear after being edited. This will make the text file ready to import into a spreadsheet file via the import wizard.  How to ENTER local SPREADSHEET captures to a TEXT FILE or EXCEL spreadsheet software continued. 6. After editing the ASCII text, click on File, then select the Save command and close the text file. Then start up the spreadsheet program. Example: Saving the ASCII text file data.  Delete Local Pathogen [LREPI DELETE LOCAL PATHOGEN] option This new option allows deletion of local pathogens entries ONLY. NOTE: National emerging pathogens entries CANNOT be deleted using the new Delete Local Pathogen [LREPI DELETE LOCAL PATHOGEN] option. Example: How to use the new Delete Local Pathogen [LREPI DELETE LOCAL PATHOGEN] option to DELETE a local pathogen. ENT Enter/Edit Local Pathogens GEN Lab EPI Generate Local Report/Spreadsheet PRT Lab EPI Print Local Report/Spreadsheet DEL Delete Local Pathogen DRS Delete Local Report or Spreadsheet Select Local Pathogen Menu Option: DELETE Local Pathogen LOCAL PATHOGEN NAME: HISTOPLASMA428 Do you really want to delete this pathogen? YES Entry HISTOPLASMA428 deleted. Delete Local Report or Spreadsheet [LREPI DELETE LOCAL REPORT] option This option is used to delete local reports or local spreadsheets. Example: How to use the new Delete Local Report or Spreadsheet [LREPI DELETE LOCAL REPORT] option to DELETE a local report. Select Lab EPI Primary Menu Option: LO Local Pathogen Menu ENT Enter/Edit Local Pathogens GEN Lab EPI Generate Local Report/Spreadsheet PRT Lab EPI Print Local Report/Spreadsheet DEL Delete Local Pathogen DRS Delete Local Report or Spreadsheet Select Local Pathogen Menu Option: DRS Delete Local Report or Spreadsheet Delete a Local Report/Spreadsheet Option Select one of the following: 1 REPORT 2 SPREADSHEET Which one do you wish to delete: 1 REPORT 1 APR 14,2004@11:02:11 REPORT 1 Choose the number for the report you wish to delete: (1-1): 1 Report deleted. Select one of the following: 1 REPORT 2 SPREADSHEET Which one do you wish to delete: 2 SPREADSHEET 1 APR 14,2004@11:02:11 SPSHT 1 Choose the number for the spreadsheet you wish to delete: (1-1): 1 Spreadsheet deleted. Pathogen Inquiry [LREPI PATHOGEN INQUIRY] option: This new option is used to inquire into the LAB SEARCH/EXTRACT file (#69.5) parameter description fields (i.e., INACTIVE: NO, LAG DAYS: 15, RUN DATE: OCT 07, 2003, CYCLE: MONTHLY, PROTOCOL: LREPI, FOLLOW PTF: YES, REFERENCE NUMBER: 23, and ETIOLOGIES) for defined emerging pathogen. Example: How to use the new Pathogen Inquiry [LREPI PATHOGEN INQUIRY] option Select Lab EPI Primary Menu Option: PI Pathogen Inquiry Select Pathogen: ALL ENTEROCOCCI NAME: ALL ENTEROCOCCI INACTIVE: NO LAG DAYS: 15 RUN DATE: OCT 07, 2003 CYCLE: MONTHLY PROTOCOL: LREPI FOLLOW PTF: YES REFERENCE NUMBER: 23 ETIOLOGY: ENTEROCOCCUS ETIOLOGY: STREP D ENTEROCOCCUS ETIOLOGY: ENTEROCOCCUS (STREPT. FAECALIS-GROUP D) ETIOLOGY: STREPTOCOCCUS FAECALIS ETIOLOGY: STREPTOCOCCUS FAECIUM Description: The enterococci are a group of bacteria that can cause serious disease in humans, including blood stream infections, urinary tract infections, wound infections, endocarditis and even death. As with many other organisms that cause disease in humans, resistance to antibiotics is emerging in the enterococci. The presence of antibiotic resistance creates a challenge in treatment of infections with this organism. In order to determine the prevalence of antibiotic resistance, a baseline of occurrence of ALL enterococci needs to be obtained. This particular EPI pathogen setting has been created to identify ALL culture positive isolates of enterococci from any specimen site in any patient/client receiving care within the VHA. Note: Even specimens that have been obtained from patients (not the environment) as part of an epidemiologic prevalence study or survey should be included if they are present in the VistA laboratory package results from your site. The results from this EPI pathogen setting will be coupled with the results from Reference #1 (Vancomycin-Resistant Enterococci [VRE]) to help determine the percentage of all isolates of enterococci that have vancomycin. Lab EPI Parameter Setup [LREPI (EPI) PARAMETER SETUP] option: The Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option is used to define the search criteria associated with the National Emerging Pathogens Initiative (EPI) extract data. This option allows editing of the National EPI ONLY. Note: Local pathogens CANNOT be added using this option. This option has been enhanced by adding the new PREVIOUS CYCLE field. This new field is automatically defined as 1 for TB ONLY and CANNOT be edited (as highlighted in the example below). For all other emerging pathogens the new PREVIOUS CYCLE field is blank and CANNOT be EDITED. The existing PROTOCOL field has been modified and can NO longer be EDITED. The field displaying ACTIVE "YES" has been modified to display INACTIVE "NO". The following input screen example new functionality changes are highlighted. Example: Laboratory EPI Parameters Input Screen Page 5 of 5 field changes LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: TUBERCULOSIS INACTIVE: NO ____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: 1 General Description: ____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Insert Save changes before leaving form (Y/N)? Y Lab EPI Protocol Edit [LREPI PROTOCOL EDIT] option This option is use to edit the LAB SEARCH/EXTRACT PROTOCOL file. The option is located on the Lab EPI Primary Menu [LREPI SEARCH EXTRACT MENU]. Example: How to use the Lab EPI Protocol Edit [LREPI PROTOCOL EDIT] option Protocol Parameters Setup Definition PROTOCOL: LREPI Title: Emerging Pathogens Initiative (EPI) Message Size: 32000 Report Mail Group: EPI-REPORT Send Alert: YES Send Alert To DOE,Jane Antimicrobial Link Update [LREPILK] option: This option is use to link the ANTIMICROBIAL SUSCEPIBILTY file (#62.06) with the WKLD CODE file (#64). (See the EPI Roll Up Modifications User Manual, Appendix-A section of this manual for an example on how to use this option). Emerging Pathogens Names and Reference Numbers This chart lists the 23 emerging pathogens names and reference numbers: EMERGING PATHOGENSEMERGING PATHOGENSAll Enterococci (Reference #23) (NEW)Hepatitis C Antibody Positive (Reference #2)All Staphylococcus aureus (Reference #18) (NEW)Legionella (Reference #7) Note: The new Legionella Urinary Antigen test has been added to the existing Legionella test criteria.All Streptococcus pneumoniae (Reference #22) (NEW)Leishmaniasis (Reference #14)Candida (Reference #8)Malaria (Reference #11)Clostridium difficle (Reference #4)Methicillin - resistant Staphylococcus aureus (MRSA) (Reference #19) (NEW)Creutzfeldt-Jakob Disease (CJD) (Reference #13)Penicillin - Resistant Pneumococcus (Reference #3)Cryptosporidium (Reference #9)Streptococcus-Group A (Reference #6)Dengue (Reference #12)Tuberculosis (Reference #5)E. coli O157:H7 (Reference #10)Vancomycin-Resistant Coagulase Negative Staphylococci/Staph epi (VRSE) (Reference #21) (NEW)Hepatitis A Antibody Positive (Reference #16)Vancomycin-Resistant Enterococcus (VRE) (Reference #1)Hepatitis B Positive (Reference #17)Vancomycin-Resistant Staphylococcus aureus (VRSA) (Reference #20) (NEW)Not Positive for Hepatitis C Antibody OR Hepatitis C Antibody NEG (Reference #15) Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option Input Screen Definitions LABORATORY EPI PARAMETERS INPUT SCREEN PROMPTS:LABORATORY EPI PARAMETERS INPUT SCREEN PROMPTS DEFINITIONS:Name:The LAB SEARCH/EXTRACT file (#69.5), Name field (#69.5.01) is modified to include the following 6 new emerging pathogens entries. All Staphylococcus aureus (Reference #18) Methicillin-Resistant Staphylococcus aureus (MRSA) (Reference #19) Vancomycin-Resistant Staphylococcus aureus (VRSA) (Reference #20) Vancomycin-Resistant Coagulase Negative Staphylococci/Staph EPI (VRSE) (Reference #21) All Streptococcus pneumoniae (Reference #22) All Enterococci (Reference #23) Answer with the EPI name or reference numberInactive:This prompt is renamed from ACTIVE to INACTIVE. This prompt is used to define if this entry is active or not. '1' or 'YES' indicates that this is an inactive entry. '0' or 'NO' indicates that this is an active entry.Laboratory Test (s):Consider these synonymous with, chemistry, serology, hematology, and blood/serum tests. Results anticipated to be found here would have had a test done under the chemistry/hematology accession areas, even if physically performed in microbiology and other areas. Select tests from the LABORATORY TEST file (#60).Indicator:Select the code that will determine how to match lab results. 1 FOR Use Reference Ranges 2 FOR Contains 3 FOR Greater Than 4 FOR Less Than 5 FOR Equal To Note: This new INDICATOR field (#69.55,1), located under ANTIMICROBIL SUSCEPTIBILITY sub-field (#69.55) is FOR FUTURE USE ONLY.Value:Positive, etc. Answer must be 1-15 characters in length. This is a Free Text field.ICDM-9:ICDM-9 standardized code used nationwide in federal and non-federal/private health care facilities. Select from the ICDM-9 DIAGNOSIS file (#80).ICDM-9 Description:Title of ICDM-9 diagnosis Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option Input Screen Definitions (continued) LABORATORY EPI PARAMETERS INPUT SCREEN PROMPTS:LABORATORY EPI PARAMETERS INPUT SCREEN PROMPTS DEFINITIONS:Selected Etiology:Consider synonymous with organism, final microbial diagnosis/isolate. Select from the ETIOLOGY FIELD file (#61.2).Selected SNOMED codes:Answer with SNOMED CODES You may enter a new SNOMED CODE, if you wish. Answer must be 1-15 characters in length.Antimicrobial Susceptibility:Enter the Antimicrobial that will be used in screening out sensitive Etiologies (e.g., Vancomycin for Vancomycin Resistant Enterococcus). Select from the ANTIMICROBIAL SUSCEPTIBILITY file (#62.6).NLT Code:Displays the associated NLT code if linked. If no NLT Code is displayed use the Antimicrobial Link Update option.NLT Description:Displays the Description of the linked NLT code.Topography Selection:Enter a date to screen out patients born before the date entered. Examples of Valid Dates: JAN 20 1957 or 20 JAN 57 or 1/20/57 or 012057 T (for TODAY), T+1 (for TOMORROW), T+2, T+7, etc. T-1 (for YESTERDAY), T-3W (for 3 WEEKS AGO), etc.Include:Selection of Topography screens all others out except the ones selected. For ALL leave blank. Not to be used in conjunction with the exclude Topography selection. Select from the TOPOGRAPHY file (#61). Exclude:Select the Topography to screen out. Not to be used in conjunction with the Include Topography selection. Select from the TOPOGRAPHY file (#61).First Encounter:Limits the output to the first encounter for the patient. Otherwise list all encounters. Choose: 1 FOR YES 0 FOR NOFollow PTF:Indicates if the PTF record will be followed until a discharge has been entered. Choose: 1 FOR YES 0 FOR NO Before Date Of Birth:Enter a date to screen out patients born before the date entered. Examples of Valid Dates: JAN 20 1957 or 20 JAN 57 or 1/20/57 or 012057 T (for TODAY), T+1 (for TOMORROW), T+2, T+7, etc. T-1 (for YESTERDAY), T-3W (for 3 WEEKS AGO), etc. Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option Input Screen Definitions (continued) LABORATORY EPI PARAMETERS INPUT SCREEN PROMPTS:LABORATORY EPI PARAMETERS INPUT SCREEN PROMPTS DEFINITIONS:After Date Of Birth:A birthrate to screen patients (i.e., patients DOB after 1/1/1950).Select SEX:FOR FUTURE USE ONLY.Run Date:Date that the last Auto EPI processed.Protocol:This defines the protocol associated with the parameters. This prompt has been modified to be UNEDITABLE.Run Cycle:Enter the date that the last Auto EPI processed.Previous Cycle:This new field is displayed on input screen page 5 of 5. By entering a number here the Lab search engine knows to look at a previous cycle for updates to data. How far back it looks is based on the cycle and number entered. For example if the cycle is monthly and the previous cycle is 1, then the search engine will also search 1 month back for data. This new field is UNEDITABLE.Lag Days:Defines the Lag Days parameter as 15 for all 23 emerging pathogens. Lag Days for the six new EPIs has been defined as 15 with the release of the new EPI software.General Description:To review or edit the General Description prompt use the key. Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option The following information must be adhered to as recommended to ensure a successful implementation and utilization of the software: NOTE: There may be more etiologies that fit the description/definition than just the ones that load automatically as part of the EPI Roll Up Modification software. NOTE: It is highly recommended that the Laboratory Information Manager (LIM), a representative from the Microbiology section (director, supervisor, or technologist) and a Total Quality Improvement/Quality Improvement/Quality Assurance (TQI/QI/QA) staff (or person at the facility with similar function) be assigned the Lab EPI Primary Menu [LREPI SEARCH EXTRACT MENU]. These will be the individual(s) responsible for initially setting the Lab EPI parameters descriptions and doing periodic reviews of the parameters descriptions to assure they are current. The Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option is used to setup local parameters for the national emerging pathogens. Each emerging pathogen descriptions must be reviewed prior to setting up the Lab EPI parameters. NOTES: There are a number of different ways that sites have chosen to enter results into the VistA database. As long as the results are in a retrievable format (straight from the VistA database without additional manual input needed), how it is entered is not of significance to the Emerging Pathogen Initiative. However, two preferred methods make it easy to capture the data. Please reference the Helpful Hints section of this guide for the two preferred methods. Site-specific spelling or alternate spelling for data entries must be consistent to guarantee accurate data capture. The Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option, Lag Day parameter MUST be pre-defined as 15 for ALL national emerging pathogens. NOTE: If a lab test needs to be entered more than once in the parameter set up for a particular lab EPI pathogen name (e.g., because there is more than one test result that may meet the definition), the second and subsequent tests must be placed in quotes ( ). Even though the marks are used to enter the data, they dont appear in the final product. This process can be done unlimited times for one set-up. The Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option input screen examples display how to setup EPI parameters (i.e., including the 6 new emerging pathogens. Several of the Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option input screen examples display partially pre-populated entries. The ETIOLOGY FIELD file (#61.2) site-specific data entries are used to partially pre-populate the fields in the LAB SEARCH/EXTRACT file (#69.5). However, further data entries are required for site-specific data. Additional data entries can be added or deleted to meet your site-specific needs. New Legionella Urinary Antigen Test The newer Legionella Urinary Antigen test is available with this release of EPI. The LAB EPI parameter setup for the newer test is POSITIVE FOR LEGIONELLA PNEUMOPHILA. (see helpful hints for Clostridium difficile in Appendix B.) LAB SEARCH/EXTRACT file (#69.5) Entries and Parameter Setup Examples The following table (first column) contains the 6 new emerging pathogens added to LAB SEARCH/EXTRACT file (#69.5). The (second column) contains the Lab EPI parameter setup example entries for the emerging pathogens: Note: The LAB EPI parameter setup entries are ONLY examples, as sites may have different names for tests. The table (second column) examples DOES NOT use the indicator mechanism of whether the result CONTAINS the POS or is EQUAL TO the POS, etc. LAB SEARCH/EXTRACT file (#69.5) Emerging Pathogen 6 New Entries:LAB EPI Parameter Setup Example Entries:All Enterococci (Reference #23)ENTEROCOCCUS STREP D ENTEROCOCCUS ENTEROCOCCUS (STREPT. FAECALIS-GROUP) ENTEROCOCCUS FAECALIS ENTEROCOCCUS DURANS ENTEROCOCCUS FAECIUM ENTEROCOCCUS AVIUM Note: These are just samples. There are many other named species of coagulase negative staphylococci.All Staphylococcus aureus (Reference #18):STAPHYLOCOCCUS AUREUS STAPHYLOCOCCUS AUREUS (MRSA) STAPHYLOCOCCUS AUREUS (VRSA)All Streptococcus pneumoniae (Reference #22):STREPTOCOCCUS PNEUMONIAE DIPLOCOCCUS PNEUMOCOCCUSMethicillin - Resistant Staphylococcus aureus (MRSA) (Reference #19):STAPHYLOCOCCUS AUREUS STAPHYLOC+ OCCUS AUREUS (MRSA)Vancomycin-Resistant Coagulase Negative Staphylococci/Staph epi (VRSE) (Reference #21):STAPHYLOCOCCUS (COAGULASE NEGATIVE) STAPHYLOCOCCUS (COAGULASE NEGATIVE) STAPHYLOCOCCUS EPIDERMIDIS STAPHYLOCOCCUS HAEMOLYTICUS STAPHYLOCOCCUS SAPROPHYTICUS STAPHYLOCOCCUS SALIVARIUS STAPHYLOCOCCUS SIMULANS STAPHYLOCOCCUS SP Note: These are just samples. There are many other named species of coagulase negative staphylococci.Vancomycin-Resistant Staphylococcus aureus (VRSA) (Reference #20)STAPHYLOCOCCUS AUREUS STAPHYLOCOCCUS AUREUS (VRSA) All Enterococci (Reference #23) The enterococci are a group of bacteria that can cause serious disease in humans, including blood stream infections, urinary tract infections, wound infections, endocarditis and even death. As with many other organisms that cause disease in humans, resistance to antibiotics is emerging in the enterococci. The presence of antibiotic resistance creates a challenge in treatment of infections with this organism. In order to determine the prevalence of antibiotic resistance, a baseline of occurrence of ALL enterococci needs to be obtained. This particular EPI pathogen setting has been created to identify ALL culture positive isolates of enterococci from any specimen site in any patient/client receiving care within the Veterans Health Administration (VHA). NOTE: Even specimens that have been obtained from patients (not the environment) as part of an epidemiologic prevalence study or survey should be included if they are present in the VistA laboratory package results from your site. The results from this EPI pathogen setting will be coupled with the results from Reference #1 (Vancomycin-Resistant Enterococci [VRE]) to help determine the percentage of all isolates of enterococci that have vancomycin resistance. Example: Lab EPI Parameter Setup for All Enterococci Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: ALL ENTEROCOCCI LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: ALL ENTEROCOCCI INACTIVE: NO _____________________________________________________________________________ Laboratory Test(s) Indicator Value ICDM-9 ICDM-9 Description ______________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: ALL ENTEROCOCCI INACTIVE: NO _____________________________________________________________________________ Selected Etiology Selected Snomed Codes ENTEROCOCCUS STREP D ENTEROCOCCUS ENTEROCOCCUS (STREPT. FAECALIS-GROUP) ENTEROCOCCUS FAECALIS ENTEROCOCCUS DURANS ENTEROCOCCUS FAECIUM ENTEROCOCCUS AVIUM Note: These are just samples; there are many other named species eneterococci. You should review these and add/delete as appropriate based on the description definition provided in the EPI Technical and User Guide. To enter additional etiologies please see (Appendix-A, How to add an entry using the Lab EPI Parameter Setup [LREPI PARAMTER SETUP] option). Antimicrobial Susceptibility NLT Code NLT Description _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert Example: How to add additional etiology/etiologies NOTE: The following LABORATORY EPI PARAMETERS INPUT SCREEN (i. e., Page 2 of 5) is an example on how to add additional etiology/etiologies (organisms) entries for this emerging pathogen. This functionality causes the added etiology (organism) to appear and the next line will be a blinking cursor. At this point if you have additional etiologies (organisms) to add, just type them in and repeat the process. OR, if you have finished adding etiology/etiologies (organisms) entries, just press the key to proceed with the process. LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: ALL ENTEROCOCCI ACTIVE: NO ___________________________________________________________________________ Selected Etiology Selected Snomed Codes Note: To add additional etiology/etiologies for this emerging pathogen type in the following etiology and select from the following entries. Example: Enteroc ___________________________________________________________________________ ENTEROCOCCUS GALLINARUM L1E606 Are you adding 'ENTEROCOCCUS GALLINARUM' as a new ETIOLOGY? No//Y LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: ALL ENTEROCOCCI INACTIVE: NO ______________________________________________________________________________ Topography Selection Include Exclude ____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: ALL ENTEROCOCCI INACTIVE: NO ____________________________________________________________________________ FIRST ENCOUNTER: FOLLOW PTF: YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: ALL ENTEROCOCCI INACTIVE: NO ______________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: E Press H for help Insert All Staphylococcus aureus (Reference #18) Staphylococcus aureus is a bacterium that causes much disease in humans, including furunculosis, boils, acne, cellulites, pneumonia, toxic shock syndrome, and even death. It has always been a significant pathogen in the community setting, as well as in the healthcare setting where transmission can occur through contact and from the hands of healthcare personnel. The presence of antibiotic resistance creates a challenge in treatment of infections with this organism. In order to determine the prevalence of antibiotic resistance, a baseline of occurrence of ALL Staphylococcus aureus needs to be obtained. This particular EPI pathogen setting has been created to identify ALL culture positive isolates of Staphylococcus aureus from any specimen site in any patient/client receiving care within the VHA. NOTE: Even specimens that have been obtained from patients (not the environment) as part of an epidemiologic prevalence study or survey should be included if they are present in the VistA laboratory package results from your site. The results from this EPI pathogen setting will be coupled with the results from Reference #19 (MRSA) and Reference #20 (VRSA) to help determine the percentage of all isolates of Staphylococcus aureus that have methicillin (oxacillin) resistance and vancomycin resistance. Lab EPI Parameter setup for All Staphylococcus aureus (Reference #18) Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: ALL STAPHYLOCOCCUS AUREUS LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: ALL STAPHYLOCOCCUS AUREUS INACTIVE: NO ______________________________________________________________________________ Laboratory Test(s) Indicator Value ICDM-9 ICDM-9 Description ___________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: ALL STAPH AUREUS INACTIVE: NO _________________________________________________________________________ Selected Etiology Selected Snomed Codes STAPHYLOCOCCUS AUREUS STAPHYLOCOCCUS AUREUS (MRSA) STAPHYLOCOCCUS AUREUS (VRSA) Note: You may enter a new etiology, if you wish. If your facility uses a separate selected etiology designation to report Staphylococcus aureus with resistance to an antibiotic (e.g. Staphylococcus aureus (MRSA)), be sure to include this etiology in your list of names here so that the EPI process will acquire all Staphylococcus aureus isolates. Antimicrobial Susceptibility NLT Code NLT Description _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: ALL STAPH AUREUS INACTIVE: NO ____________________________________________________________________________ Topography Selection Include Exclude ____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: ALL STAPH AUREUS INACTIVE: NO ____________________________________________________________________________ FIRST ENCOUNTER: FOLLOW PTF: YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: ____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: ALL STAPH AUREUS INACTIVE: NO _____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: S Press H for help Insert All Streptococcus pneumoniae (Reference #22) Streptococcus pneumoniae is a bacterium that causes serious disease in humans, including pneumonia, bacteremia, meningitis and even death. It is an important pathogen to monitor in that many of the more serious sequelae of infection may be ameliorated with preventive vaccination. As with many other organisms that cause disease in humans, resistance to antibiotics is emerging in this S. pneumoniae. The presence of antibiotic resistance creates a challenge in treatment of infections with this organism. In order to determine the prevalence of antibiotic resistance, a baseline of occurrence of ALL Streptococcus pneumoniae needs to be obtained. This particular EPI pathogen setting has been created to identify ALL culture positive isolates of Streptococcus pneumoniae from any specimen site in any patient/client receiving care within the VHA. NOTE: Even specimens that have been obtained from patients (not the environment) as part of an epidemiologic prevalence study or survey should be included if they are present in the VistA Laboratory Package results from your site. The results from this EPI pathogen setting will be coupled with the results from Penicillin-Resistant Pneumococcus (Reference #3) to help determine the percentage of all isolates of Streptococcus pneumoniae that have penicillin resistance. Lab EPI Parameter setup for All Streptococcus pneumoniae (Reference #22) Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: ALL STREPTOCOCCUS PNEUMONIAE LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: ALL STREP PNEUMO INACTIVE: NO ______________________________________________________________________________ Laboratory Test(s) Indicator Value ICDM-9 ICDM-9 Description _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: ALL STREP PNEUMO INACTIVE: NO ________________________________________________________________________ Selected Etiology Selected Snomed Codes STREPTOCOCCUS PNEUMONIAE DIPLOCOCCUS PNEUMOCOCCUS Note: You may enter a new etiology, if you wish. Are you adding a new ETIOLOGY? No// Antimicrobial Susceptibility NLT Code NLT Description ______________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: ALL STREP PNEUMO INACTIVE: NO _____________________________________________________________________________ Topography Selection Include Exclude _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: ALL STREP PNEUMO INACTIVE: NO _____________________________________________________________________________ FIRST ENCOUNTER: FOLLOW PTF: YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: ______________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: ALL STREP PNEUMO INACTIVE: NO ____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: S Press H for help Insert Candida (Reference #8) Fungal infections are rising in significance especially in severely ill patients. The same is true for bloodstream infections acquired in the hospital, especially those associated with intravenous lines. Fungal bloodstream infections are increasing in prevalence. As a marker of bloodstream infections, the fungus Candida (and Torulopsis) has been chosen as an initial indicator organism. This organism may not be a prevalent or significant entity at your site; however, its presence is more likely to be indicative of serious or true infection than other organisms. The fungus Candida (and Torulopsis) may commonly be isolated from the blood in association with IV lines. Additionally, this yeast is more likely to be associated with nosocomial acquisition than other organisms (i.e., Staphylococcus aureus and coagulase negative Staphylococcus), which can cause a number of community acquired syndromes not at all related to IV lines. All episodes of Candida (Torulopsis, yeast) isolation from blood or a blood source (central line, IV catheter tip, etc.) are being tracked. The VistA Laboratory EPI software has provided a partial pre-populated list of (etiologies/organisms) that fit the description for Candida (Torulopsis, yeast) to choose. These (etiologies/organisms) should be used, in addition to any site specific (etiologies/organisms) that may also fit the description. Lab EPI Parameter Setup for CANDIDA Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: CANDIDA LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: Candida INACTIVE: NO _____________________________________________________________________________ Laboratory Test(s) Indicator Value ICDM-9 ICDM-9 Description _____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: CANDIDA INACTIVE: NO _____________________________________________________________________________ Selected Etiology Selected Snomed Codes Examples:CANDIDA CANDIDA GUILLIERMONDII CANDIDA KRUSEI CANDIDA PARAPSILOSIS CANDIDA PSEUDOTROPICALIS CANDIDA STELLATOIDEA CANDIDA TROPICALIS CANDIDA, NOS Note: During the post Init, the ETIOLOGY FIELD file (#61.2) was searched to pre-populate the Etiology field (#3) in the EMERGING PATHOGENS file (#69.5). Listed above are examples of etiology entries which may have been populated from your sites file. Additional etiologies may be added or deleted at the Selected Etiology prompt to meet your site specific needs. Note: If spelling differences occur within your ETIOLOGY FIELD file (#61.2), be consistent with your local file and spell the results here, as it is spelled in your file (even if it is spelled differently in the example). We are concerned more importantly with data recovery. Antimicrobial Susceptibility NLT Code NLT Description _____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: Candida INACTIVE: NO ____________________________________________________________________________ Topography Selection Include Exclude Blood Bloodstream Catheter Tip Note: These are only suggestions from specimen source code table 007 (see table 007 in Appendix C). Please add accordingly to your site definition. _____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: Candida INACTIVE: NO ____________________________________________________________________________ FIRST ENCOUNTER: Follow PTF:YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: ____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Insert Save changes before leaving form (Y/N)?Y LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: Candida INACTIVE: NO _____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: ___________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Insert Save changes before leaving form (Y/N)? Clostridium difficile (Reference #4) Disease associated with the presence of Clostridium difficile enterotoxin A can cause significant morbidity, as well as mortality. It is of importance, as its predominant acquisition seems to occur nosocomially. Presence of Clostridial toxin (either enterotoxin A or cytotoxin L) by assay (whether it be EIA, latex agglutination, cytotoxicity of cell culture + neutralization, or culture of organism with subsequent colony testing) is the best indicator that an inflammatory diarrheal disease is due to presence of Clostridium difficile. Laboratory Services are quite varied as to how they identify the presence of Clostridium difficile. Some labs are set up to identify C. difficile as the final microbiological (bacterial) etiology of a culture, even if a culture method was not used. Other labs use a final etiology of see comment and then enter the results in a free text format. Still others enter the text under a hematology or chemistry format where a reference range and positive and negative result values can be entered. Wherever the facility lab places the results which are used to demonstrate the presence of toxin-producing C. difficile, we need to be able to track them (that means it must occur as a retrievable positive or negative result, or as a bacterial etiology). Results in a Comments or Free-text section are not acceptable. There are a number of different ways that sites have chosen to enter Clostridium difficile toxin assay results into the VISTA database. As long as the toxin assay results are in a retrievable format (straight from the VISTA database without additional manual input needed), how it is entered is not of significance to the Emerging Pathogen Initiative. However, there are two preferred methods that make it easy to capture the data. Please reference the Appendix-B section of this guide for the two methods. Lab EPI Parameter Setup for CLOSTRIDIUM DIFFICILE Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: CLOSTRIDIUM DIFFICILE LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: CLOSTRIDIUM DIFFICILE INACTIVE: NO _____________________________________________________________________________ Laboratory Test(s) Indicator Value Clostridium difficile toxin Contains Pos Note: This example is only a suggestion. Please add accordingly to your site definition. ICDM-9 ICDM-9 Description ___________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: CLOSTRIDIUM DIFFICILE INACTIVE: NO ____________________________________________________________________________ Selected Etiology Selected Snomed Codes Clostridium difficile toxin positive Note: This is only a suggestion. Please add accordingly to your site definition. Antimicrobial Susceptibility NLT Code NLT Description ____________________________________________________________________________ Exit Save Next Page Refres COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: CLOSTRIDIUM DIFFICILE INACTIVE: NO _____________________________________________________________________________ Topography Selection Include Exclude _____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: CLOSTRIDIUM DIFFICILE INACTIVE: NO _____________________________________________________________________________ First Encounter: Follow PTF: YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Selected SEX: _____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: CLOSTRIDIUM DIFFICILE INACTIVE: NO _____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: _____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Insert Save changes before leaving form (Y/N)?Y Creutzfeldt-Jakob Disease (CJD) (Reference #13 Creutzfeldt-Jakob Disease (CJD) disease is a rare illness associated with prions. The DVA has chosen to follow this entity because of historic problems with certain blood products used in the private and public health care sectors. The data will be one of a number of ways used to identify changes in trends of incidence of this illness. This task is remarkably complex because of the long incubation period of CJD. There are no specific tests for diagnosis other than central nervous system histology combined with clinical presentation. As such, this entity is followed through ICDM-9 coding. Example: Lab EPI Parameter Setup for CREUTZFELDT-JAKOB DISEASE Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: CREUTZFELDT-JAKOB DISEASE LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME:CREUTZFELDT-JAKOB DISEASE INACTIVE: NO _____________________________________________________________________________ Laboratory Test(s) Indicator Value ICDM-9 ICDM-9 Description 046.1 JAKOB-CREUTZFELDT DIS _____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: CREUTZFELDT-JAKOB DISEASE INACTIVE: NO _____________________________________________________________________________ Selected Etiology Selected Snomed Codes Antimicrobial Susceptibility NLT Code NLT Description _____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: CREUTZFELDT-JAKOB DISEASE INACTIVE: NO _____________________________________________________________________________ Topography Selection Include Exclude _____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: CREUTZFELDT-JAKOB DISEASE INACTIVE: NO _____________________________________________________________________________ First Encounter: Follow PTF: YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: _____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: CREUTZFELDT-JAKOB DISEASE INACTIVE: NO _____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days:15 Previous Cycle: General Description: _____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Insert Save changes before leaving form (Y/N)?Y Cryptosporidium (Reference #9) The parasite Cryptosporidium parvum is a cause of water-borne diarrheal disease. It has gained recent prominence after evaluation of the outbreak in the greater Milwaukee area in 1993 which is estimated to have affected <400,000 persons. In addition to affecting HIV-infected persons and young children, information exists which demonstrates that the chronically ill, elderly are also a higher risk group than the general population. Microbiology laboratory data (parasitology for most laboratories) as well as ICDM-9 coding is used to track this disease, both are narrowly defined parameters. NOTE: Microsporidiosis is a similar disease; however, the EPI does not currently wish to follow this disease process. Microsporidian etiologies should not be entered. NOTE: If a lab test needs to be entered in the parameter set up for a particular lab EPI pathogen name (e.g. because there is more than one test result that may meet the definition), the second and subsequent tests must be placed in quotes ( ). Even though the marks are used to enter the data, they don't appear in the final product. This process can be done unlimited times for one set-up. A new antigen test for Cryptosporidium is FDA approved. If your laboratory uses this test, but does not report the result as an etiology of just the organism name, please refer to Appendix B Helpful Hints for Clostridium difficile to review ways by which these data may be captured. Example: Lab EPI Parameter Setup for CRYPTOSPORIDIUM Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: CRYPTOSPORIDIUM LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: CRYPTOSPORIDIUM INACTIVE: NO ___________________________________________________________________________ Laboratory Test(s) Indicator Value ICDM-9 ICDM-9 Description 007.8 PROTOZOAL INTEST DIS N ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: CRYPTOSPORIDIUM INACTIVE: NO _____________________________________________________________________________ Selected Etiology Selected Snomed Codes Cryptosporidium Note: If Cryptosporidium is reported under parasitology, add Cryptosporidium species at the Etiology prompt. Antimicrobial Susceptibility NLT Code NLT Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: CRYPTOSPORIDIUM INACTIVE: NO ____________________________________________________________________________ Topography Selection Include Exclude ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: CRYPTOSPORIDIUM INACTIVE: NO _____________________________________________________________________________ First Encounter: Follow PTF: YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: _____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: CRYPTOSPORIDIUM INACTIVE: NO _____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: _____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Insert Save changes before leaving form (Y/N)? Y Dengue (Reference #12) The mosquito-borne disease of Dengue Hemorrhagic Fever is a rare but re-emerging infection, especially in the Caribbean. The VA has seen cases of Dengue Hemorrhagic Fever over the last several years. Most of these cases have been in Dengue endemic areas served by the VA. However, as our society becomes more mobile, and the area of Dengue endemncity expands, more cases are likely to occur. Because microbiologic culture is not routinely done and serology can be difficult to track, initially ICDM-9 coded diagnoses are used to track this entity. Example: Lab EPI Parameter Setup for DENGUE Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: DENGUE LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: DENGUE INACTIVE: NO ____________________________________________________________________________ Laboratory Test(s) Indicator Value ICDM-9 ICDM-9 Description 061. DENGUE 065.4 MOSQUITO-BORNE HEM FEVER ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: DENGUE INACTIVE: NO ____________________________________________________________________________ Etiology Selected Snomed Codes Antimicrobial Susceptibility NLT Code NLT Description __________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: DENGUE INACTIVE: NO ____________________________________________________________________________ Topography Selection Include Exclude ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: DENGUE INACTIVE: NO ____________________________________________________________________________ First Encounter: Follow PTF: YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: ____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: DENGUE INACTIVE: NO _____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: _____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Insert Save changes before leaving form (Y/N)? Y E. coli O157:H7 (Reference #10) Escherichia coli serotype O157 (E. coli O157) has gained prominence as a food-borne illness with potentially life threatening complications coming from the associated Hemolytic Uremic Syndrome. Not all sites routinely culture for the presence of E. coli O157 in stool specimens submitted for culture. In addition, E. coli O157 is not a microbiologic (bacterial) etiology pre-existing in the most recent - national microbiology lab package. In order to nationally track cultures positive for this organism, each site will need to make an etiology specific for E-coli O157 (e.g. Escherichia coli O157, E. coli O157, E. coli serotype O157, etc.). Some sites have already done this and will not need to generate a new entry. NOTE: Entering Escherichia coli or E. coli from the bacterial etiology and then entering serotype O157 or O157, under the Comments or Free Text section is not acceptable, as it will not allow the data to be retrieved nationally. All subsequent positive cultures for this organism must then be entered under the new etiology. Other serotypes of E. coli will also cause disease, but we will not currently track these as O157 causes by far, the majority of cases of interest for the national database. The EPI criterion is dependent on your site. If your site already has an etiology that will select positive cultures for E. coli O157, then enter that etiology. However, if your site had to enter a new etiology to accommodate the EPI criteria, be sure to enter this new etiology here. NOTE: If a lab test needs to be entered in the parameter set up for a particular lab EPI pathogen name (e.g. because there is more than one test result that may meet the definition), the second and subsequent tests must be placed in quotes ( ). Even though the marks are used to enter the data, they don't appear in the final product. This process can be done unlimited times for one set-up. Example: Lab EPI Parameter Setup for E. COLI 0157:H7 Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: E. COLI 0157:H7 LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: E. COLI 0157:H7 INACTIVE: NO ____________________________________________________________________________ Laboratory Test(s) Indicator Value ICDM-9 ICDM-9 Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: E. COLI 0157:H7 INACTIVE: NO _____________________________________________________________________________ Selected Etiology Example: Escherichia coli O157 Note: Entering Escherichia coli or E. coli from the bacterial etiology and then entering serotype O157 or O157, under the Comments section or in free text is not acceptable as it will not allow the data to be retrieved nationally). Antimicrobial Susceptibility NLT Code NLT Description __________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: E. COLI 0157:H7 INACTIVE: NO ____________________________________________________________________________ Topography Selection Include Exclude ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: E. COLI 0157:H7 INACTIVE: NO ____________________________________________________________________________ First Encounter: Follow PTF: YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: ____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: E. COLI 0157:H7 INACTIVE: NO _____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: _____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Insert Save changes before leaving form (Y/N)? Y Hepatitis A Antibody Positive (Reference #16) One of the goals of the Healthy People 2000 and 2010 initiatives of the Department of Health and Human Services is to decrease certain infectious diseases, especially those that are vaccine preventable. Acute infection with Hepatitis A is one such disease that has specific objectives present in the Healthy People objectives. The purpose of surveillance for this disease is to record all cases as diagnosed by the laboratory. A positive laboratory test for the presence of Hepatitis A virus is needed. Usually this criterion is met by presence of antibodies to the Hepatitis A virus. In particular, the IgM antibody against hepatitis A is the test most commonly used for determining acute hepatitis A infection. There are other antibody tests available for Hepatitis A. These tests usually indicate past infection with hepatitis A (or in some circumstances may indicate evidence of previous vaccination); usually the IgG antibody against Hepatitis A, OR the Total antibody against Hepatitis A (a test that does not discriminate between IgM or IgG, but can show evidence of exposure) are the tests done for this purpose. What we are looking for is evidence of presence of any antibody to Hepatitis A, whether it is recorded as weakly positive, strongly positive, positive, or present. If other phrases are used to describe a test result, one should be able to differentiate responses upon entry into the program. As an example, the words present and not present might be used to designate positive vs. negative, however, they would not allow retrieval of only the positive cases as both phrases contain the word, present. Also, numerical values of results (e.g. at titer value) are not readily useable. Therefore, parameters for this are to be laboratory based and should include all tests for antibodies against hepatitis A (see examples above). Also, some institutions will use ICD-9 coding and problem lists as a means to abstract data on this disease. DO NOT use these methods for this particular program. We are only abstracting laboratory confirmed cases of antibodies against Hepatitis A. NOTE: If a lab test needs to be entered in the parameter set up for a particular lab EPI pathogen name (e.g. because there is more than one test result that may meet the definition), the second and subsequent tests must be placed in quotes ( ). Even though the marks are used to enter the data, they don't appear in the final product. This process can be done unlimited times for one set-up. Example: Lab EPI Parameter Setup for HEPATITIS A ANTIBODY POS Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: HEPATITIS A ANTIBODY POS Note: The four hepatitis pathogens (Hepatitis C Antibody Positive, Hepatitis C Antibody Negative, Hepatitis A Antibody Positive and Hepatitis B Positive) are tightly integrated with the Clinical Reminder data stream that the EPI national roll-up accomplishes (see combined products VistA Laboratory EPI Hepatitis Extract Patch LR*5.2*260, PXRM*1.5*1, PSJ*5*48 and Patch PSO*7*45) and changes in the EPI parameters may need to have concomitant changes in the Clinical Reminder data being passed over to the EPI national roll-upconcurrent review (and changes, if necessary), should be undertaken in conjunction with the local Clinical Applications Coordinator for the Clinical Reminder package to assure that appropriate mapping of Health factors to the national pathogens has occurred. LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: HEPATITIS A ANTIBODY POS INACTIVE: NO ____________________________________________________________________________ Laboratory Test(s) Indicator Value HEP A ANTIBODY-TOTAL Equal To REACTIVE HEP A ANTIBODY(IgM) Contains POS HEPATITIS A AB(IGG)D/C(2/99) Contains POS HEPATITIS A AB(IGG)D/C(2/99) Contains Pos HEPATITIS A AB(IGG)D/C(2/99) Contains P HEPATITIS A AB(IGG)D/C(2/99) Contains p HEP A ANTIBODY-TOTAL Equal To R Note: Enter the appropriate test for your site, and how the results are reported. ICDM-9 ICDM-9 Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: HEPATITIS A ANTIBODY POS INACTIVE: NO ____________________________________________________________________________ Selected Etiology Selected Snomed Codes Antimicrobial Susceptibility NLT Code NLT Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: HEPATITIS A ANTIBODY POS INACTIVE: NO ____________________________________________________________________________ Topography Selection Include Exclude ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: HEPATITIS A ANTIBODY POS INACTIVE: NO ____________________________________________________________________________ First Encounter: Follow PTF: YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: ____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: HEPATITIS A ANTIBODY POS INACTIVE: NO ____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: ____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Save changes before leaving form (Y/N)? Y Hepatitis B Positive (Reference #17) One of the goals of the Healthy People 2000 and 2010 initiatives of the Department of Health and Human Services is to decrease certain infectious diseases, especially those that are vaccine preventable. Acute and chronic infection with Hepatitis B is one such disease that has specific objectives present in the Healthy People objectives. Both acute and chronic diseases have significant morbidity and can contribute to mortality. Further, infection with hepatitis B can complicate the medical course of persons with other liver ailments. As such, surveillance for both acute and chronic disease is important. In order for the VHA to do surveillance for these diseases, we are looking for laboratory evidence of infection with hepatitis B. This laboratory evidence of infection includes the following standard serological markers: Presence of the Hepatitis B surface antigen Presence of antibodies against the Hepatitis B core antigen (in particular, the IgM antibody) Presence of antibodies against the Hepatitis B surface antigen Presence of the hepatitis B e antigen. These are not all of the tests that can be done for hepatitis B, but they are the ones likely to pick up acute cases (new) or those chronic cases that are likely to be infectious to other persons. Please list only those tests at your facility that is in keeping with what we are looking for acute cases or those cases likely to be infectious to others. NOTE: There are advanced PCR based tests that can measure amount of virus in the bloodstream; these are not done at all sites and have not yet been FDA approved. As such, these PCR tests should not be used for case determination. NOTE: If a lab test needs to be entered in the parameter set up for a particular lab EPI pathogen name (e.g. because there is more than one test result that may meet the definition), the second and subsequent tests must be placed in quotes ( ). Even though the marks are used to enter the data, they don't appear in the final product. This process can be done unlimited times for one set-up. Example: Lab EPI Parameter Setup for HEPATITIS B POS Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: HEPATITIS B POS Note: The four hepatitis pathogens (Hepatitis C Antibody Positive, Hepatitis C Antibody Negative, Hepatitis A Antibody Positive and Hepatitis B Positive) are tightly integrated with the Clinical Reminder data stream that the EPI national roll-up accomplishes (see combined products VistA Laboratory EPI Hepatitis Extract Patch LR*5.2*260, PXRM*1.5*1, PSJ*5*48 and Patch PSO*7*45) and changes in the EPI parameters may need to have concomitant changes in the Clinical Reminder data being passed over to the EPI national roll-upconcurrent review (and changes, if necessary), should be undertaken in conjunction with the local Clinical Applications Coordinator for the Clinical Reminder package to assure that appropriate mapping of Health factors to the national pathogens has occurred. LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: HEPATITIS B POS INACTIVE: NO ____________________________________________________________________________ Laboratory Test(s) Indicator Value HEP B SURFACE Ag Contains POS HEP B SURFACE AB Contains POS HEP B CORE AB(IgM) Contains POS HEP Be ANTIGEN Contains POS HEP Be ANTIGEN Contains Pos HEP Be ANTIGEN Contains p HEP Be ANTIGEN Contains P Note: Enter the appropriate test for your site, and how the results are reported. ICDM-9 ICDM-9 Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: HEPATITIS B POS INACTIVE: NO ____________________________________________________________________________ Selected Etiology Selected Snomed Codes Antimicrobial Susceptibility NLT Code NLT Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: HEPATITIS B POS INACTIVE: NO ____________________________________________________________________________ Topography Selection Include Exclude ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: HEPATITIS B POS INACTIVE: NO __________________________________________________________________________ First Encounter: Follow PTF:YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: ____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: HEPATITIS B POS INACTIVE: NO ____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: ____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Save changes before leaving form (Y/N)? Y Not Positive for Hepatitis C Antibody OR Hepatitis C Antibody Neg (Reference #15) The first version of the EPI gathered data on persons who were positive for antibody against Hepatitis C. This version will continue to gather such data. However, there are many cases, and it is important to try to find out what differences there are in those persons who are positive for Hepatitis C antibody as opposed to those who do not have Hepatitis C antibody present. Therefore, please review those results that you have designated to be place into the Hepatitis C Antibody Positive portion of the EPI. Be sure that they truly meet the definition, as noted in Lab EPI Patch LR*5.2*175 Technical and User Guide (distributed August 1998). All the results of Hepatitis C antibody testing that are not considered positive should be reported in this area. Therefore, all of the hepatitis C results that your facility reports should be mapped to either the hepatitis C Antibody Positive file or the Not Positive for Hepatitis C Antibody File. Not positive terms may include negative, indeterminant, indeterminate, undetectable. As with the Hepatitis C Antibody Positive component, be sure that phrases that truly differentiate results are used (e.g. the results of present and not present are not truly differentiated by computer retrieval as both contain the word present). NOTE: There are PCR based tests utilized for Hepatitis C. These tests are not used at all facilities and are not yet FDA approved for identification of hepatitis C disease. As such, they should not be used for reporting purposes with this iteration of EPI. NOTE: If a lab test needs to be entered in the parameter set up for a particular lab EPI pathogen name (e.g. because there is more than one test result that may meet the definition), the second and subsequent tests must be placed in quotes ( ). Even though the marks are used to enter the data, they don't appear in the final product. This process can be done unlimited times for one set-up. Example: Lab EPI Parameter Setup for HEPATITIS C ANTIBODY NEG Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: HEPATITIS C ANTIBODY NEG Note: The four hepatitis pathogens (Hepatitis C Antibody Positive, Hepatitis C Antibody Negative, Hepatitis A Antibody Positive and Hepatitis B Positive) are tightly integrated with the Clinical Reminder data stream that the EPI national roll-up accomplishes (see combined products VistA Laboratory EPI Hepatitis Extract Patch LR*5.2*260, PXRM*1.5*1, PSJ*5*48 and Patch PSO*7*45) and changes in the EPI parameters may need to have concomitant changes in the Clinical Reminder data being passed over to the EPI national roll-upconcurrent review (and changes, if necessary), should be undertaken in conjunction with the local Clinical Applications Coordinator for the Clinical Reminder package to assure that appropriate mapping of Health factors to the national pathogens has occurred. LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: HEPATITIS C ANTIBODY NEG INACTIVE: NO ____________________________________________________________________________ Laboratory Test(s) Indicator Value HEP C ANTIBODY Contains NEG HEP C ANTIBODY Contains SEE COMMENTS HEP C ANTIBODY Contains * HEP C ANTIBODY Contains # Note: Enter the appropriate test for your site, and how the results are reported. ICDM-9 ICDM-9 Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: HEPATITIS C ANTIBODY NEG INACTIVE: NO ____________________________________________________________________________ Selected Etiology Selected Snomed Codes Antimicrobial Susceptibility NLT Code NLT Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: HEPATITIS C ANTIBODY Neg INACTIVE: NO ____________________________________________________________________________ Topography Selection Include Exclude ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: HEPATITIS C ANTIBODY NEG INACTIVE: NO ____________________________________________________________________________ First Encounter: Follow PTF:YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: ____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: HEPATITIS C ANTIBODY NEG INACTIVE: NO _____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: _____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Save changes before leaving form (Y/N)? Y Hepatitis C Antibody Positive (Reference #2) Hepatitis C is much more prevalent than originally thought at least in certain key patient sub-populations. As new and more sensitive assays come into use, we seem to find more evidence of this pathogen. We are looking for evidence of exposure to Hepatitis C in patients as demonstrated by Hepatitis C antibody positivity. The need for confirmatory testing or demonstration of active disease is not currently necessary in gathering data for this program. Different facilities may use different assays for this test. What we are looking for is evidence of presence of antibody to Hepatitis C, whether it be recorded as weakly positive, strongly positive, positive, or present. If other phrases are used to describe a test result, one should be able to differentiate the results upon entry into the program. As an example, the words, present and not present would not allow retrieval of only positive cases as both phrases contain the word, present. NOTE: There are PCR based tests utilized for Hepatitis C. These tests are not used at all facilities and are not yet FDA approved for identification of hepatitis C disease. As such, they should not be used for reporting purposes with this iteration of EPI. Example: Lab EPI Parameter Setup for Hepatitis C Antibody POS Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: HEPATITIS C ANTIBODY POS Note: The four hepatitis pathogens (Hepatitis C Antibody Positive, Hepatitis C Antibody Negative, Hepatitis A Antibody Positive and Hepatitis B Positive) are tightly integrated with the Clinical Reminder data stream that the EPI national roll-up accomplishes (see combined products VistA Laboratory EPI Hepatitis Extract Patch LR*5.2*260, PXRM*1.5*1, PSJ*5*48 and Patch PSO*7*45) and changes in the EPI parameters may need to have concomitant changes in the Clinical Reminder data being passed over to the EPI national roll-upconcurrent review (and changes, if necessary), should be undertaken in conjunction with the local Clinical Applications Coordinator for the Clinical Reminder package to assure that appropriate mapping of Health factors to the national pathogens has occurred. LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: HEPATITIS C ANTIBODY POS INACTIVE: NO ____________________________________________________________________________ Laboratory Test(s) Indicator Value HEPATITIS C ANTIBODY Contains POS Note: Enter the appropriate test for your site, and how the results are reported. ICDM-9 ICDM-9 Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: HEPATITIS C ANTIBODY POS INACTIVE: NO ____________________________________________________________________________ Selected Etiology Selected Snomed Codes Antimicrobial Susceptibility NLT Code NLT Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: HEPATITIS C ANTIBODY POS INACTIVE: NO ____________________________________________________________________________ Topography Selection Include Exclude ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: HEPATITIS C ANTIBODY POS INACTIVE: NO ____________________________________________________________________________ First Encounter: Follow PTF:YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: ____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: HEPATITIS C ANTIBODY POS INACTIVE: NO _____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: _____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Save changes before leaving form (Y/N)? Y Legionella (Reference #7) Since the American Legion Convention in Philadelphia in the 1970s, Legionnaires disease has been an illness of keen interest to the DVA. Because diagnosis is complex, we have chosen to review for presence of Legionella in culture and in ICDM-9 DIAGNOSIS file (#80). We will not look at Legionella direct fluorescent antibody positivity because of the potential high false positivity of this test. Likewise, serology is not easy to interpret or easily extracted from the VistA database for our purposes and will not be included as a marker in this first iteration of the EPI program. Because it is not yet approved, the newer test of Legionella urinary antigen will not be used either. The Selected Etiology screen display has been partially pre-populated. NOTE: The new FDA-Approved Legionella Urinary Antigen test is available; as such the ability to capture the result with this release of EPI is addressed. This newer test must be added for LEGIONELLA via the Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option. The preferred method to capture this is to have the Etiology (result) of the accessioned microbiology be POSITIVE FOR LEGIONELLA PNEUMOPHILA (or something similar). This issue is similar to one encountered in with the Clostridium difficile pathogen and samples of how to address this are provided in Appendix B Helpful Hints. Example: Lab EPI Parameter Setup for LEGIONELLA Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: LEGIONELLA LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: LEGIONELLA INACTIVE: NO ____________________________________________________________________________ Laboratory Test(s) Indicator Value ICDM-9 ICDM-9 Description 482.80 LEGIONNARIES DISEASE 482.84 LEGIONNARIES DISEASE ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: LEGIONELLA INACTIVE: NO ____________________________________________________________________________ Selected Etiology Examples: LEGIONELLA BOZEMANII LEGIONELLA DUMOFFII LEGIONELLA GORMANII LEGIONELLA JORDANIS LEGIONELLA LONGBEACHAE LEGIONELLA MICDADEI LEGIONELLA OAKRIDGENSIS LEGIONELLA PNEUMOPHILIA LEGIONELLA SP LEGIONELLA WADSWORTHII POSITIVE FOR LEGIONELLA PNEUMOPHILA Note: During the post Init, the ETIOLOGY FIELD file (#61.2) was searched to pre-populate the Etiology field (#3) in the EMERGING PATHOGENS file (#69.5). Listed above are examples of etiology entries which may have been populated from your sites file. Additional etiologies may be added or deleted at the Selected Etiology prompt to meet your site-specific needs. Note: If spelling differences occur within your ETIOLOGY FIELD file (#61.2) be consistent with your local file and spell the results here, as it is spelled in your file (even if it is spelled differently in the example). We are concerned more importantly with data recovery. Antimicrobial Susceptibility NLT Code NLT Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: LEGIONELLA INACTIVE: NO _____________________________________________________________________________ Topography Selection Include Exclude ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: LEGIONELLA INACTIVE: NO ____________________________________________________________________________ First Encounter: Follow PTF: YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: ____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: E. LEGIONELLA INACTIVE: NO _____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: _____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Insert Save changes before leaving form (Y/N)? Y Leishmaniasis (Reference #14) Leishmaniasis is a significant tropical disease that can cause serious complications. It is of interest to the Department of Veterans Affairs as Leishmania has caused illness among military personnel for many years. In addition, the Persian Gulf War occurred in an area of the world where the parasite is endemic. Because no simple, straightforward serology exists and no standard culture techniques exist, we have chosen to follow this entity through ICDM-9 diagnosis codes. Example: Lab EPI Parameter Setup for Leishmaniasis Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: LEISHMANIASIS LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: LEISHMANIASIS INACTIVE: NO ____________________________________________________________________________ Laboratory Test(s) Indicator Value ICD9 ICD9 Description 085.0 VISCERAL LEISHMANIASIS 085.1 CUTAN LEISHMANIAS URBAN 085.2 CUTAN LEISHMANIAS ASIAN 085.3 CUTAN LEISHMANIAS ETHIOP 085.4 CUTAN LEISHMANIAS AMER 085.5 MUCOCUTAN LEISHMANIASIS 085.9 LEISHMANIASIS NOS ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: LEISHMANIASIS INACTIVE: NO ____________________________________________________________________________ Selected Etiology Selected Snomed Codes Antimicrobial Susceptibility NLT Code NLT Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: LEISHMANIASIS INACTIVE: NO ____________________________________________________________________________ Topography Selection Include Exclude Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: LEISHMANIASIS INACTIVE: NO ____________________________________________________________________________ First Encounter: FOLLOW PTF:YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: RET> _________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: E. LEISHMANIASIS INACTIVE: NO _____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: ___________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Insert Save changes before leaving form (Y/N)? Y Malaria (Reference #11) The plasmodial parasite is responsible for the blood-borne disease of malaria. Malaria can cause acute as well as chronic, relapsing disease. Occasionally, U.S. troops are deployed in malaria endemic areas. This placement could potentially put troops at risk for acquiring this disease. For the Emerging Pathogens Initiative program, we are interested in tracking patients with malaria, acute or chronic, relapsing, and in either inpatient or outpatient status. No standardized serologic test allows for easy identification. Since not all sites consistently code and record malarial parasites seen histologically or on blood smears (not all of these interpretations are done through the Pathology and Laboratory Service), we have currently decided to track malaria based on ICDM-9 coding. Example: Lab EPI Parameter Setup for Malaria Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: MALARIA LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: MALARIA INACTIVE: NO ____________________________________________________________________________ Laboratory Test(s) Indicator Value ICDM-9 ICDM-9 Description 084.0 FALCIPARUM MALARIA 084.1 VIVAX MALARIA 084.2 QUARTAN MALARIA 084.3 OVALE MALARIA 084.4 MALARIA NEC 084.5 MIXED MALARIA 084.6 MALARIA NOS 084.7 INDUCED MALARIA 084.8 BLACKWATER FEVER 084.9 MALARIA COMPLICATED NEC ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: MALARIA INACTIVE: NO ____________________________________________________________________________ Selected Etiology Selected Snomed Codes Antimicrobial Susceptibility NLT Code NLT Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: MALARIA INACTIVE: NO ___________________________________________________________________________ Topography Selection Include Exclude ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: MALARIA INACTIVE: NO ________________________________________________________________________ First Encounter: FOLLOW PTF: YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Selected SEX: Exit Save Refresh COMMAND: E Press H for help LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: MALARIA INACTIVE: NO _____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: ___________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Save changes before leaving form (Y/N)? Y Methicillin-Resistant Staphylococcus aureus (MRSA) (Reference #19) Methicillin (or oxacillin)-resistant Staphylococcus aureus (MRSA) is a pathogen of continuing importance for healthcare facilities. It is also an emerging pathogen from community-acquired sources. It is an organism that can be transmitted easily within facilities and in the community. It can produce a spectrum of illness from asymptomatic colonization to severe, life-threatening disease in those patients who acquire it. Whether this organism is causing disease or not, it can contribute to spread within a healthcare facility. The purpose of this pathogen on the EPI list is to capture all cultures that have MRSA present (whether the patient has disease or is just colonized). This should capture all methicillin non-Susceptible isolates of Staphylococcus aureus. NOTE: This includes all positive cultures for MRSA, both clinical cultures and those done as part of epidemiologic prevalence studies or surveys (such as nasal and rectal swabs) at your facility. Any Staphylococcus aureus isolate that is resistant to methicillin (or oxacillin) should be captured for this. Laboratories may use different methods to capture these data. An appropriate National Committee on Clinical Laboratory Standards (NCCLS) testing schema used and captured in VistA should be adequate. Example: Lab EPI Parameter Setup for METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: METH-RES STAPH AUREUS LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: METH-RES STAPH AUREUS INACTIVE: NO ______________________________________________________________________________ Laboratory Test(s) Indicator Value ICDM-9 ICDM-9 Description ______________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: METH-RES STAPH AUREUS INACTIVE: NO ______________________________________________________________________________ Selected Etiology Selected Snomed Codes STAPHYLOCOCCUS AUREUS STAPHYLOC+ OCCUS AUREUS (MRSA STAPHYLOCOCCUS AUREUS NOTE: In addition to Staphylococcus aureus as an etiology, some laboratories may specifically indicate MRSA as a separate etiology. If that is the case with your laboratory, please be sure to include that naming convention in the EPI parameter for Selected Etiology also. Note: You may enter a new etiology, if you wish STAPHYLOCOCCUS AUREUS (MRSA) Are you adding a new ETIOLOGY? No// Y Antimicrobial Susceptibility NLT Code NLT Description OXACILLIN NOTE: For this, place the antibiotic (oxacillin, methicillin, or nafcillin) that your lab utilizes to determine methicillin-resistance. Are you adding a new ANTIMICROBIAL SUSCEPTIBILITY? No// Y OXACILLIN 81844.0000 Oxacillin NAFCILLIN 81808.0000 Nafcillin ______________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: METH-RES STAPH AUREUS INACTIVE: NO _____________________________________________________________________________ Topography Selection Include Exclude _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: METH-RES STAPH AUREUS INACTIVE: NO _____________________________________________________________________________ FIRST ENCOUNTER: FOLLOW PTF: YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: METH-RES STAPH AUREUS INACTIVE: NO _____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: S Press H for help Insert Penicillin - Resistant Pneumococcus (Reference #3) The emergence of antibiotic resistance in microbial agents is of great interest and concern for health care. Penicillin (PCN) was once the mainstay of therapy for Streptococcus pneumoniae infections but resistance to this agent is becoming more prominent. Different therapeutic strategies need to be developed once the prevalence of PCN-resistant S. pneumoniae reaches a critical threshold in a community. In order to monitor this, we are looking for the presence of any resistance in the pneumococci (either moderate/intermediate or frank/high level resistance). As such, any S. pneumoniae, which is not fully susceptible to PCN on PCN susceptibility testing, should be recorded. Example: Lab EPI Parameter Setup for Penicillin - Resistant Pneumococcus Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: PEN-RES PNEUMOCOCCUS LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: PEN-RES PNEUMOCOCCUS INACTIVE: NO ____________________________________________________________________________ Laboratory Test(s) Indicator Value ICDM-9 ICDM-9 Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: PEN-RES PNEUMOCOCCUS INACTIVE: NO ____________________________________________________________________________ Selected Etiology Selected Snomed Codes NOTE: You may enter a new ETIOLOGY, if you wish. STREPTOCOCCUS PNEUMONIAE 12 Are you adding 'STREPTOCOCCUS PNEUMONIAE' as a new ETIOLOGY (the 1ST for this EMERGING PATHOGENS)?Y Antimicrobial Susceptibility NLT Code NLT Description Penicillin Are you adding ' Penicillin ' as a new Antimicrobial Susceptibility (the 1ST for this EMERGING PATHOGENS)?Y ___________________________________________________________________________ Exit Save Next Page Refresh COMMAND: Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: PEN-RES PNEUMOCOCCUS INACTIVE: NO ____________________________________________________________________________ Topography Selection Include Exclude ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: PEN-RES PNEUMOCOCCUS INACTIVE: NO ____________________________________________________________________________ First Encounter: FOLLOW PTF:YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Selected SEX: Exit Save Refresh COMMAND: E Press H for help LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: PEN-RES PNEUMOCOCCUS INACTIVE: NO _____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: _____________________________________________________________________________EExit Save Refresh COMMAND: E Press H for help Insert Save changes before leaving form (Y/N)? Y Streptococcus-Group A (Reference #6) Streptococcus-Group A can be associated with or cause significant disease such as severe fasciitis and streptococcal toxic shock syndrome. We are especially interested to find out how much severe/deep seated disease the VA is experiencing, but other disease entities are of interest also. To this end, we are looking for all episodes of culture positivity for Streptococcus-Group A, regardless of site and regardless of inpatient or outpatient status of the person from whom the specimen is obtained. We are aware that some sites may use rapid screenings for Streptococcus-Group A, especially from pharyngeal sources. These rapid screens may be difficult to capture, so we are not asking for them on this first iteration of the EPI program. However, if you do capture them in a retrievable format they should be included (see Helpful Hints for Clostridium difficile in Appendix B for suggestions on how capture may be possible). Example: Lab EPI Parameter Setup for Streptococcus-Group A Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: STREPTOCOCCUS-GROUP A LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: STREPTOCOCCUS-GROUP A INACTIVE: NO ____________________________________________________________________________ Laboratory Test(s) Indicator Value ICDM-9 ICDM-9 Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: STREPTOCOCCUS-GROUP A INACTIVE: NO ____________________________________________________________________________ Selected Etiology Selected Snomed Codes STREPTOCOCCUS-GROUP A Antimicrobial Susceptibility NLT Code NLT Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: STREPTOCOCCUS-GROUP A INACTIVE: NO ____________________________________________________________________________ Topography Selection Include Exclude ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: STREPTOCOCCUS-GROUP A INACTIVE: NO ____________________________________________________________________________ First Encounter: FOLLOW PTF: YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: ____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: STREPTOCOCCUS-GROUP A INACTIVE: NO _____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: _____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Insert Save changes before leaving form (Y/N)? Y Tuberculosis (TB) (Reference #5) Mycobacterium tuberculosis infection is an important public health concern. Recent increases in incidence of disease, and occurrence of multiply-drug resistant strains in outbreak situations along with the increased susceptibility of HIV-infected persons for this disease has generated renewed interest in this entity. Since the national data show that 80-85% of all reported active tuberculosis cases are culture positive (with acid fast bacilli smear-only positive cases increasing the reporting by 2-5% more) we have decided to use culture positivity for Mycobacterium tuberculosis to track tuberculosis infections in the current iteration of the EPI software application. Information regarding susceptibility will be tracked as well. For the national EPI program, there will be no need to enter specific antimycobacterial agents to be tracked; it will be done automatically. ICDM-9 coding is complex and confusing for many cases of tuberculosis and therefore will not be used. NOTE: The new PREVIOUS CYCLE field displayed on screen Page 1 of 5 is automatically defined as 1 for TB ONLY and CAN NOT be EDIT. Example: Lab EPI Parameter Setup for Tuberculosis (TB) Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: TUBERCULOSIS LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: TUBERCULOSIS INACTIVE: NO ____________________________________________________________________________ Laboratory Test(s) Indicator Value ICDM-9 ICDM-9 Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME:TUBERCULOSIS INACTIVE: NO ____________________________________________________________________________ Selected Etiology Selected Snomed Codes Mycobacterium tuberculosis Antimicrobial Susceptibility NLT Code NLT Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: TUBERCULOSIS INACTIVE: NO ____________________________________________________________________________ Topography Selection Include Exclude ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: TUBERCULOSIS INACTIVE: NO ____________________________________________________________________________ First Encounter: FOLLOW PTF:YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: ____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: TUBERCULOSIS INACTIVE: NO ____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: 1 General Description: ____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Insert Save changes before leaving form (Y/N)? Y Vancomycin-Resistant Coagulase Negative Staphylcocci/Staph epi (VRSE) (Reference #21) Staphylococci are significant contributors to disease in humans. Staphylococcus aureus is the most virulent of the staphylococci, but the non-aureus staphylococci can also cause disease. As a general group, these non-aureus staphylococci are referred to as coagulase negative staphylococci; some refer to this group of organisms as Staphylococcus epidermidis because the staphylococcal species S. epidermidis is one of the more common members of this group to cause disease. However, to be accurate, the group of organisms called coagulase negative staphylococci includes many different species, even if the generic terminology of Staphylococcus epidermidis (a.k.a. Staph epi) has been applied. The coagulase negative staphylococci are important emerging pathogens in that they contribute to many infections acquired while in a healthcare facility. As a general rule, the coagulase negative staphylococci have lesser virulence than Staphylococcus aureus, but they can still cause serious, life-threatening disease in certain settings. As with other organisms, antibiotic resistance is occurring among the coagulase negative staphylococci. There is concern in particular for resistance to vancomycin among this group of organisms, as it is currently the only antibiotic that has consistently shown activity against infections caused by this group of organisms; however, decreased susceptibility and even resistance to vancomycin has been identified in rare cases. The purpose of this EPI pathogen entry is to capture all isolates from all specimens that contain a coagulase negative staphylococcus that is not Susceptible to vancomycin (whether your facility calls it coagulase negative staphylococcus, Staphylococcus epidermidis, Staphylococcus saprophyticus or the myriad of other staphylococcal species that comprise this group). Example: Lab EPI Parameter Setup for Vancomycin-Resistant Coagulase Negative Staphylococci/Staph epi (VRSE) (Reference #21) Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: VANC-RES COAG NEG STAPH LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: VANC-RES COAG NEG STAPH INACTIVE: NO _____________________________________________________________________________ Laboratory Test(s) Indicator Value ICDM-9 ICDM-9 Description _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: VANC-RES COAG NEG STAPH INACTIVE: NO _____________________________________________________________________________ Selected Etiology Selected Snomed Codes STAPHYLOCOCCUS (COAGULASE NEGATIVE) STAPHYLOCOCCUS (COAGULASE NEGATIVE) STAPHYLOCOCCUS EPIDERMIDIS STAPHYLOCOCCUS HAEMOLYTICUS STAPHYLOCOCCUS SAPROPHYTICUS STAPHYLOCOCCUS SALIVARIUS STAPHYLOCOCCUS SIMULANS STAPHYLOCOCCUS SP Note: These are just samples. There are many other named species of coagulase negative staphylococci. Do not include the Staphylococcus aureus, etc.) Note: You may enter a new etiology, is you wish STAPHYLOCOCCUS SP Are you adding a new ETIOLOGY? No// Y Antimicrobial Susceptibility NLT Code NLT Description VANCOMYCIN Are you adding a new ANTIMICROBIAL SUSCEPTIBILITY? No// Y VANCMCN 81485.0000 Vancomycin _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: VANC-RES COAG NEG STAPH INACTIVE: NO _____________________________________________________________________________ Topography Selection Include Exclude ____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: VANC-RES COAG NEG STAPH INACTIVE: NO _____________________________________________________________________________ FIRST ENCOUNTER: FOLLOW PTF: YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: VANC-RES COAG NEG STAPH INACTIVE: NO _____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. Vancomycin-Resistant Enterococcus (VRE) (Reference #1) Vancomycin-Resistant Enterococcus (VRE) is a pathogen of increasing importance. Not only can it cause significant disease, but also it can be spread within facilities. It is important to capture all positive cultures for VRE (not just disease). As such, all positive cultures for VRE will be reported. In addition to Enterococcus sp. as an etiology, some laboratories may specifically indicate VRE as a separate etiology. If that is the case with your laboratory, please be sure to include that naming convention in your EPI parameter for Selected Etiology also. NOTE: This includes cultures positive for prevalence and surveillance review, including specimens of stool and rectal swabs. Vancomycin-resistant Enterococcus faecalis and E. faecium are most common, but we wish to look at all vancomycin resistant enterococci whether speciated or not. Therefore, it is important to be sure to list all the places in the Micro Lab package where Enterococcus are found, either as Enterococcus, E. (sp.), Group D-Streptococcus, E. faecalis, E. faecium, E. durans, E. gallinarum, E. casseliflavus, etc. NOTE: Only a partial pre-populated Etiology list is shown in the screen display example at the Selected Etiology prompt. Please be sure to review the entire Etiology list. If you have other etiology results at your site, they can be added to this Etiology list. Again, if alternate spellings are present in your sites ETIOLOGY FIELD file (#61.2), be certain those spellings assure capture of all data points possible. Example: Lab EPI Parameter Setup for Vancomycin-Resistant Enterococcus (VRE) (Reference #1) Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: VANC-RES ENTEROCOCCUS LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: VANC-RES ENTEROCOCCUS INACTIVE: NO ____________________________________________________________________________ Laboratory Test(s) Indicator Value ICDM-9 ICDM-9 Description ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: VANC-RES ENTEROCOCCUS INACTIVE: NO ____________________________________________________________________________ Selected Etiology Selected Snomed Codes Examples:Enterococcus Enterococcus (Strept. faecalis-Group D) Streptococcus faecalis Enterococcus durans Streptococcus faecium Streptococcus sp. Group D Enterococcus avium Enterococcus avium - (Group D) Enterococcus casseliflavus Enterococcus faecalis Enterococcus gallinarum Enterococcus malodoratus Enterococcus Enterococcus hirae solitarius Enterococcus mundtii Enterococcus Enterococcus raffinosus pseudoavium Enterococcus sp. Enterococcus faecium Enterococcus species Enterococcus durans Enterococcus (VRE) Note: During the post Init, the ETIOLOGY FIELD file (#61.2) was searched to pre-populate the Etiology field (#3) in the EMERGING PATHOGENS file (#69.5). Listed above are examples of etiology entries which may have been populated from your sites file. Additional etiologies may be added or deleted at the Selected Etiology prompt to meet your site specific needs. Note: If spelling differences occur within your ETIOLOGY FIELD file (#61.2) be consistent with your local file and spell the results here, as it is spelled in your file (even if it is spelled differently in the example). We are concerned more importantly with data recovery. Antimicrobial Susceptibility NLT Code NLT Description VANCOMYCIN ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: VANC-RES ENTEROCOCCUS INACTIVE: NO ____________________________________________________________________________ Topography Selection Include Exclude ____________________________________________________________________________ Exit Save Next Page Refresh COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: VANC-RES ENTEROCOCCUS INACTIVE: NO ____________________________________________________________________________ First Encounter: FOLLOW PTF:YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: ____________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Insert Save changes before leaving form (Y/N)?Y LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: VANC-RES ENTEROCOCCUS INACTIVE: NO ____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: ___________________________________________________________________________ Exit Save Refresh COMMAND: E Press H for help Insert Save changes before leaving form (Y/N)?Y Vancomycin-Resistant Staphylococcus Aureus (VRSA) (Reference #20) Vancomycin-resistant Staphylococcus aureus (VRSA) is a rare but emerging pathogen for healthcare facilities. It is of concern because the resistance to this antibiotic can be combined with resistance to other antibiotics; it is this multiple resistance that will make infection with this organism difficult to treat. Staphylococci can be transmitted easily within facilities; the easy transmission is of concern for this organism should it occur in a patient. The staphylococci can produce a spectrum of illness from asymptomatic colonization to severe, life-threatening disease in those patients who acquire them. Whether this organism is causing disease or not, it can contribute to spread within a healthcare facility. The purpose of this pathogen on the EPI list is to capture all cultures that have VRSA present (whether the patient has disease or is just colonized). This should capture all vancomycin non-Susceptible strains of Staphylococcus aureus, whether the susceptibility interpretation is Intermediate or Resistant. NOTE: This includes all positive cultures for VRSA, both clinical cultures and those done as part of epidemiologic prevalence studies or surveys (such as nasal and rectal swabs) at your facility. Any Staphylococcus aureus isolate that is resistant to vancomycin should be captured for this. Laboratories may use different methods to capture these data. An appropriate National Committee on Clinical Laboratory Standards (NCCLS) testing schema used and captured in VistA should be adequate. Example: Lab EPI Parameter Setup for Vancomycin-Resistant Staphylococcus aureus (VRSA) (Reference #20) Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) VR Print Detailed Verification Report LO Local Pathogen Menu ... PI Pathogen Inquiry UP Lab EPI Parameter Setup Lab EPI Protocol Edit LK Antimicrobial Link Update Select Lab EPI Primary menu Option: UP Lab EPI Parameter Setup Select LAB EPI NAME: ? Answer with LAB EPI NAME, or REFERENCE NUMBER Do you want the entire 23-Entry LAB EPI List? Y (Yes) Choose from: ALL ENTEROCOCCI ALL STAPHYLOCOCCUS AUREUS ALL STREPTOCOCCUS PNEUMONIAE CANDIDA CLOSTRIDIUM DIFFICILE CREUTZFELDT-JAKOB DISEASE CRYPTOSPORIDIUM DENGUE E. COLI 0157:H7 HEPATITIS A ANTIBODY POS HEPATITIS B POS HEPATITIS C ANTIBODY NEG HEPATITIS C ANTIBODY POS LEGIONELLA LEISHMANIASIS MALARIA METH-RES STAPH AUREUS PEN-RES PNEUMOCOCCUS STREPTOCOCCUS GROUP A TUBERCULOSIS VANC-RES COAG NEG STAPH VANC-RES ENTEROCOCCUS VANC-RES STAPH AUREUS (VRSA) Select LAB EPI NAME: VANC-RES STAPH AUREUS (VRSA) LABORATORY EPI PARAMETERS INPUT SCREEN Page 1 of 5 NAME: VANC-RES STAPH AUREUS (VRSA) INACTIVE: NO ______________________________________________________________________________ Laboratory Test(s) Indicator Value ICDM-9 ICDM-9 Description ______________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: VANC-RES STAPH AUREUS (VRSA) INACTIVE: NO _____________________________________________________________________________ Selected Etiology Selected Snomed Codes STAPHYLOCOCCUS AUREUS STAPHYLOCOCCUS AUREUS (MRSA) STAPHYLOCOCCUS AUREUS (VRSA) NOTE: In addition to Staphylococcus aureus as an etiology, some laboratories may specifically indicate VRSA as a separate etiology. If that is the case with your laboratory, please be sure to include that naming convention in your EPI parameter for Selected Etiology also. Note: You may enter a new etiology, is you wish STAPHYLOCOCCUS AUREUS (VRSA) Are you adding a new ETIOLOGY? No// Y Antimicrobial Susceptibility NLT Code NLT Description VANCOMYCIN Are you adding a new ANTIMICROBIAL SUSCEPTIBILITY? No// Y VANCMCN 81485.0000 Vancomycin _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 3 of 5 NAME: VANC-RES STAPH AUREUS INACTIVE: NO _____________________________________________________________________________ Topography Selection Include Exclude _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 4 of 5 NAME: VANC-RES STAPH AUREUS INACTIVE: NO _____________________________________________________________________________ FIRST ENCOUNTER: FOLLOW PTF: YES BEFORE DATE OF BIRTH: AFTER DATE OF BIRTH: Select SEX: _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: N Press H for help Insert LABORATORY EPI PARAMETERS INPUT SCREEN Page 5 of 5 NAME: VANC-RES STAPH AUREUS INACTIVE: NO _____________________________________________________________________________ Run Date: Protocol: LREPI Run Cycle: MONTHLY Lag Days: 15 Previous Cycle: General Description: _____________________________________________________________________________ Exit Save Next Page Refresh Enter a command or '^' followed by a caption to jump to a specific field. COMMAND: S Press H for help Insert Conclusion Once you have finished entering the information as directed by the National Infectious Diseases Program Office, these fields should not be changed again except for the following conditions: 1. As requested nationally via the Veterans Affairs Central Office (VACO) Infectious Disease Program Office to update, modify, add, or delete data from the existing files used by the Laboratory EPI software or an addition of a new entity to be tracked. 2. The yearly review must ensure that the entry is acceptable and to update the EPI files with any changes in etiology, lab tests or results parameters that may have occurred locally at the site during the previous year. 3. If your laboratory alters its accessioning or results procedures for one or more other parameters for one of the national EPI pathogens. An update should occur to the EPI to reflect these changes as appropriate. Annually the EPI national program materials should be reviewed by the VAMCs and updated. It is suggested that this review occur in February of each year. If no changes have occurred in lab practices, etiologies, sites, or results parameters leave the information as is until the next review period. If changes did occur, then enter them as appropriate in order to capture the data requested for each EPI national entity (disease/organism) to be tracked. As entities (diseases/organisms) are no longer to be tracked nationally (dropped from the list), or a new entity is to be tracked (added to the list), revision will be forwarded to the sites to assist in updating your site files. NOTE: Remember that if the parameter setup needs to be changed for any of the four hepatitis entities, that a concomitant change needs to be made in the corresponding Clinical Reminder logic. APPENDIX - A EDITING/PRINTING FILES, LINKING DATA, and EDITING INPUT SCREENS Appendix A Editing/Printing Files, Linking Data, and Editing Input Screens This section contains instructions and examples for editing/adding entries the TOPOGRAPHY file (#61), printing LAB SEARCH/EXTRACT file (#69.5) site definitions, linking the ANTIMICROBIAL SUSCEPTIBILITY file (#62.06) data entries to the WKLD CODE file (#64) data entries, and deleting entries from the Laboratory EPI Parameters Input Screen. NOTE: To request additional LOINC, Workload, and Suffixes codes access the VistA Laboratory website, National Lab Tests (NLT) Documentation Set and LOINC Request Forms link:  HYPERLINK "http://vista.med.va.gov/ClinicalSpecialties/lab/" http://vista.med.va.gov/ClinicalSpecialties/lab/ Editing/Printing Files, Screens, Linking Data, Request Form Editing TOPOGRAPHY file (#61): Specific HL7 codes must be added to the TOPOGRAPHY file (#61). The HL7 Code field (#08) in this file is used to add the entries. Specific HL7 codes that must be added to TOPOGRAPHY file (#61) is located in the HL7 section of this guide, Table 0070 (Specimen Source Codes). The following is an example of how to add the specific HL7 codes to the TOPOGRAPHY file (#61) using VA FileMan Version 21 - Enter or Edit File Entries option. Example: How to ADD specific HL7 codes to TOPOGRAPHY file (#61) Select OPTION: ENTER OR EDIT FILE ENTRIES INPUT TO WHAT FILE: TOPOGRAPHY FIELD// EDIT WHICH FIELD: ALL// .08 HL7 CODE THEN EDIT FIELD: Select TOPOGRAPHY FIELD NAME: ? Answer with TOPOGRAPHY FIELD NAME, or SNOMED CODE, or ABBREVIATION, or SYNONYM Do you want the entire 8575-Entry TOPOGRAPHY FIELD List? NO You may enter a new TOPOGRAPHY FIELD, if you wish ANSWER MUST BE 2-80 CHARACTERS IN LENGTH Select TOPOGRAPHY FIELD NAME: AMNIOTIC FLUID 8Y300 HL7 CODE: ? Answer must be 2-4 characters in length. Enter the two to four character codes from the left column: ABS ABCs AMN Amniotic fluid ASP Aspirate BPH Basophils ABLD Blood arterial BBL Blood bag BON Bone BRTH Breath BRO Bronchial BRN Burn Printing LAB SEARCH/EXTRACT file (#69.5) Definitions: Use the following VA FileMan print option to print your local sites definitions from the LAB SEARCH/EXTRACT file (#69.5). Examples: How to PRINT LAB SEARCH/EXTRACT file (#69.5) local sites definitions: Select VA FileMan 22.0 Select OPTION: 2 PRINT FILE ENTRIES OUTPUT FROM WHAT FILE: REMINDER TERM// LAB SEARCH 1 LAB SEARCH/EXTRACT (19 entries) 2 LAB SEARCH/EXTRACT PROTOCOL (2 entries) CHOOSE 1-2: 1 LAB SEARCH/EXTRACT (19 entries) SORT BY: NAME// START WITH NAME: FIRST// HEPATITIS GO TO NAME: LAST// HEPATITIS Z WITHIN NAME, SORT BY: FIRST PRINT FIELD: ? Answer with FIELD NUMBER, or LABEL Do you want the entire 21-Entry FIELD List? Y (Yes) Choose from: .01 NAME .05 REFERENCE NUMBER 1 ACTIVE 2 LAB TEST (multiple) 3 ETIOLOGY (multiple) 4 ICD9 (multiple) 5 ANTIMICROBIAL SUSCEPTIBILITY (multiple) 6 INCLUDED SITES (multiple) 7 EXCLUDED SITES (multiple) 8 SNOMED CODES (multiple) 9 RUN DATE 10 CYCLE 10.5 LAG DAYS 11 FIRST ENCOUNTER 12 PROTOCOL 13 FOLLOW PTF 14 PTF (multiple) 15 Description (word-processing) 16 SEX 17 BEFORE DATE OF BIRTH 18 AFTER DATE OF BIRTH ^ TYPE '&' IN FRONT OF FIELD NAME TO GET TOTAL FOR THAT FIELD, '!' TO GET COUNT, '+' TO GET TOTAL & COUNT, '#' TO GET MAX & MIN, ']' TO FORCE SAVING PRINT TEMPLATE TYPE '[TEMPLATE NAME]' IN BRACKETS TO USE AN EXISTING PRINT TEMPLATE YOU CAN FOLLOW FIELD NAME WITH ';' AND FORMAT SPECIFICATION(S) FIRST PRINT FIELD: .01;C1;L30 NAME THEN PRINT FIELD: ACTIVE;C35;L5 THEN PRINT FIELD: LAG DAYS;C45;L5 THEN PRINT FIELD: LAB TEST (multiple) THEN PRINT LAB TEST SUB-FIELD: .01;C5;L30 LAB TEST THEN PRINT LAB TEST SUB-FIELD: INDICATOR;C38;L15 THEN PRINT LAB TEST SUB-FIELD: INDICATED VALUE;C55;L23 THEN PRINT LAB TEST SUB-FIELD: THEN PRINT FIELD: Heading (S/C): LAB SEARCH/EXTRACT LIST Replace L With site name_L Replace site name_LAB SEARCH/EXTRACT LIST STORE PRINT LOGIC IN TEMPLATE: START AT PAGE: 1// DEVICE: ;;999999 WAN Right Margin: 80// site name_LAB SEARCH/EXTRACT LIST AUG 18,2000 12:21 PAGE 1 LAG NAME ACTIVE DAYS LAB TEST INDICATOR INDICATED VALUE ---------------------------------------------------------------------- HEPATITIS A ANTIBODY POS NO 15 HEP A ANTIBODY-TOTAL Equal To Reactive HEP A ANTIBODY(IgM) HEP A ANTIBODY(IgM) Contains POS HEPATITIS A AB(IGG)D/C(2/99) Contains POS HEPATITIS A AB(IGG)D/C(2/99) Contains Pos HEPATITIS A AB(IGG)D/C(2/99) Contains p HEPATITIS A AB(IGG)D/C(2/99) Equal To Reactive HEPATITIS A AB(IGG)D/C(2/99) Contains p HEPATITIS A AB(IGG)D/C(2/99) Equal To Pos HEPATITIS B POS NO 15 HEP B SURFACE Ag Contains POS HEP B SURFACE AB Contains POS HEP B CORE AB(IgM) Contains POS HEP Be ANTIGEN Contains POS HEP Be ANTIGEN Contains Pos HEP Be ANTIGEN Contains p HEP Be ANTIGEN Contains P HEPATITIS C ANTIBODY NEG NO 15 HEP C ANTIBODY Contains NEG HEP C ANTIBODY Contains SEE COMMENT HEPATITIS C ANTIBODY POS NO 15 HEP C ANTIBODY Contains POS How to Link Antimicrobial Entries to Workload Codes Entries: The Laboratory EPI software automatically links as many of the ANTIMICROBIAL SUSCEPTIBILITY file (#62.06) data entries to the WKLD CODE file (#64) data entries that are identified in your site files. However, the ANTIMICROBIAL SUSCEPTIBILITY file (#62.06) data entries that were not linked (i.e. no match found) to the WKLD CODE file (#64) will require linking. The Antimicrobial Link Update [LREPILK] option contains three functionalities that can be used to identify and link data entries that were not linked by the EPI software installation post-INIT process. Examples: Antimicrobial Link Update [LREPILK] options Select Lab EPI Primary Menu ENH Lab EPI Manual Run (Enhanced) LK Antimicrobial Link Update UP Lab EPI Parameter Setup Lab EPI Protocol Edit Select Lab EPI Primary Menu Option: LKAntimicrobial Link Update This option will allow you to link file '62.06 ANTIMICROBIAL SUSCEPTIBILITY' file with file '64 WKLD CODE. Select one of the following: A AUTO M MANUAL S SEMI-AUTO AUTO function The AUTO function identifies and attempts to link data entries that are not currently linked. This option also displays linked and non-linked data entries. Example: AUTO function Enter response: AUTO AMIKACN <----Linked----> Amikacin AMPICLN <----Linked----> Ampicillin CLINDAM <----Linked----> Clindamycin POLYMYXIN B <----Not Linked---->No Match Found RIFAMPIN <----Linked----> Rifampin MANUAL function The MANUAL function is use to add or delete linked entries. Note: Examples are from entries in the ANTIMICROBIAL SUSCEPTIBILITY file (#62.06). Example: Deleting an Entry Enter response: MANUAL Select ANTIMICROBIAL SUSCEPTIBILITY NAME: PENICLIN PENICILLIN NATIONAL VA LAB CODE: Substance P// PEN 1 PENFIELD AND CONE STAIN 88010.0000 2 PENICILLIN Penicillin 81852.0000 3 PENTAZOCINE Pentazocine 81854.0000 4 PENTOBARBITAL Pentobarbital 81856.0000 CHOOSE 1-4: 2 Penicillin Select ANTIMICROBIAL SUSCEPTIBILITY NAME: VANCMCN VANCOMYCIN NATIONAL VA LAB CODE: Shell Vial Technique// VANCOMYCIN Vancomycin 81485.0000 Select ANTIMICROBIAL SUSCEPTIBILITY NAME: Ampicillin/sulbactam Ampicillin/subalctam NATIONAL VA LAB CODE: Ampicillin// @ SURE YOU WANT TO DELETE? Y (Yes) Select ANTIMICROBIAL SUSCEPTIBILITY NAME: SEMI-AUTO function The SEMI-AUTO function looks for entries that are not currently linked and prompts the user to select the corresponding entry in the WKLD CODE file (#64). Example: SEMI-AUTO function Enter response: SEMI-AUTO AMIKACN AMIKACIN NATIONAL VA LAB CODE: AMIKACIN Amikacin 81098.0000 Continue YES/ AMPICLN AMPICILLIN NATIONAL VA LAB CODE: AMP 1 AMP CYCLIC 81029.0000 2 AMPHETAMINE Amphetamine 81528.0000 3 AMPHOTERICIN B Amphotericin B 81530.0000 4 AMPICILLIN Ampicillin 81532.0000 CHOOSE 1-4: 4 Ampicillin Continue YES// CLINDAM CLINDAMYCIN NATIONAL VA LAB CODE: CLINDAMYCIN Clindamycin 81676.0000 Continue YES// CARBCLN CARBENICILLIN NATIONAL VA LAB CODE: Continue YES// NO Delete Entry from Laboratory EPI Parameters Input Screen Use the tab key to move the cursor. Highlight the entry that is to be deleted, select the @ symbol, then press enter/return. You will then receive a deletion warning asking if you are sure. Example: Deleting an entry from the Laboratory EPI Parameters Input Screen. LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: CANDIDA ACTIVE: YES ____________________________________________________________________________ Selected Etiology CANDIDA PARAPSILOSIS CANDIDA PSEUDOTROPICALIS CANDIDA SKIN TEST ANTIGEN @ CANDIDA STELLATOIDEA Antimicrobial Susceptibility NLT Code NLT Description ___________________________________________________________________________ Exit Save Next Page Refresh COMMAND: Press H for help WARNING: DELETIONS ARE DONE IMMEDIATELY! (EXITING WITHOUT SAVING WILL NOT RESTORE DELETED RECORDS.) Are you sure you want to delete this entire Subrecord (Y/N)? y How to add an entry to the Laboratory EPI Parameters Input Screen Use the tab key to move the cursor. Highlight a blank line where the entry is to be added. Example: Adding entries via the Laboratory EPI Parameters Input Screen LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: CANDIDA ACTIVE: YES ___________________________________________________________________________ Selected Etiology CANDIDA CANDIDA GUILLIERMONDII CAN Antimicrobial Susceptibility NLT Code NLT Description ________________________________________________________________________ 1 CAN CANDIDA ALBICANS 4081 2 CANARYPOX VIRUS 3604 3 CANDICIDIN 7328 4 CANDIDA, NOS 4080 5 CANDIDA GUILLIERMONDII 4082 Choose 1-5 or '^' to quit: 1 LABORATORY EPI PARAMETERS INPUT SCREEN Page 2 of 5 NAME: CANDIDA ACTIVE: YES ____________________________________________________________________________ Selected Etiology CANDIDA GUILLIERMONDII CANDIDA KRUSEI CANDIDA ALBICANS <- The entry will appear after answering yes to the adding a new ETIOLOGY prompt. Antimicrobial Susceptibility NLT Code NLT Description ________________________________________________________________________ CAN CANDIDA ALBICANS Are you adding 'CANDIDA ALBICANS' as a new ETIOLOGY? Y Lab EPI Generate Local Report/Spreadsheet [LREPI GENERATE REPORT/SP] option Field Definitions: SEGMENTNUMBERFIELD ELEMENT NAMEFIELD DESCRIPTIONPID1Set IDPatient ID Sequence Number The Set ID field is used to identify the number of repetitions of the PID segment by HL7. The first PID segment would have a Set ID value of 1, the next would have a value of 2, etc.2Social Security NumberPatients Social Security Number NNN-NN-NNNN3VA Master Patient Index (MPI) Patients MPI4Patient Name Patients Name Last, First M5Date of BirthPatients Date of Birth6SexPatients Sex Refer to Table 0001.7RACEPatients Race Refer to Table 0005.8Homeless If patient is homeless, then Homeless prints.9StatePatients State10Zip CodePatients Zip Code11CountyPatients County12Ethnicity Patients Ethnicity Refer to table 0189.13Period of Service Military Status assigned to a veteran. Refer to Table VA011.PV11Set ID - Patient VisitAPV1 Sequence Number The Set ID field is used to identify the number of repetitions of the PV1 segment by HL7. The first PV1 segment would have a Set ID value of 1, the next would have a value of 2, etc.2Patient ClassInpatient or Outpatient3Hospital LocationAssigned Patient Location-Treatment Location For inpatients only. WARD~ROOM~BED4Discharge DispositionType of Disposition For Inpatients Only Source VA File PTF (#45) Lab EPI Generate Local Report/Spreadsheet [LREPI GENERATE REPORT/SP] option Field Definitions continued. SEGMENTNUMBERFIELD ELEMENT NAMEFIELD DESCRIPTION5FacilityServicing Facility-Primary Facility6Admit Date/TimeInpatient-Admission Date/Time Outpatient- Accession Date7Discharge Date/TimeDischarge Date/Time For Inpatients OnlyDG11Set ID-Diagnosis (Sequence #)DG1 Sequence Number The Set ID field is used to identify the number of repetitions of the DG1 segment by HL7. The first DG1 segment would have a Set ID value of 1, the next would have a value of 2, etc.2Diagnosis CodeDiagnosis Code3DiagnosisDiagnosis4Admission DateInpatient- Admission Date Outpatient- Accession Date2DATEDate3RESOLVED TERMResolved Term4TEXTText5RESULTTest resultSOURCE IDSource IDNTE1Set IDSequence Number The Set ID field is used to identify the number of repetitions of the NTE segment by HL7. The first NTE segment would have a Set ID value of 1, the next would have a value of 2, etc.3CommentFive formats exist for this segment: a. NTE||manual/automatic indicator (Null for automatic, R for Manual)~REPORTING DATE FROM from date TO to date~message number~~software version number (blank for original system/V2 for new system(epi)~Negative Input Indicator (null if input is present, N if negative) b. NTE|sequence number|reference number from field .05 (reference number) in file 69.5 (LAB SEARCH/EXTRACT)  Lab EPI Generate Local Report/Spreadsheet [LREPI GENERATE REPORT/SP] option Field Definitions continued. SEGMENTNUMBERFIELD ELEMENT NAMEFIELD DESCRIPTIONc. NTE||Totals indicator (T if NTE describes totals for run)~National Lab Test Code~Test Name from files 60 (Lab Test) or file 61.2 (Etiology Field)~Total number of tests performed. d. NTE||Totals indicator (T if NTE describes totals for run)~National Lab Test Code~PATIENTS WITH _Test Name from files 60 (Lab Test) or file 61.2 (Etiology Field)~Number of unique patients receiving this test e. NTE||Totals indicator (T if NTE describes totals for run)~Hepatitis Assessment~Total number of Hepatitis C AssessmentsOBR1Set ID-Observation Request (Seq #)OBR Sequence Number The Set ID field is used to identify the number of repetitions of the OBR segment by HL7. The first OBR segment would have a Set ID value of 1, the next would have a value of 2, etc.2Test NameThe name of the lab test performed.3Accession DateAccession Date4SpecimenSpecimen5Accession NumberAccession NumberOBX1Set Id-ObservationalOBX Sequence Number The Set ID field is used to identify the number of repetitions of the OBX segment by HL7. The first OBX segment would have a Set ID value of 1, the next would have a value of 2, etc.2Value TypeCE or ST3Test NameThe name of the lab test performed.4LOINC CodeLOINC Code5LOINC NameLOINC Name6Test ResultResult of the test performed or the MIC value.7UnitsUnits8Abnormal FlagsAbnormal Flags9Verified Date/TimeThe date/time that the test was verified. APPENDIX-B HELPFUL HINTS Appendix B Helpful Hints This section provides helpful hints, methods, and examples for maintaining and validating EPI data. Preferred Methods for Clostridium difficile Data Capture There are two preferred methods that will make it easy to capture data for Clostridium difficile criteria (i.e., as well as several other methods which sites may already employ). NOTE: As long as the designated parameter results being tracked are in a retrievable field (i.e., not a Free Text or Comment field) the method the site chooses is an individual decision. Preferred Method #1: The first preferred method is to have the site define an etiology of Clostridium difficile toxin positive. This allows a topography specimen of accession area feces/stool to be accessioned through the Microbiology accession area. Then, if the stool specimen were indeed positive for Clostridium difficile toxin, by any of the known methods of testing, the etiology would be Clostridium difficile toxin positive. To accomplish this method would require sites to enter three new local etiologies: Clostridium difficile toxin positive Clostridium difficile toxin negative Clostridium difficile toxin in determinant These would be different from a culture isolate being positive for Clostridium difficile, in that they actually are etiologies/results based on toxin testing. This leaves the etiology of Clostridium difficile for actual culture positive specimens for the organism Clostridium difficile. The Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option, the site parameter by which the software will capture a patient diagnosed with proven Clostridium difficile-associated colitis, will be by placing Clostridium difficile toxin positive etiology into the selected etiology entry screen. This has the advantage of being more consistent with other data entry practices in the Microbiology sections of most laboratories. Preferred Method #2: The second preferred method is having the data in retrievable form would be to enter/accession the specimen for Clostridium difficile toxin assay under the chemistry/serology format (regardless of where the test is physically done) with the results being a choice of positive, negative, or indeterminate. This would allow one to enter Clostridium difficile toxin assay as the test for the EPI software to search in the chemistry/serology format. The result would be retrievable for EPI under a chemistry/serology lab test of Clostridium difficile toxin with the indicator contains and the value of pos, as noted in the sample page. If your site does not routinely do Clostridium difficile toxin assay testing this way, a different method of accessioning the specimen to get it in chemistry/serology format would be needed. However, the Chemistry/Serology format would give additional flexibility in placing interpretational guidelines for the test results in the Comments field. For the EPI, positive or negative results cannot be located in a Free Text or Comments field as these are not retrievable. Some VAMCs accession the stool specimen for the Clostridium difficile toxin assay under the Microbiology format. An etiology is not given under the final culture result, but written into free text or comments section stating the Clostridium difficile toxin assay test result. This is not in a retrievable format and therefore not acceptable for the EPI criteria. Some VAMCs still use cytotoxin assays of cell culture, which are again entered in a Free Text or Comment field. This again is not acceptable unless it is accessioned and recorded under the chemistry/serology format as a straightforward lab test result of positive or negative or indeterminate. Some VAMCs choose to report Clostridium difficile toxin assay positivity under the Microbiology application. As an etiology/culture result of Clostridium difficile (even though culture, was not actually done) this is not a true measure of what is actually being tested (as most sites do not culture the organism but just run the toxin assay test). However, if your site uses this means to represent Clostridium difficile toxin assay positivity and there are no exceptions (such as the site reporting an actual positive culture of (Clostridium difficile which is toxin assay negative), then this would be acceptable though less desirable for EPI purposes. Validating EPI Data Captures The purpose of validating EPI data captures is not to require extra paperwork for QI monitors and long-term document files. The validation should be done at the initial implementation of the Laboratory EPI software to ensure accurate data capture. Thereafter, a review should be done once every 4-6 months to ensure that Lab EPI Parameter Setup [LREPI (EPI) PARAMETER UPDATE] option entries for the EPI criteria remain accurate. Parameter updates may be required when a new lab test/result is to be implemented for one of the Emerging Pathogens Initiative. Once the predetermined emerging pathogens parameter descriptions are defined using the Lab EPI Parameter Setup [LREPI PARAMETER SETUP] option EPI data captures and monthly EPI HL7 format mailman messages transmissions can take place. EPI data captures are automatically generated monthly and sent to AAC on the 15th day of each month. Upon receipt of the EPI HL7 Format mailman messages transmission, AAC sends individual EPI Confirmation Mailman Message to the sending VHA sites EPI mail group members notifying them that the EPI mailman messages transmission has ONLY been received and NO EPI data has been processed. The new EPI Summary Verification Report of EPI Extracted Data from Site mailman messages replaced the original Emerging Pathogens Verification Report mailman messages. The new EPI Summary Verification Report mailman messages are automatically generated at each site on the 15th day of the month and sent to the EPI-REPORT mail group members (i.e., in a human readable format). The new report includes the VHA sites station number and all predetermined emerging pathogens extracted data occurrences totals for the monthly processing reporting cycle. This new report may be used for quick previewing of the EPI data captures entries and totals. The new Detailed Verification Report of EPI Extracted Data from Site replaces the original Emerging Pathogens Verification Report. The new report contains the VHA reporting sites station number with Notes and Comment Segments (NTE) findings in human readable pages. VHA sites reporting NTE findings (i.e., 1, 2, 3 . . . 23) starts with a new page for each NTE findings. The Microbiology Laboratory personnel, Laboratory Manager, TQI/QI/QA, or other personnel (i.e., as determined by the sites) may already have data of isolated organisms of interest. Several of the nationally defined emerging pathogens may well corresponds. Therefore, a quick comparison can be done using the new Verification Detail Report of EPI Extracted Data from Site mailman messages. This comparison also ensures that the Laboratory EPI software is appropriately capturing all EPI cases and numbers. For tests such as Hepatitis A Antibody NEG, Hepatitis B Antibody NEG, Hepatitis C Antibody POS, and Hepatitis C Antibody NEG most LIMs should be able to generate reports (with patient names) that include positive tests results to use for comparison. Additionally, the Health Information Management Section at each site should be able to generate a report of ICDM-9 Diagnoses by date. This ICDM-9 Diagnoses by-date-report helps determine if the VACO Infectious Disease Program Office EPI and emerging pathogens data captures concurs with the defined EPI criterion (i.e., Cryptosporidium-007.8, Legionnaires disease--482.80, malaria--084, 084.0, 084.1, 084.2, 084.3, 084.4, 084.5, 084.6, 085.7, 084.8, 084.9, dengue-061, 065.4, Creutzfeldt-Jakob--046.1, and Leishmaniasis--085, 085.0, 085.1, 085.2, 085.3, 085.4, 085.5, 085.9. Be aware that a number of these pathogens DO NOT occur at a high frequency. VHA sites with previously known cases of emerging pathogens, such as TB, should run the Lab EPI Manual Run [LREPI (EPI) MANUAL RUN] option for the entire month to verify that the TB culture was isolated and to see if it is captured. Additionally, test patients known to have these lab results can also be run. Required EPI Mail Groups and Descriptions The EPI Roll up Modification software release requires the following mail groups: EPI mail group EPI-REPORT mail group NOTES: It is highly recommended that the Office of the Director (00) at each VHA facility initially designate the member(s) responsible for overseeing the EPI mail group, and the EPI-REPORT mail group.. The Office of Director (00)-designated staff for EPI process implementation should be assigned to this mail group and kept current as personnel assume this responsibility. This/these staff member(s) is/are responsible for reviewing processing (error) reports and coordinating EPI data corrections (as necessary) due to the numerous files from which the data is obtained (e.g., PTF, PIMS, Health Information Management, Laboratory, etc.). Once the corrections are made, it is the responsibility of this designated staff to re-transmit the EPI data to the AAC using the Lab EPI Manual Run (Enhanced) option. Other personnel at the site who may be of assistance trouble-shooting errors may also elect to be member of this mail group. It is highly recommended that a TQI/QI/QA staff, Laboratory Information Manager (LIM), Microbiology director or supervisor, Infection Control Practitioners, or Hospital Epidemiologist), or individual(s) with similar functions be a member(s) of one or more of these mail groups as previously noted. EPI Mail Group Description The EPI mail group is used by VHA facilities to transmit EPI HL7 format mailman messages TO the Austin Automation Center (AAC). This mail group is also used by AAC to transmit EPI Confirmation mailman messages BACK to the sending VHA facilities once the EPI HL7 format mailman messages data transmission has been received by AAC. EPI-REPORT Mail Group Description The EPI-Report mail group is use to receive the automatically generated new Verification Summary Report on the 15th day of each month. This mail group is also use to receive the new Verification Summary Report when manually generated using the Lab EPI Manual Run (Enhanced) [LREPI ENHANCE MANUAL RUN] option. NOTE: Members of the EPI-Report mail group will assist with the EPI data validation and data correction process. EPI Data Processing Cycles Currently, twenty three predetermined emerging pathogens act as triggers for EPI data extraction (i.e., as defined by VACO) within the EPI software application. The software then retrieves relevant, predetermined, and patient-specific data. EPI software builds a HL7 format mailman message transmission on the 15th day of each month containing specific EPI data extractions. Note: A local global build is used to automatically generate the new Verification Summary Report and Verification Detailed Report of EPI Extracted Data From Site in a HL7 format mailman message. EPI HL7 format mailman messages containing the EPI data extractions are transmitted to the Austin Automation Center via the Q-EPI.MED.VA.GOV domain on the 15th day of each month. Austin Automation Center returns an EPI Confirmation mailman message upon receiving the sending facility EPI HL7 format mailman message. Note: The EPI Confirmation mailman message ONLY confirms that the EPI HL7 Format mailman messages have reached the Austin Automation Center queue, NOT necessarily accepted for processing. On about the 25th day of the month Austin Automation Center processes the EPI data set and sends an EPI Processing (Error)Report mailman messages back to each sending facility via the EPI mail group. Note: The EPI Processing Report notifies the sending facility that the EPI data set has been processed by the Austin Automation Center, either with NO fatal errors indicating EPI data set acceptance OR that Fatal Error codes occurred constituting rejection of the entire EPI data set. Once the EPI data set is accepted, the Austin Automation Center analyzes the EPI data set using the Statistical Analysis System (SAS) based statistical software. VACO Reports may then be generated for appropriate use and distribution at the national level. EPI HL7 Format Mailman Message The VistA Laboratory EPI software automatically searches, extracts, processes, and transmits EPI data using an HL7 format mailman message on the 15th of each month via the Q-EPI.MED.VA.GOV domain to the AAC for processing. The EPI software is enhanced to include LOINC, MIC values, MPI values, race, ethnic Groups, county codes, and assigned patient class for inpatient/outpatient data. Example: New EPI HL7 Format Mailman Message MailMan message for LABPROGRAMMER, ONE Printed at TEST.CINCINNATI.MED.VA.GOV 01/15/04@11:31 Subj: HL7 Msg JAN 14,2004@23:03:31 from CINCINNATI [#53959] 01/14/04@23:03 588 lines From: POSTMASTER (POSTMASTER In 'IN' basket. Page 1 *New* --------------------------------------------------------------------------- MSH|~^\&|EPI-LAB|539|EPI-LAB|539|20040114230323-0400||ORU~R01|53923600917|T|2.2 |||NE|NE|USA NTE||R~REPORTING DATE FROM 20030101 TO 20030131~1~~V3 PID|1|000-00-0035~~|122~2~M10~1004151421V503772~VAMPI||LABPATIENT3, FIVE||193403 14|M|||~~~39^OHIO~45227~~~~89^HAMILTON||||||||000000035||||||||0 PV1|1|O||||||||||||||||||||||||||||||||||||539||||||20030116084420-0400 DG1|1||401.9~HYPERTENSION NOS~I9 DSP|1||20030116084420-0400~HEP C VIRUS ANTIBODY NEGATIVE~6~NEGATIVE~||0 NTE|1|15~HEPATITIS C ANTIBODY NEG OBR|1|||81121.0000~CHEMISTRY TEST~VANLT|||20030116084420-0400||||||||SER~~SERUM |||RIA 03 637 OBX|1|ST|89070.0000~HEPATITIS C AB~VANLT~1486~HEP C ANTIBODY~VA60~13955~HEPATIT IS C VIRUS AB:ACNC:PT:S~LOINC||NEGATIVE||-|||||||20030122144539-0400 PID|2|000-00-0036~~|140~4~M10~1004666645V068241~VAMPI||LABPATIENT3, SIX||1947020 3|M|||~~~39^OHIO~45229~~~~89^HAMILTON||||||||000000036||||||||7 PID|3|000-00-0037~~|310~3~M10~1008185084V033776~VAMPI||LABPATIENT3, SEVEN||19551019 |M|||~~~12^FLORIDA~33931~~~~39^LEE||||||||000000037||||||||8 PV1|1|O||||||||||||||||||||||||||||||||||||539||||||200301080813-0400 OBR|1|||81121.0000~CHEMISTRY TEST~VANLT|||200301080813-0400||||||||SER~~SERUM|| |RIA 03 244 Example: New EPI HL7 Format Mailman Message continued OBX|1|ST|89070.0000~HEPATITIS C AB~VANLT~1486~HEP C ANTIBODY~VA60~13955~HEPATIT IS C VIRUS AB:ACNC:PT:S~LOINC||NEGATIVE||-|||||||20030114135036-0400 PID|4|000-00-0038~~|480~4~M10~1004671166V025205~VAMPI||LABPATIENT3, EIGHT| |19230612|M|||~~~39^OHIO~45212~~~~89^HAMILTON||||||||282534399||||||||2 PV1|1|I|6 NORTH~A611~2|||||||||||||||||||||||||||||||||7~DEATH WITHOUT AUTOPSY~ VA45|||539|||||20021227043712-0400|20030126155036-0400 DG1|1||112.2~CANDIDIAS UROGENITAL NEC~I9|20021227043712-0400|| DG1|2||287.1~THROMBOCYTOPATHY~I9|20021227043712-0400|| NTE|1|4~CLOSTRIDIUM DIFFICILE OBR|1|||87999.0000~MICRO CULTURE~VANLT|||200301061200-0400||||||||STL~~FECES||| MICRO 03 34 OBX|1|CE|87993.0000~BACTERIOLOGY CULTURE~VANLT|1|~YEAST|||||||||20030127 OBX|3|CE|87993.0000~BACTERIOLOGY CULTURE~VANLT|3|~STAPHYLOCOCCUS (COAGULASE PID|5|000-00-0039~~|563~7~M10~1004677502V513322~VAMPI||LABPATIENT3, NINE||19300 425|M||2076-8-SLF~NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER~0005~2076-8~NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER~CDC|~~~39^OHIO~45230~~~~89^HAMILTON||||||||000000039|||2186-5-SLF~NOT HISPANIC OR LATINO~0189~2186-5|||||0 PV1|1|I|6 SOUTH~A649~2|||||||||||||||||||||||||||||||||1~REGULAR~VA45|||539|||| |20030109175930-0400|20030121104552-0400 DG1|9||575.11~CHRONIC CHOLECYSTITIS~I9|20030109175930-0400|| DSP|1||20030110021103-0400~HEP C VIRUS ANTIBODY NEGATIVE~6~NEGATIVE~||0 OBX|1|ST|89070.0000~HEPATITIS C AB~VANLT~1486~HEP C ANTIBODY~VA60~13955~HEPATIT IS C VIRUS AB:ACNC:PT:S~LOINC||NEGATIVE||-|||||||20030116134325-0400 NTE|2|16~HEPATITIS A ANTIBODY POS OBR|1|||81121.0000~CHEMISTRY TEST~VANLT|||20030110021103-0400||||||||SER~~SERUM |||RIA 03 355 OBX|1|ST|89083.0000~HEPATITIS A IGM AB~VANLT~505~HEP A ANTIBODY(IGM)~VA60~13950 EPI Confirmation Mailman Message Upon AAC receipt of the VHA facilities EPI HL7 format mailman message monthly transmission (i.e., 15th of each month via the Q-EPI.MED.VA.GOV domain) individual EPI Confirmation mailman messages are sent by AAC to the originating VHA facilities via the EPI mail group. Members of this mail group are being notified that EPI HL7 format mailman message data transmission has been received by AAC for processing. Examples: EPI Confirmation mailman message sent by AAC Subj: DOY7352 EPI Confirmation [#11057401] 15 Feb 01 23:11 CST 2 lines From:  HYPERLINK "mailto:POSTMASTER@FOC-AUSTIN.VA.GOV" POSTMASTER@FOC-AUSTIN.VA.GOV In 'EPI' basket. Page 1 ----------------------------------------------------------------------------- Ref: Your EPI message #11057352 with Austin ID #130120489, is assigned confirmation number 010462303783006. Enter message action (in EPI basket): Ignore// New EPI Summary Verification Report of EPI Extracted Data from Site HL7 Mailman Message The new EPI Verification Summary Report of EPI Extracted Data from Site HL7 format mailman message replaced the original Emerging Pathogens Verification Report HL7 format mailman message. This new EPI Summary Verification Report HL7 format mailman message is automatically generated at the VHA site on the 15th the month and sent to the EPI-REPORT mail group members via a HL7 format mailman messages (i.e., in a human readable format). The new EPI Verification Summary Report mailman messages contains the VHA sites station number and all predetermined emerging pathogens extracted data occurrences totals for the monthly processing reporting cycle. This new report may be used for quick previewing of the EPI data captures entries and totals. NOTES: The new EPI Summary Verification Report of EPI Extracted Data from Site can also be generated manually as often as necessary using the Lab EPI Manual Run (Enhanced) [LREPI ENHANCE MANUAL RUN] option. This option can be manually generated as often as necessary. After the report is generated data is automatically sent to EPI-REPORT mail group which may be use for EPI data validation. Lab EPI extract data transmissions to AAC occur after 6:00 pm and are processed the next day. DO NOT run the Lab EPI Manual Run (Enhanced) [LREPI ENHANCED MANUAL RUN] option to transmit EPI extract data on Wednesdays of PAY ROLL weeks. These transmissions may cause a delay in processing the PAY ROLL data. Example: New EPI Summary Verification Report of EPI Extracted Data from Site mailman message. NOTE: The new EPI Summary Verification Report of EPI Extracted Data from Sites can be manually generated using the Lab EPI Manual Run (Enhanced) [LREPI ENHANCE MANUAL RUN] option. After the report is generated it is automatically sent to EPI-REPORT mail group which can be use for EPI data validation. Subj: EPI Summary Verification Report [#19669319]  HYPERLINK "mailto:05/19/04@23:35" 05/19/04@23:35 128 lines From: POSTMASTER In 'IN' basket. Page 1 *New* ---------------------------------------------------------------------------- SUMMARY VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION 539 CINCINNATI Processing Month PROCESSING PERIOD: 04-01-2004 through 04-30-2004 Number of Number of Persons with Emerging Pathogen Occurrences Occurrence _____________________________________________________________________________ NTE~1-Vancomycin-resistant Enterococcus 4 4 NTE~2-Hepatitis C antibody Positive 24 22 NTE~3-Penicillin-Resistant Streptococcus pneumoniae 0 0 NTE~4-Clostridium difficile 4 4 NTE~5-Tuberculosis 0 0 NTE~6-Streptococcus, Group A 4 4 NTE~7-Legionella/Legionaire's Disease 0 0 NTE~8-Candida bloodstream infections 1 1 Subj: EPI Summary Verification Report [#19669319] Page 2 ----------------------------------------------------------------------------- NTE~9-Crytosporidium 0 0 NTE~10-Escherichia coli O157 0 0 NTE~11-Malaria 0 0 NTE~12-Dengue 0 0 NTE~13-Creutzfeldt-Jakob Disease 0 0 NTE~14-Leishmaniasis 0 0 NTE~15-Hepatitis C antibody negative 208 205 NTE~16-Hepatitis A antibody positive 24 22 NTE~17-Hepatitis B positive 65 42 NTE~18-All Staphylococcus Aureus 32 29 NTE~19-Methicillin-Resistant Staphylococcus Aureus (Mrsa) 22 20 NTE~20-Vancomycin-Resistant Staphylococcus Aureus (Vrsa) 0 0 NTE~21-Vancomycin-Resistant Coagulase Negative Staphylococci/Staph EPI (Vrse) 0 0 NTE~22-All Streptococcus Pneumoniae 5 4 NTE~23-All Enterococci 24 21 Example: New EPI Summary Verification Report of EPI Extracted Data from Site mailman message continued. For definitions of case ascertainment for each category, please refer to documentation in Laboratory EPI Patch LR*5.2*281 Technical and User Guide in conjunction with your local parameter set-up of this process. Subj: EPI Summary Verification Report [#19669319] Page 3 ---------------------------------------------------------------------------- If you feel that these numbers are in error, please verify with the local facility personnel responsible for setting the EPI Laboratory Search/Extract parameters. However, do not change these parameters if they are incorrect without fully reading the documentation; this will be crucial in order to avoid any misalignment with the concomitant Hepatitis C Extract patches (PXRM*1.5*1, VA-National EPI DB Update, LR*5.2*260, PSJ*5*48, Hepatitis C Initiative, and PSO*7*45, Hepatitis C Initiative). In particular, the hepatitis C antibody positive, hepatitis C antibody negative, hepatitis A antibody positive and hepatitis B positive will be especially sensitive to changes, and concomitant changes of all of the patches may need to occur. Number of Persons with the Term and Transmitted For Nationally rolled-up resolution term National Roll-up _____________________________________________________________________________ Resolved term-1-Declined Assessment for Hepatitis C 6 Resolved term-2-No Risk Factors for Hepatitis C 142 Resolved term-3-Previously Assessed for Hepatitis C 0 Resolved term-4-Risk Factors for Hepatitis C 88 Enter RETURN to continue or '^' to exit: Subj: EPI Summary Verification Report [#19669319] Page 4 ----------------------------------------------------------------------------- Resolved term-5-Positive Test for Hepatitis C antibody 22 Resolved term-6-Negative Test for Hepatitis C antibody 205 Resolved term-7-Hepatitis C diagnosis (ICD-9 based) 173 ----- Total Hepatitis C Risk Assessment Resolution 636 This table represents only those who had a once-lifetime resolution of the National Clinical Reminder for Risk Assessment for Hepatitis C. This resolution will only occur once during the care of a patient (unless actively changed by a point-of-care practitioner at a later date). Processing Month: PROCESSING PERIOD: 04-01-2004 through 04-30-2004 for site # 539 CINCINNATI Site totals Example: New EPI Summary Verification Report of EPI Extracted Data from Site mailman message continued. STAPHYLOCOCCUS AUREUS 12 PATIENTS WITH STAPHYLOCOCCUS AUREUS 9 CANDIDA ALBICANS 36 PATIENTS WITH CANDIDA ALBICANS 20 ENTEROCOCCUS 20 PATIENTS WITH ENTEROCOCCUS 15 Subj: EPI Summary Verification Report [#19669319] Page 5 ---------------------------------------------------------------------------- STREPTOCOCCUS BETA HEMOLYTIC, GROUP A 4 PATIENTS WITH STREPTOCOCCUS BETA HEMOLYTIC, GROUP A 4 CANDIDA TROPICALIS 1 PATIENTS WITH CANDIDA TROPICALIS 1 CANDIDA (TORULOPSIS) GLABRATA 4 PATIENTS WITH CANDIDA (TORULOPSIS) GLABRATA 4 YEAST NOT CANDIDA ALBICANS 8 PATIENTS WITH YEAST NOT CANDIDA ALBICANS 5 STAPHYLOCOCCUS (COAGULASE NEGATIVE) 38 PATIENTS WITH STAPHYLOCOCCUS (COAGULASE NEGATIVE) 29 STREPTOCOCCUS PNEUMONIAE 7 PATIENTS WITH STREPTOCOCCUS PNEUMONIAE 4 STAPHYLOCOCCUS AUREUS (MRSA) 28 PATIENTS WITH STAPHYLOCOCCUS AUREUS (MRSA) 20 ENTEROCOCCUS FAECALIS 6 PATIENTS WITH ENTEROCOCCUS FAECALIS 3 ENTEROCOCCUS FAECIUM 3 PATIENTS WITH ENTEROCOCCUS FAECIUM 3 POSITIVE FOR CLOSTRIDIUM DIFFICILE TOXIN 4 PATIENTS WITH POSITIVE FOR CLOSTRIDIUM DIFFICILE TOXIN 4 Subj: EPI Summary Verification Report [#19669319] Page 6 ----------------------------------------------------------------------------- ENTEROCOCCUS GALLINARUM 1 PATIENTS WITH ENTEROCOCCUS GALLINARUM 1 HEP B SURFACE AG 141 PATIENTS WITH HEP B SURFACE AG 136 HEP A ANTIBODY(IGM) 12 PATIENTS WITH HEP A ANTIBODY(IGM) 12 HEP B SURFACE AB 130 PATIENTS WITH HEP B SURFACE AB 127 HEP B CORE AB(IGM) 16 PATIENTS WITH HEP B CORE AB(IGM) 16 HEP C ANTIBODY 232 PATIENTS WITH HEP C ANTIBODY 227 HEP A ANTIBODY-TOTAL 42 PATIENTS WITH HEP A ANTIBODY-TOTAL 41 Example: New EPI Summary Verification Report of EPI Extracted Data from Site mailman message continued. 1. For Microbiology Lab Package Organism results/isolates (e.g. Enterococcus, or Streptococcus pneumoniae), the number corresponding to the name represents the total number reported from your local microbiology package during the processing month. The number corresponding to the line 'Patients with... (e.g. Patients with Enterococcus or Patients with Streptococcus pneumoniae) represents the number of individual patients from whom the results were isolated. Subj: EPI Summary Verification Report [#19669319] Page 7 ----------------------------------------------------------------------------- 2. For non-microbiology results (e.g. chemistry/serology results such as Hepatitis C antibody), the number corresponding to the name represents the TOTAL number of tests done at your facility during the processing month. The number corresponding to the line (e.g. Hepatitis C antibody) represents the number of individuals on whom the test(s) was/were performed. This does not represent the number of persons who had a positive test result. 3. These results have been obtained based on specimen accession date and not results reported dating. Enter message action (in IN basket): Ignore// 1. For Microbiology Lab Package Organism results/isolates (e.g. Enterococcus, or Streptococcus pneumoniae), the number corresponding to the name represents the total number reported from your local microbiology package during the processing month. The number corresponding to the line 'Patients with... (e.g. Patients with Enterococcus or Patients with Streptococcus pneumoniae) represents the number of individual patients from whom the results were isolated. 2. For non-microbiology results (e.g. chemistry/serology results such as Hepatitis C antibody), the number corresponding to the name represents the TOTAL number of tests done at your facility during the processing month. The number corresponding to the line (e.g. Hepatitis C antibody) represents the number of individuals on whom the test(s) was/were performed. This does not represent the number of persons who had a positive test result. 3. These results have been obtained based on specimen accession date and not results reported dating. New EPI Summary Verification Report for prior month - TB only NOTE: This new EPI Summary Verification Report for prior month TB only represents a second pass at acquiring data for the EPI from the prior month on Mycobacterium tuberculosis due to the extended period of time that may be expected with accessioning, growth, and finally reporting of results. Since this is designed to acquire only the remaining Mycobacterium tuberculosis data from the prior month, most of the numbers present for this report will be zero. The accompanying Summary Verification Report for the current month should contain more complete number counts on the other EPI pathogens and data items for this current month. Example: New EPI Summary Verification Report for prior month - TB only Subj: EPI Summary Verification Report for prior month -TB only [#19669069]  HYPERLINK "mailto:05/19/04@22:18" 05/19/04@22:18 97 lines From: POSTMASTER In 'IN' basket. Page 1 *New* ----------------------------------------------------------------------------- This report represents a second pass at acquiring data for the EPI from the prior month on Mycobacterium tuberculosis due to the extended period of time that may be expected with accessioning, growth, and finally reporting of results. Since this is designed to acquire only the remaining Mycobacterium tuberculosis data from the prior month, most of the numbers present for this report will be zero. The accompanying Summary Verification Report for the current month should contain more complete number counts on the other EPI pathogens and data items for this current month. SUMMARY VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION 539 CINCINNATI Processing Month PROCESSING PERIOD: 03-01-2004 through 03-31-2004 Number of Number of Persons with Emerging Pathogen Occurrences Occurrence Subj: EPI Summary Verification Report for prior month -TB only [#19669069] Page 2 ----------------------------------------------------------------------------- NTE~1-Vancomycin-resistant Enterococcus 0 0 NTE~2-Hepatitis C antibody Positive 0 0 NTE~3-Penicillin-Resistant Streptococcus pneumoniae 0 0 _____________________________________________________________________________ Example: New EPI Summary Verification Report for prior month - TB only continued. NTE~4-Clostridium difficile 0 0 NTE~5-Tuberculosis 0 0 NTE~6-Streptococcus, Group A 0 0 NTE~7-Legionella/Legionaire's Disease 0 0 NTE~8-Candida bloodstream infections 0 0 NTE~9-Crytosporidium 0 0 NTE~10-Escherichia coli O157 0 0 NTE~11-Malaria 0 0 NTE~12-Dengue 0 0 NTE~13-Creutzfeldt-Jakob Disease 0 0 NTE~14-Leishmaniasis 0 0 NTE~15-Hepatitis C antibody negative 0 0 NTE~16-Hepatitis A antibody positive 0 0 NTE~17-Hepatitis B positive 0 0 NTE~18-All Staphylococcus Aureus 0 0 Subj: EPI Summary Verification Report for prior month -TB only [#19669069] Page 3 ------------------------------------------------------------------------------ NTE~19-Methicillin-Resistant Staphylococcus Aureus (Mrsa) 0 0 NTE~20-Vancomycin-Resistant Staphylococcus Aureus (Vrsa) 0 0 NTE~21-Vancomycin-Resistant Coagulase Negative Staphylococci/Staph EPI (Vrse) 0 0 NTE~22-All Streptococcus Pneumoniae 0 0 NTE~23-All Enterococci 0 0 For definitions of case ascertainment for each category, please refer to documentation in Laboratory EPI Patch LR*5.2*281 Technical and User Guide in conjunction with your local parameter set-up of this process. If you feel that these numbers are in error, please verify with the local facility personnel responsible for setting the EPI Laboratory Search/Extract parameters. However, do not change these parameters if they are incorrect without fully reading the documentation; this will be crucial in order to avoid any misalignment with the concomitant Hepatitis C Extract patches (PXRM*1.5*1, VA-National EPI DB Update, LR*5.2*260, PSJ*5*48, Hepatitis C Initiative, and PSO*7*45, Hepatitis C Initiative). In particular, the hepatitis C antibody positive, hepatitis C antibody negative, hepatitis A antibody positive and hepatitis B positive will be especially sensitive to changes, and concomitant changes of all of the patches may need to occur. Subj: EPI Summary Verification Report for prior month -TB only [#19669069] Page 4 ----------------------------------------------------------------------------- Number of Persons with the Term and Transmitted For Nationally rolled-up resolution term National Roll-up Example: New EPI Summary Verification Report for prior month - TB only continued. ______________________________________________________________________________ Resolved term-1-Declined Assessment for Hepatitis C 0 Resolved term-2-No Risk Factors for Hepatitis C 0 Resolved term-3-Previously Assessed for Hepatitis C 0 Resolved term-4-Risk Factors for Hepatitis C 0 Resolved term-5-Positive Test for Hepatitis C antibody 0 Resolved term-6-Negative Test for Hepatitis C antibody 0 Resolved term-7-Hepatitis C diagnosis (ICD-9 based) 0 ----- Total Hepatitis C Risk Assessment Resolution 0 This table represents only those who had a once-lifetime resolution of the National Clinical Reminder for Risk Assessment for Hepatitis C. This resolution will only occur once during the care of a patient (unless actively changed by a point-of-care practitioner at a later date). Enter RETURN to continue or '^' to exit: Subj: EPI Summary Verification Report for prior month -TB only [#19669069] Page 5 ----------------------------------------------------------------------------- Processing Month: PROCESSING PERIOD: 03-01-2004 through 03-31-2004 for site # 539 CINCINNATI Site totals 1. For Microbiology Lab Package Organism results/isolates (e.g. Enterococcus, or Streptococcus pneumoniae), the number corresponding to the name represents the total number reported from your local microbiology package during the processing month. The number corresponding to the line 'Patients with... (e.g. Patients with Enterococcus or Patients with Streptococcus pneumoniae) represents the number of individual patients from whom the results were isolated. 2. For non-microbiology results (e.g. chemistry/serology results such as Hepatitis C antibody), the number corresponding to the name represents the TOTAL number of tests done at your facility during the processing month. The number corresponding to the line (e.g. Hepatitis C antibody) represents the number of individuals on whom the test(s) was/were performed. This does not represent the number of persons who had a positive test result. Subj: EPI Summary Verification Report for prior month -TB only [#19669069] Page 6 ------------------------------------------------------------------------------ 3. These results have been obtained based on specimen accession date and not results reported dating. Enter message action (in IN basket): Ignore// IN Basket Message: 7842// New Detailed Verification Report of EPI Extracted Data from Site Mailman Message The new Verification Detailed Report of EPI Extracted Data from Site replaces the original Emerging Pathogens Verification Report. The new report contains the VHA reporting sites station number with Notes and Comment Segments (NTE) findings in a human readable format. VHA sites reporting NTE findings (i.e., 1, 2, 3 . . . 23) starts with a new page for each NTE findings. The report is automatically generated on the 15th of the month and can also be generated manually as often as necessary using the Lab EPI Manual Run (Enhanced) [LREPI ENHANCE MANUAL RUN] option. After the report is generated the data is automatically sent to EPI-REPORT mail group which may be use for EPI data validation. Use the new Print Detailed Verification Report [LREPI VERIFICATION REPORT] option to print the new Verification Detailed Report. Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages. PAGE 1 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number and name is displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~1-Report of Vancomycin-resistant Enterococcus These data note persons at your facility during the month that had a positive result for Vancomycin-resistant Enterococcus. Identifying information, along with specimen and culture results has been provided. PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT3, TEN 0310 03-11-1925 M WORLD WAR II Inpatient Admission Date: 03-08-2003@1717 Discharge Date: --"" Discharge Disposition: 03-18-2003@0700 BACT 03 2038 MICRO CULTURE URINE 2 03-20-2003 ENTEROCOCCUS FAECIUM ORG # 2 03-18-2003@0700 ANTIBIOTIC MIC URINE PENICILLIN R R VANCOMYCIN R R NITROFURANTOIN S S CIPROFLOXACIN R R LEVOFLOXACIN R R GENTAMICIN HP SYN-S SYN-S STREPTOMYCIN HP SYN-R SYN-R Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. PAGE 2 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number and name is displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~2 Report of Hepatitis C antibody positive This represents a line listing of persons reported during the month that had a positive test for hepatitis C antibody (based on accession date and not results reported date). Definitions for data to be extracted are provided in the Technical and User Guide documentation for Laboratory EPI LR*5.2*281. Name LAST 4 Accession Date Test Name Test Result ____________________________________________________________________ LABPATIENT4~ONE 0041 03-26-2003@1240 HEP C ANTIBODY STRONG POSITIVE LABPATIENT4~TWO 0042 03-27-2003@1614 HEP C ANTIBODY STRONG POSITIVE LABPATIENT4~THREE 0043 03-13-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT4~FOUR 0044 03-19-2003 HEP C ANTIBODY STRONG POSITIVE LABPATIENT4~FIVE 0045 03-08-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT4~SIX 0046 03-05-2003@0823 HEP C ANTIBODY STRONG POSITIVE LABPATIENT4~SEVEN 0047 03-08-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT4~EIGHT 0048 03-08-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT4~NINE 0049 03-05-2003@1726 HEP C ANTIBODY STRONG POSITIVE LABPATIENT4~TEN 0410 03-14-2003@1004 HEP C ANTIBODY STRONG POSITIVE LABPATIENT5~ONE 0051 03-07-2003@1015 HEP C ANTIBODY STRONG POSITIVE LABPATIENT5~TWO 0052 03-21-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT5~THREE 0053 03-10-2003@0807 HEP C ANTIBODY STRONG POSITIVE LABPATIENT5~FOUR 0054 03-18-2003 HEP C ANTIBODY STRONG POSITIVE Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. LABPATIENT5~FIVE 0055 03-11-2003@0916 HEP C ANTIBODY STRONG POSITIVE LABPATIENT5~SIX 0056 03-27-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT5~SEVEN 0057 03-06-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT5~EIGHT 0058 03-21-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT5~NINE 0059 03-12-2003@0911 HEP C ANTIBODY STRONG POSITIVE LABPATIENT5~TEN 0510 03-25-2003@1443 HEP C ANTIBODY STRONG POSITIVE LABPATIENT6~ONE 0061 03-04-2003@1019 HEP C ANTIBODY STRONG POSITIVE LABPATIENT6~TWO 0062 03-13-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT6~THREE 0063 03-13-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT6~FOUR 0064 03-04-2003@1648 HEP C ANTIBODY STRONG POSITIVE LABPATIENT6~FIVE 0065 03-08-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT6~SIX 0066 03-27-2003@1141 HEP C ANTIBODY STRONG POSITIVE LABPATIENT6~SEVEN 0067 03-03-2003@1503 HEP C ANTIBODY STRONG POSITIVE LABPATIENT6~EIGHT 0068 03-27-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT6~NINE 0069 03-13-2003@0700 HEP C ANTIBODY STRONG POSITIVE LABPATIENT6~TEN 0610 03-28-2003@1356 HEP C ANTIBODY STRONG POSITIVE PAGE 3 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number and name is displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~3-Report of Pencillin-resistant Streptococcus pneumoniae These data note persons at your facility during the month that had a positive result for Penicillin-resistant Streptococcus pneumoniae. Identifying information, along with specimen and culture results has been provided. NO PATIENTS REPORTED FOR THE REPORT PERIOD. Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. PAGE 4 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number and name is displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~4-Report of Clostridium difficile These data note persons at your facility during the month that had a positive result for Clostridium difficile. Identifying information, along with specimen and culture results has been provided. PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT7, ONE 0071 01-00-1925 M WORLD WAR II Inpatient Admission Date: 02-21-2003@2147 Discharge Date: 03-10-2003@2354 Discharge Disposition: DEATH WITH AUTOPSY 03-04-2003 MICRO 03 286 MICRO CULTURE FECES 1 03-05-2003 POSITIVE FOR CLOSTRIDIUM DIFFICILE TOXIN PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT7, TWO 0072 09-11-1934 M VIETNAM ERA Outpatient Accession Date: 03-04-2003 03-04-2003 MICRO 03 279 MICRO CULTURE FECES 1 03-05-2003 POSITIVE FOR CLOSTRIDIUM DIFFICILE TOXIN PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT7, THREE 0073 10-20-1946 M VIETNAM ERA Inpatient Admission Date: 03-14-2003@1202 Discharge Date: 03-20-2003@0341 Discharge Disposition: DEATH WITHOUT AUTOPSY 03-17-2003 MICRO 03 383 MICRO CULTURE FECES 1 03-19-2003 POSITIVE FOR CLOSTRIDIUM DIFFICILE TOXIN Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. PAGE 5 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number will be displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~5-Report of Tuberculosis These data note persons at your facility during the month that had a positive result for Mycobacterium tuberculosis. Identifying information, along with specimen and culture results has been provided. PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT7, FOUR 0074 06-07-1930 F VIETNAM ERA Outpatient Accession Date: 03-12-2003 03-12-2003 TB 03 212 MICRO CULTURE SPUTUM 3 05-21-2003 MYCOBACTERIUM TUBERCULOSIS COMPLEX Outpatient Accession Date: 03-22-2003 03-22-2003 TB 03 213 MICRO CULTURE SPUTUM 2 --0 MYCOBACTERIUM TUBERCULOSIS COMPLEX Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. PAGE 6 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number and name is displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~6-Report of Group A Streptococcus These data note persons at your facility during the month that had a positive result for Group A Streptococcus. Identifying information, along with specimen and culture results has been provided. PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT7, FIVE 0075 08-14-1941 M VIETNAM ERA Inpatient Admission Date: 03-13-2003@1229 Discharge Date: 03-14-2003@1333 Discharge Disposition: REGULAR 03-14-2003 BACT 03 1941 MICRO CULTURE RECTUM 1 03-17-2003 STREPTOCOCCUS BETA HEMOLYTIC, GROUP A 2 03-17-2003 ESCHERICHIA COLI ORG # 2 03-14-2003 ANTIBIOTIC MIC RECTUM GENTAMICIN S S CEFAZOLIN S S AMPICILLIN S S POLYMIXIN B S S TRIMETHOPRIM+SULFAMETHOXAZOLE R R AMIKACIN S S PIPERACILLIN S S CEFOTAXIME S S CIPROFLOXACIN S S IMIPENUM S S CEFTAZIDIME S S AMPICILLIN+SULBACTAM S S CEFOTETAN S S LEVOFLOXACIN S S CEFEPIME S S PIPERACILLIN+TAZOBACTAM S S PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT7, SIX 0076 02-13-1973 M OTHER OR NONE Outpatient Accession Date: 03-04-2003 03-04-2003 BACT 03 1655 MICRO CULTURE PHARYNX 1 03-05-2003 STREPTOCOCCUS BETA HEMOLYTIC, GROUP A Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. PAGE 7 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number and name is displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~7- Report of Legionella/Legionaire's These data note persons at your facility during the month who had an EITHER an ICD-9 coded diagnosis for Legionella/Legionaire's disease OR a positive culture result. Identifying information, along with specimen and culture results has been provided. NO PATIENTS REPORTED FOR THE REPORT PERIOD. PAGE 8 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number and name is displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~8-Report of Candida bloodstream infections These data note persons at your facility during the month that had a positive result for Candida (or other yeast) bloodstream infections. Identifying information, along with specimen and culture results has been provided. PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT7, SEVEN 0077 05-25-1943 M VIETNAM ERA Update Admission Date: 12-19-2002@1605 03-18-2003@2235 BLD 03 856 MICRO CULTURE BLOOD 1 03-25-2003 YEAST 1 03-25-2003 CANDIDA (TORULOPSIS) GLABRATA 03-16-2003@1600 BLD 03 837 MICRO CULTURE BLOOD 1 03-22-2003 YEAST 1 03-23-2003 CANDIDA (TORULOPSIS) GLABRATA 03-12-2003 BLD 03 793 MICRO CULTURE BLOOD 1 03-17-2003 YEAST 2 03-17-2003 STAPHYLOCOCCUS (COAGULASE NEGATIVE) 1 03-15-2003 CANDIDA (TORULOPSIS) GLABRATA Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. 03-11-2003@0230 MYCOL 03 166 MICRO CULTURE BLOOD 1 03-17-2003 CANDIDA (TORULOPSIS) GLABRATA 03-11-2003@0230 BLD 03 780 MICRO CULTURE BLOOD 1 03-17-2003 STAPHYLOCOCCUS (COAGULASE NEGATIVE) 2 03-17-2003 YEAST 1 03-17-2003 CANDIDA (TORULOPSIS) GLABRATA 03-08-2003@0915 BLD 03 757 MICRO CULTURE BLOOD 1 03-12-2003 YEAST 1 03-12-2003 CANDIDA (TORULOPSIS) GLABRATA PAGE 9 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Station name/number displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~9-Report of Cryptosporidium These data note persons at your facility during the month that had EITHER an ICD-9 coded diagnosis for Cryptosporidium OR a positive culture result. Identifying information, along with specimen and culture results has been provided. NO PATIENTS REPORTED FOR THE REPORT PERIOD. PAGE 10 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Station name/number displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~10-Report of Escherichia coli O157 These data note persons at your facility during the month that had a positive result for Escherichia coli serotype O157. Identifying information, along with specimen and culture results has been provided. NO PATIENTS REPORTED FOR THE REPORT PERIOD. Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. PAGE 11 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA STATION (Your station your number is displayed here) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~11-Report of Malaria These data note persons at your facility during the month that had an ICD-9 coded diagnosis for malaria. Identifying information has been provided. NO PATIENTS REPORTED FOR THE REPORT PERIOD. PAGE 12 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA STATION (Your station your number is displayed here) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~12-Report of Dengue These data note persons at your facility during the month that had an ICD-9 coded diagnosis for dengue. Identifying information has been provided. NO PATIENTS REPORTED FOR THE REPORT PERIOD. PAGE 13 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number and name is displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~13-Report of Creutzfeldt-Jakob Disease These data note persons at your facility during the month that had an ICD-9 coded diagnosis for Creutzfeldt-Jakob disease. Identifying information has been provided. NO PATIENTS REPORTED FOR THE REPORT PERIOD. PAGE 14 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number and name is displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~14-Report of Leishmaniasis These data note persons at your facility during the month that had an ICD-9coded diagnosis for Leishmania. Identifying information has been provided. NO PATIENTS REPORTED FOR THE REPORT PERIOD. Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. PAGE 15 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number and name is displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~15 Report of Hepatitis C antibody negative This represents a line listing of persons reported during the month who had a negative test for hepatitis C antibody (based on accession date and not results reported date). Definitions for data to be extracted are provided in the Technical and User Guide documentation for Laboratory EPI LR*5.2*281. Name LAST 4 Accession Date Test Name Test Result _______________________________________________________________________ LABPATIENT7~EIGHT 0078 03-05-2003@0700 HEP C ANTIBODY NEGATIVE LABPATIENT7~NINE 0079 03-18-2003@0743 HEP C ANTIBODY NEGATIVE LABPATIENT7~TEN 0710 03-03-2003@0846 HEP C ANTIBODY NEGATIVE LABPATIENT8~ONE 0081 03-26-2003@1515 HEP C ANTIBODY NEGATIVE LABPATIENT8~TWO 0082 03-28-2003@1506 HEP C ANTIBODY NEGATIVE LABPATIENT8~THREE 0083 03-03-2003@0700 HEP C ANTIBODY NEGATIVE LABPATIENT8~FOUR 0084 03-25-2003@1039 HEP C ANTIBODY NEGATIVE LABPATIENT8~FIVE 0085 03-04-2003@1138 HEP C ANTIBODY NEGATIVE LABPATIENT8~SIX 0086 03-20-2003@0700 HEP C ANTIBODY NEGATIVE LABPATIENT8~SEVEN 0087 03-21-2003@0700 HEP C ANTIBODY NEGATIVE LABPATIENT8~EIGHT 0088 03-27-2003@0700 HEP C ANTIBODY NEGATIVE LABPATIENT8~NINE 0089 03-18-2003@1111 HEP C ANTIBODY NEGATIVE LABPATIENT8~TEN 0810 03-05-2003@0819 HEP C ANTIBODY NEGATIVE LABPATIENT9~ONE 0091 03-19-2003@1335 HEP C ANTIBODY NEGATIVE LABPATIENT9~TWO 0092 03-27-2003@1622 HEP C ANTIBODY NEGATIVE LABPATIENT9~THREE 0093 03-17-2003@1418 HEP C ANTIBODY NEGATIVE LABPATIENT9~FOUR 0094 03-28-2003@1439 HEP C ANTIBODY NEGATIVE LABPATIENT9~FIVE 0095 03-05-2003@0822 HEP C ANTIBODY NEGATIVE LABPATIENT9~SIX 0096 03-19-2003@1553 HEP C ANTIBODY NEGATIVE LABPATIENT9~SEVEN 0097 03-17-2003@1423 HEP C ANTIBODY NEGATIVE LABPATIENT9~EIGHT 0098 03-14-2003 HEP C ANTIBODY NEGATIVE LABPATIENT9~NINE 0099 03-21-2003@0939 HEP C ANTIBODY NEGATIVE LABPATIENT9~TEN 0910 03-06-2003@1007 HEP C ANTIBODY NEGATIVE LABPATIENT10~ONE 0101 03-21-2003@1210 HEP C ANTIBODY NEGATIVE Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. PAGE 16 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number and name is displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~16 Report of Hepatitis A antibody positive This represents a line listing of persons reported during the month who had a positive test for hepatitis A antibody (based on accession date and not results reported date). Definitions for data to be extracted are provided in the Technical and User Guide documentation for Laboratory EPI LR*5.2*281. Name LAST 4 Accession Date Test Name Test Result ____________________________________________________________________ LABPATIENT7~NINE 0079 03-18-2003@0743 HEP A ANTIBODY(IGM) NEGATIVE LABPATIENT8~THREE 0083 03-03-2003@0700 HEP A ANTIBODY(IGM) NEGATIVE LABPATIENT4~ONE 0041 03-26-2003@1240 HEP A ANTIBODY-TOTAL REACTIVE LABPATIENT9~TWO 0092 03-27-2003@1622 HEP A ANTIBODY(IGM) NEGATIVE LABPATIENT4~FOUR 0044 03-19-2003 HEP A ANTIBODY-TOTAL REACTIVE LABPATIENT9~FOUR 0094 03-28-2003@1439 HEP A ANTIBODY(IGM) NEGATIVE LABPATIENT9~SIX 0096 03-19-2003@1553 HEP A ANTIBODY-TOTAL REACTIVE LABPATIENT10~TWO 0102 03-17-2003@1117 HEP A ANTIBODY-TOTAL REACTIVE LABPATIENT4~EIGHT 0048 03-08-2003@0700 HEP A ANTIBODY-TOTAL REACTIVE LABPATIENT10~THREE 0103 03-27-2003@0950 HEP A ANTIBODY(IGM) NEGATIVE LABPATIENT10~FOUR 0104 03-28-2003@1025 HEP A ANTIBODY-TOTAL REACTIVE LABPATIENT10~FIVE 0105 03-17-2003@1024 HEP A ANTIBODY-TOTAL REACTIVE LABPATIENT10~SIX 0106 03-12-2003@1450 HEP A ANTIBODY-TOTAL REACTIVE LABPATIENT10~SEVEN 0107 03-12-2003@1016 HEP A ANTIBODY(IGM) NEGATIVE LABPATIENT5~ONE 0051 03-07-2003@1015 HEP A ANTIBODY-TOTAL REACTIVE LABPATIENT10~EIGHT 0108 03-10-2003@0943 HEP A ANTIBODY-TOTAL REACTIVE LABPATIENT10~NINE 0109 03-06-2003@0920 HEP A ANTIBODY(IGM) NEGATIVE Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. LABPATIENT10~TEN 1010 03-06-2003@0700 HEP A ANTIBODY(IGM) NEGATIVE LABPATIENT11~ONE 0111 03-28-2003@0930 HEP A ANTIBODY(IGM) NEGATIVE LABPATIENT11~TWO 0112 03-03-2003@1549 HEP A ANTIBODY-TOTAL REACTIVE LABPATIENT11~THREE 0113 03-17-2003@1136 HEP A ANTIBODY-TOTAL REACTIVE LABPATIENT11~FOUR 0114 03-29-2003@0700 HEP A ANTIBODY-TOTAL REACTIVE LABPATIENT11~FIVE 0115 03-28-2003@1357 HEP A ANTIBODY(IGM) NEGATIVE LABPATIENT11~FIVE 0115 HEP A ANTIBODY-TOTAL REACTIVE PAGE 17 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number and name is displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~17 Report of Hepatitis B positive This represents a line listing of persons reported during the month who had a positive test for hepatitis B (based on accession date and not results reported date). Definitions for data to be extracted are provided in the Technical and User Guide documentation for Laboratory EPI LR*5.2*281. Name LAST 4 Accession Date Test Name Test Result ________________________________________________________________________ LABPATIENT7~EIGHT 0078 03-05-2003@0700 HEP B SURFACE AG NEGATIVE LABPATIENT7~EIGHT 0078 HEP B SURFACE AB LOW TITER POSITIVE LABPATIENT9~TWO 0092 03-27-2003@1622 HEP B SURFACE AG NEGATIVE LABPATIENT9~TWO 0092 HEP B SURFACE AB LOW TITER POSITIVE LABPATIENT9~TWO 0092 HEP B CORE AB(IGM) NEGATIVE LABPATIENT11~SIX 0116 03-22-2003@0700 HEP B SURFACE AG NEGATIVE LABPATIENT11~SIX 0116 HEP B SURFACE AB ADEQUATE TITER POSITIVE LABPATIENT11~SEVEN 0117 03-25-2003@1610 HEP B SURFACE AB ADEQUATE TITER POSITIVE LABPATIENT11~EIGHT 0118 03-06-2003@1025 HEP B SURFACE AB LOW TITER POSITIVE LABPATIENT4~TEN 0410 03-14-2003@1004 HEP B SURFACE AG NEGATIVE LABPATIENT4~TEN 0410 HEP B SURFACE AB ADEQUATE TITER POSITIVE LABPATIENT11~NINE 0119 03-28-2003@1530 HEP B SURFACE AB LOW TITER POSITIVE Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. LABPATIENT11~TEN 1110 03-13-2003@0700 HEP B SURFACE AG POSITIVE LABPATIENT11~TEN 1110 HEP B SURFACE AB NEGATIVE LABPATIENT12~ONE 0121 03-19-2003@0700 HEP B SURFACE AG NEGATIVE LABPATIENT12~ONE 0121 HEP B SURFACE AB LOW TITER POSITIVE LABPATIENT12~ONE 0121 HEP B CORE AB (IGM) NEGATIVE WUDFES~JUHDFESXY~K 6546 03-07-2003@1258 HEP B SURFACE AB LOW TITER POSITIVE LABPATIENT12~TWO 0122 03-18-2003@1155 HEP B SURFACE AG NEGATIVE LABPATIENT12~TWO 0122 HEP B SURFACE AB LOW TITER POSITIVE LABPATIENT12~THREE 0123 03-10-2003@1214 HEP B SURFACE AG NEGATIVE LABPATIENT12~THREE 0123 HEP B SURFACE AB ADEQUATE TITER POSITIVE LABPATIENT12~FOUR 0124 03-19-2003@1520 HEP B SURFACE AG NEGATIVE LABPATIENT12~FOUR 0124 HEP B SURFACE AB ADEQUATE TITER POSITIVE PAGE 18 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number and name is displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~18-Report of All Staphylococcus aureus These data note persons at your facility during the month that had a positive result for all Staphylococcus aureus. Identifying information, along with specimen and culture results has been provided. PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT12, FIVE 0125 04-25-1930 M KOREAN Inpatient Admission Date: 03-14-2003@2035 Discharge Date: 03-27-2003@1646 Discharge Disposition: REGULAR 03-16-2003@2120 BLD 03 835 MICRO CULTURE BLOOD 1 03-23-2003 STAPHYLOCOCCUS AUREUS 03-16-2003@2100 BLD 03 836 MICRO CULTURE BLOOD 1 03-23-2003 STAPHYLOCOCCUS AUREUS 03-15-2003@2222 BLD 03 826 MICRO CULTURE BLOOD 1 03-18-2003 STAPHYLOCOCCUS AUREUS 03-15-2003@2222 BLD 03 825 MICRO CULTURE BLOOD 1 03-18-2003 STAPHYLOCOCCUS AUREUS 03-14-2003@2213 BLD 03 812 MICRO CULTURE BLOOD 1 03-20-2003 STAPHYLOCOCCUS AUREUS Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. ORG # 1 03-14-2003@2213 ANTIBIOTIC MIC BLOOD PENICILLIN R R CLINDAMYCIN S S VANCOMYCIN S S GENTAMICIN S S CEFAZOLIN S S TETRACYCLINE S S TRIMETHOPRIM+SULFAMETHOXAZOLE S S ERYTHROMYCIN S S NITROFURANTOIN S S RIFAMPIN S S OXACILLIN S S CIPROFLOXACIN S S AMPICILLIN+SULBACTAM S S LEVOFLOXACIN S S AMOXICILLIN CLAVULANIC ACID S S PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT12, SIX 0126 01-28-1934 M KOREAN Outpatient Accession Date: 03-04-2003 03-04-2003 BLD 03 726 MICRO CULTURE BLOOD 1 03-07-2003 STAPHYLOCOCCUS AUREUS ORG # 1 03-04-2003 ANTIBIOTIC MIC BLOOD PENICILLIN R R CLINDAMYCIN S S VANCOMYCIN S S GENTAMICIN S S CEFAZOLIN S S TETRACYCLINE S S TRIMETHOPRIM+SULFAMETHOXAZOLE S S ERYTHROMYCIN S S NITROFURANTOIN S S RIFAMPIN S S OXACILLIN S S CIPROFLOXACIN S S AMPICILLIN+SULBACTAM S S LEVOFLOXACIN S S AMOXICILLIN CLAVULANIC ACID S S Outpatient Accession Date: 03-05-2003@0000 03-05-2003@0000 BLD 03 730 MICRO CULTURE BLOOD 1 03-07-2003 STAPHYLOCOCCUS AUREUS Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. Inpatient Admission Date: 03-05-2003@1520 Discharge Date: 03-31-2003@1447 Discharge Disposition: REGULAR 03-09-2003@0940 BLD 03 762 MICRO CULTURE BLOOD 1 03-14-2003 STAPHYLOCOCCUS AUREUS ORG # 1 03-09-2003@0940 ANTIBIOTIC MIC BLOOD PENICILLIN R R CLINDAMYCIN S S VANCOMYCIN S S GENTAMICIN S S CEFAZOLIN S S TETRACYCLINE S S TRIMETHOPRIM+SULFAMETHOXAZOLE S S ERYTHROMYCIN S S NITROFURANTOIN S S RIFAMPIN S S OXACILLIN S S CIPROFLOXACIN S S AMPICILLIN+SULBACTAM S S LEVOFLOXACIN S S AMOXICILLIN CLAVULANIC ACID S S 03-05-2003 BLD 03 729 MICRO CULTURE BLOOD 1 03-07-2003 STAPHYLOCOCCUS AUREUS PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT12, SEVEN 0127 04-27-1953 M VIETNAM ERA HOMELESS Inpatient Admission Date: 03-16-2003@0035 Discharge Date: 03-31-2003@1459 Discharge Disposition: REGULAR 03-22-2003@0419 BLD 03 879 MICRO CULTURE BLOOD 2 03-24-2003 STAPHYLOCOCCUS AUREUS (MRSA) ORG # 2 03-22-2003@0419 ANTIBIOTIC MIC BLOOD PENICILLIN R R CLINDAMYCIN S S VANCOMYCIN S S GENTAMICIN S S CEFAZOLIN R R TETRACYCLINE S S TRIMETHOPRIM+SULFAMETHOXAZOLE S S ERYTHROMYCIN R R NITROFURANTOIN S S RIFAMPIN S S OXACILLIN R R CIPROFLOXACIN S S Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. AMPICILLIN+SULBACTAM R R LEVOFLOXACIN S S AMOXICILLIN CLAVULANIC ACID R R 03-22-2003@0300 BLD 03 880 MICRO CULTURE BLOOD 1 03-24-2003 STAPHYLOCOCCUS AUREUS (MRSA) 03-22-2003@0245 BLD 03 881 MICRO CULTURE BLOOD 1 03-24-2003 STAPHYLOCOCCUS AUREUS (MRSA) PAGE 19 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION 539 CINCINNATI VAMC PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~19-Report of methicillin-resistant Staphylococcus These data note persons at your facility during the month that had a positive result for methicillin-resistant Staphylococcus aureus. Identifying information, along with specimen and culture results has been provided. PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT12, SEVEN 0127 04-27-1953 M VIETNAM ERA HOMELESS Inpatient Admission Date: 03-16-2003@0035 Discharge Date: 03-31-2003@1459 Discharge Disposition: REGULAR 03-22-2003@0419 BLD 03 879 MICRO CULTURE BLOOD 2 03-24-2003 STAPHYLOCOCCUS AUREUS (MRSA) ORG # 2 03-22-2003@0419 ANTIBIOTIC MIC BLOOD PENICILLIN R R CLINDAMYCIN S S VANCOMYCIN S S GENTAMICIN S S CEFAZOLIN R R TETRACYCLINE S S TRIMETHOPRIM+SULFAMETHOXAZOLE S S ERYTHROMYCIN R R NITROFURANTOIN S S RIFAMPIN S S OXACILLIN R R Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. CIPROFLOXACIN S S AMPICILLIN+SULBACTAM R R LEVOFLOXACIN S S AMOXICILLIN CLAVULANIC ACID R R PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT12, EIGHT 0128 08-26-1922 M KOREAN Inpatient Admission Date: 03-13-2003@2113 Discharge Date: 04-03-2003@1216 Discharge Disposition: REGULAR 03-23-2003@2130 BACT 03 2186 MICRO CULTURE SKIN 1 03-27-2003 STAPHYLOCOCCUS AUREUS (MRSA) ORG # 1 03-23-2003@2130 ANTIBIOTIC MIC SKIN PENICILLIN R R CLINDAMYCIN R R VANCOMYCIN S S GENTAMICIN S S CEFAZOLIN R R TETRACYCLINE S S TRIMETHOPRIM+SULFAMETHOXAZOLE S S ERYTHROMYCIN R R NITROFURANTOIN S S RIFAMPIN S S OXACILLIN R R CIPROFLOXACIN R R AMPICILLIN+SULBACTAM R R LEVOFLOXACIN R R AMOXICILLIN CLAVULANIC ACID R R 03-15-2003@0000 BACT 03 1984 MICRO CULTURE SPUTUM 1 03-18-2003 STAPHYLOCOCCUS AUREUS (MRSA) 2 03-18-2003 PROTEUS MIRABILIS 3 03-18-2003 ACINETOBACTER BAUMANII 4 03-18-2003 CITROBACTER KOSERII (DIVERSUS) ORG # 1 03-15-2003@0000 ANTIBIOTIC MIC SPUTUM PENICILLIN R R CLINDAMYCIN R R VANCOMYCIN S S GENTAMICIN S S CEFAZOLIN R R TETRACYCLINE S S Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. TRIMETHOPRIM+SULFAMETHOXAZOLE S S ERYTHROMYCIN R R NITROFURANTOIN S S RIFAMPIN S S OXACILLIN R R CIPROFLOXACIN R R AMPICILLIN+SULBACTAM R R LEVOFLOXACIN R R AMOXICILLIN CLAVULANIC ACID R R ORG # 2 03-15-2003@0000 ANTIBIOTIC MIC SPUTUM GENTAMICIN S S CEFAZOLIN S S AMPICILLIN R R POLYMIXIN B S S TRIMETHOPRIM+SULFAMETHOXAZOLE R R AMIKACIN S S PIPERACILLIN R R CEFOTAXIME S S CIPROFLOXACIN R R IMIPENUM S S CEFTAZIDIME S S AMPICILLIN+SULBACTAM R R CEFOTETAN S S LEVOFLOXACIN R R CEFEPIME S S PIPERACILLIN+TAZOBACTAM S S ORG # 3 03-15-2003@0000 ANTIBIOTIC MIC SPUTUM GENTAMICIN S S CEFAZOLIN R R AMPICILLIN I I POLYMIXIN B S S TRIMETHOPRIM+SULFAMETHOXAZOLE S S AMIKACIN S S PIPERACILLIN S S CEFOTAXIME S S CIPROFLOXACIN R R IMIPENUM S S CEFTAZIDIME S S AMPICILLIN+SULBACTAM S S CEFOTETAN R R LEVOFLOXACIN R R CEFEPIME S S PIPERACILLIN+TAZOBACTAM S S Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. ORG # 4 03-15-2003@0000 ANTIBIOTIC MIC SPUTUM GENTAMICIN S S CEFAZOLIN S S POLYMIXIN B S S TRIMETHOPRIM+SULFAMETHOXAZOLE S S AMIKACIN S S PIPERACILLIN S S CEFOTAXIME S S CIPROFLOXACIN S S IMIPENUM S S CEFTAZIDIME S S CEFOTETAN S S LEVOFLOXACIN S S CEFEPIME S S PIPERACILLIN+TAZOBACTAM S S PAGE 20 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number and name is displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~20-Vancomycin-resistant Staphylococcus aureus These data note persons at your facility during the month that had a positive result for Vancomycin-resistant Staphylococcus aureus. Identifying information, along with specimen and culture results has been provided. NO PATIENTS REPORTED FOR THE REPORT PERIOD. PAGE 21 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number and name is displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~21-Vancomycin-resistant coagulase negative Staphylococcus These data note persons at your facility during the month that had a positive result for Vancomycin-resistant coagulase negative staphylococcus. Identifying information, along with specimen and culture results has been provided. NO PATIENTS REPORTED FOR THE REPORT PERIOD. Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. PAGE 22 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number and name is displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~22-All Streptococcus pneumoniae These data note persons at your facility during the month that had a positive result for all Streptococcus pneumoniae. Identifying information, along with specimen and culture results has been provided. PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT12, NINE 0129 07-06-1922 M VIETNAM ERA Inpatient Admission Date: 03-12-2003@1205 Discharge Date: 03-20-2003@1320 Discharge Disposition: REGULAR 03-12-2003@1420 BACT 03 1894 MICRO CULTURE SPUTUM 1 03-15-2003 STREPTOCOCCUS PNEUMONIAE ORG # 1 03-12-2003@1420 ANTIBIOTIC MIC SPUTUM PENICILLIN S S CLINDAMYCIN S S VANCOMYCIN S S CHLORAMPHENICOL S S TETRACYCLINE S S TRIMETHOPRIM+SULFAMETHOXAZOLE S S ERYTHROMYCIN S S CEFOTAXIME S S CEFTRIAXONE S S LEVOFLOXACIN S S PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT12, TEN 1210 03-27-1924 M WORLD WAR II Inpatient Admission Date: 03-21-2003@1657 Discharge Date: --"" Discharge Disposition: 03-21-2003 BACT 03 2154 MICRO CULTURE SPUTUM 1 03-25-2003 STREPTOCOCCUS PNEUMONIAE 2 03-25-2003 HAEMOPHILUS INFLUENZAE 3 03-25-2003 CANDIDA ALBICANS Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. ORG # 1 03-21-2003 ANTIBIOTIC MIC SPUTUM PENICILLIN S S CLINDAMYCIN S S VANCOMYCIN S S CHLORAMPHENICOL S S TETRACYCLINE S S AMPICILLIN S S TRIMETHOPRIM+SULFAMETHOXAZOLE S S ERYTHROMYCIN S S CEFOTAXIME S S CEFTRIAXONE S S LEVOFLOXACIN S S PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT13, ONE 0131 12-13-1947 M VIETNAM ERA Outpatient Accession Date: 03-24-2003 03-24-2003 BACT 03 2200 MICRO CULTURE BRONCHUS 1 03-27-2003 STREPTOCOCCUS PNEUMONIAE ORG # 1 03-24-2003 ANTIBIOTIC MIC BRONCHUS PENICILLIN S S CLINDAMYCIN S S VANCOMYCIN S S CHLORAMPHENICOL S S TETRACYCLINE S S AMPICILLIN S S TRIMETHOPRIM+SULFAMETHOXAZOLE S S ERYTHROMYCIN S S CEFOTAXIME S S CEFTRIAXONE S S LEVOFLOXACIN S S PAGE 23 DETAILED VERIFICATION REPORT OF EPI EXTRACTED DATA FROM STATION (Your station number and name is displayed here.) PROCESSING PERIOD: 03-01-2003 through 03-31-2003 NTE~23- All Enterococci These data note persons at your facility during the month that had a positive result for all Enterococci. Identifying information, along with specimen and culture results has been provided. Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT3, TEN 0310 03-11-1925 M WORLD WAR II Inpatient Admission Date: 03-08-2003@1717 Discharge Date: --"" Discharge Disposition: 03-18-2003@0700 BACT 03 2038 MICRO CULTURE URINE 2 03-20-2003 ENTEROCOCCUS FAECIUM ORG # 2 03-18-2003@0700 ANTIBIOTIC MIC URINE PENICILLIN R R VANCOMYCIN R R NITROFURANTOIN S S CIPROFLOXACIN R R LEVOFLOXACIN R R GENTAMICIN HP SYN-S SYN-S STREPTOMYCIN HP SYN-R SYN-R PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT13, TWO 0132 05-29-1928 M WORLD WAR II Inpatient Admission Date: 02-27-2003@1650 Discharge Date: 04-02-2003@1415 Discharge Disposition: REGULAR 03-20-2003@1740 BLD 03 870 MICRO CULTURE BLOOD 1 03-24-2003 ENTEROCOCCUS FAECALIS 2 03-24-2003 STAPHYLOCOCCUS (COAGULASE NEGATIVE) ORG # 1 03-20-2003@1740 ANTIBIOTIC MIC BLOOD PENICILLIN S S VANCOMYCIN S S TETRACYCLINE R R NITROFURANTOIN S S CIPROFLOXACIN S S LEVOFLOXACIN S S GENTAMICIN HP SYN-S SYN-S STREPTOMYCIN HP SYN-R SYN-R ORG # 2 03-20-2003@1740 ANTIBIOTIC MIC BLOOD PENICILLIN R R CLINDAMYCIN S S VANCOMYCIN S S GENTAMICIN S S CEFAZOLIN R R TRIMETHOPRIM+SULFAMETHOXAZOLE S S ERYTHROMYCIN R R NITROFURANTOIN S S Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. RIFAMPIN S S OXACILLIN R R CIPROFLOXACIN R R AMPICILLIN+SULBACTAM R R LEVOFLOXACIN I I AMOXICILLIN CLAVULANIC ACID R R PATIENT NAME LAST 4 DOB SEX PERIOD OF SERVICE LABPATIENT13, FOUR 0134 06-25-1939 M POST-KOREAN Outpatient Accession Date: 03-10-2003 03-10-2003 BACT 03 1816 MICRO CULTURE URINE 1 03-12-2003 ENTEROCOCCUS 2 03-12-2003 STAPHYLOCOCCUS (COAGULASE NEGATIVE) ORG # 1 03-10-2003 ANTIBIOTIC MIC URINE PENICILLIN S S VANCOMYCIN S S TETRACYCLINE R R NITROFURANTOIN S S CIPROFLOXACIN R R LEVOFLOXACIN R R GENTAMICIN HP SYN-R SYN-R STREPTOMYCIN HP SYN-S SYN-S PAGE 24 UPDATES This section presents patients who had a transmission of information during a month on an EPI defined topic that was incomplete. These patients have information that has been transmitted during the current processing month in order to complete the EPI files. This information usually contains inpatient information about discharge date; ICD-9 coded diagnoses, and occasionally will contain laboratory based testing. This line listing of patient, SSN, and admission date and discharge date is provided to assist with analysis should a processing/error report occur with your monthly automated transmission of this data. Name LAST 4 Admission date Discharge date __________________________________________________________________ LABPATIENT13~FIVE 0135 12-19-2002@1605 04-05-2003@1213 LABPATIENT13~SIX 0136 01-28-2003@1720 03-06-2003@1614 LABPATIENT13~SEVEN 0137 02-04-2003@1045 03-07-2003@1847 Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. PAGE 25 Pharmacy-based data extracted for EPI data base. INTERFERON BETA-1A (AVONEX) 30MCG 0138 LABPATIENT13~EIGHT Outpatient 03-12-2003 0139 LABPATIENT13~NINE Outpatient 03-27-2003 1310 LABPATIENT13~TEN Outpatient 03-19-2003 1310 LABPATIENT13~TEN Outpatient 03-21-2003 1310 LABPATIENT13~TEN Outpatient 03-28-2003 0141 LABPATIENT14~ONE Outpatient 03-11-2003 0142 LABPATIENT14~TWO Outpatient 03-20-2003 0143 LABPATIENT14~THREE Outpatient 03-03-2003 0144 LABPATIENT14~FOUR Outpatient 03-11-2003 0145 LABPATIENT14~FIVE Outpatient 03-18-2003 0146 LABPATIENT14~SIX Outpatient 03-28-2003 0147 LABPATIENT14~SEVEN Outpatient 03-03-2003 0148 LABPATIENT14~EIGHT Outpatient 03-24-2003 0149 LABPATIENT14~NINE Outpatient 03-14-2003 1410 LABPATIENT14~TEN Outpatient 03-10-2003 0151 LABPATIENT15~ONE Outpatient 03-02-2003 0151 LABPATIENT15~ONE Outpatient 03-21-2003 0152 LABPATIENT15~TWO Outpatient 03-20-2003 0153 LABPATIENT15~THREE Outpatient 03-20-2003 0154 LABPATIENT15~FOUR Outpatient 03-14-2003 0155 LABPATIENT15~FIVE Outpatient 03-14-2003 0156 LABPATIENT15~SIX Outpatient 03-10-2003 --------------------------------------------------------------- SUBCOUNT 22 INTERFERON BETA-1A 44MCG/SYR INJ (REBIF) 0951 FLUZHU~BHYYHSE U~TU Outpatient 03-06-2003 --------------------------------------------------------------- SUBCOUNT 1 INTERFERON BETA-1B 0.3MG (BETASERON) 0157 LABPATIENT15~SEVEN Outpatient 03-25-2003 0158 LABPATIENT15~EIGHT Outpatient 03-26-2003 0159 LABPATIENT15~NINE Outpatient 03-06-2003 0159 LABPATIENT15~NINE Outpatient 03-26-2003 1510 LABPATIENT15~TEN Outpatient 03-18-2003 ---------------------------------------------------------------------- SUBCOUNT 5 Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. PAGE 26 Detailed Listing of Hepatitis C Risk Assessment These Health factors/Resolved terms for hepatitis C risk assessment are the national Health factors used for roll-up of risk assessment data. They may not reflect the terms actually utilized (seen) in the Clinical Reminder package at this facility. To determine which local/facility Clinical Reminder health factor(s) correspond(s) to the national term, please contact your facility Clinical Reminder application coordinator. Note that hepatitis C infection is based on a previously ICD-9 coded diagnosis of hepatitis C at your site/facility. DECLINED ASSESSMENT FOR HEPATITIS C -------------------------------------- NO PATIENTS REPORTED FOR THE REPORT PERIOD NO RISK FACTORS FOR HEPATITIS C -------------------------------------- 0161 LABPATIENT16~ONE Outpatient 03-24-2003@1140 0162 LABPATIENT16~TWO Outpatient 03-20-2003@1300 0163 LABPATIENT16~THREE Outpatient 03-03-2003@1500 0164 LABPATIENT16~FOUR Outpatient 03-05-2003@1500 0165 LABPATIENT16~FIVE Outpatient 03-18-2003@1000 0166 LABPATIENT16~SIX Outpatient 03-17-2003@1500 0167 LABPATIENT16~SEVEN Outpatient 03-24-2003@1515 0168 LABPATIENT16~EIGHT Outpatient 03-05-2003@1000 0169 LABPATIENT16~NINE Outpatient 03-10-2003@1500 1610 LABPATIENT16~TEN Outpatient 03-31-2003@1400 0171 LABPATIENT17~ONE Outpatient 03-05-2003@1000 0172 LABPATIENT17~TWO Outpatient 03-18-2003@1500 0173 LABPATIENT17~THREE Outpatient 03-04-2003@0815 0174 LABPATIENT17~FOUR Outpatient 03-18-2003@1500 0175 LABPATIENT17~FIVE Outpatient 03-12-2003@1300 0176 LABPATIENT17~SIX Outpatient 03-24-2003@0900 --------------------------------------------------------------- SUBCOUNT 238 PREVIOUSLY ASSESSED FOR HEPATITIS C -------------------------------------- 0177 LABPATIENT17~SEVEN Inpatient 03-15-2003 0178 LABPATIENT17~EIGHT Inpatient 03-14-2003 --------------------------------------------------------------- SUBCOUNT 2 Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. RISK FACTORS FOR HEPATITIS C -------------------------------------- 0179 LABPATIENT17~NINE Outpatient 03-07-2003@1530 1710 LABPATIENT17~TEN Outpatient 03-26-2003@1300 0181 LABPATIENT18~ONE Outpatient 03-31-2003@1400 0182 LABPATIENT18~TWO Outpatient 03-27-2003@1530 0044 LABPATIENT4~FOUR Outpatient 03-19-2003@1300 0183 LABPATIENT18~THREE Outpatient 03-03-2003@1000 0184 LABPATIENT18~FOUR Outpatient 03-20-2003@1000 0185 LABPATIENT18~FIVE Inpatient 03-10-2003@1120 0186 LABPATIENT18~SIX Outpatient 03-26-2003@1000 0187 LABPATIENT18~SEVEN Outpatient 03-13-2003@1500 0068 LABPATIENT6~EIGHT Inpatient 03-25-2003@1203 0188 LABPATIENT18~EIGHT Inpatient 03-26-2003@1239 --------------------------------------------------------------- SUBCOUNT 132 POSITIVE TEST FOR HEPATITIS C ANTIBODY -------------------------------------- 0041 LABPATIENT4~ONE Outpatient 03-26-2003@1240 0042 LABPATIENT4~TWO Outpatient 03-27-2003@1614 0043 LABPATIENT4~THREE Inpatient 03-13-2003@0700 0044 LABPATIENT4~FOUR Outpatient 03-19-2003 0045 LABPATIENT4~FIVE Inpatient 03-08-2003@0700 0046 LABPATIENT4~SIX Outpatient 03-05-2003@0823 0047 LABPATIENT4~SEVEN Inpatient 03-08-2003@0700 0048 LABPATIENT4~EIGHT Inpatient 03-08-2003@0700 0049 LABPATIENT4~NINE Outpatient 03-05-2003@1726 0410 LABPATIENT4~TEN Inpatient 03-14-2003@1004 0051 LABPATIENT5~ONE Outpatient 03-07-2003@1015 0052 LABPATIENT5~TWO Inpatient 03-21-2003@0700 0053 LABPATIENT5~THREE Outpatient 03-10-2003@0807 0054 LABPATIENT5~FOUR Outpatient 03-18-2003 0055 LABPATIENT5~FIVE Outpatient 03-11-2003@0916 0056 LABPATIENT5~SIX Inpatient 03-27-2003@0700 0057 LABPATIENT5~SEVEN Inpatient 03-06-2003@0700 0058 LABPATIENT5~EIGHT Inpatient 03-21-2003@0700 0189 LABPATIENT18~NINE Outpatient 03-31-2003@1057 0059 LABPATIENT5~NINE Outpatient 03-12-2003@0911 0510 LABPATIENT5~TEN Outpatient 03-25-2003@1443 0061 LABPATIENT6~ONE Outpatient 03-04-2003@1019 0062 LABPATIENT6~TWO Inpatient 03-13-2003@0700 0063 LABPATIENT6~THREE Inpatient 03-13-2003@0700 0064 LABPATIENT6~FOUR Outpatient 03-04-2003@1648 0065 LABPATIENT6~FIVE Inpatient 03-08-2003@0700 0066 LABPATIENT6~SIX Outpatient 03-27-2003@1141 0067 LABPATIENT6~SEVEN Outpatient 03-03-2003@1503 0068 LABPATIENT6~EIGHT Inpatient 03-27-2003@0700 0069 LABPATIENT6~NINE Inpatient 03-13-2003@0700 0610 LABPATIENT6~TEN Outpatient 03-28-2003@1356 --------------------------------------------------------------- SUBCOUNT 31 Example: New Detailed Verification Report of EPI Extracted Data from Site mailman messages continued. NEGATIVE TEST FOR HEPATITIS C ANTIBODY -------------------------------------- 0078 LABPATIENT7~EIGHT Inpatient 03-05-2003@0700 0079 LABPATIENT7~NINE Outpatient 03-18-2003@0743 0710 LABPATIENT7~TEN Outpatient 03-03-2003@0846 0081 LABPATEINT8~ONE Outpatient 03-26-2003@1515 0082 LABPATIENT8~TWO Outpatient 03-28-2003@1506 0083 LABPATIENT8~THREE Inpatient 03-03-2003@0700 0084 LABPATIENT8~FOUR Outpatient 03-25-2003@1039 0085 LABPATIENT8~FIVE Outpatient 03-04-2003@1138 1810 LABPATIENT18~TEN Outpatient 03-24-2003@1700 0191 LABPATIENT19~ONE Outpatient 03-25-2003@1120 0188 LABPATIENT18~EIGHT Inpatient 03-27-2003@0700 0192 LABPATIENT19~TWO Outpatient 03-28-2003@1406 --------------------------------------------------------------- SUBCOUNT 212 HEPATITIS C DIAGNOSIS (ICD-9 BASED) -------------------------------------- 0193 LABPATIENT19~THREE Outpatient 03-17-2003@1330 0037 LABPATIENT3~SEVEN Outpatient 03-05-2003@1300 0194 LABPATIENT19~FOUR Outpatient 03-19-2003@1300 0195 LABPATIENT19~FIVE Outpatient 03-24-2003@0800 0196 LABPATIENT19~SIX Outpatient 03-18-2003 0197 LABPATIENT19~SEVEN Outpatient 03-26-2003@1430 0198 LABPATIENT19, EIGHT Outpatient 03-14-2003@1245 0064 LABPATIENT6~FOUR Outpatient 03-04-2003@1500 0199 LABPATIENT19~NINE Outpatient 03-18-2003 0069 LABPATIENT6~NINE Inpatient 03-26-2003@1007 --------------------------------------------------------------- SUBCOUNT 130 ----------------------------------------------------------------- COUNT 745 New EPI Processing Error Report Mailman Message sent from Austin The new EPI Processing/Error Report mailman message itemizes all transmissions received by AAC and document the records status as either being accepted or rejected (with the reason and reject code identified). This report is sent to the EPI mail group. (Examples of Tables of Rejects and Errors and/or Warning Codes are located in the Appendix - B section of this manual). Example: New EPI Processing Error Report Mailman Message Subj: EPT/DOY #041381117683754 [#19644680] 17 May 04 11:18 CST 46 lines From: < HYPERLINK "mailto:POSTMASTER@FOC-AUSTIN.VA.GOV" POSTMASTER@FOC-AUSTIN.VA.GOV> In 'IN' basket. Page 1 ----------------------------------------------------------------------------- 2EPI0003 DOY. STATION 539 V3 EPI PROCESSING/ERROR REPORT REPORT DATE 2004/05/17 PAGE 01 PROCESS DATE SSN ENCOUNTER DATE MESSAGE ERROR CODES 20040430 000001010 20040415114936 090 240 20040430 000001011 20040408101856 090 240 20040430 000001012 20040428 042 W07 20040430 000001013 20040316145349 035 W07 20040430 000001014 20040428194521 057 W07 20040430 000001015 20040310110835 031 W07 20040430 000001016 200404271400 071 W05 20040430 000001017 19941104101210 026 W05 THIS REPORT REPRESENTS DATA FROM APRIL 2004 FROM YOUR STATION AS A GENERAL GUIDE FOR INTEPRETATION, THERE ARE 2 TYPES OF ERROR CODES. ONE TYPE HAS 3 DIGITS (E.G., 240) AND THE OTHER TYPE HAS THE LETTER W FOLLOWED BY 2 DIGITS (E.G., W05). A LISTING OF MEANINGS FOR THE ERRORS Enter RETURN to continue or '^' to exit: Example: EPI Processing Error Report Mailman Message continued Subj: EPT/DOY #041381117683754 [#19644680] Page 2 ------------------------------------------------------------------------------ IS PROVIDED BELOW. THE 3-DIGIT ERROR CODE INDICATES THAT A FATAL ERROR OCCURRED FOR THE LISTED PATIENT AND THE ENTIRE EPI MESSAGE FOR THE MONTH OF APRIL 2004 WAS NOT ACCEPTED INTO THE DATA REPOSITORY. YOUR SITE WILL NEED TO CORRECT A 3-DIGIT FATAL ERROR CODE FOR ALL PATIENTS HAVING IT PRESENT, AND THEN RE-TRANSMIT THE APRIL 2004 EPI MESSAGE USING THE MANUAL RUN OPTION--L AB EPI MANUAL RUN (ENHANCED). THIS MANUALLY RE-SUBMITTED MESSAGE WILL BE PROCESSED AT THE AUSTIN AUTOMATION CENTER. KEEP IN MIND THAT IF YOU DO RE-SUBMIT A TRANSMISSION, THE NORMAL EPI PROCESS WILL ALSO GENERATE AND SEND ITS NORMAL MONTHLY DATA AS SCHEDULED; THEREFORE, AT THE TIME OF RECEIPT OF PROESSING MESSAGES, YOU SHOULD RECEIVE REPORTS FOR MORE THAN ONE TRANSMISSION. A WARNING CODE DOES NOT CONSTITUTE A FATAL ERROR. THESE WARNING MESSAGES SHOULD BE CORRECTED IF ABLE, BUT DO NOT NEED FOR THE DATA TO BE RESUBMITTED. YOU SHOULD MONITOR THE WARNING MESSAGES OVER THE NEXT COUPLE OF TRANSMISSIONS TO BE ASSURED THAT THEY DO NOT PERSIST. IF YOUR PROCESSING MESSAGE CONTAINS ONLY WARNING ERROR CODES (I.E., THERE ARE NO FATAL ERROR CODES), MANUAL RE-TRANSMISSION DOES NOT NEED TO BE PERFORMED. 240 Period of Service was invalid. W07 Specimen Source Code is blank. Enter RETURN to continue or '^' to exit: Subj: EPT/DOY #041381117683754 [#19644680] Page 3 ---------------------------------------------------------------------------- W05 Patient Date of Birth is not in a valid date format. END OF REPORT TOTAL PAGES: 01 Table of Reject and Errors and/or Warning Codes The following Table of Rejects and Errors and/or Warning Codes definitions are used by the Austin Automation Center for the new EPI Error Processing Report mailman messages. Examples: Tables of Rejects and Errors and/or Warning Codes. Tables of Rejects and Errors and/or Warning CodesERROR NUMBERFIELD NAMEEDIT DESCRIPTIONERROR MESSAGE000 SeriesMiscellaneous001Message Control IDMust not be blankMessage control ID was blank002Batch Sending FacilitySending Station not valid. (Refer to table AA001)Invalid Batch Sending Facility.003Segment NamePID Segment missing. Do not edit for the existence of PID when NTE segments are present.PID Segment missing.004Segment NamePV1 Segment missing. Do not edit for the existence of PV1 when NTE segments are present.PV1 Segment missing.005Segment NameInvalid Segment Name.Invalid HL7 Segment Name.006Message Creation DateMust a valid date.Message Creation Date is Invalid.007Message Creation TimeMust a valid time.Message Creation Time is invalid.008Processing PeriodMust a valid date.Processing period in the NTE segment is invalid.009Processing PeriodHistorical processing for V2 of EPI (commonly known as HEP C) must be received in Austin sequentially from 1998 forward.For V2 only - Processing into AAC must be sequential from 10/98 forward. Examples: Tables of Rejects and Errors and/or Warning Codes continued. Tables of Rejects and Errors and/or Warning CodesERROR NUMBERFIELD NAMEEDIT DESCRIPTIONERROR MESSAGE100 SeriesNTE Totals Segment100Action IndCurrently not being used.Currently not being used.105Totals Total CountMust be numeric, if Action Ind is 'T'.NTE Totals Total Count was not numeric.110Negative Input IndMust be 'N', if Action Ind is not 'T '.Negative Input Ind was not 'N'.200 SeriesPID Segment200Patient NameRequired. Must be alpha numeric. Must not be all numeric. Must not be all blanks.Patient Name is missing, or not alphanumeric, or all numeric, or all blanks.205Patient Date of BirthNot required. Must be less than the processing year.Date of Birth is after the Date of transmission. (Also see W03, W04, and W05)210Patient SexNot required. Must be blank or match table. (Refer to table T0001)Sex code is not blank or a valid code. (Refer to table 0001)215Patient RaceNot required. Must be blank or a valid code. (Refer to table VA07)Race code is not blank or a valid code. (Refer to table VA07)220Patient AddressMust be blank or H.Patient Address is not blank or H.235Social Security NumberRequired. Last byte must be P or blank.Pseudo SSN is not P or blank.236Social Security NumberRequired. Must be numeric. Must be greater than zeros.Social Security Number is missing, or not numeric, or is equal to zeros.240Patient Veteran StatusMust be a valid code. (Refer to table VA11)Period of Service was invalid. (Refer to table VA11). Examples: Tables of Rejects and Errors and/or Warning Codes continued. Tables of Rejects and Errors and/or Warning CodesERROR NUMBERFIELD NAMEEDIT DESCRIPTIONERROR MESSAGE300 SeriesOBR Segment300Universal Service IDMust be a valid code. (Refer to table NLT)Invalid Universal Service ID (Refer to table NLT)305Observation DateMust be numeric date. Must be a valid date. Must be less than Processing date.Observation Date is invalid date or after the date of transmission.307Observation TimeNot required. Must be blank or numeric. If numeric, must be a valid time.Observation Time is invalid.310Specimen Source CodeNot required. If not blank, must be a valid code. (Refer to table SPC) Invalid Specimen Source (Refer to table SPC) Code. (also see W07)315Parent Observation IDNot required. Must be blank or a valid code. (Refer to table NLT)Invalid Parent Observation ID (Refer to table NLT). Examples: Tables of Rejects and Errors and/or Warning Codes continued. Tables of Rejects and Errors and/or Warning CodesERROR NUMBERFIELD NAMEEDIT DESCRIPTIONERROR MESSAGE400 SeriesPV1 Segment400Patient ClassRequired. Must be 'I', 'O', or 'U'.Patient Class is not 'I', 'O', or 'U'.410Discharge DateNot required. Must be blank or a valid date. Must be less than or equal to processing date.Discharge Date is invalid or after date of transmission.411Discharge TimeNot required. Time must be blank or a valid time.Discharge Time is invalid420Admit Date/TimeRequired. Must be numeric. Must be a valid date. Must be less than or equal to processing date.Admit Date is invalid or after date of transmission.421Admit Date/TimeRequired. Time must be numeric. Must be a valid time.Admit Time is invalid.500 SeriesDG1 Segment500Diagnosis CodeRequired. Must be a valid code. (Refer to table AA010)Invalid Diagnosis Code (Refer to table 0051)600 SeriesOBX Segment605Final Result DateMust be blank or a valid date. Must be numeric. Must be a less than or equal to the processing date.Final Result Date is invalid or after the date of transmission. Examples: Tables of Rejects and Errors and/or Warning Codes continued. Tables of Rejects and Errors and/or Warning CodesERROR NUMBERFIELD NAMEEDIT DESCRIPTIONERROR MESSAGEW00 SeriesWarningsW03Patient Date of BirthMust not be all spaces.Patient Date of Birth is all spaces. (Also see 205) W04Patient Date of BirthYear must not be all zerosPatient Date of Birth Year is all zeros. (See also 205)W05Patient Date of BirthMust be a valid date.Patient Date of Birth is not in a valid date format. (Also see 205)W07Specimen Source CodeBlanks in code.Specimen Source code is blank. (See also 310)W09Observation Nat Lab NumBlanks in code.Observation Nat Lab Num is blank. (Also see 600)W10Date of PrescriptionMust not be all spaces.Date of Prescription is all Spaces.W11Date of PrescriptionYear must not be all zeros.Date of Prescription is all Zeros.W12Date of PrescriptionMust be a valid date.Date of Prescription is not in a valid date format.W14Resolve TermMust be numeric.Resolve Term must be numeric.W15Days SupplyMust be numeric or blank.Days Supply not numeric or blank.W16Release DateMust be numeric date. Must be a valid date. Must be less than processing date.Release Date is invalid date or after the date of transmission.W17Fill DateMust be numeric date. Must be a valid date. Must be less than processing date. Fill Date is invalid date or after the date of transmission.  Examples: Tables of Rejects and Errors and/or Warning Codes continued. Tables of Rejects and Errors and/or Warning CodesERROR NUMBERFIELD NAMEEDIT DESCRIPTIONERROR MESSAGEW18Stop DateMust be numeric date. Must be a valid date. Must be less than processing date. Stop Date is invalid date or after the date of transmission. W19Primary IndicatorOne DG1 diagnostic code must be designated as the primary code - valid starting with version 2 of the software. No diagnostic code designated as primaryW20Release Date/Fill DateAt least one of the two - release date or fill date - must be present. Release Date and Fill Date are both blank. W21DSP NomenclatureMust not be all spaces.DSP Nomenclature is all spaces. W22Resolve TermMust be 1, 2, 3, 4, 5, 6, 7, or 0.Invalid Resolve Term.W23Lab ResultMust be spaces if Resolve Term is 1, 2, 3, 4, or 7. Lab Result is not insync with Resolve Term.W24LOINC CodeMust be a valid code or blank.LOINC Code is invalid.  National Laboratory Test (NLT) List The NLT WKLD Code Request Form is accessible via the following web sites: VistA Laboratory Version 5.2 Home Page  HYPERLINK "http://vista.med.va.gov/ClinicalSpecialties/lab/" http://vista.med.va.gov/ClinicalSpecialties/lab/ VistA Documentation Library (VDL)  HYPERLINK "http://www.va.gov/vdl/" http://www.va.gov/vdl/ DEVICE: 0;80;9999 UCX/TELNET VistA NLT List 3/25/2004 MAR 25,2004 15:04 PAGE 1 WKLD CODE PROCEDURE --------------------------------------------------------------------------- 80000.0000 Analyte NOS 80079.0000 RAJI Cell 81000.0000 Urinalysis Chemical w micr Man 81001.0000 Urinalysis Micros only 81002.0000 Urinalysis Chemical w o micro 81003.0000 Bilirubin Conjugated 81004.0000 Urinalysis Components 81005.0000 Sulfonamide Crystals Qual 81006.0000 Urine Volume Measure 81007.0000 Urinalysis Microsopic 81008.0000 Bilirubin Unconjugated 81009.0000 Cholesterol VLDL 81010.0000 Triglycerides VLDL 81011.0000 Amylase Fractionation 81012.0000 Angiotensin Converting Enzyme 81013.0000 Histamine 81014.0000 Desmethyldiazepam 81015.0000 Drug Screen Opiate 81016.0000 Pepsinogen 81017.0000 Thiothixene 81018.0000 Phenobarbital 81019.0000 Vitamin B1 81020.0000 Primidone 81021.0000 Vitamin B2 81022.0000 Procainamide 81023.0000 Vitamin B6 81024.0000 Propranolol 81025.0000 Vitamin E 81026.0000 Citrate 81027.0000 Carnitine 81028.0000 Chromogranin A 81029.0000 Cyclic AMP 81030.0000 DHEA 81031.0000 DHEA S 81032.0000 Encainide 81033.0000 Hemoglobin Fetal Feces 81034.0000 Erythropoietin 81035.0000 Estrone 81036.0000 Ethmozine 81037.0000 Fiorinal 81038.0000 Fluoxetine 81039.0000 Fluphenazine 81040.0000 Free T3 (dialysis) 81041.0000 Gonadotrophins REL Hormone 81042.0000 Insulin Ab 81043.0000 Insulin Free 81044.0000 Insulin Immunoreactive 81045.0000 Ionize Calcium 81046.0000 Iron Liver Tissue 81047.0000 Ketones 81048.0000 Mepho Barbital 81049.0000 Mesantoin 81050.0000 Methylmalonic Acid 81051.0000 Metopirone Response 81052.0000 Navane 81053.0000 Nitrogen Total 81054.0000 Pepsinogen I 81055.0000 Pepsinogen II 81056.0000 Phytanic Acid 81057.0000 Proinsulin 81058.0000 Pseudocholinesterase Total 81059.0000 PTH Related Protein 81060.0000 Sex Hormone Binding Globulin 81061.0000 Hemoglobin Unstable Isopropyl 81062.0000 Testosterone Free 81063.0000 Thyrotropin Bind Inhib Immuno 81064.0000 Thyroxine Free (Dialysis) 81065.0000 Tolmetin 81066.0000 Trazodone 81067.0000 Verapamil 81068.0000 Acetaminophen 81069.0000 Arylsulfatase a 81070.0000 Vitamin B12 Binding Capacity 81071.0000 Carbohydrate Ag 81072.0000 Ativan 81073.0000 Urinalysis Chemical w micro Au 81074.0000 Carisprodal 81075.0000 Beta Glucuronidase 81076.0000 Beta Hydroxybutyrate 81077.0000 C1 Esterase Inhibitor (Qual) 81078.0000 C1 Esterase Inhibitor (Quant) 81079.0000 Hemoglobin electrophoresis 81080.0000 Homocystine 81081.0000 Dibucaine number 81082.0000 IgG Subsets 81083.0000 Cotinine 81084.0000 Chylomicrons 81085.0000 Total iron binding capacity 81086.0000 Opiate group 81087.0000 Transthyretin 81088.0000 Protein electrophoresis 81089.0000 Free Hemoglobin, serum 81090.0000 Lactescence 81091.0000 T-UPTAKE 81092.0000 ALA Dehydratase 81093.0000 UPG Synthase 81094.0000 Clozaril 81095.0000 Myoglobin Serum 81096.0000 Misc Chem Test 1 81097.0000 Misc Chem Test 2 81098.0000 Amikacin 81098.3035 Amino Levulinic Acid Delta~DU 81098.3103 Amino Levulinic Acid Delta~EKT 81098.8044 Amino Levulinic Acid Delta~LAB 81099.0000 Misc Chem Test 3 81100.0000 Misc Chem Test 4 81101.0000 Misc Chem Test 5 81102.0000 Misc Chem Test 6 81103.0000 Misc Chem Test 7 81104.0000 Misc Chem Test 8 81105.0000 Misc Chem Test 9 81106.0000 Misc Chem Test 10 81107.0000 Instrument CH Setup 81108.0000 Auto Chem 1-2 test 81109.0000 Auto Chem 3 test 81110.0000 Auto Chem 4 test 81111.0000 Auto Chem 5 test 81112.0000 Amitriptyline 81113.0000 Auto Chem 6 test 81114.0000 Auto Chem 7 test 81115.0000 Auto Chem 8 test 81116.0000 Auto Chem 9 test 81117.0000 Auto Chem 10 test 81118.0000 Auto Chem 11 test 81119.0000 Auto Chem 12 test 81120.0000 Auto Chem 13-16 test 81121.0000 Auto Chem 17-18 test 81122.0000 Auto Chem >18 test 81123.0000 General Health Screen panel 81124.0000 Pre Marital Profile 81125.0000 Executive Profile 81126.0000 Obstetric Profile 81127.0000 Amenorrhea Profile 81128.0000 Male Infertility and/or Gyneco 81129.0000 Hepatic Function Panel 81130.0000 Hepatitis Panel 81131.0000 Hypertension Panel 81132.0000 Lipid Panel 81133.0000 Cardiac Evaluation Panel 81134.0000 Cardiac Injury Panel 81135.0000 Cardiac Injury Panel w CPK and 81136.0000 Metabolic Panel 81137.0000 Malabsorption Panel 81138.0000 Pulmonary Panel 81139.0000 Lung Maturity Profile 81140.0000 Thyroid Panel 81141.0000 Thyroid Panel w TRH 81142.0000 Arthritis Panel 81143.0000 Renal Panel 81144.0000 Parathyroid Panel 81145.0000 Prostatic Panel 81146.0000 Pancreatic Panel 81147.0000 Pituitary Panel 81148.0000 Microcytic Anemia Panel 81149.0000 Macrocytic Anemia Panel 81150.0000 Transition Panel 81151.0000 Muscle Panel 81152.0000 Antibody Panel 81153.0000 Unlisted Panel 81154.0000 Thyrotropin Releasing Hormone 81155.0000 Therapeutic Quantitative Drug 81156.0000 Serum Antimicrobial Level, Bio 81157.0000 Serum RIA Circulating Antibiot 81158.0000 Vitamin K 81159.0000 Folate, RBC 81160.0000 Microalbumin 81161.0000 Felbamate 81162.0000 Glucose 2hr 81163.0000 Glucose Tolerance 3hr 81164.0000 Glucose Tolerance 6hr 81165.0000 Xylose TT 81166.0000 Lactose 81167.0000 Lactose TT 81168.0000 D-Xylose 81169.0000 Creatinine Clearance 81170.0000 Amorphus Sediment 81171.0000 Ascorbic Acid Stick 81172.0000 RBC Urine 81173.0000 Bilirubin Crystals 81174.0000 Bilirubin Stick 81175.0000 Calcium Carbonate Crystal 81176.0000 Calcium Oxalate Crystal 81177.0000 Calcium Phosphate Crystal 81178.0000 Cystine Crystal 81179.0000 Epithelial Cast 81180.0000 Epithelial Cell 81181.0000 Fat Globule 81182.0000 Fatty Cast 81183.0000 Filamentous Bodies 81184.0000 Glucose Stick 81185.0000 Granular Cast 81186.0000 Gross Blood 81187.0000 Hemoglobin Stick 81188.0000 Hyaline Cast 81189.0000 Ketone Stick 81190.0000 Mucus Urine 81191.0000 Nitrate Stick 81192.0000 pH Stick 81193.0000 Protein Stick 81194.0000 Pyrophosphate Crystal 81195.0000 RBC Cast 81196.0000 Reducing Substance 81197.0000 Renal Epithelial Cell 81198.0000 Specific Gravity Urine 81199.0000 Sperm in Urine 81200.0000 Squamous Epithelial Cell 81201.0000 Trichomonas in Urine 81202.0000 Triple Phosphate Crystal 81203.0000 Unidentified Crystal 81204.0000 Uric Acid Crystal 81205.0000 Clarity Urine 81206.0000 Color Urine 81207.0000 Urobilinogen Stick 81208.0000 Waxy Cast 81209.0000 WBC Cast 81210.0000 WBC Esterase Stick 81211.0000 WBC in Urine 81212.0000 Yeast in Urine 81213.0000 Anion Gap 81214.0000 Albumin/Creat Ratio 81215.0000 Amylase Pancreatic 81216.0000 Bicarbonate 81217.0000 BSA 81218.0000 BUN/Creat Ratio 81219.0000 Calcium Normalized 81220.0000 Deoxyhemoglobin 81221.0000 FiO2 81222.0000 Hemolyzed Specimen 81223.0000 Icteric Specimen 81224.0000 Turbid Specimen 81225.0000 LDH Isoenzyme 1 81226.0000 LDH Isoenzyme 2 81227.0000 LDH Isoenzyme 3 81228.0000 LDH Isoenzyme 4 81229.0000 LDH Isoenzyme 5 81230.0000 O2 Content 81231.0000 Oxyhemoglobin 81232.0000 Volume 81233.0000 MASS 81234.0000 GGTP 81234.3000 Ethanol~MANUAL 81234.3035 Ethanol~DU PONT ACA 81235.0000 Dilantin 81236.0000 Ethanol 81237.0000 N-Acetyl 81238.0000 Mysoline 81239.0000 Tegretol 81240.0000 Bence Jones Protein 81241.0000 Motility 81242.0000 Mesothelial Cell 81243.0000 O2Hb % 81244.0000 COHb % 81245.0000 MetHb % 81246.0000 Base Excess 81247.0000 Pt Temp 81248.0000 pH 81249.0000 pH Corrected 81250.0000 PCO2 Corrected 81251.0000 PO2 Corrected 81252.0000 pH Urine 81253.0000 WBC/HPF 81254.0000 RBC/HPF 81255.0000 Bacteria Urine 81256.0000 Urine Cast 81257.0000 Crystal Urine 81258.0000 Amorphus Urate 81259.0000 Amorphus Phosphate 81260.0000 Leucine Crystal 81261.0000 Tyrosine Crystal 81262.0000 Cholesterol Crystal 81263.0000 Calculus Urine 81264.0000 Addis Count 81265.0000 Transitional Epithelial 81266.0000 %O2 81267.0000 %CO2 81268.0000 Osmolality Calc 81269.0000 Leukocyte Esterase 81270.0000 Mononuclear Cell 81271.0000 TCO2 81272.0000 Xanthochromic 81273.0000 Amiodarone 81274.0000 Ritalin 81275.0000 Methyl Tertiary Butyl Ether 81276.0000 Phenolphthalein 81277.0000 Phenelzine 81278.0000 Sertraline 81279.0000 Silver 81280.0000 Propafenone 81281.0000 T3 OK Ag 81282.0000 T3 OK Ab 81283.0000 Myelin Glycoprotein 81284.0000 Molybdenum 81285.0000 3-Methyoxy 4-hydroxypheylglyco 81286.0000 Anafranil 81287.0000 Bile Salt Conc. 81288.0000 Bypivicaine 81289.0000 Diltiazam 81290.0000 Xanthine 81291.0000 Bupropion Hydrochloride 81292.0000 Levodopa 81293.0000 Midazolam 81294.0000 Molindone Hydrochloride 81295.0000 Hexosamidiase 81296.0000 Disulfiram 81297.0000 Vitamin C 81298.0000 Trimipramine 81299.0000 2 Methylcitric Acid 81300.0000 Benzene 81301.0000 Beta Lactoglobulin 81302.0000 CPK BB 81303.0000 CPK MM 81304.0000 Cystathionine 81305.0000 DNA Analysis 81306.0000 Estradiol 17 B 81307.0000 Gentamicin 81308.0000 Estradiol E1 E2 81309.0000 Fluconazole 81310.0000 Gabapentin 81311.0000 Homocysteine 81312.0000 Metharbital 81313.0000 Normethsuximide 81314.0000 Fatty Acid VLC 81315.0000 Arylsulfatase a Leukocyte 81316.0000 Catecholamines Fract 81317.0000 Imipramine & Desipramine 81318.0000 PTH C Terminal 81319.0000 PTH Intact 81320.0000 Folic Acid 81321.0000 Vasopressin 81322.0000 FK506 81323.0000 Gen Chem Specimen 81324.0000 Sp Chem Specimen 81325.0000 Kanamycin 81326.0000 UA Specimen 81327.0000 UA Chem Specimen 81328.0000 Tox Specimen 81329.0000 TDM Specimen 81330.0000 STAT Lab Specimen 81331.0000 RIA Specimen 81332.0000 RIA Sp Specimen 81333.0000 Gen Specimen 81334.0000 IgG 81335.0000 Buspirone 81336.0000 Desethylaminodarone 81337.0000 Norverapamil 81338.0000 Tertiary Butyl Alcohol 81339.0000 Trichloroethanol 81340.0000 IgM 81341.0000 Meclofenamic Acid 81342.0000 IgD 81343.0000 Moricizine 81344.0000 Naproxen 81345.0000 Procardia 81346.0000 Pyridinium 81347.0000 Schlicter Test 81348.0000 Spironolactone 81349.0000 Tripamine 81350.0000 IgL 81351.0000 IgK 81352.0000 Glucose Fasting 81353.0000 Urine Dipstick Manual 81354.0000 Urine Dipstick Auto 81355.0000 Electrophoretic Fractionation 81356.0000 Methotrexate 81357.0000 Electrolytes 81358.0000 GLC Analysis 81359.0000 Immunoassay 81360.0000 Alpha Galactosidase 81361.0000 D-Lactate 81362.0000 Alpha1 Globulins 81363.0000 Alpha2 Globulins 81364.0000 Beta Globulins 81365.0000 Albumin Fraction 81366.0000 Relative Index 81367.0000 Excretion Rate 81368.0000 Iron Panel Chemistry 81369.0000 Adenosine Deaminase 81370.0000 Trichloracetia Acid 81371.0000 Acetoacetate 81372.0000 Augmentin 81373.0000 N-Telopeptide 81374.0000 5 Hydroyindoleacetic Acid 81375.0000 Adenosine Diphosphate 81376.0000 Timentin 81377.0000 Free Hemoblobin, Urine 81378.0000 Fecal Electrolytes 81379.0000 Mycophenolic Acid 81380.0000 Phenazopyridine 81381.0000 Phosphofructokinase 81382.0000 Antabuse 81383.0000 Bertylium 81384.0000 Phencyclidine Quant 81385.0000 Bromociptine 81386.0000 Captopril 81387.0000 Malathion 81388.0000 N-Telopeptide ELISA 81389.0000 Pimozide 81390.0000 Sotalol 81391.0000 Sulfonylurea 81392.0000 Toxic Analysis 81393.0000 Toxic substance Analysis 81394.0000 Venlafaxine 81395.0000 Vistaril 81396.0000 Osmolality Urine 81397.0000 Osmolality Stool 81398.0000 Ictotest 81399.0000 Protein UR Quant 81400.0000 ACTH Stimulation 81401.0000 Amiodarone & Metabolite 81402.0000 Grepafloxacin 81403.0000 Trovafloxacin 81404.0000 T3 RIA 81405.0000 Clofazimine 81406.0000 Arsenic Nail 81407.0000 Trazodone2 81408.0000 Aldosterone Suppression 81409.0000 Hexacarboxypoprhyrin 81410.0000 Pentacarboxyporphyrin 81411.0000 Norchlordiazepoxide 81412.0000 Cathartic Laxative Panel 81413.0000 Orotic Acid 81414.0000 Clonidine 81415.0000 Microalbumin Point 81416.0000 Arsenic Hair 81417.0000 Electrocardiogram 81418.0000 Cardiac Stress 81419.0000 Sulfonylurea Hypoglycemic 81420.0000 Dexamethasone 81421.0000 Beta-lactamase 81422.0000 C-Peptide 30min 81423.0000 X*C-Peptide 81424.0000 C-Peptide 60min 81425.0000 C-Peptide 90Min 81426.0000 C-Peptide 120min 81427.0000 C-Peptide 180min 81428.0000 Insulin 30min 81429.0000 Insulin 60min 81430.0000 Insulin 90min 81431.0000 Insulin 120min 81432.0000 Insulin 180min 81433.0000 LH 30min 81434.0000 LH Stimulation Panel 81435.0000 LH 60min 81436.0000 LH 90min 81437.0000 LH 120MIN 81438.0000 FSH Stimulation Panel 81439.0000 FSH 30min 81440.0000 FSH 60min 81441.0000 FSH 90min 81442.0000 FSH 120min 81443.0000 ACTH 30min 81444.0000 ACTH 60min 81445.0000 Cortisol 30min 81446.0000 Cortisol 60min 81447.0000 TRH Stimulation 81448.0000 TRH 30min 81449.0000 TRH 60min 81450.0000 Prolactin Stimulation 81451.0000 Prolactin 30min 81452.0000 Prolactin 60min 81453.0000 TSH 30min 81454.0000 TSH 60min 81455.0000 TSH Receptor Ab 81456.0000 Nifedipine 81457.0000 Lipase Urine 81458.0000 Normetanephrine 81459.0000 Norclozaril 81460.0000 Heptacarboxyprophyrin 81461.0000 Tripramine 81462.0000 Prednisoline 81463.0000 Porphyrin Feces 81464.0000 Joint Fluid Panel 81465.0000 Steroid Anabolic 81466.0000 Alpha Subunits Pituitary 81467.0000 Bentiromide 81468.0000 Phosphatase Alkaline Bone 81469.0000 Baclofen 81470.0000 Glucose Qual 81471.0000 Albumin/Globulin Ratio 81472.0000 Serotonin Release Heparin Indu 81473.0000 Phenolsulfophthalein 81474.0000 Trimethadoine 81475.0000 Tobramycin 81476.0000 Benztropine 81477.0000 Porphobilinogen Deaminase 81478.0000 Trifluoperazine 81479.0000 Tricyclic Antidepressants 81480.0000 Cardiomyopathy Panel 81481.0000 Apolipoprotein E 81482.0000 Lipid Phenotype 81483.0000 Plasma Volume 81484.0000 Blood Volume 81485.0000 Vancomycin 81486.0000 B12/Folate Panel 81487.0000 Valproic Acid 81487.3035 Vanillymandelic Acid~DU PONT A 81488.0000 Adenosine Triphosphate 81489.0000 Methyl Tetra Hydor Folate Redu 81490.0000 Oxypurinol 81491.0000 Free Valproic Acid 81492.0000 Hemoglobin Acid Prep 81493.0000 Allopurinol 81494.0000 Polychlorindate Biphenyl 81495.0000 Pyphylline 81496.0000 B-Human Chorionic Gonadotropin 81497.0000 Protein electrophoresis HR 81498.0000 Alpha-naphthyl acetate esteras 81499.0000 Lamotrigine 81500.0000 Acepromazine 81501.0000 Furosemide 81502.0000 Acetaldehyde 81503.0000 Free Thyroxine Index 81504.0000 Acetone 81505.0000 Cefuroxime-Sodium 81506.0000 Alcohol Ethyl 81507.0000 Epoxide 81508.0000 Alcohol Isopropyl 81509.0000 Cefuroxime-Axetil 81510.0000 Alcohol Methyl 81511.0000 Alprazolam 81512.0000 Aluminum 81513.0000 Dimenhydrinate 81514.0000 Amdinocillin 81515.0000 Cefipime 81516.0000 Aminosalicyclic Acid Para 81517.0000 Cyclobenzaprine HCL 81518.0000 X*Amiodarone 81519.0000 Antihistamine 81520.0000 Amobarbital 81521.0000 Albuterol 81522.0000 Amoxapine 81523.0000 Trihexyhenidyl HCL 81524.0000 Amoxicillin 81525.0000 Tin 81526.0000 Amoxicillin Clavulanic Acid 81527.0000 Thiamine 81528.0000 Amphetamine 81529.0000 Phenol 81530.0000 Amphotericin B 81531.0000 Paroxetine 81532.0000 Ampicillin 81533.0000 Long Acting Thyroid Hormone 81534.0000 Amrinone 81535.0000 Anticonvulsants 81536.0000 Antimony 81537.0000 Crystals 81538.0000 Arsenic 81539.0000 Crystals Id 81540.0000 Atropine 81541.0000 Atrial Natriuretic Polypeptide 81542.0000 Azlocillin 81543.0000 Sperm Count 81544.0000 Aztreonam 81545.0000 Fluvoxamine 81546.0000 Bacitracin 81547.0000 Clotest 81548.0000 Barbiturate Identification 81549.0000 Barbiturate NOS 81550.0000 Barbiturate Screen 81551.0000 +Amikacin Peak 81552.0000 Benzodiazepines Quant 81553.0000 Marijuana 81554.0000 Benzodiazepines Screen 81555.0000 Amikacin Trough 81556.0000 Benzoylecgonine 81557.0000 Vancomycin Peak 81558.0000 Beryllium 81559.0000 Vancomycin Trough 81560.0000 Bismuth 81561.0000 Gentamicin Peak 81562.0000 Borate 81563.0000 Gentamicin Trough 81564.0000 Bromide 81565.0000 Tobramycin Peak 81566.0000 Butabarbital 81567.0000 Tobramycin Trough 81568.0000 Butalbital 81569.0000 Butorphanol Tartrate 81570.0000 Cadmium 81571.0000 Saturation % 81572.0000 Caffeine 81573.0000 Cyclosporine 81574.0000 Cannabinoids Screen 81575.0000 Cyclosporine Metabolite 81576.0000 Cannabinol Tetrahydro 81577.0000 Albumin Fract Urine 81578.0000 Cannabinol Tetrahydro Car 81579.0000 Alpha Globulin Urine 81580.0000 Cannabinol Tetrahydro Hydro 81581.0000 Beta Globulin Urine 81582.0000 Capreomycin 81583.0000 Gamma Globulin Urine 81584.0000 Carbamazepine 81585.0000 Amphetamine Quant 81586.0000 Carbamazepine Free 81587.0000 Opiate 81588.0000 Carbenicillin 81589.0000 Opiate Quant 81590.0000 Carbinoxamine 81591.0000 Propoxyphene Quant 81592.0000 Carbon Monoxide 81593.0000 Insulin Like Growth Factor II 81594.0000 Carbon Tetrachloride 81595.0000 Iodine 81596.0000 Carboxyhemoglobin 81597.0000 Estriol Unconjugated 81598.0000 Cefacetrile 81599.0000 Bartonella henselea Ab IgG 81600.0000 Cefaclor 81601.0000 Bartonella Henselae Ab IgM 81602.0000 Cefadroxil 81603.0000 Bartonella quintana Ab IgG 81604.0000 Cefamandole 81605.0000 Transglutaminase Tissue 81606.0000 Cefatrizinc 81607.0000 OK T3 and T Cells Total 81608.0000 Cefazaflur 81609.0000 Olanzapine 81610.0000 Cefazolin 81611.0000 Urea Urine 81612.0000 Cefmenoxime 81613.0000 Albumin Urine 81614.0000 Cefmetazole 81615.0000 Albumin Urine 24h 81616.0000 Cefoperazone 81617.0000 Report Chemistry 81618.0000 Ceforanide 81619.0000 Thyroid Ab 81620.0000 Cefotaxime 81621.0000 Adrenaline 81622.0000 Adrenocorticotropic Hormone 81623.0000 Adrenocorticotropic Hormone St 81624.0000 Cefoxitin 81625.0000 Phosphate Urine 24h 81626.0000 Uric Acid Urine 24h 81627.0000 Iron Urine 24h 81628.0000 Cefradine 81629.0000 Glucose Tolerance 2hr 81630.0000 Ceftazidime 81631.0000 Glucose Tolerence 1hr 81632.0000 Glucose Tolerence 30min 81633.0000 Glucose Tolerence Fasting 81634.0000 Ceftizoxime 81635.0000 Lactose Tolerence Fasting 81636.0000 Ceftriaxone 81637.0000 Myeloperoxidase 81638.0000 Cefsulodin 81639.0000 Cystic Fibrosis F508 81640.0000 Cefuroxime 81641.0000 Deoxypyridinoline 81642.0000 Cephalexin 81643.0000 Oxalate 24Hr 81644.0000 Cephaloglycin 81645.0000 Corticosteroids 81646.0000 Cephaloridine 81647.0000 Creatinine 24Hr 81648.0000 Cephalothin 81649.0000 Cryoglobulin Panel 81650.0000 Cephapirin 81651.0000 Cryoglobulin Comp 81652.0000 Cepharadine 81653.0000 Cortisol 24Hr 81654.0000 Chloral Hydrate 81655.0000 Cortisol PM 81656.0000 Chloramphenicol 81657.0000 Cortisol AM 81658.0000 Chlordiazepoxide 81659.0000 Amitriptyline Panel 81660.0000 Chloroform 81661.0000 Amiodarone Panel 81662.0000 Chlorpheniramine 81663.0000 p-ANCA 81664.0000 Chlorphentermine 81665.0000 c-ANCA 81666.0000 Chlorpromazine 81667.0000 Alpha Amino Acid 81668.0000 Chlorpropamide 81669.0000 Alcohol Screen 81670.0000 Chromium 81671.0000 Isopropanol 81672.0000 Cimetidine 81673.0000 Naltrexone 81674.0000 Ciprofloxacin 81675.0000 Cocaine Qt 81676.0000 Clindamycin 81677.0000 Pyridinoline 81678.0000 Clonazepam 81679.0000 Clorazepate 81680.0000 Cloxacillin 81681.0000 Cocaine 81682.0000 Codeine 81683.0000 Colistin 81684.0000 Copper 81685.0000 Coumermycin 81686.0000 Cyanide 81687.0000 Methadone Qt 81688.0000 Cycloserine 81689.0000 Cyclosporin 81690.0000 Dapsone 81691.0000 Daunomycin 81692.0000 Desipramine 81693.0000 Dexchlorpheniramine 81694.0000 Diazepam 81695.0000 Dicloxacillin 81696.0000 Digitoxin 81697.0000 Digoxin 81698.0000 Diphenhydramine 81699.0000 Dipyridamole 81700.0000 Disopyramide 81701.0000 Doxepin 81702.0000 Doxycycline 81703.0000 Drug Screen Acid Neutral 81704.0000 Drug Screen Basic 81705.0000 Drug Screen for Mult Const 81706.0000 Drug Screen Hypnotic 81707.0000 Drug Screen NOS 81708.0000 Enoxacin 81709.0000 Ephedrine 81710.0000 Erythromycin 81711.0000 Ethambutol 81712.0000 Ethchlorvynol 81713.0000 Ethionamide 81714.0000 Ethosuximide 81715.0000 Ethylene Glycol 81716.0000 Flucytosine 81717.0000 Fluoride 81718.0000 Fluorocytosine5 81719.0000 Flurazepam 81720.0000 Formic Acid Formaldehyde Expos 81721.0000 Epinephrine 81722.0000 Glutethimide 81723.0000 Flecainide 81724.0000 Gold 81725.0000 Hydrocarbons Halogenated 81726.0000 Alpha1 Microglobulin 81727.0000 Haloperidol 81728.0000 Alpha2 Macroglobin 81729.0000 Heavy Metal Screen Reinsch 81730.0000 Aluminin Urine 81731.0000 Hydrochlorothiazide 81732.0000 Hydrocodone 81733.0000 Hydromorphone 81734.0000 Hydroxyzine 81735.0000 Ibuprofen 81736.0000 Imipenum 81737.0000 Imipramine 81738.0000 Iodide 81739.0000 Isoniazid 81740.0000 Ketoconazole 81741.0000 Lead 81742.0000 Lidocaine 81743.0000 Fentanyl Citrate 81744.0000 Lithium 81744.3103 Lung Carcinoma Surface Ag~EKTA 81745.0000 Mitotane 81746.0000 Loxapine 81747.0000 Aprobarbital 81748.0000 Lysergic Acid Diethylamide 81749.0000 Amino Acids CSF 81750.0000 Manganese 81751.0000 Amino Acids Urine 81752.0000 Maprotiline 81753.0000 5-Aminolevulinic Acid Urine 81754.0000 Meperidine 81755.0000 Amitriptyline and Nortriptylin 81756.0000 Mephentermine 81757.0000 Amylase/Creat Clearance 81758.0000 Mephenytoin 81759.0000 CPK MB/CPK Tot 81760.0000 Meprobamate 81761.0000 Synercid 81762.0000 Mercury 81763.0000 Insulin Fasting 81764.0000 Mescaline 81765.0000 Insulin Total 81766.0000 Mesoridazine 81767.0000 Alkaline Phosphatase Other 81768.0000 Methadone 81769.0000 Arsenic Urine 81770.0000 Methamphetamine 81771.0000 Mercury Urine 81772.0000 Methapyrilene 81773.0000 Immunoglobulin G CSF 81774.0000 Methaqualone Quant 81775.0000 Albumin CSF 81776.0000 Methaqualone Screen 81777.0000 Methemoglobin and Sulfhemo 81778.0000 Methicillin 81779.0000 Methemoglobin 81780.0000 Methocarbamol 81781.0000 Albumin Index 81782.0000 Methorphan Dextro 81783.0000 CSF IgG Synthesis 81784.0000 Methsuximide 81785.0000 IgG Index 81786.0000 Methylphenidate Hydrochl 81787.0000 Albumin/IgG Ratio 81788.0000 Methyprylon 81789.0000 Estrogen Fract 81790.0000 Metronidazole 81791.0000 Exposure Panel 81792.0000 Mexilitine 81793.0000 Lead Exposure Panel 81794.0000 Mezlocillin 81795.0000 CPK BB/CPK Tot 81796.0000 Miconazole 81797.0000 Microglobulin Beta 2 81798.0000 Minocycline 81799.0000 CPK MM/CPK Tot 81800.0000 Morphine 81801.0000 Arsenic 24H 81802.0000 Morphine Diacetyl (heroin) 81803.0000 Arsenic Panel 81804.0000 Morphine Glucuronide 81805.0000 Arsenic/Creatinine 81806.0000 Moxalactam 81807.0000 Muramidase (lysozyme) 81808.0000 Nafcillin 81809.0000 Nalbuphine Hydrochloride 81810.0000 Nalidixic Acid 81811.0000 Triglyceride 81812.0000 Neomycin 81813.0000 Barbiturate 81814.0000 Netilmicin 81815.0000 Lipoprotein Beta 81816.0000 Nickel 81817.0000 Lipoprotein Pre Beta 81818.0000 Nicotine 81819.0000 Lipoprotein Alpha 81820.0000 Nitrate 81821.0000 Iron Index 81822.0000 Nitrite 81823.0000 Microalbumin/Creatinine 81824.0000 Nitrofurantoin 81825.0000 Xylose Absorption 81826.0000 Nitrophenol Para 81827.0000 Amoxapine 8 Hydroxy 81828.0000 Nordiazepam 81829.0000 Creatine Kinase (CK MB) Mass 81830.0000 Norfloxacin 81831.0000 Color 81832.0000 Norpethidine 81833.0000 Norepinephrine 81834.0000 Norpropoxyphene 81835.0000 Tube Number 81836.0000 Nortriptyline 81837.0000 Desmethylsertraline 81838.0000 Novobiocin 81839.0000 Sirolimus 81840.0000 Nystatin 81841.0000 Organic Acids 81842.0000 Organophosphate NOS 81843.0000 Platelet Function 81844.0000 Oxacillin 81845.0000 Phosphorus Urine 81846.0000 Oxazepam 81847.0000 Phosphorus Timed 81848.0000 Oxycodone 81849.0000 Phorphorus Urine 24H 81850.0000 Paraldehyde 81851.0000 Procainamide N Acetyl(NAPA) 81852.0000 Penicillin 81853.0000 Comprehensive Met Panel 81854.0000 Pentazocine 81855.0000 Potassium Misc 81856.0000 Pentobarbital 81857.0000 Sodium Misc 81858.0000 Percodan 81859.0000 Urea 24H 81860.0000 Perphenazine 81861.0000 Hemocystein 81862.0000 Pethidine 81863.0000 Homocystine Urine 81864.0000 Phenacetin 81865.0000 Liprotein Fractionation 81866.0000 Phencyclidine Screen 81867.0000 Zonisamide 81868.0000 Phenmetrazine 81869.0000 Carnitine Tot 81870.0000 Phenothiazine Quant 81871.0000 Carnitine Free 81872.0000 Phenothiazine Screen 81873.0000 Chloride Misc 81874.0000 Phensuximide 81875.0000 Phentermine 81876.0000 Phenylbutazone 81877.0000 Chlorine Esterase Inh 81878.0000 Phenylephrine 81879.0000 Glucose Misc 81880.0000 Phenylpropanolamine 81881.0000 Levitracetam 81882.0000 Phenytoin 81883.0000 Uranium 81884.0000 Phenytoin Free 81885.0000 Uranium Depleted 81886.0000 Piperacillin 81887.0000 Pesticide Exposure 81888.0000 Polymixin B 81889.0000 Prazepam 81890.0000 Primidone+Phenobarbital 81891.0000 Carnitine Esterified 81892.0000 Prochlorperazine 81893.0000 Alpha 1 Acid Glucoprotein 81894.0000 Promazine 81895.0000 Lipid Assoc Sialic Acid 81896.0000 Promethazine 81897.0000 Didanosine 81898.0000 Propoxyphene 81899.0000 Zalcitabine 81900.0000 Protriptyline 81901.0000 Stavudine 81902.0000 Pseudoephedrine 81903.0000 Lamivudine 81904.0000 Psilocybin 81905.0000 Abacavir 81906.0000 Pyrazinamide 81907.0000 Tenofovir 81908.0000 Pyrilamine 81909.0000 Nevirapine 81910.0000 Pyrimethamine Sulfadoxine 81911.0000 Delavirdine 81912.0000 Quadracyclic NOS 81913.0000 Efavirenz 81914.0000 Quinidine 81915.0000 Indinavir 81916.0000 Quinine 81917.0000 Ritonavir 81918.0000 Rifampin 81919.0000 Nelfinavir 81920.0000 Salicylamide 81921.0000 Amprenavir 81922.0000 Salicylates 81923.0000 Lopinavir 81924.0000 Secobarbital 81925.0000 Lopinavir Ritonavir 81926.0000 Selenium 81927.0000 Norfluoxetine 81928.0000 Silicon 81929.0000 Creatinine Urine 81930.0000 Sisomicin 81931.0000 Clozapine 81932.0000 Spectinomycin 81933.0000 Norclozapine 81934.0000 Spiramycin 81935.0000 Atenolol 81936.0000 Streptomycin 81937.0000 Calcium/Creatinine 81938.0000 Strychnine 81939.0000 Sulfhemoglobin 81940.0000 Sulfamethoxazole 81941.0000 Saquinavir 81942.0000 Sulfonamide NOS 81943.0000 Arachidonate 81944.0000 Teichoic Acid 81945.0000 Temazepam 81946.0000 Tetracycline NOS 81947.0000 Azathioprine 81948.0000 Thallium 81949.0000 Linoleate 81950.0000 Theophylline 81951.0000 Platinum 81952.0000 Thiazide 81953.0000 Procaine 81954.0000 Thiocyanate 81955.0000 Quetiapine 81956.0000 Thiopental 81957.0000 Magnesium RBC 81958.0000 Thioridazine 81959.0000 Tranylcypromine 81960.0000 Ticarcillin 81961.0000 Acteazolaminde 81962.0000 Ticarcillin Clavulanic Acid 81963.0000 Succinyl Acetone 81964.0000 Tocainide 81965.0000 Alpha-naphthyl Butyrate Estera 81966.0000 Tolazamide 81967.0000 Cortisol 90min 81968.0000 Tolbutamide 81969.0000 Metanephrine Total 81970.0000 Toluene 81971.0000 Triazolam 81972.0000 Trichloroethylene 81973.0000 Tiech Acid 81974.0000 Hexagonal Phospholipid Neut 81975.0000 Dioxin 81976.0000 Tricyclic Antidepressants Scr 81977.0000 Metanephrine 24H 81978.0000 Sulfapyridine 81979.0000 Sperm Non-Motile 81980.0000 Trimethoprim 81981.0000 Sperm Slow 81982.0000 Tripelennamine 81983.0000 Blood Occult Semen 81984.0000 Volatile Screen 81985.0000 Hemoglobinuria Paroxysmal Noct 81986.0000 Warfarin 81987.0000 Topiramate 81988.0000 Zinc 81989.0000 Thin Layer Chromatography 81990.0000 Progesterone Binding Receptor 81991.0000 Allylbarbital 81992.0000 Talbutal 81993.0000 Demoxepam 81994.0000 Desalkylflurazepam 81995.0000 N Desmethyldiazepam 81996.0000 Flunitrazepam 81997.0000 Lorazepam 81998.0000 Mecloqualone 81999.0000 Levorphanol 82000.0000 TCP 82001.0000 Mercury Urine 24h 82002.0000 Blood Occult NOS 82003.0000 Carbohydrate Deficient Transfe 82004.0000 BUN Urine 24h 82005.0000 Microalbumin Urine Rand 82006.0000 Desmethylclomipramine 82007.0000 Glutamic Acid Decarboxylase 82008.0000 Antenolol 82009.0000 Clonidine Suppression 82010.0000 Cytomegalovirus PCR 82011.0000 Fragile X Syndrone 82012.0000 Glycerol Lysis 82013.0000 Hepatitis B Core Ab & IgM 82014.0000 Herpes simplex PCR 82015.0000 Tiagabine Hydrochloride 82016.0000 Hepatitis C RNA Qual 82017.0000 Hepatitis C RNA Quant 82018.0000 RBC Agglutinated 82019.0000 HIV 1 Qual PCR 82020.0000 ACTH 82021.0000 Natriuretic Peptide Brain (B T 82022.0000 Ovarian Ab 82023.0000 Microalbumin Urine 24h 82024.0000 Luteinizing Hormone Beta 82025.0000 Serotonin Platelet 82026.0000 C Reactive Protein HS 82027.0000 Sulfonylurea Urine 82028.0000 Viscosity Blood 82029.0000 Thrombotic Risk 82030.0000 Adenosine 5 Monophosphate 82031.0000 Mycobacterium TB Complex DNA P 82032.0000 Toxoplasma PCR 82033.0000 Viscosity Plasma 82034.0000 Glutamic Acid Decarboxylase Ab 82035.0000 Adenosine 5 Triphosphate 82036.0000 Clonidine Hydrochloride 82037.0000 Cortisol Stimulation Panel 82038.0000 Immunofixation Electrophoresis 82039.0000 Immunofixation Electrophoresis 82040.0000 Albumin 82041.0000 WBC Clumps 82042.0000 Albumin Pre 82043.0000 Ammonium Biruate Crystal 82044.0000 Lead Urine 24h 82045.0000 Malanin 82046.0000 Lactose Tolerence 30min 82047.0000 Lactose Tolerence 1h 82048.0000 Lactose Tolerence 2h 82049.0000 Lactose Tolerence 3h 82050.0000 Glucose Urine 24h 82051.0000 Acid Quant Urine 82052.0000 Macroglobulin Alpha2 82053.0000 Macroglobulins SIA 82054.0000 Saturation of Serum w Iron 82055.0000 Cholinesterase RBC 82056.0000 Potassium Urine 24h 82057.0000 Tetrahydroeoxycortisol 82058.0000 Heparin Cofactor II 82059.0000 Glutamic Acid 82060.0000 Transferrin 82061.0000 Extraction and Quant Chromato 82062.0000 Concentration of Specimen Dial 82063.0000 Extraction w Organic Solvent 82064.0000 Derivatization Compnd Chromat 82065.0000 Precipitation and Separation 82066.0000 Hemochromatosis Scr 82067.0000 Hemolysate Preparation 82068.0000 Kiniogen High MW 82069.0000 Cefotiam 82070.0000 Cephradine 82071.0000 Concentration of Specimen Ultr 82072.0000 Concentration of Specimen Evap 82073.0000 Levofloxacin 82074.0000 Levofloxacin Quant 82075.0000 Entrofloxacin 82076.0000 Fosfomycin 82077.0000 Fusidic Acid 82078.0000 3-Methoxy O Desmethylencainide 82079.0000 Dry Weight 82080.0000 Total Solids 82081.0000 Phosphatidyl Glycerol 82082.0000 Glucose Mean 82083.0000 Glucose Tolerence 1.5hr 82084.0000 Glycolic Acid 82085.0000 Procain+NAPA 82086.0000 Cloz+Norcloz 82087.0000 Oxcarbazepine 82088.0000 Amylase/Creat Ratio 82089.0000 Hydroxylysine 82090.0000 Aldolase 82091.0000 Niacin Vitamin 82092.0000 Niacinamide 82093.0000 Sarcosine 82094.0000 Aminobutyric 4 82095.0000 Camosine 82096.0000 Anserine 82097.0000 Transferrin Receptor Soluble 82098.0000 Digoxin Free 82099.0000 Hydroxyitraconazole 82101.0000 Promonocytes Percent 82102.0000 Amylase Salivary 82103.0000 Citrate 24hr 82104.0000 WBC Clumps Urine 82105.0000 Amino Acids Nitrogen Total Ur 82106.0000 Opiate Synthetic 82107.0000 Prostatic Specific Ag Free Per 82108.0000 Busulfan 82109.0000 Amylase Macro 82110.0000 Phosphatase Alkaline Placental 82111.0000 Parathyroid Relate Protein 82112.0000 Tocopherol Alpha 82113.0000 Tocopherol Beta Gamma 82114.0000 Corticosteriod Binding Globuli 82115.0000 Glucose POC 82116.0000 Glucose Capillary 82117.0000 Glycohemoglobin HbA 1c Capilla 82118.0000 Comment 82119.0000 Acetylmethadol 82120.0000 Ketoglutarate Alpha 82121.0000 Creatine Kinase (BB) 82122.0000 Callagen Crosslink N Telopepti 82123.0000 O Desmethylencainide 82124.0000 Isoleucine 82125.0000 Lenght 82126.0000 Calculus 82127.0000 Length Calculus 82128.0000 Length NOS 82129.0000 Leucine 82130.0000 Amino Acids Quant 82131.0000 Leucine/Creatinine 82132.0000 Isoleucine+Leucine 82133.0000 Lysine 82134.0000 C1 Esterase Inhibitor Function 82135.0000 Creatinine eGFR 82136.0000 Atazanavir 82137.0000 Oxycodone,Rapid 82138.0000 Cytomegalovirus DNA 82139.0000 Cytomegalovirus DNA Probe 82140.0000 Ammonia 82141.0000 Epstein Barr PCR 82142.0000 Amniotic Fluid Scan 82143.0000 Lysozyme 82144.0000 Magnesium Stool 82145.0000 Methionine 82146.0000 Carbidoba and Levodopa 82147.0000 Liver Kidney Microsomal Ab 82148.0000 Hu Ab IFA 82149.0000 MTHFR DNA Mutation 82150.0000 Amylase 82151.0000 Carbidoba 82152.0000 Methlmalonic Acid Urine 82153.0000 Calculus Appearance 82154.0000 Androstanediol Glucuronide 82155.0000 Norclomipramine 82156.0000 Stone 82157.0000 Calculus Analysis 82158.0000 Calculus Constituents 82159.0000 Ornithine 82160.0000 Androstenedione 82161.0000 Other NOS 82162.0000 Drug NOS 82163.0000 Angiotensin II Enzyme 82164.0000 Phosphoethanolimine 82165.0000 Phophoserine 82166.0000 Pidgeon Serum 82167.0000 Band 82168.0000 Band Predominant 82169.0000 Sperm Progression 82170.0000 Proline 82171.0000 Vitamin K Protein Induced 82172.0000 Pyruvate CSF 82173.0000 Risk factor 82174.0000 Risk Relative 82175.0000 Cholesterol/HDL Risk Factor 82177.0000 Serine 82178.0000 Steroid Screen 82179.0000 Steroid ID 82180.0000 Ascorbic Acid 82181.0000 Sodium Urine 24h 82182.0000 Sodium Urine 82183.0000 Phosphate Urine 82184.0000 Uric Acid Urine 82185.0000 Iron Urine 82186.0000 Glucose Urine 82187.0000 Potassium Urine 82188.0000 Magnesium Urine 82189.0000 Lead Urine 82190.0000 Threonine 82191.0000 Homocysteine Urine 82192.0000 Amylase Urine 82193.0000 Calcium Urine 82194.0000 Bismuth Urine 82195.0000 Nitrogen Urine 82196.0000 Chloride Urine 82197.0000 Carbon Dioxide Urine 82198.0000 Copper Urine 82199.0000 Calcium Urine 24h 82200.0000 Thiopurine Methyltransferase 82201.0000 Valine 82202.0000 Amylase Urine 24h 82203.0000 Chloride Urine 24h 82204.0000 Carbon Dioxide Urine 24h 82205.0000 Phospate Urine 24h 82206.0000 Sperm Viscosity 82207.0000 Zinc Urine 82208.0000 Sperm Volume 82209.0000 Zinc Urine 24h 82210.0000 Sperm WBC 82211.0000 Dopamine Urine 82212.0000 Protein/Creatinine Ratio Urine 82213.0000 Calculus Morphology 82214.0000 PaO2/PAO2 ratio 82215.0000 PAO2-PaO2 Difference 82216.0000 Doxepin and Nordoxepin Tot 82217.0000 Phosphatase Alkaline Intestine 82218.0000 Amitriptyline and Nortriptylin 82219.0000 Phosphatase Alkaline Liver 82220.0000 Amino Acids Qual 82221.0000 Epinephrine+Norepinephrine 82222.0000 Clomipramine + N Desmethly Clo 82223.0000 Hexosaminidase A 82224.0000 Hexosaminidase A Percent 82225.0000 Drug Screen 5 82226.0000 Drug Screen 5+ 82227.0000 Drug Screen 6 82228.0000 Misc Toxicology 1 82229.0000 Misc Toxicology 2 82230.0000 Hemoglobin A1 82231.0000 Misc Toxicology 3 82232.0000 Misc Toxicology 4 82233.0000 Misc Toxicology 5 82234.0000 Misc Toxicology 6 82235.0000 Thiopurine Methyltransferase R 82236.0000 N Desmethyldoxepin 82237.0000 Nefazodone 82239.0000 Bile Acids Total 82240.0000 Bile Acids Triunsaturated 82241.0000 Cholylglycine 82242.0000 Normephenytoin 82243.0000 Organochloride 82244.0000 Operator 82245.0000 Serial Number 82246.0000 Trichomonas 82247.0000 Russell's Viper Venom Ratio 82249.0000 Bilirubin Direct 82249.3000 Bilirubin Total and Direct~MAN 82249.3035 Bilirubin Total and Direct~DU 82250.0000 Bilirubin Total 82250.3000 Bilirubin Qual Feces~MANUAL 82250.3035 Bilirubin Qual Feces~DU PONT A 82251.0000 Bilirubin Total and Direct 82252.0000 Bilirubin Qual Feces 82253.0000 Bilirubin Binding Capacity 82254.0000 Trichophyton Skin Test 82255.0000 Tuberculin Skin Test 82256.0000 PTT Aged Serum 82257.0000 PTT Incubated Mix 82258.0000 PTT Immediate Mix 82259.0000 Prophobilinogen 82260.0000 Stone Risk Profile 82261.0000 Sulfite 82262.0000 Sulfate 82263.0000 Histamine Plasma 82264.0000 Strontium 82265.0000 Cadmium Urine 82266.0000 1 Methylhistidine 82267.0000 2 Aminoadipic Acid 82268.0000 2 Aminobutyric Acid 82269.0000 3-Methylhistidine 82270.0000 Blood Occult feces 82271.0000 Blood Occult feces spot test 82272.0000 Amino Acid Interpretation 82273.0000 Alanine 82274.0000 Asparagine 82275.0000 Aldosterone Urine 82276.0000 Aspartic Acid 82277.0000 Alanine Beta 82278.0000 Blood Qual Duodenal Gastric 82279.0000 Chenodoxycholic Acid 82280.0000 Cholic Acid 82281.0000 Citrulline 82283.0000 Deoxycholic Acid 82284.0000 Ethanolamine 82285.0000 Phenobarbital Free 82286.0000 Bradykinin 82287.0000 Glycine 82288.0000 Histidine 82289.0000 Diazepam+Nordiazepam 82290.0000 P50 82291.0000 Coagulation Profile 82293.0000 Coagulation Profile Hyper 82294.0000 Thrombin Time Control 82295.0000 Trypsinogen 1 82296.0000 Trypsinogen 1 Free 82297.0000 Vitamin K Dependent Coag Facto 82298.0000 Anti Nuclear Ab Screen 82299.0000 Anti Nuclear Ab Stain 82300.0000 Atypical ANCA 82301.0000 Lacatose Tolerence 4h 82302.0000 Drainage Site 82303.0000 Sulfate Urine 82304.0000 FSH Beta Subunit 82305.0000 2 4 Dichlorophenoxyacetate 82306.0000 Apolipoprotein A1/B 82307.0000 Apolipoprotein B/A1 82308.0000 Carotene Alpha 82309.0000 Carotene Beta 82310.0000 Calcium 82311.0000 Trasferrin Saturation 82312.0000 Color NOS 82313.0000 Mono,Eos,Baso Percent 82314.0000 Sperm Motility 82315.0000 Tissue Cell Percent 82316.0000 Pressure 82317.0000 Tidal Volume 82318.0000 Ventilation 82319.0000 Lactose Tolerence 15min 82320.0000 Lactose Tolerence 45min 82321.0000 Lactose Tolerence 1.5hr 82322.0000 Phosphatase Alkaline Heat Labi 82323.0000 Reticulocyte % 82324.0000 Prostatic Specific Ag Free/Tot 82325.0000 Log 82326.0000 HDW 82327.0000 Histocytes 82328.0000 Phosphatase Acid Tartrate Resi 82329.0000 Leukocyte Stick 82330.0000 Phosphate Alkaline MacroHepati 82331.0000 Calcium Infusion 82332.0000 Porphobilinogen 82333.0000 Testosterone Bioavailable 82334.0000 Reticulocyte Immature 82335.0000 Terbinafine 82336.0000 Brompheniramine 82337.0000 Conglutin Immune Complex 82338.0000 Amacair 82339.0000 Ammonium 82340.0000 Methoxsalen 82341.0000 Hereditary Neuropathy Heridita 82342.0000 Hemachromatosis 82343.0000 Fat Neutral 82344.0000 Quentiapine 82345.0000 Calcium 24 hour Excret Feces 82346.0000 TAU Protein 82347.0000 Uroporphyrinogen Decarboxylase 82348.0000 Propoxyphene+Norpropoxyphenen 82349.0000 Nucleoside RT Inhibitors 82350.0000 Calculation 82351.0000 Nucleoside-Non RT Inhibitors 82352.0000 Protease Inhibitors 82353.0000 Calculus Nidus 82354.0000 KI-67 82355.0000 Calculus Analysis Chemical 82356.0000 BUN Blood 82357.0000 CSF Panel 82358.0000 Cytotoxic Rejection Percent 82359.0000 Mexlocillin 82361.0000 Norfentanyl 82363.0000 Spinocerebellar Ataxia 6 82364.0000 Occult 82365.0000 Pristamic Acid 82366.0000 Protein C Activity 82367.0000 Collagen/Epinephrine Platelet 82368.0000 Collagen/ADP Induced Platelet 82369.0000 Cortisol Binding Globulin 82370.0000 Ferritin 82371.0000 Schillings Test 82372.0000 G6PD Screen 82373.0000 Carbon Dioxide Combine Power 82374.0000 Phosphoinostiol 82375.0000 Phosphoethanolami 82376.0000 Persenilin 1 82377.0000 Colchicine 82378.0000 Citalopram 82379.0000 Insulin 240min 82380.0000 Carotene 82381.0000 Insulin 300min 82382.0000 Insulin 360min 82383.0000 Insulin Bovine 82384.0000 Insulin Porcine 82385.0000 Left Shift 82386.0000 Oxyphenisatin 82387.0000 Cathepsin-D 82388.0000 Biscodyl 82389.0000 Triiodothyronine Uptake 82390.0000 Ceruloplasmin (Copper O) 82390.3035 Checking Timer on Centrifuge~D 82390.3103 Checking Timer on Centrifuge~E 82391.0000 Neopterin 82392.0000 Renin Direct 82393.0000 Tigabine 82394.0000 Mercaptopurine 82395.0000 Biotin 82396.0000 Limulus Lystae 82397.0000 Chemiluminescent 82398.0000 Hydroxypregnenolone 17 82399.0000 Pincered RBC 82400.0000 Chemistry Analysis Profile 82401.0000 Blood Unit Release 82402.0000 Hydroxyrisperidone 9 82403.0000 Hydroxyloxepine 8 82404.0000 Arsenic (Inorganic) 82405.0000 Arsenic(Inorganic)/Creatinine 82406.0000 Cadmium/Creatinine Ratio 82407.0000 Lead/Creatinine 82408.0000 Copper, RBC 82409.0000 Copper, Plasma 82410.0000 Instrument Set Up 82411.0000 Western Equine Encephalitis Ig 82412.0000 Ritalinic Acid 82413.0000 Brodifacoum 82414.0000 Varicella Zoster PCR 82415.0000 La Crosse Virus PCR 82416.0000 Jamestown Canyon Virus PCR 82417.0000 Eastern Equine Encephalitis PC 82418.0000 Powassan Virus PCR 82419.0000 Cache Valley Virus PCR 82420.0000 Multiple Ion Analysis 82421.0000 St Louis Equine Encephalitis P 82422.0000 Western Equine Encaphalitis PC 82423.0000 Enterovirus PCR 82424.0000 California Encephalitis PCR 82425.0000 Viral PCR Panel 82426.0000 Interferon Neutralizing Ab 82427.0000 Myositis Assessment Profile 82428.0000 Inhibin A 82429.0000 Inhibin B 82430.0000 Charcoal Urine 82431.0000 Dichloromethane 82432.0000 Perchloroethylene 82433.0000 Barium 82434.0000 Tellurium 82435.0000 Chloride 82436.0000 Fat Stool Total Qual 82437.0000 Fat Neutral Stool Qual 82438.0000 Muscle Fibers Stool Qual 82439.0000 Fat/Fibers Stool Qual 82440.0000 Zolpidem 82441.0000 Chlorohydrocarbons 82442.0000 Volatile Panel 1 82443.0000 Volatile Panel 2 82444.0000 Volatile Panel 3 82445.0000 Volatile Panel 4 82446.0000 Volatile Panel 5 82447.0000 Acetonitrile 82449.0000 Acrolein 82450.0000 Acrylonitrile 82451.0000 Allyl Alcohol 82452.0000 Amyl Acetate 82453.0000 Butane 82454.0000 Butanois 82455.0000 Butyl Acetates 82456.0000 Cumene 82457.0000 Cyclohexane 82458.0000 Cyclopentane 82459.0000 Cyclopropane 82460.0000 Dichloroethanes 82461.0000 Dichloroethylene 82462.0000 Diisobutyl Ketone 82463.0000 Enflurane 82464.0000 Epichlorhydrin 82465.0000 Ethyl Acetate 82466.0000 Cholesterol Total 82466.3035 Cholinesterase plus DN~DU PONT 82467.0000 Ethyl Benzenes 82468.0000 Ethyl Ether 82469.0000 Ethyl t-Butyl Ether 82470.0000 Ethylene Oxide 82471.0000 Freons 82472.0000 Halothane 82473.0000 Heptane 82474.0000 Hexane 82475.0000 Isoamyl Acetate 82476.0000 Isoamyl Alcohol 82477.0000 Iso-Butane 82478.0000 Isoflurane 82480.0000 Isopropyl Ether 82481.0000 Isovaleraldehyde 82482.0000 Mesityl Oxide 82483.0000 Methane 82484.0000 Methanol 82485.0000 Chondroitin Sulfate 82486.0000 Methoxyflurane 82487.0000 Methyl Ethyl Ketone 82488.0000 Methyl Isoamyl Ketone 82489.0000 Methyl Isobutyl Ketone 82490.0000 Chromogenic Substrate 82491.0000 Methyl Methacrylate 82492.0000 Methyl n-Amyl Ketone 82493.0000 Methyl n-Butyl Ketone 82494.0000 Methyl n-Propyl Ketone 82495.0000 Methyl t-Butyl Ether 82496.0000 Methyl Acrylate 82497.0000 Methylene Chloride 82498.0000 Methylpentanes 82499.0000 n-Amyl Alcohol 82500.0000 Nonane 82501.0000 Octane 82502.0000 Pentane 82503.0000 Propane 82504.0000 Propanol 82505.0000 Propyl Acetate 82507.0000 Drug 1 ID 82508.0000 Drug 2 ID 82509.0000 Drug 3 ID 82510.0000 Drug 4 ID 82511.0000 Drug 5 ID 82512.0000 Drug 6 ID 82513.0000 Drug 7 ID 82514.0000 Drug 8 ID 82515.0000 Drug 9 ID 82516.0000 Drug 10 ID 82517.0000 Drug 11 ID 82518.0000 Drug 12 ID 82519.0000 Drug 13 ID 82520.0000 Drug 14 ID 82521.0000 Drug 15 ID 82522.0000 Drug 16 ID 82523.0000 Collagen Ab 82524.0000 Drug 17 ID 82525.0000 Drug 18 ID 82526.0000 Drug 19 ID 82527.0000 Drug 20 ID 82528.0000 Gamma Hydroxybutyrateacnc 82529.0000 Amylase Pancreatic P1 82530.0000 Amylase Pancreatic P2 82531.0000 Amylase Pancreatic P3 82532.0000 Amylase Salivary S1 82533.0000 Amylase Salivary S2 82534.0000 Amylase Salivary S3 82535.0000 Porphyrin Copro 82536.0000 Amylase P1/Amylase Ratio 82537.0000 Porphyrin Proto 82538.0000 Amylase P2/Amylase Ratio 82539.0000 Amylase P3/Amylase Ratio 82540.0000 Creatine 82541.0000 Amylase S1 Amylase Ratio 82542.0000 Amylase S2/Amylase Ratio 82543.0000 Amylase S3/Amylase Ratio 82544.0000 Fentanyl/Norfentanyl 82545.0000 Fentanyl Total 82546.0000 Fentanyl 82547.0000 Pancreatic Elastase 1 Stool 82550.0000 Creatine Kinase (CK) 82555.0000 Creatine Kinase (CK MB) 82562.0000 Creatine Kinase Isoenz (CK MB) 82563.0000 Xylene Exposure Panel Quant Ur 82564.0000 Ion exchange Column Prep 82565.0000 Creatinine 82565.3035 Creatinine~DU PONT ACA 82565.3103 Creatinine~EKTACHEM 700 82566.0000 Pyridine 82567.0000 Styrene 82568.0000 Tetrachloroethane 82569.0000 Tetrachloroethylene 82570.0000 Tetrahydrofuran 82571.0000 Xylenes 82572.0000 Acetone Urine 82573.0000 o-Cresol Urine 82574.0000 Ethanol Urine 82575.0000 Hippuric Acid Urine 82576.0000 Isopropanol Urine 82577.0000 Mandelic Acid Urine 82578.0000 Methanol Urine 82579.0000 Methyl Ethyl Ketone Urine 82580.0000 Methylhippuric Acid Urine 82581.0000 Methyl Isobutyl Ketone Urine 82582.0000 Phenol Urine 82583.0000 Phenylglyoxylic Acid Urine 82584.0000 Trichlororganic Metabolites Ur 82585.0000 Cryofibrinogen 82586.0000 Paraquat 82587.0000 Paraquat Urine 82588.0000 Osmium 82589.0000 Osmium Urine 82590.0000 Osmium 24Hr 82591.0000 Pentachlorophenol 82592.0000 Pentachlorophenol Urine 82593.0000 Pentachlorophenol 24Hr 82594.0000 Pentachlorophenol Exposure Sur 82595.0000 Cryoglobulin Qual Blood 82596.0000 Carbamate Pesticides 82597.0000 Bendiocarb 82598.0000 Carbaryl 82599.0000 Carbofuran 82600.0000 1-Naphthol 82601.0000 Propoxur 82602.0000 Bendiocarb Urine 82603.0000 Carbaryl Urine 82604.0000 Carbofuran Urine 82605.0000 1-Naphthol Urine 82606.0000 Propoxur Urine 82607.0000 Carbamate Pesticides Urine 82608.0000 Organochlorine Pesticides 82609.0000 DDE 82610.0000 Lindane 82611.0000 DDE Urine 82612.0000 Lindane Urine 82613.0000 Alpha-Chlordane 82614.0000 Alpha-Chlordane Urine 82615.0000 Cystine 82616.0000 Gamma-Chlordane 82617.0000 Gamma-Chlordane Urine 82618.0000 Trans-Nonachlor 82619.0000 Trans-Nonachlor Urine 82620.0000 Heptachlor 82621.0000 Heptachlor Urine 82623.0000 Heptachlorepoxide 82624.0000 Heptachlorepoxide Urine 82625.0000 DDT 82626.0000 DDT Urine 82627.0000 Hexachlorobenzene 82628.0000 Hexachlorobenzene Urine 82629.0000 Dieldrin Urine 82630.0000 Amino Levulinic Acid Delta 82632.0000 Dehydroepiandrosterone (DHEA) 82633.0000 Desoxycorticosterone 82634.0000 Dehydroepiandrosterone Sulfate 82635.0000 Deoxycortisol 82636.0000 Dieldrin 82637.0000 Methoxychlor Urine 82638.0000 Methoxychlor 82639.0000 DDD 82640.0000 DDD Urine 82641.0000 Organochlorine Pesticides Urin 82642.0000 Organophosphate Pesticides 82643.0000 Organophosphate Pesticides Uri 82644.0000 Methyl Parathion Urine 82645.0000 Methyl Parathion 82646.0000 Dihydrocodeinone 82647.0000 Vinyl Chloride Metabolite Qual 82649.0000 Dihydromorphinone 82651.0000 Dihydrotestosterone 82654.0000 Dimethadione 82655.0000 Mevinphos 82656.0000 Mevinphos Urine 82657.0000 P-Nitrophenol 82658.0000 P-Nitrophenol Urine 82659.0000 Parathion 82660.0000 Parathion Urine 82661.0000 Phorate 82662.0000 Phorate Urine 82663.0000 Terbufos 82664.0000 Terbufos Urine 82665.0000 Azinphos-Methyl 82666.0000 Epiandrosterone 82670.0000 Diphosphoglycerate 2 3 82671.0000 Azinphos-Methyl Urine 82672.0000 Carbophenthion 82673.0000 Carbophenthion Urine 82674.0000 Chlorpyrifos 82675.0000 Chlorpyrifos Urine 82676.0000 Coumaphos 82677.0000 Coumaphos Urine 82678.0000 Diazinon 82679.0000 Diazinon Urine 82680.0000 Deoxycorticosterone 82681.0000 Dichlorvos 82682.0000 Dichlorvos Urine 82683.0000 Dimethoate 82684.0000 Dimethoate Urine 82685.0000 EPN 82686.0000 EPN Urine 82687.0000 Ethion 82688.0000 Ethion Urine 82689.0000 Fenchlorphos Urine 82690.0000 Fenchlorphos 82691.0000 Fenthion 82692.0000 Fenthion Urine 82693.0000 Fonofos 82694.0000 Fonofos Urine 82696.0000 Etiocholanolone 82697.0000 Malathion Urine 82698.0000 Metasystox 82699.0000 Metasystox Urine 82700.0000 Dopamine 82701.0000 Cadmium Exposure Survey Panel 82702.0000 Oxychlordan 82703.0000 Oxychlordan Urine 82704.0000 Paraoxon 82705.0000 Fat Qual 82706.0000 Heavy Metal Panel 5 82707.0000 Heavy Metal Panel 6 82708.0000 Heavy Metal Panel 7 82709.0000 Heavy Metal Panel 8 82710.0000 Fat Total Quant Feces 82711.0000 Paraoxon Urine 82712.0000 Barium Urine 82713.0000 Barium 24Hr 82714.0000 Tellurium Urine 82715.0000 Tellurium 24Hr 82716.0000 Heavy Metal Panel 1 82717.0000 Heavy Metal Panel 2 82718.0000 Heavy Metal Panel 3 82719.0000 Heavy Metal Panel 4 82720.0000 Fatty Acid Esters 82721.0000 Heavy Metal Panel 9 82722.0000 Heavy Metal Panel 10 82723.0000 Trichloroacetic Acid Urine 82724.0000 Trichloroacetic Acid 24Hr 82725.0000 Fatty Acids Free 82726.0000 Toluene Urine 82727.0000 Toluene 24Hr 82728.0000 Trichloroethylene Urine 82729.0000 Trichloroethylene 24Hr 82730.0000 Fibrin Degradation Products 82731.0000 Trichloroethane Urine 82732.0000 Trichloroethane 24Hr 82733.0000 Trichloroethane 82745.0000 Folate Bioassay 82751.0000 Folate 82756.0000 Fructosamine 82758.0000 Fructose 82759.0000 Galactokinase 82760.0000 Galactose 82775.0000 GAL 1 PHOS Uridyl Transferase 82785.0000 Gamma Globulin 82790.0000 Transpeptidase Gamma Glut 82804.0000 Entrance or Correction Pt Dem 82805.0000 pH Body Fluids 82820.0000 PCO2 Direct Reading 82830.0000 Carbon Dioxide Content 82840.0000 Carbon Dioxide Titrimetric 82870.0000 O2 Saturation 82880.0000 PO2 Direct Reading 82883.0000 Blood Gas Analysis 82884.0000 Blood Gas POC 82885.0000 Coagulation POC 82925.0000 Acid Free QNT DUOD 82930.0000 Acid TOT QNT DUOD 82945.0000 Gastric Analysis Tubeless 82955.0000 Glucose 6 Phos Dehydrogenase 82963.0000 Glucosidase 82965.0000 Glutamate Dehydrogenase 82975.0000 Glutamine 82980.0000 Glycoprotein Acid Alpha1 82985.0000 Glycoprotein 83001.0000 Glucose Tolerance 4hr 83002.0000 Glucose Tolerance 5hr 83003.0000 LDL Cholesterol Direct 83008.0000 Guanosine 83011.0000 Haptoglobin 83012.0000 LDL/HDL Ratio 83013.0000 Cholesterol HDL 83017.0000 Cholesterol LDL 83020.0000 Hemoglobin 83030.0000 Hemoglobin Fetal Chemical 83031.0000 Fetal Hemoglobin Detection K 83032.0000 Hemoglobin Plasma 83052.0000 Hemoglobin S Solubility 83055.0000 Hemoglobin Unstable Heat 83057.0000 Hemoglobin A(2) 83070.0000 Hemosiderin Urine 83071.0000 Urine WBC Cast 83072.0000 Urine RBC Cast 83073.0000 Urine Grandular Cast 83074.0000 Urine Fatty Cast 83075.0000 Crystal Am Urate 83076.0000 Phosphate Am Crystal 83077.0000 Urine RBC Clumps 83090.0000 Homogentisic Acid 83110.0000 Aldosterone 83118.0000 Calcitonin 83125.0000 Catecholamines 83132.0000 Acetohexamide 83133.0000 Renin Stimulation 83134.0000 Tryptase 83135.0000 Glipizide 83140.0000 Vanillymandelic Acid 83141.0000 Phosphorus 83145.0000 Metanephrines 83146.0000 Pregnenolone 83148.0000 Protein CSF 83150.0000 Homovanillic Acid 83151.0000 Prostaglandin 83155.0000 Chemotaxis 83156.0000 Sialic Acid 83185.0000 Troponin T 83186.0000 Troponin C 83190.0000 Cortisol Free 83191.0000 Troponin I 83199.0000 Cortisol 83200.0000 Trimethadione 83201.0000 Tropomyosin 83210.0000 Insulin Tolerance 83224.0000 Nocardia 83230.0000 Corticosterone 83232.0000 Estrogen Binding Receptor 83233.0000 Estradiol 83234.0000 Estriol 83235.0000 Triprolid 83236.0000 Terfenadine 83245.0000 Estrogens 83248.0000 Gastrin 83249.0000 Hydroxyproline Free 83250.0000 Glucagon 83251.0000 Hydroxyproline 83252.0000 Iodine Total Urine 83253.0000 Hydroxyprogesterone 17 83254.0000 Insulin 83255.0000 Ketogenic Steroids 83256.0000 Ketosteroids 17 83257.0000 Hydroxycorticosterone 18 83258.0000 Amantadine 83259.0000 Cobalt 83260.0000 Gallium 83261.0000 Glyburide 83262.0000 Heavy Metal Screen 83263.0000 Palladium 83264.0000 Para-Amino Benzoic Acid 83265.0000 Protoporphyrin 83266.0000 Protoporphyrin Zinc 83267.0000 Risperidone 83280.0000 Ketosteroids 17 Neutral 83290.0000 Ketosteroids 17 Beta 83305.0000 Luteinizing Hormone 83306.0000 LH/FSH Panel 83310.0000 Follicle Stimulating Hormone 83316.0000 Placental Lactogen 83319.0000 RBC Transketolase 83320.0000 Pregnanediol 83340.0000 Pregnanetriol 83350.0000 Progesterone 83351.0000 Progesterone Receptor 83355.0000 Prolactin 83355.3035 Protein Bence Jones Heat~DU PO 83355.3103 Protein Bence Jones Heat~EKTAC 83360.0000 Renin 83370.0000 Angiotensin 83380.0000 Growth Hormone 83395.0000 Parathoromone 83400.0000 Deoxynucleotidyl Transferase 83405.0000 Testosterone 83415.0000 Testosterone + Dihydrotest 83440.0000 Triiodothyronine (T 3) Resin 83445.0000 Triiodothyronine (T 3) 83446.0000 Triiodothyronine (T 3) Rev 83447.0000 Triiodothyronine Free (FT3) 83448.0000 Alpha1 Antitrypsin 83449.0000 Alpha1 Antitrypsin Phenotype 83450.0000 Thyroxine (T 4) 83455.0000 Thyroxine Free (FT4) 83457.0000 Thyroxine Free (FT4) SA Ligand 83480.0000 Thyroid Stimulating Hormone 83490.0000 Thyroxine Binding Globulin 83495.0000 Hydroxybutyric Dehydrogenase 83496.0000 Hydroxycorticosteroids 17 83540.0000 Iron Total 83550.0000 Iron Total and Combining 83555.0000 Iron Binding Capac Unsatur(UIB 83575.0000 Isocitric Dehydrogenase 83600.0000 Kynurenic Acid 83605.0000 Lactic Acid 83620.0000 Lactate Dehydrogenase 83620.3000 Lactic Acid~MANUAL 83620.3035 Lactic Acid~DU PONT ACA 83625.0000 Lactate Dehydrogenase Isoenz 83642.0000 Lactose Qual Urine 83665.0000 Lecithin Sphingomyelin Ratio 83675.0000 Leucine Amino Peptidase 83690.0000 Lipase Blood 83700.0000 Lipids Total 83715.0000 Lipoprotein 83735.0000 Magnesium 83775.0000 Malate Dehydrogenase 83795.0000 Melanin Qual Urine 83857.0000 Methemalbumin 83865.0000 Mucopolysaccarides 83875.0000 Myoglobin Urine 83900.0000 Biotinidase 83915.0000 Nucleotidase 5' 83920.0000 Ornithine Carb Transferase 83925.0000 Osmolality 83930.0000 Osmolarity 83944.0000 Alpha1 Acid Glycoprotein 83945.0000 Oxalate 83946.0000 Anticentromere 83950.0000 Oxytocinase 83955.0000 Hippuric Acid Paraamino 83960.0000 Apolipoprotein A1 83962.0000 Apolipoprotein B 83966.0000 Antichymotrypsin Alpha1 83967.0000 Antitrypsin Alpha1 83968.0000 Endorphin Beta 83969.0000 Hemoglobin A 83970.0000 Hemoglobin S 83971.0000 Red Blood Cell Ag A 83972.0000 Red Blood Cell Ag B 83973.0000 Red Blood Cell Ag H 83974.0000 Gonadotropin Chorionic alpha 83975.0000 Gonadotropin Chorionic B Qual 83976.0000 Gonadotropin Chorionic B Quant 83977.0000 Melanocyte Stimulating Horm a 83978.0000 Melanocyte Stimulating Horm b 83979.0000 Secretin 83980.0000 Somatostatin 83981.0000 Substance P 83982.0000 Vasoactive Intestinal Polypep 83983.0000 Lipotropin 83984.0000 Vasopressin Arginine 83985.0000 Vasopressin Lysine 83986.0000 Oxytocin 83987.0000 Somatomedin C (IGF 1) 83988.0000 C-Peptide 83989.0000 Preinsulin 83990.0000 Pancreatic Polypeptide 83991.0000 Gastrin 17 83992.0000 Gastrin 34 83993.0000 Cholecystokinin 83994.0000 Parathyroid Hormone C Terminal 83995.0000 Parathyroid Hormone N Terminal 83996.0000 Protein Total Electro 83997.0000 Vitamin D 25 Hydroxy 83998.0000 Vitamin D 1 25 Dihydroxy 83999.0000 Osteocalcin (GLA protein) 84000.0000 Enkephalin Leucine 84001.0000 Enkephalin Methionine 84002.0000 Bombesin 84003.0000 Neurotensin 84004.0000 Corticotropin Releasing Hormon 84005.0000 Luteinizing Releasing Hormone 84006.0000 Cardioexcitatory Peptide 84007.0000 Choline Acetyltransferase 84008.0000 Butyric Acid gamma Amino 84009.0000 Serotonin 84009.3035 Silicon~DU PONT ACA 84009.3103 Silicon~EKTACHEM 700 84009.8044 Silicon~LAB1 SENDOUT 84010.0000 SP 1 Chromagranin 84011.0000 Parathyroid Hormone Mid Molec 84012.0000 Parathyroid Hormone Intact 84013.0000 Chymopapain 84014.0000 PTH Panel 84015.0000 Tubular Reabsorption PO4 84016.0000 Fractional Extraction NA 84017.0000 Fractional Extraction Nitrogen 84018.0000 Sandostatin 84019.0000 Cortisol Tolerence Test 84020.0000 Globulin Electro 84021.0000 Griseofulvin 84022.0000 Pimarcin 84023.0000 Clotrimazole 84024.0000 LDH Electrophoresis 84025.0000 CPK Electrophoresis 84026.0000 Protein Electro Urine 84027.0000 Protein Electro CSF 84028.0000 X*Glaidin Ab 84029.0000 Fat Stool 84030.0000 Phenylalanine 84031.0000 IgG Synthesis 84032.0000 Lymphocyte Absolute 84033.0000 LAP Score 84034.0000 Bleeding Time Surgicut 84035.0000 Mycoplasma Titer 84036.0000 HIV 1&2 84037.0000 Retinyl palitate 84038.0000 Interpretation 84039.0000 Parathyroid HRP 84040.0000 Phenylketone Urine (PKU) 84041.0000 Mercury/Creatinine 84042.0000 Copper 24H 84043.0000 Copper/Creatinine 84044.0000 Citric Acid 84045.0000 Citric Acid Urine 84046.0000 Cholinesterase Panel 84047.0000 6TG 84048.0000 6TG Metabolite 84049.0000 6MMP 84050.0000 6MMP Metabolites 84051.0000 B-Human Chorionic Gonadotropin 84060.0000 Phosphatase Acid Total 84061.0000 Phosphatase Acid Non Prost 84065.0000 Phosphatase Acid Prost Tart 84067.0000 Phosphatase Acid Prostatic 84075.0000 Phosphatase Alkaline 84075.3000 Phosphatase Alkaline Leukocyte 84075.3035 Phosphatase Alkaline Leukocyte 84080.0000 Phosphatase Alkaline Isoenz 84087.0000 Phosphohexose 84100.0000 Phosphate Inorganic 84100.3035 Photochromogenicity Test~DU PO 84101.0000 Alkaloids Screen 84103.0000 Phospholipids 84105.0000 Phosphorus Elemental 84110.0000 Porphobilinogen Quant Urine 84115.0000 Porphobilinogen Qual Urine 84120.0000 Porphyrin Quant Fraction 84123.0000 Protoporphyrin Free Erythro 84125.0000 Porphyrin Qual Urine 84140.0000 Potassium 84141.0000 Fungal Ab 84142.0000 Mycotoxin Ab 84155.0000 Protein Total 84156.0000 Protein Total Urine Point 84157.0000 Protein Total Urine Timed 84158.0000 Protein/Creatinine Ratio 84159.0000 Beta 2 transferrin 84160.0000 Pt Temp Est 84161.0000 Pt Temp Obs 84162.0000 Pt Weight Est 84163.0000 Pt Weight Obs 84164.0000 Pt Height Est 84165.0000 Pt Height Obs 84166.0000 Date LMP 84167.0000 Specimen Weight 84168.0000 Specimen Volume 84169.0000 Specimen Volume Reported 84171.0000 Globulin 84180.0000 Protein Quant Urine Fluid 84181.0000 Southern Blot 84185.0000 Protein Bence Jones Heat 84210.0000 Pyruvate 84220.0000 Pyruvate Kinase 84235.0000 Endocrine Hormone 84263.0000 Hydroxyind Acet Acid 5 Screen 84265.0000 Hydroxyind Acet Acid 5 Quant 84295.0000 Sodium 84305.0000 Urobilinogen 84310.0000 Sorbitol Dehydrogenase 84315.0000 Specific Gravity Excl Urine 84330.0000 +Glucose Quant 84400.0000 Body Fluid Exam for Crystals 84408.0000 Charcot Marie Tooth Screen 84409.0000 Enterovirus Ab by PCR 84410.0000 Spirometry 84411.0000 Bronchospasm Eval 84412.0000 Pulse Oximetry 84413.0000 Fibrinogen Activity 84455.0000 Transferase Aspartate SGOT 84455.3000 Urinalysis Micros only~MANUAL 84455.3035 Urinalysis Micros only~DU PONT 84456.0000 LDH1/LDH2 Ratio 84457.0000 Creatinine Random 84458.0000 Creatinine Random UA 84459.0000 LDH Total ISO 84465.0000 Transferase Alanine Amino SGP 84465.3000 Transpeptidase Gamma Glut~MANU 84465.3035 Transpeptidase Gamma Glut~DU P 84466.0000 X*Drug Dependant 84476.0000 Itraconazole 84480.0000 Triglycerides w o extract 84481.0000 Desmethsuximide 84483.0000 Helicobacter Pylorii Breath 84484.0000 Tryptophan 84485.0000 Trypsin Qual Duod or Gastric 84486.0000 Ethotoin 84487.0000 Ethinamate 84488.0000 Trypsin Qual Feces 84489.0000 Fatty Acid 84490.0000 Trypsin 84491.0000 Phosphatase Alkaline Heat Stab 84492.0000 Temperature 84494.0000 Temperature Observed 84495.0000 Temperature Body 84496.0000 Temperature Corrected 84497.0000 Phencyclidine 84498.0000 HDL/Cholesterol Ratio 84499.0000 Urine Microscopic 84500.0000 Legionella pneumophilia Ab EIA 84501.0000 Cyclic Citrulline Peptide Ab I 84502.0000 Calcium VG Channel Ab, N-Type 84503.0000 Calcium VG Channel Ab, P/Q Typ 84504.0000 Neuronal Ab Type 1 IFA 84505.0000 Purkinje Cell Cytoplasmic Ab T 84506.0000 Amphiphysin Ab 84507.0000 Levetiracetam 84508.0000 Nickel Urine 84509.0000 Nickel Urine 24Hr 84510.0000 Tyrosine 84511.0000 Nickel/Creatinine Ratio 84512.0000 Aminolevulinic Acid Urine 24Hr 84513.0000 N-Telopeptide/Creatinine Ratio 84514.0000 Lysozyme Urine 84515.0000 Microglobulin Beta 2 Urine 84520.0000 Urea Nitrogen 84550.0000 Uric Acid 84581.0000 Uroporphyrins 84582.0000 Urobilinogen Quant Feces 84583.0000 Urobilinogen Semiquant Urine 84584.0000 Porphyrin Uro 84586.0000 Viscosity Fluid 84588.0000 Vitamin B12 84590.0000 Vitamin A 84591.0000 Retinol Binding Protein 84592.0000 Retinoic Acid 84612.0000 PCA I 84613.0000 Glycophorin A 84614.0000 Glycophorin 84615.0000 Xanthurenic Acid 84619.0000 Xylose 84686.0000 Bromide Serum Quant VIS 84719.0000 Cholinesterase plus DN 84720.0000 Cholinesterase Pseudo Serum 84775.0000 Galactose Transferase 84902.0000 Heparin-Protamine Sulfate Tole 84906.0000 Parathion Urine Quant 84930.0000 Appearance 84931.0000 Urine Appearance 84988.0000 Misc Sendout 1 84989.0000 Misc Sendout 2 84990.0000 Misc Sendout 3 84991.0000 Misc Sendout 4 84992.0000 Misc Sendout 5 84993.0000 Misc Sendout 6 84994.0000 Misc Sendout 7 84995.0000 Misc Sendout 8 84996.0000 Misc Sendout 9 84997.0000 Misc Sendout 10 84998.0000 Misc Sendout 11 84999.0000 Hemogram Manual 85000.0000 Bleeding Time Duke 85001.0000 Bleeding Time Template 85002.0000 Acquired Inhibitory Screen 85003.0000 Protein C 85004.0000 Autohemolysis Test 85005.0000 Antithrombin III Assay 85006.0000 Protein S 85007.0000 Coagulation Factor II Assay 85008.0000 Blood Film Examination 85009.0000 Russell's Viper Venom 85010.0000 Blood Smear(s) 85011.0000 Cytoplasmic Neutrophil Ab 85012.0000 D Dimer 85013.0000 Fibrin Monomers 85014.0000 Granulocyte Ab 85015.0000 Hemogram I 85016.0000 Hemogram II 85017.0000 Hemogram III 85018.0000 Hemogram IV 85019.0000 Hemogram V 85020.0000 Red Blood Cell Count 85021.0000 Heparin Aggregation 85022.0000 Platelet Ab 85023.0000 Platelet AB (Drug) 85024.0000 Platelet MAO Inhibition 85025.0000 Protein A Ag 85026.0000 Osmotic fragility 85027.0000 Glycosylated HGB, total 85028.0000 Factor VIII Related Ag 85029.0000 Ristocetin cofactor 85030.0000 White Blood Cell Count 85031.0000 Misc Hem Test 1 85032.0000 Misc Hem Test 2 85033.0000 Misc Hem Test 3 85034.0000 Misc Hem Test 4 85035.0000 Misc Hem Test 5 85036.0000 Instrument HE Setup 85037.0000 DIC Panel 85038.0000 Alpha2 Antiplasmin 85039.0000 Antithrombin 3 Ag 85040.0000 Beta Thromboglobulin 85041.0000 Factor 8 Inhibitor - QN 85042.0000 Factor 8 Related Ag 85043.0000 Lupus Inhibitor (PNP) 85044.0000 Lupus Inhibitor (TTI) 85045.0000 Platelet Neutralization Proced 85046.0000 Tissue Thromboplastin Inhibiti 85047.0000 Plasminogen Activator 85048.0000 Plasminogen Ag 85049.0000 Prekallikrein (Fletcher) Assay 85050.0000 Hemoglobin RBC 85051.0000 Glycohemoglobin Fast Fraction 85052.0000 Glycohemoglobin A(1) C 85053.0000 Glycohemoglobin HbA 1c 85054.0000 Buffy Coat (prep smear&count) 85055.0000 Hematocrit Macro or Micro 85056.0000 Protamine Sulfate 85057.0000 Von Willebrand's Profile 85058.0000 Protein C Cofactor 85059.0000 Activated Clotting Time 85060.0000 Indices Hematologic 85061.0000 Acanthocyte 85062.0000 Anisochromic 85063.0000 Anisocytosis 85064.0000 Atypical Lymphocyte 85065.0000 Auer Rods 85066.0000 Band Neutrophil 85067.0000 Basophilic Stippling 85068.0000 Basophil 85069.0000 Basophil % 85070.0000 Blast 85071.0000 Burr Cells 85072.0000 Corrected WBC 85073.0000 Crenated RBC 85074.0000 Dohle Bodies 85075.0000 Elliptocyte 85076.0000 Eosinophil % 85077.0000 Granulocyte 85078.0000 Granulocyte % 85079.0000 Helmet Cell 85080.0000 Howell Jolly Bodies 85081.0000 Hypersegmented Neutrophil 85082.0000 Hypochromia 85083.0000 INR 85084.0000 Lymphocyte 85085.0000 Lymphocyte % 85086.0000 Macrocytes 85087.0000 MCD 85088.0000 MCH 85089.0000 MCHC 85090.0000 MCV 85091.0000 Megakaryocytes 85092.0000 Microcytes 85093.0000 Monocyte 85094.0000 Monocyte % 85095.0000 MPD 85096.0000 MPV 85097.0000 Myelocyte 85098.0000 Neutrophil 85099.0000 Neutrophil % 85100.0000 Nucleated RBC 85101.0000 Other Leukocytes 85102.0000 Ovalocytes 85103.0000 Pappenheimer 85104.0000 Pelger Huet 85105.0000 Bone Marrow Diff Count 85106.0000 Plasma Cell 85107.0000 Bone Marrow Film Prep 85108.0000 Bone Marrow Stain Romanowski 85109.0000 Platelet Estimate 85110.0000 Bone Marrow Aspiration 85111.0000 Poikilocytosis 85112.0000 Polychromasia 85113.0000 Promyelocyte 85114.0000 RDW 85115.0000 RDW-CV 85116.0000 RDW-SD 85117.0000 Reactive Lymphocyte 85118.0000 Red Blood Cell 85119.0000 Rouleaux 85120.0000 Schistocytes 85121.0000 Sickle Cell 85122.0000 Neutrophil Segmented 85123.0000 Siderocyte 85124.0000 Smudge Cell 85125.0000 Stomatocyte 85126.0000 Target Cell 85127.0000 Teardrop Cell 85128.0000 Toxic Granulation 85129.0000 Spherocyte 85130.0000 Malaria Forms 85131.0000 Malaria Smear 85132.0000 Factor V Leiden-DNA 85133.0000 Prothrombin Fragment 85134.0000 Eosinophil Smear 85135.0000 Erythroblast 85136.0000 Eosinophil Urine 85137.0000 Eosinophil Sputum Smear 85138.0000 Eosinophil Urine Smear 85139.0000 Porcine FVIII C Inhibitor 85140.0000 Hemoglobin & Hematocrit 85141.0000 Hem Specimen 85142.0000 Chronic Lymphoid Leukemia 85143.0000 Huntington's Disease 85144.0000 Vaginal Discharge Panel 85145.0000 Thalassemia Panel 85146.0000 Plasma Mix 1:1 85147.0000 PT 1:1 Mix 85148.0000 Hemogram+Platelet 85149.0000 Hemogram+PLT+Diff 85150.0000 Misc Sendout 12 85151.0000 Misc Sendout 13 85152.0000 Misc Sendout 14 85153.0000 Misc Sendout 15 85154.0000 Misc Sendout 16 85155.0000 Misc Sendout 17 85156.0000 Misc Sendout 18 85157.0000 Misc Sendout 19 85158.0000 Misc Sendout 20 85159.0000 Misc Stain 1 85160.0000 Misc Stain 2 85161.0000 Misc Stain 3 85162.0000 HLA B8 85163.0000 Eosinophil 85164.0000 Cells Other 85165.0000 Capillary Fragility 85166.0000 Chloroacetate Esterase Stain 85167.0000 Neutrophil Seg Fluid 85168.0000 Lymphocyte Fluid 85169.0000 Macrophage 85170.0000 Clot Retraction Qual 85171.0000 RBC Morphology 85172.0000 Euglobulin Lysis Time 85173.0000 Elapsed Time 85174.0000 PT w INR 85175.0000 Clot Lysis Time Whole Blood 85176.0000 von Willebrand's Factor Ag 85177.0000 Ristocetin Platelet Aggl 85178.0000 Plasma multimers 85179.0000 Plasminogen Activator Inhib 85180.0000 Report Hematology 85181.0000 Report Blood Bank 85182.0000 Kaolin Clotting Time 85183.0000 PT Mixing Study 85184.0000 PTT Mixing Study 85185.0000 Platelet Ag 1 85186.0000 Tumor Cells 85187.0000 Platelet Ag 2 85188.0000 Platelet Associated IgA Direct 85189.0000 Platelet Associated IgA Indire 85190.0000 Platelet Associated IgG Direct 85191.0000 Platelet Associated IgG Indire 85192.0000 Platelet Associated IgM Direct 85193.0000 Platelet Associated IgM Indire 85194.0000 Platelet Morphology 85195.0000 D Dimer Quant 85196.0000 MuSK Antibody 85201.0000 Biopsy 85202.0000 Bone Marrow, Flow Cyto, each m 85203.0000 Bone Marrow Aspirate Smear Int 85204.0000 Bone Marrow Core Touch Exam 85205.0000 Cytopath Flds,Brush,Wash w/out 85206.0000 Cytopath Fls,Wash,Brush w/out 85210.0000 Prothrombin Assay 85220.0000 Coagulation Factor V Assay 85223.0000 Mucin Clot 85230.0000 Coagulation Factor VII Assay 85240.0000 Coagulation Factor VIII Assay 85249.0000 Differential Count WBC 85250.0000 Coagulation Factor IX Assay 85251.0000 Factor IX Activity 85252.0000 Factor XI Activity 85260.0000 Coagulation Factor X Assay 85270.0000 Coagulation Factor XI Assay 85280.0000 Coagulation Factor XII Assay 85290.0000 Coagulation Factor XIII Assay 85299.0000 Fibrinogen Ag/Fibrinogen Ratio 85300.0000 Coagulation Factor VIII Inhib 85301.0000 Fibrinogen Ag 85302.0000 Fibrinogen Ab 85303.0000 Protein C Ag 85304.0000 Protein C Ab 85305.0000 Anticoagulant Circulating Scre 85306.0000 Bethesda Inhibitor 85307.0000 Wintrobe ESR 85308.0000 Anticoagulant Circulating Titr 85309.0000 Liquification 85310.0000 Reticulocyte 85311.0000 Viscosity 85312.0000 Methylenetetrahydrofolate Redu 85313.0000 PT Control 85314.0000 PTT Control 85315.0000 Prothrombin (20210) Gene Mut 85316.0000 Reticulin IgA Ab 85317.0000 Reticulin IgG Ab 85320.0000 Thrombin III Ab 85321.0000 Osmotic Fragility,0.50 g/dL Na 85322.0000 Osmotic Fragility,0.60 g/dL Na 85323.0000 Osmotic Fragility,0.65 g/dL Na 85324.0000 Osmotic Fragility,0.75 g/dL Na 85336.0000 Eosinophil # 85345.0000 Clotting Time Lee White 85346.0000 Coagulation Factor Assay Panel 85350.0000 Eosinophil Count 85351.0000 Eosinophil Nasal Smear 85355.0000 Ethanol Gel Test 85370.0000 Fibrinogen Screening Test 85371.0000 Fibrin Degradation Prod Kit 85375.0000 Fibrinogen Chem Quant 85378.0000 Fibrinogen Semiquant 85379.0000 Zetacrit 85390.0000 Fibrinolysis Whole Clot 85394.0000 Von Willebrand Multimer 85395.0000 Fibrinolysis DIL or Plate 85397.0000 Plasmin 85490.0000 Heinz Bodies Smear for 85500.0000 Heinz Bodies Induction Test 85520.0000 Heparin Assay 85532.0000 Iron Stain for Siderocytes 85555.0000 Phosphatase Acid Leukocyte 85560.0000 Platelet Aggregation Substrate 85569.0000 Leukocyte Count 85570.0000 Platelet Count Whole Blood 85571.0000 Platelet Count Plasma 85572.0000 Platelet Count (Phase) 85573.0000 Factor VIII Activity 85574.0000 Factor VII 85576.0000 Factor VII Ab 85577.0000 Factor VII Ag 85581.0000 Blood Film Screen 85582.0000 Beta Galactosidase 85586.0000 Plate Factor III PF III 85587.0000 Reptilase R Test 85588.0000 Hemolysin Acid 85590.0000 Plasminogen 85595.0000 LE Cell Preparation 85596.0000 Activated Protein C Resis 85600.0000 Platelet Adhesivity Salzman 85610.0000 Prothrombin Time 85613.0000 Prothrombin Time+PTT 85615.0000 Prothrombin Consumption 85620.0000 Red Blood Cell Fragility Qual 85621.0000 Platelet Aggreg Spon 85622.0000 Platelet Aggreg ADP 1:8 85623.0000 Platelet Aggreg ADP 1:4 85624.0000 Platelet Aggreg Rist 85625.0000 Platelet Aggreg Epinep 85626.0000 Platelet Aggreg Collagen 85627.0000 Platelet Aggreg Arach 85632.0000 Phosphatase Alkaline Leukocyte 85634.0000 Red Blood Cell Fragility Mech 85636.0000 Red Blood Cell Fragility Quant 85637.0000 Metamyelocyte 85638.0000 Normocytic 85639.0000 Normochromic 85640.0000 Aniocytosis 85641.0000 Microcytosis 85642.0000 Cryocrit 85643.0000 Aspartate Erythrocyte 85644.0000 Iron Panel Hem 85645.0000 Reticulocyte Count 85646.0000 Natural Killer Cell 85647.0000 Foscarnet 85648.0000 LSA Lymp Subset 85649.0000 Fibrinogen 85650.0000 Reticulocyte Absolute 85651.0000 Fibrinogen Fragments 85652.0000 Polymorphonuclear Neutrophil 85653.0000 Ivy Bleeding Time 85654.0000 Hemoglobin E 85655.0000 Sedimentation Rate 85656.0000 Protein C&S Panel 85657.0000 Hemoglobin NOS 85658.0000 Reticulocyte Index 85659.0000 Kennedy Disease 85660.0000 Sickle Cell Identification 85661.0000 Snovial Cell 85662.0000 Sucrose Water Test 85663.0000 Sezary Cell 85664.0000 Malignant Cell 85665.0000 Sudan Black B Leucocyte 85666.0000 Epstein Barr Ab 85667.0000 Hgb Phenotype 85668.0000 Lining Cell 85669.0000 Epithelial NOS 85670.0000 Thrombin Time 85671.0000 PT-PTT Factor Assay 85672.0000 Hemoglobin C 85674.0000 PT Substitution 85675.0000 Thrombin Titer 85676.0000 Hemoglobin Phenotype 85678.0000 Ventricular Lining Cell 85679.0000 Columnar Epithelial Cell 85680.0000 Specimen Count 85681.0000 Mast Cell 85682.0000 Sperm Morphology 85683.0000 Ma Auto Ab 85684.0000 Ta Auto Ab 85685.0000 Metamyelocytes Absolute 85686.0000 Myelocyte Absolute 85687.0000 Promyelocyte Absolute 85688.0000 Plasma Cell Absolute 85689.0000 Red Blood Cells Nucleated Abso 85690.0000 PTT 1:1 MIX 85691.0000 PTT Mix 1Hr Incubation 85692.0000 PT Ratio 85693.0000 Prolymphocytes 85694.0000 PTT-Adsorbed 85695.0000 Prolymphocytes Percent 85696.0000 Promonocytes 85700.0000 Thromboplastin Screening H P 85725.0000 Thromboplastin Gen Defect ID 85730.0000 Thromboplastin Time Partial 85731.0000 Thromboplastin Time w Sub 86000.0000 HLA B27 86001.0000 B and T Cell Quant Ros 86002.0000 Misc BB Test 1 86003.0000 Misc BB Test 2 86004.0000 Misc BB Test 3 86005.0000 Misc BB Test 4 86006.0000 Misc BB Test 5 86007.0000 Instrument BB Setup 86011.0000 Phagocytic Bactericidal Assay 86045.0000 HLA Tissue Typing 86046.0000 HLA Tissue Typing A,B 86047.0000 HLA Class I II 86048.0000 Homocystein Genetic 86049.0000 4:1 Plasma Mix 86050.0000 Chlamydia Diff 86051.0000 Chlamydia Probe 86052.0000 Factor II 86053.0000 Factor II Ag 86054.0000 Factor II Activity 86055.0000 Factor II Mutation 86056.0000 Factor IX Ag 86057.0000 Factor IX Inh 86058.0000 Factor XI Inh 86059.0000 Factor XIII 86060.0000 Factor XIII Urea 86061.0000 Hepatitis A IgG/IgM 86062.0000 Hepatitis E Ab IgG 86063.0000 Hepatitis E Ab IgM 86064.0000 Neutrophil Cytoplasm Ab 86065.0000 Coccidioides IgM 86066.0000 Cell Marker Panel 86067.0000 Triple Marker Panel 86069.0000 HIV 1 P24 86070.0000 HIV 1 P18 86071.0000 HIV 1 P55 86072.0000 Transglutaminase Tissue Ab 86073.0000 Charcot Marie Tooth 86074.0000 Parvovirus B19 IgG 86076.0000 Parvovirus B19 IgM 86077.0000 Phytohemagglutinin 86078.0000 Protease Gene Mutation 86079.0000 Coxsackie A 10 86080.0000 ABO Cell and Serum Typing 86081.0000 ABO Cell and Rh(D) Typing 86082.0000 ABO Cell Serum and Rh(D) 86083.0000 ABO Hemolysin Test 86084.0000 ABO Cell Typing Slide or Tube 86085.0000 ABO Cell,Serum & Rh Typing on 86086.0000 ABO Serum Typing Tube 86087.0000 ABO Cell & Rh Typing Unit 86088.0000 Rh(D) Typing 86089.0000 Coxsackie A 16 86090.0000 Coxsackie A 2 86091.0000 Coxsackie A 4 86092.0000 Coxsackie A 7 86093.0000 Coxsackie A 9 86094.0000 Coxsackie B 1 86095.0000 Coxsackie B 2 86097.0000 Coxsackie B 3 86098.0000 Coxsackie B 4 86099.0000 Coxsackie B 5 86100.0000 Rh(D) Typing Slide or Tube 86101.0000 Coxsackie B 6 86103.0000 Neutrophil Cytoplasmic Ab IgA 86104.0000 Neutrophil Cytoplasmic Ab IgM 86105.0000 Beryllium Lymphocyte Prolifera 86120.0000 Ag Blood Type 86121.0000 Red Cell Mass 86125.0000 Ag Blood Type w Antihuman 86129.0000 Blood Unit Labeling 86131.0000 Blood Component or Derivative 86132.0000 Blood Compon Deriv Exter Reloc 86133.0000 Donor Blood Collection 86134.0000 Blood Compon Deriv Inter Reloc 86135.0000 Ab Absorption Blood Bank 86136.0000 Donor Autologous Schedul 1st 86137.0000 Warm Autoadsorption ZZAP 86138.0000 Donor Autologous 1 Unit 86139.0000 Ab Detection w Antihuman (1 st 86140.0000 Ab Detect w o antihuman (1 sta 86141.0000 Donor Autologou Sched Add 86142.0000 Ab Detect w o Antihuman (2 sta 86143.0000 Ab Detection w AHG Donor 86144.0000 Ab Detect Antihuman (2 stage) 86145.0000 Ab Detection w/o AHG Donor 86148.0000 Ab Detect Capillary Test 86150.0000 Ab Elution 86152.0000 Ab ID w Antihuman 86153.0000 Ab Identification w AHG Donor 86154.0000 Ab Ident w o Antihuman 86155.0000 Ab Identification w/o Donor 86156.0000 Ab ID Capillary Testing 86158.0000 Ab ID w o Antihuman 86160.0000 Ab ID Antihuman globulin 86161.0000 Ab Titration 86162.0000 HLA B7 86164.0000 Compatibility Crossmatch Salin 86165.0000 HLA Phenotype A B 86166.0000 Compatibility Test Crossmatch 86167.0000 Ab Detection Type & Scr 86168.0000 Ab Detect crossmatch 86169.0000 HBcAb Blood Donor EIA 86170.0000 HIV Ab Blood Donor 86171.0000 HBsAg Blood Donor RIA batch 86172.0000 HBsAg Blood Donor RIA 86173.0000 HBsAg Blood Donor RPHA 86174.0000 HLA B14 86175.0000 HBsAg Blood Donor ELISA batch 86176.0000 HCV Blood Donor EIA batch 86177.0000 HLA Ab Screen 86178.0000 HLA Single Ag Screening 86179.0000 HLA Compatibility Testing 86180.0000 Leukoagglutinin Compatibility 86181.0000 HLA Phenotype A B C Complete 86182.0000 HLA Phenotype A B C initial 86183.0000 Irradiation of Blood Component 86184.0000 Lymphocyte Separation T&B 86185.0000 HLA Typing Tray Production 86186.0000 Lymphocyte Separation fr Blood 86187.0000 Leukoagglutinin Screen 86188.0000 HLA Phenotype Dr (initial) 86189.0000 HLA Phenotype Dr by Lympho 86190.0000 Calibrating Centrifuge 86191.0000 HLA Phenotype A 86192.0000 Checking Centrifuge 86193.0000 HLA Phenotyping Donor 86194.0000 Checking Timer on Centrifuge 86195.0000 Lymphocyte Thawing 86196.0000 Alarm Activation Blood Storage 86197.0000 HLA Lymphocyte Cell Count 86198.0000 Blood Storage Recording Daily 86199.0000 Instrument Thermometer Reading 86200.0000 Blood Storage Chart Change 86201.0000 Reagent RBC Freeze Glycerol 86202.0000 HLA Lymphocyte Cell Ct & Adj 86203.0000 HLA Lymphocyte Viability 86204.0000 Reagent RBC Freeze Liq Nitro 86205.0000 HLA Phenotype B 86206.0000 Hemoglobin Fetal 86207.0000 Reagent RBC Thawing 86208.0000 MaTa Auto Ab 86209.0000 CD3/CD7 86210.0000 DNA Mutation Analysis 86211.0000 Reagent RBC Prep A B O 86212.0000 Myotonic Dystrophy 86213.0000 Reagent RBC Prep Antihuman 86214.0000 Myotonic Dystrophy, DNA Mutati 86215.0000 T Cell Lymphocyte 86216.0000 Reagent RBC Prep Enzyme 86217.0000 Monocyte % Lymphocyte 86219.0000 Coagulation Concentrate Lyo 86220.0000 HTLV I Blood Donor 86221.0000 HLA DQW1 86222.0000 HLA DR(Ia) 86225.0000 DNA Ab 86226.0000 DNA Single Strand Ab 86227.0000 DNA Ab Native 86237.0000 JO-1 Ab 86250.0000 Antihuman Globulin Test 86252.0000 Autologous Unit Invent Blood o 86254.0000 Directed Unit Invent Blood or 86269.0000 Cryoprecipitate Prep (4+) 86270.0000 Platelet Administration 86271.0000 Cryoprecipitate Preparation 86272.0000 Cryoprecipitate Thawing 86273.0000 Blood Products Administration 86275.0000 Frozen Blood Preparation 86276.0000 Frozen Blood Thaw & Deglyc 86277.0000 Rejuvenation of Red Cells 86291.0000 Cardiolipin Ag Prep 86292.0000 Washed RBC for CF HA HAI 86293.0000 Sensitize RBC for CF 86294.0000 Complement Titration 86297.0000 Preparation of Gelatin Water 86299.0000 Hemolysin Titration 86380.0000 Factor V Leiden PCR 86381.0000 Campylobacter Ab 86382.0000 Leukocyte Poor Blood Prep 86383.0000 Leukapheresis Donor 86384.0000 Lymphocyte Storage Liq Nitroge 86385.0000 Plasma Exchange Therapeutic 86386.0000 Thrombocytapheresis 86387.0000 Plasmapheresis First Unit 86388.0000 Platelet Agglutinins 86389.0000 Plasmapheresis add Units 86390.0000 Platelet Concentrate Prep 4+ 86391.0000 Platelet Rich Plasma Prep 86392.0000 Platelet Concentrate Prep 86393.0000 Platelet Concentrate Pool 86394.0000 Thrombocyte Leukapheresis Dono 86395.0000 Platelet Freezing DMSO 86396.0000 Platelet Thawing and DE DMSO 86397.0000 Red Cell Exchange 86398.0000 Dithiothreiotol Destruction 86399.0000 Prewarm Technique 86400.0000 Thrombocytapheresis Therap 86401.0000 Leukapheresis Therapeutic 86402.0000 Separation of Red Cell Mix 86403.0000 Decontamination of Lymphocyte 86404.0000 Mixed Lymphocyte Culture Setup 86405.0000 Mixed Lymphocyte Culture Pulse 86406.0000 Mitogen Assay Setup 86407.0000 Mitogen Assay Pulse Harvest 86408.0000 Transfusion Outpatient Setup 86409.0000 Lymphocyte Separation fr Sol 86410.0000 Transferase Alanine Amino BLD 86411.0000 Transfusion Outpatient Each 86412.0000 Transfusion Reaction Clerical 86413.0000 BB Specimen 86414.0000 Donor Specimen 86415.0000 Crossmatch Specimen 86416.0000 Sp BB Specimen 86430.0000 Blood Administration 86432.0000 Blood Products Admin Other 86472.0000 Influenza B Victoria Ab 86473.0000 Influenza B Panama Ab 86474.0000 Influenza Profile 86475.0000 Lymphocyte Stimulation NOS 86476.0000 Lymphocyte Stimulation Candida 86477.0000 Nitroblue Tetrazolium Dye 86478.0000 Chemotactic Study 86479.0000 Lymphocyte Stimulation Concan 86480.0000 Lymphocyte Stimulation Phyto 86481.0000 Lymphocyte Stimulation Poke 86482.0000 Surface Marker Alpha Chain 86483.0000 Surface Marker Gamma Chain 86484.0000 Surface Marker B1 86485.0000 Surface Marker B2 86486.0000 Surface Marker BA 1 86489.0000 Surface Marker Delta Chain 86490.0000 Surface Marker Epsilon Chain 86491.0000 Surface Marker Ia 86492.0000 Surface Marker J5 (CALLA) 86493.0000 Surface Marker Kappa Chain 86494.0000 Surface Marker Lambda Chain 86495.0000 Surface Marker Mu Chain 86496.0000 Surface Marker Leu Chain 86497.0000 Surface Marker Mo Chain 86498.0000 Surface Marker My Chain 86499.0000 Surface Marker T3 86500.0000 Surface Marker T4 Leu 3 86501.0000 Surface Marker T4 T8 Ratio 86502.0000 Surface Marker T6 86503.0000 Surface Marker T8 Leu 2 86504.0000 Surface Marker T10 86505.0000 Surface Marker T11 86506.0000 Surface Marker Tac 86507.0000 Surface Marker Leu 7 86508.0000 Surface Marker Leu 11 86509.0000 Surface Marker Leu 15 86510.0000 Surface Marker Mo 1 86511.0000 Surface Marker Mo 2 86512.0000 Surface Marker My 4 86513.0000 Surface Marker My 7 86514.0000 Surface Marker My 8 86515.0000 Surface Marker My 9 86516.0000 Platelet Associated IgG 86517.0000 Neuronal Nuclear Ab 86518.0000 Neuronal Nuclear Ab Panel 86519.0000 Ri Ab IFA 86520.0000 Hu Ab 86521.0000 CD1a 86522.0000 CD1b 86523.0000 CD1c 86524.0000 CD2 86525.0000 CD2R 86526.0000 CD3 86527.0000 CD4 86528.0000 CD5 86529.0000 CD6 86530.0000 CD7 86531.0000 CD8 86532.0000 CD8beta 86533.0000 CD9 86534.0000 CD10 86535.0000 CD11a 86536.0000 CD11b 86537.0000 CD11c 86538.0000 CDw12 86539.0000 CD13 86540.0000 CD14 86541.0000 CD15 86542.0000 CD15s 86543.0000 CD16 86544.0000 CD16b 86545.0000 CDw17 86546.0000 CD18 86547.0000 CD19 86548.0000 CD20 86549.0000 CD21 86550.0000 CD22 86551.0000 CD23 86552.0000 CD24 86553.0000 CD25 86554.0000 CD26 86555.0000 CD27 86556.0000 CD28 86557.0000 CD29 86558.0000 CD30 86559.0000 CD31 86560.0000 CD32 86561.0000 CD33 86562.0000 CD34 86563.0000 CD35 86564.0000 CD36 86565.0000 CD37 86566.0000 CD38 86567.0000 CD39 86568.0000 CD40 86569.0000 CD40L 86570.0000 CD41 86571.0000 CD42a 86572.0000 CD42b 86573.0000 CD42c 86574.0000 CD43 86575.0000 CD44 86576.0000 CD45 86577.0000 CD45R0 86578.0000 CD45RA 86579.0000 CD45RB 86580.0000 CD46 86581.0000 CD47 86582.0000 CD48 86583.0000 CD49a 86584.0000 CD49b 86585.0000 CD49c 86586.0000 CD49d 86587.0000 CD49e 86588.0000 CD49f 86589.0000 CD50 86590.0000 CD51 86591.0000 CD52 86592.0000 CD54 86593.0000 CD55 86594.0000 CD56 86595.0000 CD57 86596.0000 CD58 86597.0000 CD59 86598.0000 CDw60 86599.0000 CD61 86600.0000 CD62E 86601.0000 Cell Suspension from Solid 86602.0000 CD62P 86603.0000 CD63 86604.0000 CD64 86605.0000 CDw65 86606.0000 CD66a 86607.0000 CD66abce 86608.0000 CD66acd 86609.0000 CD66acde 86610.0000 CD66ace 86611.0000 CD66ae 86612.0000 CD66b 86613.0000 CD66be 86614.0000 CD66c 86615.0000 CDce 86616.0000 CD66d 86617.0000 CD66de 86618.0000 CD68 86619.0000 CD69 86620.0000 CD70 86621.0000 CD71 86622.0000 CD72 86623.0000 CD73 86624.0000 CD74 86625.0000 CDw75 86626.0000 CDw76 86627.0000 CD77 86628.0000 CDw78 86629.0000 CD79a 86630.0000 CD79b 86631.0000 CD80 86632.0000 CD81 86633.0000 CD82 86634.0000 CD83 86635.0000 CDw84 86636.0000 CD85 86637.0000 CD86 86638.0000 CD87 86639.0000 CD88 86640.0000 CD89 86641.0000 CDw90 86642.0000 CD91 86643.0000 CDw92 86644.0000 CD93 86645.0000 CD94 86646.0000 CD95 86647.0000 CD96 86648.0000 CD97 86649.0000 CD99 86650.0000 CD99R 86651.0000 CD100 86652.0000 CDw101 86653.0000 CD102 86654.0000 CD103 86655.0000 CD104 86656.0000 CD106 86657.0000 CD107a 86658.0000 CD107b 86659.0000 CDw108 86660.0000 CDw109 86661.0000 CD115 86662.0000 CDw116 86663.0000 CD117 86664.0000 CDw119 86665.0000 CD120a 86666.0000 CD120b 86667.0000 CDw121a 86668.0000 CDw121b 86669.0000 CDw122 86670.0000 Washed RBCs for Transfusion 86671.0000 CD126 86672.0000 CDw127 86673.0000 CDw128 86674.0000 CDw130 86675.0000 Leukocyte Agglutinins 86676.0000 Factor V Mutation 86677.0000 CD8 Percent 86678.0000 CD4/CD8 86679.0000 CD4 Absolute 86680.0000 Leukocyte Common Ag 86681.0000 CD8 Absolute 86682.0000 CD62L 86683.0000 CDw124 86684.0000 Strongyloides Ab 86685.0000 CD19 Percent 86686.0000 CD55/CD59 86687.0000 Ri Ab 86705.0000 Therapeutic Phlebotomy 86706.0000 Isohemagglutin Titer 86707.0000 Blood Salvage 86708.0000 Fetal Screen 86709.0000 Bone Marrow Freezing 86710.0000 Bone Marrow Conc. 86711.0000 Bone Marrow Modification 86712.0000 Rh Typing 86713.0000 Apheresis 86714.0000 Rh Recheck 86715.0000 Immediate Spin Crossmatch 86716.0000 DAT 86717.0000 Splitting of Blood Products 86718.0000 Leukodeplete in Lab 86719.0000 Concentrate 86720.0000 Prepare Frozen Blood 86721.0000 Thawing Frozen Blood 86722.0000 Freezing and Thawing Blood 86723.0000 Enzyme Treated Panel 86724.0000 Antibody Titer 86725.0000 Chloroquine Dissociation 86726.0000 Cold Autoabsorption 86727.0000 Complete Crossmatch Incub 86728.0000 Complete Crossmatch Antiglob 86729.0000 Density Gradient Sep 86730.0000 Dithiothreital Diff 86731.0000 Neutralization 86732.0000 Mucormycosis 86733.0000 RBC Antigen Type Other 86734.0000 Rh Phenotype 86735.0000 Serum Dilution 86736.0000 Unit Phenotype/Screen 86737.0000 ZZAP Autoabsorption 86738.0000 Mycoplasma 86739.0000 Plateletpheresis 86740.0000 Insulin Like Growth Factor 86741.0000 Protein S AB 86742.0000 Acetylcholine Receptor Ab Pane 86743.0000 Acetycholine Receptor Binding 86744.0000 Acetylcholinesterase 86745.0000 Protein S Ag 86746.0000 HLA Bw Phenotype 86747.0000 HLA Cw Phenotype 86748.0000 HLA DR Phenotype 86749.0000 HLA DQ Phenotype 86750.0000 HLA A Phenotype 86751.0000 HLA B Phenotype 86765.0000 Enterovirus Ab 86790.0000 Packed Red Blood Sediment 86795.0000 Packed Red Blood Cells 86796.0000 Packed Red Blood (4 or more) 86798.0000 Fetal Hemoglobin Detection F 86799.0000 Red Blood Cells Unit 86800.0000 Fresh Frozen Plasma Prep 86801.0000 Fresh Frozen Plasma (4+) 86802.0000 Red Blood Cells Leukocytes Red 86803.0000 Red Blood Cells Deglycerolized 86804.0000 Platelet Pack Unit 86805.0000 Fresh Frozen Plasma Thawing 86806.0000 Platelets Leukocytes Reduced 86807.0000 Platelet Pheresis Leukocytes R 86808.0000 Granulocyte Pheresis Irradiate 86809.0000 Fresh Frozen Plasma 86810.0000 Separation of Blood Unit 86811.0000 Fresh Frozen 24Hr 86812.0000 Cryoprecipitate Reduced Plasma 86813.0000 Plasma Solvent Detergent Treat 86814.0000 Cryoprecipitate AHF 86815.0000 HLA Typed Blood Product 86816.0000 Platelet Ag 1 Negative Product 86818.0000 Donor Recruitment In Hospital 86819.0000 Donor Recruitment In Comm 86820.0000 Blood Unit Credit Function 86821.0000 Compatibility Crossmatch Plate 86822.0000 Type + Screen Platelets 86823.0000 Neutrophil Ab 86824.0000 Leukocyte Ab 86825.0000 Donor Rejected 86826.0000 CMV Ab Negative Product 86827.0000 Pooling Products 86828.0000 Compatibility non RBC Crossmat 86829.0000 Washing Blood Products 86830.0000 Volume Reduction 86831.0000 Directed Donation 86832.0000 Transfusion 86833.0000 Transfusion Blood Products 86834.0000 Transfusion Leukocytes 86835.0000 Transfusion Procedure NOS 86836.0000 CD3+HLA-DR+ Percent 86837.0000 CD3+HLA-DR+ Absolute 86838.0000 CD 2 Absolute 86839.0000 CD20 Absolute 86840.0000 Phlebotomy Therapeutic 86841.0000 T3 OK Percent 86842.0000 T3 OK Absolute 86843.0000 Cytoplasmic Neutrophil Atypica 86844.0000 Richettsia Panel 86845.0000 Phlebotomy Therapeutic Bedside 86846.0000 Norwalk Agent Ab 86847.0000 Inhibition Neutralization 86848.0000 Microplate Hemagglutination 86849.0000 Microplate Hemagg Tech Serum 86850.0000 Inventory(1) 86851.0000 Red Blood Cells ACD-A 86852.0000 Red Blood Cells Div Unit ACD-A 86853.0000 Red Blood Cells, Irrad ACD-A 86854.0000 Red Blood Cells Leuko Dep ACA- 86855.0000 Whole Blood ACD-A 86856.0000 Red Blood Cells CPD 86857.0000 Red Blood Cells Div Unit CPD 86858.0000 Red Blood Cell Irrad CPD 86859.0000 Red Blood Cell Leuko Dep CDP 86860.0000 Rh Immune Globulin 86861.0000 Squamous Cell CA Ag 86862.0000 C3 Nephritic Factor 86863.0000 BCR/ABL Gene 86864.0000 AutoImmune Ab Panel 86865.0000 Aspergillus Fumigatus Type 1 A 86866.0000 Aspergillus Fumigatus Type 2 A 86867.0000 Cytotoxic Ab Screen 86868.0000 HGE IgG Ab 86869.0000 Quinine Induced Ab 86870.0000 Toxocara Ab 86871.0000 Nabferon 86872.0000 CD138 86873.0000 CD125 86874.0000 CD NOS 86875.0000 IgG Subsets 1 86877.0000 IgG Subsets 4 86878.0000 Human Monocytic Ehrlichiosis A 86879.0000 Human Monocytic Ehrlichiosis A 86880.0000 Burkholderia pseudomallei Ab I 86881.0000 Burkholderia pseudomallei Ab I 86885.0000 Coombs Test 86886.0000 Coombs Test Indirect 86903.0000 Type + Screen Blood 86910.0000 Paternity Blood Typing 86960.0000 Hemochromatosis 86961.0000 Heparin Anti Xa Unfract 86994.0000 BKV ViActive qPCR 86995.0000 Adenovirus Ag,IF 86996.0000 Influenza A Ag,IF 86997.0000 Influenza B Ag,IF 86998.0000 Respiratory Syncytial Ag,IF 86999.0000 Rapid Respiratory Viral Panel 87000.0000 Bacteria Ab Coated 87001.0000 Fecal Leukocytes 87002.0000 Bacterium NOS 87003.0000 Legionella Culture 87004.0000 Bacteroides species 87005.0000 Bartonella species NOS 87006.0000 Bordatella Parapertussis 87007.0000 Bordetella Pertussis 87008.0000 Brucella species 87009.0000 Legionella DFA 87010.0000 Clostridium Difficile Toxin 87011.0000 Rapid Viral Smear 87012.0000 Clostridium Tetani Toxin 87013.0000 Corynebacterium species NOS 87014.0000 Corynebacterium Diptheriae 87015.0000 Blood Culture Conventional 87016.0000 Escherichia coli Each Sero 87017.0000 Francisella tularensis 87018.0000 Haemophilus Influenzae 87019.0000 Feces Macroscopic Exam 87020.0000 Haemophilus influenzae Type A 87021.0000 Feces Microscopic Exam 87022.0000 Haemophilus Influenzae type B 87023.0000 Feces Pin Worm Examination 87024.0000 Legionella species NOS 87025.0000 Sodium Hydroxide Procedure 87026.0000 Legionella pneumophilia 87027.0000 Strep Grp A Coagglut 87028.0000 Listeria species 87029.0000 Neisseria species NOS 87030.0000 Neisseria Gonorrhoeae 87031.0000 Neisseria Meningitidis 87032.0000 Neisseria Meningitidis Typing 87033.0000 Norcardia species NOS 87034.0000 Proteus OX 2 87035.0000 Strep Grp A Enzyme Immun 87036.0000 Proteus OX 19 87037.0000 Strep Grp A Latex Agglut 87038.0000 Proteus OX K 87039.0000 Wet Prep for Trichomonas 87040.0000 Pseudomonas Pseudomallei 87041.0000 Escherichia Coli 0157 87042.0000 Salmonella Each Grouping 87043.0000 Ziehl Neelsen Stain 87044.0000 Salmonella Paratyphi A 87045.0000 Zinc Sulfate Flotation 87046.0000 Salmonella Paratyphi B 87047.0000 Fluorochrome Type Stains 87048.0000 Salmonella Typhi H 87049.0000 Formalin Ether or Ethyl 87050.0000 Salmonella Typhi O 87051.0000 Iron Hematoxylin Stain 87052.0000 Salmonella Typhi Vi 87053.0000 Kinyoun's Acid Fast Stain 87054.0000 Salmonella Each Typing 87055.0000 Merthiolate Iodine Formalin 87056.0000 Shigella Each Grouping 87057.0000 NALC Procedure 87058.0000 Shigella Each Typing 87059.0000 Staphylococcus species NOS 87060.0000 Streptobacillus species 87061.0000 Trichrome Stain 87062.0000 Streptococcus Group A 87063.0000 Zephiran Trisodium Phosphate 87064.0000 Streptococcus Group B 87065.0000 Viral serology 87066.0000 Streptococcus Group C 87067.0000 India Ink prep 87068.0000 Streptococcus Group D 87069.0000 KOH prep, fungal 87070.0000 Streptococcus Group G 87071.0000 Haemophilus influenza Type B b 87072.0000 Streptococcus Group MG 87073.0000 Neisseria meningitidis by Late 87074.0000 Streptococcus Pneumoniae 87075.0000 Streptococcus species NOS 87076.0000 Vibrio Cholera 87077.0000 Histoplasmosis Ab yeast/mycel 87078.0000 Yersinia Enterocolitica 87079.0000 Chlamydia culture 87080.0000 Yersinia Pestis 87081.0000 Misc Micro Test 1 87082.0000 Yersinia Pseudotuberculosis 87083.0000 Yersinia species NOS 87084.0000 Misc Micro Test 2 87085.0000 Misc Micro Test 3 87086.0000 Misc Micro Test 4 87087.0000 Misc Micro Test 5 87088.0000 Herpes Simplex Encephalitis 87089.0000 Culture GC 87090.0000 Coccidioides Precipitin 87091.0000 Enteroviral Ab 87092.0000 Chlamydia/GC Panel 87093.0000 API Etiology Rapid 87094.0000 Misc Culture 1 87095.0000 Misc Culture 2 87096.0000 Misc Culture 3 87097.0000 Misc Culture 4 87098.0000 Misc Culture 5 87099.0000 Misc Culture 6 87100.0000 Misc Culture 7 87101.0000 InHouse or Send Out Test 87102.0000 Etiology 87103.0000 Specimen Source 87104.0000 Instrument MI Setup 87105.0000 Acyclovir 87106.0000 Almecillin 87107.0000 Anantadine 87108.0000 Amoxicillin+Clavulanate 87109.0000 Ampicillin+Sulbactam 87110.0000 Betalactase 87111.0000 Azithromycin 87112.0000 Bacampicillin 87113.0000 Betalactase ext Spectrum 87114.0000 Butirosin 87115.0000 Cefatrizine 87116.0000 Cefepime 87117.0000 Cefixime 87118.0000 Cefemetazole 87119.0000 Cefodizime 87120.0000 Cefonicid 87121.0000 Cefotetan 87122.0000 Cefpirome 87123.0000 Cefpodoxime 87124.0000 Cefprozil 87125.0000 Ceftazindime 87126.0000 Ceftibuten 87127.0000 Chlortetracycline 87128.0000 Cinoxacin 87129.0000 Clarithromycin 87130.0000 Colistimethate 87131.0000 Colinstin 87132.0000 Cyclacillin 87133.0000 Demeclocycline 87134.0000 Dirithromycin 87135.0000 Erythromycin+Sulfisoxazole 87136.0000 Fleroxacin 87137.0000 Floxacillin 87138.0000 FP-Amycetin 87139.0000 Fusidate 87140.0000 Ganciclovir 87141.0000 Gentamicin HP 87142.0000 Gramicidind 87143.0000 Hetacillin 87144.0000 Imipenem+Cilastatin 87145.0000 Kanamycin HP 87146.0000 Lincomycin 87147.0000 Lomefloxacin 87148.0000 Loracarbef 87149.0000 Lymecycline 87150.0000 Skin Test 87151.0000 Borrelia Burgdorferi 87152.0000 Meropenem 87153.0000 Borrelia Vincentii 87154.0000 TB Tine 87155.0000 Treponema carateum (pinta) 87156.0000 Tazobactam 87157.0000 Treponema pallidum (syphilis) 87158.0000 Neurogenic Viral Panel 87159.0000 Treponema pertenue (yaws) 87160.0000 Piperacillin+Tazobactam 87161.0000 Leptospira species NOS 87162.0000 Trichinella Ab 87163.0000 Spirochete NOS 87164.0000 Echinococcus Ab 87165.0000 Methacycline 87166.0000 Miocamycin 87167.0000 Mupirocin 87168.0000 Coccidiodes Ab 87169.0000 Coccidiodes Ag 87170.0000 Nalidixate 87171.0000 Ofloxacin 87172.0000 Oleandomycin 87173.0000 Mycoplama Ab 87174.0000 Oxytetracycline 87175.0000 Chlamydia Pneumoniae 87176.0000 Endotoxin 87177.0000 Chlamydia Psittaci 87178.0000 Pefloxacin 87179.0000 Penicillin G 87180.0000 Penicillin V 87181.0000 Phenethicillin 87182.0000 Chlamydia Trachomatis 87183.0000 Pepemidate 87184.0000 Pepercil+Tazobactam 87185.0000 Pivampicillin 87186.0000 Ristocetin 87187.0000 Chlamydia NOS 87188.0000 Rolitetracycline 87189.0000 Rosoxacin 87190.0000 Roxithromycin 87191.0000 Sparfloxacin 87192.0000 Lymphogranuloma venereum 87193.0000 Streptomycin HP 87194.0000 Sulfadiazine 87195.0000 Sulfisoxazole 87196.0000 Ataxia Profile 87197.0000 Mycoplasma NOS 87198.0000 Talampicillin 87199.0000 Mycoplasma pneumoniae 87200.0000 Teicoplanin 87201.0000 Misc Culture 8 87202.0000 Actinomyces species 87203.0000 Temafloxacin 87204.0000 Temocillin 87205.0000 Tetracycline 87206.0000 Ticarcillin+Cavulanate 87207.0000 Aspergillus species NOS 87208.0000 Helicobacter Pylorii 87209.0000 Trimethoprim+Sulfamethoxazole 87210.0000 Troleandomycin 87211.0000 Viomycin 87212.0000 Aspergillus Fumigatus 87213.0000 Zidovudine 87214.0000 Giardia Ag 87215.0000 Giardia Ab 87216.0000 Giardia Ag EIA 87217.0000 Blastomyces Dermatitidis 87218.0000 Misc Culture 9 87219.0000 Misc Culture 10 87220.0000 Misc Immuno Test 6 87221.0000 Misc Immuno Test 7 87222.0000 Candida Albicans 87223.0000 Misc Immuno Test 8 87224.0000 Misc Immuno Test 9 87225.0000 Misc Immuno Test 10 87226.0000 Streptomycin Synergy Scr 87227.0000 Candida species NOS 87228.0000 IgA Quant Cardiolipin 87229.0000 Congo Red Stain 87230.0000 Acanthamoeba Culture 87231.0000 IgG Quant Cardiolipin 87232.0000 Coccidioides Immitis 87233.0000 IgG Qual Cardiolipin 87234.0000 Adenovirus Ab 87235.0000 Adrenal Ab 87236.0000 Acid Fast Org ID 87237.0000 Cryptococcus Neoformans 87238.0000 Fontana Masson Stain 87239.0000 Brown Hopp Stain 87240.0000 Leptospira Ab 87241.0000 Leptospira Ag 87242.0000 Fungus NOS 87243.0000 Dengue Virus Ab 87244.0000 Voriconazole 87245.0000 Sjorgren Syndrome A 87246.0000 Sjorgren Syndrome B 87247.0000 Histoplasma capsulatum Mycelia 87248.0000 Cytomegalovirus Ag 87249.0000 Chlamydia Trachomatis DNA 87250.0000 Cardiolipin Ab Panel 87251.0000 Cardiolipin Ab 87252.0000 Histoplasma capsulatum Yeast 87253.0000 IgM Quant Cardiolipin 87254.0000 Hepatitis C EIA 87255.0000 IgM Qual Cardiolipin 87256.0000 IgA Qual Cardiolipin 87257.0000 Micropolyspora faeni 87258.0000 Herpes I&II 87259.0000 Sjorgren Syndrome A Quant 87260.0000 Sjorgren Syndrome B Quant 87261.0000 Influenza A&B 87262.0000 Paracoccidiodes Braziliensis 87263.0000 Axonal HMSN Eval 87264.0000 Platelet Associated Ab Dir 87265.0000 Platelet Associated Ab Ind 87266.0000 Herpesvirus-8 IgG 87267.0000 Saccharomonospora Viridis 87268.0000 Skin Dermal Epidermal Ab 87269.0000 Skin Intercellular Ab 87270.0000 Oxidase 87271.0000 Pipemidic Acid 87272.0000 Sporotrichum species 87273.0000 Pritstinamycin 87274.0000 Antibiotic NOS 87275.0000 Culture Clostridium Difficle 87276.0000 Cyclospora 87277.0000 Thermoactinomyces Candidus 87278.0000 Thermoactinomyces Candidus Ab 87279.0000 Mycobacterium Gordonea DNA 87280.0000 Mycobacterium Avium DNA 87281.0000 Neisseria Meninigitidis A 87282.0000 Thermoactinomyces Vulgaris 87283.0000 Misc Flow Test 1 87284.0000 Misc Flow Test 2 87285.0000 Misc Flow Test 3 87286.0000 Misc Flow Test 4 87287.0000 Misc Flow Test 5 87288.0000 Misc Flow Test 6 87289.0000 Misc Flow Test 7 87290.0000 Misc Flow Test 8 87291.0000 Misc Flow Test 9 87292.0000 Misc Flow Test 10 87293.0000 Staphlococcus Aures Meth Resis 87294.0000 Streptococcus Group A Scr 87295.0000 Sarcoptes Scabiei 87296.0000 Culture Vibrio 87297.0000 Viral Smear 87298.0000 CH100 87299.0000 Friedreich Ataxia Mutation 87300.0000 Parvovirus AB IgM 87301.0000 Varicella Zoster AB IgM 87302.0000 Amoeba NOS 87303.0000 Cryptosporidium 87304.0000 Extractable Nuclear Ab 87305.0000 Fluoxetine+Norfluoxetine 87306.0000 Diasialyl Ganglioside Ab IgG 87307.0000 Tetrasialyl Gangloside Ab IgG 87308.0000 Cysticercus 87309.0000 Hepatitis C Superoxidase Eis A 87310.0000 Myelin Associated Glycoprotein 87311.0000 Neural Thread Protein 87312.0000 Hepatitis C NS5 Ab 87313.0000 Echinococcus species 87314.0000 Linezolid 87315.0000 Parainfluenza 2 Ab 87316.0000 Parainfluenza 3 Ab 87317.0000 Entamoeba species NOS 87318.0000 Entamoeba Histolytica 87319.0000 Neisseria Gonorrhoeae DNA 87320.0000 Trypsinogen 87321.0000 Leishmania Braziliensis 87322.0000 Lieshmania Braziliensis IgG 87323.0000 Filaria species 87324.0000 Leishmania Braziliensis IgM 87325.0000 Leishmania Donovani 87326.0000 Leishmania Donovani IgG 87327.0000 Leishmania Donovani IgM 87328.0000 Microfilarial Ag 87329.0000 Leishmania Mexicana 87330.0000 Leishmania Mexicana IgG 87331.0000 Leishmania Mexicana IgM 87332.0000 Leishmania Tropicalis 87333.0000 Leishmania species NOS 87334.0000 Leishmania Tropicalis IgG 87335.0000 Leishmania Tropicalis IgM 87336.0000 Basement Membrane Ab Titer 87337.0000 Basement Membrane Zone 87338.0000 Parasite NOS 87339.0000 BCL 2 87340.0000 Intercellular Structure 87341.0000 Intercellular Structure Ab 87342.0000 Intercellular Structure Titer 87343.0000 Plasmodium species (malaria) 87344.0000 Hevea Brazil 87345.0000 Melas MT DNA Mutation 87346.0000 Hereditary Familial Hemochroma 87347.0000 HEF CYS 282 TRY Mutation 87348.0000 Schistosoma species 87349.0000 HEF HIS 63 ASP Mutation 87350.0000 PR Gene Mutation 87351.0000 Puumala Virus IgG 87352.0000 Puumala Virus IgM 87353.0000 Toxocara species 87354.0000 Prostrate Cancer Risk 87355.0000 Toxoplasma Gondii 87356.0000 RT Gene Mutation 87357.0000 Celiac Antibody Panel 87358.0000 Trichinella species NOS 87359.0000 Sulfatide ELISA IgM 87360.0000 Trypanosoma Cruzi 87361.0000 Sulfatide ELISA IgG 87362.0000 Trypanosoma Rhodesiensis 87363.0000 X25 87364.0000 Trypanosoma Gambiensis 87365.0000 X25 Allele1 87366.0000 Visceral Larval Migrans 87367.0000 X25 Allele2 87368.0000 Thyroid Stimulating Hormone Ab 87369.0000 Islet Cell Ag 87370.0000 Islet Cell Ab 87371.0000 Acanthamoeba Stain 87372.0000 Strongyloides Ab IgG 87373.0000 Cystic Fibrosis 87374.0000 Reticulin Ab 87375.0000 Smooth Muscle Ab 87376.0000 Arbovirus 87377.0000 Culture Varicella Zoster 87378.0000 Coxiella Burnetti 87379.0000 Herpes Virus VI 87380.0000 Rickettsia Akari 87381.0000 Influenza B Guandong 87382.0000 Rickettsia NOS 87383.0000 Influenza A Taiwan 87384.0000 Rickettsia Rickettsii 87385.0000 Influenza B Beijing 87386.0000 Rickettsia typhi (mooseri) 87387.0000 Intrinsic Factor Ag 87388.0000 Rickettsia Prowazekii 87389.0000 Pneumocystis 87390.0000 Rickettsia Tsutsugamushi 87391.0000 Precipitating Ab 87392.0000 Salmonella C H 87393.0000 Salmonella C O 87394.0000 Salmonella D O 87395.0000 Stain 87396.0000 Paraneoplastic Neuronal Ab 87397.0000 Hepatitis B e Ag 87398.0000 Hepatitis B e Ab 87399.0000 Endocrine Neoplasia Type 2 Mul 87400.0000 Cryptococcus Ag 87401.0000 Cryptococcus Ab 87402.0000 Adenovirus 87403.0000 Pregnancy Test 87404.0000 California Encephalitis 87405.0000 Hepatitis C Neutral 87406.0000 Colorado Tick Fever Virus 87407.0000 Viro Specimen 87408.0000 Corona Virus 87409.0000 Myco Specimen 87410.0000 Coxsackie A 87411.0000 Parasite Specimen 87412.0000 Coxsackie B 87413.0000 Rubeola Ab 87414.0000 Cytomegalovirus 87415.0000 Rubeola Ag 87416.0000 Dengue Fever Virus 87417.0000 Rubeola Ab Quant 87418.0000 Eastern Equine Encephalitis 87419.0000 X*Hepatitis C RNA 87420.0000 Echovirus 87421.0000 Viral Load 87422.0000 Epstein Barr Capsid Ag 87423.0000 HIV Viral Load Ultra 87424.0000 Epstein Barr Early Ag 87425.0000 VRE Culture 87426.0000 Epstein Barr Nuclear Ag 87427.0000 Epstein Barr 87428.0000 Hepatitis A 87429.0000 Epstein Barr Ag 87430.0000 Hepatitis B Core 87431.0000 Diasialyl Ganglioside Ab 87432.0000 Hepatitis B Delta 87433.0000 Diasialyl Ganglioside Ag 87434.0000 Hepatitis B e 87435.0000 Myeloperoxidase Ab 87436.0000 Hepatitis B Surface 87437.0000 Hepatitis C 87438.0000 Herpes simplex I 87439.0000 Hepatitis C Ag 87440.0000 Herpes simplex II 87441.0000 Myeloperoxidase Ag 87442.0000 Herpes zoster 87443.0000 Herpesvirus NOS 87444.0000 HTLV I 87445.0000 Chancroid Culture 87446.0000 HTLV II 87447.0000 Parvovirus B19 Ag 87448.0000 HIV 87449.0000 Phosphatidylserine Ab 87450.0000 Influenza A 87451.0000 Phosphatidylserine Ag 87452.0000 Influenza B 87453.0000 HEp 2 Cells ANA 87454.0000 Influenza C 87455.0000 Parvovirus B19 Ab 87456.0000 Japanese B Encephalitis 87457.0000 Mouse Kidney ANA 87458.0000 Lymphocytic Choriomeningitis 87459.0000 Mysoline Ab 87460.0000 Mumps Soluble 87461.0000 Mysoline Ag 87462.0000 Mumps Viral 87463.0000 Sarcolemma Ab 87464.0000 Papillomavirus 87465.0000 Sarcolemma Ag 87466.0000 Parainfluenza 87467.0000 Skeletal Muscle Ab 87468.0000 Poliomyelitis 87469.0000 Skeletal Muscle Ag 87470.0000 Q Fever Group 87471.0000 Arbovirus CALIF Titer 87472.0000 Reovirus 87473.0000 Arbovirus EEE Titer 87474.0000 Respiratory Syncytial Virus 87475.0000 Arbovirus SLE Titer 87476.0000 Rhinovirus 87477.0000 Arbovirus WEE Titer 87478.0000 Rotavirus 87479.0000 Clostridium Difficile Ag 87480.0000 Rubella 87481.0000 Clostridium Difficile Ab 87482.0000 Rubeola 87483.0000 Candida Complement Titer 87484.0000 St Louis Equine Encephalitis 87485.0000 Parvovirus Ab 87486.0000 Vaccinia 87487.0000 Histoplasmin Ag 87488.0000 Varicella Zoster 87489.0000 Histoplasmin Ab 87490.0000 Venezuelan Equine Encephalitis 87491.0000 Histoplasmin Titer 87492.0000 Virus NOS 87493.0000 HLA PRA 87494.0000 Yellow Fever 87495.0000 Influenza A Bangkok 87496.0000 Western Equine Encephalitis 87497.0000 Influenza A England 87498.0000 Influenza A Phillipine 87499.0000 Influenza A Singapore 87500.0000 Intrinsic Factor Ab 87501.0000 Bacteriology 87502.0000 Mycobacteriology 87503.0000 Mycology 87504.0000 Virology 87505.0000 Parasitology 87506.0000 Micro Misc 87507.0000 Thyperoxidase Ab 87508.0000 Aerobic Culture 87509.0000 Culture Fungus 87510.0000 Culture Chlamydia/GC 87511.0000 Blood Culture Manual 87512.0000 Blood Culture Automated 87513.0000 Gram Stain Blood Culture 87514.0000 Organism Identification Auto 87515.0000 Biochemical Test Automated 87516.0000 Organism ID MIC Automated 87517.0000 Body Fluid Culture Automated 87518.0000 Susceptibility MIC Automated 87519.0000 Brucella Abortus 87520.0000 Urine Bacterial Screen Automat 87521.0000 Org ID & Susceptibility Auto 87522.0000 Yeast ID Automated 87523.0000 Salmonella E 87524.0000 Bacteria Ag 87525.0000 Culture Mycobacteria 87526.0000 Culture Virus 87527.0000 Shell Vial (Spin) 87528.0000 Culture Aerobic&Anerobic 87529.0000 Culture Aerobic Routine 87530.0000 Accession Specimen Bac Cul 87531.0000 Planting 1 Pc Media Bact 87532.0000 Planting 2 Pc Media Bact 87533.0000 Planting 3 Pc Media Bact 87534.0000 Planting 4 Pc Media Bact 87535.0000 Planting 5 Pc Media Bact 87536.0000 Planting 6 Pc Media Bact 87537.0000 Planting 7 Pc Media Bact 87538.0000 Planting 8 Pc Media Bact 87539.0000 Culture Campylobacter 87540.0000 Planting each add Pc Bact 87541.0000 Culture Verotoxin E. Coli 87542.0000 Reading Bact Culture Sterile 87543.0000 Culture Yersinia 87544.0000 Reading Bact Cult Non sterile 87545.0000 Culture Group B Strep 87546.0000 Reading Bact Culture Any Spec 87547.0000 Specimen Preparation 87548.0000 Reading Bact Culture 2+ Org 87548.7038 Reading Bact Culture Sterile~M 87549.0000 Amebiasis 87550.0000 Recording & Reporting Bact 87551.0000 Ehrlichia Chaffeensi 87552.0000 Babesia Microti 87553.0000 Urine Culture 87554.0000 CSF Culture 87555.0000 Blood Culture 87556.0000 Wound Culture 87557.0000 Stool Culture 87558.0000 Nose/Throat Culture 87559.0000 Misc Culture 87560.0000 Environmental Culture 87561.0000 Pertussis Culture 87562.0000 Thermoactinomyces Viridis Ab 87563.0000 Q Fever Phase 1 Ab 87564.0000 Q Fever Phase 2 Ab 87565.0000 Bacteriology Susc 87566.0000 Culture HIV 1 Qual 87567.0000 Cefdinir 87568.0000 Mycobacterium Susc 87569.0000 Coccidioides IgG 87570.0000 Bacteriology Organism 87571.0000 HIV Genotype PCR 87572.0000 Hepatitis C Genotype PCR 87573.0000 Niemann Pick Type C 87574.0000 Tay Sach Dis Mutation 87575.0000 JC Virus 87576.0000 Parasite Organism 87577.0000 JC Virus Ab 87578.0000 Fungal Organism 87579.0000 Neural Tube Defect 87580.0000 Down Syndrome 87581.0000 Trisomy 87582.0000 Trisomy 18 87583.0000 Acid Fast Quantity 87584.0000 Bartonella quintana Ab IgM 87585.0000 Platelet Associated IgM 87586.0000 Lymphoma Phenotype 87587.0000 Fetoprotein Alpha Maternal 87588.0000 Acetylcholine Modulating Ab 87589.0000 Mycobacterium Organism 87590.0000 Viral Agent 87591.0000 Myocardium Ab 87592.0000 Neutrophil Oxidative Burst 87593.0000 Salmonella O 87594.0000 Culture Skin 87595.0000 Salmonella O Grp D 87596.0000 Salmonella Flg d 87597.0000 Salmonella Flg a 87598.0000 Salmonella Flg b 87599.0000 Salmonella O Grp A 87600.0000 Inoculation Blood culture 87601.0000 Salmonella O Grp B 87602.0000 Histoplasma Ag 87603.0000 Weil Felix Ag 87604.0000 Subculture Blood Culture 87605.0000 AFB Smear 87606.0000 HIV 1 Genotype (PRI) 87607.0000 HIV 1 Genotype (RTI) 87608.0000 Calcium VG Channel Ab 87609.0000 West Nile IgG 87610.0000 West Nile IgM 87611.0000 Culture HS Virus 87612.0000 Autologous Collection 87613.0000 SGPG Ag 87614.0000 West Nile Ab 87615.0000 ECHO 11 87616.0000 ECHO 30 87617.0000 ECHO 4 87618.0000 ECHO 6 87619.0000 ECHO 7 87620.0000 ECHO 9 87621.0000 Chlamydia Pneumoniae IgG 87622.0000 Chlamydia Pneumoniae IgA 87623.0000 Chlamydia Pneumoniae IgM 87624.0000 Chlamydia Trachomatis IgG 87625.0000 Chlamydia Trachomatis IgA 87626.0000 Chlamydia Trachomatis IgM 87627.0000 Chlamydia Psittaci IgG 87628.0000 Chlamydia Psittaci IgA 87629.0000 Chlamydia Psittaci IgM 87630.0000 HU Ab 87631.0000 HU Ab Western Blot 87632.0000 Aspergillus Niger 87633.0000 Aspergillus Flavus 87634.0000 Neiseria Meningitis B 87635.0000 Neisseria Meningitis C 87636.0000 Neisseria Meningitis Y 87637.0000 Neisseria Meningitis W135 87638.0000 Coxiella Burnetti 1 IgG 87639.0000 CD3-CD19+ Percent 87640.0000 Aspergillus Flavus Ab 87641.0000 Aspergillus Fumigatus Type 6 A 87642.0000 Thermoactinomyces Sacchri Ab 87643.0000 Human Papillomavirus 87644.0000 Diasialyl Ganglioside Ab IgM 87645.0000 Aspergillus Ab IgA 87646.0000 Aspergillus Ab IgG 87647.0000 Aspergillus Ab IgM 87648.0000 Brucella Brugneri 87649.0000 Brucella Interpretation 87650.0000 Organism Identification ID Kit 87651.0000 Brucella Canis 87652.0000 Burcella Pertussis 87653.0000 Candida Species Ag 87654.0000 CAR Associated Retinopathy Ab 87655.0000 Endomysial Ab IgA 87656.0000 Cysticerus Ab 87657.0000 Interferon Beta Ab IgG 87658.0000 PMP22 Gene Mutation 87659.0000 Sporotrichosis 87660.0000 Sporotrichosis Ab 87661.0000 Staphlococcus Aureus Toxin Ab 87662.0000 Staphlococcus Aureus Toxin 1 A 87663.0000 TSH Immunoglobulin Panel 87664.0000 TSH Immunoglobulin Index 87665.0000 Cytoplasmic Neutrophil Pattern 87666.0000 Culture Skin,Hair,Nails 87667.0000 Fungal Identification 87668.0000 Fungal ID Mold 87669.0000 Fungal ID Yeast 87670.0000 Bacteriology Organism ID 87671.0000 Bacteriology Organism Aerobic 87672.0000 Bacteriology Organism Anaerobi 87673.0000 DNA Probe Culture ID 87674.0000 Clostridium Difficile 87675.0000 Concentration Infectious Agent 87676.0000 Gatifloxacin 87677.0000 Moxifloxacin 87678.0000 Saccharomyces cerevisiae Ab Ig 87679.0000 Saccharomyces cerevisiae Ab Ig 87680.0000 Babesia Ab, Total 87681.0000 Babesia microti IgG 87682.0000 Babesia microti IgM 87683.0000 Babesia microti DNA PCR 87684.0000 SCA 7 Allele 1 87685.0000 SCA 7 Allele 2 87686.0000 HIV 1 Ab GP160 87687.0000 HIV 1 Ab GP120 87688.0000 HIV 1 Ab P66 87689.0000 HIV 1 Ab P65 87690.0000 HIV 1 Ab P51 87691.0000 HIV 1 Ab GP41 87692.0000 HIV 1 Ab P40 87693.0000 HIV 1 Ab P31 87694.0000 HIV 1 Ab P17 87695.0000 Arthropod Identification 87696.0000 Tick Identification 87697.0000 Cockroach Identification 87698.0000 Epstein Barr Nuclear Ab 87700.0000 Acridine Orange Stain 87701.0000 Digestion Decontam of Spec 87702.0000 Agglutination Slide 87703.0000 Anaerobic Jar Flushing 87704.0000 Autoclave Control Attest 87705.0000 Bactigen for Group B Strep 87706.0000 Biochemical Test Rapid 87707.0000 Bactigen Meningitis Panel 87708.0000 Conventional Micro Tube Test 87710.0000 Dark field Examination 87711.0000 Direct FA 87712.0000 Direct Fluorescent Ab 87713.0000 Disposal of Contaminated Matrl 87714.0000 Freezing Organisms 87715.0000 Gas Chromatography 1st inject 87716.0000 Gas Chromatography subs inj 87717.0000 Gas Pak or Biobag 87718.0000 Gram Stain Direct from Spec 87719.0000 Colony Count 87720.0000 Gram Stain Organism 87721.0000 Calcofluor White Stain 87722.0000 Autoclave Control Killet 87723.0000 Colony Count Fungal 87724.0000 Media Preparation 87725.0000 Monitoring Incubator CO2 87726.0000 Phadebac 87728.0000 Phenylalanine Blood Guthrie 87730.0000 Single Disc for Identification 87732.0000 Autoclave Control Spordex 87734.0000 Streptex 87736.0000 Subculture PBT 87737.0000 Strep Grp B Latex Agglut 87738.0000 Strep Grp B Enzyme Immun 87740.0000 Giardia Lamblia 87741.0000 Strongyloides 87742.0000 XV Strips for Haemophilus 87744.0000 Washing Bench Top 87745.0000 Biochemical ID 87746.0000 Abbreviated ID 87747.0000 Species ID 87748.0000 Species Typing 87749.0000 Biochemical ID + Sero 87750.0000 Organism ID MIC Combo Manual 87751.0000 Cellophane Tape Prep 87752.0000 Probe Test 87753.0000 Non-Immunologic ID 87754.0000 Gram Stain 87755.0000 Calcofluor Prep 87756.0000 Acid Fast Stain 87757.0000 Tzanck Prep 87758.0000 Giemsa Stain 87759.0000 Wet Prep w/o Iodine 87760.0000 Nucleic Acid Probe 87761.0000 Nucleic Acid Amplification 87762.0000 Darkfield 87763.0000 Agar Dilution 87764.0000 Diffusion Test 87765.0000 Disk Diffusion 87766.0000 Microtiter 87767.0000 Macrotube 87768.0000 Microtiter MBC 87769.0000 Macrotube MBC 87770.0000 Bactericidal Serum 87771.0000 Nuclear Molecular Diag 87772.0000 Enzymatic Digestion 87773.0000 Interpretation and Report 87799.0000 DNA Probe 87800.0000 Accession Specimen Mycol Cult 87801.0000 Planting 1 Pc Media Mycol 87802.0000 Planting 2 Pc Media Mycol 87803.0000 Planting 3 Pc Media Mycol 87804.0000 Planting 4 Pc Media Mycol 87805.0000 Planting each add Pc Mycol 87806.0000 Culture Urea Plasma 87810.0000 Reading Mycology Culture 87820.0000 Recording & Reporting Mycol 87830.0000 Germ Tube 87832.0000 Mycology Slide Test 87834.0000 Yeast Carbohydrate Assimil 87836.0000 Yeast Morphology Agar 87850.0000 Accession Specimen Mycob 87851.0000 Planting 1 Pc Media Mycobact 87852.0000 Planting 2 Pc Media Myco 87853.0000 Planting 3 Pc Media Myco 87854.0000 Planting 4 Pc Media Myco 87856.0000 Planting each add Pc Myco 87860.0000 Reading Mycobact Culture 87870.0000 Recording & Reporting Mycobac 87885.0000 Mycobacteriology Stains 87886.0000 Cryptosporidium Spec Stain 87888.0000 Arysulfatase 3 Day 87889.0000 TCH Sensitivity for Microact 87890.0000 Blastomyces Ab 87891.0000 Catalase 87892.0000 Sodium Chloride Tolerance 87893.0000 Niacin Test 87894.0000 Nitrate Reduction 87895.0000 Photochromogenicity Test 87896.0000 Growth on MacConkey Agar 87897.0000 Tellurite Reduction 87898.0000 Tween Hydrolysis 87899.0000 Susceptibility Test Mycobact 87900.0000 Accession Specimen Parasitic E 87901.0000 Candida Species Ab 87902.0000 Fetoprotein Alpha Tumor 87903.0000 Micorsporidia Spore 87904.0000 GM1 IgA 87905.0000 Myelin Ab 87906.0000 Sulfatide Ab 87907.0000 p53 Tumor Suppressor Gene 87910.0000 Recording & Reporting Parasit 87920.0000 Concentration of Specimen Para 87925.0000 Parasitology Examination 87930.0000 Parasitology Stain 87942.0000 Extraction of Organism Ag 87943.0000 TB Specimen 87944.0000 Heat inactivation 87945.0000 Sputum Liquification 87946.0000 Tissue Grinding 87947.0000 Culture Herpes 87948.0000 Anaerobe Suscept Test Disk Elu 87949.0000 Culture Mycoplasma Pneumoniae 87950.0000 Antimicrobic Assay 87951.0000 Antimicrobic Assay tube 87952.0000 Bactericidal Activity 87953.0000 Hepatitis C Genotyping 87954.0000 Sensitivity Testing or MIC 87956.0000 Sensitivity Testing Broth 87958.0000 Sensitivity Testing Kirby 87960.0000 Accession Specimen for Viral C 87964.0000 Parvovirus B19 87965.0000 Recording & Reporting Viral Cu 87966.0000 Media Prep Basal Medium 87967.0000 Media Prep Each Additive 87968.0000 Media Prep Basal Medium (500m 87969.0000 Virus Specimen Collection 87970.0000 Tzanck Test Viral Inclusions 87971.0000 Shell Vial Technique 87972.0000 Decontamination of Specimen 87973.0000 Viral Neutralization 87974.0000 Tissue Culture Feeding 87975.0000 Cytomegalovirus Culture 87976.0000 Tissue Culture Passage 87978.0000 Tissue Culture Reading 87980.0000 Tissue Culture Specimen 87982.0000 Tissue Culture Viral 87984.0000 Clostridium Difficile Toxin A 87985.0000 Report Microbiology 87986.0000 Fluconazole MIC 87987.0000 Thermocatinomyces Sacchari 87988.0000 Chlamydia T + Neisseria G DNA 87989.0000 Thermoactinomyces Vulgaris Ab 87990.0000 Anerobe Identification 87991.0000 Micro Smear Prep 87992.0000 Micro Serology 87993.0000 Micro Bacteriology Culture 87994.0000 Micro Mycology Culture 87995.0000 Micro Mycobacterium Culture 87996.0000 Micro Virology Culture 87997.0000 Micro Non Billable 87998.0000 Micro Anerobic Culture 87999.0000 Micro Misc Culture 88000.0000 SP Specimen 88001.0000 Alcoholic Hyaline Stain G3 88002.0000 Amido Black Hemoglobin Stain 88003.0000 Amyloid Stain Group1 88004.0000 Argentaffin Stain 88005.0000 Bielschowsky Stain Group 6 88006.0000 Bile Stain or Gmelin Stain 88007.0000 Bodian Stain Group2 88008.0000 Bowie Juxt Glom Stain 88009.0000 Calcium Stain Group1 88010.0000 Cone and Penfield Stain 88011.0000 Connective Tissue Masson 88012.0000 Crystal Violet Stain 88013.0000 DNA Feulgin Stain 88014.0000 Elastic Tissue Verhoeff Stain 88015.0000 Enzymes Stain Group3 88016.0000 Fat Neutral Nile Blue 88017.0000 Fatty Acid Fischler Stain 88018.0000 Acid Fast Incl Auromine O 88019.0000 Acridine Orange Fungus Stain 88020.0000 Fungus Gridley Stain 88021.0000 Fungus Silver Stain Group3 88022.0000 Giemsa Stain Group1 88023.0000 Glees and Marsland Stain 88024.0000 Glycogen Stain Group2 88025.0000 Gram Stain Group2 88026.0000 Halls Stain Group1 Anat 88027.0000 Hemosiderin Stain Group1 88028.0000 Holmes Stain Group4 88029.0000 Holzer Stain Group4 88030.0000 Mucin Mucicrum PAS or Alcian 88031.0000 Russell MOVAT Mod 88032.0000 Lendrums Phloxrin Tartrazine S 88033.0000 Lipofuscin Stain Group2 88034.0000 Manns Stain Group2 88035.0000 Masson Trichrome Stain 88036.0000 Mast Cells Stain Group1 88037.0000 Melanin Stain Group 88038.0000 PAS ALCIAN BLUE 88039.0000 Myelin Heidenhain Stain 88040.0000 Autopsy Attendant 88041.0000 Myelin Luxol Fast Blue Stain 88042.0000 Myelin Marchi Stain 88043.0000 PTAH Stain Group1 88044.0000 PAS STAIN 88045.0000 Initial Handling Clerical Aut 88046.0000 Oil Red O Stain Group2 88047.0000 Orcein Giemsa Stain Group3 88048.0000 Spirochete Silver Stain 88049.0000 PTAH Neuropath Stain Group2 88050.0000 Sections Paraffin Aut compl 88051.0000 Reticulin Stain Group3 88052.0000 Romanes Stain Group3 88053.0000 Saffron Stain Group2 88054.0000 Unna Pappenheim Stain Group1 88055.0000 Sections Paraffin Aut Slide 88056.0000 CY Specimen 88057.0000 EM Specimen 88058.0000 Immunoperoxidase Stain 88059.0000 Immunofluorescence Stain 88060.0000 Sections Paraffin Aut (Cut) 88061.0000 Misc AP Test 1 88062.0000 Misc AP Test 2 88063.0000 Misc AP Test 3 88064.0000 Misc AP Test 4 88065.0000 Misc AP Test 5 88066.0000 Instrument AP Setup 88067.0000 Unstained Slide 88068.0000 Calreticulin 88069.0000 Cytokeratin 2D 88070.0000 Tissue Culture 88071.0000 Consultation and Report 88072.0000 Picornavirus 88073.0000 Filarial Ab 88074.0000 Leishmania Donovani Ab 88075.0000 Phosphoserine 88076.0000 Smith Ab 88077.0000 HLA A3 88078.0000 English Plantain 88079.0000 English Plantain IgE 88080.0000 Agar Dilution E Test 88081.0000 HFE C282Y 88082.0000 HFE H63D 88083.0000 Ribonucleoprotein Ab 88084.0000 Polio Type 1 Ab 88085.0000 Polio Type 1 Ag 88086.0000 Polio Type 2 Ag 88087.0000 Polio Type 2 Ab 88088.0000 Polio Type 3 Ab 88089.0000 Polio Type 3 Ag 88090.0000 Latex IgE 88125.0000 Forensic Cytopathology 88150.0000 PAP Smear 88151.0000 PAP Thin Prep Cyto Interp 88152.0000 PAP Thin Prep Phy Interp 88160.0000 Hormonal Evaluation Cytology 88161.0000 Sperm Isolation 88190.0000 Slides Cytology Preparation 88191.0000 Smear Cyto Prep Pick&Smear 88192.0000 Smear and or Cell Block Cytol 88200.0000 Electron Micro Preparation 88202.0000 Electron Micro Embedding 88204.0000 Electron Micro Scan and Photo 88206.0000 Electron Micro Thick Section 88208.0000 Electron Micro Thin Section 88230.0000 Chromosome Karyotype Amni Comp 88231.0000 Chromosome Karyotype Amniot 88232.0000 Chromosome Karyotype Per Blood 88233.0000 Chromosome Karyotype Peri Bl 88234.0000 Chromosome Karyotype BM Leuk 88235.0000 Chromosome Karyotype Bone Mar 88236.0000 Chromosome Karyotype Tiss 1st 88237.0000 Chromosome Karyotype Tissue 88238.0000 Chromosome Karyotype Tiss Com 88239.0000 Chromosome Karyotype AST 88240.0000 Fine Needle Aspirate 88241.0000 Chromosome Karyotype 88244.0000 PAI Genetics 88245.0000 Sex Chromatin Smears 88257.0000 Autoradiography 88282.0000 Cystine Urine 88300.0000 Stain Group1 88305.0000 Stain Group2 88306.0000 Brown & Brenin Stain 88307.0000 C Schenk Stain 88308.0000 Iron Stain Colloidal 88309.0000 Fite Stain 88310.0000 Stain Group3 88311.0000 Mallory Heidenhaim Stain 88312.0000 Mallory Collagen Stain 88313.0000 Methyl Green Stain 88314.0000 Maxwell Stain 88315.0000 Stain Group4 88316.0000 Papanicolaou Stain 88317.0000 Wilson Ezrin Stain 88318.0000 Pentachrome Movat Stain 88319.0000 Mucicarmine Stain 88320.0000 Stain Group5 88321.0000 Warthin Starry Stain 88322.0000 Myeloperoxidase Stain 88325.0000 Stain Group6 88326.0000 Stain Only H & E 88327.0000 Steiner Stain 88328.0000 B72.3 88329.0000 Ber-Ep4 88330.0000 GCDFP-15 88331.0000 Properdin 88332.0000 Dieterle Stain 88333.0000 Steiner&Steiner 88343.0000 Case Review Surg or Autopsy 88344.0000 Case Review Cytology 88350.0000 Frozen Section Rush Dx 88353.0000 Frozen Section Add Rush Block 88354.0000 Frozen Section Not Rush 88355.0000 Frozen Section Add Section 88356.0000 Body Brushing 88357.0000 Body Fluid Exam 88358.0000 Washing Fluid Exam 88360.0000 Frozen Section Add Cut 88363.0000 Sections Plastic Complete 88365.0000 Sections Paraffin SP Cut 88366.0000 Thyroid Transcription Factor 88375.0000 Tissue Processing Plastic Emb 88410.0000 Chromosome Karotype Stimulated 88420.0000 Decalcification Tissue 88430.0000 Photographs Gross Specimen 88435.0000 Photography Print Enlarge 88493.0000 Temperature Patient 88499.0000 Scanning EM Analysis 88500.0000 Gross Surgical Description Lev 88501.0000 Gross Surgical Tech Assistance 88502.0000 Tissue Preparation 88503.0000 Gross & Microscopic Pathology 88504.0000 Interpretation CytoPath 88505.0000 Cytopathology Procedures NOS 88506.0000 Buccal Smear 88507.0000 Consultation Referred Slides 88508.0000 Consultation Referred Specimen 88509.0000 Stain Cytology Extended 88510.0000 Pathology Surgery Consult 88511.0000 Gross & Microscopic Pathology 88512.0000 Gross & Microscopic Pathology 88513.0000 Gross & Microscopic Pathology 88514.0000 Gross & Microscopic Pathology 88515.0000 Surgical Pathology Procedures 88516.0000 Homogenization Tissue 88517.0000 Tissue Preparation Drug 88518.0000 Surgical Pathology Level II 88520.0000 Surgical Path Init Handling 88522.0000 Transcription File Search Retr 88524.0000 Transcription Report Prep only 88526.0000 Transcription Report Disp 88528.0000 Sections Paraffin Surg Path 88529.0000 Autopsy Gross Only 88530.0000 Stain H&E Automated 88531.0000 Autopsy Complete w/o Brain 88532.0000 Autopsy Complete with Brain 88533.0000 Autopsy Complete with Brain/CN 88534.0000 Autopsy Limited 88535.0000 Sections Diagnostic Thick 88536.0000 Sections Thin EM 88537.0000 Fine Needle Consult 88538.0000 Cytogenetic 88539.0000 Specimen 88540.0000 History 88541.0000 Clinical History 88542.0000 Brief Clinical History 88543.0000 Diagnosis 88544.0000 Diagnosis PreOp 88545.0000 Findings 88546.0000 Findings PreOp 88547.0000 Findings PostOp 88548.0000 Description 88549.0000 Description Gross 88550.0000 Initial Handling Cytology (Gyn 88551.0000 Surgical Pathology Level I 88552.0000 Initial Handling Cyto (Non Gyn 88553.0000 Surgical Pathology Level III 88554.0000 Stain Cytology Routine 88555.0000 Surgical Pathology Level IV 88556.0000 Stain Cyto Membrane Filt Prep 88557.0000 Surgical Pathology Level V 88558.0000 Stain Cyto Rapid Pap or H&E 88559.0000 Surgical Pathology Level VI 88560.0000 Stain Cyto Romanowski Diff Qui 88561.0000 Cytology Misc 88562.0000 File Search Update Cytology 88563.0000 Description Micro 88564.0000 Report Record File Cytology 88565.0000 Section 88566.0000 Cell Block Cytology 88567.0000 Cocciddioides IgM 88568.0000 Smear Cyto Prep of Spec Saccom 88569.0000 Frozen Section 88570.0000 Smear Cyto Prep of Fluid Centr 88571.0000 Diagnosis Pathology 88572.0000 Smear Cyto Cytocentrifugation 88573.0000 Report Pathology 88574.0000 Smear Cyto Simple Special Proc 88575.0000 Report Preliminary 88576.0000 Smear Cyto Complicated Sp Proc 88577.0000 Cytology Smear GYN 88578.0000 Screen Cyto Tech Interp Neg Gy 88579.0000 Cytology Smears 88580.0000 Screen Cyto Tech Interp Abn Gy 88581.0000 Nerve Tissue 88582.0000 Screen Cyto Tech Interp Memb F 88583.0000 Report Final 88584.0000 Screen Cyto NonGyn CMC<50% 88585.0000 Report Amended 88586.0000 Screen Cyto NonGyn CMC>50% 88587.0000 Report Partial 88588.0000 Screen Cyto Tech Interp Cell B 88589.0000 Report Supplemental 88590.0000 Screen Cyto Tech Interp Sp St 88591.0000 Diagnosis PostOp 88592.0000 Screen Cyto Tech. Interp. Sp. 88593.0000 Report Cytology 88594.0000 Differential Cell Count Cyto 88596.0000 Screen Cyto Rescreen Neg Gyn ( 88597.0000 Report Electron Microscopy 88598.0000 Report Histology 88599.0000 FISH Interphase 88601.0000 Report Immunology 88602.0000 Report Laboratory 88603.0000 Consultation and Report, Compr 88605.0000 Cell Block Any Source 88606.0000 Autopsy Single Organ 88607.0000 Autopsy Forensic Exam 88608.0000 Autopsy Exam NOS 88609.0000 Cytology Smear GYN Auto Thin M 88610.0000 Cytology Smear GYN Phy Interp 88612.0000 Cytology Smear non GYN <5 Slid 88613.0000 Cytology Smear non GYN >5 Slid 88615.0000 Sudan Black Stain 88616.0000 Fine Needle Aspirate Deep Guid 88617.0000 Estrogen/Progesterone Receptor 88618.0000 Coxsackie 88619.0000 Sacchromyces 88620.0000 Sacchromyces Ab 88621.0000 Sperm Ab 88622.0000 Sacchromyces Cerevisiae Ab 88623.0000 Spinocerebellar Ataxia 2 88624.0000 Proline Beta Alanine 88625.0000 Machado Joseph Disease 88626.0000 Myelin Associated Glycoprotein 88627.0000 Fascio Scapulo Humoral Dystrop 88628.0000 Creutzfeldt Jakob Disease 88629.0000 Echovirus 6 Ab 88630.0000 Echovirus 7 Ab 88631.0000 Ethidium Monoazide 88632.0000 Rast Profile 88633.0000 Pork 88634.0000 Wheat Bran Ab IgG 88635.0000 Milk (cow) 88636.0000 Milk (cow) Ab IgG 88637.0000 Wheat 88638.0000 Corn 88639.0000 Peanut 88640.0000 Soybean 88641.0000 Beef 88642.0000 Fish/Sea Food 88643.0000 Shell Fish 88644.0000 Fish/Shell 88645.0000 Egg 88646.0000 Egg White 88647.0000 Spinocerebellar Ataxia 3 88648.0000 Spinocerebellar Ataxia 7 88649.0000 Egg White Ab IgG 88650.0000 Bladder Tumor 88651.0000 Borrelia Pertussis 88652.0000 Leptospira Australis 88653.0000 Leptospira Australis Ab 88654.0000 Presenilin 1 Allele1 88655.0000 Presenilin 1 Allele2 88656.0000 Streptococcus Pneumoniae 1 88657.0000 Streptococcus Pneumoniae 2 88658.0000 Streptococcus Pneumoniae 19 88659.0000 Streptococcus Pneumoniae 14 88660.0000 Streptococcus Pneumoniae 23 88661.0000 Streptococcus Pneumoniae 51 88662.0000 IgG Subsets 2 88663.0000 IgG Subsets 3 88664.0000 Echovirus 2 Ab 88665.0000 Echovirus 3 Ab 88666.0000 Echovirus 8 Ab 88667.0000 Echovirus 16 88668.0000 Fitzgerald Factor 88669.0000 Fine Needle Aspirate Pathologi 88670.0000 PAS Stain Micro 88671.0000 Orcein Giemsa Stain Micro 88672.0000 Giemsa Stain Micro 88673.0000 Fite Stain Micro 88674.0000 Cytology Smear Any Source 88675.0000 Cytology Smear Auto Rescreen b 88676.0000 Cytology Smear Computer Rescre 88677.0000 Cytology Smear Auto Man/Comput 88678.0000 Cytology Smear Auto by Phy 88679.0000 Cytology Smear Auto/Man Rescr 88680.0000 Cytology Smear Bethesda Rescr 88681.0000 Cytology Smear Bethesda Rescr 88682.0000 Cytology Smear Bethesda Rescr 88683.0000 GD1B Elisa 88684.0000 GQ1B Elisa 88685.0000 Sensorimotor Neuropathy Profil 88686.0000 Beta 2 Glycoprotein IgG Ab 88687.0000 Beta 2 Glycoprotein IgA Ab 88688.0000 Beta 2 Glycoprotein IgM Ab 88689.0000 EGFR-Paraffin 88690.0000 ER-IHC/Paraffin 88691.0000 PR-IHC/Paraffin 88692.0000 Micropolyspora faeni Ab 88693.0000 Aspergillus pullulans Ab 88694.0000 Toxoplasma IgG Ab, CSF 88695.0000 Toxoplasma IgM Ab, CSF 88696.0000 Spinocerebellar Ataxia 8 88697.0000 Spinocerebellar Ataxia 10 88698.0000 DRPLA DNA 88757.0000 Cytology Smear non GYN 88885.0000 Misc Stain 4 88886.0000 Misc Stain 5 88887.0000 Misc Stain 6 88888.0000 Misc Stain 7 88889.0000 Misc Stain 8 88890.0000 Misc Stain 9 88891.0000 Misc Stain 10 88978.0000 Febrile Agglutinins Panel 88979.0000 St Louis Equine Encephalitis I 88980.0000 St Louis Equine Encephalitis I 88981.0000 La Crosse Virus IGM 88982.0000 La Crosse Virus IGG 88983.0000 La Crosse Virus Ab 88984.0000 Eastern Equine Encephalitis IG 88985.0000 Eastern Equine Encephalitis IG 88986.0000 Dengue Virus Ab IGM 88987.0000 Dengue Virus Ab IGG 88988.0000 Galop Auto Ab 88989.0000 HIV 2 88990.0000 HIV Quant 88991.0000 HIV Qual 88992.0000 Herpes Virus VI IgG IgM 88993.0000 Rubella Titer 88995.0000 APC GENE MUTATION 88996.0000 Complement Total 88997.0000 Hepatitis G Ab 88998.0000 Charcot Marie Tooth Profile 88999.0000 Interferon Alpha Receptor 89000.0000 Surface Marker Leu9 89001.0000 Surface Marker B4 89002.0000 Surface Marker My10 89003.0000 Surface Marker KC56 89004.0000 Neutrophil Cytoplasm 89005.0000 Farmer's Lung 89006.0000 Histone 89007.0000 Hypersensitivity Aspergillus 89008.0000 Hypersensitivity Pneumonitis 89009.0000 Alpha Pituitary G Hormone 89010.0000 Alpha1 Antitrypsin Clearance 89011.0000 Anti Adrenal Ab 89012.0000 Anti Dnase B 89013.0000 DS DNA Ab 89014.0000 Anti Single Stranded DNA 89015.0000 Anti Thyroglobulin Ab 89016.0000 Anti Diuretic Hormone 89017.0000 Antineuronal Nuclear Ab 89018.0000 Anti Streptolysin O 89019.0000 Aspergillus Complement Titer 89020.0000 Blastomyces Complement Titer 89021.0000 Legionella IFA Ab 89022.0000 Coccidiodes Complement Fix 89023.0000 Complement C9 89024.0000 Febrile Agglutinins 89025.0000 GM1 Autoantibody 89026.0000 Immunocytochemistry 89027.0000 Legionella Ag 89028.0000 Lupus Anticoagulant 89029.0000 Lyme Disease 89030.0000 Measles Rubeola titer 89031.0000 Monospot Screen 89032.0000 Polymyositis Ab 89033.0000 Purkinje Cell Ab 89034.0000 Rocky Mountain Spotted Fever 89035.0000 Tetanus Ab EIA 89036.0000 Tularmia Agglutination 89037.0000 Typhus Ab Titer 89038.0000 Anti Microsomal Ab 89039.0000 Anti Nuclear Ab 89040.0000 Oligoclonal bands 89041.0000 Psittacosis 89042.0000 Endomysial Ab 89043.0000 Surface Marker CD30 89044.0000 Surface Marker CD15 Leu M1 89045.0000 Surface Marker CD11c 89046.0000 Anti Myocardial Ab 89047.0000 Surface Marker CD25 89048.0000 Surface Marker FMC-7 89049.0000 Anti Mitochrondrial Ab 89050.0000 Cell Count Body Fluid 89051.0000 Cell Count with Film 89052.0000 Anti Parietal Cell Ab 89053.0000 Anti Glomerular Basement Membr 89054.0000 Anti Smooth Muscle Ab 89055.0000 Anti Cardiolipin Ab 89056.0000 Anti Viral Ab 89057.0000 Anti Skin Ab 89058.0000 Histone Reaction Ab 89059.0000 Diptheria Antitoxoid ELISA 89060.0000 Pneumococcal IgG Vaccine Respo 89061.0000 Tetanus Antitoxoid ELISA 89062.0000 HLA DR2 89063.0000 Legionella Urinary Ag 89064.0000 Hepatitis A Ab 89065.0000 Hepatitis B Core Ab 89066.0000 Hepatitis B Core Ag 89067.0000 Hepatitis B Surface Ab 89068.0000 Hepatitis B Surface Ag 89069.0000 Hepatitis B Virus DNA 89070.0000 Hepatitis C Ab 89071.0000 HIV Ag 89072.0000 HIV Ab 89073.0000 CA-15-3 89074.0000 MAG Autoantibody 89075.0000 Protein S activity 89076.0000 Protein S, Total 89077.0000 Protein S, free 89078.0000 RAST test 89079.0000 Acetylcholine REC Blocking Ab 89080.0000 Acetylcholine receptor 89081.0000 T cell subsets 89082.0000 Cell surface markers 89083.0000 Hepatitis A IgM Ab 89084.0000 Immunodiffusion, histoplasmosi 89085.0000 Immunodiffusion, aspergillosis 89086.0000 Immunodiffusion, blastomycosis 89087.0000 Immunodiffusion, candidiosis 89088.0000 Immunodiffusion, coccidiodiosi 89089.0000 EIA Clostridium diff tox A or 89090.0000 Latex agglut Clostridium diffi 89091.0000 Direct FA, Chlamydia trachomat 89092.0000 EIA, Chlamydia trachomatis 89093.0000 Hepatitis B, early Ab 89094.0000 Hepatitis B, early Ag 89095.0000 Hepatitis B core IgM Ab 89096.0000 FTA ABS 89097.0000 MHA TP 89098.0000 HIV 1 by EIA 89099.0000 HIV 1 by Western Blot 89100.0000 HIV 1 by IFA 89101.0000 HIV 1 P24 Ag by EIA 89102.0000 HTLV 1 Ab by EIA 89103.0000 Lymes Ab by EIA 89104.0000 Lymes Ab by IFA 89105.0000 Nordoxepin done by GC 89106.0000 Rapid Plasma Reagin 89107.0000 Pneumococcal Ab 89108.0000 Rabies Ab 89109.0000 Poliovirus Ab 89110.0000 Drug Dependent Ab 89111.0000 Mumps Immune Status 89112.0000 Chlamydia Titer 89113.0000 Helicobacter pylori Serology 89114.0000 Antitrypsin alpha 1 phenotype 89115.0000 Heparin dependent Ab 89116.0000 Viral serology panel 89117.0000 Striated Muscle Ab 89118.0000 Misc Immuno Test 1 89119.0000 Misc Immuno Test 2 89120.0000 Misc Immuno Test 3 89121.0000 Misc Immuno Test 4 89122.0000 Misc Immuno Test 5 89123.0000 Instrument IM Setup 89124.0000 Hepatitis C RNA by PCR 89125.0000 Myasthenia Gravis Panel 89126.0000 Heparin dependent Platelet Ab 89127.0000 Hepatitis B Delta Ab, IgG 89128.0000 Hepatitis B Delta Ab, IgM 89129.0000 Hepatitis B Delta Ag 89130.0000 Gastric Contents 89131.0000 Toxoplasma Ab CSF 89132.0000 Toxoplasma Ab IgG 89133.0000 Toxoplasma Ab IgM 89134.0000 Sulfatide Autoantibody 89135.0000 DNA Ploidy 89136.0000 Hantavirus 89137.0000 Multiple Sclerosis Panel 89138.0000 Complement C3/C4 Panel 89139.0000 Immunogloblin Panel NOS 89140.0000 Report Delivery 89141.0000 Interleukin 6 Receptor 89142.0000 Report Charting 89143.0000 Gowning Degowning 89144.0000 Specimen Rejection 89145.0000 Gowing Degowing Only 89146.0000 Surface Marker Panel 89147.0000 Gluten Sensitivity Eval 89148.0000 Hepatitis Immuno Panel 89149.0000 Varicella Immune Status 89150.0000 Gloving Degloving 89151.0000 Hepatitis A, IgG Ab 89152.0000 Kappa/Lambda Ratio 89153.0000 Candida Precipitan Ab titer 89154.0000 FMC7 89155.0000 VDRL 89156.0000 Hepatitis E Ab 89157.0000 Hepatitis E Ag 89158.0000 Sjorgren's Ab 89159.0000 Sjorgren's Ag 89160.0000 Ribonucleic Protein Ab 89161.0000 Ribonucleic Protein Ag 89162.0000 Serology Specimen 89163.0000 Immuno Specimen 89164.0000 Flow Specimen 89165.0000 Sp Flow Specimen 89166.0000 Ehrlichosis Ab 89167.0000 Hemophilus Influenza 89168.0000 Ehrlichiosis Ag 89169.0000 TdT 89170.0000 HTLVI 89171.0000 TORCH Ab Panel 89172.0000 HTLVII 89173.0000 HTLVI/HTLVII 89174.0000 Brucella Ab 89175.0000 Herpes Ab 89176.0000 Helicobacter pylori Ab 89177.0000 Leishmania Ab 89178.0000 Listeria Ab 89179.0000 Skin Test NOS 89180.0000 HIV 1 RNA Quant 89181.0000 Tetanus Ab 89182.0000 Diptheria Ab 89183.0000 Toxoplasma Ab 89184.0000 CD14/CD45 89185.0000 CD2/CD20 89186.0000 CD19/CD10 89187.0000 CALLA 89188.0000 CD19/CALLA 89189.0000 CD3/CD8 89190.0000 CD3/CD4 89191.0000 CD19/CD5 89192.0000 CD22/CD3 89193.0000 CD10/CD34 89194.0000 CD7/CD13/CD33 89195.0000 Flow Cytometry 89196.0000 Fasciola Hepatica Ab 89197.0000 Anti Nuclear Ab Quant 89198.0000 Lyme Ab Quant 89199.0000 Immunoglobulin Heavy Chain Gen 89200.0000 HCV Ab Quant 89201.0000 Lyme Ab 89202.0000 Lyme Ab IgG 89203.0000 Lyme Ab IgG Quant 89204.0000 Lyme Ab IgM 89205.0000 Lyme Ab IgM Quant 89206.0000 Rubella Ab 89207.0000 Rubella Ab Quant 89208.0000 Extractable Nuclear Ag RNP Qua 89209.0000 Extractable Nuclear Ag Sci 70 89210.0000 Extractable Nuclear Ag Sm Qt 89211.0000 Mycoplasma Pneumoniea Ab IgG 89212.0000 Mycoplasma pneumoniae Ab IgM 89213.0000 Streptozyme Qt 89214.0000 Leukemia Panel Acute 89215.0000 Leukemia Panel Chronic 89216.0000 Leukemia Panel Hairy 89217.0000 Cancer Ag 27.29 89218.0000 Pneumonititis Hypersensitivity 89219.0000 Gardnerella Vaginalis 89220.0000 Scleroderma Ab Quant 89221.0000 Streptozyme Ab Quant 89222.0000 T Cell Receptor 89223.0000 Beta 2 Glycoprotein 1 Ab 89224.0000 Western Blot 89225.0000 HIV Genotype 89226.0000 Complexed Prostate Specific Ag 89227.0000 Varicella Rapid Culture 89228.0000 HCV Genotyping 89229.0000 Cell Viability 89230.0000 Fat Stain 89231.0000 Tumor Necrosis Factor 89232.0000 HIV 1 Proviral DNA PCR 89233.0000 Toxoplasmosis Ab, IgA&IgM 89234.0000 Proteinase 3 Ab 89235.0000 HIV 1 and HIV 2 89236.0000 HIV 1 89237.0000 Epstein Barr Ab IgG 89238.0000 Signal Recognition Particle Au 89239.0000 Epstein Barr Ab IgM 89240.0000 Proliferating Cell Nuclear Ab 89241.0000 Herpes Virus VI IgG 89242.0000 Herpes Virus VI IgM 89243.0000 Centromere Ab 89244.0000 von Hippel Lindau 89245.0000 T Cell Receptor Alpha 89246.0000 T Cell Receptor Beta 89247.0000 T Cell Receptor Gamma 89248.0000 T Cell Receptor Delta 89249.0000 Centromere Ab Titer 89250.0000 GM1 IgG 89251.0000 Asialo GM1 IgG 89252.0000 GM1 IgM 89253.0000 Asialo GM1 IgM 89254.0000 GM1 Panel 89255.0000 X*Hypersensitive Pneumonitis 89256.0000 Neocerebellar Degeneration Pro 89257.0000 HCV 5-1-1 Ab 89258.0000 HCV C33C Ab 89259.0000 HCV C22-3 Ab 89260.0000 HCV NS5 Ab 89261.0000 HCV RIBA Panel 89262.0000 HCV Panel Interp 89264.0000 Lyme Ab IgG/IgM 89265.0000 Microspordin Stain 89266.0000 Mumps Ab 89267.0000 Mumps Ab IgM 89268.0000 CD3/CD16*CD56 89269.0000 Basement Membrane 89270.0000 Basement Membrane Ab 89272.0000 CD20 Percent 89273.0000 Lymphocyte B 89274.0000 Lymphocyte T Percent 89275.0000 CA 27 29 89276.0000 CA 72-4 89277.0000 CD2 Percent 89278.0000 CD3-CD16+CD56+ Absolute 89279.0000 CD3-CD16+CD56+ Percent 89280.0000 Echovirus 4 Ab 89281.0000 Echovirus 9 Ab 89282.0000 Echovirus 11 Ab 89283.0000 Echovirus 30 Ab 89284.0000 Galop Ab 89285.0000 Hepatitis C Band c100-3 89286.0000 Hepatitis C Band c22p 89287.0000 Hepatitis C Band hSOD 89288.0000 Human Granulocytic Ehrlichiosi 89289.0000 Human Granulocutic Ehrlichiosi 89290.0000 Human Granulocytic Ehrlichiosi 89291.0000 HIV Log 89292.0000 HIV Log Ultra 89293.0000 HIV 2 gp105 Ab 89294.0000 HIV 2 gp120 Ab 89295.0000 HIV 2 gp34 Ab 89296.0000 HIV 2 p15 Ab 89297.0000 HIV 2 p26 Ab 89298.0000 HIV 2 p31 Ab 89300.0000 Semen Analysis Sperm 89301.0000 HIV 2 p58 Ab 89302.0000 HIV 2 p68 Ab 89303.0000 HIV 2 Ab Western Blot 89304.0000 HPV Hybrid Capture Inter High 89305.0000 HPV Typing, Biopsy 89306.0000 HPV Hybrid Capture Low Risk 89307.0000 Herpes Simplex Virus DNA 89308.0000 Herpes Simplex 1 DNA 89309.0000 Herpes Simplex 2 DNA 89310.0000 Herpes Simplex Ab 89311.0000 Herpes Simplex Ag 89312.0000 Parainfluenza 1 Ab 89313.0000 Parainfluenza Ag 89314.0000 Parainfluenza 1 Ag 89315.0000 Parainfluenza 2 Ag 89316.0000 Parainfluenza 3 Ag 89317.0000 Coxiella Burnetti 1 IgM 89318.0000 Coxiella Burnetti 2 89319.0000 Coxiella Bernetti 2 IgG 89320.0000 Semen Analysis Count Motil 89321.0000 Coxiella Bernetti 2 IgM 89322.0000 Thphus 89323.0000 Typhus IgG 89324.0000 Typhus IgM 89325.0000 Rocky Mountain Spotted Fever I 89326.0000 Rocky Mountain Spotted Fever I 89328.0000 RNA Polymerase 1,2,3 Ab 89329.0000 Varicella Zoster Ab IgG 89330.0000 Cervical Mucus 89331.0000 Yersina Enterocolitica Ab 0:3 89332.0000 Yersina Enterocolitica Ab 0:5 89333.0000 Yersinia Enterocolitica Ab 0:8 89334.0000 Yersinia Enterocolitica Ab 0:9 89335.0000 Capillary Puncture Out Lab 89336.0000 Capillary Puncture Collection 89337.0000 Hantavirus Ab 89338.0000 Microbiological Specimen 89339.0000 Herpes Simplex 1 Ab 89340.0000 Urine (coll by lab) 89341.0000 +Venipuncture Travel Time 89342.0000 Prep Sterile Venipuncture 89343.0000 +Venipuncture Outpatient 89344.0000 Drainage 89345.0000 Venipuncture <3YR 89346.0000 Venipuncture (Scalp) 89347.0000 Venipuncture (Other) 89348.0000 Specimen Dispatch prep mail 89349.0000 Specimen Dispatch Ice 89350.0000 Arterial Puncture 89351.0000 Specimen Dispatch w data handl 89352.0000 Specimen Dispatch Nonal w dat 89353.0000 Specimen Dispatch w o Data Han 89354.0000 Specimen Dispatch Non w o data 89355.0000 Travel Time 89356.0000 Specimen Handling (Misc) 89357.0000 Venipuncture Transfusion 89358.0000 Arterial Catheterization 89359.0000 Specimen Collection Time 89360.0000 Chloride Sweat Test Quant 89361.0000 Tay Sach 89362.0000 Specimen Preprocessing Airfuge 89363.0000 Reverse Transcript Mutation 89364.0000 Specimen Preprocess Sphingo 89365.0000 Ward Collect Spec 89366.0000 LEDI Specimen 89367.0000 Referred Specimen 89368.0000 DoD Specimen 89369.0000 Research Specimen 89370.0000 Fee Basis Specimen 89371.0000 Contract Specimen 89372.0000 Hepatitis C RIBA 89373.0000 Pokeweed Mitogen 89374.0000 Concanavalin A Mitogen 89375.0000 Lymphocyte Mitogen Prolif 89376.0000 c100 5-1-1 Ab 89377.0000 c33c Ab 89378.0000 c22 Ab 89379.0000 NS5 Ab 89380.0000 Zea Mays Ab IgG 89381.0000 Arachis Hypogaea Ab IgG 89382.0000 Chronic Granulomatous Disease 89383.0000 Glycine Max Ab IgG 89384.0000 SOD1 DNA 89385.0000 Familial ALS 89386.0000 MA1 Ab 89387.0000 MA2 Ab 89388.0000 Satratoxin IgG 89389.0000 Satratoxin IgA 89390.0000 Satratoxin IgM 89391.0000 hSOD Ab 89392.0000 Satratoxin IgE 89393.0000 Aflatoxin IgG 89394.0000 Aflatoxin IgA 89395.0000 Aflatoxin IgM 89396.0000 Aflatoxin IgE 89397.0000 Trichothecene IgG 89398.0000 Trichothecene IgA 89399.0000 Trichothecene IgM 89400.0000 Trichothecene IgE 89403.0000 Hepatitis GBV 89404.0000 Rh (D) Typing 89405.0000 HBs Ag 89406.0000 HBe Ag 89407.0000 HBe Ab 89408.0000 HBs Ab 89409.0000 HBV 89410.0000 HBc Ab 89411.0000 HCV Ab 89412.0000 HCV Ag 89413.0000 Cutaneous Ab 89414.0000 Extractable Nuclear Ag NOS 89415.0000 Herpes Simplex 2 Ab 89416.0000 Nuclear Matrix Protein Tumor M 89417.0000 Leptospira Grippo Ab 89418.0000 Leptospira Icterohaemorrhiae A 89420.0000 Leptospira Pomona Ab 89421.0000 CD1+ Percent 89422.0000 HLA -DR+DQ Ag 89423.0000 Mumps Skin Test 89424.0000 Spinocerebellar Ataxia 1 89425.0000 Molecular Cytogenetics Probe 89426.0000 FISH 89427.0000 HEREDITARY SPASTIC PARAPARESIS 89428.0000 Spinocerebellar Ataxia Type 17 89429.0000 Spinocerebellar Ataxia Type 1& 89430.0000 Lyme IB 21kDa 89431.0000 Lyme IB 23kDa 89432.0000 Lyme IB 28kDa 89433.0000 Lyme IB 30kDa 89434.0000 Lyme IB 39kDa 89435.0000 Lyme IB 41kDa 89436.0000 Lyme IB 45kDa 89437.0000 Lyme IB 58kDa 89438.0000 Lyme IB 66kDa 89439.0000 Lyme IB 93kDa 89440.0000 Hu Ab CSF 89441.0000 ANA-Atypical Speckled Pattern 89442.0000 B Cell Gene Rearrangement 89443.0000 ANA-Homogeneous Pattern 89444.0000 Inflammatory Bowel Disease Pan 89445.0000 ANA-Mitotic Spindle Pattern 89446.0000 ANA-Nuclear Pattern 89447.0000 ANA-Speckled Pattern 89448.0000 RET Proto Oncogene Mutations 89449.0000 Muscular Dystrophy Duchenne Be 89450.0000 Interleukin 5 Receptor 89451.0000 Presenilin-1 Analysis 89452.0000 ApoE Allele 1 89453.0000 ApoE Allele 2 89454.0000 ApoE Genotype Analysis 89455.0000 BCL 1 Gene Translocation 89456.0000 ANA-Peripheral Pattern 89485.0000 Hepatitis C RNA 89486.0000 Heparin LMW 89496.0000 HCV Viral Load 89497.0000 Aureobasidium Pullans 89498.0000 HIV Viral Load 89499.0000 Immunoglobulin Lambda L Mon 89500.0000 Immunoglubulin Kappa L Mon 89501.0000 Helminth Ab 89502.0000 Rubeola Immune Status 89503.0000 Varicella Zoster Ab 89504.0000 VDRL Quant 89505.0000 HSV Ab IgG 89506.0000 HSV Ab IgM 89507.0000 PL-7 Autoantibodies 89508.0000 PL-12 Autoantibodies 89509.0000 Mi-2 Autoantibodies 89510.0000 Ku Autoantibodies 89511.0000 EJ Autoantibodies 89512.0000 OJ Autoantibodies 89513.0000 U2 SnRNP Autoantibodies 89530.0000 CA-125 Cancer Ag 89531.0000 Complement C1 Esterase Inhib 89532.0000 Complement C1q 89533.0000 Complement C1r 89534.0000 Complement C1s 89535.0000 Complement C2 89536.0000 Complement C3 89536.3035 Complement C3b Inhibitor~DU PO 89537.0000 Complement C3b Inhibitor 89538.0000 Complement C3c 89539.0000 Complement C3 Mobility 89540.0000 Complement C4 89540.3035 Complement C5~DU PONT ACA 89541.0000 Complement C4 Allotypes 89542.0000 Complement C5 89543.0000 Complement C6 89544.0000 Complement C7 89545.0000 Complement C8 89546.0000 Complement Activation Products 89547.0000 Complement Decay Rate 89548.0000 Complement Factor B (C3PA) 89549.0000 Complement Properidin 89550.0000 Complement Total (CH50 CH100) 89551.0000 Immunoglobulin A 89552.0000 Immunoglobulin D 89553.0000 Immunoglobulin E 89554.0000 Immunoglobulin G 89555.0000 Immunoglobulin G Albumin Index 89556.0000 Immunoglobulin G Synthesis Rt 89557.0000 Immunoglobulin G1 89558.0000 Immunoglobulin G2 89559.0000 Immunoglobulin G3 89560.0000 Immunoglobulin G4 89561.0000 Immunoglobulin J Chain 89562.0000 Immunoglobulin Kappa Light Ch 89563.0000 Immunoglobulin Lambda Light Ch 89564.0000 Immunoglobulin M 89565.0000 Immunoglobulin Oligoclonal 89566.0000 Immunoglobulin G Low Level 89567.0000 Delta Ab 89568.0000 Heparin Induced Ab 89569.0000 HLA DR 89570.0000 Multiple Serum Proteins 89571.0000 Molecular Diag Separation 89572.0000 Helicobacter pylori Ab IgA 89573.0000 Helicobacter pylori Ag 89574.0000 EBV-VCA, IgM Quant 89575.0000 EBV-VCA, IgM 89576.0000 EBV-VCA, IgG 89577.0000 EBV-VCA, IgG Quant 89578.0000 EBV-VCA 89579.0000 CMV Ab, IgM Quant 89580.0000 CMV Ab, IgM 89581.0000 CMV Ab, IgG Quant 89582.0000 CMV Ab, IgG 89583.0000 CMV Ag 89584.0000 CMV Ab 89585.0000 Parietal Cell Ab Quant 89586.0000 Parietal Cell Ab 89587.0000 Smooth Muscle Ag 89588.0000 Smooth Muscle Ab Quant 89589.0000 Gliadin Ab IgA 89590.0000 DNA Ab Quant 89591.0000 Varicella Immune status Quant 89592.0000 Immune Status 89593.0000 Varicella Ab Quant 89594.0000 Varicella Ag 89595.0000 Varicella Ab 89596.0000 Toxoplasma Ab IgM Quant 89597.0000 Toxoplasma Ab IgG Quant 89598.0000 Sulfoglucuronyl paragloboside 89599.0000 T Cell Receptor Gene 89600.0000 Deoxyribonucleoprotein Ag 89601.0000 Deoxyribonucleoprotein Ab 89602.0000 Acetylcholine Receptor Binding 89603.0000 Chagas Disease 89604.0000 Acetylcholine Receptor Blockin 89605.0000 Polymavirus 89606.0000 Actin 89607.0000 Helicobacter pylori Ab IgG 89608.0000 Adenocarcinoma Surface Ag 89609.0000 Acute Myeloid Leukemia Panel 89610.0000 Adrenal Cortex 89611.0000 Lymphoma Panel 89612.0000 Bile Canaliculus 89613.0000 Chronic Leukemia Panel 89614.0000 Bile Duct 89615.0000 Acute Leukemia Panel 89616.0000 Blood Species Specific 89617.0000 Cat Scratch Fever 89618.0000 Bovine Milk 89619.0000 Histochemistry Panel 89620.0000 Breast Carcinoma Surface Ab 89621.0000 Lupus Panel 89622.0000 Brush Border 89623.0000 Carcinoembryonic Ag Polyclonal 89624.0000 CA 19 9 Carbohydrate Ag 89625.0000 Lupus Erythematosus 89626.0000 CA 125 Ovarian Cancer Ag 89627.0000 Delta Ag 89628.0000 Carcinoembryonic Ag 89629.0000 Genetics Study 89630.0000 Cardiolipin 89631.0000 Helicobacter pylori Ab IgM 89632.0000 Centriole 89633.0000 Tiech Acid Ab 89634.0000 Centromere 89635.0000 Gliadin Ab IgG 89636.0000 Cold Agglutinins 89637.0000 Gliadin Ab Panel 89638.0000 Cold Hemolysins Donath Land 89639.0000 Fetoprotein Alpha Stain 89640.0000 C Reactive Protein 89641.0000 Herpes I&II Stain 89642.0000 Cystic Disease Protein (CDP) 89643.0000 West Nile Virus 89644.0000 Cytokeratin 89645.0000 c-erB-2(HER-2/neu) 89646.0000 Deoxyribonuclease B 89648.0000 Deoxyribonucleic Acid Double 89650.0000 Deoxyribonucleic Acid Quant 89652.0000 Deoxyribonucleic Acid Single 89654.0000 Desmin 89656.0000 Desmosome 89658.0000 Extractable Nuclear Ag H 89660.0000 Extractable Nuclear Ag Jo 89661.0000 Microsomal Ab 89662.0000 Extractable Nuclear Ag Ku 89663.0000 Extractable Nuclear Ag MA 89664.0000 Extractable Nuclear Ag Mi 89666.0000 Extractable Nuclear Ag PM 89668.0000 Extractable Nuclear Ag RA 89670.0000 Extractable Nuclear Ag RNP 89672.0000 Extractable Nuclear Ag Scl 70 89674.0000 Extractable Nuclear Ag Sm 89676.0000 Extractable Nuclear Ag SS 89677.0000 Extractable Nuclear Ag SSA 89678.0000 Extractable Nuclear Ag SSB 89680.0000 Epithelial Membrane Ag 89682.0000 Fetoprotein Alpha 89684.0000 Fibronectin 89686.0000 Gliadin 89688.0000 Glial Fibrillary Acidic Prot 89690.0000 Glomerular Basement Membrane 89691.0000 Glycoprotein Beta1 Pregnancy 89692.0000 IgA 89693.0000 Histone DNA Complex IgG Ab 89694.0000 Heterophile 89695.0000 Machado Joseph Panel 89696.0000 Hyaluronidase 89697.0000 Prostatic Specific Ag Free 89698.0000 Immune Complex Clq Binding 89699.0000 Hepatitis B Surface Ab Quant 89700.0000 Immune Complex Polyethylene G 89701.0000 Rapid Plasma Reagin Quant 89702.0000 Immune Complex Raji Cell 89703.0000 Interleukin 2 Receptor 89704.0000 Intrinsic Factor 89705.0000 Rheumatoid Factor Quant 89706.0000 Islet Cell 89707.0000 Viral Titer 89708.0000 Keratin Squamous 89709.0000 DNA Binding 89710.0000 Keratin Nonsquamous 89711.0000 Hepatitis D Ag 89712.0000 Lactalbumin Alpha 89713.0000 Hepatitis D Ab 89714.0000 Lactoferrin 89715.0000 Rochaumaea Ag 89716.0000 Lung Carcinoma Surface Ag 89717.0000 Rochaumaea Ab 89718.0000 Melanoma Surface Ag 89719.0000 Microsomes Liver and Kidney 89720.0000 Microsomes Thyroid 89721.0000 Schistosoma Ab 89722.0000 Mitochondria 89723.0000 Heamophilus Pylorii Stain 89724.0000 Myelin 89725.0000 Thyroid Peroxidase Ab 89726.0000 Myelin Basic Protein 89727.0000 Hu Auto Ab 89728.0000 Myocardium 89729.0000 Yo Auto Ab 89730.0000 Myosin 89731.0000 Chlamydia Ab 89732.0000 Nuclear 89734.0000 Neurofilament Triplet Pro 200 89736.0000 Neurofilament Triplet Pro 160 89738.0000 Neurofilament Triplet Protein 89740.0000 Neuroleptic Receptor 89742.0000 Neuron Specific Enolase 89744.0000 Neurophysin 89746.0000 Panfilament 89748.0000 Pancreatic Carcinoma 89750.0000 Pancreatic Onofetal Ag 89752.0000 Parietal Cell 89754.0000 Pigeon Serum 89756.0000 Prekeratin 89758.0000 Prostatic Carcinoma Surface 89760.0000 Prostate Specific Ag 89762.0000 Reticulin 89764.0000 Rheumatoid Factor 89766.0000 Ribonuclease 89768.0000 Ribosome 89770.0000 S 100 Neural Ag 89772.0000 Salivary Gland 89773.0000 Mumps Ab Titer 89774.0000 Sarcolemma 89776.0000 Skin 89778.0000 Smooth Muscle 89780.0000 Sperm 89782.0000 Streptokinase 89784.0000 Anti Streptolysin O (ASO) 89786.0000 Streptozyme 89788.0000 Striated Muscle 89790.0000 Tamm Horsfall Protein 89792.0000 Thyroglobulin 89794.0000 Thyroid Stimulating Immunoglob 89796.0000 Tubulin 89798.0000 Vimentin 89801.0000 Percent Recovery 89802.0000 Thyroglobulin Panel 89803.0000 CD3 Absolute 89804.0000 CD3 Percent 89805.0000 CD4 Percent 89806.0000 Bermuda Grass 89807.0000 Bermuda Grass IgE 89808.0000 Scleroderma Ab 89809.0000 Johnson Grass 89810.0000 Johnson Grass IgE 89811.0000 Timothy Grass 89812.0000 Timothy Grass IgE 89813.0000 Alternaria tenuis 89814.0000 Elm Tree 89815.0000 Mountain Cedar 89816.0000 Oak Tree 89817.0000 Sycamore Tree 89819.0000 Pecan Tree 89820.0000 Ash Tree 89821.0000 Privet 89822.0000 Ragweed Common 89823.0000 Lamb's Quarters 89824.0000 Russian Thistle 89825.0000 Marsh Elder 89826.0000 Cat Dander 89827.0000 Dog Dander 89828.0000 Mites 89829.0000 Allergy Panel 89830.0000 Endomysial Ab Titer 89831.0000 Giardia Ab IFA 89832.0000 Ribosomal P Protein Ab 89833.0000 Pneumococcal Sero 3 89834.0000 Pneumococcal Sero 7F 89835.0000 Pneumococcal Sero 9N 89836.0000 Pneumococcal Sero 14 89837.0000 Pneumococcal IgG 89838.0000 IGF 3 Binding Protein 89839.0000 Glomerular Basement Membrane A 89840.0000 Glomerular Basement Membrane A 89841.0000 Glomerular Basement Membrane A 89842.0000 Pneumococcal IgG Type 08 89843.0000 Pneumococcal IgG Type 12 89955.0000 Grass Allergens 89960.0000 Tree Allergens 89965.0000 Mold Allergens 89970.0000 Weed Allergens 89975.0000 Epithelial Allergens 89980.0000 Food Allergens 89981.0000 Chocolate Ab IgG 89982.0000 Lycopersicon Lycopersicum Ab I 89985.0000 House Dust Allergens 89990.0000 House Dust Mite Allergens 89995.0000 Venom Allergens 91941.0000 Acetazolamide APPENDIX C Health Level Seven (HL7) Protocol Health Level Seven (HL7) Protocol The EPI Rollup Modification patch LR*5.2*281, utilizes the VistA Laboratory, PIMS, Pharmacy, Clinical Reminders, and Social Work databases for the EPI Rollup Modification criteria. The VistA HL7 software is used to transmit EPI Rollup Modification data to the AAC database. 3. General Specifications 3.1 Communication Protocol The electronic VistA Mailman software application is used as the communications protocol for sending the EPI HL7 mailman messages between VistA database and AAC database. 3.2 Application Processing Rules The HL7 protocol itself describes the basic rules for application processing by the sending and receiving systems. The HL7 Version 2.2 protocol is used. The Observational Results Unsolicited (ORU) message is sent using the HL7 batch protocol. 3.3 Message The following HL7 mail message is used to support the exchange of data: ORU Observational Results Unsolicited 3.4 Segments The following HL7 segments are used to support the exchange of data: HL7 segmentsExchange of DataDG1DiagnosisDSPDisplay DataMSHMessage HeaderNTENotes and CommentsOBRObservation RequestOBXObservation ResultsPIDPatient IdentificationPV1Patient VisitZXEPharmacy Prescription Order 3.5 Fields The following HL7 fields are used to support the exchange of data for each of the segments listed in the 3.4 Segments: FIELDDataSEGMENTSEQUENCEType/LengthFIELD ELEMENT NAMEUSER/HL7NUMBERHL/7DEFINEDDG114/SISet ID-Diagnosis (Sequence #)HL7360/CEDiagnosis Code (Code(id) ^Text (St.) ^ Name of coding system (st)HL7419/TSAdmission DateHL762/ISDiagnosis Type (PR=DXLS)HL7MSH11/STField SeparatorHL724/STEncoding CharactersHL73180/HDSending ApplicationHL74180/HDSending FacilityHL75180/HDReceiving ApplicationHL76180/HDReceiving FacilityHL7719/TSDate/Time of MessageHL7840/SYSecurityHL797/CMMessage TypeHL71020/STMessage Control IDHL7113/PTProcessing IDHL7128/IDVersion IDHL7OBR14/SISet ID-Observation Request (Seq #)HL74200/CEUniversal Service ID (identifier ~ text ~ name of coding system ~ alt id ~ alt text ~ alt coding system)HL7719/TSObservation Date/TimeHL715300/CMSpecimen Source (Specimen source code (CE) ~~ text (TX) )HL7 (Table 0070)26400/CMParent Results (OBX observation id of parent ^OBX sub IDHL7 3.5 Fields continued FIELDDataSEGMENTSEQUENCEType/LengthFIELD ELEMENT NAMEUSER/HL7NUMBERHL/7DEFINEDNTE14/SISet ID (seq. #)HL7364K/FTComment (five formats exist for this segment, see Note #2)HL7OBX14/SISet Id-Observational Simple (seq. #)HL722/IDValue TypeHL7New LOINC380/CEObservation Identifier (identifier ~ text ~ name of coding system ~ alt id ~ alt text ^ alt coding system)HL7420/STSub IdHL7New MIC value5Observation Value (Result)HL7660/CEUnits (Units)HL7810/IDAbnormal FlagsHL7 (Table 0078)1460/CEDate/Time of the Observation (Verified Date/Time)HL7PID14/SISet ID Patient IDHl7216/CKPatient ID (External ID)HL7New MPI320/CMPatient ID (Internal ID)HL7548/PNPatient NameHL7719/TSDate of BirthHL781/IDSexHL7 (Table 0001)New Race101/IDRaceHL7 (Table VA07)11106/ADAddress (Homeless{where applicable}~Zip Code)HL7New County Code124/ISCounty CodeHL71916/STSSNHL7 3.5 Fields continued FIELDDataSEGMENTSEQUENCEType/LengthFIELD ELEMENT NAMEUSER/HL7NUMBERHL/7DEFINEDNew Ethnic Group2280/CEEthnic GroupHL72760/CEVeterans Military StatusHL7 (Table Va011)PV114/SISet ID - Patient VisitHL7363/IDDischarge Disposition (Type of Disposition {Code}~Type of Disposition {Text}~Source ID {VA45=VA File 45})HL7Servicing Facility 392/SIServicing FacilityHL74419/TSAdmit Date/Time (Event Date/Time)HL74519/TSDischarge Date/TimeHL7DSP12/IDSet IDHL7380/FTDate~Text Term~Resolved Term~Result~SourceidUSER52/IDResult ID (linking DSP and ZXE)HL7ZXE120/FTNDCUSER275/FTDrug Name~Coding SystemUSER34/NMDays SupplyUSER419/TSRelease Date/TimeUSER519/TSFill Date/TimeUSER619/TSStop Date/TimeUSER72/IDResult ID (linking DSP and ZXE)USER NOTE: The NTE segment is present in four forms. EPI only items tagged with (EPI). a. NTE||manual/automatic indicator (Null for automatic, R for Manual)~REPORTING DATE FROM from date TO to date~message number~~software version number (blank for original system/V2 for new system(epi)~Negative Input Indicator (null if input is present, N if negative) b. NTE|sequence number|reference number from field .05 (reference number) in 5 (LAB SEARCH/EXTRACT file (#69). c. NTE||Totals indicator (T if NTE describes totals for run)~National Lab Test Code~Test Name from LAB TEST file (#60) or (ETIOLOGY FIELD file (#61.2)~Total number of tests performed d. NTE||Totals indicator (T if NTE describes totals for run)~National Lab Test Code~ PATIENTS WITH_Test Name from LAB TEST file (#60) or ETIOLOGY FIELD file (#61.2)~Number of unique patients receiving this test Definitions from Austin Field NameStartEndLengthPropertiesDG1 SEGMENTSET-ID94974alphanumericDIAG-CODING-METHOD98992alphanumericDIAG-CODE1001067alphanumericDIAG-TEXT10714640alphanumericDIAG-CODING-SYT14715610alphanumericFILLER157467311alphanumericNTE-SEGMENTSET-ID94974alphanumericACTION-IND98992alphanumericvalid total indicator TNATIONAL- LAB-TEST-NUM10010910alphanumericBACTERIA11014435alphanumericTOTAL-COUNT1451495alphanumericFILLER150467318alphanumericNTE-SEGMENT (alternate type)SET-ID94974alphanumericACTION-IND98992alphanumericFILLER10011920alphanumericFROM-DATE1201278alphanumericFILLER1281314alphanumericTO-DATE1321398alphanumericMSG-SEQ-NUM1401423alphanumericNEGATIVE-INPUT-IND1431431alphanumericFILLER144467324alphanumeric Continued Field NameStartEndLengthPropertiesOBR-SEGMENTSET-ID94974alphanumericPATHOGEN-NAME9813235alphanumericUNIV-SERVICE-ID13314210alphanumericUNIV-SERVICE-TEXT14317230alphanumericUNIV-SERVICE-CODE17318715alphanumericALT-UNIV-SERVICE-ID18820215alphanumericALT-UNIV-SERVICE-TEXT20323230alphanumericALT-UNIV-SERVICE-CODE23324715alphanumericOBSER-DATE2482558yyyymmddOBSER-TIME2562616hhmmssOBSER-DATE-A2622698alphanumericSPECIMEN-CODE2702734alphanumericFILLER2742741alphanumericSPECIMEN-CODE-TEXT27530430alphanumericACCESSION-NUM30532420alphanumericPARENT-OBSER-ID33533410alphanumericPARENT-OBSER-SUB-ID3553406alphanumericPARENT-TEST-SYS36135010alphanumericPARENT-LAB-NUM37136010alphanumeric Continued Field NameStartEndLengthPropertiesFILLER38145898alphanumericOBX-SEGMENTOBR-SET-ID94974alphanumericOBX-SET-ID981014alphanumericVALUE-TYPE1021032alphanumericOBSERVATION-ID10411310alphanumericOBSERVATION-TEXT11414330alphanumericOBSERVATION-CODE14415815alphanumericOBSERVATION-ID-ALT15916810alphanumericOBSERVATION-TEXT-ALT16919830alphanumericOBSERVATION-CODE-ALT19921315alphanumericOBSERVATION-SUB-ID2142196alphanumericOBSERVATION-NAT-LAB22022910alphanumericOBSERVATION-VALUE23027445alphanumericOBSERVATION-UNITS27528915alphanumericOBSERVATION-REF-RANGE29030415alphanumericABNORMAL-FLAGS30531410alphanumericFINAL-RESULT-DATE3153228yyyymmddFILLER323450128alphanumericPID-SEGMENTSET-ID94974alphanumeric Continued Field NameStartEndLengthPropertiesPATIENT-EXTERNAL-ID9811417alphanumericPATIENT-INTERNAL-ID11513521alphanumericPATIENT-NAME13622085alphanumericPATIENT-BIRTH-DATE2212288yyyymmddPATIENT-SEX2292291alphanumericPATIENT-RACE2302301alphanumericPATIENT-ADDRESS2312311alphanumericvalid patient address HZIP2322409alphanumericFILLER2412411alphanumericPATIENT-SSN2422509alphanumericPATIENT-PSEUDO2512511alphanumericvalid pseudo space or PPATIENT-VETERAN-STATUS2522532alphanumericFILLER254450197alphanumericPV1-SEGMENTSET-ID94974alphanumericPATIENT-CLASS98981alphanumericvalid patient class I or O or UDISCHARGE-DISPOSITION9913335alphanumericADMIT-DATE1341418yyyymmddADMIT-TIME1421476hhmmssDISCHARGE-DATE1481558yyyymmddDISCHARGE-TIME1561616hhmmssFILLER162450289alphanumeric 4.0 Transaction Specifications 4.1 General The VistA software sends an Observational Result Unsolicited (ORU) result type HL7 message whenever one or more of the defined emerging pathogen initiatives are identified. 4.2 Specific Transaction A. Identified Encounter When EPI data are identified an EPI Observational Result Unsolicited (ORU) message is sent to the AAC. The EPI ORU message consists of the following segments: Example: EPI ORU Message ORU OBSERVATIONAL RESULT UNSOLICITED MSH Message Header NTE Notes and Comments PID Patient Identification PV1 Patient Visit NTE Notes and Comments DG1 Diagnosis DSP Display Data ZXE Pharmacy Prescription OBR Observation Report OBX Results MSH|~|\&|EPI-XXX|170|EPI-XXX|170|19961018113521||ORU~R01|107|P|2.2|||||USA NTE||REPORTING DATE FROM 19850101 TO 19961018 PID|1|000-00-0008~0~M10|5~5~M10||LABPATIENT~EIGHT||19220912|M||7|||||||||052167946 PV1|1|O||||||||||||||||||||||||||||||||||||||||||19950315151907 NTE|1|Vanc-Res Enterococcus DG1|1|I9|451.19^DEEP PHLEBITIS-LEG NEC^I9 DG1|2|I9|511.9^PLEURAL EFFUSION NOS^I9 DG1|3|I9|670.02^MAJOR PUERP INF-DEL P/P^I9 DG1|4|I9|331.0^ALZHEIMER'S DISEASE^I9 DG1|5|I9|500.^COAL WORKERS' PNEUMOCON^I9 OBR|1|||^CHEMISTRY TEST^VANLT|||19950315151907||||||||SER^^SERUM OBX|1|ST|84330.0000^Glucose Quant^VANLT^260^GLUCOSE1^VA60||25|mg/dL|70-125|L* NTE|2|2^Hepatitis C antibody OBR|2|||^CHEMISTRY TEST^VANLT|||19950315151907||||||||SER^^SERUM OBX|1|ST|84330.0000^Glucose Quant^VANLT^260^GLUCOSE1^VA60||25|mg/dL|70-125|L* PID|2|000-00-0009~8~M10|7~7~M10||LABPATIENT~NINE||19591229|F||7|||||||||023456666 PV1|1|O||||||||||||||||||||||||||||||||||||||||||19950315152721 NTE|1|1^Vanc-Res Enterococcus OBR|1|||87999.0000^MICRO CULTURE^VANLT|||198612100835||||||||^^BLOOD OBX|1|CE|87993.0000^BACTERIOLOGY CULTURE^VANLT|1|^ESCHERICHIA COLI OBR|2||^ANTIBIOTIC MIC^VANLT||||198612100835||||||||^^BLOOD|||||||||||87993.0000^1 OBX|1|ST|81812.0000^Neomycin^VANLT^18^NEOMYCN^VA62.06|||||R OBX|2|ST|^^^35^BACTRCN^VA62.06|||||R OBX|3|ST|81852.0000^Penicillin^VANLT^23^PENICLN^VA62.06|||||R OBX|4|ST|81676.0000^Clindamycin^VANLT^3^CLINDAM^VA62.06|||||S Table VA011 - Period of Service ValueDescription0KOREAN1WORLD WAR I2WORLD WAR II3SPANISH AMERICAN4PRE-KOREAN5POST-KOREAN6OPERATION DESERT SHIELD7VIETNAM ERA8POST-VIETNAM9OTHER OR NONEAARMY--ACTIVE DUTYBNAVY, MARINE--ACTIVE DUTYCAIR FORCE--ACTIVE DUTYDCOAST GUARD--ACTIVE DUTYERETIRED, UNIFORMED FORCESFMEDICAL REMEDIAL ENLISTGMERCHANT SEAMEN--USPHSHOTHER USPHS BENEFICIARIESIOBSERVATION/EXAMINATIONJOFFICE OF WORKERS COMP.KJOB CORPS/PEACE CORPSLRAILROAD RETIREMENTMBENEFICIARIES-FOREIGN GOVNHUMANITARIAN (NON-VET)OCHAMPUS RESTOREPOTHER REIMBURS. (NON-VET)QOTHER FEDERAL - DEPENDENTRDONORS (NON-VET)SSPECIAL STUDIES (NON-VET)TOTHER NON-VETERANSUCHAMPVA--SPOUSE, CHILDVCHAMPUSWCZECHOSLOVAKIA/POLAND SVCXPERSIAN GULF WARYCAV/NPSZMERCHANT MARINE Table 0070 - Specimen Source Codes (continued) AbbreviationsDescriptionsAbbreviationsDescriptionsAbbreviationsDescriptionsABSAbscessFLUBody fluid, unspSERSerumAMNAmniotic fluidGASGasSKNSkinASPAspirateGASTGastric fluid/contentsSKMSkeletal muscleBPHBasophilsGENGenitalSPRMSpermatozoaBIFLBile fluidGENCGenital cervixSPTSputumBBLBlood bagGENVGenital vaginalSPTTSputum tracheal aspirateBLDCBlood capillaryHARHairSTONStone (use CALC)BPUBlood product unitIHGInhaled GasSTLStool = FecalBLDVBlood venousITIntubation tubeSWTSweatBONBoneISLTIsolateSNVSynovial fluid (Joint fluid)BRTHBreath (use EXHLD)LAMLamellaTEARTearsBROBronchialWBCLeukocytesTHRTThroatBRNBurnLNLineTHRBThrombocyte (platelet)CALCCalculus (=Stone)LNALine arterialTISSTissueCDMCardiac muscleLNVLine venousTISGTissue gall bladderCNLCannulaLIQLiquid NOSTLGITissue large intestineCTPCatheter tipLYMLymphocytesTLNGTissue lungCSFCerebral spinal fluidMACMacrophagesTISPLTissue placentaCVMCervical mucusMARMarrowTSMITissue small intestineCVXCervixMECMeconiumTISUTissue ulcerCOLColostrumMBLDMenstrual bloodTUBTube NOSCBLDCord bloodMLKMilkULCUlcerCNJTConjunctivaMILKBreast milkUMBUmbilical bloodCURCurettageNAILNailUMEDUnknown medicine Table 0070 - Specimen Source Codes (continued) AbbreviationsDescriptionsAbbreviationsDescriptionsAbbreviationsDescriptionsCYSTCystNOSNose (nasal passage)URTHUrethraDIAFDialysis fluidORHOtherURUrineDOSEDose med or substancePAFLPancreatic fluidURCUrine clean catchDRNDrainPATPatientURTUrine catheterDUFLDuodenal fluidPRTPeritoneal fluid ascitesURNSUrine sedimentEAREarPLCPlacentaUSUBUnknown substanceEARWEar wax (cerumen)PLASPlasmaVOMVomitusELTElectrodePLBPlasma bagBLDWhole bloodENDCEndocardiumPLRPleural fluid (thoracentesis fld)BDYWhole bodyENDMEndometriumPMNPolymorphonuclearneutrophilsWATWaterEOSEosinophilsPPPPlatelet poor plasmaWICKWickRBCErythrocytesPRPPlatelet rich plasmaWNDWoundEYEEyePUSPusWNDAWound abscessEXHLDExhaled gas (breath)RTRoute of medicineWNDEWound exudateFIBFibroblastsSALSalivaWNDDWound drainageFLTFilterSEMSeminal fluidXXXTo be specified in another part of the messageFISTFistula Table 0005 Race: 1ST RACE COMPONENT Identifier comes from table 0005. 2ND COMPONENT Text- comes from table 0005. IDENTIFIERTEXT0000-0-SLFDeclined to answer9999-4-SLFUnknown by patient1002-5-SLFAmerican Indian or Alaska Native (self identified)1002-5-PRXAmerican Indian or Alaska Native (proxy identified)1002-5-OBSAmerican Indian or Alaska Native (observer identified)1002-5-UNKAmerican Indian or Alaska Native (unknown identifier)2028-9-xxxAsian (xxx identified)2054-5-xxxBlack or African American (xxx identified)2076-8-xxxNative Hawaiian or other Pacific Islander (xxx identified)2106-3-xxxWhite (xxx identified) Table CDC Race: 3rd RACE COMPONENT Identifier - comes from table CDC. 4th COMPONENT Text - comes from table CDC. IDENTIFIERTEXTnullUnknown by patient or Declined to answer1002-5American Indian or Alaska Native2028-9Asian2054-5Black or African American2076-8Native Hawaiian or other Pacific Islander2106-3White Table 0189 - Ethnic Group 1ST ETHNICITY COMPONENT Identifier - comes from table 0189. 2ND COMPONENT Text - comes from table 0189. IDENTIFIERTEXT0000-0-SLFDeclined to answer9999-4-SLFUnknown by patient2135-2-SLFHispanic or Latino (self identified)2135-2-PRXHispanic or Latino (proxy identified) 2135-2-OBSHispanic or Latino (observer identified) 2135-2-UNKHispanic or Latino (unknown identifier)2186-5-xxxNot Hispanic or Latino (xxx identified)  Table CDC - Ethnic Group 3rd ETHNICITY COMPONENT Identifier - comes from table CDC. 4th ETHNICITY COMPONENT Text - comes from table CDC. ValueDescriptionNullUnknown by patient or Declined to answer2135-2Hispanic or Latino2186-5Not Hispanic or Latino Table 0001 - Sex ValueDescriptionFFEMALEMMALEOOTHER Table 0078 - Abnormal flags ValueDescriptionLBelow low normalHAbove high normalLLBelow lower panic limitsHHAbove upper panic limitsFor microbiology sensitivities onlySSensitiveRResistantIIntermediateMSModerately sensitiveVSVery sensitive Table Specimen Source ID Code ValueDescriptionProblem List1Encounter Dx2Discharge DX3 Table Hepatitis Risk Assessment Resolutions ValueDescriptionDeclined Hep C Risk Assessment1No Risk Factors for Hep C2Prev Positive Test for Hep C3Risk Factor for Hepatitis C4Hep C Virus Antibody Positive5Hep C Virus Antibody Negative6Hepatitis C Infection7 NOTE: Term other than Hepatitis C National Risk Assessment Clinical Reminders resolution term 00 APPENDIX D VHA DIRECTIVE 2001-039 JUNE 27, 2001 IMPLEMENTATION OF LOGICAL OBSERVATION IDENTIFIERS NAMES AND CODES (LOINC) FOR LABORATORY DATA APPENDIX  D Department of Veterans AffairsVHA DIRECTIVE 2001-039Veterans Health AdministrationWashington, DC 20420June 27, 2001 IMPLEMENTATION OF LOGICAL OBSERVATION IDENTIFIERS NAMES AND CODES (LOINC) FOR LABORATORY DATA NOTE: LOINC is a registered trademark symbol. 1. PURPOSE: This Veterans Health Administration (VHA) Directive defines policies on the need for consistent laboratory test names across the national system within the Veterans Health Information Systems Technology Architecture (VistA) software. 2. BACKGROUND a. Improving health data is also a high priority that is consistent with VHAs goal of improving the quality and accessibility of medical information for clinicians and veterans. In order to provide optimal clinical care, accurate, comprehensive, accessible, and timely data is necessary. Improvements in the provision and outcomes of VHA health care can only be measured by consistent and valid information. b. LOINC is a data system that provides a standard set of universal names and codes for identifying individual laboratory results. Developed as a collaborative effort including VHA s Office of Information (OI) staff, LOINC codes were first released in April 1996 and have since been formally endorsed by the American Clinical Laboratory Association, the association of large referral laboratories whose membership is responsible for over 60 percent of outpatient laboratory testing in the United States. Numerous private commercial laboratories, health plans and health care provider systems have since adopted this system. LOINC codes have been incorporated into the National Library of Medicine s Unified Medical Language System and are the basis of the Health Care Financing Administration s (HCFA) proposed International Classification of Diseases, 10th edition (ICD-10), laboratory codes. The codes have been incorporated into HCFAs quality assurance testing pilot programs and adopted by the Centers for Disease Control and Prevention to test reporting of communicable disease information electronically. VHA is represented on the committee responsible for introducing new codes. c. The primary benefit to the Department of Veterans Affairs (VA) health care is having a system that integrates data across inpatient and outpatient settings and across facilities, allowing easy and timely retrieval of clinically useful information needed to provide efficient, high quality individual patient care. LOINC allows the aggregation of clinical laboratory data within Veterans Integrated Service Networks (VISNs), and nationally, efforts that are currently encumbered by the high rates of variation in local laboratory test naming. Such mapping provides a way to support multiple, normal ranges based on test, method, specimen, sex, and patient age. d. Hepatitis C infection, an important public health and medical problem for many veterans, is a high priority for VHA. The Under Secretary for Health has requested the creation of an electronic database to monitor the clinical outcomes of patients in the VA system with Hepatitis C infection and information needed for the oversight and management of the national hepatitis C program. A prerequisite for the implementation of such a registry is the availability of standardized laboratory test result data across VHA. THIS VHA DIRECTIVE EXPIRES JUNE 30, 2006 e. Patch LR*5.2*215, to Version 5.2 of the Laboratory software application, was released in April 1999. This patch provides a mapping process for linking VA National Laboratory Test (NLT) codes to LOINC. 3. POLICY: It is VHA policy that VISN and facility Directors must provide a national system for laboratory test names by ensuring the installation, set-up, and maintenance of each facility s laboratory software mapping to LOINC. 4. ACTION a. By June 30, 2001, each facility must install Patch LR*5.2*215 to laboratory software version 5.2. b. By July 16, 2001, each VISN Director must have designated one lead person, to be known as the VISN LOINC Coordinator, who will be responsible for ensuring that, at each VistA site, the appropriate mapping of NLT to LOINC codes will be performed. In addition, the VISN LOINC Coordinator will serve as a VistA corporate liaison between the VISN and VHA Information Technology team responsible for providing training on the use of the mapping tool. NOTE: The VISN LOINC Coordinators will work to ensure complete implementation of LOINC coding within their respective VISNs. (1) The LOINC Coordinator needs to have a broad-based knowledge of clinical laboratory medicine, an overall understanding of the VistA Laboratory Service software package, experience using general VistA applications (i.e., FileMan, MailMan), and be able to grasp the analytical concepts to properly encode test results in all areas of laboratory (i.e., serology, chemistry, microbiology, blood bank, and immunology). (2) VISN LOINC Coordinators will receive training on the lab linking process and orientation to their roles as LOINC Coordinators through a series of teleconferences for that purpose. Training will be coordinated through the OI National Training and Education Office. Specific information on the LOINC training is available at: <HYPERLINK "http://vaww"http://vaww>.vistau.med.va.gov/vistau/loinc/loinc.htm. Training and support through teleconferences and audio question and answer sessions will be made available to:;fgij{|޼˝ޒއteS#hh5B* CJ\aJphh-hB* CJaJphhB&hOVCJ,aJ,h !CJ,aJ,hOYhCJaJhOYhG=CJaJhB&hCJ,aJ,hCJaJhG=B* CJ,aJ,phhB&hB* CJ,aJ,phhOYhOYCJaJhOYCJaJhOYhCJaJhB&hOJQJjhB&hULfghij{|}~!$a$$a$gd-9 <  . / 0 w z$%DEοθ{tibbbbbtt h3`\]hpJh#5\] h@\]hUh#\] hPKu\]h#hPKuh#CJ\]aJ h#\] hB&h0hB&hCJ!aJ! hB&hh-hOVB* CJaJphh-hB* CJaJph#hh5B* CJ\aJph hhB* CJ]aJph$   / 0  gdPKu gd#gdPKu gdn*gd# gdz$a$gd- + , Z[#$D&$d%d&d'dNOPQgd#gd# Z^Zgd@ gd@ Z^Zgd@ gd@ & F gd@ gd#DE6BC67vwab, - gd h gd hgd\gdz gd#  gd#56BCP#6NTX\ *+,367ļ̸̸̰̰̼̑̑̑̊̃ h6:hA h6:h\ h Uh[DhcOhPCJ] hcOhP hB&hPh[Dh)hPh\hI hh-h\hAh hB&h]{hh-h0aJ$ hB&h0 h(\] h#\] hr:\]378BCFklxy57Cwb&4ABC- : M!ȽϽϸϸϸϸϸϽϬ h58\ h#M>\h#M>h#M>\ h586\ h#M>6\ h h] h h6 h h6\h; h;\] h h\]h (jh h\]aJ hB&hh-hh-hFh\ h6:h\hA7- N!O!`"""z#|#:$;$$$%%%%%#&$&A&T&g&h& & Fgd]{gd]{gd]{gdz gd gdo]gd hM!N!O!\!"","."0"\"^"`"b""""8#:#J#L#x#|##"$+$,$9$:$;$J$$˿酪zs_M#h h5CJOJQJ\]^JaJ&h r>h h5CJOJQJ]^JaJ h h5])hzh h5CJOJQJ\]^JaJhzh h\]hzh h5\]h h5\] h h6\h (jh h\]aJh[D5CJPJ\] h58h h58h58h58OJQJ^Jh58h58h#M>6 h h\]h#M>h#M>\]$$$$$$$$$$$$s%}%%%%%%%%&#&$&@&A&S&T&e&g&h&i&m&Ѱѩя}y}rncc}_[Wh Uhh4'hB&h]{mH sH hq;! hB&hq;!h?^ hB&h]{h]{ hh]{ h (jCJ&h r>h h5CJOJQJ]^JaJ h h5] h h6\#h h5CJOJQJ\]^JaJh h5\] h h\]#hcO5CJOJQJ\]^JaJ)h r>h h5CJOJQJ\]^JaJ h&i&&&((P((()d)e)))***+++&$d%d&d'dNOPQgd(fgd(f gd(f gd(f gdXgdMigd Ugd Ugd]{m&&&&&&&&&Z'g'i'n'w'''''''((9(O(P(n((((((()))8)<)B)D)c)e)))!*@*Q*V*o*p**********+ +@+C++++++ϼhh(f5h(f h6:h(fh5CJPJ\hBxhXh Uh UCJaJha h h Uh?nphr0h U h Uh Uh[Dh@LB++++++++++ ,,&,,,M,j,k,l,----].^...m0000000000000111;1X1Y1[1142622222222222 333ĹĮĠ hn.]hB&h6|RPJhB&h6|RPJ^JhB&h6|RCJaJ hB&h6|Rh U hf:Xh Uh[D5CJPJ\ hyth(fh?nph(f5 h(f5 h6:h(fh(f=+k,l,m,,,,-G-t----m0n0o0000Y1Z1[11152gd(fgd(f&$d%d&d'dNOPQgd(f5262222n4o445s55666?6@666N777 &dPgd6|Rgd'gdc $gd+ $&dPgd+gd6|Rgdzgdcgd(f3!3(3.33353@3R3n3q3r3{333344l4m4n4o4t4|4444444444444444 555'5>5@5A5B5긮긮tjh.eh+U^Jh.eh+0J'^Jjh.eh+U^JhB&h+^J h+^Jjh+U^Jh+ h+5h6|Rh6|R5hB&h6|R^Jhf:XhdhphL0h6|Rh7!" hB&h6|RhKa:hn.] hKa:hn.-B5Y5Z5[5^555555555555555666.6/60666=6>6?6@6A6D6666666666佹䏄{skh PJ^Jhf:XPJ^JhB&h6|RPJhB&h6|RPJ^JhT\PJ^JhB&h6|RCJaJh'h hkw hf:Xhf:Xhchf:Xh6|Rj~h.eh+U^JhB&h+^J h+^Jh+ hB&h6|Rjh+U^Jh.eh+0J'^J(6666777 7707<7N7O7X7c777777777777777778888+8Q8U8Ľѳ}riehn.hB&hPJhB&hB*phhB&hPJ^JhB&hCJaJhd2r hzhI z hzh h]{>*CJ hB&hhB&h6|R6] hB&h6|R h6|R]hKa:h6|R] hKa:h6|R hA] hp5 hA5 h8=5 h6|R5h6|Rh6|R5 hB&h'%7777888i9j9999999>:::T;;;<<= $ $ gdX gdX gdAgdzgdT\  gd,jU8Z8[8^8_8~88888888596979g9h9j9k9n999999999999ܹǪܣǣ|ǣqf_ hB&h)hXh^JaJ$hcOhCJaJhcOh0J'OJQJ^JjhB&hUhcOhCJ] hcOhhB&h0J'OJQJ^JjYhB&hUjhB&hUhB&h6] hB&hhn.hKa:hn.]hB&hn.6] hB&hn.999999:::::::8:9:::;:<:=:>:?:@:[:\:ʼʼncTʼh156\]mHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHu2jch.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuh156;CJ\]aJ&jh156;CJU\]aJ\:]:^:o:p:q:::::::::::::::::::::::źv\źK jh1UmHnHu2jOh.h1>*B*UmHnHphuh1mHnHuh15CJ\aJmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jYh.h1>*B*UmHnHphu::::::::1;2;3;L;M;N;Q;R;S;T;U;V;q;r;s;t;ϬݜqfV<2j;h.h1>*B*UmHnHphuh15CJ\aJmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHuh.h10J']mHnHu2jEh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuh156\]mHnHut;;;;;;;;;;;;;;;;;;;;;;;;;;;;;<<ֺ֧fUֺ֧ jh1UmHnHu2j1h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHuh.h10J']mHnHu<<<g<h<i<<<<<<<<<<<<<<<<<<<<<<<<<źv\źK jh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh15CJ\aJmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2j'h.h1>*B*UmHnHphu<<====d=e=f=====================λ񰡰u[񰡰J j h1UmHnHu2j h.h1>*B*UmHnHphuh15CJ\aJmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHu$jh.h10J'UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu======>>>>9>:>;>T>U>V>X>Y>Z>[>\>]>x>y>z>{>>>>>ݿݿuݿ[ݿ2j!h.h1>*B*UmHnHphuh@@mHnHu jz!h1UmHnHuh1mHnHu2j h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHujh1UmHnHu==[>>?Q???J@@^ACBBFCCLDD(EEFF2GG5HH8II $ $ $ $ $>>>>>>>>>>>>>>>>>>>?????? ?!?²¤qffUF¤h156\]mHnHu jf#h1UmHnHuh1mHnHuh.h10J'^JmHnHu2j"h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu jp"h1UmHnHu!?"?#?/?0?1?J?K?L?N?O?P?Q?R?S?n?o?p?q?y?z?{???????źӀw]źL jR%h1UmHnHu2j$h.h1>*B*UmHnHphuh1mHnHuh156\]mHnHuh@@mHnHu j\$h1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2j#h.h1>*B*UmHnHphu????????????????????@@@ΫܙncT:2j&h.h1>*B*UmHnHphuh156\]mHnHuh@@mHnHu jH&h1UmHnHujh1UmHnHuh1mHnHu"h.h10J'PJhmHnHu2j%h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuh15CJ\aJmHnHu@@(@)@*@C@D@E@G@H@I@J@K@L@g@h@i@j@@@@@@@@@@@@@@@ԴũߐveũXߐh1CJaJmHnHu j4(h1UmHnHu2j'h.h1>*B*UmHnHphuh1mHnHuh15CJ\aJmHnHuh@@mHnHu j>'h1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu@@@AWAXAYA[A\A]A^A_A`A{A|A}A~A!B"B#BB@BABBBCBDBEBźӂy_źNӂ j *h1UmHnHu2j)h.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHuh@@mHnHu j*)h1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2j(h.h1>*B*UmHnHphuEB`BaBbBcBBBBBBBBBBBBBBBBB$C%C&C?C@CACCCDCECFCλ谡x^谡Mx j ,h1UmHnHu2j+h.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu j+h1UmHnHujh1UmHnHuh1mHnHu$jh.h10J'UmHnHu2j*h.h1>*B*UmHnHphuh.h10J'mHnHuh1mHnHuFCGCHCcCdCeCfCCCCCCCCCCCCCCCCC*D+D,DEDFDGDIDJD߼߱y_߱N j-h1UmHnHu2j}-h.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu j-h1UmHnHujh1UmHnHuh1mHnHu2j,h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuJDKDLDMDNDiDjDkDlDDDDDDDDDDDDDDDDDEEE!E"E#EүҤy_ҤN j/h1UmHnHu2ji/h.h1>*B*UmHnHphuh@@mHnHu j.h1UmHnHujh1UmHnHuh1mHnHu2js.h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHu#E%E&E'E(E)E*EEEFEGEHE{E|E}EEEEEEEEEEEEEEEEEFӸӸyӸ_Ӹ2jU1h.h1>*B*UmHnHphu j0h1UmHnHuh1mHnHu2j_0h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHujh1UmHnHuh@@mHnHuFFFFFFF F!FF?FbFFFFFFFFFFFFFFFµ§tiiXµ§ j2h1UmHnHuh1mHnHuh.h10J'^JmHnHu2jK2h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu j1h1UmHnHuFFFGGG+G,G-G/G0G1G2G3G4GOGPGQGRGGGGGGGGGGGGGźӂy_źNӂ j4h1UmHnHu2j74h.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHuh@@mHnHu j3h1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jA3h.h1>*B*UmHnHphuGGGGGHHH.H/H0H2H3H4H5H6H7HRHSHTHUHdHeHfHHHHHHHλ谡x^谡M j6h1UmHnHu2j#6h.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu j5h1UmHnHujh1UmHnHuh1mHnHu$jh.h10J'UmHnHu2j-5h.h1>*B*UmHnHphuh.h10J'mHnHuh1mHnHuHHHHHHHHIII1I2I3I5I6I7I8I9I:IUIVIWIXIIIIIΫΠuhNΠ2j8h.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu j7h1UmHnHujh1UmHnHuh1mHnHu2j7h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuh15CJ\aJmHnHuIIIIIIIIIJJJJGJHJIJbJcJdJfJgJhJiJjJkJJJJJµ§§yyhµ§N2j9h.h1>*B*UmHnHphu j9h1UmHnHuh1mHnHu2j9h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu j8h1UmHnHuIiJJ=KKK^LLMdMM&NuNN-OO)PP Q[QQ RcRRRSSSRT $ $ $JJJJJJJJJJJJJJJJJKKK6K7K8K:K;K*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHuh@@mHnHu jv:h1UmHnHujh1UmHnHuh1mHnHuh.h10J']mHnHuK?KZK[K\K]KwKxKyKKKKKKKKKKKKKKKKKKѮߝrgMߝ2j<h.h1>*B*UmHnHphuh@@mHnHu jb<h1UmHnHujh1UmHnHuh1mHnHu!h.h10J'\]mHnHu2j;h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuh1CJaJmHnHuKKKKKKKKKLLLLLWLXLYL[L\L]L^L_L`L{L|L}L~Lµ§§yyhµ§N2j>h.h1>*B*UmHnHphu jN>h1UmHnHuh1mHnHu2j=h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu jX=h1UmHnHu~LLLLLLLLLLLLLLLLLLLLMMMMMMM M M%M&MԸԥgVԸԥ j:@h1UmHnHu2j?h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu jD?h1UmHnHujh1UmHnHuh1mHnHu!h.h10J'\]mHnHu&M'M(MBMCMDM]M^M_MaMbMcMdMeMfMMMMMMMMMø}ofoLo2jAh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHuh@@mHnHu j0Ah1UmHnHujh1UmHnHuh1mHnHuh.h10J']mHnHu$jh.h10J'UmHnHu2j@h.h1>*B*UmHnHphuMMMMMMMMMMMMMNNNN N!N#N$N%N&N'N(NCNDNENFNSNTNµ§§yyhµ§N§y2jCh.h1>*B*UmHnHphu jCh1UmHnHuh1mHnHu2jBh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu j&Bh1UmHnHuTNUNnNoNpNrNsNtNuNvNwNNNNNNNNNNNNNNNNNNN𶦶udWh1CJaJmHnHu jEh1UmHnHu2jDh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHuh@@mHnHu jDh1UmHnHuh1mHnHujh1UmHnHuNNN O O O&O'O(O*O+O,O-O.O/OJOKOLOMOOOOOOOOOOOOOźӂy_źNӂ jFh1UmHnHu2jyFh.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHuh@@mHnHu jEh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jEh.h1>*B*UmHnHphuOOOOOPP P"P#P$P&P'P(P)P*P+PFPGPHPIPyPzP{PPPPPPPPλ谡x^谡Mx jHh1UmHnHu2jeHh.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu jGh1UmHnHujh1UmHnHuh1mHnHu$jh.h10J'UmHnHu2joGh.h1>*B*UmHnHphuh.h10J'mHnHuh1mHnHuPPPPPPPPPPQQQQQQ Q Q Q&Q'Q(Q)Q9Q:Q;QTQUQVQXQ߼߱w]߱L jJh1UmHnHu2jQJh.h1>*B*UmHnHphuh156\]mHnHuh@@mHnHu jIh1UmHnHujh1UmHnHuh1mHnHu2j[Ih.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuXQYQZQ[Q\Q]QxQyQzQ{QQQQQQQQQQQQQQQQQQQQRݿ݌peݿK݌2j=Lh.h1>*B*UmHnHphuh@@mHnHu jKh1UmHnHuh1mHnHuh.h10J']mHnHu2jGKh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHujh1UmHnHuRRRRRR R R R&R'R(R)RARBRCR\R]R^R`RaRbRcRdReRRR²¤qffU²¤ jMh1UmHnHuh1mHnHuh.h10J']mHnHu2j3Mh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu jLh1UmHnHuRRRRRRRRRRRRRRRRRRR0S1S2SKSLS·qhqNq= jOh1UmHnHu2jOh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHuh@@mHnHu jNh1UmHnHujh1UmHnHuh1mHnHu!h.h10J'\]mHnHu$jh.h10J'UmHnHu2j)Nh.h1>*B*UmHnHphuLSMSOSPSQSRSSSTSoSpSqSrSSSSSSSSSSSSSSSSSSSSҷҷxiҷOҷ2j Qh.h1>*B*UmHnHphuh156\]mHnHu jPh1UmHnHuh1mHnHu2jPh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHuSSSSSSSSSTTTTT0T1T2TKTLTMTOTPTQTRTSTTToTpTqTrTշveշK2jRh.h1>*B*UmHnHphu j|Rh1UmHnHu2jRh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu jQh1UmHnHuh1mHnHurTTTTTTTTTTTTTTTTTTTTTTTTTTTTTUU׻רxg׻ר jhTh1UmHnHu2jSh.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu jrSh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHuRTTTLUUULVVVFWWW+XwXX(YYY3ZZZ/[|[[\\\] $ $ $ $ $UUU*U+U,UEUFUGUIUJUKULUMUNUiUjUkUlUUUUUUUUUUUUUźӂy_źNӂ jTVh1UmHnHu2jUh.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHuh@@mHnHu j^Uh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jTh.h1>*B*UmHnHphuUUUUUUUUUUUUUUUUUVVVV*V+V,VEVFVGVIVJVKVLVλ谡x^谡Mx j@Xh1UmHnHu2jWh.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu jJWh1UmHnHujh1UmHnHuh1mHnHu$jh.h10J'UmHnHu2jVh.h1>*B*UmHnHphuh.h10J'mHnHuh1mHnHuLVMVNViVjVkVlVVVVVVVVVVVVVVVVVVVVVVVVV߼߱y_߱N j,Zh1UmHnHu2jYh.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu j6Yh1UmHnHujh1UmHnHuh1mHnHu2jXh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuVVVVV W WWW$W%W&W?W@WAWCWDWEWFWGWHWcWdWeWfWkWlWmWWWWүҤy_ҤN j\h1UmHnHu2j[h.h1>*B*UmHnHphuh@@mHnHu j"[h1UmHnHujh1UmHnHuh1mHnHu2jZh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuWWWWWWWWWWWWWWWWWWWWWWWWWWW X X X$XӸӸyӸ_Ӹ2j]h.h1>*B*UmHnHphu j]h1UmHnHuh1mHnHu2j\h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHujh1UmHnHuh@@mHnHu$X%X&X(X)X*X+X,X-XHXIXJXKXUXVXWXpXqXrXtXuXvXwXxXyXXXXXXXµ§§yyhµ§N§y2ju_h.h1>*B*UmHnHphu j^h1UmHnHuh1mHnHu2j^h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu j^h1UmHnHuXXXXXXXXXXXXXXXYYY!Y"Y#Y%Y&Y'Y(Y)Y*YEYFY𶩶xgXh156\]mHnHu j`h1UmHnHu2jk`h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu j_h1UmHnHuh1mHnHujh1UmHnHuFYGYHYrYsYtYYYYYYYYYYYYYYYYYYYYYYYYYźv\źK jbh1UmHnHu2jWbh.h1>*B*UmHnHphuh1mHnHuh15CJ\aJmHnHuh@@mHnHu jah1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jaah.h1>*B*UmHnHphuYYZZZZZZZ,Z-Z.Z0Z1Z2Z3Z4Z5ZPZQZRZSZdZeZfZZZZZZZλ񰡰x^񰡰M jdh1UmHnHu2jCdh.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu jch1UmHnHujh1UmHnHuh1mHnHu$jh.h10J'UmHnHu2jMch.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuZZZZZZZZZZZZZZZZZZZZZZ[[ [[[([)[*[,[Ѯѣx^ѣMx jfh1UmHnHu2j/fh.h1>*B*UmHnHphuh@@mHnHu jeh1UmHnHujh1UmHnHuh1mHnHu2j9eh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuh1CJaJmHnHu,[-[.[/[0[1[L[M[N[O[Z[[[\[u[v[w[y[z[{[|[}[~[[[[[[[[[¹Ÿ”xh¹N”2jhh.h1>*B*UmHnHphuh15CJ\aJmHnHuh@@mHnHu jgh1UmHnHuh1mHnHu2j%gh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHujh1UmHnHu[[[[[[[[[\\\ \:\;\<\U\V\W\Y\Z\[\\\]\^\y\z\{\|\\²¤¤vve²¤K¤2jjh.h1>*B*UmHnHphu jih1UmHnHuh1mHnHu2jih.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu jhh1UmHnHu\\\\\\\\\\\\\\\\\\\] ] ] ] ]]]]],]-]淧ve淧 jxkh1UmHnHu2jjh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHuh@@mHnHu jjh1UmHnHujh1UmHnHuh1mHnHu-].]/]A]B]C]\]]]^]`]a]b]c]d]e]]]]]]]]]]]]]]]]źv\źK jdmh1UmHnHu2jlh.h1>*B*UmHnHphuh1mHnHuh15CJ\aJmHnHuh@@mHnHu jnlh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jkh.h1>*B*UmHnHphu]c]]^n^^_e__ `T`` aZaaaGbbcSccdbddelee $ $ $ $]]]]]]]]]^^^^^^^^^9^:^;^<^L^M^N^g^h^i^k^λ񰡰u[񰡰J jPoh1UmHnHu2jnh.h1>*B*UmHnHphuh15CJ\aJmHnHuh@@mHnHu jZnh1UmHnHujh1UmHnHuh1mHnHu$jh.h10J'UmHnHu2jmh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuk^l^m^n^o^p^^^^^^^^^^^^^^^^^^^^^^^^ _ݿݿuݿ[ݿ2jph.h1>*B*UmHnHphuh@@mHnHu jFph1UmHnHuh1mHnHu2joh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHujh1UmHnHu _ _ _______/_0_1_2_C_D_E_^___`_b_c_d_e_f_g______²¤¤vve²¤K¤2jrh.h1>*B*UmHnHphu j2rh1UmHnHuh1mHnHu2jqh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu j*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHuh@@mHnHu j(sh1UmHnHujh1UmHnHuh1mHnHu*`+`,`2`3`4`M`N`O`Q`R`S`T`U`V`q`r`s`t````````````źv\źK j vh1UmHnHu2juh.h1>*B*UmHnHphuh1mHnHuh15CJ\aJmHnHuh@@mHnHu juh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jth.h1>*B*UmHnHphu`````````aaaa a a a a a(a)a*a+a8a9a:aSaTaUaWaXaYaλ񰡰x^񰡰M jwh1UmHnHu2j{wh.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu jwh1UmHnHujh1UmHnHuh1mHnHu$jh.h10J'UmHnHu2jvh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuYaZa[a\awaxayazaaaaaaaaaaaaaaaaaaaaaaaaѮѣx^ѣMx jyh1UmHnHu2jgyh.h1>*B*UmHnHphuh@@mHnHu jxh1UmHnHujh1UmHnHuh1mHnHu2jqxh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuh1CJaJmHnHuaaaaaabbbb%b&b'b@bAbBbDbEbFbGbHbIbdbebfbgb~bbbbb¹Ÿ”x¹^”M j{h1UmHnHu2jS{h.h1>*B*UmHnHphuh@@mHnHu jzh1UmHnHuh1mHnHu2j]zh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHujh1UmHnHubbbbbbbbbbbbbbbbbbbbcccccc c!c1c2c3cҴҴuhҴNҴ2j?}h.h1>*B*UmHnHphuh1CJaJmHnHu j|h1UmHnHuh1mHnHu2jI|h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu3cLcMcNcPcQcRcScTcUcpcqcrcsccccccccccccccccccշyhշN2j+h.h1>*B*UmHnHphu j~h1UmHnHu2j5~h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu j}h1UmHnHuh1mHnHucccccddddddd"d#d$d%d@dAdBd[d\d]d_d`dadbdcdddddd淪yh淪N2jh.h1>*B*UmHnHphu jh1UmHnHu2j!h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHuddddddddddddddddddddde e e e eeeee,e-eԴũߓyhũߓ jh1UmHnHu2j h.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu-e.e/eJeKeLeeefegeiejekelemeneeeeeeeeeeeeeeeeeźӂy_źNӂ jth1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHuh@@mHnHu j~h1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jh.h1>*B*UmHnHphueeeeefffff f"f#f$f%f&f'fBfCfDfEfSfTfUfnfofpfrfsftfufλ谡x^谡Mx j`h1UmHnHu2jh.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu jjh1UmHnHujh1UmHnHuh1mHnHu$jh.h10J'UmHnHu2jh.h1>*B*UmHnHphuh.h10J'mHnHuh1mHnHue%fuff(gggMhhLii~j'kkll mm3nn(ooppqq6r $ $ $ $ $ufvfwfffffffffffffffffffffggg!g"g#g%g&g߼߱y_߱N jLh1UmHnHu2jчh.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu jVh1UmHnHujh1UmHnHuh1mHnHu2jۆh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu&g'g(g)g*gEgFgGgHgagbgcg|g}g~gggggggggggggggүҤyjPҤ2jh.h1>*B*UmHnHphuh156\]mHnHuh@@mHnHu jBh1UmHnHujh1UmHnHuh1mHnHu2jLjh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuggggggggggggg+h,h-hFhGhHhJhKhLhMhNhOhjhkh²¤¤vveV¤h156\]mHnHu j.h1UmHnHuh1mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu j8h1UmHnHukhlhmhhhhhhhhhhhhhhhhh*i+i,iEiFiGiIiJiKiźv\źK jh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh15CJ\aJmHnHuh@@mHnHu j$h1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jh.h1>*B*UmHnHphuKiLiMiNiiijikiliiiiiiiiiiiiiiiii\j]j^jwjxjyj{jѮѣx^ѣMx jh1UmHnHu2jh.h1>*B*UmHnHphuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuh1CJaJmHnHu{j|j}j~jjjjjjjjkkkk k!k"k$k%k&k'k(k)kDkEkFkGkxkykzk¹Ÿ„sh¹N„2jwh.h1>*B*UmHnHphuh@@mHnHu jh1UmHnHuh1mHnHuh.h10J'6mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHujh1UmHnHuzkkkkkkkkkkkkkkkkklllllllll5l6l7l8lnlշyhշN2jch.h1>*B*UmHnHphu jh1UmHnHu2jmh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu jh1UmHnHuh1mHnHunlolplllllllllllllllllmmm m m m m mm)m*m+m淪yh淪N2jOh.h1>*B*UmHnHphu jԓh1UmHnHu2jYh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu jޒh1UmHnHujh1UmHnHuh1mHnHu+m,mimjmkmmmmmmmmmmmmmmnnn,n-n.n0n1n2n3n4n5nPnQnԴũߓyhũߓ jh1UmHnHu2jEh.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHuh@@mHnHu jʔh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuQnRnSnnnnnnnnnnnnnnnnnnooo!o"oźӂy_Oź> jh1UmHnHuh.h10J'5mHnHu2j1h.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2j;h.h1>*B*UmHnHphu"o#o%o&o'o(o)o*oEoFoGoHogohoioooooooooooooooooҷҷxhҷNҷ2jh.h1>*B*UmHnHphuh15CJ\aJmHnHu jh1UmHnHuh1mHnHu2j'h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHuop p p p ppppp,p-p.p/papbpcp|p}p~ppppppppppppշyhշN2j h.h1>*B*UmHnHphu jh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu jh1UmHnHuh1mHnHupppqqqqqqqqq4q5q6q7q|q}q~qqqqqqqqqqqq淪yhXh15CJ\aJmHnHu jzh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHuqqqrrr/r0r1r3r4r5r6r7r8rSrTrUrVrWrrrrrźӂy_Nź!h.h10J'\]mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHuh@@mHnHu jph1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jh.h1>*B*UmHnHphurrrrrrrrrrrrr s s s$s%s&s(s)s*s+s,s-sHsIsµ§§yyhX§h15CJ\aJmHnHu j\h1UmHnHuh1mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu jfh1UmHnHu6rr+sstitt,uuvvww xxyy'zz;{{7||,}} ~~ $ $ $ $ $IsJsKsssssssssssssssssssst t t t ttźv\źK jHh1UmHnHu2j͠h.h1>*B*UmHnHphuh1mHnHuh15CJ\aJmHnHuh@@mHnHu jRh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jןh.h1>*B*UmHnHphutttt,t-t.t/tGtHtItbtctdtftgthtitjtktttttttttϬϡvfLϡ2jh.h1>*B*UmHnHphuh15CJ\aJmHnHuh@@mHnHu j>h1UmHnHujh1UmHnHuh1mHnHu2jáh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuh156\]mHnHuttttttttttttt u u u%u&u'u)u*u+u,u-u.uIuJuKuLuu²¤¤vve²¤K¤2jh.h1>*B*UmHnHphu j*h1UmHnHuh1mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu j4h1UmHnHuuuuuuuuuuuuuuuuuuuuvvvvvvvvv8v9v淧ve淧 jh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHuh@@mHnHu j h1UmHnHujh1UmHnHuh1mHnHu9v:v;vkvlvmvvvvvvvvvvvvvvvvvw w w w wwwwwźӂy_źNӂ jh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHuh@@mHnHu j h1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jh.h1>*B*UmHnHphuw,w-w.w/wuwvwwwwwwwwwwwwwwwwwwwxxxxxx xλ谡x^谡Mx jh1UmHnHu2jsh.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHu$jh.h10J'UmHnHu2j}h.h1>*B*UmHnHphuh.h10J'mHnHuh1mHnHu x x x&x'x(x)xixjxkxxxxxxxxxxxxxxxxxyyyyy߼߱y_߱N jګh1UmHnHu2j_h.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHu2jih.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuyyyyy8y9y:y;yyyyyyyyyyyyyyyyyzzz z!z"zүҤy_ҤN jƭh1UmHnHu2jKh.h1>*B*UmHnHphuh@@mHnHu jЬh1UmHnHujh1UmHnHuh1mHnHu2jUh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHu"z$z%z&z'z(z)zDzEzFzGzzzzzzzzzzzzzzzzz{{{3{ӸӸyӸ_Ӹ2j7h.h1>*B*UmHnHphu jh1UmHnHuh1mHnHu2jAh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHujh1UmHnHuh@@mHnHu3{4{5{8{9{:{;{<{={X{Y{Z{[{{{{{{{{{{{{{{{{{||µ§§yyhµ§N§y2j#h.h1>*B*UmHnHphu jh1UmHnHuh1mHnHu2j-h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu jh1UmHnHu||/|0|1|4|5|6|7|8|9|T|U|V|W|||||||||||||||||𶩶xg𶩶M2jh.h1>*B*UmHnHphu jh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu jh1UmHnHuh1mHnHujh1UmHnHu| } } }$}%}&})}*}+},}-}.}I}J}K}L}w}x}y}}}}}}}}}}}}׻רxg׻ר jh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu}}}}}}~~~~ ~ ~ ~ ~ ~(~)~*~+~z~{~|~~~~~~~~~źv\źK jlh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh15CJ\aJmHnHuh@@mHnHu jvh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jh.h1>*B*UmHnHphu~~~~~~34589:;<=XYZ[λ񰡰u[񰡰J jXh1UmHnHu2jݷh.h1>*B*UmHnHphuh15CJ\aJmHnHuh@@mHnHu jbh1UmHnHujh1UmHnHuh1mHnHu$jh.h10J'UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu~;R? {_ń,jÇ1 za؊ $ $ $/01JKLOPQRSTopqrݿݿuݿ[ݿ2jɹh.h1>*B*UmHnHphuh@@mHnHu jNh1UmHnHuh1mHnHu2jӸh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHujh1UmHnHuՀր׀؀789<=>?@A\]^_~µ§§yyhµ§N§y2jh.h1>*B*UmHnHphu j:h1UmHnHuh1mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu jDh1UmHnHu5678𶩶xg𶩶M2jh.h1>*B*UmHnHphu j&h1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu j0h1UmHnHuh1mHnHujh1UmHnHu8abc|}~ )*׻רxg׻ר jh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu*+,XYZstuxyz{|}źӂy_źNӂ jh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jh.h1>*B*UmHnHphu#$%&<=>WXY\]^_`a|}~„ÄĄńλ谡x^谡Mx jh1UmHnHu2joh.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHu$jh.h10J'UmHnHu2jyh.h1>*B*UmHnHphuh.h10J'mHnHuh1mHnHuńƄDŽ $%&)*+,-.IJKL}~߼߱y_߱N jh1UmHnHu2j[h.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHu2jeh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu ./01opqүҤy_ҤN jh1UmHnHu2jGh.h1>*B*UmHnHphuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHu2jQh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuІц҆8;GHӸӸyӸ_ӸOh.h10J'\mHnHu2j3h.h1>*B*UmHnHphu jh1UmHnHuh1mHnHu2j=h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHujh1UmHnHuh@@mHnHuHIbcdghijkl‡ÇćŇ𶩶xg𶩶M2jh.h1>*B*UmHnHphu jh1UmHnHu2j)h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu jh1UmHnHuh1mHnHujh1UmHnHu )*+./0123NOPQpqrֶǫǘhWǫǘ jh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHuh.h10J'\mHnHuh.h10J'mHnHu ؈ڈ '()*WXYrŵŪriOŪ2jh.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHuh.h10J'\mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2j h.h1>*B*UmHnHphurstwxyz{|׉؉ى>?µ§§yyhµ§N§y2jh.h1>*B*UmHnHphu jrh1UmHnHuh1mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu j|h1UmHnHu?@YZ[^_`abc~ЊъҊՊ֊׊؊يڊ𶩶xhW𶩶 j^h1UmHnHuh.h10J'\mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu jhh1UmHnHuh1mHnHujh1UmHnHuIJKdefijklmnɋʋˋźӂy_źNӂ jJh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHuh@@mHnHu jTh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jh.h1>*B*UmHnHphu؊l[ی7 ~؎G̏fېf͑J&| \ $ $ $ $ 89:STUXYZ[\]xyz{ӌλ谡x^N谡h.h10J'\mHnHu2jh.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu j@h1UmHnHujh1UmHnHuh1mHnHu$jh.h10J'UmHnHu2jh.h1>*B*UmHnHphuh.h10J'mHnHuh1mHnHuӌԌՌ،ٌڌی܌݌/01456789TUVWµ§§yyhµ§N§y2jh.h1>*B*UmHnHphu j,h1UmHnHuh1mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu j6h1UmHnHuƍǍȍɍ &'()𶩶xg𶩶M2jh.h1>*B*UmHnHphu jh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu j"h1UmHnHuh1mHnHujh1UmHnHu)[\]vwx{|}~ЎюҎՎ֎׎؎َڎ׻רxg׻ר jh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$%&?@ADEFGHIdefgďŏƏɏʏˏ̏͏Ώźӂy_źNӂ jh1UmHnHu2juh.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jh.h1>*B*UmHnHphuΏCDE^_`cdefghӐԐՐِؐڐېλ谡x^谡Mx jh1UmHnHu2jah.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHu$jh.h10J'UmHnHu2jkh.h1>*B*UmHnHphuh.h10J'mHnHuh1mHnHuېܐݐCDE^_`cdefghőƑǑʑˑ߼߱y_߱N jh1UmHnHu2jMh.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHu2jWh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuˑ̑͑Αϑ'()BCDGHIJKLghijүҤy_ҤN jh1UmHnHu2j9h.h1>*B*UmHnHphuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHu2jCh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuʒ˒̒͒ #$%&'(CDEFӸӸyӸ_Ӹ2j%h.h1>*B*UmHnHphu jh1UmHnHuh1mHnHu2j/h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHujh1UmHnHuh@@mHnHuۓܓݓޓYZ[tuvyz{|}~ҔӔµ§§yyhµ§N§y2jh.h1>*B*UmHnHphu jh1UmHnHuh1mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu jh1UmHnHuӔԔpqr𶩶xg𶩶M2jh.h1>*B*UmHnHphu jh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu jh1UmHnHuh1mHnHujh1UmHnHu4567–ݖޖ׻רxhW׻ר jnh1UmHnHuh.h10J'6mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu jxh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu ޖߖ *+,-9:;TUVYZ[źv\źK jZh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh15CJ\aJmHnHuh@@mHnHu jdh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jh.h1>*B*UmHnHphu[\]^yz{|֗חؗۗܗݗޗߗ9:;TUVϬϡv\ϡK jFh1UmHnHu2jh.h1>*B*UmHnHphuh@@mHnHu jPh1UmHnHujh1UmHnHuh1mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuh156\]mHnHu\ޗ\5V&K#zѝ0]~, $ $ $ $VYZ[\]^yz{|ژۘܘݘ-ӵӵviӵOӵ2jh.h1>*B*UmHnHphuh1CJaJmHnHu j<h1UmHnHuh1mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHujh1UmHnHuh@@mHnHu-./234567RSTUљҙәԙµ§§yyhµ§N§y2jh.h1>*B*UmHnHphu j(h1UmHnHuh1mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu j2h1UmHnHu!"#$345NOPSTUVWXstuv𶩶xg𶩶M2jh.h1>*B*UmHnHphu jh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu jh1UmHnHuh1mHnHujh1UmHnHuvȚɚʚ˚ #$%&'(CD׻רxg׻ר jh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu j h1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHuDEFǛțɛʛ()*Cźv\Lźh.h10J'^JmHnHu2jqh.h1>*B*UmHnHphuh1mHnHuh15CJ\aJmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2j{h.h1>*B*UmHnHphuCDEHIJKLMhijkŜƜµ§§yyhY§h156\]mHnHu jh1UmHnHuh1mHnHu2jgh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu jh1UmHnHuƜǜȜ !"#$%@ABCWXYrstwxyźv\źK jh1UmHnHu2jSh.h1>*B*UmHnHphuh1mHnHuh15CJ\aJmHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2j]h.h1>*B*UmHnHphuyz{|ɝʝ˝ΝϝНѝҝӝ ()*-Ѯѣx^ѣMx jh1UmHnHu2j?h.h1>*B*UmHnHphuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHu2jIh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuh1CJaJmHnHu-./012MNOPyz{֞מ؞ݿ݌peݿKݿ2j+h.h1>*B*UmHnHphuh@@mHnHu jh1UmHnHuh1mHnHuh.h10J']mHnHu2j5h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHujh1UmHnHu:;<UVWZ[\]^_z{|}µ§§yyhµ§N§y2jh.h1>*B*UmHnHphu jh1UmHnHuh1mHnHu2j!h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu jh1UmHnHuן؟ٟڟ89𶦶ud𶦶 jh1UmHnHu2j h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHuh@@mHnHu jh1UmHnHuh1mHnHujh1UmHnHu9:;[\]vwx{|}~źv\źK jth1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh15CJ\aJmHnHuh@@mHnHu j~h1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jh.h1>*B*UmHnHphu6789vwx $%&)λ񰡰u[񰡰J j`h1UmHnHu2jh.h1>*B*UmHnHphuh15CJ\aJmHnHuh@@mHnHu jjh1UmHnHujh1UmHnHuh1mHnHu$jh.h10J'UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu)*+,-.IJKL̢͢΢Ϣݿݿuݿ[ݿ2jh.h1>*B*UmHnHphuh@@mHnHu jVh1UmHnHuh1mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHujh1UmHnHu !"#>?@Adefȣ²¤¤vve²¤K¤2jh.h1>*B*UmHnHphu jBh1UmHnHuh1mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh15CJ\aJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu jLh1UmHnHu!GdեFKW%trtvx|~gdV$ $ $ $ $ȣɣʣ $%&?@ADEFGHIde淨wfVh15CJ\aJmHnHu j.h1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh156\]mHnHu$jh.h10J'UmHnHuh@@mHnHu j8h1UmHnHujh1UmHnHuh1mHnHuefg~ߤźv\źK jh1UmHnHu2jh.h1>*B*UmHnHphuh1mHnHuh15CJ\aJmHnHuh@@mHnHu j$h1UmHnHujh1UmHnHuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jh.h1>*B*UmHnHphu !"ABC\]^abcdefѮѣx^NNh.h10J'mHnHsH u2j h.h1>*B*UmHnHphuh@@mHnHu j h1UmHnHujh1UmHnHuh1mHnHu2jh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHuh1CJaJmHnHuͥΥϥҥӥԥե֥ץ#$%>?@CDEFԸԥgWFԸԥ j h1UmHnHuh.h10J'mHnHsH u2j h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu j h1UmHnHujh1UmHnHuh1mHnHu"h.h10J'6mHnHsH uFGHcdefxyz̦ͦΦ߼߱y_߱N j h1UmHnHu2jm h.h1>*B*UmHnHphuh1CJaJmHnHuh@@mHnHu j h1UmHnHujh1UmHnHuh1mHnHu2jw h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHu$jh.h10J'UmHnHu ()*CDEHIJKLMhijkүҤy_ҤN jh1UmHnHu2jYh.h1>*B*UmHnHphuh@@mHnHu j h1UmHnHujh1UmHnHuh1mHnHu2jc h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuçħŧƧ֧קا456OӸӸyӸ_Ӹ2jEh.h1>*B*UmHnHphu jh1UmHnHuh1mHnHu2jOh.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHujh1UmHnHuh@@mHnHuOPQTUVWXYtuvwԨը֨רµ§§yyhµ§N§y2j1h.h1>*B*UmHnHphu jh1UmHnHuh1mHnHu2j;h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHujh1UmHnHu jh1UmHnHu"#$%&'BCDEQRSlmnqrstuv𶩶xgXh156\]mHnHu jh1UmHnHu2j'h.h1>*B*UmHnHphuh1mHnHuh.h10J'mHnHuh1CJaJmHnHu$jh.h10J'UmHnHuh@@mHnHu jh1UmHnHuh1mHnHujh1UmHnHu,.0bdflnpr~űŦ{pleMF;7hhB&hCJ!aJ! hB&h.jh156;CJOJQJU\]aJ hV$hV$hV$h10J'mHnHuh@@mHnHu jh1UmHnHujh1UmHnHuh1mHnHu'h.h10J'OJQJ^JmHnHuh.h10J'mHnHu$jh.h10J'UmHnHu2jh.h1>*B*UmHnHphuĶŶ]^/0 $h7$8$H$^hgdR $h7$8$H$^hgdJ & F 8$7$8$H$^gdcO $7$8$H$gd~ gd< gdTgdzgdS)EM h: )\]^./04deҺӺԺʻ˻̻ӽԽսY9:;ǹǹǹǹǹǹǪǹǹhR hJh~hu h~hR h~hJh~hJhPh9Chnfhhj h~h~hhB&hCJaJ hB&hTC0deӺԺ˻̻Խ:;  $h7$8$H$^hgdR $h7$8$H$^hgdJ & F 8$7$8$H$^gdcO; STU56789:`a01OPQĵϢ|sohohohoh hB&hT`hT`hCm1hT`0Jhv/j3:hiUjh~\UmHnHuh~\jh~\Uh jhU7hHqCJUaJjDD hHqCJUVaJhU7hT`CJaJjhU7hT`CJUaJhThph~CJaJ h~hRh~ h~h~& TU`ab012OPQgdxgdzgdT`gdCm1 ^`gdJ & F 8$7$8$H$^gdcO $h7$8$H$^hgdRQBXilmno{ !$)*0Ƿǰ}qjc\Xchj h_ho h_h~ h_h>ehB&h>e0JaJh hB&hc hB&ho hB&h>e hB&h/q hB&h{hB&h]hB&h\ hB&hhB&h>e0J5CJ!\aJ!hB&h0J5CJ!\aJ! hB&h#h# hx5 hxPJhx hT`PJhB&hT`PJ"jklmno 2367gdjc?gd~`  gd_gd_ gd5gd>egdzgdx&$d%d&d'dNOPQgdx0123 567`g 39<EILfĽ}}uhB&h5 hB&h\F hB&h hB&h22 hB&hf hB&hY< hB&h+U8 hB&hhB&h5 hB&h hB&hc hB&h b hjc?]hwphjc?5\]hjc?5\] hjc?\]hjc? hB&ho h_hohj.7+,-qr(~gd>e  gd@  gd[9&$d%d&d'dNOPQgdJgdzgd~`flmnorsv056OR-.7oqxսնxthEhB&h \ hB&h hB&h"\ hJhKQ hJh"hB&hW'>*CJhB&ho5 hB&h" hB&hohB&hY<5hB&h5hB&h5 hB&hY< hB&h+U8hB&h225 hB&h hB&h22 hB&h+9Ta/SW\-0LOl| "𻴪𪜕x hB&ho hB&h hJhJh>eh hJh>e hE>*CJ hB&h]hB&h">*CJ hJh" hB&h@&hB&h1Q\hB&hW'\hB&h \hEhB&h"5\hB&h"\ hB&h"hB&h"5-+ !Fz+ $$d%d&d'dNOPQgdS!* $d%d&d'dNOPQgdS! gd@gdzgd~`gdJ  gd?""&+0347>JMx !:æveaZS hB&h3+ hB&hfhE hS!hS!CJOJQJ^JaJ hS!h-KCJOJQJ^JaJ hJh-KCJOJQJ^JaJhS!CJOJQJ^JaJ hB&hhH hB&hEXT hB&h.g.hB&h.g.5hB&ho5\hB&h-K5 hB&h-K hB&h^hB&h^5 hB&h hB&ho hB&h>e ;ijkWXYgd" gd gdJgdzgdE+ $$d%d&d'dNOPQgdS!:;@CDKQUWbcsw=FNOPX^cn!,ž򺳪㣜||||uu hB&h+=f hB&h22 hB&hdhEht=U>*hB&ht=U5\ hB&ht=U hB&hohB&ho^J hB&h$h.I hB&hD hB&hFhEhF>*hEho>* hB&hd hB&h^hB&h^5 hB&ho hB&hf.,-RZ[`afg (,-6=MPijkWXYĽĽy hB&h.g.hEhE>* hS!hEhEhB&h U5hEha>*hB&ha5 hB&hahx hB&ho hB&h$ho h$5\h$hB&ht=U5\ hB&h9t hB&hN hB&h+=f hB&ht=U hB&hd-[$%@ & FgdJ  gdwp gdwpgdS!gdS!gdz* $d%d&d'dNOPQgd0&$d%d&d'dNOPQgdJ79R[`dktu{"$%)yung hB&h hB&h9th$ hJhQP hJhlO hJhhB&hz1>*CJ hJhz1 hB&hz1hEhS!>*hEhEhS!5 hS!hS!hS!he hB&hoho hB&h.g. hB&ht=U hB&h UhB&he5hB&h U5 hB&he'),-5AB_chiq @W`ahiopqļ˵Ĝ˜ˍĆģxqxghB&hf\] hB&h. hB&hsg: hB&hIK hB&hf hB&hy:hB&hm=H* hB&hm= hB&hU  hB&hJhN hB&h]hB&hQP 5 hB&hN hB&hQP hB&hAhB&h6 hB&h hB&hlO hB&h;hB&h5\(@p5 ?@"78h^hgd@@ & Fgd@@ & Fgd_L( & FgdJ  gdH0gdz gdS$ & Fgd & Fgd$ & FgdJ45 (,=?@DGHQ^{| !"ùèҚÐwpppplh_L( hB&huqhB&hy:5 hB&hS$hB&hS$5]hB&hS$\] hJh hJhy: hJhS$hB&hy:>*CJhB&hy:\] hB&hy:hh5hhB&hU \]h0 hB&hQP h$hB&hN\] hB&hsg:*0BO56789Qin~KMNy#),-FGZ[}vo h >*CJ h 5\h >*\]h h \]h 6\] hlhlhlhl56 hl6 hNx6 hk} 6 hNx5hNxhlhB&he>*CJhYh@@ hB&hjhB&hj\]hB&hYI\] hB&hYI hB&huq+8z,-.FGZ[v@AVSTgogd9gd9gd6/hgd gdk}  gd gd  gdk} gdNxgdNx[N[KNO@ApST-0opq0½¶~~~~phcOhGk\]mH sH h1{\hGk6\] hGk\]h >*\] h 5] h ] h9*6h9*6h75CJPJ] h7\] h95h9h7 h9*6\]h >*CJ\]hNx hNx\]h h 5\h >*\] h \]+op\&89:VPgd#C  gd#Cgdm  gdm gd G$gd  & F $G$gdGk & F $gdGkgd9*6gd gd 0D\PT68:UV[lpuyNOPQR`ۿ}oaZ h@hhB&h5CJPJ\h#CCJOJQJ^JaJ hB&h#CCJOJQJ^JaJ hB&h#C hZh#Ch#C h#C\] hm6 hm5hmh >*CJ\] h \]h1{\hGk\]h1{\hGk6\] hGk\]hcOhGk\]mH sH hcOhGk6\]mH sH !PQ`aRSkTLACDEFs gd@gd  gd@gd@gdzgd@gd `abef}RSWZkUy"(be}»~www hB&hhB&h!5hB&h({5 hB&h({ hB&hK h@hWU hB&hF;'hB&h5\ h@hJ h@h hB&h! hB&hQk hB&hb hB&hNDgdxdgdgd~`&$d%d&d'dNOPQgdxdgdzAEFGSU !>ȻȪȖȖȏֻȈȈȏȄyupup hxd5hxdhB&hDpCJaJh hB&h! hB&h%hB&h5hB&h6CJ]hB&h5\ hB&h41w hB&h.g h:CJ hB&h hB&hUn hhh: h:hxdCJOJQJ^JaJhj6oCJOJQJ^JaJ,ABP^_j(;<Ngdcgdcgd: & Fgd: gd41w gd%8gd~`gdz 015=@ABPms^_j&(+29;<Nclo3\auxණvrhchB&hPJhB&h~mCJaJhB&h\ h:hh hB&hqi hB&h%hB&h%mH sH hB&hmH sH h: hhhB&h%>*CJhB&h5\ hB&h hB&h%8h%8 hB&h hB&hWU+46rs56j4;       üÐh5uh\hh h5uh hc>*CJ hxd>* hxd5hxd hB&h: hB&hh3T h:hh:h UhcCJaJ hB&hchB&hc5\hc h Uhc856s6<gdxdgdzw_gdcgdcgdz&$d%d&d'dNOPQgdc<=b  &     !!!0! $$Ifa$gd=gdzgd5u gdxd & F gdxdgdc & F gdxdgdxd   ! !!!!/!1!9!$$Ifl0;%0/%64 la """"### $%%'')'|'}xs}s}}s}gdVgdgdzgd(gdcskd>$$Ifl0;%0/%64 la  #### ####### $ $ $%%%%% &!&$&%&'''''(')'|'}'''''''=(>(H(¾¾¬¾vkgh7h6M5CJPJ\hB&h4CJ]hB&h\hlQ5CJPJ\ hB&hd0hB&hM5CJ]hB&hM5\ hB&hM5hc5CJPJ\hy hVh hhhB&h>*hB&h56 hB&hhB&h~m6CJaJhB&h~mCJaJ'|'}''=(>(`((((j)k)|))))\*t*++.+X+ gdV $X B&dPgdV gdVgdVgdV gdgd\gd\gdzgd3H(L(_(`((((((((((((((((((((($)C)j)k)z){)|)))))))))))**\*]*r*s*t***+žžŶŭšŌłhB&h5\h6M5CJPJ]hB&h]*aCJ]hB&h\hVhB&h^JhB&h>* hB&h]*a hB&hhy hVh hQh\h xhc~h5 hQhQh\h7 h\h\2+.+9+<+^+_+b+++++++++,#,$,&,C,T,V,X,u,v,,,,,,---#-K-L-M-T-W-X-i-q-|-}------..𶲫hVhVh3CJaJh6M5CJPJ\ hB&h3h hB&hvhvhh3h5hB&h5hyCJaJhB&hCJaJh. hB&hHhVh3 hB&hhVh52X+++++,C,u,v,,--#-@-L-X-|-}-- gdlQ $"gds $!gds $X &dPgd3 gd3gdz gdV gdV gdV-..(..{/|/////R0S0T0a0b00051z1{1122 7$8$H$gd#{#gd#{#gd#{# gd#{#gdVgd3gdz.&.'.(......{/|/////Q0a0b0l0p0q00000k1l11122222'2(2+222@2P222222Q3r3s33žźųųųōɺžžʼnɺł hUh#{#h h#{#>*CJh#{#CJOJQJ^JaJ h3eh#{#CJOJQJ^JaJ h3eh#{#hb hB&h#{#h#{# h3h#{#hV5CJPJ\ hVhV hB&hhB&h5hhy h3h/22'2(222222r3s333333-4j4444445515 $gdbgdbgd#{#gd#{#  gd#{#3444444455051525w5x5555555061696Y6c6d66666%7&7=7m7r7|77788xxjh':CJOJQJ^JaJhCJOJQJ^JaJhBpCJOJQJ^JaJ hbhbCJOJQJ^JaJ hbhbCJOJQJ^JaJhbhBpCJaJhBpCJaJhbCJaJhbhbCJaJhbh h':>*CJh#{# hUh#{#CJOJQJ^JaJ(15x55516d666&7o77888*8<8}8888888i9j9w9 $gd gdC gd gd $gdb888)8*8;8<8|8}888888888888g9i9j9v9w999::B:C:U:t:u:}:::::;;a;¾xxxxjxjxxxh+pCJOJQJ^JaJ h h CJOJQJ^JaJ h h CJOJQJ^JaJh CJOJQJ^JaJhC h h hC hC h':h hbCJOJQJ^JaJ hbhbCJOJQJ^JaJ hbhbCJOJQJ^JaJhCJOJQJ^JaJ)w99:C:u:::;f;;;;<<<<<<<====gdzgd~` gd !G  gd gd58gdIuNgd58gd s $gd a;b;e;h;;;;;;;;;<<<<<<M<b<<<<<<<<<<*=-=z========·{{wslelah h~`h. h~`hh !Ghy hB&hWU hB&hh?]- h sh hIuNhIuNhB&hIuN\] hB&hIuNhIuN h shIuNhIuN5CJPJ\ h h CJOJQJ^JaJh7CJOJQJ^JaJ h h CJOJQJ^JaJh CJOJQJ^JaJ&===========>>>> >!>9>:>@>A>B>>>>>>>>>>$?%?R?S?????0@1@N@l@m@n@o@̷̻shBaCJOJQJ^JaJ hBhBCJOJQJ^JaJ hBhBCJOJQJ^JaJhBhAfDOJQJ^J hw hw h !G h !Gh !GCJOJQJ^JaJ#h !GB* CJOJQJ^JaJphhl7hBa hThw hChw h?]-h~`hw -===>>>>%?S???1@m@o@@@@+AnApAAA-B|BBC $gdBgdC $gd !Ggdw  gdpo@@@@@@@*A+AKAmAnAoApAAAAAA,B-B{B|BBBCCCC&CCAC_CcCqCrCxCCCCCCCɴɴɴްxhcOh=\]mH sH h1{\h=6\] h=\] h !G5 hIuNh !GhP0h !G5h !GhB(hcOhBCJOJQJ^JaJmH sH (hcOhBCJOJQJ^JaJmH sH hBhBCJOJQJ^JaJ hBhBCJOJQJ^JaJ,CC^C_CCCDeDDDDDEE:E*h1{\h=\]h1{\h=6\] h=\]hcOh=\]mH sH hcOh=6\]mH sH !FFFFGGGGG H H;HHHI8I9IdIeIrIsIII gd !Ggd !Ggd~` gd+% $gd+%gdzgdgd+%gd?]- $gd"^GlGtGwGGGGGGGGG H H H H:H;HHHHHHIII7I9IcIeIfIrIsIIIIIIIIIIIKK&K)KŴũũ}}uhB&h !G5h)UhB&h !G5\ h?]-h !G hB&h !Gh !G h sh h?]-\h)rh+%CJaJ h)rh+%CJOJQJ^JaJhP0CJOJQJ^JaJhP0hP05h~`h hB&hWx hB&h.hah1Q5 hB&h1Q.I(K)KcKeKKKLbLLLAMMM N!NLNMNNNjNkNlN&$d%d&d'dNOPQgd.gd.gdgd !G $gd !G gd !G)K1K2KbKcKdKeKKKKKLLaLLLLLM%M&M@MaMMMMMNN!NKNLNMNNNiNjNlNqNvNyNzNNNN OOOO.O/O2OLOMOĽhVBhB&h5\h-v hB&h.hAfDh.5hHxh.5h.h hB&h h !Gh !Gh !Gh !GCJOJQJ^JaJh)rh !GCJaJ h)rh !GCJOJQJ^JaJ h !G5hP0h !G54lN O O OOOOOPPFP{PPPQOQQQRMRpRgd-v $gd.r $gd. gd.&$d%d&d'dNOPQgd.MOOOOOOPPPP&P'PEPFPzP{PPPPPQQNQOQQQQQRRLRMRNRpRqRrRsRxR}RRRRRRSSSS S!Sʹ°hVBhB&h5\ hB&hYahAfDhYa5hHxhYa5hYa hB&hh-vhfTCJOJQJ^JaJh-vh.rCJaJ h-vh.rCJOJQJ^JaJh-vh?]-CJaJh?]-h?]-5h.rh. hVBh.1pRqRrRsRSSSSSSSSTTNT~TTTGUqUrU $gd+% $gd?]-gdAfD gdYa&$d%d&d'dNOPQgdYagdz!S"SASPSSSSSSSTTTTMTNT}T~TTTTTFUGUWUpUqUrUsUUUUUUV V*V,V0V6V7V8V9V:V?V@VGVfVkV{VVźźźźźźźŬ h sh2Qh2Qh)!3h)!35h)!3h____/`0`1`2`x`y`z```` gdH gd'n&$d%d&d'dNOPQgd s gd s gd_____0`1`2`x`y`z`}`````OaPaQaaaa'b(b)bxbybdddeeeeeee ff"f#f$f%f&f_fž})ht>h)rB*CJOJQJ^JaJphh)rhl0haJhl0haJhB&hCJOJQJaJ hB&h h hh h hh'nh sh+hB&h5hB&h5\ hB&h hB&h'nh.`OaPaQaaaa'b(b)bxbybbbbbddddd3e4eee gd ^gd sv^vgd v^vgdgdzeeeee f$f%f&fsftffgg]gkgggghhhXhYh&$d%d&d'dNOPQgd2*gd0gdz gd_fcfkfrfffffffff[i]idiiiiiiijj-l.lss>s@sBsDshsrsssԽԽԽԽԫԖ}yrkd]k hB&hR hB&hpj hB&h hzh2*h2*h#)hih)rB*CJOJQJ^JaJph)ht>h)rB*CJOJQJ^JaJph#h)rB*CJOJQJ^JaJph,hcOhcO5B*CJOJQJ^JaJph)ht>h)rB*CJOJQJ^JaJph,h)rh)r5B*CJOJQJ^JaJph"Yhzh{hhhhhhiieifigihiiii2jqjjjjjjjj&$d%d&d'dNOPQgd2*jkk)k+kAkfkhkkkkk-lNlslullllll&$d%d&d'dNOPQgd2*&$d%d&d'dNOPQgd2*ll0mnnnnns@sBsDsFssstttttuuoupugd9" gdbk  gd^gd_w* gd  gdN gdNgdz&$d%d&d'dNOPQgd2*ssssss tttt't+t1t?tJtRtVtktsttttttttttttttttttttuuu u uu¾೺򡚖yr hB&h5lhB&hf5 hh5l hh'I hhvh hhfhj hh hh hB&h_:h!h^hCJOJQJ^JaJh9" hB&hfhbk hB&h'I-puquuuuu v4v^v|v}vvvwwMwNwmwwww+ $$d%d&d'dNOPQgd^&$d%d&d'dNOPQgd^wx9xTxnxxxxxx3y4y}y~y z z9zmznzzzzzzz+ $$d%d&d'dNOPQgd^9xSxTxmxnxxxxxxxx y+y2yeyuy|yz)z0z7z { {1{2{3{9{>{?{A{H{r{s{ٹٹٖٹslha]aVaV hhcgh hhvhj hB&h h>hn.0CJOJQJ^JaJ#h^h.5CJOJQJ^JaJ h^h.CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#h^hn.05CJOJQJ^JaJh^CJOJQJ^JaJ h^hn.0CJOJQJ^JaJ)h^hn.0B*CJOJQJ^JaJph!z{2{{H|I||||||||}}0}H}c}+ $$d%d&d'dNOPQgdm5gd~`gdzgd+ $$d%d&d'dNOPQgd^s{y{{{{{H|I|Q|R|a|c|||||||||||||}}}}/}0}G}H}I}b}c}x}y}}}}Ƹydydydydydydy(hzhm5CJOJQJ^JaJmH sH (hzhm5CJOJQJ^JaJmH sH (h~\hm5CJOJQJ^JaJmH sH (h~\hm5CJOJQJ^JaJmH sH hm5CJOJQJ^JaJ hB&hm5hm5 hm5hm5hv hB&hvhhcg5 hB&hcg hhcg hhv'c}y}}}}}~~~O~~~~~~~~EX+ $$d%d&d'dNOPQgdm5}}}}}}~~~~N~O~s~w~~~~~~~~~~~~~~~~ DEWXŴŢŢŴŴŴŴŴŴŴŴŴŴt hm5hZ{CJOJQJ^JaJhZ{CJOJQJ^JaJh2~5CJOJQJ^JaJ#hm5hm55CJOJQJ^JaJ hm5hm5CJOJQJ^JaJ hm5hm5CJOJQJ^JaJ(h~\hm5CJOJQJ^JaJmH sH (h~\hm5CJOJQJ^JaJmH sH (  tuvÀĀQRgdKgdz  gdjgdZ{ $gdZ{gdXmgdZ{+ $$d%d&d'dNOPQgdZ{   Yirstuvw޾޾}vaPa hm5hm5CJOJQJ^JaJ)jhm5hm5CJOJQJU^JaJ hm5hXmhm5hXmhZ{56 hZ{5hZ{hZ{5hZ{ hm5hZ{hm5OJQJ^J hm5hZ{CJOJQJ^JaJ hm5hZ{CJOJQJ^JaJh2~5CJOJQJ^JaJhZ{5CJOJQJ^JaJ#hm5hZ{5CJOJQJ^JaJ€ÀĀŀȀɀˀЀрӀڀNP&8SXY{ yupupuhdupu`YR hXh< hB&h=7hNhuhKhK5 hK5hK hB&h< hjh< hjh^ hjh)N hjhJ hjh.h hjhW{hj hjhj hm5>*CJh hm5hm5CJOJQJ^JaJ)jhm5hm5CJOJQJU^JaJ)ja?hm5hm5CJOJQJU^JaJRS>?@sυpq݆ &$d%d&d'dNOPQgdXgd~`gdzgdK&$d%d&d'dNOPQgdK!%&*+015=?@W^akrąDž΅ۅ  ;B23ɇʇ·ϾshaZ hQhQ hN>*CJhXh[H^JaJ hXhXCJOJQJ^JaJ#hXh[H5CJOJQJ^JaJ&hcOhcO5CJOJQJ\^JaJ&hXh[H5CJOJQJ\^JaJ hXh[HCJOJQJ^JaJhXCJOJQJ^JaJ hB&h p hXh hXh p hXh^ hXhN! 23ȇɇ=>yz{%Ugd~`gdz gd( gdNgdQ* $d%d&d'dNOPQgdX&$d%d&d'dNOPQgdX·Ӈԇ݇"ln׉ډ=>GOUZ_`aeqxz{ǽǶt`&hXh p5CJOJQJ\^JaJ hXh pCJOJQJ^JaJhXCJOJQJ^JaJ hB&h p hB&hJQ hB&h hB&hpj hB&hbA hB&hcg h( H* h( 5h( hN\] hQhpj hQh)N hQh. hQhJQ hQh[Hh hQh=7% $ELOT}vw|Ґې123{slsldYdjghGUjhGU h9hGh9hG5hhGhQ hB&h_hXh ^JaJhXh p^JaJ hXh CJOJQJ^JaJ#hXh p5CJOJQJ^JaJ&hcOhcO5CJOJQJ\^JaJ&hXh p5CJOJQJ\^JaJ hXh pCJOJQJ^JaJ"U'j|QRАѐҐRSgdGgdG* $d%d&d'dNOPQgdX&$d%d&d'dNOPQgdX3GHQRSTxƑБґّJQgnڒےݒ-4 8c>սսկսկկսսսսսhoShUh= 5 h= 5h= h hQh= hQhQ hX>*CJhcOhcO5CJOJQJhG5CJOJQJh9hGCJOJQJhGCJOJQJ h9hGh9hG5hGjhGU hG0J'0STpsڑRorɒ5gdG* $d%d&d'dNOPQgdG&$d%d&d'dNOPQgdG=>?TU|ɗgd~` gd= * $d%d&d'dNOPQgd= &$d%d&d'dNOPQgd= gd=  gd= >UX|ɗ̗#&GIQRۘޘ *WXZ_9:;.4ʞϞ"%)ֻ촮제 hO\] hU6h4 hU5hUhB&h p5CJPJ\ h= CJ h= 5CJ hS!hr9CJOJQJ^JaJhr9CJOJQJh= CJOJQJhQhQhQ5h= htOJQJh= OJQJ1#FGHIۘ *WXYZ9:+ $$d%d&d'dNOPQgdr9gdQgd= &$d%d&d'dNOPQgd= :[\+,-.st$%OԠ+X & F $G$gdO & F $gdO  gd&$d%d&d'dNOPQgdU gdUgdUgdU)78>estzԠ=GxymzѢ¾¥xxpxhB&h4:6hB&hK*6hB&h6 hB&hK*hB&h5 hB&h hB&hWU hB&hhhAn20JhhK*0Jh4h04h1{\hO\]hcOhO6\]mH sH hcOhO\]mH sH hO\]h1{\hO6\](Xx%&'()  $gd04&$d%d&d'dNOPQgd04&$d%d&d'dNOPQgdy#gdy#gdzgd4 & F $gdOѢҢ֢ݢ().8=GIy|ѧ֧קا٧:@| hoPJ hy#PJ h04CJh^ h;0J'jIgh;Ujh;U h;h;h; h@^ hsrh4hsr hsrCJhB&h045 hy#5hy# hB&h04 h6hB&h6hB&hAn26hB&hm6/ا٧~23ʩ˩̩]^gdy#&$d%d&d'dNOPQgdy#gdy# gdy#  $gdy#  gd'Ugdsr012]a̩ѩpquxx "#)P^_e}(2cdef}k˲˒~zuz hp(*5hp(*hDW~>*CJ\]hsFX>*CJ\] h04\]h1{\hB\]hcOhB6\]mH sH hcOhB\]mH sH h1{\hB6\] hB\] hy#6hohsFXhoS hy#5hy# hy#PJh3'h96 h96PJ-:}Ccd !"{&$d%d&d'dNOPQgdp(*gdp(* gdp(*  gdp(* gdsFX & F $G$gdB & F $gdBkаѰҰհ"'16@Bru|}ĵIQ^_ĶŶͶ%&'ce(V׾ӯ׫׫ӫӧà h6:hythLEh' h6:h'h?nphZ{5 h'5hythhZ{5hz)hZ{ h6:hZ{h hp(*5hp(*h]hp(*56 h6 hp(*6?{|&'(R׷/Z&$d%d&d'dNOPQgdZ{gdZ{ gdZ{ gdsFX&$d%d&d'dNOPQgdp(*()*xyz~UWXYZ[!gdz&$d%d&d'dNOPQgdytgdZ{gdZ{Vgvyzϻջ)=~UYZ[\_ )Gü|xrxmxmx hgV5 hgVCJhgV hB&hhB&h4:B*CJ,aJ,ph&hB&h4:5B*CJ(\]aJ(phhB&hB*CJ,aJ,ph hB&h h6:hV$hV$ hythyt hythZ{hLEhyth?nphyt5 hyt5 h6:hythZ{ h6:hZ{h'*   gdgV & FgdgV&$d%d&d'dNOPQgdgV gdgVgdgVgdgVgdzGNSXABCstvwx./4^mns  +9:C+,}yh = h =5 h =h =h$hcOh$6mH sH hcOhgV6mH sH hcOhgVmH sH hv\Zh$6hv\ZhgV6hr-v5CJPJ\hgV5CJPJhgV0J'OJQJjrhhgVUjhgVU hgV5hgV hgV>*/cd  QR & FgdgV. $d%d&d'dNOPQ^gdgV*$d%d&d'dNOPQ^gdgV ^gdgV & F gdgVgdgV RSuvwEF $gd & F $h^`gdcO $h8^8gd & F $h^`gdcOgdgVgdgV&$d%d&d'dNOPQgdgV&'TUuvw+,-a gdgdgVgdgV & F $h^`gdcO & F $h^`gdcO & F $h^`gdcO $gd & F $h@^`gdcO,eh.2:;<=DEx~ 56OABrstu\_qĿ̸}yrjrjrhB&h+5 hB&h+h0* h[`hS_ h[`h4:hT CJOJQJ^JaJ h^h#<CJOJQJ^JaJhI@lCJOJQJ^JaJ hB&hb\ hd#5hB&hS_5 hB&hS_ h^h+ h^hb\ h^h#< hB&h#<hT hM!> hgV5hgV);<=NOfe&$d%d&d'dNOPQgd^gdzgdT gdgVeW Ob23@A&$d%d&d'dNOPQgd^Atu#Lj)$$d%d&d'dNOPQa$gdT &$d%d&d'dNOPQgd[`gdz gdqgd[`qt ]hhp  ɻ{tletath-r hB&h[`h[`h05 hB&h0 hB&hG hB&h9hB&h.5 hB&h9 hB&h.h hB&h4: h[`h[`CJOJQJ^JaJh4:CJOJQJ^JaJ h[`h4:CJOJQJ^JaJh[`CJOJQJ^JaJhB&h+\ hB&h+hB&h+5#    gd+&$d%d&d'dNOPQgd[` gd0*gd~`gdz   89@GHIilmqszƾα|xtt||x|t|h-rh-h h-h-CJOJQJ^JaJ h-h{?CJOJQJ^JaJhHh{? h{?h{?h{?h5 hH5h{?h{?5h{?h5 h{?5h hB&h9h\ hB&h9hB&h95hr9hgH hB&hgH,BCVVV* $d%d&d'dNOPQgd{?* $d%d&d'dNOPQgd-* $d%d&d'dNOPQgdH+ $$d%d&d'dNOPQgd{?#ABCJK]^ev ?@QV^h׽wf h[`hp=CJOJQJ^JaJ#h[`hU5CJOJQJ^JaJ#h[`h95CJOJQJ^JaJ h[`hUCJOJQJ^JaJ h[`h9CJOJQJ^JaJh[`CJOJQJ^JaJhr9hp1hSh hB&hh{? h{?hS h{?h{?hhh" ?@VWXq~gdgd~`gd\&$d%d&d'dNOPQgd[` gd0*hit 67<=W}~°аааАqmib^Z^U^U^ h5h0*h h\aJhh{?hr9 h[`h[`CJOJQJ^JaJh9CJOJQJ^JaJ h[`h9CJOJQJ^JaJh2~5CJOJQJ^JaJ#h[`h95CJOJQJ^JaJh-rCJOJQJ^JaJ h[`h9CJOJQJ^JaJ h[`hp=CJOJQJ^JaJhCJOJQJ^JaJ!r%&+,12OPUV[\notu  $./4<@r|}鿵髵鿫锵锵锵hrCJOJQJhcOhCJOJQJhCJOJQJhEKCJOJQJhcOCJOJQJh0*CJOJQJh2~5CJOJQJh5CJOJQJhCJOJQJh h5h0*:qrs>^-D)$$d%d&d'dNOPQa$gd&$d%d&d'dNOPQgdgdD[r+BVm3]yzf&$d%d&d'dNOPQgdf8cK;{G&$d%d&d'dNOPQgd* $d%d&d'dNOPQgdG=>$r\F0~hR&$d%d&d'dNOPQgd&*\fgltx FPQb0;<AHL~%&*26hstz hEKCJOJQJhCJOJQJhrCJOJQJY R]^bjn <GHMTXĽ޵hB&h4:5 hB&h4:hB&h4:5\ hB&hh hxh hB&hhahX h'\/hhYhYhY5 haha h>*CJhhEKCJOJQJhrCJOJQJhCJOJQJ2R<gdzgdgd~`  gd&$d%d&d'dNOPQgda  gd&$d%d&d'dNOPQgd Arab~y~~q gd"4gd~`gdz&$d%d&d'dNOPQgdr+ $$d%d&d'dNOPQgdr* $d%d&d'dNOPQgdr  _`abjkz/678Xƿƨyrgr`Y`U`U`h,j h,jh,j h,jh Vh Vh V5\] h V\] hgo\]hV hB&hj hB&h5Ah>Xh5A5 hB&hS hB&hhB&h5 hB&hVhB&h4:5 hB&h4: hB&h hxh4:CJOJQJ^JaJ hS!hrCJOJQJ^JaJ hJhrCJOJQJ^JaJ stuvwyR&$d%d&d'dNOPQgdgo* $d%d&d'dNOPQgdgo* $d%d&d'dNOPQgd"* $d%d&d'dNOPQgdu[ gd" XYZ^rstvw^a{˷nZSHA h7\]h7h75\] ha\]&hgoh7CJOJQJ\]^JaJ#hgo5CJOJQJ\]^JaJ hS!h>XCJOJQJ^JaJ hTCJOJQJ\]^JaJ)hgohgo5CJOJQJ\]^JaJ&hgohgoCJOJQJ\]^JaJ hgoCJOJQJ\]^JaJ h V\] h\]h V hB&h h,jh Vh &Hh*[{* $d%d&d'dNOPQgdgo&$d%d&d'dNOPQgdgo{ijkOPsssssss&$d%d&d'dNOPQgdm gdm gda* $d%d&d'dNOPQgdgo+ $$d%d&d'dNOPQgd>X HMefghij-YZƻƪƻƖzsldl]YOKhI "hh7\]h hhP6hj?h75 hh7 h7\]h7h75\] h7CJOJQJ\]^JaJ&hahgoCJOJQJ\]^JaJ h9hmCJOJQJmH sH hm5CJOJQJhmCJOJQJhmhJ)hgo6\]ha hahI@l hah7hhJ)5 hahJ)$LN9;gdm&$d%d&d'dNOPQgdm-DHINOPgdI " gd7&$d%d&d'dNOPQgd7&$d%d&d'dNOPQgdm  S*+* $d%d&d'dNOPQgd &$d%d&d'dNOPQgdFUgdFU* $d%d&d'dNOPQgdI ""#v}~9:;#<=>?@'(ιή{qmfbh0* hh3jh3jhG CJOJQJhG h hhTh>Xh75 hh7hh7\]hh75\] hLZ\]hFUh3CJOJQJhFU5CJOJQJhFUCJOJQJ hB&h*h*hI " h,jhI "h VhI "5\] hI "\]$+y9:;<Z[*gdFU&$d%d&d'dNOPQgdFU*+uvw?@A#$%ab&$d%d&d'dNOPQgdG gdG  gd7&$d%d&d'dNOPQgdFU?@()AB* $d%d&d'dNOPQgd3jgdzgd3j&$d%d&d'dNOPQgdG ()1@ABCDE+ . G H t u 澭sehCJOJQJ^JaJ hS!h>XCJOJQJ^JaJ)hgoh5CJOJQJ\]^JaJ&hgohCJOJQJ\]^JaJ hCJOJQJ\]^JaJ hh3j h,jh3jh Vh3j5\]hh5A hhUh3j hh5Ahh5A5 h3j\]%BCDEab6Z[( H &$d%d&d'dNOPQgd* $d%d&d'dNOPQgdgdzH u v  4 5 6 ~     U Y Z     &$d%d&d'dNOPQgdFs gdFsgdiP?* $d%d&d'dNOPQgdu v        2 3 4 5 _ `    =QRS[ñp[JF>hB&hm5hm hhECJOJQJ^JaJ(hhFsCJOJQJ^JaJmH sH #hhFs5CJOJQJ^JaJ hhFsCJOJQJ^JaJhFs hhT hhiP?hhiP?5hiP?#h5CJOJQJ\]^JaJ)hgoh5CJOJQJ\]^JaJ&hgohCJOJQJ\]^JaJ&hgoh>XCJOJQJ\]^JaJ   U V       9          gdFs* $d%d&d'dNOPQgdFs&$d%d&d'dNOPQgdFs =AQRt* $d%d&d'dNOPQgdI "gdK! gdm* $d%d&d'dNOPQgd{* $d%d&d'dNOPQgdFs [\)012RSTbcghij-.jklmuŽŽ{wohohdh= hhThhT5hm h i#hCJOJQJ^JaJhK!CJOJQJ^JaJ#h i#hK!5CJOJQJ^JaJ h i#hK!CJOJQJ^JaJhfr+hI " h,jhI "h VhI "5\] hI "\]hK! hT6hE3hm56hiP?hm6 hB&hm$hijkOPU* $d%d&d'dNOPQgdK!&$d%d&d'dNOPQgdK!* $d%d&d'dNOPQgd i#gdK!* $d%d&d'dNOPQgdI " P&NO56~ gdK!&$d%d&d'dNOPQgdK!  QRb#$klgd= gdT&$d%d&d'dNOPQgdK!* $d%d&d'dNOPQgdK!13{ ACWXq01gdzgdgd~`&$d%d&d'dNOPQgd=/012CI~  9TZ[hi»·xxnxjcYhB&hx|5\ hB&h=Eh$hB&hz6]hB&hU6hB&hU6] hB&hUhB&h0*5\h0*hB&h4:5\ hB&h4: hhh4: h(hU h(h4: hB&h q h i#hCJOJQJ^JaJh=CJOJQJ^JaJ h i#h=CJOJQJ^JaJ"y/ $$d%d&d'd7$8$H$NOPQgd\X$* $d%d&d'dNOPQgdj?gdz&$d%d&d'dNOPQgd0* 0FGZtz{|ļ渰}ohZohi CJOJQJ^JaJ h=Ehi hY/CJOJQJ^JaJ h=EhY/h\X$CJOJQJ^JaJh,E# h>Xh=E hY/h\X$h\X$hY/hj?5hY/h\X$5hj?h}h}5h} h>XhKh>Xhx|5h>XhB5 h>XhU h>Xhx|h>Xhx|5\h>Xhx|\ $+-0HO  Ľᤓp_QhCJOJQJ^JaJ h8h>XCJOJQJ^JaJ hS!h&CJOJQJ^JaJ#h8h85CJOJQJ^JaJ h8h8CJOJQJ^JaJh8CJOJQJ^JaJhj? h=Ehj? h=EhY/ h=Eh\X$h,E#hi hY/CJOJQJ^JaJh\X$CJOJQJ^JaJ h8h\X$CJOJQJ^JaJ,.0UPcd G/ $$d%d&d'd7$8$H$NOPQgd8 xy& ' !X!0"^"_"`"r"u"|""""" ############$$縷݁r`r`r#hj}h85CJOJQJ^JaJhj}5CJOJQJ^JaJh85CJOJQJ^JaJ(h~\h8CJOJQJ^JaJmH sH (h~\h8CJOJQJ^JaJmH sH (hcOh8CJOJQJ^JaJmH sH h8CJOJQJ^JaJ#h8h85CJOJQJ^JaJ h8h8CJOJQJ^JaJ! ' : D W g z      !+!9!J!U!n!!!!/ $$d%d&d'd7$8$H$NOPQgd8!!!""-"F"_"`"}""""#R######$$>$a$$/ $$d%d&d'd7$8$H$NOPQgd8$$$.$6$=$O$Y$`$a$b$$$$$$%"%#%(%)%.%/%4%\%c%j%k%l%%%5&6&_&d&k&!'"'#'ͻͻͭͻޞ͉tttͻͭffͻfh8CJOJQJ^JaJ(hcOhcfCJOJQJ^JaJmH sH (hcOh8CJOJQJ^JaJmH sH h85CJOJQJ^JaJhCJOJQJ^JaJ#hj}h85CJOJQJ^JaJ h8h8CJOJQJ^JaJhj}5CJOJQJ^JaJ#hj}hj}5CJOJQJ^JaJ&$$$$$$$%%%"%(%.%4%k%l%%%%%%%%%%/ $$d%d&d'd7$8$H$NOPQgd8%% &&!&6&l&&&&&&& '"'$'[''''''''(/ $$d%d&d'd7$8$H$NOPQgd8#'$'L'S'Z''''( (((()))))0)1)L)S))))))ᲤycUᲤNDhHh$5\ hB&h[2hj}CJOJQJ^JaJ+h~\hj}5CJOJQJ^JaJmH sH +h~\h85CJOJQJ^JaJmH sH (h~\h8CJOJQJ^JaJmH sH hCJOJQJ^JaJh8CJOJQJ^JaJhj}5CJOJQJ^JaJ#hj}h85CJOJQJ^JaJ h8h8CJOJQJ^JaJh@[CJOJQJ^JaJ(S(\(i(u((((((()1)k)l))))**gd=Egdz/ $$d%d&d'd7$8$H$NOPQgd8))))))*** ******/*E*F*Y*s*y*z*{*}*~***********߲qjj h=Eh=EhgACJOJQJ^JaJ hgAhgAh=ECJOJQJ^JaJhgA h>Xh=E hY/h=EhY/h=E5h=E#hHh$CJOJQJ\^JaJhHhH5hH hHhKhHh=5 hHhx| hHh$hHh$5\hHh$\"******+C+t++ppppp/ $$d%d&d'd7$8$H$NOPQgdgdz/ $$d%d&d'd7$8$H$NOPQgd=E* $d%d&d'dNOPQgd=E *+++++++,,,,f,,,,,,,,,--#-*-<-=-D-|jXjFj#hf~hf~5CJOJQJ^JaJ#hf~h5CJOJQJ^JaJ#hhf~5CJOJQJ^JaJ#h8h=5CJOJQJ^JaJ h8h=CJOJQJ^JaJhsCJOJQJ^JaJ#hh5CJOJQJ^JaJhCJOJQJ^JaJ h8h}CJOJQJ^JaJ hS!h}CJOJQJ^JaJ hhCJOJQJ^JaJ++++,, ,f,,,,,,o/ $$d%d&d'd7$8$H$NOPQgd=/ $$d%d&d'd7$8$H$NOPQgd/ $$d%d&d'd7$8$H$NOPQgd} ,,-+-E-h--------..M.S.Y._.e.k.q.w.../ $$d%d&d'd7$8$H$NOPQgdD-X-`-g-y-----......M.q......R/S////000V1]1d1H2O2V2W2g2˼˼ze(h~\hCJOJQJ^JaJmH sH hCJOJQJ^JaJh@[CJOJQJ^JaJ(hcOhCJOJQJ^JaJmH sH hh@[CJOJQJ^JaJh5CJOJQJ^JaJ#hhf~5CJOJQJ^JaJ#hf~h5CJOJQJ^JaJ hhCJOJQJ^JaJ%...///'/-/4/?/G/S/]/j////00%0=0H0Z0p00/ $$d%d&d'd7$8$H$NOPQgd000011.1e111111111 2 2W2222222/ $$d%d&d'd7$8$H$NOPQgdg2~222222222,3-32353H3N3f3k3l3t333333333364<4Ӿngc_cZcVcVcVcVcNVcZcZcZhWjkhWjk5hWjk hL|5h^EhL| hB&h$ hehf~CJOJQJ^JaJhy*CJOJQJ^JaJ hhCJOJQJ^JaJ#hhf~5CJOJQJ^JaJhf~CJOJQJ^JaJ(h~\hCJOJQJ^JaJmH sH +h~\hf~5CJOJQJ^JaJmH sH +h~\h5CJOJQJ^JaJmH sH 222,3-333L4M4N4444445=5/ $$d%d&d'd7$8$H$NOPQgdL|gdL| gd^Egd~`&$d%d&d'dNOPQgd<4D4J4M4r4t444=5i5j55555r6s6{6688J9K9P9W9f9m9 :*:::::;;??????&@BRCCCEν꜏xhbwCJOJQJhcOhL|CJOJQJhfThn CJOJQJhfThL|CJOJQJhn CJOJQJhuXCJOJQJ h8hCCJOJQJ^JaJ hS!hCCJOJQJ^JaJhL|5CJOJQJhL|CJOJQJhChL|5hL|.=5j5k5l55556606P6R66667G7w77/ $$d%d&d'd7$8$H$NOPQgdL|/ $$d%d&d'd7$8$H$NOPQgdC7778E8x8888$9X9t999+:i::::;d;;;;</ $$d%d&d'd7$8$H$NOPQgdL|<:<l<<<<<<<=h=== > >+>]>>>>?O?r???/ $$d%d&d'd7$8$H$NOPQgdL|??&@I@J@@@A?AgAiAAAA5BgB|BBBBB/CRCCC/ $$d%d&d'd7$8$H$NOPQgdL|CCD]DDDDDEIEEEEF4FfF{FFFFFFGOGG/ $$d%d&d'd7$8$H$NOPQgdL|EEEEEEFHIII/ItI@KAK LtLQQGRPRQRcRdRRRDXEXZZZZZU[A^J^K^[^n^^ʼʤʼʤʚʐʐʐʐrhcOhL|CJOJQJ hcOh@[CJOJQJmH sH hntCJOJQJh@[CJOJQJhuXCJOJQJhn CJOJQJmH sH hL|CJOJQJmH sH hL|CJOJQJhfThL|CJOJQJhn CJOJQJmH sH hcOhL|CJOJQJmH sH 'GGGGHDHyHH I0IBItIIIIJJJJTJJJK@K_K/ $$d%d&d'd7$8$H$NOPQgdL|_KKK LLQLtLLLLLLMMMPMMMNN\NNN O/ $$d%d&d'd7$8$H$NOPQgdL| OO0OEOUOhOxOOOOOOO8PvPPPPP-QbQQQQQ/ $$d%d&d'd7$8$H$NOPQgdL|QQ@RdRvRRRR2S{SSST T>TpTTTT/ $$d%d&d'd7$8$H$NOPQgd@[/ $$d%d&d'd7$8$H$NOPQgdL|TU$U7U_UoUUUUU%VcVVVVVWNWWWWWWW X/ $$d%d&d'd7$8$H$NOPQgdL| X"X3XCXDXzXXY@YgYiYYYY5ZHZXZtZZZZ#[U[x[y[/ $$d%d&d'd7$8$H$NOPQgdL|y[[[6\t\\\\\"]i]]]]]:^\^n^^^^^C___/ $$d%d&d'd7$8$H$NOPQgdL|^^kaaaaaaab2e^e_e`eheiexe{eeeeeeeeffffg ggggg鷩seWeWhcOhcO5CJOJQJh^EhL|5CJOJQJ h^Eh8CJOJQJ^JaJh^EhL|CJOJQJh;phL|5 h;phL| hL|5hL|h;pCJOJQJ^JaJ hS!h;pCJOJQJ^JaJhcOhL|CJOJQJhntCJOJQJhuXCJOJQJhL|CJOJQJhcOh@[CJOJQJ"___`8`m````#a;aaaaabbbIbbbc5cScc/ $$d%d&d'd7$8$H$NOPQgdL|ccd3dHdpddddde2e_eexsgdL|/ $$d%d&d'd7$8$H$NOPQgd;p&$d%d&d'dNOPQgdL|/ $$d%d&d'd7$8$H$NOPQgdL| eeee1fbffff g5g7gYg[gvggggh"hKh~hhh/ $$d%d&d'd7$8$H$NOPQgdL| gdg i!i(i+ijjjjkkkkkkkkkkll%l&l7lplmmmʼʼʼʼʲ|kkZIZ hcOh@[CJOJQJmH sH hcOhL|CJOJQJmH sH hfThntCJOJQJmH sH hfTh@[CJOJQJmH sH hfThL|CJOJQJmH sH h@[CJOJQJhCJOJQJhL|CJOJQJh QhL|5CJOJQJh QhL|CJOJQJhcOhcO5CJOJQJh^EhL|5CJOJQJh^EhL|CJOJQJh)i+i-i^iii2jvjjjjjjkk8kikkkkkl9lIl/ $$d%d&d'd7$8$H$NOPQgdL|Ilpllllllm.mUmrmmmmn3n[nlnnnnnnoeo/ $$d%d&d'd7$8$H$NOPQgdL|mmmmgopoqooopppp4r5r6r7r8rssssuuuuu(v1v2vCvevvhwqwrwww4x5xHxIxxxxxxyyyzy{yԕhL|h QhCJOJQJhcOhL|CJOJQJh\CJOJQJh@[CJOJQJhCJOJQJhL|CJOJQJhntCJOJQJh QhL|CJOJQJ hcOhL|CJOJQJmH sH hntCJOJQJmH sH 1eooooop!pEpVpipppp q*qRqcqqqqqqr&r5r/ $$d%d&d'd7$8$H$NOPQgdL|5r6r8rIrZr~rrrrrrrr ss7sOscssssttAtQt/ $$d%d&d'd7$8$H$NOPQgdL|Qt`tqtttttttt uu1uBuTuiuyuuuuuuu/ $$d%d&d'd7$8$H$NOPQgdL|uu&vEvevvvvvwwfwwwwwxx5xIxxxxx y/ $$d%d&d'd7$8$H$NOPQgd y1yByfyyyzyyyLzMzNzz+ h$d%d&d'dNOPQgdP\) hgdl gd))=gd~`/ $$d%d&d'd7$8$H$NOPQgd {yyyyyyyyyyyyyyyyy zzzzzz*z+z@zAzIzNzOzRzSzTzdzmz{zzzzzzzzzzzzzzzzzzغةhL|jhhL|UhL|<B*CJaJphha ha@ha@ha@ha@5ha@ hP\)5hC[xhC[x5 h))=h))=h Q ha@hP\)hC[xhP\)hl h))=hL| hP\)h ehWjk hP\)h8 hP\)hL|4zzzzzzzD{E{b}}}}} ~ ~~~~gd  gd h@gd e gd e gdL|gdL| gd))=* $d%d&d'dNOPQgdP\)zzzz{{8{9{:{C{D{E{H{N{X{Y{f{t{x{{{{{F|G|H|M|N|m|x|~|||||||||||}b}j}r}x}}}}}}}ĽjhL|Uh'hF#hF#5h7hF#h eh e5hl]xhL|5hah ehL| h8hL|h8h eaJh h8aJhh8hF#aJhh8hzaJhh8h85aJhh8hL|aJh3}}}}}} ~ ~ ~~~~$~)~*~2~4~9~:~L~\~c~~~~~~~~~~~~~~ 2H_`efmq庳᫧᧫hhak/5 hak/hak/ h))=hh(:hhak/h8@ hak/hL| h8h8jnhL|Uhh h h 5h hL|5hL|h8 h8h h8hL|h8h856~~~~ h@gdak/+ h@$d%d&d'dNOPQgdak/* $d%d&d'dNOPQgdak/ h@gd8@ gd8 gdL|  #$(.NRqrv|~р%)89?BN^mtÁāŁƁȁˁՁ܁#(;Up{j=hL|Uh|hdWhAOh4h8h8h85 h8h8jZ hL|Uhak/hh(:hL|h9I|}XY[\gd5&$d%d&d'dNOPQgd4gd4 gd8gdL| gdL|{|}ɂ  1;BăɃ܃%&'(YZ]di|ƄЄFQ_fiƾh~hK8uh>4hmhGjNnhL|Uh5h5h55h5hL|5 h5h5h8h8h85jhhL|Uh4h4h45h4hL|5hL| h8h8:ghi؆نچabc gdL|gd  gd8gdL|&$d%d&d'dNOPQgd~+ h@$d%d&d'dNOPQgd~ h@gdGinqv{ąʅׅ҅')rt|نچ  :U`abcjklƇчއ̼h} hdhL|hdhd5hdhL|5 h hmh h8h8h85 h8h8j{hqoUhGhG5hGh>4hmhL|h~h~h~5: #*/B\wňƈȈˈ͈̈Ո߈!CDEF‰ʼnƉɉʉػͫhB&hw 5 hB&hw hB&hrb~hB&h4:5 hB&h4: hB&hU;j!hL|Uh^@h^@5 hmhm hL|h^@hkh^@ hL|hmhmhih8h8h85 h8h8hL|jVhfTU2!"BCEÉĉʼnKLM&$d%d&d'dNOPQgdgdzgd~`gdm h@gdm gd8gdL|ʉ IKLMUVeiŠŊȊɊˊ!IQRhɺɧziiiizi hhw CJOJQJ^JaJh HCJOJQJ^JaJhdCJOJQJ^JaJ hhrb~CJOJQJ^JaJ hB&hrb~hrhWjkhw 5 hVRhw hVRhT#5 hVRhT# h7%hhVRh5 hB&hhB&hw 5 hB&hw h]zh hB&h4:#ŠIh֋89WXYabgdP $gd"'ygd~`gdz&$d%d&d'dNOPQgdhq͋Ջ܋-07WXYZ~±||kg`YUYQJQJFhP hMh"'yh8hM hgkhP h"'yaJhhB hhBCJOJQJ^JaJ hhrb~CJOJQJ^JaJ#hhrb~5CJOJQJ^JaJ#hhw 5CJOJQJ^JaJ hhw CJOJQJ^JaJ hhPCJOJQJ^JaJhw CJOJQJ^JaJ hrhPCJOJQJ^JaJhPCJOJQJ^JaJ$%>@GJPabc͍̍֍ 1248;QR[~ijqqqqq` hgAhrCJOJQJ^JaJ hrhrCJOJQJ^JaJ hrhrCJOJQJ^JaJhrCJOJQJ^JaJ#hSChSC5CJOJQJ^JaJ hSChSCCJOJQJ^JaJ hSChrCJOJQJ^JaJhrhCJOJQJ^JaJ#hgAhM5CJOJQJ^JaJ hgAhMCJOJQJ^JaJ#hgAhIVYstuv   :CDjkǵǵǵǤyqyqygy]SyL hB&hh h#&6]h h 6]h hb6]h hLR{6h hLR{6]hB&hLR{] hB&h8:h$$$Ifl0H$   04 lap $$Ifa$gdUDgdUD{|}~ $Ifgd0lkd?$$$Ifl0H$04 la~ʣ1 $Ifgd0lkd@$$$Ifl0H$04 la1234 $Ifgd0lkd@$$$Ifl0H$04 la45h $Ifgd0lkd"A$$$Ifl0H$04 la $Ifgd0lkdA$$$Ifl0H$04 la $Ifgd0lkd*B$$$Ifl0H$04 la $Ifgd0lkdB$$$Ifl0H$04 la, $Ifgd0lkd2C$$$Ifl0H$04 la,-./ $Ifgd0lkdC$$$Ifl0H$04 la/0P` $Ifgd0lkd:D$$$Ifl0H$04 la $Ifgd0lkdD$$$Ifl0H$04 laۥ $Ifgd0lkdBE$$$Ifl0H$04 laۥܥݥޥ $Ifgd0lkdE$$$Ifl0H$04 laޥߥ $Ifgd0lkdJF$$$Ifl0H$04 la $Ifgd0lkdF$$$Ifl0H$04 la6~ $Ifgd0lkdRG$$$Ifl0H$04 la $Ifgd0lkdG$$$Ifl0H$04 laǦ $Ifgd0lkdZH$$$Ifl0H$04 la $Ifgd0lkdH$$$Ifl0H$04 la'o $Ifgd0lkdbI$$$Ifl0H$04 laopqr $Ifgd0lkdI$$$Ifl0H$04 larsŧƧ $Ifgd0lkdjJ$$$Ifl0H$04 laƧǧIr $Ifgdb $Ifgdzgdzgd5lkdJ$$$Ifl0H$04 laILSWxɨʨҨ֨ݨ"#(O^_d|'(1abcںںڪںںڎރ΃hm hB&hhhcOh}06mH sH hcOh6mH sH hcOhmH sH h}06h}0h6 h5 hIuNhh@*hP0h5h hB&hhB&h]hB&h]h hB&h09|BbhhhhhR & F $If^gdcO & F $$If^gdcO $$Ifgd $IfgdzhkdrK$$$IfP40Z&j @@3f3fR&4 Paf4p3f3f bctu<MkdL$$$IfP40Z&jR&4 Paf4 $IfgdzMkd(L$$$IfP40Z&jR&4 Paf4 $Ifgd $If^`gd˪Ъststuxyܭ߭ jvwxy|د踱즟월~wswswwswskhB&h)]h) hB&h) hB&h-h5h5CJaJh6 h5h6h5 h~\hhB&hmH sH  hB&h:.h:.hv hB&hQhAfDhQ5 hQ5hHxhQ5hhB&h5hQ hB&hh@*h@*hm5*uĬŬЬ+<Qct $IfgdQMkdFM$$$IfP40Z&jR&4 Paf4 $Ifgdz PQYZMkdVN$$$IfP40Z&jR&4 Paf4 $IfgdzMkdM$$$IfP40Z&jR&4 Paf4wxZUPgdzgd6MkdXO$$$IfP40Z&jR&4 Paf4 $IfgdzMkdN$$$IfP40Z&jR&4 Paf4lm@7 $IfgdfQMkdP$$$IfP40Z&jR&4 Paf4 $IfgdzhkdO$$$IfP40Z&j AA3f3fR&4 Paf4p3f3fkmѰҰtu-.}Ʒʷtu   ILYimnqrwx򲮦򛗓h9vh9v5h9vhA?CDF56&$d%d&d'dNOPQgd5&$d%d&d'dNOPQgd|gdz gd|jkrxy #lo} &/AFKLn}4>ruV_7:Tꨬꉂ h~)hh ,ohB&h>*hB&h] hB&h.hIhl6 hB&h_7 hB&hWUhB&h5\hB&h5hB&h_7CJaJhB&h.CJaJhB&h\ hB&hh|h5 h|h|167[@AVW $$Ifa$gdvk gdvkgd0 $gd~)gd ,ogd%gdz TZ[_d/@AB #4;_`dfjnqUVWŻŻŲūţŝ|uqjfb\ hvkCJh]jhvk hB&hvkh hB&h0 hB&hWUhB&hPJh0h5PJ h05PJ h0PJhB&h>* hB&h7chB&h^JhB&h5\ hB&hhB&h\] h0>*CJ hB&hB h ,o6 h ,o5h ,o h~)h h~)hB$xoo $Ifgd7vkdZ$$$Ifl0u$ @@3f3f04 laZp3f3f-CWl $Ifgd7vlkd[$$$Ifl0u$04 laZ WD`bcef~ ?gzw|  56RTUuʾʳ hhvk h@@hh@S5hvkmH sH h@S5h@S5mH sH hcOhvk5CJmH sH hcOhvkmH sH hcOh]j6mH sH hcOh]jmH sH h]j6h]jh]j6h]j hvkCJ hvk5hvkh=hvkmH sH 0'Da $Ifgd7vlkd;\$$$Ifl0u$04 laZab $Ifgd7vlkd\$$$Ifl0u$04 laZ *> $Ifgd7vlkdM]$$$Ifl0u$04 laZ>?3Mew $Ifgd7vlkd]$$$Ifl0u$04 laZ  6S $Ifgd7vlkd_^$$$Ifl0u$04 laZSTuvopqrYZ[]]]&$d%d&d'dNOPQgdaigdz  gd@S5lkd^$$$Ifl0u$04 laZ uzJRSYZmrwENRUz{NOV]^036OmĹĹĝqĹ`ī hcOhvCJOJQJmH sH hvCJOJQJmH sH  h=hvCJOJQJmH sH h=hvCJOJQJh=hv5CJOJQJhcOhcO5CJOJQJhv5CJOJQJhvCJOJQJ hhWU hh hhSW<hB&h5\hThh6 hB&h%[\Dz{#Ee&$d%d&d'dNOPQgd)$$d%d&d'dNOPQa$gd gdvgdgdz^kl-I\x3&$d%d&d'dNOPQgd3Llm)wxOwx&$d%d&d'dNOPQgdai&$d%d&d'dNOPQgd@4t{|GHO̺̺禎qfqXJfXh+6h_5CJOJQJhcOhcO5CJOJQJh_5CJOJQJ h=h_CJOJQJmH sH h_CJOJQJ hB&haih!&#haih5CJOJQJ^JaJ haihUCJOJQJ^JaJ#h+6h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ haihWUCJOJQJ^JaJ haihCJOJQJ^JaJ[\23@U{&$d%d&d'dNOPQgd_gdz&$d%d&d'dNOPQgdai234t|=>&$d%d&d'dNOPQgdaigd|gdz&$d%d&d'dNOPQgd_O*-.9BX`{4eiz˻Ҭ˥˥˥˔ˬˊm\ h=h*(CJOJQJmH sH #h+6h*(5CJOJQJmH sH h*(5CJOJQJh*(CJOJQJ hB&h0 +CJOJQJ^JaJ hB&h4 hB&h0 +hB&hR 6hB&hR >*hB&hR 5 hB&hR hB&h;h|h;5hai haihCJOJQJ^JaJh_CJOJQJ$!"lAh&$d%d&d'dNOPQgd*([]de!"#$<?ͼ}rdrSL;* haihWUCJOJQJ^JaJ haihCJOJQJ^JaJ hB&hU haihR CJOJQJ^JaJhcOhcO5CJOJQJh*(5CJOJQJh*(CJOJQJ#hcOhcO5CJOJQJmH sH #hcOh*(5CJOJQJmH sH  hcOh*(CJOJQJmH sH  h9qh*(CJOJQJmH sH  h=h*(CJOJQJmH sH h+65CJOJQJmH sH #h+6h*(5CJOJQJmH sH >?@e"#%jk01`h&$d%d&d'dNOPQgdai&$d%d&d'dNOPQgd*(?Y]`gh23:vwxdel̺nn\̗\̗\̗\̗\̗\#haihg,5CJOJQJ^JaJ haih_ CJOJQJ^JaJ haihWUCJOJQJ^JaJ hB&hg, haihg,CJOJQJ^JaJ#haih5CJOJQJ^JaJ#h+6h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ haihSW<CJOJQJ^JaJ haihCJOJQJ^JaJ$()vwxTUMuvgdz&$d%d&d'dNOPQgdai'*DFq#*7>Edkm|}mnuijܳn\n#haih5 5CJOJQJ^JaJ haih gCJOJQJ^JaJ#haih5CJOJQJ^JaJ haih_ CJOJQJ^JaJ haihWUCJOJQJ^JaJ haihCJOJQJ^JaJ hB&h haihOnhCJOJQJ^JaJ haihg,CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#ST+,lmcdgdz gd!zgd%&$d%d&d'dNOPQgdai$/0FG{}")*ڶڮڧڣڜyyk^y^h9qhSSCJOJQJh9qhSS5CJOJQJhcOhcO5CJOJQJhSS5CJOJQJhSSCJOJQJ hB&h%ah> hB&hWUhB&h\hB&h5\hB&h6 hB&h!zh h+6hLU hB&h haih+6CJOJQJ^JaJhCJOJQJ^JaJ$FG\]u&$d%d&d'dNOPQgdSS)$$d%d&d'dNOPQa$gdSS gd\Tgd~`&$d%d&d'dNOPQgdh|gdz ]1UVW*78Kh&$d%d&d'dNOPQgdSS*9gnop̻}l[llGl&hDh5CJOJQJ\^JaJ hDhICJOJQJ^JaJ hDh%KCJOJQJ^JaJ hDhWUCJOJQJ^JaJ hDhCJOJQJ^JaJ hB&h hB&h%ahcOhcO5CJOJQJ hcOhSSCJOJQJmH sH hSS5CJOJQJhSSCJOJQJmH sH  h9qhSSCJOJQJmH sH hSSCJOJQJ(D`n89oq&$d%d&d'dNOPQgdD&$d%d&d'dNOPQgdSSGHCD$%k&$d%d&d'dNOPQgd6,gdz&$d%d&d'dNOPQgdDGNOTʹʧʠshh]]]OhcOhcO5CJOJQJh6,6CJOJQJh6,5CJOJQJ#hcOhcO5CJOJQJmH sH  h9qh6,CJOJQJmH sH h6,CJOJQJ hB&hOnh#hDh5CJOJQJ^JaJ hDh#0kCJOJQJ^JaJ hDhCJOJQJ^JaJ#h+6h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ+ODlmF&$d%d&d'dNOPQgdD&$d%d&d'dNOPQgd6,JQ{}RSZ罶q_XG hDhICJOJQJ^JaJ hB&hOnh#hDh5CJOJQJ^JaJ hDh%KCJOJQJ^JaJ hDhqCJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hDhWUCJOJQJ^JaJ hB&h hDhCJOJQJ^JaJhcOhcO5CJOJQJh6,5CJOJQJh6,CJOJQJh+6h6,5CJOJQJFGJHI XYgdz&$d%d&d'dNOPQgdDYjqyzbͻޘͻ޻޻އޘvohW hDhWUCJOJQJ^JaJ hB&h hB&hOnh hDh%KCJOJQJ^JaJ hDhFSCJOJQJ^JaJ#hDh5CJOJQJ^JaJ hDhICJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hDhjTCJOJQJ^JaJ hDhCJOJQJ^JaJ hDhOnhCJOJQJ^JaJIqrDE)*rsgdz&$d%d&d'dNOPQgdDb!(5<Chjqs#$pqx޻ީީީޘީtcީ\U\ h+6hNr hB&h hDh $CJOJQJ^JaJ#hDhLv5CJOJQJ^JaJ#hDh%K5CJOJQJ^JaJ hDh%KCJOJQJ^JaJ#hDh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hDhOnhCJOJQJ^JaJ hDhCJOJQJ^JaJ hDhLvCJOJQJ^JaJ!fg+ , - .      R S h -$ $d%d&d'dNOPQa$gdJr gd8ugd%gdzgd%&$d%d&d'dNOPQgdD]j4L. 3          7 8 R S       % & - 4 5    Ƽwjh QhJrCJOJQJ h QhJrCJOJQJmH sH h9qhJrCJOJQJh9qhJr5CJOJQJhcOhcO5CJOJQJhJr5CJOJQJhJrCJOJQJ hB&hQ//h8u hDhWU hDh hB&hQ\hB&h5\ hB&hhB&h6'h i      = a b     5 B C V s       * $d%d&d'dNOPQgdJr  3Oky #CD}&$d%d&d'dNOPQgd * $d%d&d'dNOPQgdJr &Du|}~78>?aƿttbPbP?? h hQ\CJOJQJ^JaJ#hXE;h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h hICJOJQJ^JaJ h hWUCJOJQJ^JaJ h hCJOJQJ^JaJ h8uhCJOJQJ^JaJ hB&h hB&hQ//hcOhcO5CJOJQJhJrCJOJQJ h9qhJrCJOJQJmH sH  hcOhJrCJOJQJmH sH  YZ/YZ78{gdz&$d%d&d'dNOPQgd ab $()Njm{ '̺޳ޑހoހހaހP h hJOCJOJQJ^JaJhXE;CJOJQJ^JaJ h hzCJOJQJ^JaJ h h CJOJQJ^JaJ h hWUCJOJQJ^JaJ h hICJOJQJ^JaJ hB&h#hcOhcO5CJOJQJ^JaJ#h h5CJOJQJ^JaJ h hCJOJQJ^JaJ h hQ\CJOJQJ^JaJ ()[F+ $$d%d&d'dNOPQgdXE;&$d%d&d'dNOPQgd + @$d%d&d'dNOPQgdXE;'()OP_~NOK`)0189 JKLWZsܹ˹˧ˠˏ~ˏˏ˹˹m˧ˏ~ h hPCJOJQJ^JaJ h hWUCJOJQJ^JaJ h hICJOJQJ^JaJ hB&h#h h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h hCJOJQJ^JaJ h h CJOJQJ^JaJ#hXE;h5CJOJQJ^JaJ)FG'(n)9J+ P$d%d&d'dNOPQgdXE;&$d%d&d'dNOPQgd JKL !mnEF"#ggdz&$d%d&d'dNOPQgd s!29belnMN޼ޘ޼޼އ޼uudS h h[CJOJQJ^JaJ h hg\bCJOJQJ^JaJ#h h5CJOJQJ^JaJ h hTACJOJQJ^JaJ#h h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h hCJOJQJ^JaJ h hzCJOJQJ^JaJ h hCJOJQJ^JaJ h ht CJOJQJ^JaJ<W '+24CDIK^_`f裒耣耣o]K#h h: 5CJOJQJ^JaJ#h ht 5CJOJQJ^JaJ h h: CJOJQJ^JaJ#h h5CJOJQJ^JaJ h h0CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h hzCJOJQJ^JaJ h ht CJOJQJ^JaJ h hWUCJOJQJ^JaJ h hCJOJQJ^JaJ hB&h34JKf'(v: ; !!gdzgd &$d%d&d'dNOPQgd 129:vw(+  K R T `       J!Q!S!_!!""" "T#V#ĽĵĵĭĵĵĵĵĭĵĵĦęĵĵęĒvh8u5CJOJQJh8uCJOJQJ hB&h} hB&hy hB&hWU hXE;CJ hXE;hhB&h5hB&h6 h h hB&h#hcOhcO5CJOJQJ^JaJ#h h5CJOJQJ^JaJ h hCJOJQJ^JaJ,!" "5"6"^""""" #.#/#0#v#w###$&$d%d&d'dNOPQgd8u-$ $d%d&d'dNOPQa$gd8ugdzgd~`V#]#######$$d$$$%%%&'&*&.&5&6&7&8&,';'D'K'f'm'簢ܑ܀yododoR#hcOhcO5CJOJQJmH sH ho5CJOJQJhoCJOJQJ hB&h hb h}CJOJQJ^JaJ hcOh8uCJOJQJmH sH h8uCJOJQJmH sH  h9qh8uCJOJQJmH sH h9qh8uCJOJQJh9qh8u5CJOJQJh8u5CJOJQJh8uCJOJQJhcOhcO5CJOJQJ$$$$$A$a$l$$$$$$$%%9%G%X%c%|%%%%%%&&$d%d&d'dNOPQgd8u&&6&7&9&&&&''f'n'''''&$d%d&d'dNOPQgdo* $d%d&d'dNOPQgdb &$d%d&d'dNOPQgd8um'n''''x(y(((()****+,,,2,6->-A---- . ...O.Q.e.øæÕ|ø|oøhW h hCJOJQJ^JaJ hB&hh9qhoCJOJQJho>*CJOJQJhtho5CJOJQJ hcOhoCJOJQJmH sH hohcOhcO5CJOJQJho5CJOJQJhoCJOJQJ#hcOhcO5CJOJQJmH sH hoCJOJQJmH sH #htho5CJOJQJmH sH 'F(n(o(((())O))))*'*E*g*****+,,,@-A-gdo&$d%d&d'dNOPQgdoA-----..P.R....(/)/X/Y//////&$d%d&d'dNOPQgd &$d%d&d'dNOPQgdoe.h.///////////u00001:1;1N1Q1m1p111#2*2O2V2m2t22222'3(3/3l3m333333333̺޺޺޺ޯ̺ޞލލ޺޺޺޺޺̺ލ̺ޞ h h: CJOJQJ^JaJ hB&hh9ycCJOJQJh9yc5CJOJQJ#hcOhcO5CJOJQJ^JaJ#h h5CJOJQJ^JaJ h hCJOJQJ^JaJ h hWUCJOJQJ^JaJ0/u000091:1;111122W2X2222333gdz&$d%d&d'dNOPQgd &$d%d&d'dNOPQgd9yc3l3m333333(4v4w44444 5 5%5q555556gdz&$d%d&d'dNOPQgd 333334444444444444444 555$5555555666 6.6ީ޺ޛ|ne^ h%hhB&hCJhc1CJOJQJ^JaJ h[h[CJOJQJ^JaJh[CJOJQJ^JaJhCJOJQJ^JaJ h h(8CJOJQJ^JaJ#h h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h hCJOJQJ^JaJ h h3CJOJQJ^JaJ#6.6/6I8J8;;=======!>C>^>>>&$d%d&d'dNOPQgd a)$$d%d&d'dNOPQa$gd agd~`gdz  gd%.6W6m67728G8888899s:t:::::u;x;;;;;;;<<`<a<d<e<<<====>>>"?#?*???????ǽh9qh aCJOJQJh9qh a5CJOJQJhcOhcO5CJOJQJh a5CJOJQJh aCJOJQJ hB&hU3 hB&hWUhB&h6CJaJhB&h5hB&h>*hB&h6 hB&h2>>>> ? ?+?Z???????@@8@K@U@h@@@@@@@&$d%d&d'dNOPQgd a?;@k@nAqAAAAAAAAAAABB=BZBBBB C̻׭xggU@(h/hCJOJQJ^JaJmH sH #h/h5CJOJQJ^JaJ h/h!CJOJQJ^JaJ h/hWUCJOJQJ^JaJ h/hCJOJQJ^JaJ hB&hhB&hU35CJaJhcOhcO5CJOJQJ hcOh aCJOJQJmH sH h a5CJOJQJh aCJOJQJh aCJOJQJmH sH  h9qh aCJOJQJmH sH @@A*ACASAnAAAAAA"B#BiBBBBOCPCC&$d%d&d'dNOPQgd/&$d%d&d'dNOPQgd a CC0C7CGCNCPCUCCCCCCkDlDsDDDDDDD±~lhWF h/hWUCJOJQJ^JaJ h/h/CJOJQJ^JaJh/#hcOhcO5CJOJQJ^JaJhth15CJOJQJhcOhcO5CJOJQJh9qh1CJOJQJh1CJOJQJ h/hCJOJQJ^JaJ#h/h5CJOJQJ^JaJ(h/hCJOJQJ^JaJmH sH +hcOhcO5CJOJQJ^JaJmH sH CCCCC9DaDbDDDDDDDAEEEEEEOFgdz&$d%d&d'dNOPQgd1&$d%d&d'dNOPQgd/DDE3EEEEEFPFFFFGGG"G`GaGwG޸{iWFސi? hB&h hcOhCJOJQJ^JaJ#hcOh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ(h/hCJOJQJ^JaJmH sH #h/h5CJOJQJ^JaJ+hcOhcO5CJOJQJ^JaJmH sH (hcOhCJOJQJ^JaJmH sH h/hS4SCJOJQJ^JaJ h/hCJOJQJ^JaJ h/h0]CJOJQJ^JaJOFPFFFFGG`GbGGGGDHEHtHuHHI.I/I}I~IIIIgdz&$d%d&d'dNOPQgd/wGzGGG}HHHHHH8I9I@I~IIIIaJhJJJJJJJJJgKhKoKKKKKKKLLLLLLLLLLLMMM M޻޻ީޢ޻޻޻޻޻ީޢޑހހ޻ހހ޻ h/hS4SCJOJQJ^JaJ h/h!CJOJQJ^JaJ hB&h#h/h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h/h0]CJOJQJ^JaJ h/hCJOJQJ^JaJ h/hWUCJOJQJ^JaJ2IPJQJJJJJJCK]K^KKKKKK;LLLLLMM%M&Mgdz&$d%d&d'dNOPQgd/ MMMMM$M&M:M;M@MMMMM N!N(N)N*NYNZNsNxNyNP̺練tbtTMF>F>FhB&h6 hB&h h%hhB&h>*CJOJQJ#h/h0]5CJOJQJ^JaJ h/h0]CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#h/h5CJOJQJ^JaJ h/hS4SCJOJQJ^JaJ#h/hS4S5CJOJQJ^JaJ#h/hl5CJOJQJ^JaJ h/hlCJOJQJ^JaJ h/hCJOJQJ^JaJ&MAMMMMMM)NYNZNPPPPQ)$$d%d&d'dNOPQa$gd6gd~`gdzgd%&$d%d&d'dNOPQgd/PPPPP!R#R*RYRZRaRRRRRR1SrSSTTTTT UUUUVV>VEVậȭᜎ}qj`U`hQ5CJOJQJhQCJOJQJ hB&h%hB&h%5CJaJ hcOh6CJOJQJmH sH h6CJOJQJmH sH  h9qh6CJOJQJmH sH h9qh6CJOJQJh9qh65CJOJQJhcOhcO5CJOJQJh65CJOJQJh6CJOJQJ hB&hWU hB&h hB&h,QQ,QYQ{QQQQQQCRDRbRRRRRRS.S9SRSoSSSS&$d%d&d'dNOPQgd6SSSSTT%T0TITaTzTTTTTTUU\U]UU* $d%d&d'dNOPQgdQ&$d%d&d'dNOPQgd6UUU>VFVGVVVVWW9W:WWWWWWWgdz* $d%d&d'dNOPQgd?* $d%d&d'dNOPQgdQEVFVGVVVVVVCWDWKWRWWWWWWWXXXY Yų񛐥{tcQ?A΄bc()vwxy gdtP&$d%d&d'dNOPQgdyzQRׇ؇ Xqrgdz  gdErJ&$d%d&d'dNOPQgḋ͇χև؇ {|ޕ޺r\+hcOh5CJOJQJ^JaJmH sH hh94CJOJQJ^JaJ#hh%uP5CJOJQJ^JaJ hhSCJOJQJ^JaJ&hh56CJOJQJ^JaJ#hh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hhCJOJQJ^JaJ hh%uPCJOJQJ^JaJ%5< NVCJVfmt{ċNj  MTbi  ^aϐАǼ~ hB&hShB&h\ hB&h7chB&h5\ hB&h%uPhB&h5 hB&hhB&h6hcOhmH sH hcOhCJmH sH (hcOhCJOJQJ^JaJmH sH +hcOhcO5CJOJQJ^JaJmH sH 1֌׌،ٌ9: ϐАgd~`&$d%d&d'dNOPQgdErJgdzАѐ<^yߑ&'EtԒ-$ $d%d&d'dNOPQa$gdErJ* $d%d&d'dNOPQgdErJАѐ <=DU”ϽϽ᫚p[TC hvhCJOJQJ^JaJ hB&h%uP(hcOhSCJOJQJ^JaJmH sH (hErJhSCJOJQJ^JaJmH sH (h~\hSCJOJQJ^JaJmH sH  h~\hSCJOJQJ^JaJ#h~\hS5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#hErJhS5CJOJQJ^JaJ hErJhSCJOJQJ^JaJhErJCJOJQJ^JaJԒ5Reo͓,D]m”* $d%d&d'dNOPQgdErJ56{ȕɕgo4567|* $d%d&d'dNOPQgdvgdz&$d%d&d'dNOPQgdv#&(Rlەgno567LOin?FHMWͼުޘuުq`ޘު hvhvCJOJQJ^JaJh h~\hCJOJQJ^JaJ#hqh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#hvh5CJOJQJ^JaJ hvh94CJOJQJ^JaJ hvhSCJOJQJ^JaJ hvhCJOJQJ^JaJ hvh7cCJOJQJ^JaJ |}!GHޘ56{ΙEFG&$d%d&d'dNOPQgdvgd'* $d%d&d'dNOPQgdvWgksݘޘ6RV{EF]`78?~ܹܹܤ|jܹ|fU|j|jܹ|f hvh7cCJOJQJ^JaJh'#hqh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ+hvh5CJOJQJ^JaJmH sH (hvhCJOJQJ^JaJmH sH #hvh5CJOJQJ^JaJ hvhSCJOJQJ^JaJ hvhCJOJQJ^JaJ#hvh6CJOJQJ^JaJ КMN-.}~ĜŜ WXF&$d%d&d'dNOPQgdvܜhip۝ܝjkrĞǞ*Ÿɟ՟޼޼޼ޙު޼ޙޙއ޼޼޼ޙrު hvh -CJOJQJ^JaJh#hvh5CJOJQJ^JaJ hvh94CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hvhCJOJQJ^JaJ hvh7cCJOJQJ^JaJ hvhCJOJQJ^JaJ hvhvCJOJQJ^JaJ,F`a8ʟ˟  "#>&gdz&$d%d&d'dNOPQgdv՟֟ݟ  !#78=%&'U"<[˺˺uݺ˺˺le^Z^Z^hh hB&h hvhhB&hCJ#hvhS5CJOJQJ^JaJ hvhCJOJQJ^JaJ hvhSCJOJQJ^JaJ hvh94CJOJQJ^JaJ hvhCJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#hvh5CJOJQJ^JaJ hvh -CJOJQJ^JaJ &UVW,-lm gdXIzgd~`* $d%d&d'dNOPQgdXIz&$d%d&d'dNOPQgd:c gdsgdz  gdv;>OSTkmث׬ج߬>?FMN k ʵʵʙ{m``h4(hXIzCJOJQJhXIzCJOJQJmH sH  h9qhXIzCJOJQJmH sH h9qhXIzCJOJQJh9qhXIz5CJOJQJhcOhcO5CJOJQJhXIz5CJOJQJh@CJOJQJhXIzCJOJQJ hB&h hB&h7chB&h5\hs hB&hhB&h;$mث6Vz{¬N[\o* $d%d&d'dNOPQgdXIz-$ $d%d&d'dNOPQa$gdXIzЭ 9LhǮ߮#<\]* $d%d&d'dNOPQgdXIz &?]r}òݲ߲$ǼǮwp_N_=_= hQhCJOJQJ^JaJ hQh7cCJOJQJ^JaJ hQhCJOJQJ^JaJ hB&h&hXIzha.CJOJQJ\]^JaJ hXIzhXIzCJOJQJ^JaJ#hXIzhXIz5CJOJQJ^JaJhcOhcO5CJOJQJhXIz5CJOJQJhXIzCJOJQJ h9qhXIzCJOJQJmH sH  hcOhXIzCJOJQJmH sH hhXIzCJOJQJ3ųeM* $d%d&d'dNOPQgd?&$d%d&d'dNOPQgdQ&$d%d&d'dNOPQgdXIz$%ٳ*1FM]dѴشڴ&07ELkrt|޷+hcOh5CJOJQJ^JaJmH sH +hcOhcO5CJOJQJ^JaJmH sH (hcOhCJOJQJ^JaJmH sH #hcOhcO5CJOJQJ^JaJ hQhCJOJQJ^JaJ hQhtZCJOJQJ^JaJ/ȵϵݵ89ryz?@AX[ux^eܸܮܸ܁p_NN hQhG!CJOJQJ^JaJ hQh7cCJOJQJ^JaJ hQhQCJOJQJ^JaJhhOhu5CJOJQJhcOhcO5CJOJQJh9qhuCJOJQJhuCJOJQJ#hQh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hQhCJOJQJ^JaJ#hqh5CJOJQJ^JaJ89rzǶ>?@A˷* $d%d&d'dNOPQgdQgdz&$d%d&d'dNOPQgdu&$d%d&d'dNOPQgdQ˷^fg*+yz{PQ&$d%d&d'dNOPQgdQgd'* $d%d&d'dNOPQgdQefg45<XYxyzڹٺcdkĻ޻ '¼ɼǵ}l}l hQh7cCJOJQJ^JaJh' hQhG!CJOJQJ^JaJ#hQh5CJOJQJ^JaJ hQhCJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ(hQhCJOJQJ^JaJmH sH  h~\hCJOJQJ^JaJ#hOh5CJOJQJ^JaJ*1YZ5ʼ˼,ygdz&$d%d&d'dNOPQgdQɼ#$+=Y¾ɾ346=?NO凜ީr hQhtZCJOJQJ^JaJ hQh7cCJOJQJ^JaJ hQhQCJOJQJ^JaJh#hQh5CJOJQJ^JaJ hQh94CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hQhG!CJOJQJ^JaJ hQhCJOJQJ^JaJ'&'j>?UVq׿ؿ%&X~gdz  gdQ* $d%d&d'dNOPQgdQOTVjkp MNOPWXY~˺˨˺˅se^WMWFWFW hB&hQhB&h\] hB&h hQhhB&h>*OJQJ^J#hQhw5CJOJQJ^JaJ hQhwCJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#hQh5CJOJQJ^JaJ hQhG!CJOJQJ^JaJ hQhCJOJQJ^JaJ hQhtZCJOJQJ^JaJ#hQhG!5CJOJQJ^JaJJgd~`&$d%d&d'dNOPQgdQ & FgdQ & F $hgdcOgdzTW018Iy;ǹǹҫҍrraҹ hcOhUCJOJQJmH sH h4(hUCJOJQJhUCJOJQJmH sH  h9qhUCJOJQJmH sH h9qhUCJOJQJh9qhU5CJOJQJhcOhcO5CJOJQJhU5CJOJQJhUCJOJQJhB&hG!\ hB&h7c hB&hhQhB&h5\%0Rm9h&$d%d&d'dNOPQgdU)$$d%d&d'dNOPQa$gdU)FYcv 8Qa|&$d%d&d'dNOPQgdU(/FMahiy  9@T[ls||||j||||||j||#hOhU5CJOJQJmH sH #hcOhcO5CJOJQJmH sH hUCJOJQJmH sH hcOhcO5CJOJQJh9qhUCJOJQJhUCJOJQJ hB&h&hUha.CJOJQJ\]^JaJ hUhUCJOJQJ^JaJ#hUhU5CJOJQJ^JaJ':;i \KL-&$d%d&d'dNOPQgdU* $d%d&d'dNOPQgdU "*1CJLQ_`gn] h[hCJOJQJ^JaJ h[h[CJOJQJ^JaJhh#F(CJOJQJh9qhUCJOJQJhU5CJOJQJhOhU5CJOJQJhcOhcO5CJOJQJhUCJOJQJ#hcOhU5CJOJQJmH sH #hcOhcO5CJOJQJmH sH  hcOhUCJOJQJmH sH -UV4k&$d%d&d'dNOPQgd[gdz&$d%d&d'dNOPQgdU%@X޻q``\KK h[hwCJOJQJ^JaJh' h[hOCJOJQJ^JaJ#h[h5CJOJQJ^JaJ(h[hCJOJQJ^JaJmH sH  h~\hCJOJQJ^JaJ#hOh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h[hG!CJOJQJ^JaJ h[hCJOJQJ^JaJ h[h7cCJOJQJ^JaJ&'jH  QR)*t* $d%d&d'dNOPQgd[gd'(@GH   $'ADQRn!(?Fls=ϽϽψsb h[h7cCJOJQJ^JaJ h[h[CJOJQJ^JaJh' h[hOCJOJQJ^JaJ#h[h5CJOJQJ^JaJ#hOhO5CJOJQJ^JaJ#hOh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h[hCJOJQJ^JaJh'CJOJQJ^JaJ%tu<=>?YZ&$d%d&d'dNOPQgd[gdz* $d%d&d'dNOPQgd[=>?RUqt&KLQXdels>?Fz{ڸڸڸڸڦڸڸڦڃqڸڔڸ` h[hwCJOJQJ^JaJ#h[htZ5CJOJQJ^JaJ h[htZCJOJQJ^JaJ#h[h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h[hOCJOJQJ^JaJ h[h7cCJOJQJ^JaJ h[hCJOJQJ^JaJ h[h[CJOJQJ^JaJh%45z{gdz  gd[&$d%d&d'dNOPQgd[=@lo"QRY̻ugugYh9qh20_5CJOJQJhcOhcO5CJOJQJh20_5CJOJQJh20_CJOJQJ hB&hRg hB&hOh[hB&h5\ hB&h7c h[h hB&h h[h'CJOJQJ^JaJh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#h[h5CJOJQJ^JaJ$Qswwwwwwww* $d%d&d'dNOPQgd20_-$ $d%d&d'dNOPQa$gd20_gdzgd~`&$d%d&d'dNOPQgd[ ;<Z&1Jgz (A* $d%d&d'dNOPQgd20_)j \   8ʼۯ۞ۓ品p\UD h[hCJOJQJ^JaJ hB&h&h20_hcbCJOJQJ\]^JaJ h20_h20_CJOJQJ^JaJ#h20_h20_5CJOJQJ^JaJh20_5CJOJQJ hcOh20_CJOJQJmH sH h4(h20_CJOJQJh20_CJOJQJmH sH  h9qh20_CJOJQJmH sH h20_CJOJQJhcOhcO5CJOJQJh9qh20_CJOJQJAYr  !ef&$d%d&d'dNOPQgd[&$d%d&d'dNOPQgd20_* $d%d&d'dNOPQgd20_8;UXGNfm{ .5CKR^eglz{޻޻޻޻޻޻޻޻޻޻޻޻ޗކޗނq h[h[CJOJQJ^JaJh h~\hCJOJQJ^JaJ#h[h5CJOJQJ^JaJ#hOh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h[hH &CJOJQJ^JaJ h[hCJOJQJ^JaJ h[h7cCJOJQJ^JaJ,9fgHpqNgdz&$d%d&d'dNOPQgd[5:07815Ys6=_fj 01ﻩqmﻩq\m h[hOCJOJQJ^JaJhJZ#h[h5CJOJQJ^JaJ(h[hCJOJQJ^JaJmH sH  h~\hCJOJQJ^JaJ#hOh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h[hH &CJOJQJ^JaJ h[h7cCJOJQJ^JaJ h[hCJOJQJ^JaJ#08CD6j/02vgdJZ&$d%d&d'dNOPQgd[12ILfi"EHOfm !(defmq}HOtuz޼޼ުޘުުުޘޔ޼޼ުރުރރު h[hwCJOJQJ^JaJh#h[h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h[hOCJOJQJ^JaJ h[h7cCJOJQJ^JaJ h[hCJOJQJ^JaJ h[h[CJOJQJ^JaJ-vw  PQcdef* $d%d&d'dNOPQgd[gdz&$d%d&d'dNOPQgd[>?E^_gdz  gd @* $d%d&d'dNOPQgd[hipީީ|und`nUnNn hB&h7chB&hCJaJh[hB&h5\ hB&h h[hhB&h>*CJ h[hOCJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#h[h5CJOJQJ^JaJ h[hCJOJQJ^JaJ#h[hH &5CJOJQJ^JaJ h[hwCJOJQJ^JaJ h[hH &CJOJQJ^JaJ%&N{w-$ $d%d&d'dNOPQa$gd&i* $d%d&d'dNOPQgd&igd~`gdz&$d%d&d'dNOPQgd[  CEL{|QññÍ|kkVA(h&ihH &CJOJQJ^JaJmH sH (h~\hH &CJOJQJ^JaJmH sH  h~\hH &CJOJQJ^JaJ h~\hWCJOJQJ^JaJ#h~\hH &5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#h&ihH &5CJOJQJ^JaJ h&ihH &CJOJQJ^JaJh&iCJOJQJ^JaJ hB&hH & hB&h hB&h_nhB&h\ef.NYr &4* $d%d&d'dNOPQgd&i4EPi45GI&$d%d&d'dNOPQgdW* $d%d&d'dNOPQgd~* $d%d&d'dNOPQgd&i,345:;<?CGHbe~ųšxngngn`O>O hWh7cCJOJQJ^JaJ hWhCJOJQJ^JaJ hB&h hh\]h>ihh\]hcbhh5\]hh5CJOJQJ^JaJhH &5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#h&ihH &5CJOJQJ^JaJ h&ihH &CJOJQJ^JaJ(h~\hH &CJOJQJ^JaJmH sH (hcOhH &CJOJQJ^JaJmH sH ~IJIPQ   0 3 L P ~  8 ? @ A ޺޺޺ީ̺ޓtcc޺ hWh_nCJOJQJ^JaJ hWh7cCJOJQJ^JaJhWCJOJQJ^JaJh#hOh5CJOJQJ^JaJ h~\hCJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#hWh5CJOJQJ^JaJ hWhCJOJQJ^JaJ hWh9^CJOJQJ^JaJ!"#kIQ    ^ _    8 gdz&$d%d&d'dNOPQgdW8 @ A      R S T U    0 1 ` a    9 :  gdz&$d%d&d'dNOPQgdWA       , 2 Q R S T U i l        Ƕٓ~m\KK9#hE4h5CJOJQJ^JaJ hWh FCJOJQJ^JaJ hWh7cCJOJQJ^JaJ hWhWCJOJQJ^JaJh hWh_nCJOJQJ^JaJ hWhwCJOJQJ^JaJ#hWh5CJOJQJ^JaJ hWhCJOJQJ^JaJ#hOh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ(hWhCJOJQJ^JaJmH sH    C D K           v} {|;ʸʱʠʏ~ʏʸʸziʠʏʏ hWhWCJOJQJ^JaJh hWh_nCJOJQJ^JaJ hWh FCJOJQJ^JaJ hWh7cCJOJQJ^JaJ hB&h_n#hWh5CJOJQJ^JaJ hWhCJOJQJ^JaJ#hE4h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ)    ef WqrJgdz&$d%d&d'dNOPQgdW./46JKP&'(/01K)lwީ޺ކ}voho`o`hB&h6 hB&hw hB&h hWhhB&hCJ hWhwCJOJQJ^JaJ#hWh F5CJOJQJ^JaJ hWh FCJOJQJ^JaJ#hWh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hWhCJOJQJ^JaJ hWhsCJOJQJ^JaJ%56Q0KLMCDE&$d%d&d'dNOPQgd Fgdz  gd~&$d%d&d'dNOPQgdWw%&)*NQDEKOS129 q`` h~\h FCJOJQJ^JaJ#h~\h F5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#hWh F5CJOJQJ^JaJ hWh FCJOJQJ^JaJ hB&h9u< hB&h{rhB&h\hk h F5h FhB&h6hB&h5 h~h~ h~h hB&h#EzMzz-$ $d%d&d'dNOPQa$gdW* $d%d&d'dNOPQgdWgdzgd~`&$d%d&d'dNOPQgd F* $d%d&d'dNOPQgd(1Sn:i*GZdw* $d%d&d'dNOPQgdW Jz5()0ŰŞŞ}shsZL?sZLshZh9qhzCJOJQJhE4hz5CJOJQJhcOhcO5CJOJQJhz5CJOJQJhzCJOJQJ hB&hhB&h F5#hcOhcO5CJOJQJ^JaJ#hWh F5CJOJQJ^JaJ(hcOh FCJOJQJ^JaJmH sH hWh FCJOJQJ^JaJ(hWh FCJOJQJ^JaJmH sH (h~\h FCJOJQJ^JaJmH sH !9Rb}%&k&$d%d&d'dNOPQgdz* $d%d&d'dNOPQgdW5knopqIJ&$d%d&d'dNOPQgd'gdz&$d%d&d'dNOPQgdz0op\fz     ! "4":"=#E#H#d#e####$$$Y$[$r$u$$跩x螷q`O` hlh7cCJOJQJ^JaJ hlhCJOJQJ^JaJ hB&hh9qh'5CJOJQJh9qh'CJOJQJh'>*CJOJQJh'5CJOJQJhE4h'5CJOJQJhcOhcO5CJOJQJ hcOh'CJOJQJmH sH #hcOh'5CJOJQJmH sH h'CJOJQJhhzCJOJQJJ\{ 6 X p    3"4"G#H#### $ $Z$&$d%d&d'dNOPQgd'Z$\$$$$2%3%b%c%%%&B&C&&&&&&&* $d%d&d'dNOPQgdlgdz&$d%d&d'dNOPQgdl$$$$%%%%L&M&T&i&p&&&&&&&&&& ' 'y'z''''''''''(( (|(}((((޺޶ޗuuކu޺޶ hlhsCJOJQJ^JaJ hlhwCJOJQJ^JaJ hlh7cCJOJQJ^JaJhlCJOJQJ^JaJh#hlh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hlhCJOJQJ^JaJ hlh"CJOJQJ^JaJ*&'h'i''''' (X(r(s((((())K)))))"*#*gdz* $d%d&d'dNOPQgdl(((((();))))))))))))***!*#*2*8*9*:*N*O*T***޼޼ޫޫޙވvޫޙވdވSvv hlh~CJOJQJ^JaJ#hlh"5CJOJQJ^JaJ#hlh5CJOJQJ^JaJ hlhBCJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hlhwCJOJQJ^JaJ hlh"CJOJQJ^JaJ hlh7cCJOJQJ^JaJ hlhCJOJQJ^JaJ hlhlCJOJQJ^JaJ #*9*:*U**** + +>+]+^+:-;-n-o-p--$ $d%d&d'dNOPQa$gdDBgd~` gdDBgdzgdDB* $d%d&d'dNOPQgdl*** + +3+4+5+6+=+>+?+]+^+k+:-;-o-......B/C/ܹ˞ziWiWiE#h~\h9u<5CJOJQJ^JaJ#hDBh9u<5CJOJQJ^JaJ hDBh9u<CJOJQJ^JaJ hB&h0 hB&h9u<hqZh6 hB&h hDBhhB&hCJ#hlhs5CJOJQJ^JaJ#hlh5CJOJQJ^JaJ hlhCJOJQJ^JaJ hlhsCJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJp------.:.Z.~...../R/_/`/s//* $d%d&d'dNOPQgdDB-$ $d%d&d'dNOPQa$gdDBC/J/Q/R///$0*1C1a1v1y11111111111 2z2̷̍{{sl[J[[[ hDBh7cCJOJQJ^JaJ hDBhCJOJQJ^JaJ hB&hhB&h9u<5#hDBh9u<5CJOJQJ^JaJ(hcOh9u<CJOJQJ^JaJmH sH (hDBh9u<CJOJQJ^JaJmH sH (h~\h9u<CJOJQJ^JaJmH sH  hDBh9u<CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h~\h9u<CJOJQJ^JaJ/////00!0=0P0l00000000 1'1@1`1a11* $d%d&d'dNOPQgdDB11112g2h22222*3h333"4`444455e5f5g5gdz&$d%d&d'dNOPQgdDBz222222234455 5'5f5g5h5556ʸ|gcRA hDBh7cCJOJQJ^JaJ hDBhDBCJOJQJ^JaJh(hcOhCJOJQJ^JaJmH sH +hcOhcO5CJOJQJ^JaJmH sH (hDBhCJOJQJ^JaJmH sH  hcOhCJOJQJ^JaJ#hcOh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hDBhCJOJQJ^JaJ#hDBh5CJOJQJ^JaJg5h5555D6E66666637[7\7777777&$d%d&d'dNOPQgdDBgdz&$d%d&d'dNOPQgdDB66666666e7f7m7777777Ӿsas]Ls;s hDBh7cCJOJQJ^JaJ hDBhDBCJOJQJ^JaJh#hDBh5CJOJQJ^JaJ hDBhCJOJQJ^JaJ#hE4h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ+hDBh5CJOJQJ^JaJmH sH (hDBhCJOJQJ^JaJmH sH +hE4h5CJOJQJ^JaJmH sH +hcOhcO5CJOJQJ^JaJmH sH 77 8'888 999F9G9N9999999999:r:s:z:::::::::;q;r;y;;;̺̺ިޡސmިf hB&hDB#hDBhw5CJOJQJ^JaJ hDBh=!CJOJQJ^JaJ hDBh7cCJOJQJ^JaJ hB&h=!#hDBh5CJOJQJ^JaJ#hE4h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hDBhCJOJQJ^JaJ hDBhwCJOJQJ^JaJ&7588888899<9=99999:a:b:::::;M;g;h;&$d%d&d'dNOPQgdDBh;;;;;;;C<<<<<==1=2=M====>>2>3>gdz&$d%d&d'dNOPQgdDB;;;;;;<<<<<<<<<<<=====+=0=2=F=G=L====>>(>)>*>1>ᮜῊygyyኜᮊ#hDBh9u<5CJOJQJ^JaJ hDBh9u<CJOJQJ^JaJ#hDBh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hDBhwCJOJQJ^JaJ hDBh=!CJOJQJ^JaJ hDBh7cCJOJQJ^JaJ hDBhCJOJQJ^JaJhDBCJOJQJ^JaJ$1>2>3>4>L>M>>>>>bAcAAAABBBBBCdCeClCsCtCCļļĵnn\KnK h~\hVuCJOJQJ^JaJ#h~\hVu5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#h.whVu5CJOJQJ^JaJ h.whVuCJOJQJ^JaJhB&heCJaJ hB&he hB&hVuhqZh +6h + hB&h h.whhB&hCJ hDBh.wCJOJQJ^JaJh5CJOJQJ^JaJ3>L>M>bAcAAAAAAAAB:B\B|BB* $d%d&d'dNOPQgd.w-$ $d%d&d'dNOPQa$gd.wgd~`gd +gdz  gd&XBBBBC5CtCCCCCCCCD&D0DCD_DrDDDDDD* $d%d&d'dNOPQgd.wCDFDLEeEEEEEEEEEEEFFFFŰŞŞyhWhEh/+hcOhcO5CJOJQJ^JaJmH sH #hyh5CJOJQJ^JaJ hyh7cCJOJQJ^JaJ hyhCJOJQJ^JaJ hB&hhB&hVu5CJaJ#hcOhcO5CJOJQJ^JaJ#h.whVu5CJOJQJ^JaJ(hcOhVuCJOJQJ^JaJmH sH h.whVuCJOJQJ^JaJ(h.whVuCJOJQJ^JaJmH sH (h~\hVuCJOJQJ^JaJmH sH DDEE.EIEbEEEEEEE3FFFFFFF+G&$d%d&d'dNOPQgdy* $d%d&d'dNOPQgd.wFF+GHHHH0I1I8INIqIrIsIIIJJԿxg`O9+hcOhcO5CJOJQJ^JaJmH sH  hyh7cCJOJQJ^JaJ hB&h hyhVuCJOJQJ^JaJ#hyh5CJOJQJ^JaJ#h-h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hyhCJOJQJ^JaJ(hcOhCJOJQJ^JaJmH sH (hyhCJOJQJ^JaJmH sH +hE4h5CJOJQJ^JaJmH sH +GTGGGGGHJHvHHHH&I'IrIsItIIIJ* $d%d&d'dNOPQgdygdz&$d%d&d'dNOPQgdyJMJNJJJJJJ7K_K`KKKKKKK6LLL&$d%d&d'dNOPQgdygdz* $d%d&d'dNOPQgdyJJJJJJJiKjKqKKKKKKKKKL'LLL MMMԾԬwfbQ@ff hyh7cCJOJQJ^JaJ hyhyCJOJQJ^JaJh hyheCJOJQJ^JaJ#hyh5CJOJQJ^JaJ hyhCJOJQJ^JaJ#h-h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ+hyh5CJOJQJ^JaJmH sH (hyhCJOJQJ^JaJmH sH +h-h5CJOJQJ^JaJmH sH LLLM_MMMMMNN_NNNNN?O@OVOWOqO* $d%d&d'dNOPQgdy&$d%d&d'dNOPQgdyMMMMMMMMMMMN N N,N_NNNNNNNNNNOOO6O7O>OMONOUOVOWO{O|OOO﹨uuudd݆ hyhwCJOJQJ^JaJ hyhtCJOJQJ^JaJ hyheCJOJQJ^JaJ hyh7cCJOJQJ^JaJ hyhyCJOJQJ^JaJhyhyCJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#hyh5CJOJQJ^JaJ hyhCJOJQJ^JaJ'qOrOOOOOPPLPPPP Q!Q7Q8QSQQQQRR9R:Rgdz* $d%d&d'dNOPQgdyOOOOOOOP=PPPPPPPPPPPPQQQQ!Q1Q6Q8QLQMQRQQQQRR/R0Rڸڸڸڸڦڸڃڦڸqڸڔڸ` hyh|CJOJQJ^JaJ#hyht5CJOJQJ^JaJ hyheCJOJQJ^JaJ#hyh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hyhtCJOJQJ^JaJ hyh7cCJOJQJ^JaJ hyhCJOJQJ^JaJ hyhyCJOJQJ^JaJh%0R1R8R9R:R;R~RRRiU~UUUOVcVVVhWiWlWmWWWWWWYYYIYJYQYY̻yyhVhVh#hyh@5CJOJQJ^JaJ hyh@CJOJQJ^JaJ hB&h| hB&h@hB&h@CJ]hB&h\ hB&hhB&h5hB&h6hf hB&h hyhyCJOJQJ^JaJh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#hyh5CJOJQJ^JaJ :R~RRUUUUHVIVJVKVWWWWWW-$ $d%d&d'dNOPQa$gdfAgd~`&$d%d&d'dNOPQgdygdzgdfWWXIXkXXXXXX3Y4YRYYYYYYYZ*ZCZ`ZsZ}Z* $d%d&d'dNOPQgdyYYYYY"ZcZZ[[[[[[[\\\\ܹzhhYHA hB&h hyhyCJOJQJ^JaJh@5CJOJQJ^JaJ#hyh@5CJOJQJ^JaJ(hcOh@CJOJQJ^JaJmH sH (hyh@CJOJQJ^JaJmH sH (h~\h@CJOJQJ^JaJmH sH  hyh@CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h~\h@CJOJQJ^JaJ#h~\h@5CJOJQJ^JaJ}ZZZZZZ[[![:[R[k[{[[[[[\\\* $d%d&d'dNOPQgdy* $d%d&d'dNOPQgdy\\"\<\>\g\\$]+],]`]g]h]]]4^5^<^N^w^x^y^_﷡{iW{SIhfACJOJQJh#hcOhcO5CJOJQJ^JaJ#hyh5CJOJQJ^JaJ hyhCJOJQJ^JaJ(hcOhCJOJQJ^JaJmH sH +hcOh5CJOJQJ^JaJmH sH +hcOhcO5CJOJQJ^JaJmH sH hyh@CJOJQJ^JaJ hyh7cCJOJQJ^JaJ hyhCJOJQJ^JaJ\K\L\\\\$],]-]`]h]]]]*^+^w^x^y^z^* $d%d&d'dNOPQgdfAgdz* $d%d&d'dNOPQgdyz^^^_R_____``"aFaGatauaaaObbbbcTc|c* $d%d&d'dNOPQgdfA____``>aEakalasaaaaabbbbcccddddd$d'dAdEdGdKdjddɻӻӻӻӻɴziiX hyhwhCJOJQJ^JaJ hyhXOCJOJQJ^JaJ hyh7cCJOJQJ^JaJ hyhuKCJOJQJ^JaJ hyhCJOJQJ^JaJ hB&hi) hB&hhcOhcO5CJOJQJhfACJOJQJhfA5CJOJQJ h9qhfACJOJQJmH sH  hcOhfACJOJQJmH sH "|c}cccddXdYddddeeXeYeee f fWfXf&$d%d&d'dNOPQgdy* $d%d&d'dNOPQgdfAdddXeYe`eeeeffafbfifsffffffffffͼucu_N= hyh7cCJOJQJ^JaJ hyhyCJOJQJ^JaJh#hyh5CJOJQJ^JaJ hyhwhCJOJQJ^JaJ#h-h5CJOJQJ^JaJ#h-hc 5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hyhc CJOJQJ^JaJ hyhCJOJQJ^JaJ hyhuKCJOJQJ^JaJ hyhXOCJOJQJ^JaJXfffffff,gzg{ggghh+hyhhhhh:i;iQRYZ[uܹzhWhKD3 h*hCJOJQJ^JaJ hB&h-AhB&h-A5CJaJ h*htCJOJQJ^JaJ#h*ht5CJOJQJ^JaJ(hcOh-ACJOJQJ^JaJmH sH (h*h-ACJOJQJ^JaJmH sH (h~\h-ACJOJQJ^JaJmH sH  h*h-ACJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h~\h-ACJOJQJ^JaJ#h~\h-A5CJOJQJ^JaJв$%Z\<=~Ĵ:&$d%d&d'dNOPQgd** $d%d&d'dNOPQgd*uxس;~ôĴ:;BCѵҵӵԵ޼ުު޼޼އud`Od h*h*CJOJQJ^JaJh h*h:CJOJQJ^JaJ#h*h5CJOJQJ^JaJ h*h){wCJOJQJ^JaJ#hh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h*htCJOJQJ^JaJ h*h-ACJOJQJ^JaJ h*hCJOJQJ^JaJ h*h7cCJOJQJ^JaJ:;ѵҵӵԵe=Xt÷շkgdz&$d%d&d'dNOPQgd* ;V÷շڷ;Bٸڸ-4h龎vbPvv#h*h5CJOJQJ^JaJ&h*h5CJOJQJ\^JaJ#hcOhcO5CJOJQJ^JaJ h*h){wCJOJQJ^JaJ#h*h){w5CJOJQJ^JaJ h*h ECJOJQJ^JaJ h*htCJOJQJ^JaJ h*h#^CJOJQJ^JaJ h*h:CJOJQJ^JaJ h*hCJOJQJ^JaJ#5vw()stKɻʻ&$d%d&d'dNOPQgd*hmnuv01}~̺׺ںտ뙈vd]L;L h*h7cCJOJQJ^JaJ h*h:CJOJQJ^JaJ hB&h#hcOhcO5CJOJQJ^JaJ#h*h5CJOJQJ^JaJ h*h){wCJOJQJ^JaJ h*hCJOJQJ^JaJ(hcOhV(CJOJQJ^JaJmH sH +hcOhcO5CJOJQJ^JaJmH sH +hcOh5CJOJQJ^JaJmH sH (hcOhCJOJQJ^JaJmH sH 9=  Ca߼ !0;>ڽ =AHbiݾ-.z{ͻͻͪ͘ޔrͪͻ͘ͻͻͻͪ͘ h*h7cCJOJQJ^JaJ h*h*CJOJQJ^JaJh#h*h5CJOJQJ^JaJ h*ht.CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h*hCJOJQJ^JaJ h*h:CJOJQJ^JaJ h*h){wCJOJQJ^JaJ,bռּ !efIKgdz&$d%d&d'dNOPQgd*+ P$d%d&d'dNOPQgd%&pqI56Qgdz&$d%d&d'dNOPQgd*˿ֿٿ!; /46IJPQ޵ޣޒƒޣހޣnހn#h*h:5CJOJQJ^JaJ#h*h5CJOJQJ^JaJ h*h3CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h*h7cCJOJQJ^JaJ h*h:CJOJQJ^JaJ hB&ht. h*hCJOJQJ^JaJ h*h){wCJOJQJ^JaJ%JKlrs{4P/4>$02;DQS^`jluwǿǷǭzǷǷǷǷǷǷǷǷǷǷǷljs hB&h3ahB&h5 hB&h,h h,h h,\] h,Ai\]hDnh,6\]h,h,\]hB&h6hDnh6 hB&h h*hhB&hCJ h*hCJOJQJ^JaJ h*hLHCJOJQJ^JaJ-JKz{DEFgd~` gd3agdzgd*&$d%d&d'dNOPQgd*Gwx*Z`ƵnnYD(h*hg)CJOJQJ^JaJmH sH (h~\hg)CJOJQJ^JaJmH sH  h~\hg)CJOJQJ^JaJ#h~\hg)5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#h*hg)5CJOJQJ^JaJ h*hg)CJOJQJ^JaJ h*h` {CJOJQJ^JaJ h*h$h$ hB&hc;hB&h>*hB&h5 hB&h2MoH* $d%d&d'dNOPQgd*-$ $d%d&d'dNOPQa$gd* ':DWs2B]v* $d%d&d'dNOPQgd*`y*Hųų}l}[}[}E/+hh5CJOJQJ^JaJmH sH +hcOhcO5CJOJQJ^JaJmH sH  h*h` {CJOJQJ^JaJ h*h7cCJOJQJ^JaJ h*hCJOJQJ^JaJ hB&hhB&hg)5CJaJ#hcOhcO5CJOJQJ^JaJ#h*hg)5CJOJQJ^JaJ h*hg)CJOJQJ^JaJ(h~\hg)CJOJQJ^JaJmH sH (hcOhg)CJOJQJ^JaJmH sH V,4>?,gdz* $d%d&d'dNOPQgd*,34XtտrarK6(h~\hCJOJQJ^JaJmH sH +h*h5CJOJQJ^JaJmH sH  h*h7cCJOJQJ^JaJ h*h` {CJOJQJ^JaJ hB&h` {#hcOhcO5CJOJQJ^JaJ#h*h5CJOJQJ^JaJ h*hCJOJQJ^JaJ+hh5CJOJQJ^JaJmH sH +hcOhcO5CJOJQJ^JaJmH sH (h*hCJOJQJ^JaJmH sH ,^>]~C}FGZ[)* $d%d&d'dNOPQgd*# GMPX[34ȳ|jYGYjYGY6Y|Yj h~\hCJOJQJ^JaJ#h*h>*CJOJQJ^JaJ h*hCJOJQJ^JaJ#h*h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hH,*CJOJQJ\]^JaJ&h~\hH,*CJOJQJ\]^JaJ(hH,*CJOJQJ\]^JaJmH sH "hCJOJQJ^JaJmH sH (h*hCJOJQJ^JaJmH sH  hcOhCJOJQJ^JaJ)*xzMN}~*RSgdz&$d%d&d'dNOPQgd** $d%d&d'dNOPQgd*4;xy\]dg~#ܳܳ܏ܳ܋zܳܳ܏ܳ܏܋ h*h*CJOJQJ^JaJh#h*h5CJOJQJ^JaJ#hh5CJOJQJ^JaJ h*h` {CJOJQJ^JaJ h*h7cCJOJQJ^JaJ hB&h` { h*hCJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ0-z{$qIJgdz* $d%d&d'dNOPQgd*!!-.5<WXZacsxz JKrsz{|޼޼ު޼޼ު޼޼ޘ޼ޘ{pehcOhmH sH hcOh/~mH sH h@@hmH sH #h*h` {5CJOJQJ^JaJ#h*h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h*h` {CJOJQJ^JaJ h*h7cCJOJQJ^JaJ h*hCJOJQJ^JaJ h*h*CJOJQJ^JaJ%"#bcyzJK{gdzgd/~* $d%d&d'dNOPQgd*g|  !"UW^ǿλ|j|jX#h~\h` {5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#h*h` {5CJOJQJ^JaJ h*h` {CJOJQJ^JaJ h*h*CJOJQJ^JaJhc; hB&h` {h$h$h$6 hB&h$ hB&hc;hB&h5 hstC5hstC hB&h*hhB&h6 hB&h" !"78`zzzzz* $d%d&d'dNOPQgd*gd~`gdz&$d%d&d'dNOPQgdstC* $d%d&d'dNOPQgdstC 01wx&Ccn* $d%d&d'dNOPQgd*f)->?ELMNhk̷̍{{j{cRARR h*h7cCJOJQJ^JaJ h*hCJOJQJ^JaJ hB&h h*hbCJOJQJ^JaJ#h*h` {5CJOJQJ^JaJ(hcOh` {CJOJQJ^JaJmH sH (h*h` {CJOJQJ^JaJmH sH (h~\h` {CJOJQJ^JaJmH sH  h*h` {CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h~\h` {CJOJQJ^JaJ;IZe~MO.0&$d%d&d'dNOPQgd** $d%d&d'dNOPQgd*ryz밞{ieTC h*h` {CJOJQJ^JaJ h*h*CJOJQJ^JaJh#h*h5CJOJQJ^JaJ hcOhCJOJQJ^JaJ#hcOh5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ h*hCJOJQJ^JaJ(hcOh` {CJOJQJ^JaJmH sH (hcOhbCJOJQJ^JaJmH sH (hcOhCJOJQJ^JaJmH sH 0rz|./yz[&$d%d&d'dNOPQgd*gdz&$d%d&d'dNOPQgd*-IL[ =BCQV޾ޙq`O;&h*h5CJOJQJ\^JaJ h*h'CJOJQJ^JaJ h*hbCJOJQJ^JaJ#h*hb5CJOJQJ^JaJhcOh.0mH sH h.0h.0mH sH  hcOh.0hcOh` {^JaJmH sH hcOh'^JaJmH sH hcOh^JaJmH sH h*h` {CJOJQJ^JaJ h*hCJOJQJ^JaJ h*h7cCJOJQJ^JaJ =PQ+,m&$d%d&d'dNOPQgd*&$d%d&d'dNOPQgd.0&$d%d&d'dNOPQgd*#*_delmrsz9 ܵxq`O`` h*h7cCJOJQJ^JaJ h*h@YCJOJQJ^JaJ hB&h h*h]3CJOJQJ^JaJ+hcOhcO5CJOJQJ^JaJmH sH +hcOh5CJOJQJ^JaJmH sH (hcOhCJOJQJ^JaJmH sH #h*h5CJOJQJ^JaJ h*hCJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJmnhiH&$d%d&d'dNOPQgd*&$d%d&d'dNOPQgd*  $%&'2=@$MQXpw3Pʸʧʁʸʸ۸ʧʁʧʧp h*h@YCJOJQJ^JaJ h*h7cCJOJQJ^JaJ h*h*CJOJQJ^JaJh h*hbCJOJQJ^JaJ#h*h5CJOJQJ^JaJ h*hCJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#hJYh5CJOJQJ^JaJ,b$%&'qr }}}}}* $d%d&d'dNOPQgd*gdz&$d%d&d'dNOPQgd*+ PA$d%d&d'dNOPQgdJY  YZ 34~`&$d%d&d'dNOPQgd*gdz* $d%d&d'dNOPQgd*89OPk,-xDEBC !gdAe  gdAe &$d%d&d'dNOPQgd*!079INPcdek67>?xy  04nopxܹܨʖ܋|w|sl_h5hB*aJ0ph hB&hhc6 hAe >* hAe 5hAe hAe CJhB&hCJaJ#h*hb5CJOJQJ^JaJ h*hbCJOJQJ^JaJ h*h@YCJOJQJ^JaJ#h*h5CJOJQJ^JaJ h*hCJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ!!mnop} gd5! gd5! gdz&$d%d&d'dNOPQgdAe gdAe xyz{N]!"&HgijkpZynjhB&hD?U hB&h*h* hB&h qhB&hD?5 hB&hD~x hB&hwQ2 hB&h hB&hD? hB&hD{ hB&hl@hJ hB&h hB&hJ hB&h hB&h{'h{'hh5hB*aJ0phh5hB*aJ0ph)hijk gdl@gdl@gdl@&$d%d&d'dNOPQgd*gdzZ[\lw »{jX#h;h5CJOJQJ^JaJ h;hCJOJQJ^JaJ h;hw qCJOJQJ^JaJ hB&h"8hl@ hB&hD~x hB&h&hB&h5 hl@hD~x hB&h hl@hhB&h&5CJPJ\ hB&hD?hB&hD?0J'OJQJ^JjhB&hD?Ujq_$hB&hD?UDqL01mx*v$d%d&d'dNOPQ^vgd]~ ;<C\`hipBDKUV789:nopqtܹܧܧܧܛ{t{mf_m__ hB&h hB&hD{ hB&hk hl@hD~x hl@h"hB&h5CJOJQJ\aJ hB&hw qhB&h5CJaJ#h;h5CJOJQJ^JaJ#h;hD{5CJOJQJ^JaJ h;hD{CJOJQJ^JaJ h;hCJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ%(789pq=>?VWX&$d%d&d'dNOPQgdl@gdl@gdz*v$d%d&d'dNOPQ^vgd]~$<=>?FX|7 8 9 @ x          }i}Ui}U}i}i}Ui}Ui}U&hl@h5CJOJQJ\^JaJ&hcOhcO5CJOJQJ\^JaJ hl@hCJOJQJ^JaJ h~\hCJOJQJ^JaJ h~\hl@CJOJQJ^JaJ h~\hw qCJOJQJ^JaJ h~\h hB&hk hB&hw q hB&hl@h~\hk\h~\hk5\h~\h5\ hB&h!X+ i      * f s      + d     &$d%d&d'dNOPQgdl@  W X _   $FZa In)n۶ۤۤۤۓۓۂvhB&h5CJ\ h~\hCJOJQJ^JaJ hl@hLCJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ hl@hw qCJOJQJ^JaJ&hl@h5CJOJQJ\^JaJ hl@hCJOJQJ^JaJ&hcOhcO5CJOJQJ\^JaJ+  + K d      + =   6z%b!d&$d%d&d'dNOPQgdl@d@p*Y'^;j&$d%d&d'dNOPQgdl@F}M12fg&$d%d&d'dNOPQgdl@gdzgdl@&$d%d&d'dNOPQgdl@/0126AD\IL '*+9FdgpqͶ篨͠wfwT#hcOhcO5CJOJQJ^JaJ hl@h7cCJOJQJ^JaJ hl@hCJOJQJ^JaJ hl@h5*+CJOJQJ^JaJ hB&h*ahB&h*a5 hB&h%F hB&hD{hB&h\hB&h>* hB&hLhB&h5hB&h7c^JhB&h^J hB&hhl@ hl@hD~x hl@h  ?B]`uvx|}'()12?@ARSZͻxxpiﻩZhB&hCJOJQJaJ hB&h5*+hB&h*a5hB&h5hB&h5\ hB&h*a hB&h hl@h5*+CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#hl@h5CJOJQJ^JaJ hl@hLCJOJQJ^JaJ hl@h7cCJOJQJ^JaJ hl@hCJOJQJ^JaJ#1QR)*C^|}~()@AB^gd~`gdz&$d%d&d'dNOPQgdl@^U23NOmK* $d%d&d'dNOPQgdl@gdz gdl@gd~`&$d%d&d'dNOPQgdl@3;MNO_elƴƴ|fP|+hcOhcO5CJOJQJ^JaJmH sH +hl@h5CJOJQJ^JaJmH sH (hl@hCJOJQJ^JaJmH sH  hl@hPPCJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#hl@h5CJOJQJ^JaJ hl@hCJOJQJ^JaJhB&h5 hB&hPPhB&hPP5 hB&h*ahN hB&hP    ! X _ u |      !! !!!(!/!0!Y!Z!a!b!c!d!޺墨޺޺ރ̺rr`r\U hB&h9hl@#h~\hPP5CJOJQJ^JaJ hl@hCJOJQJ^JaJ&hcOh5CJOJQJ\^JaJ h~\hPPCJOJQJ^JaJ#h~\h5CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#hcOh5CJOJQJ^JaJ hcOhCJOJQJ^JaJ h~\hCJOJQJ^JaJ!! }  !0!b!c!d!w!""/"0"Q"R"j""""""gd~`gdz* $d%d&d'dNOPQgdl@d!n!v!!!"""."/"0"@"I"P""""""""""""_####ññßÊt^tIt(h~\hCJOJQJ^JaJmH sH +hcOhcO5CJOJQJ^JaJmH sH +hl@h5CJOJQJ^JaJmH sH (hl@hCJOJQJ^JaJmH sH #hcOhcO5CJOJQJ^JaJ#hcOh5CJOJQJ^JaJ hcOhCJOJQJ^JaJ hcOh hcOhPPhcOhPP5hcOh5 hB&hPP hB&h"&#Z######$T$k$l$$$$$$%%&&gdzgd9* $d%d&d'dNOPQgdl@#####T$c$j$l$$$$$$$$$$$%%%%%%&&&믝|unud||]|]YH h9h9CJOJQJ^JaJh hB&hD~xhB&h\] h9h7c h9h hB&hhB&h5#hcOhcO5CJOJQJ^JaJ#hl@h5CJOJQJ^JaJ hl@hCJOJQJ^JaJ+hcOhcO5CJOJQJ^JaJmH sH (h~\hCJOJQJ^JaJmH sH (hl@hCJOJQJ^JaJmH sH &&9&:&&&&&&%'p'''''(e((((()@)))* $d%d&d'dNOPQgd9& &&&&&''%'F'K'L']'(()))))*k*s*t********+ɳɳ{skd]d] hB&hF hB&h]hB&h]5hB&h5 h9h7c h9h hB&h#h9h5CJOJQJ^JaJ h9hj;CJOJQJ^JaJ+hcOh5CJOJQJ^JaJmH sH (hcOhCJOJQJ^JaJmH sH h9h7cCJOJQJ^JaJ h9hCJOJQJ^JaJ)**j*k******;+++++++,,W,X,,,,,&$d%d&d'dNOPQgd9gdzgd9+*+++,, -%-&-'-,-.-/-;->-~--..N/R////ɴ||udS޴B| h9hiECJOJQJ^JaJ h9hcqCJOJQJ^JaJ h9hWUCJOJQJ^JaJ hB&h #h9h5CJOJQJ^JaJ hcOhCJOJQJ^JaJ(hcOhCJOJQJ^JaJmH sH (h9hCJOJQJ^JaJmH sH (h~\hCJOJQJ^JaJmH sH  h9hCJOJQJ^JaJ h9h0CJOJQJ^JaJ, ---.-/-0-g-h---.&.6.|.../M/N/c/* $d%d&d'dNOPQgd9gdz&$d%d&d'dNOPQgd9c///00 00&080 $$Ifa$gdkgdzgd~`* $d%d&d'dNOPQgd9//////0008013141e1111Q2S243S3n3333S4T4U4X4~44-5.5ࠕ~qhaXaTh9h9h5CJ h9h5h~\h5CJh9h5B*CJphhkmH sH h4hB&h5mH sH h~\hkmH sH h~\h5mH sH )hB&h5B*CJOJQJ^JaJph hB&hkhkh5CJaJ hB&h4 hB&h hB&h5hB&h^JhB&h5^J hB&hE 8090=0?0F0a07.... $Ifgdzkd`$$$Ifl    \p `'      (0    `'4 lalp(a0111141U1a1^UUU $Ifgdkkda$$$Ifl    \p `' 0    `'4 lal $Ifgdza1b1c1e111g^^^^ $Ifgdzkdb$$$Ifl    \p `' 0    `'4 lal11111111g^^^^^^ $Ifgdzkdbc$$$Ifl    \p `' 0    `'4 lal111111g^^^^ $Ifgdzkd%d$$$Ifl    \p `' 0    `'4 lal1111122g^^^^^ $Ifgdzkdd$$$Ifl    \p `' 0    `'4 lal2222202E2g^^^^^ $Ifgdzkde$$$Ifl    \p `' 0    `'4 lalE2F2G2I2R2S22g^^^^^ $Ifgdzkdnf$$$Ifl    \p `' 0    `'4 lal222222g^^^^ $Ifgdzkd1g$$$Ifl    \p `' 0    `'4 lal222222g^^^^ $Ifgdzkdg$$$Ifl    \p `' 0    `'4 lal222222g^^^^ $Ifgdzkdh$$$Ifl    \p `' 0    `'4 lal22222223g^^^^^^ $Ifgdzkdzi$$$Ifl    \p `' 0    `'4 lal3333+3,3i3g^^^^^ $Ifgdzkd=j$$$Ifl    \p `' 0    `'4 lali3j3n3p333T4g^^U@@( $If^`gd9 $Ifgdk $Ifgdzkdk$$$Ifl    \p `' 0    `'4 lalT4U4V4X4f4~4g^^I4( $If^`gd9( $If^`gdk $Ifgdzkdk$$$Ifl    \p `' 0    `'4 lal~44444444g^^^^^^ $Ifgdzkdl$$$Ifl    \p `' 0    `'4 lal444445'5@5g^^^^^^ $IfgdzkdIm$$$Ifl    \p `' 0    `'4 lal@5A5555555gb`TTTT $$Ifa$gdh`gd]kd n$$$Ifl    \p `' 0    `'4 lal.5A5B5k5555555556717777777788888{888O9P9ü~nYPh~\h5CJ)hB&h5B*CJOJQJ^JaJphhlh5CJ\aJmH sH h~\h5mH sH hB&h5mH sH  h~\h5CJOJQJ^JaJh9B*CJphh9h5B*CJph hB&hkhkhkCJaJhkhkCJaJh]h]6h] hB&h]hB&h]^Jhk hB&h55555567.... $Ifgdzkdn$$$Ifl    \p &`' :     (0    `'4 lalp(6666%6C6^6g^^^^^ $Ifgdzkdp$$$Ifl    \p &`' :0    `'4 lal^6_6`6b6v666g^^^^^ $Ifgdzkdp$$$Ifl    \p &`' :0    `'4 lal6666667g^^^II( $If^`gd9 $Ifgdzkdq$$$Ifl    \p &`' :0    `'4 lal777777g^^^^ $IfgdzkdJr$$$Ifl    \p &`' :0    `'4 lal777777g^^^^ $Ifgdzkd s$$$Ifl    \p &`' :0    `'4 lal7777778g^^^^^ $Ifgdzkds$$$Ifl    \p &`' :0    `'4 lal888888g^UU=($ $If^`a$gdM $Ifgdz $IfgdMkdt$$$Ifl    \p &`' :0    `'4 lal88 8"808>8g^^^^ $IfgdzkdVu$$$Ifl    \p &`' :0    `'4 lal>8?8@8B8G8L8g^^^^ $Ifgdzkdv$$$Ifl    \p &`' :0    `'4 lalL8M8N8P8W8c8g^^^^ $Ifgdzkdv$$$Ifl    \p &`' :0    `'4 lalc8d8e8f8p8z8g^^^^ $Ifgdzkdw$$$Ifl    \p &`' :0    `'4 lalz8{88888P9g^^^II( $If^`gd9 $Ifgdzkdbx$$$Ifl    \p &`' :0    `'4 lalP9Q9R9T9\999:::g^^^^^^^^ $Ifgdzkd%y$$$Ifl    \p &`' :0    `'4 lal P9999:::::';[;\;e;f;g;h;;;T<W<====>>>?-?G?H?@@@@@@@ܵ籪zqj h~\h\@h~\h5CJ h~\h5CJOJQJ^JaJh\@h5B*CJph h~\h5hB&h5mH sH  h\@h hNHfhkh CJaJh]h]6h] hB&h]hB&h]^Jh  hB&h  hB&hNHf hB&h9h5 hB&h5%::g;h;p;w;;;gb`TTTT $$Ifa$gdh`gd]kdy$$$Ifl    \p &`' :0    `'4 lal;;;;;7... $Ifgdzkdz$$$Ifl    \p &`' :     (0    `'4 lalp(;V<W<+=,======^UUU $Ifgdzkd{$$$Ifl    \p &`' :0    `'4 lal $Ifgd  ==>>>>>>RIIII $Ifgdzkd|$$$Ifl    \p &`' :0    `'4 lal( $If^`gd\@>>>>>>g^^^^ $Ifgdzkdc}$$$Ifl    \p &`' :0    `'4 lal>>>>>?g^^^^ $Ifgdzkd&~$$$Ifl    \p &`' :0    `'4 lal??? ??,?g^^^^ $Ifgdzkd~$$$Ifl    \p &`' :0    `'4 lal,?-?1?3?H?\?@g^^^II( $If^`gd\@ $Ifgdzkd$$$Ifl    \p &`' :0    `'4 lal@@@@#@,@g^^^^ $Ifgdzkdo$$$Ifl    \p &`' :0    `'4 lal,@-@.@0@:@^@g^^^^ $Ifgdzkd2$$$Ifl    \p &`' :0    `'4 lal^@_@`@b@m@x@g^^^^ $Ifgdzkd$$$Ifl    \p &`' :0    `'4 lalx@y@z@|@@@g^^^^ $Ifgdzkd$$$Ifl    \p &`' :0    `'4 lal@@@@@@g^^^^ $Ifgdzkd{$$$Ifl    \p &`' :0    `'4 lal@@@@@@g^^F^($ $If^`a$gdM $Ifgdzkd>$$$Ifl    \p &`' :0    `'4 lal@@@@AAEAFAGAHAIAbAgAhAqArAtAAAAAA$BBBB* htH*h> ht5ht h>CJhB&h5\hB&h56 h}hhB&h5hB&h6 hB&h hB&hWUCR[S[N]O]``bb h}h hZ+>*CJ h^]5h^]h^]5h^] hZ+\] h\] hgt\]h>5CJPJ\ hB&h`hB&hB*ph hB&hWU hB&h&$hB&h\h> hB&hht(ggggghhiiKjLjMjjjjjkgdlgdl&$d%d&d'dNOPQgd}gdb  gd>gdgtgdzgd}&$d%d&d'dNOPQgd^]0i:iAi^iaibiiiiiiiJjKjLjMjRjjjllTlYlllmmWn\n#o%ooooqqrrr껱zsls hfha@$ hfhhB&hCJh3 hl5 hlH*hlhZ+5CJPJ\ hB&hbhB&hb5\hB&h}\] hb\]hB&h-v5 hB&h7hB&hH* hB&hP hB&hP 5\ hB&hhB&h-v>* hB&h-v&kkmmmmoooppqrrssssss+tvttt&$d%d&d'dNOPQgdfgdzgdfgdlrr"r%rrrrssXsfssssssssssssssssttttﹱ|k]|k|k|hE*FCJOJQJ^JaJ hfhsCJOJQJ^JaJ hfhCJOJQJ^JaJ hfhfCJOJQJ^JaJhG hB&hshB&h\hB&h/5hB&h5 hB&hTI hB&hKhB&ha@$5 hB&ha@$hB&hH*hB&hCJ hB&hh~\h\]tuuuuuuuuuuv#vxxxxx x1xAxxxxxxxxxx yybycyyyyyyyyyzzzzzzzzA}ͿͿͿͿͿͿͿͿͿͿͿͿͿͿͱ}ͿͿͿͿhh6 hB&hhB&h\hB&h5h hfh3CJOJQJ^JaJhCJOJQJ^JaJh (CJOJQJ^JaJ hfhCJOJQJ^JaJ hfhsCJOJQJ^JaJ hfh\4CJOJQJ^JaJ1tuVucuduuuu-v.vvvwvvvvvwwUwcwdwwwwKxx&$d%d&d'dNOPQgdfxxxycyyyyyGzzzz {!{q{{{{{"|gd&$d%d&d'dNOPQgd3&$d%d&d'dNOPQgdf"|$|B|D||||||:};}}}h~i~~~~ !ij!"&$d%d&d'dNOPQgdfA}D}E}G}H}K}r}}}}(~1~ !рҀӀY[5XYfwᮢ|sssk|dd hB&h<hB&h5hB&h^JhB&hPJhB&hH* hB&h hB&h hfhhB&hs5CJ\ hfhaCJOJQJ^JaJ hfhsCJOJQJ^JaJ hfh\4CJOJQJ^JaJ hfhCJOJQJ^JaJh (CJOJQJ^JaJ$"rрҀǂȂɂу>?no* $d%d&d'dNOPQgdfgdzgdf&$d%d&d'dNOPQgdfƂȂHIJfgуփnop„Ʉ΄фք,-5j̡{tmtmt{c\{\{\{c{\{\{c{\ hB&hyyhB&ha5\ hfhGM hfha hB&ha hfhCJOJQJ^JaJhfCJOJQJ^JaJ$hfh-0J'CJOJQJ^JaJ/jJ$hfh-CJOJQJU^JaJ)jhfh-CJOJQJU^JaJ hfh-CJOJQJ^JaJ hB&h hB&h$oɄʄ@Auv֊׊؊* $d%d&d'dNOPQgdh`gda&$d%d&d'dNOPQgdfgdzgdfɅʅ̅=?Іކ#)U[^‡Ň҇߇$%:BȾȳȳ~~hB&h9*|\hB&h9*|5\hB&hz5\h;p ha5 hB&h=`hB&ha5\hB&ha>*\]hB&ha5]hB&ha\]hB&haH*hB&hz\] hB&ha hB&hz hB&hyy hB&h9*|/BÈ?IQpqvwԊՊ֊؊݊ ).;ѢѢћё|k]khk}CJOJQJ^JaJ hDhDCJOJQJ^JaJh|CJOJQJ^JaJ hD\]hB&hyy\] hB&hhhB&hyy5\hB&ha5\]hW5hB&ha5 hW5\] hB&hGM hB&hyy hB&h_ hB&h9*|hB&ha5\ hB&hahB&ha\$ pz*G׍*x•Õ-./@gdW5&$d%d&d'dNOPQgdgdyy;<_`nopyzڌ)*FG֍׍8d")*Yx•ĕ͕̕٤ٲٲٲ٤ٲٲٲٲٲٖٲٲٲوwp hB&hW5hB&hW55\ hW5\]h|CJOJQJ^JaJhd~CJOJQJ^JaJhxCJOJQJ^JaJhDCJOJQJ^JaJ1hDhD0J'B*CJOJPJQJ^JaJph hDhDCJOJQJ^JaJ)jhDhDCJOJQJU^JaJ)͕Е!"+,-./wx?@o֗ח#$noxJKۙܙ&'pqijxg hDhd~CJOJQJ^JaJhDCJOJQJ^JaJhd~CJOJQJ^JaJ hDhDCJOJQJ^JaJh3CJOJQJ^JaJ hDh3CJOJQJ^JaJh|CJOJQJ^JaJ hW5\]hB&hW55\]hW5hW56hW5 hB&hW5hB&hW55(qr],ggv}gdW5&$d%d&d'dNOPQgdqr\]ڛ+,@_fgJKkݟޟfguv»h|CJOJQJ^JaJ hW5\]hB&hW55\]hW5hW56hW5hB&hW55 hB&hW5hB&hW55\ hW55\hd~CJOJQJ^JaJ hDhDCJOJQJ^JaJhxCJOJQJ^JaJ0|}./5TijTUVW_`c¬FGŭƭддддЦ~zrzg`RhCJOJQJ^JaJ hW5\]hB&hW55\]hW5hW56hW5hB&hW55 hB&hW5hB&hW55\ hW55\hW5hW5\h|CJOJQJ^JaJhxCJOJQJ^JaJhd~CJOJQJ^JaJ hDhDCJOJQJ^JaJhW5CJOJQJ^JaJ hDhW5CJOJQJ^JaJ /jUV¬<'gdz&$d%d&d'dNOPQgdW5gdW5 gdW5&$d%d&d'dNOPQgdƭEFخ<FGͰذ&)fg´ЦЕЇyrk hB&hG hB&hDhCJOJQJ^JaJhhCJOJQJ^JaJ hDhP3CJOJQJ^JaJhd~CJOJQJ^JaJhxCJOJQJ^JaJhP3CJOJQJ^JaJ hDhDCJOJQJ^JaJhW5CJOJQJ^JaJ hDhW5CJOJQJ^JaJ(BCc@A~23u>Iصٵ?@ABCHINQlrǶȶ  LjļĴܭܭܭܭܭܭhq]hh`>*hX?Whh`5 hq]hh`hq]hh`5h(CJaJhh`CJaJ hZ,hh`hZ,hh`aJhh`hG hB&hd hB&hh hB&hG hB&hX >@ABC¸  &$d%d&d'dNOPQgdh`+ $$d%d&d'dNOPQgdh` $gdh` gdh`gdzYZ¸˸ϸ UVyz<E[\ƿo^^^^ hwhvoCJOJQJ^JaJ hwhkc CJOJQJ^JaJ1hwhX?W0J'B*CJOJPJQJ^JaJph)jhwhX?WCJOJQJU^JaJ hwhX?WCJOJQJ^JaJ hCOhh`hh`5CJaJhCOhh`5CJaJ hX?WhX?Whh`CJaJhq]hh`CJaJ hq]hh`hh`$ IUV5νϽ#qrE $gd@tgd@t&$d%d&d'dNOPQgd@t&$d%d&d'dNOPQgdw!&'jk12TV45f½ͽνϽEtӿԿۿܿ޼ޮ޼voo hCOh@th@t5CJaJhCOh@t5CJaJh@t hwh@tCJOJQJ^JaJh@tCJOJQJ^JaJhvoCJOJQJ^JaJ hwhkc CJOJQJ^JaJ hwh1uCJOJQJ^JaJ hwhX?WCJOJQJ^JaJ hwhvoCJOJQJ^JaJ(ܿ45}~ ST45|}  V  MϾϾϾϾϾϾϾϾϾϾϾϾϾϾϾϭ hCOh@thCOh@t5CJaJh@t5CJaJ hwh@tCJOJQJ^JaJ hwh1uCJOJQJ^JaJ hwhkc CJOJQJ^JaJ hwhX?WCJOJQJ^JaJh KjCJOJQJ^JaJh@t h@t6h@th@t625  ,Amgd@t&$d%d&d'dNOPQgd@t&$d%d&d'dNOPQgdw $gd@tMm  +JOPVW NOOPEF  O?Ap$Ϳޮޮޮޠh KjCJOJQJ^JaJ hwh jCJOJQJ^JaJhaXCJOJQJ^JaJ hwhkc CJOJQJ^JaJ hwhX?WCJOJQJ^JaJ hwh1uCJOJQJ^JaJ:W@A,-NOgd gd&$d%d&d'dNOPQgdw$+-FMNOP*-WeHJrzdg;<{mbmbmh (CJOJQJhhhCJOJQJhhheCJOJQJhhCJOJQJh hH* h>* h5h hB&h8hwhwCJOJQJaJhh`CJOJQJ^JaJ hwhX?WCJOJQJ^JaJ hwhkc CJOJQJ^JaJ#hcOhcO5CJOJQJ^JaJ#:;<Z\^`bFHy*h$d%d&d'dNOPQ^hgd gdgdHbPQ&*\ghiktx FQRV^b0ȲߙߙߙߙߙߙߙߙߙߙߙߙߙߙߙhEKCJOJQJhh (CJOJQJhhheCJOJQJhhcOheCJOJQJhhh6h h5hcOhCJOJQJhhhCJOJQJh#hhCJOJQJhmH sH 8-i]QX$&T gdgd*h$d%d&d'dNOPQ^hgd\F0~hRSTgd*h$d%d&d'dNOPQ^hgd0;<DHL~%&)26hsty QRS]^a !#'Yde½hCJOJQJhhh6h h5hhCJOJQJhhCJOJQJhhhCJOJQJhhEKCJOJQJhh (CJOJQJhA YC-{eO*h$d%d&d'dNOPQ^hgd*h$d%d&d'dNOPQ^hgdejqu CNOU[_-89AEI{"#'/3epqv}  hhCJOJQJhhEKCJOJQJhhCJOJQJhhhCJOJQJhh (CJOJQJhLOZ[^hkclnoO_mqB&/23 ҿҘ{#hhCJOJQJhmH sH h@tCJOJQJhhcOh KjCJOJQJhhcOhCJOJQJhh@@CJOJQJhhaXCJOJQJhhh@t6h@t h@t5hEKCJOJQJhh (CJOJQJhhhCJOJQJh-2}noKwy{gd@t*h$d%d&d'dNOPQ^hgd1{}O@Bn123gd@t*h$d%d&d'dNOPQ^hgdOQn79;m  uvwgd@t*h$d%d&d'dNOPQ^hgd   jsvthrsvDEFGIǼǦǦǦǦǔǏxjx_h tCJOJQJhhhO?CJOJQJhhO?CJOJQJhhhvy6hvy hvy5#hcOhCJOJQJhmH sH h@@CJOJQJhhaXCJOJQJhheCJOJQJhhhCJOJQJhhh@t6h@t h@t5hhaXCJOJQJhhCJOJQJh%S 6wxBk[*h$d%d&d'dNOPQ^hgdK;w+,tghi!cgdvy*h$d%d&d'dNOPQ^hgdEFGHI%egtvx * h^hgdO?*h$d%d&d'dNOPQ^hgd        MVY$./2  (347@Doz{~     D O P T \ `  hEKCJOJQJhhaXCJOJQJhhO?CJOJQJhhhvy6hvy hvy5hhCJOJQJhh tCJOJQJhD* , [     O     \      H    ! Z  gdvy*h$d%d&d'dNOPQ^hgd   fh8xzI. h$d%d&d'dNOPQ^hgd*h$d%d&d'dNOPQ^hgdIXYa,.G. h$d%d&d'dNOPQ^hgdgdvy*h$d%d&d'dNOPQ^hgd   ['(@Q!L*h$d%d&d'dNOPQ^hgd !q>@_#$%gdvy*h$d%d&d'dNOPQ^hgd. h$d%d&d'dNOPQ^hgdk   R(oD   !`!!!5"|"*h$d%d&d'dNOPQ^hgd            !$!%!*!1!5!`!k!l!q!x!|!!!!!!!!!!!" "5"@"A"E"M"Q"|"""""""""""" ####"#&#Q#\#]#a#i#m#############&$hM<%CJOJQJhhVCJOJQJhhhCJOJQJhhEKCJOJQJhh0\CJOJQJhN|"" #Q###&$m$$$B%C%D%%%%>&&&&&&('(n((gdvy*h$d%d&d'dNOPQ^hgd&$1$2$8$>$B$m$x$y$}$$$$$$$$$$%%%%%C%M%N%Q%%%%((((((( ) ))))K)V)W)Z)c)g))))))))))))*1*<*=*A*I*M*}*****ۿۿۿۿۿۿۿۿۿۿۿۿ۴hY,CJOJQJhh.CJOJQJhhhvy6hvy hvy5hhCJOJQJhhEKCJOJQJhh[(CJOJQJhG((K)))1*}**+d+++J,,,0-}---1.2.~../d/gdvy*h$d%d&d'dNOPQ^hgd********+"+#+++/+3+d+p+q+v+|+++++++++ , ,,,,J,V,W,Z,b,f,,,,,,,,,,,,,0-<-=-C-H-L-}-----------&./.2.>.?.hhvy6hvy hvy5hCJOJQJhhEKCJOJQJhhYCJOJQJhhhCJOJQJhhY,CJOJQJhG?.B.J.N.~............/#/$/)///3/d/p/q/v/|///////// 0 0000G3R3S3X3_3c3333333333333,47484;4D4H44444444444445hh PCJOJQJhh PCJOJQJhhEKCJOJQJhhhCJOJQJhhYCJOJQJhLd///J0K0L000)1i1j112222G333,4445b5k5*h$d%d&d'dNOPQ^hgd55 5$5+5/5k5w5x55555555556!6"6%6.626_6j6k6n6w6{6666666 7 7777g7p7s77777777777788888!8N8Z8[8^8f8j88888½hhvy6hvy hvy5hCJOJQJhhhCJOJQJhhh PCJOJQJhhEKCJOJQJhh PCJOJQJhFk5556_66 7 7r7s778N888A999&:~::;o;;;gdvy*h$d%d&d'dNOPQ^hgd888A9M9N9Q9Y9]9999999999999&:2:3:8:>:B:~::::::::::::~====>E@@@@@@@@@DEػضؐhCJOJQJhmH sH h"mCJOJQJhhhvy6hvy hvy5#hhCJOJQJhmH sH hEKCJOJQJhhhCJOJQJhh PCJOJQJhhh PCJOJQJh6;=<?<j<2=4=6=~==='>)>X>>>>??L????@@@@*h$d%d&d'dNOPQ^hgd@@@@@@@!A]AAABMBBBC=CyCCC-DiDDDDDgdvy*h$d%d&d'dNOPQ^hgdE EEEuIIJJJ%J&J)JxJJJJKOOOOOOTTT"TqTzT}T1U2UfU}оrrХdYdhvyCJOJQJhhhvyCJOJQJhh&+MCJOJQJhhcOhCJOJQJhhcOh"mCJOJQJhhhvy6hvy hvy5h@@hvy5hcOhvy5mH sH #hhCJOJQJhmH sH hhCJOJQJhhCJOJQJhmH sH #hcOhCJOJQJhmH sH D,ESEUEEEEE-FiFFFGYGGG HIHHHH9IuIII*h$d%d&d'dNOPQ^hgdIIJJJJJJJJ"KkKmKKKLNLLLM>MzMMM.Ngdvy*h$d%d&d'dNOPQ^hgd.NjNNNOHOOOOOSPPPPQQDQQQQ4RpRRR$S*h$d%d&d'dNOPQ^hgd$S`SSSTT|T}TTT1U2UaUUUU&V'V(V)V*h$d%d&d'dNOPQ^hgdvygdvy*h$d%d&d'dNOPQ^hgdfU{UUUU)VVXXXXXY\\\\\\\\]]2^E^P^T^_^_#b´qfWW´h&+MCJOJQJhmH sH hvyCJOJQJhhhvyCJOJQJhhhvy6hvy hvy5 h%ihvy#hhCJOJQJhmH sH h&+MCJOJQJhhhCJOJQJhhcOhCJOJQJhhcOhvyCJOJQJh#hhvyCJOJQJhmH sH hvyCJOJQJhmH sH )VyVVV4W6WlWFXHXJXXX YKYLY{YYYY5ZqZZZ%[a[*h$d%d&d'dNOPQ^hgda[[[\Q\\\\\\3]o]]]]]]2^o^^*h$d%d&d'dNOPQ^hgdvygdvy*h$d%d&d'dNOPQ^hgd^^^ _\_^___`>`z```.ajaaabZbbbc@ccc*h$d%d&d'dNOPQ^hgd#bbDc%d ffffgfpfsfbgcggghhopypzp}pppprrQtRtSty%y&y)yxyyy{ļĮߞyytptphphhA6hA hA5h0CJOJQJhhh0CJOJQJhhh06h0 h05h%iCJOJQJhhh%iCJOJQJhhh%i6h%i h%i5#hcOhCJOJQJhmH sH hhCJOJQJh#hcOhCJOJQJhmH sH $cd drdtdddeVeee f frfsfff'gcgg*h$d%d&d'dNOPQ^hgd%igd%i*h$d%d&d'dNOPQ^hgdgghShhhhh6iriii&jbjjjkRkkk*h$d%d&d'dNOPQ^hgd*h$d%d&d'dNOPQ^hgd%iklBl~lll'mcmmmnSnnnoCoooo3popppppgd0*h$d%d&d'dNOPQ^hgdpqDqqqq4rprrrr%sassstQtRtStt*h$d%d&d'dNOPQ^hgd*h$d%d&d'dNOPQ^hgd0ttt1uqusuu~vvvvv>wwww xxxy*h$d%d&d'dNOPQ^hgdyyyyyzazzzz{{{{!|L||||*h$d%d&d'dNOPQ^hgdgdA. h$d%d&d'dNOPQ^hgd{{{| }}!{GWei:בܑ$./2澹湵摟hhzCJOJQJhhc6hCJOJQJhhcOhCJOJQJhhhz6hz hz5hCJOJQJh#hhCJOJQJhmH sH hACJOJQJhhhCJOJQJhh&+MCJOJQJh3| }}=}y}}}-~i~~~Y!Ly{. h$d%d&d'dNOPQ^hgd*h$d%d&d'dNOPQ^hgd{@BT̂D4pgdz*h$d%d&d'dNOPQ^hgd8_a܅ޅ E5q%a*h$d%d&d'dNOPQ^hgd. h$d%d&d'dNOPQ^hgda0|։G]_Ȍgdz*h$d%d&d'dNOPQ^hgd@|89:Ŏ13b/k[ב*h$d%d&d'dNOPQ^hgdD4p$%ɔA}*h$d%d&d'dNOPQ^hgdgdz*h$d%d&d'dNOPQ^hgdz ?Q]aƘB}~ɜ՜֜ڜ $(O[\agkƸѭѭѭ||#h^fKh6j|CJOJQJhmH sH #h^fKhCJOJQJhmH sH hhz6 hz5hEKCJOJQJhhhGF4CJOJQJhhGF4CJOJQJhh&+MCJOJQJh#hcOhCJOJQJhmH sH hhCJOJQJhhz*?֖mї I=}~ϙיBɜ*h$d%d&d'dNOPQ^hgdɜ OCK|}ڞPƟ. h$d%d&d'dNOPQ^hgdgdz*h$d%d&d'dNOPQ^hgdߞ"./2UY]iju˟ϟӟߟ AEIUV[|ˠ̠Р -15AB̫̫̫̫̫̫̫̫̫̫̫̫̫̫̫̽̽̽̽̽#h^fKh^fKCJOJQJhmH sH h^fKCJOJQJhmH sH #h^fKhCJOJQJhmH sH #h^fKh6j|CJOJQJhmH sH hEKCJOJQJhmH sH C<w(c١OŢ;v. h$d%d&d'dNOPQ^hgd*h$d%d&d'dNOPQ^hgdBGhlp|}ޡ!-.1TX\hitʢ΢Ңޢߢɷɨɷɷɨɷɷɨɷɷɨɷɷɨɷrr#hEKhEKCJOJQJhmH sH #hEKhHeCJOJQJhmH sH #hEKhCJOJQJhmH sH hEKCJOJQJhmH sH #hHehCJOJQJhmH sH #hHehhtCJOJQJhmH sH #h^fKhCJOJQJhmH sH #h^fKh^fKCJOJQJhmH sH ,  @DHTUY{3j"&*67<]aeqrvӥץۥ blmpۺۺhz hz5hcOhCJOJQJhhhCJOJQJhhEKCJOJQJhmH sH #hEKhEKCJOJQJhmH sH #hEKhHeCJOJQJhmH sH #hEKhCJOJQJhmH sH 8.jXΥ *h$d%d&d'dNOPQ^hgd. h$d%d&d'dNOPQ^hgdGF4 Pabcʦ˦̦Lkgdz*h$d%d&d'dNOPQ^hgd. h$d%d&d'dNOPQ^hgdȦ˦̦048HKLquy̪ϪЪ 48<MSTpuy}Ыԫի38<@ڡ#hEKhEKCJOJQJhmH sH #hEKhCJOJQJhmH sH hEKhEKCJOJQJhhEKhCJOJQJhhEKCJOJQJhhhCJOJQJhh"mCJOJQJhhzhhz68+l/p3t7x;{ۮ*h$d%d&d'dNOPQ^hgd@QVWy}¬Ҭ<@DVx}­ƭ׭#5  PUYhhz6hz hz5hhGF4CJOJQJhhCJOJQJhhhCJOJQJhhEKCJOJQJhhEKCJOJQJhmH sH #hEKhCJOJQJhmH sH #hEKhEKCJOJQJhmH sH 6ۮQ  )PҰTֱWٲYgdz*h$d%d&d'dNOPQ^hgdY]nstװ۰߰ 0Y]av۱߱ $9\`dz޲"&8#hZchZcCJOJQJhmH sH hZcCJOJQJhmH sH #hZchCJOJQJhmH sH #hZch!KCJOJQJhmH sH hEKCJOJQJhmH sH #hEKhEKCJOJQJhmH sH #hEKhCJOJQJhmH sH 2AEIX´ƴʴߴ>BFVõǵܵ@DHPRWŶɶڶ ѿѿѿѿѿѿѿѿѰѿѰѿѰѿѰѿѰѿѰѿѡ#hhCJOJQJhmH sH hZcCJOJQJhmH sH hZcCJOJQJhmH sH #hZchZcCJOJQJhmH sH #hZchCJOJQJhmH sH hhGF4CJOJQJhhhCJOJQJh8Գ<}9z;{=y:z=*h$d%d&d'dNOPQ^hgd BFJ]~÷Ƿݷ?CGXĸȸٸ BFJZùǹ˹ DHL\źɺͺ޺ FJN_»ϽϽϽϽϽϽϽϽϽϽϽϽϽϽ#hcOhCJOJQJhmH sH h'CJOJQJhmH sH #hhCJOJQJhmH sH hZcCJOJQJhmH sH J=~?A»{|}˼ L*h$d%d&d'dNOPQ^hgdCOgdz*h$d%d&d'dNOPQ^hgd»!py|˼мԼؼ*QUYiӽ׽۽-TX\l־ھ޾0Xǿ񭛭hnCJOJQJhmH sH #hnhnCJOJQJhmH sH #hnhCJOJQJhmH sH hhz6hz hz5hzCJOJQJhht\CJOJQJhhCJOJQJhhhCJOJQJh4LνOѾSԿ'()Mt7. h$d%d&d'dNOPQ^hgdCO*h$d%d&d'dNOPQ^hgdCOX\`rԿ&'()ty}<@DU};?CS|źКyyyhnCJOJQJhmH sH #hnhnCJOJQJhmH sH #hnhCJOJQJhmH sH hhNCJOJQJhhNCJOJQJhhCJOJQJhhhCJOJQJh#hhCJOJQJhmH sH hnCJOJQJhmH sH /7x6w3FGRSTgdegde*h$d%d&d'dNOPQ^hgdCORST\]`p|tcNcN)jh8hNCJOJQJU^JaJ h8hNCJOJQJ^JaJh2Z;he5hbIhe5hz he6 he5hp>heh<;heCJOJQJ^JaJ#h7%hMnCJOJQJ^JaJhhhCJOJQJhhnCJOJQJhmH sH #hnhnCJOJQJhmH sH #hnhCJOJQJhmH sH J'qrzz&$d%d&d'dNOPQgdzgdN gd0)&$d%d&d'dNOPQgd8* $d%d&d'dNOPQgd8-.1:lu&IJ&'()pr´´´´´´´´£££££££ykhzCJOJQJ^JaJ hNhNhzhN6 hzhNhzhz5hzhN5hN h8hwCJOJQJ^JaJhrCJOJQJ^JaJ h8hNCJOJQJ^JaJ)jh8hNCJOJQJU^JaJ-h8hN0J'B*CJOJQJ^JaJph(d'#)@b $%/05>ABFL^̻̻̻̦{wplplphphphp`YpYp hB&hNCJOJQJ^JaJ h0)hNCJOJQJ^JaJ#h8hz5CJOJQJ^JaJ h8hzCJOJQJ^JaJ (MN#`abpwo gd gdB8 gdN* $d%d&d'dNOPQgd0)&$d%d&d'dNOPQgd0)&$d%d&d'dNOPQgdz ^_fgmnopqz{%)7;?pt+,26xy-1h*hZh(hc@ hB&hc@h.h6hANh5 hB&hA0 hA0hA0hA0hA0CJaJh5hB&h.5hB&h5 hhh hB&hN?@߹߹ş hnkhzhzhz6hz hB&hzhB&hz5hB&hmH sH  hnkhhnkh5mH sH hnk hB&hnk hB&habhabhab6 hB&hhB&h5\]hnkh5 hB&hA04!"#$rkdM$$$If\,$p~  4 a $Ifgdz$%)>i $Ifgdzrkd$$$If\,$p~  4 aD $Ifgdzrkd۠$$$If\,$p~  4 aDEIZ $Ifgdzrkd$$$If\,$p~  4 a#e $Ifgdzrkdi$$$If\,$p~  4 aefj $Ifgdzrkd0$$$If\,$p~  4 a?@ri$$Ifa$gdA0l+N9gdz gdzrkd$$$If\,$p~  4 a@rs(,15op=>BMQ\]adeطبuhh5mH sH h h\"hhnkh56hnkh5h*h6]h*h6 hB&hhnkh5\hSsh*hSs6\]h*hSs6 hB&hSshnkhSs5 hB&hA0 hA0hA0hA0hA0CJaJ,rsuuuu$IfgdA0l+wkd$$$Ifl$$   t 0$644 lalp ,## $Ifgdjkd+$$$If\,$p~       t(0$644 lalp(rkd $$$If\,$p~  4 a $Ifgdj' $Ifgdjrkd$$$If\,$p~  4 a'(,; $Ifgdjrkd$$$If\,$p~  4 a0 $Ifgdjrkdu$$$If\,$p~  4 a015E $Ifgdjrkd<$$$If\,$p~  4 a%< $Ifgdjrkd$$$If\,$p~  4 a<=>?@A $Ifgdrkdʪ$$$If\,$p~  4 aABMNOP $Ifgdrkd$$$If\,$p~  4 aPQ]^_` $IfgdrkdX$$$If\,$p~  4 a`aet $Ifgdrkd$$$If\,$p~  4 a $Ifgdrkd$$$If\,$p~  4 a $Ifgdzrkd$$$If\,$p~  4 a45mx|CD_併zsk`szs\szs\sh.^habh.^6\]habh.^6 hB&h.^hh.^5 hB&hA0 hA0hA0hA0hA0CJaJ hnkhzhzhz6hz hB&hzhB&hz5h3 hhh5habh6\]habh6mH sH  hB&hhh5mH sH habh5$ $Ifgdzrkdt$$$If\,$p~  4 ax $Ifgdzrkd;$$$If\,$p~  4 a4i$$Ifa$gdA0l+N9gdz gdzrkd$$$If\,$p~  4 a45BM^luuuu$IfgdA0l+wkdɱ$$$Ifl$$   t 0$644 lalp lmxy,## $Ifgd=Z/kd6$$$If\,$p~       t(0$644 lalp(yz{|rkd+$$$If\,$p~  4 a $Ifgd=Z/ $Ifgd=Z/rkd$$$If\,$p~  4 a &^ $Ifgd=Z/rkd$$$If\,$p~  4 a^_cy $Ifgd=Z/rkd$$$If\,$p~  4 a_c,0rs9:= +,/*+,hiklvȺȺ hnkhzhzhz6hz hB&hzhB&hz5hSs hB&h hB&hA hh hA5hh5 h.^5hB&h.^mH sH h.^ hB&h.^hh.^56+ $Ifgd=Z/rkdG$$$If\,$p~  4 a+,0HX $Ifgd=Z/rkd$$$If\,$p~  4 a $Ifgd=Z/rkdշ$$$If\,$p~  4 a8 $Ifgd=Z/rkd$$$If\,$p~  4 a89=Rh $Ifgd=Z/rkdc$$$If\,$p~  4 a $Ifgd=Z/rkd*$$$If\,$p~  4 a* $Ifgd=Z/rkd$$$If\,$p~  4 a*+/< $Ifgd=Z/rkd$$$If\,$p~  4 a,jzzz $Ifgd $Ifgd=Z/rkd$$$If\,$p~  4 ajki$$Ifa$gdjl+N9gdz gdzrkdF$$$If\,$p~  4 a "$-.~DFnpt,-LOS_`  ½½ h]gh} hh}CJOJQJ^JaJ hB&h} hh} h}5hh}5 hB&h]g h]gh]g hh]ghh]g5 hB&hSs hA0hSshA0hSsCJaJ;|||| $$Ifa$gdSswkd $$$Ifl$$   t 0$644 lalp  $.\SSSS $Ifgdq]kd$$$If\,$p~       (4 ap(Fo $Ifgdq]rkd$$$If\,$p~  4 aopt $Ifgdq]rkdw$$$If\,$p~  4 a-N~uuu $Ifgd]g $$Ifgd]grkd>$$$If\,$p~  4 aNOS`zzz $Ifgd]g $Ifgd=Z/rkd$$$If\,$p~  4 a zzz $Ifgd]g $Ifgd=Z/rkd$$$If\,$p~  4 a  9Qzzz $Ifgd]g $Ifgd=Z/rkd$$$If\,$p~  4 a89ORSTnqry*+,\]_`cdyyk\yhcOhd2r0J'OJQJ^JjZ$hB&hd2rU hcOhd2rhcOhd2rCJ]hcOhd2r5hB&hd2r0J'OJQJ^Jj!$hB&hd2rUjhB&hd2rU hB&hd2r hB&hJhcOhJCJ]hcOhJ5hd2rh>sh[qhr; hSshc6 hB&h} h]gh}$QRSxy^_wwwrrrrrj gdd2rgdd2r 1$7$8$H$gd[qgd[qgdzrkdZ$$$If\,$p~  4 a -EBe,$d%d&d'd1$7$8$H$NOPQgd0 $d%d&d'd1$7$8$H$NOPQgd 1$7$8$H$gd[q-p}V~ d"t#$%'*m*.}/p12"6788Q:: ==&?C7HHl`aeEfhYitppt)usv=xx^k›8Ү*µj(hcOh[qCJOJQJ^JaJmH sH h[qCJOJQJ^JaJ(hcOh[qCJOJQJ^JaJmH sH h[qhd2rL<]9Un3Pi|,$d%d&d'd1$7$8$H$NOPQgd0Id$DZw;,$d%d&d'd1$7$8$H$NOPQgd;Wp2^2PeGp,$d%d&d'd1$7$8$H$NOPQgdp:V| "@_~;Z,$d%d&d'd1$7$8$H$NOPQgdZy7Xw.Mm>`,$d%d&d'd1$7$8$H$NOPQgd`1Rl#Ae8V|,$d%d&d'd1$7$8$H$NOPQgd|Bo.Hl1Sk,$d%d&d'd1$7$8$H$NOPQgdk >\z  ? Z u       : ,$d%d&d'd1$7$8$H$NOPQgd: ^      4 T p       3 K m       ,$d%d&d'd1$7$8$H$NOPQgd * K j     7Sh{(?ax,$d%d&d'd1$7$8$H$NOPQgd3Pl?]| ,$d%d&d'd1$7$8$H$NOPQgd  >_~$=Vk3Qk,$d%d&d'd1$7$8$H$NOPQgd1Jb}7Tm.,$d%d&d'd1$7$8$H$NOPQgd.Vy =\t<Wi,$d%d&d'd1$7$8$H$NOPQgd4F_v ;_:Rq,$d%d&d'd1$7$8$H$NOPQgdq)KmDe1I,$d%d&d'd1$7$8$H$NOPQgdIa ) @ _ ~     !1!F!`!{!!!!",$d%d&d'd1$7$8$H$NOPQgd"#"J"d"|"""""#9#V#t#####$$$@$\$y$$$$,$d%d&d'd1$7$8$H$NOPQgd$$$%:%R%j%%%%%%&%&=&U&y&&&&&''7'U',$d%d&d'd1$7$8$H$NOPQgdU'o'''''($(K(e((((()4)P)i)))))*3*Q*,$d%d&d'd1$7$8$H$NOPQgdQ*m***** +.+[+t+++++,?,h,,,,,,!-7-W-,$d%d&d'd1$7$8$H$NOPQgdW-s------.3.N.e.....//0/Q/k/}/////,$d%d&d'd1$7$8$H$NOPQgd/ 0#0<0f0}0000001=1V1p111111292V2z22,$d%d&d'd1$7$8$H$NOPQgd22223)3I3_3}333334!4:4]4s444445,5N5,$d%d&d'd1$7$8$H$NOPQgdN5v55555"6>6^6666667&7R7u777778'8P8,$d%d&d'd1$7$8$H$NOPQgdP8i888889+9D9\9u99999::8:Q:j:::::;,$d%d&d'd1$7$8$H$NOPQgd;6;S;k;;;;;<5<]<w<<<<< =#=>=Z=x=====,$d%d&d'd1$7$8$H$NOPQgd=>&>@>\>z>>>>> ?&?E?d?y?????@#@:@T@m@@,$d%d&d'd1$7$8$H$NOPQgd@@@@@ A#A=ASAiAAAAAAAB*BCB]BBBBBB,$d%d&d'd1$7$8$H$NOPQgdBBC4CJCdCCCCCD,DDD_DxDDDDDEE6EOE|EE,$d%d&d'd1$7$8$H$NOPQgdEEEEF'FAFbFFFFFGG2GIGbGwGGGGGG H7H,$d%d&d'd1$7$8$H$NOPQgd7HNHeHHHHHHICI\IIIIIJJ3JIJgJJJJJJ,$d%d&d'd1$7$8$H$NOPQgdJK1KMKiKKKKKL,LHLdLLLLLLM:MTMqMMMM,$d%d&d'd1$7$8$H$NOPQgdMMMN5NXNrNNNNNO(OIObOOOOOOP.PGPfP{P,$d%d&d'd1$7$8$H$NOPQgd{PPPPPQQ@Q]Q}QQQQRR1RLRiRRRRRRS'S,$d%d&d'd1$7$8$H$NOPQgd'SCSeSSSSSS T-TGTqTTTTTUU4UKUfUUUUU,$d%d&d'd1$7$8$H$NOPQgdUUV3VOVkVVVVVWW;W_W{WWWWWXX=XXXyXX,$d%d&d'd1$7$8$H$NOPQgdXXXXY:YRYxYYYYYYZ3ZLZeZ|ZZZZZ [#[B[,$d%d&d'd1$7$8$H$NOPQgdB[Z[r[[[[[[\\6\N\i\\\\\\ ]#]?]Z]s]]],$d%d&d'd1$7$8$H$NOPQgd]]]]^4^R^m^^^^^^ _%_<_S_j______ `%`,$d%d&d'd1$7$8$H$NOPQgd%`B`l`````a aAaWaoaaaaab2bNbmbbbbbb,$d%d&d'd1$7$8$H$NOPQgdb*cAcZcmccccc d-dOdkdddddd e6eRexeeee,$d%d&d'd1$7$8$H$NOPQgdef$fEfbfffffg7gTgggggggh>h_h}hhhh i,$d%d&d'd1$7$8$H$NOPQgd i,iYiiiii)j?jXjrjjjjjk8k[k{kkkkl(lJl,$d%d&d'd1$7$8$H$NOPQgdJlolllll mKmwmmmmnn8nennnnnooKodoo,$d%d&d'd1$7$8$H$NOPQgdoooopp6pRptppppppq*qAqlqqqqqr%rRr,$d%d&d'd1$7$8$H$NOPQgdRrqrrrrr'sFsjssssst1tStvttttt u)uBuXu,$d%d&d'd1$7$8$H$NOPQgdXuxuuuuuv3vQvsvvvvv w'w@wewwwwwwx=x,$d%d&d'd1$7$8$H$NOPQgd=xfxxxxxxy*yAyeyyyyyyz&zNzizzzzzz,$d%d&d'd1$7$8$H$NOPQgdz{0{O{j{{{{{{|0|H|i||||||}5}U}}}},$d%d&d'd1$7$8$H$NOPQgd}}}~<~U~p~~~~~/R{FsՀ,$d%d&d'd1$7$8$H$NOPQgd.Njʁ8Qpт!;eރ,$d%d&d'd1$7$8$H$NOPQgd&S|Ȅ-Mm…؅+Klφ",$d%d&d'd1$7$8$H$NOPQgd"8Qq҇(Gbʈ!Im׉,$d%d&d'd1$7$8$H$NOPQgd <`|$A]sӋ)D^Ќ,$d%d&d'd1$7$8$H$NOPQgdGYkύ9a+XvՏ,$d%d&d'd1$7$8$H$NOPQgdHo֐0H`8eђ ,$d%d&d'd1$7$8$H$NOPQgd 4Rrܓ-JhΔHuܕ,$d%d&d'd1$7$8$H$NOPQgdܕ-RmږHoė.Hk,$d%d&d'd1$7$8$H$NOPQgd)Mzř 6`x˚/Rw›ٛ,$d%d&d'd1$7$8$H$NOPQgd8Wvǜ/Fcxȝ%=ZvÞ,$d%d&d'd1$7$8$H$NOPQgdÞ9Nf|͟<XnĠ /Su,$d%d&d'd1$7$8$H$NOPQgdu"C`}Ӣ7Ogǣߣ,$d%d&d'd1$7$8$H$NOPQgd*C\uڤ 4X|¥$KiΦ,$d%d&d'd1$7$8$H$NOPQgdΦCfħ :g̨ ?aΩ,$d%d&d'd1$7$8$H$NOPQgd ,Nk*Wtث8]Ӭ,$d%d&d'd1$7$8$H$NOPQgd5Lkƭ 4F\tҮ*Hlį,$d%d&d'd1$7$8$H$NOPQgdį4Zw̰8Op 8]|Ȳ,$d%d&d'd1$7$8$H$NOPQgd %=[wϳ5Sq״6Nl,$d%d&d'd1$7$8$H$NOPQgdµ۵2D\qȶ߶.Lj6,$d%d&d'd1$7$8$H$NOPQgd6Moո1Kiʹ.Psĺ@,$d%d&d'd1$7$8$H$NOPQgd@eֻ'BYuּ*Giӽ1O,$d%d&d'd1$7$8$H$NOPQgdOp#;b}ſ8Vt'Nl,$d%d&d'd1$7$8$H$NOPQgd@U`${2;1]; \;01:c:;r==c?DEGFHPLLZ[^^_GddgpgZnn"oop/uuwhz{}b}oݳ(hKh[qCJOJQJ^JaJmH sH (hcOh[qCJOJQJ^JaJmH sH (hcOh[qCJOJQJ^JaJmH sH h[qCJOJQJ^JaJFl'Ji,Dg &,$d%d&d'd1$7$8$H$NOPQgd&@Yr+Hp 7Tv,$d%d&d'd1$7$8$H$NOPQgd0E[s+Qu9Up,$d%d&d'd1$7$8$H$NOPQgd4Qm,U 9c,$d%d&d'd1$7$8$H$NOPQgdLr?`<]y,$d%d&d'd1$7$8$H$NOPQgd2Kr$Jk$O{2,$d%d&d'd1$7$8$H$NOPQgd2Lx(Af4W~I,$d%d&d'd1$7$8$H$NOPQgdIu%Hk9`9[},$d%d&d'd1$7$8$H$NOPQgd}.PhCd} )<,$d%d&d'd1$7$8$H$NOPQgd<[)Ly;Zv=`x,$d%d&d'd1$7$8$H$NOPQgd>_y8V}4T,$d%d&d'd1$7$8$H$NOPQgd*Gr7a7d,$d%d&d'd1$7$8$H$NOPQgd >h,Ys9f>,$d%d&d'd1$7$8$H$NOPQgd>[wIf1Mk),$d%d&d'd1$7$8$H$NOPQgd)H]#G`-Jg$,$d%d&d'd1$7$8$H$NOPQgd$Me6S{4Mp,$d%d&d'd1$7$8$H$NOPQgd.Ty8Vx<`L,$d%d&d'd1$7$8$H$NOPQgdLi 3Sz3Um 'B,$d%d&d'd1$7$8$H$NOPQgdB]w,FXq $;Tfx,$d%d&d'd1$7$8$H$NOPQgd3Mr =Yt!;,$d%d&d'd1$7$8$H$NOPQgd;^w6Rt;c5,$d%d&d'd1$7$8$H$NOPQgd5Rk#A_} 8Rt,$d%d&d'd1$7$8$H$NOPQgd:^y )Ss)Er&S,$d%d&d'd1$7$8$H$NOPQgdSuFs-Y~ = h    ,$d%d&d'd1$7$8$H$NOPQgd  % @ [      ( @ m      ' T      ,$d%d&d'd1$7$8$H$NOPQgd I h     "E\ 5Qz;`,$d%d&d'd1$7$8$H$NOPQgd;Zw$Gm+Pw,$d%d&d'd1$7$8$H$NOPQgd!=VqAYw"=^~,$d%d&d'd1$7$8$H$NOPQgd?Yv )Kf.Fe~,$d%d&d'd1$7$8$H$NOPQgd%Rl Kv =Zw,$d%d&d'd1$7$8$H$NOPQgd&Ce2Mi"Hg,$d%d&d'd1$7$8$H$NOPQgd < ] ~     !1!X!y!!!!"9"V"r"""",$d%d&d'd1$7$8$H$NOPQgd"""#6#R#{####$8$T$|$$$$%I%p%%%%&D&,$d%d&d'd1$7$8$H$NOPQgdD&m&&&&'='V'v''''(9(`({(((( )/)R)v))),$d%d&d'd1$7$8$H$NOPQgd)) * *L*t**** +5+_++++ ,/,X,,,,, -5-V-,$d%d&d'd1$7$8$H$NOPQgdV----.-.W...../3/N/d/////$0D0j0000,$d%d&d'd1$7$8$H$NOPQgd00 11A1]1s11112A2k2222 353W3~3333434,$d%d&d'd1$7$8$H$NOPQgd34R4z44445=5`55556*6W6|66667:7b7777,$d%d&d'd1$7$8$H$NOPQgd7838^8888 979Q9n99999:C:c::::;-;X;;,$d%d&d'd1$7$8$H$NOPQgd;;;;<6<_<<<<<%=K=r====>->M>s>>>>>,$d%d&d'd1$7$8$H$NOPQgd>?A?c????? @3@U@}@@@@@@@AA+A=AOAaAsA,$d%d&d'd1$7$8$H$NOPQgdsAAAAAAAAB$B7BKB^BrBBBBBBBB CC1CDC,$d%d&d'd1$7$8$H$NOPQgdDCWCjC}CCCCCCCDD(D;DODbDvDDDDDDDEE,$d%d&d'd1$7$8$H$NOPQgdE)EQ`Q}QQQQQR;RTRsRR,$d%d&d'd1$7$8$H$NOPQgdRRRS4SOSnSSSSST$TLTqTTTTU9UfUUUU V,$d%d&d'd1$7$8$H$NOPQgd V6VcVVVVV&WHWnWWWWXEXkXXXXXY1YVYuYY,$d%d&d'd1$7$8$H$NOPQgdYYYY%ZGZjZZZZZ[-[L[y[[[[\0\T\\\\\,$d%d&d'd1$7$8$H$NOPQgd\]F]m]]]]]^:^g^^^^^ _!_5_I_^_z____`,$d%d&d'd1$7$8$H$NOPQgd`J`d`````a2aQaqaaaab'bCbdbbbbbc1c[c,$d%d&d'd1$7$8$H$NOPQgd[c{ccccdGdldddde3e\eeeeef6fZfffff,$d%d&d'd1$7$8$H$NOPQgdfg-gUgpgggg h+hPhuhhhhi)iNipiiii j)jLj,$d%d&d'd1$7$8$H$NOPQgdLjujjjjk,kIkmkkkkklClpllll m/mOmmmmm,$d%d&d'd1$7$8$H$NOPQgdmmmn:nZnnnnno"o?o\oyooooop+pIpkppp,$d%d&d'd1$7$8$H$NOPQgdppppq3qOqvqqqqqq r"r:rRrlrrrrrr s*s,$d%d&d'd1$7$8$H$NOPQgd*sBs\sysssss t"t\y 7,$d%d&d'd1$7$8$H$NOPQgd7`ޣ*UvΤ 1WΥCj,$d%d&d'd1$7$8$H$NOPQgdܦ,WvƧ?lШ $@\x٩,$d%d&d'd1$7$8$H$NOPQgd$Efߪ"Ahū>ZpӬ,$d%d&d'd1$7$8$H$NOPQgdCmȭ 'HgƮ,Hoͯ ,$d%d&d'd1$7$8$H$NOPQgd )HlɰްDk /Tyβ,$d%d&d'd1$7$8$H$NOPQgd8]˳Gj״>kʵ2W,$d%d&d'd1$7$8$H$NOPQgdWy6]Է6c׸:gֹ,$d%d&d'd1$7$8$H$NOPQgdֹ;XuȺ5Pw 3Uzʼ,$d%d&d'd1$7$8$H$NOPQgdBgнHhϾ=]ſ1N,$d%d&d'd1$7$8$H$NOPQgdNv =Zs<Us 2J,$d%d&d'd1$7$8$H$NOPQgdJf +Pr.V~2T},$d%d&d'd1$7$8$H$NOPQgd}Ah 2S~;b,$d%d&d'd1$7$8$H$NOPQgdBdz.Uv6cH,$d%d&d'd1$7$8$H$NOPQgdHp6^,Ot -Y{,$d%d&d'd1$7$8$H$NOPQgd@_|:_1Z9\,$d%d&d'd1$7$8$H$NOPQgd\|?j#CiLr,$d%d&d'd1$7$8$H$NOPQgdDe;d&ItI,$d%d&d'd1$7$8$H$NOPQgdIf5Ro "7Vz ,$d%d&d'd1$7$8$H$NOPQgd +Ig Gr8_ 7d,$d%d&d'd1$7$8$H$NOPQgd>j3OjCh,$d%d&d'd1$7$8$H$NOPQgd(Hc*AYv2X,$d%d&d'd1$7$8$H$NOPQgd*S~%Mo :`$Ly,$d%d&d'd1$7$8$H$NOPQgdy-Qw%Mx;Y ,$d%d&d'd1$7$8$H$NOPQgd (Me<e 9b)Is,$d%d&d'd1$7$8$H$NOPQgdsBd*Kx &Ol,$d%d&d'd1$7$8$H$NOPQgd.Mz8Vv .Mz Mz,$d%d&d'd1$7$8$H$NOPQgdz 2Uz6Wr0C,$d%d&d'd1$7$8$H$NOPQgdC_x (DeGq 'Da,$d%d&d'd1$7$8$H$NOPQgda~ , M l  D p     ) V     ,$d%d&d'd1$7$8$H$NOPQgd  ) O v     ' L g       2 _      ,$d%d&d'd1$7$8$H$NOPQgd K m       0 P o      B d      7 ,$d%d&d'd1$7$8$H$NOPQgd7 b " H j % G f  # A ` ,$d%d&d'd1$7$8$H$NOPQgd` * J d  1 T y     5 W s  ,$d%d&d'd1$7$8$H$NOPQgd    - C g      6 S h }      ( T y  ,$d%d&d'd1$7$8$H$NOPQgd    4 a     @ i       A \ ~     ,$d%d&d'd1$7$8$H$NOPQgd  = U q     ( K n      4 V {     @ ,$d%d&d'd1$7$8$H$NOPQgd@ _       = b      * M p     # D n ,$d%d&d'd1$7$8$H$NOPQgdn       + P p      ' 9 M j       ,$d%d&d'd1$7$8$H$NOPQgd  ' C a z      % ; Q h  ! 3! `! {! ! ,$d%d&d'd1$7$8$H$NOPQgd! ! ! ! " " =" j" " " " # 5# X# }# # # # $ 2$ U$ s$ $ $ $ ,$d%d&d'd1$7$8$H$NOPQgd$ $ #% @% ]% u% % % % & "& 6& X& & & & & ' 3' S' w' ' ' ' ( ,$d%d&d'd1$7$8$H$NOPQgd( ( 7( M( j( ( ( ( ( ) *) C) `) ) ) ) ) ) * ,* O* j* * * * ,$d%d&d'd1$7$8$H$NOPQgd* * * + :+ W+ t+ + + + + , 5, b, , , , , - (- D- _- z- - - ,$d%d&d'd1$7$8$H$NOPQgd- - - . ?. `. . . . . / 7/ X/ w/ / / / 0 "0 H0 q0 0 0 0 0 ,$d%d&d'd1$7$8$H$NOPQgd0 1 81 ^1 1 1 1 1 &2 S2 |2 2 2 2 3 /3 W3 3 3 3 3 4 #4 M4 q4 ,$d%d&d'd1$7$8$H$NOPQgd^1 S2 W3 3 !9 f9 9 < < B }B E I vJ J WK AL L M N O P :Q W hW %X Y [ 4\ ` $a c d f #g (g )g Xg Zg ag g g g >h Ah h h h ȽxhB&h2V6CJaJhB&h2V6CJh3 h2VaJ! hB&h2V h3 h2Vh3 h2V5B*phhcOh2VmH sH hcOh|mH sH (hcOh[qCJOJQJ^JaJmH sH h[qCJOJQJ^JaJ(hcOh[qCJOJQJ^JaJmH sH /q4 4 4 4 5 D5 ^5 5 5 5 5 "6 96 f6 6 6 6 6 7 17 Q7 r7 7 7 7 ,$d%d&d'd1$7$8$H$NOPQgd7 7 8 98 O8 d8 y8 8 8 8 9 !9 <9 Q9 f9 9 9 9 9 9 : (: D: `: : ,$d%d&d'd1$7$8$H$NOPQgd: : : : : ; -; B; W; l; ~; ; ; ; ; < #< P< s< < < < < = ?= ,$d%d&d'd1$7$8$H$NOPQgd?= j= }= = = > > <> X> t> > > > > ? ? 4? `? ? ? ? @ '@ J@ u@ ,$d%d&d'd1$7$8$H$NOPQgdu@ @ @ @ A #A HA oA A A A A B *B TB }B B B B B C (C JC mC C ,$d%d&d'd1$7$8$H$NOPQgdC C C C D 4D _D |D D D D D E BE _E E E E E F &F BF ^F F F ,$d%d&d'd1$7$8$H$NOPQgdF F F (G GG fG G G G G H =H ]H }H H H H I CI lI I I I I J ,$d%d&d'd1$7$8$H$NOPQgdJ 0J UJ vJ J J J J K K =K WK lK K K K K L &L AL mL L L L L ,$d%d&d'd1$7$8$H$NOPQgdL M ,M YM |M M M M N CN ]N qN N N N O 'O FO kO O O O O P (P ,$d%d&d'd1$7$8$H$NOPQgd(P RP lP P P P P #Q :Q \Q yQ Q Q Q Q R &R ER dR R R R R S >S ,$d%d&d'd1$7$8$H$NOPQgd>S XS yS S S S T 0T HT oT T T T U +U SU {U U U U V IV rV V V ,$d%d&d'd1$7$8$H$NOPQgdV V V W =W hW zW W W W W %X NX yX X X X Y 8Y ^Y wY Y Y Y Y ,$d%d&d'd1$7$8$H$NOPQgdY Z )Z FZ `Z |Z Z Z Z [ -[ J[ e[ [ [ [ [ \ \ 4\ I\ d\ z\ \ \ ,$d%d&d'd1$7$8$H$NOPQgd\ \ !] G] a] {] ] ] ] ] ^ =^ `^ x^ ^ ^ ^ ^ _ "_ ;_ N_ j_ ~_ _ ,$d%d&d'd1$7$8$H$NOPQgd_ _ _ _ ` :` g` }` ` ` ` ` a $a @a `a }a a a a a b ,b Ib `b ,$d%d&d'd1$7$8$H$NOPQgd`b |b b b b b b c 4c Mc fc zc c c c c d ?d bd d d d d "e Oe ,$d%d&d'd1$7$8$H$NOPQgdOe ve e e e e f 5f Rf qf f f f g #g %g &g 'g (g )g 6g Xg Yg Zg !gd3 gdz,$d%d&d'd1$7$8$H$NOPQgdZg [g \g ^g _g `g ag g g h h h h h h yi zi i j j j j j k k k _k  gd3 gd3 gd2Vgd3 gdzh h h h Yi \i zi i j j j j k k _k `k lk mk }k ~k k k k k k k k k k k k k k k k k k k k l l l l l +l -l 1l Ll Ml Nl Ol Pl [l l cm ̽İĩĩĩĩĽĽ̠ؗhhRg hRg6h3 \]^JhB&hPJ hB&h3 hB&h3 PJh hB&hhh3 5hh5h2Vh3 hB&h2V6]hB&h2V6CJ hB&h2Vh3 h2V66_k `k mk ~k k k k nkd+$$$Ifl0$ \    t644 lap $Ifgdzgdzk k k k k k k NSkd$$$Ifl0$ \ t644 la $IfgdzSkd$$$Ifl0$ \ t644 lak k k k k k k NSkd$$$Ifl0$ \ t644 la $IfgdzSkd}$$$Ifl0$ \ t644 lak k k k k l l NSkd$$$Ifl0$ \ t644 la $IfgdzSkd;$$$Ifl0$ \ t644 lal l l ,l -l 1l Ml NSkdX$$$Ifl0$ \ t644 la $IfgdzSkd$$$Ifl0$ \ t644 laMl Nl Ol [l \l l l l l l l l $Ifgd'\/gdgdRg gdRggdzSkd$$$Ifl0$ \ t644 la l l kd$$$Ifl    rF :f!F T         20    4 lalp2l l l m m m $Ifgd'\/m m kd$$$Ifl    rF :f!FT      20    4 lalp2m m %m *m +m 3m $Ifgd'\/3m 4m kd$$$Ifl    rF :f!FT      20    4 lalp24m 8m :m ?m ]m am bm cm em Kkd>$$$Ifl    rF :f!FT 0    4 lal $Ifgd'\/em km m m m m m m m Kkd$$$Ifl    rF :f!FT 0    4 lal $Ifgd'\/cm km m m m ko vo o ;p p p p p Qq iq q q q r r Ns ds s s t t t t t t t }u u u u u u u aw ew vw Cx Dx Ex Kx x x x { { hB&h2VCJOJQJhB&hR5CJ^Jh2VCJ^J hB&h2VhB&h2V5\ hB&hR5h'ChCJmH sH  hCJ hh6hehr hCJ h6 hQ6h h\"hhmH sH 1m m m m m m m m Kkd$$$Ifl    rF :f!FT 0    4 lal $Ifgd'\/m m m m n n n TKKKKK $Ifgd'\/kd$$$Ifl    rF :f!FT 0    4 laln n n n n 1n 5n TKKKKK $Ifgd'\/kd$$$Ifl    rF :f!FT 0    4 lal5n 6n 7n 9n @n Tn Xn TKKKKK $Ifgd'\/kd{$$$Ifl    rF :f!FT 0    4 lalXn Yn Zn \n cn tn xn TKKKKK $Ifgd'\/kdT$$$Ifl    rF :f!FT 0    4 lalxn yn zn |n n n n TKKKKK $Ifgd'\/kd-$$$Ifl    rF :f!FT 0    4 laln n n n n n n TKKKKK $Ifgd'\/kd$$$Ifl    rF :f!FT 0    4 laln n n n n n n TKKKKK $Ifgd'\/kd$$$Ifl    rF :f!FT 0    4 laln n n n n n n TKKKKK $Ifgd'\/kd$$$Ifl    rF :f!FT 0    4 laln n n n o o o TKKKKK $Ifgd'\/kd$$$Ifl    rF :f!FT 0    4 lalo o o o o 1o 5o TKKKKK $Ifgd'\/kdj$$$Ifl    rF :f!FT 0    4 lal5o 6o 7o :o ?o Mo Qo TKKKKK $Ifgd'\/kdC$$$Ifl    rF :f!FT 0    4 lalQo Ro So Vo [o fo jo TKKKKK $Ifgd'\/kd$$$Ifl    rF :f!FT 0    4 laljo ko oo qo vo o o TKKKKK $Ifgd'\/kd$$$Ifl    rF :f!FT 0    4 lalo o o o o p p TKKKKK $Ifgd'\/kd$$$Ifl    rF :f!FT 0    4 lalp p p p p 5p 9p TKKKKK $Ifgd'\/kd$$$Ifl    rF :f!FT 0    4 lal9p :p ;p >p Ep p p TKKKKK $Ifgd'\/kd$$$Ifl    rF :f!FT 0    4 lalp p p p p p p TKKKKK $Ifgd'\/kdY$$$Ifl    rF :f!FT 0    4 lalp p p p p p p p p TOOFFFFF $Ifgd'\/gdkd2$$$Ifl    rF :f!FT 0    4 lalp q q  $Ifgd'\/kd $$$Ifl    r f!  T        20    4 lalp2q q q 0q 9q $Ifgd'\/9q :q ;q  $Ifgd'\/kdw$$$Ifl    r f!T      20    4 lalp2;q Bq Gq Hq Pq $Ifgd'\/Pq Qq Uq  $Ifgd'\/kd$$$Ifl    r f!T      20    4 lalp2Uq Wq \q lq pq qq rq tq {q q Pkd3$$$Ifl    rF f!FTF 0    4 lal $Ifgd'\/ q q q q q q q q Pkd $$$Ifl    rF f!FTF 0    4 lal $Ifgd'\/q q q q q r r YPPPPP $Ifgd'\/kd$$$Ifl    rF f!FTF 0    4 lalr r r r r r r YPPPPP $Ifgd'\/kd$$$Ifl    rF f!FTF 0    4 lal r r r r r r r YPPPPP $Ifgd'\/kd$$$Ifl    rF f!FTF 0    4 lalr r r r r r r YPPPPP $Ifgd'\/kd~$$$Ifl    rF f!FTF 0    4 lalr r r r r r r YPPPPP $Ifgd'\/kdW$$$Ifl    rF f!FTF 0    4 lalr r r r r r r YPPPPP $Ifgd'\/kd0$$$Ifl    rF f!FTF 0    4 lalr r r r r r r YPPPPP $Ifgd'\/kd$$$Ifl    rF f!FTF 0    4 lalr r r r r r r YPPPPP $Ifgd'\/kd$$$Ifl    rF f!FTF 0    4 lalr r r s s s 's YPPPPP $Ifgd'\/kd$$$Ifl    rF f!FTF 0    4 lal's (s )s ,s 2s ds hs YPPP;P( $If^`gd'\/ $Ifgd'\/kd$$$Ifl    rF f!FTF 0    4 lalhs is ms os ts s s YPPPPP $Ifgd'\/kd{$$$Ifl    rF f!FTF 0    4 lals s s s s s s YPPP8P($ $If^`a$gd'\/ $Ifgd'\/kdT$$$Ifl    rF f!FTF 0    4 lals s s s s s s YPPPPP $Ifgd'\/kd-$$$Ifl    rF f!FTF 0    4 lals s s s s s s YPPPPP $Ifgd'\/kd$$$Ifl    rF f!FTF 0    4 lals s s t t t t YPPPPP $Ifgd'\/kd$$$Ifl    rF f!FTF 0    4 lalt t t t !t %t 6t YPPPPP $Ifgd'\/kd$$$Ifl    rF f!FTF 0    4 lal6t 7t @t Ct Ht Mt ^t YPPPPP $Ifgd'\/kd$$$Ifl    rF f!FTF 0    4 lal^t _t `t ct jt t t YPPPPP $Ifgd'\/kdj$$$Ifl    rF f!FTF 0    4 lalt t t t t t t YPPPPP $Ifgd'\/kdC$$$Ifl    rF f!FTF 0    4 lalt t t t t t t YPPPPP $Ifgd'\/kd$$$Ifl    rF f!FTF 0    4 lalt t t t t t t YPPPPP $Ifgd'\/kd$$$Ifl    rF f!FTF 0    4 lalt t t t t t u u u YTTKKKKK $Ifgd'\/gdkd$$$Ifl    rF f!FTF 0    4 lalu u u  $Ifgd'\/kd$$$Ifl    r  f!  T @ F      20    4 lalp2 u u "u 5u >u $Ifgd'\/>u ?u @u  $Ifgd'\/kd=$$$Ifl    r  f!T@ F     20    4 lalp2@u Gu Lu Mu Uu $Ifgd'\/Uu Vu gu  $Ifgd'\/kd$$$Ifl    r  f!T@ F     20    4 lalp2gu ju pu }u u u u u u u Pkd$$$Ifl    rF  f!FTF@ F0    4 lal $Ifgd'\/ u u u u u u u P8($ $If^`a$gd'\/kd$$$Ifl    rF  f!FTF@ F0    4 lal $Ifgd'\/u u u u u u Sv Wv Pkd$$$Ifl    rF  f!FTF@ F0    4 lal $Ifgd'\/Wv Xv kv lv mv pv uv v v YPPPPPPP $Ifgd'\/kd%$$Ifl    rF  f!FTF@ F0    4 lalv v v v v v v YPPPPP $Ifgd'\/kd]%$$Ifl    r  f!F@ F0    4 lalv v v v v v v YPPPPP $Ifgd'\/kd6%$$Ifl    r  f!F@ F0    4 lalv v v v v v v YPPPPP $Ifgd'\/kd%$$Ifl    r  f!F@ F0    4 lalv v v v w .w 3w YPPPPP $Ifgd'\/kd%$$Ifl    r  f!F@ F0    4 lal3w 4w 5w 7w ~ @~ M~ N~ O~ 8kd>!%$$Iflֈ  o &y!+0'4 la $IfgdzO~ V~ Z~ ^~ a~ n~ o~ $Ifgdzo~ p~ z~ ~~ ~ ~ ~ A88888 $Ifgdzkd("%$$Iflֈ  o &y!+0'4 la~ ~ ~ ~ ~ ~ ~ 8kd#%$$Iflֈ  o &y!+0'4 la $Ifgdz~ ~ ~ ~ ~ ~ ~ 8kd#%$$Iflֈ  o &y!+0'4 la $Ifgdz~ ~ ~ ~ ~ ~ ~ 8kd$%$$Iflֈ  o &y!+0'4 la $Ifgdz~ ~ ~ ~ ~ ~  8kd%%$$Iflֈ  o &y!+0'4 la $Ifgdz     # $ % 8kd&%$$Iflֈ  o &y!+0'4 la $Ifgdz% , 0 4 8 E F $IfgdzF G R S ^ d h A??666 $IfgdS\kd'%$$Iflֈ  o &y!+0'4 lah o z { |       $ $Ifa$gd` $IfgdzFf*% $IfgdS\        A88888 $Ifgdzkd ,%$$Iflֈ  o &y!+0'4 la       8kd,%$$Iflֈ  o &y!+0'4 la $Ifgdz       8kd-%$$Iflֈ  o &y!+0'4 la $Ifgdz       8kd.%$$Iflֈ  o &y!+0'4 la $Ifgdz   ' ( ) ; 8kd/%$$Iflֈ  o &y!+0'4 la $Ifgdz; ? C F S T U 8kd0%$$Iflֈ  o &y!+0'4 la $IfgdzU i m q t $Ifgdz A88888 $Ifgdzkd1%$$Iflֈ  o &y!+0'4 la ɀ ̀ р Ԁ 8kdr2%$$Iflֈ  o &y!+0'4 la $IfgdzԀ 8kd\3%$$Iflֈ  o &y!+0'4 la $Ifgdz      8kdF4%$$Iflֈ  o &y!+0'4 la $Ifgdz    ! . 8kd05%$$Iflֈ  o &y!+0'4 la $Ifgdz. 2 6 8 E F G 8kd6%$$Iflֈ  o &y!+0'4 la $IfgdzG U Y ] _ l m $Ifgdzm n u y }  A88888 $Ifgdzkd7%$$Iflֈ  o &y!+0'4 la 8kd7%$$Iflֈ  o &y!+0'4 la $Ifgdz Ɂ ́ с 8kd8%$$Iflֈ  o &y!+0'4 la $Ifgdzс ԁ 8kd9%$$Iflֈ  o &y!+0'4 la $Ifgdz ! 8kd:%$$Iflֈ  o &y!+0'4 la $Ifgdz! % ) + 8 9 : 8kd;%$$Iflֈ  o &y!+0'4 la $Ifgdz: J N R U b c $Ifgdzc d s w { ~ A88888 $Ifgdzkd<%$$Iflֈ  o &y!+0'4 la 831gd?ikdj=%$$Iflֈ  o &y!+0'4 la $Ifgdz ‚ ɂ ͂ т Ԃ $IfgdzFf?% $IfgdS\ A8(($ $Ifa$gd` $IfgdzkdA%$$Iflֈ  o &y!+0'4 la 1kdB%$$Iflֈ  o &y!+0'4 la$ $Ifa$gd`      $Ifgdz  " % ) + 8 A88888 $IfgdzkdC%$$Iflֈ  o &y!+0'4 la8 9 : E I M O 8kdD%$$Iflֈ  o &y!+0'4 la $IfgdzO \ ] ^ m q u 8kdzE%$$Iflֈ  o &y!+0'4 la $Ifgdzu x 8kddF%$$Iflֈ  o &y!+0'4 la $Ifgdz à 8kdNG%$$Iflֈ  o &y!+0'4 la $Ifgdzà ǃ ˃ ΃ ۃ ܃ ݃ 8kd8H%$$Iflֈ  o &y!+0'4 la $Ifgdz݃  $Ifgdz  # ' * 7 A88888 $Ifgdzkd"I%$$Iflֈ  o &y!+0'4 la7 8 9 N R V Y 8kd J%$$Iflֈ  o &y!+0'4 la $IfgdzY f g h {  8kdJ%$$Iflֈ  o &y!+0'4 la $Ifgdz 8kdK%$$Iflֈ  o &y!+0'4 la $Ifgdz „ Ԅ 8kdL%$$Iflֈ  o &y!+0'4 la $IfgdzԄ ؄ ܄ ߄ 8kdM%$$Iflֈ  o &y!+0'4 la $Ifgdz     $Ifgdz  0 4 8 ; H A88888 $IfgdzkdN%$$Iflֈ  o &y!+0'4 laH I J Y ] a d 8kdO%$$Iflֈ  o &y!+0'4 la $Ifgdzd q r s 8kdrP%$$Iflֈ  o &y!+0'4 la $Ifgdz 8kd\Q%$$Iflֈ  o &y!+0'4 la $Ifgdz 8kdFR%$$Iflֈ  o &y!+0'4 la $Ifgdz ȅ Ʌ ʅ ˅ ̅ ͅ $ $Ifa$gd`($ $If^`a$gd`ͅ ΅ Յ ؅ A88 $Ifgdzkd0S%$$Iflֈ  o &y!+0'4 la؅ ۅ ݅ $Ifgdz($ $7$8$H$If^`a$gd`  A<:11 $IfgdS\gd?ikdT%$$Iflֈ  o &y!+0'4 la   ! 5 8 < ? L M ($ $7$8$H$If^`a$gd` $IfgdzFf{V% $IfgdS\ M N b f j m z A88888 $IfgdzkdX%$$Iflֈ  o &y!+0'4 laz { | 8kdlY%$$Iflֈ  o &y!+0'4 la $Ifgdz 8kdVZ%$$Iflֈ  o &y!+0'4 la $Ifgdz Ɇ ʆ ˆ ׆ ۆ 8kd@[%$$Iflֈ  o &y!+0'4 la $Ifgdzۆ ߆ 8kd*\%$$Iflֈ  o &y!+0'4 la $Ifgdz       8kd]%$$Iflֈ  o &y!+0'4 la $Ifgdz & * . 0 = U $IfgdzU V Z ^ b d q A88888 $Ifgdzkd]%$$Iflֈ  o &y!+0'4 laq r s z ~ 8kd^%$$Iflֈ  o &y!+0'4 la $Ifgdz 8kd_%$$Iflֈ  o &y!+0'4 la $Ifgdz LJ ˇ 8kd`%$$Iflֈ  o &y!+0'4 la $Ifgdzˇ χ ч އ  8kda%$$Iflֈ  o &y!+0'4 la $Ifgdz    % & ' 8kdb%$$Iflֈ  o &y!+0'4 la $Ifgdz' . 2 6 : G H $IfgdzH I J K L M N A88888 $Ifgdzkdzc%$$Iflֈ  o &y!+0'4 laN O P \ ] ^ _ 8kddd%$$Iflֈ  o &y!+0'4 la $Ifgdz_ ` a b i l o 8kdNe%$$Iflֈ  o &y!+0'4 la $Ifgdzo q ~  8kd8f%$$Iflֈ  o &y!+0'4 la $Ifgdz È Ĉ ڈ 8kd"g%$$Iflֈ  o &y!+0'4 la $Ifgdzڈ ݈ 8kd h%$$Iflֈ  o &y!+0'4 la $Ifgdz      $Ifgdz   " & ( / A88888 $Ifgdzkdh%$$Iflֈ  o &y!+0'4 la/ 0 1 @ D H J 8kdi%$$Iflֈ  o &y!+0'4 la $IfgdzJ S T U d h l 8kdj%$$Iflֈ  o &y!+0'4 la $Ifgdzl n u v w ~ 8kdk%$$Iflֈ  o &y!+0'4 la $Ifgdz 8kdl%$$Iflֈ  o &y!+0'4 la $Ifgdz Ɖ s t E F _ ` ͋   4 L Y Z  H$gd2V  H$gd2V H$]gd2Vgdzgd2V ˉ Ή ω Љ  ʊ F N ^ _ ` Y Z [ ڌ ݌ ތ  ԍ u yyyydyyyy(h?ih2VCJOJQJ^JaJmH sH h3CJOJQJ^JaJ h?ih2VCJOJQJ^JaJ hB&hS\h2V hB&h2VCJOJQJ^JaJhB&h2V5CJaJhB&h2V\hB&h2V\^JhB&h2V^JhB&h2V5hB&h2VCJaJ hB&h2VhB&h2VCJaJ'Z [ Ԍ ' g ԍ % N ݎ ; ۏ  9 ~  P u  Hgd2Vgdzu ' A f s + K X ` n y z ͕ L M ̘ ™   # 3 j } ˼|q|qhB&hS\mH sH h~\hS\mH sH  hB&h"`h"`hh6mH sH  hhhhhhmH sH hB&h2VmH sH  hB&h2VhB&h2VCJOJQJaJ hB&hS\h2VCJOJQJ^JaJ h?ih2VCJOJQJ^JaJh?ih2VOJQJ^JaJ,     ' ( * 1 ckdm%$$IfP40 "   %%4 Paf4p%% $Ifgdzgdzgd~`1 2 4 @ A C P dHkdn%$$IfP40 " 4 Paf4 $IfgdzHkdGn%$$IfP40 " 4 Paf4P Q S d e g r dHkdo%$$IfP40 " 4 Paf4 $IfgdzHkd?o%$$IfP40 " 4 Paf4r s u dHkdp%$$IfP40 " 4 Paf4 $IfgdzHkd7p%$$IfP40 " 4 Paf4 dHkdq%$$IfP40 " 4 Paf4 $IfgdzHkd/q%$$IfP40 " 4 Paf4 ̒ ͒ ϒ dHkdr%$$IfP40 " 4 Paf4 $IfgdzHkd'r%$$IfP40 " 4 Paf4   dHkds%$$IfP40 " 4 Paf4 $IfgdzHkds%$$IfP40 " 4 Paf4   4 5 7 Q dHkdt%$$IfP40 " 4 Paf4 $IfgdzHkdt%$$IfP40 " 4 Paf4Q R T l m o dHkdu%$$IfP40 " 4 Paf4 $IfgdzHkdu%$$IfP40 " 4 Paf4 dHkdv%$$IfP40 " 4 Paf4 $IfgdzHkdv%$$IfP40 " 4 Paf4 ٓ ړ ܓ dHkd{w%$$IfP40 " 4 Paf4 $IfgdzHkdv%$$IfP40 " 4 Paf4 & dHkdsx%$$IfP40 " 4 Paf4 $IfgdzHkdw%$$IfP40 " 4 Paf4& ' ) @ A C S dHkdky%$$IfP40 " 4 Paf4 $IfgdzHkdx%$$IfP40 " 4 Paf4S T V p q s dHkdcz%$$IfP40 " 4 Paf4 $IfgdzHkdy%$$IfP40 " 4 Paf4 dHkd[{%$$IfP40 " 4 Paf4 $IfgdzHkdz%$$IfP40 " 4 Paf4 Ԕ Ք ה dHkdS|%$$IfP40 " 4 Paf4 $IfgdzHkd{%$$IfP40 " 4 Paf4  dHkdK}%$$IfP40 " 4 Paf4 $IfgdzHkd|%$$IfP40 " 4 Paf4   * + - 5 dHkdC~%$$IfP40 " 4 Paf4 $IfgdzHkd}%$$IfP40 " 4 Paf45 6 8 H I J z { d_ZUgd_gd~`gdzHkd;%$$IfP40 " 4 Paf4 $IfgdzHkd~%$$IfP40 " 4 Paf4 ̕ $Ifgdz̕ ͕ ѕ  $Ifgdzkd%$$Ifl(ֈL :K<$S <%%%%%%4 lap<%%%%%%ѕ ٕ ݕ   ]kd.%$$Ifl(ֈL :K<$S4 la $Ifgdz     " + 0 G K [ ]kd%$$Ifl(ֈL :K<$S4 la $Ifgdz [ \ ` j n v { f]]]]]] $Ifgdzkd%$$Ifl(ֈL :K<$S4 la f]]]]]] $Ifgdzkd%$$Ifl(ֈL :K<$S4 la Ɩ ˖ ۖ f]]]]]] $Ifgdzkdք%$$Ifl(ֈL :K<$S4 la     . f]]]]]] $Ifgdzkd%$$Ifl(ֈL :K<$S4 la. / 3 F J V Z h f]]]]]] $Ifgdzkd%$$Ifl(ֈL :K<$S4 lah i n { ~ f]]]]]] $Ifgdzkd%$$Ifl(ֈL :K<$S4 la З f]]]]]] $Ifgdzkd~%$$Ifl(ֈL :K<$S4 laЗ ї ֗ f]]]]]] $Ifgdzkdh%$$Ifl(ֈL :K<$S4 la      # * f]]]]]] $IfgdzkdR%$$Ifl(ֈL :K<$S4 la* + / 4 7 < A X f]]]]]] $Ifgdzkd<%$$Ifl(ֈL :K<$S4 laX Y ^ p t f]]]]]] $Ifgdzkd&%$$Ifl(ֈL :K<$S4 la ˘ f]]]]]] $Ifgdzkd%$$Ifl(ֈL :K<$S4 la˘ ̘ И ؘ ܘ  f]]]]]] $Ifgdzkd%$$Ifl(ֈL :K<$S4 la     % * 6 f]]]]]] $Ifgdzkd%$$Ifl(ֈL :K<$S4 la6 7 ; Q U a g w f]]]]]] $IfgdzkdΏ%$$Ifl(ֈL :K<$S4 law x | f]]]]]] $Ifgdzkd%$$Ifl(ֈL :K<$S4 la ™ ˙ Й ݙ f]]]]]] $Ifgdzkd%$$Ifl(ֈL :K<$S4 laݙ ޙ    f]]]]]] $Ifgdzkd%$$Ifl(ֈL :K<$S4 la    # ( , 2 f]]]]]] $Ifgdzkdv%$$Ifl(ֈL :K<$S4 la2 3 8 D I U Y i f]]]]]] $Ifgdzkd`%$$Ifl(ֈL :K<$S4 lai j n x } f]]]]]] $IfgdzkdJ%$$Ifl(ֈL :K<$S4 la ɚ ʚ ؚ   faXOOOOOO $IfgdS\L^Lgdd@gd~`kd4%$$Ifl(ֈL :K<$S4 la ǚ Ț ɚ ʚ ך  * ӛ q ڜ ۜ Ş ў   ! % ' 1 2 D F P Q c e o p ػ h(hat hB&hElhEl h(hz:hJ\hz:hd@ hB&hd@ hB&h2VhB&h2VmH sH  h"`hS\h~\hS\mH sH hB&hS\mH sH hS\hS\6mH sH hg{g6mH sH hS\mH sH 5  !  $Ifgdzkd%$$Ifl(ֈL :K<$S <%%%%%%4 lap<%%%%%%! & * ? D L M R a e k ]kd%$$Ifl(ֈL :K<$S4 la $Ifgdz k n t u z ]kd%$$Ifl(ֈL :K<$S4 la $Ifgdz Ǜ ˛ ӛ כ f]]]]]] $Ifgdzkdi%$$Ifl(ֈL :K<$S4 la   , f]]]]]] $IfgdzkdS%$$Ifl(ֈL :K<$S4 la, - 1 5 9 B G Y f]]]]]] $Ifgdzkd=%$$Ifl(ֈL :K<$S4 laY Z _ q v } f]]]]]] $Ifgdzkd'%$$Ifl(ֈL :K<$S4 la f]]]]]] $Ifgdzkd%$$Ifl(ֈL :K<$S4 la ɜ ͜ f]]]]]] $Ifgdzkd%$$Ifl(ֈL :K<$S4 la    1 5 ; f]]]]]] $Ifgdzkd%$$Ifl(ֈL :K<$S4 la; < @ L P e j o f]]]]]] $IfgdzkdϠ%$$Ifl(ֈL :K<$S4 lao p t f]]]]]] $Ifgdzkd%$$Ifl(ֈL :K<$S4 la ȝ f]]]]]] $Ifgdzkd%$$Ifl(ֈL :K<$S4 laȝ ɝ ϝ f]]]]]] $Ifgdzkd%$$Ifl(ֈL :K<$S4 la   ! ( - < f]]]]]] $Ifgdzkdw%$$Ifl(ֈL :K<$S4 la< = A H L Z ^ f]]]]]] $Ifgdzkda%$$Ifl(ֈL :K<$S4 la f]]]]]] $IfgdzkdK%$$Ifl(ֈL :K<$S4 la   ! & faYYTHH $$Ifa$gdz:gd2V gd,gd~`kd5%$$Ifl(ֈL :K<$S4 la& ' 2 E xoo $Ifgd"`kd%$$Ifl    0,"L L    0    4 lapE F Q d $Ifgd"`lkd%$$Ifl    0,"LL0    4 lad e p $Ifgd"`lkd%$$Ifl    0,"LL0    4 la $Ifgd"`lkd %$$Ifl    0,"LL0    4 la & $Ifgd"`lkd%$$Ifl    0,"LL0    4 la % ' 1 2 g i s t à ͠ Π    + - . / 9 : ? @ A a w   ; < m n { | } Ӣ »߻ hB&hikdhikd h(h( h(hikd h"`aJhhd@ hB&hJ\ h(hJ\hJ\h(hEl hB&hathat hB&hEl h(hatB& ' 2 h $Ifgd"`lkd%$$Ifl    0,"LL0    4 lah i t $Ifgd"`lkd%$$Ifl    0,"LL0    4 la   $Ifgd"`lkd%$$Ifl    0,"LL0    4 la  à Π $Ifgd"`lkd%$$Ifl    0,"LL0    4 la  , $Ifgd"`lkd"%$$Ifl    0,"LL0    4 la, - . / A w xxsgg $$Ifa$gd"`gdJ\ gdJ\gd~` gd(gd2Vlkd%$$Ifl    0,"LL0    4 la sjj $Ifgd"`kd*%$$Ifl    0,"L L    0    4 lap $Ifgd"`qkd%$$Ifl    0,"LL0    4 la   $Ifgd"`qkd%$$Ifl    0,"LL0    4 la  ! ; $Ifgd"`qkd%$$Ifl    0,"LL0    4 la; < C m $Ifgd"`qkd%$$Ifl    0,"LL0    4 lam n u { $Ifgd"`qkd%$$Ifl    0,"LL0    4 la{ | Ӣ  tt $$Ifa$gd"` gd(gd~`qkd%$$Ifl    0,"LL0    4 la     . 0 : ; M O Y Z ~     R S T U m n | Ȥ ޤ ߤ  ! ' ( : < B C Y [ \ ] üټټټټټټٱh"`\]aJh hB&h2V hB&h(hU hB&hUh H h(h H h( h(h( h(hUhikd hB&hd@ h(hd@ hB&hikd h(hikd=   / sjj $Ifgd"`kd%%$$Ifl    0,"L L    0    4 lap/ 0 ; N $Ifgd"`qkd%$$Ifl    0,"LL0    4 laN O Z  $Ifgd"`qkd%$$Ifl    0,"LL0    4 la $Ifgd"`qkd%$$Ifl    0,"LL0    4 la $Ifgd"`qkd%$$Ifl    0,"LL0    4 la  $Ifgd"`qkd%$$Ifl    0,"LL0    4 la  ) Q R w $Ifgdd@ $Ifgd"`qkd%$$Ifl    0,"LL0    4 laR S T U n ޤ ߤ xxoo $Ifgd"` gd H gd~` gd(qkd %$$Ifl    0,"LL0    4 la xoo $Ifgd"`kd%$$Ifl    0,"L  L     0    4 lap ! ( ; $Ifgd"`lkdk%$$Ifl    0,"L  L  0    4 la; < C Z $Ifgd"`lkd%$$Ifl    0,"L  L  0    4 laZ [ \ ] n o u {rr $Ifgdzgdzgd~`gd2V gd(lkd%$$Ifl    0,"L  L  0    4 la xoo $Ifgdzkd!%$$Ifl    0,"L  L     0    4 lap $Ifgdzlkd%$$Ifl    0,"L  L  0    4 la $Ifgdzlkdz%$$Ifl    0,"L  L  0    4 la ͥ  $Ifgdzgdzgd~`lkd %$$Ifl    0,"L  L  0    4 laͥ Υ Х xoo $Ifgdzkd%$$Ifl    0,"L L    0    4 lap $Ifgdzlkds%$$Ifl    0,"LL0    4 la  $Ifgdzlkd%$$Ifl    0,"LL0    4 la   0 $Ifgdzlkd%$$Ifl    0,"LL0    4 la0 1 U V $Ifgdzlkd %$$Ifl    0,"LL0    4 laV W Y c $Ifgdzlkd%$$Ifl    0,"LL0    4 lac d f p $Ifgdzlkd[%$$Ifl    0,"LL0    4 lap q s $Ifgdzlkd%$$Ifl    0,"LL0    4 la $Ifgdzlkdq%$$Ifl    0,"LL0    4 la $Ifgdzlkd%$$Ifl    0,"LL0    4 la ͦ Φ Ԧ  $Ifgdzgd~`gdzlkdy%$$Ifl    0,"LL0    4 la , - . / 4 Ĩ  . 0 J d f h   b d " $ . < Ĺܙܕ{ng]V hk6]hk56\] h6y\hkhk5OJQJ\^Jhk5CJ\aJhkCJaJ hk5\h h|+hkh|+CJaJ!h|+h|+B*OJQJ^Jphh|+h|+B*phhcOh|+B*phhcOh|+5B*phh|+hB&h2V5\ hB&h"`h2V hB&h2Vhd@ vmm $Ifgdzkd%$$Ifl0x$   064 laZp $Ifgdznkd%$$Ifl0x$064 laZ    $Ifgdznkdf%$$Ifl0x$064 laZ    ? @ F R ~~ $Ifgdzgd~`gdznkd%$$Ifl0x$064 laZR S r t vmm $Ifgdzkd%$$Ifl0u$   064 lapt u $Ifgdznkdi%$$Ifl0u$064 la $Ifgdznkd%$$Ifl0u$064 la Χ Ч $Ifgdznkd%$$Ifl0u$064 laЧ ѧ $Ifgdznkd7%$$Ifl0u$064 la   $Ifgdznkd%$$Ifl0u$064 la  ) + $Ifgdznkdk%$$Ifl0u$064 la+ , - . / b;;&$d%d&d'dNOPQgdS\* $d%d&d'dNOPQgd Lgdznkd%$$Ifl0u$064 la Ĩ . 0 2 4 6 8 : > @ B D F H J d f h  gdngd|+ hgd|+!gd|+gdzh Ԫ ֪    D >Jkd%$$Ifl0H$4 laJkd%$$Ifl0H$4 la+$$d%d&d'dIfNOPQgdD ` b d " XX0$$ h$d%d&d'dNOPQa$gdJkd]%$$Ifl0H$4 la+$$d%d&d'dIfNOPQgd" $ > ? M N / 0 ͺ κ ؼ ~~~~~* $d%d&d'dNOPQgd* $d%d&d'dNOPQgd, h$d%d&d'dNOPQgd< > = > ? L M N  m  Ƶ ʵ / 0 ڸ ͺ κ ؼ  ˽     ƿ п ҿ Կ ؿ ڿ t ~ J T j ڿڸڴکڟhk56\]hk5CJ\aJh6y\ hkhk hkH*hkCJOJQJ^JaJhkCJaJhk hk5\ h6y\hk hk6]hk6OJQJ]^J;ؼ ټ ڼ     ؿ {OO, h$d%d&d'dNOPQgd* $d%d&d'dNOPQgd* $d%d&d'dNOPQgd/$ h$d%d&d'dNOPQa$gd L N M N XZpr~* $d%d&d'dNOPQgd* $d%d&d'dNOPQgd, h$d%d&d'dNOPQgdj t v x  J L b l n p N S X   : D F H ~ ʼҸʼʼʼҮҀvo hk5\hk56\]Uhk>*B*ph'j%h{hk>*B*Uphjhk>*B*Uphhk>*B*phh5hkCJOJQJ^JaJhkCJaJhk h56] hk6] hk6CJOJQJ]^JaJhk6CJ]aJ+ the VistA site clinical laboratory VistA liaison (Laboratory Information Manager (LIM) or Automated Data Processing Application Coordinator (ADPAC)). NOTE: It is requested that facilities do not initiate the mapping process until they have been appropriately trained. c. By July 16, 2001, each VISN Director must forward the name and contact information for each VISN LOINC Coordinator to the National Pathology Enforcement Officer (115), Veterans Health Administration, 810 Vermont Avenue, NW, Washington, DC 20420, or fax to (202) 273-7561. d. By September 30, 2001, each VISN LOINC Coordinator must ensure the linking of Hepatitis C-related laboratory tests at each facility and report completion to the VISN Director. NOTE: The actual mapping will be performed by the LIM or ADPAC at all facilities. e. By December 31, 2001, VISN LOINC Coordinators must have completed the full mapping of LOINC codes within all facility clinical laboratories and report completion of the task to the VISN Director as well as the Pathology Regional Commissioners. Complete mapping for all laboratory test names is required. 5. REFERENCES a VHA Executive Decision memorandum approved by the Under Secretary for Health on September 20, 2000. <HYPERLINK "http://www.va.gov/hepatitisc"http://www.va.gov/hepatitisc> b. Logical Observation Identifier Names and Codes (LOINC) User s Guide, January 5, 2001, c/o Regenstrief Institute, Indianapolis, IN. The LOINC is copyrighted (1995-2001) by Regenstrief Institute and the LOINC Committee. The Department of Veterans Affairs abides by all copyright restrictions. For further information go to <HYPERLINK "http://www.regenstrief.org/loinc/"http://www.regenstrief.org/loinc/>. c. National Laboratory Test (NLT) Mapping to Logical Observation Identifier Names and Codes (LOINC) Patch LR*5.2*215, Technical, Installation and User Guides, Version 5.2, April 1999, Department of Veterans Affairs, Software Service, Clinical Ancillary Product Line. Further information is at <HYPERLINK "http://vista.med.va.gov/softserv/clin_nar.row/lab/loinc/loinchm.htm"http://vista.med.va.gov/softserv/clin_nar.row/lab/loinc/loinchm.htm>. 6. FOLLOW-UP RESPONSIBILITY: The Chief Consultant for Public Health, Strategic Healthcare Group (SHG), and Chief Consultant, Diagnostic Services SHG, are responsible for the contents of this Directive. Technical support for the preceding actions will be provided by the OI Software Design and Development Group. Content support will be provided by the Chief Consultant, Diagnostic Services SHG. 7. RECISSIONS: None. This VHA Directive expires June 30, 2006. S/ Timothy N. Buckley forThomas L. Garthwaite, M.D.Under Secretary for Health DISTRIBUTION:CO:E-mailed 6/27/2001FLD:VISN, MA, DO, OC, OCRO, and 200 - E-mailed 6/27/2001     Preface June 2004 VistA Laboratory EPI Rollup Modifications  PAGE 73 Patch LR*5.2*281 Technical and User Manual Preface Preface  PAGE 72 VistA Laboratory EPI Rollup Modifications June 2004 Technical and User Manual June 2004 VistA Laboratory EPI Rollup Modifications  PAGE 65 Technical and User Manual Orientation Orientation Table of Contents Table of Contents Introduction Introduction Enhancements and Modifications Enhancements and Modifications Austin Automation Center Database Processing Austin Automation Center Database Processing SeuX\`bȜМnprtz*46 РԠ֠ؠ(*,dfjtԡޡ û񤯚hk>*B*phjG%hkUjhkUhd'<hhk\hk56\] h55\ hk5\hkCJOJQJ^JaJhkCJaJhkh5 hk6]7jl}S* $d%d&d'dNOPQgd* $d%d&d'dNOPQgd* h$d%d&d'dNOPQgd, h$d%d&d'dNOPQgd`bdpz|~ӦԦզ ;FGõϙχvogch>jh>U hB&h|+ j%hmV/h><CJUaJh; hk5\ h55\h5hk\'j%h{hk>*B*UphhkCJOJQJ^JaJhkCJaJh5hk'j%h{hk>*B*Uphhk>*B*phjhk>*B*Uph& ||MM. $$$d%d&d'dIfNOPQgd;0 v2 $d%d&d'dNOPQgd* h$d%d&d'dNOPQgd&$d%d&d'dNOPQgd   ()*EDEkd %$$Ifl0$4 la. $$$d%d&d'dIfNOPQgd;Ekd%$$Ifl0$4 laEFGUYlXXX. $$$d%d&d'dIfNOPQgd;1 $v2 $d%d&d'dNOPQgd;Ekdz%$$Ifl0$4 lalmnsrrr. $$$d%d&d'dIfNOPQgd;]kd%$$IflF $tV%    4 la©éĩ]gdz $gdS]kdj%$$IflF $tV%    4 la©ĩΩϩҩөߩ/0189DEKLNOQTayڴ쑆ypچچi h^?hnh<hnaJh h0J aJmHnHuh<hn0J aJjh<hn0J UaJh`hnaJh h0J mHnHujh<hn0J Uh<hn0J hh~hn]h<hn\ h<hnhB&hnCJaJ hB&hnh>jh>U(ĩ019CD )*=>) gd&) gdF_) gd1)gd  ]gdNc] gdNcgdz) gd`  ]gdPaӪԪժ۪ܪުߪ )*+=@MNO\]|~˫蹰}rkikU hIhnhzhnCJaJ h<hnh`hnCJaJhnCJaJhF_hnCJaJ h hn hB&hnh`hnaJhB&hnCJaJh h0J mHnHu hn0J jhn0J Uh^?hn0J h^?hnhJhn]h^?hn\'>?@MN\]|}˫̫*+HIgh) gd!")gdA) gdI gdz gd ) gd  gd` gdF_gdzcurity Information Security Information Pre-Installation Information Pre-Installation Information Installation Instructions Installation Instructions Post Installation and Implementation Instructions Post Installation and Implementation Instructions VistA Laboratory EPI Roll Up Modifications User Manaul Use of the Software Use of the Software Appendix-A Appendix-A Appendix-A Appendix-A Appendix-B Helpful Hints Appendix-B Helpful Hints Appendix-B Helpful Hints Appendix-C Health Level Seven (HL7) Protocol Appendix-C Health Level Seven (HL7) Protocol Appendix-C Health Level Seven (HL7) Protocol Appendix-D VHA Directive 2001-039 Appendix-D VHA Directive 2001-039 Appendix-D VHA Directive 2001-039 SAS Numerator files EPISASD creates SAS file PEPI505 gathers data for denominator file triggers PEPBLED reads incoming messages triggers triggers triggers triggers triggers triggers P PEPIDSP PEPIZXE PEPIDSPB PEPIPV1 PEPIPID PEPIOBX PEPIOBR PEPINTEB PEPINTE PEPIDG1 PEPINSRT separates master file into separate segment type files PEPI320 Creates master file PEPI315 combine new w/ master file PEPI310 update messages PEPI305 eliminate error messages PEPIXMIT transmits error report PEPI240 creates error report PEPI200 edits messages PEPI080 parses incoming messages AUSTIN AUTOMATION CENTER EMERGINING PATHOGENS INITIATIVE PROCESS FLOWCHART *+HJgh=>RSThEGHuv:;ռ՞՞h0hnB*CJaJphh9<hnB*CJaJphh> hxhn h{Khn hJhnhnhB&hnCJaJ h&hn h$yzhn hB&hn hh~hn8h=>RShitu) gd{')gd2`) gd0Tv) gdJ )gds) gdPa)) gd&gdzFGuv $7$8$H$a$gd~\) gdx) gdu)gdu) gd0Tvgdz)gd4@):;DEM\efopyz 7$8$H$gd~\ $7$8$H$a$gd~\;DEefopyzDEFbc쏂h_hnB*aJphh9<hnB*CJaJphh ZhnB*CJaJphh0hnB*CJaJph#hihn5B*CJ\aJphh8hnB*CJaJphh~hnB*CJaJphhnh_hnB*CJaJph3 1 $7$8$H$a$gd~\ 7$8$H$gd~\1DEFNVbckw  $7$8$H$a$gd~\:;ST_߲ߣߐ hB&h|+ hB&h hB&hnhnB*CJaJphhihnB*CJaJphh~hnB*CJaJphh~hnB*CJaJphh8hnB*CJaJphhnh_hnB*aJphh9<hnB*CJaJph!1:;T $gdSgdz $7$8$H$a$gdi 7$8$H$gd~G 00&P/R :p>0@PBP/ =!"#$% Q 0000%&PP/R :p>0@PBP/ =!"#$% J 000%&P/R :p<>0@PBP/ =!"#$% J 000&P/R :p>0@PBP/ =!"#$% G 00&P/R :p>0@PBP/ =!"#$% G 00&P/R :p>0@PBP/ =!"#$% G 00&P/R :p>0@PBP/ =!"#$% G 00&P/R :p>0@PBP/ =!"#$% G 00&P/R :p>0@PBP/ =!"#$% G 00&P/R :p>0@PBP/ =!"#$% G 00&P/R :p>0@PBP/ =!"#$% G 00&P/R :p>0@PBP/ =!"#$% G 00&P/R :p>0@PBP/ =!"#$% G 00&P/R :p>0@PBP/ =!"#$% G 00&P/R :p>0@PBP/ =!"#$% G 00&P/R :p>0@PBP/ =!"#$% G 00&P/R :p>0@PBP/ =!"#$% G 00&P/R :p>0@PBP/ =!"#$% G 00&P/R :p>0@PBP/ =!"#$% G 00&P/R :p>0@PBP/ =!"#$% G 00&P/R :p>0@PBP/ =!"#$% Dd$ i<  C Ab$NӪiM-CWDnNӪiM-CWPNG  IHDR$LgAMA pHYs  IDATx_h[OW3Z\T7v  G"'PC B9CtJ՞wv E5 @/-h4FSm<RV&5~}InFKKYVχRȵ"*-͎\+ruKMt63]*ՒS7e:wdPRyraE)T>2٭ɅWL.XMCk]aql<ϊ HN/\ 2K{Dc|[ʈӽî>Ji-|P*_\)L$;4E_'0^6wu;tYշT#OR(ǯ/ixgˁ-A:-ʙVޓ\@ W^[;[)W{a7y _"2q1;m 4{4J5Ո1וRn/.(˧pS`X"֪%Ԡlw O` R'S@,WS5re-מ«Ch[ʈFb5d7w_a"٭j\sS->2s GoMBA+vEaW⠖>'VdjD/TU`oDv*2:O#uӔ–*@llNΔs59Jcct FUƲezKdA ć5Rʬ--'psuxlP.Ӌwe~&￸`(ݲ\iRY{;W|Pm PwmbSAY2^]$'vz(^/eYP*+kс` !oE ' vH5|4lNΨ^>cnscXUfDW&C(%8ͻ7TX>wdFn A̒~Pz+6Oژt?9uS`o%RCDZ._FB=D!%' |v@#X9/Bi7 7V.?UWfOk~n([-rߐٕ8{M//gK]0vfڷ5IןL{Jŧ.j;*j<vGF YR&ӽ~N0tk~Y (sQpt, L_3}aSND?0?O[ѩY5[d0j-[S7o,%i7iH%9uSn L$s&)}f9@lҙ>w47'gv ?D&&6k y._\X\X }X끎fJ#UpZOB3sf̀4<ۙ+q0;r^˫̧fUX9uˤn%nGRlW|"-UZ)=:eKԻ_ʬg6Z_)֍͹TyS,!J#l9Ab{4vGIbYXヲ'ًf,Xجx)M:nHx'dl0eeׯ*yv:1Q1)>.[RↂlN ҙŇ!? [Ҁ~BvivK:Ucg;4R93*zZ#-V9(3iy0IZ9+wi[ZJto Ŧo*_ӗhrHJs|.>qdj*l̲Wuᦀ%ujG;_i7uƾ,~ՙ"|>B7&RG*MYz?(_<_4ΗގHCŧ&G7/Fԙeׯ:*\&qA]{;8V9~?m>JĉVGH+3_"RmPlM*hS(fG.C_Azl8RA^|ͦ_,?b4j\Xأmd7lcC'BoRkDiMYtJo._+сH6ԢʈI|APwޅ/>whEOGHU2:'kՕJ4 ȵ26KJoI3}W2-4X+w3e??xVq E7 Ξm̢x3e{su׻*s?gfNBc/>n=?^o6-ѽ~QJ}}]fL!4 8YeuFfS&}]eD[́%2#'f2qH: 6J< -;\c'r"ncO8M)x$v$_ʵdA7 e?Jn]<8}UK{o[,'񟪳 yYavaX#'"-kSΫC!~)WʼS(3٭'rUM+E#!kGWPVᦀY|CC% ˣ6#Dpd{!lkY>%x+w:svGCxPcBf(ǧ,fJyF^mӝw-w 3q#ߘP)i9pmf$bgjXy(p! ~5 XUWG*YʬCi5A`ƼFZȞn`i5"Xlh8[sN`hrq&!fssPzʬ*j]q#>V  ."EtfC򍟗jXh_ $D`Sك"&]l-6n,~ lHWl`Dww4p:lx#8 6g7NQ_i$~ F^|ә4^?pzI#ĠxqCU܀Hx%x<܃#i8i$~* g&l܆7Hx8#6[g|]s4^?p-J#7>N gfYBdj~P+8&62IxV5,6xpLljZlA%xqLlq ^?Qj/jH-mA1yAMSKi$~P8)6CZI<@ 7p6d:; ^?ݺi$pAx lpi x'揶x'ŦUui$~Uftp://ftp.fo-hines.med.va.gov/DyK ftp.fo-slc.med.va.govyK :ftp://ftp.fo-slc.med.va.gov/9DyK 1http://vista.med.va.gov/ClinicalSpecialties/lab/yK bhttp://vista.med.va.gov/ClinicalSpecialties/lab/DyK http://www.va.gov/vdl/yK .http://www.va.gov/vdl/{DyK  _Toc76869005{DyK  _Toc76869005{DyK  _Toc76869006{DyK  _Toc76869006{DyK  _Toc76869007{DyK  _Toc76869007{DyK  _Toc76869008{DyK  _Toc76869008{DyK  _Toc76869009{DyK  _Toc76869009{DyK  _Toc76869010{DyK  _Toc76869010{DyK  _Toc76869011{DyK  _Toc76869011{DyK  _Toc76869012{DyK  _Toc76869012{DyK  _Toc76869013{DyK  _Toc76869013{DyK  _Toc76869014{DyK  _Toc76869014{DyK  _Toc76869015{DyK  _Toc76869015{DyK  _Toc76869016{DyK  _Toc76869016{DyK  _Toc76869017{DyK  _Toc76869017{DyK  _Toc76869018{DyK  _Toc76869018{DyK  _Toc76869019{DyK  _Toc76869019{DyK  _Toc76869020{DyK  _Toc76869020{DyK  _Toc76869021{DyK  _Toc76869021{DyK  _Toc76869022{DyK  _Toc76869022{DyK  _Toc76869023{DyK  _Toc76869023{DyK  _Toc76869024{DyK  _Toc76869024{DyK  _Toc76869025{DyK  _Toc76869025{DyK  _Toc76869026{DyK  _Toc76869026{DyK  _Toc76869027{DyK  _Toc76869027{DyK  _Toc76869028{DyK  _Toc76869028{DyK  _Toc76869029{DyK  _Toc76869029{DyK  _Toc76869030{DyK  _Toc76869030{DyK  _Toc76869031{DyK  _Toc76869031{DyK  _Toc76869032{DyK  _Toc76869032{DyK  _Toc76869033{DyK  _Toc76869033{DyK  _Toc76869034{DyK  _Toc76869034{DyK  _Toc76869035{DyK  _Toc76869035{DyK  _Toc76869036{DyK  _Toc76869036{DyK  _Toc76869037{DyK  _Toc76869037{DyK  _Toc76869038{DyK  _Toc76869038{DyK  _Toc76869039{DyK  _Toc76869039{DyK  _Toc76869040{DyK  _Toc76869040{DyK  _Toc76869041{DyK  _Toc76869041{DyK  _Toc76869042{DyK  _Toc76869042{DyK  _Toc76869043{DyK  _Toc76869043{DyK  _Toc76869044{DyK  _Toc76869044{DyK  _Toc76869045{DyK  _Toc76869045{DyK  _Toc76869046{DyK  _Toc76869046{DyK  _Toc76869047{DyK  _Toc76869047{DyK  _Toc76869048{DyK  _Toc76869048{DyK  _Toc76869049{DyK  _Toc76869049{DyK  _Toc76869050{DyK  _Toc76869050{DyK  _Toc76869051{DyK  _Toc76869051{DyK  _Toc76869052{DyK  _Toc76869052{DyK  _Toc76869053{DyK  _Toc76869053{DyK  _Toc76869054{DyK  _Toc76869054{DyK  _Toc76869055{DyK  _Toc76869055{DyK  _Toc76869056{DyK  _Toc76869056{DyK  _Toc76869057{DyK  _Toc76869057{DyK  _Toc76869058{DyK  _Toc76869058{DyK  _Toc76869059{DyK  _Toc76869059{DyK  _Toc76869060{DyK  _Toc76869060{DyK  _Toc76869061{DyK  _Toc76869061{DyK  _Toc76869062{DyK  _Toc76869062{DyK  _Toc76869063{DyK  _Toc76869063{DyK  _Toc76869064{DyK  _Toc76869064{DyK  _Toc76869065{DyK  _Toc76869065{DyK  _Toc76869066{DyK  _Toc76869066{DyK  _Toc76869067{DyK  _Toc76869067{DyK  _Toc76869068{DyK  _Toc76869068{DyK  _Toc76869069{DyK  _Toc76869069{DyK  _Toc76869070{DyK  _Toc76869070{DyK  _Toc76869071{DyK  _Toc76869071{DyK  _Toc76869072{DyK  _Toc76869072{DyK  _Toc76869073{DyK  _Toc76869073{DyK  _Toc76869074{DyK  _Toc76869074{DyK  _Toc76869075{DyK  _Toc76869075{DyK  _Toc76869076{DyK  _Toc76869076{DyK  _Toc76869077{DyK  _Toc76869077{DyK  _Toc76869078{DyK  _Toc76869078{DyK  _Toc76869079{DyK  _Toc76869079{DyK  _Toc76869080{DyK  _Toc76869080{DyK  _Toc76869081{DyK  _Toc76869081{DyK  _Toc76869082{DyK  _Toc76869082{DyK  _Toc76869083{DyK  _Toc76869083{DyK  _Toc76869084{DyK  _Toc76869084{DyK  _Toc76869085{DyK  _Toc76869085{DyK  _Toc76869086{DyK  _Toc76869086{DyK  _Toc76869087{DyK  _Toc76869087{DyK  _Toc76869088{DyK  _Toc76869088{DyK  _Toc76869089{DyK  _Toc76869089{DyK  _Toc76869090{DyK  _Toc76869090{DyK  _Toc76869091{DyK  _Toc76869091{DyK  _Toc76869092{DyK  _Toc76869092{DyK  _Toc76869093{DyK  _Toc76869093{DyK  _Toc76869094{DyK  _Toc76869094{DyK  _Toc76869095{DyK  _Toc76869095{DyK  _Toc76869096{DyK  _Toc76869096{DyK  _Toc76869097{DyK  _Toc76869097{DyK  _Toc76869098{DyK  _Toc76869098{DyK  _Toc76869099{DyK  _Toc76869099{DyK  _Toc76869100{DyK  _Toc76869100{DyK  _Toc76869101{DyK  _Toc76869101{DyK  _Toc76869102{DyK  _Toc76869102{DyK  _Toc76869103{DyK  _Toc76869103{DyK  _Toc76869104{DyK  _Toc76869104{DyK  _Toc76869105{DyK  _Toc76869105{DyK  _Toc76869106{DyK  _Toc76869106{DyK  _Toc76869107{DyK  _Toc76869107{DyK  _Toc76869108{DyK  _Toc76869108{DyK  _Toc76869109{DyK  _Toc76869109{DyK  _Toc76869110{DyK  _Toc76869110{DyK  _Toc76869111{DyK  _Toc76869111{DyK  _Toc76869112{DyK  _Toc76869112{DyK  _Toc76869113{DyK  _Toc76869113{DyK  _Toc76869114{DyK  _Toc76869114{DyK  _Toc76869115{DyK  _Toc76869115{DyK  _Toc76869116{DyK  _Toc76869116{DyK  _Toc76869117{DyK  _Toc76869117{DyK  _Toc76869118{DyK  _Toc76869118{DyK  _Toc76869119{DyK  _Toc76869119{DyK  _Toc76869120{DyK  _Toc76869120{DyK  _Toc76869121{DyK  _Toc76869121{DyK  _Toc76869122{DyK  _Toc76869122{DyK  _Toc76869123{DyK  _Toc76869123{DyK  _Toc76869124{DyK  _Toc76869124{DyK  _Toc76869125{DyK  _Toc76869125{DyK  _Toc76869126{DyK  _Toc76869126{DyK  _Toc76869127{DyK  _Toc76869127{DyK  _Toc76869128{DyK  _Toc76869128{DyK  _Toc76869129{DyK  _Toc76869129{DyK  _Toc76869130{DyK  _Toc76869130{DyK  _Toc76869131{DyK  _Toc76869131{DyK  _Toc76869132{DyK  _Toc76869132{DyK  _Toc76869133{DyK  _Toc76869133{DyK  _Toc76869134{DyK  _Toc76869134{DyK  _Toc76869135{DyK  _Toc76869135{DyK  _Toc76869136{DyK  _Toc76869136{DyK  _Toc76869137{DyK  _Toc76869137{DyK  _Toc76869138{DyK  _Toc76869138{DyK  _Toc76869139{DyK  _Toc76869139{DyK  _Toc76869140{DyK  _Toc76869140{DyK  _Toc76869141{DyK  _Toc76869141{DyK  _Toc76869142{DyK  _Toc76869142{DyK  _Toc76869143{DyK  _Toc76869143{DyK  _Toc76869144{DyK  _Toc76869144{DyK  _Toc76869145{DyK  _Toc76869145{DyK  _Toc76869146{DyK  _Toc76869146{DyK  _Toc76869147{DyK  _Toc76869147{DyK  _Toc76869148{DyK  _Toc76869148{DyK  _Toc76869149{DyK  _Toc76869149{DyK  _Toc76869150{DyK  _Toc76869150{DyK  _Toc76869151{DyK  _Toc76869151{DyK  _Toc76869152{DyK  _Toc76869152{DyK  _Toc76869153{DyK  _Toc76869153{DyK  _Toc76869154{DyK  _Toc76869154{DyK  _Toc76869155{DyK  _Toc76869155{DyK  _Toc76869156{DyK  _Toc76869156{DyK  _Toc76869157{DyK  _Toc76869157{DyK  _Toc76869158{DyK  _Toc76869158{DyK  _Toc76869159{DyK  _Toc76869159{DyK  _Toc76869160{DyK  _Toc76869160{DyK  _Toc76869161{DyK  _Toc76869161{DyK  _Toc76869162{DyK  _Toc76869162{DyK  _Toc76869163{DyK  _Toc76869163{DyK  _Toc76869164{DyK  _Toc76869164{DyK  _Toc76869165{DyK  _Toc76869165{DyK  _Toc76869166{DyK  _Toc76869166{DyK  _Toc76869167{DyK  _Toc76869167{DyK  _Toc76869168{DyK  _Toc76869168{DyK  _Toc76869169{DyK  _Toc76869169{DyK  _Toc76869170{DyK  _Toc76869170{DyK  _Toc76869171{DyK  _Toc76869171{DyK  _Toc76869172{DyK  _Toc76869172{DyK  _Toc76869173{DyK  _Toc76869173{DyK  _Toc76869174{DyK  _Toc76869174{DyK  _Toc76869175{DyK  _Toc76869175{DyK  _Toc76869176{DyK  _Toc76869176{DyK  _Toc76869177{DyK  _Toc76869177{DyK  _Toc76869178{DyK  _Toc76869178{DyK  _Toc76869179{DyK  _Toc76869179{DyK  _Toc76869180{DyK  _Toc76869180{DyK  _Toc76869181{DyK  _Toc76869181{DyK  _Toc76869182{DyK  _Toc76869182{DyK  _Toc76869183{DyK  _Toc76869183{DyK  _Toc76869184{DyK  _Toc76869184{DyK  _Toc76869185{DyK  _Toc76869185{DyK  _Toc76869186{DyK  _Toc76869186{DyK  _Toc76869187{DyK  _Toc76869187{DyK  _Toc76869188{DyK  _Toc76869188{DyK  _Toc76869189{DyK  _Toc76869189{DyK  _Toc76869190{DyK  _Toc76869190{DyK  _Toc76869191{DyK  _Toc76869191{DyK  _Toc76869192{DyK  _Toc76869192{DyK  _Toc76869193{DyK  _Toc76869193{DyK  _Toc76869194{DyK  _Toc76869194{DyK  _Toc76869195{DyK  _Toc76869195{DyK  _Toc76869196{DyK  _Toc76869196{DyK  _Toc76869197{DyK  _Toc76869197{DyK  _Toc76869198{DyK  _Toc76869198{DyK  _Toc76869199{DyK  _Toc76869199{DyK  _Toc76869200{DyK  _Toc76869200{DyK  _Toc76869201{DyK  _Toc76869201{DyK  _Toc76869202{DyK  _Toc76869202{DyK  _Toc76869203{DyK  _Toc76869203{DyK  _Toc76869204{DyK  _Toc76869204{DyK  _Toc76869205{DyK  _Toc76869205{DyK  _Toc76869206{DyK  _Toc76869206{DyK  _Toc76869207{DyK  _Toc76869207{DyK  _Toc76869208{DyK  _Toc76869208{DyK  _Toc76869209{DyK  _Toc76869209{DyK  _Toc76869210{DyK  _Toc76869210{DyK  _Toc76869211{DyK  _Toc76869211{DyK  _Toc76869212{DyK  _Toc76869212{DyK  _Toc76869213{DyK  _Toc76869213{DyK  _Toc76869214{DyK  _Toc76869214{DyK  _Toc76869215{DyK  _Toc76869215{DyK  _Toc76869216{DyK  _Toc76869216{DyK  _Toc76869217{DyK  _Toc76869217{DyK  _Toc76869218{DyK  _Toc76869218{DyK  _Toc76869219{DyK  _Toc76869219{DyK  _Toc76869220{DyK  _Toc76869220{DyK  _Toc76869221{DyK  _Toc76869221{DyK  _Toc76869222{DyK  _Toc76869222{DyK  _Toc76869223{DyK  _Toc76869223{DyK  _Toc76869224{DyK  _Toc76869224{DyK  _Toc76869225{DyK  _Toc76869225{DyK  _Toc76869226{DyK  _Toc76869226{DyK  _Toc76869227{DyK  _Toc76869227{DyK  _Toc76869228{DyK  _Toc76869228{DyK  _Toc76869229{DyK  _Toc76869229{DyK  _Toc76869230{DyK  _Toc76869230{DyK  _Toc76869231{DyK  _Toc76869231{DyK  _Toc76869232{DyK  _Toc76869232{DyK  _Toc76869233{DyK  _Toc76869233{DyK  _Toc76869234{DyK  _Toc76869234{DyK  _Toc76869235{DyK  _Toc76869235{DyK  _Toc76869236{DyK  _Toc76869236{DyK  _Toc76869237{DyK  _Toc76869237{DyK  _Toc76869238{DyK  _Toc76869238{DyK  _Toc76869239{DyK  _Toc76869239{DyK  _Toc76869240{DyK  _Toc76869240{DyK  _Toc76869241{DyK  _Toc76869241{DyK  _Toc76869242{DyK  _Toc76869242{DyK  _Toc76869243{DyK  _Toc76869243{DyK  _Toc76869244{DyK  _Toc76869244{DyK  _Toc76869245{DyK  _Toc76869245{DyK  _Toc76869246{DyK  _Toc76869246{DyK  _Toc76869247{DyK  _Toc76869247{DyK  _Toc76869248{DyK  _Toc76869248{DyK  _Toc76869249{DyK  _Toc76869249{DyK  _Toc76869250{DyK  _Toc76869250{DyK  _Toc76869251{DyK  _Toc76869251{DyK  _Toc76869252{DyK  _Toc76869252{DyK  _Toc76869253{DyK  _Toc76869253{DyK  _Toc76869254{DyK  _Toc76869254{DyK  _Toc76869255{DyK  _Toc76869255{DyK  _Toc76869256{DyK  _Toc76869256{DyK  _Toc76869257{DyK  _Toc76869257{DyK  _Toc76869258{DyK  _Toc76869258{DyK  _Toc76869259{DyK  _Toc76869259{DyK  _Toc76869260{DyK  _Toc76869260{DyK  _Toc76869261{DyK  _Toc76869261{DyK  _Toc76869262{DyK  _Toc76869262{DyK  _Toc76869263{DyK  _Toc76869263{DyK  _Toc76869264{DyK  _Toc76869264{DyK  _Toc76869265{DyK  _Toc76869265{DyK  _Toc76869266{DyK  _Toc76869266{DyK  _Toc76869267{DyK  _Toc76869267{DyK  _Toc76869268{DyK  _Toc76869268 %Dd *@b  c $A? ?3"`?"j$D113 zoOF$W @=>$D113  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~                           ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~                            ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~                            ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q s t u v w x y z { | } ~   ~      ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } Root Entry F< Data r %WordDocument ObjectPool^<_1145363866F^;cOle EPRINT 8CompObjs  FMicrosoft Visio DrawingVisio 11.0 ShapesVisio.Drawing.119q Oh+'0 X`lx Preferred CustomlmYz EMF8@F, EMF+@``FpdEMF+0@?@ @ @L @$*8CףB9CpB!b $$=='% % V0gs ~ > #> #~ ~% % $$AAFEMF+@@4 ף>@H<*8C#CUC#CUCףB*8CףB*8C#C@$$==_888% % V0ft > #> #~ ~ > % % $$AA( FD8EMF+*@$BB*8CףB@0$=ARIAL6@Define the Search =>&>>f>>ς>>r>>>>>>>>U>>?>@?>@?>1?>A?>QQ?>Z?>i?>??   RpAriald680:w858ʌwx5w57w$@88; X)Dw=))ppwp8wDwp}w:wH) Q ~ d 0p8wDwp}w:wd9P)@+wUw ,pdv% TxAALpDefine the Search)% FtEMF++@ *@$BB*8CףB6@@4/@x?>??   % TTxAALP/% F<0EMF++@ *@$BB*8CףB6@Extract Criteria in ^?>ډ?>?>?>?>?>`?>?>`?>غ?>@?> ?>?>?>W?>?>h?>@\?> ?>n?>??   % TxjAALtExtract Criteria in % F EMF++@ *@$BB*8CףB6@Laboratory Search<:=3>=3>->3>dl>3>Օ>3>Ǩ>3>k>3>9>3>>3>@g?3>@?3>@?3>.?3>Q>?3>#N?3>W?3>e?3>??   % TAALpLaboratory Search% FtEMF++@ *@$BB*8CףB6@@4/@u?3>??   % TTAALP/H% FEMF++@ *@$BB*8CףB6@ Extract file @}?3>C?3>`?3>S?3>?3>?3>`?3>?3>`?3>?3>?3>A?3>*?3>??   % THAA LhExtract file % FtEMF++@ *@$BB*8CףB6@@4(?3>??   % TTLNAALLP(% FtEMF++@ *@$BB*8CףB6@@4#?3>??   % TTPTAAPLP#% F|EMF++@ *@$BB*8CףB6@H<69`?3>@?3>??   % TXU_AAULP69% FtEMF++@ *@$BB*8CףB6@@4. ?3>??   % TTabAAaLP.% FtEMF++@ *@$BB*8CףB6@@45?3>??   % TTdhAAdLP5% FtEMF++@ *@$BB*8CףB6@@4)q?3>??   % TTjlAAjLP)n% FEMF++@ @*MCףBUCףBCأBUCBUC٣BUC8tBCG_BVCG_BVCG_BVCG_BVCG_BUCG_B*MCG_B FCG_B*AC4tB*AC֣B*ACB FC֣B*MCףB@$$==%  ; 6X@ =>=~~~~~Y$~ ~X4i ~  > i  =<>7jP % $$AAF`TEMF+@@4 ף>@$$==_888% % ; 6X@ =>=~~~~~Y$~ ~X4i ~  > i  =<@6kQ% % $$AA( FEMF+*@$BB*ACG_B@0$=ARIAL6@h\START0?"">C?"">T?"">@|i?"">~?"">??   ( RpArial8ʌwx5w57w$@88; X)Dw=)) w )ww7w`w`w  ~H)`͋ww0 Hw2w`w ~0۷ ~ ~ !dv% Tl<&IAAGLXSTART% FthEMF++@ @H<*/CnCUC5CUCnCUCC*/CnC@$$==%  % V0|( S^ S~ %  % $$AAF`TEMF+@@4 ף>@$$==_888% % V0}) S^ S~ % % $$AA( FEMF+*@$BB*@CDC@0$=ARIAL6@pdSearch#>Ͱ>>Ͱ>>Ͱ>?Ͱ>' ?Ͱ>`?Ͱ>??   ( RpArial X)Dw=)) w )w 7w`w )ww7w`w`w  ~H)(͋ww0 Hw2w`w ~0۷ ~ ~ !dv% TpAALXSearch% FtEMF++@ *@$BB*@CDC6@@4/1(?Ͱ>??   % TTAALP/% FEMF++@ *@$BB*@CDC6@Extract Process 0?Ͱ>C?Ͱ>JQ?Ͱ>1Y?Ͱ>b?Ͱ>@|r?Ͱ>Z?Ͱ> N?Ͱ>A?Ͱ>?Ͱ>z?Ͱ>`c?Ͱ>?Ͱ>h?Ͱ>@?Ͱ>?Ͱ>??   % TLAALlExtract Process % FPDEMF++@ *@$BB*@CDC6@Scheduled Time to Run J >>-V>>>>,>>>>s>>@ ?>] ?>.?>)?>0?>GB?>@H?>K`?>p?>x?>?>@އ?>ы?> ?>?>?>??   % T=AALxScheduled Time to Run  % FtEMF++@ *@$BB*@CDC6@@4(`ܩ?>??   % TT@BAA@LP(% FEMF++@ *@$BB*@CDC6@pdif not?>?>@?>?>?>z?>??   % TpCXAACLXif not% F|EMF++@ *@$BB*@CDC6@H<, n?>a?>??   % TXZ]AAZLP, % F|EMF++@ *@$BB*@CDC6@H<15>?/>???   % TXAALP15% F4(EMF++@ *@$BB*@CDC6@th of Month for EPI>???@??@??[+??B3??);??R??b??@~r??@ez????????`??৙??`???? ????   % TFAALtth of Month for EPI % F@4EMF++@ @$*2CCECB$$==% % V0Gy# v# v# v% % $$AAFEMF+@@4 ף>@H<*2CCUCCUCC*2CC*2CC@$$==_888% % V0Fz# v# v# % % $$AA( FEMF+*@$BB*2CC6@Search PTF file \=͌>D>͌>>͌>O>͌>A>͌>>͌>W>͌>?͌>@ ?͌>@k$?͌>@5?͌>@=?͌>@E?͌>K?͌>b?͌>??   % TWdAAbLlSearch PTF file % FtEMF++@ *@$BB*2CC6@@4(i?͌>??   % TT W dAA bLP(% FtEMF++@ *@$BB*2CC6@@4#ns?͌>??   % TT WdAA bLP#% F|EMF++@ *@$BB*2CC6@H<45 ?͌>?͌>??   % TXWdAAbLP45% FtEMF++@ *@$BB*2CC6@@4)q?͌>??   % TTW!dAAbLP)% F|EMF++@ *@$BB*2CC6@H<, `.?͌>!?͌>??   % TX#W&dAA#bLP, % FEMF++@ *@$BB*2CC6@LAB DATA file `?͌>@?͌>z?͌>?͌>?͌>/?͌>@?͌>@\?͌>?͌> ?͌>?͌>?͌>`?͌>@?͌>??   % T)WmdAA)bLhLAB DATA file % FtEMF++@ *@$BB*2CC6@@4(=>??   % TTdqAAoLP(% FtEMF++@ *@$BB*2CC6@@4#t=>??   % TTdqAAoLP#% F|EMF++@ *@$BB*2CC6@H<63*>>i>>??   % TXdqAAoLP63% FtEMF++@ *@$BB*2CC6@@4)>>??   % TTdqAAoLP)% F|EMF++@ *@$BB*2CC6@H<, y>>G>>??   % TXdqAAoLP, % FEMF++@ *@$BB*2CC6@XLand Updates Laboratory Search>>>>@.?>?>?>q/?>C??>@O?>^?>f?>v?>`l?>_?>H?>1?>?>`?>࿪?>?>@?> ?>A?> ^?>Q?>?>?>?>@\?>x?>??   % TdnqAAoLand Updates Laboratory Search% FtEMF++@ *@$BB*2CC6@@4/a?>??   % TTodqqAAooLP/% FEMF++@ *@$BB*2CC6@ Extract file ? ?'? ?5? ?=? ?*G? ?V? ?5e? ?m? ?u? ?|? ? ? ?DŽ? ?ௌ? ???   % Tp}AA{ LhExtract file % FtEMF++@ *@$BB*2CC6@@4(`? ???   % TTp!}AA{LP(% FtEMF++@ *@$BB*2CC6@@4#_? ???   % TT"p&}AA"{LP#% F|EMF++@ *@$BB*2CC6@H<69H? ?1? ???   % TX(p2}AA({LP69% FtEMF++@ *@$BB*2CC6@@4.? ???   % TT4p5}AA4{LP.% FtEMF++@ *@$BB*2CC6@@45? ???   % TT7p;}AA7{LP5% FtEMF++@ *@$BB*2CC6@@4)? ???   % TT=p?}AA={LP)% F@4EMF++@ @$*/C(CKCB$$==% % V0|   % % $$AAFEMF+@@4 ף>@H<*/CCUCCUC(C*/C(C*/CC@$$==_888% % V0}   % % $$AA( FEMF+*@$BB*/C(C6@`TExtract Data that Met CriteriaD>"r>6>"r>>"r>?"r>4 ?"r>?"r>>)?"r>%1?"r> 9?"r>M?"r>@i]?"r>@Pe?"r>"u?"r> }?"r>x?"r>`?"r>I?"r>@=?"r>0?"r> ?"r>?"r>?"r>ٵ?"r>?"r>`?"r>@?"r>?"r>?"r> ?"r>?"r>??   % TYAALExtract Data that Met Criteria % F@4EMF++@ @$*/C{4DKCB$$==% % V0|< N! ##N! N!% % $$AAFEMF+@@4 ף>@H<*/C{DUC{DUC{4D*/C{4D*/C{D@$$==_888% % V0}= ##N! N! #% % $$AA( FEMF+*@$BB*/C{4D6@XLPrepare Data for Transmission>"r>>"r>>"r>9>"r>@n ?"r>@?"r>#?"r>3?"r>q;?"r>O?"r>@_?"r>@g?"r>w?"r>n?"r>?"r>`?"r>O?"r>`C?"r>`?"r>௡?"r>?"r>?"r> ?"r>w?"r>?"r>`?"r>?"r>?"r>?"r>??   % T!^.AA,LPrepare Data for Transmission % FEMF++@ @th UUB{(DUUB{D*bC{D*bC{(D#IC{%D7,C{%D*C{(DDB{+DmB{+DYUB{(D@$$==%  ;c6*Y(cF&#F&#6*X4 v) v)C 6***c6*=<>Fd % $$AAF`TEMF+@@4 ף>@$$==_888% % ;c6*Y(cF&#F&#6*X4 v) v)C 6***c6*=<@Ec% % $$AA( FEMF+*@$BBUUB{D6@l`Process Verification Report if =}>].>}>AT>}>ĉ>}>6>}>>}>K>}>>}>E?}>>?}>@*?}>@3?}>9?}>A?}>H?}>LV?}>f?}>n?}>@Wt?}>?}>`?}>?}>@6?}> ?}>?}>?}>`?}>࠸?}>`?}>@?}>?}>??   % TOq~AAO|LProcess Verification Report if % FEMF++@ *@$BBUUB{D6@pdNeeded@.?3>2?3>B?3>\R?3>@.b?3>r?3>??   % Tp~AALXNeeded% F@4EMF++@ @$UC{4DLCB$$==% % V0t#N'#))N'#N'% % $$AAFEMF+@@4 ף>@H<UC{&DUC{&DUC{4DUC{4DUC{&D@$$==_888% % V0s#))N'#N'#)% % $$AA( FEMF+*@$BBUC{4D6@xBuild HLr>"r>Uj>"r>Δ>"r>q>"r>>"r>>"r>>"r>N?"r>??   % T|!GAA!L\Build HL% F|EMF++@ *@$BBUC{4D6@H<7 ?"r>"?"r>??   % TXIOAAILP7 % FdXEMF++@ *@$BBUC{4D6@$Message for Transmission*?"r>@B?"r>\R?"r>`?"r>n?"r>~?"r>8?"r>!?"r> ?"r>?"r>?"r>?"r>?"r>Q?"r>?"r>?"r>?"r>@?"r> ?"r>?"r>?"r>7?"r>_?"r>H?"r>??   % TRAARL|Message for Transmission  % FthEMF++@ @H<UC{CDUC{CDUC{1DUC{1DUC{CD@$$==%  % V0B 0c0F,#F,0%  % $$AAF`TEMF+@@4 ף>@$$==_888% % V0A0c0F,#F,0% % $$AA( FEMF+*@$BBUC{1D6@ Send Data L=͌>=͌>U>>͌>}>͌>q>͌>?>͌>U>͌>>͌>@c?͌>5?͌>??   % T_AA_ L`Send Data % FEMF++@ *@$BBUC{1D6@THto G>>>>>>??   % T`s}AAtLTto % FEMF++@ *@$BBUC{1D6@ Recipient= ?%> ?Gd> ?> ?9> ?ܺ> ?> ?#> ?c? ???   % TbAAb L`Recipient% FEMF++@ @@C=D@C=D;C=DC : % $$AAF`TEMF+@@4 ף>@$$==_888% % ;(c/6c/X@ Xc/"/..XC.C.C.C.C.6(C.X4C..."/c/(c/=<@;% % $$AA( FEMF+*@$BBC9D6@\PStop >">V>">xv>">ߚ>">??   % Td+AALTStop% F@4EMF++@ @$DB?CG)B$$==% % V01-% % $$AAFEMF+@@4 ף>@H<DB\0BUC\0BUC?DB?DB\0B@$$==_888% % V00.% % $$AA( F\PEMF+*@$BBDB?@0$*>ARIAL6@-AUTOMATED EMERGING PATHOGENS INITIATIVE DATA v=.>l>.>>.>=>.>N?.>8?.>W?.>q?.>?.>?.>l?.>?.>m?.>?.>?.>?.> ?.> ?.>J@.>@A @.>^@.>@.> @.>J(@.>0@.>8@.>@@.>G@.>`N@.>Q@.>T@.>r\@.>pi_@.>pe@.> h@.> p@.> w@.>z@.>@.>&@.> @.> |@.> V@.> @.> r@.>??   ( RpArial@0w:w )w 7w`wX )ww7w`w`w  ~H)`i͋ww0 Hw2w`w ~0۷ ~ ~ !dv% T\<AA<-LAUTOMATED EMERGING PATHOGENS INITIATIVE DATA         % F EMF++@ *@$BBDB?6@CYCLE FLOW CHART;?>?>?>F?>N?>D@>P;@>2 @>@>:@>@>`(@>+@>B3@>:@>B@>^J@>??   % Tl(AA%LpCYCLE FLOW CHART   % FthEMF++@ @H<UUB{9D*C{/D*\C{9D*C{CDUUB{9D@$$==%  % V0L b.C + b.C 0b.%  % $$AAF`TEMF+@@4 ף>@$$==_888% % V0Kb.C + b.C 0b.% % $$AA( FEMF+*@$BBUUB{X2D@0$=ARIAL6@ Data Correct>>>>>>x>>?>u ?>?>/?>J9?>B?>@R?>@`?>??   ( RpArial:w )w 7w`wX )w 7w`w)ww7w`w`w  ~PH)(͋ww0 Hw2w`w ~0۷ ~ ~ !dv% TsAAs LdData Correct% FtEMF++@ *@$BBUUB{X2D6@@4?@h?>??   % TTAALP?% F@4EMF++@ @$UUB{RDCA$$==% % V0FKic4c6#6#4c4% % $$AAFEMF+@@4 ף>@H<UUB{ ZD*bC{ ZD*bC{RDUUB{RDUUB{ ZD@$$==_888% % V0EIjc6#6#4c4c6% % $$AA( FEMF+*@$BBUUB{RD6@Make Corrections>">>>">>?">>J?">>@&?">>@.?">>B?">>_R?">>[?">>Qe?">>#u?">>@?">>?">>ʈ?">>?">>`?">>??   % TjR_AAj]LlMake Corrections % FEMF++@ @@4 ף>@, *C{CD*CR QD@$$==_888% % W$ FC 0C I4% % $$AA( F\PEMF+@<0CqPD*C{RD|CqPDCqPD@( $$=='%  % V,CK~ :4C 4 :4~ :4%  % $$AAFEMF+@@4 ף>@, UCCUCpC@$$==_888% % W$.CSS% % $$AA( F\PEMF+@<0`lCCUCCKCC`lCC@$$==%  % V,@HSv%  % $$AAFEMF+@@4 ף>@PDBcD""B{tdDUUA{tdDUUA\CUC\CUCH!C@$$==_888% % W4-8*99BSBS% % $$AA( F\PEMF+@<0KC CUCC`lC CKC C@$$==%  % V,'0S~%  % $$AAFEMF+@@4 ף>@, UCףBUCB@$$==_888% % W$NcSS% % $$AA( F\PEMF+@<0`lCBUCףBKCB`lCB@$$==%  % V,`hS~%  % $$AAFEMF+@@4 ף>@, UC#CUCHa/C@$$==_888% % W$S> S % % $$AA( F\PEMF+@<0`lCu.CUC5CKCu.C`lCu.C@$$==%  % V, S^   %  % $$AAFEMF+@@4 ף>@H<UCnC0CnC0C,CUC,CUCHa/C@$$==_888% % W0GG S S % % $$AA( F\PEMF+@<0`lCu.CUC5CKCu.C`lCu.C@$$==%  % V, S^   %  % $$AAFEMF+@@4 ף>@, UCCUCC@$$==_888% % W$SS% % $$AA( F\PEMF+@<0`lCzCUC(CKCzC`lCzC@$$==%  % V,S%  % $$AAFEMF+@@4 ף>@, UCCUCRD@$$==_888% % W$SS % % $$AA( F\PEMF+@<0`lCq]DUC{4DKCq]D`lCq]D@$$==%  % V,  SN!  %  % $$AAFEMF+@@4 ף>@<0UC{DUC{tD*C{tD*CRxD@$$==_888% % W,:`S#S$C $C %% % $$AA( F\PEMF+@<0Cq=D*C{D|Cq=DCq=D@$$==%  % V,]e~ %C F& %~ %%  % $$AAFEMF+@@4 ף>@4(UC{DUC{DUCRD@$$==_888% % W(Rzp#>%>%&% % $$AA( F\PEMF+@<0`Cq]DUC{4DK>Cq]D`Cq]D@$$==%  % V,tm|u&N'H&&%  % $$AAFEMF+@@4 ף>@, *C{(D*CRX.D@$$==_888% % W$C 6*C +% % $$AA( F\PEMF+@<0Cq.D*C{/D|Cq.DCq.D@$$==%  % V,~ +C + +~ +%  % $$AAFEMF+@@4 ף>@, UC{&DUCRx/D@$$==_888% % W$wz)+% % $$AA( F\PEMF+@<0`Cq=/DUC{1DK>Cq=/D`Cq=/D@$$==%  % V,t|+F,H++%  % $$AAFEMF+@@4 ף>@, *C{CD*C{GD@$$==_888% % W$ !C 0C 1% % $$AA( FEMF+@@4 ף>@<0*CED*CED*C8JD*C8JD@$$==_888% % W,+ l1C l1C 2 2% % $$AA( F|pEMF+*@$BB*CED6@H<No=>r)>>??   % TX%AA#LPNo% FEMF++@ @@4 ף>@<0*\C{9D*nC{9D*nCH;DCH;D@$$==_888% % W, b.b..1.% % $$AA( F\PEMF+@<0Cq]:DCH;DC{4@<0*cC@7D*\C@7D*\C;D*cC;D@$$==_888% % W,3- - .3.% % $$AA( F|EMF+*@$BB*\C@7D6@THYes=>I>>>>??   % T`AALTYes% FEMF++@ @UC{taDUuC{taDC{taDUC 2`DUC{^DUC]DC{[DVuC{[DVuC{[DVuC{[DUuC{[DUC{[D C{[DUC]DUC{^DUC 2`D C{taDUC{taD@( $$=='%  ;7^86^8X@ 3^8 87F7366666676X46F77 8^87^8=<>Ho % $$AAF`TEMF+@@4 ף>@$$==_888% % ;7^86^8X@ 3^8 87F7366666676X46F77 8^87^8=<@Gn% % $$AA( FEMF+*@$BBUC{[D6@\PStop|>">n>"><>">o ?">??   % TdmsAAm~LTStop% FEMF++@ @@4 ף>@, UC{CDUCR8ZD@$$==_888% % W$w zk06% % $$AA( F\PEMF+@<0`CqYDUC{[DK>CqYD`CqYD@( $$=='%  % V,th|p66H66%  % $$AAFEMF+@@4 ף>@, UCCUCC@$$==_888% % W$2 5S>>% % $$AA( FEMF+@@4 ף>@<0UUC`CUC`CUCqCUUCqC@$$==_888% % W,)$?++% % $$AA( F|EMF+*@$BBUC`C6@THYes7=>=>#9>>??   % T`",39AA"7LTYes% FEMF++@ @@4 ף>@, CGCUCGC@$$==_888% % W$P~ ~ % % $$AA( FEMF+@@4 ף>@<0C?>CUC?>CUCPCCPC@$$==_888% % W,    % % $$AA( F|pEMF+*@$BBUC?>C6@H<No L=>.>>??   % TXAALPNo% F@4EMF++@ @$B`DCA( $$=='% % V0I89 9 88% % $$AAFEMF+@@4 ף>@H<BfDYCfDYC`DB`DBfD@$$==_888% % V0H9 9 889% % $$AA( FEMF+*@$BBB`D6@ Manual run>"">?"">\ ?"">@.0?"">@?"">O?"">#V?""> ^?"">g?"">@Uw?"">??   % TwAAw L`Manual run % FEMF++@ @@4 ף>@<0*C{ ZD*C\DC\DCl^D@$$==_888% % W,g{C 6C <7 <7 7% % $$AA( F\PEMF+@<0.C1^DC`D C1^D.C1^D@( $$=='%  % V,xS 7 87S 7%  % $$AALd)??" FEMF+@ ObjInfo VisioDocument zVisioInformation" SummaryInformation( ( 6)( Visio (TM) Drawing zOvRR `@ `@תl !fffMMM333UJ:DT5I[1hXT@. /UbW##_b0zGz? L\&B1r&b%UoMhd)P? ;$ A) & , %&!.%D//M$? ,0Aq z*,,,'a/6 6) q+} \)P?z"  U UA3` 0BTfx$)- <\ ?TAr /LP#i v$,%b+D'?K4!5e2:CG5CW5Cg5CG R /D$#~U åu##bCi (f1G'0@UHε%E0> (f? OCXݖ3!{ߍC&9Q~ å345{&6:Djߊ9G/!%3BCD9H<^1?C?U:a6?Ot`smURЯ}%7-BkkvOa:UhBi89etDzT?iæ`R`dH khd1(@1Ti1 7%Uh.6/?&R"k%h-s0zGzvIQkG@QmQc8]&aʎ/(*?6$8{ LA"!B?9O+I?Ocu<$7I7/!/3/E/W/i/{/?//\!_彜s2q`?of_?&O%?QfB4K|K|Kw/V; oOOC419VooooI]T 2vZEtf nb_____/څo`sX%7U Wb6峀yC1fG_⇤00@r ߝ??r䍵*<@N`˂䍶k0<33ib hbia gB" kAAkɱɱֱֱ$1k  ukuu01k$KKYuYeeYrr2qOONI7/HOTf`څ_[_%*[܋IU YU{bY"~ȧڡ ,9ϫ qώ@+=Q_}=߮0O_贁Nk {Z%*>.fItyFO0Ҕ@3EWﴮJ~'JuFf.[]Fiao-o7߃M߹q߃y+ÅF -vcu]F_//,/>/P/b/////////??(?:?L?^?p????????CO(O:OLO^OpOOOOOF_OO!!_3_wb_t________oo(o:oLoůjo|oooooooo 0BO_xvX_,>Pbt2ҏ,>PbtΟ̿(:L^pʯܯ %7I[mǿٿ>c);'vcuϙϫϽ );M߱i{ߟ߱ /Aey&8J\ nE+=OasSe!3EWi{]f/'/9/K/]/o////////Qc#?5?k?}???????? O O1OCOUOa`kO}OOOOOOOO __1_C_/jk_}__K?_____ oo1oCoUogoyooooooo -?QcueS U#5GYk} ŏ׏_);M_q˟ݟ?%7Y?mǯٯ!3EWcmǿٿ!3E4fqtw|ԎϠPb?z@p˻s .@Rٻrcu߇ߙ !"4FXj|ZXp +sIk} fA$6HZl~xr'P9Kut?eSƩPNeR/,/>/P/Daz//////// ??.?@?R?0s???Zu??BTO/OAOSOeOwOOOOO aOO__&_8_J_\_n_____Zrq_oqluooooO@aooe1CUgy -?QcuϏ*T@h]]9 ֍UA@ ??Pn6 u` u.A.@(.P8oPMJv5 LƱ5 y`7CoprigTt 19 " Vso r!!a !nU  Al< s@"e evR dU/`#_BFSUcTm!#2N"68b! g#a-M ?9@hl>]Uhz  5MJTH : :b26x6 2o2M4 =? A%O/O9=AEaK 6xM=I 52O;rA ZRS b 'I1eg_j]__k<__qZ(bA jF@L?PfPf1 OC=aMRbO\onlCo:dIdoo%`g%kjFa3m=_Tn+THM!."J!vap  P`"`s c c,E2 t*V"  hR } U * s o} i*"]! w!% rS!s`#"`Pa>1NdvamvDu(*c K R ^ = fˊBea":% nq` ERR"o<ރc U:V 2 u b|pR lQ!qm w =_H'+D !OyaGE_5>F Ow#PMB R=aT@o@$OoQC?"4aTAVp_ ! "$'%*4&A UFDfP h TPYYmVUA@ ?I?3P?ȅH?>P {?%0e^ T 4BoV4!2wA"V` FlwcPaort V`n!u )G  ?wpT]pK?w6]This ymbolrep s nttetUa to d1faog a Clw.$vNndmb?ȿ贁Np:m??54 HD # =ih 4>T  ;TB'AUA@ ??]Q6 BA >pY, u` Ut]Yq2q 7]<g BuLJU5 L`-/ @BIHBBH%%!BJ"]HMI-1245 y"`7CopJ0rigTt 19h2 V\0s\0od0S1rV01ab0w1n.d0 Al0 Z8s2et0eZ0vz0d0/`q3_BFS0cTm!#22851'7[ 305-M93 97 ?9MBhrl>AUh@hE MJX=& "s#b}Hb !1=S"qM(9'*Ys'rF#78ѱ_K*F y?P&'r=S3brdR #H*LU/PU#Q5SA$ _N sX<3dTPc#QS_0uof'2eeBdN`]ooa3br mhe7+TMt" r2J1pM-5-1  @D`S1sRcL3,E0t2 b0h0 T0N 0st0o09i21 w\0kis1 V0r1s 3B`o 4 %@A35<EODu:0KL3 _ 0 T0fPeV02 5؏<A` R2o 0UL3:% 0u0IbdKp0U1lnJ1q i2tx2smct|k bqH(b!}y V'/Ar/%$bMJ$ӯ%#w.3dmt$ig5phsBŸ8Qe  %}sAY'AJis1?9=I!3 '%Pr2~3bb %Hu+$K !OyaGEF>FlO#M{B DQva@o@Co4aO oUFDfP h TPYYmVUA@ ?I?3P?EVVȅH?Oa ?0e^  H!oVE!2R"V` FlwcPart V`!u D??!?T pNsNp_imƉp}wv|lcY?~This ymbolrep s nUtad cino wrt'ngtp f%uc..HD # =h4>TB]]9 B֍UA@ ??Pn6 u` u BAE ><1XX,2<<sYT^MJA @EEUrJY-j#%q)-@"s$@ 5 ^?L)Ƶ145 yO"`7Cop0rigTtq 19<2 V00s00o$q '1r*0S1a60K1n.q AUln0 .8sr2eH0e.0v0df0[/`E3_mFSf0cTm_!#226<00'[ 305-)M 3  7 ?9 Bh,*rl>1Uh@hE T!MJZ Ll0!<$b(M/' B(RJM(: @8)+ TbP>U%N[MQ_>UN_:i_{]Q>U2OUrA k\bbc"( b qH(b! *F@Inf&f #_dMR_|%=#T 9w%K{\Xd0vy8#w"S#:v%dumhhek +T!!MIƄ"ӄ"J1 51>]  `2`'1s600cV 3,Ed0t2 60h0 0$ \0sH0o0i\21 w00A?G1 *0rdX1s32` 4ま%A zDuZ:*0K 3 5 0% (0fp&e*02߅%>^"` R2oT0 3: d0%u0b:!p0)1)lD1qi2etL2Imˤ9qtRk8 z$%A'dA Ji? =I!3 %P~ơr^2\bb %mb?ؿ贁N8i6??54  ~&8J\j oH+E !OyaGE6W>FOR #PO!B CM""ga$@o@̯OoĽC'4aT܏IBaUFDfP h TPYYmVUA@ ?I?3P?EVVȅH?Oa ?0e^ * E!oVE!2R"V` FlwcPart V`! K?$6߈kdz:< This ymbolrep s n]thuaad%be2t%,uEc %iUe1 upk.mb?ؿ贁N8i76??<k4 HD # =ih4>TE=T'AUA@ ??]Q6 j A  >A 66  T(mu` WL(YA<iutJU",!#?P6 @jpur(jp}bi%"ru"*"#)񉄍5 +@%?1D45 yU"`7Co}p\0rigTt 19z2 Vn0sn0o e1rh01at01n. Al0 l8s2e0e vz0d0/`3_BFS0cTm!#2270197 3F-9MK3 K7?49uh<$:l>aUhz $1jMJS$O?!B$bU"i%#Z9RZM(a#Z(8_:R#GPyU05[[Q_{S EA3]0_UJ\!2c#.'~&C0>/|J\s/}B)Xf$A#_gmo8JRrA VPJTLro$qdAAeP E9 Mjdzf0euf?F /P:3p bi#8_UAR #(qH(b!Py Fjc@\?L2 QjY-MR_5C#bs1%Rj|c Z'q2cA05 1mo5PԟJo0LJAe{+BT11Mܤ"T!T!02J Aˠv?5?1" s B`e1ist00c^3,E0Ut2 t0h0 0: 0s0o0i21 wn0WUJ1 h0rn1s3"B`; D%Q "(1Du:0K^3 RK 0 f0fBm w =_H'wE !OyaGE7>FASp(#Il)B UI]maO@`*@+,Cd5a4BS홁IPI?/paUFDfP h TPYYmVUA@ ?I?3P?EVVȅH?Oa ?0e^  H!oVE!2R"V` FlwcPart V`!u C?{&2 NopZZdZr?Wup`ڑetxWp~ vThis ymbolrep s ntayocp rufredb#a5sn.H D  # =h4>TB]]9 UUA@ ??P6 u` )u LA ><1XXUB2<<}YThMBJ =@bwrrc/| {)-@"}@č5 ?-,@%Ƶ1 45 y\"`7Co}p%0rigTt 19C2W V70s70o?0.1r10Z1a=0R1n.?0 Alu0 58sy2eO0e# v0dm0/`L3_BFSm0cTm!#228HA007 305b-)M3 7?9|$h,*l>1UhhDE !M"JM L$%# Y P"RM() LF'rAH"m w =_HuI !OyaGEB>FDS0#CP1ݮB S2^a?@3}@ES +C74aTlI18pUFDfP h- TYTYV[U@@??I?R3P\VȅH$нVе?J0o^ f2V` Cn ectr6 V`#! " /""eV* E# ^   -}|5 p`I`V?}`xa833ސ]3σ3u 33?, ?Gxpx^& This coUnetrWaumtUcl#yrebtwe h *hp3is.b?2jZ/0? HD # =hj8T! ]]9 B#F U@? ۿP6 u `u bA@u  J 6Q+&LBF u`l?dpz)u-aŝJ@%-?jtG'jQ-p{'H( 2rqǿ?@I ϵ?$%? @S2*=L  -br f~j~282u .2284~2ul9BhLHK/M#IAD5 /`Vis_BFS.cTm!w#2MB91y!`7CopyH0igTtk1S@yA Z4Cid@ cArf@RAar@AnA@ kWAl@ jHsBUe7@eH0v@dA@X@B0#A G?9#3G,/A%0E+4Pv'~a8l>$Uh~E 񹉤\bJ4*1 4b2 4b([ kP jcai e59 :UVTg'2"q V!(=QE m`K2pWH!N !OyaGE_L>F4ISN9#ԔIV:w7OB I;fdo@{+C"sLJS<#PUFDfP h>$/T 6D U[UA@??I?R3P O @DVQVs3ȉHй{?%0e^ T Go/!2ԫ"` wFlO wcPart `!u σ } 0_O d 4=LH] x~ x^x`_iݖAnotain cl o]u frumkngNes 5Up3cfc6&8Uwhr.bܼh` ߶`?? t@ HS??迴N32IUGDF P# h8T PYYB z0UA@@@߀a??Q(-DT!?^t` u`u u`h?uu ` uBYY' nCQ ap^ TW]gg{{fqRʉ][X:{$Z".8/J/D#o/w d%%7+]L"ʞ^ 56BW% Bml3#g tNYs+1ҍ2 <1l1t7y`7Co}p0rigPtg19 B V0s0og1r0 Aa@An.g Al;@ 8s?Be@e0vQ@d3@ /`C_BFS3@cPm!#;2B94 i7#hA0E>U\]ehaM%6! qH1Q=T HWpXda_[91TkkZS@A&9@Bt.b'P -a;P'5`A]@ju@ABN'BckQ@ALQ@%n0tP2dO, __6;AX?ahhDDMu "qdC`:Prq@PQr @BD Adqp! cucT?vvE *4q" zdAb4p)2HD: # ;h0>T@h]]9 *AUA. 1?A@AwPMΊF@>u `u bu  -R :u` ?Vua"@0S >a@J5@aۿ?A{@#t(^ bt("+p YG(X'.'$/ "'/"/ B#U0O贁Nk?<L>3f`aJx7~145 y`7Cop0rigTt, 192 +V0s0o, 1r01a01n}., Al@U 8sBe0e0v+@d @015)2>3#LM!#$&-Sl>!UhDo5= L^BMJaB^tB!4F'_HD # =ih0>ThE=xAU@a?A?Q(-DT!>#t`  ?tTw@uLMu.A?1P `u ?a>V\ A 5 >8Y%J!U5 #$@#~/P6 @`Pf|`)s9|6u/z %9""2@#K~2aFSW"0-#@# `a."7145 y`7Cop@rigTt 19,B V @s @o Ar@CAa&@;An.  WAl^@ HsbBUe8@e@vt@dV@0 35l>, >UhB{2MJUCx$XИ'49p Y$F3#l( {'AV6YRUo5AfYiVe#VQ5# \WurA ." dAb59 MAP8 Pobh( 3?~fP-#jl8heoi@8oo42TTTe /q!GWof t.ttt@Ux&Bb@x aT@Ud ilDa8@s@Qc @MAA ^@iT@1qqcrBsquAAqr dt@}sq @ou`rdfrQuWAT LS?w#ԀP@ݴB QAqa?|@ Bh@+gT@G$MSP|PNSBOSU't40uAf@6i&@ zL M}C-$@7 "AU 't40uAf@6i&@ DzLiM}C-<@}7 "AU!'t40uAf@6i&@ zLM}C-Ę@7 "AU"'t40uAf@6i&@ zL)N}C-@=7 "AU$'t40uAf@6i&@ |LN}C-@7 "A%t40uAf@6iC&@ gBNUA-37 ;Y&'t40uAf@6i&@ gB_EO A-D@O7A @TOMJR@OMJR@OMJR@O?NJR@4ONJR@lONLR@OQOHRH<(H<(H<(H<(H<(H<(H<( EOmP RELOzP REOP REOP REOP RE,OP REdOP R_X($T OݫSCq3B~!O$/"DO'S@SR0SdDS8/"HS8?SKS?JL/OOPDܟOP rh;y VU@ @w "*^p? N(C*ԁRROCU+` ,0uAf@6i@ LFDNTyB@ uh$TB jUI#w@I+&@?[?8I?J P 8/41 2?s u ` """u ); ( 2y&в.ؕ.y(sU!`&/ o!! &f O1O1 ` Fl wcartm0 p2 v?285H?Z?l9C n0e 0t r?2?4Ue">A>A uk *4 A* !UR!p1 4!A# HAT [ T [Tu [T}A [}AHA [AHA [AH1 [5T A [AH [AHA [ AHA [TA [AHA [AH! [AHA [!HA [AHA [AHA [AH [AH! [HA [!H [AHA [@HA [AHAG ZAHA [AHAEAHA [p1H>A [DAH#BAH&BD!%T) ^ET* Zu P>A!!!!({ AAAAu((}AIIA]EA1-֑AA A1A.ơA%$A/1B0>A11KA2XFA3eA5!16A78A9AA>88122(AI*u.@R QU}uCc}AE z&" }Au"&XuE8@@N贁%@2.z'Q cf"*<AuBSzdb4`Mq֑ƲM  K~A4Bt0>Q"{?m߰SY Tp1p1AA AAAAtSoARo iC &X'2qP.D! % lzH>sݐAUiOWŊA?b#4-L?s!$&\'U. q~DHB uEfEHdESAǷA²'*FZ%ZWnDDA0'$v QsedcşkQ߹ gݵ 3(:!U$LAԞzuEB˅aA6 `,8J\n\U|ߎnťO/7Im3*6bYbz_07K_^_JU?.?_!+/z]o@o 6!378[4s[o;@<:[8Zk_Defnp tܰSparcܰ/b0x rc C*i e1aqw Lbo%EtMy!lU(6.)AR/v/#5GYN!ͱ/,/U//道?Bo\??U!LL?Þ$Pj'j(x}o`@o_o:M/uo?7I[`!3BTfŝg_y_R\?V^Q@eq"66fbf"Zba%1'o@1f61$11lGĊIf'?[@Ur?   4A14[q 1yvR,tASXld{Vp΂ ?Q e{`7A7+ρ1iOgO*OxU]7@(A SUdPsooZl~_<5б $ݻDa C* "rc ?( #5GtQQu 6oGOOL 2K:6oJDHK.RwOCMNXj//]/o//*co!5MxxhßF$Jȏڏ/Gj1 4@32?>=V9/!n?:R5,J8?3 @@Y"/?@ ?Q(-DT!ʇ㝶Xxy0 ]@ )pp5/ @z3s_@(O:IZp t`QzsOŜve_O@OHJN_YeW@Cs 助?4UבgrCc>1s~ ` `n["4F߇?QH߿@g?aBFDt9YOv>pcaoPX/v0]g?A(Jh1*Q< ?*Qj$?Gbeb?3?Y?avelUo@8D@Z6=5? -S#?a+=asC-0]b?VS;Y9v5 x&y4Rdv<kcߧQv1foxoo'o9oKo$ "]E-:!p//??&?8?J=S?u=4JZH@?ybx$?AA I]O0OBOTOfOJ_OO%HOwW$ϥ_UlSnY軱H^a4FXoĺbaAܡoct7 uVq/c: @@A tp&T@@@i6]x O~(яaղՇƑv1Οz(<V|Yi?ίX<_H"Zl- ޿#(ಿd$$ !N+AWTOM#TDĠEE? GIN PHGN% I IIV.!AĠCYL F OWH#R E Es\/n/X|Np'K2U"š!D NqQqj|]b_S?/1 H e?);xU@q[@?@:m6uVTӉUtE2SSrBrASF*WVFB A 2o{{l~5_5+=OfssEcotG;onEo O!OVho@o/mLp#ϰŅEW`PO $2?wKaO~şÆ>Makeorec:insÐ/P?b?/?#?5?);}?6۝AXL^cA1 a?3w=14+!Y5YQXCMsYM 俱vťԿ3uﶀ@ujP`u0`a|Xꥯf@ @ZLn@)p1X_;0@z3Y_qp1þqCF"Ba[hЦ쐢ޠ2r[B?@IP?FRNſ2EsBx&O& vQQU]_oP1sUFaa.Kʄ QW^c,Q81_!W tN 1zs Һ1w]@SewՔqq} -?Qu/&ƓP?);MBN?@@6i?D @u~ `u = d1z !XpY4GAOOZ!cFOOfAFWAV aW/y8޿@Ð?@oEu_);M\VBlfpRlf5G}YX/ƑA/?}Ƒg%3y"?7)o!G11Fe//-x/%'}'}Π?~Kq%%V G1 P?i6"ue%6`FezE.4&?ń??c;%y?????cu%BOTO(xAL$GuF_EWZa*_ ȁeY{_/___ oo/oAotȅdž&oooo}9oȁ/ȁg/y///B >8@q ςΏc?1CUdg>oQ#Ɵ؟mtx!#ECO,S1CˣZk~s'9K]oGɿ;edspc-?Qcŀo#%sks%7ߎi{88#3&ߍ/,>P?8 V"U *O5>4>5ˠi?߸ߟ?@@q?BS!ZE&//'CZE@6,???yB!I<6D7M@Au);_q4F2SF+eZ*hA^Kh!l_]!i,VmogE>oȗ|O'XiL,wro // A u/Q%0cAl/~///cٱG :8 @94hqӕ:U?9z?29 ?i/?OO*ODD]OoOOH5ObQpOD__$Vhq}sL_\_aFgcY]__o"o4oPvdo|og{oo#5GYSLV+|ӎà +T+AO l MK7Jt{ŏMu$HZl~OOCOO +UHW=X dKjj_Gog"Ώ3>%Je Wt(J`/CѨEStop q2r3C0ϊF^`i߶Ŀ2r`!?@I@?J4EgiYƪޕ*1.afUaq?O.BbqrF2iaB%WyC# ao}gι" tN "!zs& 2Rda;S/^qlp_\yq? ޝ8JV @_,ŒT53g Lg+o (p&VkGt%so0DP!\ E0?<ϥ.M :u B#ut. ?D?-?Q?,>3VhED1T8_#_5_OC(aC===lOCe)x-tB%DbXp x̗ޔ! -paQM ` 7`?oYax@i"fp?ap3¯T3jcApI-tjXT'Rh/!hUͱq@u^Q̇bie)0^UP /r^Ydvϓ,-;D^S{/u$W1L>_Njo8o  ,8/+ޔvuu/A^TA^U%?c2)<ѴHA^ޟw߇-$6 \U_ܥv)>gm0G.ys$ %Ys"esǙ4?aa@ amaEqz$ ĀkLd%&@ڇ2u`u|0`d3}/p u%fwn6s6kr??P6?1?>sP҅BGzi(2rq?o@Ic@?YD%aEcKhe@ M si 1Hu7A!V%BU!Vhb́ɏۏ퀜1 1  5!!M!%ɟ៙YE@n*6Uv:q-<҉H Bұtµ-KE!ySe-׵-*9=Lh9uuMaWnul0rn@0mKAOO'+C1KBH>K9n4OH+1C\׳1shseZS4w9!5@ t @~﾿2r 2?@I@?4E'9Ӎ9Mdt@5A`1exA6aCO.^h%W}C ׳8ߑW" tNOu zs& 6R5?S[aU@p 20?i6hm&f57gQgjUU !U"#$%U&'()U*+,-U./01U2345U6789U:;<=U>?@At4'0uAf@6iC&@ R&C-DlBU7 A@RSORH<(E SS3 R\DSSS1<L@?dRS.PDRS@.PU1( UO"D&aUAUNj )h"T} U+U |ɉB&Q- -H*=(XiwEQ//,/feArial UncodeMiS6?/?`4 R$fSymbol$67fWingds*7 fEArial"z@D/ R$fSwimunS$fGPMingLUj (  R$fGMS PGothiqcj (  R$fGDotum"j (  R$fESylaen  $fEstrangeloU dsa@`9$fGVrindqaj (  R$fEShrut1i$&<fEM_angl$$%>fETungaH"@&>fGSendyqaj (  R$fERavi"&5<fGDhenu"j (  R$fELath#&<fEGautmi &<fGCordia Neqwj (  R$fGMS Farsiwj ( _ R$fGulim"j (  R$fETimes NwRoanz@D$JUEBTJUƇ.BIU%BdIU5BHUN2BtHU=BGUCBGU9B GU97BFUp=BFU:BEU'B,EU"BDU0#BB@U8B|@UGBGuideTheDocPage-1$Gestur FomaViso 90Co}nectrVi}so 0Viso 01Viso 02Viso 03Viso 10Vi}so 1Viso 12Viso 13Viso 20Viso 21Vi}so 2Viso 23Viso 50Viso 51Viso 52Viso 53Viso 70Viso 80Flow Nrma Hairlne.Flow cUnetrtx ProcesCostDurationResourcTerminato DecisonDocumentProces.8(Manul opertin*Dynamic onetruAn_otainRow_1Proces.2Proces.5Proces.6 Terminato.12Proces.13Decison.9Proces.14.Dynamic onetr16.Dynamic onetr17.Dynamic onetr18.Dynamic onetr19.Dynamic onetr20.Dynamic onetr21.Dynamic onUetr2.Dynamic onetr23.Dynamic onetr24.Dynamic onetr25.Dynamic onetr26.Dynamic onetr30u An_otain.31 Terminato.27.Dynamic onetr34u An_otain.35u An_otain.38Proces.41.Dynamic onetr42BB3!L G3!LG3!L2G3 oKG%G3"VlG3"VG3#VG3$#VG3D#VюG3d#VG3#VG3#VG3#V5G3#VNG3$VgG3$$VG3D$VG3d$VG3$VˏG3$VG3$VG3$VG3%V/G3$%VHG34oKaG3D%VG3|U+G3d%VĐG3@ܐA3!LE3%VG3%V G3%V$G3%VBG3&V[G3$&VuG3S(G3S)G3D&VG3!LE3d&V G3&V'G3&VBG3\oK]$G3&VG3&VG3'VG3Uؒ/G3U/G3$U6/G3\Ue/G3U/G3UÓ/G3U/G3?@AUbU U UUUt40uAf@6iC&@ <TޛNC-xB_, A%t4 xB_ A-@7AJ@U6QR@4U6RH<(H<(JEU REU RuAM1AM1UPTPT1h/ "L?C/$"LOC/<"LbC/T"LsC{  w"4FX ,h(9j@([05m竔(@z cK@P]BO P OkU`L#%<L CfBo@OQR$yQSZRI!1z)*',RSrh1UUҮ U6wP2D T?OUɜ'"D?lUH%a/.5xerPreferred CustomerMicrosoft Visio@@/3՜.+,D՜.+,| `ht  DMPC Page-1Process Terminator Decisionr DocumentrManual operationNDynamic connectorN AnnoDocumentSummaryInformation8 @1Table[3SummaryInformation(DocumentSummaryInformation8(d]tationn PagesMasters(`ht_PID_LINKBASE_VPID_ALTERNATENAMESAOh+'0  0 < H T`hpx Department Of Veterans Affairs Normal.dot475                          ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~   zoO8Nxju $x} |ELE$@& !$=Ba VýȱFŸDDqVkAADXDE*KUO:cgfHz&c߮[^U:Z L_Bia<{"EH_ʋX^zҙ:=uv8^Q ~A3w1~_3 tMoB1=NeM+n:ۻ?*\м5<2dϖ!6ఌC_#PzH"Om4hx>Y:x5_͢=yx\^=%!p+q,Aj0ZUe#K)<<ŖV MęFvDV1rxVu)h3@oX&FR[3akx'aB3HCGK9œ.:m2xR@QOq sdODZaPgZ&/GmuqYļo{4G| C C A?~Q;Z.cTv,[UeAk! 7JVC%0xHmcÏsEd/c^%0?kCH' >Y;Y$FӤ4{L8QLSO?SQPd(c1BEPt1rh˧L-0F<-|FQ%7>_3>hy_şO+;z$;zu@me}d"{é hߖF0-_ pO ,'!/o24>$aiV %u%*qÈtuЭS7֕vq]Э.gӕrm'Mn4 |<uЭZ>`,Ŏ@~=).Bџ A% o V&Ļ K3v}b?tC9mCB9rtP"8ՅZMm>r|f+E&GQ?@`>GT 򱈺YuCgO"ļ8P[8d6 .2R<΋ /𜞮;qD漛ded'\8םntE711N1.C,sOp>&(|VlulF!6[]ŋyk2|4-]\ƅ S> {d~ǭ g> ̟ZObmQHvB;"1:ΨP~:U˨3PwR|DXu7ko4CdZЉi|HI ^!e^x.?O.oRel;^l2.v^m-Z;;onn%O҂${ا\>xMi}0˥ikIB:i`Y)"8qxg6b6f[=v`/>&ف1-}1-KѢH&QR?0{)A1z^8E'YE>&~Y)Zev͆|`Oe<LlkM8Ze#>vm%rRS[9 UVp/wJm('І*wŋWykPF}*QlǔQ)hh}\݈o\GN(ngxr˺[mrIū:X@i.]oY]Yeyo% G4G alUw=TJ+Reݯ$[nn׻ GKvz.ryqwdɽ`m.JΕ JΕs[xlɾBt @z=^%S?=F$0,:A]!n8k2G, П޳?990{3m^u}-\#`S(#y&3[]5+PA4P웳zǐi=>`Is94Ca ahY7O6chkBb/% dh|! 5cBD +s0م?'𵘏l`X~WOnQw4g;=jwɷL6Nn6HsުI8׳kKznBY@O.I(ົQSj55oTq[FgOQU ٣ =9s6ϩ07]bt'm#-|>rn.~3n9kD>~-7l azo-LS,!5z[É1m:o![1$脘1C9 -[Fcٓ>c{_Coz+/|CJvvy9~[?r q5Njmk4/YSHm(~@((VV>(Qe`.oRכFQq*QMF5(Cn砘[E7)^5jlvpY~lP h] fq32_J!ïKid`e.Cˀ3F|?| `YJ!OދI77_x!/Ckf1\O{fp~̣;9LmS|ܾk?[nwr3č\?(QR0M|r>t |ȇkz_HKҹŪGׅp^Z+yq֯KtЯsĐI+$+m9'8i뢬xXV`a[)o-yKh|DXfy2H&]E yaې;9?C~ӟ_ߠ+w ͺ1/T/R3P&O)I /fN:ۮmpm(ٲ$莻Aޣ8Ɏ[(6LM||X"nCHWB#1S[/^r^Zmej{d'G\hC-[dߜOx - Z:gR2H!Ql'̃9Gd ;L1fK-Z'3 ax#a34Oxaaix0ULfLW& `}1{ {%?*g\OW}ᷲrJkNV}N~Inkb7/PŜxR:t辉/6I ݧ~*>~y!4ݲ?ݺ>ď!HCr{bO!j!^Pa.CrpmKѯ~+|mQ+tf u/Fq+bnU3 _\>rhG{|8X)Cfj׉lH|P#E>y|T^M|q>HsULŊʾ"!̙ZCUf[_ E1gJ)ې%&79SX~׏r^Wst5E.{A3 [^(Ll 34}4sO,~$B,0)CkV]RZ8Qāc1i~ xay gL  y24{7?'zQ6p{Iè;o ehLZs弚֕(Aq5t&&uiuiOT]V88nXt̟@ڐ%&7T]A]f+e~5u),.Rϑ]ֵ%3Z]Vs f5L!Odz5_LsZ6E\)j -wEZqRpF;21"Ă9ns1jUB8`Ոc%fTa'ޯ5h1#?)`+5hz A3i~μƹ]Vmoŵy{4:U#skw)f<mbڂѢ ixs}(v0%Pnjydzj .G @}Ճpo CR nA{畘ڋ\A =33Zv~]46g 8Ì#&r#ľ_!At7dh E\ܕ!"qoCkHb!cM 0S,C3,'0Է-m_wc?ݾچ0HNSm׆@, WMmҺ=n9yZcSdΖUqO\kӓMvq3ƵI']ў K2Z04ƍx2{z򲆳dWX|O}|: [LM)Tӈ[}(]}Q=1ZXsGS^UHxXN?PNr^W+]?p I;ςZ2 X@<G2^BV<0<[mx`>m,TQS>=;=|曒ay^u@ P|S2_ jͽ,-(89YNH5f#8}q6bBѶ[#U}̷u#_ڄ8h;76ȊxsymOOa;c_??oU̗%u9+{/>eg&gϫ5^sޠc'pFsP*x;EcFS#["#> _0: dzкg0 ǏDn,CK # ~aDᡎ0og-FϿqj\8[>/XO`d0[v O@[D+Șh]V ǎOٰy[ΓydzyA8{8?O>~m^{4{nߔ_{@Y`F~/5,O%'ݧewu]= LO5{?lft6=M3׷ٷF=߽{smfbfWĊ3G ~%>qߝN$w__8KθkO:3>`9[A΂glf2QM%ndh| q% _;)NkZٖx69ǖNs(ɵǶ8 x1UV Վ5k{b׼fz{bX<%|II kfhqr^௏?%ٟ'jWP7,s!|>Ԝ1#6!Y:2|Q0ֹ|/V04/|'sxHݷգZg:n=#]uaJm3o7!\c o VB{*ȵP[П$jOv|}'I★ֵ_ ͕[h}\xr61D-,'~})µ㚥ϠV${geϳ\X 6$9H/"[*suzZNyWQgKJr3_ h!wHhnzhEVSՐ޶]Yoj~~̩ch_|Y0l/>j(r~rJP׾X6p!:p=- ?o!+pO}\nF÷Qƨ;;K{f6Dݙ;x½Cw֚)[!8"N_o*1QG7o\wd_2oZ훯 =%[ kmp zk^xfj|NqIFlprwYzns;\;2y_xpOOx'(2W 2"\7Nx)њ ~e0Hc6KIjM2~)S2A H2xZnAՔ֤ *dg4Q7933WvנLyD+;ס^i|E [R 9yT6ɱ&y׫/EVS6ԐD=KgBP|NœV JOFsoMQ:Cpp:z\W^}V[bkS_?_ <^yvӸ< ?ݱ8<,pTL7kp5ƿip.=4+=ߩ^tb8z4_ NuզuuS.숺pF|"J: \T/z0-`hԃ/{JG6=xSqxYQA>= RJsi颦 zzl 1hk Iy F#B_7VQfYĕS?Ggdt@5CϴТ=ݚ:?~v^׷(˧μz¹ߺ'lBcXC}q]NyKU{?3vJ#No8*Y<\76b1텐C=Leً 6;v@p6ls;?G c-~Ee=-+9Ԣ?g2__ȗzdgg٢O\w^gNeʛv+?줨p#~QS)ğiW< {a/x!~?+Zu ճ/Ru.wt.Bז#R[R9e-+dHr|.Њ^š~)'CG$H Xc5 kh?b).>YHR-b_Z'3g_7 +Blzg_xz6D.NQn?w<;SוTo|· ?x+kzyk0lh)(.u<F8A]cVZ’ ElhΉz(ϤkqpZXY?ـ~⚸6 gZ\\'@'nYI]{a&:Sec_{pK)%^ũ%ZB#eX-o{}h&Vq&ğ3S֧-d2/Hǧ %A逖zƸ0QCG ?xzuτ.1ׁBr3[,wҷo>>%.DIC;C  ;("(;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;"h    !1"2AQURTVaq#6Se$3s%457BrGbuCEFtv&cÂ8Hd5R!1QASaq2"#3BC( ?\*$*zZY+%O p p?s 'TƊJw$Z1Gx77(_ s2 dsk<[u햂F魲D`;`mDѲÃǀGv&,OFÃU7(vk.H#7j(Co$^%!ot%kiOӈH>g4H_Gkfi13_Yjo[<)j'$1AwMmgvqc m,\~ˤfJjjGݼ=]@)\M:晧3Zv]oQG wڣ]dq&:>RL ppܰaWwGPV*wNw<O_QXmZsoVcݽT~P}?(Tޭu===ٶnxNH~wQp 8\C,#dC.>(qǁ2WJ;ɋG盆&[7G}?(S*ţࠛNߣTj=GM'!;<>6JK_\fXUG;7qwlV_ڣ;QB].IWpwM|<3hv0IpTB;VʊR*)c\)d;du<>܏"O wڧqlBlBnGhvڧ;SBO6O7#ȴ;{SB\['Л'ЛZNTP-MM-TP}(W&&yo}(S?+ddr>܏"O wڧqlBlBnGhvڧ;SBO6O7#ȴ;{SB\['Л'ЛZ2U>Ws>grA6H,5Ϩ$IH6j3)p>OoKTܪo፱.apZ_һuwTT,.lh.$99_ƣ733?KMtչoYc:eՕf`ɰ |3Wq3_>S6=GfF׆`nr\H'p%5]1SRHFX^渆 #qZSUSSm=4K\Ak!!6OVv@5ں7;rgw=V+7_f1ͼڮѻnwwKh_Fn,h}=,c#[܃p8` @O} MV*YT贮r3㯨T,2RrbOL]jnoCl::lls;Cid)zzZª)%Q#)Ç_BL[-DhuT,`29]%;ӷCìY8je:z)sE4$"nkLp#d<X1vino9Wjn6tOm;ҊXTLv\cpd0 Kvino9'DD_kC h́5Һ&JrX$ҏ ,+ypm;;<1ו dz)^Ƕ }Knvc!' uߺ>v7{g8?8TY,5- Uel 492q6J}\SSW9EF^ݼd$ JO |RacZn ¢puҭB \饛5F>Hc0s3,!r*Yz%x/$8.ˈw3C{OcןID]=›q8Hp'H|zgG}ubǭbS) {ңc$25KszZ8xLfm-L[ Nr]-%Yd,9711|FpG8m47Z|1?lUK)I@/_>g_-{~}\Bӷ6@#x;jjAM1؀8 1z8TUOriH+j[>o .q }gX#n;xcrp$$uG}G>Ρ7V:(i&t6@ygQ#z매vu =tj4sU5^NWu&m1lUNO,2~03]-1-==8졒K(%52 D7^!UAAE^[_+ƟOQk"ho?)܉tIOFhLtls\8Z@ںbCd/`~cР税RfQZaLSUTA%Es$Y|§rf/1읛 bmu96[i^5Ӓ|QCO-I-$BBbt8222-}=ගnụqV:8,"yےai3< m"Q.<6\StFBb{*ds\2!A ?ϫOh[DgֿUsVSL020Z3YrVzG/b٨h|'?4[iKtLZ(݉jT<ѵsGC= sSԺ7L֝m7}],\+x cI蜖<8/BL}L}ήتG=SkWjꪊn-H06Cm/  haֳ5ckc07ogu]?`EasX)pp;yǧ+=3%;cb}Y6E;EյǧTp|d7phYnelTn"yc|f^-ihq8+wzgէK-W{DMQnUpJ"6Ǻ-e,,ansư5ߤM+jeO)?8zwzgէK.zm)f H*ǹ;$a?=~=7&{]U"x_4OPT ݂pxhp};\qU=3%=3%7gWU 2KVӂ2#[iiOfr}%\<>=_i<>=_i83{6>hy۫7Yc83g-tk|1Q7JiIiI_ٝ#ϹGTij,Ҽ99+[h`t"X#<ǓƆ=3%=3%ϵ:Gms抟֚iugBcaGrL} L}83{6>hIvG~x{zp~[<>Oi<>Oi^7 }Ϛ)k"4uÃJo{Io{I_ٝ#ϹEOÃk[0?mf>?Zgտ'Zgտ'fts>?o_ݧճ-3-3{/Αpg5U]ш8zgճ-3-3{/Αpg=ovioGO<-3-3쿳:Gms抟Ãjo{Io{JqgH8m|( ٜӺ  T+ Hbi2!.ӈh=]k<>Oi<>Oikts>{*cWG|m*Z4;2B93O*o{Io{KS=<~~sQՕQ ekda]jh衎vA X+πZgտ'Zgտ)_dLHjpvN/zƺs5E5=ENN8>Oodbx}[x}[ғvLHg>6662)0c! qBS_[Pꊫmy%c 3-3-3ʵ=06^vŢq}LOJeG'p~eiV'iV'q8;tW uDR |f3|Z-I#\xIJx}[x}[OhuØs>_ؿ.W셌nm@zZgտ'Zgտ-j1TUU˳VǵU|< ROM$jz$s&m5 #9>u} L= L=6jZG}DϨuUMOi<>_in٦ttwvf5e%ZVy )\>'0zݜJR6zjmU+\x%TQdmappx*gK1m=z&&wbcjݛŭ7Q7(jYUj'|ϟ9֢/S>+]jښw[9Y!q$9 мOi~;{KM<]N,MsiӮxs4TSOWfl4Vk)|-sA(pD^Hmqx$|nE]!!o2I Op~q8[;!,9ܷ3vy=͂G5#[)U" beJjqՊbcvG|^':Twb{^#;Ov6z>7&W x7Sx߃7gWk<"55# * N[[/w I<ӽ45ofo0NF1\ј7Sx߃7gR2^~5Li(.VNwtCm4 P $q㒯./9'i=ҴRg>6p,sFKS#VňHsぃ+dUt3 |MOda/._֏4?ꕩS4.ޘ"--|@2?G?[5][uƹ55g7m%!rz'q}4/q˝\O@+/TzM>H^\FfQ:[}ӵ6GǾdN@'}j㍵aMs=;lzKB'h` 7Á#|/-dO+c/!Ei &縓Q ORн3츌?{F$aqn+PeZv9S psCAdPڞUzOMepdu8~ j<U2ULXqs<$OJ5?&bc+z'aq|!9;O/* 2M ÜS#-k%]9c%"2 {#.x;XH89*he8Y\0F$g9+llk\CF2e%Aj ̈^p pE1I#1>7Gqq Q\5,.pIKM[d4LJ9{q.$u7De[uSZd)cYj3 2|fq$/6u w J-cYpxk*$B`1_O\v[F5NGһrGgn $7a 0&oV,kms>YdډŠԼwzFf,7 eˁt| mפ*oDg=d '1a- qxOpq.׺tzN i8.$O g%#]҃ iv]LKZ-|_qlk: 5:d2dQi#y >x3x4l;'|^4&$QܝH#5w]vi$yxk$>ʤtYtp\=4fj8@\T9vɑ82­fW+FNxgZE`24=y>W9X4#α8<~bc79hcON?ۓA }1wp@.8'$I$$"5:jYÀQ bcn $4GwG:5$D,g8k ;.Ns6mvzڈ u=U%i'4Kr-{q̂%o܈Éu/eaF럟zGypfh1npԺkewϥe ''$g zb" """ """ """ """ """ """ """ """ """ ""4D\qW.3<楒1SK\Z\3Kj K[` K,|oU9i 'GL"% usOpQUNq:OXRiK*hiٝac܌28 -3ST:xDGnD|QuֵkCZֆ< D5j+yDrUKI77hN3d㬮GiKTt*Xsp#S(39?Kd X-@pX9 U\n|'#$܈"a6x# qEC.MkZIhiԢ9ojD6n p.'qӶۥHmN470M zCl9\O+$AQ 6K,{湤`X!GZ՞Q4&ÜCA9!x J"]DDDLݸn$mGJ4pxae͗>uoRD-l7͗>X7 ͗>;+&W{'}6\bD܂}6\˟cجH]]˟c؝sor so.}b"nAuw.}bweϱV$M.eϱNl7ĉl7͗>X7 ͗>;+&W{'}6\bD܂}6\˟cجH]]˟c؝sor so.}b"nAuw.}bweϱV$M.eϱNl7ĉl7͗>X7 ͗>;+&W{'}6\bD܂}6\˟cجKtNS^hl6aP6\Zr#Λ]d˟c؝so3KMj{KR1ŰyM)ѽso.}b"nAuw.}bweϱP4zT-V:;$2+.`~dl`c>uyҾZx,18'@)Нso.}b:{uu5lMvV8#Ϋ=qK?}_ntKE6a7p8܂l7͗>Xj;scyѧl3N3r '}6\+SyQECUs|n坭L 01Q:/R~i#e|fYǹrI>܂l7͗>L>o i]LتSehlpC|bGPjtž[ͪ;DhmP^7goY_̛]#͗>;+ͫO'k|=]\Sr '}6\bD܂}6\˟cجH]]˟c؝sor so.}b"nAw>l7͗>Xcr}6\˟cجH]]˟c؝sor so.}b"nAuw.}bweϱV$M.eϱNl7ĉl7͗>X7 ͗>;+&W{'}6\bD܂}6\˟cجH]]˟c؝sor so.}b"nAuw.}bweϱV$M.eϱNl7ĉl7͗>X7 ͗>;+&W{'}6\bD܂}6\˟cجH]]˟c؝sor so.}b"nAuw.}bweϱV$M.eϱNl7ĉl7@܇FXֹRi~dz sEO+#ti5Y} !`'yUt9οٶOd?̬Y]Z[~%+ߋi/\XȈ" """ """ """ """ """ "iI畑EK#4 IyGZ[-E E ᖖKh{IᖖKh{H&BeR;t^xeR;t^TPioioi/Z[-E'Z[-E E ᖖKh{IᖖKh{H&BeR;t^xeR;t^ tW}%GCGJd8W [GnT;f˿&{+m5G eMޖ+<)˲ݠ#NJYvDZ%3Z̴DX8%8d]=XfYdFKT]e_es^ݗdu2H%ּ[}zjimIbkd夏#zbK[M UPEUSg|#Mp|Eu *]Eh&;kFvOA\u`>KIYO!at-iahaNJzKCܲk.voYs A FO'$%X2)m/iY :>>YeFƗ91$Q_p )dPntF mp-w8Юio4v]jQ)&1ސAuX! )/ͨ/~De˲0196}CMFJchh `F2zyu ^qSi窍lHsaĜ.>z^y\nM =`ug fzxGF6qp^Rѡ蛭Gݍ1ճ¨j3=e2Arln'8%'eKQj}oQZ#DFvZр2]yCh*[tMiKEM -<}b(c csOZ4|꺛˻\ sNִ@CHpoz]sZWp;ün8``0 2MܻQ uj+. X]<#,^'raMOM-+iXi\ZZ۴_dQ-'M UEj^edqp01޴'y2bXᬊ6l;@c9=^Z= Kݡbh:1zs>P[VڞC=Vi:M ڒL yq=*3--ۢ--ۢQGs/5ԎTlan';'hxM^nm7hjh#K-U1 Hx=04רT"p{ +1`~#8H_+jJQMxت 0q89 =JZuli-JMӆ @kI`z-~֖hlk-#gpt\X<9qOPܨOuYk&yFGagUtnE=O{5̮XͰ̸~~+v7Y^e=fMPfD G ք7G4+Ƕ2Hp Jn?ƍG{[gzJ,r6Ӌ3W-˝X;87 h%Ou`>KIYO!at-iahaNJX5]PTKKo|K^蝻'-$x qf46I疚Ye|.-z ڻ޾o۽vA%-$[ fی[1U|?OݽFΑo<jvΑ{4asX6FOğ0J WSVl)l8I8|o]7Po䞚ZggjQo!cF8)=EKo)hlE anbq8I(/*]bڷ;n&`m7H01֮jw@UQ)b+2F]dq/z'z:no}8:mS ކW7lGQR[3 hꪎPWYh>iaabKĝ9$$pTWfZpSWKmQӺYѵcc'g` o i]LتSehlpC|bGPkM-\Gwts"l5,y @ : w#дUQ)u"#ipFG{=VCC{2cq I-cGS[1@{M}jks6`eq<>e9+C#״yז^-u;pPSRS;Op:&ax\ $#R̠tԖ*uS 7T{| CiioR M[͌kgg<3ՕhT;thz^s7cyu:_6n_6 .5j)&w/;Q$:|-e~j?ug1Ӥ,6 y\[Ojm=9Ot4"=kvԌ>.Q8àl46ɨWpZ`1lWkwem1 llmuy՝X[z~M‹}#r6AxgTgs&jU.}ih&(KLm7:+7 )[~ҵ޹cmm5ͬ-,0O`miwaj{^$QSJC`kOSF0=9KOMbv%%\TI> ᖴzzgwr/h +7~wnt΁ngaq Y+/}.zYuÖ X8n1xv$Ψ^Acwrdc#Bnα+Y;aK-7R 9=ku < KiSWkUQ[3- w< [?'lhY[Q@X-@Α4u u?Q4,}3vH={*w, #$N=+ .}]4G] @|sʆSܲCg5\C<%osx7.1֯ZVt^YM]IMjm`C<8`zyvav_tuyF31sdiv6Aa@+]IjVh[tU2v4 3X--#.9 *J" """ ""D@DDD@DD3??΍wTja/>yk5Hy#O<PG</yiNM, |Q#At=`ug.ھEX.t+ ˑdx A\c4u-ng3P?ƈh8NJI9"C\z_|ֺL FYk<22EO}۠1ˬ$$$Tjnswgl{xqFqTEM+"&G5h$ˢw}~^7 FO'$%NַQ\(gZ$J62)82e R=2{[h9 ϣ鴽;z^}ymlzC-=4M&wc֌Oynw]9=uU:4մދS L2ݼupx+5TW˥ ΣOWoti;0e9 R^:}?he]wdyݖp0``0 c_PT\lmIHmh\87g c>|X)7[olJ&pks>}Mh_:+e҆Q:4n۲ LmTuP\૟ygkd'e yki`jc|#.gR vW/+.SAvݦ8#qpD2%}嬕/=``לuU,0QSvF]:YkUSڭ [uT軶>+O̭u VUQTUO&v%@;px#z-5Q*ba;!Ҽ4 Y :>>YeFƗ91$xWݓ^MYK[*]À>(vN*J]tmcx'{t]z[;;;[<3kU][ki**9F8pÛ2A}ђ)+ژLٛ p 9ϙwOQ ,.hቾSpkG(>guLzުKc55'N2p=aWA uMeQ?{\o]=mVQS+m9$7-+&NaK؉o'⾟IWS; ᠟FOT^t$zh/+eY@=_: \mp-mnN\\x2z̭.U"ka:ZSsY__DQ퉃̅8!TM17| hq%VMqYkTXn路:4}xiCrrGn5w2+!M[dž3mm84gb| ?&_ev\wҷ=;;[[9xc8_Po4w;vv8㌪|o~ӳf~vvvq9x7y5x@=+s['3k;]uwe%wcsaL[|/EGEdcwٌ;8.g)KpuTlcks ~zè₿e%6e)ni{s caDl L},n'iZq#vk=K))O;'<gӶ7KȐӗzP|CdZZ[ ݴn"ud4x#B7T}to-6z3~eɾꟓW~/ꟓW~/D&~M] x~M] |n5w2)n5w2+$Ao߰직߰쯬ɾꟓW~/ꟓW~/D&~M] x~M] |n5w2)n5w2+$Ao߰직߰쯬ɾꟓW~/Ԕ.u\=_#+{=шYnQJ.FkGA */z'z:no}8:iVk4pb9}R渇I׆3 62vxTEwz'C.n>Nq>vw;_=^oۣ%m ]g][[jD(5Ü[[ï$"9+C#״yֺjZE}ĦwRn:u8g&ʓf;v)j7m9P=]yGKMlRAMO:W1wH=~RFʋՊ}dkLjd '$yMMCMQYMY,{Sn_Føuhꫩc;m5Ɯi!<6Kd>nt44]&(ۙc5Wq|낞C=UI ,nF3Ğ#ņ-KtV*VIs?X|1ok d{An՟J ekOG+rJGͽzLMv17k'h8KZ*h_qqSqt x$ ?F:U__te`\=JwG1ւSIBu]CBoSV3ׂ\]j]u45a{KX?Vky)[8% >aXmt3C5%tBƺ,/yYǭJxHU{]uKfeTc-#n8IgSHGN 11mf0ǝKV5ƽtP1@v:ÿH<8u.ku`L#8 #X 폖MBbhc`mT}Bi{%kmzmb@ͮG#?Xثutʋe.L88o֗`Z󫆍Rl♑K]m-u @4SJ62ӲA#}~7Eme"PAx ʘ1P$.AdhZ\OmÃz"F6H;'rچB*)*GPց$ <*JP^+ߵyN8Wqڻi %skhl||Ahy 80GA'hkMT{jbe`dp0l0fXd;E[$p3dǑ״:z=qݩM-t "CI#yGֻ]f[%ގ$>sATm?5/}4of|N xc'lB\eQjku B72x&pu|؟;sZF -d/_uEʞetJ"'qï*ᡦ=w'kda:B@DDD@DDD@DDHy#植<ϻyC9w9a_-]DioRG@DEATD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDHy#植<ϻyC9w9a\[~%+ߋi/\ >ks[5l侢;'cs*!zV5Y~+TwSH$MH̥aɲ'k#NxkZ֏eD+Tw[N`I Z֏etSkGֲM"ju#Oi"\s N<HZV5Y~/J>}k/ӥjSZ>iDS< MǾ#\ @pqJGS $2Zmmpnc CNxcD Z֏etSkGֲM"u!yZmlnˈ,㵃0` ' 88ҵOZu4!zV5Y~CS}k/ӥjSZ>iDSk{vZI}F @>p}Mh_A ҵOZuJHkss u@F0sÉ#2e/J>}k/ӥjSZ>iDIiY796Cp0Aq$d`c }+TwSH&jHZmo8=97< 6OV}Mh_A ҵOZuZH6[۲Kr4`m rp%/J>}k/ӥjSZ>iDS#1mnqnd]xq$cN}Mh_A ҵOZuMH̥aɲ'k#NxK"^}Mh_J>}k/ :pm6(sCX.rl䓸AO:V5Y~/J>}k/u!dKM a9s8 qȖD+TwN}Mh_AN/"kMq9vvF 8':V5Y~IԛiKsd7NF08ҵOZu4!zV5Y~ Iy6X996KprIp `'dA ҵOZtZ֏eD1B [\nrdp'p01<@㑯jSZ>iBSkGֲlR5츂˜;X;#|dA ҵOZtZ֏eD0GOkdE=5@0 y>SkGֲM"^}Mh_J>}k/ R6y[!}F@͓jSZ>iBSkGֲlR 촒;XC| dAN/"kMq9vvF 8':V5Y~/J>}k/ju#Oi"\s N<HRȂjSZ>ҵOZu4!zV5Y~MS< MǾ#\ @pqJD+TwN}Mh_A-NMi%9v698V5Y~/J>}k/*u df;M-́9kx9$pɖD+TwN}Mh_Aju&ZmfR0 qē'<5SkGֲM"^}Mh_RnM%hkMw;891YBSkGֲlR 촒;XC| dA ҵOZtZ֏eD2T@v[[rdpr1IᓯjSZ>iBSkGֲl5:p-6)snrl`Iȃ}Mh_J>}k/ :pm6(sCX.rl䓸AO:V5Y~/J>}k/u!dKM a9s8 qȖD+TwRto}+[ 0 V<0֓aވ |Y%G?Iyw9~s>s¸4?KW)u_KDPDDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDDATD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDHy#植<ϻyC9w9a\[~%+ߋi/\ um5E9E&1jIюFqcTW&_B]7=[N :8*:ޠIӺ PʺwЗ|lZ$'EW\.]$SCLRT#c\"ڌ4`\V:Ot*[t1Ba )sNFG(-[Jja_:MCp:]zfn/s[PX.ϊrv=<=*B}!߃-8c9eUuEhn4Rna1 E.'xC}mc\+wѷ$0QkjU~k,Y kYLpnr:/h]C]FmGD#8GEM]<(B8IyX4ΠRc2)d#nV9x)eLe{]IsURIռ4;c]x+ *.66]ot6Jf.hs1>SGWl6x[D%859ǟ Y~$_ڏ4oEMPԟZk]n[midtLISQnie u; o)bl?m5 y*NT%9.\^2h,Z8FAA,Qw@{MMlTQ:3fxu;g$Đ3 ׎QC [tTi*FDxWAӇB kzoL^􌍷4SEQ= >n׋UX41{J9wsvNp89*jz1o42GVvc7sU53oH| 5䍮;mcEmƑSExqv헻j`Ǒe|dO ޵uG雍pKmC_c>) G~t{з$gk͕R43s]o뭱`~̑6|>s>>n#[ p}ҾZx,18'@+zYEKp}-m45Tcn)cr2_^6im sni<ޕ`UEGA-k yOrF;@xn 8's (*@ld23decu™햖XL!d$;FGiu7obq<6=%7Gh5m\xxgcG9Zu~,[{*)$go?|{?ň>v sks8 n-<ÇWJ ]/2lK]S-Y~qk@oF8XFlz؛I5$ msq;.GHQqf8coQu4~xJiꊉjG:i^I?98z|:)ntd`o$8x7*Jtk k*XL [8<@<8;V5vܵl#jP=^CSK/ʫs=p^H,nF5x-s\2X! S精EFݪ!Hfl΍28<4筼HNOQ ,.hቾSpkG*Bj!h2F4Q7Gmܒ]r`gyʭ~SvA a l} |Mx6J⥦gl x*1Ou`F: i NCppW{l\0KYRǼgZx l]&cm̬cx8Ϙu9@_VC {_xxPVG@预?/x_G,TD@DDD@DDD@DDD@DDD@DDD@DDD@DDHy#植<ϻyC9w9a\[~%+ߋi/\ >a;qUL\AkQAJEDEiڭcdG=9!?1YHWvC%\^=ޒvNq#%YeNZu= (4*9DfÀ eΓ!-[6rt]qDW/}HddO? -]DioRG@DEATD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDHy#植<ϻyC9w9a^{I~=Ӛr;G }K@,?e_Ѻ+GaxQɩ:'O>G঻ڪRY-ڹۥeuc9ӋviGҨݨ/VA.ԿmӂX#nԘ ?l#8Pښ-Ƃj{󡺨L^a$ˤz}V)YT6zXznA~̘sd>7g CSOA;Zj%>ROKuoǀ'aFZnzOoԖkUVYN 6Pp8ic9ҿKj I%< p.qkr@+UPطsMWY~63i8'' __N2r0N$v'dGx+뇿}ޅ6v8|^s=W7nƠuo0|n8ϠT ]"l{ߵ$q$PoTjk՛Obm=qWݼkwyy:oڿuwn:sڇn8[k/]nsCakA$x©ǭ5%T]4LVE$Ga8kCFNzfuCi/{X*^fW9 rp:KQ_p )dPntF mp-w8Ђv~>NiZ, |ޞ+Hj;֪hQMvJiektnfI#-G$\ԴWF=?wewlH+dsvA$x1TsKCrՏ\\kc4ŶƵc@-um5E9E&1jIюFqcTW&_B]7=[N :8 z%Nh(bC*B^bvIAk8Nx '~wG ;w-#ivI̠uͿVKOST(c,>S#X;; [;>mݳ7w>C^tSۅrEMv#Av'X-w9qۅ\3kDGݜ__7R[NFُGqǬ+VZmex[c{K\ | %gB eem-U0Ǎf1<[֊*[+kiqM{x з""" """ """ """ """ """ """ """ """ """ """ """ """ """ """ """ ""TD@DDD@DDD@DDHy#植<ϻyC9w9aU M =mUbk3 H@\[Vg[C(Xn/rz+K~/r[- /nm\9i/RtZy%2ǿ. rOSGQ~:NtsoI%n85uVdAJZhjSF`d(?旞iSK3C!;d:3 V.ї jʊ],S 8q>e`Z(,6m7mnsrĞ|-]sb2m6`0 fƐ2Kd:2,c!g".Pw{Vqq2Z( Ov eLMi(o\2 D{l.q è H%H"+NӖ)[I-;^{^rC2 c MWpZ=S,՝ p+ ik%@(C֖`HRw9v7;eqWN+r#2"-A樞6T K dzqWlV\aL@,p! '''9$ALZ_ړh]5[y5Hkqj4QRYKEM -Glp3^zDASO%V>79i *ӷpSZZ,׍pG Zɪ`*%cHÚAᑜ@[^ } $8I$z@)Aފwq?t]ۿ<9RAYtAWoti67{mprڈ YHWvC%\^=ޒvNq#%Yq[m`ʗOrNN3p]hZ\OmÃzDD@DDD@DDD@DDD@DDDATD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDHy#植<ϻyC9w9a\[~%+ߋi/\""" """ """ TD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDTD@DDD@DDD@DDD@DDD@DDD@DDD@DDHy#植<ϻyC9w9a\[~%+mdjDe~ kFIx2ߋi/\ud2De;\[ǭ5%T]4LVE$Ga8kCFNzfxU[C. {wq7dB_WVM-]†$fmŽZݐ1cՓEtdm.`s.tMkG9$Zqo8s} nQwq3x82~rP\aӻWpSQVl۶ُ=csì-׋UX41{J9wsvNp89(EMyYQj*GG5h$zu?u-?}4ULq11цfp'*W]e%5z`H0N#GRzo5ۤl!;RC?_̫:[ISxC}j Vni#S])r:]"{;6|8>ujK^6RW[f;vgRuV^VIp7+z8pF^gs૲ +w=/t;xX㳜gpO/MFcocvcuʙ oAPjH6;g-jCW^ %Ètđ#Gn VT:RǍnzxd8|~ :}9>w qiOwDQx,/dD=i 3T}oج~;s.#.7vֻ#wyz:qm[vpٷxr($棾?RiMGG|t²  4q$q`v;U]*8YQnLf Oǎ0>ea]TTjjVM\g,{0Zl*n@7l;=M]Oegtۭs+.}@sY(;cNiwcZQ#]SKmsv=Xc|z[Yzک7t:Y_vZђp8̷Y :>>YeFƗ91$S֚ƒE.DvX+"GT#xi!'=M'yOwKi7f6d{ *0SJ婤8eZqOv߭-wT; F1H,v{UX+4{WEܹyspxnoګUj)MS#hYQ XY+#{$$]x%~~e TpsQʠrhqp>d}fT]j_,ljLr6xל-=mUWM),m\Ҳ\DhiŻ@4 #PZJ-g'bCkVdɁ0<@qpQ#Gh)s v/k `8uN|{K-BYzSLC.k@8pSEB`YL/5gpk#!ǁ`iDu {H%g4AAjgU\5M-t]˘{;h?J*N&UְX%{h^ˆӚ! y.nO=(9k֛Gj)E*v;al a稁iJ/,F힎Is[vx3~N橞5=VjyGL<@9##u~\m5=uUɲ縈㸰d#8G _OӚr;GV/ 7H~~}NdvRmMs#PF8>/l}/}.7-LۅFF8MAjA-Li`dշ i,s0I9dTdRr")j6D$';H#NiԖa(TE[nlkdぜ朿wI*kz^:z*ˋN@$uԆciI7Ky[OAI'6@8;Kuw{E_nqrtG}Nҷ;{>7g͜U1~zq6DGlcGQq 3%gB eem-U0Ǎf1<[֊*[+kiqM{x з""TD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDHy#植<ϻyC9w9a_-]DioRGAVgs-f~k.-'aZl)k):]#6v[,soQפ''$4TD-dM = `e$qO/E=E k,3QKhI4d`` sŧV=ifhc2>Glp3^zD*2]=mUyQS+*a'̤x1A_zmmy\zܦ-Hi1lָi_&v|dml8"E;Ѻ.mmmlW+D -d0C ꁕmђ1$` -K N[FZ`Kz$OP=@ .*Ee҆Q]yѤpepWj A5 t:LǹK]<@v@1GWW̕]]5pk@$9p sc*AfƐ2Kd:2,c!gE;Ѻ.mmmlW+GXmv}†T\=G788$I9*AFXtLPIio ˉ=MI WpZ=S,՝ p.Ɩ_PZ4 t01Ή-ikqFu)dAYw9v7;eqWN+r#2+NjleL I i'eNtm64-AoGcрs2NrNsrP]'N}YUJ컁Ov BO\ͷTG4@\[[i^Jvw{s)Q@\W[=B+5tω+spFZz0Fxڈ"tih&@Fs02p8g'T"ОhC,{zhL;-hm 9S~֗ cziMn20{u7Z姷C-vcyH%M({Y"kr<97t_:7 UmCcP^l=//zv;߼`c;|vc GMQEhӲJC(ˀ!vAvV3VJo4n)$ڙݲ yf\e5#s6#-kh|b?۶v1pԚKqX VR]o3oP'vުYA-x2$p/;$߃eNt0lNkOH@-sgwV-F-k ˛pA!W\.]$SCLRT#c\"ڌ4`\W ]%HAf+u#6Mؙ!dy*}+ܷoС٦;&OI9>'WmP_Rf)>+q`Ġ|4]tv;߾mc;|6q Y$V햊 EjWR+jln[X8i OiGs۽<3?@Ur۵PzZ}EX$P'$q$H]5,jhOzSS;{2M#mUo:v pҷx%ݓ'A "֞fOP5NpˁW E~Z>8hfbc k<. Ov{UX+4{WEܹyspxi*悍i|غ&mElc96|u]>.٦biDv9kG Z g8OoʏZ[|Sn3>Mv c9k]:X꫆Visv2m0PU:V\Yw5 bW7gC<6=+o dK pkgYAmzߪ:{9т>N@󎼝57ip76{V.y[0uznf)5Ʀ~{)L{#aOupC W{fj;ͨspJ 4ƛ ƫTRѲdƒHqyq>IhnECuS5.O;5H-r\㯺Z+t55'B=7kZAλQAzm5 #FCsHs\= T5߹Γ]&[wt[ p@yFXtLPIio ˉ=MGIS^Ac'ic"0vy_*ƈ#/nͩ)E5 [=A;.ss33+;%ק-he-0q~I%=dI'dP A*M9iԛE$F ϊ v?q]4.P=-+77v4c! o^zW:Mi٭HN~G夂F:?R{i^%Kdj|:gF9,q-77R"[npeE-CvdDA(?旞iSK3C!;d:3 ;kտgy'HXhhItLPIio ˉ=MI 9}z[+13ފwq?t]ۿ<9Wj w  { ĎnpqH$rTes%sWc}Pvpk^콍!$srh8 GK0nzeK_q'8%Aw: CeT;+3g<ڈ8:6(e׹2 i OC];kտgy'HXhhYMKY,6vGEP:hJח45' :e's=BNJk+#sljDcsZXF|҈"uj!@ʶs0ppxdgKY- TT P׶Xf@e$@3hOQsjUhP ۫:4n쿀89 Dmq_GF\q$$ qp}wVtϪ.Mkݴ]5r\zUAh} L}T;+$8ڈ8 ke $;ݬ88qi:D@DDpZhiF4eamvr3ϝs۴՚18=Ľ YR?TD@DDD@DDD@DDD@DDD@DDD@DDD@DDHy#植<ϻyC9w9a\[~%+ߋi/\""" """ """ """ """ """ """ """ """ """ """ TD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDHy#植<ϻyC9w9a_-]DioRG@DEAewF|7cv~leT__7R[NFُGqǬ/@T3j*(-0I[TډTPDdxל+5+^تdk sC8;ú{6OAme#[lv۷;C{ x'8R.uښG==D3, <4q,8>ΏYꛅGUdQ%}ݗgۨ5UXuU)ESlsk|y;9@ 5imDkB("2H`j CIS^Ac'ic"0vy_*[FUy\sA h`Tئp%p# p8.DUV ˥ ΢ ~In|ە:tRʨH)A_]5+[fZ"19 shJBaڬѱ&Fv%ǁA ;)dzgn9퓐0V:+Niyle441#Aq8=AN+ksI>=7kZAλQTD@DDD@DDD@DDHy#植<ϻyC9w9a\[~%+ߋi/\""" """ """ """ """ """ """ """ """ """ """ """ """ """ """ TD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDHy#植<ϻyC9w9a\[~%+ߋi/\""" """ """ TD@Tԗ I_eҰZKb5 {isDb?0>s&2[-s.~nԘ\t4f)%<N6ՌoQi{ke pcxܹcMqi8gmzߪ:{9т>N@󎼝t=tU|LU}1Rȁ {]+&OGNzohu 7CDGm92Q9텑:;Y=X¤æ W{fj;ͨspJl;Z`2Jk_SEM.̢c%ulIճYX5}է*.66кZFyZZbkgԶsBJZx|JZn܍[ХEMaW]9Oq6յ 4;k>6I8u(;ٙO ESMET0 іݬ9抛@gVEVֱ&I=@: Qd{+[48m$܌xzC/~Ӷhc^s/n0q`O22U3WtSZz]AI5D!`.=MnH<8u=Y䡞d{8B~kEf8[Oj軗0o#.v~_\u=9 5=Lr[_%\uc D]sx8jhWZe`{c.Nh?8׷Zmo,5kX1F\6]W'Ezt;~nq7skxeQOjSj fqd3z܂28p+-+Hk(uۭȟ7dgA_=7oys|ϝGϫWkX 1nzRZ΁N믶:No-7~0nPgy VV_U[S -mDbs?-$0-ExOoS2F? qR [{[;he<㙒ɽ1ZG[ 99 vZsTO c*eHݲNpKHP=Y8*uD˥i@j kz; ss䨊.2]m-wQM+e*c會#έ'Pik&oT l.9a#iFpp=(t`E@m {evdv]H YS?7?{E5}{nn8v]=,ZWw^qǔz+dZZ:q 67pqqI999DBm}k/ 5:p-6)snrl`IV5Y~/J>}k/S7&k45&nI; ,!zV5Y~+TwSH&:HY!kksmB2sLjr5SkGֲM"^}Mh_TB&ݗYskd`8Opq,!zV5Y~+TwSH&Hml9/J>}k/ӥjSZ>iBSkGֲlR6y[!}F@͓,!zV5Y~+TwSH&ZH6[۲Kr4`m rp5SkGֲM"^}Mh_T@v[[rdpr1I,!zV5Y~+TwSH$MH̥aɲ'k#NxkZ֏eD3TF k|A19Hy~SkGֲM"^}Mh_@!ݖ_skh`@xp3,!zV5Y~+TwSH&JHkss u@F0sÉ#2uSkGֲM"^}Mh_RnEe.ps M wI;YsYBSkGֲ:V5Y~HԛiCsd$rxqҵOZu4!zV5Y~GS $2Zmmpnc CNxcD Z֏etSkGֲM"u!yZmlnˈ,㵃0` ' 88ҵOZu4?S7 "k289&n;$ `q9ᯥjSZ>iBSkGֲl:pm6(sCX.rl䓸AO2ȂjSZ>ҵOZu4"cԅ-671!N`c'}k/ Z֏eN/"kMq9vvF 8'2ȂjSZ>ҵOZu4"aԎ1=ȋ{sksĀ`8d}!kZ֏eD+TwN}Mh_A5Nl-6CsǛ'+_J>}k/ Z֏e-NMi%9v698Ȃ&*H^D֛[ .r8`p N0uSkGֲM"^}Mh_GOkdE=5@0 y>/J>}k/ӥjSZ>iBSkGֲlR6y[!}F@͓,!zV5Y~+TwSH&ZH6[۲Kr4`m rp5SkGֲM"^}Mh_T@v[[rdpr1I,!zV5Y~+TwSH$MH̥aɲ'k#NxkZ֏eD+Tw[NҵOZu4"dԁ682\c<81'_J>}k/ Z֏eju&ZmfR0 qē'<%/J>}k/ӥjSZ>iDIy6X996KprIp `'}+TwSHjSZ>du:C%0ۜ9 d8K"^}Mh_J>}k/ R5츂˜;X;#|}+TwSHjSZ>d5:'p{.r9nx 'l)d@XK䏧a/>yjH?y~(}#_K-]n: " """ """ ""TD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDTD@DDD@DDD@DDD@DDD@DDD@DDD@DDHy#植<ϻyC9w9a\[~%+ߋi/\""" """ """ """ """ """ """ """ """ """ """ TD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDHy#植<ϻyC9w9a_-]DioRG@DEATD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDHy#植<ϻyC9w9a\[~%+ߋi/\""" """ """ """ """ """ """ TD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDTD@DDD@DDD@DDHy#植<ϻyC9w9a\[~%+ߋi/\""" """ """ """ """ """ """ """ """ """ """ """ """ """ """ TD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDHy#植<ϻyC9w9a\[~%+ߋi/\""" """ """ TD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDTD@DDD@DDD@DDD@DDD@DDD@DDD@DDHy#植<ϻyC9w9a\[~%+ߋi/\""" """ """ """ """ """ """ """ """ """ """ TD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDE ᖖKh{H&BeR;t^xeR;t^ Pioioi/Z[-E'Z[-E E ᖖKh{IᖖKh{H&BeR;t^xeR;t^ Hy#植<ϻyC9w9a_׵Ũ. jk%sM$v_ gޠO sSD9m-WMxK.D8>cM~]~ 69%{k5$ qV+Vm3CI-9dҺ'e9  =ii-tZmAjeҲ)$uM<; Nj]2s;2z]?E, (]A_,{ökvq$j Q_p )dPntF mp-w8Х>==LWfHk#*7Y}zj(z ͇o3^Ƹq Ÿns\f_wmvӲ);ρvx6S[ϝeM#N\u_Ӻzw=Z[5={^Fq>hQG[[; m?D? KlhimK5D YMc&Zg3vC6deq1:GZ׫ͧx 72ǀZ^vH#fxSfEr:1.llg#0@BڈZI5,-蕐b,uҲb^hlghu`4䠚jK5򪮚p{ cv-üuq*n]+4uhX-; cc~ %=g ᤫ䚖[t^m<,f5;OgK I_usUl0?cz`AZo-NLCB v_5@p㞾8R :s#D﷛y m|¬ cdQKE1d59=Mr V=㫽rnsxMŕw[d sڔ^*xZOve$UHvv %tNݓɦerO΂ߛW};:>MwNבvޗ:Fq򶷾.z\c:I!JJ7TaC$Ens]6hintsu'MyVWKCKs i❮<psU3h}hGmm-kQw[ĒxJ jnswgl{xqFqޕg;v<]q38^OGf5^٥jrtO$t̉KZрa˰rN(-/SF.5R&.^aeōs sCuԨZ*[Ou j -K[4`Fʁ! q1^På7>we]Zt307 mvOcW+nu*CMH-1TRLap~kꚊJRgpv` F;*5zVwBTKOk*wHwQ81gP!3YAl]gtZݳeZ.osk%4c6JN)2C Oͩh:NEoj`tu]F/I9kz΁÷^Vϗy\:-1QUOK=T4IOMȶzOjzIHʽo5͕exa;G6s*MadBPZO{, p%r: unlw`t{xqqՌw:x] N!FF2Av=y_ޮ6 ޺&lGQR3k7=#ɼvsYAC-4A=oZ(r{DDPX݉Ypp2x -q6eTU=Q%pKZe1y nxєw]Ct^OU{e|$9ǁ\ x3{Gz~/A+_ewJZIdQQlͶLnp#gw֢<<ͼ{;[_g9as]1l+Խ=8gFpn~l߭O,n8^!pҚnvN]+lmXݰKÉĝGZinK5dF pi쏃qvF68 --ۢ--ۢͺNAEY(+YE)ik/ xg>ioiot:zWg {e #ʧ>,ny o0Nz֍YlPU[*\M<gAŤfv1z2)m/i<2)m/ix&uS[`ޯt̵Y@+[-C2A;'vكtqS+}$f )yn6eRQ$%rC\)a -vxl~ioioNDXeR;t^xeR;t^9}cᖖKh{IᖖKh{KAZ[-E'Z[-E/>ioioNDXeR;t^xeR;t^9 [GnO [Gn_'"|2)m/i<2)m/i|>K|v轤K|v轥r --ۢ--ۢȃ [GnO [Gn_'"|2)m/i<2)m/i|>K|v轤K|v轥r --ۢ--ۢȃ [GnO [Gn_'"|2)m/i<2)m/i|>K|v轤K|v轥r --ۢ--ۢȃ [GnO [Gn_'"|2)m/i<2)m/i|>K|v轤K|v轥r --ۢ--ۢȃ [GnO [Gn_'"|2)m/i<2)m/i|>K|v轤K|v轥r --ۢ--ۢȃ [GnO [Gn_'"mal_RA,v\\xKC߭s[.wD#-p=`yH [GnPnڎU]kSTYpdOK|v轤K|v轥r --ۢ6m H6qŎˋ8|A-UC](nuC΍'|X7{mvxeR;t^9}Kw{keh}}cvŮ:K|v轥r --ۢ-C+tC*'|Xw g |>=R,vܯӸ8ᖖKh{KA]n 誵Jzci#!(>EKDآg|#;-h.Sw.uB]bu˃"{<`s2 gAolَ6WG?k''$WDR=ҺO~22wŇyݖp.>`sWI.ZU;k8m kAޟu-H!= `ey8p3*[--ۢȃ [GnO [Gn_'"|2)m/i<2)m/i|? [Gn_6u֥/\-<\oˈ4~;;_o[[[8ǕA]rfV?výl/OaF" m?ozZy׾Ӵ6@׵88rV.3.vԒ?̈-1wM֐ۍ5IxkA~x9`(+m޾ LYFn'iAp8+ֺK4k颙2Yx n]=mTʊ],Nq8ZQ}cᖖKh{Ku5u[5:zHc8i<2G| ë]OJakp %)=j]Y|^)hi4QV2xvl'$8Ō2R.k]923ϥ}G'jZ7߭&ԡ1_w>e|??B+nӗK]UGeTt}M%Է.*zXا c}<$g %ZZS2fUT2!_3 0mj`v ᱑ghd gh6RL1]OOoURޭOvq02|IMlī)ڍ8xg#υGM5HyAR?iAx-7[>:hVT;yi%; pѳ.8gA#ig~|ҾG 1T縒ƴqNEn:VU lKfkyQ>Žٵt .LYvOx8Gٯ4ŷ EKRY枰Aiu׃ MXusVվ 4eiړ}9-Q U=O%V50H <t=S<3^wB؁h'' k@ᓌ@[}GdݝBƶMqks%5Nj?T|v}?T|v}<&݆_e<&݆_e:)GɻaOGɻaAcQneSQnePC?T|v}?T|v}<&݆_e<&݆_e:)GɻaOGɻaAcQneSQnePC?T|v}?T|v}<&݆_e<&݆_e:)GɻaOGɻaAcQneSQnePC?T|v}?T|v}<&݆_e<&݆_e:)GɻaOGɻaAcQneSQnePC?T|v}?T|v}<&݆_e<&݆_e:)GɻaOGɻaAcQneSQnePC?T|v}?T|v}<&݆_e<&݆_eSꏓwn/ꏓwn/ǁ۰직۰젇E1~7v2)~7v2(!Lx>Mݻ x>Mݻ tSꏓwn/ꏓwn/ǁ۰직۰젇E1~7v2)~7v2(!Lx>Mݻ x>Mݻ tSꏓwn/ꏓwn/ǁ۰직۰젇E1~7v2)~7v2(!Lx>Mݻ x>Mݻ tSꏓwn/ꏓwn/ǁ۰직۰젇E1~7v2)~7v2(!Lx>Mݻ x>Mݻ tSꏓwn/ꏓwn/ǁ۰직۰젇E1~7v2)~7v2(!Lx>Mݻ x>Mݻ tSꏓwn/ꏓwn/ǁ۰직۰젇E1~7v2)~7v2(!Lx>Mݻ x>Mݻ tSꏓwn/ꏓwn/ǁ۰직۰젇E1~7v2)~7v2(!Lx>Mݻ x>Mݻ tSꏓwn/ꏓwn/ǁ۰직۰젇^7ƿLbT5?˷bW륃Tr\lreyФu7 M3t2FE;IN1]=cY;kP_a8YEq$dJVOp&L9~ͧFwvI?]tƲ'ݰזIޡmm*zȣJ\xetA|S̊&/N >eMs3pe|6:\fŮDl3pfy~y}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}y}yy}y}}$5:9'yWhWRwx~$5#m+s\5 r.I{b퍵&ek>(|z3ov~=:Тs 3ʶY$Ւj;95Q6(ccY;6'W=|JM d~s8P6ۜ[QYFDIayy4; +m5=XLp=0ܬ w!`gw!7d,/#=o w!`y]~Mo KzBo]~X"^F{|߲zB3޻|߲7޻Dd&7셂%gw!7d,/#=o w!`y]~Mo KzBo]~X"^F{|߲zB3޻|߲7޻Dd&7셂%gw!7d,/#=o w!`y]~Mo KzBo]~X"^F{|߲zB3޻|߲7޻Dmo w!`{|߲zB3޻|߲7޻Dd&7셂%gw!7d,/#=o w!`y]~Mo KzBo]~X"^F{|߲zB3޻|߲7޻Dd&7셂%gw!7d,/#=o w!`y]~Mo KzBo]~X"^F{|߲zB3޻|߲7޻Dd&7셂%gw!7d,/#=o w!`y]~Mo KzBo]~X"^F{|߲zB3޻|߲7޻Dd&7셂%gw!7d,/#=o w!`y]~Mo KzBo]~X"^F{|߲zB3޻|߲7޻Dd&7셂%gw!7d,/#=o w!`y]~MǣB?zJJgQSIǂЩ>+QdIXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅iTa:'a[IXvR|V݅ޅIXvR|V݅z'aNIXvAR|V݄TanDz'aNIXvAR|V݄TanDz'aNIXvAR|V݄TanDz'aNIXvAR|V݄TanDz'aNIXvAR|V݄TanDz'aNIXvAR|V݄TanDz'aNIXvAR|V݄TanDz'aNIXvAR|V݄TanDz'aNIXvAR|V݄TanDz'aNIXvAR|V݄TanDz'aNIXvAR|V݄TanDz'a[ ]A\pZVK( Q{Uo7@`6,o~=/erm5U1_?,^g4^"^|z9;y4^{(^|{+tyE$W7{ҧEz({4^"W>|h9{+mW}FrI/ev٪Ǣ'9՗X;짅X;/p9#HyLөm{)m{( 3NX;짅X;'4:}`}`>H4x[y<^x[y<^"p9#H;Lөm{)m{( 3NןX;FpwfDRv|,cbfC/H;E짆7X?E'q4:=`=`H4xcx4^xcx4^"w9#H;LӫhhE$ibfO of_>H:]>]>>H4xew4^xew4^"p9#H;Lө{){( q3NWE짆WE'4:]Ohb3(9#HN4xove<7~N؈>H4xou<7~N؈>H4xou<7~N؈>H4xou<7~N؈>H4xou~xqu8|&i;4?bxqu8|&i;4?bxqu8|&i;4?bxqu8|&i;4?bxqu8|&iՔz+_ g4>m{(!;Lөm{)m{( 3NX;짅X;'4:}`}`>H4x[y<^x[y<^"p9#H;Lөm{)m{( 3NX;짅X;'4:}`}`>H4x[y<^x[y<^"p9#H;Lөm{)m{( 3NX;짅X;'4:}`}`>H4x[y<^x[y<^"p9#H;Lөm{)m{( 3NX;짅X;'4:}`}`>H4x[y<^x[y<^"p9#H;Lөm{)m{( 3NX;짅X;'4:}`}`>H4x[y<^x[y<^"p9#H;Lөm{)m{( 3NX;짅X;'4:}`}`>H4ҐvxvxE$ibfYSkԭG罸?~}i/gDX iFX^DW=g~xKya<%^!3h:}i/gO o>"'43ΧZK[ϭ% 6-֒x}I{<>">H3h:}i/gO o>"'q43ά|'z^}i("+!x=XP2 h @=yr>=XP2  $c#~Gx`T7>%IUBaO}*>ARl& % o;HK۴{ٻ){:=3s̙3s& !! @hr{";GOPj^ 19=w~TBWω(aCsmo m ;0EbG 6; e$ 4F_)7 /&Yq8ȏ8LM)yS0YA^# 07@2 aÐ!c:)7 /&$#:$!hySr\ԩSڵk|]_OH ? |!M$p THeB4rV5TTNI KtoDyLyo?wwwIJQ{Q' +1]&3|媧ir;,7|A4z2CZmt:^Bn@G.I@U &y(d'?aDMI.4~\$Dz_5f4u~zHZ}sD -d~+@? !m#IFm`?3^tsd#UL]HT !tnCẁL`!$۽n-+O"u%gEZ2hɯH~>ԕgXDomoHrBܧ5:3R1H +*7n._W˻~%lVSOdw4$}:mM+ F脧iro|ں'[i{C{ɳimh%ҜﰅY 1 m]SA[-giifdoC& U9hw9 7vamd ,U"\J&7𛴍vqXkUVrG9|n#*#?H!DRȺs>Îi{kh%m"a?~k3E!,mܯnj)?Y^2Kh/yXz͌fHt-*$'ʇZC(3S=LicsӤ|ړ`=,?+9D˕Ji5n FO~<3I|Iqc(?:>ېǎ?nBP$A?~lH㹽f8U)7*+8Ӑ-tvbY'|UK#|6Z L˻zS?#γ믟cJz@mz';T`QJ ٽOtBď?f,_@ oRd .?ʋ |ɖ||Xz6~RbW}?.t>qKp3o|h?Bzzp_UܧFeyE]5|H5zE$ Öii=u~x _ <#a`OA .G=[ L OoR}%3.ptBTr2?Y=?UyTL)RLL~RÓKk5SS$RIoHSo 7~SR^ -!˟V|(#W*a  /)3ܮVJx_GK4Bګs Z?,O$<%sOPR/LO6< tƍouvPbvp[,6Q邦mf )iCC_F-b5o XÂʋ:CyzVY["X[\Wi4&VIn{a̢(򓹠NNW?^ ;wy=~9NAz̸qz0"ɓzr^:K{ʗ|KŒj&_x:eV+ iWl+:t݄-"9!ʷQ4q+^ϰ4izXKX=ְ'\b~ rb=nx@:,FZ'ͷde cW_Ćtݪ5#3ş9Df6X55'tjf>lZ= XOy?',<Tgs. ~v)_(.?p4.PHǏ|D OʀQ*S- ."6EH]|8\E:hbAey\[|?X\Ts \Ca?aNm a= U") ȅnwsb:h{?%?Bl {|.]E<5|q2D,iČC Tvqg@ǒg$o &K^Ö1,iKC2^zY.jLyN&#BƎ턭$>@/?jõ&cC@z#yBH'lyK rt¼IN89q7Wm7츳&Up Gw_M;t;(_2FF{I]U [ +/*mxS:.o&mqt\<{=&Ff\.&bԨϻrL"x鯖ʺZ+Ԇ) Jq;(JLr.Ũ[{~kú[$r] nS,B<`rC'xue~|-sv&SWЬ^wW,\lKN4u惧Nk㱱tz|3ř[WZ|Zɡ[j xh}?{/Їo ,aK>/L?=zeaqWǍz|7uow޹}/r!JD_J:]Am|x%з >aJ/_Am/IS,cf DVZDLI귑99J\C\8:yߨT#S7Qz=nbm|d\#*vrWA(1O̎Yc?~N9uGGvƭ#fo5_Ͳ)qd70.b=Bи|=PaF?Efn&܊y>AS?˽7T϶V|3z| .b)3?A5qi,.WM? po݉aחAt%ߢGQa C"ynښE16]7 6k׽irׯ! &d5JI}`MIaK紇.G O(* ?KQյl{&ż^By-(zCHy1Ę AD$ Y&Z0カugU53۽)k5 ?zGn/=ofXVpǼ7m?M.oy}Ó' 8uvꡔuLV0ƛ0zkVNQpٷb|=w*{id[yŏ݃v9l[-6-˷"_ G3nP(ZM"tRe%`P2,K\e!)RIRNw9a W&&%&y:Nb߁ ?"8oI !m6h&EfMOd0 Tl(~2 =(T#OJoίp7$f_hx}SOkܿ⋨Wj ;Mü7|(P_޶xoIryyVaÕ=''+#CeggC2O6P(98Tz2 쀖dooy!i2/hd3z@aE+҇_ #]!3%t/%*8!ڒKC;Ƌ'F>^ Te,-~y=R ;JՒe91Cq>p84|UXX7[r @*O3?,O?"O3?gY쓌>}r?{S7쑣c&DV ȷPzj+69|^/"ɺ`q|)cL#ZNCXi,xu6?3AmqMKD0^h!Ǝ/{NP'ߢ՞lPɚN(ہڬNsXԲ5j x~4F/I iFn-.j>r+}*]}Re._ZzR]!GffgȄ-âI8tNiy9Q\ud-g],Ujpdu6۰*$z] RXz]VU~ Bb iv6 ?|y~F CnEdծBەqm,NZt٢SNy9k֯%=#d]Z 369zBSTu~p;.Ķ tg]QA]xwiwJV){)ec׮ЯIJ|LCQa8=̥)N3z]#@/'Y&D$-m6CbFt{N8srm\f>ED׀)'4:}=l @1nEHZbo7\notC_}Ywg7߸:7Nu/wdžݳԻz'OP:4(~;{[Ĉ.b_uSN;\?ٹ$jjun^>o;!F!w\ r)Fo/@pTŖ$++9b;dɹjTBVmdX.b$,pK"l}+?aó%E')vO H93K%hd@<+dre;E_?mc}FV \ydlBVqK2m:lf}e%\}c ;Yxo}#BN-!ߏk4<|)KZ>{͡W~W9꒳K?˛ g%=ʢ(eO.AMH7Ւ; #ޒT*h-|oK)2).7O ߈Ta׽9Ơ:řO6݁q҃r$IGؙqe E1&>X͜d z !թZ\-(Iz旳~UϿ|_3~wFjUB #ʯ?Z^SFV]U_ [*B_]TNs}n`+{EzI-9M!Pp*oEh+H+hR9479{݂p&؝8;/8fS^N:ܒء:@6e, ys:fمs\!C(9 IVV E10Qbn183 "X0Sqn>묩RL8_Q~_y5b*Xw^S맽\n7$ps(cko'Lqܱ5O{ /y:~;-7KK3,CYqJ)Ycʇwe+]ϛ_>ޣ: Ʒ`igݎe>˷em)]RttO=JڬL}(s4.plA;al03dfɸ6a{QE@YvGYՇG/tC\|Jq\wP`\64)a gwpJa_fwYc(Vl$9 ?aEfjֶ &E RXOFzf^^Px !;_!,/ْA42#X@DA|:*%`3&#G{|/NT$l*?tdfYc/pאAmzt 8D%;˱ CCsi`GQc9YuZ>ܶmg#iij8U}2n-6biᯬm@9 *X.OQ=\١9w0/veeBHAށ7yOs#C_9'.b-|%%16m|d-!%e!KnOV|4awn>Eu?3CLf.U,EJʐ>(,DAɰ۠+m6_h઻߱!KOMo6ecF~-/L_1lWoDO5g mԮ(Fh(V0EnVqGZw`3׵~>㐬d9";|Kj 5Bf2rf.swiSx@Fޯg{5m=}1K=FߙxZ@{5np9j*BxhKXEU%0$S~T雙K{OZ/f޷׆uVIU +ݒrs9)] z -\t|zʲՕ=aG [Ed94ZaElҕHcN- iSUN^. ~ziȝG!s13_XCI8`%9CNS@* e~L|A>M fJ.بK'l؁}Zۦ | Zz@ص$c;S1,*4:D0Wd&.v ֗BRbӠ8 L׼~ZKSWb^-l^̆onŔrղ3uamk:wtc;w=qxwC _?[wU{xU_772>VI`IM0`Bޔ.NA:GJ\{*L,v=G2)4 {аaM`ȴiw?3 /:׹<~`+?I?K:^b+b)r_BA&TBTL[o%q5Wqy)$ܺɠln: `ܝ8 ?WgeUTo ɸeA>.Os_]1lM%<⼹ /Ϛ%LO "' w&Ȍ7[aU32^jCIs-&9a3 sKڨ [~fYzT¼ne ;b&Lp͢h{Q {7mdǷ8//Ao[Xo 콌oVf\:9yAB/ t&2gk:^}4Gy_9N@8'_‹ϾWn ޕ+WK]ZT\h`܆})S?Z)@n'b.K:^Æ UQyH1؜90>OY m/ ht%EMIVI~cԜA +J|4`dAg<:f詮nh}u+s#|᢯)Ij~7X?/]RQ:$Q\Q_rkuet]UWV)qy>!ƙPmmmED"ׄU?[MQ=INT9~b|&x^'g ~aKT=<;]T%;?ۤB [['{",dg/#Nd #Idc6 zlo37\{;oodnj#Ehgo|+/LaQUArXLٻ[7Tڪ*ᙲrW7P([ٸdX{7i9/e8~igeuwY;z=AśhekxҸVTv Twk\>gǵ?)OW&~\VrArbb\|gV,KY蚷d޳P|oEhYlsKLGs/3h9 IoJyI5'+?w3 JyG .04XGI[t*eWF" O dmqP{ pcaii-Rl0[m&-%*|[dxMj.)RTX5.b秾Q|lj-~{XdrL,MloL1T7vӴ {Ǽ0wWYg4d2}ȐqՑXI0[%}.:ёWX/"m.`G Ji卣vsD?]>p mzzmmcJ2~V^lDl, `8*ڜvDu=O~X_\`E?׮nDŽpsWOEDV/OAo|f|ȟd'3; D~E /AĚ̘xX%׫+{{AjӽKM@'^D6Ze}d=F~a,bnY+{#C=l}6Z H9[2%sxW9pA§j|\ǎs84F;p46o̫2P>}K;:ŘXK`qt0r M~'>/O=wى&M˓^q?y꣏Ҿ{OoTnFC ;/뤒S=AE:Dn{#ڟ&~VdfLz4Yae/_gC,kԷQ70RK@ cDS=I/P $>S^ftާ(>Ea<}{9c6XRzs'Y~B-f= n%1"9/;1d]?sʃV 7wN14}^|̀U尵Ɯ(x]^jEɰKp:/_SLW@=kiGhziU;m9~wKMsؐkzGW5kO]k m,2F%|7*S V2U-=\uE%%uѨ+d0xDbBA9󱤄/KG꧔P Ռ!vcw:4VGkej6H8@N-Ċ!cmS]݇t>+cirr[ }om&4kpT^zF^&J!&;S^}>l99E|/Q>2T:I~+i^d/#cagNlWuq+r>up^o;PrRs|qiWP_9?3oo>5x9]o}q3o xͳKyqfOg4K{Dd9+t}[tk~/N r<_Vը5jf[ga>D!4z ;vIJN{i>Gs/z{Fݱ/z0;1lG8(WA4hIދ,=gO~Z0;Aha6g|}"_φ@s' =OOfsƍ4F n禦8q,M$ϧg3(3y[3)Z玙|,CYzq&E~c͓9Z2,6ʻ B}; \ Y5ws.c8r%9(ErI2/) Rni0A6tDD_=i[_q//}=:[W?][_,SG"EI[K /D'~F)X!;'#+#=UWUj\/W]_ح]<`BwOY,cd箻ΝDCGuCz4{S_%}ةû6zm^o/VF%2vu$3}MUW&e]7gzOv&%|\YŅw(SYj?2sNՂ߾o/U%_uz*!Z!X&TTUJr7b5Ucx+Y Q CIN6[$D?l$V3'Vr8%뱡#YC9876Et~M~Kp.'6ΰ/ھXnRMA>Qk BAX_>?8RW\Yg`AΜxG?zb0wuG5el󑏧>׹%yЯ"6KaOɝG>?/9wvK-=9Csg 0ԡѓgϗEA 'ܑ:hR,} :x}RJhP(q>p]O΂SEx=aΧjD1_/~3x0b%eHcYy6?+^vA ;Y">[_sK Db}9Yf5u\?D2羚aK0umu kڔ%2?"K)$ eɦ' ͷx<4X "!k_&[|7ܩӫ>}_A2_*P`9{hÌ[nOXt+<׺ w}=hěk^gq4Š_{(`rqĹj\u_Jt [!b[BLM/`֬so^(%=Eǟ|WU僕s@xW(mkW*XS٪Ѝ+ /SWU26 Y~9_t@]Г##O1AdDYD%lwPF_1XA ް3KX $K|k4%LXP,]hVm~|݁ݰhnmNM`/\x4۱|6; ^¿֏זoNkԪy߉WLd7-͒q)6qw{r:z)0a0whRcw]G !tܕ0PE R>;]b,Q{'B lspv'B#c[ c<z6 G2t\sVV2V(& {&FΈ1-Bcд$J =$2F}%70P,4aO=[ku5]U?<+-@?_s/im#Y vif &zsh8 [A)W:6\Q l9o-l{?Í/b7 :I:}Wi;?rk٧&}yVo4jH掹YS?(g[N_^r/Swwl|ʵWLIٜŒ|1Iи!i!? #/WU;?DAPe @Dz Nv|[^uX&q_Ј|f>^QDӱ툗%%h/]HXy9Y.Ss2Fr ,̌1qdԯgb\iŤ_U5&G qXJUUY]4ܲҨQ-^xkum7Ɣ]K)3y V0/VVTUrx~CA @VJV˔rpj#:R;=^f2>_-"E'6NOpz6؋ja.Mw޽3<Ǣ)>*RlUKIСXɏn^x͡5]R1~}TWѼxJF暕1Ķ{Co-QciQΫUl8h\'&)6IIq]~^lՋtRB?vc<()1l]qQq84|ͭ\D GGvuB/$$^T͓ժojwn+p#-F=FFrZ!8(9U)E;kfRj4|x iݢwOxLgmV'//x<> _WqnG7[2SY+ʸeWrχH]M- ݞbTrPRFgћJ $Lxu W0y \wט)\w:0>p3Ջ #TY+K&W>enڲI-).HИLT(5O!`?V&OsG. ᴼ "Pk?.h)X#AMaKTj 'Ago{dSR^x|~ͷw:*H?f=((<"W7屢2?ՓN>'Aʁ{Hᩓ͕ƏqUm菤ty>z 6goc0O嘋JQ{hKhso]{=[ `q%7o"[C,ʓ{` rEVΚU6fi:Y8N~L'>o>qLy|^ٱ+˺WU>Sz m-j\651*ž|vly+u+ƕ:ONp #ȁ*!0$ՄKN[֤t/;SbKqF۬//*JmW(Ao70#xCh,nh^:@oA%WYB l ?Qy}mXɽ,pZ?lk-~4Y Z!쎂0PvǝCBS{&x7 +DZO^)ڑyg+F*&[Vu(O?Jꛬ[-U=~Ub=rD.jH0 eQ%/rS+aoz]65mˇ' %#W襔V+H|P%뭐߭TnvG岡k}vxS$&<<{xT&eNz~VHkUR5j-L8?:1>#Il}DAh`ἆsTѶҪv]…_9%`fqް% 7ʻ3a4x9wW*7%㰤1Ӷww3gqEF2;(xEAvS+N ӟ{rβ~4g?L_3P[Oy=sAP@cHo@h|gO-<]=ΠTWVTU(7 K|_[Y]n{tf.lNm)׋\_+zmh_3Ys::kJſ/XՂ\/rrwBm;7˕XX*+21u6-~լ2:[0k|^PY+Q)Z~ƵnՕ=+n +/mR.,.4"BϹ|WT2UeMmi4G\Y[#oO g k3LxK7Aא8_Hrjw;|'8>? _Q/XMۑ|n:ExS\#Yw:" IN?4?1eПuQvACrIaLKʋ>26чhȩ;\t$>|;\>Xw_3Y\) OݓԬBԤ>z_oc~ z/ր頾'UT7^ކwz/ {;*+B]gOs4Uu5KoWqσUe|$< {zsv.(Hlqfn3Ѷ笶ϞYݶ7m:~Y1EwmJy²;,1a(n.SÞsv܇-bʗs:7S=ѮϊX,o5 +azT%\Xz-e? SzW:WCtk=WϜ/ ?= >zfqϸ3G2ˑLe` 0J7NgZ'cB1T.#qgөOSP>gG;ܶ$K3)$1+ [te(~~"V;ˇAe$ gIs9~r;GȒ)˻+UT.8y"%%Wʠg{ؿ"=vWxV]d\^m60e"Nlb"@*j j?hj9BeR%tN!/k$RO{XVmF @yo_JZe_}X}A]OPa}.v[SNjZ 9cќ9W=)r/D_cAf6>?Qqbojyȷ8aqD8مltڟ¬E^r?lLX?wԘxw=4Fc0tP,[{}i$FVpsۆ1pn6˱g Ƙ'fO߰5+WD'O(Etgr?{x=?,O?秙(d3gvG\/ ^%K+Kҟ_Oi~)Pՠ|q1\Ɨ]0h>fQOt8?{.mnm6+ڶ987pVg:\4Bcyq?oP(6mEX_9}nR;=)3T%ﱼtlu9.whߦ_ZU+o(eE^ooʿ@ܿ)|ӮS7tF(HAJ!I{ &Q7tėK[*`Wg^5֧)45rtdq 20`iS}#TjI34rX=z_QX.sL5s4n7vl=O=γj9=f KM[ t96=4AIYRJ"iJ"Q~jEU|2qJ[U J!$qc28lkv{ ,;-O4} Km|ygBeEU|' %%' MJ%r}"O W LJ|0>i.G4QmD7)j8tHbS.u\E6^ q+h[t-0ܹ|۰1m>68ؒa^:>1~qں[vQ#QK> ڜn\Fqѡk<.'>8I04z*daDy_`\%'2ۛ~,ڜ#is];2AuϾ:|S Y|w 8^U=={c;3 yv<@q| Ifzg AHSī% |3]JZ- L?3IQEҚ[fAkڷ0kfȽfgE|lۥ\VAzk햤ݎwbN7}hy 3y3|7So0>AZ5Ȉa{g̳d (^wl3Ube_aDٿ{ƣֿڣ4JpYYџ֞zT~tn }֏JWrm'2Ϫ}Z3^J4P{at~~]nxك_Vm*[/^i/hP^17]F*wD {COt*s{hmWβrU-1 ]YCu ?pIꟈV;ϑqWw?ypK,ee|kVJ?oce̶CˍU8et)tS鯤R^{mp_:uSٵbeSu{o1rmb9Ssٿ_)<{ڕ4r@dJ=&^pZ/d/_(R۵rtR?o8Go^t>ux778{/qbz#c _Yöc{.BGp/(8UXe9ޒ0[3<'N>~|YqN_Pk>aZƞfZ|YѓÇel3i@$553mȫYxwE{iS8@/[^<~)h 螲=N}sɹ_ş9h8/6'^|bOcyZi<##㳵ۥ lCT!й^~O{d޷[\,_OWW}n_ ?Rg?WV_4=f~|.dֺfѳ9i^ץf 𥖉/vcK##Ǯ9th#=zcG>|TЏ;BxSGóNW3([ $l S鴥Ž}<? jooP:nմW{zYuL?)?K> *]K<7뙞_@[`F~& [q>;{sgo[9=\oG/ϝ:PW酓DmO(|?gN^ՋOϝᅴR?PoW5hJWI>o})8eaxʿx]*ޢy:g,%o`Ŝ3۵'5~ Cg9O{ohcP t52@֏iK{}ϻ?>hW+f~.\A'ߝxL|;] p)yJBz:o=#o[['S,,iϔӾ{xF޿ү~m,$} 'UOU+eR獸,81'ޓn 7=ƾ!/޹Gkp28o. - cw@|\{ʵ5΂܏g:mY'r]ɣՇ ƛyj 2 7 5;kWzп84CѼG3o^u;⇠y >5/E.~`>CUcOgy$q9n{x]Iڞ k{|#o3%-%=ϯɡ;~%xo_tiw~q>7ǃ3G"}¯(U0{hv\Mo+]7vÍD@8õ2A4WoUtcg_*z|ڃ븎OɧϠx߹4vmyCxv 'GO9q (mqP|+#tfs>kǛa~kK/=>|\nջ{`0ܾޫo&o>a joޣqu?v<vŨ߫^c9qensVs/j>]נW ս90ڗQ,|)Q~GD}wv 9#v;FZPυ8O_ ^Yڍ:~ɸX7ӝO_:m Ǐt:_y٧Ψ#o"u q9U_K1!up;{^r'?qMOh7mY f #3?|6;`j?os-լ>yq|Fެ7ܯXsXzř}() AȢs|r+Z٢oy)\y) 篎yz7=s.(k0z~t=9O0omj=<v8m}/[o_#;ڛyKG:ѾmZYKGlbi}ol=M0LZiWsɹSn­Y^`^a 2߬׼%yjm͖ѺeYj52`K'9/¼FR ֔\rH+~S%F]rꪙ6='9S +FYY Bή554Dze̴n\Ȁ獊% H6Z%q +_W|C FX7gLb^`! "1s8`,d2'62r|!}^%JVBUŠ`Z*?!#"ekm*̡$+Z/ n+,̩4k4l1$eй:z\>֫9E:\a!6L1f!O toGoBRtZ1 CeQdw+Hb<3,x3g<$+YViEn0 O5zCbh caK^edUa %+I0wCx>ǡLW0kyC^_,"+O?*Ƀ KrCb *@fDcEl-ǘUQߐM;Zֲ^'|Ч8s gY eSק!p XRoR__xbѴ*L9R YգK_~E)ȀҫHYZIN+R[Q+䟗ߪU*qя?@_d.W>ˊeS`6zeJʪK'۲/NP[Yt mǿ$YǧzV~+f7Ro_7WriBL,6][x3g<ŠO]1L*/|ׅ1ODhHo,9 bu/1\w5]wgYƓo)V*uOJ=X7cxɣM6kҝ:Ut -K>DﻶHK/Ym: KF_k'U.} o ֓K[}jա#B^mTj;@x3g<xەO{u/5Wytl2-|ݿ-_;=.Λ]齗amH)Q>mu&hD[l CrJ'-k+&ZI:Q['o? i@+n2u=aR!ʘk@j@p!c@cZ/_W|+_~$MȏM1jL]=\qSt/XMp1ϸM nL^3c |d;lۆL8K"Hߛ@{w&c2Rcڰ`o8XEH)?VW"tw: GT~g׊v$R'qcӮX DI K0Z*'sRZQo5+I_ɥx3g<OH~XƷSljꩵF}-|lyi ╬$<W Ĥn@@zEῒ$93פM6%#`çL1"]I,Q[hrbEV)U^k<e:' hUδEr=yWx3g<~v=q|%Id.z}~J_>Y46>j$#Ϫȳ:\zU}䧟~a~=W|`w'ȓ#IWk A1]v9nӏ#,+^ُ)cDz/r2Lg:әt3d{ /2'ٖye yG)]Gɸf«Q1|TA~3g<K|<0_(_1/9=0SV93g<x3ǃuF6˯_}1#|k1$c?劷Q-hF,;/g<x3񌿒dq=K4 A2A5~:/@SGqx3g<xƿd{xsA+h\^P.kk{ ڭF+nGokDot{V-V:mqOV}Gt|Tt3g<x3퀷Ѻ#K[J kM\Exf3Sg3sE&+r:E މfuz*S<<(IMfEBьqRbx3g<+yӊ+'SZfh 6 YvA/7$ F1X85{5Gf;zhv#=zf>~L @y04p{ZGr Ni\l9$1g<x3ge _3|mah}qv8ҥ}}e%ntz: ΜIϟO=PNξLL1_nՁImCkS*g<x3g_IuӅzۼtՅbO-,H< !ԛ6n/Ngrlf%+T2rJp_WMS_ͧj֪w^k0}J0g<x3ocr:vjo[-t*#V: /sƲGW b.YyzlyDܨg׊8gd>m 9c }55hfD$3g<x3v;ܒnɽ*n';,?yGEPjNK Qw/+Y}SiU b] K^ﴈK3g<x3W<}V5OaA>kE?_fg|dUgZWf ™}z8i^FMq\(ٍ3Jx3g<+]+\1_k}nOOt[t!vXhLK[;|:LlJWDSs◚zX H{l1N.tm` >g<x3g7l֪od|io/?a'iVmcL0zGM;߈I)3.p*z;|Q7ۭ50t>,2d>g ?AɹN-9='He_Mw_$x*Y!*qށK`=Y,8EGP,Sz-mye7yPZۉIa:;x3g<+?` ;g."-,a < >z.<f5k|Q*x$uqӖTޟϥS\ UAJg<x3g<$Y"fuϜ[iM}20g<x3o_o)ao@Eg1"(ecyDa^@qAr~!sʫ<-O6zYqx3g<1gs͝si9N5ŞGy +kD5RI,yDZj8c|x3g<+o 5?yq[_ TY59_WۭjSnjnݮzpnN,:vKn+̏Jg<x3g6|X\'N<\o;}jT1%Sfk,3dܑ׻FI3;Po#b<x3g<J:Ql{$m'X8>Xeh+1]g<x3gc3v);)ej!/ڮ _{yڢ##əT=G(ns]ӺMQ݆3*.Nk/GέfFħj*:iS@M5AVmӌŲ6jtU9I[{a6~֪i0赫\nkc$kߕg<x3رd ='/ϝօ9[Og30/8yz^\9|b}bs^j֪j7M%JIoz `x6׽ZB(pz_o5SB )0g<x36\")NY˯z|+IWf%ES*Fk1(`>^u]ԩD3ZƵ TB BEWW)Z ?W' mgnEEqp"!O\)E2anBeB{m/> g<x3gsսV#`>ɿ Yfua7{#vl#*;ߪvς-"|zm\oDѨsXڄy'޸(b%0i]cxq*F {@Gt"<CAV=܈a8)^p;HgVPwe<x3g8>Ig<x3g?^FБG p=|ѣj5./c)o[ 5>K_+V~j3`llj[_oJ5z&LpnD';[` ܚ5wȃBQR%!;@9U%peWwL⯜m!ev` O3g<x3ކ{;S,X_X\_8szn"osMr+yk`3}{ -N[ KOLO}|wŸ`)rԪ'zV/}ljۛ_ž Vw"XTپv DDqsz(+IUչ[z]X{g<x3g?VT*_Τݕ4Fd,q/)Ys .IRw\[*Z''ҚUno̍Ox7a"i0[ sf ml|&)V=hW+w`00 ۊgMgQqN[`RwNN4.x3g<o9]3gJ)?Szq./ʭ:ռZf&NK7D(fUm4?3S.=0f|S&:0K` 3zKC~RMfL>VlȉSdW02= OswF۸BSUsA7Sh4x3g<xO|ޮIz||E%s@Os?Y+sʸ#okn#v~ NCYڬR8gf{p ]<UJ@Sh^5`X/bW< ?oQ@hWϕ IbvzFD:P`ΫB צ%jT#W]C?_tg<x3[N||p%ξXf-Ke^ 籯w^)U+%ILAxz/g ~{llSoy ?$[]?X\Ӂ+*Nd֠a<x3g<7r.{>YVҙвqzϦ,}MϟޡvCŘFm|*9톎i^{HzWn/ѷ/jA>BZ"l\TŢNh^9W3Lg:әt3}8zKc>\C T1ȽI@g.g4/xCt71=2^xt!˫v:P_QU2 ]*# x]'/ZUN<_)h\y߆/>]WmZ'i+ݴ_k=tp1goVs-ܲйjk9tTR_eʝ1,Ɵwe>T_^v!}v .̃[~gR492 Ibг_?6Cֲ6׵ǃ7q7O&~Wlg :]| әt_>t0K o!@?r/Tx跀"zi, ei,d*F] JB(eJGٮWh?> )b_1掷Rm:#@^f=Gdi@.t' f>wi#nuSS#lx3~8cyG'\@Spc?Jf cc$/ 1Q-Y1K>mY?۬Xr3Le2˹ߖGO㾀5ӚWoiE}txMh~1࢟Afv^1{A3!8WT]߬ja ^5g<wʿRrB!S(O2T>f^,,>yLz-.OfTW*@xjmu}.O};l׫`?k?x3ͳ1~Cǎ=z#H?rȱcD@Ed>)x+{ƊsBe%.UQTYVVdp,TZ(<\#䱵ίfiTz蒇F)Fq/ [' 1!WB ءzK<OZ;/?>٬?p…˥ޱ53'zb™s 9>k\}l;?A>+1“~Kg}H2, kZ4 py$j+?Dេe/J֧_:^dF\(l(T8X$P$z4hP8hi+spHp?{{O <3K[K6Y/(?.\p>+n/NٕL*(W< &Rs7?ϏM?aPZ^xW:r+N¾X﹆ v0mMKk7| _PԿl[blA;΁wvbB 7O+t[E52dzJ'u=ٯmk[Ztd(#&kn+~Rf6J'|/4hXh;`B ONy\F Th3K{}ci^j);Em3Lg%SŖ_mj:e?׿+=~Hat1=p _'G"Q(O~0|7=_!Ó4ku>TFyJUI"ᇣ{d4Fy/z4{OU>PT}K9 E7/$`k[7N%M%Hm6b")\֪UGN-!}'Q'4ZAQ;"9cUMncW< GR,j6P4#mHkx?I_4~pq"%/fmg en"n֨m|a8Z{VѪg8`nc4~otBէZՀX$is`|~*UKZ't- =GEO5>cXDNmTaC e/I$jw >8k:0e2񞙃ZQُ~yav@-???9I?'d-O4|<.s4nz<8F^;]V)iNH7шWO(UDI}i[~#Mj[ uw,+0ᝩ΂s oHP')3_pU?5?WbRhkvTx_ mlh e& (Qqk8puj#Ze/@$&%$'V7P`ݩm 2L>Џگ.BaEoH|&/=.du`C hK*#X+1Q'OШ7֩FsH(cהKfEA%Զެ8uSBh>~?qɉqt*Twh8diя(Ʉ:z,z`N)WЯ7`ѡP#773r Ͼ9* tN"8&f.?UЬ5F(NSVxx-mz:_D"B67tvȼBٝ;PEVe}ʤ tTD/l4Vw0w>2G UUz-G}q_`B BjYc g}L?.\\NE/Z^nz]q{)(z/ON9)ȖB'fCo[XZM8KK _ޝ-2~ UTtOPp 6Vwuq>^7'nJ}t$--8ѿ^e6ց ʿcރ̥͓OOM vhI?҇@{%`R5^mG_7y/k1{_'&N#mi:%< E UpkbRځ~jz?2= P!2Gz%5n{~:J3>Jclg糓qT&NDÒ1e"E@Zd#ƛ_'q0(I{Zuҧ*Z%"] P.9#}#LL6B'=D6noM6}j'iZn`g`#Jjjl>w &f"^#dU8S E,Ƥs[ VQꯝD2~)fNľl-ԟ_'jp++U(t_L[1L$s[vvn06)ZKbfq=L/휍?A[t u9gSǿoq?@.\prN&Zȯ"j:M @|^to{ysk`6꫁ zM լ9m0cbՒn̤BFcO=?G_ _Lɀ1ɷ/)oX0؆&|btnQBzDmƺm H~A$SĴV ,jhtXJhs,g= –Ư64ո5Zh+gk(uɳF O,[ᑈggf-/bAhۃsnWʤ=_v 7VVaE>h  2= ]Oxm2qTJƪɯ~in'H:}t:X_;WGMH>\tx sKe%Ec'Kpk3W\EZb9&<}\y)y"Nl^W+:wOcql-bɡ>1N?7 y6l}1V,=;u*?;%R(?Q!~7!sv$&i'M#И|3{g^3&->!j6p>3>K6b~aH=" .\.KMo2ig3p.eU,ZP}ufa`@n'-";u4~N;qRRo wF˭DG(|C/n>UJY@`g.܃vnwuiWǰ'3*2W;-hotakaWZZ%/`pQ(}#ҳ_ 7- Ye0sYmhKd0R@[QU.zs[ib1dU>:=FZ]6]{;Z} 5>x-}DuثVTqMё`$b05lR#L1$[䊲_ZUgʫO R#݁c-%>t; }d0/ǕHZ[맦=Og<?*j9ϵ]kSNWr_>ON/ܞPCX+kڗZլ|ZZL=|Ƿ7v]xf^W:nݣ-rQZ릩0}q߾ xlo{3~V z[-g.xA۾:?L!Q6_Ea'҃v鷵_~F;OQF8A>R0t1s03V+W2-uj 4';VT.zұN?;_7NN]7-,R4J$S} D6Ѕy*kYOOco$9@jXY@08i7i[pWtItz |d|sWig5?G't^d DnsfpeMHu+( @7L%Ckx=/"_SDm;e_Mow]17eFyL'r8`$<辈k7&z;27r-i5s~SA2ަ*5JXI__[>=yx@Pex.`z؛ 1ͺ^Kl0/(y cC75~̿wtkFŖ39'}׶86;ɯl6 o7#?qț`}#o8揦^ھ P`*G:1b6F `]w+1aR{^=q` `p ?kF'  ָl@o"W_6O10`0CLJ3.>=I3I.|lA?D$ p3bѬgQo5oHLjo\1.=y;&Cb~|bot+=ypON _p:i[b˗ &+ LMQOOYXvp/WSC5V*jIo<O>0-0'2ZM;y'*۠;x5 Art1Qji+ƞ _HI`x0_eWxJ.L~UoML\G      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~PD`3< 蹲5a̔)(4 ݓ\#[lx[w՗~؄|`jY!%p|;8||j#(jG؞gi䈶SVDWpLN'aY5k_ [MbxM!p5Ms$~~+S]S6E63s=KJ~B˹\hZQK~kbMC\ GzrAE(q'hK'4EIaoDio? Ùޖ~Sy)%D3 J? g6/:8әt? ւ/|g1cO"~E68{e:6Dw:_.[:Glӻ($)$,6R#*$`O'OZ$|:0QW uZu Z~:"*NĊDd dzh盼 3eDN-!TT+ " X۩JYVne+v6raހ1I'y[SXH/DA1#DX"$[bO0KEVFH ۑMe5 uW@6lizsj`aG}$"tOHL)`觪6ɖÁ@Vi5N~)?=GUsHN; nOD/mCy26Aȏм{su-g.z;[ɭp ʄWӽQdxWl\G/bg0ڮ/T0{2ô?Fv*U5G۳ٮn6&qZ^ W~ n7oNY/vpSWIr٤w[Bߖ"?t3MKQQ}+:vfb92g} n$ sȷ#j%l$b@TO$HOqDD})AZ߇a!3 0+d\`?< dLI+ƓD1B<5ы Ÿ 坊ߒ,Cw=z CDo8sw@t=c_Ru%/b1:i15`|7?ƞq?0\E0Ejv21ڇ)>ILzO'R j# Y/(]PW,CJr=I[ O:_j2ڏV(Y$> DzqVl'ur%3g%b@ $>>5}gi a4Y9'd=B269:"+ȶ`vM{<8_7\>6eآ' wm\KYu&)x's?W_{ xk^4cZEpIVծ1hN 3垲%x` J ZPA!1\p&3zVZ!sѷ/b-1JOk5cOxJo,ݗ(>_FNM [Rw)4_dhN! bɽǮoӞZ )yUo0le?޶A$-Fωc~C/ Lm-pypkrT M{QP=\R^Iʐw<8_T ĐF̉'o}#c?3 y^甽}26%`\mf0.]D@Ũ{uʏ-W!,U Υ\xh}mcXJdhN`?zPAś-f_EwjW/y0.l4ƖKN9ITھIWWbL=w~D\d 0:}\4xE]>ecω؟u+pZv;塶К9X {k~o~pԏFό5P];W,|Yz7jomݒ`gF2;gD엿)[P~˛_D&.\pL^j{0=Gn׀9(&uyFj/еe#rG>wF$2Fb}<Sn=0}_4pm .\?%⍇Ė=1Jn=<{/Z?Wv&g k|>Vz {gIx\~u34)V^e-O<õź ayE>\Rze%c20'Na/[c/ISo~1Lh0&;#w әtjO5uk[4[~3O\ҕn[X'.m\]!W}C#t3gW΃oooV#@~j"ۻKQb{CvR_9K}jøƺI߇8!<~a. .\5Ͽ}z \4o<[__2ߍOP@m=CcCi] Т}"_߾!%}cҕk/ }.w… .ozm糙sy. g{Fw1{D\zKrT{{/ b@KO%e;kߨys {`=Ǜ0i C?z=Y?q\pr?-G1`cz5<7]jjCWқg՛gvfe{b?xz_c{r/p…[k ?CW4~>.68U9k:֕` -SzKql^,w<5f?Uyzzڋ/Lul_=&|kFb2g<`S0m1}tqN/zKkFG(sN_yiMSY CЗKB[RĠvm yoØcgd6JCXPKyfVУcxUmuV[3gvIם?jxOwk۬yYIBÜD%EJTCj'e^e:әt3-AwS_9} GzglyG&2ն! 1ׯk[#wP.f{hAfTű1b̑7t!d^zcp#Kq@$p$ 3V"B̠b "+NZ ]OP;™n@tN'c7O&JI!sBsx}Pk:B^BG"X =5!"s80$h?'V1@Eª ψٍM*k6{dJhp؂}F{hF“QL IWFHf#dH j&Cu2(6 ?/yhN{jڃr u/@Mԩ3?q&g1U`6.VӶҎE=9`vT"c[VO'/$I^*esYa3v$|7L&nGh/ ؖvC+o\ P.myW`}OaJ% hSS:\+mgZGF\%?]|CB̀h uG$vVi[$-ҪAhH|]wzpHڀviV/co:63  sӱ  |@Bw 6/B/M裨Z9SX yuhv_BzG^; Ju6ׁ3ѱA{0f@< d2o?)fCM$\YtɁejG&z] =/`?+*4hƪh8jdbC߯˜lյr`8\7L%O?amVo_75Em2Z?l LѮCu$qļ pƂ`hjizK 4wt/౫g66NMOp3 ,y* ` t7Cé7$&&:6mZmԏE 4Oo֠wt?^X{pKrbnr4 >`Cst; _F0y U*j8:)mof$W'rvfU3(ƽщølt6|"N݇jÑc[pzq{{j'Ҷ_0=9SZCONOh"k"*߼ v |p}|a{Ց/ڕYUQYYπ_sfl{lm#c 1 $%BBɲ{,x|]窱nIEά]U-!{XZQQ{G;Too䍼7F_t?K? /7|i-puP`ypf˵@O2ދ* n ܔ)~MpZ_t 5[g c޹%A_>iSzz]hs3mUD.:]~ ?(oa 2dȐ.O/u'>@UW>kgnd_z1 1*`*S0_ LuUBș.u0I9ao^1.?zulļ\?. ~QA=UA4| tǶ:3c1eF#蘣FVG}yTnjtGE#T{w?s;Pq4ˍz 5GhԱ`7<T 7dȐ!C.6L3zSH'W}P kAB%'l`s'+Q٠2zے ߝj3a³K>)7ngR T'ʠX_G šy*СI33)iHU9W{N'>gfn; [/D疀$ iTݸs=RȖ:xqd(r;0?jA;)߾D3 _zc[c幛7E.>T aRҗJqڜ2ZG5t#ۇ *BkJ7*z^ hº ȖJ鮂/"•{{z)ޛ7; tzPߺW|~*U5lg_d$'/nH7qs4b Sƴ:=1X9HOwW+lFqb-iK7|7|7m@XX¹?_wWhۂ[EzbJ.47KE?3DYtV+3_[ss9toq Xk53KaF=,iUjj*;ڪ+1&}Hʯ7au^ i|BI#jtȮO?d[.\:+Ƴ 5n>; oD[*[Zub y}XyB':}ŸtJػV {3oH?#?An)ԗh?l{FN]ƹ.04l Mcb̝Ʒe 5 mQ$ŧyROP{˛`t:}^V7Fvo|zzTHPǪ}@W]t"ҼGD9 G|`{.ښX/␪5\/=(|vF{o 2dȐ$߷St5'GZ,A\vȖ3U{»t1* CK[1>.w|5FJʴ'`gWVSiҨwpgt3"n<)[8 P:yaSPUO#(Ugh!+jڂ ۹$.6L?`XK3|4[hZ)"Rqg(Pg@_!ymJN)U7$y&ovAK,st$_FH Z?گX[>4uuס'?/ g7j:DO~V|3p7,@4n@7OyM9<^OZnܞ/J,t_F-{7"/qP{8h#tF ϿuۋƜF["T~"5>NnNON_? 2dEDrwn[t.jA(%03?Q-P&-%ۤTcc;TAYyNϟ0@Yqk5~8ZOVIAKclyf Wb&ʦNÄ7,d l s|e Z1'/SgKШO~NcũfNV@b{Da b0AJfn[̊(f1j%t(f2+?KE" =+8/\98mV>;{b Gfv|xckXtRݖڛw=<۹#{t"7%VSr{lV޺E{2е={z|33;N?VIv2dȐ!C ]g18'5;A}NO~L5sx>nF5ҲuXd:Q~edz%*U@kgcϴBJnnqTe59< --l=*KnY,ڬl_r=[\*#CL3 dw;@#n.3c]Oߤȑ\{ʄ&ԁZ(TyX5,4ZS]A!inN["mdWaӬ+'9Uaժ9zU.g9]xcao8,%v)h?')YpFRؐ!C 2t!'2avQMD7ģa~_#o䍼7F_ycZͿz3_ <=OT Wg ^ 7Fy#o|=5G$Ybώ4a 5O*`EhjVIo̎q0wG!QO[l!J+M>qN/|Y~Hw.M C 2dEY8: ) Ґ`PP``3J?ׇL`_7V3 lڷ&2:6[Z0Ấ#sH{v0-Ý \ߕjּא!C 1U_OsYC =`'CմDtjYG4=I`7NPnr &?*p oP3֍xx|HkY[)3&8IVa}ײ ?_Sj'O7D9gEvW CX ?2ѿp&s0caY-렕=I}(SQZULl~_%!bv|Aq˾+Ga.d^Z6U>'GeN _8wo0~CVKPje`rT_1<X6:VP-l&;*;d"j%-k.5V2:~3b7vyR ԪA)pf7>9611ΣhX 2dȐ!CIo瓧j;^f2{8 $s(3VfEL(H.tO~-~H>>YHҢÄǷZ6l "&bcrP*=z{)KHnVeh#%s~΂/#c@y!4e~G؁0 ~vk<#9EuXt7YOV˷G#^ݶFTz%-N^;Z3|wtPVFo9v˰++_qb۵mKy;[]!ۏoE3nwͻAT - H`dtwO %ȺW˺2/0dȐ!C.yCǞ}pO>'0F׽'rVfͥ|K2AMmsAxHfgɗAiYO0]v;Vi 9|.6f&v?AͺbKOvVLjd}IAFDž{i[2wErs([;gXW#kIM^24[6.bZ' )d}v''s_4.!Dx/|Vm |+v6\q- mDg( :=M~/=z;QN Z"#z{rۚ.ua>Lx1& jsUa9Qk/Jw4^`ã$Z'6ɳzJ_SU$O0 ƭM)Ub.].~mϨۀ!-h|Lq >kg#Vᯠݫ̂H궤]>OS3Fy#oj' ;ч>Vlz-rba*c@D*=eR]F0i ^dG>=M(eaP`O\fK*[ɷ-9ά B; !LY j30{hJnp);!$ܪm;⟦Wmz)%jb UFAA%@Rܡ-*I"ʀ8@[ӓd<&TAt_2\P?Ƒ'Nҏ^%|+%,~>@٪8uvŦbn.jdmIEJҤJ^ o1+Y:Ɛ^D!giyLxnbO\Ytqg>d^gH]^mC1f +? X^d/Ezc.v;Ȏ^Zt:{LCwֵ_A38(3{14Fy#o/};axemr.L|(lD{Oq,?/-~#yFAAA"Wff`B'\vX_l'/&,eR莲BE+\Z)Ke?LK :x&_ >plYZ$P5yOjg\z${-C lSAĄYu#r`RI\:ID&S6>cG7j񯾎mwlD ?/$T*u&o%cKJV\aRƩ>}<[-Sk!AJ\3, },|5E12*e`TmEkT%4zY+7'a.J FB^ύY4ilWY?=#?1:`4z9h')R.GfMa{լ)p0?ӽ6e.w÷u8nWi{U^xW p |GU,EVUu,U^23iˏOԏH虰-0"8@/N>%+Yt^X3qi>h5?*#Usdk{ԭeQ9=u<hP",D2#BS75_0x' .gߑز?&K{ʨV(]j#"bxռﲲ][ljBwo7 ln:,Uw^1Pg"Т`A?$5&wOyhoԺ?;T/|I0D"R^x 3Q҂ B8UCdq@6]!u#/>o ;<$|,cQR42~pmЦc!`j-Ң.vKa3щsQB/j!G*&U^qh'۞t(RC{ñJ]Usgʐ!C ) JR4Ǩ>Ç{W]Ar9+#|2?L]2Q-,:aI}|MyXF4,UT3;.f\jS! A9 Ot0BNMr^u?;mf,MT;Ǡ-K?ek w?UKU'zʯ閰қ4iVwcT;ՙXg2@R]MjT%Bx@?L[e%Ŀ4&shºx1zoio?㻱nS7fKv/#u7Rh Ag~Fm*՜Bo*}J3g2ګ,穲;2}bv9D|G^yZU[^v5sZK$ڲ+ؠ6Vu!eig$=2ܛ^#mui:ߐ!C 2tIxD[{?ypWӵӧ&哩ƃ`JȍRuju]$OW&RSA9@>a樊YǟLj=eDIYA_ܙ#7`okYgD$.RF*;xK@k0X%mD>&`"/P?>RI$Uw4CMT"?Chsγ60MhߘtwʯK _JgUFTc6MO w,Yxo~7ʝͤwwTE>;#3+g+v\.-jTmEje"{k]EF]Uq`?{%vsthKE^:mڪՔ*<j`u )H(5yuL}u^!H۝Eް2CNȆز`"/GHkL++{U~,B!cC?|#y#o䍼7򟋼ܽ;XͿz3_ ks$)s?TaSGP?dJ5Te ~S%<첥9+;UK3ެ/W҆kE3Hvm>[Zzk=f{k䍼7F_?K? з'6Pdo%<|!Kr2~TtJvTЂĤw_}C3l.v%#*Y3ӓn>Bo؉lNR^+-A=[}e C{~58ѵxUϊK[:G:op9z`'g:4zǪ%ԳC=e}϶ޞ_.ɼz1p.ʨFRɧ։nr;G׫vh[fU 2dȐK.F/u'>@+TG>yejƫ\I~VF0/[>;t|Pjo:؛X+v!GoVuVr(/'7=4Fy#o䍼]c8ψ}XeѠ, 3-ѻch$%7X?f:ּo(= Wg{艟&?;{fooo}*}Y@OvIߡP6 }[߿Y-p&s caX=DV[ewl'GD_ux;EKzwd9#Ua5Mˏ/>|EV;i˞{XӶvyѲd+t*1LU!fȐ!C 4)IU3@{Ўj{j?Ks+gGA,L\yǕ~_Z;l{mV f?O?)mWHϲ䜠Z 8.6Tbx?j 2dȐ!CC{{\/)Iu;Z;>g2;m;EoW0qJw |3?2r!e u^m=Y ՠY8@*P!ܝQk;My#o䍼7F2O9g;ɰI-W]u%[v9 eKto;; cs@lwP&/bGa||e  JR˱ݱ/`whWvJ9b>h,JMO:)2{5wgeƤ<,e|՝p0閜cxc"#-Q}n 'G:v+l"T7:>)ȟln"$vw>X9ǙI*M$\T)}z0lkӰv>@Vb"ɷZq&p{$„*öY8YaW9KU⍚x ERU3-%)b`/; @iF\A>ЌEVVj+o&qȀlUktW>qܡ8 cN +H @kM;_gRTb_^3/q[Zd<^TވT6WyG#3b[i>O LGXw,Y5E7ʺcժwۻ6;{{b{P0ؼȻtЙ#D _\ͅI| %=ϱn_D  K[6@Pp+fd>F^Vp 2zOΞ=|H~e)F nxd]1Kޠ+ V&X6~F-p"v]d/n` ΍cŧ.qDn< "/SCTGDC+xY˷'`sX\',Uu0glix3kdl󋅠Rju G范?!e=o(:c4ct~/+mooom@XX¹z 6Pr3j\jܙ(J53_})X(S4gAF;S`&l "]/u9|B`wڈ u,P.3A.xRaRi>Vl !liQiV#yw}rReZ ,uMܒ .m6%|`g37<`x:[FQP#"x>伇<*t{0fC(vPLE{%w`r*n|f5|7FSlԲl&7o*NFtBR; xy=qhq9Dݐ6IV&7MMJB֪vidءjN鰉v5yEDxa?o.{sݖ3dw C 2dȐ$}ӞO@|BN|C=W=:won^cOYSs?z*o6Z0gަy[6tq{SE>nPiD 0ty6WVu`ci\quRտal5RR?Oٖ/|']!yzPd$Ň"ԐIv G ,RWDL7,]1CyGP/q4E0_ 5+y3*Rl9.l""k}׬Y3<nP(Gg: r ʴ+| *O K59ϒhd%ն:·O}#!U›4j,p`~|F=/-EWB'<&掙d2dȐ!CVFrwN|~'6|KWSe^gپXTMsF4[mLExP 6]1WaqApBwZ[rNLЫoܬ3G42)JV_gہZMo_,SNxO# W܁z݇E]'c1e E&px-ƧrI-;&@3~z֦@Ԡvj͸c-/hx>=[0٬ *u#c4).=Oaf,:_mhe_syp;.=>k@<2zk:|]9n TAy4GL܋I^B vG Tw> tݹEԴW/B|-T^6<[6+ӽfP;TR#[6!yۗ!C 2dhg18'5;A}NO~L5sxS?P*ͅ=X1*R]YGrg]KbHi\PUGz9v7F#LE#<&:5)&=[RyVj"V)K|Ԥ4mQ 'q% ^!^)[,sq!LprA?R2\ʓJB 8 iF*O8a[EA0u""<4# *3Fѧ[wnusV̒2=BE^ݘ?>OZp\䱇i `_;5E!ύ7mwF*w0ڥrġV\G]yoիeAe8z3we;O_f ʸrXeJ2IM8g+`]>ʙ?yza6Hnֲf%C.lpK9هedAWKYϮ˷oeݓ-"W@4#bDj}y,4*lR5Nl.~& ?GjvՆ;~*_Lg.Md<{R52Fy#o1HmW>Fy#_=ό,S!gLֲ3Ҥz-y=e9sW/Yȿ,8Q6# 5]pdx*81񪖟ǰ"GeC+`D*7.}{3KP<ĊZvն$'D?Z٣>4~e/!vO x` ?h;:g߈e'#3_j׊u1} U*}Y@OR]+xʱfFرygc9q4(-{,9wߋ;1V&2W<;Ndl?NӳBK8s~ ZgWt?fYxȐ=| 7|7|7|7'GDwJq? ft\"vH:֍a0cf+Zt0r8g_8+WgmȐ!C 2"0fvTSYjG>3kVBo,fEϲeCJOr(K>_>ҼVf_67k\2;AJy"vIf搭gl9yZD񓞉y ̃g21dLҤwF#㶤޼(IvZI?iFI1ԫgm]f5U[rNVf?hb[r: k']yKi;!i;D7< ,lLں'u0 4dȐ!C'2aDo񪫀q{<[玽]DϾz^Ɯa1||~͎ǘd@2!ǀmG4W 1]?8 p\N(0+7_Xft[lOFArne1glc/O;6y&t1ɟ.ጺ+DX*pu"ϫaz|RN_;Ώ;F-bѿ;m M^[BQyHr{I{l_uc{NYQ^~B+#e{v/yRmLWyU? i3 #o䍼7F_xds'>Pjڵ-5A>v't_W3RAwvP.a3wT+^1փzb$Yb^CF wR.ynIHgx٫?702H䫡$Ts[Pg3}g>KC=}F ߬~3BHy֥&+ke ߓʻjƪ̢]۱W}m|t՚>xd|o.uc- ]}h L`[JÁ. 0Fy#o]ct5Au95oYlЬ_w9pib'@ڃ.n:jSE0ӂG@^~jKnA췀sOњ@VFn+ohV L9ձc-vs|P%\?w6%[ xxY$&;_cZd׍je<7hFWg@%7Y"ױ] ?)ޕO74ëp#2PVd{j]G3N[ AܸW>ޞ#)u Vmx+U%|itL!@4Z/8m[*b&Aw[w7|7|7K.^+\bqG!)lpA`k铺ARЪ݊Z@Yg: )UJ%&Dj.:󕙙E i? "i#dx>qdսU>ݔ9 9OC_15PM" .#aɿ Zg(_Y# ߛ*RQ-|7<Ȼ2},=ELxon}PgOu6J.7Ye ev'$kt⁼9 X*L[T X1'k8PƻJ.BYcM\u qá"G5ե6E+9Zu5b?rDaE~RԌ3+e>4Bk+Mٙwљ%Og΂z%6a/T!!vڳ;!C 2db>̧QmOg}+7O'<7'n;Mg?)O?f$4kiE3@[)/:OE@Vߜ*k~w+얜I*@xrQc͚k;[t 4D'jEiFa ՄtTw9w M,?_v"R|*Kø=ábF1XgrR^լ?z)%}`߈!)J  Z7>J|:C/6|RϮc$I< DYkΥЊ`׵S Clٿr{_vM;G:{mE:m,utRld-=*-KtI|Y6>U]79xki^l!kUĉ43;#ml˰&®ۋiH{MwL ҿ`әQ 2dȐ$j{{\'[7}i-3jB)2]3d4j|,hOX/Z0޼f$e[,,i59=Y|"HoM,leֻ@,!ٸ3S?2Gqtb~/9Mgm{Ȫ</ مf xrj:3*ɨ(V@> nI hxG[*7RQ!8#-4QRfB&d8-&oҿU]hރ:)љb\*sG n& ߙ&7*Z\7&i;-,Vkf@.\P{SHp5tFY4?4 BN8$t5S@wO:>FNwFёg NCKtCK07_XXAvT}tpЯfanХvsYfl0:a#)̤{Url}j'b͸V~hFy#o䍼\%cZͿz3_ <+uLi AI}r-d*`i{W]e@IQ_7N낄#MHnvM)VPM4–::37T6?%K,v]q*x+V\%> sM]?s%`W ǚM3ߟWLBpèjjU𿲽.vi=@4o|7 {TKRKKS.R҇)qݱUG&-To-,-4rs=@LJte2/{6e@4ȥe#tzF$ʈ;PhFttQVŀl:P+UDF8J3ՒҜ;j^y#o䍼71=5G$|? _ZS.Po/ϰnL6bRU'RbM50yoP6`rO&,QGSAG`cg,7n4aO8Z8j(6)UmQ9Ԥ5k/pPl%a9ٵ۶@;*?|g>Loj)y~ے'Ɨo٬Lez&Zɥ×Bmn{WbkΎvA4٥r3'MOfJ;xTk#07[@N}^>ӭi5`5&/zVweF,ެ%a҉eHduqD3j2Yīơ'UV(d{ 06#{Vj{4%|_\פ2dȐ!C.cz? ?t7\u/9)l9Yd&«sF#JЪ?ogn/ruPzg(RyrU|&lY %g[zn}(*ITW+Ow-l6l̶sh_aduT>e+=rΖeR8?M EǡH!'JTpDsqΨO푗ؖNiZY: x *XS:pԩIa;S,U)HYm!C 2tYczO^뽜ɾ`۝\X 'ݶ'JKzwr_}lԱ#ئeq12C6lc $NC^Foe"I HIg֤[$ߎߤ=7l[$֑DMZ!UT/pˎvlH V1]|4*.Ydl0ꡭUMkvђ{c%eogW'cw 2dȐ!C$}ӞO@|ҭ_oc0_">1$UQG;M4$/y*R~$ԝf ~;?*R&R?5Gcvj!,C 2dP/#&)'73|jLútM/=hCAtLp&+R[a5&e&W C.P4dȐ!C LƧy#^]͢榌!C 2tSjf[JڃvTSYjk?GٟOBuqyi^OA+eiOgYoXց}0O~LfzvYPfk'L@ ¿G&,;,t(cWe!C 2doOj?rrNį 4l<[wzh+Sj3Vㅿo2IO?@s=^|*{9YfA Z3;V\ww> S]%lY m)Lenvܝo1cC3Dmjſގ1y#o䍼,nSk5YrD|#p2Rӫ?]- QLxyepz>TRPпx;T+J9ⸯ[?ofӠV JZ +AV.$ Jt`{IJ%tNWcش$Pa\oMo䍼7Fn?K?  (D#1dC7WL i-wVP; y`1jt'K{%]q]D-1ZWWٕ)yq+A=ҊY 4c֢ [ڔ\#uKU=ٯriP3wښ.V?VmzrXAhȐ!C :uA?_O|</p?Z{Ӷ_8a7kf[I^thVwkVްV$Q>op6a4O2}_g펍u\͟eo+zAGfIpg,<[6)@;.V!qEw8ŻU'qgϞk ee1,1`V cYBal ɲ@ $B#WI'"38:59QYODFFJK:4)&t/k>ߩUHJ3 ܫXa^ A򢥆?U*P }%)3eeYVLOcEt}>d%cv^j ) XW+N jX.r|ZzeFyݱ cAHjMs }EEsw -i͐S9_Izq[`oR&x@H^<{`+g 60#L/ KQݮunrowߺtd߹]7B8gwKԮՌfC 3sM17PE˃ݧl*]h3t> 6wl *-ˠ0UzR4E)\"Z^߈!ffs̊8)EFmS B)@e%7[0ͅp$K e\ EAE+@A>V"f32EGZYiuvR#zMJfP#}*˹=prn9?f3p=3W58qdP/I1 c&VTQw8K=g^hul~>X쥴950<[ f<p($\3*75"^+<~5*;G~?G);l:l"4w'Ϳ KX{=X{AڨȼLJ * n i2S?.O>,=9XEl;,h]2U$a[g_< PsopأJJ@ڐ9mi{)ɳ%^YΑ|60ci'˿}D4e! #={SvӉnM4iҤltIrO{OH9,{qSRGJ|.*es0, -m* VL1-S{;ZN~{XϜS͞[HU(X 3KW4'WE}TyI ڑw]MΟox^~鄔HfCݫ>>F=7C+(uuB*I9=#-s|QϾ]fmBi}JɡmS(A@!07`&x J-cid&ʯ>НcA~*OA|Rr!IK/&#ހ"6@)3+|':z ̋v T(]&xf~k8t+"UI_ |ɸv9q60,DQk\Gͽ=7/Fr9T#|XKRbK=&`}+a+Cv+'ui(dɞѤI&MO?WaIEԡ P9p?K-})O*0 6a8eó=jҎ4*:_,%KS~f*q̥OP9򙆊'Q}`*C;+K4P=\hI:@tgڪ>BQu4 8g>+,'9v$Nt[hר}<bitau<?EqlNͩfu`2r>LP(mjȈ~MPtGѐ >ikOHiyQѕɥg C<r_6=8-s8+> {;:RS\H&(8jyW%:f֜%5c?urj؅vZO(i.n)m~v#\^!WgNk~ͯ5[tR+P$_88竘^]E{uⓀkgX4 T}. #AFgSvt{lG=rv\'5K}Uk2b\ɳ>ViY܄J/^@ABOȧNu;RM(.o1}NJ7JkviUoP"Ҫvkmֶ99|Dfh[{5pč%_nf:e%=#lffGO/-$necc\wIuwKYzxqy!/?'kIժeWoϒ6nq%"h)=xE '7M(fE=I#v_eqk+ T/W$+rFTgcbH=:瘡NqCV2?Kx,Q!tozq"|oG[AVM=y}T,c*oq޼ ';nyr<%W?'3~XXu(ߋsoݤ?ßq`y^A^ٿ5_'?wKTr>?Qd5zbsiN,R,-.p;NE&?L8g,ہf9EW⺜+_gA'kҤI&MC^L&]_O}<[7 2%{T,O3dK uh5r 4iҤI%U3(x%?(Gw{cBBQjtߡ7iPMݛA"}Ŀ"D..T( zhnvݮun}q*?xlGW$xӆ0 G~rj<{4]vݮ?]r.]orOXhz8 #E8˚Xvǖr21F?]g( Q9fis>̥%vgg}C&M4iҴP:O@ot&LX''5Vˑv~Bm&M4it%H<>:)w텢yp-%Q*3]Zj< ?g.G'KG]u 1m@NW1nG_d/KyM4iҤ?%>gRο>> ^\3'{O߽?34=ldك&=j CagYLOC<ފJ́͢s:DNNڟrȌ(J念y$??q#)RX2٭P2O, ^OiZ!J:_NF;9\~m\ 7X =`gtn >L:7x8=z#o,ZxnO lٯNk3VW):?bp@T S/̊0.V&_BSK(}Xn]vݮۯt:IW[/\JOgHS$fP4a!eWNBh3a4׼}(R5imf((}I'>/nS8pZ]*U*F@im;dd} (b";uɇ\wco-S$ٵiapm܏[,Rx``4f#1s4VKi.ac]wK*Wyδ1Vk u xn%?x+6^$sxS"3λx@)ZO@^Oϟab`Bl61"زM -^RԬc#y8 GҶA FXĠ[O;תbǻc;~Xfj'G  YYM'HbH暔g!%n3B+I3}b̝r֤&M4iҤIi`m ![$#O\u)0h@8xұz I^ AtJ։ㄩf~0vnlX D-Ubq#ۢwY c_fyM] 3<)g5/4xZ)g%ޜQ@_k~ͯ5 m,1Kv9#p:왷;_ ݶ(",q.I1mUz(` U\KaMJ]:9K1Eˇά[#jB|mށ-۹R!yROfsξV+?&hDU?/[ʃ6_)z[Oi ePK!QnHjUj"$5LMʹڒafմ~}$qoc9nbSWITl?.#=G"'PU@l끽jUIi8g~M~Ɏw82J9"}`w(fp@>V I{5 ʴ5Ls WI{H:Bއ[X܁m6|XO+͆+)Z{i~ͯ5q?wKTrG~xf'µ@5@S@>%Ko+H$|cJO;'o xq6T?:yW$)'ujGR7fyիxνsxJ# `; 67HЯ!Ixq"Eqbk~uG1S'IM(n4X ۯX&$Ax1.sc@ YےjdNZ)%󬜕m:Ȧk1xU,tMs͜4D]ݠ<uBgzLgIs)Pp 2EzƈG({fP \ܨt,c8LO\=<炚˷Jrae*kȧ[jO"`)F*v4I&M4iҴyAǥy\_O}<[_ժOM狔 Gyχ ^M€̔A TgFB!1ؙ sK+Q!>;0ۼiYiy`IUšZ1~:P)}ՄDw! oPp6gGf x\ ~ZW)(5|%>wV~CRs-5"WO$ ~%_jU|2-g4Kj)gLq B'B+6tE-,OsfQhuXQ4q4߇Iv B>J@,F I>NCj%Hi9Sk<1J*3{:ӯۿLp^19B3;X^TK% !˨N+jҤI&M4--?'S׬_P< 7,S5“˻|>;TnI9Of&83>>e@Q*PNKݽ3R pPż> 6 Rk\oP &*]T}Ω)_5kJ7*)"m nѼU_O8 Xb?1SU9p8^'?(s{N\eC$see,s /b:dd7$wK UyD27`1:Qm+f*I/΂#YCܾ.w^]=N1K.bV34)q~yޤ>=N6M)\3{ QÔE׌m2Dx Ro`6[AW\įvv9`|S˪]_vݮunWg.>ۑU?ֵ>"$RT뷫x5GqtZFŏ\~~STJ(;ϟvzf9f+h=U(Jݖ=0oǓU[r QbLs*Qb ;dlfecU/:ϑp.ɸPt@G|3IdNEab y wá`F. {8OӵWM ׀$ +/@NNUm=9L F:ߥެtCQTi<۳n]vݮۗ?~WK;O׮c(Ӕ;%Rzk2=J׹C[I*a1vD}Tt-Z#U$Cڍﰉ͟5dLSBЂ]{Q=bjcJޓ(1EMy ǒc.!AiMIf!o%9p Ð yJb蕙WWx5-D{֖y8eMGOaLtgfa4k ^o؎3Yi!vD4uZTߒ P,aNҤI&M4]:O@ot&k?׮aΨI0T,wrd&*Ľ  4iisz,qРIeo9!q̺o'zwgh Q[P,wEWvSni=wΝhҤI&M4-# ?;yS}w׬?/F/S0F8/Xv[Y{zr^tbGLz}@Ă^:ZzIgI&M4i4__.IwOQyt)_x/ߟVOGl<۝)&3.F``#H<;x:IbPFz_ zY8?n iNޟ3 Oujw6n5פI&M4}Dlbi3JBO:,"({IшQaZMwOFK=|0{5Ыe\^-D[z_k~ͯ5oҩ3H{,/;}J(n>i/_ <0*G5_k~?;'Q?[>(|lW!]I%؃vwzϐ'C sJ~]vݮu_B{W:R?tx/ s=O^_*}"ck> un]A]{'ÞNg霻Y͗TyW"Lc޹̣sɅK)OD5ُ֤I&M4+Qwi`s{ImM^G{Oܛhxrͯ5_rV綥rճ/]HgN?X^w͒!3K~m*?7#Yy =h{Y]L"uG "w4_k~ͯ5j?,@W~w cpgHOifۑɖ\5XɈBVY Л.t6@n̜p}Ɔ̓~/h/PLfQnJel?9`UvvZ֑ =w2w5HG,!]< +B l]<'h2~xCN<6hܣCŸ2ƛqi1|U{<45{ItwǧCE6s4;Pa̫!~d"\}LeK c7*OE5?ѿڊgeC&;A]zctvݮun3Q3]_GOpS߾]we,J~k ?G ۲WGI$Nŏ YښCYI[m{maRxe^yJr^g*[["-Q=ȳ2.gSr=cXJa,ͲARvw˔}Yhʹ& G<`X{ C`Ȇ1Ε jAE.nM6a/+ ^3㜾74 iG:䉂ɃU!A@sK/&E].Z)KuM^ }ȷѱIO*ͶC2C:!08_mKn:] 0<_T#vQ `~D+3g TZʲHkQ^4̇ Is5QSIxO${X?eGh^6NVI;rY Wnc&kbA7~6Uҿ>V -o''2;d)F^/h&+z;oys`mhV6n1_no]c~yI&M4}I}z>}^%PlRX}s& -%GpvۦcHiib,{p˅W&J@jmo㄂ZMJi<ے1(}kh41qòqaۑ}~8j[qi&>R.?X4o/Bڝv& 5lB6VTuld ! T875qFdW;cP8{Pе`Muza gr9q gV dݻV^âV\GVcV%Gϰ,=dQ˾$o+ɪ.81ū[ɱ!{d﨔ԣ&'^%z/R`eoNiXi{I|L|e@sLӋD|K_&M4i1;yS}w׬;_Kx`LvKՌjk y0?JϓS9|ba R< <7Z+gPD0߬>V'\.GApXX׸yIgHӢ)Tz]dFs/Ï~n+GzEچAxh8(Hx, ~jata\?xqw67`ӈ@AqsR/s9ɮ9ƙB9j~jm7@lN.#-S9H⹐yyvο=w 1)Bg0pF !ONy `k5;j\z}"-?$-fjaAy&$C>4kavvhEϷGf90rrG#،i.Rio4Huzu=a>~x5gٯ!>{,۱ d]ܕZU.Ci,{,/df=3͎WҩJR0%ժRQbw'w Ga;9*K 4%Y_/@;;eט~>];D4iҤI&M_{"qj?ׁ% "#dɺ.N@a+KͤfL(Waz@~edB.l-5NQrQ5ݠ/.ؾ!7N݃ǒ7OeNiBYʻ 31V旗${K)?$NꫣKs D!u y6)_FibFXrBvԎP TIH. YTobFLK|c~ؕVK=?{k 9\-W`efo\wum9K23_j|+yDp+$?(>d028[`mw~)a}&UʴaQPJ `mlY>zVɵTsSW;9voЉ-tz,SyS͈l6GTU)g xWd&Ǫ>d':yӁh$Owu/*HBDWLJ3x2K.֏W1j< I]8;;~mVk~ͯ5L'|"Y_r6,j6EɁ_/{Dw! +`tV/Юv 6D'9S+%ecITD'`3M`J*lلpOuPh .('Ӻ`su21lj3W&8J <6 h ^f[rYC*15CP"/ ,}*S"~Tȋl cl./&mC0:q<O ]#)ga>%tԙǤT"?uQ*|qϟ}**xdͿWɿ=]Gӹi H|+"R#ӤP9U>s.bQMWV#]q( ?vsӢHsL} qddU֜D 9Y*DSS> 9UԬ<\).Gd-)IT:GXJMxgk :d'9]NI{e*i'O:Վ?n]vm\_.$}:U_1~XP̩)`5>pER%x&cٸ&G>> S ]JPJxZbH)6?o v\Z.oط{ڑjClU)ȣcśHJU;j6A#! HtɽQq$^݀[Q- +Y=T%25b wf fۆu2U9#yj =h͉]r1.)UwC~2)^FǾmώ8+w&Q_\@b]w]ñԟ3K?GR=q]sQX[4n+=p>V) }8Χ NSK<"4c ;f$9:D{һT0J @Ͷ#UI;5&JiU2[\]]f|X;9.xjlz+&,$g2ofN&; !n%3g-3%M4iҤIgw,@9_? }kcI(w)81-od2ISxDqQʾ1jd{38oMSIJ;Rmtx,G枎&ɈsMZ?IwG1)7;E+F搑MMP1TDSY'gI첟ϪvwLLJߗ a2" ""hZqre.4.MJH4ea}A`+w԰ĶXL|_G5'h%Y];&M4iҤU3(xqtoŠܕ!u³;%7c$ԑ y˓agrMuI;̫gxn|t//hnz^}GW'/o=vݮunmOLW9g;r\T_|~y>Ͻ8(gDO-vun]?[]r.]RZor%<.%/'kbQ dXWb|9'sB3,/gqfiҤI&M>:O> XMVNl4iҤIzgwOI\!9S@'YZD"irTS ѕGê -#g, 3g4bR}]Gm_4iҤIӟk_.I?<9KrY׮uh:4iҤIOO?W|'5}N/Z9i%d\(ʢ.;ur|-Pqo?/kv8&/0潅m5HU]F%\Út;qz"W`Ak~ͯ5EON@w=.Hyw^/=&}KS5Oǥ3kX2֡@8Bs{o|R!n < {./w;]w_5o_k~ͯ5_w·O.}ۃܝ&wjNtH0cx3g]e^0#مꪗw fg}D. /c%r?nl7> Cv J>~2d۽wsgck)I{72vݮun/s^Ni֮ε׬uǴv3aH.noC"Əgxei4A!CH`[G~ WnfA!@'xxֶJ%*W.x-x%˖~҈ zA`Ȑj)+ad^x2nZ{~dD3dS̢6&M󳖲l%aF,=aw?,2D,+?vIsݨYZuqg~հe-XωVe;׏A?{kXigۤq,^W^єSuhŋ-yz^W{4]vݮuBO=${p#9Pyqfۑ fPF:޾Ӵ#^[r6*! T@ern_Gd躉<n]$Af( ٶȳ"wM56:z>7l 2/EzD5#Dc];J3sI8&Zlt6? yLd²iUN~2w A:q-= fw>M$VZ;Jl4|vYa"-av2b wH ӜR~r=c1?>{ۓyAF:$YdHe_1CդI&M4 J~Qwi`j߼ QՋ(rMtESӑqs"Q,p(V t08^}uy""Ϗ|9pWYw4JdxQ-+]xur Lk(fնL=} Cle*zVc_ iC|q' %߮vrW?t݇ T)ӫ>ŖX3Y3;-KͥZ#IV d'FxWd0ă>1mc(؎0 gEHE2/@}6#q\ZIKNi${n)S'!H 15-ieB25 DяM?oژ;Y84re]΅Oz!ie !ivzTij==7S4eŲ:Nxbe>V;_ XiesY̔j5j*L9.iҤI&M'wy []~7p탅bt|l>Vz*HV1جQ{\쪼ȯ % o+m}y!#j?Fq  yg-{A۷AD2\ǥg#WxE`t /6zJ'@^ Ӹ^[{,3y@xnc˺T"M|#j.us~~_%~oró溏c|>hD5_k~g/g (S9Yb.$rFt\v[]DHx1_^dQ{?.1xU @)Ba=k}eD7J[Nj<+LrEy փ!yXxG`m6+Ag7HxȠWծ!%DO7-'z~u|rfx&\:$4j03o+$_Ĕ9ͱ}@->#^5As"2opmE'RX5%%zn[T'&Ô Z!dTY! ̨10a팤grwZF{ `2Ansh_^S-> Jv[ƣEe_j]EFUY hǸ?sJ|ʍnHX‹N[s3 ?/#~mHo/E/VnOIJH"gNE)2Cx`HׇA$pTEX{|o|R@|-}ݖk ?,H2ZNi{ %N,C]Jm_B1s]fviZ@ՠ[dԨ =Yx[j\٭@珺=WH?"BB;Fi*>úx h~h<i4ZT$ @ϼ'B l̹}Τ01*ĴdZ5iҤI&MyA<qHF9:xJQel}'E ?ڿRݰlM 8~E!eQNs!w0~} D{=H'8채)M9I2τy8Zw`t^ޝ 烢$sv=K}-p"KTWȋ1!Ҳhvi4xNۧ:H'J%R5Wsa_=A0Bu'pH'/s 2̈́?ű km9B@ +ȫޓ UfZ!u?@xi{|!72@}YY,|*-wxAosu 7ۼGUU?̓I>oQr@⋵̵79.o2R 8KV0M|q |8(@uSGI#"yb!KFrQ'23 UHH:K3}q E Y3;G#feЧD's98\R/&gwT._JUW%>޷"oun]tt]<}#翫Oqk8MWTٖPQw{O3y;qsě!l_Jʝaya^6cAH! Y !B F ~cUYUy3+XZvEŎرc__(~>1Yb`䥩M#0pf;]ul֥V{ '!mo3_gsK/o/\Cu,b fȊSwkxκ&KlnVn4JTXPb1|,-6@+ۖ-'<uק'=eJYyz//Ehe~2bQ^m } $qxe9efǞURRRRRRRz_1:y/o٨J.Giq*7u3"w:ַ*Hf7+u;5ij&؛\pOm|7ry!o+V%!bƜvǜ5)Lxg4u!S񿒒rINX??~CtUP{SRWX?ӵiْsǭ8,1>r.W}oJd/GG+̦4ccU|cv7`49Mr9[I/ aN.hS]QW,lgfJGX7;=\+mPIg!j%m5_&5wC7!g9=-)m%xe'4{\ն4Dk\wYW'ߟb_(.iC` SRRRRRRRZiY HP{ctя_x?؇۸Ƶ$}WoMeJ'3:RE $=8V:s)MH!ɛSS$NFÝ31{_A|>ԱIT/UG8F\fm}:OMbPxQ2MjOej3 oo$Mv98s鞇%eN4p|>]%hucIt[+%N؂I%l^WxE/9y[8-WW~W~W~Wtə#IoKC?ߞ=sB___^ߜF!!GOo]r^bUn̚S-%Ρα|qqqqOd>?8sh/ _G%?jޡK?秹?Du\u\u\T?rʁ$J\Ik]>;u sg*L|+%%%%%%f%@{mǵ}5pSUh;w^WJJJJJJJ%# \rsck+JE:p}Q쐥Qr~9jܐ3KɃ2>MnHCNmupV!ܛnL c++++4ãc'jͳϜѨc~}钋W?F\)<1G|____?%jO?> 0c? NtQmZDc㛞ܩ[V}$Wk2,hy@{cŘIszY~q*Mrg(Iz_$oQRXLg}i]Fy_F/1\N>  O|#}<2 > 04R/KmWbKVdI\ߓƿWß|'=;::::?<}X_@?;9:qѧ d^X/3HXeҒG7ycy[CǗķg3XV*a/K!+>!q臅rCkΪb'VIu\u\u\?eۀjwϜ>

ґQ6Foe3[n  E)2ٯEϦ(x)%%%%%%sEct4{?X{}!gY,;Xӎ zeXjmkcougADF*7ކ.t!\'\jxxX.%+gV3lݰVϷx.U/jw=9_o(v ` #"i[aΟT~)Bn,OG?Y\J[>:Y=!>WMR#,Cz(Y) Q!r7i9b!ll`O>qBa{ۍQ3Ւ ^ !~FV^؜]Y+}{)!K7sm(% [ ܌c_a#ۗJ':\j$@7: ?F p8`Y* 0?z6ޥyhd? N=Йix]d Z/U$Q$+ a կ\r~Pԏg,/A\bR痭4G@Z-F5Zf kPbn5vM~9FjeYGd-/t@Ÿ:H󌲻&f~ﲝ* wr;l"*WN)M`7gf JrGuZT17gۀ|iN;`LQ'{Xd u_ _0˶  5{ᚋ/2 o vgEJ.:-xߝ.P.-Y>3@^Ibt@>O7DVˀ_ʚRT`-܉A녏H 0Zf:vRApc!w]z54> $oaL OvR<#\j~cz:<|`"vD 8 +À\Y1Ifz$@vqxutNmmdD+_Y6+H; ˀOwa;zP (^D,s}p;&v8݁=~a MTaUӅG5K_Oy\#riSlrw1L f ]eKT._$|m?֪O)]7@(?H&)wif]<;sbqkW$9FsJ}7& XZ%{Ov ^f3,ψ@R]l^op)ck0SZ]+[*Y>*Vnɬ#ZZXig!-,¥~?K2瑍]x'>rƛ@ 8EF=4ޒg&&LT\[,\#Sݞ/'&YZ]$'oHxKKD FFSog̏ =STbR+´xRKF+Zkp`a____)w;ݏ>J뾚$&\ @sLFY&'s?jA67fjf TkKa9k`8T y~2!t~u8.H.dz8`?;hŘEMnYxYD&߬ZcɜϯDc/=%j( o6n]:K{']yˣ*߼3UE:5P"[sL}Au\u\u\u܍7y~/3ߍuK׮l:z$QU  9~ =hfޫUCpBrQmFoDA{3dE({M7,6k~ j9²ɍ Hպ;-h^.QHgf [x| \9`jlRNU+rtp'8MX+օ&ۓ@xxuMLRv:6nߚVZ%.()=Aïc ltd?׷[vM؈7ᗎCQƃ,s-zwni*pɴ>qA j3,Tvɷ}4L"U74 CӤ\ԧi20;Ŀ&?D˲.WxR\c2X9m/鸎븎븎ReWK |+o MqwNq^*T_r6s~Қ/%Z`}qFluGA`+6 ָ<2# #u  ]'+f@;?`u8 ۲(pN ]@PρԺDHt(2V4 F0& wu;u>&ܥz{Lr,nSCT>Xڪhо/kƴ{>?,EEԹKOА7$7*i+ç'='%M'jS O@@$+oN3RfB&xh|k5^3tF?E%K  i8#Hƫ*gJJJJJJJYE,1B&rʠFԜ#Ef &j)Z'_^],ޓN ԺZJP;?aD68o4Si 5NUɁ]®ʷg%I9ج]۹y9̺f(kwZ (:p*{6噛uǕsR?KPVu2f+@e둙[<:/,HǶN림oɶO+Zޛ ݓI'ܕFH[ĺI-Y LW@ܳ#9P)m`d78+D!G+.9y(po>'yxs"< 8,B d)N?v3a^JJJJJJJJjn? poxxu|fh>p\:|܏du+t4yLr*@Z%9y,{Sԟ_HĢ? zsjyC+%,m[ϸĩnsMK7i`IBX2x6C ֹPg~ms8H)]AC=.g4m蚀g"9dMf[aK[̬d9S- s#sU7Hs?&-Ķgqދ|y5`a}&xtIg,F]frXxxG_t{ڡ F>>/xcŷtWnjg$G AϿRy%ֻ=fD}3,yw/+.]5='____㳙|~3Po%T<.gF}Z8ese= z7U= sXt|ߦ*2/rO;sٻr~2S=4p'|39CU_h+Ȍ3S{X[sOΗlKf;dד3X[=g=_pvOEiȮڞ[,Y2ɞH둼mh[&qYۜmώ~":u=_O頋֍R'/Ӡy-g *ʯʯʯg_ͿtIgR?NyQKVFCI:ĜoDXN[kw";^҄S{3ĻCAA{R3l7w3 ?8!d/'BnO}F"gg}>=ݜ>KKǚ{u* o'i.wпCzco[wRRRRRRRRZA]Сd? NAA >C̹&;v2bQޯ=i3jQ;,FJRhy‰j~FaH#dShs p2cxXRcҵ+cWC?g=x>Au\u\u\u\L75j7ߗ+2H&#ܾZ;dg?Ku\u\u\u|? ?t1_A\MZc.35ꔱH<4-3W%-WJĽWCw[} 60>cRO˥ 4oG>#t())))))}i$rv\WOpErvDmge24`IF lKW"Q1,Lױ!E/idLv22f g16 2=KTZP#Sr2.;/6~+؟m䢌CY.V& 4IrbFK|DC-yeKRXQL4OH&;gwOVؓ 0h`W\{ɦwz:mCr eȁc:x^&{'~c{lQ񿒒1ᇮ;^Pc߿󶺞`ҧ됸թ̳g9WYw;ǜ,dnA=<پ#+No|RVH^Q_8$``9,6z>V &,veE=x/ŽAB 3;Oo"z<^tlJzco<ّ!b[ .RMyj^k$GFmB 3n֮گR}nF&ak<+DJ)d%71j[%%%%%%%RG>ӺE@J ](vXuЛ=oUw7*r,ZjXv#<|}h,37 !6فxiAY\COn3>ï9˦6d 5IƒYhުW)iT$\&4[-S3"\Ŀ`>dʹ_΄3pD`4Ir *8HVh.<$mls7䨠KzʱuD B:wZe}'@., ?E%>X3niQo]{&_Z3 f(_*]/>'^v8!'ޱSmzX浘QI<B؎pc9mCQ4-4-˼ "m2M(` L ll_F(@񿒒 d??.] 6f㶂ӡ3\|xҧkr 7?F'9˘P^-SZ_ 5 glw`M%fؼ͡ ⫳3Hf\s/ZtT@`f7\ro4$~?nuؓ] u';xwIgķp f2y~ _gxGFuDr(qeKmy[MM/Xa7bt ݬAly0%r<5>$.xŢ%I'RS'Sb.|Vۆ@B?:$k?SvCzٸwݶ ay4E*׹|7OL茀͆Bak5M#xV$)B^)~HaFJ`ƶ<34.qqq?Mx豾 S)zo\`]|2_vqLz\TRmOJ dFq?\+-vFAzlͺ7 T)>mvẐ3әXa9 g"D _^3CVTi"#Su)p*Kdܟ=z703(s"8giב68q*Y醢/@ Q_V}{q:ʉWZZ5yJ?UŴ"EsNqºμW4Yhǧ Y_afK& ثfWYg!]-exh]ڗ UuY%Lt4Ϛpx>tv%Kbf }u8Dk@Gh[8g~g!'opYڃ9X5s@^o5|.5lK"ovX0rj/\|qvMX,y`[ʵLU8f*kg+YJJJJJJJg>@|l?Ѓ߻"ʖቅ[rN$|C@PVR>s8sհd(O~L /h !(9'6w\^JI>v1/x:K-n_ 9ܠ&3_%؆W!hSn" X34cŒ l\!ё{sy€m5i >u'!M r%7g1\߳=_Lq),Dg(Z?R ԓuO͜7篹śTEx}A } 4Ԥ2|2 ǜ.nTfxRJ?5i%StJɞk@7qK>GFi/CM+tfS!%%%%%%咜?;zNͯ5kk<#Zx~?YWV4YDvmɔua$o*ùJ$}Vv8\^+CµEP+osӹt~ f5 k[|H܈HudN%8:brߥMܱ|`l |2mH 9 Фuj)$_ʍUǶkrt7֮bf`^kE$U: m)oI"\Esɓ "mC EK`UY,ڞXRuFҲDemdMh2._=gٿm@ ťqX./oҗ5gtRg<ːS'3%w4y53w)))))))EY HP{ctя_x?$tGn,Kڤ|wSY~|n=$.=g$.9gnYe cZ \+gwV.%$鈒x72WFL Oޚ-G9IkTa̹eofogVC5'w9n!,/ۑ7=ɷЙew8',Ye ZPevmR #H(@'j I7 $w7K?mQ8֜)VN"Sn91Bj9  7;7А#1o^é(WRRRRRR:[o ToƃҵyKi.m3%*d%Cl]MdMi?/Y⧹CoKQew3kF{ϓYFx8S,Sl4ܓgٞ*RlmgN'5 DE} diҟ g 3#+I~Qrڢ蓬[ߌ5"5RAG8WGTjcI~ aIoDyoeW++++ OO~L߸*"LV5U2q_xKW____ 9ҋ!jh㟧W,}qqqq||s9nsWqqqq_>q _?zBiinG=uiE2upsCOj(WRRRRRRRZ1n? p?ޑ t-ϲý䏐 a,+++c'jͳϜѨcM\_7ʯʯʯʯqjO?> 0@3֡)-59*^@JJJJJJJJJ+ J:#} +ԟrn=߽L_IIIIIII,!S#rJCS+Ssc?U鸎븎븎븎xgO=W?wG\Y}~B^҃HN7!,#3`d!DQBki_%u2+cNR'zϐy{d:owgY Y褟ͼw+Q[Fu󓮻NHVoƄd=-Iox lk4er?+))))))) &Gf<.t!WfQ +ez ͰհVkհ\A% x?Ŝߓ|}ۘK̋fHZY3T0(ȟFCAa%jp zYq+^.=g]2{?# n1ߓb;/5?8Rxs2mY+++3G>__?C9;}up'C,n"o{Av T+wr;wϩ6~6+KWH`ٙۑ\1ay`6 ?uH=d:w[{ӆ2jUAajƊ\W$|3G}S@8 \t4)Sܜ+@4-ʶ3~sfe'v1NeEfye1x hΟ irDq-Vyʱ_=c[ͫ [<ZVɕ2i{J)5 O$mMy̘V4#IS]2wʄjy Ar9o4L 6/@<_m,H2pԫlw_pβ60<-(PzJ9mogӽx9 {yݶ+ߔK KapEyq_%4=K=|ENi: ˈҦUN5_[ՒXx]mYx$y1L/|%)jt\u\u\u|@t@/jR A%jM?,uӜ?\}araH|i vߎP&<ڛ"Me3_@~OCVBPZNM jyv+[Cqzu|Ou~y`&S@Yeo 9) 8Sz0J>p)m2TO+xD-9@Br[Yۥ xݶ9K!u laXse`0֎Nwi-_v=ꤽҋRߌ%1y~afx;~0rJK;%Q}1`?)"wIf2VBa3WAf$aNz]"Y2nK[zKRo)1BGڋL$IHֻj 5{9|満q8UƑ< m~X +* Wə'+%R;3gH*:65STQBTV$KJf^2Oq2ح֓.U3\ENsy?#Cr_sN|d,]l8g*Z[H}*8_j 3yK\!T{E'X=왖5"H ,Jg_.=&~zTZ )\Z[]ag2޻ S|2-\hmu$NJbJ:Ra|B9Hn7+ea>cEye\" ˂Y_ q}eT/4 `<InJ+z^ 5[07rYWJf_ lKVUQ9U4I \G?VksT^Ij0תtaY !0u{+UNu nY>٢$ >(eDs܈s`&Kǡ&w;~kYqz\\+9).I׶J~υrhRQz ')9g]UBpå'~TN"wE|Pӌ=Ne'5E_VՔ)#0O2TֶM.=K/j=r &tn!7UO| Yo <^PFu5 ,hP?t_|n7zl{O )+++y/?Qo%T<.gFR꒵հȠJTleDefvֺW>^ߗ\:6z#%ߣoQ>7ƚ0,OGM# B2վK7# R[BWWMHH¶?a3L^3Yh(KlcQej?&uK5^v 715*?,SCYhM PLgse͞OOV˦f>3O߬/\BSDQ<-!A/2zs&__%L |=e7b#PT|EPO3'Lv0zcm'Y762~ogiDNpgiC.%N+++O_ͿtIg|<IpKFNY@t~ UAQPCQo[3o\(?hBZ/7۠rH5y#3\B/yc@4c WLmR6l&fMg}LU7m㾣$vU>J?=/$ޤ*K&)#a~>դSX*A{\GD<5*MQ5i'\_Wz;Œ7gIlݞEԡO/aIf 8Ho៏GKS? ]L7AS3&Xovl{]fu)@& [_JJJJJJJ˯ :45/uG>@I?%tmF' v$w*W2I>VzK^Tpdox]ysQvdId]C g}EC2e$rerO%[n"d(=:Y nm_mV㉜ͺ%51Ǩuwqn<^^dN{wW9Yf:?~ (!LVmkYӸKT Qޙ1d,KIIIIIIiPBkSS@A%J7LeAK5>sL{HJv4cL淜=؟;}S\Bf % vfo"ױ*ĭUs!B«<(x;|cʊq&%{IʼlM3T-r7"I?=~h= E{WFKuwZn|N2ⷤIsLw9B A{CV{~YoH>?9?455Xf^.oi3qqq_~dS>zIsOۛO'7'ly߇iK޸Ņ3ߞͺs#rYx?OPq~NdW.22({TwmUqqqq_jwϜQMґTvet9i R7C yO&!?T=b%ՈʟkTdwY4[{JJJJJJJ| 8G|8Bc(\R,88CCS&$),ƒQ*ڊb+JJJJJJJί??a^H ތ]ke~IZ"y3h2cdu7eL\^i0pCh AFrO9dhhŧoe&p[ib%%%%%%%ag1<#5;B}G?CtDWۭVOMǒjԡa+3%sF/9Ɗrh1ؒp :>$>57&9~V&Gf<?tPJWRU+b޾#>VP4%U9ʜ\c#Vk4Yr2.8'A-U~W~W~W>:̑$}jGOtʳʟQ"= ~*dJ.?Us+++>sx??QĹѥ:d|X-|%Q*Oҙ%Iae}k>-C(ځg똬xuIO|ې,h?4qq@>?8sh/ _GSi !^dž{yTPD kkڭb汦u ^ 4@=0Tm#ϛut/s9=;DWn~h:::ddS>zo%nq$;CnaHpbwIʔƌ&U<3L.rKl8<##-[Y-ײ~+Ag!ɻ!&=!*|u|v(ph5)L= [MX<><4g,~u.*& JmX8VV=ީfDJd,K3-:lg4N[;2i<_?*7r[xX b/oH jB c$Kқv]Z !'A{@(UʲϙqUoBu\u\u\3ۀjwϜǥk?Pl6nv& zwqTqo>R%bl n0,RA e>7)OI/x/n󿀎(h+a?x\?`fk мwҶ^2)qMK rSck4 AŶd34#bVˀR؏o; =4.'[E:W53$  nӤG* d_tr~f3}E[t5{WhƓbv`ifP:䜌i?eMK?'i0qtDbsv/XlX W o6̌,?Mi)PQmOLӿuċ .-ޘ/H~d"kTYO@o 1ô0/DaVSIFNBr;ܔIũ4$?h;"@7R7rIF֪T u MvR(`a> }sn,TMTO>.&eq{rP Ōx`kFl_Ẃ-ज3xy47/Wx@n Zhlksݎb;B>*78V'8_rg d;l SV/(ҩa. Α+س$r!:PqvZ6i^ffdtN-Y_ ".y n""'Ue8S8շ/_],^9ͻ*![*iˀ(mRgЖO =3MߞS?YSތ1/d ksk?_]5TT#M G'5ZX&@2UP_Xgeݜ/A3/@I3=6zW _|Rﳣ]>+6>89"k5Gyӌ|bv i;%̒WӔ- !MV;&" v|.#]7rCtY HP{ctя_x?g1sW 'νbJٹֽVt fUDשпOMuMe{vi&Q1DJǘ<@?u}9 "I%Ɖkw9:2;KY\Jv;-k JJXZ wE9p@"(s)c?yx3~'Y6#{hff…_)E?VKJueQn@UZ4nu4# "YǺɹ FVhSǛzjl竁u򙅊A,JeNӽ R`-ԤIQ|~MyT7>R&ߝ.Or%:'N wUu:ӌs$Τ8IRSߌ#O禼zpM>~ XnsT ݔ]&sNY*l80mpH.D|"uw!`mtUcS!G@ L6j#⻜Hݠd;x5{'loY_0+glo70Y_Vdq.ti{{. U^`wW'9~m {ʦD\&Nlּ̹sVo'!.ۡmk%7`\rlPEv@T.+5̔2$- l>$ǦXMvm ET1p\93KƷSH?(O3rW,޸M:l|ۉțf:M󲙙_0 Y\yٝ"'ՁH8aSɈc?jIHs&oӿ?Z___5: _?<ʠ6W 6}QհB/=g&J6r*gJov1X2}lԛ"$q|TrRrkΗ|2N3)Ks/Ց/]_̌`7Ƌ{1x~{qemc |1 B2YB2HQBF0`/3ɓzzHvFd(jS̓'yW4ϩ6TԶy>e15_[S_p+ufc]khN 4Scx.tpDomo:g άVu4-1Wꨤ 2jp>ڗid䗠oX'$it@?Oɗȋȋȋ|o5? <8/tP--Ckxޢя'zx9/Yb]Qn& iRϣ2d3FT9 z8,zUAM0GMr8I[irͼ򆕒O΋xMldpc?v2kQ8KO!4すaw򏽍 _3S\;dwF'x}7!B|_R}-|FĒDZ-5:jNf.ab-^0mN?|r%aGg _/TW}ⅷ]7~]x@z܈Yt|d tJy5x{fia'9C'sOd3e{wHY\l?SX:0$Z=F/|_yT>qP濝'?1!j~s} CuY%\Ju]T6N޵YCD<9[RpYu\Yɉ]!!!!!!#IƁO9nĵ5eoּ:My n (+Bl.*:aJUF?ҟ1+k#Ca\ ) p( \VlTw eV$x,@[W~& L"2rnsNœq3]9w9hkrW1$|F,;''5ߌ#jN F˛ռ9^O%FڭUD9xTjwܯIN9q~yyy3g|BwqDͿ~1E=m;,PGz+'W#sZ>:ޞ?|<5\M.?nu|oj n=ȉ1+o|r$g/"/"/"/kq査$jW_15]yc=?gC/| _c߽O]0q7rbU.UZc}/ϝ{^YSm/} %3YwgkW3Q%+Lu,?7!_u4OkgaC*WZxXry 3:?Ꮺ5=]w%].Gh,4$訚9HFRk5̢xyKG_q+^sV]Wu}v턭&NN6"mNiF|YM c8y%"/"/"/>Gϼx}gc[v5~Y{-i6Wq}epаSSi3uȠ pihzxhm^5,!W~i,aƣG|6(,aӶϳ <3jL`<7{,G $oZwx2g~'eCշ0-|wjv7qpR+ÌϣcvpZWVa]Jli0mjTK_ȋȋȋeN5?A԰7R F#la}.MP l6-ow]# Wvºq)a~GH >PtYr1VTs"|[D oeVУсu X`ǧ9zEFz3 yj .rN0`޷n['=5`49~p A}{j^mVe#O:ۆ0m{<6[9D~W EӼT MD޲( ĉQ}GSy_0V'>|~u|cX a;#G븈}`oFС/OU% ik+y[m륒,{>K&| _?~>}^@?Poڛ d-CEjmn%DZ˫7}ic;lBoy}AؾIyZP(l\/LOӯK mֲK^L喩=ewuf葢 ҺmWe5nhVB4&ݡ\:&W1fȘrv7LW@L#j}~fe Œ0g*qx<XWkJ y1exU?|D>vTNGuc|&%]p@|"'; :=|3u ځB@mAW u9zr+梃Hk<4?u4HEmZ|keWZ)*=W?W`\3w2qSIZY8aׅyFC!_/|_Cv?y-@6u&4`U}.ng:c^ʖ7wٜ]{5`OmQ4_r ^@ =1w7M( l"ki~V(0>; Cliln41hX&R#Z9zp0'F i.7JVVT `If!ϰ5LoZfء`kI[@X:Ud÷?.Sr?33CSn+8p3CLj{z-DpOn Hg1_O?mxhe\QE> f7)BVWsaj6NxCAYm)`,r^ Pϫ8Rk5)1OrR~eOws|嘓 u2UU?p/lUjtr6a6`],%~6… zT`v&'q\%B;a< FW7%T[C8g9ϱS*3{5] /fjF(7)<ٹ+WFU0}I@~IF H&1ݩȟqm=RƂ%ʢ(iɓPr8o5*^, aiw[OG-?6 i\ ϩ2mKOS蜿gS=v @@L׏ Ͽ\Rf_/ z)< Hk3}WH|chcUI~g-{(2$_HHHHHH'Sjn< VUo>1n^mkE&^-l?7=M3[iPOq{Q`T:l=`k:SP ;]p;7s>_M&,ڣ-H/': u)slsl _BLft q]n nRW/\c˫·iLjP|ik ꌃ>`X۝fǴp:<.Q_'R/L*Zh2WX ZB+"p>Qp~+Q9s|kY.wpj<8u-i U>_ȋȋȋȋR.'j3/|F`.?0Xi5E*~xNR6=(g޻aZލq_3TIUԴvڙiąn(J.̫k{\K4k(*SU=y??'#TOu>r"Kbjm.!LFm7ydk~u_W!>},}%3enË=9Fp~Xv\tt-}%Rﶒ+w%//՘TE@ʱTAԿ;cx{` Z )ڼ?cϞOhTR3 t_VJh s|`G-~gqݗlnf+5Tȋȋȋ_?sD|`o?I`R[*eT1Mw -:]4+ bQ|=4ޤb:Pk{V2#y]P>.( MncN(P’.wx{)\0" }DM'&:ŚʊM~(O5W&=Iὠ~GLGl?V鉤=)_jض;>Dj-_k^LQE3e ?wm: Ǣ?t Z0ǁa3詂E0yҢ}J |>ÑE\xYYAu2i:PT m%Nk$ ;u,BBBBBBBWx]l.ug'kovsEUcMU=^(4 a}pUvE%u$RU!͚k:ge;4nFpقҠz( ^ v y7MUz*F=sl] mas36v[PT9Lwlj_ -P*x>w(٦s.h6sQ{p>T7wR@䥺 KwT>`e1f^!BW)RuRfkf춭9䓂KJEsʇ,s1by%:;H.;zgƶ j2l'*} pۡ iT @Pu#o]-Pe궩s[{0[8`v@rXJ եcG=ZO,Y=C>9UhdTx@)ѭť54M*(b>ܻ4 Fzg8K93^x=m񧶥m窛4 Tܸ[SՍIOPuO2,O"T3|>%{)P&@P8lA^]clb:l x>@6lstKUTEZtoIaTڢ#|!"8MxW/| k sgjSD̸RP 3?eOUuTFi|,sƕg_UYF]~+G-`CA027gg}#&a4nz(S͵l'wܟS͔_j>Q{W*B:Kϧm'e4y/?5Lc箤ɹ__[X!*|ܱf Ռ{#1 JKfZA_/+?~?wB2X\.άB9U WάWpLUM,Le9 p̔5kjx75#85$s?:4/6$kU&率㑝)qʮL鬻{#ĎsQE3:jycZSt<Ƿȏ6is3Q/j~Z}yZq_Bg@>^>YsghtQ3W~5/VWZI6Tn\S3sX Ma"<9h՘䔴a=ѯ}o&4 |.) G=3Ǥ< XS{o[ ]a'O=;KD!QX?Pmpĕ쉌l,M9'cﬨ'9F 3dze~㱪ڡY51H-$$$$$$$teu"js{j,;Q3q?9H2q͓var_κ+WoBBBBBBBBf[UxwN̖Ƿ}ݵQ 1"}LMj.ޤk81N>Y#!b̏|J+kqv2:_mȋȋȋȋI5s|>#0;9]'GƫuLjǜQ_] ƒȋȋȋ_ jO?> 0qZn=dwkޕ5=&8Ǵ3+]:M~Z_ ,3lB߃Wq˝]M~ HHHHHHHJ J:3kF>аy c9}W8n_%| 2mxyidJ4@GL2L+!]g'vVj:yԐ;,E)L%KHMh`k|`#"I'ԺFM*##~ͿbY\֓7 #D6?(a5}#?~)?e'ϝH@+͚a̡h]'VU}'E𿐐ЕguU?9[ 6z4ͮ $R{,kM)E Ѓw( !C@O:F~zY(?muKw]s"Gg7L: N'}‹]PgDv5 67D8UY)a9mxb\Gaj<;[f} x{4/MSa;އ3hm\؉Hm]h퉿׽R{Q LC_B>חw~mQ.^/O 5M|\! _/k sgjSD,+0:ɱ=\U z 0 Mo5@t[\A|b,? 0Ui&Bs j;EkaA}J#S>h0͇^bįBT?*B{JE^ӧu^)d?<<$oE39v ZݱC߃'.&<8 dW㿡r 3‹`#=g/5Z𿐐O|w[sw|0:S ]@=2!^%LЫﴜj|NfNzaKfT*`#_`;U>k& (%m\vscӦ/B!l5&@uu @t ze.m.c^ƇxnF)GqA`n {gg8]Q l/,˝U)AO|*ViLV:Nx{YK3ۀ0p"{XT! 4ЊPC9,rJQJf|5W~$۰,:H}]5(|Q;Duhűm_"$=^yjs{j,;Q3g;;o͏>Re;Uq..π o !w;`^(,+_(MXY 7OoUӄ*X[箁9ZHOPA;YmVigff,\T;mDkPRȖ5*qV$M;PfxWL=q>UF}[x@ ?:*>e2ǯ/A_ wJSդ[qEk5- iϢӤ|U=4YjY)IM!JLHy݇V!1]F,JeQG]*~ uLjڿ QG߿Ƿ7q]aTѡR{uu͘]@Z7(9*ϯ K68D?n=kՌZWT C!j=iQ.h8UM5=k)]PIWSA9.jWo.WЈKmFj^h09*Prza'R$*h{M n١9PN![omA}]8dXY5he|44| ,0% +txG8j#[u:Ԧ6 9@q:e{}&Jz|R+Ss%5LMYW6Z SӴТoomžk"/"/"/"/?}t{>Z !eJ/{-f:ޫj{ǖGYtCL#n2U5MHSy.=L>ZlpUs1x.nZP+>Pd K;M}7GH|UtD _3M9w334u])u֠;`uwf%4w[\: tuO(݌'!4,QW?ګ4c˟+x_JC'b$ 09~]!t/Mu%ՙCٿ[%yNMyKO:zϯp_PY:]:/| _?o_vT WY\Svu>];l! ۅ A!Lf>Z,yFuڞ`V{D䵞Vu~3֣:ey.㈌MvkT.+{B\Rr\3lOضr DloѢ 59/힅(gl·Y'4,bkaNuNը+xαjTm?qP=t/wE@wřRBGGI4L+[z]Bm&gk稁_d,02-B0C#@S0uTk V#-CY|K/eh Oƿ֏_7东g|R$ r wOuJ u:TSMLg9loMl ׯ }_]_z%eu0 6"Kx3;el?'3j҄.eF,O9nĵ5eo rR2˚L| J:,3]CGH6!:jc* UegjSW'GW5:O]ixc5­5/$$$$$$t?C5hϞ}kq?1`ё)F)C|j$PzVQlvw> $'œ$±?'B3lYL"Fš"'eI2}$_'*fňȋȋȋȯA̓'j3/|F`.?w'WfOf c >b<$fld/=IRxTJu܉ڵך*4㾥 6ޞ ?6!!!!!!!_4%sg OZKk .5OXrR~zJǍ*AHHHHHHHhzV;YR9X?Q۟PSg<'FaY1Fk^~MG1+ȯ]FkHxʟZy _/|o(?3_7T?4?%-5ِu$ޙ,."_/|9OO.^H)M!^S_1]7c9?kRhm~Ot##а!!!!!!?sC_?pC #MMN'pڨ[֍+\ݻ}dNL!\#)?.cwe!^1 6A(r*zh5 D^E^E^EOZ~8}S5<#FDSC*f cSycq4^=utm&Ǐ@ͺ6 X&Pb5Cv_o{A5>:d QME^E^E^ׁSkzOIgٌ_zR}rUe&f[EwiJ'w? Rs#Gި&bq~^1=2gygsl ̤?;!KO0?kbүL/|_:~>}^@?Pjl #F(zm?ߣ˽bKuڬ?I{ L˲!v81b'mZjp+^\CSۺ\ Nz2c{ W`6fq$vHPOY?a?)ؐ9dl >9zu,y'K0,ߴUÿUƯF,@|D */| _W>qP濝X0s+칧T A [{KE p\X9Mz:;*E?PtAr2"#Oh U;`d#z0=Q F4_[*"臻ŗ<U} fNpۄa0K< ADiS#o6|n6f5XJ t¶fJ[%c꾼.:B_b{|o֌<̎?;>qD/^ "l7JiSz+6 m(ee:qm@G۪?SNa Isթrҹt5gZ큾|bqe?<={8]ʌɾG 8ܠJ [vT%w/LVh|Q+@xg,5?=zo؆!*h՛j. v7LWifJͽk9/ 4">׹y &W^Yw-5LRVu'cKCE7Zt;; |z̧"~m-{K߫jW$}{]Ob T~ԍS|w$)xwa5j*yT6̈́'Qpkׁ*v] w/$$$$$$tYܲ;3..ƍpi h}=21bݣtzEU痀JRf@=c9cܠ1F\c[) K=VyJvv~YUklx\ҟ^1t5^^7_]j}a %m붡 w]t#NsllqZG?.h |:&/ǗIBo29>ˠа7-b`yk 4VM AX˘>:eǼ I/q{vcϳ ˏ?$"/"/"/"=|ҶtDͿ~1E2әX" #^skEUᳬT;ᩚ ?gw{CIc FpTewFɬcY{жq.؄i}EHajne ҰϢ'[4h9BLz@YwmSyޥdgV|A ukr+9^ީul՛ȫW-I=NaP5y\׈H.|cMua>a*1}|2 H|3WUOhO$ε͈ЯNDE^E^E^E8?P~5Ymk"o3ńf|mS.0  lsLym c}1o6n/$7t|GFSf5~pD1d؏rŔo0{TU@Am8pԠ8`p_GAnnzoDՉ,`:KG\wsQgC#(&C_:u~xa_)>^:/SEW PxF!K%wչ򺇷n-nFX=}z@uؤ^CdO{H*@h=|+)_HHHHHHd?5~ڡ(G\W>7"YU-a/MS* LL;0y!N^35l 'W@PtoAOsT=|h.J?|4UL\V*="fbD*Xj?4оϸ+N~\_Iǒ\뜑~6څDdϠ7 Ɠe]_G;ɷ:/݉we%7u?cks۬ y`xtn\ݤֽXg _4MXѻZ]j1a%$^(K s?U'PѢ͝`>?{Ht5Ў@;W`^=@$| _/'-@TTTseJ:nğ~qH|auV4YہSar}֯OHn]osN59Eq6ا Ej5kuKYܠ)<"J$O#b^z<"80 |݀AT14O=S\xKy}ʍDhW"PkQ! 44/0ꚼZGW<5-<Ӛ"ůL; *W,O"G+υO7u_A&Y3L5ӷ^W~.}Cl^05}}#^ʫվ7r3-,qwL?y, ?wY!ۋCeD:#']x)_2>%ޅ_- w`d~PɄaK`}ڳe:i@PbƫΖ|H'}'}* !fWs @HHHHHHHhg)5~ާ6: NLOgY$pd?Gj|4 Ik~1m)ϤZS0#s{ۇ]qFw~[q V\UecUiMp?UaKxckٹȔR$13ȋȋȋ:>}j OؓO$Wh$^5~E)Hlr WqLnDݠIWsFu4`EVjtƞ+k5eE/| Su_ގ?^~[ۥz6gN'g<U? c*[-Zծ /| c?P?O95 k`Yz`UѬf&+Zg5~kT벶SU]wBBBBBBBBc$g:qm@G۪ᅲ?iW0_]iVd  ?gx,@[WdVgբ$K,3ғTp<|TŔ*ƇY{} 5W.zZ^yUȏ>}L~Byb5ȋȋȋǷ>i[_?sgs߼+6[{yKW +Dkx^ȋȋȋȋ ?sD| Lfu'BkCFZ2[]-G6#u(imcnZ۽ctUi ѫ~fENyטX` 7^sӮ I:3+Jv6Ufa|hx :7F,Ԟ\EX?1POA 74Ґ5gyĹଠimNt7zx#3-A#9PJ׃9e[ m0NVRV@ ⽆DAIQ$SG#<kZ,{mhXG50 G}(;Sb;Sd? k5$^^j3>kiS#8o/8fǬP\=\SPf zO?l7V( 䬊/| _FL5ᅹ5 Ls !:docy҇UNY5qʷO9hXMR|1( xA*'ld3L? ~jau1֛kg٬@B4%4##̿7C,WQ0*Dz z0nr'X4xFW'cϼiI?WKz~F7<` 5d jhvC31fضç4>YX K͒x~膍 *wNrYzF5(]Zb_/ ;NAVr]"{Rnتu"/_/| SS5q`mwTpEY]xʼ8cz\` 6lȲZpu(f2E'ܣdoE'vVkm4# O֬n1v]ᣉ2a c<.ڤjao)`aI֌9kvK}"g[w҇ z螬:ǒBa+;맧*!N)aHͅiiFꋂ#q'=>ṫ-vX+[Q+%s_l} e`RX[ &_K^,Izf;%7HãGE zu%9bCja.ajU-CkuFi=cSοH+Lpу_}#dxuI>a!wB s6|>0J}BRf y8O~#6qIңd|WbDQ򛏟31S,l_m-ƥz%U[1E'>Z^;3Mw˴wԡDύ:pOUXngff¥NmnuLo-W@ŽTsblzz)RmaшI96*'|PbQ¢g.oVsln/ 3jQ-EygD&ű g€kӻwxێNs~`P)?֝"`gh=NxY~p`Zu\(Bo nV)ȟA5G|9,ǺS ͝KURy==%Pm?씿_piNP F!!!!!!!ː‹\".D[i贔O|E ǎm>damEȴ[M )<8._VfA%P+*`fZrx,|8,0ܫy}b .גTEV>qO+^A; ][xTOo7-4P5QL{L .ַ٢x kn9/BK_!!!!!! P?sQ])8iY-#y5s(P^*UJ/ Q5~]^9„v;_v: ^pmjݦ/L%ʺs [y݀ ۆa_ŠH](*GFOkKhNx,A^pa`uԊ^z1VצT!w|<ﮒi/g)>|B94pH!rQ%8{p\F0EXfPsoR1ϥ^_s nBFqAÓb#VһZ:ȋȋȋN5?A 7q//N`/LBUkS!|vz `%/pOqCu{YۮfkNkE-XHD-1 փTY5wQ5W0?BXj=0eOU:Y۬P#y^?LMr J\duʙf^Rj" {#g-s *Xϱٸ Fe\IDa7Q/&FD[][Eb|;/H'lL%w=*:7O;m.sPSf?캀T=izӌ5оRkr^R\u~ӶTWBJ?|{:c̆SN h˛ 3zSY֋I1VGDUXA-/ _/ </._r:jp;0,{I?oKwquO_U} M=:o3?PmvPm6kl0rr$ ;6;qZU{Oό,.R{N jL8,qG=̅qrO+_Сlvu҉`D nPuR~0?#hĞqi2>ϚEu(<зS5TC܁yQ'A7K1=E5~VI Z g rSSɋ}k*ՌL.OVZYŠ]ˇ R ?`e}r{"Β0·G\*Rq^f:s%Ҫby _/ ?P?O6h(+Q|q:iqJ5틔EQmxC2UXK7^YQj5k?QYvKk(cQ7h qX ͪKCA`]TH'ūQ +%-5S=FXcϿ2L곦ZRaFg ތZ~SM?Թw{Ǫ3ڙ*<6+˩>_]= USpby1ch`}?tvrV?- FXJc;_T}ۢ]窆IHHHHHHrt[UU[sosG m\e8g9'ϥ ]xӜM>`s={TsN9jI9atg|^ skVd,AScc9 ii'2Gd@?7[w)5͞9!7m@DsHݐ~nܦ#2Ҽ ^͋-箛_%^t !__J:;(<ѫӷD?FI95w>ޏzS/ٴÍgbc@"/"/"/"/1yҶtDͿ~1Eξww$GZ9ޑIY{x:$fĭgҤWLbZ\ud.Ƅ绫 VHWdl'9~\=iy-ڡH?CL{FjB t BnH Tgodfk(qݶ]$ch0kխf g#<k3~" !!!!!!!uc\.ϼ.?K]@7?>q}/#BBBBBBBBbY]dJ@zuBո~jWVh`U0d]卪,/k_( {27P*=CR&)K/| _k sgjS9 OgWu`<| _/SS5:O<.QUk6.U*̪5VՕ'X_22+s9;3=c^{vnx<0a܀E I/H Bdɲƒ@TT̪3=3=ۃkdFV{/eeV=yn޼ދ>:VuiZὮe{آ:q׹9l֧ej3د!{M2%?p}n*?Z@䄧+kVhMfdo'Rķ9\}-_Ǡ/llllllld_!?ys3'^?!.TSeţllllllllloE]b]uVQ*t^ gG:eO.?2 Nf`aEOQ#>坨^{HH-*@R|<+]tng-:D?EqXZI?$DͭLOq nQ 2$LH\+ee?~/tIߺry] kB?NQ6΄]=nސ~{H5(G2dgWN(_״Cvc 4p>YP-@J2Go$ <^l?:B`je;Kw ])f.g??ǥwmm`=ĻgDW#۬>ޟvhJuhv$ϧ{*nh n?a y"\½n7`p~>˄'dn5=na%}O2|KQ^SaU;i SU=)V#v"qBQU;*'Ѵ5t FFt7?l݅*T?"I?Omt;HrW h <^B#(_[찿ME猴6Cc+ 1ܫ4KXB_(8Dp@Oo?5Z׺E혢L'?߀GkHr&GoTa)mMnY16666666 {}XB_eg/3Q+e].fŮx&,6xrWJ_IPT+gTbN(~MB٨EWUM`{ѲͪdK ǝb]a_s%@cf_\kU 8wUm6ɤ]-,.C]Ù]\h]# YL 9E`ϧR/W -alCl0hVӍtck5-oL+ouzj5 ?} x^>1 <꧕D\RUL5l^a1O.q0ok[-fA<gh$ITctGT‘IܥE^])q\#xxx(H%οsM5+]GTܴ̦NZz=5i`L gK/ e7V* d"44h,Մ0| ֞d,ZRO2`?LCSNQFhDNV!B𼡣`kiuXfwfP pӀT+ol~{ H& ա,P%GF\y:?O X,Nhobp*;Bog_,p!&\+IP~㙴kTaT̺ ًuXޣ'%Jo M|8td: 9ЩEYӊ#P|?3|fs>;4`[5{~ 3M)J+CbT0?Ho/t0Z0@ (}pGe@H8&$4>?4ϮT! O!n|hgwU0n``2_Gl؋MT1Ieo)c" f"/89auY,AiuX^jbEza*ޱn/A_ZMOpNopwGQ9o42Qj Ma|LTj`5$,LW{Gz ^@V<dIj }=s OߺN,ar, Mzd--<\\J0fdit&0 Qi7^cvvyMAT6666666bE?13E?7N?!r4Xkk@̀:Ɏxj P| EzeCkAg @z`8pB pLVT28Qn&{0'wZIv$4׊s@ۗ_5p] mա"we[/5S:C\1j+E+_\笉@j☂L"b}\DM`l*IiB#Ɵ;8htv4z0л?\7JE2A7=)}8zs=ŕwy8I;o 1s)llllllll ?2#Y(Lϧ|5Įk\7{d$[ӝ~XM8nbdż{@T-ST}+3%E +m˺Ǐ:~a@# L P&r y +g`O)ڱ-/C_:[9'`U?-p ЗfW.tC&R?Z7yhyES/:t nE 0q>@b\)}lfXF=2 vq7D2{ U&|o ™ L dꄣ߇VM%nP ?͌_~kM?sb'ӏ5tz9j}"/I\e0k)uW~g??/|)'$6n$>$1Xۧ 8~d7jL?̓BK xIe@\D'΋ș(~O TՄĖ N<Wa kTX1/yR'ι]1Oh?zܬjї߀y `苈|2ƽ y hTژNVR)MZ! /LFʕ#8ä[E# -Y|T192J瓩n~PRb%>O߄j^ b/,M}w2Y#'O`5} ;^*\ico [{g?~fp+G> ./ [4w-̙:u戳sġRB]q9`~ \7ۮV^t+T+^օr";gQG\*dNcd7$%~~D4KP8 NH?"rYe2PXo!swh~CY-U6qw{1T>T;0|L&?v>(^a?Y Ŋ!nDߛ XՇ ?]-BN=)*b=">5 -MĄ)^]]X.oN B%%P_llllllll7Q?R?:7[ͶszJ$+4#(EJL <2Ϝv.ڔ@ѵ gO{PnPn75.'DRAI.Zm/uBfNzKrTհ0@ecW] iS_T)qW73{NeOF⩖pXQh˰\IJ'7uf/Iv ơGOS(O?xtZ|GHQwl(Ze 69OdUƟ [v7zv#R#%dqllllllll wV9T KU\'Tש>L5[uq39!Qa;БpBΠ$|*WmJ⤊8V~(f7;=pGۘ τF4zZ/CÍቾhD> ;#cuגVbg@#1꾅ZSxxx>2Q&opO:Y!նce%}w9tg999561==?Y~Q7)*ПJ5B{_oR+x'~1 XY{cx޿{>wI%ͼu~A/tIߺry] kB?'.<_+Wk:>z_k|g?:=+Oqڰh֖,c >r 7|܏5[Z5Zw ܗ;xfFm(Sv)>)u-7~?666666!O`^K ׽; w2Ck]2wq *^7YEq_3&z|&Ew5QT^fX= ߢX.unƧ4*꾨kw=9W?7Wֻ?{\??xx{~$ο zku!Gbő?q/sxVUԽFʲH52Jf^޼7]tz#*zM~jpgt?(4xp1[X3ȺԲ/aB[kllllllllW󟘙kU$uÝ#]#P/ڟn`6J_˲H{8*H{%rTntGLU`F72#J0[Oɗ Inqs%0Lп }N.mҮ6D&1;1gVv:?+obt_Gzo`3ˍ?~8c||s@ቌ=z3Lߝ3u~쿱p˹9?o A??\ =D`CngSJ-E9(L"8GrZ<\G<2dJR.Mfo__SD⸪QêvLUN'!O$>_G ?^ߟ|$5z:`i~M=i;~8֕n#!XKj%1 #xWtC~JZX+oǍ92]rK:p{a۩tjuƼl_wtZ+]~ѵPs.vѳe`7v+tIAllllll[un ' qQ=#sM'O64@bE;jL$yBQ+. &G3nZG:gܻJUIEٯkvd[1L<{Dm M}[$ d]Yuu1E o .wV)(YC9QT72M ]ZF==!g!=zFrߣ/~j;hTʶvi )Ow'SvfW+I7%4¿p4}w4J~>Jk,]9jޮi'1Ҁ $OG] ytn$+uct*-AKߪN0-xAD`lڕʫғSOG𭗟D[4˪AU~ ߾ Bs28i Em]v"U4eֵTMR< / 2}$4$"> C}{IbRfKT&Mo.FI~V`_#@Y].Md2;iEki4/$to  zh!W )!ҷ8C=SK?OoF=) 8kON~#7ĻIzsڀ\N#N{pGx@a`LKCE/#Ƿ,W?:9>sxon9 w' )`~뚆ZuUe_X5{h+Zx>+e{~` 䩛/lM)b~ؕE0XMaL6-TCâ,|LAf37EIղ0fcT8Xt@@  [k6`WVIZ. )R׹cb/>ޟe k& ]єjb7D_*epAY#K06tB吿G `Ɯ ~h/c/?`xh^#/Y\u4k&xU/6)% I u"&>br*PXhB㏣+;Vkh/I'C"LN;iV?}'wh?*`[S;d3>*>Z/ /|dYzSS13dޱXTsߠ^keybIWj,N1N?TwZNեK,ZqTh:7u.pKTR%gɺ7ۏXԬ?X&1fZ"݄;"J~MEh<μb-];93f|nYd20 N瓘X"Zh|ah^hjLnY 9؄yğ=ڟ"[`;)4LTk8)9H;6_ġ҂Udx,7^n6&"]!U4o_ht,72^| #T+ʶJк?Jş<^v?xM V %- M#F |c:uĝTx^do5yD'g@IgDnXbfׄb]p!RKMe]N;[bAgہIa(]0}tq-o<]&dx5em$ rw.r^+R?sTlR ߄<| o*-%BYj$~wAK wǟ53{-q W@*0;aK 裓ٻn~w"''|jUc?~:'qw- ІپUqJaRI0+hO2Y RFh*vYܺ2ZF/*XR7ZT^ֵGc{*OMD^14@{bc IZ;-o`͆4ċOp|b@ZEd.bϦxGbڲчpLwb@iҺEJYL!D8~$#T~4RZ(}w+={~XZA|jY/8/ڭ 3n5DԨqg@Yq gO !0ـf)A60΀?ChɆNNQKZcA9]+!< >b-6 fĖ[SI_J'?=/iz@[l|sp2@5Ζx1)\{U=Nv\\w?yhc !t>g?^?PBw۟7 wΟ}nE, ˢ8hx:43~o"'q}4ERykioJ%y7wF MFKo !WVC>iZwܲ[ђ<}U,,ip w|H|?i.ViA@f-"=|_e1"ē8X5 oGi3#WJ n gOTzpƁs'#~38UΎ.[&=.#.kv[Pލ0Vu' @ ڿh8K@nOYQqHUqi48 0y|`Ẕb 2SHj/T*ĢtA񿓡Z#\Ec040۫`.tkˀHT%FIQ=qR 4E#^v쨾T__ZpG@OoT Sr?O㠉RˠVUOKs 8r!:N^`SU}ڂ*M5_r(wP0jU {WG\Wߙғp6Eo F4bP $ޫ2d7;:Z<ljfNׄ+/8Gš")FEmjk_ -ž }!x'ΦPR 2(L'J IW5U){E 8lllllll748S{,/ܶk?aaiGӥE'jLFV'L:̄F S_6\ f  <矧X$U8}>;z $? dqW)\*nC<ZM1+/3hAquu6kUck+X%D8' 0jň%6;ƷWϬ Mrt;[[ ðԴRU9  ж/ ~nݐ]-_ɃEƜ{ [.`'\2-6~*$X܆ťWyNp :Ջ J)U^7B#GU:-q\EQDO=oq{]WC /68(FmNoig1e'{= È 2:M@?sDIƓ 8ބFRLoi׉᰿-W|wAO:^A .>8sUu${T<+Gw$qX:O+~Hw@\&P!ҨU3*^՗2PK'/KFNuW/ߗN#6{Tv" .*iL=`lzDtG4Pm(WWiu7B{ÏH^OGW =w7[o^w_ؾ~}yAgdOL5e$`=98<!vv5yM uҦء;=UU bccccccYYw( gkHG2ұ>.= Gǯ^g)zH?#}}Q1_W#[Z;]ƿ58K֧D?]Zy~쿱p˹9?o I]^qD2ux ;qmF?~8֕n#1G܉wWp2ҍUh1c!tcVFb8"ճ9MhT@c*9Zzf@;S"lllllll>7-}-s֫(.nF( S$/屺V>v`~:RhbM666666,Wx} r O(SndC~(ϊfc(E֜\ҹHݜK$Y6O㯎U9999W\' Ӥ>ߏ F8J>Iʳ+jsTX߃_WloIq>ݙΧ*8999z561ϣOu 3O ?v^id6S;9p}OhI')cc*N=^{gR)aA\|~g:~+gla#Ysrb:?>_"M-eL|⎍FB)ȧ}0+dW}CfJY}?}8ދ҄A[a9 ԜX+/:~0zsgvs^ssw ocWvWnj +/ꚣ/qk_i@E(t .ŸumJ[9.N8{uuM;Euj~M0Ԝ1r6 # Ey)?IٍmtRpL؟E4~?|_-6Oߪdv l)ٖL24ia :x-Cnޟyyy(S0i Bദ%}|>ox@%sǓk.yܯ` 0i_=7sX1 r{+`?3g?~̪S4 WظK}:7A'fQ'Oy;g00n~ SKE63b!MS\ex?Sj[?\7ku?q+$&0RA˟OaL"+ sqa66Lr$'{gQU_猣y-@}bd p?E5Lfgq<9Oɘ]4¯nB#_^adccccccn:q׀l?&6?mC*FŒ#oY'`cy28W@nߴodrA^py7`~x\t]j}k 4O6DD7Y[|+ k+k"Nj޻iON?TwOop?Kf"a{Ԝ3dOFmN3*䁋;SzF6:`Vc">NB-dW)uDZ/S}wNٱ@$;o+l9oN;Qz~2v>ŷWkUW| WFS&)̾e8ߵ0xxx^LI}ߍw/SO%Cu0/MB$)zi9aDiqغ S 1O%&/VEd 0/J?Na>y?/YIU}USzl^Z;'tӞqJ2!yο\Çӹ:P?@ABCDEFGHIJKLMNOPQRSTUVWXZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Ll09ϭ;ss;N1ȿ}zˎm޵ܹiVx0#G accccccc:q׹9@;Re*t{g -8/lYSx{/̞&}?}.|,j~8S666666hohwW]bD)%qXk:!U?݉0sR&ιX++/zƟoexS"?uYw+<>sxon9 w'?kN$+qUy;PSv21稪Dg섢s'xT@g\+~~]eXܜJ`lOT\8ෛRszr8R dM7}vlllllll7w wV'w%S 0`ê[׶)@{t#Nn1TUȃJũaKzjP;c tT ~WS퇉\8Mا9~t*C^+]{k9>te?3&՟kᕉ4p?m+~]eZ .#iW+vhW cQ(|\/h )d Fj8eؕ2<ؕM.z*z V5=28imyH?mvWaL3BsT_*M'Ǒ (ƿ)2TySQljI˚ˍ{]r tjt.\s&M|ȕ>~۾=/g?E?PB֝e)j' f2bT??T POӂc>귳YҢE& ڗ燆߁C 톁P߬x))*V ~_5` pRQeW1`P\ؙLNh925LdQ|B4{_B~Efr3)gpkԳ3:Mශ#^_ہ~uN`ccccccc Y Tv)>mXXo:TT\_k5@IUzc+-k ~AL^-.!!ހ0kx];(y4]O)`k᦭S:)#JI}72^67kuCg7Vȟ΁5Oh!0 sL̍OM5|IcR?ڙAw /%x3l$k ^P c8e`kصꞤ^ p84~lun}tX{F bWMHP,xI7OتޮT@w Zdja dT^մ2\V2renyĔ{OyG؟͊Z@# t`.;e{8~۶߱!Wsxxx}Q\S%O{rN],m{h-;; `fo5HԷLƾX/6qBQ+ە7{JEt]E:= UŖT4L&ԬDŽ2uDՈC /E5zI}9J; L>?4?b$=0zb:Ok[ҢO'NZi_pUcW6m sm,M{ɂ t81Cvpw2؋?_S|?Dh4 [Ω^IH&#儢14Z'n]MV-Ÿ ?=Pdբw#P ?JvfߖaBWv xAgdOL5.ݶ~՗8Q_X o]ҴNQWʴ6U4S]-?ޮNx"9,NCe!˲K<R2G~T'1RA=?M,֔ qeQW  &OMC EzCD.Uts?ݾSgvOΎ9n# O{!7T9iIzkrDC97t .(kb+1e@}~=Wj:$߯j$B?ĔJy_xMje7D)uM{2nfk1ϟhГ %hg D~^;+r3&s^fks=f 3.4 [?~g?7OYۗ+ʜ)v g٨#$6*>8w^Xzq"?&W&6ZcO?Fg>%n?qsTދU Q4 sF%qپTo:Nv)SXO |/}T1so'<`ccccccv\D:>3s.7)5Z DN`&X[Ͽ+yx ̅; 5AƏ-ßخd_!}w/@2 CB}/w?m>Sz:s_.T?cq|n͛>q;666666;Pe;~L-Bl; "$:\ץy~{hyfC~_"w7x]/ۗIq簢9q5{# 0xxx |?;kt5eBvヨ>6On_Y{" Fzk18mGO>[j3S)r9xۃI cQi0k9r~|_/;>q\}y/Fyw?D߲~쿮/tIߺry] kB̭o5Gƿ'[cZW.Ľ*O:qc8Ň=X SN}~C| {0«Ӎ#t#ۃ;_y9n#&svg?k[!" J ~'5V F??*R7~s:ř}}\_SEY[_#@Hxc|: 3&/.1Vu[vk3K%G1#In0VrϷ%ݲQ-q /xzϪtsiMa'oWڄm;R|B_ нvk{qLN{9i"=سa;Z&_yv˖O999o}R8^XӛfL!+ʰE෧aM Y}?}8yvC܊EYwY0/*yOzN1X13ZP9Q؟sN&^%{ v=/P}8{U[9-b{^_OFS:6666666 |?'fRtW_״#rDՎ.z= _aP 5U߾ÀABjyw;P?ܒrR{:k4Ah Ey9>Imt=l'6V (ϓ91u3/W/޲+.be!pvS's'6w/mη@-B6~tVɻ23Aet߷}SD:secccccc~՞G}$ۍ].&j6+vA])I09LƮZ1G2iiٍivۅ94#li7M۬ Rړw"|8+:  /5v)jWvl}U<_qz*h(z~ mn[ ryZ w禦NOFk(4?G\z\ 90{_OLniO;O L}Ԟ]G߲4?yÐ~%Nyh?B I(އp߽_>3n^T߻e37lllllll׿Q?R?0_Ե6w "WʀB& ۋuHj}`6TlfL n xj;:ڞ2L j2^_Hǵ Z4sxS+Г1N9.5|j@>  t۩ӁM!n:lUd? gKiN٩׫M{祶?uLƮ28 ?F=/p y{Ѻw +ԒR){a2?}@1OtznTIq3'u[^.ڍƝ̴Z-'?7K:9\IFE=Y̓MպǢIs4B yh@K/*c8nw__Ϳ8[}OGzUeccccccc&GgɾBH_s3'^?!?|z@ݬS-E2?ǝmYp%?UW_{0 ݀qpE[~hJOYhؒ 4O}m(c[5{~E*yD2_\+_q%\g^:6jyd:'TcR]?pptzNNNgD?>۱yo֫$666666;Pe;~+Jlp0=܎>ayWEӾrb]QsvZM{ᖸr~&r "aڵ :/.<1s2:= ݒ&N4 s|8o +ZxdyMY߬epO=u?AsF޳+WNzZ5m^SnOX_v;-_vi{z^b۶mg?g7{tc yv1ևW& Ӥ>B7o]J,od{u/5 a|ܑL"T;%M۩ܟl7bSbTʡf>ppoMG?;=V(AI (@ZMP;W\Z˨J0oʏMO]/r/-'.fB@5}vz~/+$0nn~\/}nǹC^ܱPTirΝ_pmY{js8u=orfG5˪oÜ,{]XT眳Vr)r)r)/7q~Oc3Yb1B}d/<ԥr< 7x5~~$Nxl1@?X׊AgC,|Sci.A OD\Y?ԥ̤_uu 6ՖUWM57Ԗ]_B()ɡ6rW=UhQWlc]&f؇b)v >W+am>'f;} ]cro`I$TOQgvh~y/Mۑ]OS[?f#KKKC3?2K6`>hgs! .Iz|х<:0N5l",PG,ſq`O'v=$yDOG$,}b$eTSz )gy5 Gt}[կq5eXrs :62X}Z ?Pe~UοַYKh)aɟYt}/,ظ|q5>ՇrU=c)lX7$gr]f]yj }sY1a$,",C~Wۯ1dBoNGNXkϿәkB ARi,Sri[몳QkI(:د {[mŝwԕ\S[nj[[SG) :ڤ:nևu3֔w ?\y{MņzŨjCSScLL$<鍿vipq節جEaQ*˩  O^Vںw,_յ.;fŵKW.0FkZUkoX|j>E%kZR}sfO_rKM;}knn5g|U킵&[[T`%7TX[} ú2@ 0Uu>G 5ՈY^-CW gͲ2>W,g6la~j(\jxO_nY9B~kYֶV ԗR_K}?}W_mSf)G GC_{zv!;5̿!^ }A r_v-@Mנ$?opno_qΜ0(w׳t=^e Ƨ\FR+3}A%ŠsAodev+woYEg{kR ^SL%;>)W,fwG]׿~)|ze"gʯ_Lp\W24?jO\}  lap<~1!WԻlB '{i63PS_Uۑ]767yVԗR_K}\<ۏK(>V[v ӿV xї._L[tfɭg,{e /]Lc<ڪhS0'ٹ﨩X{Mф/NEYdEYd9⸠9"?C{α|Yy\F3#^ZsҚ*-Todz'U|uU$,Z^?{:}Ot@-?tiZ1+>$_S/-n5 ׳gAOL?Q2YJvW֜Lv麺 !;Vڋ>G}ﻠC@Of}O+XYb?Yw+p1?}ʡq\xjN ̉wi;V6UX6WYWho}Ym?/-gW弟si~<yߥӍ<y 6J3A+;yAcC6M $Q]ST>u>?;l [-Lʥ\ʥ\ʥ\bHof!-@#o7_'_Zsf ri\~5K.~lI)\uIЇK//#h?F*< z)> 70M> FV*{8Ͽ{]c_]r)r)r)ywWo3Af9v(vWω-Y`@/<K-SBSd^="ۇ.YPʥ5Ǩ8F)v/ao}{04>IE1@eH{-H>WgOS|zW_L;(l/םd-f`IPk1af ~u`n?N25OKqݱ|!sݳ^uvo^KB9",",Pߒ߮ԀP*L%^.()tSٯ= |ekO_ߥp^nvoRͭgo",",̳Qf<$bI C]+gNK.. n]g?_i7XW/GūtiO7ŽXt0\Sds}]k_U.φ6L;oO{?OL;Vv'$VӍja+aM>:4n\qgǶ7m=SEYdEY#_"_ߤg.={Efx&@J\q{zx*G1d2? 85e^ȶ>E)6~oasRnͫogCD;4,ƾgiN6_)s^S>|n N0\6/iֳY-W`;"; 5w/ԗR_zv&?^ t:wyw~ɮĢX:/@Ccx^VRbϹgz_Cʥ\ʥ\ʥ\ʥ*_38dQ!hs7oGWz{2tWP|{i32Nx[}Vۇz{ቖJ9tPV!~c^rCؽǘ+[BQ׋໠j|Ael险dW_WG_9{ J@-u'X>x߉Gb_rJkchU_ůF .쥝2Ч .=^IKKK7L$O6Sg&ɳnWSOgf4\NY>^ڙ]K.+CXY;z(ca7ᅭ8T_,- 𻆇VZQ (_0{ ?p5:~/t3-s2O%hO*'y#~m]X==Q}W~oeJ=KKi/ CrMePغnvKp90K*G˗ #,",Ȓ7+qagmg%ٜa%=Aqasd@RטRt}RÓae*}iuʇoyJ5wji)Rgܞʘގ<^|Y^~SEZoe;;1lHg,FB_)>d=nG-icѠ ]QU> w ?־Sl텕5Q9YQ/,Qeh>,-/n'Fht^и=aϰԗR_K}/Ol?SDc]CWoP&yGSY""^ Ut@lU%?QU`k0 .2Y(FmqA+-~l0V?> K<{J=[WQNPPP) S46za8<=zo"Fd6Gyւ4/}sI`G'ut`wnlXJx UW'QX>>o]E)f\Qm,;Ve?g/YdEYdEE!?Qm+V{xG1nʁC0F>?c[G1Sb#͕) ?CB0GPQpet0~{J A, =ʒV9*#Êq ȱ8FIP$ŎwǠP4/c:{myӔ!>0cHf/|>ɲα=>~x_4d"_}FF=Xs]","˜߉?wlhX nn>,)QGa 6;.xcW;CxeR\z?H𓌫>0{JϧB^L4G>Un#{OAпn CrQ 㺏Fq * Ǟs vGus~T% \_֎шЏGD#ag:A=W[?.tt/#;Q-+=b_4KKKwWo3k|«F;)$7iyOx褀Ě_Q~r O=Ǽy< y.NkD_)/*>|{'5Kn~Qp @`] rPr1|eQ6W qbNJC7IO o)){5lIEɓޣܮxpͿh%,",-πێ`jxATpe)@`RN d]R5~KC#ӝH)eǍwǢy5^@pWR[/ ~.퍟(7>2}KO ZIٷ+ZJ7i:(XD=v':gAtEa~ϣHLԗR_K DÑuߩ7Y^ĝpf84^D89ȣ=)-WyG8$HO]hHG9 $a9}C=*Iv%cY;V>QzlkvØvΓ6i\bn<١`&k?~~ϣOOֿZ&C |ּ-z|$KKK/E jtvls;< ϳޒtp7Xq!Ėw%<~]Z>% COIv"*_M$ z`KrW0],&:\ޓhǪݥӸY؍quu{MS|m}̳9_z~_=r)r)r)# I@$,",cuNNy?/? ̨[qM+H  ʹ|?ef]S4>"k1w~wZH(BhHxu 0$}xbb?hX;A֓ xǚ~/~S_ndEYdD_4#@=`]pkgk's;\y54)]v߀-&9#(՘x"b l fXz^ G(FW)_dD &e(?5fA8/pe IP$^=py<0'[)/9cc)fY*j]NYK}/ԗ>*~QZar?AgW$7ZyΑvL1~b|5 b0ЦoaY@EC A1q{ C5_-n vEU.6#1ή/ {?076[sv:_r^tac,/ԗRD?lۏӓ068_N6=NSo #H6v3V B<g?{'f1|ڟfx~4;٧x$?WTfQXgXO}尀̺ܮ-r=&?w\Ϛk ,",2Q@b秊 ^+¢ 4\mD{g`ڻ#3o,9fq0/\]?xU{މkv?1ɑwGcb^~j<yAy*?-|V6W|Nw-*}ʁG]UN EYdEvutMmTvkmnhUQxAǣO+W){;TF'5 PswNzr/-zh#K0΀SU>3xt5ɧ\'cߠ1:{{}'zf?,3ܐ}UَB"9}{ܠM?O~VS'AP <]cm:kcy9́{n3Jk[>2< +cЎޗ=nT;x<"p_RYQJKC>G2:a}ۃ:C ZWW߇?B OU&'o2>*Ã؟AIXnD3O%B}| 3oU=6?Ǯ)\}*'V2<+d~X!?u9^ZFo-1|)FpJaķ@;~l ,WV;S3FqsϲzI۪+o/u(k \Z]u*ַoyJo}磃;=YG( ;x^ ŋdpǍ"&~Vn%(>iRr 92 Z;;V44(*+UWl*+'KW^WY|bZ [>O"Zx` p3l&F <,Yt.xG| ;*[:/S 俊",ǂ8^Ų&_lQ܌edV)F''٩)#|iYyJਣ?QiPcutg5Gn,%?lVcvxFx$kۃ^x֍C PS0LZ'Cw#ATp~'ѕX&;3"^}1 ܓ2c黪 Y3( 9DP59|W)pjU ,Zf+EX~k+p ؆74 `~E>9n+&-h*mnf/ql);A@?r?;.1OA%,",'R1]1g% ?o7~]+yZQcd23~qu/wZ{\,}ח4Xg؛X\nTr}E1x/i_ 8m"pW0\Do/I˭Y Рivc۩(oŇ/ȣ:9N,hH~a4aA~+yԚ?|vJ5ϣl*=ا  v ZY-om,?vw ߯q8C˔.v~","ˉ`8?PTS[իV hxwxKvt V!:TVÂji)q^{'m> A/}~YdEYdOd;PxTKG%uùWL/ JTDfbg_]pCVU(qezZAޟ{Ӊ1eru}qO,(2 B讏BzyX濪)}}`;ԇb@1wBݜx2{QVdҰoLrQ>-9Ǚ|ΎAΤgfs=I$؜*Exk8WPώV k1<ͰG1WEh'l w|^ `H?WBoW~/p CʁCÊe~>NKJ3c k56 vXL_;u S#ݕ,",a_B8];D܀ ?[ bU&ŏ=^z!ޣǎ#[0QS||!ejBBd`26rU X S4K㏔x GO΂:AO2r|Jn?܈ʩ2dhQqbmcď eG;]IL_]jJolGyc;\.ZFmҾk@kG'cb;Mm-̷z瑖Cuӆ8c;O\N~ÜAXx}ħ8{ɭ~Tw@뇍nT0}:װ#c6#E'Rt[Iy|OY4q|XU՟\!SF !@Cώ4S0cbu]MRȧ݉h?o!iۡh8bm߮X1B{<36SǃVv-+} z`@i Ľ[Qh_ K9?a*xX06L'd7Lzn!^=ޗ4OKKK@OOhpG"ߊ +88M,:&"M+J y W;KK~rO0d;4^R>^22Ã?Y9) }VǼ>eph,v:w|x%Fq%bzPRF!i-Foc2Z{S?t{~ݗGvu]"P?8gNz.|wFYg+^zL/+,",'@,_T0?o']XS'qcƃ>eTZ8"O늞~/qS)Ox҃%>̘RLBeRg.oֲRuBT@K|7Wux*~+\أGNhڟor1@;u{~r~׆XD̛G^ڟ.֦gEYdE?DU~896HOf(bW !?PO\_h ƅolko4F@K^XGFt}'VAK}/ԗGOõag7ph$=NLAMmVmzR߂׬ceQ)'SI#}sEVMw%cBcbэrr`_ Y`h*?r"|h*ArEǒH%edc,KQ} '!pqN'Tไmznd!5@(b\ #?Іļ> ΋yOBʥ\ʥ\ʥ\/ ~|c1Kn-,Ʈӟ/>~P/(e13ӻ9dSYZ4˞'_֟7r;ř0KWƻ+ Q -IۢDcSY_ΈE} ""[c,0=BVuG 9?G ?+N wv5$0GsV#.8=Ri/ c_K}/ԷQ1BH$XaRQ'ţvuNq9 CD0 $ryH@ld%Jg'I&StL2&yaqGvls;WJ޳ai8iO~n%R5h-N;Or~>b#I5VGs*[z5Hߗڟ] ߜ/}xs~ȮՆ|Ř\&_=',I}?{nk/ԗRN%icLTK}| ,\0b3D}چ?/O>i'Pv @!o=?z̹f#GX8^VW\;?qC^Ov[E e}bFƾ.r.9{xHt|׭,O8F/Ҿ9}+߇aK}/ԗsj06̊Wo6e5}S9Jċ4hgaM913LW2&7RXN;?s%^mie:l W*L_н'U`FDZ3T𦐎avY<=逩W^֓لV=|7&N/ԗR_/M]-9:r#rԯ%bG=C,j"J/ DS=^v)S8 َ/M%GG'WAnʅG1lAf\;s`)h[z5ϼ 0ۡ4=GrU@;Щ22aE>{ C'-@{ggK[k[g{hmkƖvZ)`)<)Ƕu6V7_7-x-v|fp۠Ñ(lC3j Ɓ) 9gdbϛ+UjkO4ow<[@.ss޺퍠f "l<ޞX e%+ u13`9VG~sO _Ǝ;>@q1uԻ}M--S>h8v-9 74䒈wt($hu-AU.mF?{`'O\w_x k=;1Q7Z864g2ہ7zkSd2'S1g>'S(_X~gz[ے+w@!R.R.R.Q_EKlfjv 3=33cfq*=8%qYK67}UW/o{O.=YīvܞS[m[۾ \Z9 6akuE5[;;X,%oGSsϑ} s#s~<< Ug梋ӟ9xkKۡC&l̫Zm~Ie&=(险2]`nd;:(Eu6C)e33S$OA5rL򼒰)ʶ2O?mj,e[t688n2~§=ICP$J9"Ǣ^O\ )JZIœ8vvYv;7Dֲe-_Bװ(|4L8 StJ7,ѠU^Fفq{pYըr,<v` idjȱWȨ!?||&ZY-QpT8s*~5Ϡ>́T j-0v(L;*̲^񱫔w) X8 a/R.R.RAc4)Hiu[pE{`jiK %@[Mcl=DcLCY;k T>-@ +~Im v0oyE,334vD_ǣZ)7GާrcB6Ə50a,s)Rn3yoE,zR_jo.[oEמ+y83|X$U 8S5ॷZn4E9IЙڙ6TI6 ,a757:S=h`iĶt65=Դm Ln]ܟoliykmk9<@G[a[ZŽHf.\S??S?}.LE~EU#9N[wkN_zNպ:ԗR_KQ??( ip<&&әɱhD =e4}o*rTT.jmYXڲmAKm6npy^F(kl9i{۶]mۅ[@[8c͎5`)?:ԙq#-6̿ŽyzˎΏ_Co~zQGW.uW,ݸw,Z7ތ Dnhn֘} "ԗRoB؆SqobELR{tb x"o# 'qNQALGqNhh;]O͏2yęLNLNQo=UXqO+S&Z.QGlp2e;eK_)o^e\%ގ˽jv Vf;9{V<[ »lLM%o{N$5>*8r+@f/N',NP5Yg'y/\ĢbtWG;(?G|j|W_mǶ/}g \/rñAG'LqI>oF~ݞUfFnRL&ɶ5i|wdXzR?9ړV:J۟S3֝/`{ӽ9 >?=xUyL|[K;+9&# s֮} (ܲDwJ|˕w;lxa pbHy:~pk>h, sv .QS{_\ʥ\ʥ!= P)e2=hfrgNh'*ո{{(}8)c]UyďmGpϳor MP1W%[?$dSceEY<̕Ǯ,Q1;r=EQIHGD;A}_(P%sm1H^O-]ܕ ӓ_zk~uo[K]r쾀)>\ý,M4 C͸Uv)y'~,f ~\Cyr嘘_# QFTY*?>Dᶎ`=øMBlAFc=*6<BX̔B?ʾK?9-mli4_V5GYr떬]XͿ䑖r)r)?NhC8xF7c/Ļz^Ǟ'JO{4p2aw_m},[,Z߆x~ ?X):xTFΖd|bvʲXO͌Q=G&s~5?I& J$Y0?I b^s$X}jt0O$a  0c /Vy-oz]>߫' oZRW&mH9fae\3#X?{lG&?:3(%_D?Sl8m91A=z ~CW"M^?+w/-o呄rlQaFKZֲe}BcavTϣsw_~GtN;z55> pyDܻ]v=7 n|WdS7ZϏFğ4P vF ͆-FN'&aW\ۡYlxnn %O93 _YwL=7N yVXb~JXo)s߻DOS75}[_$RoOH&(и("l/^P {B]qG<7 }3:aӿ$zR_K}/~nB]W?s(734 ¬|Pt-`g﹀ٖ95= n?h5oKo@v]vh EZr˹Οz؝͛Ȟ}Q!@ 1}տ)Ŭ -kYZֲ@{܌ѵ yJSCqo·&/0طHA Ϗ%{ B0p}G͹-u9>Ł ;^$~~CEH{q>yu#"T`(lncoZ>pȬeW8X9 Ӄv9/|cX>:'&J&c߀?u!U.vK}/ԗZ'i.=Æʢ#`EoЏG .}$ﲴO<ۢ>fr#cynW߄k1ɳdu,D\prХͽ&VQEH#sMm }ZZV44[\ֳvk붋1*-/e׭Y߸ K,7bk7g0k0^WuNf>sEo>A\F]|KKK%Ngpn8՚J\IJOQͿ+39^%}wRX)sϩj>+w ' p{z-&XH~=8V2 򤕾n\G\_?cܟ:9ۛ1?W>' -4Izc51V!Ӕ޵|3z9/s{ookA۾}c?EٷIm )оԗR_K}~#͎@f){u>4wjmU?ТH'At4tOk{u~{ՠ/ߤO[il\:36c'ffY)Xɤ'f,-dF=wdjOjA^Q֟~S9: <缕m*ͦz{e^on׏uis_7~%Zr؇>45osZO OVM+\}R_K}/>1ި<=ݑp0tfrZãqҳqf|bvy -\?o/s,{<?h? /??+ϧoOiys̅U a%kO+ޯ# /y ?cvJDUN#؟b//ԗRӷc =S9xsۧ@.}ƊՆ? |v w=O_O~±Y9X[Q3O/ԗǗ~n.w}^oko &sc_/?|t*m`,kb8Ϗݸ/|Tכ= G?-VngXΧԗR_KTߎo"ȻnCnoSjַE/ξxS[v ro<2p,W~zv\L?ȰX;~uxnGźc1{Z)yH嘟~gr~g=8iI]cTP@ X+J=V`CD{-vTzMoj&l gs+EMv?y?gμwܹsgr/0bW?9林ߗs["Z7ۣWEi߯_|^h+(1<TOۄSmkSRln4}Ȯr1Ouf/_WjÌQ{LYXD|E}_X$sK~^ӇMY+蟃`_[ߨ>lcI&XmއO:j~ͮY;RsS0bPK,?i__eop>֗[ߓ‡t}j?'kz>//-(m1j#RfO:g<M(_ wK㨢r(PP 1tY_(*?)XLs K_v%h?iR_OvNMK6 ;[W,+]qsi|P1\0{VI:Y9OZVՈ{ofVM8W-^7+}n&cuc?ݪP>q/?[cS)e|L_R_XXXLn+v xa ?axX JKL\Wk9v|~GuiY:p(OgUP(l׬%XZnr#Z?ox} N#k¯ekrV _wjAd_;ZEҒoŕW+a篭9= ?S"[YUX1/2 5>F{^ioz'ߢZ_קhD+}׋bn-~_q7^-'[VAK}{A;RAA/犿AqiOdU?+7@/ȷ~͝OˤrZz[_ۯdU(ϧ0_9չj}jOozQbυje|O_Qj~0Z/77=k5>7f﷦[*K}KUsجOտ'/!~^F=hw>XZQiOa-*J>7~rε5j؈#2SV 燏 PTq8zhd_OYFIյ -WF"1-TYϊ-\VG %'WIȢOAG=%"A^\#'zίҷh59i74ATooh~ T|i3oT;sMͯ=Qώ\[7}AxM{4,<7?Uz:jV##1k{>$=/k~k}^&=Y"_' U>Ty@ Ӟ+''d~Y^iv/2K~)/yLz/05aS'gEY>v9Knv2QBzt:HM~突m)o@=+=kzͫWy!ƴ\rѡ`F9J(`:+V_)3'wsȾ+S?/MYg~8rܒB(yQh3̜:]Q9eYۗKsjUqd\08O5&OaQk,:"ܫkRX'_*SǽxŸˠHT W4r k׹jZj~]'z'L3he܄?01{Rqbb4 N/b2Bgk )&M*ق{OsJ֖J9&o*7y+TrޥƮp w5Lr \^mn~?׳St},=D܊ί~_LS_Z=&%`ū>fΟM nj8Ur15v>@dI3ѣݲnP{_|X|Z'>ywդ'Q}2~NMUGռOV>ZyHg~SV}^߁T^so7ԶkfhK5 ZuYk%^>^lefLZ,`fROpn?0JBx-ZV W:k<〯zfޅvҒB*|}d^;eZ+O"x2X4 **p}̞m<_+kR37 õz^uklޓޅEm[y׹%j<3>T+WVSէPnt盹zb a\QֿJ5tūռsrKKʽWͫgeNcտk4Ts4zMg(_F_vWG{n|o+ dG_M#t嗖T5]%H1?EEkSY=5-~diPZx虛W|^g.-]6U5}О%,(3XҰYقMY3'n4xWW:׎'i齛TGY.Q\79Go.r29[2FvM{ݯPvWokR߮2~-6wLk UrAUGt{JXΪ{ {CyW|X5)Bh^珆 nVr#%]ZED}ɥBy F\z9!ɒ)0FU{x,2>8pM\r)淢+kj.`; i>*g-Y%ˊ,<9՜_UܟV5~ϫ?]wR*+6~sM<}_=kz?_XE̠WB+n>7 5NV,}/? S`/3K~5r-Wg}k^$G5'@B/F#kjwVwO7+6e0ݳ{Xn+fW5cUc|y ~A?3i8O[i8\$yKGKc^&(GlGY/UI\jQ1@_FzJ&[\TN)j5(♫Osp γp}&럀 h(B#ζʄ/7kf_5κ0Uzcԃ GV{+=)'oI'}UϱKiy=; s߷ksȮ^r `{DoW{4#KH>/m}Ο7;O bS+_~]ۃs ? w7XoMk~-|%s j})cp_+uo޷~ZOa~Q#OϒrBcvYIMѓbUʭ1~:hj=X]:?`M-zIj}@?WyE}(CR?j/љ[ u|GŷwoM{1CMCfk>`a[uz(냒Ҝ[E|+J+r-}lw<-͆` Q%4|TqQ'9f}|XWMGee(;E70{|F-r{{^dw \ўRqn3̻PA^7;΃I,y*zWZw`Lʜ<7nתΨמ'4%jρǒe[ye][f|4{yտ?)q=yoέ(51;{z-qԭjX^t;U(q,[ThWRZZh_;|,_0>ոV&?5,+Mv䣀o\ct+WCQkyQ{݌*vXci 9ZkeR}gDqkz&gni/_%V^FO RK?Zk+ʫ<[Z4Xy{/Z;w:ȟ|]KގK̞xߓGeuyvmrh2+Mzo>64aлcqپvuxg[vukps{7k[;^L؈^4}#c/6OdsScܔSINdg#85bזcZNuiA:61>.ז>?CN߷[[xvئwn 촫sk7_v86 aVo{ٞ^6KF*v0^:ϊq}zY{aؾ8㊱iCeƈ' Gx #H mρQa?Łc& f8;5`αh}p“>|7hwpk+n)Cp v?5ӆojq~#=o3܁1zQG2p_?c,~l4k Ė4X7?4`K )dt8`OB%=18aXoJ%kk7!q֐ϝcl͡&'YoMl7ۓM޾`9ϟS6 O6a)qěggܩ;{o7.a^I']pʶ0gEw-m $/eѤ]؀ 쎚l#aGOd`ʒ3]+}+1\6==rճ| 6x ̿ou=1ᓱ*8-fFƪY[3k`؁ჽVÁ3}`Uȡٰ5s2>x-^7OZ7o?%8xS[acmNn]zrbl.}k^~|[%\rm8%𹔨3#+<+ŝ+Z |!u%+K+/b|!5a;]S#Ki.D_ ˥Xa_wF_N_+iΘKWcK;c/]H[uuߺ{אCFܕ}k0՗#ጸq/]syZi]{d+kîbLHY{7\~F33f;}#ύ ׏lcKk1Nۑk_ٞwr>Isn*8X"d}l3O$a=90>)&K7N=6ɰN·l'EvVpf+,gS`)8=tga+ΧM.Sv>KǖQvf-O'M):Ss߽{o^I/~;w.=u%Jjdn E8sQ I߽r5\K8<߿'9G0~Qr}}rsOl4gb{>t[c,{gyc!edPlY;tvbN7ΦD:moӳ y:9vehv`z!űuB: .ԩnC}> g197}s=\؋q4s7ǹl: \v?ϵwmX/S`zҐ1\Վmkð΍wn M.vm{y]2Kӹnú4]Эn-x[/tk5s/0p]-ޚ[]Z,z՜MބOf _j1 <`^У%F//Zһ^mjO%=_Xҧ 6`X~W.xYzw;>j֧WW0?Š~`$mly A-A#سvу>1h`3c4ƁNQK;|;~Nb_w +_w+8n!vZ;%fa/b7sNkGƽI%J>]Y; ^vT"xGa*@uMž00Fc\ak=aduѣdžhrK^;zϞkǼG{gH8o^'ѻזM8aB_l4 ѻ/<'vcdQ(>S&N#Oq'Mm[}3?m/ȶiga)oQ- x-g v;_N=y:Cv K0w e猡wga Kнv2R0̔=-tPY8lo贠A#`=sdF0‡scd ްч8Ƈzup-;y`ױ%.>8o|,َ-ػt≈)M8hiG#\6xS.2&)8zшeڑ*~4x!1[~XĔQ>oT?ߓQ4Ѩi'b}ODO30^T߉X8}m | 1|έ 31*xMX ! 7:?P콸) ˛^D8>Rlˉsގ b[^Ls~li9nQ`a9y(9x]خ&e{Vblyv)< |Ųcɕ-sRgI cI涅ד~mBW.NYz-i{^߹(+u1˖#K.>SqdM}*Z[L |غc9hܻkoP:~*1zkS X[B`ó`|tg?|{3g>d|nG{n1^|pi-콴綼f?탳i񅭷3S>^^K!^vO2cG;fLlxugWw| O$~}I_d&2ݹwε]_H{}bl_?w?؁_}o@4qfo@p\C}XWE޾ӾyG~lgf#g Ol#6 N˘y{;fOH$W|S|>oRI!L=e/d}?c#F7˧"ɰsjh} (5>d =OF,|*f&7=E"~4r6žGi]#tb̃适WL@셏%@XN @Zp,z[y;sr[}q UgTRRcD'bΨqm530U0"Lj0xzy[O `;@2!࿰17^Jل_I 6BؙY/o ;60ۦrykؕ.o8\[E5,s<$ sF@Y@l=i,0uoxɋS`d a vDɰI&/N]vcכٻع4;uK^ s bx."':"PW|F ?҇pu_C.9gy( { 3h 0F|`,QX/Zq,oޑRvh0jlH+a)?~ʼnuJT[W8neWvl ` {gwjİ+HnΙ$l'I,<a{g7!ͳh<g`7Bsrz2n4AM18ePFa9c=W0{>ҁbLRGeWry;ꄑ\AɂjAbd7R$`d$ gQ 8T#ZD=?nqu> Gن~c}M8 ^և_?eي?oct"wiA h1t:] NQl6:]3N,v=k@{ϴl |NyϮv՝jtz7>힚e,Ǻ9txNwHU}:?{:7 pToVN0[ul0å? a dcNMti0ȥ Qcd wn<åIkFgvj:K&3:7 pi:K ڵiHVtk ܮTG`?ke@\'{{&ۥhuG˰M<L^@^&j<.cڵu>j,AOc+/j˕eh?,:p __V*.r/3|9|?ԑWdؿRϖΫpA7EV/jί+5fx'sƣFS1׸Q߳|ugբѳ'Ǽ?8R@3 Mka_#RWӇD^AjmWu^FZFQyÇjZ,|u@NM#5آq }iT,}0")PV|A 2UY@.Wvj(5-FYQX ^IxS04uHxjW劀>E 0ϓ<`~H"hu`֨Zc=#t`9k0;{, X8>C P2`x]*& Gp@] b |LrhD#'Q>z#P߯Z>Ie14X:$ Ǖ?FNd{&ixu'|UE캙޳c+bkS"̖o7˰_!*ɕ p:J .&]`?0Cd8qX/ ˕s8ԧ9 +\?1y>1Ҷ9RpE“}e>u›i]FB?,ɋ]H~ʒ[hu$-^Ŏ4!e1BtZ_PByc'vZ q#Ucx]-\eZ@F4X0a~/<#a~_6 hg RH0`_WR?|L*՘G_r8@l5lQV(ǔ?gd?WnX^Ձyt|8:S#7]$+s2:@AiWT=a9.m{M+^mUB9W/$ݹ-rJ2bxl_k]Oˆxnn8aB*E 3yC `>kXwo|]p.k ӿݷsT]tʈcbH"0Qё1ҷ2Z̠eؠw񫘓QjQ G}ǧ>?銯]̺v9/3 3jfɕW3y5ZeӹA?I>rh8};Zn`mQ6G6oԂywl }?zg{߮CClHJA";" 9e/ʜ:6tn1ѱd&^Zx86pl˔[Luj:cc?&_l`㜉? D5n͈ԩQk`V㝚,k+oz a=kKLrm5֥6>]!ntmU}0&cK WOΏkd}S߳#*\md:#jGhxx|tam4U;`[F_v^&_%бG V u`  ?0zعcPgư!jc@'ƱA;^3=V: ot LGw?W#'#~"D`oAT8*dU}<V/zngW׍ynlDƴ?ʺw_݁mҗ)@\OzUb;KdK"M-i H H%OO!ɴ 0PkOoh/پ35`/U:0AÙ$W;}YO5?iAhkSkg:-r`7Ra{j(WBG+*x"HrUƒChvϥqqi#> W$lT¿'t {:(dC  Z5XH H SČ'§b<(Rloz"G p,r$. '||\'Oa/;'qѵGDT,D:K>XP*UɢU >{[1rQ9ZU&rHC:ͷ־j|zXGEun}qGg7+i|v!KI ڗX>DOϮ%!>ʎۙ;OXdnMO(;hc:wVaܰϫ'k',_!o^KATu~m_w}~]D? m4J KKeE;h_ÿ)&R%}G++`*0yѫsK M cm /[}Z+W_x5l^F<<ڵkctmQ|s?Qykzlݡ~/_绕hߨ򗻕?}\y_Fб,::֯w/94 qXw/?\Tx7_l_[o+~7M+CW*J/Y?mA;@ ejT"U]@6V@:^S]3_|~Q'?[U W(A}=Dw(lq֨ˑ(^cOGQ_ 9?3c_}i?Gtwdjl.]-:dɨ釄XQ>ښ?0,dGr9B} ب | #>=t,uZ5!?j:[ϫWX9^8MWέPߨ/`9E'8b@" R@ 'W@f} ۯll5V9T~)+gE[bd;Bqa| 1D'^O 현 KRH+m3_$$-d?du*5_3~k"/@TՑVF3=٢Ͻ#/VR=)+~9fD z+k7A;-??_x0z,%WIcѡX"d#*Rb{d?WV?8pZf_s_)??)c#V*&5$P~>}Y DQVD4^ skv#?lL< pqu0ۅ pRҧ~.:xOTn&VŽsugk)ϫobLAHawŊ?I%RP._^OF]wt1<]ʀ~?| ȃ$tRz1J>7(z",S]JDDGv־vxƷ_t=|NWGҿ5Ԡ6q\*G&ןdQ6+[7Cm{!}=;"Mk0¡)v!̞ϡT&~|}٢#@+_{߽|_#qtnԂ_>OujJq}Cڎvi3̹5twi3S;$ԵwnzT;`6 '6΅~][pk=ɵx_ߎj7ҵӻ bAajG6M#zwh;kK_ӆ;]Z?~A</Qk+m/eC>DoT^*S@0m,8jU_ @*WvWvƫpAfhX_vPm_W£1ߕ?"\#?c̶ WM/)/z4]wU8= 2K2z2U?WZsί2i_cIhg89[6d xOu~ަA86+ HWdGLkXGNP__?3wNH ;s"jc~s |^) \?>DTA1QG|HO޻hW @GP/3"92=b99{0N=A8}( A/~Y8b#:W W ڏHuW(C")PV]zO UB%~^)@YD`J(6^PWm{5QIjWE_py <7s[sto 4*gʊ9H%'-FEH:c. -ҕ.ܱ KοkigV8w-u ٿ =F*`# " H?s^?l/̈v`T 8Fc"QWV ,R8G/Tg̫++Gcz"0^jY/!\xO|-2/H EvӉaDH%f}Ƴ7E@Ws6vj8P%}l‚O)ùd ~-@]3y-&D4d H=x8?T;>wA7C +ɜO^)@$_] ":\;7k'_d*w7cE^.ۢ2x*(+U#ԘZ>+_y\V݅R!(<5x|>LZ ˨G}{f=Kݟ|<#*Uʟ~Ͽ|/UQOt~^khTݳcmTk/mphB_ m~3o4 ouͦvhz7 ;rnױ|D@M8Gx97ù%⽯F8tc#oajFܙ$ȥIp]ܩ_ <ŵĜ_L9R/l3{>}&[ a0mGyn4uu a5kοlvTSW^ Xv/:iXgi_[HOu~Q|j0 gtR94.`fs߰F'k~;#GN)QU0rHW=_,P߽gxIGTn%M/Sx<JǟH"~Z  mr= D /> B Ʋej$l?ov : @ ?0]S4}sy- |95/٤xy;gt{1b@kBH23G=XCab-ǦX0n` 6gky39*H5㵀yc-:2ƢqϒI\G~N]˽EN=,F"/ ϟBj _8/8<"n_ E/9"^s.)+0P1A(S4.øJ_s_pRp-e-s/ '? #ЮȵI|IU B*?5Rw)"[x] 'm GhXb-@tN]{ (CE>BG i *Bk. ?ZWGS~8!}]5{ H̽Dd*KDOX z|z/U8Կ)T}nJ4TyWTT97.S/~3)|?6I?[-5R 5$ϟ.g .F]F㧗Gp_ވdNZWٻ^K>0R?kT:wϗ٤ t'+kgp/0a?!P|`r?W\'mVER8G!maj寴<D[iB9}>SͿRp1j?R`V,i ?W /@*h'$op]Pz\u~D_rS40 sa?c#_;-ޣ:w7cNHTy]ٮ%$lՇ^3^zþѻW>ه?O!O iR- m?*z&Td2 [4dvo؟{Tj?.5iO( ,;?'Lھenj?D=Ad{zCn!#`weu cL<{ba OWV@)3GLPRGؿ_~ @M?P*ipQ\B =gb(X>d4 u.#8= J/#ȧR9*g V}>\vz?RY?Dl׮p <+`DM7σJB+BՇ{'-T i.p;#_?ג+Xj?3p8{He87uYHrw-G;0?\W87m˵:6u~}'OgLO[>hx~z,9@{P_"/Uh&1, Z|h5 5ƊvW8b~,Yz0H0'Bq /)@ q4?Xj* ?HDGHY I"mnRϚ? E fS 8C>ۍ*J/-x.&! "ڟw||iL:?%W?S4vFUS/S1+b?X$/rv~Ta*'OyTկ(g?o_NXT UKb_V%k.WxVкFb"_7:v!=;_>O ~/V,<'L_+WD~\1"o:]'xY l_}Bhhs_l/7{WPob& {7ӱ$@D0=S߈4OտR>rˑN@q_bf:ڢ(H.&um o.m؟ݵ-ݻzp/ F\&R[unOx{kg;kҽg? :W[SW:UȾu~=R_bL(M0G~ ¾r?;cduj?*'HoNUW|0+UͳTʿFcCYg?{¡>ߜ&>\G7e@e㰴S=S&~I>q,gO٥?RI2 z CM1sDH_Q^#PZ޻/c_nER_T)¯F[})}P%,BqxL2@o:¯< `D҄4s Tu.p:s_)_Dd*.@4 jxn&LU^_;jέ 0&m9W7W6Ϲ*}O3͹y ?%_RTY׏[s-R_(O)KnW,$%\R5yc:lk:TGE^U1ZYˈSv R~őuEbYNJ?v`ֳsۯ^X%A u:a9k?"̜k7^y'o^'DYީ),O#2lFS_qmOy_M(\ffs:S@[Kbt_2ح%حMeڹ{ Lt tm kUi~,cbUh%5GR{FA?핖^k1G.9ȏ jq1cA+ppO׍++'??WOel7kҝ1=i8o_zf `d<@gRBN@"`mON \?)5g?۹گ 0'5oQ?kV|٤VI_rӳSW9R_(ccQ1(8ƛV+`> 9]gVI"}NK>/U|ߒ ?sZWs+d5r^ϼ?)`ڕ,9R_Y5($p, !AX)#`(0ƫIsi!@Q_T(y#˂)Ă@EaaR 80f? \H_KSE7|?8TpnI4c t(>E#M?cUFZ<)#/t V 2N{[;Sg#t%nZ_l*)y$l?ʳ2#5^IfZJ%."O=&_姳'[T畕2u_nGDe%J_/ 2>3 +4zogtx|_b?Oy駋23Y 3񩧾|qsDx]ӏwvu<-qvlꌦh{_i0ծDۺ e ub]=vtlz7(RB%?cyآ/+rTǖ ع4T]忑|3ѥ$& e/;6G, wVy.|s4й{JE\mGu@_LzvVwk [u χiFLKj|o4+S@oϜO+:ɿw5Wi3@.WR9%LJ̜{e7-8Y  ~E?|*ç?4zʁކd|,bV?#@tf__U"?җ p:h?oP2' PƟ+Ʌ(,&Cέ > _8J_{P/f)4s<U/xK*@ju)/n+1#)@@~=XJ%{# 07i`U#HaPV2W_? >H_ڭKL׉-D@^bU_xQ5rOu{sΙQ'] />zE kF Iw|+?׈b?FlsZ]~/#/ua0HJ?S~I) J<5eMH]/PWQYzO>9_u<%K\*&n+WDF,[Uvrrtd3N7mz>J,nW51|SgcR-:Pj$F$ʼnc;\ Pg]}rlBS+qO}ҩI`:6aNsmQy.ީek]R $ԥi[+$8Y.ZNAbs79-4oZS"C_cXZqoU^ YGTJ[SBՇA{@/A?R HM_ORؔ'r/WẠ'>c?#Ua/( VoAF_p% ʿq*0%lQwŶ޽ X++WTgSgn?Ruų$<KzZoHjf}?;? W(o.,ax4F?w%J5 L"G`BP窾V?cxyi<`Ϳ'#|_q(O]%6/<HG"EH?56@o 8])USOa?ӁGn}+.PGD`GUAύ`"(*D8IAj-sd_5|ϽB矔|X_Emc 'j? ۟*6 {wKY TO~(d'OY?wr/u?O ڿ:F} _T_e`>%WǁE PPZc R+D_9Xqj6[ʿY^^t"ޙngܾOj#)@WD.PQr-@jSp}GNV*w~*  <lH ?97 (+U_pX?Pd^E7?Ui_ۧuF>K?ߕ?+]ʟju񷫃aC=iö^y7aݎ,&wlѱiK z3\85ױqK94)@.M]Q4s@vk;Ki.fun5ϭUp~NfR7)]J/ߵbaοF_*??U}O⟢@2{eO1 +F?[ҁ0mU/㣪=ގBq|>OGAٷC\! Ȣ",BXA2A\cn2 FQGˏ~Uuιow}rZ{sϧN_} _*Oz~/N  3h9 !I n ?H/@[aX= ]j_:h=S7_~ϭn/6~RG' "Ώ7FrUf, J&OWwd2< `oUmeY##_#;4 h[p}f /D ~Ju z%sFl:CϘP3 Q,`4df#wmot2S9'[&h?/Rdq9.I 8*e7,396 ^?=2W&_]#s]sYf^@$_@rT zzlu\iS@4G58e3W_?G?#!W{^~&?W$5m/s/u~[ 9֖/L5{*V ^4Vȕǚ4s@V_WEkMLu$G*?fTvX=ij ?"i_gvm Vep_z四ϼ+=iA?I.&_x$w5mU?jsvL/M.;?Jo)~50!g_bMmR|aW6Kʱͮ|i^҉.ˇ]yŝ/;g&4q-'ŵzR|)mqNoխmV5ZgvNlӵ]Z],rLMj;[4w?%ڑ"HK/&rG73=9vs<'/9Wq&3y䘼ޱXt()wLAʵaU$ }]n?\zquZS9gvR4tD]W/\`WD @h8_Ew92/;hJAr?UyWv o:_2ak*x2"1RG j}u[4NIOT?;uG#! OU0柜2 o*O=mTH?#O,O5~O/ o?H+/W~\0qm?]s /OxҋK&_<> а/T罃ڿu Z8d4 `T]`'W#bEZ2?[;ܞZKf'+_Ɂo GH#;]oΩnZχ/6fqlIN پ{M @g=5AJQj?iw-=Ŵ_X^$_L׶!0?Bw_NiP>f|v4qJqȁ>Km/1 ٣\b6忇/t&zM>/lw?.'K |^e2 8࿚{$_KO$a&pZ2kvfwipUnq&u \.|Ӛny7!]FBi WHj#:vBVXVtm;-U~bVj~n{dگ!sA3A?]h/ cYelL-g- J/;33y: ?m +$8ɝ$Ͽ3>t6~:wC~4<+?\u.w ̴_=A0_qh:K/e K @?3_4$qȞWo\^4e}]IM/@oWy7'}}֌1oWc˒/K #ʿmoIwGKhwɆa ؛ hEĞ/ mVږ9*忲1zӤ8'??tij g / oDO}>/o2_ph  G/~!/=oۆ]?}h:_?^j煪_]Ք) |?iQꡟ0闟?-C?:B?_vOоߜun~u%9|q찾ٍ?'9Y *=mf)|3~Ziq-gwi\b#GOZīL>+%].;5|~s?D }f#@-5[%?i|w>\ܑ6y+fvʵ_zuBNn0ӗOv s4/im7j?9S.#dhE6~cϯ+aရr?9+R}w@WE/ }I8{8 I?D Ώ/5K#_>GqTEyj-M+}cu ~{iV}wm+hf' /I=uS2Q4с1ad@4_ `]Op.J។ҧ*6>B@;2SiΗͿM1غ;sǔQ?)%m̿~/w#.g!l_4Ywϗʮy˩W*WJF/W`/b=*.^qd'(JƺX%O fF.M Vf?y:fj Z|Y~Kk|~}iֹZx{¦?YS:g:G٥o=lxo}K R 6q3|J8\V(76^HWi.M(z;w -xg(ye6:o|o$QU&yvV¦ >(FO~?U{*=zu?v~yLށʠ|Ӽ @Q5]9̡uX?e82J?/o1EVg-u6 ={|Jf,'37)\pm2q _S'RKK!sood743-.ɝ?CZ+EǓs7|WPI١P{PGuZsz+_Յx ;ˏ~?~!-F@H-_  ɣ8?/_ȡ +$!G~Gb#B&#?#?q1_qq8 +$eqox@@0qGqG!"/_qGqGqGʟEEqGq#8x ,0!ς4#8#8~\ADADD#pOH~Ap8nj8 1;Apf9&79p8~= bg.@? $( A!B!BkB!" _H~GqGq!!ѯ(Bn{-[|z 07zh_FFxbի}{>쫪:uWWWx񢯐EPF_!?]䵏Dd 0  # A" @n@Xb# @=ߏ@n@Xb\DqjD0|5x WzX Pp8ص,˶ X{7(y 01zZGx!Ć]+[:8 rxsp21is^eVVw5 }}+ P ;BGP/N cc녅M7Ds\(|~.wsoASoc?e}0߈.>بR" Qt)4R_ KCN69?@>"ȋ /b(B A9N;7D& N! LRRRRCv\ v\ 6\ 6]4q)q)q)!wOZ!E.ÆwFv@b'tv;`t/`NC*a'ذ΢;v;`NCRy$E!c1v́s`!;1v`csX r:s` yj9c;q9c;gb( Ev"!O3Q;`Cl /EacREEQ@Eqy"P6ęGBX!!B!c/5#;B#;BC^~`Gv`C!( !B!???[_g>¯lRҗT—޽{ ^{m[o-<~pB^/:uӟT_r\:<+}N!~_o=cQU_lkt=O/.L[A6/MZiwn ر`zmy'FxRirgR?Y8UUW|Omy1Ex3gJЬ5sg<Vw̯Qд %r3?+ŊWpiRg<%(`[-z%T~/_u+CڳQzտ.q+yh=5WPQBRR>9\lI~ԻN?O†Nj7>9yU]=u)^s/a],׆z'?礨3n$f%DNx glWL\Irw9>sڠsFd믌Ԟt;Ӷicif f. f˲ۥNr_tPgτ-JW&wӝt acBע@2_)Ӹ!'CVJ9%? N08 {\>oC|u|1T_1x6kS'8Gu$W^9u9Dazs=uh_?Yq ^+{~n|+<ᙿ,jжbf1A[TMHN nݒ؊S\[IߩėQBz~-ޞGT"Nhǻ_`/*_^= Le8oĩռ3S&<řAx,=gǩu_]yQ<_WGvS3;XOߥm^ʵfaBXqI+!1@a$cvYGy7[dğd,< K6)aS(~yį  rfdO=}1r+M<¢/6"fwf:.|za~Յss{A[&|6Yu?wx#gfksT3gHϜGuOq㬏Fe"= SO˩[hupC W[+5 cy+'.MJDRzOqKdVQ3}[վ"TP"fȷWMER$}Eʵ:r_6'=V{O1B)GXEј/W෻ @8'Z =wXR@"xy"q_e{O`oΑ< $\-h#NJls f>%j/f$U{D\M=r{|Cv-ė2K^j?2 apvzպخxG"z$ޗ_5ƮZa< y nX! GȽKՇ f YU>5o(;c~W~KP 5P^_b0_NՊ߽&o 8Rv`[rh9| ;=~aΚʿC9#ڨdΗUH+t* <g]J|g)^WsQ\ <]ړ~3} zګ}īQSsmUdʳC>uVAxna`JMp|'4G#o$|AJ3k[k|(-X!'ҹk/#g uA w)=b&/ohίxMN+jhysp~8nxg"g(;s w旭sQKo)EF}ǃט>G']:?qƏ۾};>t }-XTU$bx1% دF)/(5/Wk"h+IV}zلOxsiPü_߳}x]ͻQ| ~$k䢶?#Зm)-11fb<>1z-T=dwښcUܜ#<8wfq8^nS/F"uQzT߂o~g9h^7ܨ:3oZ͑y9VXs{!"aCȧiöGEz*_r4 Df,98bqOK2\ ߖ0}_ċQ*xd+kQU9ê~n A58K3?|`i8Ըxz<phN[<҈9j. G\R}??~N8<ܾ=.|F!U6&l I$_.s#}(^Op5}qwۜgvb68֊3q^?,ܞO㊒a۽Lߴf[U?|R;gardUawZ)BgvRzU_)#+6j/|[wq%qT8{֙j|2|3[$Ѭ1rM53x?gCFdXMϷE߅5T́BZX)ќ_+.2s<ў_37yyΙYiHxG>Oqg;rdޮRLPt"E?g%9ӜOx^^-1Sy*V{cRD>Γ8 Go-3,?r Mnwn䓲pr^-|՝<[s:8SZ3 ?Wg%rL;2C䏋H\2V8ǂqS~O;c/ϱqIyǁJ8nu֢?O[nb<SgYCZTqxB=x;_$͟舏SgٗM ck̳WsR,{ExƟqrRdq?s鼁8>)/r8a9Ͼh)y<>>-]uNcviF9;q,g9˝՞=q?9D9YWRguL{5ߒ8RVI<>O1g/>G38#_ߺee[Ml:$O dB~??1."˶*y^9X1>nm6IB~ ה֨pVA7.W#w 0<>zpЇ1N j}}ob~3q§U|\*רWWת$7g>fm*XsO4>n S8Q35 5ߛ3>s1g)>YW4ux7fVxmZ ܙG޴">s1g}'Eq볧5엪b~[[V(fbּk\,g9 mF|uQj=K8n=oZzT*ɯ?>j/ ֑ǍO XsL.0GoOIƬZ^u]{(>n37>83/^?#U8|yn,G|\u)~b5%#/ߐYǝqiWp kЬedʛj#ruq{'zj43Ӯ+% EȽf< ~XyO)Qr&@>ήz;Qm^j>ZآsVG#~w$v]Nw;~wc_a(.V9˕3BSxUbM|R&K$~'-U9Ke?ܙo+S1k NvO8K_ W)泇ϗ)'9,֋q|QFq%=rF'k i%x8,|C⛱C8wrѝ?Тw7zCq$Sw>ȥ?tL.ERGٞw؃^=1|>׃]|x#9ί'K=Cj O+73t5lKџa|=:qˇ k=?,y\R:'%=|F.q_[\_*vkרLOUujF(S})oP=o{qvWxyqx7882|C+ծK}Ƭ|=6$R??;4<џj|K ~g#x/^icx^U*G?[&n2>ub[MB;>99>urr֭۷[‹Ɓwl=&H߂q0&z66wΘ5Jbaxj|]I>{f\W͆ͰWѠqIVMVb8bW,v4>#$SjX“3\NJ壕׍ZYU#FV 5-x+aל9Lٿo)џ>NBKϾ+f¯oce3T;A}3S"di߀qVY4MdǸj2xĞu^O`mQ6'jl~e؟Fc|*^zsNe&?%`{V幠d9͸7qv&W.)tݺ&Tg,gb_#%b'_64=Ff m~axUyG}{U+,r\sr. 1H.'P/PJĩ)=20^&N%4xL]-ˉ@ׁL @>(B_1 r /P|RM~7,Ky$fixXrs]3~9/ oR݇pOhF&3Z}Y& AO^U}Af5r>rKOIpd5[h7x(So?;RMƟ:H۫ܞU2u󮵔 hT^J5NЏ9|ӆ*ֶ:FjYJL ·R+{l=6:m*+h {L}+naqm7ˌߢG&֐VKq_;Hǔyn]!%ԑ?ėŝQ9ޏ^}Yy\L# Ace8Uˣqy9אJ;)3?i|FW^WbASWzmJ-7 ]]^hL;XF|/Y$0;1eE`eviLNV'X! "3VQKvè$9$b'1xAkEjGߊѳZGsmn #7>7\G=K҃@m.K_R+ľij|p.JGfWSI|z~Hry )ZNZ*4M@+}o IZ# &"V==+O˨*"2'bD٩ȑʉvD6Z#:Mr|n3Fu}Q_РjU֬^q^SVWWgՠvzhF566~\`<&>lƏ-E+-AN-qRa Rf5~/8ǔgZx% |STa -4uQq F;]OV5@1W ǭtWzX_|0Gq7rV' ,xdt6c9| ѷ]TV /OM2߫RD;[,A#g6 od`<^/hw'hqн>BF%MI mo+0GI5ՄM ^r4$z{k6ɝ~]O?uuU6ko"/~0&rvR8&Ǹj*z.떺郈N^9kg%LN/8Z- 6|Zȏk']CG[F3r+> c_tMNFU:'W|y>>RʞWE5s钪=Gg$n#+E_m?_ /$c;.~yebpeǙ3S/^o#|1 TJ^ XSKwC>.Ƿb\|M0 q>5fyN._Uŝi]i-ی~S=4^5Rpͤh8;gnqsC߭K7ԏ"ujm&=-΋q~~:d|\7lkyoQl捰YsJgN3+Q;WzW+%3s]pj H{Fkkߜ l \3/ۉrW+hӃ$y. 1}'M =ZYKKN8,~\YO3~xףn%][qkN gBi '[Lw.8ud ǽHז58Y#ݠ*WmRI(@B$[9>S?ljP[eZqiX˙24~<4/JV1G4#{mg| , ͉՗u19v+Ѩۢ{Z9.x~nґn>;Ez>J_ըF#>Y_c6L]UՂ E`ޫR.#)^&t=xn4<}j2dD<qQR:±s[يWmEao)gxs˶ yO_u|ێ7/.*^לb>D?x| κ\kZv ~qiW^L^h{gOrX|\1Zސ|XiUG?(e^RyVEwAN,3;=33crz|+fy6ӞYjO||)y7W޵gN-&b{*#,j#f+ԣP^T4C^^x@ћAֺ&?%Uu`&)R/CVNcsJۨ+4LVR-_>C3ȞOeiMִ(ǭK "ukjKepP̚;6΍j}u[i9FMW33hӘoON%&}H +5+Pnި'庶\ǖDtcyCl8c'LuZ"^okL"nql;E@Xی?WLz| Oי~[p-Wrp^&ߜCm\Tdx{xUO\#Zrgų\&N=gQUVdޯ֔Wϕ 3'=yGkb{ٟRo{"qa|Jy}Bq4XǝpqN=:SG^QĚ%W$~YGb"꣏׳W5DX;eYgبYkƏJNLbZ7^rUi$+N8䓊I'쉔VFy'smRGbQigR{f`>x/Oi]ݑo ҟ͍UK)2nx O?yɅ'}\U J$XfpA&J#c=x-Z+[Kq(_J9_1{v0~Z*=yn.ޙ?.WD4|b-?T\[g?O|Z\]KY%c/GW|yGك<1., nr^F D^LxeOqaN򷵅5CC(kIr&;Ɵ6?dǤ(oH{,VbHF&j\p{ֵD9߱}v^vO~9.՘ƃ\qA9vX{H bcGgͰyϗ,-;Åq̊/$ˍ[P$ӕW8?Ej8ltSW0 >l%-_ bD%_H+ėm<_#/Jжd3{`^!qn}]uHd}U;7O|\NjЍ~;B'jOIZ =f@ixK^ =VGOgrHF ;+ej9&Z Zy8xhHTzYø\_=}\1gz,î-?njj5$O'HRaYĪ xUgώpM.x> uxCkѦX]u*5lpk5/毯5nd-5Ϊ@j>'5^Z^:I/^صjdQNos1=zzxc]N]Mգ} ;-9zXT֟(=UDSo+)y&'nܙpa֒<+D?[V9*FjVC/e3ZNר @ivy4/U_+c X5RSce IȖ*jWz=S B뱦i%5(L"%kD+j˩聒`ɖŘ3bR׍B1U~Ⱥg=DUI|\v}U.= o1d\UUL[[=rX-W(*Ŀ~\Iz OmG<`5+_Uh>.sHYU16H9 4fQw@{^/n^kd[{p@_%t\[to>]E Z'Z6S.A\|-R9܉1_,w8OW-(԰r |5#彩08G831@_nxtrD _L0,kURb_D=[Yi}UǙ j*( _Ajtt>u;C Rq~ʑ '|d RzX&ށC^/UXSLe ]'MVWJiu]}x7>-13>n`(kKlq3:n>P4ȉ*ysx: z^nY-6m^#_`DE[LcBqQ}U4g->fy"?Ҽ |jPaӌ?h4+Nڮ#Luz[J3Kg˥G̚%7fPoi+F\RZ%WgW]~Fyz2W$E%լFS,~{swSg2V~o?עWf_b/bHmQ(j;͕ל?Ί[p^oco  ~\t2lw}:mC1i?ȓVU\ԟ唷~IKh&뫮5_d^z r^ Q.L_\gjY 2͑; 1ʪNjf#@m4?quɶN5ȮryZAzeZTB+'<^u(^UI_!klzN C09 wRrߦUnrpXV{H|D)_|\l |RgSW*&?zVȴz4ާӽ9},S>rg?|¾J5kQSͩkK)qm ./=~ƻ?95}?R9q50͈35OJo -rM k}G17D8Fժh-5kzvMdWWMYH-cMvo]S=F8׊SF/>~JZNf%W*O-jƯ%ױ4->nן?.3Aa.H,j4Pq[[|7}So۱;cǎqI2[>&zcnӟGN3~rBEUXsJo+ "3zM\{f^U_5&}rx$3ckz䪟r߳c웚ݏ9LşA|HoC?nʤnnW%V=-KnTyd̃?ОZGW0qi+/S ?L>,e{a+7|2U]gVy{:=3@X8&q_뱖M}ƖԎ0#*oBqX51a]$鈏[USRƩ@ uQO_wum\)&('M>.?W;~8mz|"O+y'Da|6^2f(58nTq )u9HߖVډl]<{jIʺex4֒?nuw+6F'.)GWYu9l3.jY[g쬄[hkQѦ#+Bv<*mo9"ؖ Zgc8Ou;]O=#{ zn={ԈJMǚkRy2"ƈ58+.&O~ۓSN6V"M^nYzvO5%Wb.{r0W$% {y輟Rx|׿YmJ"唗,|SzF(:ϝ8']}9=+(-(K.9^zve {4>R''t?. /yG ƾ1>.{\r;TE3 ^q)׈%fNo|h"}䮗x3Yd:?n&LV̪YUQg5T~XCx3+N_-W~Yzmw̏V|!ra'hv? DA~CbR%v(0KxƏ,j\  ;-#Z*ghjj,Ԓ ZSFfŌg<?"|?վPI֫zɢ/jOh*ԾqT8bTڌg<AxV\xygk_$aͪRߵg2m)3}U<-֌g<7ٰ)״tTARWL>qqGc3sϋ4cg<?*<LD̴cfÊq^!q.VZO0gFMFeG.}V_n?9r}3g$^eY:A,p^Ld9o2gh*)}Ǚzzlj04YrKIVU 34sd@uEx3~= 0QUܨa`827oWWzVVgnbbBT!vˉ9p,EM ÷g<N88P]1xNKyd @8NΓ;g<aHj"ǹ2~Yύq49s\gtܸl,g<?b _oW[q=R,cOJg9o< xƏ +UӝQ?>.9gq(yr,E*`<V׫fǙyהZ4ngV_+qIq8,g<?*<%g!>%>xs ^yf>?淠bZԠ57ߒf3_/dB d~ ? ܢ3b<&k>tcqq(M-Y68xƯ_*ljqcdkW{b<QTNL.;SC;O'3ޝ?׮pM{b<QG?.i|Og<q?,g$AU935qg<ϡq*c<8xxs8ox31gnv?.zncڡrkr3X|wWbT+m['me[ƕ$ֲ,g&ߺu|r2&>xs*>nYe00LWLBS힙;==HbmB>=;={x3OOۿtګ w̯oToZKUoAE7W۲ɢQʌg<xNxqsWoxBXQ#Lț ZWc-[zx3~x$B$~ܼ8$U* [lYRMʓ~8 C35+1="o[x1uWmU3_qIq=~Ora.N omf{O3\W]C~3T6tFsFI]ogNgE̙v, FixE6%yӬ1j@LRO(k۞Lix`<<v|(}d =/z˾_2/s~k։)Ukؿn|R參!y\=jLtUU˧V=/ixFWD؆R\<&O')>U_u>$ F>ċ'my_rKZ88\r\s#~IJC]GuK a^/J'k ײuk٣gy7k붿B}+qw"''{q-M*;A0Xiv?t@t,G@{}#o-,D;AOjJnWW'$K<|;KGXHgrj׿ u$az%$hkmkl7OsvY9xkFkzGk7 ;t# N|T?ׂ7 |~+9OuQ1 Zf[)PF}Z}Q3_ٻujf&Gp5淠mͱ*K/8ިTܙo5\|6=o7r?۬D[̓LJr|7qsixiqF)z^;g'j^^1n뽰4\НViVxG.Ƒ@i 0R[1K-#W=n]g.gȅ'{˞L*xbtcmiȚ8%W;vF%aAz"{9Nv '~ ]\x8p7ڲ3_&ۖ܁OȯG3frR^F"O-q_jF2M$f_d Kk& 50Fҗ|mjܳof|JQ"C]} W.#\`XROku?|=;0̕ƷoPKh \txv[+aG.kJc]ed#"M5TG1G ;`0ؚ1>"~+FX4s}/NXT*ο>|K}v<4p4y qoNs"y QTy;JH]\JlnmW!fN-M)5bB 9 %Wq+ gID<)$SEi/]0~^W7߻juO*qp6  Xьn,WBAԲߓx(^xI ٤\w+ڄpǜ=Kxp[Ϧ"_bNBO@$䶏~%s.y!Rfxg'rN,&Zڟ'q'7/.rb%8/wօcwwjћoN}zۛoyqo}~-̘ *;n~7ßw:{;o:cԍ?VXm-5pWw\WajI~F^xTLk G6x'35{(nJU##8!'))ׄO ;.T&2鑘R1kKzxi~3|3 Z nx[5uOXp'k L۝-Ž-1*_ⱯKA@syBO2Gx9 8̯$'6n70z=(q86fx2Wȑ[$R}ubBf( JIZaPk} WT,ӸUKO]R' ɋ \X_{?xWb^`q&7`=xm7D ܏>oWrq~~\.TUwP7Uw[a- |C5q85DHC&'2sUxx Ekoβ&*FU\ZC+Nݰ}Saxo?۽78zO靇7.c\ڄAG~5w&R29AP~ô)ac &Nxu3n즨߇+ ࢅ C[Lj~_dV9x=Q67 a cUl RW;A>8* m^g~ /ޘ?,}>_6]\pryN#Soѩ7~7`o|/;D_LV.hpxpҏ>y +MRMܿa=y\X40.?O^Aݫ_3mD|#3O3!2o0OSsgV '#N%8ċ89u21H+inr+xqbѕ"#yb~N=A]RZ+3g(Pjݕ^ kPfpU4G~Tɩ->nv'|YRo/?9gN^Sy?ɂyjqI]˻^N.wG|W`Uw }/ƫ>S\Mr[x\0ƵJ]k=bk/_"5WD^2 wFbsI8Mq)C=Q8 r\6<;={`Wx]/p0<\vu[a^9 շW+\?z/\0fq1t2qkK$ל9rv2ǼP4B)= n= .SRNu ^xz=S^ٖp0ƽ? ݚ'yJx' 5β_1޾>q UMa<*\t?Jrj4JQ ̽Uz[`;;{}y 8^E1ƭ[K 1'r[u.8(?8Ly3-IM/>QVOZE, ?2K~JaKG#M?{__q7#G 7ّ;|Oo]Ǐ#zF8ꗩW7>XSo!6#ܙ/KF'ڔ؃`JnfWݞ-BUl8WxZ|"8qүq6_{ 檯W^W_9W?׿rrݷ^~Iq0]0vˍNS[0\/|@PFYm֑("DpsI?5WJ~ge[ɾVDWѮjq0'\E OyZgjǙ8Emᑧ35|x˹Qm/9t_v_ ;;< 촟Zu;WP5b+ ә:qg51n7 w:GJc4+*v3z { Gjתki,w='ɻ9F0ǕS/-g x뱓?c[rZ.|oٛ"]Wԛ!SI>fN c= Ω_j6{wRKx/7k ut6+jU|\|z/ܧ{U-3.+8ιN-;Ӽ8!3a);a7?HYm}{g^`0|!\}! +c2b o}1!͌Vn-*>μEP~Gi1\CC$i$ey|kO꧵;i|\ e[b姌p%/)T?n *~n #בO}?you+^uk?9׼w{*y^7Id  81ƭr+aNj{9O֦Ba dr[hug>~n\E`q7(Or:B1zžoew_j-S(=z@|v51x&A I D[o>Owd Ziz)R/:BPrc^9l|Y7ܙnYa6O>fWqTpXA2+k{}x/ Tӟo 뽪tq|y _2%-ނΰ|X 8d|>ӊ[sO- =φJ'ŕ.ȖLmXk?sUWr4\'a9}MS;|dR W1q[&z5gUqf+Y2j&(|3oqO#?|ڇ|p/UK˦8w \5(JՃ1_|>[?o+濼P(yE":Lgz=i=?njrǶ/;q%0Ź9o_[{aݰYVžݘ5B9Ӯx+U3kc7aNR[;xZM f3 {Xߪ(\reS䕋L\9O8d'9,>^hZ\U;I5ۊ_)6!V 0x]4?Ǚy=nmmƼ'_ ^w~1 aƵm5ڽ\~cDǶ+ROrFyV&AJ?&E >!zv@i|7^u&|ꯥkeaZL\,cի5L}oQ~ү<D@7GY.}Rx]{wo>=k5i xa0O~\V{}=9a&AZFGmx#Ԇ}U{҅:M5%'rB{"|6^_cC5ms|8:?ylߋCcjCe~.ˊ劧98#b2};+ůgYWrs e'M[R1n)Mrizͯ!^j^_grijǕglm['&'ǷNi/x@orN\6m+c~<$+[)4~ȷVCqqiϸDZlH{)m2"{~ښoh_6)Z԰V,$k-WiL\4O7pu[̨+:0zНwJ޺]T x'ǁ!,y눏sT U5Gpr*eɀda|:kiggL?oz&w@t}W̚6]Kٙi?e{&*m">δujKgEݳo&Ϟ&qy~G3g^=J:2xZkN=嚟oɣKzxm֡'gK^r[`gt]թ|tGzypywVʼ9eqiH*Hf*45bSd5yOFQp%f71yi|7r\XxOyLܢ"O 0ŮϿzh|h:Wr׾=# ihw잺bSWB \1=u wL_wN_1+_OU\-g\g$WOퟕR~zf\+g$@ 檫=g:t] t_y׉_q]k_q큃sU5'r?r=Q~o<|\/0W=R~xʯȯ?zá7n[o rѹ xѧrяWGnYo9rMF}F馣zF|п۱n-wyz=Gn喻۠q7q v7y~ޣZ)^ڃ> =cP9= }} ? o~yQ'?Ǎo~>8{GM%ɇEo}<S(>o?O> )7A ?S=R3~ :};O>>z}Aŷ? r|c=w_xo_|ww^x>C |]կ3w}v۳gf7akJCgߴ[b )W`4_q3WL^oFIV;{~ȯꙫ!슫\sCҕ:p@B 'cJh^shzյt 9t:7< [ẹ # 0HL _A{9:za0#۹` 9z( 7- ֣;oɭwf9 77qho[@ޢ; ea@-v]wQ90;a;| }MPwc{{^!(㞯ݏ0-% @KL{<`pڣB}hQ}1*=R}GCH=uc<_Ǿ8 :?Ǟxx>#O=a0ȁq?b7OHߊ-_T_?4[rɓ=ط矅t%o;z٧yo!L ps|^xǿ`H/;vE?>{/9ǍD'`P`ƾ࠽|_ՃlX&vEӀI yԾ+gHWL_Wvu]m%WVPhcbVA3[zmgO pmavm`>L?Cgӹh{F_s}pЗpy41p#mgX*->2/)?5# 6ƕ^>C&96yqS#dm,URl) )S 'y8c^6es3V@ Nqyw iL㽃VLmgkj}< !Ox:lhL9 v̓18i|vzw jK|g>;9;<{ibؽ{Ntw`P)qFx_tu<*ta?K  *a!ScP|Po`T2vԃE^dvzO )K*N̤GL(/(IM:U,N怒`XRfE>OU$ 3e j,ls6V$~c7;kb lyx9H`nyB7?-0TOj KKK83_c\g&y -)[KׁVzMnɲU7kW78ǟ/5F7ԼM.G8:Gxk}syGŭ)c+Fx<4#)[|IV{abr?4hWTׯnb@H<#gtJQ\W9 :n`(̅}^KM)3UQ2X#,xԸ;þ*fUwS)BQ*`1ƉBV6s^ׄIs:@RP>أiꛍ]VbwuR8<ͷߺw }yϻIܼw?\?ÃGcnaA<&#s͋ aب"v mmM58%7t0rQsér̐4n4]i򲯪mkb*Uv%1Trr ꛎ=%8::rx5@r7@(tgx.`Ob6t;,?^=F㸯 h6')a,Q1 JP9r$Wi|\yd,x~8ѻ:s̳ ~:J^C6U&`Idn W5!(w:]|OUS(y~_`yI`~<&#ϋ]NMTJ˓^Y)SqEhpS@@)%IDmNO;^Vk3qFS t>Fw3ʝavm.ޒ'Ak2Ǧ[G mƾ'k]K 󖯱hѾGӧY6d́;;;D}(}CG>9=-xi{/8oY!6@qjU6u_cQ}#+A̙G]_TG^X~83 (Wc=wW _{q1 _b5+NkZGn}}}C9q v=:R3q;djdkb&m=J\kZ~kpdy,K]q:*t:y^U8mPpGxC;D.ӁuPGR}s2xj!L#,&ՋWWNN+#1D*n k\xsU P=Q3r+\2RXƳ|ĶR\\}9%|^wQ s蕛6+B)OO%Ajs43e9dew?קCs:s돣omzapV?lq%P+U*<(q($}U̟LǁͩT׷st:?N;sOU珣ֶpN9Gq',..dm&j?NU\GS▂69=TgGWwYKqhq}9~쾾Sh6?wG>8yS05}cepD;}8jg`dBֳz#W/_=Y82; ͱo wzq 69|)qP|Ȟb68N7b#ay`lHo@X&)QK aD*o.aB: *0?nrȻ/ƘgIL?.m}p}YW;Q%敩*ZyU;G&?㨵qו?t|@jmFQs8l2>9'Yjp?N9'ze[8X[ߐ]׷j80zoܰ i,zCƷvNwcp r:{GHu2{{;ZOc=@nUN9;ϰc79=9qf5gﳬz9t}4/*uv8T}NU,Tx8lFpԳlP5ݩ @cWlzU U$q ذ1 v6JlYL*@vմ!#SKu5.חa^:<6G 10 fQ] Kyc-hSA5GܨV&QVW"=VVqMfگ*|MwW?sw8=LSjqGպǙG8O ;?{'PV YL޲*=q}]vp쟪6wׯ7gY[8s[ ZVv?Osò9OOqO?Nu:ԪNΕ8ܝ1>z>]z^qSTeTe N7mbc9mq]*wK8UڀmoCj+FFK3;cM{ya@Oף*a!>s}~]-NY2LLPKW>8NYX'SfN4;ӑdǕf˓3SS+wn:ޡMV=Mz4;z pgw*2dp55Uk [֟菫9o(kCܰL뉣W1KT|Oc8tQ0đ 8M]}DZ-omx? |~jZk#ھ~~q}5w)|{ܽtzBq*=V@6K L3gO"t8R>rw hmYU;Jf|Xpy`]1w615B kӽѰGceZ ®)z,k3qhԴ`nL@ܬ&w9w.v},?Yl[R8rkks=8evqkqwX7}+k\J828|ܼs8z6?kE9 !ڏ|\]) '\?:;Umqگ>[޼oysWŗo{}?75#'t࿆Gc  wjsڐbNK$GVhl(1lCN7,%MP=!-fM>וijw9Dz8UR\:݌Q)/Woq 7onqiӚN0>ى6Yn7>`jask5X̂x}w'hX[[X/Me&@xϸ\zWf!ooo4pk]-W 8@aKYyl?LWC?NmwgIkZTC}Sg'OO/N< N?>\H>w?~ ~~k_7|S$uO~Q|*315arZ((r.  Ku ADt"7Ƨ?Q|%`:C5 ` Q䢒rX1u `X.:A.rX1u `*O>Q:XGЗ kb QюE(:XGЗT_ YE]x-#:#:e:#xN!k?#:#:C~\``ӟDTW?]H::XG3::XCk;::XG WAL :ף5to$䕐U:XGbk5t.^nTr]a]ut.֡~XGb ],+x]L{/#կ"#o"^䷿mw]}dhh(f#333@m-_Dnnn"_u/KS/קo[^MDd C20  # A"ɯ"xH- @="xH- $c#~kx`T7>%WE؟  X TvԧTaE&ٞM@AJ@';JO$wz6s{wn }0;;̙3gΙ(Ї(G)}3i,BQE{PooF4!ݓQ]C?'[Q'H15HmH—aZ4E~4kd# ?0)6Bb*Mgiyi4Oä* 0`z!C<4k8#:88!n*Me0!:‎8#H:‎8!h`!:‎8kG_5_L / / N ./Bb*1 t@B>1 tp]4LB_L5y뾩@Tc*1 tp]Kbi@GБt\i@G< ^sC_A" hHH:Ҁ4# `+ H:Ҁ4>n$r0Rta:a: @h0 ܰtc?2@!d= @h04@_pq;lOT@:0Ё tpl4`C_l&t`@~@:0Ѐ̲(T2 ?P]vGGC AGF=>}:5kR*hɒ%hݺuh۶m(??9Ntitu?/'$&??LɆNTZ*S26 [ǽ|}9-C*ry; Qxy~7;W;wB(ԝ=3]NI>TtS^Z0%~K> }nmrVLK(t\ H%$Oڠݟ:{SvIc5?؅AUCB@̗ί0B3RoH3!toH[g!$I}=֨Qs ?3#gcKNBY }cq iDB ɡo&Oh= 4=DӔy%~K˓chY?mbL$|+Ү߯4uV3[h?~:R?P$iD N ~TkL?4gJʍܣI zf50vjjiLJOiC@[bp:@<=/. Vxv;2^,p#}áeF 43ey_1mBynB[ni7V)oh@PʁzBfZ]ސdn12FR?M/¥dn3[ IhFPkn| !*aJΰ=(G/1md_ C'66"DCJYWNg!m` @Z73?=t[GBm4Mu3['KF_Z{ %"[Oq] %B%@dPpR^kCcf1y\\o48"~W:s+nv/0zqǏ8}z"c' p>=!P~L|з!0aĠI%~¸'{CvRo*YӐt;Va^vT>m -Oleo;]zS?#γ_̷q"=#"%hoX롟CpCoRy(2.dKHZZ޴z)/ {+ #eq8rE,vHˇ<, 6 $ŀIPQ4Jej%Ȯz m9R5-<_|X1zxYn"E?\=z=zOط )U") ȅ.Qgsbzh{%?Bt ={GDo>jͶ&gmC@{Y!I>]F8AgNNb4g8α]MUM?=4I%#bjn1ƝCmS鹹 '93q󗌑^kz(ϷjK}GnQj| n.X7>=`hEs(\yxJ#/ԐEQZy3DFwу)tx [-lnArBđu;N{h<Qd.31"B dx\=MEНqҫ^Xyȭ/{Hkd nWJč gV [$1[QLv 1|8;6(3s{jhdɪP{ilǠ6e4 ,'9jl5C3k/q|4Ք9.rfrl;v򭌞#JPE0l2iZJW*P1|)O!#=V0v5 6Kk06ɸW9vN5lw8'%KJ%<"=,K+e8|hR",ql‚.W9iOD,X4 @u~f;lќ[PK9||`y2FǏh@1f1Bzu6Y^GΨ=Μ 7Wd)_cƀVQ]efyO͸ ڵں[֦m۴y? gYua!#+@ ^iyAOSNqDS#gb7z^Wē%-@MH|s}::9"t_~lV:3jn#fC9\zn]}r.ȟ%v%pFYXEU ^ƋO~W^gx_Myg{BCE$ JQj? H8a@2QJC|Ej-[.,yOgv;R{es)A=!aF@CB0zGT1]FCovt$EX ح{]Υw_.N. ^cs2y{#"W$?P wSf+9wd>Dqڵ_-Z =CfD,:ao~崓]QluH0"v7pVWL`s iACH?[.3c}S;̝~LI^RfUߥYhe/6eRҴQ7#Fgn[3{%/gln/xyoտ}>tQm:,a@ϾB*Yd1^PoIVtHUwHVЪa#0T%*mj9_ O~ꇍIq>==i%0^4Ф$_\.<.OmvKL7EP$̻OM)QwT){w@&忿\ ME,^ѰonE= ǟ.]Ķ9n 拁ji^9<6vDփ[!&|eLa ;_yhԘbJ}ڇ4n끷}}~IzOÆ(|m'7g(=b=t, ^ζ/`!ou:|5J%k MG.A6eدth-/ɇŝpO}͟ $-k3[N^J˓CX)I62Gb6'|5E @1@=}ᪧ"fGUyS @ɏy|N:=CVg~Poӣl#ʸemkYvo#=EB8-eBc&LMb"3;nAv I=bƠiɽ7TOV|]7f|O-c/(τMS`AN:u66hnww&GyWkM6N_r{ VE5u0T$%ckZưHؼz$g۬ʒbM~տ^GJMFjڒ#aCst]^v.{&żq^|y-(zCHy1 A$ڙI<cG6j]LYpU37߳)kϾ8vSFn/;oP^p}ce\?M)y?ՇLv!oS)딬܅7czKVNQpڷa|w*{kd8ŏރal\ jy ak~W -h}hmQ*$,M+5Z~_YYbɸ6 m%]!e0ށ[f8IIjMgrَ/\_=9,UwL[d("%-Ķ9z g M58Co?; g3$'cr@I@56 ?јcMBlUL kN~sc^@{8xϔPK`nA ʇϋ6O͜?I.[[|99Y:.///;;Ґ  B)Ч7eseϗWRgby]NVVX-?$ML< 0Ԣ/w Dΐ oq0K Gn ~e#/G?RY|qsY)ljɲߔ[iĜm{;^#sE* _zof}Qs0ߙ'ҨJ@?kKf8 ͂Zj'&?"vKNa(_e~Yg~i_~Y'<ә9yy~w{F=rt0ք*^JO-)y%ۆ?g]?E/YLs4OXe !iZKi(a>c˭-77J5%?;ݲҘ{}=cOE٠$5P"AkYek,Abɲ?xY<YmNԪŽjW*^CF҇nėݢT~WȮ/'v`}X4#:SVQAWY d62Fkh\E$|5!&1@=r@-҅ijʺjίC,$ snf6`]8'"ԂCDh wE$8َu1tj$>=JaHYr%C.XͣXMU{du݇;u^_9v0{5)on_>]j\?[r7KN{ST90~|G-뫑UӨkY1QIV.;P]nb-1癓Mθhzys}>H֭:c#?':E󓨿q!MH닊%&V$xƣKS죐?P¦J[)n~xhR 3<ǁa6-Y393 %mxS@rf0$f|]Akɱ亸#'זf[D x zBӇS@Ϧ o"%Fa4Xŷ'ga$۷Mn\Rv&ݧףCUr].}'(S%dibi'<_u;l?ٹ$jjun^>g=!F!gN$p r)FߊNR]*9Bc;dIuMըXɥ|\DIYD=ć#{K<2$>2"8r){JH@q]*A+7%눤B瑸B>2">dNnWˈ9{fzǀgL1wwt>gޗ͜os-ag=-(p:@Eq@ř)"Rơ 3Qs*媴 ~ԬVS};7[vlv#mM ܇3%vrʔn_gPҧR^~f/NY^Xͬz>sb?U&RV]t3qr[#mM!oIQfaNce^Ǹ+vo-]ZtlƏE%]oiVqp^%0;sPt#kX$[$Lg%Y?Y2.lz|v=H$K؁񘵫r/ukWS) ˆ%%e tq5k&=>mc @*3-4FF8|!Ƶx^f۽fk[~B, '#=3// (-{4A 9*>OVoVloa*zTP ?ɯ>Ë87Jҧ~_h5;u9s~LH-;} A&=OcŜpW֢nIh~ _ rIH>2򖐒Ӑ@7+H'7g?עC:9LM&3XUC^h ڕ!}"ʢbhs$r|s}1"FV ]6`Zza x7 ŭm3l=F;}æ S B J2_AjMz О IZ#Dz]Sg5&̛m6WEEE7zPS?5vE~0F]Gr#E6i5w!x4RK/ u8$'Y`ȸ6Z)v:q8K']&&;^-f賾_w\8bR/ѽŦ'cf8ڶP.]B-ZVYƂdS@,S~f{S1ׯy˙nثs$jR k;NBKha ҪQjkѢEk'*J[Wz`a^@p+rg(]4f,ߢ6%YQ劚 u><P,%@'cAGC3DNS@*򳒝e~L|A>M frبkglԑZצ | ZzU@ص$c޺;K-E2FlЄ%.?_Jl"<S1o8 >e֊5u|V}rW^v ̼mwxL`v}fsF}7_yg}7TX_5xgNzMtzAo5@8R0>a=W%=Mw[k/'$~ۿ;V4!m/uR߮cf|BX'k=/b_lj,u3jl 'bΟK:x^Æ UP`&nDBSs?e CAx_ 5%Z>4&cŦܷoi_)[C#κaAXn''{kKqA-[蘾I~cԜA WhȂOxuԣГ#GxW.OF_W(Z ^O_8lpeJInRMz%'Νvj_t]UҫwۋNcMP`G""QׄU?[MQ=INTY~b|"x^g naKT;Kwqo΅VGOd>8^>l?8O#3'Qۘ;ٞgo]LJ.uD1.巢F<|XEbILXv[hU$Da_mKaVgʪ^VO@-lUfaߤ`c6K(fěѩ=Oi{Uu]ۿz 3wkdūҸVN Tv Uwi^9oǵ?oOV]o4d26c!aH~>7ަFG2^a̿@;=f ,+eM~:&:S!r`\dq=|6ƔdFX>\qT/9?<z'Vas1ul_/Z}3 ϋ_2Fѭ^\?79Ox)fz)#K4*Icb͢xwVygaj3}HM@'^T✯Z}d=Fn4bni+}#C=l>BQ-֒M圫˸Kw3qy5>[KJ1sh{G̊pæ,cbߊbWL%0H|:( 9}n˹S&s?yᅗΙhΜɓ'^/nyMS#uod ~89WZ-=_ON1g,/KVxgռ\]AU ]0BdIꐓVg<]`qz[XsrMBż56hm\C]E[̓2gM&^Xan\0ŚKX{" FVQVdm-.fn?go'?$.w_AVjTJ9԰]\ҍ˯hV6mnS(QH\YޮFjT{_Y%uo@*"'r[iJhEVnt'}eZs(|,:*d$N}%X}%~ ,R>R9Hd)u/q!i26{W~weurFTҙV\Zg5,6c`7 6re6Qv kpyr:μ 38?qVU~fsWh tc;~XBƝ9d}s V ?oN1,}~|UQuǞ,cx݅jEɰSp:OKLW@=kkGhzkU;<"rXs+j.!0ܕn̻^~ /5Y@ϥpK|S.LM&XYq\j f/.z0)F^_%ۏq6#(eٰ&%>YRg."PbOg-Wf$;3Zd[?BrU$ =_ Q0@N-ʌcmS]ݗt!+cYrr[ }/gm&4kpT^ FXM|LxfˡHD:VQ[ep#Ǐ=8UW]X[&+c˻!'-^|dQqP()13ApJƂ m{4$opmNe0"=6&31glFe1t+ +˓ՠ?޺5> K.gwZE?#(8?wq"/W,؉K͔m΢^3޸) )D(t8\s4͠gKm ۢ(X⷟i\V 0t,i/_`>6,"{E -pe##J'o%-2׋}d,T,q?}*ROQnGR^-Jnx?y4]n,4oE@A3f>Ɠ'&>?,|^x78ϼf}!MF.P簶|pT/BKn-ׯ| ON'uy٠ںFUlry̅pXϐ~hbaz?U) ߁|^͇wkA?mCd'&Ke!tNV/l:?郧xxGCag绠)W`_(rCwDhwuE;y{WqLۺR_^ڧM*?Yh)Dn9TVBT'prPPUryri=e "Q(~KҲAOiN~|Ll fǧ=~`?[c ( HV\T m?( c|ŝ4)$Ĭňfeۮ}ٺՕV.Xy!ИW~4\lYvylƔ:E'NᎴ!o/k6޻S=zƜ Yh1JQzG#*UtNV؂1SW :ls-04CN 녴efo>xKsdbץ-Rġ aH\ݮ (0S$1lɒ s9/iy@VPF6J_iFj7Dla0"KbkZ@=&N\Vѱ 32GlUFF_O?L6YLp2ѕ!gԌjZi?}v e(_h5icO>qwx*.qk_-;RPR?QQsD1|.BYc!-Ś&'cj*7DfBLtHQPGYo\sA-3[- ܊˜ &HĞJiÇO*$vG# 䓴x/=GHK;]nj DQa ;/~~6z=ieAœYj(y%gY;2r4x?9txVOoTh%;f IsfNCƈm54b'mՒa9YW}837q*b4tiOPźY̕d٦c"ڟKy!]Ҙ[y#LЭ%8"Gg/<ͯ?=℞qwǖm^+-m}#I[K /D'~F[׹!;'#+#=UW4 KK%vR׮/ 0P]ySyyt'yoC/}ǒ'УєgɞWIvLMW1KD9{u43}mV%e]7f~uRS..B{TUڏAf݁SU<#_/BXY]QEY{2B@>D 5˄ʚJ@InQQQQj oc%kxBaD)DBJA0 H:Փpg㙓k+YYe987> t~M~M.'6ְ/ؾhnR[K|u F r I\ZYNW-fIye9I׏~|BU+c<ǽ9ja}klO=ۥ%Я6f[vjױ}}or\.ݴkV¥άvѶU/j >4;gWJն*IVp6WwOȬc;Պv)-RԽՊ݅^:se빴jH)__'8)r]Mg {~㍳Gh/mƏC$[Zc&Dd&$OesrMEُ-8FY, @񉈭|gc_묃XĪ|f8xL'6\yS\W\jmT}nfDj3@ij!K0TQqܗ(Dcǟ_?ԃk{"Xlqc-WѷM[sN(TQٯ]SY&'rWAb j^f_Te%W̟]q9%B0&/>?/1ovk-;YCg 0ԡS,EA '쑫:hX0<.⼶'I+Q9C-`;:#uu???Lyⵄ@Y|aB,`yo :;z܋ܗAw '}d̉<ve얃y`eo \%|V8_|XV Tw2K9ɱ:x9)K誇Ƚ!@!g-ȻUp Ԝ?wyf@uEOFb8B [@}@@4x0$`"3WVPonؤ%X,%ތGu*tnWZuǵn<, [q\ 4_]e 90Ppk U +d7͒qa6uw9 9L%UWcaylf8;yٽ`d^  rDci~?$vp{vm [yڴ3岑YY^XTtFhPX(춚H~#mCL[1^QHdKo͡Xhß|jN/;.ī~xF[6vw/XDnKSFE`oǛxKb?h;e~nÕ>܉̕/H\TlR&Y\~:=}Rޑ; 5Zϋ8^"G_YI>S̸` D^5>a$ D֌Sx2e1Rυ~3] [Nn ^##pӡKŭ.CSb4{ѷ}4)]^53"T$Vоo@4jH掹S/cIQ [/>ez_^wvW^^zV9(KѼOV03&ɺ_b?87?=|ar*\xJ_kp |*dz4 h}W;Ģ7%1F84ɲ;v:E9:1sEmzN9 6ۂn4J#c = f+k屚F(`/BEt9>wn-DmM+)YF3HU-NC50lyB~⍵`9Y!x45Ջ #Ti+K&g>e.ڲ)-'qi6H Ώ ܔ )Dt6les=>wQ*s'`͟5o^h&J-Rx#Cl?ϣGy}i0_f%s]Np$oos0DO2 - %HM,dy QR*nw;#rٰu^;C,T( O#ig=<*?g.Jblsn11cp(~\^>V'U^۾m hd X8swq_XiFCcA3rX:7Ys~8ttc~Fz>2y *2[5ovjJ~"X-7+Ķ(iGYWmQ8t!+ثVgY'`Gx'#<2b6_Dt*3tF{+ ^7 ]:d}w]ko?=\'}0}狏 f,_I~3b, M埴~WO5(UյUxqWrk}z)~ݭ33h۾\zk}\ Js.^ɵ{*>ը۷nC`1:R.| ~0%=? (]Hrf/Q)ʊL.wNj5M_5k Zkʞ(A11un\^UycxEYKrQq>錧7dk |5eWi! W[#nO g#j7L|!ǐ8_H|I65Ϝ6ouhiX_JS8_.%TAwL/c1n0?%>(6.[)c琭;gmRl|?̘wuڱs{lм턌qۜÙhC~JKKhU8vMVtHU*(r.\Q+j pb ׬*NJ%(:jOg׹2&zXna*\1 Aϯq^+eIcnfm:Ld4a *zl[3pkV3`/1[<:*]V+uJNjOՕi%ަXhllpՅ Yfg66_Q[uR&`5 .&iy]0u6q$.&Yw:" IN?4#cΉ#? &K0hIyG&P 5mgAGg'>|+>rroM_^I}O==q*G+4ֻ HgLz}˫_>rͷoB%p3:^XLum|>z^hݟiJ v w.*\U^'O!þ8oႂf>]m{n}a5m~Ӧmg}toڶ,k=u k/Cѭu&#>lTܜ3.v-V$Ųfy_)ǭ*~xWd YԵ+^"O\]RG7х {*^9{_+nz{4"lV1{F Hf1f\uc` pLfA%O>&dC9<}.4[x\$pCOPmkL<2JS?1Zw]&`fh`}*lvOWOt'{yƘ0.q3Sw^r+YC*7"of_ K V<.re:CۻO.QĩCC$+jC RAAPw:mbn(>F%Z Y1cE1cXs.~%{RQ]q'DO_aA3~ըXZ-{6&]&WS56KL=CO Gl!qwCck4#-r,)=xQ4#+Vʭ#frvt1k s,t})97n˫8j.2D}"h?'fhɹ?_sy_{ٟ}ٟOf|4֌zi`;d8 C`{Ҋdxou%ϿtS1cj5(_l|flh#F`WkK^B.Rsftu:>rmMmluy8+/M180ܮ'^Y j&ӭ+-Suyڛ2GU1+AKYf)~Jk:VEyH?*-+}}ڇpQO!Aon?O"#Q I{;X0_\\ܡ/!y{X>_}B[#GA4DA4?MyJ9d*U-/aC,oVw[-ֹ ^@ͬ=帜=%ۭޙgy 0nmvz.0(T@ፐcsCr%ũ(Fd*QAVU% T+d5xL%=L6/ `}7fOhz!qbɷ/OL *?>w‚2aI CDOAIrC&$-u%d,Nej2 ׷zT=9D~?5" kx>ok,PV'~}__o=uoVϭt)o,ew"XL&z51>ճg/|zKc‹CW QOU_%ߚin3ZE#4'/$iC+dߜEş/z@=-vXfi5/Kg?]M?oZF\>ZoFX9]o1aJe%#2mU*(;52ڸ?/[I>q>W3jK|iLo1%ee:6Ur/vOD{|Iۍ?D&}_Ɠ?y!WԼm ܨ$vlHnx;tfo=Q}7,a-Zmw(&8yCVv5M'QSVA>s[xⱞ>-2[nI7ְXLu7hm g>U-6`fxG܉G/61 u']$.'?-u}nx}o~L{2hIҷH>bl bL{L]Q_;#T ov}ѷ'O9Ֆ-D Y}u1?#㳱զ ,CK>ՁέP~##,d~[Hߧ닿ߧgo~a7H7Rt6Oo&=26MSG>h5 ?}-{⊯odݍhw^'\r&2Ic/Kf%7 ݑZsv¹XLf91IߑtfWcqڤccD2a:שSsT&'ׂOe<ʯ7{vc$VI=Cb;_o?+>kB_@QwK2HGbQ鴋q)7vdi'uLnx^c|Zx:llggFloOyT*;}5ΌseDV-O9C^6V{"qϚz]qw'.{4=:;}iן%kU߽K9ocmgz~+͖MU[o_Ȥ~޳qoSPS':srێz,ʏ}sQE2GO?A%98>{Tɇߜƌ)?u؉9K cvVUCr?&d>MFUS`\_f(OGwKśgnY#&mLz8L'~xמZcw0ެ-4աFy&(q^_1s&5uHy{3o=숷ϗWkr>{P.w4N^ml׶ZN$Ryn:m9.ޕ;M7:|oPb?Qގ#棷\ˠʐAQVvR`xzw>vSޏr}g|T폟.֨[ߝv=c}P~Dt}m˽wq;,>/#ߝq+c{O\k'6{X'H~Ilf[/_9c>~=(K9]&xs߷V}؛W s:wK FmCҭR4W]k*T|]k,x|kMlõ4\i|z|l38k;cːvCM|Öi9OOk|oo[_omh zu|)Cmhrw%c^ߝ;m#~[υ8n>} JqyBG?Iwow9og7HRNmxZwG~EwdDsv1ޫ~/.~9PV3NמjgNRV05=.}WBw>jAˡARkG;ym%ffNVvF*_~%|(uG0·_;6}^vF4>W4mwx^o=Fn;xWo?:6`>nzǬ?q. vOJn 8#skhW񸾎Ϫxq]I7!zNX 1ޖ)r\pDg<      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ\]^_`abcdefghijklmnopqrstuvwxyz{|}~/F/_Nj*Pc\mj>ͳ{.vc;eW迳r8}?'G#~h߇sF)SGTjƈ|{FTR͜:!#y\`|+_W=χZZIid?r f 3x3g<x3~HZV?_L L$hv@3Z2K_#Kz_e<x3g<UXmX[n%VV}b<x3g</g+7!JR g<x3gīaW|+_WwGTr)˗ 3g<x3{_ک;f~x,g9YrCϥL<_3'6 |+_W|qjn^,g9YryX4ܧk+ x3g<nв;t.w/|Q%x3g<x_T8*'YL&OfV!%`~LW~1OYBHty|Sӿ7uú\Ht # R Wu/ i񯭦.O>&|Zx3g<x_tC[ID!ĺ<咟U! sssNI'N=HN}0Lj[dfبB&Iz\ZPx&]c<x3g<ߏUwvb5stv7\5p)G.x{!IW>?|nNfgPn۝X"LS ,%t $I8|Ҭ}\6f7Vuy%^i7 Z9N㺄g<x3I*63D|%MkF"ahQz|C)8 ݷ?ao0GPKuߢٰ/<_ )Aiɹ֖QC?wA?hvw/@8%ϯٍJ1g<x3>*8J^%4%~VGOr፭vbuxؘgL%<S/(vT6ng> $bݽ'960F>g<x3g78scن7VRsf*@מDXh۵Fs)z( X&s.50'Ljsĉ'gD I'x)fCb}rAȌg<x3g%˥GgQFkçuI v^)$0L<OM&c+_o9v3t#f #̀ y|5a%u}0*x3g<x_x+O&||%MrùY4 ?Sd|f|b8Z@tU}d_I7WZv8KTNvo_HqA;ui >WJ1q)ⳔZ[-7jv_&;G%c>g<x3g% i1s \:Wf+5\#ey([fiJ֖oZMwԬtx3g<x3^6WëW:fN ;eDE$qnziwT }3Hk?; Gj#R:Q "Њ yj-S2u<^l۝\)ĹGtX[~DG݀y )j ڨh+ [2J$JTx3g<)^#V[M{,9𩩩ÇuA?2mSx@M|u>r5!VT+ÕԑQ)o*x3g<^|#WYnVvvә+@Ιfgd:DX1;3u`U5jbx.V"M3^~x3g<KO>YM\G王,\8q|ԉx&i%FL0ϐ~GB^mj:th@e(yWg<x3D߮5/,+ fy%J7~` Wu^Gy7f(|x3g<KOr~{|7g2S'9sL'ϯKurEn垾IV<}/v(wVwg<x3g}/o}ݔ'?s+/Shr*}tn/6'O:2MK#1P}hղ,K&,EAx7V/}:qǬCSb<x3g<8mμ&Օ̊_^]/ܬtg¿HõAG/=fzHZVZ$t/Mc5{lU\QgCjӀ_ǜ55̌(VXG_VU毃U7M]_,>MZo3g<x3Vn,vJb*~SٙSs9/%YBsܓ nO v ?rh>rErhOUOR_M fV!+G-xzwe<x3gJZA}Mȫ~XVr)7IjtUQCLB3,_D@N `)ž_) IQD[Pfꅘ\ȕQ TW,1vJ;ۓg<x3y<5'8o >ޯ$1.`_7}Ť)qJEG߬ NEW@Bi ?+Exkůo?~/f"чPHqҹjr(R#zEfwk ٮYG`<x3g<{(7jtO]IRT2N2zoÎxZ)Fہo-<|:[M\TG~9*0/z"{k/Ӻ 'y>T}j'G~t pn^z!ጠZV7b@f 'MEkiAnZ1h >=2g<x3RA,;VV•ݷM&jv{?qA-|hKR)!J\S_ I%GX}xS$z ` _7ER)}LD1LXв'|q@&4{7G|n^@ yZ?q w.keX>[õ}DLb<x3g<{7\:8}׃NMOU Xҿ]mԸ/)+]~9 v~Seo FKժ~noT)IA> ^ȭ^A|>/txJEXP̃d8<_. OW2ks=x3g<x v2ztnvn~~fvv䉙c3Q1;7 е k\le<x3g<{M'|xpZKʼ@Ǿڮ:uk}b R^G^?[U?Xɹ*4' U6>Zöx3g<=|]/SRTz),'v)G{-omO~4E<ƒ W*%ޭfM4_-I UvihJ|| gc,=t98@+2Ȗir,g9YroO?Bb<l /r/@LR)|t8]>uA |W R."`|~yF* K |Ty1+\騏#m%:H d RǃO/{ao?ZwW?޿pܞg<xUިul%(,:S:XqCF(B `5$l_~G ۭ\$ r?)-92 Mгwm`N+6۹_}{yO>%Z<Бi_ AnxBg 8*1/1ςqow+e P<H-t^%)-ZiaƆTbW[cMOǻ;޼Jڵk{yӻV![uaN_X>1g<㷇?3jKd5rJ bÍa,*cc&7k15Z0cz݅/>X込Vhe"~\}pZh➿RaCK5}vhV0>w_o=f1ԫm֫ӍyngM]9f~ϣkHe>}ǿEۑ<=a9YrVIċ_ Y=[ow;h6j#<^wcF>how,g9˙hSb:/`i gd']Zsw- }1p>n{p? FV]B}wy~w.=ǀC 3stnsƴͽ-[H+xh<3g<{-X]Ij\,̬R3 O}~^J2r6$?=xSoV`9;[`+v$KΟ?x3]~􁩩iNMCD_c+i)H< <.ˬdإA6լkj)kt+2lj8aOn, ^Gc]욅HS型Ԇv5{{QÃ0Qm}Za ݙжzM=?PC>MT02Vĉ= [ѹٹY;>wq`x???ȧ `/O b/%=5I?Kg=dH",lZ H py9jI?xz{y _o=o<ޅavaMz}y^2de-Uplp*9qi%_ťzK$R2K'+_I&(YsDcckӧ]#r;ʉȝV}0+e|,-એv㜏s5ה-<șxis;H{m@r hBQU㯧oAe;ϪehZpx$wgGEלV z:2,~%y~>?LNdQ0Z?_$ӧf*Wzک9YrA9,o?p7qU.=d~.ċFZX?Z>XKF'i#!7r|oKD}z>TFzAUM|''y9^??RS>uJe |:}R^U68yGJ!nh(q=%y='}AHݼ.7z /5#-4r-W2'3!iʂD qD>INx\mo0O5DT+r??6I*}IZI.ZPϝl}&9cU nc)W<Oz}%e"qGB)p$ P_8a>H:Ӌ O>U%}g1Vow4;?9gZ/jp){Zw}d.ߐԪ9w,g9&@)#$ibN{IHT?dS[Ba(}[p=  E Wa@&p/@/DQ9?' YC6(-i=PqL&/CfBrQGV֑,J Wd0M.3pD GKF+AcE(V9얳 dG!HmO5A ޻]n_DNqK4 Zƣz+ Cʜ %d0"{kTaA e/M䘤SkG'k  &jd?J=ǰ RP,P{8r oDiT;9 v-Nol#P/h{ZC_K8 Z4 #=O'*"EԾԏ4Mȑ&[[@@`;Sސ=\{VJk4~`@q0syW_ol|'NVdՑqK+i5-0|巇wm#Z6r !/! ,bղm3w[8 >ll9W,\ O|Y >i 5W,|Ѵ&|<>]#~IkX/JPqZu Px.BRnz _:ҬA/X_RCjU7)ݩudu~ir trYS^X=)_=.tcC Z%J#P@yzgJ= Eb_u!Yz%B |[HX_ _X(PT⮍FħS~DMBFPHԧ17cв ;XB:llB ܄Dh]9Э۟#/x]SM tbi% 0F:N*j.겑}<_|w|lnE/:`Y9<;JEZI x_XavI| s: e(Ez.O}q_`BM+FulU1ĉdBQtfW B2DegE#[,^5DVIF{jHaH(/FR,^M97Xt/C0R$~;#s$Y=@z|nDFXqmXBF_Le:V!?ch #_ P T*jR3zrV-:A?~Úzs X| gAWKЉ`sS`ʦժTAσdw a] yM&&@/Dz?r `C_ ͗'"HWJ?ycalL|h(dB $(^0#b)/h8 <ԱQ=^{UE /FĐ <(&B.ڄl Q37)YGDZ8?Hrc.{":Nu42Nh%iJ n`g9/z]?O_QFD` %E |4{ _}~Fu< 2eAzn9U"Z9(>6ă<:q'`PE(^ϱ8Ư6TQ=s-䊐_*e/[)_?l!Qr/]֦Gn #sL_\ȏ+r8BR\dݠ 'Io-hQ])t[-yw Kr8:~ج z+r`_;WGMHi>rx  ske3#E1Bf7?59!l%h(\~Rt>qU؄"爞o\ĩu뮗U+J-'_p0VCÇ7IoZq 3x~ou I d]? s`l:1O<X(q/N8qz+">L཈.xEwQ./)dP-(ufc@' [U_7qɥ"| bn g #sk #sh-§?/%j$:K]_2,\K(/ :{:ԫeIYʙJ<ՀVWP JiTE͚֨vb@I~1r~ 8$oagog.MС[r b"uErHdid1dߕ>?1FZ]7Z} %> >Z+Tq@{t$p~$(8nk3WJ?`$gGQKZrSx;p>qfX|t kpF]^Xs׎yxR#ɜ@[0tc8 y qCk@8 8P z/ Ug~χ#qE޴⃁͆mKvK6E:?gt=~7QbֲW{6Γ?y1w+'*3(~լOW/BbGaJDgFЇK˹3vFz]Տ;ٓ,I/zݳ_d$m3Ka';@Fw[By:ʐ=d#R0rFd,M"W,3bVGUE]**_6š{pH{ 5"*(H>X1[OMaU}r45^:&{Z,ETN:j_8K&VBe`>ҿU43 Qr(账8 3fS&qeMhu;(_W+F#Ð/nϋSNQepW]r_}hhWx3~Y'}Ӵ:<;+#Ά|d?;1qᇼ ~~9_@y!w=|VJӗ'l輍{r`Aw3ARGTAwY`'\+O iD݀c9Y\'/ ^ f㾨n+>5`ۃqKO?0bSa0O'''Ţ^F~oԯk\>.5x;"1 =~AG.aW&X⥿AiB(Eq9~e\2RcY^ZH%Jjɜވq3r[Ds"1("kʣ(>[͡zX_1Y.Arj4aè{\w:3 +,(~&~o|(z9Qc@;zYLn yGUKUDhR:C%=[8%޻jKVlB|`jY.%p;8\6_,ϋe}f9UF<%̰VUqb,'@[AEdMs ~=p5M ϑ#>wNـQϋhf=D\+qS MVXq(}GfWBŚ&ODp-?=&/W{AhiK'ZVIa4{:Lp8R̩ϸ7w2Yx^hNt*(NbnUGtYr''s tIdVZ'I7J}JlqՂs1=}ȩ;}AY<׌֨ v;C?jX@D΁g]1lj孜xh@6*}oYQ p~ɫzxѫزЭI- 6^ZZ{Ngꋜ݅wtX8䐏[\K_iUBj#f{҃i.cyΘGZ-'oyS!1Dm8!-n:XGHUAiY!=,Kc+J$pf"V鮞Yk3\ x3!"dߓͿӒr# ?=xMn:NV-|fa[ߋ>| acVǰCm{C}z {}w;c 6L{Hl钱ߝ$*u_dS[jYИ>w~DA. 0uvajy+Ճ7 |+TAFy/hj̘= N_0g<=O~@?gʲA9} wGkE8fXXQupg(ڡw\Tya%e2t>vyO&un}܎mrG^r~9.Yr_|SkĚ(Ǻgs-g#z!ɻxH:7e5RO*]ӸD=#]n,g^To_'NJ"cn 濘_w/wgPVv=&cz1{h%=o/7F.]0t{"_`ω'NDܟK%Ϯ` FWnqZ;cIg{QgC2=by.tM޾j$ 4.5owvfuv{b7,Cǘ-'=y 'N{4 }߁2t@#F(_{u[pಋMNeUν:<Vfh|Cy}عsi Mg=8C{6BA.nߟZ#;oA̡Z`39Vv 3xUm[u.]~2g<'xvmDg,v׌xR{mvNxON;Z-,G]rZkaovQ˼$7E9m1g< }u"y, gUv}OnΖs~sK>nSIm^u ) <}Oy.c9ǘ{=ꎴ1]a)Xr,gE[v~W:ec-@/nz8&|Sxڶ8ޖ>`3/{_@Mqd$o*3f|v;2IOer{{Z(kozܣa ̡z+mvڿSjg{eZ7qu(u/ː*Yr %=?P}bOe ?cQ3y܆ 'okc^zmPڞ,úͨ3ccuvꎄ#vm5m={ v1ohr *Z 7 JQ|teX8qĉ%WjZ*}M>[+"χBd-( n < # ʐ2 bZW%1ځ?]?@JXkaA#Oo F~]L iFHgY|!"HP * InTeC#D=HmB-OrG^YRIS~ѧѵC#J !$Kb.-[ 0qN5*GBj M]M@B%hХZU.&O BM= P]%̉'N8/7l P\"~䉫xT8Z qT0<JEeQB^WS|L%~ ZD7BG„V-k"DK@l\l? Z!?q<h. H'pҬi`)PbQG D0 sTѨ? Yʙ,'&0[@B7Hv--3`A|9ZѲ,$+je\ˠZO TwzYGn@ZI7yXbd Da07<akΐh(t6 h ,{4/GQ=Lc/T睷j}>Bls.M uș؃z0f@=P t:o?/fCJMXAˢt!RJLm/9Yh.Al= 51٨jxJrAYov[o9 u^z`*$/? c.Gn>ly1g<mi5Ͽ~O6NKi@ˆP׃_f 磗M|ִǣH ??(;!G=P-sJZȅr웸rsُퟄlz%(ZFתFpBZdUF"W^orJ¥K?9.z]B{̰dѿ>ITf}]{ɉOMFICЖ pj" *v" W|ĵÿNl0z8i֥\v<|M4Ju:\u P]<:LD!5p#6` g,(TY/EBH@ G.YCO~brBwɋv.C`@[E׌`H`Uy< ^76XYX"O~5Š__@vr=x/`V G*}}ds P]V nW>Ã&HsZK6)>>9 `#MJC/zqt6f#ǺMAk}j'__0=9 SZC?s_/~&8-'هAm/3g<?EQ|^{¡:n3 U`w gUH'u͑[US@]\-V8!Pہ[|W܃\$YMի4_@bVjV֚ B~.RS>Q@@f?\&&B}@A[ž'H.*nK`VP:~l{XBExpQ]@}]?c^\ *V/C֨ǞZ!-} !Q H4` 6 X+$K]?=?P&_DB&P>''HՈ@9L0EC>38ǁQk,]]Z0YZ$jW)sO]g P跡Yƣ8q%SAv& aa9'o%}LB]BgK}euP7t~toP/P+`r_½HWCA9uV`~xpAW/ÃV$y'N8qS~A@[M=Qzp7Ba(b9`'m}j[TZ9ZŰjMXp`+ &of4La7#ǼQ W>CʸZV} 횞s~|J_?I¿~dn*21t)2ߞt.{@ U-B " W|@5'7Dȁkh[aᣅ+ Krx_etׁW>"]~\!~D'PJts|GWlIձKr֡z ߒ=_ԝv|'.cb?: )c yR8e<ˑ7VFPکYtBa#lgjR[VKaòϣ_R_oYx䤳jTf:B#&>0F2ĉ'N?>Y?!L:׃N2hk7{2σ9ɯ?TD7BduR.~zBUȟhJ办m~g&|r@@ZP^Qבv>vϼΈC 刺Aisb_)JAgw.f&0Idڔ?` .+˺q@G(Ң00}7;@;ިɄڜAk{?=pwV*~!:sR'KůDw¸;د9A[CR-ru7wcrCڡ\r"+)Z)_lEy <t \=̾(.=/rՒpvƨ޿QgW&h!}ibB1ys8z_ p6,g9]SkĚ(ǔWh ;`2 }rppН!wor[wj ߬|YEW_+@EAu4,u]̣ԅğA q|s%\3P#aŜ 9= @6_D2y@AG Mbh MK1G{^L rn"?yCw<4Mn605):\ 7~a"LfAC, (6hM~(|i`;GH /v c0,6/\-~L"r Ahؘfsa?'S»wdWͫwtB+Q4*hBg˺d7naK|yI&}"Dnk_@5"G*C?C6y*w^Ji&WZhOAAu¾ n`KtG{.{q[, J`g,,g9,.oowdOBҎFx/єZ/Qb4*#@JECySpH[l?Xy$3MânC)n((MPC׭!Oom8Uǽ1|*"ZS$V(޽KGe֣WkݙuexpE+̑zҷދ]޴U ٳ4*1Z{5V0;S"Agg=obM4iҤI?y4] 8٧?;u߼f%.sqZ5 [ЖWC:нB[Tˈ66]/mPǘG4%*) 2I_euIÝU"dq@ϋdt:l\+@Y7篧W(<~BVtմvpI ]>2úIݖqP7\:w>`I|@#$Y덎~NSSwqCypoyU#z+CL$gv77c hI8p5z֚tKLN`IWGN0tۂ{#Y| ֫:Bg+4'nJ[n2BsߞQ\Ӥ)mӗgV&M4i?'5n'بH,gDCYߘ2~ַh!W,&(˦r7 ># U Z"^',M lt`n4)–,rJ}!Eolj,LxPM橠zF?NjйXİo{}RM%y~lij:{8"mAl&Woo;&ʿMS\:,zgod%f3eoŸ^Ny?ty6HI6+Q`e5"wuofg ol3T%rMv ]˻;zn\Īֶ^ Y`/m-cI Wx}tV h|S/y#ϞfN_4iҤI/G_Y.HNP{ߙO_?ԺԄ?I'e}c[?T7u$JU2rT2#ϤBJnnU%5%m? ޭ%pUlܲX%}%˱rRbf_둑c5HQRc#P&YQh䰯ڧi[ODsª= e zSs\zr4¢96yplI{#J}=" C$!>P kҤI&M.%WX߯Wfw_{MP'-#(gb9$Usb׺I41,.Kja_X@ܸbѾm8z32GBKvWeȓumX Ks&Ƈaosz ft?CXs="jȍryB@*S=5g2ؾ@uG}q;JZ^ky-嵼xNDGj/#KL_ic5m%3KX˶a7C﫱!rFjy-嵼wǏ8wE;}t?9[,芬E폄}~KzoٷjilgAבz&;=ؤ}viW?_Ͽo^8rP/NbJ?8=)V _ ~O||+?~/\/ Y;1RuMrtٗS{ޥTGPUCWZ5'}#bdm{{ү&M4iҤD%MڽVPUyb&AY;X+/NĈ4iҤIW]o T>v⣩۝Gƌ#XfM~ROuZB%k[_=K¹/wf3OÏ?ybS?_sOi?k嵼Z^k.jO? Yϊ״yP/z׌&:yV#@S}^$/{czקvgeu8 1?{g XsPm7^ct!GlW uwݤФI&M4})'ħ3@8f4 X%;/ }j}N>0ri X#Qi:Ч2:[apÒaטEcn4.WȰ}4iҤI'cs~2; x=b̞cc`#5- {!]I`+o4&\9'鷥4I~X~Ϛg|p?}eI{®%'KuOEz|~U>u뻖g9F?UͿw~tWx[Tk^ aM>JL~8hS ug<AA6{{ "3>J-0?8D칸/hy8nsE?ECԛǴ@o֡^=_ߤ]o>B-C;W[P??R?|?a YA/ۣUǪf|A}t e6 eQ-tSP2T@hՖ1zꚆ`^Irn[^ w/%ciͪ m`dnLed (#OYbW^2&z;,k3;o[~ci3B\\Xu!IAgq#l42FF{,#8OP鍔(b;y0mLYE!meFؖp]2l8oFW2Ȗ냭!o3qz+Wfs[mp{"u"e~(Yx} 7L[F{u4iҤIeOrwfrFjɥCvd R] ݚhv'mϒ/=0wi{k.BI&M4]g 5>:A}Ng>ٿ pt?Y}cg[fgZ+Z*_0$rɛ߫]ɔʁNJ%^#g֥)בqws^U#B?` UV@s'>ƬbɫT"LFk6645)$ x/y ^.ohQץ >Uzudk3Wx/ Wkre'uyp@,d[EW'JRc3gosK"hN:;aٳ^1a >II;/[6$-4Vr x(oN~vv39{KK_8Sg1AT:;"`m她9lW.-W R %oT wfN?yov$ld5b"Μ5u|2̡K+6IY6K lp!kT/[^Y%w-wi:'z#C^=3+c -(e~qfe35iҤI+,W+~wjӆ[aZ|Dȡ\ޜ&HZk(Tj"C7ϳ9Nrxޛ_m䵚ғ,0d6 C򍆜)x:~;yz_ ?cѸ/ۜv~ClCFۓ7A1^ܑyMjM?g[ik! l&n0m<+C'2ͪ5MlW^*E|=SDQDvwӤs&rf0J;,;5VP\T$_5j $Y)ݛcd^0lkmkЪօ0YAĘ<{\NeOQ;# Wj_/k"*7d(̆I.YWl|ćϧyp x5\m Ᵹ͋dؖ }jZ^ky-嵼_)x 'N}"}#5KkW(T<DDxH:_& zu`sLoIvR(^7|5͙fND8g ,Ie`ZJXx*M%7nTIV W -z()%hm y҂*^C fG8"B)nߖNG |e@N <;Gkl`<+:o͎ TJgY>Os|*%"~>7O٨6]n0vE<@j]x-1-]ELR^ D%m&UlgH/g"ailaN"giyLxnbϤYjtq_&sg>3$-.Aun/[FP;~ n(Z˷b{i^X3M ?K!!w·96ulE嵼Z^_i?6B~S@Y-ss:" [W̔?Z;7굟fB 5̫$ 5BD'99Iഞ> mg;|5ɝeAί@we,﹔]RQ/W39-Ut\lj{o]eq| j<'Ki|.=up ) qlL^SH=hYNL*)סJQMrq;eSVp?(1Bˬsz,e3y?gmKRʴ2N?l_hNj^:.$O)qZS8k恥ﶦUQRn.XU[nziy1̅XRR(a?<:~irXb"Y=qSU^?I):v>j+ îzE~{Ϸ ,s~>뿭[U)>vcL[߫{,}4_5_5_/S~s߼pC, _3?]}5kAT @N4]ܒls-S1UKj+[-SmODmq^Z&~ gDu*Q67j??LV8s>Gꆉ^[w33$>w-k @t!檉6YZd$3!dK.pNdfs| ޣ"vev *8r8a_ڕ-R:NwjkMvٜGt.ε;Mu֑Ӕ`vtųtTF~x^VhW" "(ґeVr8Xn9U!~T_ݧb{=veR^ȭ8hxdX|K@'G9>|6-A8n}qb?˸q|TG8ـ7,-.:5.}#M0ኗ :o&hT'2je2kkkˏ7c!?_y-0]8@Zv>U,:eq_E\5oqak;?*#Us [˔Q9=u xFb&s+>ҏ ͮ8Mw}9 - l!+˨*" {#nfavl= ߽$5T{̸} :wbBPTĚܛ<릃WVtPv_x&%-O*9dKy] 7/$j6ƿF1KSThwFᓑY</0قѪ- :hWT&?ז?f{ƽr$Q-cRUvJ":W9;d֥%m;S4iҤIӗߠ$1z jj?O\Ï?ybS?Zs5eDEoDhx0UXaTmd9 VC(g'i"w̋PG2IuP7M.(I%Vg͸آBLusb`J"#~.w$YnA  ACU-v[nsug2t_xOʟUQ ܌u_M˂;dmGrg Pr R!ٹ&X{ A$(H;#鉔D\j&;ҶZ5iҤI&Mw.@sg|43qÏ =)L5SDn6gV-2Y ʱ/B 3U*~`P빅PF٧?vuW.ǝy0r] Py~ol,rB}U#pm\Ou"Tlw r5ԣZ1ﭖZ^ky- U/~B5]6nٵ7pN(yKz BdP霏dIgKynN.}] &KFTr%gv͠FNORa+#tgvv:H:KC~yoHg;}t-^ g%-wp9{`g:4|ǪŽԵC=e=϶Fޞ_,ȼ ^]"9RO<NwmcW#+(9 }_,y/>TդI&M. p? ?x\: .Q4ZRD2g9NadT9ӽGzGpSK50ǘs(`Pnz{{ŧ/{5iҤI&M/?3|c~߽f5zR 㱤m:ct3"H_N3Lo}=Bc=r9o=J:3_H?>KgdG )v(~M^q݉euB=oBoiW?3_{gNwG׸N$/1?)wd X!8?ϋJпY|||?~?y?M@S{w>}42ZАMjKJY j  iY:c\zm]4z@UI_I&M4iZ>Igt5gO_}N/x #` sJ}?|ְ4_ZË5iҤI&MW#||)p(kizjNI7v/!7 eCWΒ*y.W/l&M4iҤiEςwAj穽iz̧T/?wNOtO|Kԕ$U+;8]$eӤI&M4}Y2~7WظȑCՓ_4iz6\ JzTdרeƇ†sWR+5\"-嵼Z^/8/W2a72RiOa^z5J]L=Z^ky-|;Fk9͈}[e/ؚrɛj;udS5פI&M4 z p]&OHO^ ԭ]ɯy;eY^iΫW͹M,#)˽Pr28KT }4ֹW-{iH}*Ė>hMZ?x)-嵼Z^_rYRC5Yr|#0 sG-{mlYoNwRT>R)|lm|vǟ0L!cI_j9v~^fM{7R:oIw2^5k/ڶ̢ I'Fjol#hF-1n/kC7<(K;3b4BG&ݚ_.o|hjqKPTtD¶G??ۙvmx!'?%- ca@~ŮH)Kj1RpN?T0@jURxvc:-+?A569<KW(!mvk ˃KKϻ*7-嵼Z^/WͿt wz_a]qZ+Vݫ7ר{*L00&k-*Mvx{ڝW)H}(zg|g.絚s;CDϖt HvO6ի^{:~{/xW-a*퉌C18j-W#\j^jl l%C#ˌQ{˕[y l 4(e*b.W2fqkס9@fF'ͫfr4c17+VC7~^!Ҍ!q37Z /h7LAz%R׹Ng5{ ` Xǁd@lX nԾjTx5R녑 _sVz-n529PIˤT!T:YֱӞX0ze_{5iҤI&MKO?ghՔ*/ Qr\WP+jsVza V'@&eX9dMJNLoot,Qzhܕܞϑ|"gb ߟȃl0a̰&yila[{s.}ӼT%^W_5.ߝ͑jdـQ"ƣELo> sa2睖egK˥G?e凘sYAr@3XJ{qX!L>㐑 a^3mP?a{n`iAiils[lJXj&~K[lgaj5og8=9mX\Ra#{1BxƮX ~Uu1"l|cDc{%3jCk;,/Z2ƞO[M2P\l,cWcdE6ç~_4iҤI%QU$[Mwy0=/Yp.{B\uil~q]D{ox׿jS~0o $&BqDPJjyK~gx^ly?CO#µ4/XT+W, @y<A#T%>l-eczH6|А_5RR= ~P$6ߝ̃ET3+FYwJLx{anQۃXP\!"d wd+ >ǪO:i|7l'X0#12; W5]55"ky0-e`;\P(QRu''. WOYn|ʛ+AZ'=.kBI1WD"~S ʅ=꼀 semH4ZU2S .l, <\ҿ54+dQ߿Bb(.,?*AňVLe>]|gP>˷hS nxdm.!o V&~6J8vrYd/n` ΍c'.qlayD_VI q2o(Өwn[-1vm֣ b[8)ˍ] @E7R&"N=L}¥Bw өפbeK/J7~+ɿk WtUU,sׯ zbc({L̎ο~{.ȓ p>>ZVc[-(/f>$uC,?4Z>9XΧBfTۭ_&լm3V_<>%o{ {@4iҤI&M}H='=Ϝ@??'N}~j`gɜ-?츌)k |g^uRa[TG{LVnvPzs~rR({ >Ff$g*m3iq{s2sc%fA02FZ9 \D/`vzO+!Oq3GsG?Y4iҤI?'ħf6nkeW3lߕdq$^s7Jwvh3 "䲓7{68)ǁf)R`c]uXtfafYy3p;.=M׀xd4us5#\W4 }ajBjTJ @At|Lnⳳgܩiz_@](!m'xӔ ڝ^Fݫ}|cOn-|P~ۗ&M4iҤig 5>:A}Ng>ٿ pc3|1o^0?PVaBx:ϊ%=;DTZ@ި/MOӄk9帔k##[T4zVIvB@ u0 Tc]uuLY¬0K!8X6ۑ7Liևzբn̝R;}0œiʮ]0Cp)O+'"lUt`Tb ps>Y,@U+;3A/b>@ڔS=Ό.J(UBVE,SvAfiq w㤑9u,؊=]K$;o1_uޏzܿxJuE~aRKheav,jyr5D^߶YGwПQ+6x2xI ?voxe~/Z^ky-9_8qx_Sk׌U22zt3{wꝧ 2=Vf~){)yƤz$YrCN;ʚNIvTT-g_dw|BM=K5'Ʊ~vWuz/qY2Le 1EjdQp ʍK_#5 AKՎFV1d GU- t_qHb8>„c/i1f:(&96F3stZgIYKgEꌼ5iҤI&MYx jj?O~z3?[YjNz"LR Y>w1軟|&@ Alb&M4iҤߤ]o Tk|O3B^+ᑇi8',%ay2Y#g->Y2h&YzovDiuM@īVop|Ҥq 2.+@]ljy-嵼ZJ^Ƴjճ/ rG`?k;$AI5~U wI$,ؠhA@]8dFOu4ӍGg_;#+p4-_ky-嵼 D|a1hÎXwL3ϽPgu1rҺP$~&M4iҤJ  :~,K?O#Ÿ+FO?<N+^y2οrM?4iҤI&M_rT;IS? j> pAuߏ1^-Uۿ>g(>2:Vn \yW=n?{h_5_5_5_5?3_{gNwG׸ ߕL_| \)?]8+L}Ku4|||˽?~?p=sܞ~X?T|0_j> .K_3"H={jҤI&M0>I3jNqY;>ҼFjk2̎)ۖW*y>{?=%#|H2>~3yLD4Q8}wQ[FHn^$X7縟4IM?R޳2Ⱥ^UJksiy#{C4 9.<"KHɆ| h^^*i:5iҤIB _^O|&7ܶf :}̀v(n[[qOp}Ł|;ܔv1,?dZ/v9Fdhr DzEv$Ha^?8[/Xnz6a# 3FagԌNfȒU>Q->#w`v<"mgnD)Z|KEN=yb#Yzx>X^;asg 4[ławYA} 7^~d~m6>~~zݹ eAW3Zarf*p╊ NE^#l)ǝr\ps^U#r! 5ul /IV'4t%RJe@&)fkնЧ@֑9X4r FHr/P~4m4ep7<&>N,x(ᣊgg3ScbFP%oOHVa*KI#ca;ރ|IG sM7WXR<ި֎ ?02H䫡$Tm(۵C޾/ KC?y^  50ZE++#yd65x"u$2wl^ezQkδkyG.?v/\؂k5 lK8 y/ɻ!Z^ky-ywu=7I;9ͷLj-5Õ!,<#0R>ձc-p|P%G.e&y0%NWpu6J|Z-nw|HH^kJXYxޫX'Ӵ.C,ftZ4oa#u0̈́A7T6V򷓍X VjMbT*'yoqAi/zm%*[:v%քץ{?-U3tai{u_5||˔_7/? W?胏O?Zs !W:v[T첬uPdߏuXU50 f;yҍ9?_ZgG|V[mNN@KA7؎w7&ܛc fa$14qs/mz =<7 H[>%l|AAMAi&!L&ЗC2c x><_BɥԮץŤp pIc(ɴ(ܨ{{&ObFX߹ EvROsxftyvTrErۥ?!7 /O MxnT*~loAm[ht\p Yq\h,bfFw[Kkkk͏7c!?O]-tbvo6)[qF`kAA`bkTCCsmJl[נϲ٤TDl2fZI[l 4խ?pu7eaNanCڕ{Wij"Z4<@xXl U.}{r&)h־J$oQQ=|?qdGYz(^>rBm`]n;Mu e;$kⱌ%m#3Lh6`t_Oװ8PƻL.@^aMuqþayYE% ë-V5j"VQz3aUtXrDbE~PԌ3KE>4|c+n} gg E6]#?,X;|oABKҨ`~CuҤI&M4}YG}nsd󭠶M꫹kϤNʛ[;zgF?)O?f_'4U_j% ]\ڔ &&ʚ.kp al썔5mExR j)\TXz `|F| <&`#r0jB J곜Ʀo<;)>rUfܞiSF1X֣R^U>)%}`NUCR]T.%o|t_lN]H"^8 kn ֜KW'  lٿr{_M;K& yyʥߒ#ul7(Ѻp:C"{S@p5FY4¼? 74 l uIWFNwF')t'-j鬇`vZXBvT@گo_gJXNy\|^ CoU_. WWB] 7`tJϥ)QMna[#yfb/4'Ĭ1n>JJ&Q:ϜvFwuZPsAЁZ^ky-WͿt wb?=qꓩO?" 7%׍S F_]$UJ,& P,ӄE$?U6rL2if@\SZ &ٜT-?g4YCj`;,9Xɮ="V2`u|SUMa[o.F!Leb2XɥBnsWb[ vA4٥r3? o9 ͔v hi37NK@N}^>өid5&/zRweF,^0U2=f$ML{\b->ηeq艟j߆ng^C2f64#|ikk_^ppU9U_'>4jꙉ0z<%To~KGÍỨ=qWXߑTXB~8z&߇NK&~6j=,qb#u T`}X}|ҟ9WXk##5~kVcXztw^B8'Qɰb5#5ȟB#`%DC=uӱ"02-7[B~qt&M4iҤ$߳iN_wwt2TE~42рd所@PwިJ K_.r`顪k5iҤI&MPO||)&Y;3bjLºtM/=hC~tLp&\+R[f5"Fء'_ӗdA]\hH&M4iEU9Mjg.IPxIPr321sM9fo,TJS}JݚH5ÄF*"&M4iҤRejo&W^_޹F}Z'_:Q<< tktc3&,*iO.fbNC4iҤ 'Z |/8/?D/j&ܡC]: I&M4PkwǏx]8miu||>HRrީqJƓ2?!V\~S\j c=z]Ja߈kޱ# w6㏲^B0*~ =F(G|||Ϳr*}{Cq%抇(>ˏ{:)k"||h}F h0o NkV?<ѿ}ڌѪGÙ5I8"Wn$Yß:#W+ث '~;\y>AԤI&MϫI{󭠶Mj5W9w ILU?bW'zӰQz4;q eLz0y(g^l|4v=tOS~kti܍j:V+!} @&MW.NФi{1}w.@sg>:!0Rk+w?" ]<#^!{7 p偺7݇Ù,~*ʸOd-in9M`w P5cc̸qȺd2bSfO1[aH, >A dH`6la%Fn@^gشZwoTkZ^ >k[_=K¹/wf3?_sR N P +[KW*{sXx=KRћj;o?3gJ+rś+y*[+yssYana&7X}n <` H Sؒ#?ɇ[@Jz)sgW1 1g,R8a4`d<̞nZ(AW`-Uwڥ&Rc/: jdRVƻ I8,/SzW.qDyƭ'fؘmW_-#qVDbK SoRQÄp"(q`.'Xaúڸɩ3~}GZ^ky-eM۱'{ͼfZ &M???qꓩOrݵ缹YVjUVΞ Dd^UKDZK-WˮM2t2y:~xAy$]?ר"`Yk0{-W T40 WT+W>LHU%7??mMہ>4B@glS"HanJw#Pm91s6wFf>|yy:շ`juC #dÖzln6Mȳ7:~V O;JX,s7Mb6XMuJr*c|&Q'hWGa(z\ &VZ&_[9CV ^(S H!RFh6f ^':>sg:sld0~R2pAߛ&'FM@ G_G||}#$SBϿzN|[<>I.̛~\'>9ࣙ0S'OlԏG_8?vcI{Hu-4d,ǀzVqlyxA:~cWMRQq*^y0(T=I)E9<~\iUSXuO6mLr{H[j<~E)R7tuR6789)V4zS\hBD+bF!@K}(X(_7oϓ0Yl} ȶTj5ZYyu 5;?~uMćc``3Fƌ*\k{=?\~4 [ Z:Џ\Sa7NOqd/4q0p]b]$-!w.CG̢SYuSӨ37JXߚgn ˌF6߰ ԦFؾ׽~v`(qoa}G.q9'+h 'Jٖc'" E#iD!yٲ_^e>~Wϓ~SSW_4i$߳ioNuj`u>H]`ڿrܠ! GX)r5*ˏzqxd|ov;T.}';pme)8tyoϗKferl?8R`6`qt>}3P27SaRHm٭B2+؆~mI;f̘13ԛ[~<_xy>ln3ŔF:w~7ql/s`b D*W##DXwՑA񐱴YZ!@F@NtF*k "=4ޣӔS]YXXN}ԛzSooz> P͊o)K5*妈gQ?(8S?0Wɳ=\LuL%(۪3DLbJBE'f*RQZVP"Z,@Vv`JR?A@ׇ9|aQ3?!É@_Hu!+ 4%6ѯj iRO3t%շq˥{H3 %NJ!PR+uy~1`u mwsi2>>l^\' t '0 ڈ}̻한EO,Z@Uxy&xsl8|䩤,xlq7hNiMJKHoc1Z˕+AK{mJʓS^SMa`6t:᜛@hw5EWh]IV]3CRt+IZZ5)k9\Y(2fUiOndB7|z= Mo=ӟWת_S);o)l/df?]&|y(V9GVe"$ޫRFFx ( eTJv~׶aʢZ5,^ҕ45獚dկB~ovPk?OM4a}i(`JCUTNA5'sJWa~m"A [@"ҺfڪX_c } dICQuqmٱXn1h+'əy4S>L0!# Ӊ]BthWqv0'b攀oےr;>lu:J2Z41O =VHXXHFѮ};t8]t .ln8MH"DuU-wSoX|8M]N}=CRB/ON`LGS3^31;35??97[7:Iö|okc4[3 &|v'2[GG_ {rU.E {" |?T6)[^捋ZʦߛJ=)+iu_ MPIm5dtwBz*{ i8MpX.9̜'lYKJܢYBҶAZ&Kt~@w1\tN5((Ps&iakVGYl*-WXb b'c3j\;O8 Agi.UXlj+bXܫ.3ŻA7&'e1'cf1>:ͷ:ef^"{^b49VIQS2ta-sޱDž|celn:h?r[RrnYGOOe̴םzG9/|GQ 繞v~S* NL>0M=^5Czt4igx|~Gwgbx!|~˙? nf17<} =;*nMZq~ͫW&_yN8Yu"U_}mYG (X.V3c-Ď%Xb=$ZD5e~ WJ<ۨ]z50f9xz`o K1y9q/\R<&#VGT@KmkjRI7Ls__3[.UyFU~^sA.Lny'g(7)E\#/$;#G;gAǮ~gO./~K67)=aQsIgXoo^yz^?o>oۑ Ѳ8{JfQT<0x8AOjql[QwΖ#akYXShinEqcn+ 5_4_==nǥZgIK1jm4&9^}Sҟg+0/f\wѽM~/n[&n7FmYQ-Ub:o)oq&Z?8DXD#䣁|'ƙ'1ˑ|=*N{4L9uf{6$yUϾjϨ vW|;~?/!~0:1ߗo ;oFSL魄"%FSϥjKr? o |+$1*HV@u!rpwCoth'IӷB k WIH㊜k}93Dhoiet~hzw)'_>_%{V\0=P߂r JO^}X#o*g-_OlLsU9$ͥ0c-%ѭhy/hغOlȺe61>ιמQaS3\W?Z0P.;Z㋕] qnŪztjs)f}s=3W ىi6WϷ*l|_+҆y䋘sKs:`ٕpGy]{q&ƗGY|W9t"r5sm-;]6gY:߲:W"¯ o2N9k?bJ_pt{a^{4lqhV(do]Osq-`zse~^Y_>l\ȿs֜SXQvTMFFh]iJfP2]k_~Qbڳzgηk}ןɒق9pGDa: =kݮүT2]vؿ}ǎ+W0:K)w|{̸>j/;N.8'򌂮ߓjrys)u߄UM1Ŕ>017?r-kԯ z_;rl<(׿7U}8z{~">M~ \'۸ y>IpuoWcArn80?;37DSD)Z+`A+\Yk/̊t5rQsn γ3V)_<yja~NGO>_z΍Ngxnwa>s)/ KvٻwcLhC9ʱ vA}d?T/6xOA0LϫɠR c*v_{|SF}I7 }6˜9ڊyScQS>i ;qhjt>q9353}vJ)_2=[3yѢ~fo'g ipb,U$<7_&aQT}~9 χ{mp㳽 f~jcL/''s;;jdŨݒ(8cv16;}T6pOqWo6|%?7c)=tk7rSwQ.:KsQx7,DbMvopsf|Yi!9]Ew2+?)-<ѕ) ;9"[fkgIAΓoE9G]i2lNk2Qtr+eE6p_~(ἦr]_}A?7RwtB<  :H^tprN€^㫲8}v`vF;s>3"#Gd+yIuN~ASl>_c{~bH%rςb)K5*9xnềPs}lavPo-Gg+z:F_''߱ 3xq`cm xVg9L>_~Uζz1v׻d=q7ϼWgTzc΍/b9ӮS3|6?/v"4 5;,S:[yuVBﯲg/fs;8AuvsdLs?,>$ <3y}ԈNO{V>>nN>OvS /df?.(g6ݞxEH ҙ;l:N;K.LH`/XVڇ+CJwGQ[e^.?w2 -o&z|.^NxFSnzD.q|]>uu{O^~~X{?L2z7^)peūv_MߕУ8vxޛO]ſ 2<9aCs)x,pӖuƲފΈQsQKIwS)h?x0,s?I.ͯ^zϑ}Ѳ;.[9ᄑM6ߚѬ٫'27 {<ߌ<#"3^|/W=?s]qg?wλv;q{nvO(~wRu<6H#xsRƏ|{]ٙ0{Xvo֢_? g=5&{gٛ}`;cGĬGߗ}٘"?o79ݱ'SGD$bqsw@x;4I&W8I$&RϤӀ`OR(x%'ML'4>`9)p2l``_2vG"N٭].uzISIgtym:zh a+=:LNVT_WKGóa_"j{޳kS{{ra]k:3z_c..>>v<`+s[Py~~ܖuu{Ig s.{fЯEW={__]Gv|o[(7E>{4z o^2(k߹3e3vhJvj9_He٥xs , x%8i()wһB2`=T9@VҢ]m媽 `Vrɮ_8" lW`@n6PfI-IYXˋvJ=gRv kJ.O_95ˏ3 dTժXt/>D$?Ol3jG=@T?Ë%wjXVHXY1{]^@KC!D V;\:#J-vi7!֪rC^/jq\Z~#inQ#= ,*xNs=-xg)f}I0ٔ_^c]LwzꯘB?R.y}a=;A9m~-;]eO9 :+\k_7sc& cn=1+l ȷ/s:{1.x{ܧ\'5BaǷ?=\gM}~@}3eg۵.n|6|45΢ ˂&,J WaIBh+M{uPCٴ]\^L$PVQzȩRItdIS8pZv`YPZy:;cE} 5+vnԁ'N?L᷌)NP/ =,Tg%^i<4}(3hVLc樼{pZo6mlOR0LoNa[x@z3 * Js[&l"_R6b/(E)zוrKvF~4ZăUݪiQT?eD+dhkɇ+%{q^v^kRIF3ؗL,9 yl=)AxO5c欏8kE?~,v ^B_0^O0ŋw1oDc4LF/!ay=CmnabN/wg>7WgŞϾ@~r/[vP GyRQ~{>[+7O(M1Ŕl-3rTn+PǷR|Ohpp/صx2[5GZ{h@u0aO3! lc8k:OĢ!) HJʡdbW:G?^I='1Upuu3Z?f]Fx ˄U' ߊ6bRЩ`zz.ӒYLb;iV=lc3롌TTL!|> իi(h,/[Cfe,Mx̟_sQz2bxlJaeT~yx.W14L2&W:Xi qV̐|D' }~p? 0I9gi -f&w[pקR=[/ӑ<;` Gg_ilBNؠsOͧ1> S6?-MOs>v|SJ?fs3(B@D;+FX^ֲ+okZ<)[u@;<02B찾} ).ō @,볉4a%aEc*c$rNfP;"WclyHK 4W]/ƮV<]mN+k귀)ICüɕ"ln0=-B6s##_Òv)bOxqii3wFDR'[ω}%c8KXUٳ H9;yu " nAE!LXmұ^xrM8&S߫Ƒ?LW-s7ǟbQ2ZGӿs^Y,0?+0 {4gٯXi?ɬ4O~Jn._(#K{r9^ɝ ɹͻs/]=>L0ߣ~;سykc9_8v獀0g?g=^Zo?vrA=7GΕ,cg> kؙ\(~ 5vJ_/?A!df1^_m|}$Kme_i58-ZRTb,yp IM\J&0f#մ ǽ?8tߐjՇLa~{> x}̫9@ne0p V#Y1K9/Kj iь94S_0V;I>?D`^h&T&"=Es/o\8Wo<1pVu`朮z\zԿA<s׳77p}X#o*g-_3}wlY6T4sߠ@UKoH3IKO;GZW_} ʚ}%u+S^FwUSvK?Jy9"ϕ[EzvX 6_^__5d7+%/kH`m7D=|tT%fכOc_ŋZ=6/')[\k~=;/i6ms1^oZQ'v ZyāiCa+3iFlkԟM(ʼnK\  Pٌo6},O("H?^MN q,bm"ɂEs..~S#' L%"FY h ^~aW}IŅ R,:!!_)*NM8cH&*WqA)^Zz%F۶۶ +x}4?PŻ!? O,s#>D0DD\g崟IX΂sQCQQ.wN쪼."fy)0JA۟H#J Gӯc1W稠om,zV QQ1;Lű6`<y͊68}uoIg9?"Gv=#Ԣ2+Z#_3_snmʇp|o~=hǞ~߈ߦ_|-_#o?yu+ԛz?/s+Wο&{};!rYEJ[be2^-=.E}&Ə~ޓ #Ǔv?GfE̖b(*1ox"4$Ң'6J_^ԣB~8J,n+91R^$"e UgP|DK3 z@Y0S6kmGYqJ\! F. p4su{^_: -wGGcRt?N=~So:7~pS_-iFp{MySL1yKdf/s{hg%c^j|(tqp y,0{ vƁtk%4i][bס-C{mx Zwllm_uJp߻T#">IkQ?ηa Omx=};xɏ/Soo SL1ef_,9j.bv? bQoĻq l{".;xPhHęZ@}]iN eۃa|a7lY|A=՛qk)[ewe}3_=ĮuKC'6q}k:*Jɍz=R&&Ѡhت9G +4C e'G_ {r;1l5 ͺYi#O wJ\ҕ|Cgy#y@`?n{V:ԇ]31lK0vx'aVg[z:d=zƱ/?/96xލ7W~*H^{ӵ ߣ7{e_3Ig/@W:? U~.cX{MWm7FOL'{7ԛMy+݀{_ɂ1Ŕ//u ,@SSܟǦr 9tF_]vfny~sC)qg-~3k4׻]݆~sKu| ovX}϶7Fzɣ\t/#7y#Y_&_zY_LNܻ燷f}"[ c4W?h9,??7x?֞!¯Obk===aؚl݋xfJǛB́eh#Gge*uKzcKcqP2T2 CٙNJ_'^+??S 4 |rys.dzbJM|qt󟚛ga?}W؏?ZU>^m Za=w H^\Ke{il~mD^^9kE-{y^ZKY..bu+A_X僉).WQ|ӹS~mSoMM]?1;[Y7 SL1A 5s;EAwB$ҹ]OҮ1>D#*n^uΙ k|G{y#s73ޑ<E1ԕrzS2߾ )?D:}4?1%m,v<_sp:2[;~?qhhE%F/$q"R)x% CWBM OZ2[#?ĪFp"9.x3ˍ_%$/cj"#ǁ,-@9PNc\f-Z# _-',`؆ Urlg\NJHc ( % !yXyHs2#[ohыw&c+q "(qgIE[:}aoZQ֬ É\zE =u\No?L=׎>OZ;=57W^ IP|7]A6)fsYޭEy͊*dC2{$3gĢfpa|"#F_{h~ w[$OXhϽja`굟S b{N"EkvƧmM 9}6ݿrtO)YrXn}sY? J8+)"_hy*x0["O1X.~Һ*٭Hpb'WIRFAPNH@:V ˋX~~Vs)ePBgH˩k `ZBeŢܡX_+Us%۶}SC뵿mK!zaOBr_1a"-b7y;QJ V9F.5("{\iuXkUJdi1,?3Xz޴z,FD@Q%f_hUs Eeu_'ފΈE]kǟܫ܃@NeF:WZ.+wŢ]H=(vˤy01{sq(8#n1bzzSׯ8N./tOM^E_}~'_79eQ D'ɴ_^$ެ*Y1gw!ʕX^#ɪer]1غ@ה;][-Sr P)sVq2Z>"vhs_mDf8 W`aK\^ሱj ga0Zrmuǐku y-|uj_E@TPpގqR)zD{Bo,w􇝳Sz^%AL2dYO~PDuuWi%;&KV[_匯Z`{.kZG,9/ j}>=HfB^$oЦ֪;i^ݛm?riHeӉ$uFCbNڍ,Q#6d?9a7V&56q5VE _FrՏN0?xr]?3DC/] g_e;ƻOoF66?S%D(EÙ?f.f OTzk`PHFd\v 56T.#O(%z? *&ԨL&%p0uVhaadIݷ.?Y=90L#"Jܨzmը =Yf>t@ /6;aCɧSǨFQ}ÁUb(2l1|c![mCt*>D* ZyAbEKf :9η3 =AK>LIje}Aw*/$C\D1^@˗#P5|Qb1"c?\O2L+iTW? k_bg"ё(ȊΪp҇rzZ#o .-?5??V({Ïd}.w;YўnW;{7|Rq~ͫW&_y_ 1~/; 㙋0ի@8%v{QoSD>|@;x<M&Y'帱; xf@ğ_\|0:cP#ĐClT=C/m$;%wj˃Bމ7х(0a|o o`ip?n`YQZfyz%Rk!qbO'1y.J=%=TO gL|2` BQlZ9c}'}p6}p,1)|4jz#ެq>F #bD0G j xI>2i~kl>+oCHH?hJ!Β16y#]9'f3YHC~÷0qNWLD+»\%&h:So{+'#-S|R|"5^,i,1=;%m.>,<[K& zH9#]`33/-v2ߌ$zQ\\|#~ZVQ_TQjQbq@0["##O:yCA/Rr\ V9,nz9iKrɈ7 _YDT^qǒrKHOhqI9z{77<^0otӋ~S39Q3GIUG;?+M1 ͋'wz?"L*@ E֞Xm`=Gf -p`LaP"1/SweS.p7rA=7< :YZο|˪G-guT)`5wժ{9O}A^hds絽ͤ|9;@:6GF;ފǦ!a wOky*|IbO;j[+ d=?ԛ[~\߀~z')w /&nVjwo|_]9~'hs5zgCrKv2mgXO/|H^;suƽQ=V6j.$"7|g;?'D sj/ 'v 8w~Kn.dzbJ_w7-]{Vb{7;B~z:W"w,cgWobJ?Wa+xY|GfFpee9$w:^yI_gף%/98Vi{y#oo|yyϟczZ!/{s^߸=ysALBW-?uo_Q!w6~^OBL:|^B@7F =|^g^}򝛂unr푷 q84;z3{WSH N+ϥ[x/-,=dnlȉ~V%V+-{Ӄ~3c]xM77K}]5Hϻ)Nl=9"u|OQ}?>ky]ߌ=]b)|3c?DZme]k}V%ªP4`JmIV: mA=g(2R[}}#sok7wtX>Gߘ=9"o)l /쫜 to~r,@rw?cu 1LvcXM_~x_vM^l?|:O8?1;C]kgs)l_n=ܖ~G=^s*k7i~c4vK% !ҏJߠUw]oc j7YV[FSG`oM[-[r  XoGb%Yyya}_'sav Pki}tUτl^ Mb'F__.LL`2ef6ծq蹨V,@ @;eeO1yVtrS(O<8os޲|39eN$P/./:g.tZ܀݇uM}{N|ll6 O0^n>p/~[fsǮb''y 3}]!Иs&fZ޾z'~<o79x"]rQHՇ|ox>٨u,9@?' ^Lc=${綔uݐ݇0?(yF >]*`~Ez r8o?g':k^o]DžMs19x>Gse,{ײַ];yUO,NǼ߸rT#ؖrse¬ _:^:/0|=}GWj+M|5~իx  'p=Em$|ԛ^=2/xyʤ?/fo*uʲ^ŏӖ5DɘNe8~Ʋ7~|'+Ǭӱ+zZ%eX39+z ֯ ~f4v\s̢hPZPcgE/'vh//Laۑ(`ؠS f^qYܮ=]#G&~xiؽRTن_?+?ƹWV7nt U ,=1lݪ۫=m[VL4^:Yy{XyG +_Г*Pho83yϚ7^6Ƌyz6&Fs' zg|r.3s~iKcPL>vF,Wx㙃3GqٗR,[Ph\»l!Ds6 -B g5a|i ꣎Nݩ4 ZZKwYr:.v Va[ ѣf^o?^,-S<.Kr.[.Kг7.'Wff_Z ,3 %O3&%"uƽ|(wyJ?viH&ӖGZnV^4UзX:70d~ )(} )le`Y dKV㞡g)*at}$x&)YlX犿fEwfRvbW+E  e6Q@QWkALJ69|AfLd@(-hd sh0J_b"EH_^MI !*^|3$hDV/qٶ:]Uh((_J nDAmFnx./[(}Y\#H]Y7^]3;S;Ap}e_n}Eu =W+bG L}{I1 *.c k}?{.}مAgwɆߒftu![n{OL+ <7yڤ.]TyA_]wD^F_9C?x89Ofa p̊3@0%?.r|.'H>/bN*#2I8zG,| G>z?>ԙY ͞|p1U=;v{g3O:ᬀ:*0@(EhYW<2Hf9%W.yd^iPH&CzG=€*T?A"jPZ ,!꤁P~exrZx&\"4i) cVj2-tYElбV=Ξ:;0RF-眰ON+,%ЮAШᷴ[CP(8JªVFYWУU.cԠ}A?{4n_ zLrLѾ@"G\^^\zLǭeÝsT ;ad[~&+8ync1hGL$9wT3,F߶(s7س]\"/۾dp?PF2MF_mbGRR~ppsDlaYߵ>,oĞB ߸Ÿ2W&Z/O k'C7KF~edy:}iq3\?ROL#-o7}w3ۏ}av`Z,-cNd j(dz HծrKJ] 7Bח/l6⊏aL"U6O䄖F }dH?@xΉs+ubX$enDb@m6F/j+N[+_-~m$Ko5knAׇĎݐNJϜ1FD+qEy$LºRO 8*ٍگFih%I^X|,˖~ }%hט_`mH&{ R/HV#҇m_1&'E_Yb5u mB]VGX}U˻Pt[3-j*ݟJIfvѪHzҒ:u^J_{B)<ڕsjjuC5*^U9f(x`>?u6eV}zVe]J(CGk|+MQ]O3% $d,ˣ^ +LZB '[GF=WU,__ˋ߶q~[دXSV'n5s1=jzxGmx(|V^ \U?^jt',ꨣӉ?fY3&(1BQP!d"KA\Hdq%NuUoaF]յ~s}U4`1o/N{}U{|ϊ֮dX)ZV$yʬ9~ȯX"haH>f G'|lǪ)#,4:ƐٯGbIlO?A ?oV.va7FwYPţ9E8x X ̻Jww_'!v@n7ea1=,f ͎v)m.Ћf( ^|> Ru,Qms2P$0u3 b4 ܗ|carXpDN mlfBoA7X̭g(1 y?L aO^t0l]X",fGԥrJOHaẔ{6G|Se;:yp㣄CiσU=|*5 :"`=L~¿yN;[o|V 'P͎8H^?\be`2y6?s|xɡHu'qW{';-&ħAK 'ͤ/)?40>4O[Ɖ8>98T7Ks>Rq6mٲp}pm57o2j#/?kV;>G3{fKW-L,N-ȦH CʘJޙ魑!}]xf8? YtkUM,eyRlGhD/BAggYap6a='Fw}e^"^cU;)W c:32W*z.n6_B<{,dΠq^ux%`]Q>GgX+ۣ!w~7C1}!$v_0vCG Vd6pO171!g6Kx~Na\UJzvㅁ*ȵf?˜jכ"Q/g9bž5 {0 ##gG#3GLv1ƕKY= 9d3oh|5 ?{@ss$ǂwˡ0* K2ZAl*?u^W0,3_lOm@NNCH"80|g*+׋f.h|^Wb'ҩtpt0'E1W{ʤt[Bs^;A; [0SYAEd ?ac/7[ͦv5>S \5~k6myoyy9`e/ϰ-a᷷ƨ^01oP x]sg*y_0X.a)g>GGL 7W/ZFLql8d%ӌ}l#;y*( P6Q2AOˏ4?<V1N54S|}0Pq̉>ڟ- UmG̿<2H|~>OA-m6+WdtV,h-1yWϪ|R -)ej4w5Ybo'w/݇mh{ /-WrU ],+[g{oxE˹y槕߄>(E"whmc-C{X)эǠ.XJݱQ]Zb1*N%X.罝UJOn:h0rY*E,TzѝlI?{R?[LN6v,lXbbǰ-V*qN%c6+F嵉3p){)vVpgxՄ * ~fk`=T;Ń0[[`&_f+YW0g#|逕;M|;`nzX Oǹhl;?[igXoaڵ2:c2 ]Ў/32wC8y\_hmݾmIk`~Spo}!*z0{Hs&Oψ\?ܿJb@o떿x-Q#oFJ*O)Mm/\+&4S9Kn4[I0d=[i5[b'Vi5z{nc#Bw(VF)vSm6~Ń_%RQyxh>0j^|Q'︢?eZbASާ?k# G[V\YK fGѣ :wRf>H=ɔE_XqW唛@ypw|M [b4|A`Y!wɗsU+!U7 |/+"SLٖh8Twdb#cc4GpvGQU3@'nϩ#q#1./aCr#ҮyϪ7'= 2oQ4*L\zCֹ`-Ӥ(1{o?6N.R7MH ;}q|z 10oƨ]q7ª"X3d/+0>?/V-o}?ߕEmS0("ajGGd|/{$~S _H{xawymJ}VRqF`E``߾}z} 'kL-oRmKDijgR.[g$ۤhgZNv#؞ܕ5KZI<X1MPvluLu'_ƥ-+)z(_j 1]JMSmAބ!/įİ5A0:B{鍖Y<2_;#NuF6=QӮb3_noo?Ò`vX7E/-RbL,/Q ?8|fHߩƑ!fhqEsDf҃߈X}\#vR0@pη  |BY zQ殝߸emܾܹs7֝߹X_jO+z7|c%^T$j;vd^%L0;z;ep_UX̡_u-ƞD:n_ !"?t\$tU4j/^iokHBݻ۫|ܡ W3w;@rEBy/GL-jT80h/Q+֮N(7>G/A#03 竡po ?I8qƢ6,1C#bhtd.&V[rBufXAf|LrL(p݆+*špoOϾþ?#o% hjS}LR- >q+vĢ1f{*z%tQ߾u&̍T*7#`:J<<؛"W #/zV,O7)y~5b vS&")n9 TwۊዌDݦ^ls?X:2t~q@O)riߚlHY^;+2`\;{s>Q1.(=>a9xx KPdV>$3߸ۧo 9=Ɔ9?"\VW_QW#pgoo~=Mog~{_ot=+K r`aT@mG&|'lIWϧ*ST?7_)?0'Y - ̼=j<?rjI[%mmMbQ02?İ+d eLަG+5j*͖-lz LOU@1ٽeUUcu: PKh^&R3MZŏ|kZyT͎k17z;ȓm{r#w~١qb10 GTS^̋B;C;;;_o_zd~5^}㿼GzjTnK̟e3&\VgL$/ JhQ?333TY.,͵zMrWDd*"z// ew`A  b>LF:fL>DBgÒ;@\3 S& & 1oW*c]F`?RZ1Ă>GG?qgƜH>f G'|l'xQ?`יm{)wG[:kɲx9hj&hcS*֯Xo}Sq4H=?ʭJ_Oxog'OR^|9Ep {Dp Sf J?9:ѱ_7y~S<*_zlk.zh\ϕe&/ɷo<{YY݃W<6xdU!="wxN6*/_\? L_kOx`:FtY݈3xcnxj3U-*uq*8/OV^r%߳rŊkNXr*]p}wԂg{Itc휧ˆ7']ڍ^;؈eސg\[2.sHR@ (Vhշ[04(Q/4ÿ+ҳ:bp}D7nLAs;^Kq۵YدI 8÷CzB0¯94rXE> /- Zonƿ=Mތji#hs@>g2zuRz=|k_߷/<>_y+1p,=XQUE^+}b/wx;@`@&]URYBs T2gAv2^1rw[D[o9˙߾m;6o۲u6V[u_ Mط}Ӗ-pƭ[m۷ӷz-2?ĎV;h;q,\G B \]bsq;(v80J`VJǗp]4 N]A<Mۣ[#M#GNaR~ o r@#x %CA85 rxL3FWuv蹬^ vav>ُ+;8;C843 xyU?6-n Tg&jf<)wi9jN~j߭]F z`}+~hS> :4#rz ?dfŸ4-7KvX`H? Jdd }H< ီִœz ,ݫ܅DŽhY}p[ݘPo)<[|/1 Wr3?/?o)_^7|:/zϗ{l9b(QwV ëʊ>@V@Oݑga`Zlb rA/3&g5m{-Cƨ/ΨrO؟LypR䱅*ePW]ۇ[bYn,.s7{G#<̓}A--Xg%6ov/OֳiA}jRE΀/szj .cvDC|HZ.?DWLOh (]_٩9lz! \ ևГ>q4S*t#|S)T*`-E{2 Hp?ʡ(`djRϤei2|^^թg ( S|ŬIxQ'()`ɇ[_fmSwBfllH yOq_( EX@9oF;eKG L)aj%RX<-p@rrRJۋ,M"ѯ.I)68:K)TM,jBOsia~ӓb!B9!f`zC.> `+MLO)xXxspa)#q(ww 6}s ˩o\z^oϿgcWg۰lYwC%>;|Ɂuoߪ+oK'& P`_Uy_hǾW9s5߰,vfM*??&p~{>'ߜN/9>j95T̻exY hp{\!u*Elpе⥿^+W.0zRD0]38lW!.8>?ACzX71jF$\?wr1Nwa Q巅 QSDw }̏׀oV;cwC )=]>:gA9ݝz|iݠb܏*rc 1\8 mp7G#w]CU[hs(1)3J>#zw;Yx1W:,CϣR,ZñEWt`&< igT'Z ˂Xt)w tqSh$8?d 5N}Z_Kɜ)t$ˇu˺σ91vBv'ONS n"{ P ǩ?mDQa xtuoD/ta^{-p>1j)e#L>r.ux@tfPNK0scz)K៟iƾNmbgO\pJkL ])WpaѼ ypb5z)Z]-|ݭ[xEf+˸V93_]??\r/G|s>7x)'閭kE/(LO`3V|KdK_Raۗ|T8_9`؉P{,xժD^@ba?[xc%LsWK//^ &Zpzܢ]b/Ȁ~ºc \޳kcB\[Y'q7yڧŽ] ~7;~T q })m~'|Չ"| pQ1^t0[ ܰ&е̳&=w!ԟao`T~~K~[8H~%xwT]1slL獱0,nqs12@kWlo 8OPXg˰vás7_6JRtҮK1J A"ϴeHZY@mVƛ%5/0愀|Zs;kS.I)+X5&?,X;`YQ}:Z)ogO y,Qǖ[ԏ? _a*Vi9sӶߙs- ?fReCQ7.1 c)pxD47 fUx5==sA7 8'=kA沈m"ôOnsBYm><\ɗ{WI݇X.]Ei1\pS`CO ,kU"X1Mr HI= _Qa,J|La.7. w4NBd곱-ϼ/WK!NGØ9ϰf0V:sg(UP Bn],`NDgqbp >~8cAWl,$ci0/pV LT ;V(u="pe/v ܩB?5e* cl8ruGCY嚧SI JO<9_~-?[y$M Cxr0Fx " c"-5 $0Dri}<0Ts,t]3 t$ÒIҌ<9l'+o|)/4rK*u H}l +_`e1c1B(uhEOq~9\k9;ƻ4S;\)TohW嶂iMyڕYlV&L{Ruwb|gVzx{{awp{e~ͰkNߪlI.ߟ-v{u;?`,d﹫W?2(7tDN"ցîy}ٴZIQtDga91]{W3itXD:Q/n sɻR.}D2hgj Gh`p _HDPi Vq< Kp rL#p]%%b(?"0L_y/Haieۃ*#?1N)VE4{yc/W{y),dKO!KO*-*X/0=yqy?i!Xѝ6*pJƃSc}{ wc64~c(S.>yMl-I9Wii\M`wQK- Zo'_{y˂yurmdN#Ĉ^P Lx~` j^"[`%]VU#:[贊'~~ٯ U=VFU袋yߜoŜw`ՇU?[RncΕhI^p=%^zyVt)y%j#}~ƇFǒc6>ڇc}%ͣnM9%߄q/ &2JTfbW95 >'x,TchQ3鋺:kBHq{>ϖxFQ\woS<ǥ !$e-8)>v4k*u^v1HR { $9KӸd<1seR:(4t&6ƙsĺ5<w(C+M"" >-7ͩ|{810lcʱRSQ$[TK_I $2Qz5j+HiaY#m#O R)PKu>KL~=p/`BSL bG͟<V_`h+ WʹSq~HF KlzjzJ֎p~g:>?}K^߭K:OF뎸q -c|/1*},2G o*yۓΌ7BAA/3گD`UR1zZXf`a. 0e~MK1"mUɟަ0>*U0G596yWC>+ ol(0;@"y{e+_x4? 0F U~MNɤU35~}ZO=7&Onx6'|g2.(ꋾt@;1JعI&=86fЃԙ%d J݅h ,CGleҼ6hd@=0mKx%2FI]"/fj sW: n> #00@;FiΪ} #HQ6`3 jQ1i#?vGi9)n x"O};F}g{x;q&$J% ' Ü?i6n3a77٧փlw=49 aI5_iZSo?8pa\[']vқH;r`~gWOg~u_XӾt-?_/EgTkF1S8?;@{ejhX=?w[k®x>W:OVI`]bgqٞ[R`c1fI~YnB4aVv1Zy_$A^;]߯}C{.k8iʓ=+VWkVY5[^֞d_cIsGW ;7;-ߖS!,Y0bl+xlܺe|LoF(K,WnV/G =jnT|,|M,F'9vk̆=Ȭ{R4)ZHuG]AHp+ps[;^[ L3EUN$P+9'YBnHXAYd՜avgIǞf3,2X.nW;nʼn#578(߲bP[Ok-x]TG;8Q33}d, ]jwl#>͌zg-gƁchI^؏ 3lR VF#_ŸeAj_(Q\%,$9MK+0{$(G9#Ƀ$(y%"}Wb:{h4Tռ۬T-,=g.X]Fdљ,a'yǷ@?vm=22n'kܝ93wN'r<zp~BӮbeTVşTK&yE6f2z`n5bl~x/ Jگz 1'TV0_P7eB}Q;-SG*f^͛PH;үs]ZN뗀tjgGq~cmp=33c^~"5[U=/!=9s23<3̮}YYg WGGZg2ˏ!W+VcX$ỷhcv xqTdžYl+Ǻy,jE/ )3B*b|u~q Ս$wMWKEG["O96ae.#?Aը8FщmFƧx/K5~5,k.[:Wa԰ @ck# {GʹCQ.Lv]a;6j[* yQ ?'<7~A+2_j 5S ~VwZ9]'mZx9,s!9*!s־+WWwGhRfOoKSy6' %.o6~q4SHLs+Н͕+ifǮx} 5w^b*ͳMnb1>6_·_wo0[wl90,R9ߘYlT. jێ>*>l vy<\k5g1R|i< t# y\]D-ר_`f8e 灮i@~7TR4^b}:˘?ߵiW1rǁyMwfu #S!/k΅Ht / ]WC|Tzގa^wÒS{RG-\CnF'y;no?UZ[??OJH/~gi%ϟ4|OI%~C m\<[UyGprMRБo_i ɱ>}g6lWO_ljÕܧ.ŗ}?o[J.*X}آ9 "$dj'wZP`[SWUfn3GTdXŌa Ko.,^xb<}Z)ɱ+e]Ю/?gSr.ʀnVw~-rQWsOZS j] V߁8sg:J"\Ǻv̼K;;n;)s/ono߂/)F_[N\z+m0<]7s Ts>%Hٸ Z?~\q<,8mr*`e_}uǖgG}оz~r<='#v]}<(p%Z^WEƮ)'s P {#ǖ7r?ɗJ<Aƀ9۪߰Ѩ*85O`~1.?5=*s% r.xT_{Wi,*p?cajZb4u\Ky5~RiJhI[;aw=59Jx1!.,g\80|`|Ӗ-v}ww_0?0n5>"+=9rhJT7$qHoqIry#49[ UeL,2bKnqkr,1%{'uW>ۮ*7r^C"L0V+swla" Pk*.Wi%%_جVE; Ocbx^*Fvj_lȘQ[,~cOE~lj=j a{4% +nz3Y1?zFVcJmu-98kүD0Ϭ"'[XBbP ̛}A--׸?: Cq?"|9DWaP-wL}}Ʈ}6quB?N[=*p_1gE;}CϽ5cIN= 7TWL%О\P"~=V1jUb'>y'pdk Lc+*wkG`Wuzs E C@ :C6FqP {:oPBAVgNzh9#ﯚ+a+ nkg~_OT8IRLlO(3*wY6dž\K A$Qۥ|Bn9.wѣqo}!*z0#C??#r?~@'mmH~`r8@0D 'нd"NEYM;a 80!8#Q}vzP[O%ɡ0UBQ⌵΁iW##Cp3?G{ݏ=Sy1hQM1m/~x{ce_Ռnbc#g+%c08)7a?TTId;/Xi!睞Yõ IGU8W1J}goy6SGrawGUQ1Soo&DN.c9Q쬉$aVj](,shY6>Uw+n.ceƧ[ŷ{=,QAО-qa澵kG!M3[-ߖ㑷3ߔ 'E=FˈZxAZksv)+~̘cX)8*7Ib~_f"e]9 gn~2k[K=UD̜j@=5!4pŚߐ4s{`V.X*V1ئ:5RըQ-W}\X7"=*粵&;cZI]xs\nn1sZ~jcEIZ>v>) cv9k9 oJ̰+}2""ϱR.xN( RplPH*V ;S50 ֚h0ۖ J1;3c["*A( =O v{;t&^g{3:fDjs/W RҮb.Vq_5U:UD|Vl \SPSP.R.QrE~ZCy0A ˃bG|w@oJ%l9 M1 FOJ1D mv{v ?3/4^0Au'4w0G>_sǺedqixgW/_6SN +{%B9|WvG0t{ s.Ŕ[i5}{FϿbG%_r'6$%+ bϫq8K& 0A`uBFAػ/bS_p r) NWLRx.3J9(zi<ͩ_'޵ $7!\ԯ߱ IR}sg$Nz.g%oJ=7o}IPۗi7#^gR^aOϯy?2%o|19?uq s7kM01D <=o0Uƞ]rW-Q.3e#OA/'wVd|aĒ5jn[ouv{vp%OES+yc'0+fP͖G3+m~mW Ȯ@h`*g/ڌ8XZ{c;f[/\./9v{8ᙫYe1\f2Ǚ$%_")epԡ[&s\pѕr{ϗ vCތ`NF^p1Ss%ץrE~zx}tLvk:.`-g.*gvyGc7{ ޅ\,>ev?$3/:5}n(y&{;ޯ]^w,yN]bΡȗs%3)v?>V7fœw|UeE`wlW!ƢO ` V:0GZ" &hcaroDrQbMWW/?/?Wh<~Np@ 8@MYQ{[~$TaM.@ %{$m`.v}'Y}$ )}rrS$ fH P{T?vA~ ߥ7Eh8E lD|8:٭̠Zd* =| g,$ۤ Ƣ,5?%&g8hGC3hT/r/q,_s[/A-en1Kbٍ,=sΒ㓀ϡ1j|bշaYՌr|T 'Z"+ 7gwInқtT\xՂoè[n\t:ΐ/wDXX:E|UsssyoK?.^듽Xli7X-.O|ɒ.B[.$~x}ŒN'eq_ub[@yYrx% QfI'QC}$?ΎO.=1l-YIfϹ=re~XC|G}]9U?OŠ+76\;6f1S}ןݻӗsc.]e /]qao7, Ze!Ӱc?x勻'zIw~3.^%=W0=v_dX[\3/ySzW3'_Ue's@y=4hqxx\$XY3" T}`NX'LPZen!o(7{>uVhΕ^4W{sy{:6^}z2_A`>x[쌛q5hoRG`a'zmW926O({O= FkxDXg0j?дo$E?gj 7#[#L43z&sw0Jf2>Sz6{v:{L"&g:z!k(dhJcנ! 6{h<Nʼ/>ѧRE`*,LQPu[rW=8Lpa)djHg)w\bUIz h#[OnDŠw*e#mc,{1=c${޾+#Hf28cl;a\MbO,>ٯDpqc$D_:SzH"`гv30&AY<3v|>/#C#9Hr}kJ߃;n&y}Pm;TU9۫劬ˀv-' '$t^_aMg.ރp_6<, ֦2fJ_7a{.>w׉owmWnjNö|W&?( ;c^r,_\,TV z!{[ͽ2ӄA/T؞#L4}.Xgp[-zձѻL<(\6 -B< 8RC8ECha>rO9ݝ'OO_ N8RQ/ SyXK:ฆafXic[ ѧ ^jlT ?ͼTN?{ދ<>}:rF担/FcEbdhƅ@ Ї};ή7FbwB 3.ApDy|r0/?f襘E |gSlu0Ӌ}M|D}y`-*X2M_ԕQz?-am^G%\Ŝ[C72cz-X}oTVdoS _u[x-JMX-| _sπ7θ檇?ƾˏw_^~ѭWu;r6,%u>1ڿC^ϼx2 }co?h1> rێpe^:/YyUz _ 2Ti .X*a v2{s@swL?{ "Oq!.=mz/sߠyU˒sq6y'~FEZ0ȳN6X@SK^y'y3Ӳx%psc?:j?Ѽ>pA 58GG6n|Sb BgЅlDtw%pV.SezŬ^-ӥM}\dNFϭR  /Y]~]yb)1ɧp-)O  Q=j? -gRL1{Wd JK+EfSa5; b2O~Y$xә {,ưe]蟣:va2ׁ Xy){6\ aų-LXM t ߂VX`6G[-OttiAoVi|󔷷s T3TXOlֺZvW9z?\`~[~ԭ~kx讟7>:+|]WC 8p/f,yF͢/{K^y҅=F|?9i)/]{cW÷Y3wr'1=,}*_{]oǧt^ۥW_8؋|= #x񂥋}Owk `:io={Db".)ɀm,ȒcO_rYL̥ uЊj7.KG< ǥw .wn.h,[aX-W9~Rd (ZHC˓OVg:S q齤l{83]t$`ew_Hb{wyF@$cb `$22ɒF l@!!D2ƀLZ_0(k:&tӜ u =3~׿ߪz᩷z b/p(zFɫ!&fnF Cz6{qW'H׹/-}{2gƧ~ִKf|mQPrִcl>@rNmXSz?O?zR%8OYQ)3:n<0)f9>` eĶK/Mq/WgL/jGѶ}xA<3>cuRgj:xsW{.]|sA%K'c;kҥKeϲE ߥ/^D/X+gro[ _jY(&lc{rq/R93w kBW;?U׫koϐ?o?DAzϦ-0&$W)pt=$(@eMsR۩lY]"=|yuNˑ` RhY=]eDs ,La**qÆ%d`hEXp%2Zr=I`D _ Ժ:WqBOwD/YC xϙgw#xN%7}8# |? `Z`-dLYqc'-Яdbœ3:2KY/Uf5 fv-;-ySov/ Gp*,?t0>@4pL?I{40Kk$jI##tMN8:5Uf+۪޸7t96?X])7Q-5i?nyB|qlӆo\yâMo-{g_y\ă W=Gr>O8=1t*CW=Ⱥ/'fڵ?OC/L3;OĿO8)3\K|?C~[v.x 5B}N?f֌ ]'>Ϣ_+2{±>>ft+:_Wӎ+0y}qƟ1/(.[~c҇jlW !>9#R=f7y~~/G6{>vfwihո)%t#c|q={Է86P0y0zG$2Z:|d/ Q~+\?#`a$# "fƜ҂S,0U^e5!b}\(2`N!:WY+즇\_:s?$Gj-0sR[E+FL5,TaFp}{y8Ɂx-BX[Ҁrד-Ƅ7&~S2AgWŻq:+U &|YOB9;_D8(dQZ#~vBg|=ȕJ%2g~s<ƙvg 1b(@Ǘ(xC}s1Q#\8%6[xT HA3hoKw1_@IGOGS`~wFIX,B!t|FR2%!PC0 ߷}H۳צ˽}ޢҢ>:G mco_bϟp-sw7|l ^vᄆ𱕾6M2M/|/}|+ c>V7>G]B{0KHH yíz0WM:kL׵b0grQ?!##KMВ/sʹo7}l~xgr6?~mQWx \"AT] W0g{dOzzY/}y.DOfnҫjy_kqGRŸ}TD~;_59`?1ߓ}{..www-^t̓0+;:)3Yq4629H_-/TŚֲ}B9^|o~oݵlxm[ ޹cƅ[6.~G}ۚ| Ksʌ?L;jL_zBӻ6uY3ߜ'0ԁq1_~E3z.q Xr苧wn\6ytZ'0V>c2Ec&#oM?j\H^B7~r r> RӏaWhx ~SdOx}>O'{K{&9y.MmxHǞ]o7гٳC\ FN|(Bμ~[*:E̊ Lf0oG+.{n=qfS^0É%ĥ5!bFì] ҡ!'{ 6yAWrIRԈq@pJ4l^,5/!~!ln>-YR{3_lKVFiM櫣>.YAªeMTX!Y+U$h-FVa*>3-<9C:pc 4O-,X .Oq:Comx1\*?z*|4#\#T- %A d,00)gq?X]';j =jFŞ'^?7՟`9=Sy͜wóV;^;^yý;~7V_|+}m9])ߧ~{}yN;;kXK5| :_CU{ ]P>kZ;ugu|93~4zmi:gƧv|{buŴ.\٣aM$ #`;up;yzs|ʙN;'?іA> s7\b;4ES1< ӳhBsck 9LI3K'{5Z) f#glxڋ\wki+<`>99'卷f[& ]\72do1kd(0~2z~](,3POF4prkYe!o˺;e:a߷.Lx&) )m/FGeJq2{UȨ82 `V8`BO~(V+'M|elys.us;[tE>߮I{M\;I -R!(mYM؛oCOwUciH37o+7N}Bgop;s61l!ҵ?@W{giOߞ3OC3^ߡfM~E\X#PhDLq_)"lQoݩ,!&,β_̧dxv>3gWCYfK7S)AlZ#ګ- n sKSmgYT' WuPS U{#紹yR9m|Hsl`uQQ8_Zu6u# [Fy/yl8G!x}Iڊ3{YB~3eIW?'vmZc6gNxF@F/RF*.~?rzYtF\oMԾQlWoZ102y*Swmzl▪e{.7W&lW ;}曾B~<ٿFJT*4Sߘ}1i_8oL?`Z7{.`z<˧~؏kESeBϹ3>믏KVkNƿZV'<^7`Tˑkgp@iRɡ޳n}VNtrﶫ1g_ v>o~:߿c?ӗ~ɡSUECh^gۮ=jur</G~~nρMz@'c;|gP'=7i +7Кs?x6Vn甌Gh/}><[ȀA}_4{ } Ǥ@grr?k՝ZO/^|o; = NTo|qbv{D]k6P7Oy]w{/YL?V6ſl#NrVt- rTk%,h)esk=i.k,o5(˼gݏY&NO?lq ~Nx6 =,yrM{ʽ:ޡ;{#Qo?wMU<\'s`/"V9m ߖ< )U\fYpy'bokrk~n@ ^*J g{Jt)@]˩|rhdWZE/ e\^r^[y=]^iU6u?[x_y{rɞmT{+a:Yi\#߳wp>wywf){,'pIa wM-S$@J@@Pϟ!9Ϲb5Oi/pկ>̿mc]wnޱx;6mO_ҷ{-zo`=?ڴf9^09⾈1U`7`]K3[Y8%1/ISkYm1k:e%Eլ>Z]edV ` Kd$@ ۦk5e|LΞ!Y١Tqط:^=<Ϛ>Jgt^>py{_[8p^z!6|BTo4?rR߮X m>={!ʱG_[|JSdR?rճ$WA}_d{1^e{d_5^8?{D?U_rۢa Nx+P_ͼ9E+{˝n^V󯩙Cɗӫg>t*]R|VzL+?U{X[wz虜~> YnS7V)WJnji^ ŖD)TjL1nZ#Ӫ}1>/ /Gs1iO7.joPZڴH^_NhJMEocO|#wܷgŧ<< ^:VۗrvNuSzUƥg߯zʏ OT*kz/?_:yc4!蓫̂?1Wƍg= }Wae/rEqHwC1oOMܷס_.Wz+$\i}B x(6Zm> z"pcWod5?gt׷w Pnz߭ڋiMI{}+ujቚXE|>VŽժ~M$[ReT->qί1oܴ$SBTn۸ٵF-j_g|{tJX-;/p㨩/||IQ'..$vm=u?#,د'lzn{l3pa 9sz.Mp'YΜy.,:1J6sǞh/5U'u} ]תtm|-ˡtoN$37 {+s XG[L<ǘs~k8&^i\sBv+>xz+XN0ʛ8a/Ԅ4zdp›mbh+M$/~$y'UN_)"lQϙKN;θN ^kA4z!zjTO%Qbwہ: m= #ĢcQ6  7=[.sz6%ZZ͒h='SP36>El1=@o](,3Ncob#Aue\c*9/oƈBAlpd$[^iswR3EϥHa=5mhn]֦ƜۆXe2\$[`|xĹ0#Om$O"^*`fW^RLj"PiMD0:v5b)>>,G ~}z-g"kOz6AY~k[d 9ldjRbS`gg;g^ij)^rSU{&mU~q ժzCXlo0Fd=#ޙj}{v?t66?Aww^6-ZP8=b 8 %ߏքKz q҅]qtL|K׊+FLd`V?qK:csх?ieJ%% |0 &2fF0[" Nf螓ƌ$f:t|Z  BlY /D;PplF2!K$y'-:2"挅o 3U}@ !smo8gtȶWr~#糺Vh](gu*/Xs{#A]gՅs1Xz䴿jI8X סyX# " D`N-A πۙ:~B@D0Pz*3/丸3:Fڀ3z)C q7ZXQ+|Ec̽giH"c|?_CӾSio;Tôh?4,2\\sLֶ6`eE roq>s;;!ЩgCa *k_ZFy_@C *,|yþ"qG&= =ǯgD[lRܢ~; =I{V-wrͽ\pnS^kY)NF^ U[箜v&p9_hWB=ycscҸ{78| |J6ݿmςAޫ8{U6sZշ?xmOM 4=z^y36'ת;&?ś0?:  zIb晳ߒ?#sѩ$}xęei8e,y̩4Ji*dž_ yԒZֆ,i1'!z rՓ] >eR< q]*n?W* =]88U\}Ѿ/G=/cUN%Xu^W޼S>&rl2ۤ8ۢ@R8"o`l5}u<xNWC9/Dn6A # HPo}~̄OK,CL(|>6B:ad-kbr&|W(X#)JB&hXulBDٌP9 'N1\2r_FL}$"}2FeLwEڞ ݻt)@0[>Q5`;oKE#ƱP?zP"J`nV~k[%y~z, 3Fq?Ȓƽ$)8)&~U/.* E[W,CeǗ{ d8E3WIC-s?cwO\1Z9Cn[V^p ^-jcem%+3Q(;pjl`;f%>cfdli/xKO]M+a;>quemς6wGxw׿g}.jAߒa~ oϓ? N9 0'ii\gH 0{e8 W73y2ۼCO$8p>Ub 5_E9<LWEnF: +41sWO![5AxNw#gfK/./′ZHGz}/[toob|c sM |iw(]gϿn|H< բk<}r&Uloy~*d[&icK٣8?Ǿ8wt=îơ_8{w4Z z?]vr u/@o@3t@Oǐ>X'9 mضK)yК#JgЮ&Gb5FB4Z7C!a.s_&{֊Ȧ>!`K(|!uQ}C:ј>2gHJ/bܡK _,7ôD47eg?N6C:E|BPSM@i') KV<|>at=@ٛrY! Pb5Qe`"OLEV/yD&=qb/B: =' xgIL10"N'y?b\}Jgw>9 M?i0(r4O| FcR5G LO{4pmȢ̭1 y9@:Z?u]{>UfMNkzW|)&swӎoo~gl~>_Yrڂι[ ({ӻϊ;s#)^|XZ+ e% Mx:poɆ\nrי .7~[f3& }Uf-Yq%3GRjnށb"PVSgsվ&X,D| "T꺗Atp|de<zGY眘8}_({xmߖ]nxgb^ο?-q90P_/y dRQ2##f,Q,~ ;c]NoF97Y![r_-F[ce^2̽%d/rT*C=ph7 -'wvӁH/A}G98Ⱥd1=TQ1'C#j0y$3f6ѻ"mIGYu X,4EH5`j ! u3iTӀE3̝ 7:@?&@wVԼ7IW9/913em"mD_C\h<4ee?9X@n׆+"!WϹU Y;!2šX5eR9.F#N(1$c-&5/8WJf/ygE.Qmߜ.4u]IZ"s54!{CY(mh#UXd%鎢Dڸt|>yg6iAyH=OT*ՓDG<)0w*syXŖ@{"k3m{nmm[e>P/xv 8P˝'vIqRQ< M@բFH'Ov4b% ;\;{o<rT[:Hk6׺ ,C{LpF/0?Vq85u\PiԽ 2'G}&|\"F{^W;(S_-WgnX%1DڢjR+ j$6bFPyS%m cIYb!e=Z!/Gռ:܋+νӖ 4E0U?7l->J<-{L ?N?Y{rA{=wyWk xqT?q s:3eQd`F4[|RχRv8wG2q>59/ʸԅ]\﯋9 -3qƀ۰B鋪e~n7r~$ګ]$"fأvƩ\>?fe+WWV~@mS["ΫUz㢞V6rr|jNqݵ Gj5m&S}8noƿkdMDVB@Wm-+%}-5:EXz.n9oQ6+\b3\.&;9{+ NwCAs)>W#P)lV&BYrKİXrIu X,c!QS)b_YAP޻fZ:|_ X *R'zo\ܸܓEV9ý޿b 9߲ceK0^z|/pχ\w nb>Jd6Wjh/cc9׀&`{^ /G}Ic/čOO+ʝU*ߦ!>?{h|6 7ft~ߠ8冽6FyZƀ_dƽ^e{~l4s4KYɮOp\,y_j?MY~r1_i=?ۢ~{kSiod[o/_|{wΝ7gw~9gMn[`In2۔c49cU5G|2s./2Ư*r2wmOYQq9n*Ǟ<9׮(m&ЊՅMh+Uc!JHFA\h`6S2V=?eUEsZ휂CiyC_7W7Pߦo5cUn~7jIߕ:2˖6yZb\fZ%j?1K8Pn  y~FW{G\W=G>QO?S.륩Wil+ -ݿoy'ڽq%|rfWMN;PFf6KXUre$0:j{߲jm/57|\dݍyq |V౛z_]2& /ɷ'6QM)OWl?_XK+\qiQ,1z=?b~$NjȽ<.2|'͟SP(ޯO}]ܷס2һ˻8_~`?n 7q=w,@XK[͋N7?4Ṁ-\SU*&-\ 񿺨1ΟZN]wU]o܅j(OmBǻU8˵{?{sm}[wغs |Ͽ]z03gHKwbCL2qYhsɁbCGHfo,uDvZMO8w |ǜ)fO!dM >ʾPƹ~qt))I͆O/(q+x>Tsq0Ͼ5{w:NZǻ˻xo][wfPMn`bƨ~#IFVe¢*;mo:F6řxBېp\[1j/.hoߥk HӳɟʱQ}5TiK@={ܓ/gn7@g9싚df*鴞L鉂^TXAPeeW~PX溵[99.i9,㪝nӟv86{9N{U U~dy{I:da})3}Y<ߡq{yr kYuM͕{h0,zq<ˑYwIתV ]] ^c>ُE?o1 }? @}1NA`[uqfIuhЋSβ9d݃ܟ5ྍ 2=S-6ΦJE3r^rP^:ߛo]7m~wg^}W_{W^{ gpt\Tԑx!o/$f'2p̼4QTS%lf>RERH*GO(Ќq9rW>cg ʹ.Cwȥ=jW^7~5ë_Yr5 |DH7wwywd (7Cg`#r08d;INhg̜nXeu^^,0C[ rO_ߞu:6e/]l \E^ek[K|b7hg9Urrն5SoOx{&9ҏ_-4_pݞ/r׵Myckc=YݬzNC'U>Lv=Pz)@œBAuVSS9wo[Yor OOהqo=)P3fŏ\UQksIp߲~>Kmyg&xbȓxZ{=o:Vwxgx)wҷI葙'L8q`Et'75u61JqOtg σWQyLI` O\\Wn(Sk/uڱ}\bup%\s@'jXAȺki'Emgm h rKno/M{%Yrsڻ3 O+ʛ){=Jѹz?`&n?#?P g~[.SojU|/U8M?M^Uuf宻S,r9{ rsy.G;^x{ 8PDxw*ʽ:ICw^Jit7tZͬMjT=fK{{'Ζi^C{A3'PO??vǞ9rٕs+杼\ߒ=9(Y֟/*ZqTɯ8 P[)zrc_Ɏ~u;_gՋaa]f] oϓ/X膓OaWxG~f@VoBWCpBav[<ǢqSgە@;hOƾihΛ*B6'hXtd/򐬢_)H%"o_ȶ)g[6hT:Rm:Ki x?wy]l '߷p3O1CG-pZ>'@F`Jp~hIz>0h`.'Ne(LLT;Sȉ{ U=w}zP>.7_f)'ʕ -Zw˖.[hy/޽xEKK|7Vd[u1nye8[.|nKo:BճDZ?e_oWkV}[wOvog 罐? e8.=ڙ'/D^`>.Z z`2Wr鯻gUx1 u8W~z]^@uAR-|rz">r"{}𿄗 ^8W"8bj92a+ !|\@ 4z-T=蹔{#ۈC/p?لV=%.arm093/Z5zؒw>sc{l7vHnkOY[[ϻkXU~Jqw/;{o&/2޿~K.Нۤy@ޝ*2'oFUo[+>b̭vO #ުӀ~ߗ#>_."XY={-pYG˽u\ym BJG%fTm 6,f{#OsF̾_%bADXȨPO~ E=_ѡKz.C!p 3&Dڶ[ٗF[(wEW(ϘqEy6OB0cjz#z0and:)jLg!|͉EguYs^VvxciD 9*P*6kb?V-y,-륟w7Yz4ۛٴceK*߯ /,Ί5Ԋg,g[D>5C_2'^7|flrv#^D{GÌ_ _Q}h̋ [?ftl4|<F? #хV14XLO%tP.:\WC6hX*C k)\ :Fω>2ʨJ蹌^=DJGG)E~\,H"$pPѨNBEz* GbЩ( k. 7\.܃O9ڙuOe#51^%6C|'.n" joG O^a$-O) l0a[-I}@z8wSPck3B#Qc65S~K9-\rU߅۬pqpڻ[/Jk}M=껙RU%,ޥ/2Jwe_JPP]}vn?yP2Tg슳wVѰ>JHe2VH!3;בcow;x<{wyW ӺV:;i/܆;N$n|P1dRwD"`(Pг;P77Gsqg Dm!ޅtWIFfύŗ#aOKO](?9 C1zH~'gD ˍ ]ذab"4X%;gtwZA> ͋Ů_h G='O5C?4 0BVxE@(4fW'{Xse /OE8YM%E~ -D\ (=\Iц8׋Q/S4[1z+dz#[ 0t8ܧ0{!X}%x203ΒhG㙅 LpX.AOfK>}YֆPE\X&X)Z)3z!8)2 Bx RY0FC0ix hZCNjP >̓NZq'o7.[p쟟8К3_B|nx$RVIF1 5}1g񎸷= ?hL:uF/'b9D˃!f6/_~3$:jH6Uc;dE s#Nr8M5' <1 /ډ C ҆Ok̿s )..]oǹ$FlfX8?S_v?;TO~Я?W}3ڛ=w^{"߯Lchc}K0G\`^iʀ9䲆ިW$ar5 RrZs x}嚋9i9%/^=qU_7W7Pߦo5cUN;(f3sckw  Ge3 4;:61#ziG^)@B f> 70Rw篧}PRBo$P(B/vwscqh/5x>- v1'xSbn $c\" Ua.˞(5m3?p]gwh0K}}D|f^,8kaF8yY ~ {5gl wkEqq"X.=ͦJ?eg,?XFŸ>0>Eb\ /plWMO)'-!ҎIzϦ7cM%1H""#K. KG Nt1gL{_$tCGDIfjwnO&xUpp#`Mr\JyĜ3xQ9KyT<󅮇d≾TJ- sX*c1/KFFgU˳ϹnVY Cw=!VjN]Pvd1S<SY!L_uȁ'94 PHϒ9?J$gFFUs (Us0-aRvng'\8*3FEyGwÅ3dbA4%ZƯF_Q9Q VTIzSI2Z=A4rQWD5mnw5x]51z2'Vp k/g˯mxW|޸EDRj]\q;c} 3MSi.#q̽|wyw&mAm .u)ߏ #jc Ȝ`e2 V(%!4 L̈_DD"}HzqƁi E'30v'۹4t5tm6Z`oC$poB2p(6Ė'0c|vW7sn>{~g;B\Ϧ`󌜳,')<gaF  hU90rc9ϺL =n\qQ'd28 IKW6Tky[v #=)t{*EW=6kFj YqSǕ=gt#)-,FpF/ A,?eX?5ݼB&X#߁-^ACGow룣scwY'B!RىJ2$y#x) #:Blei&z=lF1#Y[~T}9,yjJGr}i Fn_EW00ȁĝş`ߋ4ADQP঎9 xNC3V8%iBBdş(fsz&s$KÜ4VŖ O szư^ҕ5.N ĪJ^-:?\G@0'G}θP|)g'q[{Zm+kg{4-      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\^_`abcdefghijklmnopqrstuvwxyz{|}~ {/Oݭgx/@Tg򇲼[t9ªryaۂ>G67Eߴ7#z^5!7\0p ִa>F5>WD,_/7o]SEߑ7<_Gon3!N>`mc":3i{pm6)CDt̗PE_*D"G7l0 n6#YN&@|r_`N{.?;_-/<[!{ť~OBQb1h!Ch*F//7_7 G b{_>>6]\}) VQ%+e'嘅?{vk|$D*V$3s ,j1A7ħeْQkYLׄ¼']=qW4$zPɏ5KRޕ[<7n6ShowWtma.d9h{r>נH ~ES\vߖ:RٞS眽qRMj-|"K}f1uυ:v{ )kSWd=#ޙjYݬqQ=JF5Z1gAM 'p9팚0ٛP^E` *eJ, kv7YPE G?}rWVYbn61'|2|}GL/p~/η#7=&ږHbF-T|ٞGY lfuMrp @q_tJlЅ;2̧eZm`'A]*BEp`RgCaoPtk5PCƺL. \})Dkf2n,Yqq ^-Z{'^T˶ܾfhoAu%*Y},W2p_*S}+癇5~+j9{}j˳l1qE8Lcjohao1yɑ [ph0ȜyFfx6[r8]j繝\\cKs3CX_F&\0r}x*3GPW;=r|tn߆ۥiIO/h42 sI^t^# u2|0+`}[7\ hm+zr}.^7jk/jB?ʳ͖:ZI ziTS 4SvU\$4)+bۗS-YO,~M~\C<;{W.x/q .;kѿ9*L2z9;V+91n3IIG r[ˮRc={==k8\cg/y)yw*ʽ:ICw*O=٩~N1k c߱顥50r61wה[¬I;5:p8 ֫˜ ɍ.<]W]mqyToc1}vRWwݿStsżk7xg'Ⱥl?33c%]N_{?7%JK|G7>vթ?I45(ceR6ҕ Y@h#(7VRCs 3LU,~륻M߶‹Gf]dxo$kpI_sb2i`^mraK7qOƳ1du㌧6yVUs_ZLb䵖wdX3Nsl7ro⟸6ex^ƽ~}ޛ@U\٢73+3+kzgMmFiݶvcM` 4%-!1 KHB$4UI*xQ 9gޛS?'Nȸce$.ZWQ'ύ8qqbܼ+vOjߘe֑ƤdThQ!q{320.aS+ Tv~GrDclo?\ӕIl(q~ahu9[݂4B7N*7Rj'x'@z|,`[@[m +;{'}flu8m5Z8yU$rX-O6^ZZӻa톪c_޿K7uN-p'a_W+7^Y`,澺kϰhdjGٯm >y˹X>^!o)6ݪ[8?kg;u:kվ.g+):5uѕ@ ,gbN{ grBWa?s7Ns`oO #W8r|کF`P8cwNDVÁ<5-O~+Epy(oT?,@?2_}5/WQ/]pϡC]9oNU[ߪU'n_xG+/=~f!0"翖kowhV.;T֪rq]u޴ip8՞M.꟱÷\ײ7elcGo;.'dl󭯯kn.`zP^9y] Yj$RH_=Řګy: cӸQzG2L8fв^w bpq b_'M+ l]?+@A;Th{q]5>;䬄9,sۜ@k=Jm|/?^zf?-'W|? Oܡ~?vOse*{ފ)䜷-u9w}:r}v[8ÌKoKw gV0V_w?گ971oiu,o/Gd9);.^o>NY`kW@6_0wųިڍ 3j/B@1Ё ϐ:os}n>E? qDcMONms kS6>+egAWhcc~m7uS7K}˾_{N~yG.97Xm6̿SY#7^+~BaɱlO"jԟ.l|I%J97|9?;x.m7+>;_z{nUq+&=pA{m6οM0wtPLS}l):ΙXtv&Mzw]sCVS(2kw7|V\J;^۵_O_|ckk[koe CW3i4L-c҄S{5d짚_rŎCi <>H7h-f?QD+)I%V}ީcf?9OWpMο, omw?2mm2>[ ȓmKx?8yRroHa:}sρEfjثzN]r]<υj_Ozc/_<)@l埬9c <NfY\gfIǩRU 7I*Yz3XLnb Y9ǣ??ϱw)Wpݿr`p!ߵ vqTzL fO+>9loyzcwWӚI7V_7SwNnŗ7-j_qX [M?-g7\"ГoY{t]O8+3˙́=ث_̎koکln덊Px>뜈T" ӿ`ξo-߂+ #oE{]0)_ui|(ѩ⤣ۭHҞo-ym kgt&<x=dt<]q,Qrc8N?%v弃b1Y7Ϸt eV.Jo8O\'5XpCӦm=ݓu?Э*[#ю5"6=GE@L9_$&N[V,[^\\ʶUU.;"Ox=Rnʺ[ĭp\bxsۙ^epYs>M ZՒ쨳?=Nm5-C7<^{-5 ݦ|W<]]ld,c ;6%4uSGX!xllxE"iG ;c4f8ef/Jb{.wm"q]2A6\b{Qt^ýWLmR/#oȆh_a,Ooq"YrYX cxTڃ\RVȲ\dB#f_+A3#f +:GEyĠq->^Bo7^p=-fV"eUp$3ң8>`jb^/zwW˄c;76Acq<ΛP;J&3R܌9c0wvvwa;,$^BeإПQzsnaws_?ur>]R+>m".4^ YsۧhTd?2;|.~/Ch;a~;{W.={76ЂEQkHP?v8}®w W+ceH>|ҜSOA<6<2\r{ [ʧ{96f!HVK;:0[Z5^Ĝ,`v]؝J,IWDf#2f3}<,t^ U1O"t1fNSӋM3Յҗz=CW˺WsO KC׺:a55`dmBTe.?UyJYVO.?֎<CNp,qWikI%(SE/yw13_`F;PЋxtqrE8,D{hQ%M0zO\D,D1s(fc_'\Y3Tr҄coy鵗*:^v)P]''w$ E]썲K\G*x' w8wsp 0>Mp]o/9}(ZNN/pπi'y9/'kF-#Qj(`…9b3ݬVL ý"@txfp~w pcr'`<>$iGgt^WV챈HĜcp^WTJ`9X %XzP1'<1aQ±otw^VL`#^0=/#ާEHT9l+#x,X.NR!7ut\ә8\*-L6k!sW,D&>ƵA0+Zm Yw/-OXhx|v1jqX!A;p` r šXPc+D|_rgy+Zeu< 3><t]A+ba^2V1`Z/ILEh^+SWs?Rϡvj+綨\UO-{~;Ռ+OEWYCWVth[oj y2Uv79 dvpr:\}Gz9ijW<Mc} ?448tء\\mTR#[8%ѱ o#fsDwe27#lv& ^م?"Be$E0X]ZL'ބ/J=9=lvx@b4FO=|A=E`_5"1$b?==|D4U)tNBʙ0MΨ_Rd)Ȅ"Em& ; _:}Ug =d8- #b1l G7k|Y"A;&^/in^qF)ЁhTBYEf^sނx!@5]s]qHg.Ju]ԕX7`$<=W]`y!| cQЮfRз2Uf YN.>3:M|k¾r[wڋS'{{^u{_$|]g?%˙bp|+%?̮`ˀWvB_[C&fbHf#50o-LB9*4%_ڧX,6X(!U! GTӡ7$"]jw`I0  c"R.s}yeǹ+\J*XQ-4nPSq[/4;4-98@ؗs][랄=e_ؓ~ÍϽk͛p«ͻo]5oWOy~-iAY+ Ǜ y`mW>"T[AզO[|31l4s쳴W/gfw~S&B 3f_o^UZ럟 w=[̅pN5@S_XO32ƗvwrFMqUn`\|JG9$q$IU'o1fr#mDƕKĕEV2*إ,"LGZ*оc<h\,+m&C=އIYؙBo %KDl4!y^H,J kQEՃ3f!0EUE cqB-čfD4vA8qO͋5&}: 1 p<,` WJ_Bmɰ}h|x_1BxZ=3S{pϡC]9/2fږ W[Lߪ'o;6J ]{??*F^qunzr@Z8̖zk;_|^lS!mؓ7UsF|B{svwٷ/U+=Vm/?(Y 瞁k0Q-®(L]L||;1[N.A~a2 9eT8{Ϯa-Edw[< 6E.Z="44ntXC7R1$s>PbWǨcX[՛xb22#D|tUÛ+&ƱQ-xDQvQ4X>MN&_CrR)dڄjl?lYD9B%_`W7*qKRw+a-(g~?e2\j<' NX{b|2emX(IQ}6KٻheU.O<kϼ%d_4Á _[R[}4S,>C? Y<[{?%?vА\vsI-Ǧom@boڴko8mj/k^sݼo·^M9LonݾU@ ewg)[gJ*O=Vn7xE䍩o`IzIYn j^srv@=esw[{L xAQooA_d|i=/s%R:;:,_mr@¢p(bSyTN^$c\bHdw|/Usf6OS ǎfܪӣQUT̉ &^v.MEpȜęƏP ADr=?U:Ou %ž8Kk+ X^iW{(ڗ*FIez$f"0 \9_pq'Y=|tF hYJqE=ĘtĿ@'ͱ ,*ł .< 66޹@`C?3m%rSF~< A?EEQ?I <(qҫ$Ⱥ`A8IM,u: :\ j`]u/{w;0Iҁ ,DUx44|kay6j9/:O1@[h,yJ&V: F܄-j;a0ąF8w8V=B36[)d[K[uYFo]sphh+^ڽ/d瞗_w=޿w|.S?xU ^Y~FKn򙑇cІu'34>s5>B%t]YP/pmwWtTxΰ=;Є t ݩ ?~P96<ߧqE4oڿ@Kv=sTg3.JX+ϊv5)8l6s`k" t7U@ż?8ULո'jS?Ige=;GDc)B-oƄY8T:͋;cq[hltYPJbee/Q{ ?Rg/v>3t6g禳O/1?vp_crzӘN{S5{*Er<xBk*f` s_XGa{of9Vz"k*qQV6WAg%j_qPv±oժOܻbQ Pߦo sW7?φB2TR3YukH3<*dg) hY6nXVQs!|VMzP1:7;E#$?JupO[6o =giD=*!w=\锦},m6k^Xkx૳-ΓSH7k-p1+g/kUU~:)9L6/=f)5?E{_gUg }5 >ܦgݺ}ۦ-۾-m<㍏Xg}Ⴋ1hH?;!-16e& (/$GS6?fic;@zx/0c{;U^e{O9xxȡ^opWpο, oÂD]^v0d?R2XJܸQG!'צY^*zةmWb;ֻ OzϸO{WUߢ'߂.ۉNշnPQWuZOJU\?)yc:#XaXJ?F]xsQ_KnӏØy?>ziA|foԭX \\ k}(sB?4kM}x̒UvMK5+zZ{ a"ڭ3K~>i{VxΈKe{ðsm @PvZv3u,uֹ M66S|&^=|K,T+.u\n83W5ʵ6p:j3/vDM븬9A B;d~?{3#t6MJٴo߷ i"l^/>I./^~Hk)-zoWV~T+f"­mVW~+tJaV'4%ٕ;F`3ԟ6.#=2Z>MK N!w9%L}iy=O>?qcAM7+B?Ӆϧzg7o[YT2n^{'߇ + Ë]ぼ}ZGX8Y u/ܦW(B_ipNϚ:AmucރxN<ףEvn?k@,(Ԣ9!~n__oۅېh*\^1V?8+s皿jEӻښJ;YUo.^74"Mn/I,c/(A=)/{11bf?{ٻWYwo-zA{JM_?^qE\>O#w3U?xgzMr瞡rJ{=M?Z[ҏ[Տn*f[Rk H{W}R+ k+Rň80Q#ZplwKQy*A{NIC6ˮ8;≖'yF;KI̅w4JPǦ:CzNM#:a?q]ţkBe?FAr.UY,]V]2OZs?8vgMOUVSu˥91]d;UwEor m\>z3:ǫ?{hhpC?+ZWhgFYr-qOWK8bOS|[8L6݋w ^Ѩj_2uʁ'VK/?n.*:^}糪Jeǁc$~I+c BKzkq6;ΑW5fs~G{%oH񦽻`\5uoqp-[kJ\Cw߷eW~Z;\?FzǪKt~*G~BcZbK=u9oZZ @׬g xPg5w2.Vqj<}7 /zêxnSmǵ= /)Ϸ᨝jL#v+O?]Û3^IRԨw<h . 7™7:۬ʑY?kN̊[UeUgfoMK+nqҐf~Тe_vO^޷x ^`903oe~Dy~}~e)3Y4 XˠQ-Cf$ i.j93.XU5Pm0>2Vn~K{=}zê`طe'/kZw*?5VyNc2H`Ɵ'BUT ;G6Кᨮ# 5Bz?Κe|P2b\<>jo{O!7\/8? {?Eh[e7h|OUF۵3xa}[7Db ZD"'bDk<Pd E 7bQ66FG(ՃͿf>v,bYys2(tߦXnV͎ 0xyc8'0y6s:ߪibY^g ($tK8C7lqG1S>ɱS4ە]D$F3yy21yB;\y߯eEtsZՒ/.f…w{٫j<~^)^zE˃_[re_+?+*o_ c;@(6%z9BSM&v䮁ѨqP}Neٙ׾UOӒ9;+ Ci_xP#;bE b(+wk1L?1$< םq>={x _-2}+6.O'"3*Y&OqK&?7uto1:P8ɛoXF:pDIqZBϢx*GQoXn(<`ɕ{F1Vj{4PoH$JA_>9=v8c{'߄piHJ{Iq ZCNhD2/~O$#]:/??SN{_m“F{@EԒ W "0o*qH(WD؝~YިPq'@D;o"ϳŎQ]1Ljz#P;eE\Gk\v~;{W5>ڍ 3jo;©/&wgNOU_pY>Eh,ltdM|Jog16< 0C~<'o_O,I<<+؍a`erإtO?EbMQB΄gh=|?Рx0+#]=۳9xzHjҎΰ5ԼΤ|3Y0w}J ܨOO9ZO< ~eX.dVc,Hgaj0}!6uQ *>F5(E o]?av|p~De!lxGf_eބ4SGFMCY~sЍ51Yhd27?>:!'y?:D\" ZS_cc~:ێJSIƘN{S{K-Οʋ/vt+/_0o`߾y?~Qۼ٦c4}ND笲 .:2+x5wuDEe>U8`#GY>|v7cSBh^J…:ƊhO,X c}H.LVt$DcuZcQ"qUg\pX*RT "^A g=,&+8t8T,^ 9' /Juez2dX-uLxNo/T\EL]H>=%6sYb" .=òyh<\ X & !zTE])D<@G3y٤CYtz ͽDT05'ekeWAR]Za $]6cDžā2rNͱBpas6{m"1/YN{\Frһbq(@Fg 98A])l`kkhKb0k4_ODb)qM^VUSb(u9z,_Q>wK/D𱈝ְ}gh~w{3)Y{O9xxȡR:..{&>l($*.ayq<^:?YDk< p P@ed׌O`{.{^w)g{z@2L2}$equ$8C~U~2X>8?`M#+;p_`y?0Fo ݀%@bEće|mW&;auD  O,§Ba0ozh(&yd`!v1g('}3Z=v5|.Cςu:[cmqҮg /lMVI3=\dO[Ut]uu]o\_R.w+w}yΟOG[=:<u3AV T#Ѹ䯪:4U^w=_Msj9RLޟXڻ+[_90Ё}]yM1,HL!IghvzT8$?BrêfB<P965*g΀bT)w8jaQFU1 &$祐] @ [Iށ%](\`_9 [p_5յ8> W|gWFb (VJ{K?;Dq? e2ڏ cH1ߊfS"ԟoQ{cv/}{pkpo/MXz+_^;/*B x{ysq %o_WcfM}f:)O_ƿb)@HDu6Ѩ<;ە.[W֦/NMu? {_9FuXx7Q6h {f/,l8qf-V˵7*Q䢛Dv9UB;g~?{3oԚYvJٴo߷ i"l^r?В]|iFH)AWMgz#gwJ!aPԺv]gybG_Z3 &GfQ{b~'Ftc%AV,XgU |x#C9=s*WiEP*~ p{U_KysX)z㢽 }9AwR)՟bJ?!e;>ݫºXjH²9`;;\-]"QD%DQVH+c0O-+^3j󻸇|^z7ណ(|+ x["#(`%8Y,̾Xӕ9~MgQa\+o,Og=ƞ*O/qP9KEȗ{p7ޤ5?=Φ+tJaQN-iKn+/w-o{{yNME})co3[~د{- 1]lYWp,d#?GPiR_BWvFD$e,{xr_}`;xcߡnVο4`6rtPq|RF`3r84JT#{nf1ffVqx2X> C*b;g]46֪gn#X"=+@1ߒdQR yw'{ }M*ͷqߏ~?덷i^+Q@?϶.\#\U<&YhFػj.Z؛gd!{ôoQ~2ݻ&OxcݔHb?k:+doBT IW .Ov,}Eg 8`Ƈz,fȗFZ:/ w܏UmKOuҙ^{əv_{CY=_x_zR|[| no]Eu-('l'r$)EެPuE-Z 0-37_z{W.:|6,ۻ߷Ǡ=hoݦ/\K^s/@?\\L,.Mlk,(@'B>S>Z,Qi2zQSyoJ?b, #l?4_y8]n+Lf~2Ag~Ѹ@R6TBaᣪjol98u{9/pOha(Evψ3/ ^'B<ޒ`m1_,I=T)q'JoGUvo(~%z|ct^Gj6Mo7ɕ=C吋,z+{5>M*g˞t пw?G}{?zpG}v ٦|e+8'/rEos{B?2_z{ Mp]o/9}_RT 2 @wm27$jTJrUk1ҟ'IZY߆R-HXNDC\"Ybn@"/{7Oha %{)T]KQ>Q?|Vϥl<[R4#}FwXio +7o'0Z5 $>vAG1~L<`[6#[Z 3=7ak(Ga~XÏ쿯 sG; 9҇/%'/boeOYq'YO/oGׯ "|~}^ ߚPizàvu5jN{7ppC?+@X'Q~ S9ߒfYȴCt5UA! 撶=saq0xC-^qq#ルƼjmtߊ{?wWM6R0o.>3xBe;<;{i}.7%g^?ڑ_<7o>W/}/<0k C^͟,j̰n^k{c(cE:%Agܞ5 o9Z P}+e_>Qb0gv#Idhám I@^霫X 9Qo twE>dkg+*4$z0'xqZ)x?Nڿ;G×~ruZmⶊiFGc_޿Kߋno> {R³^J_⪋uÖ/~??ܞ_NWǞo{][Ѩzq˹UUZk~WYHj28 Wux:#P5w<ΪTЌq| MAg̾20 O?k2{3ŢB_{m8jSHSG}ܡig-KaWo; {}k^X}غ쐪Ɵmm>}ֆew˿!ضZOl7DyOl=!Y#mx[6[m!jːolv3g}͇輯\riGOzy/я^ ؗJ%KWE>˓$W`0{}kFg1..qch3uB; 3zê`طe'/kYxu| *kŇɴkWmʧ\L_*j'7_b"y.7x VTNؽCCrٙgU9픗wK.zEwW۲76N;0^w?5P8"5hP$܄'t'ٟ;Sp;xJ_y'jQTexl Wp~]_m|~{Cȋ7=~͟`}Չ/O5 Jh-xJ$'ߒ[R[bۋl yFJEO \?Eh[w M676S|&% Fԏ~p ߽ӵ_rOOTK}{žO?`g2MEoh{qQ^%_KrK5M=%W.aw;fffY̋^6M{ h7o\ӄEߑ745JqjV|tڰ+l L<4SCtRjM:vԒͮ<%OkmQkOh8,ZEZQюOAU%0}+UsK˝F{ SY=oT?z7tz{B''ޞПt>6_?s620l}3|nϭF^YQ>u -^~fmN{y3M niMc}?nY9Ӭo{h`ܵC&<_؆ÛP46wo+gVE߭}amٗ bohaxxNaڷ]?}`?]QU$=z8/ڝ]ҏMP%VFXO+dL9T^ko9{-O6..䲚߯~egy]zg϶K^ШƓnXIJ#wZM]v>~u]2?gUzݤoO'h7-[䣏<#Ϯ[aѵ>^n~쑇W+.i+~Nȱ+;I ф~zIħ5{OS37_z{W. Ak4U$+Z1|  =60Ldkчc1DP&>vBpAk};tF 7=l}ެa ZPi`8wvVvĠG7*s*#uI{ [ÁY(=7\z*Q`{j"82 r:1D ( ^9PȞ)d^³DᡃVhoh2j(dy褿Mo&W> U̳uvǛ^{SJ(q.}fX-]76V9~?꿭bh-y-t{orvZzڝ\eKң@˻?P\ (Tfs2/}9*A{NICzB\33 9ϰ\ :}=;sH6|e3q`k:b\+Ixdpy*!O yf\,;ӗ%b,f슎8M ȂEb\#K@? §X>` ۼ#qt2c,A(֚x" ۳Ʌ]]"JY~WzZ=5=`{LZ^Cì ]5xU-yT0aD#KǕ%lǾ%S>o]ov^HBݴόQ|:`o2QV q&|݃ёo?( +cE(:@/{xo=g _.7-ZmԦ|[8Lζ?wރcߺۯZfΏ{w{|>t޵puٟ^q [{޴w +K Gr 9EY!{;g :*!0,UQܛ(5$KΞӃhTtwrb1G0ED}ݩ[_-#Pw0[n C0O R[97w `㓽=lluJ!h9U5<1t:3W5,u-L,r]@\:%l86g3fR슟- +9ɕ%9vn{B~9ㆮ[g_FM/ j: +/IgƘ_Oע=qi с;`#brVI5ߎ'E5Ax4(;O\LS +*\ )5+Ua0v 8VC)z20.XRx8gRϢTkqR ~{{[[랄=^ﮫog+Y0k|uevc:UcW|߽|4W=e~㥳-9u됛czQic +\nD͜n_dUԨ:A grBWa?s7WP̞joEpN5?< q/\5u}QMlr_OrO;朊 2&Qsuw()dmY<~gG 1m.ۃ\ =m"5XzR"b#'A[)cwp&(_M1v +?H{2fOJ&q, M\}]OaN 3#tWwƐx%gq33E18{ b`T˸BQՋ'u@6y<V:w .2xO$ؘIc7 q{genϰfY&έJDgsnsWN۸qix[ƻ]{Uߕ{/6Ī_dg B_V~2:~ǡ]BYwd/Uwz5wlsWl?яfry6odOe:"Qc~XˊY\yYFӜ,Z5o CU%Rbl,9ҮSCnS`]TTXK~ޡ!*gٙg%.aJ2&EGι޴ip8ժ=j0{cOUGkվ*[nȳ{~Yᣟ_y/޳R;C#&g[=0+m9^x<O8\3JޫJK3#u-Etr{kOh4'd9>PmAb@t&9,OϞ4EA5N.qY5p> biP|8\d$z$rl В+÷Xuq},xo qEG#"{"I&/j a{ 9z01a\#=}*r IfySO?]--- 7[ +쁧Y1R~E1\ 4G?>E< O"%.".x)2!m3{\qg">W( ) H2+8WlB1_'AߒT;yl\^ִnXx0CIa4 ClM?D v1 ;}'!Ű%|g(9QETTc 8;rs%7Su'$&Tnb0@P.COL|**.PwA_գs'?B;GQNJqȝ$zEOy7#\mĈtV g weYtp8˙>?!ܻzGqpI2vf b,9C"?a|00[܏J05@ ')o#>kvg#L)h,|g^DQ H^ӸGtd+Da*eT?B>6'sá'mM-~E8Rn]BʔS+o]z~eSsV.]ؽ<[GVZȆJn80xǺwڍ\Q)PԽ\zZ /EױR92/cz$')5꺃z]Ik4&#`n6+9}z[L2ϣjrRhX?Hީ7JTοA?[h$bL`"v  dof F$o *B%C[A:3>LXGC] pX6c_r  `lA?+걝KZ@0rE$,oDi5?EO-Xe0RE z'%BASDz 1,Q 0ΒRסѨG;ڧnKW@gPR&BeKoq> 7н5G^h@>a,A1Q%:4&=UOjۭuXm ?fm\kR9`xnʶXguMMn<0{Yi%_?W.ҪS/bW,jwi kˑvx.G9qeWru2ٴW_Mb‚OlCaG| CpW"x\Tg3uU("z,;^#o&'g<}ZOY_WwS׮Pߠosڪ_>4]?L9)>Et7p#[!ȝg7#,%jrJEm44r뜿M1UճG`F(k|a`vzFxm}EE7#/xRrTc>KǣEU=^+BkQ|}%CqЋ]"ƻ?BKOE(WєpU"ELLI辀dL #0P GiG՜VC6/ <Ҏ;PVF)2WFJ}fqF# m5SiI,9J{f}xŎl^QC_GU&{ϻm|kZ_,t4Sp[pmt+=v{uZCƾ8^FHkMG:_㺧^{{Ǒ]{:Z\^{?4+SFyDf]z ?pe.*^GG:K:b^Q_'Y_K3V=&:)NK^L 701ύ>=!p`#k""Ɠ*^J cIgīSz% `vKԸ?7Z($v]t#TMZ|{QK86z*xl)e³GU{.5>D$'w( 5|ݡ}1hlVFOF=e\q-\RcS׮raQ DvzK-uau/5!Sޮv5oU`Sڷ6VREgR;Sf˹\WϼǷ«.d}Y1z`oR83,?o?~§>1|O岈:mSi&q%3/걽a@xi$YF>.Zk{=i~;ssw޻]u1؁~y,.KzJؐ1?_*oW[K޾ f%'\\kWe=J"W.}q 浽Ԉ3nǦwIKzwS2ɳ2qO/֍ߪk-# Dβ#X~J->ȣ=E;͖*rTq`h)JƷŰ;lຣao8mл&w7^KGd #c;P"s{t)L17U @6#>9T Ee\C{F֩~rn52oRʨ,>VmU WkݷcV_}4jzkj?[Lz5.yn</1, 6)V:ʝ|;o9>KfȾ?a8+1Ǵ>*TΕ];͖rޑWmCcLx697hяc{ae?{ı7sC單NE7=N_4GQ9qYMǎUU.gɊ.fV˽SG&(?q'}><4_x:+K[3 i^;ڴ-UHW*RVt] p~:Bnᨾ/'=_wBYC_ty^Pb Bcܿ-},3MigôӼr&i-&#iO;nZcФߗGuRWs/~>T ,/BP=aXi Rl5CW\96T\⼞34ի-Ǖ[r~fKsʏc|V/'h߷Gީޠ/\Nm-@ǹO=5"o?nG{u,?G0Xf|#vewlQ?U]3RU@9Cy5ՏO-bAI!İ+t|.vq >D+q/lpnǍiԠ[)bic/3ُw{#q 9Z?ˉfow*s:IIwC55Ƣu|FSE3jΌݬjl|%Ոۇ}]^]Eh=;:[wuC4-leT.i厗=I?c}7}s.pE'=x]x ֬\Ъ{֬wM҇_/Ϟ5eEvq1ٸB6W;l9`_X,ފ+ʦ-Ƈ`oO;/X儳_=]=&8)#Hg2ۯ?j~#Mo34lcyiM}: Zʮ;͙:}P14au˞3_c֙}nӛ̳[\G6ohͿ|7^~O{5TJLj!f<)ZdY 5{ k^2b9~k/q q-Dk4ZqS -WHsڢ]oEQt-*qck,&eS {x$8WGo4:]÷tuNQǩ=C<;:8?֊Ӌ򏑻i /WѨ7s;J{\c8ْȳCwj3A+?/hƧf?Z<s_c誨rM>o)*:Eq7sc%*\>fs}<6h^Mϵqu?:+Qr|Mv˥VU5TO=5r)LLQG@*J6ID ҍv2>SUȱ?.p׏r/֪;8pe.AVdq@tCպ/Gf0eTw rQcz1 ;(YnUQVq500O6<c/Jro輒Q4X9wlߗ^bS2h08?[;T/osFϻ[ܞgm-evr=2=T 2;(~ּuqh+1[W1P(*1F)k.P6~>WԨB mcZGG}9AKY75[;)NI6Ӹ^C2`J{+=I;{hTA_Wz|[8`ҏ:ROުWص {F]ut%hz_x17n{AwŢAT>rٍs8)0Ϗ~ gKa kU1#_xiӦxJ`:}BzR\zMo=}W`ف|u?^.,3;-^"H̟"*0<ջ*=D[h}`eUpՠEyNAeea4>c9VND__*@-5ȭuzGSVr ߢ?qȟs7z|=ܞ7(82޾O{ҋGݛ=D÷xВDŽ=v@b-W%?|N ١\W.yX_§^:{qoaXG7i]=ɃTЏ~JZd0-_c(GW<7J _ݛ+/W<݋åmK=ީIjNڶ0>lyswOd)q>wmye4)R =|hcbKluf gOSL~v㊕?ez_ 91O6S 4KZP+~ѷ\naNݝmolh`KǢm[/9`13fg!ϩL>]WsQ 3#E.އ>Z`#50Gog<meo6BWZ~ kʦ%ϟI.1)>s+9JH%t%cLY2>/D6ֲ(|{2 xG0 -"r x 8\%΢u&7^6_ChwjDE#I)2hs_~]=-Qk >`Zh\#rt>?\ OB2K4g0Ý;O3aÿ/?׉+B>SZgGA+gjZ/fP'+}A">d4˥eFxJo%LqqμRsys,sX]wϗu䳌zxgohkO2]֬= NXeSdЬGtre~YE1/W x=XW$\'܃]tӳœ8>}uKy-,Oʧt6Ʈ8kηwoh6CAȔAx'z(N{|v{Ȣ%xTZr??㱫?:;Be+ܮk}a@C@hA7n@ȓ"`RL ]V_k8%<,NtIP%\ B Pn"3#g0&YxzqP9sJ"WՇϝN]Z_ӓeУr+{–h%yO$2G&_1DpX|Fx8Ng_yzOa%ߟ81Δ LFqV$0t=I8$c9LYNjOO\gql9w5Lba(,)5p`l`^1DeGOPF=P,B^ma>j{lOO7lM?ҿw(cJgs?S˧B.ƒR'beM n2ދ\ԥ1Ѿs(,)A0l8ozYjĉp `av@U?}>w(R hvGc`@Z=PpQ;^S[y@ndz#F1?-riH? |@x-ipp)Ž18E'hMpiRka>C+:I5ad*ĐL2\֑HDp+?/$O&*\k`1i}<Fg'L: @p)hd:R;N6iYIGI59zfW'Mi_ l,_H8A|Zׄ Q G872!5 1|~Rqo1U*v: D4|n ynO9,EjBƔAu ,_9<'PnJ)@%kwы=ggQ6?oxl$O,:>ϬX8s?GnٰdӆɳM_|Ks޵i&U:k{X6IqjoOrq/(:T3*?[ 0O7g~toJ#=Xr a>N:鶞o/wi$MS^ψhgH5L *=*/.=ѨNCNt5""/Xk<^ V9g_Y-\ZM3b7ۨ Ka65X0`0$B҆0__`[Z^Kndgmu#=;Ax佀h~4crgM>&<c<O>F#" (7 \4iԨpuȕuD0yy1AB0Zu#NI |gSH\Z_)|Ʋأ9 * x6|<3xΤ3 i5a`? ?̕Īv&my%xMooX}sɿўI>cQƺv:5R:ΊRuƞ./L1IK}-/vUw}ݭԫVG}seǁj6r%ew۝g a/̡fT3mu45}4bJ 5ch_Nk;hF߬D`»gM; 0)`ܾ 'а8%ͳtRcڙL a1`I%m ] {jd3&ę'8};qE)h!RsB-'$:.!ʜs4@͕~{`~@ S],@uakyb:~6+ڄ Gsx<8;è;1gz|0̯\еmAZk-{)x7|G^O$ *cgS0?b-07??!l7Ъ"b/ŷwjZS#0gC`ltGc~^ϱ{9&b+PHQr]w^ەziK|ol.Sϩ//5}xS{x}W9Jl]oDzSr[ky__R{=~bފ=v>^]Gީޠ/\Nm-@ǹєS0f;ЏމuM8#(uDҕg&b:a8XNdnxlr<` Qg$]3_L,i9=L bw>pq~:AQ2LWF/3?a$+^hvx bF0."`/7pXy2mԮW;WL46^=5Ec#AaG+-E?!x/TUo10 D`9=ijx_q:Y Bn'J}7@*trrȶ; iZnKI00g}\i\gZ^U/2Gn %!f@\)@z5{:D\kv\YK񎮮9ƖjG{V8+r}jq{\\W_WoX1wǶfK5{Ti7ڷspz BƲ=GM-GtV}Xw֠:ީ]߬P_MTS|5k5Q[dz}A l 4t 3d@PDө Hkۭ u?jh)U0SK6.qG: .%mΙ'*LN8FTID^ğ Cm cלn^O-8;@$F{1]1I}Ia(=$ YZ_+ C!IJ?>7ԸOк oƍ $\vy0GSs]H.Mt:p%=Iip8`k9 R<ݙ5WP Ppŧ-y^n|e? 6y= =Ma4 =rڗ-pu`BpYпfCfQ9T̼YC}%xO:ľ|xV]AC$Ē+R`_IGM~us^WW_x;qhVg1w<l?:O{R!V^V-?uM֮Swx`%_Osx+UO M8oƑ( Pǥ2a舑x"*{%bkk?Z6%`r?-c/-Вگ{ً;E]evv#t>hϵc{u{vG_±qSƎ?&οn`}.@sZcVM+kU+x?kyYK5%NSn"cO>9SQB&ƄSg|S )NR "(`ix-ūiX'Ck^Joq&Tn.id׆!m`+{"޲}Vb~ov@ZE-'M\E1 U!SmC݌ MOݩk?㼊+#P~\jU=/y<0TwttܚnrE}7i?b7N*gV]ם+`k|ʰKl^`s˗ XЫI-Ǡ?Mf{Xl2Y٫qXԇ0AX)xT^+QN/Z;O\ڇvz*gjxD|9ͣy<ۺ:~_w7ݝ⼣]tT lGy0plkWq]:9\\owc؏Oj? _I۷siAYMà11?'6S7cb1I&c7d [{{$r{wgKoڮb5i3N7Dt呴Y(گ?p]w>&a /@~|CGӢWFv.|TV䳪=nOvBPU7h/Ze>λgwI-=ϕ{!r[۽5"Os}[Z,mx\#C^8v[;L8ed^Ux-t?<2z?If,:jQ,0UN2_SO?M .N^'kT{O~҄y-zO6?g!UV)<3gws:M{Su'=ũY[pl=<迫Psg{͟d?/8yIUf>6_zlE_m1e rn)gf{c.K=5Vn=A={f:pͽpǻoݷzhn/'.op;|};|}od?q@߃{mwl? ~Ŋ554J #KN ם ÃfilUGۏb>V6b/NSJr ߂?Os𿕽?;\-'@u:ځzW CM[GGKPs'L62H~7M߰kV}l+OYdc?~֑nz-rɫw~ǝg\^ U|9/)ꢈmáA O} [_/|^q9[㭢WfpϾòo.h6qw{].;ͦ2,9;;><󭽗﹡G^ }C.ftwޅ_ zsV߁o`#Yr _wWw?0ׅX. w↉֭{YfS͟}TܿFnjzvߠZ[`0pX1#l-mU-ke̢jU{Z_,T$  c:6Z@ӵs)rg#4+vs/=cOr?T`w~{`Eݑ[Z]u-u|QV2 <9g)<8Lb{CMQks0)  Tx QIh|dTR=fx[7*Y=Z_gOeGw|_^1+Xj5b|\AN\+uݑ1ۤϯnx>Ão]͑w0 tK@7O~.\UwҒjCߙޑ~L|8/PRsr~G6Pw<S^(l)Ij_]hHy}'V+yEoX|lУYI;ktg5.tT0pI9K圌U.(VOgR K&3>k2>OrʪɆsE۔v5y]5-[L)+X D|JZ[j$h_ak7;[:v^}<}5\p+\;o<so@{^s}/tn:w8x=r^uke3w`S&=ZgN aVhsO7sBE^L?u#>z;4a㵛Po9e'lkm8<J>=}<|lFV)Y|Åܧc򱏿 W0Kp[:{0. =:@'ަ'}QP8` 3wg̐Q9?ؓrb޷<ZazȰ ݷ%-;]_?S 9E/ *: P֢E%S-f\X#(XP']W744D$h}z%GDEϿGpJOi3Ns%vu@?Ãyп_yzwV}MͽW9<{އ 7XZϊ7Y>r5v-@%}G~x+bl jdgȜ⩾t\2)$tA++Db[Ѯϛ8mNq87E5O[kkB ݥk]6TAb/?T*[t鑡!ݵ,G5UԱf۸ڣ)4Y۷J$<gM6+VfYST5FZBK ? XiʪƏ>k}|Ͳ{hXVf^N>zO;[*l ?N _%7^'"mO9ǏWR^L'ωcw!6uF2PdU%S\jUm`yNPnz;(EF1i zz^ʻzc)|}DIljr7|!W5Z9Go1^ңԧ;oߞ#ߌmnT E@(I>.?\YS,{CaDe=Opxz((D-h?{ı7sC單NxoW2 o Mز_&eaP\tث^E[Vֵ_c[;fZP+a5^~w G۽>~]_c+*ٴʛUfپ]eUFt? [1_XeŻ XqPbc)߼^Ǚr7^-b)rؼ9icbv-Vb^N7ts̏`Q+L~O*Ԓl\RA֘ȗ |oO`_VXU99*Ww0jӴq +^?|=]>p=|ߞx "w"u Z_޷]ϼ/zzVm"sGUۣͻH!xzxS% 1߇dZc?tQ7&lv2zf_'FXQ52';)/H/9R)&E/&qwbظNZ՗>Mmm2ZŞ'|{26mUoېM>#GӾV0;)N2/Mz<?{ćB`Ftn7d_Ao> E)ԿN&1࿺.̒qN/p =`Ky{Rڏ? 5t<_yEZ}%82>/k%BQ]Ft BhJ‰Wd,f? `1A~O0ȫ?qИ,J< l>rz݁oB׳J:PaC X4PBX[0` -\1].焂xLM&<5GR鯚+zN6  9 cbh׿6 3'S86oZ>ODt*'q;"9p/4f4ry&pQk880+fY26]*F־.Ì$U_ οR/=m6؏][ꢋƙ'~/fX 8+'Jyw˸zJϫokEؗXђ_Ԉt{vVo;۾;[~ec":y eyޞ;{[WK_m]r W[q!vZO=m;wNYZwGonץ}0=[[;ǚ{<~{SH_sEU6MJ_h 6gdߏ8! 4۳AD>Ͽ\:ɊNj@? 墑NH`/1ˡ%|.XӐ NFhdp) &Ճ%'^P*``IO=i"6zq;܉Bh-\q'рĢ/`Ba8ٓ"820|s#_+~V^q`pAfx8+Bb44`22@U 19 |8|? s̃&O:]X6"&nj*O M|8t\p@s&68L+WYu 8'a"?1yIX: aF_8*^o:x"x*V;nJCtp(hn7y (8վ 5 S*<]zVTl8>= <޾vg'S<#%y`G}l檹 r 5AC5oe^~}4a{GRowc؏Oj? _ O{ X ҳi>Z`v^G?@0ދHI9i?C(X̃C@AR+Oz=`IPw_0$,3Ų683b,{=<-IL>3I- "O"q[(p>$,LWvEdZ^@$yL{ +e-'N=i2_Idk1> zT>-9En..%$bWևg5JAp=L`C3Ai* MzJ+"!oMKV-cݢ8323 5cz :9c:QsڙgjF`>}sOM>#?[pݣtwNqxAVϪ<:a^W%ws|WA8y0kiù <#A@`V}bkqAkAf(@z .+ /%ЎCs1@3fQS5qx*yq}f?n[pw KWs@@RZQ}pXʲxl. I<'MyDO83O{2͡` <"Qxc]bMWo{?(ZH } 4m Qh=M<у}yDNiO|S8,W 2(>rÞJPdVC dsY}=N>IhL|$910'=ƻT+ٌ^wuUM]@=9o<5w Sͯ.X8Sx׼90;~9W5w}`k̂T9XxJGmVl\WcѪwS23rmKW'L=>wi{ek-SIcH6]1XU}-2Ĺx?Q(4wBEDץ`w߀(gV>W.J,dF&UQ6$]lyڐ!<9<1n8c܊'`FP.=u ɓ΄g`Zi8t_K o 0q>@b\)}L%fX=|{ddZrSGj%U8S}). 6 ~_MH SBZ(ifԏ}Ć(o"?߉||9<:<' 3)/hX!œ&XJ%5KI lfO]Oƿυ;@lCFNԷa1'`v|p2pI| LN7ZMmoo>V{\K9z6z;vPf_˦>'U8lկqxُrvm>Q}^WwS׮Pߠos6H?bly몜y@s1lVE<:u1]y\Y'fׂQد}J4ϕsYgG<8tD:M:.to͞j (d8Sp-B8 =Vb1:|E"/ye P!sӮ<-6FcGǍ>/ 1y~.m >xda_lbq$k7Ikϋ Շ jZ5WZ]Ìf-/S3<$S¥~?eac$2;D^*)ᔇ/l1ru fN򸱔{Ɓ["l֜Wu/(sޗ枷{TmYS;ohDdTr|JgDY!  ˦n ?&O,iZYHޓN-Qγp( e9y$C2J> QGiAۨqr+w)(yH]>PMBv}t.Gרr WE0=^\12%&Hp/G ֔BQĵ-2.F&0> }\w%h~HTw{om3Ꜩl^8R/w. ;#=z?<.foSs؏QEhq|PDZ8)NsnrZ.5Tsbc8#v [Jma6`;Z"G}W|E` #pH3MH8qTJD<m"J;|=\@`!ylY1MfI@vN>e>z]yv>n3pDf=_Gs{Ac6@ {}bFq71K̞w(8G׬C ;rA:mT(&cTvϓ\795Qz#׷kxV3^E{%XconzMxZco\5+2g-ü$oao~N]kIIyZ_y~ 8) <+[k m*u#j? %9o0OQ\O֢Pj-mxiE ?Ey<w Qg-Ta,ҞbP6U+j Z!MZb%]W/ǧ =dlzts84;Du} +[}ȶw҃a"(Sh4^ST?mViG?A6votFbK*zsGglݶomސG^Q۶_ضޏj߱۷K{]}ǶSsu۷kdbX-O1ock۩_>K1ۿ٘>qz{?έ=:۱mWvYU}/Ճwu4[s{έZտjY5?Z{O5mOWV<׮ث =O+J?z{kYo?WGcU_:{q#fSm7ž-mmNqʸ7E5O[a_q`]<&NaْyOjiUn9'އ{޿=}of~}>Όc3{8:{?~xş|.?şYKYp~uO7:^_e _5p_~ʇqAk$r~ƧM_tgg#򹛿_7[_p[n~ P3B]z7tN_goz׷Niϝ2继>wϘ (s?cϜ`3^?|y"_(_U(ڽY_O//:?./Koז(Xz巡t']5W}gOσ']u\w>ج;]7ʪ|W_57~u/;p.c]Ѝn=z%kn ?xAw^ 9w]Kٻ*/=#&PQT@Q ĮhEA {A{JLbiVX?swkKg>ܾݽ{~w ebKc pD;ȥcCܳib '9>m/Nq.q`VZ~h'rCHU^G\q,ʗt^stCk=j'7.:~nG}߉MG/.ǽ zq_=$; +퍼IW%\thM5IW'Z|tH0&^xd艇~8*̓#SO?)Ԗo7݀vOmtm{OHzt̽ޝ?Y#oƠtt{1cxES? -E=BilE%J@ImԧEm V ,A}[il@k>4IP"t>|hCvX:!f:CFE0[1jn+FuI1]V,A_=rx Y}ä^k[fk ~r 7La5X6Ni mgrÔg <-9hlaݱ@1k@s=hA÷[NI2ˢK==60qH3KSY{qޠ}K3B:YΌ 9˃dCrE\K<(G"G ~|eΑ'W5W~ت'^? 7N%y㻵?OgaC~/g$F6ua;鷓w~a_B *2?5~RK; 3bv;i%;?w+-/pIIZ5vI}N+Lǻ\D~^_55$<0&:Hgգߩ}6 W4kz7Mvn;>3VﻘCz?)^>s33| tp<>!۩1.zunW] .({5:[}i-/jhuHߖ`o@#v`\6&h6m(v`|` tDw!]De>ʑȮk,A5b%*;K[w@Hz~O F;X:ijoз N֙or4G=i탾{@Pҳ 軜a ezH(@:ꀻ~;p x^}nz;9v?Xs,^/{-w){|# :N=8sBv B y*N8t(s*lS:htVw?9! ](?;쿂W&9N_uKX6F>Vͽ,zX4iطu 0ضrW/i%'`nM+Po~0C; Ń:,b=~V=gEpa05pxVaG u5QVYfgle!#-VZ=GXv=Wezq9f夾ދ@nb.@}"6NMrc;Hp("q𮹃w省 e)O=9o8"Ѡs6>豮#Ǹ?rsB܂aA/~ģ`ż;Fz"t.`Olv!31B0`?gWpG*EϬv"/_vim] ?sX6xlyi_&m~;$n=6_~3%BFl0Al cR3|?`)}py)dGtbEϋ~\8`cn/Q _j1Trz=}`n [~a3w.m#{aj]ivr4[ p;y)qܳe‰AK`Q8[ :G[/CE)phEڕKU^ke"?+J&fT 7n8MxիB[F֫kOЮP+W Z2i﹩cޞިh?ŧ[~b:pǣ[11;plFRiـV_>}m0gN5dlg3;|eF/'6`fdg%'~>ˬL;5Yб{]|5sө_wnnoy?^]?wl6hɤ-fYr+c'oXݫW7K&ν[϶i?׶m;mɨ{рI'{(`Rb90XдCဩ,hc3,(BIu2ܑ$E)2l| ZHX|f E)a ׻@9 \7Q Mq`G6_J"VDA^؊}.䝾,`OJPX r9n1wiz,C@$E>W];ڿz82`x p|e0(yG"&yB|^?x ׂU| $Lu76* Q_wi幭퇫Ҋh̟K0ow2-2sryNBzfN6ZbSҫ2=lX_˻,藼t%MMJ!┕z\E/\-Oɖ#u1?w |4?;yB4o0Y>[)[ܳM4{ B}`Ϲgc܃v?ɭm9X~1훰̌XM ּjw/;wm,,?ͪ6|vEYVƨ?={i}?e YhM:g{wpHg߿ mNC>+;PgyNPFt;>7"tL,|zsq@>qoz ?^0P?,tfFAn[8Y]@]m3(y)Or:U$S:8p z7a?ljqYMo{8(=-NJO[!@ҧ;p]Nh+k.\|iܳs #߮_xX6jъ{޲$[Y6-qOjq\ŽL|{nbݚ{qijkq~[s>] N}7ÊFvǻ<.ad5 Gwcq0Aq}Amg9ϲ G;#&G\z@1}&3`Z U!{ ?d!qsw2f`{L=K1i;{ 8xǮg '`/ھt/zA.&,tG9:6*δ:6c& |+Ʈ]δjMh?[qgE>9yK/سk6xض_` 7u{,nMi]hMac{tgQC{8=ǁZ>iP˳C 0 ?#Hijgnfdɘ޾Ygql?8tR?П`C'`f} 9*}M&(7M#N?wfi$n vPeG?wp9su`?}.61mhy]FsL?i%̟NMg};afW2Ԭ%{op!"? gW,M ޗtk=hef:%_G`mۘS;3h>[0{@+pꃋw;AiDӇf-#se,#Gy1` k6ʚklZcrE"{`oqw96Xt' zg)@r-cUhVl3mfa 8 #F0v w>&v=N燂k,9dpr!`8`>/pt[2urx  B_ ?<x;p rG.w$ PFԠY,~_)ϒr]zYܦ|fwуDaVLWyF @:*@jla 2ɃIw)@?A =.Z?—Y??z|%\q ?]̆%-@*mwv 2qX)C +'|Fomu?A5|\]զ5e |3?Ccot6ߞѹdqh;Zr2Cǫ^8ɲLxgW֎I~öl붸GƔ?uwˈ=%/hh|$_Β!]Ycz\hE؞N+pDKGYr~gzzi 6Xgut!qRm3m '[KP|οZix+Z ?#?6O2,Ι`.g%gL~v녍H{63-zob%X2H߽$ub{<]"\O./'~!u}"$S3[l/)D{) xH{df+Np貁HЎ@/.)H̨_k9SIsK"^AQ8f2hWj`NjiidGe'lU洈bUy>rkFnf;wy΍]͛M|-o |ݚzU< kcOK^-Y6G/MK}[,m߻%H^-5m,6``?6ALA,vZ6S ӥC; ÿ 4]>CĨ.ˆuX> ؗ6,NM֫'X9.r 5z/#tLXlœ)Mc]pTm_8c90iOL!ˉI_a/ 9߭uXJ :/ ࣐O,@d__ ȟt?F1_?i_tgpz-U3k~e)@RB?/%]܊^B < 8q'bPF矕SG%3'JN OLb&S_"`  hʫ*WNíMUKPka<_]T}TKvH b;2XmZZd /%.X k_5?)D' w+~X[6pz{YejA,Q}5m+Ӂr@K$4Wq 8Ztگ n [./} 0IX9գ ٨ -v@ǽ_[;Vɪ/ Q #J}ۣ+>q(d&H(a=f XMngW00;Өtw=iownnh[\Z]g][>ݙm> BFM>rnSw~ŭ ţ'fwD^q~)w匮ͦtfe-/hت(Ws/{5׋{612!}[i:Zl[ cl@%6-@0Pj>4Iڇ|0HSG5 .3%e; E gp<\:dȮ+-%teAv=&\=G8֫[_==J1vdeo vr 3?]lg,毒rUǸu!O!xϱ'\<|NjG} ~Q+Wx )?H{U_-ޤ'UOJў_9`1_'{P7gY'B> E!毆$nWPOa?F^: 3+$y&/(E Ч]8\Jܴtْ.]55ES^&Yz嬤˩*xlX]=(ɗ5oPʒ@+Z[ 7utOlG0ᚺߠ+0.QP3TWnڗ >,|e[Q!",/ ]zxA;(#bd?F3Z[oQ$\ݨMK PVЂ\2Iug64#!kGf"7==2_S[FZ٨C} TIƵ-7V쉊ucJ"zz!4::l?yЛE͒.68! 1 +ˆ\C[ JsT[/ؗنգ7 dГ ɰ}},]34FGG[Z.Z}2~Il:doo=ZnX]}zޚpQ߼j75o9|?2Jm(p\ޙ}vɻ2ԣGȫgf e؋#mطK-H|haܵkS }-Zb JPϯX}?PzB@g.H{}:ۄh /6hp;ALvFa@+G#Gv-d9;߰fkve Y PvV+X_o=`-7ÿ*l `W\ SUw,*LXl/. v⵵VBO ֦ .SR,5a SŞCkth# s.pbl|CO*ϧg./]U'ɒuG`Zp rer7xq@}'V ,*yT(+æp6l &_@cQ1x p\0g?p=6wv@h!ɒBzwEݹ;CW[%P_%%O{zڇl`Ɩ3x/q;xgNAwis7:67 囀ڼsw盼 ޅA}>qi`0e}:\.M;|F_zvlD -0ǻ[Vg [| {5 ({5O~mػE}Z dX6h`A lâ(ڏ؎û%rX5cF0[m-|dgU\ʱ]LX= J1??ʉV`I@O;g`)0 g%:# ? ` x }gO>ϒD ?2C#2 Pr1Wß@2L޾rif/IR+9j{^?$Pĕ܃aW/ kE@,` _oMXPh/ߖN.{3e6nR[Q>|\ϟr>o/E_J?oq>|V?R(9^S4必R_eD4"eĢt(Ge.73JFZ1R18Eo#yT6~=Ģ%E;c"7s.ᎈՍt6B[1U;3 hd~/)r)BX]lDsai &@24l=,ơpX_}y AMv~o5/ 0itP|X~#)ZNw,0ab@E xd7j,cU4W|n0x{UgO\a~iV+`h\Cxd~zJ#PQ=RTb`dh@:9a,%%E!>!?G0%2!0|º:0o`{^QncI ?KBq!4f/w6? =祧Vp++W֭~>^Vs#z O}|~0k_!8ce`ғ1:۳oμo/mޝcTߵ{t\&c]!k[A)niSZp7ntD_S`~p@ WUS`_ڻH@5^C|KlZ`cp"{ؠ!*"~H.c ?bXZ X9 hsQ _5*zh5j- SY7'@}0{"T rdkvV*? C! wY@yҜAW '?g|/]e+lU. ۼ*%)ZLOK"?.}YKy`>FAΡg\.ه+G~b %?XXŜP-ǹ/@wJ;n'nݷScJ'ZB۩{§_8, l{ejk++?KϾB<rkMW;!ӎVWC%N:2,TXa`H`y |HC@Zk`H4`ȭü;ut j-gUF.!$lcI#q[XZW|rР;!Ft b=*G0CpG&2 *6t_gm/?Wxb)Џ`WD<"}ϕ?`Sz{9_hPɥ Rb?>R w_=awJ˘gW#;FvT'#~P}6IgO|4thcںu}ޱ b˘Ks" i^Ḱ7 P/?JGw(_tXZ`y;TFx7r_OOyԪ#F-G*J\j?]I1Fo (n}O{|2#6S>m ?s7l$ϰo4cI?9sөչt&A-F:5qj436hZf307kbeٖ̱s{k5r92q t^A:no{7vt {6<.iak :\um9k ޿ϐ:.j33/tgpՋAΗTXß GZ,KF ?=\2Wެ+tR6&ImQN:_0 ' :YN%șÖ54dJObHGDNjְqĪYi9# L=2ilԼ1z7_7o \mtnu-^/%yNa4{v$=:pEbl,Ae"0ؐy{;ń̋tJq.P'>len{B~`{\ہV{_`okJk}t=Ъգk<{x>Nu~Xyb߱&OlOwfkO}{Љ۰ 3a[ෛOo_3Kǘ<& !6W'J:|8*(iփqbc'6^vbcʑ'7{ `O;!S[~ԖgeޔԖvdޔvgwf*ʫb.7㮞va7HЯ yy)C 7SIXKB$+ _i/)赭#9 3jk?-KIzU31YR v\>oW3ei#I?xhnW\Or۰!E64eK1ߞar6aݻp ~BnP󤰗6V[G]@0 Aq"^΢Yr K]`DJ"iP9dLQTؒoJq;Hv}Pi2qZBk3pcz`0ťC%emg2i/W0_ > [)^ϐ?]TE o@<%<ϿGk=^=>(恞#8Pz|WX!a% 1{`j}í:@W*M--`6zrp%Ezuqw0t|g}\yp'dfN?@)3fv:$d~3/_rBvr~NƵě|}UԱ~3fZ/y榒J{"_s*KoJڗ돤KnvFvMf*7rx{ns3naqfXS v?O|v5߮Wun5K9/_r̤s3~IGƋb4jҞ {vb}Xgs5oeD>s-'g]lZnb?+s%տ~o$og?_K_˸vj5Kځriש`r9$+irD/'Rdq93Z^\)/r*̫yy)y?]OКXznbLsqdOÚ=ʹ׿]v KK_=AՐNk*D>x4a-@/f)_`q&B1G?<-)T*Iq7ڼ_QŐR /SoDecAY>Q2W՝We,+?-s7 nCBg7(Cz8?0̇l~Yrcv}P B(QpN*XqE  XR cu6s ğO.5v1eczle{bd~ī,lj RL?![(5PR3ݰ{"~, h3tl蔁 }=@#R>pG|e|p363~R e̟m)ԯ+۠4Oϋeza1<2L\%],'O?x#ਟycSfP|;ܣ(.Ob'y+X>̡XCs?bf/SJWOU~Jۧ~J+|/ߎP1OAr_9{j?4oFXHW툛~1"͆`ˊ!,J;Ud/c!pfwH6xi--bǜGe49YԚ_g_kh8*>B}`?^ڗ*Di\z>G aޠeFbB&/ǜ(lj}^rYz_CvQQRO%OW|{!Jc>)/֛]zWPGwFq7쀦OŊ [`$2z0e#;;S@ԅDNep [,woe*Q>Mn g>ǁLe5NL2o]ɽsJL(jjvH뫸;*}i*-i+e U} 9{%Nbޔ<ҌST>Azս?JƛVsTZ|ޙZ<.)5^m GXK7-U٫wioT=ܜ8(Ĝ:ESS4E}en݈bn\se_  10{,L.Q`Y*|Qt}ťt!w8 Cy`BC>%>nZtd)d^di$ūtXT_a[t!HyAox K︗ i B{ʅ2 ҇(J2,z,BQG Z\L  ;˵`  ZwE?ź*}z8i,_wU>sL80ŘmUgl  Q}|l'r>{?_,3|>fF w/(/׭ 5gק*,Ƞ!/{0J; 0cT#3rb!a|M-cۑq>1mlܖ : -R#Gx'g7kd3}.Wp懖[\s\E咒! 6ĝ,*{Kq "$ŝWx֫!(HrQzWy|GCnUb;U}1zfԌHeE驯O:Ή!5k$OwVgFd,*FTeT_:Yi(?".^ʟb+݋5TvI߰ %waS9桞>]2T|ݥgwS9$K^ !zT֧oB<}K齭m}?cE )Ra;X~/@g`\OUV(m-Z7yVן+TotugM/U~OhG%g2֪(HTRS_S>[H^'d yIYYW >(v̻|-Q{C Z)挟-,s1C|cC%9c-,},IVTvw -׋bx{+ƥX|䎬w ʾatWR~yA\*D $#<#[?̺-׷"Naة#Í,BFx)ijVRב]ѴX:"SDTx_|^}2-0<{Sǫpаc*SnS&{3ԟvܥNVX)I2)-L1#R%oR%:gԩ-Ր T }%;^^oA9UUK⯖W; }7n\| UBԫM¸TG]]&O[?2Y_'Ī_ßW^_45O\?HrŽ ?GC1L;I)qJEHr4jZy:0 Uƨk,\72F]9*S"Ҹ4YK%Ebtw|}}uwT5qbMgHzBϑIU:"(1P+|gߑ&|diuLݒwj\EK(/^‚IwR7s[ ~~^ǺrRߒ UQiުDε{٩*ҽjTHռ?sGw>ƥnr^)Ns.Z ߊdZ/WukEcƵ"Sg/2xu檋y\l>'__}$i_59jhJ e?OR3_ kU&y@Q_FmySE?ky_|5KvM\SuCڬ dJd=*Լ5/y0 5^c}Up^{_~^={o7 Ʈw?|?43O._K)_CV[\QkWk^**"_]|\Z=Wq_ ΦW O- !?S+++W<{_cE7FGnBjk2xh9K^({'dd9|!mҔבWiz^y!5ESjS(_[fKu_>VYßu F_km )RBk'_JFt1ya_*XG/ Ԉ3PU SB(gT3WOskWUw8 vRSGE~Kx"o;}*F>2mMє?{F9'' {tO=-9byU&#h{kf]C5ES4|_)/d2U ?/0nr)ٙSÜLߕ^^G֫è!V}x+O)LUyeu\4#5uUaJ_/^YJ c4pug-y5慾<RB5+3UKuPkZ| }B*Js!S͸؉2y{%Ndն|tiƮk+q~OeϞ k"1ϔK5ǫr_uז3u^ Wʴd:qڲuj:ZC2|K ]c5v]c_yeJdO{T`_e]\ב7Tunҫo%bW-~/\O0&]M:;uthɪǚ))))WQ)@;WQ.?W_"- x_.I-H<%{U ML  j+.淈 V))))>_-){?W5n!vvݾuvJ xr\޻wQUzt`]g3Κ90cb K4BHR߱B t?AUYz8/vzvCB±V,VvTdرS_Ď t6z5sg/v f}k&;H,6cˑrݦ1U )"/"/"/"|F9S5s'|>#p2_ۆٶ@o".~4vHUky@햵?%͢X6Hσ_ɤ(%vX~+] ҕ3陲 \czm+=^%X!Dމ\;4cjsTδ!Oy?= j=znؾx?qx,ӞA½ȋȋȋUG?wI'gh;q|`lCzPͯNvȫŭsS7{KVe},FSg|oHz-jٲ3-d `mQuxXˣ{5?mѹhX@kh6j*;Y쫶"߇ g~0^$fzGτP*yX-{K.kM] 5W1kKqWFЍ7Pw$NF{쫗Mbj? &hWÁC ,(귖qaO$u8ݜ'`dXZMx@]hLt[jww|fWXe.[վ/&nf-7l; )isjf=ˤ!!!!!!/?A"_ͨ^$gU.pviu׃gmQú[6r[F!@J7G6Jfcgk0fs@8 e:J9 NJA9M Y{eQHֱ9H߂)Pf;Wh< eg(Ȫs6FhL-y5n=XwkFVM½\V %V:fw3׍3Iy2⽃Ljc8"{3zaբZǂR+ R6VMoCa sEO{:0bF+٪sߞj_JK<2[ؐsL~X"2I~W-=o ^É/;:2ʩ _/g.#Tʌw^ %뀸jDʖ?Rpg)y#kv?TDI҇~xDޣnᥜ1gd@ZNї}oM @F9DX_jU,s{/nuVf0oe,9Q緿1ݕh)o /| __2]j.^WT1Ʈضr60 > 4PN#SY=x%`Le6:%l=UTr[P!!}7H3נB*L*O'5qGP0 AeBd&C3:?D!LYnS@E5OEϵLx.H'1}=b~=:FTO $Ba6ksNx f4g斉˹\4D]庛lgωe vB:Uf;nY%x(=FATREz̛TQ@Z4e;#n6Ի/@1CyNLaIWc yhV` $]9sMhFOvv^-ޚ갴.[wc `K5T8*ߝ`m/yUr52ɈN.-t@.|<֑|5HEW,w(NjJ%U̻s܆^Un1-TrUM{]#EutW] =L *h?:G DٗT:"SM(- 1#LOÏW븢Ft׵@5?0hN(5LHHHHHHj?E? js=yj,qq_?ԏo_$oqzb~ks$?H[ۤ<"05{v QoOm+Kv9F8U lkz ꨙM&o~< ZmTV3￾x}+gsN%VW8|~§z{ܣE na5h'u><I"YV9aByyyyt֟.xU?J_96_>{0;0Z˲_5Lvks&`Ze0@|?Ԫ|;;=%N˓'C{ꯡOV0Jd=l 3%9u9tF5|^5C~+Ʉ̻|u}@YwuRKo卍k'WlȻۃd|; olmt yyy/wxqtn,=8[wԟjvm=&5#t$4 7zY&g3=|nu; GRf{^{9qyey>ɡwLGǔ&촟A3P͙sP]SrAOnhmp,Caog-}u%G/| <Ë>2?,Nr2h"&&zA椯#̼C SzZ"߁-S2]/%G xu}/Dg1D^/| _¿z]{'Þ4R'+{ ?Of)aBXI_V~ C}g,x prvc09$$$$$$$tՓqS=nJj;j4+=gcjc&3}Gk1wػ C^6\F\O0JFM{?9;-gB_vk֭]q.t\Jڃ޻g`g̓PYn5veD(T1ޛN^Lk1掞HC63:﻾CFW~?3\ȋȋȋȋegCm_?sgNOW= sYy99(HfTd'|}5α{]~q*j;kRfQHHHHHHHj :ɤsӧA<2kE@t)W 4g~ #T?1dTuծ 9}] ~ڞ!}4{F%3_{/䎉NsϿP/| 35]g yt?̹]8/d߾)/| __0o@]5][/Kt9mXKGriKλf^'J. BBBBBBBBBKK3t4u/Eִff 꾰K]%ޓv$e{Mcip( $$$$$$$$#w=pc&u24f3Nb٠}pIQ<0_/M!;N4}6jxkX %찐Uf\5Qٶa$xD(FB0/1gܝ&m=9_p,٥iJpk˯YN`~چMh;;j;, ])ٳ^l 5]?Jɷ^ېs(䣆[&WvW/6xmOpмgWil~(:[-"/"/"/"?z'>w\Ris0د\Tr9* ֞~(l,VeY 5TzH%]:W#n1|F à*me*öZ@T`r[k.3.eOjAlhۀ!HC4TT; OW^<#dxu##~͏N~iӈ&a _^"aW3N&IvT~,*Qw< ӎкTImúa EHF^ oA[컙L-3#P Mi!AjG7jzã)[XT$'4BRfY7,S끯0ϧR,y]0(:fNP|JG*oY9)E^E^E^Eˆ?O&!fɲ6skD|hWj?CNJ`'vX #z'[!Өih09 B!Pe~o\ ,  W}6G.x^׫77Oa pS,F@fQbDLs_@!ƉՌ\)E"f_Xy!yr'_oђKhӧ%uY;G8xBFs)HyM;ai !:|օ荬1өoO/H4əXF|V}~*7:sgL/|_:ϯs㽀>8q?' X @)t`ʥG{mZݨy2*Tε=Q?Uo/(U6.+p`QUW(?1KqaP`R9:ESFs1}~&d-/gn44( 2ѳgi:ζ5?aQ׸m*qm^Y2XYmZd$k'U5B`,/7ym9r Pw_4]:/nl1iP:\7ݥ"B!'BB$SY^ru;U@Ͳп57hϢ-_~uvY#D=.s _UO=a_tUSdU4@iqP업<听(3W˜1& 53>~UO !?\7NP?!xr6to(QY`LaO(0<6rm|}_#l Fx8@U0&ƿ71F@|cKרxwv& $ ?wT\ 9~YJ497zJnd rhBSǺhW>w@^!E=as>czp0oY7NPUJY$߯} /}v8=%#p%Աoa -ge3W׻6XӒSO9m`Z7 o)f C5מts{L}ara?q>0*C us]MLRG@氟+Y_iܸlD;&5Ys(Ԃg[P .k0P@qiͅ"ke'c xa#/&qRe -c?_V'tD^E^E^E^/<瀾_?sgNO~wT%ጴ#+ E3S@W#ñmc24 afWL,ږ462 {\Ecl|sbBe[dj':oz{F,O K!>\p't3@tCjU*ݡX:']=K)ӻ*XI;2Gy3}ٴBWwYƣLJi:DCG56]Ƕ2_pZc8UJRq,)XUyTjoU=T)V|@~c>Bk$QJ4=@!cОKME^E^E^EI査jׯu͍Ci/;aIuq4$S̹f4N>Ry6{k8OhfOb*+IFcj)HǓ4z!5]cCB-רk[!Pμuf Z Ў`-|AJk&eI>渗vZ76:g7[[`}@5bLpT}6 5x|q5:=A?&` 9v9H&gl\Y >#2rː4wiK˳+Y ^08@!l24oM}\Yժw.f!!!!!!!SS ?b'ZНVu:[V]U ڕZ%*Oa/c[o/[Ӡ)[>z;( Hg̓G*>ye?/l|^?]qOD cxܔkN|d@Nq'{8޹w> f̚+W<}ϙlf&EĀA5'?^l?z?/| _?Uu±~&RL:N&߃WeRp?H} Q!Mξrs_${s8'DsFC4ˤO.\P!BBBBBBB_>O@?k랳s}W_ X&H{zOad{9gQ`(z/upvDAu=lfuݹ<9U;(H{ h?YS4"΂!!!!!!/?8OO}x'?Jw^<Ԋ,$c;ǢyQCJcW{+vg;RAԞHfq:/$$$$$$$tu"9CB=%GRGA<V%#V@ ? JšQ~obIGAr#}5x׶ }i:XeT7yyyy_p~2ħp)_9ao''r=?:_QD^E^E^E^/wxG+n*#gc!CS{?w7תQt6Gfg2uCoM7JKgрՙo'= _ _/|wy~/|$}Ƚe+ OA\g  /| _H~W>I??qUY=R5|/e|QY\iU;3tvCO:ѵU :A $$$$$$$tyi;Qwi`PO#a5W;_&JWs8=56dy 7?:y%NA4?q pYPWDoڛy`xcF4|D *O;ܧfsoaͣM̷N&ӴaY{i4"w mؿ9#tWAE^E^E^E~|V9S5s'|>#p22ǎVq9?巍>nYOxg"q cSΎj45vu&bN$Yȋȋȋȋ|/O5'U_gG>1B;/q׻NˈQP{G0Tvߎ 22iV s4K +-7,N.Qv=5Dן#F1bHW@ڞy^&?BBBBBBBWz]M?8}_Kmb .ËݲvY.kb`' /}ŶbA!~b[(Yc'J[448im ㅜFu? Ͷ=h.\ ߚ&vxB$Yu2ƒsd1`MaӀUg$ԞQn-r#';&4L Su9^T5T /{a!8+/6&a^ȥ+iWٟz)hO&;dYX;a'hf/RhD;?_UԨG ,zyQXރ`sk@[O?~wyHu&~QYw3jQÇo,+ wG- f|xM9~@~TZsw6`0j!lA25Z䕓0z@@սR5ʓ׃d/OT(䥩SW!aRx}+TY!31?߫r r7ǰ+3U4NJwi Sy[9B> |=8hoP٨ـ1cϼ.*d;64j^m?y3MaA#"1헅<}j垢ZYUh _/?~Wz;XM9s3HJ) o+q Foŵ-~'H>oS;$lߏ!4{0/vU- k7뷏9+J`fsc犗WT׊5JgnXW;fDz|8qfC߂hLt.ʟS8τ F&"H!5{_TO0mWyV3:6I?P_W6#QjͰ'ҕiӾ?#JQyV6VX#X/S2;Lp3ri,/SpG ?k}oHQL=ͲA0 uV:HDp09ͶZ:s?,z n[B<3]RZ% lFEUh|Nx-XU- )H==khL!ۆv &Uv2\J-i1hBEC}6FRaC#X/wEp]ITgbԭrm^7Qa!|P9jQWl7mT!dS+N_Bb)?l_CI-ŵL~Rހ/&b ,Yd;|@`c0@܁qW';/$$$$$$tSݑg׸"67^:ܝ2FMz@~}@ 6@>"t Wm`Kֹn4= [mK( =KW7Oܴl~mԕQc:43 % O; u7_.j?usC~3c{觙&"MqCC)L>pԺm7OcbgO',t!_jmJv= ԝ (}͡<%@46^s%qy4F?A}yLM?;8ƻ)hvUJOz^xeЙ j*uiPi E_Sɐ:[ihieOCOWtBBBBBBBfg65 {43Y'Rẵz;fo0 fE'dZC61RzNFQxOz˴IqvJCfu$k= xƱ?ӠpeT,ng*J%ma2;ْ)`;㽀P6NPw_ytfC*Q} Uc^a֮dj?٧5랹kN4i@VM%jג8SO#xiа~ӲqnP81"xigg<~ږ6)ЀZpoxX]Q#]fCK>'zu*iN>7Fq7 4K[C|,b"9!7j`@TknPTݭJvKçu=1WG_i/ƫٌ:T`k՗lx*~Rr4"4aq _5LSk*\I+̿-fZ)? hnkAT ~HOK^1TU/Z_UM&<Ҩ3ىȋȋȋtħpA^p]z4&`,Վ2o]g{oVڝԴޝӎ4uP<'%l 5ָ*.:|v\ ʙTICG;yVo+QZVV4W0@UlGgV݄vv}-4Cp*Uo%*wܘ>`^bjwM\-s^uf`_s@R5H<"<) *IO9Wu_8Pˢ[ȇd^6Ib<UPdZPQSILoK}_z}{/&i݀y^3Ļm)`rثۈh mDfZo ʉ zroSfP9[mMd,^O RQh6/| _~WW}x‡^@WO|j5 w wcm g`$/$WwXֻ2gN<֠\LJV'Nùe4b18KϒٔKOwݠ?A7,3^ʹ)=Ü/åI5Qv#e'2切ptmY ۱L"^=jd~!!!!!!!Kۏ3V'IImGUOy3?۲#w }OԞq2ޕk/h@doc>3芵}#yu.!!!!!!+Sq pYPW}p|RQWMEo D^ػWp=)H~ƨ{7ͥ2U-)kzzRzWp4g3GјX/g_W-߻(lwFg:(H˧GI?I9pwkyyyy_<S5s'|>#p22+ލ7>"[2z!?9 I$ 27N3b#tP sRb!ɜo90N.hFȋȋȋ_?wsTr,m-͂kKb؃oGBs;>5_kG1L/ALuAG2t?q?].'*hmqR#/|YB4L~ч%Gt3xc׮z[S=ZLZ_OX _E?Uuxy'7A9jN#A]j (^5A59VgP<%$$$$$$$tU|  8}( ?UG- ,s gߓ|? \p6{Ⱦmd)R cepHzǂO?ph:'~;XFJiMـw4a_vfF?"whOQ{o7Fɽ4uډT?;C_HQϸFv|:."/"/"/W|o'>we kagoDV6iCNcڻMki=($~4SeLI8,PVKKVTDjX$iN S 3b;>5d|ɾcɌf{ +1/'홃O'k῞50Ȥ;;fYۛ ^3u{ͬb?%,;OmBhČA_`DL}*%d/ W޶Zwҽ1ׅ?z#^~iFcY,kޯ]L5:1"/"/"/" [@uϹm{'}4X˦E}ZoͶηU)g37JV;v7xb849cn|U2qmYץQyFg{ᱼKyյO6l؉YWfKlLCגe?YvKLnY nyqx fsLwcZ EG+ 6hjDCKCe=g^Os)WouN!|$~5>K@Dv%gIl,W#v~cSrVB`3tB XW#pރ9Fla"_@^9G^&ts4UH??ߪA#/| __}aO.$3FM^]Hد1>O;ѬsyX SP[Q̯(c%D.`/1 mK#JP^nSpWU*Y*Fi5tlmşT<躌 6ɮM oM6=b ƊBqE4'TJi.ac` @wK?. U^x|,{o,y+G _;l^6G rפ<8Or. nA*#އKE,n~ZZQeZY3^GA}dgaSM"3« 5'c $ֱXR+TRz; (VPF|X?0t%Kb8<QX=Nwǿ=1Nam̷GG: #$$$$$$$4ghFJj;j4U\LUtIGPQp=ѕy60-9؉R :DI!mc[ )U6 JۇCP()=ڜKՖZ-T 9d ]K:u{UE9勐   V=UJ|l5N"ju?[ӄ~BJJPYŕB4C0# l3s jleK5C8_trxR>6~j@PEp aL! msKjwꯅ"5@fY\Ck' ?_*S aM>;T4o,jT#~GtRwbɸQ31C-1MB'aw$_HHHHHHhOO-gB_;3ŀ5-*qQ=x4L EkEohi4 (DW.c`!Jt5fyCX*ܨ>c;,{6<wDȼV gd[<3bx# vmyB6[J *׿3>%ѹ1Ffe%ޘ𩎈"#fBC[ `Ia.z=>{P2*!#ڙh{[3|!}VOR- B3}|ɶU!VmCN݁Ÿp59AmpCN&4З/1|Ɲ6h659lNa\ۢ~ãïIx,i#r}D(/z烆kyyy/< 9>8?O}+k;}njHة*T 87-q~~/`Xaеٛ뾒y'<"v6vM9{9ϥZ]?4GP,5Q'ꗀ- ^PK&t9Pߣ<4xGFTN;L(Hg뷌ɸlS99e*l)ϷBqzK=WKc+b/z.-|6 BO8Bes: eq@1j雼z''4*d#| Qzp4DC3U T/,N KO@4f:J5CZ oML'h6KuПs]БL&O>#.O^QaJrK?3$5Q<3eUg3w%_~,4afVUN܃xo5 Va4)Tg0]_fR ]_طLTYbۡw~8ӄU=*.UVxo5H  $Q~N'arQQ=su$=bj2y5#.tBB0`4A_o qWO: SD^ć*Gϻ##)jsQYT޵-:j<ڊxSq+8>wU!L"1CG|΂{a̿k׹ -Gr9UJL0ɬ?ÃBAT0KacW9~=GYJw~##O ,5W]-Ys8#*oOEVrb2ުf^眚5!Q"FE*iKo(xʱSi|bcJU 0Hu`rv"(UC'R4)ݍ9&&nZ6g~ lYGALf3*VgP\Y]s/ ů-[Fixv8g9)[0A|CX6NY|Pe QHiRuBw}i$YkVoSȻTl롂b牿.JK[ #6X3 Zدu|$ao)abfuo|lU'q\E_T?1 _?ut䙎?Q:ۙ;zV ?uTjh)ZBr*ogַF)_UAR88r}N~/^=]{9gg@{BWl{E2ybagSmR9s΍//nHc~2zu\šU:κ}ח>XٍK>D[%{L[yA}K]4sm:n8njoJGvjy;)M/| __o@]5][/tu>m:9< 7|,M,I΂SWмjP*Ty-Ɯ%=&19Ǜ2it:0`6Wp.=~ofaq`3[$YNt0]+]äq-m|2};,+1@Y@ɶ9x^MeMVhV?OVnO_d̠֘NrIukp3]7.&ۇ{ ғs;ɓ!N9z :vXH썂 #{[[n',@;~Go47'@eF=Ibv̺ɴEg ;=e!!!!!!B!?pc̙N~f3_-%9+7_ֳ0ExФOIi(bOùɞJ|?@%#Q{Wv!k^f-_8KHHHHHHH(?E? js=yj,qg?;pWaNtuPԨyѹr dstը93F+/-ˎ.#H 3b9FUBHHHHHHHha_{2q=Sӈ= ZGmw]ч|@~{x|_&?]G&"/"/"/Z+?'濷?ч~_"0g e%"/"/"/  اe2siw}'/k?9 Jpahkd=?qQ937n0hs/| _Xvy~/|$ɅEKK2Z8 y}_(<(| _/5g1\!twPET&,U\R~L9QmjQ6]#Lh75Fg?1T"ъh&Qg$9'?;voٹBKUQ6LvȹR\BBBBBB_&OI 9 wN}Lhͺ|o_4 Bsk̡sN,О5'#9p( tz"wi_L\m>]2Qw <&"/"/"/_<}ζtT+R=9|OU;ɇ>YSpR2n_2hkC#4At k/"/"/"ep\O%;?0Wl]8F<[y, }ˌ؞!0Nb[,gi66lgMɒ_ hN5dMvN|U@տD7~렯~ߏ??.@ՅkѵaRze D:,GؾzbfR}rvˊ*77I}!ݱ$ {ɑv"Fީp.O3M9;*W卶ODs| ϴI }^nSOYv5k=?^ dz>8v CUG^\ w1Wج_hzx2d'F!B~w2)=xNp~uܫg`?=xCf7H?U mG0j60 EsyZ߮OMcF婨v{g/]H=Ƒe+=$ _/+%hxlNT<<)?ɘBP>f:?al-gԁ[nY{ +]t(KL ġ' %/,|" 2 $ٶHRo H?F^ٮ 18 ~kA/WڟGaٶy^ge]eNƤV;enSs$emSébN8|9V4(?nz0T?:5ism{>ɿ9R:i`R40(MN#Z'Ύ-[⇝6k@ =jQog^&ư4YOߚKvkuL,{il.w󺰟{ G5bqC|i0χ3d\/_PILif'|ϛm^ >kLWo,_/| }&<SO}?7~د̀x`q A6"_svV&gY "!%[3y<哫FQxTi y |m[Bc| tu"f/&jaOUa'rk=^Uɹ @(Irz =X} dY*됄|OM|c-4@s] hUN_۶u\Ax#*c *C\4ß*Dbͼl3 *U=_L^_0lioLw(~#Y 9zѲf3{x*OzM' VYsM矷0((T!L<$Q}?{o&Wq݋_.$s$?wb%Ď8cˋclVc IuF!Њ$`֞ۈE2w;NkwόwJ=ԩwN)jS&Z6{.BxD08/>2a P̒ɪD ԏ` /+ϿY.uK]R ? n<:\PiNcْI%FR *^w_\7oݿmb0oP^=m09C_f2zSoZw7NE/7v؞nx9= {S'_[3kbucUU |_3Me_TQ泫wZfHGZ6m<ZlN_﷦N =-EAgvl ۽1)o^3h!gL\_V.,^A>QgFgkRnЖk&ה-|Wֶ #yAmtShҵS?TM]l6CnwwC<+P])ixx\gMӮ"4Jh iyo=f'ͬh;}|&38ԩN6@ ?OQ]8˜;8E:7Mz h2q"Lol/ Medhd7W36b/7^3U x7u{)YoyELa>Ls$uJJQΜ/EksmsDdŦ l_8Ϻud88$ɹe:$m;),Nk?\Aa.?袃k:0e *pM-:,7laDԭν]L$BH'BYьЖo N\?m z]h0x^,.jfM 8FxXTU3{mk3u ZtSc?< g( h˞281si0_)SsCТoSv{'έYLKɣ7&lrbɪ4/ﮭH}=\.V` 0|96a1Y"ȯ@_41 'z!r]ȁ.\6ٓ ԥ.uK]R׻{Y}I=h4 3?L_XYx#]TckLeo;Nf) nۙbD,g`F<~氵ɵ2Jf:;kj8"pXEF{$YHD@\zh ߘz Es:FY|3Mkѽ询zi6dq~naxY9LomdGkEqD2 ]] myz؁^w܎MhozX_7<}fPQ 8A=u2`Î\O/Ct9scɷMfت aHLV^m?' ʝ;ChG9?倷/F8 o?{!׎?'O&|I5 z8tz0<TW]~Wԥ.uh<?K=hBf ߄f>Q@OXJ-Q [e>ƙ1Rj@^ǝ)E|ʏ'M\v#("ÍwwdD Ed$ *|m5_6 A5D :C}Y_ ]h??tvɘt,Wwtނm+kֳLJƍˇاjBH6A4m*h9k 4 e wЖGE*܉Cs50q-gWϭɓIߟۛ:3wvѨv8@-מ.م?p~:g%΋8{|WcS+=ᚉ q?o ;h= ^>+ u8 8PZ8qFa< 9]y|O.1?kv p߷(|-#7*]´,f.b?]WWV̭Fǿ\S YT],؎&༵w ,ؽ]P/  V:^6_ۦLD9Οv:ḯ\pZx|fn¿AіUUAΝHstPqyZ vmiZw;x- /1\l;?Ͻv@:o v̟Əs Ɲ#kڊjw4[^phN/C"nem#wB_k' 6( jទ67t~ pU#9A[cv"8EOcE'0 Zdy9i`.uK]RZP]|TX3 p@u=NYQ)p]gp CbcEBnQ5sr|c'(px::0fq;`=]7Lr4]#>hq$+zDFf򹓶U2 ƄBxVm5>t\\\%:3!dZLxNlmXa!۠ s(cC@Y sHG\w7 _ B|G08akky;;1Po/ؙg@2BM^_VwM+l0 ?fX~eOWRy/0JCuysE9PV%xn}PɶT4">8ׅ{.g,yN&84TGzX֦3MAbG;qФ΢:/NXeIE!DFb-pWUlOG;SeX6t@ι3 ss`u^]QA;̬WO̽NBLp pl7װ=)@@,kc>%!ioW޶ £%\N:Sy]]]gtwt5M9b)8!%"!Oe2?? 8v2LFVَS&md=Οmb>555KJp!#RS9Y 6T#୹"w帋nvY#co:|6D1')@pln|:y-ض3oba"әɳvư-oϝ=um1"^/YaDa$F|9xcou硉Ud: v(,f%:&bdSSC5ՍGh'kk0 ع8VT7UU4 s  XMfB۟(3&U TTTNK0$q/b% ,dO|I&ݨW-?_ F45f+ɠ$| 3=k5i3(VA^+|WtEWtEWtEj-i݈`Dw] Q6NdiEmIudMxw΀K8vR|nEpAU."E8)."v?$c Ew %r m;U;iSʔo+XV!`T58h ~ Hg*\ѽHr9ŶE3J)#q'aK9ǁ4 RlqY^ffK>;Ó(,GݻEl\P᧕1&4TkYO#He=q22 O;J˰x"}{k e&mJ+r|Y6鉔zF%;U؏m0l;艏U>$W氌v.uK]R*wW(ySru5 cq˔d:]rWlo-h9i,jώ!!P3Q@-L@L3ϊ?&OaEU fQo&ptvaRQ!ϘTPMU7Fuņr^E:Pt#4bNQzF/սfE^ԛhc}Z1&R\"8eejOm*./؟-'q.A&{dS^K]RZOb?*EO$uQx:f'/gdsjxr=nNv;GqWJTEoŁ7VTR<t6Anv>棻II"R;}Zī=ee~7Kv֕MVv@dKbKƻ$?f#-0#5AʂQXt5g ^4l `ҬI.+9y~S#=ogrr;rPz}G4DF)g/o_Zu7alvzdF-"+-XsůW__>ZA!>xwpT|,Oִ/~ډڑR]*$UVQIiAu|%r<.*(aae5\2 ^f1?@ܮ5"Y)~:Efp_PKѧ4BRu[GN?5휲<%]&%cF}půW__ 5v斤㉔ޒA٬c)NPod9)4z߻{]{ MˁήLBQ|p_bme*o={Kgry_ƹ芮芮49O7tur+QS_(he}0 =A((q`(ƆPJW}c%{M%ɇV\?$et_=!$xzpR{< Kc?n_R_+~ůF'>>n-i=MD,dcoy!'F$ߢɌvtݜks=u~ ~xuv9>w`>>^?]sK{MvvmOgfFY芮芮芮*)ϱ&?X 3FHТvCHGK EiGcS7AZcwO!~0c-ӡ].rD-0~Jw{ndhA~3fpJ-*NjcI[>1qG"3V]]?E}7B'~8rٵe3D;q,+_7i(^f@8BwQ"K5Fm xKl;59͙Ge}.lg`].(clXGviO ˉ/T<^"/>:Iw\T*U_),%]JȢ~<#$jI%-nLD_D<͸bR>GY"_%tK_Z"Of:HM={"r 2GBBB v;ciM‰TҧޭsK+wE[/?nKvw>8PLHw{8`~,MڒGHJ/ůW1BH$8aQ5+vF^z=,hBY0̂?j,LXvp,hE$+y=uV[eodiCLzouðpB0N#wiK]P >Ep=a'ܿ s:bb/1)vG2↝Əx8C{j䨸>ot>rnϿd_qfO>_^bI+ |I&pz>*~ůWW!?JyA;aHnI<"_[ ϵS.[b,f,˞ seϿj<״^t#LtEo>@?p%o㱔NęLa)|v%ݍ2p_vO;bȁ_Ξp{"0dzc/_V1s)ȹ:ZLh|&q_W>%t6>ʷIecpѿtůWƮb$ZӳBpQJjOҚ"}j-yԇ'Ma(Beߥ!_~Af^7ӡOfHZˑ09qRQq1hli8ql4qo9-yێ/sŹ)K=YA:`>elrg\tQ7lW_+~s%扔Q֡ҟϤ%#Th:x:BR!:*S nϜvo4[2zءNQh/=`72=0?r{pF z~p =DfVzQB~,cR{>B(bas֠M|Y7>Q~7wlY#M{C7څQxWy4;MЊ4EW[8ajkZh=k!"3ᑞ.3GnKdbD"ҜYe1JURTYڱͩ+9 FM4,EyGL/a)*Hy"fE~g[f B(*&hZr`hU6`˘pST.7"Fҙڎ} EySh`g_1^/d3C&P\xz(@PI f>ٚ: tMs"EMmiD|>wd e*`̎rH>WffUs Ԥ.NpS@/nus̹/ꖏ7&M~q2ljq:aeyAhpc?5e$4Y7)(YWTwTٗzO= SF7%v>č#!_FxC8#i5ЍkRW!}OboL֦N֮jSs<{W_+3c.k0C:}}itB$S^ɮ U\J?IuԇE򿮛YZu7ƃ-r">ީ7=N0sȆ Qx8x$|~E|?kVS䇍̾1r9wD C)36 cV9sf{ nrmrbs' iqloԆ-r0059zω7W"2ټYRV9 /x3|/zWpC7F1Ԡꆠ!Chô 3} ݃{p5*w2=9QV?ƅEVn/HЋC芮芮nҽs,DХa3΍ 5#,Jp'CgWUɬOXTNz,7|&V__7Kp-̈ۖW|>ݳSTSB a\GԩǦq'\2I5[Sc}dh(780ҏenNwxG4iKXp鲞g%*?{0@t/.Q%АNvmqVnx;oOt鯿:wDyt; ^{ٳt3.o=uI $ /y%In`n:z z]*ֳ-2I"wOA& } K4QK#CD_Bs =,qnф:L],mz0f{Ĕ~c4hp/1Qϓ4l:yt~M?y?\G.ן˦22-!NmܣJURT, :qoCFgG1o#|/֦L քB `y$ `jUVISȒ˩MPH4g}nV]Ŗ&0OGrGd>!!fa\[GOF~ _xScA(CINb8@:y9EBPGgLX"ĺ 65?t.G Jԧ\Ka=:rvS۾;۾CNم w:왻CfYοq {O=vӧH\%m <{a౿<,\ZkSG6t挑EpUt,Gw Mմ 3HZBz#l7xJ45& pܽ_֎td6WoĿ~˽k_m~%ס@Iǽ%נ芮芮#J&Z1G A+E:8"'?7an}k.wh~pP` P ^ }S'c˩-@ZѪq PŮ_ ~`|,E,Ҝh;E򃑇Ϛ%/!f>ճ;ϱa8`ui8{E^qiB6V`0)!6HF#j:HBOpPqcGR7D?EF. BIςE;7M흔0"|-Bιs>}r`"r"ri&􉼖#n9qlo~ ٟ&0ylV|=`˜4zع >ׅ羆zZb刭d 4MW[~N N&g4|s}3C3wMO`@(!_3l?hVh »C ž\&^]rsCاO~_~th")Dvȧf{3 fϣNFpDg;A /`tvIr|ᆙpCK:N1^ FK dKgO 6[)O'aY1)4LPGHg !6viRTn^V#nWNfݙC{N74W{Lʵh1_=W_Vsg._~9AMG挻XGD]Eۇ>;oi/O0s^Li}`@nPJjN%GN utބCON46hl3޲nq-7F[ϥ3}Nr89h/^_igG>Ϲ7s>o?k~ruDͯ%c8=4n1<1W__ b@x6Y1Aw@W;#g)ߒ{܂\nƅsZ$mR &N0~ehʵ m $?ZyGpON # \PF[ƎҒhMR;܎#`sjR4(DVGKyt5m?mA dOo* 4AyEeW:F3);c$x@(F`kaq3>˨i`[m7ox^?pʟf^/>i5Z˺=K-d90x-_,y엗{i,~Gqřˆ4_&ϟʟe>GDG5m> s7Zϒq֣W^+>X)S=zc=Q?EV4]9?hZ^Ćҏ򕠷Viƌ5c+<%K摯XXԮA4>Sz_Y5cǵCw]M[l|9w>tǵm΀@}|ӊ̷芮芮~ r \r`yec.w+rCܺ:=Z)N̖gnO_VY9X &V}N@W @=}!/x`Q(o?E1@FN0bp{"/!c9ڒYē 7<(|FnՓ?pS~v_mh;~5^?̧^e>f7$I΅ ?`_=?dWWM>ݿ:>zݐw|QKȤvm`D߉zzlh9A>eO ^8o;94f͖A;*YD~4{8pHl:lkF}GehD] eM(OJ:r$'N_OOh};OΝ'~Oj*0Awkb~^ʯ.r#Ђ9l⢎y{GE^|DOfOiRd2c伉 Y #M 07a=9 l)a)Lp±C6}t.[:vx;7GNu:ؙo^߲[_=5:rM%wԺ|y K ^%{!W[rojcUɳ_K2E۝(+3ꊷ~T A?Μ~H)O 3VxaZa½-Gy*EL H$a1WM 0w< (eD,gPʎBAXg&s| E8| EM Xv(x1bv9+9r[sgrLr/rmC,ɿ7;6qA<,97| w]?j{.4˒GD\%{Ҹh6!YX.}1Kq/c铩$uOZf}m#F]3FeOCJ$e#h\DE-'ͭ- zd״GvN6y%Q৽>me !s㯾q7srOfŌ!O7qڇZs[[r7m~%6K'EVtEWtEWo|pX"Y /gN{f^<|Nf5s5r#E42I˿RW) ^nWT|x"<*kLj#Ko<@K'96Aruq$Go)P0A`aBלIN4< !pvJxޗ37N/~x}k_}垹sx}΁ ng KEΜӧPΜw,׷__f>}Fb:> W^9C}|[IMճ.a7~4.aD\r#t҄]&r^Lbh%? sF~Б?=k1i8qN|ir#!9?1,h>9'ONu7>/ӹ{߼nƟpWǛצ=x5?1QM^%UJUR|_7O [ۜDu@ ,8N&Is˿6a0Z v_VU<|qSPoH>17Qz&y-/:e'8lqd'h2|f9)U!䣵IvW~)72Q--M=sVYߙ3Ϟ][͝s(9K~t[o|F|H*ctM6w3d%ԭ_>w/Ŀ{?} EgnA$twYwlVpwRbqY4~^L> ,e.@лѿbWS5gɡzI>%wPծ&qECDu'sJr>@`l#% pr_}r[s^i/}h?OYGfy-o<̊_+~ů/cByTRbdO߇앱${ ,ahSP)(ֲT&CYY0;*;Ký}=]0!qs F}]p42ˉ'\NbQ`S|9s,-y̆ziT0a̢3 0ԡ=mEl/ F<8s#('2'[fGgGnk9gg7ԊEw??__omy9s=}uo~!گhѓt%Oi!Gs8B0&X=#6̿xy8i)cZlv |(og;|- G@y8h 42,ï_Nc;;S}/>Lծ}%q*j~6dz[^eXsU2|$ůW]c,X&*hݜ;ȚT:$r0xc9 'UfV):c Np˪Ur}޳?L~$TD=0-9Jy)L(h!?qz $#c=G|ͱ}pe:cE֠~)K^t?AyKO_%OSV)>z̉6o$h+ |KsS}({~W;pyO2r }B‡k|5~"ϱe{.瓱٧)8:NSb<*Ojυ3=8O4f!a iQ?4_aNC@0XohG9>So>u psݿ}CگfmOn5'tK+~ůǝ02zYep;j)-p&cU+fG@jQAd>9ݨ2YȩnF_@S$CnFb{SXP77E$9Gh n u.L"WZo[yޡ}H;/|r~=t^ËwO-}J'S8g3Z>pgO_錽{g |B1)l=~d'oGEkzd;ȼʊ_+~ůUP쫜~,GH]ϘӂfɾnGRIuyXn{MeZ/F+;؂rl#o 1&mLG{8;l7$nc9oat<-Pm#SY˻T>yR +RX3P#k,)IÖڇuOY^_=YFS#=hy׀ JUR@g1= t;F1hF4 ϖ4[$=ƗĜ0ͩ.0ySvlxM[W)$)V阿]b,3 8>ײ׀ʤt,æNUR:et1խYs5`O1|26^C0Yyr)9 ?4Yny"R}Ǐ>s4\jscx<y̡#,NzZkEq=GvLVOҜ$_M^ޯR*3_+~ůߚG Tp9Ϣ#a[< In72Ϗy 92Q>ٖ)Vl[3bMr :0-O11tV ~(ajol,/,c/; c$<*7a*~ z@*2?`_K{Et/{ڰ9qr}U &6Z'2}܆NYn/8E BOKZy}#t.+(^S?:E>Οigg*++K"O/y)~%N?$чG$o&Ǯ9iwz|&~KSLZ%;x3)0?SƤ>?(? n~3H˱zϟAؿP{c3f 6\m%?װ%w`1͐?P|ůWnS G1 çpC0"#C(~ t*? Xem$o D0?JW_Pяnt|_CE>@1xGU !m)zv?ML- &8-x0ٟ*_I8ryS<^]Md|ٞc?ѮɗNv!g'bv.׀S|L=?>Aw7a=KzJe]-xv},A8 P@xW_+~ůM~g1ȳ]\(\7b)kq ^;ɏ_>(˥?Vr1C#$)B2_{u9#G,'gA} [Apoc{%/8ɱT4N(_/_>_d}ly/[Hi*ZOW_{ޙ]Y',1yZA\$H)%<93^EW3\+g|nޒQr|JBF?T_+~jZKO9G%ߚg~tXb3_nKoJ!-g|bxG=_? ESS+~ů{->aF^Gr7bc^'Dhȼqnj1}Lb)ߐ(ўKﯘ>lޞx>bǃq~=Λ{1VDq~:Gޘyc_xu(oi|geZWI@)~ůWr[tOlԜ]|9~>[|~|OGN+袽Χ:#䋓XeD-|=-ts5>v/I~,E"[f!ᮿ4?[vqR|>]h9=gV1-酿'QIxWrۘ+;>>%ޢ;-z~ו}>Qe+B[䰿)LҊQP0iCqM$aw.1SVPgH}0`)W=ň`88B.xVv]Qez/--8}+QڑóB~s#8@eW amF>QHۤI>Ӧ|/fCO;[bnda:]W~ID²-I 0x?j㷯)o乺~:ʗ ۫+;0Rlϻ/}ʩL2F(z,N6(1pl,9N [_J,MD." :sD1&i]ȧ=FCb} ' .+PH>{V4=+B_B5cD,=[_#F$?}@7(u{ A39Zfu"lr}Ux:I[o֓s۳@MTcb`5?Uc."+3~/U1Cyu>P9+_`KyoMxbە?䏛}6UNJZƳk,5Wvig1{)~<:->j/Uп,}Zo1}7^eןVLh@#0ht7ld܈:EcTŠ7뉺,d=+,OwH14# x`/%h/CrJmL Q󞅒0dQ;a(y(=i$. c_K/>nnc{OyyS㞈0},{|=W?U;SxIߞҞQ.}8~:p~kK_=Mϕ>\-/^gDÓ/).q1)})B|zJ^!(#z5\PN^g1xk+;oד "u?ue?i+"Aםu|@7cmr[{F]}og{7$@IG" ,}󒍵:r:[Z7+~A槷Ugtߋo9D_+~4(Ο`@K1sAzQd Cf\,PdÆH$SW;Xp}c3IYONU yiH%A=gB@s1݇+ gQzho #xmF8#aBRmè d2f2 }zrDn!;i_Bv*xU~.+jPx}WUORK^[s~B`Ldug -cx;ʦlZY̻N婤̇/0WOuF$ vESd!/'*\85.G9zբAV"$}\M ~qM{ve3K~acOKV8=Mqӊm I\x3OzBfdgyOI"־Gyx_~U;X9YwOO$X[cn2'Jʞ_{t"4rH/BBׅQQ'5O$1k1-NeYA%ڛTD᳟_Ğ4'uTe:"0an[>sKdnFZ43/Z$lf:h2Ovsԧٍ]Ƴޑ2|D&>io;W3ş/0.hk,U#2Gw_/ۨ۫{xJs/>ǯ>x?7iu81ޚu~/]WMNbPBR32e;cJm|V.M:f2hW;E^9\L;%?pE>a7,U|Ie<ċhkXΖ(,PR/we],čDoK1-6tF9~OJEZloOK>}K/e/1#)w%q9b_QbCH~>_(o[4N(_EߤU|>l㌢4bMNF'GS|=塉7XPq/9_=KAZ_,bsf|аTI-ؼYOhgR=ORp/ErS߬+\-n{g!.Wtq_bx,eRltW/Y2*/Ă#yx'k1cd={{-ϵÜؿn|>n6nwY/pmF+~]JwּjWS9U-0^Retuv/22nr>s$e[k7vܶY& 6oߖ[ȷS||3ƞcA "]s2F'‘NzD.{CC(eݛ`AO Y!ny=~2co~B-ﮅ΃$Nؼ"JŒ/OGto]{p-Eys!_=57E1#zLyWA?~7l[w^})ߋ[{gϥ-{O2]Oݾ_ w&Y,;(9G1~;e/{BF߱>N1B,Qg309b :kL8Xh3Mn/xJy\XzZȫߒbA9,lm^֔j̃l@")pL:٦v}_~A`kƉяraG啣01cF)e):4L *I|| 񰿣czLE'#' w#:lɞ 3r{톯dX{Tj~{2nrzw(}Fw;z~߻G˥hIhxL {ȣqOwoxmY?Ke]{oG[0]ݡwyw<#J]Y_d1b_"u.q wlLkcߋM]e2.{cY2XK7L/ M%vbiouػq/yS >w)4(Y}oMf,*(H64ˆRnQFӦzsR/bvG{cS3YF5l1|Yg٪B>H7SF)fkz.[]pē;'[n9~ylOi|=ƹ݈u{m#Тk/ytIt`_!{` /ƀWNɻ|o,PbT=Ғcؙm$k1l1c.yvMou1G J~S~-2¿EWG}Grc{tMy#xH(+}@c H @pn :Bfu?u,Y%.Y@}wVC?D'~OYf3=AJC #"i'4xTС]Be9u:X82`OQCF=iDfϝkG9ԡD=2w'd[#bszhNM:,.Z0g\D Es.%^@\`9p ~:Td .[b7-@g[b)4F[|<^F_Z_GW x"GWٰWxdc_ }d[UL uGy5k=kV~ݰU8JuK!ǐ؆M`l g:I      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^`abcdefghijklmnopqrstuvwxyz{|}~&7<2ױuxY}=kׂQ_k>8(Ψߴgݦ O%۴(ؼΠÍy-HYe7mݸ ؆o6<3ҟd]B߰u'6f %P ]P|F{7l(l ֍gPؾڼ}+ܸ٨%YOlFT۠eVoeu mOn,ӷ}D߲}3Tzr;Щ}ȳkۈmדpm fN .gmOm 6OGv P}S|Y}Noޱ~Ӝ{vAem#ܧX8%x.:|ꩧv:;vӠƮ=Ag<anNQFП~P{{i>s=> Ϟ]X߳BrSP?ܳ<?}gݳ&{?{"с?O7gK: >DBIt`aWCc hԉyNB9:x~>jeЉh#;xС7nƹX= c& ?``\<' \p9?:Љg ,:T-n6xebX_8'~@0q勈u/\*P  9s pueKח.3}^<_o|bpcy-O%N>@_h.ETЁgI[uUX|Rp2:֮W._ ˀW\ck;Y|)ՉW 'w:80 :@[ý[c|:ggv?{p ~Kp΍{FWn1 8F,sAs>AKAH߻ tNtϡA_`Bg̜n_rY6ӡ=ԟXC/t9zŗ= lÿ_|S[;J8 Aut+5:Mvg'IIpd OA#@=5ך3 O|pL (P"~(}e] և# ; (bpr:a.NNpR0g\6M6{?'nilF412Tz#D#CGp`7Y8_tb d;@W ^:t? 0ȼN /g++-r-1!Sx2Y<ţ+yGA7p?yupcQeY )էIS5FlYZc g(/H0B39U(g;a:9.;S:VzST{Սp :D~fafۈ hẋ:qm>_`1yt/0~eSP*5& 45(g|؈գM M!~w& ?_egkx/X/H7VN)8|E@xKМ0s~*Bce%_h jyl9/"\޾/g.:EE7p 5/f_Ir(J3Pk7S}e/]2 7E(bP8PFBy:[/:8?)Vt`@m~Ύc{,iFC"N~Hl`% .$ɦ(]xkH)R7#H@9Hsqԯ~8+~.OR2\η>Em9PX?}\lj>11F v+WoU6cslG?<Q' 2Oߘ \z&E}zr 01F/h{&nL O^_oLrQf)>wvnkZwiWÇ|JnM>q6ȁ_jhjjbbh5v Pr#8D>o-tJ X?=7oO,a{嚀eo[dVj[fYk.خ6%2¿,/򿸸Pd+}jƭ%8VZ+n/ h߾?8߸Tc~oQy{ȃx_ >olGl9{[Ý]~n c{槷q#@G9\<_}w(}~=~zpPFx流SzO>%O{%?z!$/őis=m=?<}F/J[M]\[[$>zp_Bw=xP}>O)=ٔþ˵ ME98|tLJO=uGz*HsG?yXRf]r_%ޭ)OJ)1?zʧfyo>{X~4^iW?X6q~?UsMj[[ۋ--ΖG{ Hޞn@خ6:QW yO#Rkkz=طtBWΟ})$(ěk[q kʍɹ@MI|t" VttA/h_/5vh_t(χ%×Dx[=Ef_[<6̥{ w#)+#W)誯#<E%|&jVCۏ{U}ɧk=O`b~%I#Eg8Xrrlb""jGzBSbs\]1AԴp9{;YNg(vf/sOhUVF 5mF/yM|=^OxUf9w,`Ke\X'Sq{igo:%76k_Skޯ?Օ@/e׭55'{euU^ Z?J'V~Qj[\V?ٔxYk $ś['|E~] IE2~Mկ~[w:?w~IwaMT=*y"{v7o^GrzO?+e3Rf}r¾YWg{{Ox8:-ߌ2?x#)?t>~oJ.~jM,ʓ l:H6oGt ?-ubk@8(Z 7q/@I>%oUuOWj@L?:<8<c Qί`/|]2a>zxU?: 콀*#;?:&d_@>ʝ ScVt ǟ;"v$Q Y5~:@xU&d#vmj͓77J8sӸYt`_o K&O;ˋs1(%z>’UCEh?⭞_\wśQGr٥Y#+䄽zϑ?ac HimgkK_\ɕ>鏋F%rF^Z~/9j؜q`}*#J/_Mڎ#.M6n}m,$zk k~<u{/ȇ:㨍I'$@W=QO9b@_=9~˩xC,r@U 2^/F{t6rϜSӅg|E_V^|EgOvv3?=:  @qqb+]t)OEg+h^أRsH1m{75x}tH競^z+ i)AVӋ]S\lMfx:Q4Tpze.[^]js{%m]֏~p2OKuPg>y#B2GN׻Z)~r"徃nu =u;;R`s_-{x5P$X|oJwAh?:h\醶W2/k:=?(CtƯ:H$̟Kt#wK϶􊼿O4d ?'/퇟 ?~#iYO?; W Ci9E^ab>w`d2Ü[Up{,'$O:אl{/`B.(qFP`ۘԞbP5]W źӮdπ&\)WbLOTd;ק=;o&]城zֈf(J~yF BT飣^s@҇f:`jzUzOٸ譁hm_Q }Ĭ# ܜr٥i+.?/@z7i@Sq:}*_(Ίn \'XGA%"w-+(퀪q]@L#KMw?x-&iǒ Rh+6j+ˁnƫgɿ};򛚿@jV/@uOLOH. kg|k4)kcs/^p_2v;*߽Of6At__boO~}3oyoΞ3VOS\GoOrbыΟ76sYktrYci"v 4s Xw1 ,B/:JOGh=@GCŇbዧ2|zVQ7:.N iXw1oi!P[1Sͼn*F s$WGIڛ[aڟ;.>nRF_=YYn טT{\ϗdb;gޚ?}?_\_u<秬fӧM:CÏq2C=ΔS_qVs@KڧfL_rcFh;.-#0l{#@v*?!`'sؑZ mj^~jf=8T?^}- .eg)mls{A X'=q ?>[矹Cޟ j;:;)XjW?s$ ;T/GA x~as7~j?xAVV?8tj)JY`^{p5K_2 5T+ ?Qw1ūVT;Ihtùw}}|GL/6O1GW'=9bS: Ohxq{T=ϟ2k" 4yYP:WLm?ہ8fqm_x>~!w kCa_5%'Qؙ#$LLfe)g :hP?5s+_E>c9c ?&k% O [4¼s,?|>9 @x_l@Z)@-KƎ`0tkoݺt2?ZqqSշ5$~֗ 1_;7 M%?|ʾS~sSPgSڿqw;b;";JI>%h= Sx._)}7r{sݮJ~@t.t G;w |}E>?ᓧ/6yH)%  * S>.PN" { %_W>__lX@w@CA3;0N[{?|wyɷGn@s/Ȯ "?x߯?Of(:sKS($u/u%\O;;&dk}-;/k]%W?IÎsԋ>dH2Hj B:l,H{{2!?}Ѥ`FpgcKi~\gz@CCz'gqO$Zu?zO}m?hGN7S'Gi#?/~OO_}x/446܏ /̊H;{v6ÞJbh-'Y$U_ k_@ɿ 6ĠZ鹩eFyf$017G?)gU/^M?OƊ`g_a^Oǁ$?um9 {T?%uοp] ?5?߽,o+x<_q>9t1lZ1A>O~+ rע>7P{O'V^|ʫO~[w>|\NS['₍Z\߫ɦ\}&75KG Hc\ >V9>Zk V(fηuAC)hC?kG# οN |~ FYT_ Oʪ? 3ݝMaOgGQѼq%k?>|$Р$G2?6' R Ԡ"AW}s?=}ߜ><_|~[7ӷN}ӧ~|rB_[w ]8! ~®+\cu_m ucFxМW~WCB\om7a |A\-?ً[]i{?*y Wo'@#οrt>?Gow[F@f hB:8-@*)9ܓ Ylo8YJY9f~h0T?v0w UY᱑S:MJU :?b.z9vP,P%gm; ġ'Fa H&?Ǯbn׸J>ɼ?!,4@FX?^I?#S#2g5F07? [t'LJEH?ugmp- <_/`>k (%q'1E8E3 /,Z.{.h9LX'9 `qskbc:W Aب/x}o,=j@ڭ5Um(GU#UOf;L@>KeǧG저n_*_x|,ϘX/{u2+g$>|28ѱ紎coz_ BXA[Sc_q.O}?[->Ar+,#7)}`{R*X[c}BP[Hם'IMO{($ߡ;eMgKL*Up;7s>\hhl.+=:hmMy.@7~G׭Gf^@sl%/=hmQ=6Jdv.@g''7I}iiIp^/`9_&_w~a.Gїs-+C'r }~W?h?s{3s8^_Ts=?zPg)krb"p?Dg~W?|09&O0})t@O{KW UO=l&H{ZF7z~ǘvu_g#)]?67Y/,hpBYijC?RqJbOgi*,@ؿDlP=o%bȗ&Des^^bO|.@ׄy)z~_hcy->Gp g϶o'kƳ6 ܹکv[;Ƴ_}՗|ӯ{W_~w?xw_|5|3ϕO^|٫W>CN ]Ŧ|rCy\o@ ._ύ]_khT߂?\;Dzy %_WCE66菸)p暂/fs_^8Ĭ׺ņBs&Vo+,o&C*':OsUZ_@1-t|dg1/DŽT?=3fduvxvU};/uv\LՙW Te L-@_On~7}]%_z/z~WrH_<px)_כVU?(@?}(G ށ?4| Qemk u.v _lLM#Z$?5qM~dthx$c5# o'_1F>]CK;Ȑ8'yNޡxc'7%6f))oc8S97~oo9@XP4nxxG hj)ܥ{e tPw{:[1?*Vk-fݪ T U[RO&mW_O m)@ }}b{;;Wb~8KA~;?z/i:@b.{}s ߔxG1b;n! \ BkWi:%?9EC%(]p/)*5|# W_7 )~.z b#O麳tNOU @/7 K @'n/FZvR4U?F9ѡ)Okcw63h#Qe^> _ޕϥwT77`z:3ktz|Z9F)NMy|:g`2?;xpTM?W"0 /3?O:]h0?1Q/30sq~e{O̲n?3$h셟rYj-;ڏGYdrU ?}lYM=k%Qm؆ۿb5؃(o+Ouee___MbXC1`οڔ[7wIfJZXgYm4 ߲b32;"?oɜJt;ɿ:vho {?~mݽ{g{syl߽'Rogsk{;wbٻb?jh5:QC{=RS!QC}ȷ'[kijɨ}>jido>jiQjic_E~|ZG-QK$x{1,JD(>N(>J%-,%C~WC(>JD࿮D(>J듿ZRcGأ}_3cG{أ=_;m|Gأ ч?Zh޴GA{أ}?=a@? "o B>* CY* ,*B>* C>* B?QZBU };}{??̽;g_\WWWڵk9?FѣGo~o9_4qakkozKUDd C2/0  # A"sMrRPP09'ځZ @=ҁsMrRPP09' $c#~x`TE?< BBAGI`|^,**(7JM}7)( Uj&wSPRv7e޹{nI~nٹ{f̙ߜ @E^BӚiB;$@w.Q |^@v7Cѐ (NP深#> S> "y1|/&o:*R_H//&D%bt-Hz:&U)J (1]=@@@Ø܎_LX/ |,}@Kh |>}: <G鋁|>}h._Ln7I ZA"dD#,H>ZTC"HTR4L/H>D#EJKB d|G:AH>pt~a:dҁtjt#H>ҁuG:|Я~4J&PJC |(5JC <(JC |(%܌VH _RB!%JA <()@@ J>0Z <`Nh |`0P90|C!L'22u Ƣ~!C_͙3}H(u֡;w'Nd6ѥKݻw_'ILGFFDD2Ӝ!SG2TO1y~:)~ =Yo0_,|q>|a3l|I~]?Ym6MšXfsXMjQkSդ.Z,*iK84+-YZ%ڼR['ywsJkωդ2&S&4E{i>7O@+Qݸ&7/_}fBezg0~ oByRHjC٢5ٻP jVM|_{oY|[W~jg5 mGe(lXo q?}n~H{LQJ_krc7QckFC[}NOrW.-WK8 {*MX_~o_nGSt,\9Wޯ@zhPuFS^m06$V' ZIOTaTH tZ, }:5++ }}}IZh2}P[[2\~(O#ߧM9BU?Hy }yG<_>?C/?rnBߜ½TgZQSxg/V}=w߳詚ޗ6Mit r3 1.6衱TGl`L: ˡ~W^Zh= aSz7H-- 9|F^nj:ɿA8CGP3^`|O߼QGPQ]x*gO(7L{IƟק} yV#g7l 9j[3|'BTd:^UEU]5\$߷Wt;հy/z\9Xz-0)_MGWCHw_ o.oJ@9CӏJG*3y.ܾy过>{yd}6boW>gB!O"硜ۋ7ܾ@}4r1t|h 9>g.A෼K=aEKfX'WrG/ݎ=ys6H~^~IK.Ww7?a\ ?zp~%.><$g|7y9)IP&T*s"OtRgyMџJ%2P"Toqçt61[4&| OUh4rܙkA<29Í_*ךc~?5gZ+ F$NNtFO=:fk~'|A'-3tk6jH?h=::wi kEׄ`{~˳32 f\xlOytwjx[y5RG#te?)LDqe] pDH`Hs4Zs%rMEe[J-)tTl˱bAܫatߝ~Akr tDH -36"돥Eߖvlw%ŐtwhIiYa4o~/ <Ű#ul!Gh4-o~/_3W~kSY,f3{Tapm0SKQ^[LElʟ@'?ϙ *Ӫj<ٰpC-_U&$B?RT}?P푤2S̷V8~*tS8IN{= B̿ZʳVl瑬T Eg25bl6(g(^iAݘ<2Gp\WfQ81͔ 'D׳d:nVF;@zu`>gwcZs4R'ZiQ&`ukGC_ʓD]=|&ſsި:-֨7[LwdQӵiߚ~w^,^]5Ui0bk_Ӡi HOKj?KgNKo16z_}{NG8@R6#asQpTy~l옞1?3=w.Ì'ufUx 2n@?Wh3@3#n 0 Zs.ƥ9%쳖"sN5jαX tFՇ;n1%y) ySzq"^ϊEg}?W]cXzE&%GP^k^C7z/N}/Ewm2l2LI~.% ?/y>i^ro! $x})@R^-LDx[c0>1Ə{G~?5:k]{/ 䏟wm5li6C>l0C2rK4~vTQ] CNRXؠC>A"0TV;A` t_AWr|޽ܟۡwPS[j_M)_) K5p9{ X v Mzeg6ԛ*yr{7 gZ4Mɤq ޚ7[o.o,xkǓ\8q⢷'ϝܩHۨ[ޗg\knV\ذyqcgS邸p|颸a#>'.bnl"SB_1ߧWEL@y6nl&IsԯU诨@2ICdFèTb^iDŽ1r@+tϐsKSxQmN72 FO$QT&Ƭ ZQGZAwb^o󻉄Ox`l,d4|Cc$X?:@ E?"twaBwIޚʓ7>{p {M>ҔĺP^WcwjtjrɄ @rSc=܊l .F]S\]!gCP潐?l(Wl9piO0Zf\:+?ղHǤ*ݶYil^mgL2cd Yz."Ҭ,,S7K3m]m+ߍ_>秓c>y7~\*ɵY:/9Vl:KŽ0zo/J;0/i1 W^'ꇉtrcradкߗ'?qx򠄄.IVދV^Nx? =F |!L Se`bh} dn}3i2_"Ͼڇ"td؀ЁaL;<ק#j0[ Z켽%0ɏK|eu!ݽy5ͤ)hkB<fID )溺 ԎRLOʓ^ șY=̬|36Nm%Y8Wۏb)#?6Ӟ-Ą̄6ǴM$1բ^|5/&la U=ǹaSblQW>īs2L^{X㙌 T bjsl+fe?0ժKz^2#-N(?[Wf|]PMPdEZ`ǵ.f|ɤ]$4)Qj*;Ξ=m3Mr`=2.4](9kyeESz/@adɼbK`|ׁXQ))QBQkH8l_hY%'MNYd;it{`.WjO/"'Bo Q;V~3AQUdbN=J Q~`WUf?K/3^$4u{Sϝq Mm  ]'ꔻ{Ew٠C4#9zݰ)I{Q)X y^Y'Y|哬E_d/̗0;ڒ_~v+TU]5C$¹lc+ Z 6qW(-"D#f(9j}](E;Lܟ3[bZ`I ZZ*'gϝٵ }NMcfLeЖ?:ι\8"[ͦ}Dξ'N}ͫ;x#cn!°fݲ3&D®~@"a!oΝ0)/S-)δ8{p\+ىEZxɇMFӻtbXؠq|rWw QͦcFQGF2 !K^j4G >G^ Q[.K=G%ۯ!+p9j5cX⹲ 3V#!:l4[rZ#Xz֗z vNRڴKm Y񙹑@@}.o[t{C< FTOBO}5 o1mU)8iGG.gg/S8=h[g˓Ӕ~Ҿ\Cgl7`OEno2y[c-Fu"əB .?`oow\\T\WUfʄ o:Egbz~cVJpMUE1.bB%D͌ 5=cO09&znB/GQOZA:W4z`ALg۾rbl4ڐsbl>L(  L:D&=B9yyb%鍥l/#p˧ՏGOk֭L.>1} -6e^0k}#PH3)Y,Jւ~U&'I/\e۴eK{,[bWbLA}"Nl?PHU{NC_Ya)@HsqiZ3Tqa2j )DJ0~M4~^PgL b{Nxp q9g1HZXٻPxu 걗F'g]{`^)=0 kNjzKZ%G:Q: 4u,fPXר BJ_U bg\L|v(9QbOܸN3C>%+,RCg$1+WM5N[UUlp9{0ע!A,sS~=1uZFm}WR$~oH(>a_nڰׯز F/n &}k7\ގ-Rbޖ7.Mç&$SE0Yg2p1`-ƍE7_WQQJKζmXysS(M \hEC}]+9tEdr8\xE-Dz{{ 3HJd3ImwV30ߢV H\e>p&g2ɑcYY ' G9u4;d~>_"&dwg(tZN +g_].תtWٵZOt,/ƛ ' 4 s0D^. ?[vcn鶆=a^.NO{3ɫ??d'?С$f>llSPa p*8ɯ:*Ȑ>K{׋gV тEv1O27|%leeew-)-lʫEًͅ)?ҽLtEx%> ]K{gE~ָ*v^ŵWǶ'EE/Ay۱.Ή>ƵTmPs9Ƶ7k<FO54)npQ11k4}&)kG-j^|DfW;-uWψ]~Z-^cОc/ YTyAi6ѶyGB͛((4iڥes=l>`P>eş?ws$KLK7h3]fc@0M*(-uhj6ߕ+ªaF*"ۊɃ~Wg;сݱEFϧV YT,籶&-ht`>RaZS0q~duիu+ e93Hd庎HfLzjTڵ*m[cbyt{"3<.Ƞ'/ 2 f5S~ZK kOv0e̢…&jK9\K"4?y_r]ey7[uwU0>aFl 3Sf^o5lkN|p=KW~Ww>w~qgM;LjM,|bQ`Gq}͖#EE`GZz Vէ1> S{QJ7l 'd~1+:=sHBJoxsG"~]ܩԠ<1z!ͧWrߋ(MxEg2v {sa1LaHEIYAʮҢL'L<0C^oAc1Pˆj)6̦ɞB"zay)Dhph3'{{ӟ TJ8|sϴY&xޭPPǮHz-9y܊BY1~37?VIyH ybb30|%x]QW>S *aӗq q⏒B>{:VYijg˙x~O3\$-P@]:̶;{>naҕgx!q}핷_zg?WQY^vHmE֢u/Q74Il`]qIë-gy)?۳͜1-cYwsjqISPP`@9@`/JJ /MvL\uqvBi0 >>Ԍ(ոv<|^^MOڀ?^ ѫ-eE%Gq"q?PL}9'yvDŽoW?n \4:oj yREuhPlcZ˟S8zU{x/?4e̶-oJZHfשּׂtٽDAwddB zz#Z1k`iX4hs~B L$DΟ֍UVTiHXvIuwW[9k}=!\⊋H3R.@ve]'ipO  O|b0텺myu VK1Y;P٫BoCCYXqxuޗ,y9^{zhPr`A͘O"h\ OތB!^`6_s]|6f,_p2n,Zo AP(2w T\c;퐦nN-P~蝎j#פoVz?˳E_]<2X$v{}9g,'/W}ocM~jXo&\%zBr5}QGoCo]{T WIYMz("˘3kW_t*shsxژsy7Vˍ5*܌-ŀ_)— Tfx<nݐc<6e倔 R$']bm]Ev"QgiA2LD!`gT2~\({'fvG.c0z2tRpC .U騳;pu 3ա}-wF(>"e"EBii<ЎŎjLF1 nove}oPuvjIScmvZ@v\_'?enCx0<(ɡ^rvyT Y͂f7^bXsS^6oRx%7']*>)>ۻtGkƠkt;k:RuaYܐ}/'-YWW.^?|e (j靅Q+.J~#=&FI#bAU^jԆG d7W&}0@_&k@db2Pse=Z:|0eT L&XOi ׹=oiəg㜏.6`q[Dbd'b 8S-wndz-g`'dD=? 'n%g\ fRYqQk2-Ջ'0^uZqsaaWN)ߎELx?.ꃘhfL{>kt|/6zjlیi11ӣ#9#6;m7%> !#!??>f";'=As{)ϓͪy`B鬩Ccy)j[pETz4X.:;_f|t>vmw3Z䧤ˡFgh}Vvͯ0ݺAA\?wΗ۲O CÂnd|UsEpQ_JDB>pj^RZ<ݎw;*b@ZB2ٳUUkh-6f{'藀OÁ8XyRPOs&+\*'PA7zEG^9z*#;{-l]cII~ln?wAL{V&7)nN~Om衞m2=ЇmZϦQXqVݨ@8]E*Glȫ\ 8,8,6Li6{j^wjP@ÉO Ǫ ޺lE/S~MupJФe=>rs+ $}rE}\2BqNۺVIa M&0:.N, =k;J`JDKl,Ͷ\7kmX2O9 exgݟj-y`?xiRfߋ0MX0JKSRJ-X7s0[ȋSa?_HI;/5(AԖI Rs^9h뉺!xV/Z::MjQP"1CBr9Cè|n #jsyӻKjfgG|,*Ճ2hu΋u:玬_Żso~;|)|rS'(qPh0\L#0pn3O`T.d>;?vP0LvDGxɐ1f" mzgCo5wMs !\28/% ^WAgX͓֭؂a } j>yJ0,,L}鮰 .4/;zqW̧^P'Pt6;9n`ϓإP)`xfT =אj5Sշ75| V8h?(9o;U|c_Ƹ_ķ'4S;:׹C_ZCq#u37+ŴCYԫՔCYOqu=;f#L% cb:LOh;;nb|fz(muݢu7ƴvz]߄qѻ Ć.jVl(D@(kt&Z9.i b4xI|*_x4:GXNbU/=_36$l>}4W2ՐPo.5.˜\%g.PX?wڵ؝N `qID Ewwr6zqk^.jW@ 0Va28PH` 6գquxVJ?3,]o?J3<7~٠ ^k~*!pm.SwǼ@~G J.,=Q0xb7Mq*i[cbsDZ> ̗g6Ĵp4=kqܧ_[f1識8.uKxd&N\|ҍK\4H,d$Z_`Kyh9>CE Մռ}Ϲ2?xqíK`njlk0Ƶ0mߣݸvc:kXlq(H|aL+\}Pǹq! ̌4KU;wqvܱm#GZ5[}|#hM{%.}2uk{YBxU_߼G6*+eg2vѠ3_"]բX)KZI6PZR[V鸈KJTU^ f?je j;p rG+ t~YSx YEP & k#q$\>[|JWy ]nD>At*Ύk\ {IŤpJ }&g˝23sq^A%ͮc oL"0h dqa}LmkE/@@(UzQk5^q Vhʝ^w|纳jö1瞚NUGY4)r4gxM0*rBZxiʣ˞{̻G}&=Y۞q۾{7.:6O˄OJ_G%<RyX* Jw qӧm%7* 4 1ޓn텉/ﺇ7sg{ozjkZ5y/ &م=>a0*)$ A2k8 R1>yIGg]T2M6Xͬ03h;ջBsxOL늣 <3K[rs3@ƖW58$2◎ ́rsc8< %,VK K? ƛ=a+\;SvV]MQoF!.\':ro6 w͂г?=?:-~/dGkֈD Ίc0*H>1kd\ I]3}tP0B~c{o[ Se5/KS<*o-(׮b\XWK~KO#¦rFF:ςW,lY3TVU}r.0 M󬨩CZL[Odzrch鷯 @ڼT/,=|ZUOQ3|y{zvpXS>^G.971Y)i$)t&Y}V|j<3ƼsLoWxUU*o,f9#.Q3x{= ^ q{ԞH>>%[#(O[Wbp%cޡ'Bşg~NL`;LOh;%%e)̘wGce & B@M&ƶuqթfgBb=`J\k7k3t҉];K!o?p֓[z {#vna=SzYJV$m kc; M.y_z᥋ׁ` =Y\_ b.QP3`;;ɘ-=6W@/#k*IJoZ?kɒ˾*gBLaٽGK۷8qJQԽIܽY]co^눿_Hpؖge++>^[Cm`1*~(0BG @ $\{"56u. iLyIn$H F/bu ~4Ƨ\`?_W=&Ba4<ޭ^ ڢ+ h>gSq1: "Tăh<2D^c048!P^"03]9٢I3ͻpن-ks䶟^ub=LEn8m9F̄n2 *oҔ]ۍ~G>Ȳ[/m}Q{ ,>f5O1z S.2Awqלǵn?'/ Dq'-MEWiq5k`Yժ}U),S(QfF?.4N{;clX 癌]|h?c7is)Ir-u5'h-%^"jϢ^^UD|*?q\O{KNK[3fg<z5;[A*xTpo"‘wG㥽^z.~s/X}}.䒜mR#I5U?0pꋨȃHs]{8CS:V`$|0uNa=tRͥ\mTOXM h\fk9Y4QƳ"+GRZ$+ZHylf^\{m@?U كМ-wtݧobةRsИ-<{ `)ӧ0x*s FΔʭ| M~_\=t{IQҽ7S=B=n2{X; H6?7Yj4 en{'bB5&7~gbDEE'I4V7Z^̪?.cOQ3>ML mM5tm{zݠ-Ia_dؓ[J]T?o$G{ 9K'Јb>7LiƋbOA&ejߢx#mbBۙ1$2ό؈qѫW'kq L>-%FǷI9'.Ql^m1F{Esfu Y`tq>>5`~O\By(Hɹß=Z Utd$X^({L񥋸woI=,1vvhU8QԶxz(tn?~ }?y-! +1+1~٨V -ͺFe̤y.ΐs` ե|.7{X'"dT,%ϞܴcZ#_\枹#NxWtrǔER-,]qy>E#?[^xzvgC(KEqevԁ+QuhI\4.(&Njl7l'Lݠ0)عϼ<&"¢W%p{!4}GQfhɠUvB F m>EША<zMWu$o&ڨ"PܫS*LI\2`*i*ɬ5del3$sZӸ{>.SYdvkh9VS-ߍ<9j֧r@ϷZ<{o"r2w3y_JYr?bxxǩfW=z a o3Tu sa q 5p>3pxDg v˙ M7@eZ"ni~I1&/5|9O;+=\ZV([5gNXe_9Ǫ|{ m~v\Ԅ m_Mwߦgܽ5LĄ=$n?Y5KWEn l!,)?'cxqGZ{ǻ<%Y$S\^]Wsqw:7oZ'uFJm|"bWfџGv\肈K":W|&<Ǘt"zMDK^sN°; 9iE# y[+Ozrf&*޵Τ%X\yOyIfZYl3G6h4,qz,?&k?]]7.;WtbWU&CQ{b㙮g[Vm:lCEba{0\}խMMn𑑄`KK% 6C0Ɓ!5 8R'`gZMeәoUujgӃeiZ5sZjU6Գܩ?~o;tXγo;|fޯ-~_:[_y@}izG&qЯM|š9΂tWr-Be%%k>}w޶}QOwj3 ]'bŵ ؊{WnCi|E??_o71~zS,אַ1x&uJXT|y U[~Io,ߪOWQCD^Si]gc/]k:_9}+W]w+DSfU95}5kdu+=ޗkgӉ5*aZb7X*0?-fC|;rɢ<ℰgLgd,h%Ǝvxp|O܂leN窞LGgȟL=_|G/g` pU e]} vGN0$&O/._X}?2GS?xw?tw~k goA}مG t߶.{_tl_]6[~ߛ./F4{KꗌM]/佗3Z/_[kK6Tq$;=mxUgKE܊s/~z%OΞ}*~?R mR駵'X~F~xΑaў '䒳d6{,yd!nx? M6594ӷO?}aH6_Ml\ϝ?ե,.nOS=q'O}ݿ#<}t7_09OG._dKOCkƫm]4f7wmz2y{S;19.k_ !,$;S[oOw磉F~7~k|sS\~Τg"%Z,֟JSLz)R!Uge7~?\T& cvXS r?{gO=̳=sgO?r7NBNe_qo}_.Nٞ -zgb}[۾ç=1(sn&,z]>g?\su805ىwR|v=ggI~R.'/}S7Ցu:]w[{-Bȩdx7 vRt\l\"D@dz'Fl'uf褃ʝ PەK'b'X[m=ss>dW}z̳OڿYvL0 1]O&kשL4(OI~{vd!S''O1}{! >O N˟B[;F~>6q_l@>r^+>8VZM[xb573][ر_YnY[s\qongR0SΙ;O׸X0O(>:M_{筻>Ү] b\/i{{>rxrjC|Çwxlǿz'-~q^?m{睾l˩yQO'f'|944g(_|oO?ޓ+d~r|J/̧VA>Pֽ{ yg1{I~؞ 2|Ҷu~6^{guOg?ǿ|.7܏b?ŞMQ> 9bN%gQB P³Ybφr|e9F<2.߯ /eHN5S^"Hpg=}&l\Gst4RT&}..>M,wY6}[MsrS{Mt~gKƾ<̝SM~ oy};lDV.gvqUړvqM jC{9Wel}CemM%+MOx\oLb[~٨-ի8V,r~Ha#kSi7,(lX_eV _h4L_V׼M?A׹&ywߵgn̯صkl s޽{U$cckl|6vJ~._U1-Co77v>?Q筻.bZ͈/]:E?s=wxmCڵٶ^|9ϭ/>%o̾% d z@u :?o: GLMphr||$q|"aO>E9LLTAS0n(79txT/!k;)Q r=WP\xT?,Q^JLG.+ej˴jT&ى*N=jthśLE/5vP|\N.tխ|H]JvDxxDž^?϶?ţ2VtGNgӫlIQm'$gO堅ͩko|{ےNMz>W^y#ZQso={z»&ސ{qǻ?&]5|k ~{tݱNcL¯zW_(NjIX}L~_|N˚ v,nۖ3NtJ=S`_$W⸔oPi6]Ͼʏѻ[ԡ\L:.ث}];z ϺE^w#RqO7D R~K/̟-Y>=l}n/gl?oT!`i#Kx=wy3}dJCkkZnsuYi7@"5W+&IṦ;.t<@!*MWyu5VN[V峭7Oml,Gm|\=QO><_zէ7`\h#Uv-cj=gcn`~ٗo=곽^tg~I^0RͫXu^Ɋ֊-X<%_vo4OLO%|^ XK'g*^]9y9*d%cvOLv^N,x[r=>Ld\z<ywsq]e\b\,o\ـڎOS9Gu7};Z^X;񽡿w8s֎M9OrA<r .صx߿ ;ø'y9ɭϯ=ΓWE=.g{SZZ;r_/?=h+ot/:[u^.G?#GxYsE]ﻬ[K-G?c?:[17qu+wmnV7w.{qoj9w,iA7Cu(8j] ~s67{|qLS bVR+yu=ީ<.+/ˏ\薍^qɻؠ Ox`D߄{6^-޸bϞq^O̳>ϟX=Yv޻\|{EyX{d߭ϛ0ֿ7#|^jۼy1ƬSMlԸ=}}QƱ|l繵 x*ܬ@>~TG.xzc y⩞ʙ2G<'\_ϥY<|Ω5n?cX{Y3:$E\7đ^U|./_Ɠ7SBV qq;ϟ8^N$^(QOУ'Oq:ر^osk?lE9>Γ-]Wo^8a>o>-_z} {w<:'=yes({x(ohBoh7ıO۞DI|>!~8!)U΂>ʌYQ4Dq8̿c)gMȳ&}. ꯗoPna?:j{nr!rZGclG[l-5Wo$}:BVo.ǃ>Q=6$*Wg{.g6<޻n]$c8M_Ox?,ϟ~泋r{UuV^iy>{(_Y^;b걉b{ ކ%Z%tXs7EM,<,TkL}Q# 1yi)UƧb LCy@',pˣ2YCP&pi5y]"RnBQ/3iu>cw@-G BO\)_`IG}j'}PuwMb}(WK@ FB^>J0FM?\Qq)r)r)~(`t5jՎ!Y+ewZm W"ep+-1Xl.%\߃w"ꮄ|wz"-6Nk9jT[}GO%z{|?_υ執hM井냷$dtFj &51R.JN،ܭ0>ϵm]߉,ۨG5X7fe>'$< Ox'|?xsԬ ,'#UꀾU>AГKOwlɩ8ꆖyĹo?c^?`rygGO6WךOOF<˸bZ̪p2g*.rz_nϩN> ]nTNB_ER]"r]&󊟿Vk'bgɆ?kQG{ K;kҙ^@6#՝`phcܸ#54k@d{un rP]S1_=1 nuAݳ`cNKOg:b>QN9SN9S59'hN*>϶8w酼fxN,0_B>yՓϿL)/aYޮhi-IųSix?qUnd9ڨ]NvrK:걌ЇA󗥩Q[o)q2OgVq}%DtdxBGe7q;rB2~3^;oM\_~'iLùE~Sg(wplSg$'9IN-V@׽G󥏺<`ޟ4EwoF񺗻Fc nu)0嬁G{rxaEWz 磕rlʡCvTY˻x r`(8‡ߵ%>KYM偉r6r'< Ox»P;1s=:xݧ$wqxaW|l}m}YpS'ˤ'C|loR pǶ]Iu[џ$'9INr$_|6Ir3z<5o4%~3R}c[>T=SMz*N 3js=s9NgӿW<R9k'< Ox¿&wuJxͳ|^+ g|ҮI>o'< Ox@c|{O3^"c{vEu[[z Ox'< O "5&/StCzz{{ϯ)#U8 Ox'< {31\|l̦x,fW|: CXu/?eARd5Ox'< Ox'W-&-[959?O,;gr :z=z.-~DS'rY'< Ox#>OF|^QSug ]`zݒyF6V{^+[Fb1W(sV*UNx'< Ox_ xkص62mK;\ExYσD磩đT>) T*cd"ɻt<{w|q Ox'< O y sD:2\p^In3FZM1/Sc{w_{l=;ݽs={^=k׾B%WA(X@ϸυf- fLgaOx'< O I# mNi:Ù\s&1sG$d|%2q+ºԑð( S%< Ox'L>[U{{Vxx}e|~K[y> _P:!"fXwRM/x,Fu^ Ox'< u\Y@Zϗ|{I бyx<_V`; o|ݟ'%: d.?H>rdG x7,BhYD&< Ox'e-x/S d'< Ox.SEifMGK˿ɟVk7]M3MƁϟL&fZ5NdӰX0EOOIVC'='_" Ox'< y|~o'80O@yk?0/ºB:,ӶO&yV Ox'< O.әY?NKqA?7998JGTYJ/J՗ Qo[ Ox'< ;['Z璉~#pT+ۥ/ ?_w =L&P>3y.k>᳔I(@Ohw99== 9NC2?^",LUnV C{Z]sY7ɫJÈ<>{/'< Ox0ȓU| Wr|Lɔ'Fc%@.F_uD|3W% ~ϥ\&x> 7N35eu;JZmpg=gR'< Ox'GoVxn7O9slx>6l*N7"r6?P`,h盄+n>N'< Ox'Gf|rd&uB?~a~@~.cԩ\:m P.ի }1K{@leUӪE|)n*UVe jYi z}VFXN^S>+&ݬZн_-ãVAώ/Q^W7 Ox'< Ox37|[r욅c4L?FQL3MƁ%QcG_&SK-)oiMaRXy73b681l|U-Ai.#۴EU҃&UZ嗪eK}(PۇzYkVvu4nk#ߕ'< Ox7Xs$>qOhgx@`.uÓmqwMbrI״z o>rV\*efry 0k*(Yo7*|a٧ ,&"9uXe^NCfrYG$9jn`mzʦ1v׊'m'< OxwK8'U=gSd\ F"C|V^LX7|FUfˁR0ݮ3w޹} }djc?_c;t+uCß #Mj q( k7UJŠƿ+.Dks Ylg)b;߭RlrO'< Ox7.osΟGHB9zI+fQJyZ0$`Xpl`3v]*edxb0=쇇^?:VArKx@;{N[]Vz^XER=d83+}Α lEP)>E>1i+0eX7<ð`5?k\YժUU" jbnw ٪G < Ox'2--ºaFϝ5 U/Hܾl)|q-SЙ3 ,%*P~P-kxP#,7jnM;PXy w*V-ߕ'< OxwN VnZZrL2ZmZ{ Yη6E.Ux.0IqEֽZgak 3/bQJ32xŢ-`9mi \w3\{mV}E+o@KV]j 52ս ko8?I'< Ox';^z@s={wyw5g_ 2K/ZzUDw?:; \y,jK@?<]zn卣#lEKvzX+Kojeoчs/WB;o_lUjYʇEa۶2ksڟ'< Ox' |;:rx|j6?49> vQ!q(bmcЮ5CM#>:͂N]ZXPxek'< Oxk?IϥStf>Q_ߎ?0n75?,|򫭆A#d_\^:WxSp9Qo]V֮(8?NJM}_Eoz\)n)!9INr$'9׹?I3\>HX&Ya OͥӸ.=;eo#gȳTR^ A|QjQ> nlIR*˯˱{Ÿj^E <|w\[\q~O6iMKjmZj2 τ'< O/BBL[KX;@J(y[Ñ[ *ǻ=䙾jފzc',m}8!xo\B@I33wOzҾƞV *O=K`ճ1 Ox/X1%vgka/\5v}_RݸZzr;v|j`p$'9INGn˄BgxICQz{]rG76]^^ݽu܏|?,ƕXZ;^ag$'kQ̦RLFo# %5v~22G_ e|91՚cnwPQZG/XVs<"wd 5 % +]<%J(Q?P&sX.ϳnGj &[ǟd~ 7xfIo ߹te[o6>%J(Q?X ToT[mCި35g#ک:hkw?Mwŋ:Yy['sd^O>(^~qd=e{F~za7mW:}z綸 =27vV+Z~ji;c OxZ#'sT&R\<0%d:\4cWdSɅl*~Au9άgW}gπl=YӬkv7}'{_}ν{v1=|޵{^zlHdx9Xnݢ";oSP+pfvU~0W@'+Gc8N#rF$|KwkWt\5ًi.Yת3vowR`S̫iQO `!?[\U-?ﯔ%J(Q2OFɩI:rx|jX={Wc?0h>k173;6߿CJmr6[8P&=Mc>{CC{BoxSnr^7*qoC'"gZFy䤆=q.K ǕWתM%5\( l&>u}$>&5LP,ʾvK`L(QD9iDkv r yshnrrh-B`x+ojxﴬtT)zk5_o\y-){ z):"@Cۆ<:QRΞ5Lg\Q]BGBOWG4>Mg6mqyXB{Q_? $ἣqd/z n5+0kH0`j[C؁YQ}Jo%lߣwͤ'Et~}'V/Dc:0h5?db?x ?(f2k#{@o K>kX]=2+&S/Q$'9m?1ۇK2Mk<4n"9b(p ‘/Ì*ȿ Jѥ4 + Ҁ' {FIg lwzeX~p %2t[hyP/i^b d[5~潤/c ?M@I=$ß ¹|sdH/!Y&kèN,XBg&Epȷ1-oPfugćsyd-&=l0XHVԙchV*}dg)j+pFq9$lx_T?1jO|oY`0o? O%J(YI e%n>QO9x  igj+Ⲷ|{84AmeY;wN[Z~zF9T,iK0k*/.rX  =`fj?XN^LeQv\FjA[Bhw]X- C/ۂ;ƶ,#7Y!@%Ypۦh Ps;} 䅂a%?0;D񶬬łVX%my5C#,rBX)_%6Z'6c[&0n ZD? `_a#^ {h 9ӠEXZ!$8RQl&,3{˷r6XKc->.F疀`uFy|NGAЃC-bD@3go5+tQ;w Lǹމ Rt>4je#טPhm+L˫OWbK l=!t )='NXNj0%(QDSWr]h4$ q/q c>BSW!?NmÜYV+F|'t_ k >auG %e8Y(o,IǴFu!˂+9z^5\ 䫫apHOƃ@+e֖A [/`["쯼|݃EI++p$Vk cmeG>`mC6}>=0j/nGY)?@_Ks+kKo>aZM0f%W@&Ev=h˪h פK Ve\s |9EdNYm^JQ@=6` V-_mesOL?\0{'>=W sp}4)!rp ԟlK%֫]8\gpqoׂA`wCl³X {7A_0[(,8@f|r-(m]\~''̡~mZ,}22.= 52.T\d 7sPF(>n7^{ze5\~"Kv0f t2*(V{-2%6^C|' dDGHQ鱈-^Anu ߤXW1CC}Uv$ z%N72!1<0|dm 3X %PL@b+7Z l0ܞ=׎xላ V޶es,B\<ع D-r\Jj/gh5J?y'縉9)ekQZX= 0;|pZg(QDEh/xvk6d<\:ϳDYs &cJ t`@8TJZ̙FRўjP_WW^OEVW>m ~m$plLXAfrti挟ZUagzb W oP0TܛF`K̸ YnJU+f[栏YefKX f뺅s]#F9Za\ʅ$SZhXa]V`$;a}Ҭp[  >5:cakƎw p~ȣPJ_ zYHVa_Qف6{OJO L5oGc:`"JvkN{;=3'#|ˇIzp~f{o;2ˠ!s\1-_/I{C0d}Ϟګxg7>?'Fd6C*;ch q"{GFT7e'B9<sPhJ`>~y@Fw9::Uf9M̺y/ 9OX}ՋvE;"bymC #rdaΥWpۀ)l %IYߺ}cJ5./oxXx?[݄]7ckUᇿ"NH ͣ{/e/3ہ6oYG+70'`*|u~ҖlӽYd1[kx#4DD&,آ[]anEˌՊZQ\IvJ7Á!^2qʷc1Duܯij21*,Wlࢍ ݃g wNAe1ʽ-0jlE͜Ke~dhP+<`]a pwqlڗ5*:6 ܭkz鱌 oްcϜT:3Vyp{%#I0qǶ} #Syqw G2[[ 'YGs0W 4fr` 71PdČת跌:"R!N/.-KGrxppgvF\W[!cUrk Da"zO9%d !jcϷoǃw n&@y[h-~&l"ҹt3׽ǩT-,F ?>ȣ\ʣt?4y(w6rC? Q{^%fK-PpyqLoKEbъ2r6V2^Gf2dt;:g`W^ln lǤ"JTo\fGXjŇeΣWډ|J峵6VL @y*[Vծd'XWG:sYfgb|/Ǹg;|[Y`JwYɛ{<#Br9[k,-2_fEs58D8d%;K^Œ1%p 93~*@ө|?1aaUL7c\>u?5Zp&+W"+u 6[ Ϋ+3ʻx[n8{+3Fuee¼Y%#E2J3n}d۠uaNz}u {=30vƜES/x8l\@w4১y{ttg~a‚ YZn@Pޞ,@=ƇWa5YNx> =WY?sde҃pI+'>?`3ۅ/=ȸqhHCs:Ba TϓRe$~XDB<1h#NJm\W!}v~u?vetz? ckoS$'9ɍEQmP}!nr5_]Va_\B~wHܺӣyͺ#=2Ĉ[ט|oraUB1"dQ; |XC촥ڈm3߻cY_F$E55'p$Cu?Z`d_W:}2q0&*|kv:kyo (nj3.]7<"KX#FtT{#@#Cb\UxCl7j 9O6{+ݗ`Y૸c;Mqmc"16,L6w`jQ(? kvSvv8 ^*q ݓrb^%'&X5@ZX3Ţ80$n"f* "T~ׂA釃ʹ@PwUp@hC̥{s7e T$E}6zy,M=O*J(QD酙#(A l̶} >kgU\Ȗךq?#< e ĉcF(2N}d^ݒv,i9[JRQ-d#mpe*jofOT-_'ef,_DXE/zoƿ40 #)`쎉en;D̒ܓL"/79fNSbDY (}歳 ¹\#+*-K6s/#wI nP@U>c%wfsh|N&϶!X[Ρ]}[O퐾sǭ񰠸W=eoxpW:C}vΨ+iL)QDW ,4XXK&d<肁?3~7@kNk/ÆP,:_mom VЖܲ7~E12CjH;WuWO|F膻_=lcBzN(UY.B8ZNM tO0|;Dg¡Oٟ ;{Tpq'PN`8^%f1 Z~<`п`/C6~hEa5r9zۿ>gZuqU5,9to(,~o?( ?[\k%mgn'< Ox¿@GYQ}3M)3I>L.dgS)_\S3mc8E]f/Dߌe!x5mo݊uԩ )gnv<%4ATKd&trХIjr'M( Yaoj/9[4%$jOl\|c̜wcLWd'(|8^,.a֎ж䃵**S)|O~w Ox?GD(>,?Dz4qcW@Q}3`~_;x9q`+t.{]=O  Dݷ=c(릶jyꥍ.{u}΄{"U?vglZlr`O.~toT(QD_1G?x.@myFd$7.h'_)G9<,{EflĻBm2v5C7Gy(QD1qw?k 5pUXЌ+w)# RK7nfatǻ{Sb>}tvn^K yU!z9Z_{;بB6bMa}xwֵ-OE 9^Ņ#9INr_lr5_kǕ߫f󴮮=΢KG(?% }Kr$'+s@MM>vdvOF<(ZxUQ>9e_CD9ŷ 36u(QD (6οsr gU-=pP'<Ϙv<8@M>N"'< Ox'#l?PQo:$'9INr$$)8nOG?INr$'9INPnoT_/[(?H)QD%J(Qt~aXuo!/_=k0ÓM^z1}H.G[OzBoӸNb?js@~\z}zEzifo_3>!< Ox~S?`&^_QoSّu `Oo|{~ '< Oxo}z߫7>:UVr< t}ޢ[9l$w_%o{GY INr}Mv+<o&(3,L|.|ovINr$8@e%?c_o3%fxP˱)WױA;(33EJ/[(QD/9?ijo_s_MC"5H>xo-%J(Q1`Y2{r ձQ  ˭HZvmN'/^mqdO`=)z;xÖ0W g9N̎me=-zLKXYm0zwU~=dwF6}Z?KR^U(QD%[|LGzSu}vLX9j>ʗ&%>FoZ3j&ש6vm*8b{{ꋅx(YZHHjvj{?w]( Xxy(INr)ZϿ)_|x{6,/ꏼJ{kp to0tw(tO8p0?+!/_7~o}u;Πnj9kY/uʪBr$'99&SZe_ XA|eO+M2}ӟ0CmqY;{F+hŕ"/Ï[J ͡-j£=T}6{{Dw_Xl J(QDBMh\`GGWmΩZ;Ѳ3q9|0?z4 ,ވWJ&K%@_ݒ//uڿ*waШGBAUsiR(l[o|жJܹl#z< ~%4k |z`CÃZg(|sj9un>=p{g`1ƃAcF2f1!dY,# QY,ݭzUUuEЂxxYȈni<׊Fs\%D;rȣz6S El'XD 1ǗHPѯ^ܳh9硒j9yL5,t!wFjQM )oQ}rU/T:n>;zT]^yk P) rqv^rqo@h*RA!+:jUhجrON$:wPZ(N.J[~D8<]PJޚɴwUr*A>ZBXK(Ws jEgu 25Z#\6/&kq9t<8vu{z]NJpϻ:R7{̱UL,$} y7+Q}K廪h\yX*3g  A⇵*wmKC;hW?R04<.<5uKNm-2@NAXM<ʉV\r_.)Ч,xg'1x':?;yA|#hCj.}sȶe$^pݠ :`L5v&yXɨNqWD2mC*/(Xg0 -jykJ X?A?zx =CL8 z?T"u1R a;: NFߧʕ`aHm.9 n$2+زMجۻ\㸄N;-@*.fΪ=mw}+SMXW{;(`qOտ1U#VᑖKG {ͼSUAF u*<9[ yhocQ^@E=q!FZ7 2&JZx?!?{;.w{蔊 wt8s(L'J^|55.F PR9_,5fDؤ<敢B:GxN\yyY>k_yS>+' pipoN;!Q׉%lmyP`;ԷW+ ? 矟;N͛b}ov{Ѹ][!gۇU&G9 5iSdڭ5iB}&^&6F{ƵݺRda7XAanpJR#k9v՛"T ha^e~ٶCCKmMPyK=sjЙj&\;U>& ,XKys($(l(Pqmk ;D]ʝ;SU>W6?5^h\:m=zm _'pWwx<#JgOW/w}."/"/"Z N\ES_i7,_핆@Ӗs̲55V g dM!kZW<@)'{5K 5tnvȇOh\ ͠mhVQ_Ϗ"O{ FSt1Txrdztqz [.gGd[گ1cfHQ=?h^#l?gؽC;QŘ̓AԡѼ-:.h/A_Wҳ}i,y1ո`g7ҀWF S3zJӮzѳ^G/| _SyLm VAGUO!_aiv CKd>LM?Piv(tͦ{&Q߹{dg& CN%f1#r<\|“o$,GTT߬וӷj@!ߘpVl9 > a{nӐkPWl"P0ZMQD:ƽcJ-WH_T)?!F+MY|8ZY1/9p Z+1կEv?~8^ ?h׈٢,j'.&!w03*֞ߎḨgԨWAxBSEpuВCQ$oWTr k7Uԗ+w-#G*S?kL%ơd&do4[jƁgm2y.Kj^"L"0ӘZfh7񿾓wP1QF`[j1צxU( s 'KNލ{, ;ۀh<}y-y*>m*msf{GO|V=BNHʇZ~~ h5u*yn3)ڬ-A^#1پi?\ie[Qߌq CEzGfJ|ǙR6 >jLdW?:;*L sUt;UjPmJ]tmL;"i\n'5.n Z hΞDٴ|K̻Z5HRA;hK!!!!!td,@gg#. yzkrwy_(.%'ܧ9K oms8{$*a7v8>EÛ,.AYkVȳϝzT~[*?\k+4-~'ҡp׾4>hG¾QH{ QKt:{#NnxIX9xxuO c X5UEYm 0;Jɬj޳OE?GȲݽR=$^QCt.0g!眥Y - ᳆h~>9թJi^_pOo/yO:^͛v6 Vk ,;ӰI~vA=&yRpDžT NA|8(P⥢gX=.jgmcBjLe>yyy?P7|3/#0ghVdrɌeQʬrޜ }O~,_f.MH%2t^B <.|6Ü*fF_XE:.igrqq?EIEZ8+*a'QTBsU1OUiKKvyԵR2q 8\G[Uf7qO%kSszhCӭ 4]FMj*hy}&8~1K"ϦngJѡku;:Rhyyy#石>Q,?Yywg˶3Z>7Dh ώ$[dſ]f=PdnZ2fc-Nr*o@δyB`@X{E'֞ʢFQf:XVQobKc\)Q^sm&:=QW8J|(XI։5b&7JY'BBBBBBBk :^(3ƽPmhkIAzstVu$m />^1bm:n('hu]ZiUGAYBBBBBB`k/|K#;/uB4HbD9iD"Sʡǒ3uêϦ|Οss495MOaF/|_J} g>3r+g w_i>h < 8فv!s _׎z P??xB?֧:Qf\(hr2Z`3|],3&iO?NFy1gC mbGeXZ~g4~x/AE^E^E^E^䗕WG]G7|3/#0cVEzv@xxXſ=VL~yuw+V1(eXk뀢8+yȶv{rPGG, b"8bdrP*BuhJ5ZnϮ:Eڣy7b(-|ďxvXTKL.aB~쀾i[5oҏa/{/̵7rg7U"/"/"/"/ G?g1|X1ʀy^0w6>m۷WjNm= P( ;~h }ʱҶP=7hPJykߚn෩dygq_ =v|vr߆>7 Y8j|贂v0~0~'4<~ߢ g8hU{wGG#P ZMj fA1{Aڝʝ2oqji6~= ]/EA9jbKrL陆סHoU!!!!!!!! tP0gIw"gmЦV!#s T\(&kZF,Axn)m`ۭ5*Ӿ}Tk*;l[n! W.][j{]%%kG/~TQ%w 7jwUJwV=@n@'.=΁ijgD7 >&zxG[ qh2/,l"}uSF# H3P~nCcߪUI~K[j('asCwU؀y Nv ]>NeF{v˛_b~ؘ-,1!!!!!!!kD2컀{mMʃ , +Aɿ\$uBt(0Ugd`tMO'?+%2z]} TH̉4v1hg &z^9=P[&~~0@;V{nREpslQySy( [{:7dO ,6A͛@|cj5K%/H]lZy%Gh\NsîM-hgK*g5~_XA$/| _/i>3 T_?mUW{;֔ۺZʎ,%w'ۖEγ36ne +;7뵯3V@mye*^nj> ttNt޹M`O%soԙeOh`~g!wרm Yw/| _~*?⅔/^J~O{;2 qpnV%?:;gS-5>ҡ|K!j}I{uOdr%i_&|Rԗy̝"T-Qsm7Nto+Wp滁Y`0Mąs.Ws.c~:A{cQ'Pe/z\Y_R9[>0 ydu"uLHHHHHHHHRG{=C@>_+oTi͛beqkFKs@ʁϙyy?DϹ_|}F1;ϦfNeBn\2lOD QQn ɐ_8'B\>E_FO)TraGf!9fa_M(d񣥅sDi8P]cPJ8o%w9 nSKF&O"Sԗf3}%!t{BaAtۻ<ڰ|7AggKMtȋT&|pOO(#??bǽkлM~\RD_*їqB]~r=]鄝o"v;=&BBBBBBBB,OSz3t?O}/\E`{~j-_2Dd?r =Ϙ{ ܎ !yh=⋣ق͸K{* ~漠Q)W YVZD8ss7ثe9V,.P=e>л<^ec-;/>p Atӓ#;GQA* @yЖgO8A6@WoOVfl'.lo{~K|Oţ]҇s68?۫=պ[xYrU^:[EfxsΘ,JӤv$?݌uĢm~`V/;ޝ6$OȒObo#:@ !.>~[ezʫOOz?a@S[J$iхm}¾tށ9|t>?q^?Z`,(9Ts??ziyyyyg]<_8?}?/[j>2_ȻDZ(M`oG hb[}֠kX#bB?|΢#␑qx>Q1XT*βR]UQg y!yyݲ.rɻ%| _ίs ogQ?krwB3yT" +)9|VT>+sr4c(e!?],,K/| 2d30r5u{(hDGrڶlY`ؤʭ¨k јH0Dqc^9XF rT/eTXy}Iҗk؇MJI$N9?q p2`+NtϘYH~gLF#b(K|òRDܞg+N$L@|3u_yyyyulx>slV7f&\\E:OR7叏/̌r[%y/| _/_} g>ݱ7,?zG# /| _SS>/[Ǽ೴Z/5g#AHHHHHHHHh#=Ϟ Sܕ%s%>z__5O3u6W#_ˈ]*"0!!!!!!!,xg'1x'LdGꐼ!!!!!!! kzk`|ur㈼ȋȋȋȋȋ$ŏ.~/>yyyy j+m/| _/KOv~.^x;< wUY#3/| _d3O9gho? [U? b|ȋȋȋȋȋ_Ry}ut_?1a8}J"/"/"/"/"/G?g1|X_%$$$$$$$$$t/w6?3 T_?-/| _/ ~*?Ⅼ_ mpbg c /$$$$$$$$$$1g,Vߌ5Q4o+yyyyyg]<_8?}E"/"/"/"/"/{S'WWf _/| _*?\vx_/| _¿@{8|>)/$$$$$$$$$ah8 0PdyyyyyϿ~fcfE"/"/"/"/"/G?g1|X m4ㅂO.?:Іǵ?>ɉK% _/| ??0{&%/| _OO/^K!!!!!!!!! Nl?y @ ]6zڐg)> ;>3a,;a6&?J37cm"/"/"/"/"/"񣋧 O4_E^E^E^E^E~Cop*8J,| _/| S_]V _/| _??P??gے_HHHHHHHHHhchğfho?/6,'c*?= "/"/"/"/"/Tcuulx>sl6?_E^E^E^E^E~l? 0a!!!!!!!!!!tP0gUP?9qɿ$| _/||3_f$|S}/| _/7?[)Tŋ/$$$$$$$$$#=Ϟ SH!!!!!!!!!ˆ8wB[sBBBBBBBBBBB,xg'1x'j+qAx/Zm=k; ݈Ҋ]9XbQ;3y3-ώvw/Hf=əkdMʧf+]/"/"/"g_yS>yO~k弦B.Czɲ)8o!;fIgݠVѤ([6L5 zIQT~Wkj18smk\,Fսjo_:̖hqGb4,s &=U3M6 p̲S%GuObQL+z~ݲ̠Sd;t0l krS8TRXo4D/%uB|+\KFqɎuw^vıقޑ%l, GzhGþG4қe/k4X떅*^(ڤ̂eC백 R-B!@rJ$3Uq|*F%dxk%Y-XX鵓z,gR8ύĜ|β +}y\6heI[9H[UȋȏU?E_ > 88>]wvߚ`a&;KO*[˕^ySfy|*{At!/ày+M<[ݮjrb+\0F2oT>)2&p9 5~hNH1VS+sȱ..%DmjNU8ZEǟx#[+RQ =Ѐj{T/±pQ콥ΰd%c\V]goXUoIYYTqٚ6Y!-zF_*Z,^"eʏt.JQ~q[2~ x-sn?aLTW$ܩjqa΁p=Fe+}Q=_v>?urh6zc]nz]=}uB _ίs ogQ?;*?hVFY;xA4A9GޞAIN>ɠ G*X¤?iJfvZBve;s1ʏ]S|mNjMV;8;4^ah߬ %di3ݯm;:]@~sdwk4p%DT) gƢK@G'O—y=C츘z! ] [[[ZzugIgR(AsszM6m |ԈAt:{JKyn7;g[}{T.Y)VYz>)uNѺ׫ZΞ ۉXZ7+A+hprV?B4ђylҾƘ;%b1T g_2/=ۙs4Jno|̉Z!ƹyFݩ>L|.\GSKT'\:Ջ::f++=V %Fe!ըqzh(]3* [/U۫z~ww;4,ژP1vs=K#-5nj"N'K7.fc-Qˮ\wh`CnǻmxEvύ{rz;l6Y.3?|>9oRq1UHM&c 5WBb' 4^4KjqDy526^awx7>*"tԎnɾW$$$$x7~ȷ?Qnv$Skc{(^[f,- CyE}N0ۣצ_,qG4C:ի9uz::==}'D}PeO"߳:=tSRRo mu2 ӿf+=u_6k5~Ԟ&PН0!i\$) XnZA0Jw7渀sK Lc}q(+phSM6=[m'DzWS9l(3EJr({dŅzڊ*%[d>:ItHQQix ~=On9 W4I{hޏ 1-Ҭ*a1Z@A%7c{PB$Q\>cOq+? ./v՛7um6:Te۔繚ɾQ(Uvf\26QQ+FsV.aѕWl٫1 ~X|lֶԴQR`G=/ǫ?y@#އ*?j?niϮC<-!z\_yegqyyH}R>mG| Ϟy;lnd}\I{MTU 'r.StWsĖfôҏ35o~UK8K3K n/nuKv[.@a!*_f+#6e-97%8SR#.-RR*%mvݭa_]U|}yW5j6K_W#bbۥf  ioeTx܇QNՋy'~͛N[V#JTԵq͟ՖPv#vtFm`ִ]LPl 4j6Ou9 Jc=j;B{=RZ]ЕcS50Y?>mM=z6_ {NH3s'S> e&iݑ~h`]GbSX*R)krDtM?rCL#L*&<Fߟ9?i|B1UA[ iQl~9ʅ漊$cI趿2]W:~OFȋȯ cG_ ،3f"9SV)g2V)$t X_%aP6qI|/" 2mP/2Z[:[E{':4I~ vq5{A=C`D,W;XD_/MhK ()yO$᥾[C+%YD]+xBf(Jx~p|阻'3.R#g>(jZ7OF|6)4joժh$ |Xbu?i^oEuOnR5|&ب8NZ8z>ӣ^`?f~{Z::69'_[ô?T/7=~?_{D@3Osr93FPp/K>%ɑ/8FgCr.{xᣮGYznPx:^x5HAXntzќ jÕc'j\$OKud̐tpԠm;/7iϛlغBW؞pn=s^8RbǖCe-"U6$# _PZ0O.?/?篤ߵucV+sPoDNǍr~u|oxhj)oPTP e)^%"O>ʹ{}kscܗNjM%;u}o4|#,&??WMn!lKKZ6h>Q\V0y8"Ead7sVb!}RVB; pP/ --)aq&뷦~@meWo kQֳ| ]d78Mb+Ue̳xPI{~fkP2;s5F?ait^C`]uj~ ?[xv[ wZqNϪ:-G{Cs|_ef~,}N;A_xE}١IDŽ)wV=٠Q UJNR>H]sasZ`0_!!!f?/\3 ߘ*o<} +orGuϾ?n&|SNߑJjn!#ja;({Z(q[S;U @pQbJxlh~o~,.'Ϊ>}^]m@jʢy|ʛJx}$=*{NLZTd'yV⧥} J}q&"'28aDY,_/~34}^eƾ{(5wa]7YqAɜ2dҀ[־44#(lΧP%8a@d7)^,0d5w}LBtxҵU_(C>.|)ONn[5 cOՎ@K7^/;ƪ>sU:!V^IZ??2RT 8RkVߥ!y,Wls51+DRjAX.@PJOiKwT0pzau4]^rK,)yHhD O+eS|FtG8B5G%%)Zǘx;*8rGs%}]r\xjM*]@cwȷyu QQn5^_&_]w{K&O9zX)[XΔ6ޓXe~lc“u~,a3BKjE??^VѝfRP'| _4k완*>}v5Q׼  kR=U97 ɞ*dP.p $MgrW8ڱǙf3hαv.g+#D;*BE;̮JJi]RMսxoM",4:S:C-H.jLQVvݹӝ'['/PQ*%0(AZrGU ,+Mg%Y |$N<8>! 7s Qkql%:}hF>7h!=TKH<ߦv|a K݋f ɊC(YAcilg( L{UĺS5ؤws)*T4c_%LuzBc%LZL͞X_fx2먍S>BS ΛGC~}ԍ(zLxӦóښyK/XEe~iFs}y;7e Qbn"Jv4:ME&W.)(3-F]z$]I΍@[͟_9v|"Ams>* __S@T* )*3@cd'O.gR͟%= lmq[=wKޫH[|F >Opl;c{\ܣGWWD3o oݫR>>YoY'M>SKK~֡OD3kO`~BOUaOl+^,3!֓*Fp^* }Sx82 X [ҾPKWCFG[k Gyy4L3Pk !| gV5AjEY~}Q"_qd]cϞ S'r3kezx*@u N'%a,$۟璚{#nDO]!<YEi#V%+țh貙1zm d&5hoL^|cmRbrmvZ#5C+]Mˬ,èٞk +Uyw+h&'c*&Tǵ+^5th@LE+xo$k@𿐐c&O=;'{gμ5d ͚)+mgZi8)? f_WX1Jzm(cc NN]?i J]+]仼r'^?wDKVr/Y{Ul[L?n/]0t e+fd $$$_3_?p2]= /+G)kvfÃbuM~F풬,G зg-VX:Z\}Y%3׺变!? 3\E^E^E~uŏ.~/>\n (\~ף5Q]/Z۸_:xdFt($~kF }\J%Xho'nIgO@];ҧ(_HHHHHhrL-X'|:wR?}?VvODy`rK보Bܵn.91K[J͙Ugćdt~̇t::|0_ O[tA1k#,7E,Ow[tykܣ<}op?9__/[J D+5L;#O7»Kȋȋo>brYy EROx v8;`,}GyΎ;~J~$+ vY/#еDbD1nv#k<6.Ѫ^D15;&u-Ow:B'ĵ&E]ˍoyOlלWxLv8-3g?+m~ 8c>]4[NۂS? 0ɧ?#_XGw%H{lSs?raVcv3k`ѿ [Ʈkp<}2/J_?f[:.&vG*0)0Jؚ)ړk~EV弶M{I=CR\6Cvha0mJ=cgm7 m\{y4߯ PN0 '\DOawWsA{W9lC*ޑ;6H4EBZV)|nʮf!.'eg&Y~iZ߯PϦLJol7 #E5.pqnVFRGrKt7Ǝ Iw1Pe~Yr»c*Q3cۙ{Tgry4n7D.ɏUdz䖘Q>|H>: _'7paL?WO+#aW,k<쫏/^k} xn4b񰭄!zҮ]e/A\y6~0̞>N/2E8xM0}k t,cVY1t(|09alU~~ٶWmzB?)ڹ%~:dV1Ը-ZEs Gw/ vj5|+/h<. +:hه-=~$Q=$8*9.t,P{ ZJ'+R6|nGGmQ *As|RĜi|`j&@x& P e-ېʣm53$;qDWf )bIRQ_i;Z;qEQԯg\ݧ&tvqb[YS%#/K%n4g5/uFE)ZDrh/n3Ϝ7[/| OO/^p2u`.mlnසn+Ѹ,.0'| ^O˷Ax;e~ow!0G!ﲅH;t%DX?}=?v(ꁲ*^(y9JRf%-!(>t&cgZ5߻VAT2S8Zpzl!o j&4+A?4C;xYy€ oКQ8/-|n}67h0E;ȆaA zoxy[Вဆ-Q >v.|qW{{d0hwA`ǁ]0 ݗh\J3M@w>xe[r 3%K#$$$$$"b=uԴ}cm'(!Vstϲ=]w<=V:b?pW?|l"hZU@k8@pe=!7KP+n6?R4W_1jlm-׀BQ8,G_~!i_;UvFhTkܗk6o=V᳡oM[M ^?Es bMM 8{Qc_TMl:Q4 qR3u Giډ |S-cuկ0+n׸_?(WX*h|i^q_qQȘٔsN磏 4g;+U€jT_CuFZG*v2Uq8XWSE_^ih AfeWjk> cJZ}cBhrL|il?Vvna4 +T𿐐!?ֻ||m>o0LW>XήkhZ_Wd6Igm'!ܘ$b!+/8i눃pg@KcoȘP')@PpѸ]k`#is^Bz@ =m0 M.:n6?aWVq4 #m=x\qU"v8^!ɷ@Z#HVBשr=h-g-0w5OK\ -uht 6wW~ZwױVa rPG%Wޮ3Bű\ u{Cr?d[E|> \]+?>vùG}/Wvp>ǥZ/xu1b\8^(@Ǧ@5>ؘ!_Ϝ}lT aj=)jTș8E1;x\4.8bz>rbgPKu_^"חRpzߡ+^Q1}uK ̇ãrO84AG;˲tgf҆*N6_Y .?<9CξO>c N4'?ܝj=#o:5Pt!'njJlC>#{VFݯv, m=KGXvSy@XK ٯvSꀣCI!C=$~>3C!M-p{HstJ=-Yс͖r4}Wװ|mƱz1Z~PcmQ{}Ih}=]EI*Mg,[ar A5)'bS#3^},-*npn_;*S~LPj^8E^9s |>?j-s-/z׮A G#[?=_k }\ߋ?RW>B!%wBd%'ܐnE$0TWyِ9DڎnbuֺSSdQ-߉^Džhq#t1fP׶>! .MیR뗚񘫱}S-졅[s4Q5/K5̢9ѻO938 sq7*/s1O 3^ؘiުwt@Q-m#`?%vyM+*"/"/".YGOx_6wЃU_'](N۴>f֗=@#״%-c#R9׾ZυfNlXvVst0 %|۷TO^K!qkǾ1unn)g{ f4}߮ѥj^X׷29R:]ɰґGu+F KX^8m7Rv8%U}bkN[" ԉwIo}#jᛌ:.=0D8,{ S.cğ/Gsmծ ]-ʁ맕Wy/6G%)<')00aHc uK<[>K܋2lVIU>}cڀLŽq)\8&E:mx0V*e@myj 1{;V=^}됭(b[)d{3{^2 bDC8Z?w}*մʦ[6oE^E^E~Cop*JW `,%KǗ6>;ahIKYM|5}zT U.S$w&OQ1ޥlОk䄡]U1tos^\ǿ?+8/}4G!] m%3 9֕0ƙm&7IϦsdWzӘYG{ Zft1c 򞵼V$}Z&̯R9{VuKѸdG_~h)^# 64}I6`%A#E1_>?{@b?sv .C|t"S@(&3ml;m}j5)BzzTp~Cy"{ŕ/ڕʪ|>s0Ǭg-9ܹa<< 2a0^Y4XHh!dK[0y|]Un w?"##3[-^k^ٻvE{`IZ}!fsCOc ,[9%6GAɧ_||߱B=.?stLg5v4/0wQvU9ծOV{T>+|ݪj<0_[Fv^زY鈨}jn|(>aFN 7U+~s`*"!ƴm{Sk K'8~kv@1?~wTlq(0YP< Q.r Ző Isn 穪sUU%m]Otńَ:?? pC ec5i7mkPxII /̵/ B.\08Y`CϠI3]9a@F&F;iǖa!Fq,x>-TU$velPfd8QCDwqmyE%иڃ ao1>I)!TwTW7_Ko)U 9֘U-dIxx-~9E`{jy=p\oxJ^lh@zvS4Gzv/Nt[-FB=6&^w4 Z{0_K%IU)7 xҸ&l+al[Uk|">M1ƪN;LB'}xPQUT WgV>a6W=b-п}///Wu[sBMKnr*D$GQW.b@)& F/B lΒBS  |@`i9Z*09VwG(C?{[C>y&B>Gɝ:H#Ag=QfN\ƐTuacB-<_;&&Л{(̈|=Vq7籘Oma&sG#P(8׀𥳐iρO4r\:SA\~ˮWZUWY)v.\bJoe,ژ.0J =e%DU/|^ ].ʬG[t\.wnsenUvNj0zx@-29JDGZʯKo#}gۅy$Mwޣtثv}XZ)[Ԫ{gBZW<>v~6ni|hG{ۆTr̈́DXkn:?1θ+c|ZO+iseOjs/#׏{k ?bcUf v(ߔgh߫q}x֐}{dTa)v}ЁO7OB[opXkX8 +ԫ3uc1o71̣ύf&\5GjÈPR/ _&v`KcҖ[xvեo n>p]:?.t+,zg=s߱4wO:G2f$&͵w4x1Vc/ih5oƂyU&3SkrJ13x׹aOy*3%Z_S? [o¿ݙVAX m Y1Y83IF[9pMr'#!mJ_r/0Ah\@_]k12`4Y>I.?T*2XhP 0~h8期M>?az`i.{p8u:NxEōPv f?qm8A칦4!xn7zbkk&oS 'sYyS>&;5W|NYoYis>mM/l[Ɍ9l_a1G+Vz9b.׉^9GDz@2c@JOMs\|ڃ-!kL5_6}5&kzkoXEwe0߻;RNwǐx,_'KfX0vl~/ 1kxȋȋȋ'>˗4sΧò wgJW%߹/ɔկ_ﮮ}?eZ9Vq,Fk}_0{xYkkQ7O6@1ݜQS_dž 9JE52}s1ςS^eo/"/"/\?W1bu.@+ܮDrqx3촥 \mS eJᄈuswinn5u%+O<ېrg-32j-[xߥZ~OW};>qAwZ}!??{_AgWW*?3YUw1ጆ'x,ȞuŠ诰!!!!6,|g1# /[ڿzJUzDf 33x@f2z>_jSu (vˏnxխvEP;}ub{v5-o 0rSW^ߓN/| +PP_pW]k|Vzȓ+ Xcx ,ە|3p*18KwE6)ŶK<4Gun5U} Vo*5D[O15ΕUD9/ٙ<_a}\7]HHHHH$1·}\a7g |Ȩy+WG+G5E kfw.ZbФ%z!VvBBBBB_{\XS?q |+q@ M3W/$$$$$W?Wx˼_b[?em7%W QUyZܗW7P[YG9[VksrllJ!"vF_~&a:Fj_(6'"/"/"=ʗ _\>_?B +GnVߴAȁT~-?/B @$,)tYsf@bX)uT-#/P?Խ+L bQgrI/;lVw_{$ߏNȋȋ^7Wg㺛n :N҉0`͞^H><T1|1vvla(o"!zXpm1(qw`YZބO1i|!KTɗ]%v^9?ō{* \΂fm8_ЇOɿ>5x } ګ)J}YR'֭_h췧:o/|/W~~˟!?fG_auR9Z[:RqU2 ;O].4an9@Ӗ cYlaZ/VN2|Qq91 S3ȧ {9M 3V<1m~^X_ Q6ڞ4^\m *p̆}rcM5@Y`l ^(9vmc3 }bh-5E]+m{ͲGV@3V@CO;8[ƴcXdicM>T&m?96Oi,k>}h+{a ͕/|ᯀ__P_Km^D_}^z?moOzuNmv@w |@Jj?v\ydt=Zz)~ (swbGzW%M<## ĭ2K֭bYhN,a <穪qc)pLzrl;3U WSZ>j̋nXRj:n45(Fk (MŴj% L,ɵl+=W=š[ ޣl~KsgG7{Tvv̒fx9Ub˖3Jƫô<{s;ZaF}ړ1Lws_'$ m=]0Hͤ&6 7-k귒v;Ig mk ;~`ֲ?t6wT@g{$v`P\3 nMLdexhYׅvvw'A:oyPaEuF;N>Gm趗I?-L voϷ$aa\5a@/sdrQaHkNE=+lՒWSAy䃡h,UX-S3;ZT?^~DZT ^`27xvўjX-𿞅W+Z ?dR|.@L)߬"I|{_|fЧ7߅cc]qH7Tyj済I(DT0r1^DR<'Q{RHhLM6}{5l? xJl c|Ș @Z=ihrj:DY8W}y,Oxt uxa[lC[]WnOL%<@u7W?VNT*j,s +6p z>[8~ VZ!q5a4AO9e:/mg 7z].7P*>QcD 5QO{`lU1R n|/@EwN4e?uƄCu2ghj-{ uI5^ zXݏS' kvf؋]$k, }TʩWg7M"/"/"/w+ og_#p>~@S6{1) ` &Vq3{KT,' βa(-k66e~0"K?2ǖ>1|LNwu|p=TOx±J\\i]VZ6_Fci`Nmޚ ޗa^jp;a/ܣyM.44e?ׄ?kk;(0<,:5~q1*_xOM25Vm7ol$-l3, lh!`r؞g 8F 9~65 Iȋȋ_ \?W1bu.Aυ^xLq1q>Dyb!j \obTQdq։ v=@>SDPn?EǪmqo;txÖvWeO _O D@Ly锄?-8@Lpf4'_~ u?GtU>CkܼfmI͢ 7 k0A~Ŗq^^s\?GˠU; +ڪ%yG$.i5ĮjƪӧNbމ "c{, y5}js l6Լu:`j5:j4;t2uL`V+tJsfeӱDm/-1w7&ܪ5FwkL,>WW`+<[ww7F#$$$$$4gތ? ?񆍘gHwx 8 }=R)'OQEQ™af#P4B9o^ fţ6/bHGDE<`ک|c j|@30hg&6+,SO Ͷ櫔&& ,?z[ssaWj_^}A M}C4/EP:WX%4N>0}"4E${b_!1\*fd;2g1T縪.ͰqS*FѷUw΃so{tTGT Uщg$&NƛYƛ.$$$$$$T?˯6=woINE /{FYww +.Uv6F*8e?zBC;]e8'zB)fFU 7Vk/Ns*@0"3ٍ~49}c2qmG>ŁT=`VPtA#5F׵_[` QQ/GC߾{|\&S}1u# ;ntN'z uAi`O * nWnVT8?cm\'uͦyh8a^6_t^NMu aV1c ppic^F"}h\<˞5{{n-G^ۭ Q5$ecM~4uO/| _?SiW1͘BGh5UfҜVyCz}&:|/(lly).zx<9j0 *=c <7gDm8v_ l֝OE#_kl%Sw2qj}hns2np26 aTgo'A 0ƽa9wv+X[)5^fI`h¡& /|_!; 1 ??u#`B x|sMk_oNBﮙXV!fT,#R]yy=i\hƢ ֊?9;G@S !\ZÒ,)ػuq'2 nbOZ- @DFш]1} :FVX<{q1{cYB=6w֮N4`,/: 7bvg .)*EubZ0`09=]C3oGΚ95^ 0}1/=Ɖ Q8s).4!=K=OSx,yEuF?uE~o+TGak/ȫژ\>q,8F[\s֨/uB0{27u=mۀj*(>DɅ983͎n[U vFxgLJ7m=hc-P6ZtisUdm)G7<5y Z/=Q-xjCU:҄'Dxyp'*lUʋ#YȰ0CV5WL! G8ZOҹ >̾ZzxV9wȧi~A-Ǩ%#O 7yZy:QVje;T8J8/0͹z^ZX9^E ;@8Ƣ"y)N%1|`U_!eg -$$$$$b  |ُ;"f~~u"=v) .u8c:ж81UcY[9)"q_z_-P.ߚ2*^%m\;]w]2H،tmz/!7G)W4g`Dv)$4 ֨W)QŸMh:Jl,ù|eaUت%qĎt#~upmh:l=U_4_Fː~/ Y0煬trl 6JU+tƀs%[AK?Y؟YX2$ rΨfJd+1r;4EMl$6Mu`{ii 20>|Zo'e=-f?;׶{ޗo C苗1JEURw|~OЕU2}=13i.isFXӥ]3X}Mk )L i9q耻P4̘Tq;Cp-f謦,_Gf@sZ38|7Q~2ڒEߵm2M[%WY+93UJob!!!!!!O?xibg~kFGWĊ}{Aˠ&U3GګrF^_.濊{/Eyyys//Y*ߺ&پME^E^E^{gWP|u_I]Kouk~.WEbɵP'jmd}0~+go/| __P_?/^zT_-/Ǿd?O }Y Z/| _WX\3==Kۼ(`iDT1W/T>Fbfv_+ ۳4̘/3LHHHHHHHh)|E6' =۟b`S?yg7[5 >J_M{33!ssbO}܆Ma^px-a+kb ϊ/Ǖ3&6bQS>+,erB`ԕgx"/"/"/"/nuU߈W|I9G|ZQ7~\K|\kjHG3E^E^E^Ej?F̿X _-7_>k%b{ҝș|TzneџVtRLA^>2#*y-m k|Au }Ϙ93.m!9d[o ZDrbi!X--ID/aR[<=6Zu;#;{2^ ;.#pet_}D:#[!!!!!!/ Vޠ; Ves<`WEAX=W- Ay3Mwدp}+Sc։|3dɽϷ̺v,d? ٟU?=sH2 _uUOs1?g_{'i gy=lY۫nn%s;\HZ}l Go/ mT?o97\'KW~CeG'7痖f\hlhvVk/ y _// B˟TZ0I/Nx &9`[OԪI)zګ$*b`8u%S_٧NJl>2vzF@[ypm}jOמ%gBBBBBBB_*oA?@~bMzvv;.O^ǁAG`A% 1qbߥbme#~yhDa׬n[(wk0ztuFa:`;&f/YMm1Z0h?l90@˱3L]`7Si~ֳ.(e }JB XS XU㸚vYh[P?6]Gt}ߡt)x={$~) m xDaaG .j6m33D4[28mVkl(#n#}xc`mcN'a;D+ -9ILj<|d\ n}4Nnh?Y~!&yWgl-t#ǡ16q ZEcF}Fjp4j5"lMa=MA#ּ{,ۓn>L:ZftQu0DS@˭Y{#Sz1z H&*EXjUz4tEa$ߋpsĵ`{--1F}jچv{I'^ug(ȝnBBBBBBBW,&9<=13i.is~y/nA#p\Ëh5QBdG\wۼbcNQknh*NNZlQ߱1vp5+YG >QmUAHqv^*ɉLN߾sq| :hH{lgvӧ'hlԺړuNEh߼v ( 7PXר:ή>S瑯0_]Kc{mC7&N_6!mR^lO5װ LN균jck8Lfg*Lۿmblf8'{N6֏{`Xؕ^6tn|MrƲ%,y-8l(ﭙ [$02?O&8nW;WWqD*W?WO(?7)^5(Y.034~q-WDCuhpBDr?/[P-%ālGLމ&&ex9L;kד^g5I7T??6#M?lO(vK}kc_o}=]qL(OAӼ0Ø*B LG:Ƀ];rtao%s*G*`@JMu!:UawN׽㉩N|7 A/a`ت|fIWPd^{Sm8@}"ǰxlulA,vh+)匉QվOME^E^E^/./\}!Pw>VO>LQk!d9:GvW}2 ±^9uī?'jpFm_ @g04 pdKg +/}LlSt.h zrl+zbF![|$sˋjΞtݧ+yyyjߋ=`װask nn։ GD[\=]ƫ@: +qz#} :zIlu(yܲyӖ.Ωՙ_@1q˶}ԙOlxKt!sz ֻ-Ef?l8oӴ"Dv'Z`d7A|>Yu0,~Us1<<ո:*DM3VT4.A>`a&,\ù$`72OcF]a-ccPKs. oY zػeċ^3CJ2 _Ou|ҳ]??)A=ǸGM_{}{Q%;ɷx,m6wa+ӘkDѫhs~Q1ur:6Ubw*kش4A2$K6j޼v꿯y@h/.deY8g>D>2N[p?o6Լ{ul'9l nUz:^Q;j}AP'rBQkQۇr|c?T'>@.dv98{FC|Z6<3}a=E01= CuVb<14O{)1m;2buΨ(u` <dvT]yU%??oH}t>gMRi}Y2]0{a;]`OtCc; vЧ(ȿ|7<HE^E^E^E^R\|!_=%i~t3OKF_\uJYvzUMZo=#[wu F* >l7i[kp,= EԀ ̭cW#rct0ֹl{4݁ M&{^ʷc;_'+tgT^lȌ{(&u=2|_^NZ\waìc1^fm/"/"/"/Wk.柫1:T_sQOc`!fv/rx8a:>R#L8e\}@i!mHu0%Q2:L0Z8rto1P/k¹ `Ϧ}Yψ֭<}Z*o[0VW4jOĩYⰶ g%l:)ZUJi M9h BCj(k0 J\PzW׼u? ;kr_&ֺ֢Wnٙ+V#:}>]挏\?'?[ ŬH6;gSg^+SƮ,]cG*JPqKK!-c\(3a|AQ3xc}oR>5.U/q4݌2/| _Wo4b #.sN'o_cb/_r{/| _ ///\s6ƽ2ܸ/W'%Α}z>)\VY-;V_Ok _x~~Ͼ.>*űIor([ˁLkPߐqe}]O&#Q,ه_PGRr5_ Խ__FbrccyOc?|? //.Y𿐐_PCI9L8BjAh-}X[hj 3|>r]DhA==66(Vbۋi+[&ڣGi6ݣ62i?%!_p3`rDjub:#+Xϖv6w|Gޤ+߶,xW:ӵ7?hi0,Bѱc(/wL/|//ǥXd֧:IӅpTPƚ$TC3LJ(0<\Zy$7U7Xڭ>=q8( 8%`UAȠ8}qɱa-ʹ}Ƙ͗Z{z`I5~;\!#=~c/ə kԚZNN}Zjeo-dcs1_ SBV}`SJ̊uIJБspb 8bQ[oZъmZWr+kfs-waJZm/mlz 0\(}PW?l3#`p"՟6_@^V!|xR5wu0|-6AUc!me[ipz,OI,ߨfJm Nө@omgfM>7޴ia9_|O[ek|h4\&/vyc_yjӚLuVkjm }]$nT^/ȗ^u՞꿱i=V1bm# q&yLV:#׭jm}V k|X4:O{u"@kaˀFw,2ۇh0MP`QҟC58(hk긻\e9f!}ޫFj+^!+v|W-P\>=9 i-Tk<_O{5hjG#|#(m (؟ǩk}|0Բa,oz/ұϻU”~[V8Xw}0b>oJcrv 7I}ڳU -g="/"/"/"W)[]G7b3/_|8??>I$ ݶjI~l.ࠉ;{#3:T=yќtر3j2"ȇ,vlB9 m^(@0- s*;Z~8{wAx/%AHNW4 fџ|ز~m چϳs3@h3[_R&6|>vt09ƴoۄ 0NIt=<:i<Ģj[[>S^~j5/c'JI09fK?@MsdXw?Ӥ5 />r J-[6#g2| [>?m>KZSj+[{٩.8y5>A@.\HB_dGjkiE^E^E^EJbڏs/?b8uj$A}KXMnYPaS Wlf].sjZ1o Z|) Us%[Z W|>Ō]y/3s['&yXļ@x^ܭcV13LzxTq{c:uDǓ tM_1j9:z,ӱ(]\Zl_e  j"j]`k1J,Lo8.{]zY=/َO#Oa"%N.PvX}#AScC8~w4}X$_o<Dh|`9 N0^==9Zt_7@( ʪ tY3Ja,^gR`}ޒ'}/| _UOs1?gٍ7;PJ)0&+3Ʈ90kLMeSEn^CקLʭj^zjjs\O{ uک1ֆ^7AD->d4|FIOsOybF.jZ {Bt"MHyZ5Qce{|"&| _Ϭ?@BB ;}Í:F{h$`<9ŷ$1굃e| Oyb0Y b5~v}XQ';YEBqs }Y`\;=ɞ䩒Gx:c0:!8կꞶ%c?`&p-G`UW9 UwXR:gnov aŞП*mC#IQAa+ yWߒsL!!!!!!|SL '3w|뛈TM.F4j];{=#CW0H2c5p ;EPSKЎNc@Zg̜E"OM>\]qX={7r`C<;Pn>QGǨV'B`seGog0/fA_btP;m[kBd+[x.½.-)|.۟"2_iTf$8tUp[>!_o?.XqF;S|k얩oLgBBBBBBB&1·g6o[7>K>LPՃ`Hwp<3yAopt7-PD&B&`tL`n5_SOr&M z0u|m D~{{ ۀH,i Uc>|SqN<`kL;$s0_xt}v6jr@G>Acck(+5"cm\6nc~:kTג_`r ,SҦj55hD)InĜw%$$$$$$b%ޛn~6l,l;P[+0! ]HiD#y&Uʬ${ S?-;˳l3y×zl\]uT-˸< Z6{-֋T@djlsxtf, A1LTd Yn:vHcҮĀڒ' hlXeƝ{p4_t~7ƠPeS^' yyy|s/1凮ߏfG TVlz3oIK383٦}yyy1wϮ/!:A lg,;Xn9:_ف?Zy ߇H\;;/| _P_?/^zTQ#_k \a;/| ___P_K^ͫ]aTRa!Kb{!v%F;ZZ3+@*О,tl.c_V/ j5&$$$$$$$t]#!ssbg?Ϭ4߶_,ҙW#?bf@,z']i*?o+y}YRhcvE\ȋȋȋ5(Ϲx 7b3/_|8?iM7|Z_Kȋȋȋu?~ 0?t Tj1 Z)(`WsC%LHHHHHH d8sW\ X#ᄄoa^A!̕5%]Hb!W/pBϋe RZ6Eu o-ȧQ/| _QB˟˪ \m<@hf*^q]qmvY3b0'hjvv ][iz9Nn'aEO~a^uV;zG%!hǖ-JcH>gT0/ EvT˚/_HHHHHH%1·h`i&qC7'kd^`ɫ_%A-eh0 $ nyOUqY#ʲKMˋ;cyIkkH3NOHPMpXi8S?<}da m ZXl=Zï؋8-Zv #lw`~hmrtqR/Л1rnc^GutxM>3LX7q+p,V#~ux,`. 92k3_59jDO1xł͹3L0 sa^xƏ$GCp:.qkL!/,"/"/"/"\}?oڗP&:8ڕFb^zoY8gf3Öy.fⶉl+xncc/& .42mWی٧ZI}MߘJzQ2d{e# p˚u:U=ʫXv1z'_7zt>29Q)~QlE&eOZ=¨ I޼vw`,0Vj 0 Z^=ыRq^l4M2P6=YXUwkXRyMh[Y o6(Dx#A,n։ "ca.h16 سlxBn@;5-CA vBe)//ϋjcwL:}Fz!ɂt!(flw'SE _/_TǗ?/= C~@>ha%Z{8D?X7Bq8[6^n綉^Veڱ倐N\jV,{}gočs?{}9 gc(|XE-wB ڌ]h<^|@;*W7usqD .n`s%}Yzq>Wu?}q;l(xwx΂Bm>gI 41Eѣ=[<6ka~zyzi;ny^8W?y1[)p.p`_v_[{x žk[o53/| z_P_K^ϱ(fzػub!y/KcG#.u,b`,@㯺.y@=mx < h z5kz}z#iP{#S϶]G'ٱEOxC>;Tu {EhQUTWP?k,~Gch<`u4w|=5i|[ccO[[{_ hՋv!^ryy"5bO^d|y^\c#-3S1rOei`%Fh8JbX?} s&X?Vn9W{L2Ey 6cW|s>}pdCg(mN>lmzWxzbxJ;hеY}(LamN.`GQ5)UOc^s_24aEr.I]EJ(䘔m(_HHHHHH?-\S'3uK/:ȵ[M?Ps Nc=Ċqmn@ΘUJ]P>l8L&@;,? G"vk|]eZgU7?S0=5vc=2^;&3/}>:1*{] ?(Ohxjr{X5awda1HxڞP>suO#Sq6'9+P :w;f.Ll:^gD#=cʯPŤbڊ234̀[* yyyyooT>˗4sΧcˇO=7_E!cՋ6hg9Q4V)/9v<4` ˟y^?qw!/.vbu4>H^3eoV1^7Mg{tၣy=nS_7Ia/ o>P[e֕}{5~TSѳl3 $w@POhnBf&i:?i6a\x҉gƫzq_ڕZwQyoY]2=c9;;3xxYƶ00YO} #\NP!{ գȷL b,,,7&WD?ujYTU!#᙮ŒqPՐa>wC|;..&-#췞x+6U Bh}H^j*&i6Fouj f)ON8'Y XĎҥҏ]:=)8bGTNDl&y-*a|yA9zF$sA~=|쁏5v"u)^><` Sv[ _Ye8:fݱq h_|߆A2C)(.sDIEjDXr.fr݇hQ+>>tcS3e]@7=Z):CCek .=J;ԥۦ ~躣*4LA?喕%[9upI7V<+e| ytb[)ć|B l=KuW2{' )=un\} ŸfR%GlKY:nݑ%J|3.} 㛅UM5y.%;߆ o}c `bbbbbbgrW[}frOXLL^Q> %{QAN[&>OA;7Lht*z+( KjiYE9Zt eg]XH8” m:/aHm@%%< DutE8b9 QCz˚D |"Kr k'KzaR=I͘dhQhtzE\?39Vq/'O2gJ9qGvg>|37CTkWD[jk)$BkEyg95MZ(;t8b"[7J'0i+@* =nbE nYfL";h21111111}]D>Eϳh _})_'wW͢L73~bb|LVXL#_ϓ?uY+(;;rW#111111118DGO=x3IdG]A$>⸹_x+Ef2VcfT 3G<7>¶B=z, 2ޥ8&5*JwEVTK; ebbbbbb5Rxjc{xgXO?Gg>ozz˯}57.W\l8aasaq̎8d7^rLLLLLLL L?QruV?ygKƪZVOm+0 <`o%g7$fX2 Z:YYYYv§}HU? _RVGM4xpRZL:[_|HP u/2>rgygygy?{fF.-)b-Ӂߏ`-m}XӹyD:n,ـæM^-Ϭi,Ϯ KN|?MD~B%祁@V_z8sqA,<yuTбTF2c,'=#JqB> jɫwLK/^~gE$(xMqǸX)cHiwJ7I^pE\d,,,2WD?ujY Z.`b[ԋ @a а4/ CNXovߺ.x^! ;r._*͠f ӭ3iHrΏKu)^B3y\/ j+ADZSN#ˋ√gbbbbbbbfJ%?<=D*4vj<M7l|a٭L#3bfi[<k9MEx06aM?la6 <"[p7l5ùyG$a8]Y~f0i`H6@2aᏎ†-s[ ^,i y-Ks/:.ۀǚh _I>jhE^B>!g],^s5;خcd5<cm_Ƈx_n%f6EGNfQ-LQO{ tA0'<]d[]Lڃ|€(ɭ2u_T%Q ?Z NT9=C$d6>[ɢH+ ڿuht<%'@'s Eo/{mIC;C ~ bX&O6o5yڊKob.}@>zcw;-^~x-s?EJ1^^(^NP.+n=l,RRmQ}]eg m6f̂J&KBb,߻BjMx.h5UNj&Lu׺]հ 3mIPH@ :+jpm%,~^uվ8ݠ-fDyuna6+ޔi=,YrcW*1Qܸ\?z lkQ\3K3&9|3g>O_vUowN TgS;e-^o`]@NT?Q+y{͎E59X4בgƩ x!eNḰ4Neةnpou^@BØw0|`;M''+ zB(Gs룂oDba1Zc'fq(wMGVxI֯/wvbW6.@U+U k}xe+(L㝠N[OǺ&#/zG\}R?' 3/c b/bu@g~7y4.]_r88ORb` ZT '{#FxEATX\8[ro=XFgw?+zqKMmI~zmvNKtyEGxr\<`.csT6 {IgЌRyX< ~49 A%{ExNgIUg~[1o5‚hB%@۱0IpdŹ\&?=#hxk;"7#N$)AەEX%wmB﹔V폠dCEw{?scVY &UK~X[{Er?!z#0üJu&O¥W9xñO23v*],1Z?Q:b$z$ȼqKu#LCmwaGfVNŻkt6>*۠&wz\u|@OTރ:.7/|~L=pM6D>,IS$0 Uv # a5Ù xzuя-X_ڹ ReSy-#jhLEWkޒn;@୽J5N193i [-:)Lx987YF;czvp]g +Z0b!챉~!\!) U@I"^¯k!JX䀒Gl#U_v7ExFoOyNPj)Z0X`V̼}qXNno/rTI .\J%r|7YYYomϞYAS=emo|ڌtdtW@% :6;)xnZю`ZY^!`m)TWE;zW$)s_t_E?o@7Q^?&@ :,! b8E4 1AN۷KZS:R.8UXT1meUoħ3oKeHf{9o2: CNNzUhx)79g>|3Oy~]( P;?ЙOf]w7utnOT9:c,7 C@*EB~/ꚪXJۙ㎖2~s\'V~Zk|ew43g>kS}L$ wMBFc+kJ i5qHΈ#(\֍#@bC/]G7cȘn(*D@'j,?Ÿg?"? Ƌ+~9056gzEjK#xbj?XYd>\W̔ב]k#?-ߢ[gُU`j=Yϯ;7*KGxXiάDX+1y>gyB>SC\]R|XVV739H?U|p ,,,,@yKx++j3]Q|:#0wSDz0~dB˹X?_b:3Vؙ},,,, OS_(r[V\ץ]XȧrV&,#" "B>IݓZNTu|:h11111111}c낢:sgcOZ|&yK㵜~g4FEIY(8":;#Q3VwJta}>3|H$4EN2KLґj~K6_U;#O+ُ8&U c>|37kO^L9I_8yQn*_w2qY= 3'^TSgG3g>_>O_v5eM^Ђay Wdb &&&&&&&&C/zGMkTx\g?Ú9: I\[~}T}6a϶2;V3.=j.vj Ѭ¹y|\!߶o8:si΅/J՜x_彽SpzB2wi/4.N31111111eg2Q?]O<˳<˳<˳<'q?{fԇ(-0; 8%Y$5m{߰D}M|RT}Տ#f~=" *@ˢC2LYh<9D}"L1p p}u:@ U Ͻ0f~       !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`bcdefghijklmnopqrstuvwxyz{|}~1lj`׾IT57Or,w-4mO),jSt]-vo|^A/[Qom6hY '+"-G& cEp7ЃYÈ{mGLh<8zܯI%acMN &yO , R;>=Rm!RzZZx|J>U~??Jw^6hYdbyPC3Cۇ%Di$Rͮ<?]W )m 7/.->0%=݀^6]!X'XM>s5UF{I䴧L+siZ (wl鷥uRxe1U:wFTzV9GK ''Qs[le2WoOx `&&&&&&[ {Pv䪶?Qea7= ߾y$)LIݎWk?,V* :(Wu.DY76T99 3Kon]=:eByZ! XE,.pBs< MZOxUh PqKp]FC~'*oբͫٹ-ƥh&wU`}W">ӹ25[g[7y2HyݵkUDre[VY㢽#wZ"CΫYwK dV' R~yj5,z-o Yēȁ/k?z`EyGp#quY i_j.aMfxfAV'k{N2okl?!8"Ҙ;xô>Jy~\Ww{RD8DLvl gygygyg@fV/)٨lwOlz`}#0%"a ңy*x/xGV!ˑ48;E|\OJ%q ?TKZ-7>)^v8m/x@&Z}=޷&qѠQؓǐAG&t x5XowOhUR U@ @Eo:3+suQ[5\2x2:ɳ(PTO%wВ;<&^N^ZS><˳<˳<˳XZ#ʹtz_YP`%irDq?t;@^xMW*G d'h} ?ztKyt,}gХC܏($w܈wIS\}.O.IɌn}v[~vVq.8*Eǡe >! 覧]n{{c|TE`m{0(EϽ?vݰcLHݴВN,9$>VjKp%_ uzq25A?V p*]3> 2FRUn:*.c;ͨR4Vlc7!<+x&#L!~b5ѣtmR(Ak { -#K@ $:3WKŋ,I-̙t?Z-L_~o>:9x>eocM!""pu/A_uXҚq+1#xKjG'Ŏ(Gh:U#=@uQ|pנ|b8OzZM/8XVDH͠g +@aֈ0ؓ ]b]<4 v7э9|x(7f< 4/[n΂xi ~wݼt[0q3DۍQ\vg>|3??:{1QTQ.2~TR_"0&(n{Ɲt0Kf@!u%x-ns$ЦNj.|\*}.6E锷z>d0k*`r˞(aaDq:Q7"?>]Fʎޙ|3g>OO/^z&uwtd8ϧE7~Nt5-zI*꤁]ruË#@@) Xpd蚏ؖ^C 8-ybq3ĦljGmSN: 4y.X^ o AIJ0q蜲\-2rsRZm4(ߞ%(:){'Ķ&C\ '# !6Jz@a=%ݒS/!o:l&&&&&&&(y"  D Yn ]}MaF+U룜 ?Cc%_n ԅR6|SG)s5pT3 󺺑$:;b ُ<̯=zT:cGu%<[;,FWpe#HgkP#*fGI{F]Ōj+آig)F5g>>}.a?$. f ϷOeF:^f'XL<|="{/2lQ`Z fimg2Q|{g٩U6GUXuV x_ɚD YYYY寷|6s>>S5sfzɍwWOYYYYW3+VR"z*G9 9J_%ȣWE"yZ֞"4ks}ű? 8q)EM{F;m=6U}okC3|3g>o~>G^g޲۷?Wv ƽ!5c5+$g>|r}Lc%ZwS%Ek]2Q>O&F,zΫў+Laԇ F5n]ѿ7>}tP!nf,ŁOY/?o85kWo_gt(_?q p,@_KǭͱR?_ר#|e=!Zk4Zc|׺~⓶˝eRST7^b8ď".S_©h3Ӗ9}{YYYY*n?ZͿ: UqGtY놭&,gV V跷aN2/úf {~`C Qs^v嚺lΥ <̫AXRSֲyViOGn{w"₯BoqkQ~c"xE}c!$31111111puAyT nG5e #yвMiR8:`N z[u?`Nxa[Frlٚ͢s8st+Q pSx46Vq`T#Dmvp,4ea ہ1OoF62,^($墖f7r’K@8.Kk;:e)oX8٥]8W˞qzMۯ% /^Xw_%nO@uZq\^(n/G@`Q3E @+?Pg>|3??:{1Q>[eTqö6m=Uv#Yzw) Mf=7|P-0PAͦf}WK( @ĕ~ `w  JJ^t\ʜ`Nt?64NhP<1Qi5ù-œ`aÈj_\I+ƒc鏎8dyx“=5繲DZwZ9`.wx`j4.D„fcӇn '[Q{f!%8z\لTO~ayl>jfh3QKӍH_<{?=.gsAGxz6:`FA]{m'F5m-ee=JիɢN 繲+_gu "mW1uf!4V-GVkO~494T3z**Tq$0x`i^Y?m&k?\_ {h3>~Q~^['׃pU{XXqWqK6m0!j?;X~o 7O$l\Xb?^7)lĶ񿌗6m#e@B\3&i/%:;b󟜹gBz6{RL׷M@w@{ݝ2|SdAnVTZSaַ-*U8f{"+ AG?ͦӝXxiT˝~Q عcTdyȝ&m{pcRuo-!{'F{v" 5"G6 Sò$@SFð'UωM@zgY>=̍=/~( ">t;?]WsUώ:T9sx; I:n{>h}zpAI/h)"O'@Q q8NJOa.Wu=lF /+ydF?31111111ݠ_3_eϿ{ǣβpR.J,&G7{9G>xf:F_j/)1XСڌC *;4ʢCkqS&ƪ~%w*.JYHw ̯XC,6|]jx!@>;┄Ȗ@s[M8?V?!U L_a/;u; _?OA'6^ν ĽM{ȞxOzUL~ۗ?}\ P|Y,RX;$T<h2/YYYY~m/)x//v툑M@)_P`M{?Xϋn.HWWK[pۊsQm~}xv:.,: r,z™$ma~49 K}6 S?Yo/%wG/6|xB5Y U #NJ|bu(1 5~=)ʂF~cty1lu~5QC>IWS!XP,'8G*)qf*|T}Տ#};"и *vG5xwnM7TE9m?)}<[Ѓ1#;56px7}MrDQ˭ :( S4 0{D!`rP_g8;;Y-э`eԁ9mF]:߭U%9r B rzLhv>)U8#=dX I?<)@fB0YK b)ѯ0)eM^ L5'5b쥣yTKaOt0 υADK|뱠4KwK1JE ,׭}Eld#˱%^2 LCvp2C u(q L}!z).7<vof熘$g;\/\D?jlu(I5Jz.Z|tj=E븺ak:U(G0 ',|qh @(ef1O[Y>bbbbbbbTLY}Xƒ1͔\Y_ypIRZf L]Ѭ .U҈tySrL,GFz/O>DS+3+5`ygygygy ψS L9kWFg/^83G?Mއej 2\f$c}2#es6gEV3#d[G{X]wXNJ$%Җz2^,k)˳<˳<˳<C'jۏVdNפeN]ߞWRzݡYC3u>Rv]W &&&&&&&oN]L:sgWt-~M؟Yݸ툟^ я r^~V|Kϟg>||_Wg/&jS_dzgK"8"c4/|3g>yjS]wZu#j?K˘}Jچ5풺zU&&&&&&&(y" DNy1gimXz'g.?g>>Eif0j('FWEsa-3ΜZRtAiU}8^7ate>ϰ|?wQw^!a6Öyr a3 B4KKfR~j=jSb_+Y\6yu$ͦ}ȏ˲/do2GY̽il+{\Zjc"% um;X( me5,4I9즪Ka>0!ʐbDhyxy,Whɢ̨0߮S/S^w#喝Uqc D#4+DF\M/˴iøY'uubygygygy]O?Of ;x.y4wf87q߲;v{AA0f4PY GgKe\q}a !#Zqmu-QS:* /5v:Q]e%5dA%I?{,,,7wgϬّ|; n8۝*iֳq_tp><ĩA?h=7lVdU:0#.A_b|>roBn:kfMHg2!pW^cҴw+WGW9hkq1Sʙl<|*jDn8q';Fb>|3̿2/SE{G-4w;+Em{cOaUps0z. wZzDw6]<`ُ{-GvݡND><$*FGŻ@Hs ~~Jrж϶a"/;^*ta^#vbD47q 4wP>\8Dg:ރL{&bD'1\?%à/;д 2ŔAEA{|u0^b4qko&*aIŋ_/ <&>Qec޿5fng>|Tl?a?t?Or<}p`ۭ<8Q..O:sOTmN3G'<t OzD, ju 6Ei$nl6Ǎ7҉m֓\~*t|><Ğ4Jrn&%pB?ܶq7Uܰ~>iUCF¬}^_+գa䅘+?KKkK;pm(m9B0Lqt7 Kao\/Ws㕍ncm3H|!)ήLLLLLLLLד h?Qea/d=ㄝN8r/j/;NJyǦl3@W-nbo 4]?넻ur~ TlI piac 遼 ֏&'d8d<0ZtFtp߬D ?? =iuGA{fso2KOo\Pt]9? }%14Sm!$ege mZtP.pX`zuQ-j?L[X e,z2w[ }o8_iZfЧu뎘 h Q#6ԟ8 {(*&Qda5O8^rzfęƼ.8?`fۜ=WPCE"|tﮊUx~-ÂuPYn?_3\˳<˳<˳<˳7PBbޕk5r׮(>^y4bo-#3~u۷j7yo6ݽa;G뷀T^'9a5\,UݸNgg#a˱`ֆjL5)C =͸KiĎGH_/; kQKGR!蠮O@>wAT_eгT$ ;`mE)L <؃sm n9U/G^O>0dY?A2i>X^^eŀQ{'$@-|9|*StS3H9cU9e\Y%%x4cf%+X_sfϝ"tb[T $+UOOFd 2җ 9}\Lg!οk)Õ{By;?YZa_Ṁm;q#S?3*篣K ]]Ľ~m繌|a:J*ekcT#t}kP;ǑynLLLLLLLL71`Qg;8*%3Mn+ Y3Yv9wJ'p"4h@ 6NtԓNkV+z17ƻh]7}o~ɖvP\I/$|oPxP`EkƥJA_pdNq_ SKYOYwqO ˚D T6#n$fשDg ,lxIwf v%@5 B ϣy'L %M[],i 4Wo#5e㴏kpFEXq`qN1 8C!Ep( wߪoOrbRqyô@8qyzo M7eIPy\T>0g>[?@TT⵫/sAt1iʞTRQM>] 1 _\AM;.5&O#`)x#cB_iF ~q 4k;GLR(i ^m#GX'@]T7 @P0 ~#Z#G{+qAhAtwZT %} W:s=huB+ejD7Q[Y)nn:kcFwd^ܰe:UʮK6au$!( fkϑi9[2^JŅnIۉ:[|q=:+7֜udbbbbbb}g/@g?D+m vóM5% T%5Jhlk[Yl*=0~i)?~P?S5 3E,Ǎv-2l yuS،|o?L-WWfhݯƥC W|\7UP[)KUM+˄w.> GGqw4仑 !%+X7p==.98RK&&&&&&[r T~n8E{ꢣ$dYG̸o]0%jxT:.r" 7D whiN5бS]T[Xwd5c[oM&uL䷧ie=x'K@J$98kx4 6duͧ2& epHyUlҋӾz2D;Sxޣ۾G.tke~5stT_Q4S X`?=j}gӣ{ѭF7O緋QJUUsLL x`ٞ6Y?y^:e^(#ܢ[dyVȞI8"&&&&&&&[&UK~*b"t7LٕҸU"cW Y/9k[WBU 2w<`uqɟ{W4%_"?%?ŧ{YW˳<˳<˳'/~y܅O?TE߹)u ![ ]=1<,,,?gVlI误H>7ՠ$-]%:~[()BΫPU斋VcwY•st{FK Ԏ7j3g>Se_kW?T?<?]zRt cޡ87 o7 |kf?3g>WO3QzwpT]_/75Zy7VT\]|3}9T/**kz`V@{8P/ Ew}N;VDpm=_MPy|_g QY/??񹧷b_^!+FP9khf-jG]Ec_"tW: zrkN'Q'mjN=q^_jb\ YYYoy:cZͿ|+OgfQOo._^o| gj&^~=h_j?˳<˳<˳<-n?ZͿ: TDc*:0Rz]@;IV(̺a6jbBIIj*X9sg6?˓g^F]}B#~ʥ$/b5樫ЕȲ״sn4s4N,N/sݨ_E iĬ TOu>;O?6?fmgSaL[eÖy\0/  yS4ٴS$fGMe8] :)$Ϲ9W6O ɡae _󧱖aStrOq w˜pUfw$W`/l.;ʹ!:wiXױQoE.it?#ݢPP|SMbs–$tL ^7l5uͪ[s@2lϖc^pX$aEnuÂOU'V+)H69cE2KыsJez䏧#h>N*^Uo:i\d?0K|QSssݰLMVl"XDo2FO++;ʋKѸ_e~k0g>?3exub??}ٙtTa>h ii>hGM!Ϲ?}x0@옉D,'{MyE)p_4/fe tĴOV~ @O47lgʲ5?b[L&m]5Y,Dh>"8h,z>iS͝䏗~;%F|(+o'gi;& O ә[E|}_Tf$éDq1OD2$PIѬI|ijIh@栕'xX8|x"Ut30Oer|^QTkWd#V(K4^7egm]rN_~ۦ 'AwW!pl<|\ ft<I+B>,{9ѥ?m oK,^l?8@TY_"5 . h,UV~mf6w;l$5"zí7/?|<5+Ggt-!Oҋnڔx Ҍ5!IߒWr>#Cוvj!*eIH><9#xZ9~c9zٓ./TP0BjtwQQV?:Zl0Y 7^p9^X\LLLLLLL+%/zG3{=7F#6>.R^O[|P[ Z [d'o%1/, ep~f}Eǡ*[-]€uq" bn`ojg.[ ,l@0, Jwn%6l⮄` ?Q[ypވR4;?'l1 KʋYPA< y«q6nFSDb~]1Gsfdd?ӊXz'g.Yvf`/,wܲux>0[pǵTk?YWCZ%)݀P^<;PtOEjBa/%q}Br'@)l"i1K[d )J, 6vp`à}ϝ60( 80ʱ=xWRAӮ fB#nԈ }.|)qzޥ%6କ<(sQ8 7a(.p[[@_1Kxh^@D^ҾO7սÕ FHyף8>U3^Q^vp LiKkWwD3㑑=]ӷmzm}=rxdeY,#k$ !` a$XB@Qų?̇^Cq>ĉYUBY{ vqYw*NC~pb/Œ|nR*@ SIz^duX8HG0~}!ehbK>Q6sryԪ*: fQ k (,,,,,,,ey:qczxE,T"vwznxDӋFlV1 ^3@D@R fBd4^ I:'9\kGΖUWI'p1w{gg|b#xtrSQ|s xjo 1+8qUoվ62pW/:mi+o?S( @~XFpIV_$  >괡q$.W**Iـa;A$ AìG*t(pJ֒z;8{a!&mydz>{oyJ?:V*~yT2i0h2㜊h̸#$~&Ow_fag#uȴǓ,,,,,,,K2l$E;N{NZ hG9,QXc cfV0-\TsɂΜ)!-9෭@t'p4!tlCTGTg+D]:z$<7ܟ_ ͻ?3_1|Gla1|<_|g7eyxwuBVػYh|𢯬 M=\GWeX%)_|ud\`֣VJe- >̋wߒ2,: P.vC. ?eu%!>ۮ C_ jx@\h l7FC֤EHDN \ za{%(nCAEi9qӊIooG|7kuNEf֕wU?ZVxQ>{+?;_jJ;/εAU~rGlll;'O\8Oy8)?{,po-ȧTa9 M2J7|!Ĝ'#A0SlB|“2"^1as%?-X&`Ea<'t *A"Q HnFTAPB"<xsn@76*p P]n!BKe6hkW`q6UdbUӡ4_?RTkra{=fO vIZe%vqx`wy&_B As0LDWe)hQxy2lH\[p:%1+8ߏ] ~G?s$Y`ߨo`-ײ$~:bvn5+br[#hV@c<69q~u^#x]6+"?Q,"?U/qޖYxN"dzɗϭF[ ݮxD kC.m5m}63/}WNd*/zֳg2/S3^ATwl3i*n9qQWV#ljFAEV#B[`ciQ9ExCG{ jOx{(MapMuD۪ <@kXh`!\BI3V*?ox,bۍWW6 (ݍ`CIn!8 bWŃ*.N-i\zZ0bߍYzֳ_>?%_w@p5Ʉ~^nD|E̬g@}F-[v"7Osmʵ"̚y_Z1_D*u;W*5R(~;w=LZ@yxd,5a57YoaK=<7nA,{_ a&MgŨߚ| 6,4ȳdP[^о^{0U>,*'d]䨟!J(I  w W DBKI5$[?wEH2ړngJ6^pݩ_`~O =,ݨ%2 2B)(n\}/+vH X刑%N/|0ґ%ev w `~P~`5j,w~kR^Âϔŝ"t~ h~x #1o):aJY,7`tR=SIHnƥ2-揉Q{Ĥ_}?EWR yV'U<{ k@h 8w0tA0y'ZF*6p;a {ŭ\x)o>9h l"(^2k1{…'Pkj"hZsQӍ4_rc?Tr 9q )g{g{g;Ğȑ8g_tF`2?oZP|ʙ>%귺؎Ʋ~W]~$++}z+eq+tʭ홌=(6쿲.o4&ʣDx?e"vK'][Qkmb}HFjCկHպR=n9_|g{g{g{T?l?_HG v+23xC8Yt~Z,NK~ZՃ %ovڤ>)%Vb߰ѵ5&~PLFO<>W|r"Bw*_nk?@oD/,,,,,,ˎKdPNBwJWnLPD?E!ŕ'ƕZD~Q>hshijeO=p8k{g=Yz֧KοmrZ\-\[߲ D?m75g=YSccXk'%'Xzq}pƢ>,̨%hԺ,XXXXXXXM(5e<%ܽMO_S f!?~#=:'?Νtg'(?߁PM0Ԡ 9K7cydxlgioע_x63Iɍn-v%ey:qO>ɋ'Y [n}w8d&jG|Z'"_iU׏k; $s~d@A]J"R ɲHܸ/D<,XhΉ?FMy_K^܈llll7>||}y>_Y0ӿ2Cv`y02#q4%Nlev6iGP;Yu ޻*7.TIź =xBѻޖ^M4~3q86ҠѠbŲ KROL/说~Jb۳=۳=۳=IN\DSnJ6~/@\0[r-HLKgYݖϴe $L&\n7rʳB1{abl7u̢y>b~7{ލaԠGO]a܈',MA '3ݞcv4W_oeTJ\Z)Z{B˯E7_/ 5"G=İg8$YzֳS2/S3^'?.a.yŃu^U^ղ Cfv{+Uzf6;f_uЯ9UE4KW ŭCaT΁ o~ibo\baaaaaaa%$4(4~ǩ=? #bh^˂ADt\MBLdïUW  oZVYv񜑥e;r^lZ N}UWvjh+>5Ouo+Kyj;<`^*V_TI*Kuu!%>h%%XXXXXXXXnoprZ-ѳ/NbH`jU1͕5ܚߨ ңRmBqn {^1F2  ʲ^yd,b3F?B YpfMz :k) ->a5Vdgᅜϵu< u^XMz6 ^\oiنׇutg004G``P?V-&+ʩG 0u򴸀&VV%4iz_ zgzSң藖%JuK/:sPrJ:,bI.b0V]A_rrǕHzl ْٞٞٞ'<(kL1WL'/_895u&_˶G]u`Pc~|k+#28G.,Fg* Ꚍ3xq/}f]MP7VsP;9GLsvXS.P֫AWyĺ3^ kmjqE Z(>0>TfHDy^MDPzy/~AMx>& =k JY9S4~Rr)YB4u? U F,̢_^V[W<\gO؞ٞٞ*S,_2+DT``~[w@N۟kҲY̎MhxJlaq O.Ly"4⋎\AOyG%RU(dH{-@{OƓm/ÑvQ%?](຦: ++b=*P`ace]>_7t; w.bsm(lk}~R,Z'LAcG>\VxmRHeSmszۘ`9?q=_0_aB2n#y<>جn >i䞿Ftj"9\ LDrϊ,h7tU<9@d1a8v=ukhyC,CZHl.| Dt+ޕ |nXvkvjbɟ}T"~ |m\NiTT7ZYzºxtOzQ@ɡWk/G_v Sg.c;i'DXXXXXXXXno\ '; ą3|n5S.KDZ O3O;RBj$4 wUp3Ӿ>)x㉝gF-lDA^:F}m2FDA?ex* !7 4Q݊asmiw_%=Vۂ?|/>[e.p;sVcg=Yzֳ?'߿n@dۻlT4">@PGW:T,eU“on j9L5'W+D@X?sާWgS͹xpU 5|;Ul͎ǙpOttr #䓸͟:,CmS̿boΪ\\x#;ÚGZǮ 68DfB):W?Buyqp]<,|Unj춭7>/ОWWm6CHs]OÊ^Eu9NKB}W4PN ˝ ?y2 R{ xoKmdm+{4/XN_-C&\tYZR{HxW#`8HqUf!͏vTW_ڶ<*'W1"+iQuAr&/2g.'Kd`{ x&fh.X/RU˒sТ"Ry[@_Xsy*Q*=.40M`'%,IuxHKx&ԋ9YGxTZOUg}mgf`M/_h QgW= -{ N_7ni"l$F1<`6L2 %83n ",#y)k>0ގ}02[j.ph0~ܺ?;ՍK,E/ٞbLQO/v>/L.P~ia/:*FQͺ гg޿Ng'0ew"rI~p`*?qŸoX,TCo!z6 )[\4ڌ cWpGC,CuF GC^ę XUtVsuz=ʩE=Z nE~ Hk~ݖI-8;W6T$Kz<뭤롚=R~@vGu% ʓ/1# UBh~Q{Wl1vJݸ8==۳=۳=۳={:NQ/) '({I`f񿎷/ٞٞٞ*S4^:z?0YhI1 a' blwj|2t|oqUeq|`,,,,,,, /x3m%ЫC A1bi7d'"źk Rs􉊻V_dZi/]0"]?˘%Izp+L^qPzFȏt<(ujd@DinˍfD9%7L& Gc_=w-g2To*g}ړ^xjXzֳg=ozM^pc]i#DzAwfkfviioG?]pm-ݳú m jb[ o&q)W2,%~=y3I{(p`L5FjX_ZXz'>ME-DW&G cIe~/}2g=YzֳccXk20-/.<$2BfțfvsUؚss۶ERS8d[ǟȯמ`sd] dΉZ A}{GENB3շ򪿠;|MK> JէNWP-Z -"?y2 R `̐Qwcc0-x8*"mD}bcFAZo~x-{<X/<׊y۷L*a ת ypƓCv<2O|#8ad5H:& 0L(9x8)_c['U-0 T?aTfpxX1(Ow(5jU~daC_I=ΠQa`l_'o|Rʼ*_3L,,,,,,,>MG5͹fA8fZmgm>gǂCq^cS=DwYm%_/H)8ދuMo =nӂc!n?Ɠz4 7A]-|Dx(,`E3fs643B;lYGelYcDZ>5^3L@{wPlLv%%8H{r6YbP_z Tv;F%tlG3Yُ9Ke!{L5:3yՠ q~_`ݱ]N- (=_I=%sX\`UZYXXXXXXXn3_'?yLsҿ O[W-˯FU+ĈiVgY{"|XD§juf`!l>|ˬlj _F_r"2~ՊGbureV]SDZuCqxWX;+x2Ew6MzZ֋*uZ >!W"P;}iG]PTg |hZ7sX&; P#a 8wB:|b] isr~|ӳ;"ȯT-/[Y׆ 2tuj2!砿?=?k%Q#62l?}{<x%<~8 ~=wmGwCeg{cIfMWw[&>/hZvSq%wEl̬M*źW?++7l9A-ڭgRuObpP:TaeIu.~i&28)ِgْ]PѢ@q]EP )xc}XzTp m >w,#a]]Ekq=hpXG/죂#H0cE1#z6~_۳=۳=۳=۳'O\8Oy8i|OH v @Ӷ\@h d, 4T7c,Qy$Se ~Öt-U{Pvh]$NۿdX=y-\7AIHzTD/hכ~^? ?^rrnD"S:Pp0_G.K%y+Ձ1P.&}lVgal|a0֭:yjd)KW (8x/:6i]q|bg=YzֳSq~{ׯ T?wotK/lHyi#vq6A L ` KQwfĥh'׹٫E2v/mMn˗ ʗBeL;΂Pq=jtA*dEn#l9Oћ:o P~ e ;^kbCakR_0b>{m ݂7K n/!>ƙWڢw΂hs:Л<_ʢuk.'vI"=@ l=;(< Y7|BvWwǩ=Eڍ}LJ3[gf1:Gi{e(À#9WٙCS>yѠE x9bBk8e&FaPoDTL08;gg-.x`cUxӬ XPcej҃iB>{o98 *ә J+ׯz2vPN j3g1јfy=tA켴񳫝}Ih-bay~ r̵vΞ D0V5¢u,,,,,,,,?GnD [6nqrU?!8eGXBieb"6j7a!iG}Ed=V*= x 6YH;kpEB? A]č[Ѵﵾb fgRn;9'rq-,u< 8&zr) XaQSU3AIyP>Zwp tw lv +R3(J{B\%I[wݗƴwFoFZr~ޫįʙ֒7iڳ9YzֳKοmrZEk盄Ӆѕ2Eg=Yzֳ˗~,߹~-ɟ `,g7f3プ\'"j yߌ6daaaaaaaE]=O^ƣO]ٹ%cB7nD׆,,,,,,,,>MOPz&-p3\kLc}#~8[r2ϼ81ew"rI~p`*?!Sݝ!;B _2}~_/^{^|& &~lTc2MWYϠ/IZU/~Q?i'0sݰ؞ٞٞo?d )?i_AKY;tm*OBRV 2 ԧ7E͡c?gc2޻ѿz Vδ g=Yzֳ>_E]v& P"dSc}!x ;Ѭ{W9'=D磃R낝OLj=7?_ 5~iu~ ui(n?f/lF~w=+\htݜS0ڷ[sNr3yf|9j g./gaaaaaaYIeS@i+nqjO~ㆌժhÉn*9l;r_3;l琱_wwj<6=q=ua4q\ىSgM-Z?199ynAt{LLݽatgZͣsMs_jl~~;λJڼK,,,,,,ˎO$8[g<7t=݂s pаRez =<m~ Lc}5QM'6;s")4uR앜0aU~oztAs_zpk_GyۀySU3A''ϟ9w~ z#˶@?fZ{-k Cͺ?߆iZn#P*_݆_]]nfg;5pb;:Fͻ=6ʾL7lN(x/q{ojF1s_jd,1mYjF3g{g{g{_F?e8,@"d@[, Fo߱Wl͉`ږ\~̴f?wO:_o @nzͯ`9{Ș8g6m^kuXtoyhQVQ/iSCm]̷s*?b _KC3sM6?׆1CE<7i^ఁn56:qKOra3|D-vN3o}-]L|\ZYL7q<|9-{ F cxvʆ|#2| g4x~~ Xfz|0i 9%+7Mc"b7"}Y1M!-b JG \XUcd|=w q3 ?) -5 =1j+XJ/X;ܾkz_ +mb|{GCC(?_7GR%#kJCXqgF`7D=`yęv1Dž"koŚ+ g )ʩC'3;rjֽxOW.qjO{4SGwĻM1q碱qGg=Yz֟XT1,4|;|rr "B 8!Yd/v s-; 9 1 Dϵy@;_Ay^ K$P /_x,yQfQs.ԟ a p"bbQ3Φm}蚻}Pnݟ Ϭ@VaaDR ßcrYy+SnkeDgj]Gs!Kajbs.Í,"sX5 \b?|r9ڮ^/tp54_m~Eݚ^h\ ,Pkˈo jh7wo  xnSTFNoPYd& ײ^90.5ݖ ՄH$વK?(7?N!!FM'ȭZ9ϿAL嵾 ج 5#-\7MN~p)-OF9s)@ɒ%3>]sګݓXvdN??( =Y,H8K*Vrx<<.\xѱovl:c fЕA&_u/ QVSMc4_}Zb Nۆմ4b˟<x@0UÙ;-rٗ_+&n΋_XK,>gKKIyퟌĢaK+J?칩还&/^:59`/ x`/~pP_63qn/xaӆ|H:P}sX\]#X‚whAuSj GǷԨL~&7)]yTi <b S9}.(g[ JPN)s>_2%2O3ډ( K3_'ɳM^D?L[i?Fv1zmD%f4D^q;s@ذò$]xLbe3 ?3 Xl!^klrȏb;m#eY?:Dp]/LqjDb>{>J:fQ7S;>=0cӦo<^*QFU<98vmW K {/s 36 0ڏ( Q0;?x#F2͗g $;Eb&@lT/ξ-K% e1[_[ O9:?۳=۳'E?"M c#/LFςk&҃в#.=x(=YT2õ"?e=IQ[zTy~Re~.L1n9<<Ó??cɩH.?pI'])ٖ=}OBe+GFCI#~wIh!Nvпn)od2ojv传qL4&yKM9kea2=mdp K}TH,$= J.g" V6N6LV {H;,;և8ۇg=Q/"?_; 2%Lwޫ?ߪ]ʟ}:R~w EB{^ï2,1L=i?/hSպ/K?9f?"fF_r܉f(3,R,,,,,K[O_7 )nqjOoUosiqBf@H73:_O&QO퓹?{Uij NEХ-q{pKXMtNY- Y>u+ #YOK'Nw_Ә<)\YOPU N?C2R_碟>?ɧ)U)>-/X/^tm 'G>.&6tMuM=~!ϊqV/E]/uUk H{CeAizT9<2Yۮ}؞ٞlK8bׯ*= O^RD Odȭ;1dz~ϟ8]|?X= S/ܽq5?~VEX084>]~ /nhugR+tO׊rhD?۳=۳_#qYoDN`,[Ϫx\7&IJ+Vb.-/E/"O<3N;z7k<772e'[XXXXX"௒x3>W;>O0̂؆^G5$?XWF7dynO'L9y5`c? ˢiOvu7?œy'3X~w,HnH*s`{'{?G޸=G_eTRr5DAYp)@էĔL>vؼj&K;,Չ;,O] ;NCzֳ'i\V,sͅS#V:}nukfݹ~ueSLρgߝoOKJ^=YIuw .8d=YiWyu,d_ El/nB_C l\~n}~MI1E? 7}`>_y7Bo*8fiӘ|)/'O+t-,,,,KwY}tWV&3~Ŵ1ҟ)q6de"2|eNہrU*a_Xtqe7,+]-6\:5?/ѳ֟pK;'ݳ[}񿕇/y4&uGꍐO!0F˯W})G/E͎= gژT3("T̲LN,7z5+DŽ~%_mf+v)7Eo|v2Ǿ7^]$T6I2gUB_W(t*3&j5hQ*@a o![-DZ1/ߚx#%Iu/`KFw3#'6:lD6ToQ_CK`l0Ɲ QafU2 rpSn &J] g{g>||}y>?&UUр>F2k _|B1s*x@OժlU?d z|64n2 ʯTBtu#׆ or>7[~3^ϽO_dl fmsZ5|?ysqkX#X[v ,#UR[sXg&Σ߂^!>y3Z#:&+jLOߙh:y_y51X-fGkegn) `NہBZk~#fqUxz%bigP5[.RA|; f' yL+57Y^̿FR]!wH{M(E n׾"8Q+?=4>Nd6Wg6#@GF!pz)@kN <3/9\}b7*$SF5(ߴ|߷=k FllީO[7=. M;Hk5A_Y~gΟogU\4?V(?TyJgNWτG4Ӡ bA[v?,ˎyO>\.=T. xT63 oYu7D~H>y@Ϫx˗yO䜟 "B'bhzg)sOt?Kr'S.nذ|+\{ ¿[u13z\Nקܗy9g?RQS㘯4za*䓙ãIZW˭TK3nt Đq?f20An\l6R,~0BkzBzo/(h긖>[oмֿ: _{XuQ&O7&zʿ ε.e]ux W Xw𽍺c@;ȼbO؉^gTd?s67H|m9&([wC..O]?-v TȏJe:[_|to5{&wXT x_I>Mߨۡq5F ~R kݨ(_| #e_M enh@y742`8{wzc=YXy)wڙ`/@WS_gDv,&/:a 3JN~ß&CeKMI}RVf7:y i' jUdA) b ~.x=)جSEWrg>w5)pr >ul<`yDgNOMl/|>yN@SNCY:w?_ R-;'NdddfeuuKO7 {Zdv]$GFSip5׹-tQ#Ãj߳m7?ߜ!E[]DzK܌u EpBZCV#>-^¨iL* lv4;hgamdXDs Y8x#I7L/;ވcaP\vfx֢vptK4##3 Qbi!)y%~f[jXuȜ iluPq´2hD{,\<#푟3cI}a[a*o]|W,@ yik##wʬ u(ğ<\Qn*J*rH| nWO?78s**F*<,PxLWz|%OߊӪF𲨖/7iYN}vaGAr6 TpB3[[(<ľ6scK 9d2 풞Ke.$q!4QVMHF 8̹= g]0TRI%n߱ s-@Gm_} x? +_3*gjr'v)9f'7xeqrYl(ZpG8 o7| 9r$~NМ~e?LP!r wYV& j,=6ZUeNE?0k'1%z\}q`@Փar056xcqƨ3phV$nt]sYkf W&Y&;2X&7.p CF&xɸeȇqE66툲Vqp)T,oI`1 p dEʅQJ3R?pBU{5KxVe$R{0[`卐KBF%lQ,/Ñ0S݇!X 1u޷ W'j[fVAIpA1ȢPt2'RfҺ 8<f_W_Oj?__sΊl_"*E*xԆX\y=niGc KZ"&GRά׵ohI* Rf{q_s*ZLZ9"*'A??XEg 'FFWфRMpէSgfQzDDťoZ)p&h{"oB\6IW9?@_(>c~WQkm~ZWjee"nQ{tu ą1~[ )Z]h =V`4yO2; s j#]:| \& 2',캱سlw'i@,xV4Sϛ]H=*L;wΊ~dOtpOamCt(tW zd-p2ĝplާ^5Ӥ(0Hc"a;ݸ`+ͯa,73[;8#ZRcX@}~RY;tEW곏0F@Ywy uɴ¬zo8L$;ȠP!,ՍSBť`x`F9DYP%"Soo,{gL%_ h'v]E |Oe&5QP%g¶9u3M8?+5K{RT:skiDk =y{٫_aYu9pQ{`7]`@D#-D-`*1/Co2 ]A| ms! 2|(cX0]10ʆ2s<;}Q={4Ƈw3mP^Daf86B& 5Fґ= !i'o03!$]S仙 ӧun 3T!',tEH6~ŞܓFM<+/36`?9ەSveWveoRS`E/0| o^Ih}#Yz UØEӼ[׹_'8|#A^ӧ>]B%POu#}tS.qX)?,ߟ!zo<_}]?vg4۩m^f{LW!mo)W\iDS_Xro}\9.q)l‰?<?\Uği7 =Mk=""??s߿}"i ++[:ueοK6{Dow wAQI>N@q>ՐnnQ0\.=Ebn?._}@q؛,vLݗ6mvYwFCMiJ|DZxڶ`{ѧ@w^ä{=iEjUU?P8?J]c{& G*J*j0۾Qem/m0"ر}֓#Wi'9oE1Ÿr3 7c'q8s=m릯}yqcpkoz;0>Wϼüs֒_m4 Myq#5gpg ̷M6Y\\'J*}m:ŭs <qc@P&I`>db>4iF1%y|-_??G&8E[|q\n yU~3+B+B'- o?CdqY7'[Cc3ΖYZ~ +~TRI%?,q A??,I3w>Fו:0ST[lc>vVz'~i@_<}9' c |v| ob|!=Cdv:߮nmNPm47VhkI䈽cp zokZUI%TD-?7wPkBUy~SM'v|?]k ,ݛ`x[+!Q1}+9O6oFܺ4'!*?k9Ҥt"PZm>kO(wq[c=AѼNJzj{IOo-j?+ו=9kOIsS;+~ςbى훾zF Ui4^:uS4_+?ܷo}\GԛCc65gz$N@խsOjU/\pmμ9~;=sM!q]NI)VSb{Zz94xDb͉4^O1dwQjذ]m&5c4_\ BMXy=<|AE}oGװUƯ5}5zm.$o!'ǯ?䙕8nA9jW_+)'/ K~L1NkRyES_]𴮛f>7jڃaL2"oc WdvAٌ9>9-{+V*5؏? ПFdeqtјLX4cAT2N9g9 w}}]Ho鬺܄>^=6-=E?/ȓՓ~5 V~8|{ۮnn۩3 [=e.NYs' PW_+`/?HO+ך'ÆaVf>  iZi #ї4]P}ĝ ̹V1+% 7G#s>G9?a=;c# hv)WG0$بv<aL܆鈊xAtl/rH絜eCIXV{TH:V1$;袮Ma$`n#ä@| ]㥐moY[m[)x/7у;[a_ f2#xղܣ*-P\ TRI%T5Yx#i:ۼuM#:͞ {BSv =oC`Y+܁*o1!׵f&{gyMF"=!c!bPfO(x{,jrf61;gqdpg I^@WvLSeH}fDQ>KEHŇs7YpN\@@SZr4@%I#~ɭRɫ\9#ZA઱9phwqSɇmW4"V Y[;|BFesZƠb+dDۣynD{V Z_u4Bex֍'- c(ZHJ[OWD蒯Y+Dv:5[?(Oh5HO:vۣ 糧MJ*J*'_SY,)874Lx^nV+gdAF''/tB4nz5Ĉ6 )ժ0^p,0bhyn=ѨY.cT3sSx;?|ELWf]ʫC}9 я ;[69(#ɡMP;eq43!h& 'B 5Co]C'pLz!oʓ{7p}sIrx?[Pv k㱕13?m =$=4z ojYk @oUM{(FV[!w;\jvF=Xj$Cmv8~ZA-<+;{r)X^T7'ZGgAY|W꽠ʮʮg_9׫:]mr$PFE,˛MHfsQJv@>*2~  ЎF6. 6[1}X+3.bC]bqe"Q씙ɬX Y/!7gRU`73-v:4^G41 Υ2ݱıO0Y砓/E\W@ <u}޻8˵~div϶8|Z+`Q֎~vƇ ȶR1oZoy{Vjmd ?IІ6 zL[4- A/39=mr 9sfY$j}86ٱ 8yKk >*ŋO F~IOװ=YaBVh;f/U3*J*$uusVߨٺn^7>\@hK?+?KZ܆_#'?׵[);ȓJR$1K8nJ,L.o8iÿOZ7ky(PWKw|C@ׂyZ%~CIݒO{w8Ъ J-[՛$E+8?tY.n4^2ʷpϭkow[,}j<o*Ggq^8p; I}&b g dfGy;{V@=!Zz3kZ[ÀŅ}h)J*JAo:Fưa"RK#xAÛx#~㖂8#Qz8U~df9R HHijXce(_㊵`XK4+x]elGdڣjzlP7FI'?5:wΕ꡶qEp3{c}{4)u+'qS_ ;2u逸r>v@S͇S\_P7cw֭8\WxsH35݊o+e«{>5 9 XȻ[oߞY?3 oJk6s.硓b?=\xw-O)N^++qbD :e<øu<yY[1Ha#IB84^8[;8oW4@*/1[" @S.bA(=Ȯ!/RQ4JZμmSv+Nݛ\{ػ7]~/<ͻ~Rb@;vMZ{ϷӍݶc9mL_ŖaV[fU'd1oDe>-jaNE=^ֶ.1D%o&]\Rð?+åϛܽ(d%Җ(NQǹ?z5MpKsAӕHFZ!훌 ?mnJ*J*5y^֑{>w7N `#ӄR^t )l 1Lݠw7(:SA)("z䌷fl8/kAs*k?rca;%M0:`kM$0zـSvib{|O3N|oaeW14yDߎgк[xZ5`r 7q!*vkeUC&0i YyM0htX?Bly躬K ? 0hmxQ?t!^ #Ο:ꇮHvxhgSo}أ!݈=mrfd; (z))s.%P_+?uwq}=۶\w7vF (=lCd!>(0SD-TPDhX)\ IZP辈2͑ Gxae;}Uc>W@)3`*1dV%(؂iR#o1q(^`tMTi>8N~dt>9DI/>OzWt8F!;v\p99 =qHx43-tݜ$4iJ^4mfviO:'/A F'bAn؆Ug2W&P 2y}<]S+]aCK zP6\]R1rfuQG m| 01CPbhO gWf t]ٕ]ٕskw8?'~k.@{ul_~_Ġh!DeOCN8qgXJ?)n+́V o}Dx?XBO'=e/Y,|G4B=OUQkZuu]-7wvw댯펯jY,FH-ҏz3K[֒ϲĺ] 8 _#_'>fOWM݉떹r>~v9._=o??bӦէqIk;q7 ô=̎id-~Ois&5я >P3WK7>eͯYZ}F.9󿡳G]mv޼QykF5KP~O6:ygLJlt+HO((`z_ւZ1Rh/!2зYkwU$ [juS06;;ki P锵ﲅPBҿWQSNBEa-r~d;]-&ׅ| JPu>7J*J&`z/3Ynͧov7W~06uJS~Qש+򚮖ҧ#,+] Hw&nj+mY oƯnXF`Kύ-eu%nn}w^ڹe;U]~L1&hIvZ#W_C6;H1/4MP0?u/YE_կ[ֺ ?ۜȜ2g\չȬ m͙?]35D_݅ίAwy}>˘Y )s6kΌ`?+#$,K;kэZWu\޽;iiok~c1{vg'nk𿳵 z;`ALy'P7zƆzcݦ|-W_+VR8b-K.X>{BǗilsc}b˜sboJ9_<:g_X_k`Dp%,_3nvv.Y6sv_Eͣ]ٶj κf)Xy4Sf :cp"\t+Sw.@SsF e xA8yxnY^q比'; N]}?v}?jbْ+گKVݙ~O~{غ(_޽O}OnNJ*J*/3}L?S_#9ze^sosh&SGHEcϼ;3lۻ?rU{Ϟo/ewri+b /+K?ZNcuWu I;pKO:CVu-Su.| <v|niY7ׯ5w7ߕ]ٕ]ٕ]?EvYSHrwH8CvCNCG1Oyd 's;6_ s6o>4~tò6_uS>b`;;QWex,v}W/-k񷻿fN (5Kza 23?463Vt7?Ykt]q9wIZ#֩侇箯~݅9q_?gS_ٕ]ٕ]ٕ]m>9Ha@qZ( /;gG ƺ\石'Wu",Ȝ0M9\S`tl¹2'}W?aNG9Ѭ95/+̃w.kϏC.#@wtk:~iˉ;'kyr\ek^c>-ͦTRI%TRs(_W89K0?*WK#ᜓ7UlKwmKkXb繦{ *w%ZS"7vů]K`$y0Qg8F5QT J\NZyDWt[yUte,#,]ѵ"V\p雿56j4 J*RDSQՏ'2ŎҒZqr?Qǣy][#~v¬4LG>2+^w7|a\}vbsCDzύPlyeK ՝-3[Z-7 .q:^ΥrM ڥ-B|јwO#BǍe<ǥURI%TR?,qϣA??,I kړ 7WB!鷛_ o|L P 3Re6\;^ݕSu*@ZrM7u'\D9w-1+^~ٲS RYzK ' ~ӵ*]9/|Pqٽzn{]Nv,G}ݲܶu׾O9~tB Y7JH%TRIy^yIv$cfO㎨af6w_8Ⱥ߬R` W;!l2ǜCQgΖ5ˑ㗗|1)4[X~WΖ/Җ_^9s'vr,K?N-cY@'U~yvY.{ j \/ł?(Ε>6g!P~Zs[>UG1U;:&v=Z/u=ߎ**WOovtv`xt޻8~Bg ޒx`pOP{U)AzM_QT:ZYйχ-q05 ys*1&wh_BǢf)/ߍ(Ly):;F4Wf5WB]h:?N^d>GI_yKm]mk%?m.#B1[j{[tCD±EiAJvvUwԆ߲vFHݺYF _os_P!pص-33Y׾WHo?,(NłwܳBlކnV+2wv#/"ѝ;ߏSfp)tIݠ5"dFϢ(' )a0X`ȯ hy.7G#״ƧRӵ_FN?u-diu.{wrS/\ĎOtA?oNi:?ؼu\ھ%ڏ0; <3Bퟀ؃fFĞ;, G ~{BWzI~١AGT*h0y$ bo%/"/~G\hP4R,z[,19O*-$/Cog/~@JHWyN Q{G >_D#Kjz [(?ޟ)ʮʮʮM]+''A䤙 ى5GDxKÆ^3"uv?ߏj̔9>5 ny%y<y% ;"sj KX* v4@f!kN2Nq/σ9>J$~o}~Cէa+f6v.oOBkyIs*Dh' }'@wJ4j{_ n=N=7{ns\ }A%#vB< EwpG hw+ qփ?O}ʫZcxjzV,7[wmB$". s/KpE* 貏[h(aEp~K*X 9#`n48+nE{gUn~cщURI%TRX3<Ppe?RG{;zrɛk;fv ƋZy]Cv1Eq>b^XxobΕZO7]Sx؇SR`gʿϓ";|Q竧ԒЋX.6a mm T /^wXڈe 宰)2ϝ.Ŧ^9,6p:̭,Vt,__#sq 9 bÝǴY?|#'̿n·O!l>8ꝩ\^2n൰z(sxR}x)5+/I, aK4B&S+OLhq!-%FBVKplFTRI%Nwx8]kLPr5D)*qe- ")C?b-e 8AD!eJFR nQ̫{եLW`\/y~<]&0oJĈ,?#7״K i㹫ອ19!1$vSIܿKa}<?ΨÊr9S0~X5 4b.:z~[ R. yKLP1j"L+֟*=,F i.Kr>k|I1Wqr)Y-oŞ |P\jϴf+,O!l) Yjȍ' 5gJEpw}KDe{d-TuG==8 y5ఘssi_CGh#Aˆ(p"f|FFY5Nq n"/MiR `?L3, ; 'W_+;8#qZ>wHI,Zsq r|+vð s[)瓚x^ȋe)oEJ46/Z% 9;Yp)=a;ٶua)O?ٷ ֝ ;6o}غyv'Y+8'[8.-!!+ˋԮxad#mj{C,~8"/q̠1Y!綇i!m8GV !j%/)Z-F}r?KOb0{"8~hDg I5T;_ZﰙpPZBJ?MM^J*txA?Ft N3gi5z8˯k?GV\o=%^*G9#zjʜq,2!s7'Q}9e3w3\~F0%/QucZEelO5ct_rpōσ}`(d2>K vqN>SG?OZ*܂||/i$jف--bf̉qꠘ̔rT`-"'$L̙@tbbl hO3NTxv}KI&*4t35bc,r`oGL(oQY]5%88[+mrNy6Pș2[[|ek0MJd~d1=@6,߫D{; {h~ZF'&Y6"xj]kqBLXL@mQK7RI%TRDds9gŽsD<HphZ1 1ke땁)xc[+\T8JLn+gEҎT>m04F4#}iBxDb*.ԪDY(d}{r?6H79IY"ﶵ'~hfG ͑0sȋg/j.ϝOb1ڊ1=q-:Nrii!l/)10^F4[, GKEh8g:sNM9 ه_a+*2 j09o?*9#V U(c%b8R.~Z7xT:тOB:&m-< \+ߥM.ho Ra^ӿ8"q߹XW{ oюO\ VfC 5\,-!}$*_u ~++ OYs#sdοK<4'qG0d岈'f>B?6H^v.,.C&m>ITb1Iǣ|-TovB\478 ky^r~B51A{-Acrp_( FL}ÞJַAg>>})M_P {aZ'puwͳab`?gk[wy4w%i#`Ii]m5gĴ`=UONDɎ`zq(5E%XVK`C'RHԵz)++wq]#zC^ԂL GGn?)b*s=wx=ZH̤,<3ߓeD"1G'݂9a~#B>FnHu ٖtˢ LPua-8k},c[ i^ggB_B/%Ib<oJB~-v#_`a/[KmO晓'\-E z!\r9>Kf.d7Yw/A97w6„۩Q{m^f0Ygxէ+Bgu{< ~qsZUݵߎ_xK cj kvJ*J'$Qοqr vElLon:>(IE6^USQ{?$z-C^ӃFN p??OBg׾1Ӟ}uZ TMXo_WMW+=,h}ωrS+Wg~;[Yr Yqq'EZFU,%:>2~:&slWS?~ `dJïׂ쀰|{W̷>?}i7v:W_+G} \d;MeYKkϪ7_wL{|&x/Z2C.`O n9$0:08d!8N #O hgav% |u_ۏ`(&0{tȁՇcP`\B") [#~|:E)ߴe+;tڡI֞]ٕ]ٕ]ٕ]O_u8?'~k.@}-1R.+FPu.ny]]~03,|Y)N÷dx8;iзd|S-d :s|XXLvpxHOΧg rc\OS?cgRɇ箯~]eWveWveWveK>e1=d"ܘfs3{=Epj?;18SZD3iE΅Ŏ :ƮY?) _E30<$EClvJZmoߤnOAIJ*J]2vV9qj`[9K#uH*7h|r(5Lけ4~MX(ҞLg?Xk}~Z~$ i^90ظX?kXI踞 ъcJ%TRI%TxOj? Y^)@b99?~ BE}O3+yZt4/wHl?Kߩ/9g`B<&/0aϸ" #?ES loiPyD P2|ȐlA)&e S,$GF,Ik_A}FyPu?:?>]W_+ϡ?s_3?g /23W4^mv@5L{9+! қlAm͊r3缎}Xh?` |oOb!8s(Is,?Į۟f|g |h@Xxu8+ 8 p֧~1o ؇ +$lڭ61NW_+0C,ORw67/C;QH =!I݀lȀ,@J Y]+M6zo^[^lG3kc.?<IǾ ۏ@Depjdߙg㻨#V k;Ke;lvzY BS7VI%TRI%T/ H^sqtyϻH\s왐aNf|]o(`W5mW03SăFű8 l,qx y&u]h|>;*O~Z˻6[NkAly~ݾzWO?iOCeV``kU(VJ*J'7w֭[q6ܲ1ܼc;s޹FC<vV3󐡛Y-?l2wr_C#QsrFwtp9 1\rn03;ay,D^bv`6z.wqS9g##iy^;'{r>{+As36?}﫹\~z?guG$ ~tTc  6I{ʻz cʮʮʮ'zWKӵ ױ}ڸ =Cô[kړ"0=^0KEVb bH  4ѱw105R}t}tmOA:uM1rG{6￾6^-w('S.i@ME=<|ۇxOT ~'&i۟N=cǍgK3^-_#Rq&QI%TRI%T:^ܷjp\E_^{/#Z1 ȦHجU|nWFp}TSZbp:kAt=9ΖKTp@^'zo!l6Tld1ٺl/ JEٟ˅C RcF^.'%]}5c^=%@rIvD@*(ϱx}FMw~x]ѨY)0p!ylNoJ U[& WI%TRI%NDrH#'!Jܿ)9(o~aA~\ly7"*DD`OOH91=4͎OM"ֹ^LT.Ügt\>/bx!ߣyR9NsIϙOH~sp}V,z u ۶r hۣl\26Y)[MװU_%TRI%T:_ &ßҞP"_sQ'?]~PD=FxSxX#" +#W"=)>'cﲏXQv}|`t68 yz=nCq礲ckOnߺ{83 \K_ֆ\2N _Gj% J*J'__ wڼcgh%=?@^!UQG 0-+zHJ>EZf`NNb6dIw!U1,h[|~2U(WL̙۫4J8]qSizFX#gC qkӵ٣?{'E玬~ O}F}r$>$IQ@r҆ ,9g1+b@$#J#W5w8t+S[3W]]]mv_K@gBKd7Ji =jUAj5O?篸?b8-*VUb eFyU{$Z_8Jtw'T9|?=rcז+O~~9rH^ p bJX:qtZY&7Jh;|=ͷIvs'TsoF~-HXGuuܾlCaIpR\?28(|;"n"Arr9ԉp0r0Ia 쐅IO"xz = 5gNV}3aazh{/4yCyH'ȀjQmiڷa8By?qt|dPx8~df Yۊ1b ofnnnec'xn 4$ռU 0l2V[Isw?zdN S7D@I4@$%D~.%^}q25y~ 0_?Wı]do:p_[J_~f]R9d-kܑqBU1ccRJ2^r"D|L1Q={WF⹪#_ XtT?ݢǫ߈gԗO{/dyNVjifff˦Oѥ(v8z$r(~}8Ș76&}q־Z[[[3:~HE{'}<*_ߒNR'6/++TxGCIvd7n)9L~499D$_ʕWjN^V5J5df|0ӌ?W͵dD(ׄ HM~~S|ĸ(=EjrW{zϵ;^l,rhwm*90aLkf%4oX*VU02bX*VUΑE<|D>Mw("!qK"A5 1gO&dl=Ct'c19R'f2)k1?ߠ=ͨ(/1pI&NrRvJ"ɧ FnTxL>(?y㐗3dzŅDx>C\6QpllJ& c8^^YO Kޒ-yKޒ>  :F0nlh?qqXS'NL< 윂]ߍ{^zyFhLhKq:ȷ-yKޒ-yK.?Be }ҞB w"V(Xo(hO^))C>14)P Zc|H)M⑗D M&>=x*|2䳸,L}Wnr5&ދ^pk)9epJAn[[[[,`?ײesҢU+ҒRUC*S,;3ncWOvN T+ost*,>?v?5UnB'xA@"p.n|BU;rsHIqfKcg:yKޒ-yKޒ-yb}w$8.o{i \ .,(G`HW^(ITLvCr] \7baz48YG@y7Q+  ㉽L>z_ԯo8pߤ=(#s*e+1.Dǧ9#ǩߒ-yKޒ-yK^a.uᾘ Qimt@@S-~\!䗅q-$ᢔfgUգ…d 8$$WdzI5hAxWd.Әp~b/Y I',f)rP񣇋x_8dH9n-yKޒ-yKޒ@s^Hov3ǔ2&?( TfgQ}U̼'VwXX!b{dp<4s5G@  B9ћ ݁< I ៎T0q[K_ gZԢE-j ,%F1#11>)Z`_3|@p~wM(X<"{Ur~E\w~pQ>쟗[[[xx^v/Ɠ&QC` фcjc׶B7=P/?~J"C~/['w?6.]c_1G}OmZ/`'oy%yAZt,NuFG]!^9߫O3#ύF=2oYΡµ-QW -e% ?vgA=~ ݰE-jQZDMr«"WȢݢcg*tW Lrk9$'3?έW_q/G^X8^KN8n%#rf{_ǫ^/wOdϛ'DOzvWh6ƭ ~*.jA%V>A}ug@|l H䛷WW}P@3-yKޒ-x RgzC!U'b^;9{H76cy66>||Lp'y ]U 7qm>'S^#$Xt|;A_tgzD`Vl/ӏ+ 伆{>u){7h2Pq]CQcLVQ==#x3k}_\ߒ-yKޒMͳ*qOhCEW]QFWq`?!j,|@ROTZzӡ?^G*vD%2;'"}⮀o߷;_mۂ]~1fxE=fG_X]{dtz?Ox"~ (ؚ1=ZrV>,j#{n^*.] (w5؅O{UV, Jj]ۇ1f:RR|#%O>z {SxTy;vPaA- hݱE-jQ}6UrF)1)M,O;淧^A3Q,.pHP^X^(_N($+'KB5P=!#[H 0n*Ǔ^49S<Ѱ8<ߠ]UG`h٪4zl< QϜb{OpOGϑ63ГgN->r*rn1|>}T{OY996ݙv!鶌,iӄrY)Rs2vt}w/w6W%}^y[3Þ |f5Lǃ3p8a= pypeK"G7-yKޒ-yK>Q ':d'qM?VVEO-+KO➠n}7OS㩓g ʷKv3Yܒ58- UG]y1y M^zݽ]_A#Srkk\C Op[{-'fL'/;grf KXnZzǔ[ Z;#UPp8OǫKzʕۖY͖!T:YZ*Y H̴ݝ~u.js3/ P>㺍v@qU)  #Gɏ['|И,g[/ܻ?L 3)vTpw'j)>q8RrSqRQm +7=Fg0zg'#%>SrID*0h_eJ<Ѕ(9i%#]>ۿ ?MNYs̽ lC ~\$_@ WI==`(+:PzZmtHD$ò oE-jQZԢ(t96 G ''k08z2G嬬$=)ǙtWg9aj T߿+ǬDoΰ]t \xzZIBt Ti*+Ta̍)>N)$C?Ggq˔] &ڮ׍T;VO}_~qhЯ:tp? *0/exx=Y =WIý`B 3淋ib`Tn] ̰Ȑyf6k/Iqʧ;, RAL?s K* 矆d:lP%tS\3~.vRzwv||Qp}> O/nnwcĢ}0=AL}?l5פ'=?qLá"t^TgzZBpj/;JE9S3&9'_-{mov&p/4Nn\Gpkgt_6x:r8)rpkMf;ru bz{v`[%o[Q>vQz4xɉS%GDWOG2uȸ(\U+WWW˴˰*$rU^>L]05''NԤIן0L۝Lby.߾Gcg{@A1_76 Ϫ?Oƽe/:1Z"*2 1ڌC|~xݽ=^x.ezEjwЪ՜9tp௿z`J~{=|U0bp*bo0 b<`22#%R.)tƐcv~iYY ^i_ ~kQ ?;sٖf(;(ГPҮ̣%$qd/=p8 m!jZ[7gYqHHLNHzMϿDZ^&JWG`c3> /`ˉLy_XJE_4?[{]^:@v^Gb7~7s N\pps-k lxktfGAGd\&vs KUU}[[%o9ONUǀ?&OmN$^D~Hd7Dk<{}dɋ8?@?&TͩSDBMTl*OB~|'2MVBI3'et^Ϗm\C.z_`W!.ϸ"%T *]tԸ"WBП;db%z}"ե)w|n-[:3~1k_)y4TƁ; 6ޯPY(PjA?sqԟd'ogy{uId9`DwO~{XSSC_щi;lٲ6i֣BM{n~w8$z&fËtj*L6a.`n?_O=vyE~-pِOT=h\z lxz{ohtTqpނ2r;;JgǢE-jы.6vOEND @|*Q'k"?΍D&򯾀)M ..{J=Z *Hsmqr'&IE2xB.1$yMbԳ Rwca-Zq{gQx`D՝ZyZ#U\:͇t 7u~p$,>q`B9A6:3|ȖbvLwq)OXwVrלk9@fŸW}xE? T[]#GrrsjxB87hHɾ9#Ӗ^nݤ0s),~GfǕK)@F,E_xZۄ۪nw ǃ/X[[7] 8Y 8FL^ǟK~r^ՑKq.=ƫy06'#\ɉJ/9 -9A*JN9:3i!nx?ޥC|`P/k#9i.Y#_ԗKd?ǥK~~}&b N-=/:inмٗȮH&{"/'G/5"ߧ2ű^UMbJsK٥F}h,|OÕI{y3`}U!QD^KT:T}%=)Dqf &NM͘as ؀MN4֞S ϼb(̎ rGv%id℔!YinEσG5#?ҙE=i^U~)]~]LX*ddcxN1ycGs d{p+)CA ܇wv j Uxc/v:23y1ï{ђE-jQ%+g^wFi,}g'*T1vRcGO.'$ލv7fϦN(zlKBU+үhv\)n O R?eU5tn~tY)/Zj['׿թS$GڽW׎.\Hyh*\U  Os0$0{CxyPjOP7Gbs82w'`򼠗X?!gJl2;'z`%-*a28qŨWܲ'2=IjxA}Fn_5޴Oϖ%o[%_|0#}$\sSQּsX8F,Dus͈# 1T<ќ!|uu>p{9h=i<.6[@R3G˭Vy a4~OTLym wPRZ=5*+{@=oB n]'|; ?l xA"Ŋsqq'"8IvȢ|ꜬT[6柽I[(!$6i ]{ R3f s xۥ͟ uzmϴeNyxL$?/hc^޾o#"\;#zx[{42˅yaxF\4A E Y%o[y/UPS7ۧ=V WdS3omV#g_!rI(hYW|ݪRLWXkւYǏ>eC'8@Vμ.e?MHo$Kƪd&ZLy9# ϝey7]Jʹ5j{Rfz/Qa>|o4Kt-om?,CGn R+xޯh}_`DT^ h 5;Z$b;2H 0['.'?BKzڲɿT[ff|Ġ>xV?noQ0;C2芁_-\tjx6ͫl6>Kޒ-yKޒu{bte)O>y5 5תxc)I8'WJá#X sTpjH`e/}.A_O'R6H'wȹpG/Xt d7{~|z&+׷a(*G%dz%o[%oɟ y}-q+'[)/ħM쀄)B-E$߸\_9Il,ŭ!ǼUl ׃ܖM2𜳓s/h3:Hs^ng{Y..OB5,}p^wj5\XҌ@/h~׀ڢE-O}zpmnQ׍;Oi(N--q+c󴳦qd//P#8"al2D)pňk$Sȋjo?~ЧݼeKQWB){[+ՏU{.[xyU^P#=8[X {៼~VM^Dǿ%o[%o@'G(3lHYtB>7*@Qyu16/OcU:cyB.}pZ+._Ce>F 2z^pʿ{x-48wD>5=/e{+ڐV'sHI1e0(Gǿϣ~aƭV^]OB2+ P7뎩_^t%}4/0O>Qp3f{---/.̩Oz?zeWQSOrI췼rꤑq$/ S9?uS>19R\8#āGMqG=ۆ'Dq?~yiCαg<_YL *QuW~C&~hL'q'*ߴY>"闦%o[%!c)Ox8`Pt_8^LdyQy^/O(pfy{ S=ˋ1YtTRnexAyQyy :~ R[^ۥ<PO0.yzR <Ѽ|sgBW\}]USLޤ߫%)I-yKޒ-yK|kb}|`\IY.hN<|ژ;O%Ǻ{\ha))>Fԓ\| g ?z&~<= igy|.Msv>x,yz=K71F2d /7t8Ƨ7{jq $\M^sY) J9ʰ>>/Kޒ-yKޒ?FB^ !fdǙK_ ::c*_8ROo'A7vŸ3M_$!{E{ٟ%o[%o>g4| :&6(dAPv߳ѯ cAOw_>cӳf$iB2)eP"xPsTVz (j[Y^?ո~ˏ_O~sb‘'8bGM`^ CQGK4nyM>> Ww-̬վG(MT'q}s;'`}7GL~H㊡?/ ?PԵkHR2kKNR?g(kq0 NC2;{¡Ii}PQn ,.藆_\P|>9jf"u2>)Yf ʳr ?|g%IsxRP΂fQ\gzq|??0؇RM8凌) ĞqiZA('0o?Ye[S2>ŽWB“}bW>u[~1>FcF)/ӈ1ܬ|hbп-R/=/Ek\GK1&:gTUbEx 5jK)`BI62l@l/0$5e8+k @)&]U+'̚wA1ǏRޣȾJG ګW Ƨ9Ⱦo>ϛo?Nyd)ON<I Yt(|[Vgcyןe;~bן.iǃ5?RC*y?Ky) g1Ϸ7Vc<ˍ-=1Kh|E}y~ŭ_.ѣݓ {XUR!?E?{^:ym9!f`{>U$mx_ԫw*R?HwǽBKMtF|Q' ~u>C 7=s@7~c"BKh܋yٞ\%Q/D}' =n@l'p;$~{C\-dVz "~hσ0?ȫA>bLFSo_sAw$\<>_{A,YvF!e;~b?_==_ת? |h?xKֿt-W?/9/YT| s|Cݳ`?'_2>iPw\K{~GsyUhD78p z(sfĩœc~@7J|,u &t`91_'~OlGJk Dq.sN4/Vq!Fz#;20~%Y0gQ, )l_CKo&3ID>d%_jyfo sZ6c1>~/HyEk(2_G )<32#|V\(IKt].~׀2&*i+Ի;og9y>u7˄\pewxE>WhB^ k~S ʣ[H>D,gsEMѹ e%oѿՏu=iXv~{*bSiL/l Bs=!bWP*<,֔f>A7KMB1L !=׀åBG Gg9sޏGX8#Il߹ wM,ciu4kU͞syϩ9N=%G}2i{qĿy^f=]!omc125ҍc1|v}?ώV2l  W1{½0k1^3wUq\V ~iYK$`$pGn<_'n'\3K{*{&v^20KV6oꂀt=_Vtd-޸`1eb=j].> M]+8GNA_&c/3ѩmw'DކJ'N7=ѿ,x. ?[hݹ&x2 m9|ub,R] ' 3Zky{uRˍ=!$53PsV`k3ͪ>W.aoYh64od5/WiV3tz&4jn?eɎ'ٷ"f߲C\V'Dq eku6nb߲>6Ek6w!qU7I߮2gX~p\5*}ٖs[1i#&PUc/esgyDǭi`"j=?7![kǀyd|̘eldŴ1]8cY>?Wb~2(0SGo*@=H?!Owiʨ*F@.MĩUg$ҝ+?M^w{]An{c0$*Ͽ1cW;Of*b(7nxr{LWF|/TA%KCZFYV]dˣD^{c"g=ϯ)Dxê {8+&U;Q}L vw֝Mc^C=1b=<sѨ>F{[A197A>(W^sإFO'>E~]lWf>1">6>(g.x ϳ҉S3LP=FE%5"^U̶ q+c|<"cǴ8Wa*qѣڃ#Յ{o,bFym^28?¨&0c)ý>[||Fvbvh'F样{V̞Won2?u$8~|Wx;u[&j\}bq?h{ _>S%.| =q[.hǭP=*=MJ{=58V})28/@<߸@ile\?OD(v&0iwȻen?,NnK0Qfmܬ ݙis/ C $]II>3YN7'U-UEZ588$,)c*N.ARFw#ɘѤqX}>e-R<8ΒIM':=e'E.!_(ܳyxYY)^D{2cְ_2ecECjn ! #sVz& C|U-b=K{Cuzӹe+H;wkkb~d/:u>RO#m𫘚:/P/}/y_H/|_Wy^KW&WU>qPl~R# EPyl;JpQyjb~T1$ C{q.B7Ո^Pb$חĔ$#ۈRy ._$a|=rbW: 7KT)e򪚨X נF=hhո&(j_ !q^ 3p=ɐo^ϾP|eK< eCYo*US0Z+B:\a2/z62oey>Fd7U ֋8iQ&B]"d9њR*C* ,EM$e>ϐ(?_[O8WgTc?F) (B<<'Z]Wujuqep5mkԢOuSoN&5nlU۽7t~UU;}mUtW}]k^߭k\]k] ޥwqu*7 ޵6Qۭ ȿXF zҽ^5Խ{]#Hd%`d烷K[{MÉmHyr :4((8<>mI}Im٩)\M2:Ll(߮P|!~4tlxg(Ks狭2;>[+ۻ`<0P=eOÖݟD޵9v 2K9/? <=Z3s^~sF|z6zګmr<?i#=A3땧pir6S>^>{?7S{?<3<=3ygk7iAP *3;¼f$?'iN9(>9C:#w3k. ]W vwxTw :X%_;kúΗO~ Fx FvYXkyz|; }m߲8$s˂>G.R[gP 'ۖg}" OWf!Rg+ eY.w l( g}r⟭ts ' Ρx/wn_3U9,ld8P _|:wdž;M%|a*ٶfuSJSuSopriԝBṽBgݛfyc[wm ^8f wm 2{ޚ;70͹xIys.2x{ U|;x<ޞ :{>]o¿3/y["<ߖ%?Xw=[P"߇ bޭ =.$u ,ܳu!\'+ŭK ~GKg<6Keo2å ڶdn_բ>^ھ{w+C;քwx@Xw s$tdǪHXhF9gݾ]krmɃ7&Cy,k#=Tk#_6?|]7MR}I7ou /PCl] >w]+a:PZN5{鮪/׸Wq٠WqZWR~׼w] |U|=W?5Ck_;vXCzpսzSu}\J#]z(WZqDkFֻfxcqxkG?x\M\3Թd(zF8^?FP5H7~&@F=\mTG<\m#?[A n6'>zh2ox; 2y6&L{ 8 @ح@A>ꀌmkb;OmtgzcR;0߁|J|Z莌WL;Mk~rJOMk.,hX2luE->EM瓵 dm$=@SV:hV r8YԅL]АL=Sur?Tu=@y>٭Myg܃Ss?c|vk"#̴6Mn-5a%|}৷קLmN{NNm`VOkP䧴{ Y/4"ӿgt|3^h<3;?>s:7a23;5չɜ.v% vyb/x.tvF ?D^bn.@J9ݚH2} _ܫЅ=ZW `%eAȯK>Zf>W}߳{6_=e=gK~ryg_%~i淪yvIꊾy[]1Y\YWh zݐ+^;yJ貁 ⫇=O(nXՃڮϮa krs! l d6@7 k~h ~x:ycl #:l㻬q׍$8P_7qt'7itt8/W7i\׷'uk|Gw7'umo$QһW6i|7-+'W^O_BH.W߲^ofȼշ2{c빙[}ʻgrAvD[^~ ~8-}~0ϻ9 ܇>M gN ԁt` 7:?)Ń:{0?3x묁[f :s0ьA |LC>;sG~mkĝEc%~餝 {Xw-tǂRw-[9$Hܵ"յr" V!^޵z9Ex; {; Z^kwJىZke&+3෮UZ"2 W#^klpY,X ! {pû! \oLnt nnJAe6OmA$&oN~s|c.h@>4 =xO==to toM;ӊ>G-ޙ0g߻3?n(::=(#@o?/hhOūl^k赃Cm mOGl PtW,DmEX>_/KlW.n粯w._|Kٵ~ŧ ߽띋җ;_N莥XC _K{w;]dߵ=^WA W~r'w;~[`XU?VR`s޳ s#c"* q4hvF8xs^l<[/>1`ȼ?^KMB~ҝse~K=s7c~ah/R2)I0 Ln(<0aR %}vbP,Ӏ05` `xf? >OWB L1(ȯ<۬Ax0I0YK "`f67zy4eQ~&`~o#ɀqNѝ` Ư\3-VZ:#F,zL}0n`俓J}pyVƒl:2ogD`Bg7;y JI Dy0yaP {*ӓL~Ȗ~`#߇SJWsȤx0A?P0}>-(tڀ-SS(N&=eZ22?&0 @3)`0?= ٜ86{8a @ij0o3( )h7~ ݾ`Go?p_@g F\<& Pgdh, _4tn<`ރ߽d<İ_ hp(.yd O1p QYr%|0ڱO%.tzb5NxXJKx,820f{VJK; gL@G`׵qZhϽkcyO&Ryi`PFP>)l:\&X^x 6Vzݗ\7& µp -RC!W •p)I;IzUjoD_{ոb@ͪ`߻k^rԼGּG+^u =k]@oKռrP_}u:}auW!O`ރzs uomw}{@0oX4uw?pS T`y4jCW-C=Pm÷կ6=t2>a?M*'7ΐ o#:MxAJf&\3^)F}H'1v~-@.ФFw>/@R)?Д(ђw?)? A~{*l]@J`АL̖(I<AfgQ#zy(??xӫ>K`vljS?<}}(S`̣j1ΏO>gw~3:> )t /4߀OS"/Ovk2052kqɊ<?Sٵт[tdʞ I-漘B4 i5g :A^-_!VRo?E$?σ2rS?ӵ2>Ϡdt-_v( k'{E>[Х xԳrHtIYvvPZsR0׎h'#!~0W xFp<㊀|Ul[G=.~RD%`C3bkɗ{p*0@Ēzy,ĞWL @1V޹ *=~%| 0 ]{\sm͙es8lل:%I`N{vCR7?^\ C)Ȓ4ey 7] jRR&o]t}ɂo׶] w۱};?$׮3i% jTKy]k_ldQZu5}תֵ-ߡ `Z7u _ڷfεJPkT*n1`ރtwKun|M]¥}s3 wKz{c7  ٩_O|cÈo.ulp1m@wznT Lo{ۻDq>|\2}kD}iɦB};Jՙ?Dd-(w8)r=PSjD=ebA>䷭jnxvnzdjВxpg?]gJzu-"`~৶y@%>0=_8 |n37I0);<2C}>}"!A>(?xL}=A:4B?6 ~Ԍljt2za‫z%<59]Ry/5qЃ/<|UgwwE % $!@ *R" i(iT &]I%!@ Psgf`Ϟ31>֪K 1%$XV R?,""\8ځo,-da9К?gEsqy_~*)ѝVD]dv<}ƾ-柜]r7Qg+;M& :s6]EG^ L"߱;DVz|0/Ze`޴ J.yR'}Ø>9 ])?((7zm1wQ$By/1|?ZJr~x '_h P?1d&ᾑ[\-0c &|.?a5H ^l ۞O oPCQύ v͌x׌!49t k'[3k؁cbE <)ǐՇcb[~Dkp|% w%5 H>eR(E75_?gJF G_,{hr&I>6!(jI.2䦜 ӹɔN.̡WנHC; yKG"5Xpv4<Ŵ^v*.]4AX?M3Q5JΟ<ğnV2elBL5:kDɶNgRF(bj_Z$~ϷK_`_ RdH%hCH5gJگc{MV*}޳ʁeYD.EվQFH'ѥ/^q%o(XռeW5XqhYA؁vlUG/ꉕD? s]N]+߳o7 oʹ[A3FO >/]:\i3j dsgz>&Ub}^e?t.os.|fc뗯xdN|UV﬩Ǐ<|x߁Gu! =:wZZeW(Qx`~"P߻f}o%wCl{5bW+Q~+߯eGs/s($6_UCUCϟcF57X2@P~O(^ T`Vh12&5߻- kbTZ:?Tmy,(()#:?o1M@/WB9QۂUe@~t Y'[x(`=ŋQ^U]_HoGq.ϯ/01YQ; V(_v/- 7HS ̲(ݼj/@fX֨&S#2eJ\qߝsSB}%&?ۂO`/g}mdoRek<*yRC[4 Uh\} - 0y| A+Z?,?h+\?d8Q :erZsuxE?+#{gק\Ngצ85,y:`ʩi)XC>"FϿ/x3#6NSϳ3L,3Hy>B5@)__옣fڿ}m-k_D _|8 X~Jwܽ}_&أvxh1R݁%Emλ8_YKȮOۿXv\zil< wuΣEzx{{:,uµˌxegI|k#fl2\Ʊ(2'bsl1)-h۽D/:C+d!;Kw%=+PDHV"%=KWN0wsQ4^yTM7[I6[E zA>/bkoA^t*o*CrC| 4ȧ~U F kapyoő<`#K߽үh6޽AuܫA+5Bu}| |SRXZa5"z$Uݴj *5ִ.8<%|O ~U\{PPMgSA~l׸FVGQ;^19[IWS$)^}QME4|) - ձ?7w1$uq'_6I~.%&=?(Mf^z˻ިE o׏!K:?~czX{Kf#ےm>7qEP"\ߚ<06򿍕oKE>xK/SJOYqKx9&)d ۞fG9) E~~ӎ,r0;CX1x p`]j ,Cz `QY@F # &%j_@eXA=L żzG#M8byƠtGUqbޒQǖ%_M/uhi"9]Ԏh%(^:O@ _ܵɠJWS[1oJ_5$OVc/@ſ?|Ap_fR'bɠk@!(EFO\]G} [ M_<\Y}9\Z(;sq,k1WODU7OX4k+/V^ae^x:}]E6}ӧoO5,R8m9F[U-3>-'_upc<'?Uj]ZasǽwqG|ԡC3ҟ=]f0̻tBu߷`zyPm|fJü# {xVh[MtU#} ([_~D+a 9hdrz<-V_Gwo_cp*+ ̝ɤ?7F-%)1"#q #W\584g~%h(ҭW{s@cf/9(@SNX_1&f_@4/W)kWe/@bg.K?Io[diLj=牀I-Ll-:Ig+4lq9pm=tl/ D6F@~Y%?piԌ@gMO]] {?퇕1{`͂E+Y`|Ǐh"#~ `X2ܾ- #%z MAHf$YVEKb^(Da翺k .FϿ;ϿL$"yYMX5w`4^s񺸞F$Шq}֎~kx gt7G ntc<X\m{4I4N&Q̟AVD{)mDw+_EG̜_6 x厺]Uso+s>,EgpQQ+j?&8k|@+ Gw@JD3 p$c9#Ԏ@#h~X C}((Z `ϿGY,J,4#`5bZ2^Ϛ?xتw^~!IF r&'?8&5?{zO;,Ciga]a @BLvR$u O:+9y.lx8N2HL,B"3eyX#A 13CgBb2@u>\/ )"_4(ࢯx-Ӿ~\޿i `?-sp_:?z ۣ._i\ۻxg<)` 7P#&O6i'V''.?Ċ:rQ-:k~(ȾD?ɧ99gXOkF_S@Ogo|6zHwBձ^zARK=io4~9t&~мm66[dzF ϻ뽽FٯZw }ASo*Ex=ߧOz/=Wxc|_'/8{*߽A"+fsv[Zk)߃έuX1h!b&6_\n~' 5VP? 98F/=Ҹ>4L_;_S/ 9yjkZy5y;@O ?x#*IXLkD-^7xp,:J}uR珪F}.@ C>A/ʿ (ŭM *r|d1/ xe;q0ol 4yb_y+l<|QK,y{grLP^|=JQM&(o>ӳsy:#w-X'AгX,fGQ>u@DWq[ C,i?%o?vU4Z =IҏD!o"#?XLys֌ "E*ܸ wuxzH^{݁ӝ=q=%O]na5su i /"]fA7%~QU!pon|j?ys#_$1ZFG|2{ nN*y?+?̙bf/ޛ-ίR~_bM&DYApa@OsbW_&PPg/yHx/hгfJȢKAx%'gI->8Zi P0MZO,)8OO>"h >g#,s~q>{2?۩D7lR@ާAJ}ɻ(j`"|׷‹l= /:,ᬋZ^^~Y1VE~< ߈;3?2x+o*?wOOYIGaY"I/o?V?)wMqY_._Dr'7W)vtUc__}xU,Spr_9J ]?g_|ړ7ywQ-iЧi?| (eJTNsC<:گltJ΃#԰ 2נ 2=Oo7T#aőxRg-R_/v -^nLS 5to \4`!^otlIߥY`aAU?/+1obIg%NOh dOaɴP,jW07/E~*j"5|)]<E)/ uj+ߊQ߫#[8qQmK/W#: YWh濘2 yE*?,GuV-SgEӅ /\  ?cH^~H'Ͽ+DGHI6>OKgw:뵇G)%=ƁJ)[ÿR# >$5|!/w: =i@@Zw _]W/B;gug̏ߧdqRF5`ߴN 'ϿY`Pѕ|dHW?MX##)̆TwY/5 _fw';gx"65™ʸ..OEIw2~'&g(h,Z7r@ c>|C yDT> ȝoU?E&?(ȏee_'LF/j]3_Ś|'?*S.dďӉt`?ob*HN>"' s8 כ]/8 `O}qC'.s rwKNQ+Q2|\ K8xKG9C`g_Oᔳ(Cq+ݻs5)SEEEgUF+S(: .B#|foGKJz𜔴ӦaRS&͝vUm:6[:c|˅{>C.;W@?˷"R|*3-Icϫ*}3hw1|.@0ʄ|P@1Fw.Sjd7s_])D`ΙC*ioO1͈(NTH;/YÜi?JA/2\`埌=G)hZH '2,s# un'?E헼b3w۟ǤgO«V'?ύS <'VNF/&+ߙ/SO3ߙdWn fHG156pNG pNмV+pk 5߅/w;W=_[Y$ٕAϽ{7߻EW/th72h P \ҜLQ]*^ 12[iz"[&kZ9݇r)@`.HFoj=S163W[?|@ p3wj?t?A6[R'fnfw䙿l )a_巽{O?eTB_*t VBo^U ܯ~e񫊏JCz"pb C jXe* _np`> 7:~吀Z=ȿ 8r%_%!V oP9&zJ* -@QM J`Q >YAM^۸qME7AͼB֊oVAg?iM=TF<!_YqZGR;+%ݭHܲVO~Q _~'?.w Lx]gP; BZ[[<@Y忡aO qhߜu֝M/[o|rN b9@x?-bsjqs~f.`Ϭia}_ksZ#ʉ|/){ʹ]s2F^;_@0J\3Y+?x/LE?P'Ͽ.`;??a(%άK*/j?.,}she}.C( Z>*CH__c:+/d{`2[1_ҷ2hbT+8ڧB 㕆OſOYri ɿ<@q}4ɌO_32^ŝU(AXidct *$6G#Z{uPe05H.'2ߩD?U.yp/9y?._xtG.%3[XK/lp(wx#e?OIG9( 7Io.O/4Q]f _?r>q W7!;`F¶mGv\8%(@)RmI )/tX;ҢL1{R}[w͌b?2YQD0+7L?; Ī;_b+_&) OSVK,j %'+Ͽ_فJeF@25_?rGϞd[1.\VzU{r,2Gv(8:r!Q 0]PLq_d~oq1ng3%sq":_xi.3:c;%QԗJ}_?qxɁ<2 pJe.H4۰ļQ'ZDio; q!2^tSq|vgmv6[g_6o -ijy?e qs1}_@y4C="^aώ-,bt GN5sOlX!ޯ<z/`drB2Ht(fQ8RxEO с$V@ 02v PN+KI?IM=n<͉?i5Y:.?嚣OwXW,IN9ׅo?zIW\ :fe@Dm0PR~]m}gș? :ҥ,N.ſpX3gߝohOMyمO-P^I󗖁)@Qx/?o 'm_u>A$6_@(7ۯmVƼi,W1C:- mg~fw4o(@߱$:@ B p<&dkFߝe_حm4p;aSFw_O=;Ͽ2mj _&vΊ>3r<^G3y/ SdWVvSap5Y+_ ?oָXkV=2>hO?GG?PuG`{ZrwpɎ G5ibMbu @46Vt~T~ 3J<R_:9%w.x{YfGk\؛7ޯ¯7L/y!\[ņo ջGq!Gpx㫯峤JNQX-Ǘ./HMr#¤-SvUߊ[w6\;^ǚn̟zzbXҸF=7v*SJf|?FzS!>=Գ%FU/ 1*ϠW&ާpf=+^_vh@S_f42|j|81" KD#=b8fU*&75PӏZ/OqZ4_IJ6!S#dx'%6j'TgdܲJ)oCO3߱ | JB]?AW0a^,Tl8XcϿ[C$Owi~V+GS{_vhۇ- QϿտ ?c?sՙn+g@jӹ_'?6][NUVe {`'QWl~S@1]/ _Ωц/kP+;.AeVq09/9kDQS 0JNU䟅c^0POAq?{ f]>qp?`0 vz0gI ȞygO*DϿg$.ZM1yF/iE/:,N[  bLjbK; "?q~\w` S^/-@I ާB`k vTx_?8ҁeB׬~/?{]ܻ ?\:HoA(N+yh֥T&5m: `)MaP|bG.xcِ73[gq^d;7^QگvS(k'o֌B~ȒKY%S~x}p5񱬤\S~b Ċ/@T} ΏW$]'VN(~@gHzW$S Jq3|pY?2Iobx/xsӴOkWI,_f:nrw?hC* b6FL7oZ><>9>;DT ?0_dFx[é7 D);5Vr*gvVHny?~տZ㞿-)_f=-sIUlmO(zJW]^Vv)__M -˲p#ne"\&~D>.U| Q`珷ّ#g/1:'29x~$'(G(s9 xcs9 xcǃ9 x|UMXTDz  .$w9x;Î9gN9Usv<as_?<a3v+x追gyaZliԩmȐ!D[JJmΜ9+V>ݻmǏ?v%ۭ[lI_4.$ߏK6y+Dd C20  # A"4-P|v4v @={4-P|v4v $c#~Ix}Em .QT1#""IA}G~O@c 3~?/Pj|d&@L,ҡ,~ItL2@ PnG0a(ØKw"cnhO:Enmهz6zJ^辈Xۗq#w7Ȋ |'ԍA?uBŘgؔ|aԗq;M.%ZFrDcqA[_BK[ƽ/1cu1hH%4`k6Bߜr})q;&oD$1FQ8:O%%d|ʳFMKx#ꓚAz#SBSei2~OIHԚ<Б+͈<#۬5FKf#Ǝ20~A! Qr?7bߜ³vfc8i!5ayp 4Lۉ(7NRMx9G037.71/1$cp*՟9Lah0='9JV-aG@7 +ox/=6K(6RχmL ZKix#R$hh2 P+c0ֿG$Pi!%/s#=ѣFC9?3arI_oC1jA yʰQ#B 6۩J^UNʸNV˭\yևb;Rk =Aoh')r(u/d2I 6jtrE@m8y'U#t}6cd ?BGj.R$>R2|~ߐ,>_Q _Zd@}^~8> B ID7װFP?JZ}5%H*kH9kUP^}Z>: •sD(Kd}­[D>TUO? KRpy_LDV/S+%/jM\>B}JI>E-5}a|TZA(W)Fi~5byܳPz/,kg )"Z&p44к PIlMVH)ϡ|" ˧@aJ |lե&+Α/h|\r6U/X<[tb,2(dӹs4:2uPR?g糠ht' 1JL~. 9VXyfŔarb f iHFJ>g뿱bΌw'9/[a.eXnf3۱ٓ۬'0`5Cf 7;%lK3rr(,KdJS)i]u|hsۣ{"̖%?DOpbO' ПⰞ )Ս7sϥL:T/Ps"zdzcg{_e?CR:b!SrEҰ >.x~H+[Hq' FFEr$4|ۚ3 {,|3>~aGO%c<L7"a9OJ@hB4J&&1wQyCi6+#I5h/3\>PY߬o)&Bo2To,bKg![7裘q"W̸Nƞ; cw/l H x.}JysX\-WHJ ʡ$Tا3b}"V&FGvWM&WQ [-ljAq9BDv./e^oP_|"ZUAǵX[9_Lȍ= oXaۡ]mz PתQb0DðYi[?;;v@\k;`G#ӪBVƘ iZ&8o0q(!5CvFt 8 ܹzesJ2WLUhu}.rY/lR"eR2ZC%Q@y?b\JO'5jxm1lYMB$RQ RzNǯNȔ)IdIOeɒ{+e=e^ E/R> %A*K$'87!8 4?y;^5jZs%/x^68F"fw ,ctqRm ?#pWY{>f(p!=Děn;mbaMsX?5S?c{s}rְ =tNfCY>cC'n0h&[2h3o1_/i/˴9*~RΎzy~5xqNWxu y?~9)>z{{~)Dۘ"FחLr2N{:4]Vnvfffa~~~A^N^Fnξ"}Faav~AL&hU&eWTvH ]NyMBt?˩?#Ұϝ(!O~_N 9PBOU+4?Ԯ> V-[zIxgNvqtӥY[BղJ3|?{ռ|x[LWo>C?; C3B'@Ӡ !$Tm/:Cp@9a?09IJqR~FNC[J l,f{8>/%DހGE7 3&=ֺ- -,l;7S oDE;~/˙t]z̽{|.tW]2MiDz ?3B,B"ͤh|nՊ-[bbm˃-*=F|6Daq7S CD|:C 3'KSiC! ([#Y"]E5o6dN7<{go]|w{6_$? ɿ0B^/mϭ[u] cǏ>yıc'!=G0>/ڏԷY+=l|YmX}_%X~ Է~vWy/!(x&`%-Ԕj5;Q;0М_5ū&ynvKMƓ6ndpt%??&8F4.X-6CMؼq= k96kǵ^?׮" iVRSa=쐇wA\"7??vy@1.4Y\|h(ܺ4s͔龍Hs!3Ox{Oi쬉v@.B-;MUM3v %G Ő B(f>{Zj#^|}+eѥ0b}.k.9ˀhgf0uGm=~cRzOQQ_wC][wY3o#M|VilY/JEɮ|yO-ҝ_xvN,٤`34a;Za ][SUuj-dƾƸNU#8%{C6!CfC^ 3Wh[H 0Da_yOF/y98Y|nآlXXyTLsм#n>2jH)Bsk]w|&@^3_~MsWY_}ʹ/䫬3<<'306>o[}M'v v\؍jQ૯c#IZv,S'9vŰf6VwK֎k'}0r΄1lt Oѥ#s$  ۔]~_/|Y=dL'U.3E; (nZ9Uq>O[ ԲyOF zBgV@r3K=/_lSNyYkrko S܁d36:f_թ*_D%E =B&^WR:09"e'ƻ0~*e7B n*eWlڵڋ')?gz<4 ߝDT=rlEh1(˳9s\y\Wn-/JJNE w CG'#BzFp9=$.M W*o .gݪ{'^+۽[oo~+_wߪ[Bf8a!qtҧ; |v|KQ62kEg}¤}>}Ӡ9 ZAJS/>2y$>dŮ'þU?7^9kቢS2yKLƴN^E[1rQaLc05kg|u5,6NĠZ;gweu5˩VΗp |n!|S :7u8&HԜ5s9ȷmJBj% _Mޜe`yF;/8cfSQڵMnfRw"tBue -.lY6!y"IcV)Y%FǍ[m0B- H9*ibW8k+/UUWQl~ўm{L9v!H.̭ۿ{=NޟF]ggS߼C?UJܹt጗N{펢P67KZ5+QV^3q/tW#05U-N;}>c9bmuxѳ[*ꖔS{gI-VFq?J rrQCXH?YVB_h!ƱzB,iϯYՓC/x7!K\z@x@.Pa\60%i kw[NN6þXwŘ@hd@UgX+FK;v01eg԰4 3%(ȤU%9&GD~(7Ny.)C3HҤ>(jv{;!EҖ׾'UW++Q_X[߈& R}[u3mJiPKDwM,JK'V#+sfFV><9yފ I9}Ht,}NK_'+Pa]9~rS(ZHO 09D~8K xvxw<,͔l4o_Xݙy94"Wi;!k(6v.|*f<7Up1}Zр}&d\l/wϰwB6T2R<"Db =` Q|DO쩯{sͤYm@z˗/_zfOEW.3s96 DLs }CXӓmFg&Y\2v9rLcmjGr ;c~1&:_M:·~ak62bkrU%/0of̞&NiZ7tRk ۮ2SgNxҙޒP|df3]g Vx:wȘN9~{cNZ"%0|t9zm˧ʹˆTj7{& e\^XҷJSO-uV%Q$50>aS ^*DR$nHɨ|;PZxєoti9e[O5QӸ`̧skzC t$4/ij$u3k.R'> gc ; m>B>"e]7D 5GfۜH"Z o`ϕ4I!, xYl!ahxޒMopKNV(:v}EWNNy"ƞ\ V\=lbi}GݻTeTWQ׮!_>'=^~/uyc^'rRA ;Ts@?y5>KX's[0NspXVh wE|UxI(bY% J>=MNAH`|!11sf stdICy/*bs]"?"6UJNr!+I>|kZ>6AovN8ؔޭm~W֥ѐӽC.-7SJS~rK yģf{gqi-(]CT*AΉ_%=F-cEtBOtF>u[ySnҢo))j>'hه*WUR *ՄWV:[k|j}]GD2rY~, UqGTIXqoXR@OvxB|1xryJXY#lI*S)NF\mVP`~Q9ʮrci5$>YO N2a&.?zxC)?|xU|B;\H巢%_KIDSU/w|dn E8Ľ[ӾtZieR]}/cl5fzaٮ ӗf+[e7'vp+{o5s\ϯz[䁲Ŀɓ)W_<{RS6Sv} zaŲ̼%E3= -Ѳ4sLG]Q8:ZFKZg3`wQnWd_~|>cR$>H7qޢtS);T]4ɰe (6~mqH~$NG0 ]ƎcMmd_B4ߴjJ\qM-AސN[%41 "UHJh4G9 Ah8/=&6aq876zvxݟC_Nש+\g2TTZ=2W|px~rK[(7R#ȊbdRgRA"6߬)g,B|'g4l3ikKL^](eHgіp9gU=q‚I0P^7JLZYz#'/D$tRR3WbSs9Fм`XbHI?[(U"\UL&2[4ߐh P-R1#&?[ݶ3|:gS==|z2dʀf}pGe~53˜/M>^yY5Ǐ}o+)-vq/ɯNG&܂}@- 3rt,PbWjv챓gkocxsGE~/^fAm&{TSY[UhT>i`5~qmVh'J_#F%S~ww2J?wV-ȃ+𰺶65#^'iՌ'uhBIJsv3@4`Gҹsi<fg} ^Hs·.g!Џ>i?=of{lߣN:^_>3ej?*2%RJVʡnfViW;W\}_VJԶ-UU[W}=Trq q:BNN?1Drda";/pVI_VBBanD8]!6J.faQ8 r04XB8&pi4A[t~#wxcf6 t7ȣcY~jٜ8C]'|C8`1NưRg^3/b m'jZ_quշ?Z_bç@#ţZ;}8·"Y/cvdвu̩=Q }n|y 5}rU}+5xqAKw{qS0ރPtѩ(S)d=:kItթxD<0A#%/XjtƆNCcxοE4% ^`z X>7i ͟mќi>?P-#Bd'_6&.wgGgqdcx켹0fb n8q7?'ӿ)-]͞ѐ_]мEjoc$P+ZEf!"͌@s79 4=o]qc!Ogc S(N7A2ʢ#cl_h?g^&n^?:i 귨]u>+^İmz[@RZm.wDxs1$.]S|bkÇG0_~_y7}bZ4t?½KK5%g@ 1A4*Rfλ`j:z{U\y½ضwj.]3macb 1?a]Խ7]9i?Q_k~Z]W_֨j؛m.9 [Ѕ=PHVl0Llg*5q虏LWszNk#GNrҙypnz:h^kuƳ9lO|;; ~{'rG!u D!ϕ8۴C>x*X{+ׯvwj{s2oyR9ZʄZ?U<tqm"* YZB  *_\]/'QD"nqr+%pkH !"g|Nǻp(SoSO(zj.{鉻{{g|[nwo3Ԭ>AM@i@^-9h`ȍlF;#ьm{$M}=8s1iٺc_>]_yje+\+渦jO|WMŪ]WY$ f;زme%6x=e_:0N,}Ag~|OmHUd?&U n W;q]WVc Ǝ:va;kw90=Wҗe3Oک se͆ecE %3$Rq` @FtW] XÐ@ư(KyD.yICIZax\]TԉV+ ܤ H>KΞ2tAӸ,iޤP:T- R~ -Zq~F#ElKN^"͜gTSuXɎ= 9^e J9ll-S%ao@l%9yaۣRH;M)p|f>s\4N$bld (l6beCbcD;!L04Sw醡45Os@/-4-r"9SA"vֲ_*:[Kݐde_рe5oB}x 'p6      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abdefghijklmnopqrstuvwxyz{|}~9&6Ċ:#G 5 F/Q{qa^x'1ot}{^oڱ_=we?B$2C3ВFY7w8ΜgT|-شcH7qe{^Avl'v{_p (## # .~7 OrF[9wNnfvfFNiU+WqN7s籷2O]> )0(Z,8?~v{w/z3zVDOZzrfʤJP+?.NœYkpO][Tӭ]⢭W5k֣ӿzc[6m..bXQUW ~6Tf;pm|M9#[U!G RgǮdY{2{yCq]U[]ŝ 6&&^#oI4 k>>&,A;FNI'4ntX}VKr S8y8;`fyf.+u"FB>#\0tIA8[+ؑvQ2FA;2'HUZU%q V̝]?sUKW8v/`v=+E9S?~cuSp_jN3.?HӇܭz|tn1%Oxl+_Y5s1oQh\tlK)*v;k:kewjdVWJ1jETm|ZKcy%җK S0X`Zw /-gG0lk,&/<&YוNݡVwP)3.'PdsA?\:EtZ}RRO v7#J/]M-b#axML/]6iI|Kl8 ON^Mf- \u頖[ x<ƛ9(/rXXkt4,(+l*(xZ_{Wv㏦ύ0Z NL(sH k̂Ēk89gKc7 y>x_@"`/2H&O"3zNτƥ'NR-gN籑~@ן=X__Ŀ3s<5'ƑoQb9m"'D,`+7$poFs|}>M3,6p4֣fNsqZm,Z{%B,=|Xvg;e7V| `=xqܤwzLN ~%pCH|@xMvl:N"g?_ӽ`^c+ﵪJy<_B`5Wދ l{8A">8>Z}M[ `a"+'%/WV^8ې7UkDA}x=EmW ct,d8`½ Eߊo[,'v;˅!l?p}4z#t˥˸m-@) vږVFߵz Ə!o=y=an'=PHYv0~:Q|PA6Ȝ.y+^iAVu)>|ɧf=2gF7GzuE-=ﻻě|؋.uU\5eմYNՕk}M_|Jؓ9-@`W髫exF%=RkZcOUލF[g|"3"VJϓo-ܱ,'h|٬qS<={y !SZYp.[Aqݻo}d-iÐC!CNHc&f#IJ' oU_Xv`R6Fڙ9 },bdWV|xɤ3KW.zUZ5|lZ/?ɫlGah\Ye݆u&ڼwo`sy`ˬ~һ6\Yk'j&2ʔA)aUx@bGq<"K k}ct_꘳bz--+ Oʿ֏V%tE4.a+`nP_M˵'W'ttUahqߤS1v1-O d{J㲤^v/b\y *8{/"Sccf{/і၃mդ;M7(e> -dgj'쓐eo2 ;/-J\,/ݕ Hpo.&4>ˠg_=V[\,qNd.={LQ Ql]<+ԷQ_ȷ$"Ax> R M|E9'ӖT ,%xϋzX}E%1޵bhv=oWJXj@pݎ3's,vDZ'Efד&*p|BgрѲAN?_$C{Ce0h;Jg!`l^T^YFUt3\vzE4 P_#" aޫ!y`)FϢ޻~|{/| nƗ-xogM'>4W7]Zb!4ezMָM.}Ȧ'~}fÐ_^I>La,?/%U}!NvP(Zr 1.<̪Q+cSޏ)&/Zwq:Jy5-x||i_/H\&_Hp':))}e)1vr}j٢+rV]ROa|\{b&<\/Hn7my`8A)|~p{O$MII"$^RE'O޽5Z?u][--:喱, #Ʋ6P A̛XH#EO#pc~WmU\y[xߗ^ǏOӱvl}(vr'?4l˳FnPrXI΢(?'[ lUwhh=U)hCzzsNb+9rdS~Րd(J,, eE c+\xeϬX2jŲח~ |xQ6-J(aIO]R[=Tn ywrwq=H{aщ4?^:Jt~7BZKh\**߇+ԏ+}ު HƅrS0.!ЪlL[nñ{KK/3gD!;aGx1i}0Gnܒ峯2"V)BSrZ$i,tCўC?1M7!MhIS?IMN8_Is 7+{Q֢/r?T$B"BJd_O"ԧO9\֕Wa_ !wq䫫 '3284np{ vB4v 0FQsΨy;!۲E+]`\o1i҇`ሕFn/)a k+t}mk~޽e֭i|}߶xVI0x%ayltfg~?O6lW? X-{ٲ}{~rmt~B/S[wb<ޢUMS)oKS]ep&;p};.(?kf{\P86}F\/`׮.mb,fWw/W:d&C_ 9 :MGE<)4R|UnU?w:vp_mo|8;y!$^7~66(?OPNp"\# uA_.8Y?_:-G]X:,]J~㲍e9*S/fz.d/ӯ8ĝS:p`#JwyP.S쫖R$OK;t*XFK#BdJ YZӘFH3{ _lЊ#V.C no.f3Ce`sMQo9D {C?YR?E} *lnѰSrRRz)eOG='?\SDˇ[=^k~!X,J?yY,<-HPzĈF/b; z烰]2$)p0VW!g֘W^s[4=unmE+X)ˉJcP|vӖ/ !}iSR(}4DৄQX:\}΅ㅎe|Eﯿ\9:o~eGSfn_MմorZWSN˛oG4>p&Hɏ EOMʏ)lzdc[|{d朗w_}5/ϟ:͗"gmA5ՑaW NvC0?7;-NgĮIkeKa;xdv p _;vzOD_(0y,X_Y8?i~V&$hssp^/ڵ;g1Bñ4~Biɨ `)*_T=ҶSo~R%²;0_K|2VƱђ1ҥu VRVGم<'z O?1p#Dkp>wC ֏ oߢa$y~ч)ܠm_5M%aq4~|i:$/ ."Hio%y%knp9n&)zv2JdW1ksn35<²~>ӁmzM ')CT'O何^jEOUJ)BR[ЧSJX\;?](.M: ` p~;*1qt`JR,<88]Rwz7MCPTۛX;g(燔t3u>It8F= Exn;=~aqctjp\V2/t\z+Ϸ8%GY%$ϴ4Fi&y_/"{% 5y_ J`Xo c=#mD> 4C`]o$K~w_0`}巰`¾\4>c7[c4dkX $ ذI5;ҜӜ&O}43+b!9UYUFTdDdVVyf_z ;#jofw&|ok}e_]4YnfO?b?R'Ϳ7Pm|8r}rgkom^.]۳]pV&7/~ŗOo>˛ݯ/u=Ý;W_M{>nno?LFMf2^L&W#ks7>Yyǟ &ZKyçxGk6q?ɧ}|?GuS?K|TϺ3o_F}g/;?Go_Ŀ׋,fY%:lAWcÿO'm6Ƙ딻~a2]m?X~GkD>xwxm?㻏Ӈ5Sf+|9myFnQz͂o&ބ3&ҩy<3E_w}??\ZIܤ̗*_E/үtmkmVhw*r?ј2y/7K{4yNͿ O/ſoulm{>|li$o/nSrYr?7[O'?s1^7Yg6Gl|㎼tsx7.9<ՠw/a#^OAF0lO>i8zqe5O>=tO~`ؼ/Ҡ97=ؒdzW.q?uxe^ːsBӟ~$F'a/?O:~ԶpZ&@}ӿ'ퟙYZhT|9} /oUwt|=彫*ϗj*v{5Sˬ\I]fV=|>+dCnwq[k{둯>9u{|ϡr]X0gRqgۼXLe~Ecr]w/V˶X׾=|nnnz6{ozձ}̂ڼen,ek<~6+G^[YuQ迄:_~>ߩu̾ϳy~nS㷟 қL_'A~GY_ş]Ϸzyyן9y}볳7oޜɶ٫3SٛIyygNN}i*?OQm};6\߻|^Ut{.FV~pݻ6Efd>w~]xO"xߝ~qY끒~?NׯyU|EK z>}^Ǥw{qSMvjmݞ/Qgu}۝L|{Jz˽V}}x{ ף{G>yɬd_/}y;^g^Y~f7:n>{|~LZaߗ^g{<}?z7:L,3~s~x;5fF]A '>޶5j}´ػq'_σY ;2y~nJx|=d/sY񑷙.֡\-N߯~GŏFZIX;:>xgk}1oz];|C?E~/lgOz{}w?-~M?}^~s}g7yg}C~?~ܵ{o\I#}ΫuuU!ٺ_ܬt=_,[KW3>T7zSvW?~^z?eVS&ԃ?w?\aٿ~Zwۧwx^mW.};odZ} }wmbs|g=&?~2;ޗgGcqyN^ٿ~_|=oy{?Ϸ߻3]{b}Cox=g¿RwjsoP{u}q<_=y;<_d$R_%QGgnF =Z,=4#x?˵J hūmjXlsս㩯tU!b\~r:<^O9{uu>]ǿ֟lѬ/{O7FuH]ˑu%y=yRu ~ڏ#?χz^󬿾>D7?yx:o8<|-R:9y>_?;K]wr2E4XlyŒku=zՃ+{Gc?5d]&Q-ǿ}vcs7a>~=^zꚘ7>>TyKg O8~߇Y^-Ϸ/:we߁#~.L}y}[nXt~ޯ}h?s>2s~M}M~:q۾g}Fk]o:=}OߜZ䲐Y{W#&ǣY>=T0]q'Ǡ+uuu?=z?zluڏ.hu??W|ǿ.Er3Sn?{f{}λ_gm?u|v}~^s,>y~/zW_s:Vwq~Fxڮzf}J_ó6l6lmwg2W|N.ZtV 0c]uD >Ǎ5Lԥ/{M^Okpx<jyw^?\-Ӄ>uv21[o6>z9rLC;ָG߽<[+3v{tzz9x<x<׫NGÇܻ D- _ٞw]w{z;<Ȣ#<>_狱AHћoSNl6l6lvw^zo@9/;tskԳmfmfmޖvdS]~^-V,媾ԓw sdWwH^ѷ}O5UACl{Y/@^QzgU~x<_GPͽsr*ogϾV{/=nz0&zLG3mOk3~ҎʔD$Ex<x'!>cϢ{Uƺ9K?_@{GHE_F/MqtZ2x<_֫/֫ۖ]]Sw75';n'2k͎h~@Sۊx<xSߑƿ38A@w9_o+76~z!u2go\SY1YW_2x<69SR'Gïe] ;wO>m <O].?7y>#Iգ =#ug+K&K]]F4swx<JxO Or]>Ww}_55sN;?zz}fY}__U]?yTF٭l6l6l}ض}𲭿Yޖsr9ߞ>rN>1vIO/z%_\fz;d4TU~>0?'fFNiO:uԩSNx}ϽЯ[{?8 ._%WaF˵_fTuPeT+Y,̶_qN:uԩSNWnϳyP홭OZͳLξٛ>{uz[%uO\Q2vU媨BWg߯WߋjP5m]_=v:x<sl7ת>ǖq}8]\] ;em]oͷx%=Ezcig۶^]u7rM-x<n țyx<x<8Wn\/G@Vrwt]z~|WӁޤzVrTˬx<Ͻ']~o~~b_^]likdM:x<]_z7AN]_|ӣ~Hwuڛdr}WdB{wx<x| {w}gpn' zfPx<oZ|YuO.gewY@7ZrGIz `fq/x<͵\#9??N~=zUٲ.7ɭ#Б_x<Er.@[ސd@jc,ڑ;]o[Gx<z"I,I2H)R^R"?/Rx<}T?/V|S/6ʤ秺_\~Ȍ/2]sx<xf2+7wc=Low]1dtG)3(7Ek9ԩSN:uԩS \Ձ}>y7hX-Tm冷6+9<=ꊮW勥q,sǦzYx<v.Zuo&#z|VXC}/'H nՅѠϿ6„.m=٧o>x<x|sœWW;}'y3SG7ɫ˨D ״ x<n;_.x?57qn],w&뺘̶7 x<?WnNkr ^I;w/`[.yf\x<_7_Os6^ߑ8v{fE>w}Jx<x<96Uv/]w>%Wg%)}%sJx<x#h P(YEw/.NN_>"}0yք=Kx<x!>/ۯ֫*G .ևwH U޻x<&x {e R?nFx+ x<b9oM9|J>Mc\SŽLx<x<o ?_=zUٲ.@[G#x<ػS=q빚)3{%wT#x<y2^KO29G@HREj<x<E2HGjAqse&=H=x<㽮wOmӳ)Rf4QnsSN:uԩS~t&y?z4 ze.\ l϶(EeƱgz MJxg x<js&y3_\]Had4|ػzd~$[x<Vc /_, ^Su=^#.:w4#{x<x|[sOgf2med]s3x<x{/潀0ߒ;X摚q x<z\kH^ߑ8v{>7{x<?2ۧ9/3<x<7˫WHLk5vR<x<ws6K8_jbs5D?_5?"H.u9 x<CZվXw/.?AoVPx<Y.Ɯ\/?ߔÇ~$=H0uY˄x<vzeߣ)_-λu:Kx<x>{7)_޾2 ZrGz:x<x

*ӑe[)(.s$_ x<{^$]ty4G<`Qf҃sx<?zWf\<=;Y"eFh=G:uԩSN:uGm"PGà_|hQl{*YTf\zޤzx<x|߸;=n?q8`27ՅIF~ PGGex<xMc\SŽLx<x<o ?_=zUٲ.@[G#x<ػS=q빚)3{%wT#x<y2^KO29G@HREj<x<E2HGjAqse&=H=x<㽮wOmӳ)Rf4QnsSN:uԩS~t&y?z4 ze.\ l϶(EeƱgz MJxg x<js&y3_\]Had4|ػzd~$[x<Vc /_, ^Su=^#.:w4#{x<x|[sOgf2med]s3x<x{/潀0ߒ;X摚q x<z\kH^ߑ8v{>7{x<?2ۧ9/3<x<7˫WHLk5vR<x<ws6K8_jbs5D?_5?"H.u9 x<CZվXw/.?AoVPx<Y.Ɯ\/?ߔÇ~$=H0uY˄x<vzeߣ)_-λu:Kx<x>{7)_޾2 ZrGz:x<x

*ӑe[)(.s$_ x<{^$]ty4G<`Qf҃sx<?zWf\<=;Y"eFh=G:uԩSN:uGm"PGà_|hQl{*YTf\zޤzx<x|߸;=n?q8`27ՅIF~ PGGex<xMc\SŽLx<x<o ?_=zUٲ.@[G#x<ػS=q빚)3{%wT#x<y2^KO29G@HREj<x<E2HGjAqse&=H=x<㽮wOmӳ)Rf4QnsSN:uԩS~t&y?z4 ze.\ l϶(EeƱgz MJxg x<js&y3_\]Had4|ػzd~$[x<Vc /_, ^Su=^#.:w4#{x<x|[sOgf2med]s3x<x{/潀0ߒ;X摚q x<z\kH^ߑ8v{>7{x<?2ۧ9/3<x<7˫WHLk5vR<x<ws6K8_jbs5D?_5?"H.u9 x<CZվXw/.?AoVPx<Y.Ɯ\/?ߔÇ~$=H0uY˄x<vzeߣ)_-λu:Kx<x>{7)_޾2 ZrGz:x<x

*ӑe[)(.s$_ x<{^$]ty4G<`Qf҃sx<?zWf\<=;Y"eFh=G:uԩSN:uGm"PGà_|hQl{*YTf\zޤzx<x|߸;=n?q8`27ՅIF~ PGGex<xMc\SŽLx<x<o ?_=zUٲ.@[G#x<ػS=q빚)3{%wT#x<y2^KO29G@HREj<x<E2HGjAqse&=H=x<㽮wOmӳ)Rf4QnsSN:uԩS~t&y?z4 ze.\ l϶(EeƱgz MJxg x<js&y3_\]Had4|ػzd~$[x<Vc /_, ^Su=^#.:w4#{x<x|[sOgf2med]s3x<x{/潀0ߒ;X摚q x<z\kH^ߑ8v{>7{x<?2ۧ9/3<x<7˫WHLk5vR<x<ws6K8_jbs5D?_5?"H.u9 x<CZվXw/.?AoVPx<Y.Ɯ\/?ߔÇ~$=H0uY˄x<vzeߣ)_-λu:Kx<x>{7)_޾2 ZrGz:x<x

*ӑe[)(.s$_ x<{^$]ty4G<`Qf҃sx<?zWf\<=;Y"eFh=G:uԩSN:uGm"PGà_|hQl{*YTf\zޤzx<x|߸;=n?q8`27ՅIF~ PGGex<xMc\SŽLx<x<o ?_=zUٲ.@[G#x<ػS=q빚)3{%wT#x<y2^KO29G@HREj<x<E2HGjAqse&=H=x<㽮wOmӳ)Rf4QnsSN:uԩS~t&y?z4 ze.\ l϶(EeƱgz MJxg x<js&y3_\]Had4|ػzd~$[x<Vc /_, ^Su=^#.:w4#{x<x|[sOgf2med]s3x<x{/潀0ߒ;X摚q x<z\kH^ߑ8v{>7{x<?2ۧ9/3<x<7˫WHLk5vR<x<ws6K8_jbs5D?_5?"H.u9 x<CZվXw/.?AoVPx<Y.Ɯ\/?ߔÇ~$=H0uY˄x<vzeߣ)_-λu:Kx<x>{7)_޾2 ZrGz:x<x

*ӑe[)(.s$_ x<{^$]ty4G<`Qf҃sx<?zWf\<=;Y"eFh=G:uԩSN:uGm"PGà_|hQl{*YTf\zޤzx<x|߸;=n?q8`27ՅIF~ PGGex<xMc\SŽLx<x<o ?_=zUٲ.@[G#x<ػS=q빚)3{%wT#x<y2^KO29G@HREj<x<E2HGjAqse&=H=x<㽮wOmӳ)Rf4QnsSN:uԩS~t&y?z4 ze.\ l϶(EeƱgz MJxg x<js&y3_\]Had4|ػzd~$[x<Vc /_, ^Su=^#.:w4#{x<x|[sOgf2med]s3x<x{/潀0ߒ;X摚q x<z\kH^ߑ8v{>7{x<?2ۧ9/3<x<7˫WHLk5vR<x<ws6K8_jbs5D?_5?"H.u9 x<CZվXw/.?AoVPx<Y.Ɯ\/?ߔÇ~$=H0uY˄x<vzeߣ)_-λu:Kx<x>{7)_޾2 ZrGz:x<x

*ӑe[)(.s$_ x<{^$]ty4G<`Qf҃sx<?zWf\<=;Y"eFh=G:uԩSN:uGm"PGà_|hQl{*YTf\zޤzx<x|߸;=n?q8`27ՅIF~ PGGex<xMc\SŽLx<x<o ?_=zUٲ.@[G#x<ػS=q빚)3{%wT#x<y2^KO29G@HREj<x<E2HGjAqse&=H=x<㽮wOmӳ)Rf4QnsSN:uԩS~t&y?z4 ze.\ l϶(EeƱgz MJxg x<js&y3_\]Had4|ػzd~$[x<Vc /_, ^Su=^#.:w4#{x<x|[sOgf2med]s3x<x{/潀0ߒ;X摚q x<z\kH^ߑ8v{>7{x<?2ۧ9/3<x<7˫WHLk5vR<x<ws6K8_jbs5D?_5?"H.u9 x<CZվXw/.?AoVPx<Y.Ɯ\/?ߔÇ~$=H0uY˄x<vzeߣ)_-λu:Kx<x>{7)_޾2 ZrGz:x<x

*ӑe[)(.s$_ x<{^$]ty4G<`Qf҃sx<?zWf\<=;Y"eFh=G:uԩSN:uGm"PGà_|hQl{*YTf\zޤzx<x|߸;=n?q8`27ՅIF~ PGGex<xMc\SŽLx<x<o ?_=zUٲ.@[G#x<ػS=q빚)3{%wT#x<y2^KO29G@HREj<x<E2HGjAqse&=H=x<㽮wOmӳ)Rf4QnsSN:uԩS~t&y?z4 ze.\ l϶(EeƱgz MJxg x<js&y3_\]Had4|ػzd~$[x<Vc /_, ^Su=^#.:w4#{x<x|[sOgf2med]s3x<x{/潀0ߒ;X摚q x<z\kH^ߑ8v{>7{x<?2ۧ9/3<x<7˫WHLk5vR<x<ws6K8_jbs5D?_5?"H.u9 x<CZվXw/.?AoVPx<Y.Ɯ\/?ߔÇ~$=H0uY˄x<vzeߣ)_-λu:Kx<x>{7)_޾2 ZrGz:x<x

*ӑe[)(.s$_ x<{^$]ty4G<`Qf҃sx<?zWf\<=;Y"eFh=G:uԩSN:uGm"PGà_|hQl{*YTf\zޤzx<x|߸;=n?q8`27ՅIF~ PGGex<xMc\SŽLx<x<o ?_=zUٲ.@[G#x<ػS=q빚)3{%wT#x<y2^KO29G@HREj<x<E2HGjAqse&=H=x<㽮wOmӳ)Rf4QnsSN:uԩS~t&y?z4 ze.\ l϶(EeƱgz MJxg x<js&y3_\]Had4|ػzd~$[x<Vc /_, ^Su=^#.:w4#{x<x|[sOgf2med]s3x<x{/潀0ߒ;X摚q x<z\kH^ߑ8v{>7{x<?2ۧ9/3<x<7˫WHLk5vR<x<ws6K8_jbs5D?_5?"H.u9 x<CZվXw/.?AoVPx<Y.Ɯ\/?ߔÇ~$=H0uY˄x<vzeߣ)_-λu:Kx<x>{7)_޾2 ZrGz:x<x

*ӑe[)(.s$_ x<{^$]ty4G<`Qf҃sx<?zWf\<=;Y"eFh=G:uԩSN:uGm"PGà_|hQl{*YTf\zޤzx<x|߸;=n?q8`27ՅIF~ PGGex<xMc\SŽLx<x<o ?_=zUٲ.@[G#x<ػS=q빚)3{%wT#x<y2^KO29G@HREj<x<E2HGjAqse&=H=x<㽮wOmӳ)Rf4QnsSN:uԩS~t&y?z4 ze.\ l϶(EeƱgz MJxg x<js&y3_\]Had4|ػzd~$[x<Vc /_, ^Su=^#.:w4#{x<x|[sOgf2med]s3x<x{/潀0ߒ;X摚q x<z\kH^ߑ8v{>7{x<?2ۧ9/3<x<7˫WHLk5vR<x<ws6K8_jbs5D?_5?"H.u9 x<CZվXw/.?AoVPx<Y.Ɯ\/?ߔÇ~$=H0uY˄x<vzeߣ)_-λu:Kx<x>{7)_޾2 ZrGz:x<x

*ӑe[)(.s$_ x<{^$]ty4G<`Qf҃sx<?zWf\<=;Y"eFh=G:uԩSN:uGm"PGà_|hQl{*YTf\zޤzx<x|߸;=n?q8`27ՅIF~ PGGex<xMc\SŽLx<x<o ?_=zUٲ.@[G#x<ػS=q빚)3{%wT#x<y2^KO29G@HREj<x<E2HGjAqse&=H=x<㽮wOmӳ)Rf4QnsSN:uԩS~t&y?z4 ze.\ l϶(EeƱgz MJxg x<js&y3_\]Had4|ػzd~$[x<Vc /_, ^Su=^#.:w4#{x<x|[sOgf2med]s3x<x{/潀0ߒ;X摚q x<z\kH^ߑ8v{>7{x<?2ۧ9/3<x<7˫WHLk5vR<x<ws6K8_jbs5D?_5?"H.u9 x<CZվXw/.?AoVPx<Y.Ɯ\/?ߔÇ~$=H0uY˄x<vzeߣ)_-λu:Kx<x>{7)_޾2 ZrGz:x<x

*ӑe[)(.s$_ x<{^$]ty4G<`Qf҃sx<?zWf\<=;Y"eFh=G:uԩSN:uGm"PGà_|hQl{*YTf\zޤzx<x|߸;=n?q8`27ՅIF~ PGGex<xMc\SŽL?{o%qif/$ 93W,i$ER\ Az{Vef%{GsD :#dd:fYGzDIe掼$X_ R<* 0r#0ǿ~~?OG~?qnrՄ &G|#2%2*H%âzߜݜ.(G p8b<<<<<<<<<¸ ZF ß:\=}gytwpЭGj5g9Ϳ6\.@Ɋ߶zPMvtG=Sr4+Oiʏzxxxxxxxxxx ?L{敫/8Le ]t`Q&d[֌-HDιEdHw~Iߝ_40<<<<<<<<<<᠛Q+iZ0ąZ&xxxxxxxxxx^@ZG`qi4H.RxxxxxxxxxxEa;T?EƵ׻AbV烤W;/#\4ߋESxɨ0G 1Bs P7wsp;Wa.''U|z[sw+)Jjb4#@8qĉ'N8ǭ#Pok9Ϳb ذ?3Q_;JƱ&IYgNs⨛w6hHu_4e)GVG'<<<<<<<<<<|us/: ("] 8/>NyqY}ie-}GJ{7s|G *7k)L |rr_eϞAYß 4.`(sCOw$+>uCR7=ß? gۡ?NӬ >)?Oě30C;WtDj0~ɷ+w9ӁG'ql}8Z3V9Z#9R! <<<<<<<<<*MQ 'X ?,|ދ )@_qh*ßWy o|ݭ׮ (1tXtqĉ'N8qO@e]4 p/ ׊*`̴F},*ǒ fx &f :9HfOn_n j;єYoKRՇ}/d2u:Fke~ :߷k ~*8[#z-`߬e01<<<<<<<<<<ɵ}~?{OK|Gݪ~f]&| \m=ݑ8 m uJZ.@mNwԳ:%O+z?o2dl^Z&߮_ LjLƱW kXhOK]DT{''I KY%.?9mN摒 >90ß ?\? I6I5 sL\^e? ouv_AJ/_O5Q_oom\y$f5z>Hz%ɑ:!H|_4E;* scI*^<<<<<<<<<,7s7 #zA;r^7;w^20Ĭ&Fa9ĉ'N8qĉ?q:vK.l.^+V 3dK.@}l*NT{%xxxxxxxxxx|t i]?> YqgSF$ _ESƞzdEz$-}WK;Wz8*#4G;Z&xxxxxxxxxx|~4H woA;w0}'.'e_}Y@?/=tu <<<<<<<<<&ä&tp8frr=tTk7D&G}J$(0q{ $X_ R<* 0r#0ǿ~~?OG~?qnrՄ &G|#2%2*H%âzߜݜ.(G p8b<<<<<<<<<¸ ZF ß:\=}gytwpЭGj5g9Ϳ6\.@Ɋ߶zPMvtG=Sr4+Oiʏzxxxxxxxxxx ?L{敫/8Le ]t`Q&d[֌-HDιEdHw~Iߝ_40<<<<<<<<<<᠛Q+iZ0ąZ&xxxxxxxxxx^@ZG`qi4H.RxxxxxxxxxxEa;T?EƵ׻AbV烤W;/#\4ߋESxɨ0G 1Bs P7wsp;Wa.''U|z[sw+)Jjb4#@8qĉ'N8ǭ#Pok9Ϳb ذ?3Q_;JƱ&IYgNs⨛w6hHu_4e)GVG'<<<<<<<<<<|us/: ("] 8/>NyqY}ie-}GJ{7s|G *7k)L |rr_eϞAYß 4.`(sCOw$+>uCR7=ß? gۡ?NӬ >)?Oě30C;WtDj0~ɷ+w9ӁG'ql}8Z3V9Z#9R! <<<<<<<<<*MQ 'X ?,|ދ )@_qh*ßWy o|ݭ׮ (1tXtqĉ'N8qO@e]4 p/ ׊*`̴F},*ǒ fx &f :9HfOn_n j;єYoKRՇ}/d2u:Fke~ :߷k ~*8[#z-`߬e01<<<<<<<<<<ɵ}~?{OK|Gݪ~f]&| \m=ݑ8 m uJZ.@mNwԳ:%O+z?o2dl^Z&߮_ LjLƱW kXhOK]DT{''I KY%.?9mN摒 >90ß ?\? I6I5 sL\^e? ouv_AJ/_O5Q_oom\y$f5z>Hz%ɑ:!H|_4E;* scI*^<<<<<<<<<,7s7 #zA;r^7;w^20Ĭ&Fa9ĉ'N8qĉ?q:vK.l.^+V 3dK.@}l*NT{%xxxxxxxxxx|t i]?> YqgSF$ _ESƞzdEz$-}WK;Wz8*#4G;Z&xxxxxxxxxx|~4H woA;w0}'.'e_}Y@?/=tu <<<<<<<<<&ä&tp8frr=tTk7D&G}J$(0q{ $X_ R<* 0r#0ǿ~~?OG~?qnrՄ &G|#2%2*H%âzߜݜ.(G p8b<<<<<<<<<¸ ZF ß:\=}gytwpЭGj5g9Ϳ6\.@Ɋ߶zPMvtG=Sr4+Oiʏzxxxxxxxxxx ?L{敫/8Le ]t`Q&d[֌-HDιEdHw~Iߝ_40<<<<<<<<<<᠛Q+iZ0ąZ&xxxxxxxxxx^@ZG`qi4H.RxxxxxxxxxxEa;T?EƵ׻AbV烤W;/#\4ߋESxɨ0G 1Bs P7wsp;Wa.''U|z[sw+)Jjb4#@8qĉ'N8ǭ#Pok9Ϳb ذ?9dK.@}?M*3廕<<<<<<<<2Ӂdw\8fƝMR^_d2m1sr E{%qT Z#S,)UdܯKxKFwmLK&'6_6oy ??Uڻqzݙ)4<0l\SRŸ bhQfL/cU~'nh/, /ZIr8tƧt|/gs1<_15P?o\l.YQ;itpoOzb';\xxxxxxxxeg?ݑkY|Jώ .L/p|GxxxxxxxxO7ga2k[w6\}`JHmβ)YЏ41z$3ᳺY.PAfᗅrrC5O&+pfnZqwU?Ȑr S &e|z;Y_5 Y%V0|JU{4jςz] r]W-Nxuc|>_6~:8tÜPOGvCtj_EƵS:R1J]OSKG>YePVk`r=xxxxxxxxm@4U{4M "'Y< +w1#p,<<<<<<<<C(/?۸t_Ԥ=>ѥD IrT𛅇t~ȇ:Ҩ;/>o͗^R#?!vL䥛 s܍c!҇Aty/>,7sWkQukc;nV;wqSwoom RK.ВzXw~9y:a=ĝuAdv#H]g ~G`Qq?iߋt\' s79ĉ'N8qu*}z-\{\54T llNVi7sZs|.Z^Twwh$C\dqpqaᗒϜ$3Ϳ'Q7/w@_;=f5>ڙ |\;vW!SjÆ"* r/_ʘ E{%qT {Z\v߈gF}}_xUT\E56o; dZL}bXxxxxxxxxewAOSG}~O4-U< gNS5~5~kh$Sˑ9s4D?G_} _z>wgz0sw[Fl.@ڎU?XŵVߪw9vSIJA.@Nr? rrU>.R}?_9?D-u4Њ醊QZLmjzPW~Y]?;%4{͆ךq-jv7,G]ϭVjH Mn}bfWMQO_6ޜd<]^E/Өr:mzh}~TEN+ mQn3:j\w7o_{j0'sui]0<<<<<<<<$^/wg|U>ja+"d?6G) Am޿s*5i8S\.a+-\tp8fr<=tTk7D&U_?oTQ3ޫEcvkxfxY,'^gnkÜ̬KsԚjzUr?] H,h_k ?m,/~ABr?|ax:y/:͘j'C6 5"87;*;z[\*J}Ȟ8N5r_9s(kJ|?CiԝϿw\7d\ݙ]_u=e~sq"u,<<<<<<<<{a9(99oze_wv_`l_QO4c/'?sy_IO܏a!_Yĉ'N8qK@e]4 p/ F4қ{x'_vQۿsog`2e͘f@ Ӓ sc{3xxxxxxxxOϜ$3Ϳ'Q7/wp<8i uN__SWW =jO>PDh*_ʘ9=}/d2uE\Q]kP60uZL}bP{}˻v_ 'ލ~0+^^QW?wuxwsD,=o:*1ud?ՀMU/,n9ZK5{zi};qѽmxaSPOz8O32.y`U|3ݭ_}a`4cрUu1OᗟO5Smj՜ZeFwos ~v<r;bkh9z?mFykJ|?CiԝϿ;պd=Դj}&9~SʫQ[Wz?~?k 1uENl>n,d/?*7sZ 0o~ҷ~N.{']Lgz?=|tc_unZh*_N^7fֽ#hJKoqrnEs+5R= _kjLQV+j꯷MNAj\8TKߙ3Γ[gw^?{.pqJiÜRW8qĉ'Nƭ#Pok9ͿZԢouhM{[u\rUDvF#v\xuUSh/jڵVs7ְ8Sr 29}fVS(EJ:~Dnd:o5NciE6oj$z%x(f̿:~`><<<<<<<<Ӂdw\8fZ2z?JlO DӞpV"fEGK_TQSoWRnt=#s=rԺ@v jÆ"*B]~RK]`/: ("] -K/p[qE:Y-]E9O~՟ë_M V{A?;~w88c x5Հ }m9ͺ dL_"~|:K%,/tus=;>w,~*W(p9oȪ~L}rI <<<<<<<_o{8_wOOyfL4C>בF{_i4#e~GGNuYzneuNW??vX `,dދ )@ nHV?^9_ z0{'/tmуͲK|eG=ьU oXsZ>;qg? `4TUSzUoWg۸.F>ʹjҏG8MAAyK/pqɹ(W 'N8qĉ_Ҹu*}z-\{\54g|MUFlzVVZ3U?~QM(ӿW4"][e{ux EީAP,\=_2L=͘_~>s:4? GݬC%][-5; V.Rws 5]O5l;+Y_}U/ZHT۶Unu/^ipr^?Ԇ ETfㅺ2xxxxxxxxeK/z/: ("] 8}F*e9H\"e޴ ").Tȫ>#X9kn]՜ҷ!BΈgeZ2Y->,<<<<<<<<}˻v_ 'Vs~(7{_EFSNKni?}މ> ך÷Cz\YYnⱷ/mgnʞx2>:{>A?VfY^<<<<<<<<2}~?{Pk36YGߍj^^*q=7gZ4w 7BοjynMuܜNl\n>o{(ЪXx5_ V5Pxxxxxxxxrr m\2~IUNkE2S#nlWVfLNy\4ԫ78w$a3h_jοzg˘C$BA2Yc/3? gۡ៹*~G=5b9p~5wH^ow^_k]Zo9\gWt?ݸu'Viy_ٔ<<<<<<<< ?L{%5{w|ޟ?/Pc~H|J<(xqƍ6i4@W%wmNq/ӢThK3/26n_ve_?iT{<_~~?Og/ANs.^@NI<#y-J?'dL7}gWcTq?$TLE YxxxxxxxxBs P7wS] df=xw?sB>1ezX~9y߰'ow|'漖 jӺZkf2|Zϼ~%N8qĉ'qTZN/j>AQVU\@ ǓAo43GW(8n8y58 qY3f̿AWgNs⨛&, Tn);6o߾۷ywsöu#-q;6fs|a Yt8#?ܐ^?uBoaCq_?ᗁ/eο=}/d2u`jDjxPk DԵ֌n /5^Ty}wyyWO0D/jXmX?VVOlj?]oyז>&z 5Tfqیm_Ѣӫd;ڝ?292/﷊rAݕ9ZBX웵gz'_}Y@UZx>^mmyw]|7BB>\~|Ky]=o.,yv]%i&[?֬C>i].Qr\Zxy~,O} d݉$Kw;v}mJF@N3v놺Yc/3? gۡ?7난ۼy }|߱w;gwO,>޶ s+4{_:ޜd<]iRg>݋6ԗQoFB~sV;mE@yzkUcN,<<<<<<<<.G`:0(Wd2Ͽ\_kf9_KD^S8]+m`o4xl^|_ꮿwWfݔmyٽjH*݉; H*)8o_@\2YY>n,d/?ŇXo%"%ϏZ/'fwFk ۜ\ ]'uᗓWy o sdŵ_:b&9M~orLߞV~EO9/hR|g(Y(exϵS/ מc'N8qĉ?`qTZN/j>iA3|C~?G@%n_vxWSzQ ]zoD5???hfN4>ٍɁ?Hzʿf,_f0s⨛9SyUx+supw}O+8X/UhjÆ"*B]<<<<<<<<_tP2GE@pVѻVs/?)?^y98OȇeZ2Y->,<<<<<<<<}˻v_ 'V~?g?__N+]uo/_]f*yx oIhgW!7^9(גǪ`߬=ᗘO$n>ٳ#5-|1siiK ]?2`_Yâ97J0]Y?0| \mWwN5;mUfB> gϠ*ϻPm7m^7ԕexƄ_f~V ϶CW,?vsmߌ*~Sr zϫӍ[n^}bfWMQO/o2d^(4Ai~U})(?: w:MCT^>RX ˷+/ rÏB5O&+pflV 3*Zt5)ǵBZw#;syi4C~yNĢ].j0'sui]D$ItKY%>_"kce^;m\ }Z-' p x/?O? }h7}Fھ%u֎T]w(.=(:aNAa]c3ol\q# sZ2~,PkF=Uty[/ #/o?ES Њ8֪G 5O{_ŬA0N81g2 Es)qG=en>NS‹s\s+V+"z{\Ⱦ> )~}<_=^\M{^_k>c>w󮜛}wcE YxxxxxxxxBs P7ws9 "}Z)߻Q."tyh% _9V܎9R{q}=x' gs]ݏBy‘޵ezX~9y߰dx*kHOtz;n]nB߉걅e[1Q4&?*/o&|H.CnK4.a2A]DGAT\N?_1,+K8qĉ'N|I뵜_res|(f3#|_4;{NT.'9#?.qQ)PϵӊY@h9ȎwUܻ:8Q+3/^ f̿/?9HfOn_:s~'Wz5ŭw:`%=;/,Hky ӢZk~>ߡFk~Y2J[q1y~{v>ޝ2~At*$ EX`  wF(߳jb幧Z?^v𿻟zˮi?sNN O]r߶} s@3v놺2Ӹ<<<<<<<<2]h#ok|;q[[_{oknvkc>th2_8x7ގw[Fgی*z[KǛ30Cf=vv_>'u>׫g X_[{m|?gT_[K_]pwxs9Wu?ی;q~|#e]S/]?دǻX?j ~»5(Wd2Ͽ\_kV-}i7֟#?Zkxw}5*>i=#+}kM7#G?tg,x~xѷ Mv?O>yw)=qx[+WS~31 S9Y?L+/ x KY%jOԛ9ˏ`矐]]gP]UxK\<6Ol?# #ߘdƳoj~WR'1gs-4W]?GӱalW\.a<<<<<<<<2᠛Z!:)5_ŵ5+.m5X;o=KU{:xk_7y9P}Dw~^z-sj >+qŷ)G>i[v57zdu\XK&ϸz^}3pyqmw]I?}ȫ?l }04_K5{ziwڣǿkO؏λ]h;F7=6ۅ~>U﨩./W/~s+]}t:ԄDOS_[-PǿvO^ڣ?&<Yd㍳aZ?o^]~۫}gqu'_J'HQcV{}o>̗t?[{B=;kp_<ܿkW9QN3~a;T?ƞ:מ~x]^/ittu㯭>G7f: jV@E^3OTZ>>scj'tޙnj: EV'?x5ds6; ?Oꅯq~0Mt[S8剤-VGƣHſVFN>o//>5|UoN*Z N~g>?;s"K[o_ws)SV/jמ =Z¨q}w=FFWZ SO1_={Q1T˙iTܽo?t=ݵG^^6)W'X},?VMբ ᗋBs P7wgQL/;&{돾ƃ_}q⛟{G^7Y_=3M>ӯ>;|k|kk}ғtq֞~F/qQQxvX~kkj߾ޫVQ3LW_^;O|sŸN~ZesKkOq鱷^~AoƯ~˗>;o׆ĎzX~9y߰'Fo?gONGjT\M_]0}'~f:'7zx\c-tTOVN~/+z/?O/o_}X~Kr$'fqwBj-;>?Z|L'=/^T˓jao~;k+^s}4M>N|~7RugJ-|uM_W.??vciÒb_Yĉ'N8qK@e]4 p/ ׊"H__v.t֞~̿uQ-I>N޾$ӵg.n*ןQ̷ 󵵋Z-o}ᫌ ~*`]ߒӍEu1{_/_Fe3jV.}O~k>J0j/NAj/5_qMa!~蕠nش.Wi|VcӁ\_vY?U/:y8?o?WzmW~ _׻E=h:t|g-7Һ|Fa/B|T} ,/ YWI _3X<ķ߫bйj`}8\~g~sPwuzWY~5ԆMCc;B] Sxf?i_KtU•k K^^{[jw/]څZ \z.(쭵G^c\{\ſvA|c֞KOZAoeue9!Dc暖w_~{W/=G԰iÛ]1]BQO-5'_nj"]իk:a_WMn?ѠPK&'6_6o_Xfw-?U]KuRBi0V|r27o>ֺgsno?*7Wϫk@{s™ x %@WzPG_YS/?N[^}_|Y]Kޥ&^;7$~'cjT_7^a`߬g9K̫ Yo}W jK$#w?2zxk'_MkW/~ғ@ǞuZaބy M1m>j9/{@{.Fm[08x۞|cɯ='s; _lTK3갢YKG<<<<<<<<2aw `"6.A9Xho(?t'OCj9DƯ3 VQ??esIrꡘw+yWƯן4?srsZ^7ԕexƄ_f~v:϶O&a30^f/Wÿv^4o\zUWm_yoY{y_Da|a}҅׌xI]sg߿k_}vO/}7y0ьY|eS~ _ >$3=/ڡZ2$hgy_Z+WӪWO}i/۶%:~驿 ]<׿g/O-gխ{t?js~os|,<<<<<<<lڼGh\Ҵ|~9Ǐ9^Ow77;62k7nFPہ~՚Z:{QkZq)G-FufdڝzQ)/n>מI=o[̛xW篾0(ь~Z)byǝ֝[W]ҽ[}FmV,;*^kߚ]OPf+w (_;XM8~߈=g.x^ǫeƯxj6L3/?_wd:ߎb>YkoܼgZ&,\3˲3O-{7t+V]oU[O)vK?ϩxQC+NڧmG&~=dx:{9]q[QOQ=<<=W]{7Pǿͻ[_tbz P Y/?m7{dg*AiFs+ uU\ٵV={Rڳ}`|v/QW7r,( y.,(@J]V8~+vo@z)1{6wJVxI.}xxxxxxxxdz&Y q$]sW?ռWq ~D՜7^Zf: L}vGMj7ڪFa+䮾HTqV|^/mrZӒniRxW -69p}e'N8qĉ/iyC5oT3|5?TO53-uUSͻ[ֻޑylltL)Y{cQ)Ԯh[zUjs4޾o8=tߕ%/oLf?{yH3-y{-WÓuܵE&,|f,^֏_"?(Gn\W[fkg6jf?vPDӾo*^v}onuW=#&_@v[ž?\]rg㒿5P!3ھg=<\g*yY QYɏG2PDQ׊^#nvg)Ӊ0:)"+T򛅇aA{_ׇ;:Y׈u?wTH.G`NosOR}ˏ Գ-f_ۺ}S $(zPW&|4;мcќ::1W*QW1#TӍ[j|b݊gaiy_.<<<<<<<׹e|QxJ3֊CYGsr`}\sc.󛅇_~_kƵ5ֆɽ}ޜIlĆ A˱$5EA^) EPJg,%䤫s5ڕ jrr>˻ƚ{ގ1;HcN^ZVaNתs}zS2Efs·S혧4ݺtޕnֵ{w&|ٗٗٗٗٗٗٗٗUxNkA޵B/TC?=z'?<~x =o*ck~yT2<Ģv8,*rQXXDdG`d /b~y܁b`Tvk: LՎC&<^%_f_f_f_f_f_f_f_f_f'd5:z.q ,v֝&T >o%Ʋl,Ʋl,Ѷi>.Xfɼi`t`gczMx~ίNJ>FW^j'yy$b3̾̾̾̾̾̾̾̾^J&>98]mEjE|m{:kdOS<\c9k+,rpx 9h/P,/Z9ٗٗٗٗٗٗٗٗemr -][]Sj?\8Gt_UxYF]χou<294ͼ^3^|f';/?S[y׵XҢS傺p>/WϿ)p2+kk~<|XOzg}x^3WƟ?N 3{+LC90iFiGZO'LcesQwPpz Ғ`˽V g&0g{4y]y>"%/VI%_p K2K9yE^+yO^`q|+S}I:Yŋw"QdUYQߎ"uXz~K}i쟯?%9ewƯo P5?7}ad8G[N73ٚLZXY>1 0>F'\09 bs-ÃΜqvn.\ |0E=vgbjgzY<t٪l+j1hۮ^={K:U{jȋ>FELi7bc΢ܴTTQ`;cٿ4CɯOٟ?5?/%Rͯ{3YQ翢{e|ʾ/ϵw_F/νfj3_Tի]&0vWE-? s"(J-~"NgD;sSm}Ljq#r ٳr^UK%✫ku- l7 &lye!ϐKfiylc)(Љ%ߨ^ÿ 4Ŋ)(Z_||L&gF/8]I#uL5 74o#`96?V{OohIn1pv_t={ퟓeZM}m 9#mxf]@$MA5ׁ&ߠ)9kEƛp"0*9]2R;hwٯ(ޤi?[TJ~MAW@YliiʐKƚrɐul]̽t7U/sx%TKs忆Q.WF2{QrA]~_hml,IF*h_6ecII,nW+Ĺ7% ?ͼ<:u0; 1dMp uRk*&7Ѱ UEddmJV\`FWd|hkҲs5Bm_ z>ЏU<_y4O jLdO13@,j2dͪ5퓪4qB[$/7ø{ѹ|2u?X8;@ϯe~Q{=l?_#sM bG_}wk^lW_i_{DcI~oJ1`|] / |o+{I:roCsEtKcvA~qj1Ec_ˤ*bpl_<{Qgݪ}E;-̃3<[~6l(^[VzXڸߴvػdf{L (=N'iM^iTR\ҍlcE\79[.Ox֮ oV^s~ֿ%Sژ|켯Jw빌%*ۗO1+XR/yk㞴Q{"#6C*^?qesx/W|X5g4{A +}Ӏ~bT%i yŞks>-+JN\0oC;*-[ԔڣWgyd퀍i{ZWo>5yZf9תΙ"0?>?RM=k?/}RdȎl8fϬ{NJwY|5Eko=ʱm{ZEތy銮i[\M+9&</l-dpnPTlmyLG^iktryT{b~ql"O?Y?2i8Omm~TN1sԜV¼b@`;c ?>W>/߫\k?ZNߍ?^ +۵=aL|2gקAQJo<܁稭Hͬx3jجi-%z_bjԈOe[Ӑ[;<+5CkjM3hKmZ߼OaorϹx^ڧ^ZGooyfjrbkW5Ml{dme8}YK{[5__Xk`|lNbrjs%lUܷfK~|J}| W}˕}k4Y5'=/pKQ \kٞkA{s\ҍj3u7˞ X:O[/>;?/<:raDXXp9.Xr{ 24 ,| k}m8 }cT[ZAV{>ş+5>/ʌyZWfY;κ?s)p/Yf3 ؤ{W"[_;+hl]?C,5mN3ڔgT}g^=wݻRZ=wm:u #E/[Y껷סt.\^k}!7t72Gyұtr3 X ?֥}RQ/v Ӝ$/"o{fU&#φ336(I~rt-؃/(fr>4b4)s+|ZX25=Ǜ6y]ܮ~R~Swƫgb{kׄӢW*ߋn&w΃IYKH3.#=26=y3^S|-{F<1~\y-W{<_0ƫ9{31u{~L0wmmu|^d~Rz^MnX"s핫c*UFaV^Ih_1",y !5j_{Fy5*չOA{ 9֎|" yL{Tm4Ǫvr^7 KVic;ǂr EKoKqKz&gnm/_%ۖ6^FO Lf)޵ U\..Hn~ދ'{NssukxVTf|T,yӑO^Gׇ/7Qu_6^Nos,ץ^wWڸf*؀8c*Wac{:к-7ıoX +x685<ر

Ƶ\{߲ݪs^FO:^Ma^{,t6`nQ<̰k^oz>D;oUoBGV^:oסф6uǟ 'uh85F>mi h4u}pb߶F w߉d}:bMhrA\OfAi~trxa`&uvN.L}8[Pg׀w`b4 !]5%scww L6]IZ}HȦ'r1>.G0?{صd| }/oO_`2^5q0Y1 X1qr02z`-.`06X' Y0+czt8@q 7Iz06qk<Ƕf0n0lxE&ccyQutؘOauSm>^!~)#6Mbc%^LDxc b[33a }gz6 s,M5zqg qѱu Nn=*CĆŧ,>ӛm$-1\3I{0綆z:)p%GI8%̹(/f)K0u!9 synQDu>9Lr/n_J1v,n?1D&M͍$6~!%T"r¶߸rBRŔksVlb*F"|io*c*$֏.(`.~zu'l>/2+;0~igxo2hw egӇ6lόwt]3=!Cao(v`Hey#z?b׬a=po#v/4#1no_}0{Hxza<u(HFM>s8>Pϡ{|/c0( _c '9b~K&ɥ`/^DD`v4rS+Y 񩸀+O,ɕ'V0>rIWaS_=Ԋ±⃁O=(3+8N;?`ɜ O?+Ϯ .2ňb4`dJsB.o-y?]a6ͽvzFKb籠 4Wfa&Ƌf'λ0-l4`*i[2/#i6Y)i[3}!s=9?QO}ϮONc|zn =k?9/ϮO}n#F_Izwn|&D߹S^t\gݹM_ٙuluy#W6}yiv}~iӽ-Ƌn_uoғo]ՕMw.&|xeL{y3[`sW]قۃd—7c<xJAFҷY拉RWps.]_^F|`wUAzwn]._eeˏɓ^_N;7C=39g]9y|֥K]}|o;8 ĺ/Ovzm` hH=A9xpݱwaʭ{pCZ8pv'ϟƶgxacD~v3#` :yXna,RP+ۢqnb]Y '_0؛N0^#T87x^f ,LZΡĵK=kc_ƒKh;K A3q c8])1x%vcnC {{ml78:I6zc BWǃio8j~NOr.o5~ks_7u8-dRѯ\hWmV`Z/@78 ?7&Vwy#ؕp`J] knoVs8An&UZ=9ѵjԢZp>-jO:LSWܪ,'zUC lU?uM[@J;o'#E?7^/r<Εcǚڵuu累=:` _ϧS}(ŶKδSLÇ6߭!A C ?σl[#16 /g^?rnb䋬>3ͣ?tUf9/lW٧8/bb.W1p G[؈ vKDxG;n?R@3 L~٠_*BWÇa*ˇY$R;x`P_ 0׍l֫k547 #e5DlcUrE` Fk1v?f?ZMތ7Oɖ^I"X&S&&J f{sV_XaU8 3K?ܟ{G>9NqFR 7[p1^(~OV?gMB)(8NCN™?0+&K'_kqT^@̅5Sէ9 +?j2;t| Sy%Pt8кę+0^.Ĺg+l)Z)H 0!q\tZ_PQż1 ,@+p^M{ |^`sF Se`%~wDΎP펄=c%w 9*L0e`̣+hRfUݑJ>%QCK_;Whup,ln-:#W~5~8uHc9ϫ3 ({E+(/23V3?{ɫؐC9g$ܽ9޺>f-}l8VOҡ^uxUǪoګvU!##'N=rl}ճF78F}mH*r|']﵁x~M* v|ӣ[~ ߘݤJ76 .Fr N>tU\å:U\qs!onR}p\!dUD"9M+MnVyl7}\*Vֲ}Uc^}KךCjyMoYϵZCvϟ-kQg{]o?I-iA-km8U-i8M]VIݦ>QmmU'M-zg;9sd}߮.-2ve8v9 ]hlw&k` RBKB 2$L^)dBpcox-f pN"e%ӟ i6W2-?xZ E+[y~|wkBR/".chw  %ϫBϵQ w@`_h2̴56Jѻ) dhw%?V\d z_hG!홏fI/jDmV{t\)xiSߣcwÓ W'l?YJF&`ZҠ#ߓuZ$fi-Bwգ;<u] R @ v3}׎钤j\$&UP[&@S @#pſ>iQW P R&P} )-G @9c))cTC?EQq,sGG frb*E^+pcQTptx4nqpWG{Z<  ѩeU7 8*.pR`@ `X!US%_5SU?2?bO?.%/V.y_19ʪR:.JBBj]1  sIB+Lx_?p/A| 3Yϫij↙J,<|s5"ï{x- oG(l:*@_E-,]dqEuޅl#cjD`/Q2Ϛ>3pql%aݑT#cqc-1=Q$R<hUp㯉XE g?=w2V_s]? 1gr+~i?Y Y(:ϑ9Ϲ[*og$õgד\Yǫw%:+!jE-z W<lgmM8A&?2fm5s)wR5+$kD-n^r0^#ޅavGyٹ:`K?? 'DP<DhDXn1+%qMV{]p܂E0EFaxaܬiӚ]O8wy+Ospt,7kz?Op0ލ*K"?ñ*z=z8VzGpG;5 OT\RmT7G#5@wTmT~4ASE&oWVpM@kE G}dWZ[nucu5C?Vc{n50wDZnkLr?y[Mo80Y~7U-Q[5ٞ~ݺVz=6uI ͿRбyVOkj)ޡX lPw < 2yXe`g2 f˙X"3"å+ .^)n|,1HxPWb<]r6'SX7H|*ڟBa-@]0(y-jD4 W*]5_UuFEF'D`?f ؛[gne9{JR8rGds9zӿrD`oXbÚ [+a^WcuEr %[H>_ir74oI?~IQx^z@nSƾ{{2 a޳[ҏ(ѱ1|ݟ;URk߿?[1¹_;9G tO~޴\}D68I!oS4@`$,ū{5J|9ɹ ZesIMA,RA1Ն [8Kncn>,18G tㅈE [s^klj5OCѣyCLhSכ,qJ*J Ӷ4*mQ@pY `hE_ g^SοH3]-^ ߹,_T,PNuDzhHɧr`?X/7UO f?' @p_S1?lc7LFC *̀3 @-?H~DEA8]C3/52d `AhW E>Gw^(u,Rr-`jCB ĵ, b,ktI<0gycl1¼ŷ'Z#ʨRƩ^*ug? :M~=YUWbL @YC p}8"d߰ I?pjࠝH54eX c 5cjưm yjO2@:un>|F`0mN2xLCs U;sZ0T@ؘbvsS_sXWjEN&ᷳɗUf:5ïeXoZM 2Y ~ Ϳ?g\5!g?9fꯞ&k.O=SUA,b%Q}>3pϯQ  ?\Nyv4 HOu+r-fS;3?9$Vl-sG fx] #yUjTb-@Tdo KOZ{uF0̖J!`ZYH 'G  2 UVɯho \"!8Bj@#.@ 1pw hVÍn?aɧ=a<ĮuƝ>~.@7syu >x 3, b']OϭRό?FW dӺsLQpiIx:U_DN+}ۛhjQ)] ?IO,;gY'vo t =#W'WӮ_{ӷځ^#dtT[gmxg3^Q0J_[7MK`FHcQAү?nAu_;>+p#/~8T"qE  +k ɏO!2{7I›'?:bƕ'_*Ó'&:W?ͨvu˭~õn:ѬC]k72ܭ~po??yrm >t}ߧX5 8U5S}M^n? ?p2pۓoϫZ?kxN ?ً (80#ܡxla_nPWOR_ @">:s"( " -䗈?#Hh9Ϛ^ u{5C `_B*y#0'p3g~ ؁pgs N-@_qY?%_b!ǶbI}O`vXGv8$9 ZգhXhʁ`tgLEWwz{ǿjWx]3 s.\ v̿}e`m/:L.@`6=)?7zaSD03!@4~̧lr??p :8p? Wg _Ϙa!+C89;#9ph@"MY`5OstDBO"}Y>?R8D}N~T ?LZ5):zJd3oWjNk}~6|!@b|zbl"l߽Ź 2R")goĨ}n~p?Ѹ` ^U@o:c}%۟~F a+j2p)5I~vaQ2:!`cg }?(h]j D*1R_vJ=ޮkBje]/vO'^vӨ7d_Zu??Lg _T֫,2? mTa %sj"~^ ߤc<.N9׹FowRww&4߾RS'Qo|?IaUǵz+u1Թ;]QC>&p@|=.鵾עXykʵ߾߼qx]oQ^ØV^kԼmBKZާH^5kmj?Ls՝7?]-oO5 1n߁xx 5 H9#F@Gc?H(;c7̃^Μ罔UMWll3pM4Pe536/̛X#rxv?x/,/ %Oο|{k:ũ?;'xwñWgg7(d-H91]UQ P˼?F\7QF5JEqh)2/*x;&FN6s_J-μIY˥>Qfz";k9#Me_tjKGr7TS`WeBpQs!UѨpԭuc0?ge\%~*7ot_c|9, G_;j:\ 1ʘzOgW_X3?H ~X~5SS>N9ڽGf ZO!ϔO‰s/nP/'$OS{Ƙ3+SHO~_/tf3SB E+jeV?+5gT_ɽtQ3-?6i8{nI.Uc)DA7-n# z*ye_> ggHIԨ_]jn#O:άc?|uWo.ofIOlWKzj]M-W7-d;jf>#/Gk_~{?+/  UçfS *r~QA"#ʠ֧{//o1;9Չors?-/rN\_)b- RW^|~R rh1J/IdoE/lJy?" {qjɏ3zl׶ԎpnWLvF}SjjQzdVp'?:+^*_?6ku!nÿY#@`^vQpi?޸M.lޡ7-ZuVGTk~v 2}^KNQ~εˍzȈNw~[$e3B/ ¢mcCUXPI'6qXVn^g/>.م\_vvŹ^u<=ˉԖ+U<}ШRzolT\)۹gCwsp'>9OD-@GTܸGj#Ws8ɹF;Wt{ՏjR%@G`Q.y;b .ov6̭g^n5]+SG Xs_:-jVeTj[pբfp-zޢVZmUۿyͫüWKj ԢjPZ>-ki؏~d_-zKIi3q\d]`?@s(F?G >WLx7'dM(.P{!ߧ߼?fXLt?7S#.?fqeE@+݁VD >(waZPX_i eF\)ywaͿQ`0lGO_/aK dIEvǫT8JϽ?0ko3`@W/CEcd/?kƫ IcD7HC/F0f*a\j8C”7W?*V7^1Ms8G}.9b. &j ,.@~$9vA+y]@kDf=-N 3`G##TYH]dԧ3u_?BpB◪2|>}X9ܺxy;_^dlζ]nzNv1~~0;_T ~vnnnR;/'_YSթ*8*͠ozaD+z}ӱ_8`|?]S:/mԀ9GwTW(7޸FoC뾮6BawT؆a ۩eTQo6-F:W h\޷Qy}EOrSo7'8-gTmJ5oYkDG_6Nt߬A-kв;ʹJ@*AnW t}{bZTJӣk{i-Om]K>kF[Vqg*ֵV]}#hZ3vug9-o_u{'6ɿ\ jUE8 T{)'=p#EGWn=E"@I~+hZsJJ81*^9 Bf}Zb[1JMXCZhMs]w4Xx޼?gm?RŊgH?ϳf$)K R_=I[>xE|~uxXEA5}zY-R&(W5_#GO6/;ijT]/92LE={`ze)C9Pj?D 0BWP&./LtRLIW/ʁD+Q??,R2Hq?<m8\%aV8gE柄=Yt&N_;tAFfe_Z:pM jgy{/tg^/c'M`'쭋d Tv&Qs潙m؄À24@P*<@eo ;$$-@ $i`@BDD4"*@ap8Ww{v6}rsԽ}Ω_"m?'O~ޱa+v.W_8'U}+0ߗd+?>T_G0{οB p~ÙV{85fAScʿu̟,ɃqqeQ])λVMZ? ;"68?Wңy{h/)exgG]{ >?I i+Ο ٳԕ_ k%v_y_m[?qO<߼9 2l6>8`l`-Pn`˩LbfVqM7vT`3D[L n .zu'vb6zEhԐ;#=Y=8|j؝CZ _9=U d$N k !SO3B&H RvHnVx)]}F?OȎO opt;i?b>GM tӧ1wj?Ɂ?vS{Mo忶/ F6.k a W=N  Ңg5&gP: =4 Yf志fj7kl&_5_W=׬?_F^ Mj0=!+Ӕu^\#)CA"߬Q|j_`ȮaۦQg:?-UjA_7h] hGp_Sz/D ~Ju zj[짫eg1?6(Cx0Kw&G$oL#?2#5^iE˦gk뾀ckb_3گ_`s`#~e"0 `g"{I t@W5FX1[L[8?חĦ&8se #gB8_uj/%g˥_#]e.pO~ _~iKl{5_*65F/ߪ?ϕGNAL9>M!Kߨ7b73 _|&R{{Jʉ- ?"쩃_wt㛯wW ?+.K/?;򛛮s46#Q~nGS~_Qyg`2?utU-/Ov Ϙ5{l;nfߏs,x_?'u~/]zFzbdݵ{ l(6M'tB}t`w"'k-㺷t 1LFۭCж֫}B6xL~Hz)@ ٣9D ;Tglc/ٽZDRq_@\hl}>iܻmjv:&wH)=9-#ɾ~?"4AlPW}R"] @TG:X}&H3#$G| Z Arh?Uy*#kY:p(e"pl(x7d<;GIG._s hC# e'A@࿩?xfh?9uG[(@?}#$Saߟo01 ~[/ S 鯙?L`xd]?ȲË&O8QNye٤K'~P30.+H_:C+\G3g0vjf:o ]'Wb[) I`?uX?6[;؞Zsj['+Ϳ_Ɂj϶G@2+vˎUKO 3 $Do#]z.u3Eߓqi?_^}֟/m&Xɿ>!`h\047_S>q)M@/7ܗoa_o)+%yRW|1+h忍/t}ZM>oT4?&{K |^*y_g?4=}=GM(ov[J2l+vJm<5ı*K[)e'rn}y8aUѿ):}|^8qG"". 1F\f-d%Or6ۉ^m=[ :3]R'O=#'Ei_g(ֻVh5?})@%ߨk $_ۨ{.Ef]{lit*>_z/3_?^.ݤiV[@/@U >v(+K;uE|@˶./CI>j~-Qi|㷣`85}Mh/}^ZϏ7<齈 jB;Gϱ6ެİq=38I ˈJ Ɋ911o@P?>)h#AMq~0&jWü,'"UzeH~V i _WفiLuOFZOG"7?@ 80P&h&?s' 2W3VOJj\ɃHc`.h-.ob~^zI!q4>QD+f4Eo%h?lg*zۆgVD+iॹ?"eyTiOP/U?_lD4,%@V^P;+DS BHm#Q/ ? ;)<q7*tۿ)8,]>j;U$T_E8ɜoM?e5G 6IsAkQWעJr[Fg "#`b wʳ_4,X x_жh%Yc{y~l:58p?%+(X(HQɿҧŹd+~cAEk_QK쒼+%y~j.5Ht߇)~{{)ثn T3_<;YO_u0Fvr%@_U Fk+^ƙY=V|` þZz*sȾه8Zx|W6A o㸠F 6i!8&GI=1#S+Dӎ@`#ka'FNvPcRpګ ;% C[ ?smC[( # ;;hNg! o?7}rq?v Q)uP_dm|psgOX%Ow㞅"O$U"N??"FW ?$F6!<|  ?Y?٠xj<lPw:?9 hK(`QW}#@`PХ2ǃ=dÿq P/ 0"{W$Oƨ,!"XG@"D D'#tT}54:\X pa'A+1> 7:XpcnoƃGnnς4XpcnÍuЏˍu7:? #: @=6c@룤F $c#~x}_ QT1#""I|H3|P̅ͻw @'%aos $]ؽp~cnVu Bh z?.w4"tc#[އB~, { tI~ǣ q=$[osm "-c߆>o%P#i|Qfѥ\ Lc4MITjfhFRpߘWX +8}\F?͇Hr 8Y f55xLvGJwʇ܁6bpp/uZ-]|BP,ʧVd -%wPa_Ja [X&=z|smvwvKQdn|@Jc20=oqS+ s7YF;O10vм p8DhmsRЙϛ\ XH1.՟9Hah0='9JV-a{@5 ox_Y^oҳP l[dxGH<={<:#W`ߒ/̩"[D"F5|XZ๑GQ5ѐO {~ب@._R~F??,ӐG5rtP$A2lԈGkCvR}UR2.~AJ ZlyHsV!?hMCwAY,YS?"./۸mrJ Z:Q'B꿡r(u.d2I 6jtrE@i8y'Q#ty6cd ?BGΏR$.)|I7"5.s?×狅P03𾢨z$_!#(YG`̸~F9zFr+=a[|q"sT?yD0"BgC,&JN7j4?z*9X~v1>\믯毄}U5$b ȯ> -ƂpAD><cy2?-"* %)j4.BXOE+|ոWIK.xVu۽! Atި#|ݵ(4}D T4rZ]*NV(|*.G}kt:Fl'ߢç\6Xϛ&| oƥw8(=2uo˒aWf;]Efz%eWb!p/p;lǁ LƑgtF酵ߋ3\X ZWRbG'𧪶mD:1MV==MN3s~*goTjifvZ:%MˆT>%FIc@ނWR Q)WK뗩oZ$WߡB$?@Gaп`(gvsBV4?1?ByYZ]( =|5BTV^\^VT8kju[\:-5T4D?[՟ ~6Fs(=ys)P(hXb1;lpH[6,O[|Iʕ5z&$C<7|/7[ž52iYl74bnD=u@ZdRNcl$vk>7S:s&=z!D6kc 2X͐.o7G*{bCX9ameq9h+8XϗYl.Q#$U20I(AZ(Bm#k>]u|hsۣ{"̖%?D=9P,(C_a= S֍7sϥۅ :T.c".agKR:xbJ*)447{vxy"+5t[xGr5nGonH\^!GL3簵].=7oo;LEM=O>?'94|f% lLyoTC=H5h/3\>PY߬o)&M>dXk![7轘q"W̸N; cwϑ-٘\Hns9*3mx?jaQLs)_EʃN wv\9@$$PcΈ<7Y5B;J=k2:ljfU Ҍ)"jNVy5zKG_fNgc ?o-vxz|15b6.S=7 ,#P(0HnV7Dƈ!*(-Ȋ.O؁1$ojڹ+Vj2ƄfMs5iyCdžZġx$"X5J(,s箞y>)a\y^&s39.WQ #OeJJʔjEFTrS*y??DXn uN2oGŠc6fi| 7}Z&ij] Gl"ېv:~u:G$LI KzB.{L[))R(zd})ɐI]Ls>Ryk@s푷>[3έ_O*+I}IĝpDڰ>4Ә@^`g9ۥKP.ҙ+fC|K4F6#,T$%47 viG Ħg}finMk:]Y+\-;x4sW{9͇ȴ~Ó|dIm:-a@ϞbC*YBR^ߪUMSժЩa!0@%c*j9_ '&ꇅqy`]9ا:i+}n<!פj+vkT$%OTە[4v*juwX0%W¢`#"$LVh>?ڲ%]-&vy*<آlTl.gsY\@zsP?I!_!>Dħ1߰<}¸D:E&AB52%a,UTSfC|SOp >=b{ím,aH^qe5hyqQ̶;LKsAA;wNlw'gOАK ,5irUՀn?v'O;v'gEQv7k8K~=/X P3VN7D'רC!?+]5y=b)9naBeR0w{<_5 尴C|'P 7inȶA@{OKc+/oʇ Qe@3 #Ň6jy1_?ਯrApݮ-Lٻ7a&mqV46dwu~dWyyo>뼧q~/<;'llG}ۙow 0~̝JY{rƇ0ބ.뭩:ekr2cߊ~wcQ쪑me5!ˁ`_qܟq4'?|{ZqCXěWjTu, oo(dVe)e1ކ-v))픪jMr"8^HN9X`-*W`+H'țf'Q;$Kݬnmb#h;F,(8 F&e}i>%9\#~+H٧Ѹ׺'~m毼5?$TKpQ^J9Q ,ى ?{vK$Bg}(9ߟPS+>}6:LA~իyv  }43 Q"Ϡȴ%0}v:?O>[4m +ʂiw$ VG@T 8Eh.b$69_~fϿɝuW*or%|5uFg`7`}F߆獐p-VhV诿,i5jh_ۡf͐ż%,ڷ#+kId4o,~'JU}w $-E4|!^ÜeL: eϨelqz_֯U3\[Gÿ͚THG;jq8a?&Mwg$/66GXӯ<7hiѓ]vw՞kc4~{*{]}t*=Z~}XyJob;`vs83 ַH9啕d3*͍1 g÷a9!ot=z#Ā4G!朲۰ل zl2@#w\]Ղc31,-!.: :AQƎ&˱n15.Xura7E1<'#-fi*8ϱ<.6 r[v];郑s&ekx.ٟ%kئϓyxs걮#cR=¾p\.rAqkwx]ՊΩ\1~zjHߧ{*ehT5Jc :kݴ~ʽWXy}f&ߘjt ZSo\c~,n$[51;_I_"Qt#$2u%)Rvb ORvS{((RvUF] HI~RcIqC8Hp\1v.;);&fd,bDAA^-/ϙsrsly9GT .ZS0, tox^418\?5Ewݞx}lvo˯|Z~u=޻~n] A$I424Qx>3ںp|. |vq|fYm!?8<ҲQY[ ;NSkT:iu:}r4 H g }BLyGTN~e0͡v9l`T۷H 8ytaml?d־G97]z,Nls'hmltJ*.O;(ڿp"L";ϛ_^zVxl{笅'NGj-3a9C޲:ymlSDEyE?@3gQ#TiZ|ؾ/s(B2سwA?`ơIĬWtjլ հ8<kkݕM8ϧC瓕"9l\a 9MY5_g"KEd>⸓G&(-9پ:p.Ԁ~p.>ޭm^k38c A[>"t9Z ̵4;-&@Lڷ̘ݾʷf9gj:MyKu*G|dzBڶ9kOTViԡU׻UWv` Nz*8}^ 7C/  Bt [[o%q@M9%~#\V'C{O!CsA$0=9yOl,a Tm2~Աìvm۵ԡ݆GnABC-/;M dE^"qHcX1`s TS7nh qfȧ2 "h8Kq^ >㬭VL:WUy;_Gq[LE{1lڵw_lv#mI G3&o;yytͳ%KM};w8W*r҅3^:ɶ;Bq L;h㺷׬|X+G-[y>Ľ9^?T,84l˱b:-uKJ]Խ[c+%wlm9Y!5,~,FOU,i{qvP<.KچkV/cȒ+P)ˆ}= LIZ쒓 v/6Vݱk|b1$P>@#QN LY*5LMs9BLbI ijU<}I8y #s$-@K2BЌ14)Z|b;}f#4FIfTV'7 ƾ}@V]l~b+&9] Fʤb(pq<' [QD!ɧO/pڿiv de*_+?Ovgg((kԄwFBT|J!Ù\b WŽsaidy{~m?G,H9/iJ I_C[no |*?7Up1}Zр}&d\l/wϰwB6T2R<"Db =` QtDw쩯{sͤYm@z˗/_zfOEW.3s96 DLs }CXӓmFg&Y\2v9rLcmjGr ;c~2& _MI2§~aK62CcKrU%/07k|Q3HFO'4p1HkԞ1tf-ũ$''ٟYLY{=2f'wޘV*ϵ[3>m6ST]Ab}0̰l/)K~vܻ|=7?{twdMvKX8z)]"r-Xnik}-k|]`E0?;GJYdi椋f|ATZ-· {\cI!bc9-3[>XrJ m|G"55 , )3_t 6sKl(۾?ڄ 6w2\V0p{pRcg8M" M4KBNT>~ב@a}kO.\n,Oa%ö xb3۳7SU˚IJJ;=G9wj3|?߾ӽȞK-ӦO/R=߼v4חqzaJ*M=[,Acgv!|nBsL|v;bY95 UUG'ae j,(gzo/Z849?"̙n((MJӑ) ! 罨Y_hw`W)9aLr 'Lc3=qKz19yszhYf"zܬ!Kй*{ 9 dJa5<ͅ>Yw۠N[Yf%W*\vSѱL66x?~HUa@]`E/'ZҢOKt|C8~7q5//?%%s3QwڗDapʎ-ܢ;oU K(7b-$LeLx?XUSWMoő2Ko9Y7`fTTUi`,[Fj%en#Sr D<Ll9A6}|T-*\6AozN8ؔޭm~W֥ѐӽC.?-7SJS~rK yģf{gqi-(CT*AΉ_%-F-cEtBOtF>u[ySnҢo))j>'hه*WUR *ՄWV:[k|j}]GDsY~, UqGTI~oLssuj2Ɏ'}8Ir$Q]p/=W Ps?΋#}^'__ |1f,'U/W|dn E8ĵ[ӾtZԕ`J>^~تk&ò]/gV02oOzϏWZ-߾k渞_3սyԹQ"8ʐϢ-?rΟgՅ`E͛fMa:VoP?G G6-N^>I褤"gZFŦF rvyUadW~,b0?GyE ,=Le2=h!!AXtc~y3FL\mugk5uvϜ90z|5o2{d4JhmnRG#^ fw2gPeΗݦtsYyǿ>n7ƕ8`v#psn:KM tNJo9t:J+ PS3絷1`ƿg/rh),{*4n6ZYGyѶoʈ2bt x_) >>YǩsiUѼjA]յ->si<ȪؖxeWynqo*%xiZAleZ70JKNIEnTEK6TЀ-r4m6Ṥf~qķr(kJg:`>e/W.^xCi}/:h~cqH4H, 4s-.hM$/QKI&4Es BZ@Hxl :sP|ژܡ~"-f-^ 1qtDNקpt!,6GCVC@e? BBE.2 G?ifiyy늌 yE?COD&vH ^KvfۏZTF<6q TI[PE>(@Yy"mgm Ғls'»|&q/c_>w>1/+/K1s{иm ^Zi/P( LU9_9ۿ{ʾtaEOXU^ې4EL42v⺮:Ebu0r .U7C8ra{\/5}fʟ 3 Sʚ ң\6_Kg-,"JZĕ?贯vz)0."7a 0P\:'󒆜JE{ :2a yL]jbDGb].}Y|򒜜1͛ʓCJssټWjԏ"48E+oYۯBh q%;/pfijO_:_W}ֿdǞ ?[|GTC o VҒ' DKsn璜|Qh^$VDSș& }8>g3kv9}^.jsA 16cVXLa 6c239l҆0L{f H,d$e%96F"\Bsg Y P8s΃OcYSu_~AbӚ!qmyyHm%)8x7X$#qҗS4J޺asr333t:O_;vwɝ;喱}zQ tODub_Lu޻{?ЀГ춪'z"gғ3S&u@WZ?0~ww?//ŨDf.X6oՇC~Jܢnm]Y#ۢnsqgJ6c݁t0olWު98;vMUM%%c؝ދ<&*n n@111Lp}CfMIhܾXHܬ1B0t kDcqJ֣|v8gW,y\^HHGјqb\柎w<(X\H0`c5#S(HbTjUU8lYg`e܉o?|_9W]tՊiGf;m㮺rYc><;6A^7h4;dO:}ھIwGw`3)^2Ԫ'|ζU3GEʦi>bǹ9VvFfx_/VNƧ;4YQz)}YQ D<\MuҲ+;yvi~b"c~}]Iiju80~29 EJ6TY[å]dIշ++Jgw3n^ڄ"8N$Ayi&oPXtÐdf m˕ jټ ]c(l.7 IG ҏ"⫂x=Њ'|)k7h*(e͔r9籎T!= #`sbc$:-A|ݠV&4y>"R^Rd$"M91Df KOF73'M(&[Μc#ց0?{Z5gLyjKO#-`Si(N|E,E,dc+7$poFs|}>M3L6p4֣fNsqZm@fy-T Ih>d,RT;͂}O+mg0kÞsx 8n;=&;FJ8!c$> &q;Q6[zp^Kb3/^0xO_U|~w ZUqzt/!+X|@A6 |hIj|ľϦ-a|HH+Y|Ye/mț۪5">B<²챰;-`MRQO flP\HSToEXǻ7vn|'s5/-a\OWcntwm裷9e4barNے݊?u@44/߻'^:}1/)k0n/_X1jp5%rs o|+3 .eҧc/t֬G覞HEv =}wx{ҥվJQ쳚6i\ҽ}iS)v{q\#E@L*}u;CC$2PPaP+uJѨ|OA䓘Y&01s!!̺'{\?j{и\yBf"cL]u)\{q y#$(zFXp9{L9+bނi0[kxm%^XrJWd@M2JVHڅ\]~r}rNGWM;0%)cW}$XMv:$=.KZe"ƕ@ڬ"b;56&nvm8^ uކ[M$~RLv-/oV{> ^>PV-Mڟ ^ד}ڿ vW. aٳtXx.yO[nqu9a к"8yDfB`IXEB>% YJl /9Z5 L`,ƋH|Z3++C#|CxUVDPW2\v9dA'l50%jR=)b5^T4Qw'ϧ-y ss_*LN9 v괣ئM@ pB+FrD43LG7n4{g]gjiAQA>ѲAN?_$C{C8e0h;Ӧ#l- <ݨXQ.tX}•N[AWYN({U|>󂥜>{2߾1:VmL;BuGeϝ2yž96|tђb/| soH/{.$ ={?DL_/C&h'rg.}+uz _=A4{WESNi,kgtlv9ɒȒtϧatWNn6cwџޢ\LnV-HK6x}7xt͢5 Bs9x<\ܭUM*(65i4jCZ>jj&`.r9r ) huV-Sʁfnɏ8j滍 n/ZT$'ioȾ`H4Y?/N7B -N\7Lg3_[(vguѐHዋnȰ Z 8~hyYwȁmKz[}Ox~\[X[^Iχꦿ٣K T5l^TwIdOlR?ǜ)>`V>u)\>Cۮ*C[kVøV!吇YUV2jpar2sPk^\1N{mV^Msn#^1_nh Il܉DJJ_YvG]\vZʅ\U=S){]+-DO `y/#AG)iXz+Q67ۢsҵEj(ӪհXR *Y*0~}@b*dhO}Bp͜,=;گQLo~TQ)>լAMeh6 Q%vJR6jU8A p|>/TtZZ|N.+ |3Khd#mx ʿZ]kl,$?\?k?}1%g.BGI<\|$<[3?oROa|\{b&<\/Hn7my8Aw <ȥI2*ɷ$M7%DbIzZ CO{k._õ~뺶j[[t8{-cYd=yfcW/JJkj = ^}H3 1mkv#˙v;ʥ%&q9}ı%=f[s}Z5_UkuɟMzys~ڔ1b~pE=VrzdGUQ{*jݒ7k:ZB?*ʛz2J \Y}'lI|ݛ@I9p*clc_Fw}'3J-z!BZ-/,/yfi0=BEQT;#4ឋD[WP/ 1ٯ(4 bLEW2E /z:)ݷۇ+7-xZl>XC:~|hߟ}csdwC1Tl>Ɛ ?ivFghϦAe[4rKgJsE19ߪUd?Cx@+JyD:VpSUwj[͙L?.%򓭆$CQba\_(+U_^dW.{fŒQ+nWf#c϶mQDS~x]2X"=HuSȻV; EC ]\)ڰ!_5G1 R2 :h$8ޯȹR1Mr[pw^QNo >:v,}lJz'E뺙B79j1>__2ͽB_0#[~QV|:{<08z^NWUUW*MtWW^Ýo{Mgl[w>Ͳם\rq+׮V5^:yWu6WF;ro̟?s~jFa$S<4贮l&;cJ,MVbq-cFlZ73)2:!Zx=/_kuԼ9jW;T]TYD\PZψ'ӧ WpE Wjʫ؀3GB?ʅY{O_xa_Ec=HZK`vn;vX9gԼMmY".OFV.4LYCpDa!b\cf0}˶5?޲hִ]{yu?>Gjokl<$<ޒ<6cq:3Nsot6﫟S|lYƾ=?96:n?gwԩpέ;1Xo*ڦ[딷.q48FUjȵZ=.t#k0^kWT|1jv+vx2lE/SX#"@uMS)[.*v܁[e՟;;`S84?Ao];e6 nW'hz<\3"t{"y.K?g쏁xVD,.9v|sanig.S="s8"w=)x8&v0a(G3}i}wN{tf=f'c8gf}nDVN)<9&U[^]bΪG4y`^YXrr{VVʒœel:_YWMZ2lk\4 1nƣx7'ѐb"K|.|͵r`"U%|?p:Bwَ>MoZwΩ ]f?LJ!j-+-Ԭn}AV~^96,T޼SyNxṎM~Q$fyi ^w/_~jXςg\ɫJKw&lZиgK^Dg^ 6wؚLgә?Wli\8x*K_l LϚ%BHQy5W~pyKBYNkgM汾t#4JSEk\!BGPFq Nzϗ;|~08vGv hX)I}iC))'e#מSZ.)C-{E^k~!LJ?yY,<-HPzĈF/b= z烰]ҿ$)p0VW!g֘W^s[4=unmE+X)ˉJcP|vݖ/ vӦ4vQ {iO ȏ)t K~EdԿ_.ύ s 79Myx~9VUYxP>~6,ô77"TBYn?q,3m>eGSan_MմorZWSN˛oG4>'Hɏ EOMʏ)l|dc[|{d朗w_}5/kONƦKVUw6`̿ Vʚ0˫@OzPu&!D{; kDR2]\/ Lc6 ~ֱ=Å=?oikVJ98/iڝByyv MJh!Q贤W?0/Uihg7?Xa%ic+XXhɇWxRKZyF)+pqƣ‹\|kE=PۧorI"58ġuGnj{7 oH0O1|N 3-Q9$7\Y乼{c/~~Ӡ9} 8?A'?Ǒ,/|a}'@0|aŪ2z|`~ Lw%3Y /A`zG;ݕ$zgFk[$YvF9Ynf|N~EgzWnuj~M'+5osrgom^6^ۓ];*ύ?_|?q/'?zWv1ݍg?I16տn<L&$Q_P/̟ew.2/k-=Tiwwwo&ayl 3WWO~;w?ث_ZreRyj7:r___zbS^~ Y׽yN!oUu 󓃜9fq{_eUV ]uUO˼}޿WÎW{xy"~n_}[^J.b8ɻ!xmҹfz=eӖ-YmD<ϟ>g:OWw{~~n8ˎ{~;pϟ1߻~|V=r;_|Q=7/mn"pm)]>=MSx ;޽:4NS/lUE-ҭtmkXowx*Q{?W_^?~+a4Wb< Er^6?u'hm{ruU.q+fno輳_~>GXvy/?B>;Uosm϶7Kw{=7л=풓SzU4u?}1ӫ^9^Q3W?yh|?v'_YY&-s JYw}6kznE)Y>?O^ s)~s5>|?ן_O1ӟO~G7G~e꿘jWϮ??~h}?{\O'C>X}-~g>xtf8ppv*T=Vp04á_z|~~>ӪD/U<#u5a~6I2g};Q}"9G9W_}u9L~}= CU.>,$rMHx? {~/?f2}/ƣĝ v3m~L:>?GYZ`T>x/s"^_ßwWm]uWѿ^Uu0,_JrEoǮߚYY:oU#'ֳ!o={<5zjvwOyG:=yqP|ckX~UW3Xom^,z婛㭷l{93UOe|S,ßz׾=~-Q|l썟We7՞/3fA},]7m9R#6{ۗ٪׿6o~v^=l7>{z6XU7s쩖t1|6޼i~Ui?G9uƳ c|Gggj~j}un_v;Mjv>uz?^Specoƫѧ?x}Uݧ>zں=vϪ;F[ۭp}wzl'&#Oqc~.+/}loߋ^nf|z;tZ~/;fu!X|'vuп=^}Qykȳ }<~WOsoww~PCo;m?Rb=vy#}}UWbSm?u3 6S%w:iHmTNyauHq`\sG+܎+{?S~o>{g=[7ه_oY.LgOz{}w;-?s<~]?'{_9?;~z:z}UP}@/Ǿm?o{O~9MsN=_d B}xYzR4]+_fylSXt?,ojw>>^gN=U?].ßk[ogyT.ujnﻛgl_n-?y?E!Υ>Y]z*?AjϿo',qȷ}u'㖶_vw)<}8_mzt;Vcg8IoFjli]N\/XoUi~Uwߨ߾vq3mzgXc_x9е_ի$A~vg{}=;~W.нn_˶wdU߻쭷毠.{N/߾o#kޙge?znjKu~}^OuymQyz^sy;>jɳ{a޿~3q<J=Wߩ~~>?:w8r2_=x[=^rLJ&g%cឝٺ>_RK}ngΣۯBuuԳ틏~_{5~m|:zY.cuw;y}v}s{wv;+[[eE4S?=_!{{9D_>gmm9?]_Oѳ7O?ϛuoyz|~}![:'R:犽Ͽ9X3{d^h^MsQ }XU]K]|KG\Y[oy/c??jOw7w]_9j`cl4Zg[wl}?g\sy}u~VW޷ۺ;s޵>|χ\z}c:߻g{OzGso~xexO䪾&?\8w?iK n:=?>9O^׏^~+~D=*yttB~z]uW/'Y>Udor|uNUZ|djTer[ӣέncQK۹1yo]T0z?Wsuy}vx֫ϕz~[wl?Z^Gٻd$߱??]INټnS.~c>w\$;x[s 'O<}w{~_YT݇wO97nos9~x[ե?m<;>5}uUKe~wߟm^GIo'N٨w}wyD÷'~=w|?u]_=U{aOu>ԟ9sXw߷4ZN8ܫ^u%:֓(wU ^=;Hީ$仹Պ|3;s]ˌGwSz O+.exwq]U O}'[ϜI:oYqc7gG_^mtz<_0kRkw=w{tb{z9x<x<׫Nǣػ D-s1=9=r`^+uu3(Г οs!F~:;1f̘1cƌ3f̸縭^u F1Lܾ/}רg?cƌ3f̘1cƌugjRK=>] !u.0wz~Su :WSOoeSz.~~ekT8 x<`A5ɵsop ~|ޭra_zdb{=H9B2$B|/MO+J3~ҎʔH$x<xxx9PGQ{eXu;'? ?7r@urogpIIHN9z{ZNF1x<Cz51zu:ԟ<܎>?jY$ިow} \nvL=zVx<?Rߑ28^@wN.n[r|;zkwSu!u9ePǟ sMe\f^}1D<x<Mrx[ KOԥ_˺gfOoLOMWtXGY:cfqkҹR[3;x<^:cp.uG㶫v{|m&:z75\u=uB^=|7YUW?<+Y9٭3f̘1cƌ7v+u /cX8|{du}-2u(1<~9Qam:P_>XsUljUEJ]JT%-u_ ԩSN:uu}=_տN^]gvjG'#5/:>EˬT/WEu *TvzXT g2V>5>x<?fXqcl9׏d|6 ~?42+sq ^:W_SK3 zeTKmlx<ۺM5J, yAۛY>zӇlzcU2KWY=n$/g(Ţ:x<3us^= u` vsخ`RZ7zѺ*fdx<xS`NfM $.^@bkT)-z؛$3x<xS<3 l=+rj\痜Y)x{?wf"W_BD{fzҬ{|r=E>(7EksSN:uԩStuԫϛ=6xT-P7R7+9OUEիtl{8c]VI,x<~;`ucWX=~9W֫jEuq9~9cujpu3gosD>z#]zO6x<x|cBWWujb֓S3FoS\zmLx<x<όL|{Ifm,wF몘smox<R9_uz.z%@νm}ے;X<x<,Y_%cLN}+M/#9䋺}J ox<xSmp{q/mw>%[g%)}FsJx<x^#h P(:ȩώ_>"3yx<x<~~׫*G w.G7zʽk\j+KAx<x_b}/ p{@.?^o_݌p՗yx<o1'6n*} 7Wo:׈ui˄x<fze\_уʖuJ:x<x<~_=rO'_Y&Ԗgyڒ;?Zo[Gx<ЇUe:9Nl;\G/bx<S/.@_?W }GG8`Q҃sx<?ܫzWd ߞ-uOQ&MњԩSN:uԩ\7@m 96Qg5ʪdQq,sǺ`{"Yx<}@ dg3/tM}6_6.@Y6x<x|j̱zKWX@p3_rDmȩG;䑆Lx<x<όL|_%Y:U1201x<r9_u~7y/.yx<?x=v.D H8"f?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdfghijklmnopqrstuvwxyz{|}~MњԩSN:uԩ\7@m 96Qg5ʪdQq,sǺ`{"Yx<}@ dg3/tM}6_6.@Y6x<x|j̱zKWX@p3_rDmȩG;䑆Lx<x<όL|_%Y:U1201x<r9_u~7y/.yx<?x=v.D H8"fx_|1ꅓ/}nP^Mb^{V+2Gex<~uixŷ~z;AOU2Qo'f_u:sG7KYhxW#ULl}g~)>\ks^<C;'57 ^rmyx<W~xs;Bw{szf;3iұxc~~~{7a\oq=+GNi4:wx<=FFkwa#R;^qwzx<wcx9e*19 sl&QOL} /Vd"Xyx<W<yud.Xhg-^KK)G2<gjbԗy,ys6n*} O9˘9sޤ){M>Y/^G`:g8+-˲1,ޤY:o,=Hʯx<Jz_s{`Zzevj/BoM9yo__]1=E}rG=fx<+]-xgtlszّ5ZaؓyǵfrGxGzwY?p33f̘1oc5]x (SN ߽wOMq4jCUOQxU]}F}q٬x<_X,XOlKn6uԩ&ͻ/s5\&,իW/9㓣W_˓ju=V.7ca>lu?|'_}|Ndu*fy#_oȷ=۬ ߟ Ly6lp6ԏppvzzaM_=#gۂ#aP}=Tx~'?zF>?|G33G^}eo5ʿwjVD=^%TGdr2+=cbƾ>}M>zz|.?/U OݾJny]?k6t<6{̻{ejXcxg۱̍Je X}#7Y>'wD=syM _.F?Nׯ*?ܪ?~>x}F>{=Ny=ګ7۶S{Ѿýoޛz&덎X֎^h>*f_L'S_}y3A-|l~{{yloٻuO5_?>y;+Q?=7]U'o''']f꟭:Y|ls;Bw{síO5ۑvw;_ ԵS^syoSW ?{[ݍ2'Yf]9t6֯Ь߮ 7a\}Arj{VWk>&r ^[^|(/< u/TNOOoIr6|{tr,k=&%#sse>9x<A#Ȼq}ŽT/۞Xn2qW749~mڏq빯?k?яe~c}=x<R2Wzܹ6t賆^Q7ۨ~o:\:>3nݯWs_ot_q{|~^M>OQ|VA67[ku]^*x<YKR;=wwhQ%^+w~W;?7n-^=t}wUm=}KrZasIV}TDv5LVOy؋\D__hy<^xC b{?z.u>nׯUѹK~/cV'MrsWe_'I]Կk'm~rw/Oo>}3 }_U+A/ݷYuӣͻx|{ݫUV>ll/|4iz/dɤ$%j1bKww'LLs(!$$t.']U@B BI?3컳$ yz޳ͼ+Fio8]nɈսĨmwy>~'?Gg:9Aq:D*EɖCڙD6 UO g*D-@[aٛip@.*x#[[)}[vʏK;xj(l[ZGlP/lހeb抔aReس}~Y2 73XZ8|W3a(seGj%z^OA/<]:'s<̑zec}sz@+`7 w"gCgC?g<ɸNw:qE,-ڥ3yɈ\L Ud~jʗ]a"  Nu]%KF+O~\r3zڮڮ.XM6p!`3όĹ@^BG2eYig ,HNιu^͈PpE9TQ. 4B~5>5L7/;dG jtkrs\8޼~ihݞԈvblODxsJ9o>T-get:˸جȬbz>Gd,#ҥ{/jgz?ڒqq; #\Cu1dʿ呚I7޻xx~j.@>7w?VlYmN>Ɠ>ʱ9 ؛RnWTCjKo'cb)1x3>AND18ffY3i[g[j:hzK;漁mc.⊞cw^~?oZn]"fU|?  u,<ݰ s<[qo #Jzdze7U?tqXIɡOۙ0)y!/އ+ya`jkƿwrT#珵zK.d;njg" f#Oc0R}}#x!7br\{o_b} k~*=}E/r;fI25Ia^jUp_'.|],cڲL/@?JZp$@ ̈xjDxҕG-80uu/J^9lޗmHAMӌD",g2`oTY&%;v-~hE'fNQ" 4 R>ԥPf>Ǐy 㞧 I: UF peqzI@:\i!w ?pl>[?Qee{C9Y%ϸ)6Txˈ:Pcl BAxۿ>mſmrO%R8I{~ZS c <\O#}4חFsy$NqqKS c`:2^Iv}s2}hoU*t"m@DȁFӀO;%獼Nt 6* sX8/Ctf 6FxN@(^r8f*N*GkVYh?vrO9v1F-*i?gm\V& yҁo^ U=/wD#X\gǰq'?+7K%5,+u(0JOtt%ŝCY5ϑN=GahkO,:ε #ụo$y67(>6x2ԏɄ'Ydv/]l|p, b>X`(NG݌9,#St 3el? 8?cQY~䭧W889y?}fZ 2/%6̦zd'~Xhٕa$0(ymH;'cpe/@rd%gu}ɱaK:\>eDr}9&3XO׻C\z̖ nH-'cߓ/ B{0; N_e}K=Qzaq>.Ns,gxxxW.k_Wd-J?!o_ųὍa$CD>#Nڣv%8j%@_  9WfdD V`-ow{:KZ>y0.ϣ/yDv؇(ӦTgS 1l9ix5A-b]xtuC\}o*߅?j5;kqa_蟓7`]P _}v ?Q9bϗcw<;V'UdD,BW)g:,ǖE3'ND+V9>84^5^'4_n',z}Y}F<<'dG2ZHs#fO#c{$d ~ApK?;LK/hR}Z i%C]r̎yo(:8^le%&| OY`n^.OKMqPF"xOsTk%WcGb@`x 8}%הo5\ENĒalqE,8)Xs'>Clч} kkO\OP?k2YS.1d/cqHvlZ~^@煠jh`_nv2iJFۙb? .U}!=y^k?= p$ٱ%+.81p-OWP;?::*XXA(ZI VoJ땹POu ⽻n lTxW^C]Fβ?{v S9//tsfaٔ\G}\w= } B- @.OW #8.;w@5k/ ! Ǯ4kkO<p?Q" 3<5 W3W7G0b;X5b7'_cο/0p _Ug|{(?6|`Ƙqt^BN`Зa#?R.n(EҎI6/{2?a \=, @RQwC=0,G{*~y8Q(w˶}^w@cr+-U,$dg*l׸A OULA,{΅HH t~--fȍ ԉxICFbZSK/̯-8J>?c{&8oEpe$BHo:-^9 X\t\yFx5յxx/0=?o؝q$yeꐜ|ǹϫCboHdNؠ:&9RZQfJA '> cg[%_DwE| m/bF0jZO x`r;qELt 8x_$L.f=Aιn(w"*kth? ox> ?ף2b?qc9I?*,"W!EhP6b~gPMrMK~Ts1K~xS5^5~HeX۔/64{qug=@?ߍ]3*.$={a3y,ײW䋩UCj~+w!xz4xg x|R.p{, Ct^#Ix3ϰ<#)Q-6~^4^5^'ޣ?rEο?<F vvsA_.GaD^K7l6hX44ؠ`5 )aӹN)WxΝu}告+z,=XG?nr ^'xQ's|jB ssPVlq qF ?t|+}/2+ .?M)^OI|6ח)f6BW[jGl~s*t;hl#͔$p{8V2gNgG`Jy@|xD_?s?ƓZUə'wu'O.筏VO2s3A( o4wV7RyrjV];\h~'̤^p}!z~;bwNN HrvQ;۞~f [jmk#"2$[l/fomi`<3fӽ:jF4b>+C;0툖m;m֬0i/-υs2 2y󼄩\\3~2yrBo?  u xii/,к^0!]۵]']0 XM6p!`3L^xHpDq?I3)78HM* Kl \zP2\d*KF|M1L4wta,% l5sgG5?~0u4H[ȥtOڳ~JPgeКuX}c5ʨGkŐ28X0mοWsa? ϔV?'k* '%yQy,_cyJbQ}21\o,b0e{m5rlA&Gl[\^@xaRῥ}VUS4kE ]8WH ̻xx(x_dk?]F\ O3O,O#d r0Qbz:_Ded\gF2M3Jeށ'7ېk U >P*sYE:{wr @ωPkjU% 9\x߷05T1I7nvlV*l vهJV[{vd~lmm_rlCcvsk5^5^' ,r@ԵkVeGz]r!@rG%鰜j,bO#abu&mI G:p%'d5ę+>l9u( Z"׀_(18)Jp6!Ls}<"}r?iO#<,(ժlퟸ] _/+?]Wh?>pޞAߝAxOu|9Mj1mܥ^Sdqk\Y7 bk:#%x79PRX߹O?ۇY R?#9@L~`R3e8pL%_K)Dy̧Ӑ?jƒQ2TMEϟe! &+O?? ީ%ǚ!~ /=nϧM??k9+{rY?(wCϫa=cڟo=^wU!'s@4>,^Ȍ0Nn@ A>3~Ě uq5q|7n]sqWyv>6@4^5^'!ޕ pe.Wr6&+`%@..=K$j.18V V9tK ).Fd20YB,6AMUn 8.zǯE`SϬ͈̝^S/3<|5C#WaNc1UwqZ=T[ݰPi͛Uw<x n'}a)e8ToR6'?>Ws=4?>ldJ/R(:Wڊx^jhJTƊRb#*ȔCx$ߍgGyT!o%lϨ ѵ3>hXl^ֹj|otdzo8#j O 8d*fvm1u /.N,dBfsV=@ϗ3B-[geLߎ|K F:xVOϥɫYckOk[XdruЯfPF, Čcב?FO[5^5~eU(?Wɨ5/t HL1f YP/b1g<*ݱtţtHJJ^'vϏr0W`HƔp(E/sd]w{ntqӡnp{s]I^AT9a\c2PqU]vrBo/jY\(3^x?٢u9*pmY{vI>G|^?>|v{MpuMxGw܎oS<2.[C=92dO02bx4T3NJ#wm}ۓH5v+0 ƃ'o8;HoSd˞^^s;, Cn]\6Gvpj%zV %oŋwmwp5I<|[)yix.V?9* 'h<˰%mߡU5<Q8dBH;[SOgwO->]5^5~E^GyB}&k*ε}!R_yG~|C+ﹶ+tZyߥ_7{u= !ϋ ÷|pnɇj8ßqre3>,gL|$nODBCn!'-$G v?Ca+ ?6V|d+v*>0EC'$m6Qb?ZZ>9AM?_u7 J뀄C~: />dݳM%[DOr}ZkϷ?IZqs=aFa@agg8; 0miےwO:减?`>Yy}/㢹;dj:cz;7wӪ?2J K*%n5^/GNoi11".;K;Tಃ Wge6ml:pP0?#5 ^9,v .<^!vS(1s?ץicx%XwCpu:< 8?h<7zHd rc^uF Q^\SLzO>Kp>~ئkk${nj)d?Wt]#ٕJ$l7msq?= .^?sϽ |V>&誋Nv-N_BRI9c(O~-%[ʰzw9u6g*X /O(t@;8 ^G#9#Ō,{Ni?#t?0ijV =Z:MqXbF[[[ )t9>_xe~xvԺL"ikO0b~vx҈u'H&vksκd#:tw6|>ݗy)_aN9z'~s\zah 4՞{xW괓1^-qQgr Ƹ9y>sB!r;o?`F%N@pL(Qs>$gdʂOMb32ZCw<k|L> ƙnz otwBpOJ/'H+qUaX{<(H}~X$ lA:Oo!׃~qXf{jA?rEO`On;7D5^5~i.[Ah ɹ%('FSv/H/s_ܳ/^<^^;ϽyDg7 >f4h''WhWW[~dlt\ Dl )܎pO{Q2xAɐV7y^Dn(2_afGb06MͽcoWNj"Ar0+^ t@?&%!䓭w_Ч;[>cz/ٚ SʯHrM lNs$zb"3(دwPHrhA|u08rB|4^5^' ޱ:`ڜǭsNx SI!~a"vMwj}#T$HdIdDn_S>@,'6ӋSEknҭ>c^;~$;+)yrK#xEXOm) *g ɫ>Z6 bdK0رQ9F p>_xU A5^5~}1?2G9/@\`|}J\_ny{WF/[+VeOb?cM?dQga#? /㑁?-+Zy@h#~Rbt۟EuXMpRms Ve3ws1qB6q)/H휑l.LHJ%!⣟mC#]{)9 n%rG+PiID;Ez$_;=5^M<0sY;qLrbU3wR -McA9sW]Tk|qt=G5;s=*/?s!!Ώuk`& q$Y:?Gԣ]G|v`e=ح'JcK[)os JA#9X'wΎX:R?d~:vwO_W##ND"~w⁕O_yT&>+[Pb%9/ .=cf 7e=_yI;dWQKn?K ^z3 #">X(ӽq_+!xxxW.k_W8TOrAj]Î<?hYyϵU*]h凕f޸CkY/ΛuЗ"5~u]EkXdOD_u7v|"&.5l?v1R[Cʤ?zfUlmH]w(6lh^7d׬-0[uWx'/\On]wOSd3:/+c:SF~oͪϰ. CaTȓx\Iu7E-ߎS>`Zܜ|)U_QϣWוR?|0&rt+;#ou3wϯkksϴ?,8y*1F?R11푇_oV՟sKϩ[Vi:[v]ugu܁_> MョRM:7ܯԣ7tǺ<ͧUe ]7$'opRBdT"^ܶϹ(\ ]YVm O5{]uO[JƇ;tOۀg׋!&EVwf y a}fzהgPѢC a3 |K!t9cϯkkDų5Xj}ޥjf2Y;MM ðlY}2ؿ[o?v޼aZdY)ts[~]uO~M"DLnL]bvhOV\hAx>iȆ+:H[KN~vpufG}~^܄B#It+Ȯ?2G@n[d*HL1f YeZ Z0:c`vb!|lQWܲϓ?|*F߽ߪfUoy3no~ʟ}4͟v}fa'P$M9K}(Շ#_x長-ӵu%yy$ οl@?#BHμeĂ=/`{/;D"ؗ|aQR0G۽Ӂwvۇ?{WƳ.b&RsљVum17~5^5^'$R<((\ `?jBjٿrUgZo޺k/oa::z1/na|Wi3ݶ&{|NŻS ݲ*ZkQGw+vbrT|?L遠w'Ö7eK^n|X;"xF[{گ8k|c< Gػo9 u i _cO~5S_ɩuQ >k5bkk[ʰ dߦLx+ @RCS?="-pC}g5Ok'_~nD}"VNgsiӞ{tWx>[;.SIol;n,5}wZ@\^ÌiBGyމi/2ο^Sj_;r5k|0<=,e3l/S%sZ-ĜydH^||_V7;VdՆʛ[75wkmk-zco?NNgY軮^l\{ǭ3Dg-ݩ.^l gZ|c|V3~g| {|-\N9Lɖ5cFˬvr۩]9}1Ƴ}m{{̙3hO>GC~`<竑N>1'Z#*=%YW!~lJhWFmmNzS9yt@`}lɉxxtxPˊ4'WÈNgB[u̽}?>G#+V|Ϳׯxw=O<{g=ԣ/y7kyTjw1|Λfշ~xҟsl/ivl-[n>k_˯ZղK:]qtNSTt5履ﶧׄg`W sL1M6#L TɽNX* zC O|%7߀v6<{.~oO s! 7i|<\UoD"ߛW8{DA.KS mjkORGBV#{-@^R]tեοp܂~d{^_ͮszR;v~k۶ugn\ٛ] 3o:ol6ԋO6t뭶gN;SNq'qdwϜ?>fr؍#5msW _Q{uO&4>\/~`w8Rȭ?ƒ;fy?E6ߝg5k{ǟ#YϑcH-/ZƳ >o@_<ۗ~/d_ǫ#&So_*YO7%.CiN:v{r@_\j@}[>T‡Wc~>?Uh|x; `Xc7/Ļ=`\;dٟ5z`N j|J9:Ok K_r?;8~n({2`u)fON|Ⱥ6kѶgG:'zVf/6}0w'O"R~{;OfE?}Î'?'6=椓_rIˬ#M[o;usƻɀ?v+MzO:cY/t`{C Ϡ:GC^v'ă>K|!{gR !Kr~^nmouɆĻs[^x.V— s'X4^aOY(kefkkOxPc5ٌ\\3#?rؗtGo,U~3o#nS-A/a+3|?Y+?CC C[m[oٶnf;nV_Rw`lt$L[4i_>_v7Ǯ=Z,?RvW\wxЙ/xw '3"qH<~^{=N|xcO;v: dѭ T$fV\Y8C?QK?n5 vûdq{jēF;W{~jYywrk}Zٽv^?WLqiيi, g4{vA_`!k2n՞Fb՟jkm/B'd-\)vjkOV|?Z x}pWd?AUEZ@h=O #.{_,j}eOcDZ{h怗zvq{7%'}fz.VX/=_tSffى7=xYmV؂ֶv,k,<^ONkk$۵Ν q5T:# u]nnkkD^_p?.0-gSϟs{MtBxwo-a~ewn~3rOqvuײ=';]Zn޿s_ o=rµmeYogyo*~Ufݏxx/rxȑd :ج >6YlMikkO,́:ε?{sμ8r{pQV'ud2Z/?w?cڣϿv/wlڃ̾^Y0uޯlݙ;@֛\Uo7[园]e}Q%w~r~H-_'xE?ӯpk*>#,@[r5^5^'{D}yG}f1R_ fq6xIw( 1\?K%QZoWq׾m}rVw{̺wy09>#,;lѻ,[~}ߵU|ò[8 v;F_ ~ObvkkOzf>}Oi#_8޲lv/zᇷlMbvΏoqfv7GJo'wGçLsPk1 . /*ukkOJ|EeyZ~_;`}:ǵikkO<*'*]Bp.'X6k}L_3a 3 :cxՃ}uל+YY+3hq¾OO??~}ɻ|n7VdLoYC򺡑wmr̗B2 lZQB׮PIEG6\1vlGC2J yZ!ucHx w֯uUw2}+N%mbxƗkkďJh"7ʭ/0=?!5w:^wyV}/O{zAVzv鶃}KyJtgω}vܹ >gyu쳮sgϽꜳGSE?˪CUʫ2 +e,ٖQS5^5~#-Q)"#Wfο -%`ojkO\U ;r?W36 @B[?'Ƿ8]v Ϻ̳?sç'1_ݷgo+,]t-=Xޖ0EIE'uɤ?O=<9X*T{rx7VI5^5~:53-unrOl/:cn3[gbοX z3>x>-*u5_sٵ_y,[.:.\v/+\xQFu)ۈ.I%dwܠ[#8JDw”G_]Y(ܠ6=3TBr8˛6wxx4pͪլWY'}̶֚l{jJ{ÌSÈNg_G# O;)5h bQ%ѪB'[LZZZjʹX.]VTu\5^5^'+^N:Ml}lS5^5~=C?Rk>8>Aa8燨KioB9Wzd4Ѩd iJDֲ*dEZZQᦲP nAlnsz_V;th3?75>4o5^Wպ3JnA4vD 2Py]a?kk?b]5E_熝.%y' 21cúnr H{ф|F<9C?;8[kW,$D5?֏%ՏOk8/\qr9v y%"dTzIͤ=IsJdx+{A"S=)3j/\il1*֪U3Ga kUa c1|y^+u)xuY} _݆Az#7%7&b5nOI\ FX'd-hcP82` c+~  ='[FM +/-42a Bx mKUi< !OFQ``,JEr*F*eF^wsdX*)Mj@$2%"MAD>l {~GNghNVyXnTb<bi/ۯ!S>h'hTJn#Ly(?zr60buVd^ÿkoTx_u;OLR;N(iI'}i(J/97؀NKOYDƢCo6fV+Jn&9#lkt&^z؝YѪ\ygRajzٴ>80sft0l*ӵXULru&^-iy ]{;R.74w1aF;],fB ?cC<\h[O?ĵ|ϒ#i3}ޥ/9L?5gs'xWd4: N>uGQ~5"3ut[%SJ4dVw]% ӓ[qM y zRC<%g <5Y$г=e5*aw|j5N2F7*|aM5^7*Y q;?\)٬u~HJ_2lb89ƓEf%oo(ϋ}"uV cYߐϳ~4 RĜ2?AD,b (eU+fT8cT8/U+4oG 'wH/Ͽ:R}̳dsϴ?Ñm?#>FMs]=FMǘ*=>0_V/9!eeQI5>$^~@4񳀷v]SgweYEY?kkFgKfG_`?{0!$CV9ẑJ,&̋5|Sl )=A 6[!AJ֛nͦ_Җ[m6_v͟ӣp઻M/5{,_Uo_U)iJZ]PҐ2& QzH$m[O+"嵒GJ몬Fm6Uk$,|p[hK|Յwnx s z MG' SRe*?U}5^5~[ʰ_Ed/ϟgZ5hm!os í~CL 0ͫz>N2d@7V`YpN"yed`2?`?^#V=OzѲF_[~_wL$%l_:NF3AbȔ"KPS=cE{F3MoL%?ͬ?c(O:%"3,sJDJrc\s+p4>[VypmŏGzfu;Px_t("0.9Tg90*+%qבFnD >*0Q7ph޳/]UTh`l}5Bذ4u %[/}.eoƇy(_碆8ۍ5~JøN'}̶VϜ}?5^5~{Rsk?/vW\ns/ҠvIzy0$Hc?2<N%_K[?IiUT{n4vwhɪcw[U2TjΜ><,{/##NLu3DmhՇ)[]G lqwm|y;\ڀ9oeJDWyO]zOdns?/ζOQ_N:MlPOxH[Z Yx8Rmw Z_44(+=BΘo 9[?RXUϹFkiĪV?W_{1 m*~ٯF(]3?dp 8˸Ccȱsws|_E2&VXstU=?֍mxrM8 Z_svH%5^ aU~=;G7T+#lҔq}=~Cשi ҟ9ŏsP?kolxb/19/q?,ӎwT<a|bs$ss/;w .?cnrY~s;^1<s^7E謳sD>xtI?Δyyѱ(9QO3hZu2X"jͲY/YV56\ϗڧ^~ﯼecsY^j+|{j'd K>B&#`.\qgPikxAr+V}hG@q`j%R¤ #y]}p;uEkJ'}x]nc$Zf\~uCvmd@~x&Q8 ڙ @[{b/\妐uY\ ]_.}=&Y~i۶~/f_yo/ l_xl޵g{Ńn ]~ų^;Oc1'v|ٳ'EX'RE:սBsX*FW'W?'^tWԅ_:w@dNfmi;}di6?8黊?{G$g~PA1sKH?U_/thWI桽V$K4+7N.st̏0ޟS|xã Wg&jz+ W˽> #ZfЊ- ?T^G}īhP)j.@>7w/WCrI)=_L[n]̳o]vO_qC'zƍ.oy[ozt,ѕ+X~]?3+6«~}=|sq:x"1o'Ū2h}ݒyZ[{ɻ?=uno#HSߘS|w َٵK./ mU̯Ɯ|2zGQ{IZhkVc)wsyE-(?2P|2jT[]q ɑSj(+u=BOUpp\^_xOٯ6|~eDw6s? 2I9m%/1_[\ju7?>WُV qXoC[O>ν㶻V+ivW0/w5-]z)_S>K~p=ZY̮k+W9 yԽ?|9 {e׭+Wb.b]0IyoW2E>AM%^ kGyBX'~eWtfOGV_}i񋎏 w̑.Yԉء*+c50SpTN,;!l'_0EV.~ ;S/Ƈ67?Lxt1^7Gkz5~i?0Z&-m櫓_5^7>]:ε?:FI#T w~٧ڗ/n9m3Ϟl!{ܳ9+}雯⮇wkV/3{z >=+|hK|\{_sN1QQ{?禢*2.okxzw1;p/Oϝ{$֗^|oŞkV'+DȝvY-sy2 gX'f4sNn簗](~N/Πy;l 9)^3d-_1ł?kk{ܥpe.Wr6&N#&8dǎ;͛}Y>§w3| \:o=?~wݷSϸ{Ox;׳zԑ-ēf>͋o~l#vWg+࿫ ԥ*c^yzc}he]) ?rCUuO zC~o2TvP'o:ykxĿχ ^~_c./ xӪ^M+z>ztz=< 'z,vr_Ə /WE0R zT=kkƆUsϴ?,B~=N;my\y՟s}ǟ{{m7zN엶ݦo~pg~ȥga_~;}|ڹ.}ųw?so~:2u] c=)`3T}((Y`]ֻ/9gZmvpƥ{oٻ6xeSXqDνujhe jqQ ߱z]qFlg2KDk%~?{_'Uq.Aܒ%'5Q Ƹ(#+LAEdgL* 3w{UuyOfx[ΝSQp+pGMU[(xփw9L_t3N&իZN.UX G$"\}Ol|s}:Մ~^=Fs|KUYk7w\)uU& +ß.T({'ZLܷWބ 0?vUN|*A{={-z]| !㾒p |;cfn[^f~&Ёޚzݚč_?o{پO)on޺P>U uůO3𥇞|!8#p9>A~zha$:V {PX:Tkc/[tŢKjْK?1 Zt钕˿[p| ?Q2wL3+DPvYsA&/n@TغRsqU'q,CA0$4; L?_Vf<ߪ:#\ F ~D}`5*%N6U+ڵz ;͍a=??xpǟ_~KO p~eW]Ig&Lݩ~\pѕ opKr{rſ>$J ۗ3#;]W\\qZ*UQ&O7W |ҁY]H+}lӳ 6f-`UUmce[nٛs!sGI&h9v>^PMXVns,.ӹoB7k" r^#W-컬 S~sG$gyzraZ m]8j{xrex |[:nfWoH75:x]ڧw+ū0-%ѷ. zxjryn?`+FֿȫߓJ߶LkiڌHCN}9K2:V=_5i(Ɩf$l?@eK sNhrN+0xu0H-JtޒSaN ,jH83zYdlr Tsv%9+ P19Q`AtqmX|1>A cYp=S![ qTO7gϞCr^u]p첷м7nҠMrO.~mS\ƠK& |GPfDgn׸..@X>jg9l#F>S^xz W,s!h,x M^{gy<zSP~lj"ԷX1 %7 Y dZ#x0YܞTۋlJY ,[!A0>~zi>?x+\'<ߨ/_;spa1/P*K1.Қʲ?q$8Œ.﫮B:e?2owݷKuy}ro[Εڷ{w[]cޟ_搋P"Y}ۤQ+B.eWkꪫVUU(,-[j[PWe* E*~u7Tݗ}Pc,Sx@[r~<8/o߼u}`^w.305>TC P,K돔O+!#rl3n{P+k`ex VWZX݂|vj/ Ǝ5$ZpUcq5;ם"UrhЦU3,nNcs\qyU"f?ur RQ>VM@imǁpuL!w)zqs x,g]9!VnQX熴wU^La#\]3ߓ_H'`Ϗ.kFn\-jTOnzmsimՃւxYƽZr}y;^y cJ|G+AI\鵯SuWC.{~:ΕzSyw?ۅaofGry'+`rd(T|0=Pړ/o~플/+ˮ~6Z༼eųUjw$B/h8}h4Ϧ? w tYY[gWVY[x"||/˿قO|E R8hes|uCuern`wY3nUhoq^^v\)^K/~q;Z J`qR 7_3U[K;7*8+zv^gE?ĵ@Dܱ'%_^[$o>)ӿ7_i\i|}lXz>:k}eΝ5ksɬh]T.??2-0IsՓbFҬճ?P1BhB/h}{Arӳ+uYriϚigM}ߴC 0Q'?6oZ;8Zvlx< eCQ { "ՎL ;-S.;?ĎY  7?It@x 7\]6n8A:>' ZR{txg}U/իLz |Y[|\(8Q+;y/+jQbό7XEW^/w/=/w {?ЁOP>Ggs(NW_i/3*n?i cBW44u5erϺss]snl˳cf_죽1r~5rY恵}6 r\_Iؓܟ;r]7r H0;M$ϬnsyЁ?W 2 |YmB3@}[ҥ8T?ڣW/[lܞ ɱNjAтtW_~g >%}w!G=8:z]ԒӓE6 Ѷ_I]u%޹Q~(o\ M? M?IB0{rVyޜ3>{tyn-^ҭ+~g{<{8/ \~ ' I5q\UkkqKj횠yxVg9f.v)Y#n_4:)1]KLKIG&F\+Жݰso_|hƕ)fÚuK dLcZ~5yśoqUJ׸ %ڜvINn'N;%Զ'#b9Iڷ9]VU-xl]r/0 A};>{9vǁ</>>ہ`r;'o}wms7/O|" |F|.)ҶߓsyyՏo0ewOYlǽYW|?1C|"@>?'>N<Ƴ^5^vA0~_ xo-x{HfF^?jg5|'_*g;Յhqdl0^LBiMˁ䑱h[)}ŵ{?ݨ㑷]ѦY K-Ƈhf~fJ=;8n˚o}vAwy7?;GzvuÆes=>ss/6g:mT$|x<5sON{{wvwصݠvOd۹ghsا{t>Tv'w߭svt$nݓy@d.eӸݽc9tdzߛs_vOߏyowtQu !YM kwvAɝHہ]vC䜁؍mt;L?넒==黠yfw“s@ږsx$z/øg#"mvwܖs6#vcLxq/ay̷睋{g;_n{sϠtߜsގu'|<%\rsσ< 9) ^?v'VyOj~x |[:nfWo=3  |c rYu垺ʒA}vS7.?k8C̎s:;=ucW?'?S~[~?,dvtD.JKךz ezFRkH&{~ěK&\4n7ḅ _蓉,-<OvK{F?O*=Pru?로Qr<<~8c٧;okenn(YOGƎrx׳TNw9O)NSȾv|r>/>CxQ-gEDNHW'ܳsݟ0ƜpO߉ 7^w$vݝoxA콤[Wի.y|xՌ9{~`}ğ}zr:jZt>?~y%S^[7}M?e9"ϗ?ř|uzppl+/PrGdm톍,FGb萌)AIG7m[~$7oJ(;7"Жʲw:)fx˫߬鯲([|5#W^&~TQf^/EL\. Ks߿uܐ:~9gߗwփx{kn>Ƽs_=η[vocsCg>}ƃg݁?w=wnG^ln>3vtyg~'vC:)NR~9]n®r#%w=sy?>ooӎu'{s~l]Wyei54[߯8r"үWswJ+є|x |k{RUt9F~VT3矵kZ_]-*/Skb5-55-kk_S:m:H[VU3-?hFޅw3 ',|ŽGW,~3nדW.z._?t7O~Йoz{)Jߒ}ν;$Fܖ}-Ov's;ޑ}__N?Qr?w cl4'\lIA}Ē<3<@1}O<;{NOg68/?_7iKG}v4؆O5H9~!Ͼ[&y=+ sI|?F3>S0YAIٳ C+NJ}L뤈xօ OƊ~WO>bi;ڏ~93zgַZ2E3Z8z\0ml=Κ՜ٸY~_ #"y3|7lܤч3} {d\7bhIْe,\߾.X/x7dw1kZ}[cJo9i{o|99D.w圉AxMup3;-u7ܺ'lCM+bTR]nsC]*,c}]厼sLs:"u9ݗ{fPSH#o'^;ܛ?Ụy$xQil/_,w ?ᇋ(&qOx߫_f =o}+/¼?.jwTV)fZ/  gϤ6uY{~7+$.Sݹ*=Xj'Hs^[hª"˾.Y0ɥMXU Ǘ-~zkeM^>l6OK&oL^'E]niE|gwxkA;?|S&S4Z@٧=Cy;m]ϾOgحs&~HwRA[id.t6GО;c rHvhxG ~0=]];]sMޯJsm%4yq3yV?z={I]6=a5 |+yeKx4*I` 0}f\tzi0:._7?CXm@4UՌbde/V?Nkَ(qT.뗗cүfg^|>?x~nܰzCN2''D(>9IvN!ypCrO9!v-{^<LpdvVO;p}:`ܛyߍs*;/o}㟪4 ::n1HzS//-XxG"E6.7_irG[g0 {ᱽ/Bb}._5ܟ1 >]a֕n&6_ oSO1{6V\(3IuU5Қ_ ?M"_gk]Q?zP^dY^ [q^SU3R؊uG_ItaӞMl_, #o\L|hX(Zaety$Î>5M?*UipӍ?dz7u:2x<T>r7ͽ_1#UkkqKrR!7xoMxg]!ݭxZic ˪+!0vYMuAXr ‚H4,ڊ*t:2 2iW8aS)qYoiv^cLv` ~AT~aa8"1)*e^2W*T:]n#2O>#<{^dڴ5fY?mI'Q;m1WcӮZڤ ~;pwU]K :g}* մ$ѱ[J?e=ǘFUk4:ƿ ]_ _UFfF^?nPx!)4+41v;]c&)eg8T|1|ǣA15~/L_V\RilTM%fꋷVy{J5BLʪU% EK1Bګ1t͸%e3Vu=3R(a6g)@*vSGj}G0#o<0k0 Sud+:kM㳻t9ΪSUzM9J~st Y)޶g&|`V=F4e}k{_]UpY\2ra(3|"(j(mkcN1뇴e?Cޏgp9=9r܎oX_7x}٪zOB4ۣ :{-S^}M?e9"ϗ?@%4i>'FaU}Zɧv#`@* h!^>Ì؛;Dn?`;ЃVz2,4y۽ij<,:⬦eKǕrRxMEM&~}+3 mVќFTRgaBj_Z,; #RS7Z0,|Je(cLJw u5OS}#MTwJ+є|x kûsv=?kК0 a\'x$(^R]n.+5ÖgOS ^r<9?P7dau-'4:iڤ/i(o[>#l=W&w)?o@V!djŒ_9mX h` 6",wu[j?{LY-xj.['Yq*?AOΦW?BkeEGtei(3ԆYIezj5Jo/_8>]ucF9N>y.=3L,?Û{Vgхl )0Vƺzr«dxG  tw.<euoxVVM) ^}u$#? |}\.ǭS3&0|+noCηy'lSϼGNUA~"EEM]2wp}M~r<!#d|OP}CLdrd>X6C_iYt ?S?z. 7/>ϙ_wNG-3yuֵ|xwx}^oxO^mRݹ'7xoτkkIK@<'4fnLH(?yI EDŽ`Qa ,ȘH)1x9~ᐇU5n.k̥0U-Ҹm<_;_jsGZ6|eG^~ӴI=^ck_{yubBtթA_4!7fix9kzz&GWS຀n|zGc*xai  27V__ǛWSc ?11Rg ̮W[6aVC\s$ۓ//-7\HrV/wxWwq콸l"r E[GHϖDJ%#Q%ED]YR4[#9(Dzzr2_;Swdd,??z?L%]s+"mJNN>5ڤm76oEM e2Óc؏ I}Ln0?|o_}uG 6nW}w掿G" M_MxL|_X8<OR92|Kų]Q?zP^dY7L=p_b^HN{g>~Pa7)Ӟ~-o7zgQtxĆ}m: 1Z㺃/l\4,.g?zd/'r%&T< pa߉HՏX~m<0ŸTgPG ͣڝC׮矊BۯOM^э9;_ C%_{Wqv#ͻQ4n CAF4~ u{q{pU[vTcg|<oO ?iΞqj= ܁ + .tf2`<Ϫx^U37ʭx?P3WK&*ۧL^Л73, 7n9q4OC;ߋM*3z)?8=|߀^ᑨ|?9 ڛ%|Oͅ&I^˖,/]hҥ+,_^y_;16Y.]\e\l (nlKmƓY,2_E.]YC"ffŁTՐaer=] ?n'Vڼ>D&|8hx&8`xa|;>jr9?wY@i#8ƍ}>e=<0-g4gq`<}|"'4SRfrb^bOղ*VM 2o%EL(k&?wemϔ*z;f7lO## HvJLXkM;\@p^8KFGgv?9Mrk: \um^Z8 փr^֊0x; qo8%)vcwPh?7>omU.: gf10nM{ǵ$E*r zpTRY;μ 1g=kf,);܆_sO?\}Õ2Wuy湅\yf!˸rC\oUx'VyOUE ]/>razƁZTdAP)r89 ?}*Ϥoxu)(GSy)/>tKU9zYUSm{l\z=<뵉 4O39 cz\)޶gmۃWx 0[As4!9qy4ڏfGG˵^\&p_zJt~s@;u]z:H K6-2tU&TW~K-aWp r-isa>)[uU,<\oS`zEyRiKf|$1pTi3;O7KyV<͡V 1OXƆ*?yy;n-?H *1/؞NxLK,my~nFv<9ђS^ 96MJj xϕѬzCVfid`fLMmƼe/SH^ *Y)S?:嬋/z."NUUcz׬]SUU]ln/Y߫{oA_/+ċfD'.oWT4o'r o7x1s6lMJmer!zj]>ayHd!6ΰa<5 "&}gn;~5e]PWe? e^B X;_W (/sp!`=oS+{1Un'gb8xI),Bz|Ǔ7[>CfTa E#[v]rPb3 f^̎≑+V> TBRiZ?RH^ݨʩʶJZ+*o~[1/bߟKg2:1?| CƧHix#}>uJbstC؉goxoPhַuc KDx;at_̔$1mtϺmR齡%'Z=8Zv>'bc_I UAFpeBhRqSr;Re~m15ވ Ҷɪe|4'y~х3Tx39 &>3⽅<ǓWܺ Ws_@'k'spYr)6.!g悧o<]oߢڤ?ܹ'> | ~4%8Z@jҨ'9.{gU넢[N,EBC56WWޕjb>?#nsǵ$'_ݼoL7lk7ʚRv9:esOaMWU3īY[qcېC+k+j/_ZقO|ud_6oRgZގ⍛`WT Ӓ*/k&Xjʳ>ŅښesGfgOȥ9禲4OظN>ov$^Is0Vl<=e-eb[7m9x\%>3'hOWcWWܮIt׳:,"W%VZxioBk&n| pߐsƯG?{^/og+~x4K%I`YZ |rlWԦ^|)ԫW/qЌ~L[q^ySv?g?lŒ8W?j?.@I) UX*o~8/-_nOs:Ln.ºu_V]}+vÛ6,z`Oo~{Dzyt7>:~;G}Hf;W} xHߵتݝxw2v w뿹?~Ҥy^?}TۤQg8>GOp}P𿃲xo=xG`_t3N&xr$RP~P/>֩~ThZ7몾{sZ7ĺq۴i{I`l oSCМ:/ol .GÝ®]IzA<WR/kRoM^[ޙZ+- sYu%]5yf..KT /̎-A~иT.WM?ۊ}E_s`U۰G!c#4Qr_Іk=<ח.Qb鹎??%)R]`(3ijqy5{Mi:tuX+fT1 2 =+Vhk˙ !w@Kqm9d0,^K[Vx V~ ӌf;H32L1جedt]_ /Uzمs ~))zxG+v5sD˓ECcj%oj~dX-,}UՍ*7';$Jh&ҺO Op{ЙԭuscORmx+u m8=%6ӓ|SշF\ n 3o\`/G1a陒q C6?GR?Ef!%5ux0 5W9hO/?O"Cyj#^E>{3qn<Y`OvHy/z^(bk$qO89~؃}1Noˮ6sIW?n~;tEYti4ۣ W1/ߺCor)k.μ䫫 ſR ْ`vR}#!wM*~>7jB@ІU |pXO%Y`v[=ij|Jۓ~v|qC]ڿgx '\_ߝҊp4a)/>tKU9zYUSm{̜w-x8zm_Z8+ X8摗F=z"%`&uO!(GdjGqOک{qS\/"/7+ӟmS.[ܛCl@0 ucَ@jX=yHTü]sv^T{c*7t1IϏgϺ n=pO4q?FroSO9=_C<ތ7?{h|yǤQ}㗸Lg>=ǒrV̿ jKůvg.@[k90ZxN8G>~oY[Lϧ\;+/B/ɯDz|< 9[@0}>HNƾ=ϖDKcEK"qtz>7[vˆ~:OPw;D>wǓ؟X~ZCkVuy̠a 9LcU`'no>Uk<,zޱOOh?uk9jb^ӧw`(Ods}-?Ϸ8<ֳ <o%[ͳKz~~^뚇^Tẓǿ5C5Cs[^YWB̧i+_ :Tm92sO/B/O?<~oGf<ؓ~:?zMUSȿ}Ƌ'wxxnd56T&#K2yKם0f1Sخ3g\؁2=go<og'塧"tB(B)I"8|&x>p{?Ws@a/çU=/?|}BQwY Kzɐ=pHVlaH B/B\{?|p? }<~Թ=Q<8Y=j)RH ѻiػo?sͤ~4-;G޾-G͡_ؿlMI BH~uCzՓK) }oѻQ/w\ɤĐ[lܞ 鱏[݌8/=]Ӫ~1w<,?=:c(IH=8!|K: G:6mc^_z x/x\9ۮ^ӆU<ޞY3?oօ۶1o *Nu;^Y,sÌ;;bQgh(G|COx< |?-"|9Q/#>uXmɩw?*^'P#e?wF^= cJ'\jJ<St4?_!&A[xh?;Y;7aO?ҁf5^vgg<)R?s+v<wp .z둫~eNS G^z Cf.M?אY.h-ck??*,iQ{OA|vO+n} /W?\=;z?N5_KdA̧ __?iioa]Wcg3b$:6}iF2%(LX8^ ##0#?D~c.s@3o9y.+gJVwO۽%ҭ5CW"t ;hTŽ:7c0 9nWwsofI) w sc0r@n5Bb~>@ϻR=`СߊU5%/7Nv93>B ?;~:pw] wL*':#׿u$cf?th)w_c2.=xMo6W?Bp*=#wj,A̱ xt:?j[z= G/[~| ?*Mu!s~zzR*n1-iu:ۚ>o|s9SkM4G1ЋbQ0Әinbx<#/Dg!G@GwnBg%{n'{=TQr?^XN #t\vu{_1"LC@Rti^@{$!G>!6U+ X"3bO|}>G0O8Mڳ96~-g-~#D)M̏hlto*^R?"Yvm@~z_C.@=?o;{1)7-?zsKB?m;Y}CNCzxWwR?k&d`8mx1M^N*defgs-=#q-C52{Pf'>^8*y\$YRd'g{&/2[`k`0lpO=?BQ)Xy;*[8f=y+_^?Ot˥b\֔?s`"0(C?\=)5 1:wO ;X5qb >w,[.mZl,7K KeN"$ X7,.|=e{OD#tϪ ^Oe23)h, \|&[z_A]?Ox=WsI=V</B/?-?y1Z@0}>|9=oX$X'1v0n):zw0w3^SJQŝu}/ E} v9~{EAd5Zhd >|w{٪J 9x,7<_7bU"1>rgI <~՚Ox\iG?1BVur[?ZO3)1B/B;֓,irI+[;ϟsRbѬ xq%XJI)yq^|OiãﶼK1$5({`;щG;[* <JAM7 ^2,@i)ez~=sf9o- `_;9 9 6O%5  S=N/ yusF/B/O?<~ϟyq3~n}$-ھ|ίx"ʬl=3z/r.O*O,ʤg$~7⯖f<1iJj?_[䯞g,UͨeN=.>uApf1~βz0b~_+Wv??)B/B^g:<,:~39~Nn/}~<9ogVRJ1bzλgd$];J( ǃuxGBY?֏}h @]wxZs'%gF%zv*jù|4RPP Q"T8+Vjb [pn>((]iN_-3Bs'zپC3?qe8S 22;Sp;Ws<\q23?;'?/S̿ ==#4%ݻm.?dRbHA-6nC*nj׵^ܰqݚ7nڀ_ڴaͺ~ƗZ7&uZ3358GSs3nCod"uDSٽ>scym^4Xad\zkO!B}[ooƀܿ!oB/B߫}aTn?^Uk>;!9(uF`>0$R^g }B_g.8+g?;t9s2q17E8١~%>7B7tV^̻s p$??Tً{BJ&',o _V.79q==2o{UlI#p/-> PWs 7*O$Q~#~k\>p\߄^腾WJ,7ggC{?y2Jzn#}Msf?r~f=F;'G1ȑ?^81=|m񇯚VԇS5Sn-~q^w*PPxo*YՆ1bĈG=p/,,|q5z4 G2?7]!럝,{p~z@W? g ^1sUSd$Δ|s᷃ApͧПI=| }P2?.zޣG*8=Y^mji^iY;Liw.xI_m'6o~c/#ז.onrښ+kk+WTXK\a}!k8;5_9^<kP3/{g}4~ۺTU f̬-ohf([58-w/J\^IxWhϞXR!͕On%?z>8+&ּ'WV̧ jU/#s?wsYpoX}"%#Z= ӿsθ;=mmͤ57,l-kWXzꎖIKf]ps_),)y_mWƚ/-? \yD"Í,dvz.܎&?Ƶ&%oO^1}؈G1bĘǟ1c µ^1r8^h5Y0Z Ә$O P 8%Ixʁ7+  07giV;x3 <<ߧ^3TӢ2tkb>^^ozkÎ?>"O޾7W߫^IcWn+= ޱyޚݧoB^jyӐ4u|niӖ'Xl5Xh޺=T| Sr7-8o] {iߖoEGB{dh_a-[jjkߪ7_iWWPkVLOcpw& {O'[E IrZ>+s=F6E8)xpg.s#JRBEg{:FЁw{'F:Vd^3H4$)rKxէ~7-[[5e頂(ɹu#g^?=9])~4Q_3|̹꧘s 1B/BNSb[^7t5g|h/pQU^~)/P'XTmAS2mYcë-d?!1eHT/ʉKf[^Wtyþ(~xu~6_n//4P,iN3f̚ko lذj[b5/^*>b޷@=KF}>hޥw<U?8#蝝P;u75;cқVjT B[4oEh{*gtY|4|YG[ٚUW.[۴n=WO ;X`bw{S=4'䳈=1_=:oi]9ߗQ!9f&pTz/[5#b>ss5'S? ?-?y1Z@0}>o~>Z:l⨥fOj&7dȵӐcskNJ6!/Y&݆UuWxqKbUU@f• <>7}[V}^G@Ꮥsix2OZ̟Oo 摜VꓯnL`磅Vɹc>Csx| }@; C\LJ̿ *%l~.i\=7?>>26RV4gw֡)x P+u.fWR{4i72TV;GM(n]\bXmKV/_2oOBN>s^Ow{S2U`=#jg{cIu# u&yH 8_a)pU^yz#՝# ׻Ϡwn@k1B裏uR q<6h`9'A01B/B+b9?ߌ{ھq3~Hixd廕dr)ΘvDMҕ==7HIV 2ҩw #ԯDlyc݂k㫪45$ϯM^P|ÏBxEwm,ozSՔHzIw.ѳ#@: ڡr5dYSݲ9-u ZJ)L^Sr[#G?~og*zx=^ɻ==cySg,;jHɕŋX$ Y;X'~|6/]ό7*%zvgù|4RPP IZV̿ N}lQ,'bWDųW/߫$ 5Uy.O]%e| ue*֍TЛ=:O,Yܰy^sCUc-n^>&A*WTq) S0k9! yIg;#>ͨ+ g>~3’uG7!u@ \ 1{g\qx]?czsx1Szc q-筘z-zkf[w{7gLO )({YXXه_ *=C@Brv{y?'3+?}P'_IDN5wgU->2.-i ˚?ζ- Z&rsx!B3/Olm㖷jT / 7QӸuzŚG1-׀^ K?SFKqlֺsh^{Xa#%:8Y]j1H5h=f'OY=O?zOR_̧pU)W|z=zP\׫]73r TɃƯ=jjxb5 U#)#&C>9ugW0LJ[m쬪ZB-tg֥y-u'FXRWK3_{xnۻǯhtBSzK&R+1"[e~ғ$_vD1[|~!|9b=/vYa9Ν Ϳ$gP|ra| _Ws5MVyOL^Y1B/B߫VYG0!: y+G <\yc{:"Jҏ驖LG}~Y~Ql~/4m0d뼮EM [:G '{<8wv ŵ&DMC7ՄKx_RcxƗ_g˻65GK"cƌ@`0JIjރC6X?C Q};M -d:{`U8'ꇜh+9ķʁO@O-AПq}.WRn='|?{ su@| =S׊'|4 qEE,zhxj_?0zyۚ#㘚ORT>Ӥ&|=1v[ xnx^@Y<\7gu~/B!:=kI SaO?ҁ8<'?'7W5oU&^7x4rH'g0eٮd+`>ޞS=nC?-S( KxI,w )wmu*yXtp71?BSO\_NCkK,Oz6OZ[kaT3t̒ʻ>{ˠH:괙ӟ1|FEgU̬ Ϛ5r󿝻+Ö=d Lo{gO\__ bxT"19?X?b RAdOGB ΅:nX$΍oF C$duc{% `75\<ކaԣpu YOyc7ׄom}zޕOCJp"lXW1B/B>:PƊ~'ڣ'Wn_)p}g>ۛ)N2RHH;@3*j1 sHκ>p$_3^к]ttk?_ Ϗ'6#=i]C.eѷ[`K[G44Ҵ_|e d%2>u7O Wț>G ?pX O*p9}pF]w糧/HO:_- 1BOJu=cǜV?"_^{l [kZ]ζ,<\ܼ'.yǒI?[Wj*/ӵ6RFF=H?HߩMAR3hy wz yX`֥ >w/~0rA863/P^nep{zL^U-:!96$RO G k'h,z[.yÀ&8fdyiyAg $9MbuȪ#06o]k=wG\\~ۭ0&풮PWދO?ؠ[ d#,Eh'frjy)؋Iioqi3S'_%S.^3K5c:=R7:&Od4 -疗rM.ٶt5|/wAț_oċ)_nCFvR!;/3;[N*ݜ"2+y\/IRQoսؾej^*K~C?۽fOW9~y#?zqk1 гB^~ _|fkrc R-~#>zs\cL?pZ*wV̿ j^IhkM]3&8P !?j#JoUL R42)Zo{QC2Ffy`x 𙳊JpCoT~-8߿'bɳAK&.'[j'Qq=3bSNI*)}kR:+`>ΓW,odtFh1Ȑ-,ϕ͎NڌvjV@+ROkCH\e zg՜8t?'3D̿ {=q, %czI` 0}\<倫?; @G$oo_ymEwmWZw1]>}:^%j^׌ 4dr pccBz.1/&,sA"<ngUkrn ?_Z̧<.q-G?PRK;Τ R/[zv4Q?'oq<WwcfN{hJ9e_d%/^9Ғ .Ջ,[/~_W/nuu%3TW^1m؊OW>+ }=k{eҗ-?+bs^Owx`#7羂 F B;ڍ. olX8j=>on-_@$^b?z"S=N/ ?~ z}z9?ߌx3鴞Qb).+?|䌩y~T;|]Xew--hVlx<1v\iX_GƖĞGǖ{hyjB/ wN+B}܈/|g?)+*Ic2O4cGD-5KrR7ʪZ8}y[8ֻBgqr=#;@^\n%)۽i5{tr4]p{G?z0b~_PU:gsĻ ;gu;ܘD̏s'xQ鄢ҧ-zrYIc N3tԲNLKF,u<%25f~{֍;s\{ Q,gwvܼzʐ=^#C'!*.vZgДKLk^'>ux߾++['$_> #@/L#ۚ5C<9y??4) Ǩ X9)b~ޡg6?zG#$FG{n)87x2#_sE / /E߽[}߹~7u߾}uOQ'.A?'߫?v3kooE7x(q~1Пa-ߤx1Szc OQ筘z-zzF sn<RP`s<=x&{?N$FXqx9Gz̏?y_\}+'175}s /?45~?zMgoշo ^m[7M^{1vjm8X0sG5d<7wvŢhQ8b #/'yݱwG"?=_ۗC ;;='7S(7yW?QMΥ?ze;7wy]}ʅ ӏ="|_BsƳ5i n# rLo(,}6'OO^VǮ' wU;7x>(&B/JO0"ˍrYO<.mÏ\ +q%..ЇW辌Ug)G_vcG=9vK뮮wxgֽl?(UKWt7劎-YrL䀘/5)W3&?.;#ie3uJ)j'_7򳹽~>$| }P2?.zޣGjZM9s<-?^6w̴/P}{[?'x1^vXһci~s'sgx @ n{R?\vٷX\{V\?9_sÀin%% U}ysG+*Z}CK{R@l'v-,;1kl6:f|5ПA=3)7_̧ } ߪ5"Ḑ jU/#s?wsYpoDx<^O@*5j7cx/cd=)17"xlm\k7M(s?fC3 ~>B}Yڧ?/~.6\0Rza# oybBDOQ>~z ´/vY$^ T`՟ɳ T; gDo`:b>{>)t$gu#b>^^|:ozkÎ?>"gޟ9D1+O<^G`DrG>7alؓOtu(*; Дc]te+|(n؇2exii\`_~M1V p"ROwO|?Sz.&S8|_NCkK,Oz6OZ[ka=l͌:5svFVn/s@~搇Y߹]v +ڻ3G^/ hˇp.|?f0޾]=< g=c$w}\ֿbx 4AdBg8i5?zM̏]p4:tP-X|/kJ?/ [Ezg-F_䔪\uÀkl܌wS/kJ+9:LJ_}Pf!7I.?u8Y익c=IMB.5;A0Qe|,ϟෙی?# ! "-{٢Ɂc7^?z+jU| ?*Mu%.G?.Y'_^{V96ϼ޿='Nh72;@x-h=/5F7h0&f?f"lO8m=2M׽R_{*C'AJ@𲺟<lqxࠛ$4﷜[1B/Bi{~ܺ_M9\֔?s`yNjnGJ}X&w{3siƓg-</cԠkظXoBtC@ov诡 tJ{o0??c3﫣FUu89z?o-(Yn`vW ~5PׄcѳZ3~1B=칚ݹ'瘘z=lϳ'9/{sG6IVb\E+Ol<]p.rDQlH$z<<݂jni[zNysTea*=_0;n7Nz}-s\*1¿O濤6 F,>IV5ac+ݕr?%/{>csx| }@; C\TҎ3)1B/Bˮ`}e~.i\=7?W]rу D62Vh?A|)j!`@4[#KC8so%wddGKEGkvmTR'2rEǏ>w^C}6tgC?2G~ӥzy\/=1]y~%CjcT0x:0mwxw! MԜ^_kVcsC^+]̧i+_ :璕czާW\+C<~3ۏNU׬NH=Kx1] x#@p [O_5sk昇|* rO(@ycj#xG?d.n?=1~!'|ϋzB[* ~3#I̧ ;gu;ܘx9=c3>,񒕝/mzA`Ǭqsߛy/+,]ʅV/n/.vs`ު/]Ӟx!$%QFp~{0?Xfij{'`II<G}ѿfO{nd8MzpH'f~S筘zUs߻X'ON72[/~3&O}8{7nϼ21]>(qXS3 MNeo/{e;coҧoώ?y8=~͏^9 BIzՓ? q$_^{6y2)?1 R&nǮ{\/v^9,='e[p"ꆞ |YǔHߊ5WuW+/!W^yΕtECcYafvybLtw7si磷Ds >p|24ۺ}}p4 ~z^fvjm8X0sG5d<7wvŢhQ8<[PHKiV#8 [;s @) z۹k</S=PbfTƟ@Z!bʍӧ_]9WV"׊WN}+f]Y5顫̥J(wA  xxnϿoImWh}aNi }^}(a"oB/B߫47[Qn?; =<ڃɓҏPq>zA; >8O|V YFrF&ܷHF(#uWWU2y͚n= hcaz5~<YuW  xҸl3+)p̧ $~1B?ṪK~kb^腾葚VS*vVoo T㽏&bY;P |qw'4e/zڤ*udi7JN8UЕWV1ϜJp,W&ߊt#`p4_'d+iWp\wVMiپ!`5ai o.7R>B1u()A)]4[=U^腾Wzfy ,{8=p-p%f!wv ŵ&ƷhQCWo>eBtHA %PA%;H[=2bF+:W߯nq .宫ZnX&NP|H&D3ht7V7{u']$ni7]k ǭyO^H{NB?~:X51B/B/~C7=Ե{aG \=6/OR\\ 6|r ր,5k<V"me raO?ҁݤjF $O m+R0mFd,ԥ*5]ih:nRfb>/UWNX$/t~p駨 _S(lE`fF9N;Dz0/7yEzX|ץq[ /OOxw1?BSO@\_NCkK,;s| 8\[W~lv+nY`R#B? q'*ZFd={ֶsvzHe4QwpJ\ieabU6-od2bJr{CϰZq͟z v^j 89|j>y`=JѡCJVfD^{ =V?.O>n-!Ώå1 %W̯2[9[_Psr=wAzbg9m@Ք!USoϦOuۦUlůMwJyE{EM}<2e' .'[ kHBʢ]sgY_VdՌ[y*V7vK= 'Bo囐s"]ُO'U|Ξc = }o ?olk3ͫ/8i*&7rj3o;p3~U~@́3\;]_9s`lHϺa\|sC7Òs5꟯ oF#D gqf%{gx%|mK *uk5_ju¯d;[wtfKpއ/Y^k80=w5Nq^/i_ !m~`g}B#W\-ro-M;%]ۡJAȆ=1Ϣ]Om;u-?s6Sr8g>'$~^^RP9 *y{d%JT4q(1а='gГ{LP0ѸfjY }h̞#44zr=S>W}rnGNd_]/'7/ɋ^Bv^fvyi?o1ntr?Jp ] o=/^CWlyZ[^k3yׅ󗓺 v g[=ǛUU ̜tW $:gI%MJ)r>+vje 'EOs[TNȳeu?WyA7?r7{=o ɟpTqm); 翃{jDAQ/LrjB$mOC{tf(kz -om߻OpE}dy-Ico'ui7qr䘽WO{֕׌'%xuR?Z6ff\}` ]__4-[1Խs):ߠSoZ]'D+{_ة_xh%]dqV*v7jۋ˸@@i8 Ǯ*8\] ?OVW%' q>SQ̿ g\Y@Jhas3!ʩŽs/$zvU+IR[nӆ5^:j|oxC ~t1lljʮO}bB?"xr ȟOhj3m#4T5uװANZ6M j}C8d8s 轝ᯰjqV;cPp3Y4.ެW ywH3)<.q-G?PRK;Τ R^_MrI+[osY}^rrgT!rZZ.Tф]{U}Cw;(w66Zկ҃n)åZ2W Z՝u|1T#Zq Ŷ}杓= /YϿ9E]-o*~ޭJ}@hgn)z殱yv v՟'2j>#HK B{bC'o:Y&{/gTϽx):)FSW84t0~ z}z9?ߌ{8DٌWdiiZ}AA'!o6m<|ԈGUΪ9':bjŴ˯i%K'~ʁ/Tt_cn?1?\ҿu>qg3>:PPg_ }_輳BtV謾}DU#;>:eY+Y~׏Ǜ9=gs,|zՓK: UWz=zW)8+|ܽ3O&'b\O.q{ @hC%:OJϙաR)۶9q˛[Xi-57YuC~d^Ţ7C^:EU;xsfTO}.|p4 ~z^wn?^Uk>;!9(uF`q4qKG!_T_kҩsghvM}WJRޱo-cV?0og]p7ǖHnmGv|A7zr1{IM?GSʪS)c0aʮ{ثIkkWe7r}7|4v=+ɬv(V4}e9Y;M= ;) $1@ M Rd?}P,=-8 |?>eg՞FBԧe{^ه_OM^{!z3W̍rYO|{v-,rʄVNnDhC"CYKx#0r۟s?D:u*ս}<549l̯)ŗmk ╃/rShiMdlI=o3T03߇:%7DG9YP>܄f^ZGU3>xo~!{aO';v|֞m͝mpX2`]E9%.,wW\z|M=_?^=~&ޏ/St{^ #5m__)WofZ-S_{A+Jj^`Hkܮ]=J4h͝ v\<`o\k_6"v۞Ǟbgn?4aŧ)T}s?q߇i+1c?:G;Y>*~M[uV-_U}t|Jwɟx\YK C,Y8g8:(@{޹^ _?^=!O/OE"]4UWʊz^+:=7 =Y@{9rɢ:JS~>MJj̕/x|OO%WkjO~>l+Űx $0Qtt]/gYȬgikK@swݺYy ǔQuc]ug{%otN,yY ߇B)I ]qY yn~Oa@_SOMA|-_YOnjznsi{Z_ ǫyy]g'PLN5-:!CY&S^y矺VܞO?#y ihm%gOzvOZ[kaau?m(2#$ءI|">*{wW]{YT+ DA,B/IfR!zXANLf&t$ޝL&]fޝswO?C?{)@dttWG@V+'6.a%a!qa^0!,]u^&ӂ? ~ 7l܆kn)yL|n/_BƎ8˓j@0J)fB\ ĵjt+ap{Soؿ)GLJYFcTTUhbQT}wg{W_/Xmw3Sv<:/zݗ^LCvU"ݗ*2#g组'63A' NT?ݲ䧊_~\߹/|󌛷> 7p- 缍" Y=e; c>#r= 3G}eklNY}+Wѕ9 <Q?c5ѿOLkz%E?l_DuB&iK? X. m%~_t Ωs 7#i׿ٲ`ɗz_̜KL?_{i7ceFꮻ+81g+F^F&xe\2lPKv xUD!b[tyx?WEO.%=~ݯY X ?x) rcR<1(+jv`Ԥצ'[@ 'K.;?)q|a Z;KfMgd?<O~HT4Ϝw53>1_G]?fuYI=<(^83s~عY/o`Sb𯾓 5 …^MvsMr؏J'FZot5r=Ws ?4!Ora#aw NjBER{ l͂ |CWԆco!0P権ɓMt#_vAa2۬%BGq1y|XfR͗Loսku.Z:kM[FlE[;DopիX_zj|B<e+R~8:^Nj9i$V՘k)W_Pwq6StWx(y~^_u5Zz7&Пh4;5ݩI3S&=#g/)9{svO^Sd'+#gO]f«bRNNl0}+}f gHO?kȩ_x<.h"~Є2;A8*8g{S~A 9~}mT ,sUu_O&C z~//ԏ`xƗOG"kI__xla\%?'P~u^U ZWgm~ iL90vj)&ڿOMZ{J{ϵ { |Ò#i;j*G`$ڑI )IiƞP@Fc=Rî{*\PNW~ }]Οip\9nYΖZq?rIU^/25Lֿ:r<:!$(ٛ/.iOCG__{xCV|T!*'N'*x?:^ r[g<-hq)WĎMI|gZRԯa5̨p9+ܩrh,s!8D_ʱc]Uc2SW Lg&7[nTO K/xk/ ץz=kiu -VG,CB>œ ~Q`>%/^psf15ͣzBԛ:!}?pkkuJq_<8& ݿ>x/ʧqVV:k@S?o;Fc6#odʜ܌sҞJW/}Lh&)^z`BfeWY}Vn;jn$z>&io_ZlEx\>\\B wd"#_ѳ~r xka5ךF) ,Wx)ҋ6Jx?`3x&`Hq)ed'gR0LkƔdJq:$os BY֤=ii{ ݽ,?7kyE݅rgͷ6m#rY>Q4^_9˓rnD[]^Tf3D9.Jn6]59lw9xו@۱ߜ~jԪmm5Ga8 T?.?Mx"Y؆<Ҫ2?rrmV>5[]}jҾ!0!cթ钌J^YCEIf:Vz6[5gҬi/9tvzɹH>p66'ݼ,|eE?0lDlD?y$@qpwuG6e`jUTkٸ%24~qxK5u~>U0Mt))).jR"M3OsңW4)F\Q*8Wc5B?)s Dgm*6]r}+昫otoiGa^Y%'[lg9|y=2v0{G?M9`/w~>lˮK>h5" 8f>C[ެ|- w3+٥?)&[WpY1ngAwI|8C+*ךH?S>OEp:} y Y.Hh+/~n>'S-\ř8TT*Z`OZդϯ:+zVWmѦDuM/U}hGFnRց_F;;!YǼS>)W:ymj6Z0s M1?#W?~)*U-r56/L=ZCٚ}ZGiZx#jϚN* |l3?پ>,uo4%J 9xi\ۃyI]:qa041~[p#?I'=廥 YH=;[!4y3汗_'ȅ54)20#GK~OIH/6x<X]@h]YݯOs6x83)nK7qPo ]w6ПGݯu5yYZZo)#(,rݭTb[ l`[F=%iSG HšgH U!6 ލ޲Ο3? =β:^vٛr1y$Ok$yN5M%a #:n̘~j+krɰ9rw(Y82IV/Տdeޱ'ˢA Oe_z/uxq\GWg[D&.yp7LɍoPB:^xeWX xVG?dҌա+T%?Yn< ׂgB|+B\8S^ObG_R,Px śvP]{C"S" "Vx|P cG?j : OZ/>H#ۧ\dϳ^:!Ϙc ;¼?֚v9#3S#fʜFzj 89q_J5⫢ߩZܳ,WaUF0Gtw~k+k%fd 'PCQ[:^?>%ᙍqQcH r2ූ8r5K0s8|AJxǯCGW*;fKiKujƣBEuL|gif^4-Y..!a,_9Z:!WӪi-Cx:zA5˨2_H2(Vn|! Ł:kGq6'`C2v>tQNuno=dj^R׸~Ԯ ?ƄhӉVg:R^vy2м=h'{#G?x[#hB5,~k|t<>? U_ v+5jv!8<_jj)4m+0Y̜-UͶB8+-a<|j!G\u~d\]U'uVTjl- &Em ?VPm!eFBWVw3N\'%i!׺6}z ?4-5n8xf | 𕻝|LyFW;WB{#Fi62:no<;m4O+{B(V]wl-8d|kj5qE;wxuՋ<2~L|b!\\_*^U te('yՖJ)2^30uSf!lϫ~_xàjO|%!9 0MK4_iPi3ŔՆ)>'lȍK\-/: O1CD$J'1bJ +Va| Cۭu(^c߃_: nzNր=>ÆWUsj;Ux?^%4>ORQQ C{nPٞ>W|{PV3=z#1Ӆsn,(I;ր 5k,-]cGnLj -{mn%^={]&Nh-|g%K~?"n6yƹ6X?U~ꛔsUu4 o4%-:޹B+Mr\}96#[ '%E{ 6$Wp-`N.s:=9#m ,8]Sg繅ģ?,IYza?o3O]2R!/s_f -\ e' l n4^8-q-'O?g'rL8~t??q bx֏ cB͚ ; S'C#ㄓ0EKp ~u̿LtWA(|?1"FøQ}ihW>_/)9֯B?.6FޕrhO3ݍFjIk+E葵VF@R`[i+` 'XylI2KLZAXq.z|]²sk/ ^l>L2Wv9׋uZh80.9'=eY<|}J|?K?Oz-b-q\lj@}s^XakviBrt|uY SF=L"[/2j;oPRr0v]v4bCZb\^TlU+aK\8?7g,9sz!O8t s*sլ[ZJGccG?rk8(j@?FϷ I. S\| 8vȃR]_]'ŷhMjU"~"yj:^xe矯T+ker<]["7a c_v.aHBC"G 2],Eb 3hc.a`[B*TO6&g.9ǹW0:-p iG~xI_dXeR>QE'1/>/f=ӕx &b%2T\>pI;2iY_%#?qN!a뇿6kԨJj'2@`^{))NxZp@$?( FI?'䶿~q/_ \{“.?p=L,tPWǹV#G2Ϟz0[j-?#/t$ qǏb_5ѵBqd~xԉ~?㔸Bn4{w-3=#ܼ7+!?3|7GB6jIHR_g ":^#E^Ny_O6G?83g#y(yR~_y<s_ ?' nloyߛs\ GNe NN7Aq{1gXwYNs>`<$xpEMi .ڧ/sXu×qqXl< 搩׏B8kA⧣Q΅)P Geq9[wOu{/q ?p??t!#: O!iHEg$<`fRPssMtK#Giq٨w xqD,-Mm3D>H1O?r1Ogty[u@ow.!W+K3Gt:jy~T?0Һe:1mW'\b6䯇.r: YR8 FV c\a-scN*=(TtbnzyϟSY͛S{^ <=^vvY W:9> րĖ8}d񵴦%PL^>Jg׃ wr$O]B  كK?tעO~;199J:{(ǟ)+P#/p @V䣇!S0x#"ۿV7ȫ`Ub& 5s{`q.Gzk-DgFsv*|񹣝\I땑q:ϫt\)" 7J\HHv~fga:^x(y~^_9AtUPT%.h0zl?_#~V8_k`.Q ݗ/ ~w <7gv Wd$~Q nMgUxgyKsƸr.ۙM }4O p+.GƭTϜ;(w^wiJg^ճe\& [_x/ l,)63uN_s<)t䕔~vzo],Ev ezYd~ӱM?wn]Q_{ұ P#GRϟ1Ԥ?AhnϖO-+vl?ujN ɻ+R+7qI{_N[97ˍqMnEpK?t wZW.Ÿ+ϫǮLl:^x U ?WGZ`6Ljcv;+ 1+")>a(_J0s)zOxA~$HL<۟Np|MlLwSm5?m-Q?K={_glt/Q+SmoͱoU~JjԮ9XYu /{K}U/!:sf3;f9sf)gkL!륔95޹V ݁8c~; H@NUK5Fw9)+hܢf_x0BޫJ{|EObdP%5Z[n&-1jjZvT[nwo<_Zk`ĽBƕA=$ݰ.T7&\H íECӾN2uMI<>"'u:5YE.so:'^Lq 2f*|)?-. KZ?_wеf07M3<!'K~dCKp3Mf!k5i&z=tuoͿObQ>S&>Gytgڈ/]er 'Oe>wGJyA=%㌕&ŕ":Z!﷔}(jYӲ=/=~_dhUM݇[־zj0K~N?x[#VWZ}l[0=mu|Gk{[%\gLl?}i糑_rKX9wf윙1m13 YO9kȴW. ^W~;)`<պL_HѺ||@FN*M.Vݓ쬎^<:0a-6lV_oJhu4nUNyqG~RPFEoPR]8aTpjX Phl0`{w0XlחOO``Wg:^xiG&FZjj[CT3/CӽO=ҜWvuڽ63OKbj~]Y7w=.zZ5N'p`:A^d@A`Sjf!c:?_k^(ux.)-=> |EQTTl/qtXta[a]i톉~&"AnuzrV_k~s yG.PhmǏa]2z&nW%?s{[nyjsSs<_!^vj)[ " @k+@RdóоG_7nX9+ Ț¯yE#u>V_]]ɕuSB uRݥ@yj0x Ƕ9!G*rm"ڐ6:UăGۨڼK/p~^ݿʯu|<Uo[`m4I8ȹZۂ3_y?ڄl<1k?D9maެ}=yu(hqէU⯨\qbu:kL_ DSAe*jyj/@}im@#H'/jI;RB$bu9 }l:^_xPO<6 x0mjß]kzn{TwXT"{0$5} w؃a^OxVK:ӿW;YgrPW0?o1n}a/q*:a#|3`ߘfу!WqMC=ۃutV㯔+hS߀bϚ"e*fKs9:^kOZ o4%Jnm_@qB\ßkQ1?rtC\MP?XKu 8G??ﭤ(8ޡy&!xY5ǩ6KZꮗTzy\: Rݷb-Lx55U\~5/![~uv[ƽ`x|?1"F" =mݯuj"P0)W7`]q8T?di@dAÜ0?%!qCz-W=/8>-' 2\b\|cvw -{ W12<ǡ:^/[Ъkq1_&dzR?_#cRRLW5g@`|{lynwlC`{/YP65~`pZl*;4Y( ߵ:{@=cJ*ݽo۫]i~o>E?}ڭ֎k)*_\=W)B`N`!Ny Rl]k~vMv`Wl E:^_%xٸǿByD2 Q#WiQ,f׆0WrU3{Jy QT(u9Q[= }'Yԟ.L9{]gwO$9l:ۭjl-#*kpwx~Qpj![y`+XSZg3;AtxzG_~cZ*ĵ!z<~K 'qKobJ[ͭ:^eyDJWX_ϵj Zmn> y*Ng,6s@Hz7gôݵ8BJB` _5b7;m)Y Y K8fMj,[CO>%d`uC}3/}b?=>4˹{0_CDv?[9Ҽ4&1)) u>838H<}y=VG'WDy=}^[!^O~y QH+>'y(.ՆDlnu$1>:^_-x<(y~^ PXbMB Gm9GyGl.%B+"#W"uEb~x/gh~(ɑks~VmvjIH+=ec\:^_Kxur?ɏAKͯ{'Vnl{4ڷ]RB ߽ ߽}5ySba㇠8qGU`lp_gMgQjQ|y>mg~h<c^ mVOz6}=%u+/<퐖߯œ[Ъ#kF=O14ն Fm<,ihi0]#p1MCУzyYlmZQ6}qoo>7&xnMc7c,=Ĵ̔N- <:BlcZŽ1s+zb'ļ0s 1-&vj9KG$S'ؚk m{m0-?3%Mm{ ~jJWmҳ}N߀coLᅱU^OM^o©ޜMa=?[!_ xR{vN}ނ#}Pgr |!]f GƠ.h.s5t9kpûQ y'{Tw<2vevc~l=~`F0wDw̋1'Z:IcфG<˦>p,#҄%q}']?`ٔ~`J)H$杖$m5S)&Y;mʤ{E hW'Y?} 4cԆNvOf±aH7͎c$u4'ћn9 Zў5rscK2'9#vKfgs= M|ϲoK bDh: "Ț8| n뼸5o6O l[jڶ(%zɆkw,Oٺش}yʎعkg?}E2ػWMS;WM{iZ3ٻܳzF7޷!uސjِ%sY Md9d$#w[>FOL >Km9_d皩]傂ϲn.2 ZBzX.m[E6~mc2-_γn[x` -ٹܱ{YhtꃻVq`=(ݽtʣ{{Ϫ#ڳvAoCC6sp=ȧ9OMO=#3{G4oX7gt3 &}QMmg샤mfQC^xX{3#_|lBy_ZgbGoVgKߢM)-9ԁ#>6O$xR`֏mBT]bG5'CZ6}Dx io6{M_!S`O{Ѵ7' ɯڔן&)7J8l[M?=]ѩO{./L ڙ]_ީ9xfuza-8ǖOic޴Ծ&ɽll䏶̀m%j>Y>ki~:iCNuh fof~9|v>{(3N{ܕ=9Cweؽ vG=sGpܮrߙ5r?C=vOc-o%؋,o^)]dyu򈇜2-b&d ikYcֺ~?j^koH.\kZǦi8p=%mZ&d L-<O-SU%|:_q"fb;8eƁ-3DOSvTٚq٥[3ˌC}䛌miN@m6Gh{t[&x۽y' stG= O]ݞOhO]p ,.9{ѿ{ᅜe-NA{fߒ3K.W@ݾ-+ϚL3ƟY >SZf_w:wk>guh<;o^ sC?9Zf-0%kFU2afx]uW/~ _Sp߮}'!:P` z$ֽ{'DA ~4cx;F4b{8 ئ lGM5A?C><ك7ك_70~tc>4!@ל$oYgB[-G>ȸV| 6uQO#lSZ? ?$ȇP]=v)z61)!rOj nD'C? iO~8EBWfcb$fCA̘gfuj /#c.ϧvja̎Mӻ<#ڀYVvl6y nǜw#f"KKhӻ8{TjCHOw#һJrYHmf$w#t <0#c"1? zcaQgyeAv )NkzñbY9⾯,Ao,DN-'+w+t?s٠Ǭt"1d0a`"!+N `?~bla1m=;gèn0x֍&0}xl}혮{n~RUcn`s ~7)a @ mZ |Zrz, |jOS>r`i— ԇ!voh!tp@m୳I6IØMwgaB3cĮo҇ٱo=G7r`7fghBcwщ0IA `)tR!]6<&C螻t Ю[< O_oYW2>oi\/\mܥ V&`]e lX%Ƕ1mLA?)Ӭk)6逝bzSz@_M3 S_̆Y05)cL;>K=:w8U&L ?8 ֌c_!z@}tos9v=Mw1o@02g.ϩ] =ဳE$D`ݿڋ+/,BO<+ƼBv-xZuhת}sВ㵶/J+8Fg{鱜63۵vl/?s4gsi*MZ{uWbxPSV[.D}k'_=yu:<ջo{ꟃ޻}{zwwFhpw kpװYD{bXF4wxF6~pjrg4{L&揠=ch/>- ?a.@m-C-܋kDB'0ghHĶO"]'')>qu1ۏ1M `Rwx )? ;C7 ӄ>=11?=6faRi1B?s8dR@33cO\ڻ-fwmG;-tkխ5G?l)@ggRVψ#QXe!#f#Ŝ>^Bޯ8 );0%4$&0G?8v``w0fx khkGuAGCQ֍y = dbw 7PS1!}w7Ng1SLjp '|Z'i),%3PNZЉ ~bٴ_ږF25gC`m@IOW k!?GQ0G 4Ϗ-/<-?rh_1/-`^P-˦+M0?U $o?oU<[$byDU>~L'}2BzItӰwc4#_)/UKH/ݚ H!'= ȂYfI&9s0?cމs8# ;=}ObǼdOZ%$hN*c~ x} [~O,ٷQ~N6M1&&N1 8o$6x)SL h'&L٬4sǾ- ĸxgZr[Qx=E0k.gÂQw:^x+"и(QfZR[Ht P` P?^\nz=v[屿]OVԽw?z^r>u{Zui@ק^ Z>ӄ ~Cݞ ~h|Fwlrϒo|Ol쾡Ii?ئ?|C ?&z[$@K["0E-@ q>x "0 描zbJ:vm]p"Pz'?@xOמNzɯGҫO_mFcz7!M쌷j`|VLNb;Se$ s*ۃ=2|fS[4߽?%Kla< z qܞ$_Ы|@b\Pzb~ W~ui ?x ')}`t0)l {&o ]@?׏S׍.+خt -?t4-Sz~:U~&1]1'q~Xc2fB`-L~>>ʎ>_L#_NDSB):~Cr}@|:>RUx!;N3Y#wR";FBs bK`"@VG7ڽ bQw.g= GCK揃vq&_<"|)q-MWQ"^:``[)_a*ڌT1Hm nL9y-_(t&LR.!?(@S:@BGJϦC`2|=8kGhضc@=0LhK S%j# 贴E?L -Dlb_ ӇKΛ+}qb) R(m@tKǼD>U?)oŎdSۯ:1B'&`)E-@ :^ cf H0N*m m9Fl%xZQ{^{݂>GL U,ju}n"k2mn9?Ô~mk%s?|um҃_*a /D=Grp- dS?j0YX>8f)e*a10eX=#L%*+@?)gc-@+z;+cv;t)`6MVt0& ?hDi?d- xx? *o 0%c ?7o6Ad @WAS0ؑE{/W~ 3w ӆ`]GMpE?ؿh kZk-da P'n-ЁV_:Q'V'.Lk`c m}Rڄ">qZ.Z2kd?*|6l-Cbkn$AWGh;B e*ȷsOYx&w |r,30 !Կ  W@O^oESJ_ m ~C  VTC9[}Y*qiOTl Ǿ-og.[+ R ҽt:*Ż8O|NY4Ï֔oro@xqA\w{B.T\hWު};O%T"~~{c?A{z׽;kpY)p]{6=! ACA*h a"d Cc=VwNz[)0؂ChW;2!mG[3_?gO-oZw3{r"hߓy~sw@)K9ۯ\{G0k_{5cz՜rw;]u7H=r_=JwG#,Mqmx{˱-oqß3oثs9a??\?j= Ƞkhۆuc~[?}|})?pFO}N9)eğnۣ' cSχF/鿎ݗ~oyby.;i=<~Յ^vG=W~W~ ZQ gյP/hWs5|%Y h!aM?A&O?R8L yP[;R)G ,(??oGTI ?O< *G7kt*W7&ws%(YX cM&lS?m/EnG0!P 0g,Q,Y趜'EdEr.P%,]|sߥY3IA+#T,4~WZ7}!b~)HsۧYG>bZ.ިT4`oٕ1O^j p<řQ lTYL\=mK` e0LY@Wz]/s-@Oz$l~qO#% Zd  X bX+>?B`@- nP7,1mNc<7&p >-Lmtf?-"LܞƙhؖnA Qmۻ wvqfU ށBڝCҀC޼wC0_ ǂCj./}#58~H#.w>8)ɏ浯u=2:WθiaދÇ:vcǍ: =a?/ol'חǷZp13fʑE_3?χ`!?_]' |\)uGG*%)-#!篽sk\ʟ\}G 6:P(?{`=W{/CVbT~!g[/GR!g;bd;Z6k*+mw\N)=DgރEl3'i/s?ܔYD Gn~c@YPEEOZ ςAfοogH;K8ݭ8~ VPZzN,u~ ؆>Zj~_ >o\=~V-k\ж1k"o~)1Y3["xBtt?:2Z_-9Rzbɋvd,ߑtG/ߝ@ ؘKf/CKö?wY+%@7aPq[*@85EA@}hM6@頻br 'u`ǂsk`V!?*BE愑dMJTa* 6p#4 ౭iBଡ뻲!*f&3؞ >**oY> V\@ *Vwz^i=gfDnB<#Ø톗~Y/p8{Ϝ9CR8~  Z@(`Dg?S1_.ךYWjn8nj3ݾKɿ`ޔsO^@?2큩ϝzɿS3zO`4oG4]Ӿ=C}k F?Ͽ=swYٴ8W OW Z_+rw.@{SctxasKE 8^~sD٢PMZnO=@,)?2!hۼ)ϻX=Ͻ ~3MKv+}ơrK3>2]v O^]ΝvW}ilI{6_cK5\MB5s-5/2u~y`aZ\gQgӽ?/304TmWn ? 8w4Z@j?"P7W!VN{'(mܟg<|#ؙ}Cſ{sIZR?1% *@7/Oo^>K2eKgc[+!w,̓uc@#̫̿/~c8e@Zd?P8ؑK0Xͨ#y+v-QIH^3ciݺ \Q9D]-vZM^?j"evejJH?:4Ď4' PhW,FdR?J*@Z_ے-w3W`?U( wag.*L+(79()WewHk?Hjo,fwYCO?B9I-bt!?(?W j؋=Q7N?NJŌN|x\w"U?W^h QЪZxЀA]Co36zOH9>ơ?E?}jס]8WdW_S `81sy90\~0(o\`_+?ki 0NpÍ_sÅJE\g Wlq2ߊ wzr kĺ*OS^Ct7t/R\gE?iF?!h3* 0y f?Z 3_#;˖S/zːxsZ V.GC߸Oݚ9?Y2v5|-{F RP[䂖OT}PWC)Bm5yFBzq. VǓ7Iv?Jgw-ۚ9(q$O % TPgS?޼K8|`E  8L^<}-V[T?ITP$q]; t!> p#+Ϟ?C њ#d?Jխ^"gZJ8d#_pKpʔ;U}`3,\ dGΑ|ο)pj&+Iw폈4'OH92,V]?asxP?_8?!ŸwWro|^0-r΢lנ] @sV^u}7]5OW_M:_Co7Wʿ t/0_-b./|Vx7U @_I_7mc͚={* _-{.H>48}Lis@޵H?VΘKa jgОKyg13(G9)'gH *@?|xg)Ztg8]%-[GDA?M^_I+*QU4V?M3Hs_ tV [㟄ݤ+>?в?s;jP_. 7SD1uV}O 0v`3kI{Wp=ꛔ!·Q {֐FDA' B#kbWDI\>`w,J)RA{k8ߒu]c3~͇!sڛǚoy{O繀7=XĜMAcsa,@*GJ?{z&Kq498TXvwyz{=nF@qSQ6U z*+ Opm aϿ?ڴ">.1' mN#?yk. j'.SY|]e||?Mҩ_8>wWSsOJa#+! _q鹫DRAg ]}Dqa-s_o_`,3[~:xFz1vҫZjEJ l! _>8;`a}-lq k2?DGI_fȜӨ !Oy92=: PUy [C:SEOL,ϙ];y/󏅽˶W T9*!DR `O_N߸Us*WGB'?o|%1UfPCge1¢ I ?oKXICS-y"@ڏaK+d-5w,UB?w͡u G ? @ECeu+"ʄ?j]רּGO?DB@2mARViIeڰ@ش)W"$GJp 3 /ٜC ppUvw`/W,g_{;cr5ԑv%ɯHGݏc{w'a>cǧ>:Eד~uq ZF qUqtVK)`;=qϳo >1cS`WO!2_g0/ l/2ϫ*?k_Bj f p_- 5'sOp_??]@Cp-.xϙIK_Q kS>9{h/>D?;sVl'^<7K9kT-筕knG (`z,^C] ~E_6KfsjЦB`4zH>pߞjx-a/@;y_5|!o_ۻڕ~3#0xcoT?.ŵY޲wz^?R?:я2}t ۏgt?ҧ;w~ןZ+_n>v͡Cw_L\!?Z6 EO?9 bO;[y.}72?/3}bœ8+/9繟,DK~|Yz9+Cgex_u&UV?@;+>ϵ}[-컬 ŅnVO?#ᏼbQ3P(cx`~^wR~IB_Wþ#_|isKݵ?c?l`(U A>l/h/yy Kzy ӕPB|^E!uYVq@hPB}_?j- puʗi @F3__ 9 R[uRBd/|TMD.us6q߼ ?i-`@(@1K_@濏?TS-r;*FS"T, :7AR!?gGZ0W+ĻR:XS3HoxuGu93u? aw`Z@gdݽ<;Y?-}U[^_=6@^oo yF@S?V揰Z4uBZO#l1f~NxV|O_ެ?_ag_|yFOR_?6{%ߚsM9n'^y?̛rӾ@Sd74.˾ȴo>v|5[B{W~.Յ]GC} W_Ok?\p`?3lO_'37Lv.z<څpђ/yg-|~M,'Ko 8"7^[+_=C-~:eN[1}[/[0+g^¯Z9ճz~`/qjW 3|~]|/~;YuOhq5﹁uw^o~a{/sNk<}~ҽv7B [[^{{oz`on|povӜ[޺w7ozpKsUCB3oFC3ȇf{Cc "so?cm1#' 'H]xOw=~'liܛ  vm ! My7iSI[xғw,mw>Sߛ~I[|)\`ʳe/hsZ2g[Ps9]PΊ-sW?5d??pAb^9+vyЮ~O篝摢u J7W>KZ @]&SV6aemiσSꖌ`3V mkn|jZ؄fkXߜ֬5f*ذ%[<R=Ŏn^Ѿ6lhoF펢-`o/vG2^kvwWo+_U⮲= ;*sޚD$C:pSڤ)вmwciG큺Í`4eO;ؔ~%,[ӏ4gtdveiےlgG~OKgKi\rUיږߙ#߹г}3 .vpW)CJ]ZVΒc*v (U"ފT_Z^0~?B8%7/$>ưGumǯ0q:~k|^qw{߈I? 9a{5'vC=%_}mM:~T;p W{x];N~g`:Qa{_y{MQ?9<̠{Gu;Oo_gF~1\L8&W{2~lգ}uB?^|q};3>G?xG=Hޗ{~W(|q~:_>cPvt%>?qRǎa?< qzG{%?~4|c=OQ8͡ޡap?c`k;asxj_Otr?}6y\`wh{\G 'GTq̸_ 1Kr8\Y_Xzx4(Lq߄hš \sw9cu>O_(DGCzNqOqٖx XYnM g<_d)?;~'ׯOp|Cy,|S}oO [K\exUt oWq_g {% _+2:Fq_ه:?a?/ TGj_Fyx;ͭqiD?}G 'h-o?%Ƒ9  YLVe?&&Zk=+_"Axw/٢7?:{p)FZ>ϛ/0zt7oJP>yʟ XW>G?ϳl'WO}9񫬎}~8.' _ޯ 6ۭ3gΚ5k6{_cٳ>7_<?3|Ogd*:с{ m@ZӇ'd^}W̏?]+'_oǯp0<4 }Z6}cǣ}c{}$.F޿~!>W,Nߣ/! y|yԯC'mi8߯:~ogmޟ2o<˽DVL~[O@ &.6a6Ҏv-Fa<0 Ljn;>Jvzγ+dOw?Qaw? ѿ3?0)8{dxCnW^O~>z{wBwzm:_/~׮xꭞgsFgW|w8ߐWbsX{N}qa<0oa}ü WTJawV5;8c5ӧw4_пNi`sUq*h}>;hϘ3Z U52|t ߅?{&Qh9pz?U}4_X ˽{ 7]gq-%;?{.w{X›W/73lF["bb??sޑ!&-Y?~ ;ۿ:Ozsg'܋l`>ـ3̛>~_\+`϶'dMGԵ6܆6@li #qej C6H?gbToQ FS1g'^ߺ?g^p͒[[;IJYfuOT?3 ʟ695JcAa`q;{hh##]./yhwyW?KzGxȕ       !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefhijklmnopqrstuvwxyz{|}~`_'P?c"!xN?h1p~\CÊcQfاaȢN wgX#@y_*|q^u};qx|u6>~X?I|x =`^=bݏ%]a\=C5kaj1Fp_34 MY21o d}-W=3AԯV#&h=#9u[bbQUCSʼG[}q\b>n~~S=Vx3(gg[{kqe~^:v=Ě3D߯@n=}W#PgO)wYbݍ`y#Xip;}YnTϖ8{}7qPzwsSuxhNvM݀gctk7&![| tǠo r]<+x"/gB/g4^dƲ UylŹXH{ ǑxѴVehWGķP޿=ƘۏaF@T?#pS=Wc4U^=pCT2h爃uxbL%unVk xzcV7O=9--kzGyc^G=2Kbklg >z?(3<_|tG0i }; {= ^B4@Bη}Quh{t,虆B Hcs88ZER\w`վ DRu qM)Նz>QxWn?K+|j׆~`6J_])=8t;.'GF=vK]#N {du]?a~7ATC}N']ljȠz>\A_SY0]?)9 )+qS߻:\=eP_{ ߯ e> f=Ļ=5kGȠRacf)2)ሁ9 }rƛ4yz9>Y`n9ٛb# 4k@ߞmOP(){UOϋ'Wtl $qCб?]޿?Y:q'8CǒC{ k6u~z&|Rs9ٻ>g}?:XkƧXWVWl5VAW_ zReCYR%7HZ]CÛbl} lMA+Wտ?s YOq'*ؖLc}wB>6# 昃yꄈJW Ȟ |ΊzN5 PyP7]C~niWpbm}^C~xfyBzJ'd=qDM7~p}&s7 |BzN1 3>uV 5[ҲVJk| ğ73͜R/+gd:/5GXxڠ}->Q\޵  =i}U|?v|\C|cg-Wg0o3*wc>O-s?`=_ |='o15 ˴~el3ނ㻿fYWN_U+0QSe|>u<w?2p9q8-u1r;8{q-_`ɉBM*'XЉR!o?4 ^ ﵺ8x<^ۡAK`+u.:~~h}tE?G|b׮~͟ I/ ~/Z1/W0s1sv+kgu4΍tߵ{r8뉵B~j\se|O=;2 !aKqwRr,0y~KJ^EgТF@NX7gly^>~[>'n:~˿ҿ?`p " 7՞q>ceO߻g0gQ=?Aw|j9g9?sܒ#iꖏc6GΒcoopX~V;yCoWyտ:r5E} s=+f?$XμxGqL=s/py'_9 #sdb8xżp]Pw/!]߲~uM{I 's`Ǵ"ky"WYn|$~Xdpwf-@?Z.w*{ln[6AeYo/=s\/Ǥc_}3޿ *g9׏ğ=m\c9+0&y 0q ㈆zu}#,3wg«Kΐ*_}_t>V=}a]ӧjeaSK%"1S%~<^C^q`XI9NP=# g!oyǴ5Ӓ:?|}Ա6zOѿH>ל{9^+ÿ`R[_yK?.|ax=պ̾φeֿDxp_ҟ. >#wLW# 5[}]swZ[@w:vYafqg7 {_;75a7C4ߗ:?Cb%;l$y<I- 1q6WkkFDGBev᧱m7Dlňl1:*n۰i|)"fGآ#Q/mڰ)*":ց888"r-{ƘMd[XDQ16[ZNG(I6?o i\r5Mt=!q[\ v#q8$'I I†p OJPX OLK;6971-m{$evRz*϶8ʆO`xrFZvɎOM,S7“NHMNJTxjVoJV*Y:YJvFjNfjvZrfNN,ȆNR23rse v~VVA6lgC i)}NlΆ67 i,͔>Er?م9䓙lbʖx!O.yfAyܜ͙*"OxUśS埿9OC >1oa|G>-*,첢²§ h J4|D}W/.t YZ^}]QVBfg)U*m/_ˡ-)~biH TUeSZU^*-TⰣA*ƫ*+k+֋3U&ԄWUV1VVQ[ B+ s.dطRSx]%TRP{U7[jٟmklƕ}Sg2^xMC555vCs#\Px}Kl5u`7f觡Zg _M--oZ[ꚛ؟FMm[Zk eζ斶68-ppx;d7KC o@ ؗ:$f;uqoll%0liA{K ojo{:`Sv۶[:wm5[;vn%m/k+⻶1lv>Swbnھuwΰ){Νloݱ͟l!lv؆8m}{޽w/lgo}{l{sam0>pЧ>}DT+6{Tlm&l0 tD;hmhhl ~6E3툂: -ёwDA˸h-p'~3H'7y8DbOa0!% cGg8xیCFD'PppmIJ>p<`#Nx" qIO\b<%v\|,%P6|c"C_.pINOR6Ģ8XH|S$;mJNHOHHB_-pP9CTlrV^lCW&?IlLoge(׆kC4a9Gbo)C-iOBnZF>|ijv~&`g<  >s?>68m "q Sxn6x?|v^NaqOfNی'EG]ھ}mv >`Cc 罄?Ep<1{ P\cdN 8|q5CΑ9۰#l06a"vh!B"#V"J*ɆX|\\T^QRZUճh+п\a_ӊ i(8UhWV20αh!7F KV/(qʍss%%55dQ8\Հ]VSrW-]T @D v]S-dCP !\؍5lطJ}k}p@!}(0kQ=㼁 Uc#t]ƶ'khZ6Q}SBl,ֆ%֢pinf366hɮNv›>d};pe b`[ZhYmK;۝+#-[.þm6|/[ &"l>][;;ںv6ȷBP-0FO?ۻ(%pSKAyέp$cv 8 7E]V8ga[@( M89 \ڻ4{vm#{:C߻sn} 8;v2[߿3:8D  8  ȷQyaSؿqF([4~gha/h#m6eGJψvl$ّOmoBwPC"j^79 ?>!CROn1O@8 FSS L)g2dAO))R؟#'d`?553613-۩C|,ə">Yyl+<=/ZޱP)ȐQ>;}'[b\@D̼ a94NeAԭ}h.@|/Ȇ͸psɆc`XS\9WB9Gu-o1cCV6E2/)-.s`c6byv/r90%%%",Fʦ|!7(tվZ*C9yh!J?O5\UԊj n7ƹdKZ,(eѬVKڌAی Rey <`1|$j/1n6iXWG`,1YmΜ h6΁?;'%KX"I)/xwxo|OC WUM!Нl b,Mf938x[^rm{}D u["\u;q>W-,+Enp6`HG0)OILY} cd 1tgBkI$ƃ ChuLk?gaHfn:D?gͻ+SREOq>g3rsqˌ=a{g(c8\akEq1.qq6!7)"Ċ>e9%9~T_{My@ɣO9҆Q 4\p&L1"ft[}9nUQ}{*$pGRj5;)݇ZˣR0{A\Mc Esu-4)\ز+|]c=X="zolC__ϸl0oCS)75 -u -\flp5Px898UZ&oml[gyjF M7엡y@ ۺ?(!8:.kwW`\}䃓~U?8`s`Rli]/ 롻9o5 W|`۽ܿkwN˳9x'Bo }e2s[mtC+n>ca/|[ :1cݻa@9YI_o/} 7_ڷo۞+4 ȈH ?f bh`Z h9@݆f3m陷9D4Gmy ٦Ap!!m#Ce, ݇s~l%v47/ . 7k63SREN^xU26t4#y$q<`O%?-+T@>ΐvJfzZ6giF Gg;' L}f6UVߛ?y"{/B\K\e Gn?ť33uñ!r_5\{>Efrq+nQfK4`짤ԀxyF3븬L~I /..^k2o~eUӇt.^Zekkk~t#p$N~UM &Z2ؘSQ[]\Y8l+򯭫Q8e奌 %Q|o}C =g7Wl 5ֈ>ɇ2VkjjHcSf!N|vEL1ٸ )ïft`2p4XY콲iq͹zƋ~t[hmV9|"l?\Dv]ttt,x&[oEfJP 'xXhwl.3f{- o^;g?][ 8[uA޵sN%aS}߾>:/h.5FXC~.8½UZ>߀6JAtT&}l<. N>o"Θ=N0n?vӾğf1]#BUu]?#EÃj-9KWLC۞kXgߋmhk[ҹ={7&=5ã9i!98vxuۈJs9[Źl{`_pxoiKxNP'O95!p(헜 Ș(.ōI}ce&z˄m?t"c?G/*Z- `Ϟ|.np]\pc튷ϜQ8svm;p_ϯ? 2,;!))6>^4XY#W,ơ2j8٢@\Ayu0'8dVyɇ7*W5OM` W6<,5 69n v1 y~P}Ҍ@>b읗w F ^a^r3\ljv Ce l3@cg<0_ K|ƋIߞMylb泿g<_?[H?bLs-b>/)0D2'?F3/9y 矹{AFbSe&2*"ۯ/T] m|zm5b@d5hhǀ[ 3XS@~կ#B>FFοֹXOR}j%BY={-Ƭ~Kk/_---F^p[k6rǬ)`[r|0{l9h7qqo'n?h?.S]d{3qH!?P_wAۮp!6볋Z6 |+7ds"h!,ݦ[2*Ws(kN֙~o:,ɩK6nc8⎾JwԱ!ېW V]1|`m;7>r#J`pƙ>0.u\mdp=q37v,$9-:j?8hlO lcY'=8Ξb`Ǧb 0?%$Yqv %=5~DA{Z@5ؒ?)9'O|,ϳ_xr{g3 iX,@J_ĹCO6+qaLt9t3*k*@"RǬDJ>"1_2Y^s?σaU-ఉh6!_Ÿ/g8y1l/,-Ζ:ζbC$\L|,iF/-.,.2hA̯ ˶O|D8~,ߋ˺cs% Tbe1&{uY1-̅"KI_HgkuՏ E F$fCUh*ft_#g%^xtK)"yٿA#Z(ECfCS?EC77U<8#oiK?|5c׷?nhVaGcp5 8s=g0bjcVh3"1M"o!ۯg5yld̘ϧO}mC=O!U'mh}]͒f L<9.~?mDY19,?*Tm94`fӧEEg~DP#!/*dK6R~ ,|T+˅8c{]秀u{tZlja\8O~,D{1ßqVse%?X+ο^#PQSnfKy.@2 ˊ QB[҆X=_|Biyv`ۇZ}8;PY.204Pc #_j5R2c&N)1' _fPC4P]SYz#Rƕ5P3*^z,Ј *EgJqؚ ZFka| aaqU?fiQL>x>ծ|qPlOQ ``P/x: ?KÁ[ ?\@Tsy0as[M}f<1?woZ_aazW XnM@A2U^?<]a˖m1[y傈]_gjLaLٿl¹|j5kCXG\|׬gph詖Mo2a֮^9yxnx9[1Gnp,6;26FbE؇]N=<.@tdaqK)̙4>6Cʟۉ]}t@U> |<~|PT|Kgnwd€IY-EߨfbVQ=oqH8ێX}!> uN'&lhWXce߫d'|8W>o^ tϧ_ au3Bl3eGQ8⚶!/V&B ~~h5Hο3spaLKrY,Eο\";qIg601qq,@>r.@.f):9ޔ\^ʱ=+uDǎ.ُw`ˊy~1^v? a޽e?xvmۆ9fN{d9)~?ŇIN=3!q b sH2."x:x6bjڢUяZO|m=z^Kx/Ig[oG,^)BM6l>!w F1v8N7mR3ѱv^ H[se:ІR~.?~ZMypXGlr_;矫hؤ ZWoL^οdZ/4m&v.q]J\qP.Ze*goP\8dU"!%ٖ+D @  $ #RT6JRȡ-4}Ͻw&g=9>}iLf:06k濱9y1O*WXZ-}) Neg)m=ww@0O*_k`c?~N!y/@Go7 r` `6PI |W Z NZmFßcC: h_(C?I?.0^?>=1mOm?w:Wοߑy~Ygff8'ӄ}fnnڟ̤r}-IXd/@ayG >?,i# לbgq]~-=@[X<|U\2@:o3`g_W?$CÿXVqCW=_s`?~+?i!mmui__7h< (yDj$FRB!@.G&g?{'9uמ#.aPcmko}k\Rlù+qxyj0X {:Swug{GͲ_SivF=K.7UT?R*47% o&v^{gki»]PU;9 vTg:77&BW}/Ƥ]@WwUWf;O6}>P[? m hi8N&@f@{O;4_0JoŖ!A! ?:)h5':@ r OW,yN>dkdΟCd!TB5 wt5w =E#MA~bO$1ڿ$POou6qj|`W'W H-0@@9pϯ8ߒ<*OD ? !Gm?M%&97k b"`JG|&%/HKg?zR23&O_ZͿJAxL8?,/r`?755r¸f+s?3 ~0蕅Y.z?)Wq>2/,.+]Y)WG6{RM~0/Dϲ")Ż[ڶ/@,sq?YÐ32p{z!jd*Zz_ݫ #q9/Z* r52p`Eo$ _~u߫7OQyZՍk[W7 ?~gwҵ#۹Rifkhh8r(r"ݡjRmīaBMMcsR5|)@VF} ӽ7ն4~_F[]]:\D_ڣ@#=0Ub2XUq ~R-oz¯͉0C#/@ol?f|3Ƌ?vos[rmv?OWo'Qo1ow#@G~?vi!ۮGrmd-|z?1Ϳ Q?9=GmxQ~Dß#yiw%d(sIgAx?erߝ'  )3=>j|?}f 9~ ~?{?<a{ GGYѸ,m4(Ǿj"GzHOwپ s"A1fMd9J_6/e'{$53=x]T@ZT)@JĎ`?*F@e.R\@c~9hmI?j"6|K+A&>\f)]T~/9PgSؿN׫b;";ĖJI^b[{7t֝wU1˝)ܾSO_rٖOrZ?o>~:Wz~}\VI\޽C|CG`kdBA9??m@vcoKCPq\_<~pڟ[/l8w-l8r"`$|a8?4m'?4y(_ YT :H93wMD}kx>2c?2ǻQ>? 1C$~]_?i۾H.M_Ϳە:K0ʄ8P^LD={N=? `N+w'P*gq С?d`d_?9}Gr?j9hݮF ^ 0Ϳh'L-#*?xez&D\Ξ 8 Ӝ4^ n7GV?j/i)qZP/+d|` [ bFfI2aBo:?n!4~3Wm`2k6 ?K O~z?m$/Rz{;v55e?/mMK5P+9p9.5Շ70*)ִqx1jU޾|/ïܘ<͏"[j)EVE tũ2| \}l}~vS(,`Ouqw~9H4ͭ-,-?vgOwo}F 1VE)vSߕFOX&y1ح5SwW @3`k׾gFNj?a%Za,{0|G1s,m.FY~S#H5:0| pGS z \@5cO; ɏ޹8;3;/^Pr-W? rn5Շ' b'wp;DO_%(?MoIEk99D x C?'>G! οN x~Uit,POG7eU yucM[4Ir{ÿ ~h%gV;wTd)BVޝo]a K3u"UϽr/)kk/gy"/Lw!οk_Ag׾^,P/Z8TK67~m+_EA!8X>$]~_ǟg[;y O;?KeǻG저ҽ7Uz]}hs3eVK%Ә}zm^˗ E;;.Nձ nշuwhګ}s?[7/F;{#?]=7#[x:ace<@gD/~?uf[NϏ3o/=/B `K_ 9?Q-c~y/e %:A4XSL峆Q 4v.#HZ}Z[*b(W?#j^ =S=o1fοG~SzmN.؟ ?a7቙Yq+f,_ra)= P aBYe@h?&_z !6}viU=_K>Oa#<@qv9i-e=C}9A_6^A$ʕ?E_Neo^Z/nl_5>>|S{}=x+_/R^ }s&k%>|gxm; MM-h_~/|[g_ _|OSOw~嵣A#ס/GGƤ(!Xp-454oD:2HC z~5Vo[>'?d RS"_tDzSz$a l>tAmB* xI:̽pmV':T;/:jOk\_2紿I+Imɞ>ɗe+Igeb_zR`@8{qQßޔG 8}Zkb:8?؃gۨ@:k_2c9|S#`؛rFIx73C)lʨHGx9q?T1|?_!}tm^@ggbEO:9ɱO1g&L,3 51 TL]}gKs:O4y=?Jo/l5ֶ vmοbGxO?@?IrZ8Hϵ4vmy%_5[%)'q^"q--_^[Fq70?wvnK0$YپN@@[ն͞޿Fߩ|dU_( x _+ T89Ɩ&oG՟I'j(ovuz<纀chiկm o9y[msqoؔ~NXP4nR/ )(v~R"wiZgٮïvo8Pqt~W dc~nUbSUV˶]Idi=]L]@-ގNoOp#t1Y}o{;{?,)@ hqQ{uվ23A38;# t{cp00x)σ]~S4Pځb` xB~^Oc(}PS;/T?Ά$}JۯrL_z¸XX@ 4|,#v󥘜ƠЩCӎL?q??2<0.1Us~yNnPW{expqο 015:1:!~p^=z:o.dzj&=R#4{ ܯ4Dgy8>u`ŒjV4Ϗ`ss#Οf^gYϥgF!? {~9|G1i uYlTOoLM% 5`6l_XXD(n_\BF翴@,cXCc7)<W2#ťlJtR`ueR,h{ zew{E+~ߒ9?,vuka Fh {?~onn^ߺbl3kloy{kW7X6%!_Jw0rϢ9\.>Ek3 ^-zz.n_EjzYw.U"VMj2W]mEW//1U%_"G,+\o o'Yge,.U*ZGCDk5TU}e,QE먢uT:htZGPEkoL>ZGQEoOV,ѳo޸ޤ& #ɨuT:idғjZG5C>*ZC5>U:iմjZG5C>R$x%zgQuiEZG!;H(қ͊4("EZC> :"H(:UuiEZG!?>IT J)D(:JC~̴Dk(N /:J-Do& 4Qn*Ѡ9J(J> uI'2L(:ʴ5i e,+WQuieZG!~2Lk(+Ji2XAo'=䓹}sz*/})}-^~\}}}#788q7nsnp:?Sp-Dd C20   # A  "BkY<n @=}BkY< $c#~Kx}_ QT1+""I|H3|P̅ͻw @%aos $]ؽpw[1(#G轸r~НύP o}wN7=$96ġl-5v2l/Ywxl '-$4oz"si@*36^ιQ) I,c|O_f[LLOIRnअ햰m^К7X_<,/7i%?D9·LiDג? wD'Z2Cp GCc|c3H*R=bH谆X <;j13F"ɦG y#cR>Rt~ pI(r5! >Y!|/v῀<_,4Ȁ p|E#J4D)^WWWʪi1ZUWp__sAzn =i~ V3l_i=1ryQVNX[Y\E.:ʸ,N&('nv:"w;%nsQVrP2̤h0Z(Bm#k>]u|hsۣ{"̖%?D=9P,(C_a= SVS˛B&EFlȇ9zdzCg={?e?Ct=KykmIo"Z5B;JF'Zk2?G6l`i# Кq'җHPhNgc ?o-vxz~15b6/S=7 ,[i[>@=v_Cg_"cD}GdEQplpv[2x;3v.FUí1j%BZpбaVq(!5CVFt 8 ܹk|zssJ2WLUhu}.SrYolR"eR2ZJK*@I*O kKOf: '÷ƣ[b1j4 -nKE5.# Hېv:~u:G$JI(Kz\.{TG)%V(zd)ɐI]LD5IYBV/^j$NS8zzmbDXiLi/֭렁[ LƕKy#á^y>p|f`ELgft*o&ȃݢwd&C?տS>c{s~bI: 3l.@ː?e&m4x3xm_-i/˴9*~Rzyg}9)zLze*~iʿ}1ᕩ6 |k|)d1E]^B3˵ ˸ћ],/W(,/ȁizuiy~C9d|/<p9gd=V#%ɯbB9er\Po)xu]ns.'=@!Hr;e4:̌9HG[Vr.fKK.Rޥ>vp Ga.(r@a/pZ֔[#kM(Oՠ_}UԆƏAm!bY1am~*ƨ[{~Xkú[$r4 +ύmsJ-ʋ'xa2C>܏:->cvJkK~˗Y{cS>yCrm4ntigT-Y=7'M~㱓%괄={=dݴ> œJ(߬UOSתoөa!0P%*j9_ '&ꇅqy`5':i+}TkRB Ďwf5d+’'i}*ŭJMu6',drP{˕(,OXp}4D_ K,7 of:b#lMT= zmZ i$$:KHLnX7!P>x^f.gӁw7^Aw`F7C+64zMϏnFW!b.?6*6X^9,l.w S9J$",dK9XTClS!sF|!GLp`>=r2{惭.aH^qe5hyyQ̶;%- w!ԓWOP6;޵q'ihH%|yҚ4uh{U~'O8v$Oz1>8nJq*b'{_W ~|g|yUd UaCQDAy&;>&)jJ~3L4+cpMIC߾aӗ =?NUk^"kԡzH~r[l Ԭ%{A浈8جʲR>s\4*EZ5JM}`mY!ﴇ僨"7??VypgbSSWGgq 򡆢pzi#)O ߾+ehyspyrE_7k~k&6CX]o*7㴚yXKl! P|>FVʢKa\l >_d,V)>AU{&?sYoNU)۪7iSVc:ewl+㔬9l\x]hقД[cCj&ao8_QUʊj.bdYr/mxLq::tP:5TIWx`rru^GkP2[E:Aތ6;!]fEvmcA5Zmda#pDY8ƿ3qΫ;w|etG7ZCNz$ Ϩʉ QcQh0'xOn;C3j}ti"6f ?ՀT5(*&EOvU{ݶaP{^} Z J H7+x}4+'pf,oF #s++3*͍1 i DK[G2-sP1OSv6AMHt+Zq,Bb&%EGA'(d94-ƾ&N.F(Fױg^v%.['9vŰj3@v%ku5wX.]St-_6{ūe֌skIEKh2w[VtMUbS@FK)OQBc(UU,+PRk+-4[4TS^`֚|Z)/@Ե!YQ3/թ*_D%E =B"^_R:(9"e'ƻ0~*eA=TJu`5)OS~()x(inS%; "-s $!NY%4X;bPgsr9[^N!65 EG'=BzFp>ݛ$.M W*O .gݦg_'۽Ûo?~+_w;ЦGB(f8@#Nap9z4gUU[.L4>KG8FE';lTΩNpeݽs)=b|f:𙻤y_>4aU_LsA]'+տQ#M3iٶ[.^栾yoxGۻ YϱGc3WRp9xJAaG&g̸X?o?yaʚ)[5(:O)3d^̄LOGHgП>&U.;,<JSe}EC?; 3eNmfKGog =W6|WWâj@ svW6]W`>JOVNurex·%4g/g,NN^8X=6Gi5O-ѬmpցSLw'v|v;33HԲc)O.Հ寯Uli)1i|=s3fjƀޜ9i6)/ө@<'nA^ jt@ 7êJk7 #Ul??q}^ 7C/ $B@< J〲 qeWn8R94KIؓg)f΢vpڏM&㇝;>Cɝ:ގ-}馑,8ԺgBPU,W4&E[(1.ZfI6Cc"1Y6[_qoC^tJq\6@lPJZ`l}"j]1%"&*?Ϡ+FK;01egԠrÙĒ@HU%9&GD~7Ny.C3HҤ< VvC~ű-ׯ}WO_V6ڿ:qN<Şv{>g۔[1͉X $N(6gGV&̌(|(Ns!%A7$I"ѱNW:.}C w^X rS(ZHO 09D~8K wxw.?,͔l4o_Xݙy94"Wi;!k(6v.|*?7Up3c{ޱN̈χ٨Qߟ` :m,:d,xHEz1p鈲d%)^^g)m۶z=ŗ/_zjIi11N˞BL}s=]gB slA'cmFۄg&U\2vz,#mZ⬇j ;c^DWr}ppeRvhhlIPI aM?_$eVGؘNj x5BfjOO:|´,{[!=?}SՉSo|wI^Dڭc̶[ܮP.\@ U>AfXH6e˔}~o;~={70 {tdMvKX8z+^"r-\nk}k|`E [G4s?:3#ܳi椋U rry ]VQ䉺ž`"=Ř>:8?5!{,$^},P0NdwU2FnbQ> ;#;ZfeaW=ef]nƢo E:v KH y/ nUs; Y'W1l` -vz=~3ZY,;(vt>wOmyf㐒y꛷{st_u3aeCw׼^2]^/mJ]}TCq!b|¸*AlcoSOHfwdtkGNLYBmYh7r{AƿzֶDz'̨y\^0 9 5mRy.n' %ͶKZ'#x:`?s:zɹN E[0G讐-G!HY_>dL"6Vs X 7Jj| Ql,BZ~,doO3vɊEXp6b xJ@]HZ=lbi{[V={TeTWQ艡_}?B^>ǵ/O,,wnswE8>,Acgv!|nJsL|v;bY95 U NF.!XPԟqMXhXr ME/$';PP9͛#* ! 罨G_hw`2Rr泙 YANBNgz\7-2Br@sѸٳ DY $k#|CsUs@Ja5<ͅ?^N[]v%W*\vSѹwMO72d?~HUa@]`E/'ܰ)E)p33? k^^^Ee+u{KJL3 f/ƋCZ);s|p W!3,< ?k/yOޛ񾏱v*#eJsgס=:r4zo(fTTUʍ6XhJ\UGTr Ld[Byh/Pl9Ah&,ZkUl¸A9bS޻7])[ECmONmN@/$O)MM.8l ,h+E>K0FqMS9'W?(Z<2\r ]W(S: }^OѲ.XU޿jT"u7ZW'^|JkgHeM(0#TWWWLI\R@dOxB|1xryJ,dĵ#,I*RmV%q[xz(naq g s>QS,''_V0DF=jsԩ>}e*>pj)_㼨:RT1cI>XEb~˗ `L6;\:ΌC\;˶n.٪}pO]+W(>V_k6l2,ߵ}Q le ,f:~Į{Uߴ;fs^{Pݺ.xVل;ۙ'kmw@KS]KY;{RWù g_VLJ188%qE~_JEQ=H%(Fv+nC#q%x b/ܼلY>e\9>B@m${pIXR<_RdRF(C>t?>柉HL lZ4uz0:1iU~VÏ3ضf}NxIIE7d1曅ՅE_IL]@\Z* da,E 鏆 2,˻9rqVw:VO^g,9ckx9#& KLSLNԑȟÝYp|&<16E=/5{z~f„ 7%.Et_*td~DB'o 2#NB !Vawj;y6m7wTTeVnM6} *'VY^[2 +}~ޗ|J|OAOVy;eZx~4Z+𰺶65#Q 'Ռ'wBIJsv 3@74`Gyi<fg}YXs7.g!Ў>i?=of{hFߣN:^i_<=uZ>,2[Q%+Pv73x]+篌WQB­ %jt*V]AվTrQ}1B`\:D4}켜Y,'}Z 2e ;ۭp$rōooŸD,7&zO'%}U q8G eFX4A[t~w÷xs;6 t'ȣzs'Yqjݒ8C]'|C8`1Nưc )?3/RNǙaa5~OW^E1-S0"ţZ;~8·"Y/czdͩf%>A{jV^7{ t+wYV-NzOML{u(@ItשxD<0A#%/\fl>ƆMMx.Y_ʚ"*ExO:K'Kfe.ސkyee,G90| 4 m5 8-ZSi:K4|n .a -iՒi>ߏPV#Bd'_6&.wgGgKfcxy0fb n8q707_Ζ.fhȟ*qh^qwl1D[Ef!"͌@s9 43}qc!Ogc S(N7Aˢ#cl_h?Cf^'m^?6y 꿸wq^Ġ2df`g-H)-6;{"Xg⎩?>#>~ck/ />S>=o: V쥥F= a7f"|4Y>9ڿο޿Cwp,-]:K- xn2$?mg~XBObyru.@'8m'uЋ r@Wuj=ҙB꫷"#y :vIJM\~'z{5܃xgX0z0'9L|/:[NZ'Wf݆?.6W'>}sAr z3ڐ:J~JAzƀv^; VE"?ݫ}\Q[ߤT֣2֏|15Ur>.:=9VSU!*8jYIur5HDG/.L!-@oJXp=D"G])rkBRFѳPsOM}·tqf[]MpA5< R9h`ȉlF#ьm{$My98s1iٺc_>]_yjG~<s\s{GCbͫ.olٶ2wcOfqo/avw'=qz3?g3hv9]^.jsA 16cVXLa 6c2#$g#r(ؑ a":K7 y59wl nDhBXi˴Wu\X_&/sr~{; ]{E`X&?!1A;VԾ9hwOI'pg>d=:h觇pv~\WX:}O,6%`xU%[+ؑvQ0F\A=2'HUZU%q V̝C]?sUV<wAi`wՕ΢iй)e@vq${oKz>{7pAV:óU/5(4.:gW6O%h;Ν5]52+ǫ}z|Om6>U]Y1<׋ˋj̥ o,0|lOGO]Y#EKEi,`KJnS;ŗ؇ɏ+R/&KYU)L)__'8%.XS &ǑtP> z/ #$i9$2ƙиit3s4[@rt糧Qg͒D86"éO۸< :8 @79on>Ծ E({s\k}[/Z%\PlKO$42n)ƮgzfҊ/aZ~}:IϹN/NrH?(-=D8S`HtϛhOIS|ւq|w ZUqF /!+x܋ lsE}p~b'>: @"EVNJ^.;#(g1fp!o^b? ?XF*R0` @:/ }+<['v;˅!lɥ?pN s4z#tӥ˸-%@_) Swٖf4ܱA(>FC߼OKz3n'=PHYWv0qzQ|PA6Ȝ.y+_nFVu)?b'g?y+=+;~bW'5[TW髫exz%=RBԱ*y_jzF-¸g|"=FuqYl!'@Ct2NIkqflZ8sgϞz tz0Y0H7ҘIYl# [e&VG!8!P^ӉՂgV>g``++>VDG e[fO߿ qmRI޷@04i2nz߉5}~yu;?ֹo߷e=G<]ϣ7RYk'j&1>ʔ)a]ObGq<,Kmhuct_꘻rF--4',R_*S"jWd5M|(F.&vZr+?s:+еŸ_ҼA)Ik'h3%1Y:/1f5ӫiNrg}qýhKARlf2GvF߄Vgmyy˴MHr~i`q%z/~Sqt87{nK__oeOU//)b?+[B2,]g=&(b(6.q[/S <{Ϧ`>HiYU|~A ,%xO K1޵bhv=oWJP u5 EnǙ9N;}V[S[V-'Ef'Mԝi uE :D0OoN;0mjy̼-B}m$ADO9ttCsF~[[0x,>4#H2?zvmtyxtv{D 5z>S92h72ֽd'+/Vp֟-lpzqʞj߫!yϼ`)ƍE?wo(Yy6PvNmP]E7ENdom&A _3_:C %ߕpvwυAqGqG=ʿVeȄl)bҮYm=o0`n }5eS;t8f;]䁲$i+/+'7Xacw8?9U ܬZ\lZ¯V}hr,x>rG{UQlji(M,w}Db!6(`.r9r@cɾVQi2h:pInX@0L8CJ|$副/|F2I@O #3kڼF^PIλ6Q Q_JSXxNmS(\jƝ 1.<겒ѫcSޏ+ڢ1t*a<>7v qv!lxuee\Y}#)IgK߅q.ҒlK.$F2ttO1HӅ[و A=߲ܝU/VCqV%J_HފP1S"S]$%C{ hleQU~b|㕦GNYf-B/7GQ,KXP:# ܌syJj*jua^=_B=$'~.^oA6X@ 4q cТO̥OSց'P\,;]r)oiJ{8EI:S'l '4I~y>N-Cf8}=wXsqGγGywry]|wЇ9їW團~qB]dٹyv|o5g=kiTw9vAZɝ!~ׂf=?#Wj.fvQ| #;' }2#x~4)\^S"Ŀ&uҴwH,WTA=t ܧ5\Ǹ{E374^E֓m6W}Bh(ĸ=CO>4mڷfO>һyn>{Kq ̼S\Z1jK,7I{XovA57{ZٷMeZV7M)&v Q ]^>۪}/_Em[G_XO^GEyKR/7\[i2B]+kCdW-<{H ;Ne~mlKdfQ%R@65WH{aOՉRn7SA8Sx]P%l=z˨7@WT1o&ʢ+b"=*6-|[l>X\}u9-J?HЇb>h+<|`!giA~<#1M˶f ggUʽ;-X4h!򟘦s&AZJ\8Mæ?ϿVadkh'.|(h韟?], R}W#X#{˓sY}#=w; CO}u  GL$2,v7&XIi mX?Xl[-nM۵˝ZS}FƳ[6x,Ngv~wim}S5.w-طGF':ιu'SMZE4u[4W%.P31ށ;huA\5q6`eveu+1={nǾba'ƮX$09&04iq_rhLG_Ҽ^Jbo'\vZӱh ƽn7+hZ~lnWX:ȡY9Zt(`RN5ۢ{͛};YsYYܛGjշuvY,b, `C+J "K!v X3xZ!ޙ~/Da%&L`ahy>Ý-[Ӽ;0q ~Y-[|IZ~ atSC6Kە˹\\^aӐ_v| ۿ3a:.Bg-ҟrsXqk8yͿg5Zm7V>}^a p>|?޳.b8,?3.}Wؓ9ca`IB$>>)чΏxT.hqyjOcG, P):8r#g;gפj˫+X={YUs *+ \UCnϪj^^YRdLV_U+xQW-V!q-|ߛ<__d υV".j\]/_Of tgkum)momv vgNߦ͢ݲis|8".ҒIkϝA-d9Gܸ K%*7/TE3zm_) YjrZBs׭8| WG\0+}rgyݰ> =[V!4Y|`w@l۱5 >340` pTv|0 >kҔMQy5W~pyKBYNkgM汾t#4JSEk\!BGPFq NzO?|~08vGi>KYGScp3"\v_/Fs 7169VUxP},~6|"TBYn?q,3m>%LJSaNW_͘ܯbzޗӲMϛoE`q-S =w_7uʀ/O5'Mg%GHcY~0t~eMudl~D'=:mwgy2z; kD2x ..Wp.o퟈ &1 ?Mu +$ pvYLyyv KJxQ贤W?0/SnɎhg?XAߴLƱq,*|x䃫LtFJYxAQvz-M增vAS|7$O{º%cc}uEy⛆oHa$y˓vч)m_5TVM!(&KT'%r9uH_ę\NEҰtyKK <9frLS3w?OudȮ4bfkvyŅe%9&V}78=F<)CU'ɏ}jE/UJ_JviJW!{F)w ]l juq)rX\;?](.Mh: `p~;:1q0JYY2y2p1F$=n7$vP1wǛ,f'[F]It8F= Dhnw Sr非O=$}}.1onp\Vҏ/t\z[g#A4|Bc,gZchIW\Y乼{c/|!}~ 8?A&o8 >9@a~,E~$_#Yw_€6+ 2z|`~5vf+ydIk[ {^hv3d0UhA%m7Ɉ`I8O眈 _ 9ӑL&+ߨ_}ïޕm]o=|SJv~=YzM$~}׼s?rW_\?/?O>b/ݽQ|:7_F~/M>_]zWwzn׏_nGf\7YЇ?nWʪ?\񾸫*̫vw_n?o;{tRv!Oogk>w=Nn.w5)DnQ|͂o$3&}-D?y:s܃}}s^vSi~/EZ=[/}]_,Ͽſqmsmwy?kC\LQj!nzk㾟%D/׹u|g}\=.lYnl^ۯzج,SٿrߛјRޗz;_^_.xR{Şأ]]Uli{'o؛o輳O_ݿO~>GXvy/?B>;Uosm϶7Kw{=7л=풓Sz~hGͺ͟ǿWUzèW_a4Oae5tY\ú:R^A7sn;z>վEg\~,ʼ Y!~Mea{ x~罟_CR?(Ý6=l^yWsmUóW~}~vֹTtN9梫lxsnRycՙG.gɗ}sIܢB>zhdlymy]_ [muӮ/h\ gi{Mi;jW_L?'WV2V_L~i5+O??~h}?{\O'C>X}-~g>xtf8ppv*T=Vp04á_z|~~>ӪD/U<#u5a~6I2g};Q}"9G9W_}u9gL~}= CU.>,$Vo\zRg45sB~z FnO/FL={߶(qL۶_-On.?/,-C0y9}/ǻVo6z﮺ _/:_j/r%u[׷coͬ,zF}Vdh?w\ӷ%۝=q{_s<ƝCrm飿baV]ZϤbήyqnW8:Tkg?_mM ^g^[Gs}׳7~^K#ڷo?W{̚5^?tG߼_g畽<-y,MQOBy/Z^g޾?~S~~ܾv|߷7׿2E 7*|?}??V{?}?O^<~ɫWNdl_:yq||?y01H {o_g{_yvӳ|F=Vc]5l7걪 jigoS-+?8Scꭽl߽yfgo?;?Ӭ6TjDݾvOׯ~U|x7z6=/ǨڏWO;}c+ 'O5}u{>GUmwV3)֫-[.N+LGuMP٪q.ԗg+5NUjg6ՍEâ{^};|Sem?v6lNR~wz}{?2N}~ρ[|;} ߧn_{o=niez\~}>0ǎË=^jk8^MGc5+~֏fƶ>Pvhz=QWugz^{mw;v~z;uЏk]o^ZN'n}׳j}.lyG_zi m$r~y6R{z}v˫\fG?^7y~\Tˁ{?.??W߻}v|<ۿw{7?3ź>Cp/'#S+MDdrV<ٙ3:[,>g(v<*d,ܾ[Wg+N=k۾WgvO}ͧï 2Vwgi|z>w\]wnSλkwzm?[_4K?Ns=9xǮ޿Kzv\ߖ&.#iߟo|?T=Y}}dY}>w{鸥cqxɻo?WNFU=u^gUW޵]t{ݾԝ=|d;5h]%R=tw}7!u~ZV/ N=vMOsuv}E}mFՏ=ﺟG{oI^-?ouE}:w~]ρ?ϧ|违ϥ穏\}79yЯC{vg{>&m]}]gzy~LkUpfڪ㓣O>|Q_rǯNԣGGG,U}5r2N]UOF/[WOTGAU&wku;=j;6(ۿߺfEs5'xnnYga\gzE}uu:\NF31Snou?>~}?~x7Vwm~O?OO~׹~5?7}YNԼwn߿UKk}z$xSO3}8>ޖ}pZy_IVq&z]m^E^L@ 7gj\Q ՏU}0zJ-BJ]UՇN<e}1ʘWW^F=guo;^]*ͳQ#[cˏ~۷]w^^T}|~~xdz{~|wOO~>|;|ssW݅~:uST^G#xO3}Nwý:nYWc=/R}^0ڳJB[':ӿ3׵xt7ڬꚀ8~RRUw>oy^94;Oߞc:VPsvz啹fM +ؽvw3f̘1cƌ3fq\1ÇkyZخF7}u^n2iA{. E~A{?lpzzwx<xӧ-^|G|wQϷ^K]&#sqYtsH_O'ǩg#x<|zt<@2wӓ/nOoR_g9=l11gkGXcƌ3f̘1cƌ{{Q^aK_A{, 9q{z3f̘1cƌ3f̸{,@QV-V,媾ԣRso>Uosu?1V >%b^&F@u*iP7݃T#$M)Y|:/ȫL8IRPx<L^Su^E9W:Ϫju]srSs# Yw..,v&n$J:4{_c麽dx<?WS_W-ʿC_5Lv׷Ap5ft<ߣm[<x<#h'S1yv[5??/ǷSר7URSuqɫ0T8kh֫yL4x<$gu{@aH]z1 pfv..$QtU9L%qTe󑪿h:VXm֨׽F,K(/u9S<x<?.:Qw}4noXfrm}~XWPP}.ي:7q]~Uuȳ5ʘ1cƌ3f̘~cqR2V_[\÷GQBndW'5:]MGcy%MRէ[jH ;=uԩSN:u?H{7#[W];?&^S U賉:W_fn]U\DUrY[aN:uԩSN\Utx{fqxlXiNN~ɫO>yq|G?Rc[T_n̪MrUTBUo߭WEuP|&cUS\/[q:x<Cȹj>Ɩq8Jgয়Cx*2G_Տ^x%=Ej4걩WFULݞ&6x<x|;jYs;D ɢ4죬0}֫7\ߞ,tf]JrYy{R,ީx<>3Q7cP v`7>z6/(5?uHݞ bA x<?nd oY@;$&FurI2#x<?3=ֳ"u~g˼o?sg&r,dA7i>yx<x<0r_:ӳeLW/ ?^I䠞i5Ox<?;sMi?矞ȮE]?=2χgG/y:AۼSx<Mq8^<1O?=HS3$""޹x<{o]'SOޞ:l\zN"Ox<xxʮ5y? _eii&s\]5 {x<x|ͽurNjD=صlU Mtx<]| Ж2ԹOne)՗fze*eS]/W6G=_/¹2M]sx<x^*nv}T]%//'GKS볉rS?>G:uԩSN:uOWK:ޓlS^GBx|#|^UTZ/@K϶([,͌c P>uoۛNx<sy]י?v;j|㗓zlVX:q:VW7x&6GǺ^0ҥGܱlx<~]o=V/yuU?Qjl&N l=˚9:h&9u9+˥k˄x<x;ėz;NO}Ϳ*d&yGh>&x<'k嚿\W '-o>x<uU2=dԷ;3HLۧO x<? ?r{}GSzVrڗi4x<=ƺE.?Ӂ#R;ӚGj?_x<~|}pLL}tF[xɥ"<x</r_N$_{=_}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?^J2}*7)❞%<x<7۞0ߟ Lyv0~׾Xhg-^K]~߮>&F}y~x<x }_Uc˶)ʝHu$"^x<;"^pwqse*=H=x<ýwOMqRlN:uԩSNusou00?/7 =XԳEGoR3<Yׯ>_|@ dgó*gLd5*tRXox<$>1Exŷs^8f$_-wLhXl^@^.y^&<Y_>_|a_%uvxbU_:wtzűxOY,^}ޖGxq[w>/}0s.t7mھ#/?szf/x<?x<asF[׳{־Lsx<x^#hlgώ_>"3n寧yg |w>6ޟ[ ?_;n]w{ԷKmEv)⋅wx}WG⋅y֒o=nmd.ݞy*x<}Ȯ)F}y~x<r7>'lS:3:hMx< ܴx؛uvҲ,sMfR݃jx>ܬ5w ֫W6mjx<"6ߔHf081S'wix>}0L6ߩ^u=ܬ<_x<w{\i/w4ީ} '11cƌ36Y5m2؞xݫzWdoKj6T\\՗oת:xU%"ffSNnڼ1y=2]s.mNNN^zB:9>9zO^y}gÇ|y"w}~HV2/`95x<q݁| dgOgA8ggoߨGy6 D?kգ=l!>2}}v}=->zOէOu}mI{=gs3OO~:3s/ Xv<VK>7 (_&j`u0IU2Lq4Lj<N/'coọ$bo?6/Fko3>'G#g+?<_?k^^/RU$_Ϩ>wFosNӉ:8zyl3ͼWV9A>6}fܨ\ ':>xrOԣ:GۤPbtZíag_}}nyz/m05y/n<{罙gHk蕍cb|^F6_9{~9#r\$˛K}}[~eRucUv~(~:MGϛ}trq;՗7[ο?[WdpPWUCӳ첾:9};<99)m2SlI cKF|> ۹ߛ `LnU}bA]ߎE۱Wܧ}x<7>̫S䟒ll0۪UOߞOndNIO>0kz4o~f v]09 T+^QW7kh*x<reCy7EYC}+ݧr W~z~z}\MۣeY]o5)#Н-LmoEޕ,vt1ĺw[D;>?Ho{G~{^}}Y~T/.F<|]䳟^N?;wԛ7W|W홧?olڗa:׫+D5Խ@ZzἿ?G=,)ZT?uozl{wK]FUO K*u ';aJz^ix<7rX 6n*}XdZPM]ap[u[oMy>;?>ѥwuyw5u|yI_:`ʊn] xz:-z][|󣬻qJ$2@{Tԓwg?v{qK~:P^B{Q/bm=Ln*r|)r 9f 'ۙ(h!fcqvp] bxlO9/.v@%^%~M?C5EcdERvTV{+7S@|xࡌEg3M|m*էeeh'+׿?;=y $C;~l`t)/%AcGE9jaMCɦГ80zפ|W|zډqn=8sCRdgx*acQ"B1u=TWGhq{* _Ƈu Kx A ]H0ԼS6t`ۏ3//_miw@58 Nu]+6's36abތ4GCjDx\t:פ.|{xgfr; }#|"*%.+&ruvd$aJB!LuV(ijO̘myW*< ,ߏ#xcSumq[STgwgmSmrSBTCY+Y~0;b8easw.=ouS3Y(ˆqFV?iƩI NJػU7# ʢ^B[!`%^%^x;6a絀JNodV?kiETVh4jc2W? )AVF֞__\nz੤5wk{NgYNR(i>I.:k=әp4<_W+06|2# OX(:XVxJ<^B^Nsث3]fu-VnKK`( NǢ YW?YM }2ƣ1%8gNÓzo^QR?w̧\)|x?1{ZcK's3{;۱7=􍈧<7ٞaHPG$|Z Fϥ;:я5;M:3u6>q-xXD;&y>VP8nlGV18{Zگ;z&d/M*vQz5U?Kk번 ]+d– ߣnyUߛh )tkΙs*\Xyn5q}>g/_1xA2/=tZ(Vb8x7 \ƙgev<wO؉Ǝ mc~}L OU`m^(X&2-4] 2Q-^^t,=NqHbk·XVf@y.}Bw'ц=%Aʼ b9 YRzS$C :8}yҏ%^%^/~ Q+עu@={gb9{O'T?wē0ak u濇ӄ;Ahd ki\-Dlw𘣋gs9K@8ss .86A;]tN/oG 2@9=[{?j*ü}/s{ {/^Mr297OtYmz{(ev. izmןIvoJeOu {݈AVxK\C^FN?;)܏rृ.=o/j/Nxjf:5A[`<0x4DV;|,Odd` \D{BLwE Xd PN~@ v;qޭ~Wއ/.K'Mg[1?6 |`˜=i,^b=罎,HÿؼFx؇Ik/k15WG< Jyur|coR/t9q ʺCqȸ.;>Fvd@F%EsU9Ia/c=܆_>rQe5И{s;)C<'pÛuxV>HK$ ƛVsyA4 O! [>dR푓oV-|~u2zMaKsc|n-(ih |Y<Ʃ/k]f Zח p"*x Mw D]\ >;2mMzDn_2B`/ؼ6Ռ"A%ڹP.qrݙ|ew쮥G pUu{/|1>?;ʼn>:I+hބ( .$ΈE Si.@:0>3AoXAˎ+!/?4tΣ];qCH}|.H,tpBd@ <,_ثr=݋K=q};*D{\jMlQrI&:" @쀕줿jwccxkVnEʅDv\"+]JU9u̫"Wa/@)v=gI6[v<< y~ߝbm1!̱'NuG8ǁ"16îߏO\Aɟc l9LO]?JпXE%^%~hmC?dL石]F_~Xp风|~t5v/N ~"ou~6ݮaYk[?㶩7`\"g78W_Կu5sY _0cMx /[.v9 a1^WS #~8T.h]LcG#8H~E(x*JCCCX׊~dWHKybO6.oqNjBI [yD_h.#B Bf."K_0W~}(۬d= #'Qהu2!SooWTݜSF2ҝ0liiRmxןIED:jOfN&il;Idi&X63'cYҞnDM:bĉ>˭W,^ X0r%"/?TǤ,q&sPCID{̣AcaVzGlc}S_텩8֧ G69/WTTC1e"aXJoYfv8z&9nw䄇v? cƻ\ƆKhQ[ ̱h5V (GGx&ƣTRtLKJK@I~c ,xriW4O,yQbM!:= Z `GePR QOGH|L_qV3&ɷĺrnͱxCh~BNO^=mOg/в.J!(W Lf`yXk=&JsT+ ߤ> vxc,JϲUSk%s'gU^h!-HƟmq v%o]W_i,/;Cȗsja(py=v;X.V%^%~MgXXt۬3ՉO}r[ygqē_&yL"^}4Q"NaP;2- fй ZϯV"Jmqx|~\bQt@##2\}A:<0GO-xOo3z&eXĐ'D~<#l38mGڃFN3Ɖ)K[E)tBbNs܍KK`;b * x[Il d4xѱM\([>H/`Y ^3!Fu ,ì6TXKje>^@+oJ%k/z_Ge#}5L9&Bķp:7fRsŻߩ=[o5UT0EQ6+_"g1sy<ޥJÎ=gl}][59_A&:}l+V%^%~ ʐbߘ]h-8'?_TgbGcO~8CPmx؍MA`B ZWWqۏVLMXhOԯBjYsѹEOc ME y̧\)ʭM?]})> ^w>:ɝ7`~/ôGNX@=t Z8ƞ~bl?%n~}l>?H}lgxxxK,g-/8 lL4]J"9y,\zrI80Jax_}0?,rNz-2$`bT@%q AATqU߻3>aǼ8P{G *y:wHK^<#0G\٪3.(NhlQYgK@h4(Lqn_3^~هv$< (ՈV#M0I%~k6U];בs޼{֞~ၟS)os;sw dVev<ͮOnW0VjW݊/1|y3K*| }{yt>3&u'!yPyBDl09~ #h fk# D=mxg1Zbh\E4G>'ij0j=< }oc0ShԊrB!d'\ GXT?5Dpj?M`y M[=3/pؿ,*v>6!TINUVNrR 4nGgQϴ\ՖnMP/֏\{}.ܲ= $Gs=_ώ/럯n ~{ G3d4`HD%<MJ!"_P%@H?5?߷0;P.o ;ac};f%RG?V|*oHKJ|A FY^HsԋfSya \}zH/n_}n?zDϧ*?\`x7PDkSd_ؼPXa#f5 xzuf\iׯvYcf_1|:DOb7gׅ%*^Ryy\ؘl c3SyX5]+L~SyU V|K&|xU%^%~;ߦD.<4.UCwr;~K ۔$a d8JQhD'P}T;s{t^⫪荻Oqv`/a *]l8L綛 Odl•,^ݵͬǟk#!o-ekv WPkglZ7Mh7Ej4GgA_#'FoӇMZU}Sف=F.x=8?l?߼//COyjT7N^ȱwZ@ؾRw C;G/kV6Y,Kc ^?G{3G"W͜vVc=^/N.G &X.|&8qflc{<'ﰱ׈7ړ\m;x};mȑ3syM=]n,v ꁶ9]`G3@ڪ+oIIXkgIv}^{s2\ u Ys b< Av'k~64udsHpvSD= eCߩ_;}ex!'+VVMJ8.v0^ yz3w%=?9~>a'kd'1>34Sok/q׼_{a_C+F[:൶L]yC;}#}mvSI/I[xxxЪ-$exgMWߤh8>Mz㥍]u?'o}{%zr5s#c9S{|):bUg;ӻK8qpyidGgqWIwY )ң#jyS0x+Jo Xj>+J>-:fF?G}QGvO^,fMf4Ge4g뢫U~) \v'gWxN)Z. Y@xN1<g}(?˒#K_7w!&ᓝl5!/O~u 0gKSLZl1!)t>_,1/61D// K4w ['|NvT{(#7F{S6mgwa?xʮ.Aw%{w^|3fkٴy(15]fhe5.D* vbW2Fta|9(ì>O m*Jc^/[uzYW$O"+;]}BZT Vix|}3ɞ3nϹ +ͱuy)Y /a*Ì,IUO2VdmmGr-Q}p-ƆHKvS|= C{A *CZfg|,yM%}\XgSyWyzt/a?d&`xӄ( 9<;֞I7<ǾJeHc^rY3m۲V55Џ{ vt:^Ͻge8ڃyRW2n4_P*FaG@/k:b 60; J{_kҊg^,fIB焗ʘ5E KTh'3ľ92F>4'Ooa`׽zj .1 {mn12 iviAiSK2!p!`9J˞8_ɯ5͑O<>̤Kf}g‹W?n!|ʘ6GXhIdaL,e+/9: eih͑+a3: >Ti'G boV9ώ|Wo?2g`H,_6є\Qu= 6vShC&?aj{޺^8b/7G@  ŢneHNm˞/w X*}XdO>:q{g@pqm'{D+= q5oe.!lc2x?!94E&8?z~&9[|_v¯;voNkאe]v_,/X;;^׷ξݾ[^b4ˀF7x(u12ƾen|1v.lds;x=xp.W) gMѫ[ɶK-ZQa{߫s+<۟)=*0|Kb*aNy#z 4@k9Jl%BxxK^m֥D_8lwKC :H2:ar'}\cp5Kw!y| lm'C>_k*z;}xx,xG ˯ϟR{+);q\=G׾lz魼ihQ~f޽t?~gVq}3+yignho>w-3cW:`ӆfiy#g\ b\}]݂xTzo({Fԣ=ٞ׋>w>Q1̷?$Ps4X% Ug.DZ ۨ3퉪paߑ#lB/8iܢ50иV}lG%^%~୿wz=/e4~_)A''>c,'{!^wԃе':9G=m})=Z,miK+7Y&p]#;⻾ܙٸn@i#NL|t:?M 6#o3}S1Hp|+ǘnpT6㢿 <3L۷pccc>} 4vGl{{)ǞEʋx?YU9Yt+Eb(V$C `SzvnN[}`gxϹ+ߍr<4<> EwaE?oK\l_S|P1s_JAxAb2lQv?giQYͱEϗQ#/?ylџ\M4v+"{ݣo('3ڱI^yzyYˎ7j՝"ZBh!܌cn[vmWu%hȾ=A_8߻?&-f[3i>.[-YS~^9nZ:qky}.wsU]n'nNYH&ۚ̆:s OyU[P 皹s`a*NLOS1۩+q|>.JrY/ִ,l?hca3e-KPGUoy|"mw@Vqw(Yԃ`!h6qj{qv JKA%@Xbj0vs\d ̑jBȨ?>Úkg|iApZ{K?2[0DM{sSתMc{}w.W7Gww}G;໾}۷,h jѽÊgWmT=zpI)'6gD;m!UtnY0o/rx!B'n/yV֏V]wA*gW4矶vF5׏vej}fw<@:,l9o3>x3q&LK3K/bt`TNvwwcםUɀI !Fe%^%^5ޘXe+?ph2cGx=I+@w_=i^m~w:sֻ-bMjZۙpf}9xo_ 5o|yΑپq݊ #vh>wS͞Kwv5';`]n[b2馠SjxI:石8cm~Jw9Ṽ64եOs5=&(ySGsf|4/  ֘=בq'vj#AǽTj폜]%^%~YV(?WѬN! 4Y5gh5(b_E%š?yt\+|by_ʫ=ퟷ]^|o+>~<#ߏ7|f_ e]KV/u۲b=WL)矵GC?Gsщ =n?}/tBl[~ xN? 瀞?b7.o// Ob1hlU^xRdR$k/.^am|)M}i{jouy8=cv:zWXj.7ܱd>N9+H;yT;<n#tv de.zY9.:}9w*xStBnWϟ>PO]46 v4NLQ䎋߁l&x*'U 15xNagm_=j JK^V)v[@TmJ2G?^^b2^!f6Lպ?Ժ=~מs{#.1w >-ɗ}1߿C)?Au1rq?9=8Î>#?#9%ш۷Y}+KVܠvӻ^WTÊi6TuS31G\oĈ jO9k]^yE~9/1XTGQ1ZA[xxxЪ-$ex1 j=oz_5u2Z`ŚcWqoGtWeϭ<౧N.p۩ _zgpIg.?>7Gm&Ͼa=x[Q?rf?_PN9{[ug;s@ݚ3] z*בl&i N1I\=SO6xr_}l)xs76)\GtLK/{ݯ2mȢ>7CCC(ZeYmq=<.KK[tj''k'?Gt:r65lkzoGy}9%vNk_?r_㊗&^9aK|UW?^lko}#ɷ}GE6f^$Ԓ>Sn(1Ehⱝ=n'qcF㎨qs2; |Z̩jϵC~Bk;>y}ֻ~k~f4}{@Lw83>/kX,׃IJ\r%7Ug[%^%~q.! ?<&eg\nMy.'{$pZZf= Ξ۴ZX8泵_O=Kne{8qκ꿼|ϝA|>n^~g)8^_ x,w0QYYy@+ JKiw@58 Nu]۲m.BŅWYtǒyk;۵'>E/t<Wn?CK77oX yN9:3ICMV~U}YlʯiZ:O1\)vJKU?\ x9}K@xx$xG *q絀JN'@V>oﱼ$96/iM{T٤iew'Ovdij=74Zvu~+_:peegZ+m;s۴ӖNiJsO4g[۪xm9Nz//Co:7N{o|[>g꡾Ѱ;cE›mIM//OcxaH``v\ 5蠟-/?97?uΙW"{}% \V;r9;avx!'NsiÚ=MJ1U?rbVެ O|h//CoV?Ga+iJ0Ŀ3'u<=B[>q'԰Ͻкb^L)v1 ^noGoR|ZX;8cճNhݩ0۶?zi7鋢ڍJn5// [D{Z?e2d=fxT_-/?xd_RU?mgNhcl9hv+<M6]lΜG缠m*LҘ/~;NΘKo=;Wޖ&{ ?r{ƍ>xB/N3Ũǝ˒k{"c0׹RL05^ z^^<ׁ^uc2iՇxxq^-9a\e;Ύw} -/?,F@+BlUhtMSc?ǒU/3'ڳ"U0讫#KWEL_9}ںW<4%ş? N|iܩ:wSN\:8#ob^+gh]>/X(I׏#k{i0M{JEʤی xY4=][*Yл"l'kxxfxqU 1я//߫xPBQVsyAǣf?_|u+r3M^Ҟ{X{^{5?䶳CVڸkuK&/>54}ڴEg.6M2oꔛO?s͡@sv>'IQ` *T /ҥ K*/?L^) 4"QU?ˆ -!JK^V)vb84&r @T^߅'ķwc?ofSb+&?zE7Ϝ_=O]2y}(ࢻ";a@hяʰr\8+ǽNq.'rk*Nf ն-=w+//?l|gyUsa_@CiXb Ua 9⛕P4',X%B-rVW%^%^.^cjP \tS@^x//d4tYk?NqxߞyM߮(h$wqBs %+ash$6;OFǹ/yt]V^%/?TFTj]%C%_>xųr^EKr$9Ԭ; =l"MTPQX%~4*edGGۋxAAuIIAmC8Q Cj+B P; z,a>χ䁃Z>YA//CsY+m9q"Ẇz_1׏`KKë(~~^߼`tvhPh8 7'QၳxWxQ{ȎySP)(Q\FSH4GJJGp Z,Qmy<5TC"+TeРJ}z~LxWwwKx6cW yJK[c?h!!I_`c-| Sqt{z*e؇-0 ar~ ;^eq@bDT*+,{ F#nJ2tYV Ot//CxMJgWZ*L_//b^l3gAb~rPKǞXs^z?B&`o />Qh=:>*>AHo9mPbWrEUUtE8 6]XѢWxx>x?AZ|/?|d_RU?mgLh9';7|4ր#MEk)^?ɵTtdJE/?==`4LtuT?Gm*{wxx&LgV\#*9JK³QV4_E4G>y,Y53)'ڳh,E`0hoB<*m A30]Wat!oK ž VGạ\Yv6࣢MQ;qSMve \KKe=x\mUlyJK|zyU':C&$e'TKep{ ݒd1=BY*s//Cߕf<֩&I];lxxw'խ[X7)A_ P^hžXno#ؚ_AmG5¨Dxb6.gЯFK//Cߝx*s=yJKیVl$?g/ë=kkg=V)^\Sn4nVS{[9]N5l|NZ%^%~yV?-hhhE `f[us^O'8swɗO3B<~LAw ߈&TmMVVW2ɚN%^%~󕂍?G7)|>ֲVa:rxxXe+? ~1fe]6mƌ!~9Co>tߞm3|ŵϛq://9XSX8ZkƊKK?mQ]Z|/?|d_RU?mgLX-WȥypD 2vgN?w왟mٱ-/ѹ[^~c뛝/?Jv/'^~O?ݦGlCj*¿no|5W};Hدڃ}vkO76AU%^%~39Tg:;Z_K+<ЊeGU4kMSc?ǒU0r=+b_E:r dxE9y ]8{ƭGwig"5yG_1sFF뮻sG!z{ýƮ{|8c:kS+/ǟ"0DڣO~'#:C*eWfLnwi$KKpC};rxaUu<((? 9?Q3Kysfθ{-ΚyݬiN<8'Gs'Mr;o_ ^O?H-ͯli^f.>|_my}Y7L>'.RB!:u5lGE/ڣyΪKK0CVJ/e"pKKKkŞbi\!^xzU5?p6g..N?qvǙM۲ͼOߒ|*MYT?"e)*.>r*V&6*Uy m]ڥ}cKKVdBC,&s,o PMO䎜y;=@Qg꡵V,h[]>k-}q!s^)B?;yϟ[L]P|qа>zwyw)xZw{kFkhπ3.V H\6KKBXꁱ^KK0?28Z@jo%es\ 9rcbIusIN=/^3; U*IO*+opڋ=x؇ui ` >b%o]n3]բjzIKU`Z\ꁬ%_>xųr^EK7zu|}QY Q7vV_w߆/ʻ/7SUߝW麩ե{ڻ =z-+z^]{ֳ9r. J0xlWJKIvep]C=/N0%^%~Us ??o G:g=%C$)yrG~3ޛqm;mI'?#;v8kRrJN6/c{(E꾭:mđ-D [[`O`; XJK}VfggRH{yc$c줳'"Ğ*//dP8BIP;BϜ)+y '^W0WfߣOxO$J;OG;QL<_żX|z766Hr*؞< Wdg7ܰOYԳRH}sozqtb*BӔl0O.tѴ/*s;ĝ_77k+^5c3{~ 6.!%#KMÌzuEQx koX2D|;_s?ۙL/mlt;k|3ascدtݛݺiF}_{ow?':jP2-+kU^oKgwϟS25 .z8)7[~},DwEWD>ȇD>qEWD=7s;C'̍tiTfxjӐjɦe;^+U=~Ͻz#^9xN|M/ޛۭc OSP}ߕ.Gfl+|N@J\OydRjgРcߋ|MN:ꗇ3#at蹡!#' {3ç'G9Sgto6WS`ś񱕍MX>4h7im E[y.g-oL_O \8Dk9B;C;Z)tXn\TpڡjkKU7Zg-ߖ 0^7f]k<5Kq u'34Or=|<{+<>W4]r;kf57| ,O17݂J# տw?_ORwrN?&I _/p!0{=}}}6b$Exx૞CE?q!^A\|)d~WG,kap9lf__</;kl?Y=w> gw^zGPɻDc1>8 ڧ@Z0F;x+9ZecuK+r`&Omˏ x[ ۵FU w1eW y\/GW;`k0oF++9.o<˲vl/0>1^ 3G֍Exvx'G_?'ؿa<U.νog2 0^'^o'Yz$bOsֻ̳BQIu{!.JY A&kPTp;7ǛO~[{6[ E%OF"*6O&d,47}*>iW$;/+y=oˊy|$eqgcLYR<ؿ&J~#i' n!qF~/~j8Gh39kJ>u ١ev[2WvK֪xn^qy?|ME ͪwt:IV*q~jd5v؍Gڻ<[jr䌩8x|5 l'Dd<BQʻjal$?lj^*|+e ?ݿ x)y%縯RRJrfU?̤x>{X{'+0:kVV۞tR+4|?mJ'|cwuoO|,CM(K+4{g~TBih'l/X,2o`؛fcoGD;&~g5.KbO!5pp{ޏJ#ZWR6x yOwo %'_ۼ[2)OkekhбßT%3ք<،=vΟY67xu8zS8M%#uX'ߖ V8t=Ն𪟿xy:w醆0Zz;[ߪ" \x][>[:3VnqQ;;ϊjOGoqwasYmgjIqk"hxZyjM#Xpc `1pq{9r[%?oe-Mu]F2i&{0n>㱂۩3wi|!<.j ݞcWruB?І UX[z~W8k``@_ #Mf$qޘ[L5َA.ޮ5`,(GƗpgYַc<??H+.nh|׊U5xxxW7?5Tw^fYiD!a7j{eWf:k.Urtv<^V՛xVNzɺ\qsE+|U#z{?su T_3q/xk5PӞ?c\g٠>;=?]#`K;K ?KKs5_k.sݥW]xw\v66r1A?D)5xx^kCZ>O|M񲱺o0'dž <peZ^#Ҙi?O,=#_XYFko4z?ǯw)<MP~Bο=ߛʊ9ott~vDfRe*/ht?lhQxk'r6u KxxGr9?u=;iqg-oDR||| k. $ueQKshIz>Gn[H?sz,j;]r<==ȍK/sA_7/iG`>Aٞj?D}q <_#|f0>gaU[xF)6UŊX,,Ѣ\;|qY@˾7H^oKgwli3T#{o{xx ;3[;gŎoco-̩\.'D}ο&~ Xg|;]qx 0|+\Y6alUK ͓Ҩje+|Y1!MwlCVp=x{3DofoF}}^}zֱ&?|w~Q_]/.bLFXÏiJ?۵ϡ{EĿvCٵrn&ղBΓnI[TJT4ڋjVgWZ5sf{Щ/gzx;?} ? g"Ogkfx૕w2z:Wž3? ;&F?/qKv7QZ9'n *K-oEّ ym7|Կw{y7:}^I =Qg_B6nwxJ~Dϲvxkf?E0|u~| ,gys<γ%$~8}-B/ IQa'BbaT !42=F;~|x -j?;ZWuܑW"ӓxVcxc>_k5JxxX7 cx2v-@w]iLF?'WG%Κ>f^ǘy5wڭ-uc=3'33g=8c䄎䝳p ށeGΣgrtW[%[bc?*7s7x૘ X7FQIUC[x^ܛ}*V_'/8O΍-mHĿ;'O.?ڴoOj϶;>hi_Ycp}kWw _Mo{|yaփ-2|ON0d]+Ò!xk78\O{idalccmY Ǔpnx(x _`?of4q;\O~CNso:B=rKfo:Pw}+={k?g}p~ imbÛ)*SQ;C]xk}~= yU~ <o FyxgiyPf|?4X,e^&>{,X?wn1@-SS;#Α-w?!t=cPD{w=wپmb+>ic(9gF?gSIS|RV.B[V%8|uQ&ne_7pxk/&OLhVmo 3OHg~s|exSw ~8 KΊzϹ 򇦢ă)N#/Z&q5pO>|Tl$?lj^*|+e ?ݿ x)y%縯RRJrfU?̤I&|;Zۚ"< w켳ݩoiKw&wW:~ yBڤCs[&C:]#4AT2ۢ?I>R;5 vu 264+]j_-J~W*u?ߝ'|m>C_oɤl?ծϮAH 7GrXӗѯDŦc揢"~xӨ3{+I ˚~ߛr{ e+U?5|t*ϰlCCh-H-o^?_C<ծU- 5dB <_"Lǚf'OF/g35glk ?9&/nDk9B;C;Z)tXn\TpڡjkKU7Zg-ߖ 0^73kgI.:+z)j̿)  D}}&ߌwXY7xkweY]Uj<'|VQnk$p*ՖJT?^ =sɷ$o'0Ie]('ۊч]3B0?`T;.xzO aı{?_#ҹ5T)?. XSY :9=<qr]X?:0V-tfzY=Vo xZyW;-'Z~Ȯs?_dDxM1œ;O)^ٟZy{|$9Qg_B6nwxJ~Dϲvxkf?E0|u~| tߙgys<γ2>k:8x]̇5!}s_^</[_3Ao]~l[:9y;W_]eA'MQV ʲ^ePi<'Ӎ?ѿާ~ZBp@8^k^IF+ǿ?f\kŪY <_+꺯ScMu?҈Bvto'}7k,O~7w0n^~a/Urtv<^V՛xVNzɺ\qsE+|U#z{?su T_3q/xk5PӞ?c\<˛q֛ yЏ޾;>y!;تg4~azvH_ܗWr /rh=غѢ(<O|'Z ?_;WrO{v& ckZߌ=qvRZ'>yӖ<?M$[y)|3Oo }yS Y̆ O73Q?v<;{vU/x)ޮ@ |ZӖt-X㩡=h0ʱY60Cq [#yg}yF>G/|ȕ\Ȼ.D.D.1sY"yG}w+/_\y/ɼ9gF?gSIS|RV.B[V%8|uQ&ne_7pxk/&OLhVmo 3OHg~#y6~$Oq'=zO&锉w?<ɓ0')xL8wϝnֽ|3Ο}_q?K#El$?lj^*|+e ?ݿ x)y%縯RRJrfU?̤/oځi,ui?3o||Otϕ<ݪޞR;wޱnε6lݽj+/ߺsNl왞imOg~򵿸,"\8/Mu.kxkw5ٸ׼ou-YY|M~>^oKgwoߧ=[#0-s~u'};/g|BCG֥_߷b(kSm֭Ϥk7fҭVoLM_jS+6/z?ݏbGYwK#ƙ072{S'ӥQ~WbNC'Η{؆zWz<m7vWf}2~Oӯ=[K3>"t !MYݻz휶vʝ[7tع}ںUszb9[o*wYD#@8c? ׷]rdVKjQʆ\YSʜGGfܞjCJx_ <_5O]NwX$8^k^IF+WhvhZk5nUuՍk C3C;Wm{`m]R ғ}r2:y`f>Li,}VB ޏ+w 9邲]Fn$ew|*G.v[bNaú'vG%<|[W/\HR(e/`3?'|3Z.ߵbUpg ެxޕeuW]1榺[YiD!axW[*QxZ@'ߒ$Ɨ γddY4$:zANM]Pk^88˹B;<9߃о\.r%ZMtu_Vl^얮{;.3q7'^Y,(7u6|b'5W?K>pέJIΟv€_ 9̀~s|LD[MXu~\R_Q?$nA+j~_Q̏.hx?M0;mڥv-ٓܰmZbS\RY%GgәeZY/j]Lk!^Ε|5 sR?Zwu|W{s|j5`W:GMw䏨aT%v_e -u{'\f0ͭ^;׮ZIuZqM0 9Qg_B6nwxJ~Dϲvxkf?E0|u~| ~>so_\?e2$(; EJR9N*75*+j}b|B|h{W=uw 뺗6[ov{&O0w퐾V/xk-} ?Y.?6\Oxo-+oW-@ߕd.OsBtv7Pᐚ? {U:G|Bɟ@hʠHy+لĚݽkzW [R 0cӺҙǏ ?QL<_żX|z766Hr*؞< W:]L5בzTEZFhҴ]bQ>JQ&HB.)h#XҒ]=`%} sO?ru ^!&K6tV{iG[HkEF %wτRN>x@=K])`QʬX{ύ;.%Y{ڧPGP*]fW/seoJpL^ʾo~ <_MЬ(~@gi?i/'|sz)?~8+!9*y2RC_oɤl?ծϮA):"Ow?_rl"ʪHv<>gVۜmLי̛7~-\1nN~pn?.O_FCW}~胑qA!o%B9:J7TV«~jTߥDFبs+xkU_U7睾ve^yco;ݯ^o@+Jz~ )'YnTs5E;!{_{K**:g`oUuWO0@qZ׼&V}x૕Y˫4% w?xAg,o(_<nUӿΏmF?UDBQ9/H;Oܹבv@vԭ̷/o ?lN*z#g}Z?zoPfDk9B;C;Z)tXn\TpڡjkKU7Zg-ߖ 0^73eY >}ʲ[WͼJ{9>[up*ٳE59O ԧe?ܴ;!oH-3bvӸO+>w<>W4]r;kf57| ,O17݂J# տw?_ORwrN?&It6^q-'ڮxۯgN9}J[Sf$>6Mh%=6DbM4o>̧sX]?*7s7x૘ X7FQIUC[x^ܛ}*ZÿX&2<η>ݿk/)a: n7N3Zh=غѢ(<OOֵ7,"\vxԹL66:Ɲ{< '{?l1' ('bLd>G8wx>w3{0V_-_S]#R*-?ZSCO{y`claz2L\oSz;ogkxϘT,Ϻxzo_OZwdzOSos>?F*CjeU <_ݼAW 8o⋲U?'ҙ>21c02x/,|j ۻ<*yY3<5ɮa*2t*\vx䕜JI*V$ 3./'v>v;{zCcGp{}'~0ÖveM^"|&ռ~_¿7+ xi/G`:0c̿.1Mtfjଭvsm⣱@??)eˏ'a>h ͓Ҩje+|Y1!MwlCVp=x{3DofoF=`g8u /G`A g6a*oCȬբ wxB^SzHqB/9 <6s?LSZ?t{љ{mu|)ɓ6>t=Ն𪟿xy:gXA4^jx!jW}VOvNo[Sn"so߷vKvب^k^IF+ǿ?f\kŪY <_+꺯ScMu?҈Bvt/]#c=EQ$V l?oxxso?ɫX}\.097ibG=71djփ-2|Oou KxxGr9?u=;i|>~ovx<~fi&< =>⍣=h11,0g{4Q;C]xk}~= yU~ <o FyxgiyPf|?4X,e^}*w f,ZoI=Yw޵0< ڧPGP*]fW/seoJpL^ʾo~ <_MЬ(~@gi?i/'2.}^#"y{w6GW65/tfxFx_?ٕ2_CW_<sW)?W%9ҪRdvfeer$TS޳ {֠ \8/Mu.kxkw5ٸ׼ou-YY|M~>^oKgwWߧ=ē_;OC$̍tiTfxjӐjɦe;^+UEDc'(q x zZHG^QD{CE5eNA{uE4ЛSIN'9xfS<~ #Wli/86 ^tqSŌi'Y7| B~_Pxxxu_uƘng ~ՏH- Lwl||9̖ow"UThZ19OFܱS%4_AWh?/췿o}r{,<|;VeQbtۡ,>A-fbc_x^`Bi<}T?^A @kȨ˸KXUgU#$/j}<9^Q(wkK<b'5W?uP<;wR)?. XSY :_ٱ_本kg"Z I\iEmVf_0>UnmlMl՜kn='dNm<<999/Cgo(}*Sgtff?ɚk[ɆVL6Oy_,s=vw2z:Wp n1789O"LN4sw 8/MO 2tB5ge$Jm\F{\iެy ͮ>>/ !TG?99{xxGr9?u=;iqg-o5߸#F -(UD=H,7){s_rf=vlnݲc{dzۢ[EnUZOLT;Gg>??3V__S]#]Fmx֚<kl`xj(i3>r{_2Lyev$O#WxROU^'2{~Ҷv]|T_)ҋޓw@ґ;6 =@(+]@g.idP@B{33ޝ6 Jxs{v{'gΜgr`OVza'\qi)qs&0\_t}*ܱpqJ營tuP٨U!mjx翢t8ʆĿgxN)? x1UfY Sx&4am_ kib_OWE9=Y-eIu+8vy;6Lݜgwf3g-גߋo,8M:3{Y=Ǿ1*Y:FF/D"Tp8/6HO6o@+*E}~}p݂F=q~zcgxtU*\BBTT 3ZbkgxgO]+*,]U/'4إnqJvm:oI3JzϙQ,e;q^tnEgÐx <<ȶ?[3 _r&;7mD 4?U/2TG֩ڼa'ڨjP{7D{CU j[%(٭i!'WR}B\mRh b@Vhj#Bk/ӇZuܺm-}ENF?aW~} ??/Иfyj\vĽGh_g^sdױc6vۆ[h-Og?vis-N(vm>Rs;mN.q*U^xG8aQR'c7%:|h˧^>ehʬQK]1cҩCV Sfw8{7ӼC;9XAV ! ;4ZCV{;giljʐfu#.A Rct# ÃkYB;2CjN0B kZsDp 9<Кc}JDŽ TG"$ɏiV # bTÏZkTZCjF|Zo[( ВQssR#+ 1/9gxC~ bZgr0ix\Hkh+ ^2;@(kL9Rry%^ })vy9_df|㵵?ҜD}|rR<+^J@*)*?61!nqXCw)j1[IJ=1:[ЪzѡyW/(e\?kThʜFtky/x[y 9!u /Asj k^![S!Vp]4&ΰo5 kzC;:#6m~gOW6ؼRj^,J9\~,Sķݳ O] O=lp.{ۅFǮSG f֘2-%Ǻ$&-b _Qʽ>S6 DNfy\/!9.9kur1qa{Εy'G80}qrW}u8`atU*\H7Kگv Ou~-^,\gxss'Γ[iD}xTU/$?6V _(i\ ?aV<B~y.I$ڔO]ӏ%E=)Sӏ𩞫S^=f5)V.$y^bB۟X&l%3Ǵ8)s{`u ?SW4 _5up:b{oܸm(:ZA!-xppH=Gx'Ff 95q U8v B{>P[9:0:2pDѲ =pk _^?:;0<\g܁gM6_퍪/sp>! zՅ !u g2S6!Í!sL>0_熈[!pWֆAb-1o^GX w["BN}'_ƏBb-_\ +ekEd\^ h/Es$XSe?s;ۋvy;]^'ȝN ,Knmx`ڒ 3#0cirFRIp*!Jl*ɳ{t8C+jG+qBꌡ(/G5BRƜro+aT͛ߢ[u7xG(FÑAM8{a&] 77~_5֨_Z7"x^8 F{7 w]h!ѨFq_OTVD7kZ< a08fϰ&';#?;7oFCҹi=40<*?%.RőPD^!w(ɺ*ܣ%GGGl6yDW&Vsh w7LyKg-N4ڔ9n˾eK:VmkW z}gIt5k49F ~ 6+*M9A?BսH{Qq/j=WRs]B4Ο{3ΟѪX煁<8E 5Bw\GtG!Z6*$g!W:/ Ͽ/ / pmd!s Rs_As `jboW;6伅}Bk m.)?CBڄkBBAHO*gwπ0j5u8/cd ^q~'y-m;20<3wIW^ kp_(ݣGtmGIw^51SPQ?!ujDkA;9rB>2ڨfXӚ yմAu@G$<찐Z`<z@`kmZ흠Z>;i5C1.6 lѨWZC{A{C{ 8\VU?ch-Ձ>Ep-!5u9 6_;\ؐ>pRG w^sNs~W(l:/qxwuh/OkJW!j5 < Z _F7Zb ᑑ2>8-|bN=Ԛ'bjSMG@_Dq'螪 #k@?o^61^R{|Saېbhܐ\,CLN*?Ë~&8žAu>b~|x3&^b|a\ȃ`#D>y~CкOڿ8|#'t{`%XOk‰gmzgxj|"?=Lߣx1UfKorgxg ϯF)Ź'v      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghjklmnopqrstuvwxyz{|}~F?녵&,MX?~DNL[|&ia4 dMЮOXLJwt_?/طj~q_Vň4u7<Dž!kZu*{;9 AK GWKc1~gF6>16 p{}h$2YإWbLpu69|?/8QWv@vtcsNM*?!;d+en#/I Ui 9KŒ~'UI?ҪR a6nSE/'dc =AS9NmZ_`_V;jaٷ+:F띃74ؐb&Ίf5HD}TpӎqB֝~x5;|0 4/Q홠ўqgCv/LABkxI9Tŕxgx{Nv$왹*qhˡZ+k d;. xyrH}RRl<&ą4yc%=* ;_@2 ~q U{bT7%F$$tޫޔO}zѓuPOX]y־:p 72* Ar YqT$#l9=:?+r?MMl^gdRPRx|LFjhd'h}WP{~@OV &m {ユ 'ػ"fL+}qwy.Eg1EC |q G#PĜv+)=?^=}tH䬀'; `?Ts#&pxv#_{U3<3G]!E,9_UV9F]Et`xgxK*YF矲#+BZG81!~qR&%&$LU0[aOPGΟիI$K-8V<SDp[ƾޒkys? U,֮IJMCv vXc\{dO鮆ڴNݚW~'@ӛۼ H[o/i{:wF֋B\Is^8a+; хK/q;D#,3<9xhݤN5׬WVRkTT 3Zb,vq*k0EX _Qݥ/챢R3 h#ᑑDoӦ{e޲);#DDFuYp6:MlJ)G:2MxDvQovxw_y'/ ( ADxqH+H||apKSȗx|"Y >~ȧ_.~=?՞un !"ё!SĎ;;3Ow3x\{ ;ea"qggxx ??v_ }xhZ.0iitAVOW 0lg ('c4XLfMD'v厰XRvxZ~=Gͦxe~r 2̿1, J>55~d7Zږ++Ga5QgO߷2ٱ73×#K3i!siI_Al\6Av S`0%Z 8 exgx(xW/Qr䬬T\ƿ[Хˈۉ.U*PoxZm.,㵨<ăk)- _^xsEsݔ=ɳ3Vf|5;&[{=oPqFp j_INj/{H-3<3|kb5P.\@'Gm,O+e2ۇB,Y`ZO[2ek??ˣ?(6QAylX`jܚ ŧ _(i\ ?淗{V.@e ^=v ??dU7Bt] %HWU\E9n%BTOr?o>U ޔf%>Ufj?r'tL1xA')+_灜VY#RFeݍeZS,/?w$}OZJl [<y $.?J/xڞe[t1]KQv~2xG> O| ls!պҙR-|(s;cV+2iEG%&0o0<3`w:POt2CAe n7x#PoF$y{40x<nDJlS^f{ҵ$χ~$<}rb7xOe:IN=Jq͎dUdz3o}kWuT1s3~9Ë~Vq_'Tv흟/ xa/7=3__ > @z](/*"5@g1 a8@wxr~η#}xh|n)R1;3;W\ӍY?Y pB[\wykn͖,jO3ZWWɀ.3dDd`1a)ܣ&9,[k ݘTpkV--.{{[e .zsIk6As-I ]fs3$'uR^%bF$.vф89|Oqcs8ϯ䛕ZbɐpvVbYۣYF\_GW 勷JD`$olm;q|?W×GZU&\kSAFMtj5=X)ktUt]_TYpꙂז:텗FO&߸6Y>w*(@OKύ؟^pMvۿkVoZx%{#}Ey%k+~w]2؇5DyL>"*dsnIMI:wzowq /tp;m곿-U:l\yN!>v=ZX<8k"(_Uv!z'fb_YKJzC,+^R%b!ۉT(t*{%к 1mu6B>%~@GmRw#?[_ț?ɯ?r o4|-NC#+׹JԳg^)\r Uv^Zzt܍/\ ~OH_ѿB|_ox~/ ?CopP= qpïyGr^KxAr_T" 51BdI?zrQЮx\i,H^T\@32h@( xj3 *>;K|ಥJR=T{[g?{1K<}aAF f* ? &ͺIFI$3403"9_shtg,3FIG`|~~Hᯗ:;N^ 0I ϝe2S98v&&Ie~w3o_A?!x.^ >\IHS'u܏_jUǜ=;Vp܌YOӧz7nL/8 ÁX])DABUNQ}F?IuvI]%m=J-2^2[3<3ek}<.2l~R/pf7 HRcLE,9O%dt ʹNqִܰ橍!c}Ӎ6n1,- Gfgq_«o/keb.f#a9)!9|GdzMkƈHx>ř:/3H#|- I|~mJM/\SNO%&/OxD)>5rr}Ϟ{ԭ5pQV<]Ξ~mS*Uϝ0~a/ &Qcg7Ч`@V T &J{*gXO@zԃIIHDUE?>9:#Vsn'a'0VSPTgţD}xTV%"g< I?kw_@njA~zUKjF@rV~T [Ǒq[⼎xεcs3srΕqV: /S<ohTHfT<ڧ~cw:%nTO#(waj{6M>[͈&[/_]!͖l })-=RڟX3 >]W)r"b̵Aww\x')|LmbZ%-#@eM~zY[ ?PEW~$REW*C-?y${ C1:y*CC*(}xxK'^2Ͽl 7ǃ?~$.5)v' $yH1K lk D~o yȭ4?/t,@㼇8C㺧::\evgx?xFAKhJ8Hke﵄F5WǷ6d؟T??Kގ $}~L,L EN)?6F/_ͮ PF _xE?/,J7&CA1ﵿDgDwULG_HvZH#Z]%e w)^?T#(Svr"Tvֲje|Fj1=#\ Jr_zuV&>`{WF[.KIE~jQVKNr; -g~{ v1e#U'b,])'EɇWEbxgxxz%U< ^*`I&=±Id{ʘ=dfwF>}3ьZH-=ݟ?fvw[~KlVhI{7"n#@w^1@_ۢ[׻9Bjbs ^K~S]^[Y QCVßaI~\=R7 yj5W<;/55.j㭪 U⾑"j P?w=gRσѠ~)[~-L`ϡlkj?jKTXUk?m}_P-2{Z?$F=ks63;3{ @Zx?h'kA>rn2ǔwp߫7C*Zv IQa2ë=T`kگde !,6Zx?Emn?_6vz/xϘK{noY ;k/_BsYý-KY wظm '٭"-' t* T-Bje Fjh+ ^2;VORrVZR˪}UKѦ-\?PjReNUvx2ԖӕêwMz'$>~]V_Aqem3O|duȪe}fdC)ӳhJ[T^J2;;8~g۪&-c_֧4;)\{WCyW ɟ)]TDv׮nb+Ck "E /kB /U+`<#;_ն{|ޒ.SR^wndaEm=)_JorZB-'-xXֵЪ+xF=T?~TJk%KVY~Vd^3ȚAl-bOF|dKWlt[Y[ _Qv_L x+,SRu9zho5كaOVeYrZq?t/k7Gᗴנ(Q[Oj&NZ}(kVf*_:odK>KY~ C5C0JTm6?_ Vsr5Ǎ¿$~Tk jkŠ礔kjB|>RW^1?OO㐼;b;"^xOc%ϏQgF97?D9jۓ/y_TE3;R}9yNxx!\/=MԇGEPnE8l1^Os*@$O{* ES9sS9K&s~4gzN9)<&'%Ĺ,좟|\n-ޔi;g͔  g(;i!to%C_;hadmƟ{B_\1p.7[$Z>=0ȁO?2džw}lKLj=LJo>~a/sjȗ=զ` O|阖! ǵnFׂ'j>'D˨׃Ƶj>uؑ޺'?i:lRē#vς >71v G=3'9^ngb}jfv|ifwx/XvymVv}uV痐X/\س5Xt.jg˅ {;Zw=[.*O8mv8HE=_$H C?0Zz c,%FǠt@8!vZ:#tDeZNŃ;|k(,GvS+Fv]9+`_1;wK,)zzǚ1mOx?&Y57wX&%@oHg'07nrȑ:76cȦY6u efmbFpĦ96cA3Fñ5)ŏ!;mјƿ3tbAygL=~œv/I{LS`GLo]IAIt,vhK[:e߲ǁ3@?jWMpSfvHV+g|f׼ Թ];Rg^;}O6dûMwx\O7, M1_ncl|s}|9_lj;_nKJARlc;㻝`ۜ4妜#iٟi<ӑ/|d+€N6[f}Ѝm4};i,aϩwqvRptOwۋc{n;?f)3_y.e,H^>Y/eP}xsʳ%GGGl6kus,U-+f%xCcxgx;Czrh.kQ@F%FkNj^k\p jLn^g\'Ǵh8.u&՝ܢ( >ɧO~&?]uٙ>43igxY/= r+x /<^xx#_~ Y/<|9仯Xzb֫e~k/$[{Q ZN7@ =&<>&"EA!,ַ l,Sp$i? tyK>]_ֳ˻<`YeA:,,z W|iEXe=L>/Ҫ>JȞe^^|岞!땕}_[ o_KoF2mHxꀖ߉}ݐ8~pځiDfԁoYQrӐp%mxӆEnǶAn17Gu<4-ѷid;l 0v|olg8C)=cJ;, kR=Sz't=Ǟ=wOgjNsj{i=@}`ArZwO}{ bp=sw~psX0ء _8`}xȏ\8p ?>[4 ˑ/qCa't(Љ|OΎ|8_,7y#_땓,p˔D~z)㏬Z5Ui Y; _;XNi_͚)'6:6 듎m}ڴoM>mͳM~lL82[}~ gnw [o X$7&Ƿ{| {&榿7ϰ+,1HO߾а'{ L35N|?ƀ"#ر4Miګ;y.1[$Ӄzh)I K$X71r-.h៖Cy?Z |ӟBkN~t>K=yx93>q I=骂#?YOV~Ԃ/Vr ȟ]ߤY"/|vs_G\zrb9mڅc[.c /яn>XxэH'[v 3_7-7v\Yа{!}@ +Y\u-s +Y{.'X7Iq;Zg OCOC`?9@G>o] ~|4: A C} ,ñn@[ o:ңc@Wo6bHr6( E  N#Qm2=҇Gjitͣm:[Gp@`t<xl=B ]kbmc:7Ή]vLDv I |bz'BI=(`r}S{@dP3o~PC?X9s@C 7GqC ٿp} (`;P0!Cq@gIAC?F@OOxϖ>[6пX6B}X?G&Yp @O*_F`Y55`@]j0B4m:8qM3nqltP8维#;~ 2Npc%EgA>AܶǷ-g+.;G= - C{A"X;;-%CB a?  a|Z.08* )'aPg?_ OA r$/סa> '~5td/]nÏ_|to7A_:/CCahpm`柱~&8elr+H+'y#k׍p\zZYe_֮Ukݭ]ᯂDGotNuxy`L?c~_Oծ|@hڀ/K '3N[??O5tͿ:{\Z-,7\Ãjj:Ûf7͹qӢ&gܗGGGgOy3_x/!u4:d@eĂVu,I_ I$Ho' f룛ң/i>BqHد`8Ѕ$uz,y%^Ho=?I,^;H/2 {JACZJWWhok8k)p8ßF`ӆ!i"An8n:$q譣;oE:vw"8 'C!m; &uu]P?+0F;dr0}!'Csi=!ߋ$ۿofb91~(9?? "g!$Hlvp`8K04@Eh&0L sB߸;9;Q߸;! }$Oiw|6'@؟;B}M{IyDY:v.'~ BzQ2wgB~ZtI< |k $ɣ?}F$F:YG2Drx \v=?}ǯ~>±Mx'!~be2 dD'[v/f?~~K$$&ⓓ 8K@:X'㉞[KX_"|V_~&wztz,ה x1wfհ`Q ux„Fq<%Tf?" ?ek4iMӴNwkH4o4*p9ϭa}1@z:n7qMz>(~I |1O6zD7lDAŤ`h3xԓc-nE?a L|.=+[F`$M ?6QIϏHmlRh{0mO{@9OiAAA>cxAܞ9W _#g֣g?^8  )l.|hS _4-&mŒɘU',zlsÊ0`jsU+ |s+i?/,mkg,[5eSZx|)+G[BgD-ѯ1>ZmmmsT5A>ۢCP?qθ9{c +qIJ/(@*%;q>"2| !ߟ̥sWͤELh kh箤t8g5<ơZ@ΛhPhDz)y-@MJxk. 6 Z+a嬾ц#^Ͷbo\)@ш7GQ1 j tcpBp 8){;AmǖXw$ؙޮtLk;3>00ݝihٝJSR_X P3lX>G 1}"FM; .B HG~HDc]wKWop}aA{ݸΣ]]gM6LGZ>:+=n #qcF=j_hMtx+~}_ .g}O餡WcR0}ݧ?>~}C>MW22^5=^p ]tJmtՄ |=,*YV*F"޸ ` }_gG?qOyÃ94v4f J?0"22?GaR 93F%a̜9:mC/b? ns@Ϋs Lɟ#2ł--Ձ LĔ|L%* K$+PX~TkVPtrKW>rUb u*k_B_$?`:% 3UoTPYU1wϫ61#fEо3f>޾4+{c 0S}Ι .c~e?y?b_ֲiKK\[Z#yoa/쏭_s(kb9\ 1Om-@eG g@yHCq+BasؾuC2]oX O"!?%KlmuZQ==G>b?δs7C|b0ooCC/ P̅zs" ?#ӱ"_KӾGl+[L"l $22x;>Vn-n{ɷ`gF߉H-[N[reOzpʊw~$о>ҧ{Ҏ=WN;Iw+I.y~OtU?w?Z}|/O} C1}ȕ_K_zew[_μZlM?[vzK޸Ko¡-u ]׮Uw\_X~UL#_rs95Zoˀ8\-h: jõ zdp8`.'ʹ 8cذ87ĉ L 'pU @y~Q ]Hy^OSwDB&N9"$A;e;" řh9g?M@ƴ0Rق0WԊ@(k>P8?"yDscES)Z XL g?bQ\jT.yh?&-zjWR|҉VLƆA)2OD _9(@S8<5f T WL2[upm?34 Pmj 5i.@15)@[bShGwA-v."tIS\HZ'aԥ+QSM6fڟacj#Y}$Gr3k!omsa v7Zs@Dx[\#96l%A觩(8V樌`ο"^ND LZ8۔ԠRp8?q[c@\g>(?uoKxW v= ?Z"ȨdS/Sgʵ ۿ:@|v/?;B!TySq[QG߮wG"'c4uyG|Wr6ޛqDmak'=wO4|ˁ?Onjکs{9~?[O!}@v{G'?]sg70.>s6A>?WS_b:0rȵ}'^;gtΰ+&{xy5ӆ]}3|˵\Fa>)U-"|o+1s.HH=R M8 4!n\vԍ B(JCܨ4 \ BO#* ?aqqbxRasO;7f*#Giv̄{HAq SGϛ/2ScR^?SZ飲^=cṯ3gəH+2?QU \c- GHg֣p >Ɯ*O?'RŒ ?HXl+͟g*Y rի^ԠzTb#-2b-sb8U/ԄT-@ ՂQ5URWs[,W6LA~U ~K,Zi(֘9;H) 1?Z.@qeҩ.9\ Иֿ/sű7 M*@~sL*SaQ;ʃe iQo ۿsh7R: >r-3ќoΚ&pKllM02dlS3jDv]"g~#2A$;t(?C9?ڛ#ҀϏ!h'cje>?V2T{@ ?Q矕'eoFow4}|Ls{ uǏtwiomjw qiw ^V[K#4,dQc@;&]1617\}go_v;~}Nsܟ1Yx_w;׾}˵K]+3W )dE`#ȇ3y-*G9ZOsZ08\6;`u8# O *@L%t ?ދJ[#gaoM|Wҳw]&ޥ 5?gS"xR՟7/> 9GLINUrx.*zX߲ŤU^PzOG0_4I/Y ~h[,RhӴ`,}SϔQ-Ī$sLW?FEo#+VYPu/Ψ]rJfgeu!/1&pϬ %g+љ/n3%j630_*@Ԝq ٕhWʂ]`KZ7e ac#3i!\ؗBgŞ4%̥rV`R8_d` ZX΢KB>ƱuG ת ĕ\Rk-8*#`UE9ֵaʦ`VRtE@adc[hRPKb ~\ */ S;!*1)`9 ioOy`g}*6gt(W "|3|Rl*Es'M6n>'fˋǯvZ< m4?:1cƜΝ>`Y3S {D}~}7gb>zyZu>z#oZ`ObÞ>__Oi_1eg}o E/a~Jϟz]WŧaW/_EC.a/c?lD?4w;ՁT_kG/#D+/[!əu3EVAcE<~3ZwLOj0IA쓢.QOI +IgP/{jSIh?3F&[3(K˵ghˤQ dT/,li\ pX P,JS_Єf?!/347 PU򕓫xf͋\ @qnߋYl?|_1[P""7q@\j$/` =ϊ@w ?ܤ<xgo[_FwkUUA_g?Wtm1Lk1 _2+ 2_ښ'mU'%66)|? Pa"~r9 werɤp'B#9poJȤѼ?J?m.;~lVW(i Z^h9x&cQvGTdF߅̉e z/ÜؓgO<[:~=?T*yU_iO yPutICo| 䕁P=Ju{_<;_6meDԧӇ\9mSwUa,~bDB>"yz͗s?se_#bWOoK}&Ec39)uI?|аcM0wO?l*@tw7N?{ _e8ڏXX#oOyb`#IS8]?s-Y:U\ <  )*㫗?Ǔ%e9x_9e_z*>S3|5/+W,E߃+06E`3XkH K,5|8튛/CEbc[?=sᬕJڣo~q]_521h\#o/~"i+k"@i? {Ud!jG|kr+R9!4?lI8\=DAtzv }$ U-d/p/ѻHGYGȃ?_4~TC/D&8"}Ԁ`` H8ZNC}WGMpj؋UHѮаƞ:ۃI7ۏq?ǿ0"|<|  FP?,2|mp`pdDrqcZH.tA o1g:uUS\ .0\6iS\g l͗>ҩ4SnšW+ï{n5t͔W:׆^~]9W #_y5k*k蝿z@iknQBG1 ;PG?rK$m\+LSA2mQĻK?oOh-VS ”{_;E#O}AT3/k% wW|nÊSr6y[s+VY-{JӕRPm[gzN&{c?\Z@k_AGυwJRQƽ7q9'4 PIZd?L?i ?Y+g.=b*eĊ+Ǡq-Q p(CMB_ت5YJU' C~*%nT:aWS}`?{'#G b Wݞߙo01I_pYzS!/98R ϛ 'M4tw);:; dd:jR pM|WJf~YE$oo]lCn ߈]o/{vUnxΠK /FK/rɒ~{.]8ˀ xx/Z|bdbPjW.*Z ~f#_vUr?L׼;k56Z 0?4D\7a ?б f<ћF>zS7 Q|Z1'Nk B?f]S)8`#{}' 3e3FsQ?q3D^K3/U>|xg;;i-'-h*i6_am! `^wn&"M(@[Mdg]L;k8_xlKQ9Imh&k#}J>p.sћwZ@\@pKg>5tM22OE۔ +P֦V^#0U .U WϘpm~?RqY~5Y| ఐmuLӹ7bY~ͼfd\8!A?^0' ?Y$B%C.Y4'Kb[))sa(C.[.^ _gVKl2&A_վ0yCAO~o0on@HjS̍!υ eO` ]V'O?w`#x/-=9#'zIw%D .eV?p4ys'Z%?~F?mHL 2gVU2_":SY/R?guW})M*?m?/?q+)$>7HT U-Tx?ǓjB^̿4 `j -5,ȟl+#j9[@ڼYGM$wb.fE}ҳ 0Y.3VZ}${, )HU#rZ0 [Kq`s'͟·RMA$_3s,jZ@P"U+"QKwmd[Mvb 4L<0U`Wg]#U/#4w\0?wtKH%ɯwJ`WzOH[>|7gkPxѣ>Yq=Q7¡j~ފ~?/]GR?v9ϫ70Px ?\2'ms? S`xOB}،pK##y_~UR(.eb]>WZb?g `]=׭M]? ߬w?& B(Wq!\@W6/j?'I@|h<)FM]ړG(]k?iؔJ?֬o(D 193G593k`=f6~ϯ{]_eY\nTI(^6EWoݴT}*@m zo -gkp-fr"^CXZ=Rg.M3cIy uC|BPٝxóa=)~E`JU @ ^d<`\ t3&-k?Rz+X?JmW,7VΫ껯eJY-J15V"Q7R? ?~`#7,?|~ ކ}XHt7>ExOULpO|7pYR_-%*Wd(|:.WlDY/ɞEU#8\ 5D>i0'#{ ]CXUˉg&VrJPzԍF/>X\ͺjgPu)׼?RKB^b%&kfEflu1 /e9#VWiE`g'd]ہI?BBaܛ}`RO\/cqX (kYȅ8R_TP)96 1NQ@[X&}sۅOs濫B}^]'|[BǖXTL;ݕѾo]ϡS t?PbBO-e7aC3O?kꓦ h?kB>iqc5?4V~RESٟ OEK0iShke@hرcOϹ_wU|WSxJ'Λv>~W+oрGF)"?8n^6|#!'ű yq\'X짣_~,DZ%6>f?;~ĘWH}d-&;uҖ<ŴSrVMO_:m9+g/y+gd]1µf3 ^=#Es`1=o+Ess׽RZ:is[:y~ݫ%疆^sKG[$b~a% ʣF+YPb%%,bcVǯmEUc⊚U ˱Ƅ6mڔ7Wm՛ؔ ԕuhWm^Sf]ڛ5~@e%5;sZnc#;k 3/Pnwi(ޕ4jGARb1{ #E* 0>c*C{,ƤѲmCu2|mL9 C Ga7nL9\xxcњ RޜtlSrCMJCmp֬ͩdg7פٶd5֤g~ls*|k3̀OY-[찷dٶ\ێyhS`Zǎ\nw8Pұ}W%dOo*>q=~Pq"2wG+ON{_G=Twjo*}KMU+jD@f H^* oqS%O c궣t4aRwfT=f-}~?1ў>އkC*Teg?mv>hl؎}aQ3a}] .;mo Njq>E?GfƵ?:n#ᣮfhwI~_ _ 7zA'Uw58#B9<'zpb;axvL8v|x|Gt'l44cs;* ֣lflR¿Fx'#V yN0oǩxgkܿy.&]sh5}oSG4ޟs־烗}x%r(i: .OWy]~{%hïsvҨ8N7?}SU;zV#x&c'u\3NLᴘ) `)S/C LވdOZ 1ZY^٧e\z8~/RǸ}-{~O9zp߬Η~AIƓuwOڿ`_޷nӟǯl|3~_UVx|ncz>χ3._y^>יsƌ;vhmܘ1SјqЎG;wz>OOCkW1UƳmt4F{ 涖fZ>ood)I{51V6^s_"osЇ뫲cwtv8<__{wx|6x{w~o]fgdtx_gq[.jo8[hnm|-ǡ]kpŊo6>zk%,W٫5m]}_Տ6>?._ߡ#,t}c}<=<7'߯rrr}4T갼8K==|f#W a '^(o ᭱ӌxD<¿KM]-Yzutڿ:oF{wd]עWoֻ?MOry~_]=Z[ox%ll>ej]f=.Ô##szKR0Ʒ~^z߮?k\}kыqk7+|*7G?>a߾=OT2+_ގF{{>''ZʬV~W\ι^j=6w7urƄn7p=uQiʕ_Sގ[?=;:;B[:Zz6'w}ѩ8fq* )>zxWonqns׹ʾ__{{>:zyf][׷Eg/I9`^[Weݏ%N~G/sQԬqu虻?fNWn'MY2itߜr˶7[|]qoqݹ| |?hVo'^{1ᩖz^;8n<Ě3K^w7{zxf<{{xr4Z.߻?toؽ8?32 3ǼZԟ;n3ح3­]YDfC=6UL!!! ##&z10|];~4$*΀0x/#>]|$v ku Nn9i38w{G#Pi!^vF<ߺTVKz];$6=[K S4UdΒ1㓺NޗFlySE58Z؇qթG!NunځXS?hٵ wDG [n6|x\-9N.W%쭭AA7V^~/xD-@(n~CfOoٛ57wo4>go[pa6i?z/kyiI7s|?r7ҿx^_6{?oߴzJݟVט^Oo_ϓ8{[O>~}{%pX=o{}x2y7/5 PV[Ҍ <  , U{{_#[DXkߣ^{?.+ڧ ȺG4iͭ{QUuS% jsIdw(E3avmP ޓ>^Kp5^{Wߓ^7nykr/5g|OMO2^2ojdoQ>o>~i*\,pg+D-r!G͢:8٭mseM,B>jY0lj =sAhdT]4!2X{tOmoG's]z;uxC7 mF_>w޼7x>Z{>Y} {<ڕ 0ޡaoqzȁ+kΡgy>9-4yz9~wn9u!5b^nhR)HޫO|^<8HK=|{c77οS3W0q+ H>>a=qe/y_~,9`|7\;>}Mgs7>yǿx:]k]WVWl5VlnPg֓:/ %+Us]Hww[S}}9^ {?vGxӛocs?B_ٗN~|G]tATSK~A{ۿi -ѿӳǻï{Q{˘zygxzu,:}77ї/}rOr S^wP\ZJ {-贽1fƠSe!5|FRs(O|TK_s?<*_+{?ݿGO_Zwox:->~>W]ҽ|bGg'Wӗ3M>֫iU_zo1C/eO}ئ!fzڻmcE~|n8δr^1>zX?=7 n:~˿ҿŇۿ{jOtuBczNzk\~9i˺wOO_~^g)h\Guwݿ׵__ʪv!-9BJƣny9f=p,9 yjO7k&~Q DCk/~L| GKtbι<}cz|]u/}W7jI;]_Wt;u_^稣E]w{^_t{97z7X1k7ޟ[~Oy/I~7Zdewt~{n{TOO-p q=s[d\it]t|-^cm4vgԇq>&u}ϓƾfrza8=p,qH<=q?뫘y>0 MLg`z9܇cG_}_dg݇;G:^]r<.8vߥysu@B}>.Vo VZTF^>zed؅ ]^=6$2"84Wf6 8mPhpxd$}l~5kmkB׬[ YAo[.( 8"p8!ƻt׆5AHxPHThhtZ\3pg+`CXTh?o 42.Fd{11dGd<42x1pFd,kѱuQ8SQѪʎq8ߘxbaG*xLR,۱I ٟm';)669.6%6:1qƧ^l:h韘b-pCTb\bF*&8aG'%i Td/qaǧ%d且Ԭ c__i RS&e$63EɆ )sacĔm98 ᙖ>33̼)Q"/\>tyZ3s#s `ge/*¾9 rD? W>47 ss rr sUO fH-|d1+.tvACJq ,(*>..zWax.|]6?<7BXaOAi1^`[PZ//'D8~K/,)(^qQayYaEiq3&<WU*W[򻊊``".,+a[\V)fDP6Tb2[]UU6*啕+͸ڸAY+}ܰ e0h۸86U8Oͦ UWlV^ {+ lڼ[oq&|oQ^o\Si# ٰyetӖZVoQYS{7 {)e {͛ؖzӦZFM}Yw&b[^lؗx ߺcnVK~®&kLƺͰwYc 6eزeg=][޹eǶml'|v ߾gkW};{;ܿkN8cSݻ޾k'l!|vAg޻?pS{wpltal CG|;BB")@hXPDdE?6F) &;440MϺFÃZ?80WwA}~B#A;#ѡ:NmdH! FG =v9dBfaK8|bX& ё0 aE1l#(e;:):>9E4m#@$+xbz {c NNKlc|n#2wڈ3sĮEJsGx''l?15?HL—&e.*>i"~Rla`"1yV*Tƌlid|JvfzN^.݅OJz*یgg'YZ|W/qٿ-&F6GA\92g;b܄\E\a`+,-??[e@]P;D؈{}^nQq~Azg[/aJxƱ 1+.m i_4y^P?bx9 //+/.6G **a)Hn8e+ "jؕ+W A)#.r/6P@6 ڷAleC Gb~3l8T*ƶ+.].v0|ئف9߸A;-bcioP7(|6m)ߌoPu lmh]e{7)|Gƾ[ջv.pH}(Z6yaױuֺ:Hlroc^o1>۶oRmVhw ^ "( S鏰g6oۻMOo[1=ڽGUw޹s.|l0&|]E4.q޽ ,l+1; ۄ g}{t{V޽oaٿW>|Ёw݋`88ۻ1[?3C9D/,8$g  S"Ï`^"_v-OxmPh0}g m`hcSvŎv cBׅvPXPZ pQ6I$2q)#س?M8M"i ͟P?#h@-#t8C [L@1AKH\$Bwi|Dx\Șy~'6)@*@R4j/l4*1JCħ)4eM[  fnaI<>1)q}$ֻOA{J'@򧢍OAV:?.1>2 )ql?"sl 1c{Gvb$qr f&$"zRlD@jfe_ت!̛pV0.VӌTDj/mX P}6K|~Li3|4apqlU?yE3 9b笻fZ w;<p?~ 5ؔxպg;G}5|ael_- G<2; ő}K8K#rhs[FԧER r/|T&M8xÿBL 2M7-f@4pE_EV6PfI|D1e`90pՏE?}+O6V&f^ڭنpo:Mh_h?Y̌llL u[Q2͹zemrZ"P},Z-Z*+en_2/m a8M8O`l4OY} #؆g)tgDŽzc06 hRtJk?g1qD+Ÿ3ݕ?᧹g)>WY}c@:n>1If{l<NIMT8ZÓL>0.Btƕ \FyA9Ka?g]{9pn;WsӧB*Ζz_oCG{=˽7ѣGݻS~#%uO~zя~|AƏ~DE-uy;vfoj8.A~Pp`@pJ?e'rj(jLZWhJ ~ U G\M FOc~wοH '݆6f3mD cC ]7lWY}glfg s2,qd"nO8S8ÏFW2WgJαgk8Z3.z-Zo\/pycỬL>Ey:nHg&??߄!WEZЙ/kC:A/**)+S ܏WP.jJ'1 s{+Jcc\qEe0JF |oՆr=gl$U>G2*?UUUHJ*++3|v@pGDL1ٴ Ÿ)ïVt͛}87XfZ,`jɰuisW6oR9|2lz:(2u_MMMlٲe906d$jO+k\-; ޾3@a+3_۶؆|vS7-&\xJ;w q{dP #h!2?G{ @Maulzv7lP!D=n m6GG'm¿6~z˔SgwIU1[َ8cV,X<~۴GT;v˂}^(kX2-0$KqC#oGRpT(|Zmt<6bGom cA˓LUZؓa 8vGX.aϜ <*<"DH! w:qci-ÂbGFDEI[_(;¨ PMNOT5lY m :O FVywol3GUxj8cDl:S#{@بP8"$)w mAU*Sd1bT\)Uü bgsU/g ؅o*/OWY}j$.rgdb g<)D>M0_{S:GZ0yZzD0DFN ]1?3^8ufH9翐Z P(k cq@ NFQ#HbwAŊ_ 2ۯ/TV֋Mu¦zE1r 37j"2SM\JAȧHؕunQSPZORc_TzZYܹ͛Ү6mύߒjWIfi58=mp|({u&-u&ο' n?wUΟQ6{֭fY lghu㒟nC/s{)6o>)AVq#N #O})Q޻C ʐ`^*ϡΗ:.3"ߋ6Qƹpб=sY pGp8v뎤8us Vy#p-f%\`R8si64Ix :}]X gmMD@q;G̽ >%xo뺮~fƱN;LԗN݇M?\YCIgڗ:[ɱTIH7 .K :MӸubHZ:s%.g j[.珳G j˪\VHw5\a{aD1ǟ4Bh2h_Vho=mw)H#Uχ"ڿ^&a_J Q;5"VcLW~50jT ݘ_[@;uDfloj/ׁ_`(I$~ {zૌǵ˗bJ?8'FFcQ5? HEP$[Ge=PuǜG%B\ x>''27s}vr*yU#sG*=!|!Ϻ::"<^?! Yxa U,`Wܾ96JSP%{j9y`w`{ ?#<_YZK-@>>,.^DP?#cxeeQ:0~l4k{~y%{9a/%?hȥx1PiiGkr3~~ӷKDG//{Fhmbli; ̜ϗwiE 4 ubSS<+>ȯx忞:FwOAލ{YCVՏ㨍A @WP]Wb@gw!!A:C:[O13E/~'O8 ޥom=/eOJ{q 6}7m{w?xG?u1lz?܏~Xw߹D; f&Woo7WބK0{l򰌧,z_` YnWywg9f`Jw2^ZUsk >hPݓP[6Z.(8;|3`fh*I柟R(/!t>0{=?նU:ڽ?Z]}×vڻ;d<|" .I c|N@G`^wxhȩ Ю֎) Sbad1"vg~[ lp}~.7]+H]H~)@n|aSO޾h|6nC22${Lo4eaj`.?2#?R#/9n_#2~&ZG9&HjGV{5Rh iq&|8}c{2jr} 9̶vdYH~Gmlr< ZS[#0=7>< Xuy,5 !V6mY\q:0%{9N(j88Ӂ)5Y/x*p5B s&rZ BcӣZs@҇8`vnYz4OѸS=ܾf1yGZ8  'R\Z[œ\],TΨ߄ ֏3 i̷~`;k|tj:<diq׊~} bJ ]o -λ1m)p!~,U"y8Oz`#n}%CyxV?7._&篩(,c ߌ{l?`OLOn-U}|jp*4=yuX2Zp^pgk"vg* 9t (r*.z6At^_mZm 7Zx?[~pv>Ϋ?|ߝ\=74!#[#o6p, v"[wq}ܿ{k ~K{ `bփ{3䱇j=?͒?/Іb^s+y 2?4mk򻰢1ݭϥ DY`Czp ң#?RȺs#Ï>/Km'RKO=YY.u 1I['3Z/X?m 8/5 qΟuP'lHP@c.1F).)@0&Dߟ0@~gI5p 95\;TD58;~#v&^@ƌW \ ҏ;.~'u:DAb{OY?8#$~edzlȨk;=3<942OLBUϴڳS 09& N?7GBğuΏh|kfc[?{:Tv}B4<4+kH癎;5C3\D0  R+#FOYOT ;;^ wY}g)\5.dc>",ių=p5Kk_桟8E2\ϻ =5l_>OA M'$uI?-O kbӳ66/ ԏ4~ >\ss-K牶AW@ß'n@F2PvWg0uիCi<\pn<={Kw$>HoLRV_UCv<2WnrE5nmJJwݼu훅|X|ۯ]jR퓳n|狵'g<Va&-yoݛ:rc>C^t-4ZQ/N?hjm17n:'M-B%1qj:\r26͕{m)tv`'EݹhQ. Z:)揍4tol Ho)@_j1?a2lGwsC5/vXw/IO1V=@}A[BRWG7<MLczp;`̃<˙>7ο< @Ǵ/}SdkpFlPD,xD@WM0^?A\? 揯g Á_sBI1y{ !xO>jRx> >1(]p.a%EA_'9,w(df>Fß3: Oj_izn $~q՟=37mOm?w:Wοߑy~Y9'ӄJz(h_\Z:OS9`$,OF~ /rXϏsw8Hr5>c NsY+tŵZқ y{:~ y KOk9ƊC#h͞;( ~=_>  ƥMf7 οGk+]9M 77oܾ?9/sϯh< (yDj$FRB!@.G&g=yD Bwݳ|Tl,>ş=lծ=OVkO+gKc7?*7^ʽSN/,k/`VoX ݝ] Q){츳]fYNo75QR/-+U϶) ; EOaQٶTۿyP[?:#οwP<9 ?ƫ@#K2 H_#G'%5!<2]!?;:iP hޓ;Ki?Cǩg?'ف;j[ak//*s$' _qο%yfU }xÞy4|g')*|<2Bh `&T)ד_\?}k5)c~I?s3A4?+?˝"T4ojk ¬fg4`;*/x?)Wq>2/n[4JJzWQ??%垔Op&?V[zgY q8,Ajy~ =žz!jd*Zq_ݻ #q xI 8rF C5 #=?*7o޾ymqqZ^߸v.U~\F CG $ ݡG hNm fK󍾦Y}z)3OJV|GF[]Ͻȣ2OڄD_ݥ@^YX&L>V~A/fh6=ʂD_{ @A~f!Vd^jC(ߌoxm(*1( )@/ |s: ?;>%Y k?2jB]M;nrߝ' '|-@oq SgLdl49~~>?bOTGXƞb#z,T?M ggﰚ~컞?]/_9Ԡ_3&e_̧c瓽ԙ? ~d%^0PW)@V$bGS0?*F@eϟ_^>8)\Ǵrۜ?N~DlXm?+ 1L_7 M&?|̾S~sS_1r }Yl D PxOaƕKt*#Kl!sG(@[w1iSbq;SV??olk#Zm{csr{QIw][;o8zPx!l ~p7hKM8 ϴ+9>L-&86nݻ[jn%}&,,:[ -O3l?wW>@9eF`?z`nowϙmB'KP 1tt 'i|~ bÇ IIҶ}H])/CSm_/0u za 'q?8͉z+ zq?>Ĉ$'C{Ix*8@7Y}0`l?=}Gr?Oo5nW#_s82^".RΞ8g34^ n7GV?j/3R.`ο ily,/~lfI5&~ ?^Ϗο[ ?IO%~e$l W7 ?j5XK~WV8HSG^c6+ׯ2'_LG` tdgp1lO^w?Ӏ w~fCju }Ensm-u}敫GkO?Ǐ~Oɏn<ҟQ+ov1 4hniX@q(:`BV~ 7HZpSc1j敗޾|/oܘB3͏OY"~>e> 6v>|)o':{_ǧ_NR, k-S\8gڞߛjtXsO6B?mQ#r?}@ieZ#p:u|}(GX8_Ko::GсT?MyۣC: AQ?/4?Z@*~}#pi{!K'9[z#c | 0=3wPYOPfT<ӴeNiOv#{(Btd/IoJ'=ϟ^hwX-$ϯ{q0qL~LbL?~D[yV":4-jOhU=WWW٣4 &gϯ gg߫HpQ/`8Aa? W׀}.8F/x?8E&yP}07e@ Ѝz@? ʪ 3ڕ+W/o @%}3^ |OݾuPa k]^?5y7~Vۨ~ڧO>Z>yߙWkοNw!οAg7}Y:9߈w}#pK#DQ gl[`* %W) jm.?U4w)? %W)usp6?(d? /y9 W@#οrṭ?ߟߞRD@z hBڭ8)@*SsH?ԗ H,Wo8YJY9d~h0T?0͙g c?pI6yydaQ_گ"ef;t@>KeǻG저*>xޞm-oJ~$u~G/>2P|/R$-}ܧy:V]77^z ?ݻus?Iv'?NM}+?6^ƓOچk_ B3:?*է^UE]6v]ͻ `_519rlW9YȯsJUoO͉@}*&?gix#8j\\3dg5YMD/^LSک+ׯ^/_txF?{㏞=\z>z'^xk?$~;P!/ޣFh5&y7'ryZ}^j P䋑n XV|agy;B,?tk!@?מ_ӳnۭ:Y}W{ (_n_;2'?/0M§}?8؇;}r|̿]<x|?gR*'v CW?P)`dDkb:8?'&϶Qst־,1lerFѱ7koc)lϨH'y9q?T1|<_!}jjl:Ejo>Y@䟛i?yRrsFnt3zOW*2ӴB=]@lܪX9~wu6%޷g$Zm@_ %=m)Ė.2Fp>|oOb~8^ XڈUۯ1C/?7~ B1g'>%y7˾/sFZ;P>ZoSH?,9|W# }_ i þ/j b'Oẳ=}hQ^0.1M}~=1~||2д3(o1OONΊ&F$y2pSrW_K/wBƏNjk&fOs]_Ϭѹ9$R;;gΤs mL̟nIz8?^{+6fitv]58cZG0̥%dWg? TV1Ga/>gϳ>~?/ϣ. ˖jid#&_l^mΝD(n?Xbsdx:k2<4Wc{ z1r??zN{lҁ/,G}6V,b@G[67|{O~[2{G;4NNx0<˗C:m"3+Wtμ/_.5oߢKrֵ1׮}߸<(}~ٵZ-ᅨ*}M\ØL_U~\ut#_WðzדQOn+L2}S&䯒J*95>W#_|*`xSO_eW KKQG%h ug_ ˤu:hu:Z,QG먣5GQG먣u:ǓU?eW ?2=ROd:i2zZG=C>*ZC=>*j:izZG=C>R$xU#ϢL(:ʴ2C>vZGQaeX~f2LjheZGQui*:ʴ2L_&eU_)J:*C~ʹ*JkN :*-J 4QnҠ*9Q5Ti U^}E6o? ^C:jF됿VFE}5Uuh5ZGQu_?ZGQ5h5+JhXAܗܗW7ܷ믿kjjuwwN8q۷or~a?iM/gr\tuHj^Dd $k0  # AbWW& !r[3 n+W& !r[PNG  IHDRp5sRGB pHYs+IDATx^նV=;IHpm]AaZy}kk@SU9gvw 1;~aO1;~`2c0tU?"fBQ B +JWv k9.iM!aDPtPd BG橮"@#xZTuT+ڐ}敔]O|^RgBqDM따v!c2F-Bs;-ʈϡJPσqU` ;+hN`Z .P}Ngg흒sJ0 hnii- cfb exk1P8~nkoqSwvy**j'wt͸[6IW _,ÿRbSTcV1ujc}Tb֎ZB͛0ʐa744-zoH6KE},HY 󓗢9o?D{h սsà2n +dz >NpP| F/D [YaaH!tOxDoa^E/ 5N}}*Xܤd;a|5Sk1^[ƅ!N%vTyK2RFƂsBH/Զ +} 86shaxudb]H&p!vT F&$JM)^pAءfv6FDtpG #@`/Zro|,4#F{Wb'hFXmQO1mn^{,T ZZSmD&lw,l( &㗈RRԜ%klk25K  œgpÓ~#Xgq/="ۧ9$h84vςld2$1`"^+vonmvl"z\ 8mɬ+~= H 6i-M anV`2{xGb-HF7M'e0PK|", wʂ( t` Jb& +j[ Y(ƺ"irH0[Zڴ$lюc|/{?޸>{nT6ա{&߾_|5/:&8'~Qԟ d_4|Ƨ^{eOxy ׫!Ă0ᛩmom^=NcjKĦߏit˔ay笝< ߎ ɤ8k׏C+tcIfYaۭ3 E-'T 5|I؊1`;h  -h_:aZx;H,@@_y{%~y {̄Y@]=N:j5Uñ諂b+DP]R Wόe^`؛+rHʘYIEKU ,l%? ﱣ([:R]@6Pá5Q)*Wmz̔oQ^&T|'/++,3[{>p-7N 8ֻ톣3sg䗟nGc~c׍N8qXcZ}m6_rñ'Es3=]tnk^Qy8ebӔF(n{qV;yO;o7:M8~69Mgvm|k0v-=xflҤ{8?V,}mg }-&*Orl"a:MRq {n8aHXĘyZQ07N qPR؟zShqxbw)K6~ ޵ !#PDYeϜ%i5S'^}PCP+萕ԜV֮l0p=гYԕL],:)eKL \}8z+jn a4{d]')e](S2Rhe3g$٦\-{g -0T4"O_DA}iy {guԔzzDoaKE<<ʑ= )(V [AYjd:HY ~6+Eeylfs(Cw i4q/D)cap`uX6 eK= R!5wLco@kb?Y9B-Bm,vDo1s8 vqFЅ>nG [[Z+c1"~;=(B@c0ٱ_,/(5"dnC)\xܰ=.<$`d߉TsYEybVN]|cMN&(Dt R!x} ӑ5-6hX55 u 0̳?hM7Yveeszhjn{?u֙Zkw]͎19]yŁMlA?7yc[E睷 5twK~okcb7ߎ^qy:eҴ30/=vm7nS.=YxVΆ,6W[o'\]saۭ9Ď抶niTkR8jBBx `&FdZIVv\b() 4kYGH &ZI5!1SR4JDeIc&d۶N::J`S}J#Y\6eiа*QiS2x wKмFr !ua jH0?Jܔt06VmRXz#7_?L93m$~mN;wy4e*T$԰ӰuY^dž*Dl-ZGklxo>yg<|s[_SX15'uJp@s6;<ϗ~ɘV@rZTŁUM6o}'G5m| 2E&mw? \ï_->^sOpO}e[omlA*.Nlk4Oŧϟ2u?/Uzآ?J9fѭEqUG3ϱ:E$N\k|13yYyyo}X$U"^r:<KIM=$f KUP APsL^HsWBPP("-D Z uͣ{#wKAFxF::lwR R)*j@{ R' )C/o1}30'W@I6(Ti#9n'A !"21*|UXR)m4Q,<"wQbm1E-{y_g~]>Rڪ֎':NjFSSfk|(uqA@^kLj3")f+,%Qb̺P=BЀR=(wYLI&uC EVO'1IW :KT;H@4w_ρ746hWLnq;߯{{fkvGvL?}ݏ<,\S[wTH^o{Ͽ=_gm;G/!ߊ*mjҬ?+:h؈{Ͼ_w W_¦j[_u=4\ZK-܍MM_Щݴ[KwqN>l\g ~]30dU޺NSSkEsQJ,+Z:xO\{űnmO;yN|ֿ㮽),|o^ˇ;Be.驋.3!yc`WLo]p6.V S'r&)9 ~u*"JR `9&a}$_+Fo5R)0vdHT/ruqY [r`/) H E!CoTwV'S} g:Ù{c Tdѣ#Q9JAKpjG^ぶ)xK5HT%Ǝe8(4l22]eܚʶ?Ur4fg^!,F M;5(0LkyU#l9zf Z,tOt?' )gvc?הkPHq(´* t0l}"K7w!80ƷKACQa0%z]#Pߋb(Brffoc3BCzL`A$5R$}a$)[*?Fp*)Ae~D"T766sq#8fC#  >ē묳᪫5s~})j 䲷ww]K/;mw8-]:6#;] /Bkg&;?qO7csc{Υ^SyP]٢76U Whj2xy?eOg[*)?]CCcuus][giH㔦B] ~Ɖ5d5W0kä J̢ i.׵6NV-Ha LW[߯fP#'Lhܽvnm ?qrlM?a봒(Q,jFW8_%uhinm9]wܯ~ȼdL7FoRDSU.^z'')YCQ1DΟxjf8'Ww GAi7QfخwSٵ/R*3h1{oWr -L[WGX|Rdپ"~@U6n/eDEoŢ LmDtlzHE(5RVa,v[_mQ3TXx/ƽ-k*ZRJּʺpl$0XBN[ ڇ2vD"6>#B(D:/-3 `'YCp?jj`75cSeԼ:eSDٶ*O&mP\dU02活6Ԉm)RJfYRGaZ^Mph& ] ibyG7e; ҨCBggAGC{f3M8I,ǬOAxc cCjX!ՊO*aoO Vd0KaPD "FicF?\uXYXEi#7D ;ZlJs&3d:d("y6 2=b9YNzh]N n7Tɛ ! 9\2oo>xkl韻8,$M++NؤkK/}aԋϮ,:;ydTScM>)^}޶gy_?᧹Y<3RzS&Mmij{zEP,~ jZ[:OKkckS0R]E5(G&V^+ꊡ}CQԨH*ȝ=Ԙ8j[w`W<|IcPpM9-' r`\LM Z׉NAB\[W6"̖=<Τ@=f$F*1%a3U@+"–Q# d8c6$kۆaD#LhеYD-b&wJaXXU!:1dJ5$MhXx~mt"SKqU7cp w C}5wSz/E\Z[ykZΞyjC=GVw6,|vG/sݒ-?AM߄g K,vxA`LHDTuC9qyK#Rd á-Ohdt0&"O44cڦA|jU9sbp쌈zZy.Ԓ SbYжmq)wZfJ?)ǨbG@I~ 8aK(d2l @F{,V!rx b[K;t(xoQzI큍W>m~0 YsJ>#^elP [C'+ZlmUcmIfE9,C4uBwqTE tFT*h xOx$OC6Esa{~;I7$0{6ԁ Mm*yoWBnGY!dP@:+F!WkUȉkQFE(ǐa;Ytߠ4 's4"qrAÚ;* B!ﷶց>ͣBH<}kB= 7SΔĶ! Goe/D^J깷=[aіL7Tw.P!q9b7"qG;Q{! /TBIRS Jx#]ZSga1icZ芐Jp3ID!l1!86TMH Bb8mGrD{Ch. uɻA#I Ao6dK2ePjMԿ&#gXtd]ܧ@;xuXMJ)L8 gE"Bٮ42RB Zo PMuu-Hw(\衭kfo ^65Έ‘+ v7{5mWe{ DwTdOhO wŎJ5 ml,\I]8ȃsEEEv!ɚXSLWEY )Z#?׆ [ь 5 L5?Nx'd)) #>O/=)xnhIx= Z0k{r61h[3p2IGh#90qc! . PƬ P*%"Y[b~36V KK89cx 3,K 1cfG7=F4&Zl;.^ b`B*c4C(V-1` fH3$f7ZrY\ڍEс"Z%e3!bR9KikƒϜ89vz1\j$>VS ZCF&GAݯɓ.eYMǧ#Wk0YeՉQ_k ,ln*ooq'ոF;1 !aX4mDq䝰I3B[)zݳmT]"kaF-tlhhSaӈ1i|39\u#uNÊ܌쓧=l -Y.>%k3ȔXl&'$@KkK 5 a̋튙FViNi0i. h_,IiM7'fC=›t)Zx|5CxXZ}ك,0a"!0^0~+L ߉|%<93d %PF&S.[Jڔ HrS!0EY>p:pnbIiNa,bv|`R>0(Iet5Egы#CP2c3%<J( Y.#ڌs2ӧ|2x#م@FHp]ac 7'Q#`Vaǔvb;Q6 iZm(34gp'bdŤcv^NP?mR;~8#cVAE$ xcM|wǝw`auaJrC?0vETw6x!|4]iǟpNK:=m"J)#HWGyb:uJpnXir„G O0O?]e$ ;Guubxƛ Z0qH[8DMg%g |a9lÉBK$1IYBX{Y&O,a.HG̒"uM?X֕4JD.b-F#vKu%&\6 2u'Ք0_K%S!RP*LZ=iɔ9 cA,宐 f* ?V>vE`9S̐('"0ft6@+f@h%"g|Y2Hg\=; ˤe: P$t wK3*0eIe3]H'h]4Xd %TfLH}7ە3">} i>K0m%>Z% >4bpJ3I K,jxwBZRƺ3CPT{s^h}wןi?_tqFKg}~>V]}Bg⋯O7pkSoF'~7tn:7zw/8cǎ1bQuf~wfmϿ7ߦ#FbmGʬΡ#ΡeAxŗ^ihlv] ۴$KE&} :Bdon3!hpފ;< =ip5Yu5*\6Y%183f1Н-- h,1 =o04,4HsҤ RDNv`7YrXp,Xcū/!PU$PHfqIQC5ǘ!]%,q2Zƌ>XdJL;u%hqaL2B$X\ )e >$cJ}.-K|ftI'^Cm!@#FeX"Ae1 酱"З&X38!J\|,0vʄj2u2%2YcwR8˛dHoBZb]*{za2YK9ٛO&*@X%X<˅A Y8՛&]ګ;W&ƶpFC).Ҟ '3ve駟.օ-Z(|Wrɓ9Sٞ~9o ;jڝ}7^z>vğ= >GL{'nv-J0'xI+"nyϽCGuGYyJ_φ|wǜ|ⱟ~K/syٷ|gy=hbDF]ĴةS'|?u7^hw#7w_8V\s5O=o=%ݐ>ؒpO&YX=>%9_ꖥt&O3pʭ06fw4cnj[a`vҕv_y6S=`qװ1kƎ]'ণPr\Xc̐`8x*`Be 1`=7  aK{C%2H#AT`cĸpaA4̓jR&g?╳K ޼,cՔ!ѥvl 8ax ) e7ly#cMKx;`1oI'UDlҒƋ.=9`Ir݇{ i T,dբ)S4 p݇ѳ*:3c"csr }B"RO!- )n0ԍ< ,|6.`H'Rxwx^S͂.p2T %Xʄ4S8Ӎ=)4vSC&Χp! =RtH7X I'N8Q BET𣿟w:|ȻC fmy]{̥\]bӭ:`rYO);,32 M?[o~._o 3t5Kz@]}}xWWGEɥYR#2)< 6w]Lh$8vtMYL4_UYn_IXEPXhWX]M6gq#wq m.iCҚ1 f͔_xG`u0s]ײ @Q9Θd-hvaЧ]a1y-鍏Z~c%2X7 t6`Ldl+K iۃ%Ei'! }SҲYaIVwUH3d,׻v%ҌOlHj]ɔebiK lD*1l-c-K'sfș!,Q6cnB+i)lǂ1CIH ZI];h"VK9\p`BM 4Nʱ okMAUm7'%Љ|HXW SՋfS{rJe jR߯nKTBkw ň%Ϋ>ƦZ7Qۤ:h.577)Я_ݔ) nȁ@~ wYRۗ~4Vĭ?n ~7`g,|5-x|[A- uccjAOnϢ$4ی OZhY8ƲIU)t!>!9hn&E{X7 '8ڜ~U6nv55, lRRN ΦB>f$`i{7->VƀEgʨe`e٤fjna:o+!D2Z;WK0'ݥ?%X`.]aA:`1dW6' Ʉsct99Wʴe1K+tkta iUw`qZTKS9cdz~,BZ_Z.f e,&0mX )KtZ+SBYU\ߪ,OO7I3g@3,݅4Kwf(c*qAm;,Bx3mXl!Yz2vY8m# w%UP?0ݝd[q[.*9eg̶*S6KJ2Hׅ1e & kSYc 2ɬȌ@@tQ]WmF`6`Wu[mŗ|Y~}ai~a0rxh]Y"K?r&47L#Yurz*X.lQ E N N cafDtK؃Orhyy^fpeME{2Cxpa.P|ZPCMZ)>']H{XM,FChϞ7!-lS? B=&-ו>2 .%.B: fפr#0)*2svavVJr]H bCOuɗs.vj44B1Jd!nh)aC[z1&CJ~'Z-z' B+m;jpYXaȶfڌOjUЗю>&Oo8$VA< xYp8zXfɆM>PN5z>H(b:%c,хaK}22MvEeȈshܻwdZ$öY Sp)1k<yW ֽPZr~y/,Q'(P{G#JacycJmX.c9hi0&R^ BtB,QTRI.-^guژƘm25e[p;XD25hr<Gw-2nVXW[R4]l^rO,^H\st8 3-*4iNm]i6'S!a2lfgi]KÒ}8K WǤ2jk`X)h>w+YRδ2ƧaӖc6oJn''e7ё6K7Mv'7QujIja[4"JVQ3񩹮Wy*!7 ,Pa;5E+Хa. ih>'͖TZoHj`EH3=!P gK&Mi?):! j!-KnrpHE*e G&j-UkƆftQ A4JPې㰺8볙 Z=r%#KG Q9c`}4s$Nư/*\Rf &)\M, 1aZM?Uŗ8hА5x ¯E9, kΆM tjlɰ+lǷc=jP[}$HXȳ-E]E[K{FDqЃH]|!K gfFit"c)L1|p%EeJsBTT4Li}z'0`T c_,I_RF"SNUxa[a)eϰk[KAI*Zs;1ä2%ȭՋG6(/cn: 5uTaT9\"h)_^8kU2u3aȐiSS*2^bN23KȾÌF| 04cl(Ұ|6Ēǰq㽇M0KmTXR84wFˤ 2!黌Sɾa=8W%fI܅aA|r7cX%S8eWa _2CtXfBJ}?(  h8,,FSeF~͵W Cb_3O?3gVZ(EUeE#'"NG+Mc4WwymYz^>e1Qw}HFnVaZM9D=b/X-PPUV\7 W_ȣ9-H<-"AtKD,c3_r0x^tǔ\WXy7x#Bΐqګ͟Xdх\z{ﺧ+]Ah[7Wŀ9`u?/ec9k0M- *jKgnϾOHqᅗOK{]IΖNZ?]IfO`)+pjƺҕUX߰esXzpR] tNOx|$X Tq"w:F?ǯg~&0-T7 Ԑ`ok-RZ3N?~/W_{Ć 7\u>!1okn:D?~[%RTon|QS[K{ }jm%޻]}:d!NګOa6N[5\lo-rccȳS~?v=}70z7zq|= MSo'k?T{M72yh?z[OiYZUH<¨c9nЕ7hy__~F|1q뮿wt?OEKD-Z?*wsЧ3zw'L}QTrM74'eI^wk&MtuWx3̠o~7<;n{j^uF2*ގ|d~"}]~ڡu!W>/;T{N/~innZן S'GvzRl}ݷoo6L3?cZ ïaqU:,Pdz'; YzggF=W_.OEhoAoޟ'w{gv_k9}O>vuɧYymy]E"wǝw;Zş!\+b{\UM]a38]_{ih͆n(J8nmM6c\q޾κkuM^{u}`%?2R.P~74_}⦛o:餓5@X].@,I aimK֖vA$j!-#Hb07 , آAqTK@=.Q*Ja ݓZ6S=a5t`I3XY 1,ٰm/E6XrXty XZ$w =`c,%!( Ӵa+16.AׅK ^AHO],413,+ c|!re<ceLfBm?跣ۯ|*T]]CPۋ/Ўvyꉧ}_Ҩ u,3|{~tA,ݽ>)7hN:AK9fyfF[W}13'}|uɂ E"bna 9/2AaA\pC9P]KOU?6mn%_>;5»o7r#, ώuF>\geBckck[_ QRw~[oY@tU*ڦR-72pc#}W]}9t߃|Aawy0էt[q_]d?:R&30C>o#?`fqs9G7YgYGZ>lA_}[o_=VDTwJuyTf`agn<ǖnx.(^ 2#@~g{?xhK9uHccC+9`:;CVk?C z4㌇~h1p"`pDy'yB>ԳO<+crc4sız0|gODN8 V,c~?/O?jZLAꂢ˔S4J+NW)C>^T˜Gfy6}K/ I6MBU]MJž~'K.xםveҊGnOI9է*5NKsɓ^vbE C.ש;eNF4D(5܎ 1v y[Bqf!=hb[Z݊FekѴauۼT W6TPp 0%G ~]fѽ2(< rƏYiϰ8•,',́PSfXrX:`lKm Jl`!aXr_% FMZ ivEjX,|LPð9]zڅ,dJ9].%.TX93@5$> \lh D,YT](<B3[b&+gl ;SS[oQδo[)"҆Qٿ_ݞsKKMh뭶wz闟w޻x&aӨgS{w GxPczCm&QŚ6L{ ,| hYSvm?c=CGF<# ]y1tӋ-7Go._ͶXdEf ,x;o{#GN\w?zm/8x}Κz8 |-6t/>[ny}ѻkɇqk9ïޯv؎;3|o -$ rG],dMuՏcxXuaweخ>hzb$m'fsN]~b,&t:,bb̡ۜkƑGݶۿ-,wי0}W_0tE1r-8{+HR\u֛oer_vM鰝vU#P= - ;mS[6LǰudZp6-)5k;\g\LNi@A5vo}[om-335HUn?GYH!l_k(v4GnN X?|n!a*5't'hC :|I(y~reKDr_SaSE`="EOC@7J]MJy,jAXRG1LT"ycLB!6xN.dA.%[i k4Me➰Ty=B<V-&X.\g5`QJ`Iהd]aa})$l(pavoCtˆPnkk+/\`s \ eZ .<3&MدlPT.W]3~{#; bX欄qS#FkZ'G(E%sFWOjnD}HH%9aeٶ21%1!s0[L@qq //alVo_z%m·ך@s)'vil+s=_wW+Pt?(%u?T NȔyg Uv@- ̷};aď?L̹瞳: 9,rxD`r!`j+/vi(ˢ\{H 2);qH7 !,xQRTIUӒhiț B2aT 3;5`a!uXSUXhӂEFa3i,hHbf(Li"]%1R]N4i\iʙ CRٓ13Cp2;jcj.=gpx gmLA[UH!t0v vCҜQ8*AAiإ(amw#uzɴ ՟}uzk/jћ~Z?` ]yǝpnڊ+x5W.-bwGnk:=xUE-Ra83n,ïgemL;OڦnnG%{!ۢZ,ljlX{y\Z[3(L)NAx@ ]_ :tͷX}5eȞލKjREZk_|qV?:)SԠǜMRhIM϶kK[lE#O<, ekɦR]mGЈ|gzj5<BAr5VG6xFM mKe]*jW\ vky?.3CWyrEHknƬC)hZ%ˮ|FlZk;g}4ު6n<桫<0꺸IJ;쯸J?n kk_|*:QuȣJ˾{O;_{YI4 ;\~%/zc2%&0,_񟫮Xq啶ؚ;tõׯxݎ; s9ME~4|UV^zy"-Zp|JSl`? ]m[lZo֓Lv1Ȳo>۬geUv5Wg$_{a;a=34 f|Gu[w/T;㯸@`uy~w>!pmZuUQZHO9TEbZvBU-~Ce;G 4SQ('5$E=<p,xc{>+Ix<R?'KҔf0l!B[Oʰ>4& kmE3c(}RR8oԂDŽl,p%ZK>˴ahX;%c0X dF>`V^@}3%a,{WX\8S@c~K/ ]s9R!ƛ)w)&mV +[W]Gł%Cyg~0d#5|:&+[XqZ!A| =-M"r/:_jqQ@ȓeS.)A5ĨBKƆG|bc٪ʻVLD! cLm:, e.P>lQ[[)2{a*!UC+IB&ܲXNq1."&:Cū{䊯/"I*EԇlΎF4ݯIU` Vo :h:yG]4$kTZuya [QD4Ԩ+:5V[E),$?t[TpK%Gmm9QF7uҡM'\@Ϊć2=P @@EOQj, T0:\>Y|rh"bi.A2ct38`[Rfɻeا5 2qЮ+,ԊU ̒JK ti8G@ vKﰔb` ˨7ƶV_,+W8 }T%)=G ݘoDƦ&NѲ֎n뒇*Fׯ~fBϺ*T=rTRz5mR8J6 Vw,*ISj㫶n ͵ֵ荴R#hӎ1GRJdkѳ+fZ a,O Tflinׁnqw\=Y]|F?^XR1Mo]8TU5Emo GTq) AzXA{&Ո:v*ҵE[(݃,҄=FHW*RP]M)/ݠ`6Y(Ʉ@SyfIDžeDRScYU \u{!IK-q)yeHq%?ӵj9U54Zе`юKjUPV]=Et$97WXG{&4aq{jEe}@wlǀ̀(Ap͢DWB(x $AGBJQkj֖,X0iϔOWXdygR3 }1l̒BQ2X4x `5G># `B*lѥ"A zt)"c8%C2X\!Х`lB`jA3$`}K',0v/c'aco o7!s[HKȭXblWuR0fcnIL0籿貴uica;`N;u ̄- ,$QȞRJշ) j0b$p|zDx$J^6:Gʬ1)d+:#VFu'DakR:i|F P U,ۖ^YH4Wű˘Dȼ1'{Urjy9v; ŎgV'"46'f$ , 0;c UiH1G0ݸhBH7T]w<$WHhKXV0:LL5n! HNM })C'խ۩IcaA_]/C:j{n夦y'Sg*7-zќuD( Р'BjY! gi*ʙD}CR(TAc;EaBHqZ#ʗŁC̄I`g$C ࡳT|^ 鱨x0dI'瓆i',-H8 I+CM',tL e XBu.WfuН.a.E`z˯bӄv,d2aZ{"0tsC-?8V%rw Au1m{' 5҆RCO{Jƕܘ$6!b˰е~gk=]p4tmik\]02]wof b86 .gl W+lR b  [7(Kg|۸l֕  ˝ϊ04&-P&.`AcrsJp=$XV9]HjRq"FK}p6z dY֩ÂjKqi tCā}(Ji1TȝPJJH&qv3{KFMP!  0| K2LBGnJe]$6@hl)TئsBXq~B_\C<1v fIlHSS匝ĥƒ,^YjgL0lr5p ~m0N+0_fsE;ԒJS8\H{p`1u[H1lX`RkPh蟒.BvSc'D9OW+R.XcN]B$!`1'jTf U۰pO>Fo t`"BQfǥ2Θݧ q-LH!/6#}5LcC;fzptb)'xW;|9{8"Q m+nc**HB+oܲNoâT=C6)0v 3W(|[DV;l΀Fԅރ]0D~(Z 115p]lGɸ+W-Y(yV ^-ɔwl{E؅Mb,ăf3vΊTK>aah@!"ZxKiX4ٯL <.Bj=%;a2sPK)@g۹ '`f*8Bj`MUl%P}`\BtL˯ iX,&>VVTN4?8z̘?O?޻}1nZ\ڷSex`H(oS,[U\jH%h'=6j>fO,. 5JcO9F+G([;dˆ5c'f0؆ȳ..zBnɖō ¶!ae{ !9,v{B"c[Md,6ۡ"9c#9cǤd4AMXW9,fJǓX.b@ KIŤ w4Y9,a3N ' X )br!.!6e`1c!` f :ىBf%cTXb:xN-%clt ݓ._Ō^blO*B9,Ov}--MIMnnnn&e3JIz_ Tb3re>e}.V.&jQ̇&L%Id-peuٮ1Znq2i~c֤Lﻪ"VqDiʰN UH&.M['ᣢ` KV`>Q(4֡UteR!b׶JBU|  Jкo1@qf7SUIx(j@.pF61Ȕ`*4Rc┨Dhԏ 20`EF;Xp"* B3p$1Ƞ7c `B؁_dP 9]ǥ|o^ e<r)Uun ^7mEhWB cc;:UUUc´T(;;<ʀ@ iX"/ d"6kJB7`qJ[umNBhC<~xip )dZDXj~HcwXkx_f@5kS z p %F]jd'3v1',0T,BZҥ T. 2X\J,*RRIc]HBj f,uMOyA ԍG` @4vpz0CdgrU0mf&!Uְd Dҥf"lW^ĞkY Fy$KwgAY! }D6Z{O#s(#*}pxSWQ+|'œGvc 0Hq]wg!9D= ݨLJ.JУC4V SUKZ:gs6 Ki3|[C0l iQ !eؤ .e̠oIHI93 ˶B A'c% 8,) 7*!`liWX ?72Xr! A0%Xt `z%V`Ʉ LrhL  w%2!M ԐF K,F BQXB sXbLHK u]!% )|o&nqM99, } iQ X8M+Zl(p+#0;lt0 /bs7TBsMM }棢VUɒt4MJ <\sNPF7EmJ秾}*hk\ZУ!VrO¤X)WZ,bRzйN4 kTQ2PWoHN@mThQFHGN+Yڰh6`E1WbհP 9,ݨVY9,ĭ= (rTvSP*f& ;6,Jsj>K%e7`Y <FB Kԓf#1Z) @0yQj̐䓺 (l<&VF}4C"š`lp ]pX+f6.ˑ NNY̐`Ql0lT12šrwáHi7Ŋ؞,W&Top43g젋*13vw!=> XG+g2!E 9Ջj>.4C B^t iQunBjXB$7X~vU{Ki5r射 jYV8E`X8ԫZ^ K0v&1,ؽ i ބ4w!-!а )+,rXz f*03`$Vf*flF)%8kZ:r_E/9HlDž36շ7s\%" DBԍ/쨩-q[#u5H8bXj D(¢u koSСݯ"nNdVWI2,YIʴlaKa4rXcī \,.ųIA(| ( ٰ0),aw,ԅ K-h~ ?:DϢ`Q%Ή_9,a2Xpa cq&3>@`-G`,8~Q "6<&㨙R҉HM& g3o29 ƴ<;P,89c'}2CX2y)aGjǺBPB;cKH{¢W=.[H VJ%&uSH} !d#Ԫ >]o)Ճ,]o{)SKi/ \HQ{ )=~ޅ԰LKH, iKB؛*9,bl_-EH |/4cޅ%!e,} i(L.Ӷa\^H r;L C EKHIg]( >RJURsr!R[DPINiѨXp&,y}QncIU:P#.HAg(j9M꓋FWX2K t`As KL)\,ʎI&8N =` z k``wA 6Pb>5xȩ,.XJ;,~O]҃LnXG13vy"68.t,ޑdl蒊KNe3vpaImw!?$)1 !E2X~ҾwބUOJ#u%e9TѨ1s١7jW\G 4qogJs :i4F050.mC K>:hA ú}VKbHR*H5pNaI*ebtL2+AaRz ]b͈9%=v%V5xs_ ~>YOnHi7`?6=ܼYԮMޅTl*T)H=ڥj 컫w$'N ȓ EoiԀKI?bT+2J`x[TLxs"B`o$ib$rɥ^a7:L,t!#j . [aqN Ҥ9,53I`93@c Y c8%f%X` rmOZ I7|;`K',cc-Xz0vOX1ywƦtw!٤߅ؿ iۄTJ3:09ΌOWԧ!je+FYQ싺N>զ(WUOuW.;⠑#v,nYZԗP]KZRj;=Ò}ËKu%G7_4ՙVRPDq?ٸEZCu61'p܆bQO`q*tqAsemU@ X2{ݥDR z,ItgX ZW&PxVsRŚwjkk*܄ iY[YWV uoAtxvЅαt_<+%TQ-~m4CGW[5_t!r]Rq7jګASBz+\t1D?[Bx ,F Z8cl__K2 |F?ƃ9*= *^fXk攌 XfbO ẂzÂAQ04x%HR `e! c&fʅ41v 6}~¢U=aI̐?MX7,4\9|d8VN t #-g0 E%wX;R,.R%tRkap. ,^ ceЧwBZo0jbسCHZa|-U!)-Ɔ득qd*NũujGQ!Ki<u\eL%0beᩧxG^x<4iG~ל])p{fl)ՌT2kKRcJ/k+ Zڊ<2+2< Mis-ךQm(idL]w~O?3<)'/]tSO9Q/2/VCUJ_̳_`~}zu(_/FMi~z &k+Dc2nZd`͈5qKnߚyciͯv6۳d ,,Q_ 3D1XttΚ]b}GQwg&,|A,n;,}izI aSsX ܴ [~K5"Ǝ̷/X@a=^BW9rCN+G OFRnwK0R"q0 9 Z9.%{_Ex  Wwaa i1C3e+c]2f(Ž 3vF )>=2?R+<0|ʊױGF$ v6԰~ʱ±D["JiM It˷Zz?Oeo=_c̲˜V_|EwkcW^ivԳP{J55_\aZzIZOt=wmfko /z=J7`M6ل}fZiosS]_1__g]ك-ԟ~v/=+6fA#.wyk.oU961V 'p9GD j/_Eue* 2yLihwa$XvmE^tz[t5+>]s5/ϥzvgx~Գ9cLw/-11װZkG>2rЕWXq~5W\q;B}ݜ99V#$-Bs]uUg+JŊ+/_xE^`k>|O_fkF>⋿k3Rgʎښ~묻΃?V[mf-?a 64².+2=ģ23{f>Z|Yfs'%\П)ct7DѯhAi2;MrC|1v:%3cR/%ebF̀J=\&/>ez ±l,:x M4ٟ`RW˯ )Ԁ",`+dߪ k+(U@7`KC2UNÒ( pq=9Qd,V^ M&~d*K&ϧ`)1rW`,]pbRwC,H3$X|3ƦL1NpsKKt7xSs[6[o/Qh5m=oxֶ{o Ab~ǁ̳K/,"ߎfGfm7^?/{E"Q\UQknF?~>u7W^qs=sQGkK,w}oeKuG}G^z\Rl~g^g#vK/zq̘@BUf9E_}nFZ|($2 : oӺL׭SU%)H}`Ri'2 ԍ^LgjXR$O2PE)V }(/UP` ]E;d|nGNsXlcU Vw77F!3L尸uXQau`,SX'wna,(E!H+]Ta#V8 &õ(va Z5K7X(X+ 8|0Z.gڛo`$f`Q? yK * ụ!X\(`I,aLf!A G#kUz%; i쀅 %X$X~c e N.򛅴 O&*poԚAV*x/bX2u"47\k/ІoL\hE!^ۆA| X4鴅4`Iú^7jń2 t r+xѓ+z8>+`fy}&Xʣ,LjÃIᐅNE%X|(RSZn II茍q` ШLVcd W.̐1Pjq}tK̐j1+,J3=}Â\* ᙸ,t#`7fK= ! jOTtqQuu&L){E1uSC č!"bgQ-2' >8) ɮOe\sU'A 6ug~֓?C= }9-#Rw8pЄ b„ZW°8aB:q[&m=fVEH)xlf93O8>&xEQ,~ Q.mŶR/z ]hNEZ[ŽIS3-ix RC:1xO2/+}h,-2Ì3s<+٪d γSO@%8E[lÍ7xlu}rmpɥAXj [oçz{}Z<_r%򫯿6X.5`6Ov}V|ˆ}uݛk F5&1)Q3FȘ*Ystlk^`3bP|?NW%,G~MH}F ݣܖ;{4u(rX:G&.u%mfQVYWXBRCC~kX ],'AWb{,fw@`sw u(^ K*3XA˄4G]ʙ((L6u"%!<`a` .6jCc~L!x`33dL- lRc, cOCH0v,K& 5,p5&2b*(@n.BFkm '"LG#8m"mg2e\Iّ|*3,@TtiGnME٪)T¦& [ۊVԴVȸR.VE4ҡʙT?}"6bgQ9uuʅEpMEmq"MGMSEUv?UIZl)&IԗS:]1 ul׵lmy[-r)]?oVPSۦTwMZVGmQZ|D,(oa )>YtV*=,TW{inoװ,كZ9>I,:Eh9ep8'*/5i-hIÊ=PS RJ(T=d*(|t)Ez[%^Q>Kk[KN&E)%Ví4 6aPh cS9" c\U~<QY|O 9R8]ZcLؚ]cRF/?(*sO];BͻaE swp >ԅ(3cdh}e2Xm8=`QȸTcұ _ܺH]a]ZK,ƘT<A2,FYM8 638q `Xk wzاKHS, }Ri2v- Q1K},LuKL`>aka !u c% iPߪh{G]M9yd60kjzok򐯻m+h M*ZjNBf(ꥌ8 ,W;ZCώf"5!EŶ";/@bGQQyHƚ\^8hqޯʿKj+ǟ|r6d_jXZ,94Zlb[Dk;lTܥO8rRMR^t TP)E[˜54S"зdp)p@N:T,oTdUm8EcN%6WSi"0΀,TdLjĵ,5b**]EZ{즪+QL_{jmnW{-XS{fiZ4,bW^y_;H8lR'z 1"~ MzAey5PaE56Dﯾ檳9Km%KICT#vP(R} - ʅ4+։ Qj;![oRc-GPQ1iěoY[4zq=]H1KadxOPfRvSJ+Fll :] va%>3PG O%XJ>Ta>H,&ΣE0)A6a̰PbEJ0Qw?jXN$ IafA`X,']R8miub9W(|`Aa #BH-"o E i9,JD4E擴ӆE1CKB j̭,Ǝ)c'E|9QM jD)t3)w0 尘z0vR`&=wRLHe%9ckRH]~sQ=Uq)$ ?q-:EIn:F3)~E܈ )r\^Qtk%>4BNtL;osʰOo}T37J)*$Ua\8qI˛dmFqcՋ"*U7ߏVwHh!52meTb~:,n6F0 _e /F?q:H ClmsVmtY Y >Pp!9aYJQZ cu(ȈI墹 TFmf5_~S:u+*A2Id.TWi(TJfR85@J͢I5Ə"ӹ^iB`MmmEO?)=:-i"d RfyAAsSIE$(jY@hO ݫ#(,VְET,uǻ38^_M lUZ8yqո:W kkb! ,EFziyb9q:r+HH{BԐ!NBI @%}8g5\Cd§}aQN:i!\m([SyˤT&;y faXZ'w1,44/K %j V vMOX\ۭ54aY|(I.2X4KLU ]>n8E߰Db>`qQRb. ,Tѵ]Kzehl<]` -sYSN҉}SKƛx }x ׎|߰+q?jͫ,y%2)"[WY#-⫮ʫ'߯q'YsUe-M2es5;F[F$*KZy]o|ğ][nlt9,&3S|_iy=T8UV]emnz>3'15\S\kݵ.4?rCD uW_8b.CÇ߸B >-@Zx!/>U{>P.R2 ;V\Y6٘>>aVj+EƷ. F#} >J!Yc Ž{Sr ?Ne8\ἣ8,|a㔵a=izC'})h.B^ ']ap8+[HV.Ֆh-1mX8ZUG, Laq {%uib4qf ;3*+$)j]rf( @72f`ɒhafWd+,cG}ĩ~򜿝Wr>7]{ҋ?\PhuL˯:sBs7~ .BsK#-C:3qnCM|xD?J_/?O倞~izѪ8嶛N馛ozЙDtr+BPϲj?cM&Xll.oT ?(\,Y}gb7f~䀘O<)K V-'y:R~'tpG?YϺ/ v.r5^>N|%/E1}&,Hu(DL300υT(l]TOwRl="gkmj,f%,VĪ$+6i*'UА&UNW iɤ*b%lh^ =YE_[֐%DDίb&,,尘 ^$B)PTY^a)gEJؽ0Cnb,1vKt4KOXOz0Xc:cן~'cNmC]G}|skUnLCȸ>4*pd _o! Wۯ^|,b4%89x"@W[㢋.:tnOP}:y$tƸ+-]q%NϤba2p ןx jEW\y^{QM|_b Hw׏MM,>jpY[K$32XLSSG{qы/h W{YfQĀ: @*:bxTi2%|ިT{˭78W I' qJsM6SRiדǘl8AGlZukCN*][hC#@qV" U]!%حwExgif2YxJ)ܪ믿e4rZ48Nk*nV9lcǺJd5T 0c]@<&z8/WTOhn"I G-M7x7߶>dAQʹ 4H棎9r츱{WSsyذY[3M7dzؠj>Yeqq9-|1uJP0b'B*Q[UQ$r oL}"Z1V|˅Dٷl.">{ҧd]$^H IR(;_gPW+5`R6(I~&CgRWbR*+q}[a׀ԷqVKh@B ͅ<Is+/.հ j]*#t!ĘBK {biCP,&_,W,.CL@•9,i EJzUeͰ]A&4~;>vG#^`Uӂ0$U; btJr%Ci%m^}_tظF ]!9!CUh˪*;ɩrr1Cq- SĠj ǟ~L*7JWT/ /zRKOx/@dӿx6ٳ)8֩h65Oǟ|gA1bz_ŗ\4} `*[o9S'O21z{х_#{啗![W7?cpm}Iv}UV5'-2qO<ċ/0huR S*JS͉&ޢ&@G?~ǟ럴0d?Va=B(j򆤔jȬUbod/Y_ݸq?+l M-raq`u[H44L4+F&(f̒ 4 UUI,SDj%(_0qؐ?<Ǟxŗ_Ͼt3訏<[50qx;):Pd]]wݍ~({I*+{z8 AC&N误L rH4ār/7h ui~ᇟǍvsw**Ɵ`l6CK5R뒐4MnHú~Cd[Tn3dU@Qe@QKl.ZR И!SIaq`(($ҰT<DrXZ !.W}oׅ2XIl}.D}b$,%R!OBQ4IaJ ^0f˓Hc0CǮzh!+,,E55TtdbWJ4t ->Y]pY".w',eqz rXRӴ{4'X>G\-nP`UúI١(IF6F,Op^k駟t(oQz=WN(\ >591l%K/w]sok_yvnw衇wUϨzy?`,洃 "jmc%j43>MB Pe6WE@K, 8?=la=ܳv;1W_x^g?p]wљȥZ:^&?ǝwE7XUz=w_u5K,İq.jnkTtک?c;nm?@j+o 3s1٦l׿w=Ϙ;/g_~o9s馧s-9SG`U):Q[r+ПJk?xG}wsG:]$?QROG;.䲪Ya|ւ~:ZqE/,R:*_]zM7iή}.1g_⩧KnȐYgU'ڜ4K[E;~M1t]f)0K[NpBsYjhj8o[xᅄEZDR6o?-{쾻裏zmv6N9WZ]e*,Ȼ/|-Փ7"ΎYgU[ɧrL7M7W^9h?~8`}5\}^{}gkιfiYXpaU-[l>ޖ뮯].6~vqώz~aZbCMUIP~˱*IH!*d/rhI%GTI^ UPԙı>k|=S^>]`@Fֶ?)0B0:Cᐩ p^ X|`K\me\ rY %za)iW;tJZHx 䰸9WBc,7 XRi> 50.$ / &=tN(̐RB)Jt#,dx,I`a>vO_O,0vV8%XtsYlyљ̇H̘qhvyxkAEuՄS}m&ng}O:ąX.T9ov1kp+7^$]証!8E`gUi3"4ζҡ5e JȣO DJ+gU;8[NzcwMRb:ֶwbuekyϜ!/Wo)! 6[38iXq{ͷ==—T:>AѺaфA?šnoq8Q%<`/Ax$`!̢x{\n+4I@}pYfģFyD5fp'YP`Q[nv0IzҊ_ZZIaj=m3Gr}YA2޶Tm/?6)nEB4JD4Orӧr:hW8(5̑\a\;@\bi:uKL|MH'[e8tJt?rsZ a#.ЅhKGυՀ30 Q~ PjqU x^;+G4t*m`w*# TC”pMڊCW봛2K|^@6Po {1 n }Z^Tnz AP-WUğ>8MH!h_+vfa/8bKݭmbRփ@@wgx3ԅia;xX) ۞h byaPN}̓w07|k['Y' vA^`!E/VK_ӀO ua1%aa KIc Pщvt'bdt/d4hiM r(8,"+.t'%ݧ a3rfA ,)  }l!kIſ3&WPuܦ' $ (Lj!a |/hAs$O?}w%^r47΍jm-B ]"QG`M[NV(P".ŬKf&7?*D;=≬O.,Qw\MYtArBÔ{O Sm}&۠e2e=7U_e,[Uk}5̳|HՀZȮIմ]3 ]^/URJ‡9)иNd5'1Bic,꘦lq8wGq}a˸l>j|8FE*]z9e%9pMe)KuԐvR{VUslUW_C-U 0@ZV h{<1!/몪/^N~H'>a„]JzUW]eD%M 7mmlc:/Y<|0T2S 0H. F׈QW_{kČ;*ЬO0({?3C +UeT: t#8xᇮ K(cyj2qC@ 0r<>uT̀WiԬ6۩A'UbKtѵơmKV; 7 j7h _n>LgSjTw5 c 9 p\Bېqُ#>Ql!PyX0xLBOf*>aa5HXܕ TAX: ͅ0 cE K `*҅',l Ўt  KTz2,2b 3dt fЮ·BaBp XP , 0, ,]"p>6ȬN *8 *yWD:Mo.ŧ![mCQsdSCG~s='f7:Ox_ϋw}=/Hhn۳>K*?w4XvetP ԅkR |.P෠vyu>4$SN9#3Zњ=Ó>ܲm&?W6*qZÚk󸟥>`z4L/+J^y|tUV%lr ' 4W^hS= UvlJ`^{?Ok .n +lp?4Vt~ܿ=p)'h%u5GVLikoqlu:svK/=nf.ԑUiDpK2wq@SY̪×ǝt?6XeU[n9>8Yg9皓C$Xg&rXGuvdok}Yt)VofͲ)*`-/䟗eK.}%2"EBZe`r-l}UK.h?眳O *ZcuTT({4r-c \\ Y8@]`wޮrulV[ؔS7|SG}C/0߅^"d,"csmJ3*>ҪtÞ{2|՗ˑG!nT*z/Bga<ݐn~tz!dZ9LQ<@%yy?WN͖YtoΒk>`Wzu[ O;UlsijɢjmzJ2Wɬbrkz`W#755R7Ȭ܀6S!Ыyp4NN - 'a(}bX`-7BCTY&1 4,l~5] Zⓖ KD)`UWډ+]BqY!c 7[`%6!0a X_9,`XH e; *~k,gS.FuF-c9P+b3P1C 9,0LZ4%%}t}8Nr91NWkz0钘MF e^PZ?a- KwϿ̨ʍQKk;GRS|񶙷:2F: p-͊IZ;7+R/t8olfqN |BՏ} J+4~Z/ujvB ȪCB+Ӥ /,g}Z/vmA/:@%__T?QAGbM6D*q?38߷~{Egò.lZ\dEƍO?;F4Y@-ơIͲs:xz1|/\MyQ,CW{^|O>{r-iIYq(#\yՕP[x}_8yA͗ʲNj' ]j)N:INP;o^<<e?.Ћ?/?ӕޮi+ Z]};grjP̠/>?^[ox }U'o"N!kϾ$ac2rTkr6C滯λʫ6lc3ў ot0Ψ矿qz~~H b_uh m #M2y1="8[ +#/sYf׹k`TSiYs'zbR%\klgg3|NmNSFCE1Ih0k?2k5j8T8n䓆*R4&: ROj fXt|a=`/`6iF(¯dӴa iR#, 7XPFfXf^a-O7K` 80,e 3]l/~==?տoߏ?yuub;yZHQ)34\ా%Q${MUW>4ۊNON0~YfZ]Clocm9C[9ޜjQ k.N1 M7̳8Taі r-$W뮹~\sJe,²믻lv&MKմN_j뭾oFo[ofmg/.dM4~e]'2A-[m^TN4]+Zm-{g 2Rv;lCz;^{*-Z 2l-,/B/we؀~*F:;{g>;,q޴_mΧrh3>}WCE8M7hOx8f< CW^E/:?r'lCW{m݅WX\eՑ$eI cy[߄Zw]}mS]MbDZlJYiE$Xbq]\pe2xPcs㭷߱{C`lsEK뮻,k_z%]b;Fއ+Ɉ'1+j"ƛlJ&MtK3NVmV\lSj}}~7oi%%}Nt\c:$!JFӼZV[ v-b؍݈ JA)t03]뾟~?<{kkkEjcRm. ( w )5,%UcQeTJn*w HJ2ɀ+B|N-:૪8CʥXXU.olhhgE ,yǂj`'`qJ<,*bY'8\f\pΕb2ׁBq)!Ё,@D㢞07 Cb\b)$XMj@$A>`qq`0$`a+ , ɨC±wLLDZ׏Sށ2exOEo|E?6z873e2uW_9ojzÆ }z"skS&i2[-[5~J! &ϙ'}ӼyYsf:)okS6\I gYUW_y5J)Anu>נ Xt 8u3(+;㯻KNjՙ9s.Gqd [ QA&ۄ_zÍ7刯~zzTvdf{7* BŌݛ5\̖dSd (u_{UW7k\!JJ+YXm7ogz}wݽh %~7\AjDиH"Ǜĵi}}FAՋ]j~['a&B" u]suםy:6?Ѓ `?=Y#^W M]_4F|L7\_N' z]õ?uŕWPκk/4kG0X_'L㧟‹&NM9DZJbcFC㖼X՛ {ϽapY(Yj%!~AjfmW_}YZuSU\Y,再N6m/tУwE7,T^m~:DD?%fϬUN֭6k%T8 '}-89Yֲxb)/7g|u\èFcRzI(톛lŀ x̒>`!^]m~ZRȨ\õ\@>FP ]cDXLXW8'  JլeH?[-SɅծMFmre<8y(f8G_J9XUy6Qg9P`bcLo"<>šJ^ KtY4Y,̏#n, Gpca v0Dcâ5.S V&K~`Lc (}&ͮ #wpev{zfm^Ŗbc1wD`A%snvhl7 ssφVX^i$[+Ŷi\:/Z7k☣vO>d7_=xCRԨv&۬f 6TCjJQvl:d ǟO*^nK/2FBʕvȣTZoNujilּa. ƍub{)RO?(%g͢{OhLt,7"P1񚒱 k7|`Q _cFtuP;s<,cܤpu#.ѫb XVtX4"%Uh)$D%_b<jUw(d⳥_ya,e,d~G~i!ɪ-X0OȖHgZ=R?SO?E1_g$ZanKG'*MKsGu1 CUeh dICȣTټ;4+J(п+ANOhO6׭d`/++StbQeWӯ h~# .bH ꡚJ+ma+j[ 7%Cj_Y&ҩP%rU)(ʜ8w_%E7. ֊';Bnfe5sPK*In=O#Ef$L#ԧ6Rd$In2TBph"1R]yٕ?W*U3k($ N&Z'zݽIWfj"s|L½Yh. 3(EfnOÝMHCƚ1 6Sf2veŢZ¸{.*Xi%XyliK-$("|%UO@#E5yMD[4s3X"ʕLTU/Ks St[ C?PKo 3Ǟ"Y4:5oixaJ|a+1,Ib~qVZ_@׬׭}QH `*DΈBFYX`!+%R*PX|9I;Pp nt!N `qq(@ ^%4ԧ̸oҁ 1nʜKNz"u [at`" 3_;9D&XBEXV Re2n4(Y,\:.D^V2msϯQX(]L~g(R3˴(`("$lK/ÐXH;Ǟ;ucGy $$U%N8h{"%8{[J%-a.hOV?QX9z|.}#XI6H ZKY'8'Í(TMH'"۷Auo}]q@z-WT'ƽS[!65~)dqTq #ݢꊳďcё:o=LT܂ƽ)YTTzp.ȫ_O~ JqwAf5K2V6W_ڑM|t%4+A(QK] L >pJF-Z\~|Z4( ݬf.V[ϛqOR6SLӄ!8Caξ7%?75 QAN;V[YLP\d@>YnC%^ك@U+tZ|0VJv5{tyI3b]pxn3cT- 'K)+Cp)ֵ1DeUZ Qx!` ,NL`$xF7m Bpm,t ut`9, M%Bj\4NYb&#:+U 7@ؠf {㢒N ir!N_>Bt@,!}BH0$b``aSM-a9T!FY%mC;gҷ,e!+tч_cuQv1'y-Ɏ;ZTRq*Inv*PgpE%$*gLiՐ.?1o NRd^.U#LF4;Ӌj;_fUD:iM=Kw S,87K1}/K0w~GbJyX jW}}Yy߸_w{x@/8+Eoڰ <}Ԥ be`dQgȌqX*tvleEc%͔t0]tV/ ?H8}Áy  Lv[>&n 3$'yE4Z4rЯ ScH)Xu ^[cdgy%@kt`>|,9㒳bû %ˑŞ+[Ƈ`ˮ%&E1 oXq0 ,%#B!Tq0h_W`^ # Z>Y,B$,mXhLpe-95|הpQ҉Je;f|3ϔճk~?^˥i^]ȫhҴiw;< :msϒ ψ$&x"C2IW誫znݶ;uE+xͷa5j!QZͅ_s]M /}s3eʫ{*La¾3O;}w {V2+J(\U_ZJ@&' K:Ku6Ԕqk׮tGZa{~t~ч ۡIXRTe_~1N;oáf_ q[*P?9瞷;Zg5>i9\_ce)<;[U;8e K '?a¯ A;~`I4^p|~}yk\~e Et*DꁻGXX]1URue_֨Q#{عbK/ks?׉k&emG-@+9kͶ8Se7t|M@.WOmnϒM7m/[!:mt:$Xmw&HO*}4WEբu]NQԗ^{Y(םvNK#w}ۇ`{ K](Xկx:7Z^Ixcd'R(XW}֕c臏<^q?}/.yv)LN('wҠ.,j9蒋$Tgw/?.6;}1dKo2 &xV4~i IئMiu$ K6)u P那 ,!^T{jЅ/`?ND@˂yzNp8ѣE  :XbюȂ O_W 2,j:P,,ϱ$ł%gŦuBKqq9%@XHPen` w<,ʿd>T(h;q qxNƥŲ(~"a OH[_%,$f>Sĕt~wVӭlq o3~ӏaK/yTE#&_^⌌s:o [d[9ϨO>^u]G {'U3|-~ z!K4ZuG>`y@/c:^?Y[.bǟtȯF}ťK嬷z7E ֣6Tay瞷K˓IƛGq<= ~is>ER촋Y//+'J-N+W!(_-Rp /Htn{v]wEi-)'ьnqef }{ȡʗ׿??O//\aʔ,ETJEjpc8 >t[z1d PEf|Q+4w䩓Ick ߀&"{E:i]`P7ߢC4 UҨ9sgϞ;{]MkJpԣ#jBm$ϫB/*^(?ZK2TߔrV:3uwqG9UEEoeCZ/fGh%?g>L3+ P(it)`Q)ͤ?$2V\ ۓ'O_R)s?Le4QRc2}emI^$!X%kLI.EoPiKRUbI*ŒE ,jDxf_"( o܁X4jʰ%w\Xd%͑1 "?ǒ߁T%̄?6QcF1_CwߏTX砈 ap4}MGmXUؙ;cf.c?Izݎ>:lсc~s G잲_eW_~5{{{^ՓñtL*믿NPL9>IX ɓT#m9IeڱRsDμ*& zO/ό.rx&W]o@M$e7م;R/nU39_RH!0{B~n"}}=9/}/GV;^Y!-SY_)[AÆ4+/u[/] K^1|f\E_hJ G/T[XnppW_uvʴ3'%([:uѣyeZ1#Ԯ,e(PsϽ;X" E\χtbJiQs+X9wNA6e_x[mt+Zbϙ3~]A֝BAanV^4nv$$ek©f'M:tի+w՟RTZ![n!Ç>3_ybX` 7m" NQԧnK&y85Ev{[W|B5)ֈ/rC FL%x _Xb&d(t50$S֮a' I(B `eV0ncZ~NZR,E/aR`Ju l&O$aa)`I:,h,F´52uq9,aVX t\d5Eba 1sGZ0T],!`IE4wK%{\CqEɝ;xf"&CJJVZvYɔ>>-O (ccW@gK!\) IDAT3KSHeź8\ܴYuGxg>v KbܪU?~h1ϛޛn^ZuX/!h K&DŢ "!X.;?{7];Y֭g}Vz-=j_WHhѱ6O>DRE ΋%څtKۍ7묿g E9beKFj;aY l-qij#lܾ \B0H}YF~`(9j+9N?N)1װSOW^yRlfZ5sfnѢE. 7i 9 `vuQgmE^q-&Rf7cvz%A:&l۾j:b^G.s=ڵo+!KmPW^}ēNT/Y*Ґc >-ꩧxwz)ެ]qGp/rK {1eIF?9䨴I6{fW_}"I)/"J6oT!_IM6B-NuQRJ ȄrwǑ_~y7~wm~/h޴yT3{;Sqjޛzݾ}[-ܴ-nvS'z⩧Rd z֒[&T8{xAm۵S΀r3G̛7W蒪] 2m4ӌŢ e M|rMXrI}gN;[plA$\/TNg6qӠb)$+ )3ieKuti/Ґ8At\`!Y@BƮJ8Zz,ԂGC"?eJ$HI*jW d,yX8܍ɸBrĬ8+"m,N|,I`RO}[K!>ވ݇qǒd,vxqB-$,K`fKkg!V~4z0!fxĝ? w^)mBOqlr)1G1ɕ2:/+]:l0s#8~ .ؼ嚵jNrSWW5kqm֮[es!sI-Zj5H>juڮs-S-[پ]S*MFZ4odN.kvK{v;а0{obͻrʼn+Aʋpqy糄mھ- L۠ `'?$_֭Zo4U$vmܸ)]/_(&:SJ֭eU6tsޛ6kѮƵjCѹ} 7,m#Sߺuܕ2PJxqFl{//(+gxZ\\#bͷR #ڷm_Q}kؠQzuZ'* SӦ(x=vZy3{>B-{;^v5yJ3iNr2VdӸH+بI[V({nWb2iΉ,PMun*fGl =Fa7Yȏ-fۄ|)i[fc#<~ݺM4Q^Q$uڴY3:՚ͥ5L lujӎ룢"ԫSgϽ_uR% c~X:\tœLkּW䢢:~ LM6lv-hfM V;6nX-Z*G%\"y{Ҥ)@Ιg+9NŞ˄w㏍4^o۷L$Ij٭?˚kRujw^%uָpo`/K-THa6ie.͛PEo|?^[LB9N0PjB\"3S7jmBE@9”KyJEG$tj0Wu|)W w}`+-~~H/]L1[A3"nS j+g3+4iԢ\r|N6 @hDd&)\3;L8ta37@TbQ$4V -4ԪUTJؓJG.+ʕ?nd4dɀ>Se̩#OenXWtM}>{!]X9!¥t5NiEFd-7X"a ?1k-b"ix|j#=b1FR5Q$YhvHKqI߱R&!%ȩ$TL,Nkli1W8IKs *5J JDr- -FZ 됛Ź]%P4x@N|"`YjyB$3He&*bܫjTPO( QC{#װC vԭzW@"&g.=LCj<:zK?, d ӆ¹ 㨋E -NkJ!.tjhH<9TĩxGn2!*J,ZsERȢQl0b`J*" S+ÒbW%: FUсmqtD,%Gb X4۪d6ma`+Xq\<.d9u]_LO! w[o&_v~yՑd0Dug"xg9 _I(j(]'?rbrӇڣF<PstJ4Ym/ )ĥǛ6koP2 URƱz#N'*^ޞIVX|A &jݥ.\^_,流uJ$}ٞi3^%ǟ}rWeR)G{D#}>pPúu[9aTRLxw~G4(7ǑY 8 sђo{7䪩c+8BJ6R`c g3]!@FLɢEϯ I6g,MVPj52I,U/‘#G6hƇ|:6h#Q~{1VrE+G)':w\!U l_'ș]eg(HKaGui5ȗVD|:wyO+bͬ-OyUcCG۾3!}.*,xnhC}Bڻt0˫z,jN-cwqHkzu>]'feeˋjW>}?*Eex(&( -5L12cVID*QK(yo]wz<變eCG8q# 4=ٔ.^%śtva6aI:a6;Á3 MrD`'rhLŵzI{L= ZcΗu&v?\S{B슎9}4w|y*ܹ`j-XZt޼2|)@<䧟a'L /࿬X)BS?Q%|. }!MW*"*nF+/ϝ7O?X~}E7FMD10TUź ,;o]0O2O.+7P"m{II AL#H"-:L}kULG"J Y̫r?S2/^(b[]\r;nK%K2惔\I'$uA`;ov!M48 t|9pÈiri=KA ܽe41q aK+O9nLrTIJa+‚c!Xb&0B&Xi쐸KBq-Pdkb^ ,\}-2fځJCifYڡJ} b?6:8ھ@ ^޼Ӧ/`2b%vθD,;0:t nbIM*bD9aYb0T'㓤šǓrX3u5U`0`AOqN; \Ssy]~XmVWT,TRUW;z)o1hxQ:QR+.~Pŋ) /(&\;I$QC]Zt޶:CwJ"h#ўԿr‹+U g4/$Ay^|HD6pAzhe _wDVE=ܳkF;l9ru2jkPb.%E,^{޽_P9c;zg7GntVls>GCpu_s]{+?C1|>9H1^{w:l(iÕִ_~ڵURAGTj0N?t ƛl뭻nͺ} |ҩ?ӭݸ>LcUbGb=ēÆ RM;SbID>jR>#ysE le38,Gmwcs t; 4ŀ[Ul\C1~1z%Iߎ;075䶊r76Tqbg39 bf!@,8>Ăcq<拤ql08:γVaN*,4lc-Or*~Xik,V[ \cYЁt5V@b[9X wS2.c}\2Xj*woӾ N15Hma/--[NzI'3PKI[TwF{*>r7RB=Y\GpRL}BoK_+Ń/G*pkSߌmgu7}T˱}F;if(F.GqD ڟΘ+ bԘo;QcG%@JP!:?=O?tWeJ&M07J o09`9m_'}Q>J.ZLE'Ni&ůAEK2(3jM6eU:Yv7Sȣםb9Oi駝qJ+.Qݎ;YOGGG=zA_\&/|EuhX`^wܦ]Y~n<&% 1zG减p[vDc}wޮcƍoO=yg4p_Ӕ .Jɏ+7qߧ o;soF)L\R(%$еPv#92=ӃP>.mbvӋsWJ=LvIot F>Eֿwםwmq╗_y`_|B^h|ثWϿO&)m]K.H>:UHQKN|)?9tXHB?"#;8Q+YLQ[X`_0:0R],8zԪ_pw43}TN, vT7,Y, ˣ%:CbqŸCYKR)V.,"$pXi?&O8eoISbi':Ǚs&믈B i8G.u1Ј1TªJMbndTeжoR5eFMin{quWq̙r7{&;d%=9TW&ukҿ_~ZkvixG(>6 cn|%wuտrϝ?% M;TX,\-2<Ԉ)%(I8d)* rh(6^Vvtܹƍ3˦I+Ki?b~'>/׀f<>gG~\ptK:˕qQInnHсjԭ-R$aUp=D⒋~v !iJZ}]RL @ mK:dK3A%"VP-ο͊n{}x-J͕OM?T"l (oVNɪX} ($WtJIݨqc[ [OhD-x\pD,#cq4/(|ܬ<ƟV!g)!,s3X/*W r&갨sc0aIR,y`=PKTbQY8쪱`(th `Amul 4q7c a$h+ƥRM1#@hD{L808_GaOT3C%~}XxtE` ~%XaK8O&R_a|=4=egRƆJ4_X0( Ě#k3Ya)~5'5Yb]v z$ m„s9K/ILVVhoˏ?/Z:F&N&`dN;uQeV7}a9қ5mto|=jԩp&}ߏqw#'p%}dߚqW_}Q~]]jwcOr{3j\ϫ<3{mn?R];hzÌ+4bĈc7ɧɈ4+h&x(G'Gtz}6m4yM*D}GStÇJIT&G߾7ty)'jςyxI)I      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijlmnopqrstuvwxyz{|}~5}/ Nhي`4is kT* QƼT^lf WcG?Xl4rMjwlaac!&~;-ܢg=l՝f,-窍7eĉPNI队JG@{|q+<0+jEEkn{i~Iw8g"Β?$W,V_Wk!g%W^oH1#'O;{1;]}(YgC*2.X/q{\v+/v)zf/Y",*mЛG}%ؗ*?e,iV /kEz9+J"w!Ahu*e!lniR! 8FDNvS*UU>m'w,uW0-Zլ>6 242siͥmE\heRҞ$?ѼF  h:ey U7l3t,V([ھݦeԸoh߰rG1RO]YIel]$V--VQ6;gΚvTZُC:^Oe9+*=t*]6*ZVݺihE¼U6ްr_ß׋jiSQ< 1Zn=]zX[@Qt#ʤ>C+Lb N!:(@ ) 290cSf-[XQcM<|l&2wFMХu͛joԸ&82T>ed0ڶX{ϙެQ3\H5n>sgHJqby%l7ؤI#|V5)ZA e3vEnw~a!fOkѸ"0+vۢ535i*PܘoGׯ[Yל6{zMT# ͘*iYhU~Q9k! (..W%̘aXBP:}%v̸8<cScZR R 6G{S\mx&Ǐ2mdK@k$Hъ֮)jr嗭TmB/\YԎ(J*c;_yx|æ$փHCE_RB Kyiѓm()ɷl0e" "InQ]W'\ӊ=n"753:&$~0Agu|wH_9_Q<6:҇/#C eL^ DwCo8"AętMqvJT Mk0OUjC!JnuLQRfAgq 2KXV%ϼ+#x!a{L9Қ,ptVE|.$\d*.{u$ލoFaɩ +N s1 o/(,MӁZ#S6\03U*4f ?nGrks&S^z* 84bye[K rEl ocѻ>j4~\$ On\R,1}2XbM:6X^hq_+ER`ͱIOw'(j>oz2KN$.8VyzZ͙MhR sT-o'G<:˟'XX̂X`pt`vby,hS`mEyXE]Zj{>Yp,za猰ޱ[B Cf\2M >Z MvD 8e,nF;HunNQ&D0X;a4@QKóy(U>b 4Y7HN ,\@ >_D9ܫ{Ot ߯S MXX MY۬WF4\Utt9dcWkj)*%NH>kӧblYl"T,ۭGoljR8X˾Iz! |_;:yIh[㸌 #ØQeH) jKe ICdpҏ16*Y2q [xIZOθ[T"hx€Gi3n0[jK@D%"YC6xbh\X|X#f j،?[mKoJ@vR8-_etвe[ҟ%L :P!X4X~L 8 O1l :Q覯 [H@NhM#GIG4Fܣ^MUbA<<.΄7eh,XUha@ 9 %?%P,ĀJ8c]7WƁ;PڬqW LLϊ#YSgllʉHY~GZs9+}K'6|S'ɣ)/_uɘ2}ʒŋDYuHފ*2 >dа:T9F5aEZaC~FM0Q>w9jrȯJ-Q2XGڴn~S9d`-b2!iΛ7o#A1}ưC[At3~Ͽ$tBУ{w_ڽQ)}B$XCA{{\zhzTNy3{~QUW^YK/o+);:ŋ٥Gh;ou%wysϡT^T5-ɸQv!'}蔼>@h#ZӞq+dw&.LJGǶ06)w1RoػO(S2:? %C] M\>; y]̱:󩣉M  2tK`s^\! 4 ,5$FqJ5.I{,+dT>.I" l,EXV9I.0TUOdek>Gm*Eez K?1KZ;} ÂA +t)/Y,=,`,،K傭d*)|VKpr,y]_[iYpI 69ɹ%2jIN5Kg;0٨U;[ZE{&a]OGa S1"5 @BKnEǭQ$*vD[R݁¥?Nw C)ta~]ҪVDCCʥKnHxitm۶bK.V0֨]N]OFϿpuUQ a˖-ݺ*4򔭳v;v橗\z>r%hx=/6)\f CvVy:A[_; =ٳg{u*r>hxrwDG[ࣱa%jǑ'oarh5P6r-_E3.]tuQOҹОf.;C>^ۣeL[{Gߑ{~'SO;EAs&OVz=p 'ܿkt줊R쀞W)>=ۍD`7FQ/PؙIXd){=bzk׮]ZR*.rcч} ̚vEau70abb:D/Je͗;kL n!o|wrP+=a q xj}gZ,|9_b1<,ެؒd{9p3A#>M͛)`4%F\X|v`2.,07#I|Ԓbh|^$56.# €2 ,dcHKlXځY,!rOUVKK*֭Yӛ6(aK%,YFilW`Gĭ`ӒTdY3Z'S#h|"ؕb4z?/oz@s;{NRY<ܙ,]c̎R~^FpFD͡k33ҍIc#bʪ 2Q];P~uP $*%bʛKjYüXcNjg'KߧNo߮FLmjDĩReq_#Q0,]L}*::( =.k_vK 0s8& bSA;n?h(6 P.ijCSЭۮ}^Z+Elc@U03Tr79ѷ"c41;.buVKȩdG3 :@<8˳5_w ׂkuƒ0ŸüS,䒙TkEUqZd# 0r 9baS%:k,D+I|,KV8%Fԟ^4GS,1SE&8:6PdiKDI@ ;)3.%;.W=Ic"bA¸q:WK&;.v&e%1Ý:)>YpKR`kT`i> 6H[ r:n P̗$)ۉW#NҢ$ *'gV\p ߓj4mJ5kt{3xsb)#֯W?e$Aj9(-喒.#CdDx9 t}iǝ|q_K*'H^*v.PVpMYoR ΄x㩯:—W}*.H[b ɡ*]jAG =7^ +/TӦ]VTQ%mCR, S=b??>?Ӝuӿ*^Rp)AKKzڂ*uܦ*~EX'7+uТ[Q%T]bN16W4 XM5WNzMY!=Y.jsNa"CZ` #!xHH eȁKX'zӞbr+K,mJB9qhƬR6n*q17,[& ``Qf;p[rS۪`1 1l rPu,I ca~cƖQIˌ М:EB3.YZq1|ENX 3*N%#$.v%XG򂝎KҁE($0O[*ny`gq/L}4-g)?ICsV$ECy0c;ƓCH KC+Xq5.^f.U-XI\ D*A7\l+GX](9$6\v xQ-3ιK!h&_蔄OX'6EH kjxQT >KNc^`w e}xC0XzI/ dڔJ0 kA;0o\\1{}tr`aC$QY7.Ŋ0>'oDwpf\h'N[]0a:ST ]WTtXK|N`b!] ٭+!-b*Uc N*Lj&i%6!ɸ:,V.0Ò AO* j$a"g](䉾ZN0.* ,dO#I2&)OkC줫rp ѪE Lj=Y{km֦cÜIu*IxNpTAP$Μ+H;.3]u ߁Ƈ([mw>m >*(Ox:e$QF=~G63J= %˟Y"/n6H=Jaokئ!+XU:s:[Xh9-=/+t7H\E=խ/pKR'sug- *& Y6iq,`M7J^j7rbURT݌ ]Ftl jz4.vGu2=&ݶ0T- WIy,VDNJb:/g,@tbqH$BQ L -X\,Q/ -bE% =fvkKe4IX[qu|0m}NrX,SΟ CK LU  :Ed;KC$\ŒLD=.9 Ο&fj{,D02Q O_r0#H`_gef m)fguuĐ&"NxO(jdaXoyk#EI'>@w X>N rCpWo6g_|ugk9D7ߘ}%nZԂ014с`1dXZcv U{w2.qI;p'BG.ZwV`x3=ҏC.d\$ǼTu H5,I45gaR|!Ė0$XV) TδFf'ؕc`b\ ce6Š0j) vs=}{4%MpJtUNDh|:IX܁`Wrʜ]pIrXB<024#$0*$,8InORvD'8d5AcbgO*P٘~.>IW縻zFLBqnVl(H K0{}wik4,uOcWy$ Ԯ8% $Ny%H,Z\ϹKMُ2hb$89X|Ix> ,Ӽ3(hY,RpY,wȺЌE;`P4 ,0b*Bya ΎK c#J0E,xd:9.WX<)Txi =.$yT%"gP)1?PkVRfDDBƸ8?:8Vz9R)wɸT22X|q!#'\,J3=XHwl5pծ@XaAzt`!I.fe?YK?,)d&q9,VTT̸b'/ /&$߰p.Z04|J!M 58=&O7G1?U+”ǵ}$"-v Pu"C'8Q@ BA&%vқVI[D-Iun\)rZeW@.0TuTG.}؁-+M4de"hTB֐sCU'!%E^H%6 *5uЊ=[?AȲ]2"+CRχ3Mbrp"qJ vsLłĕ(Ⱥopq ǢdO.M*`$"ORi`UXHe7£)*'gt`eZ-׳j, @baJ":nh,y\,W`Cbq DR,5bR)E-ЎcNڄ'qe# w Td;Ǩ / l K-= }AbBw9F2 !M`Q /QlMX:r @b/*E8[r4W2ERE,0w%ŷy22.t\h 7VhT EhL8L`@@dyT jRǣG͡`訫EY81@8lo_ II&a aG@`/U! dUȘF#ja6Ё4>@GJZ"TʘkҁPGnvrb v* `{ ,fO츤L7e')X, 9Xdz^` j&iy,,wV*&iWN+b v4;.i[pMRV O Wl`OrI v*ͬ+u @_@c3`ee+b~T9Wu:BH|\qVa-tWS0:p8~uWJfYU?/SNEbcric*5# q5oӷheu-VhWӯe' 2)IIn.VaB9J5?(bڈGCj]܁uYA!Xמt/ 3L5YI3X|A/L@E]XbI.I-pU3$ǸK@'r-\]@ˑR)uk{mG8HH*Uk~&ֵJYU]kLxu"q OY lG.3p9»r@I q,܋}Lz%ٙk@Fb;KG@s-^i<;9#0l;b[>*E F/ $mU?$6&C9Q)KA"?P@? <'?hQyhcZ 3.#cQqd45S B%) D! 1ɲ%."yH[panjϕ!;jvai9T391Z] p!`Sc wv} ՖsĞ )/خZb6%N&骱d(4a:øx)H;Tqaph9ԒXءa0.hOWt,Yap\D o\P1!M&J22%t^?YbˡT-YZSPjXQ负O7/F )"zY^txޙ!mhVBiJU,yH7_Gx~m5qSJiw >p5!HIxJY}Z¬W96dc‘jUu`X:.Q `Dt$~†n d U 76`Z4| ԅvZY…8b oEgIJ\9#=ez Oɇ guUIh= E-o+ g>b='9 bE%2X2=äD!/vԂP3XX"&)0^Y ]nK&i,>۾] >XA.5@/ vE,с$MW4K; NCXx I`ɝYti9,(c8&b"$go;I8% 6b̼ds'vX>n3FFJa"C[i/>+^+V|^zM&rP&X#J0R"!It}C 4IS7ah6cuɆX]x#2H6qLGn`2S'|ص7;F.셴䯕+~?~[oZ|(OZ]dM0Յ]5Y24а4.^Re|͢j5}񂦡N?ww:w$; =J*W}'~-Xw]2.+WKkTa0VPs V wqw3Vރh-0̑3")],DžbzW~gp&ߠGKg5ro0+L "+E* ՟(g!ƅ@vY)-J6 hCOq1f;T#W޸$X̑t-$Mc1=.ᖎJ ` N c[i+/IEaW5u V72SO*?&1i)GyE_%9=O?9F"}TXr HxZ]bO1ԨRf‚VEՋM7(V(k酽X˾OʪJ@u":|ʕw?Q&M|O+[l[]ڽGz;s]YI|ُ%{2>}ZXZJE*~B*pJ._*Je(T,u-*̕bQ9I* tsr1=Ԇ)18ws$4))cCzp{qGyڙuKjfCm ~})'׭]#G>o=]{!/) k;懟^^ժ^'Qsnۧz%{>?~V?/Zofk1x 3T[TXT裏?=Zk~^X.~vA5裏uǭV#?9T-֛zIwDJn.\@*h\ Ǟ~_ ᩧo.|!0?~מ{jA;?u6;s_QlYYݺ˭[;?A{yey}QXK._sg:.|t.`o걦MkۇJ=ƎOzܷ?z /s=4^v>C{ƎS7|~^wsxe?õΛ7Ou([kۮfo%KcC9sNjzW_8t;b^=v7Xe1ԧTG9UVYs#/TNmRO0d I88$Gy+nPy۳SSX]v$:U6ԫ@db5ҷpfjX䪫:ʿQ9Xb!RJ7Ih\PPLX0_(mIa+݃>,-a LRuH%:c|XTS% X31]q sɹ*%(֫bZ,DΦ X iXr!bs`Wd,m,Yf\ v H\,a8h<.dU &рaVI+Ix!&XBXq'鶤O<؀ǛG֋.]߅)'xJ_}֩[G/>l;y>K//y1Gsx;FQKQ͚}ƌ^nKʖ,]Tg"k̭qE 6neob}s9-a,+V#sKʖ-]ZV/첡C%͙ RoΙ3ȣ=v4w+wM7%T =X^,];nu4ao^l_-v;}67RAovM7>gZ>ἒ奋knO}V}~ 7 ?qWhrϚ3T[wܑf(up~Ɋ;(oA)]\zLR 7kW[ PSyۮYx^?/^j:Ÿqc_oV+=?8 +ՠ.~FX)G^2&y..V:[u$_Rhi\Z\b]~Hɣ~JZ4ہ۰tIt 5 \,aiRl`Ij)MWQ/a KTaRcI:иu,0sV%![˚ay?ƒeyP.ldG-*ME.K\><CR CFWœ`W%GK`/I`)'؞ROX(b)F3ioM<3&O&M8ifL_f͞%%d%/b[P`gvgUU,5j>SPo/2]9Ŋ"֥KK{x=3h=㦛oנA鲲{_VaEl]]vcNdXF8>9X~O?_zw9J[. !-HA?mܷOHUT5Р({JKaï!~bڐk;s5M~XVh-8_:EqLտ(XVՕ5jRuڵUAiizYS~Y&fQ.5k'R`WXl=yŕWv5tt6jD}͚jJxvޮKF #'D?BE?MA(_2ÈvMcG{H_uٳy%K?أ Mکs{ԩWGE5DF9/Qn.ekQm,ɪj"8AeاHmwt ^⃁ 3 hDQ wԤ`4DD.P\xb>R̝38C[8z}磏xC22hmoxc!tMjQ3򋋗QASfi*Qp ~?|<)SC#2.]ȢE//[6tޖB2uL˿XLF@*&߄ޯ]V-+$ D JbNb>5Ù֚/ nLqR:X?`1.`D]), l(kn^ G,?U"78q%ہ|/;xm[9,F䒍`0+%!g\,9X}ybvJKce+*PT`N6QTjU]*IQȈf̉L ,q,,+<5q7մʹzAʖ_hC#pCGi#*^RZ'8g]y2q!Iȫ|G-QoT,4>Z^R#e+3pWgJ/MK!^DK JU 2i ˖Jim'ὀ JaD;*ǁXEV+݁5 jX,H"UKC;Z4.F30W@SPv]PeBqIhs}#j|_! UPbv(T_k0hRSdS4}CYD܅ b`ى͂E8F8LXT!,9J*eb-!%OiEeXX`ѺLZ^%y,X8f:cځ) lTځcI!$H˘h%9ZR,*1q1^yr%bL2.yXr`Cĕ CtT fsa`C]`'Xr:O;_',$◥@嬙crP"dԯ[?Y8!H'll|,b۔p *alWhC}D]и9 8e,PKӍQՀ9dy0HT'K.z7AT*ò]JU [HQVC|3j4sie :=(5RN)Pժ0Ir@W@G/T(*VÄ>;?Pj55mC\MRi:X5iQtZ\p\y_fP<77Z }'"C%\z WzDZN==L1犗n*R;R'PDIZ8e%QNo=:'El)BSi%,E4 2p;L6-\'(헬 b=CԒL,J~M'ibaqr2йT\, ,X2X܁ YSK`>ܓ4w\Ȑq\,ZW<,Xd>K" 'Xdt2xJc" ]}&d'wD\%LNΕ,8\ehǔ0P"  cYC*,``I}XNe,+ %;K9}e%O3XBiE.pю-伞ZtkT/4/c^Qa-iw VE0WMy('jt<Y7"f*sq'ḩ|L4_,:CWoU$ޓU M³n~*'\<{⒥:Z#I}*IW7דC>9GU"Sm=DbO5Ta8cD QW}bt/eQVcΕѿjۮR=5ϤV!-DZ`zzSUaӊ#U՚\s>{I<t*+ XE h"cEG=X5F#Z .=s>?woTo}磷~H!?8T3{#)U_r꬟.@`^3Ւ(0"Mb!'E3'4+%MTc0;#;W֨hyQ,JTE%CH@L0ЎheMX *: ,jh1Ê`!j`<_‚0nj>z$"1b0߉qdM\,Д:p4<85<,}Ta\@GOF <.]" \Il Cf\,! 6\RXVK" !so⠝!cQ"X?Rb `g|QsEy]]s*[-D,I*ᨈAl?;1at!!X_GPP^guք /͠ l[uDU)Q"_ۻ[oqݻIm8aDرc}MbTtjS"^JM@\uU<[l\]Z2u ݽ.~QmU|0nN.䁣QrH͢"7`M7U#c чΝwؼVl5p z&GR=~WK/.,薖Иq^{)3]2og|znwr EP?LYU@d[r1CM1j̨ 5O(X+w!8A`(w5y,^80KhZQlq.'7"8Qi` f0eD?ŒXE=va+`c170:(4ֲ`0 :, t>\iK:'X}X儁h)\ab wUbaCK#c*8b9a@kaj'–# (_/\}LN8_acAϰT&,Ic:.q0D'^}B2)@'|9?pxTU;b +7"W=mhSO=U%y)bݯǾ}V~[Z,]ԛgN;ܳzOSOJںbŐ!|A=>i{qPf`d=vkdAVں!C>3:+̜9{h {O?t` /21Vֆϥ_oHWbIKmt@NCQwy /KcU"ES }/XdyR ":0>-@t҂W)ޓ)>[}"] O5프IT7TKZlxRN^Kcj?UKŚJϨ1EB? sHufϱiEb~âԬO[0&%Xh-#[~\ţW KsS,1ܹba X0" X,V'KV,*dlXV) ƒlϗt\<!cI=_eunNXlo̬b ܓTM)N}4=u~ӬӒ5 t4o¹oei#ALR!C͞=FM.7-lذ"?֯__M~JM^N},o<=qFLKΘzW\p?6^4Z'ٸ;ZbY2E$ʌ(9) gN;qDJc  D-M\~RZx9G.%e,u6Q[L1(Abu}]2udG_Az}lѤ4O{?/8.Xxqƍ_gFnSe?;5F~[nuJ7żi-%2ouƙa vB|!-\Xv==U%K>I'K,+kjzk5IS4{yCo V|=:kN+11Dҿg4p̿KHq颯Y8s_5u7\ YsbaeT+i\k4æQd'm^0xL<љLJoVpF;c,HR?WbQ `!Ngb_>y{4`FG.#M0@XXؗb!dys ƺ%m1.Z- aKXk\PBư{w g,ChG}]ܻ, 3.1,6IvXT)<,,U/<}FM'"8bL.Y`HbI;Raʘd۹rAzq@: |b;Q_Rxdڥ _|I{tCT{ܱ_~)9j<Yc{k`q)k6Rah4OB~UVMh/#W Eļ. Ѣ;nKZq1oGcۉsT҂1g֌7^=("ò'2v%'W`V%Iz$93j'íN]gu.2Tq_ P{Ģ^}fFz?GCwKcAk4!'@P"h!j ~腂HmOd\& : VX ,(,)M` +WnZK0]qNxY; O-0`1QF#ڿGlł̞X!. XlB?jQ9F ʱ5”kjgZ 2ɁHnEa9Tduaq vł8>l`[qY?.屬F=]V3IsT"! lM$؃\IcU2uT9t )BBʰPZʒ? ~Eat#&o^j7-aH+ 'zԛr9d,U*VOt[ߴ[51&j N)J*ml)J}AnN dʒ 'E3XTYZ&Jne Nz&DX❸ЕJ 괘>>xz!vSq%ԟJu],J bC#\^T^+EZJ$mNN"e,N[B+0&9k:SuM)[tؒ[G-̞-21?~G2gT6* 0("PcQG ]x^lM,>!kohsÙ^p|L8&?`A7c(bПTrW@bOO4; kYrVoaGs $W 2EbA$;Òt,Z@3~c,$,{ܰ,) ^ ,r!X';@6/7.Rbx3X|,93 Ya1GHu.8)K`ϰL1`4P J,#HK\<In͙>4+'iZC ÎߕSұF#ߝ7Tdׯx:r` 8 "-oL\!=vIlT L-\R,A=J?n!;Oz`WՖ/UR3?O]v\tM&Cm|^'HO\Pn ?KO=-]Y(:h!zh%NZM!=SLS&˩?tLHzqb4|ZDK/;v:|:닓6hGô [rYd>ܟ ޚ@oY7>W0)H77$掾 9+$_G/SOFX<%'ُYhcYKki.F{jғ\vJ800 ؗ9Iz$V[" %t H:Y@Ǝ MG0IBُ.2kMEZZRa\bvF](z̵x g%XUb,fJUbqY1_9öf!cE쩴XgHbLF\.A4)K6H@ڣ8%Œ&Of3&4qoF#T 'iX') *dO0d&W?슓FK9 j'i*Y,ID+@Y3y-9%d1DG.!KDJ*XY~J2ջ;C@-Zh|wLn߷m7^Qn/R6REW~3kt[wz'h5^-vSEUwnmz+)?M۷_ouU'm׮O<& _uUϽ[Iٴ$za;Ӯ]*6'zoF:IDM/"%;^-<}txPL;&٬f\kENl&F:](rX00$N Y, 6"HD>iIa,$ ~o Ik'i΂# IU.$Ec/6#y`c⒠d;IcvApU&%ńSRREnJN6z;8 >F=ݤߋf2azT5mdݻ_rgFWVZ2˯%o~Wm]?uÆSC=o"p9^qՕ(}~G}4h}^!_{bNZ\tJA/,Zl ;{O\zm_6\n=/=igڣ9&l{UVv&TqnNrYtAO>שUk.bEq۝ٳs7s 1MَBuz:# *n!HoP|yfeZ&S{!2S&p\g ICp(툅ukq;`G"l6iN-!%k6 )X tb$;1rF;&{.IXIF@ ar/L3"H-<HXTf:0!VGq\, JqBX$_Ifs gƥ"w *Da08' *ϰВb.y.,~$fc]Z<, 6X ld 79'/03X X(V󰤂K.{'i Pn"#``7%xei7 *g.8 n͟^pWG%6gDi"Ft~i:k&T2v0GRc!nx K4ÂSpN $Fì #0w6ޜt򪄈Mr`Q=ZGOah Dn$b~U|ƥRh$gLK,Y$T^Ʋ|,0xq @JaXw7L2f# vb1> 6XK`W%'mO%]Q[`M|5XaoBs%0ڬ`[vf\|D vq:G3 NvvI'i &ir'CJKi+UL\YΓ4!ܿâ͜NwTPShxs\ |yY9y~5E~AzqYgN3VbmvKd0}'6xN-Xv5=5P~$+] V*Rqԝ)^#Wʃޫ[꧟}>*nӦM{Ͻ^x Mw^zqE!("4.W`P~~4 r8_Vf[0$oPc/Oi<{s%|2XHQK$:Jm`0TĂXf,7 { #G+R`1d:,a@k@g!%#ƒ*#A(1#|qWœ0ISK"@;du$Mۡ#RE7I*X~*I,%g܂!}#.?Iq I`t7LR$(!W35?/ bcwSAqҍKuG&U-O<>q&65+ev>(&&9pkVVv* irWTCn~Ct5j>%U#>BFc]wqх_16"gL`ƍmݪu M^)fTgORU1n^* Sܯ?HI_W\>ctQ}Zuꄑ~R*5E+Pu7FtXę)\ʝ녿"Ct-Č x(b˥ tlV+bk,P6bŘX`Y) ?K%l즤N"m2K.^Z $ԽQn?80_ENdGP ^q]|LލdD^ʠ6a4LKHz+rAZjPcKW־Nzm5‹/ 3jګw8&E8SzCYSCWbSXHzEl"ܺV~S#rPi"A>f5[O!1BBSm wuxTs#F>Zԁ:Wۥ8@acǍRZ=cVLI#¸ 82)Xs_s1 [@x0.k@x焋ѧ4`rBR)DCOo)ƅXBr@K7Iĵ!UV z^aϱd*8D9o]؜rd;rEId հ5^=j9X'%>1.&i 4&(CW%M+ǒ+ 9`nKǥ$5N8H΂`XI vނHr*ؙq᪚6 W#ɸX85h$eA[`{\t'YLRl@ÑXmжHI>z"%%oNPUDV1Ɏ|Ho[nR.䢳>vッ3Ng?b䗌Vcuƙgvi< +;}?7ovUOxE")ξ:dh9>N8N!ucӤwhR믪XEb1jʐJ~c䵢Fk5|TZPC|?_}u-'ͩT<8푇 76m9#ĕ`1 t|svjq!CS|wO9d'(G!RrAO?2g|B́1y=-z Wv2BHVC ƝsAw!QC#K+3W^HNTlhlMrhiqYiΒ#=b|UKt8D͂7ۍ ǃo?+#Xd$D:h*_YౖR=bd5DH<8w|8 ί.,M |ǨERtX.,o5V2X4QTGpR3r C޸ć D= ~:>+,̫b"OqI*M`E ܹ3BTS,!Ƃ`'X9˘c0Aԧ͸PX%E/؎l\SK"9&Y%Tj\,\,b$U,q)ROR;7wppI:+6t{kk{U v%$DD"k,zчHUNfPߣ8jvx3 4K[-W+M+R1ww&Q]eqWUӆև}ޟ9g?| v^(1{Wl8(XE/J"hS|H~=^|7܀G'u>^{&Ņ[g[MElڵ.wK?XWU1w꺓|[vaǟEȣ{|܇|ڬ8c{ܓX%eˏ<(?um#轷|g.aߴy뮻n<5j} y~9+=Rsi->#^z͉DC;[:vÏq~*_Uaw{u;{<@xgyZ\�}Y98u~[zݢJk&Fg_?xZzWxUx o`r*#C >l}՘QBYiy矧 ,EEFT]yX0hO<~ÍuIot\еɧ|wsΙ0+;c˱j@lSgd '7kvBT~`?K) 7Ӵ:W+>|ZCX#rbwGNlS SK#:pHX\o $Ud#gqF1Q#]F XбbR;fhkIoݚb!!:KA#M۫39'T٫MIUKo#Iџ'Qh6EF4>Hq@iu}x#EȾ` phXYbeɁ ہŵP¿qKZK.(9X2bA$,p%r:3;Ӣn޸@?Złt R0dDž1#9Ի,cF?K,ymaII: ?ӏXO83BaDX}Ee"gX6`"RXbWI8rJ' PmN\2p2x6;5߰~oFϞW b@VmF;|nu4`ЉǞ8foeW~#%Q(n/7_}>(^4&evzתv:-9{W봑%큜YTmZWc 䠡me}ŗ}?Eʄ F qGVw߾;z{{?[A/X8]pdKjݰQԷ㾽 mo6\ Ԯ]{ xAXlJ\K.~$}1@8 }H bygqߍK NK# W2qz^y9眫S԰C/r؊!I6v۽'>e]?p lm9s;4 ;s]0ଳRlaK}:c5un#Y&̛3ۈհ~C~Wva>)'DŽ߷n>}="3‰Pt =^ufhe$vfuoP5q5{ErD&8Q J| K^>"'Ӭ& 4>r6eX7GIl[@#l{ފ3n6 |] ,Cv\g`(UVK:ISRvŌP?yb)=l2+b6 bz'\GnAWX䔳FF/~񛯿p'<#f\Xc+Uh)PMFAdU!崊{~"1}F}AϼLQnBཛZSNYtC>t{3뜔bN;o%e 0p;h}k֚ѪbC1U00'#6ԗO>D:LղN;ԕQ/%Amc~tҒ|-7ڸquj|gռysu>?c,Jk|)|g0P scƶƴYS<#>RG%ӿ 0`ު4m뭿.y9\!!d8䡤KO7q\גEώ<7x#*rZ.4[tJD7Lߟ7o^t!({yMT3y)SzQ{'tyg3^x酣>JxM]vU$oѡ1\X0ӺylGI=ʎ@(nH;{ *h_oZR(ȉGMwT&h: -öV|.s`CYao*ecf5?ݵ#xF'cZ=  r<e&Z/"uqY(P\ù/br*ԐHct580dZ<.Е+|Y ,̗<,1.L1cƧvB@ ' @ e@JjCB,g-h,4t\(q7^dBfD4rLXR &ikGP\|L{Œ `dl(,+EZ8y`aa1[bc#w"csq`Z* ,fK`LR!Œt\ y<}XRNF+!kzR[0ќ66Xְ^=ЃOL:f4'4z5%2_C)#[4o~ˇ+BٸQÆLM]Q(}/)ٰAcG]҅ 烿ة_C?:|[m믿iww޹o/oіk{a֭W_@vW,尉Hq4ٓfM~\77ߺ=rXXD-1`fiűSp=y5W/ˮ$M;l:d!#bqwZmWK]8Oߏ{\֣^zEtR>W]յ>MW+ F5jh;뮻o~[4׸ۯz(W^v(&(dr.(h֤Ɉ/k50y%cŊO>o[&erG;a*(]z?,X z8Zg}#z߯$3˯M6 y_4NHj)倂1+Z(*"ɰs+"t_ Hc\ȋqDbo/o6bI;0x+W4cq8|,X਎\,tM.g5 u;hCބEʌ/P4%:0;I=j@`I; `U[ O'VZ.,IA+AFmХv"dK`@tuvO+aEGY/2x!Êjv}y?>Y>}?2y*DVj}4苁^vYO>-^&!o}giݏZLއ 6rH>ēb_ y6iwE.[֬Y/EkUFk4n^^suW tWVaˮ_z3f`j>-ה[)nLZ+ΰv]p ?sL+-VVPk>?b؈ڵ]p.sW\=ǟ~2nwzshnPCG/\d6:je_n,7߇z_'#_$oLޢ}p}JrG֯[_K&N<ԓxw /0ؕxrِAhiq9}z‰ǵj>¡S,~WܖO7d=c=ì,&Ld3AEP$ &@A" $$(9#9g·֪g9u{g]UM? 2-sb3>ƍP9 㫯hi'Nرsr! 8ࠁ0whsBauMJ{tZ:+ˁc)Ń̉Dn/3J_VZv9T~jJJ F_…`$)1wLYEݕnPp֛6 P =CL(݈zG(evbcF qE:_-g bCت`\4,lmX3ݴ.7y^ļ딽 ׭.^FГd wDj{dBL":-X arLYHOs]rs'#NIP@ -l{JgFb^XaD$¡'Syw( :ŤQ~0o-1+UnڴѢ V֩Gh,Ծh1RT-`'`hŐEp4ky0vyQ9c\ 14šp-"5Z͋OZ@eB0&N]W)T_k&"A'\bݻuϖ5aW|.{.@d Fᣆn:&$*K4uVvJwAx uAXﱈ&d Oo(Ƥ0HxDӕ &y>ю qAYZ p4Fz `mmy,z'Q4|8<xVrES0cA 2?}QڈUS DŽDcjbAp2K.ǘ6n `U%ݠ~c-؀8N_ *k'nG=+!/C-2a?Yq/'VydNr ,т?bڹa!_j8BֻC2qlSʭdڹe{1B8c $s%K\sucSL| !h3R1ϝL8}P#MRxk ɕ8t,0>?{ !"(G8J)MH5 &!rTyZ'J8D[3%%200]U&{OBnK!{"u,,D6m*[&Y\xsW= it*D*V1?v(^0Fx( Ib8/ x2-R+2ZtRe̽fq&<' t K19- wS-V]MiQF  sZujHǴc"ԏGKH#yib$ ^ݪ4y>t0O %XMsU 9R"r`uq%HN 49$.\¾-ֆMpUe53zD [n`nh/v,TlW=c9%b b0OʦL_߭eoq۴ߴ^0"]CBsd8{@@i.QT@< 2 JG [;8MY&:H ?(^xr`/xhѢe>Gx'\1y"iC(c g!? ,BREQhb=R Kk,(j:u脠&7zA18Mql#(埣 .%k]{v @xq,6kʗP!5~bTRh]gGi)za2FE ci ۲c+ ^^4pȰ[ٷӔM VZGpZ (lEdyN9oO1܍Qsg#c$ ~C00x% g2FJz=:7DҢi%)TZ䗗ef5i$ &J 0xPhqJTbU^!X]/\8S2d(1)8fVzPJˀgϞf1ACItI%H g!dH=a&SHr8`<\3"#Ϳ8tæ#t2M3➓$sP 4D )nÑn^HR"^d1;E$ ʁyY?iIC/5nR_ Jcz($ `҆ߒ]ql`>U6@-j(+Ə| ı4zs-L@9^0%i?u3ܻqذY3g-&A.Є%)… fwѽT钽?ͺ~" wC.I;=`cix3Z$&IfYh& n>G_Z#i` -CJ+"#1RC-d 8-\9Zuj,B|CEm^%-K޽G{z_~,q2yd$0ͬ#_##Ց /^$:*qغkV:v a.i]mڶƩge˖/X 8v1B޽:w,hN:0wC(Uq,_j2„^vͺ*ժL8 !B|G``|yz 1wbE)2k֌{ UJ)jڼ% ]­;`.ݻf|&S;a9{F"5y7C =A(%st#ũ'J/g?nҨwÎ(͋A$1HuخVfҮ2`x~~6]x><$4_|=>tpeʔZ*2pm{#Fa/^#G/VJ?,VXء izgdٳk7s~/,ZI qPfXR pC Z0TPG|?:uj/7m^W ~ 6L2#qC0yDUb"Aڮ^6?kWx n$f˚5c+W\VԩSCF,BKdSNZ$]LR/[DiA)#t-Y/>%qp0@Zn^جb/5+PVCL&<ӂq9}*Zڳ$dXBc7XZ8yLO 4A4nHuH!#^hm?t6[9R&ZLLqR@'۰x4ndx4o\<0LLdnݎBHݘw)r5x3yy@<'7cN(wpZ1o3z m72K oxz Mۓڵkc94{x 㛽_PA}};Ј'7bGߍRKEhtlNO6 X<ϖ=ߦZxvzjqzqʑ3>de`ܸq[.jy5k Μ?'%Jp0(B9{2} usuگ_+8-7cn"SɣПnƒ x+ǖ__Z{[|j9v{}ԙxr+c?.Z¹ƞ?dƌӧOE?ݺv۲oͤVbֲdX3D݌fňXq4/Ύ[nGcWq/oFݍFJm0ܒ`/?Іc R/Qb+vfB`㽟ϧhnl/}Zz f8i |-~-iW{4łdn |X/ş ļ)~/ܢ. % La^(r1wN=q񓧎>scϝGΜ;qN;KAfE^nΣ%4eŗXg ѭKT;6WT\ٲeK>ߤJ@š*\BN2dENP+F:nÊCEȩR?pi [tCpnfE}w? ;^|d[;_t1LFI UvZb:&KD)$jand71ro1f-=v ÇiԐs:kRkW#5͝ۏ<(7K{әA:}l͛1tęgԚ':<p)S&4 C?!vsnϳwP}Uqi{ Qد,fdE7M1 ,ыE1"|Q,Y護Q(1DxIԭ(~PDo7t xCBF `|2>pat&;3g޽D]L PW7{ݻ~<\=rmI$|@@;}&M_tVE^W:17̀'f OX9qb\?,LFFdxaÆ]|qC0ʕklQ_D D@+)MObcH2Vj~Çf/f&2=T &O%˖\Ş?HD],b՛;u' cseKU17H*n ` ۼrN+98x{7LeqV%6oEf Sfjs}eCfhN B#orԧEWgJ D@w- YӢOziaECr UD*^8޸+%L: E*[6/V+ij#12c;:y1Z"HL>@ K*6)0ĥSM#(|ELQHqA|X"l1')9'Q?nG`I۶1M(sM[$ye%FPfi$gOWPsLgy&S#ܴi3$r 0p3۾}'R]t̘_Ǐmݦk|OFF[}ۡm{||_bu-x>̳Is9sK߼r鲵}UQ=e˖ϖ{ix_}?4ةw#VД,3O?O4 i^~r9tZ$:8f 38+W,x1cܾ=GH\0qxN9GD4ol„_?A߭Eg\XMCL)Oaٴen޼MY0".>&~ؠ!F+vɚOH1أ/ZlI&M~F1]'w>u^/^lʤI Ŷˣ-nx\޼H z-FP78f8ĉa5vpO0,^*eT>xX4TtnF)%_hA933DYahCEJ'5-:XPNO*m͙_ .P8FqP].7v!?9c&DhPz?z}X-q0yMEQlY`8bL%S%`ITwf6_A*hXo?Bb%V sK/#o#9O@+/>S3SFK(icHQfp&K6,/1VO^`Zx7Hn`H!$g;7Zš1Bh1G sM>UelyRV9x2/fZfBo^؋]4m^,h1a`TN0O ܼX/8}aPH-7IbBuUlPfu=Koэj|5kVITr=X6nq*zLgvx6m܄(O˗/1Y2+D^r*ȣt5ʂ \0+?@5YxT #/,b .]ʝY\/nAOYYzKW“E/Z'eȹsϟ\y(QJ͛W3gBGdɐp-}y󣵹D:CSh,_ʅKoWX!Mڴծ;sͭQa~*yJ)UyxÇٶm;Xn}pfΜPȞJgLB^ZΟu+:o9iuEP0nr͗aС#3<4\W,`";lGm`ߛ-[6XJzo xǁ޲y uw\tŠ%++#/RCBESs?|ܘ>cɒ8]syN 0̘aޒ' Cmޭ[lY3GrfI SP\r7ɻM_FJh.L豣6j8~kg/YcĢ#-צw2?Z 5< ٔHʂkǎѻܔ^-'^ͶE -8C9_V=KaGV8K+)Ol ϥ w~8C|x15Xӻ1Cae<{DP5' [ m;=2 K0Mc."4hoR2 w|prÏB{m %tj/#]R=WfOz-:쨊N2fc,8m5k4d-xhgЅ=钪A ŭ d1"T{C!z'l͚H4)Q/YĜ#$V&ɒFTWUGu:@e@/& G J.ֹxkKD[U n̙;R&G{FCxǸ<2Nn I*:?-բC[`#[PZZ_5 ]s``:1f$4L3c9݄P!)c1'd&ʆ@hԏՀDF_g& 6?Tt*DFSłxcf@~jc,۩O@J ůN9Т<$YT8TT6/´M.-3ՑGhhάsѢyQ`/qip(dE~ب_GC鑸wxejnM5EֶlYsȚ(v !d3< \TX!Eaȼˊ6xfsEPV ~덷f̘ip8݆bSsY&pH * bI&G2?1< kpFPPOM1<@+>5'<,|nB0-*3>Τtgk֯Ijz $ _U`r~*Q$B"-iX.;9~۪UoH<›=!#8K-rAoLT4 8$xšmZI=܀skXWܰniYY]kV%=a 6ȶxbCha6GLl:}MrY  ؖM|ECg녗/'KgjBhb"[E&N=Z@iEj-p$ǫEj Z["ǛG/>!GTa ゖXln#;FLrEEcu9 jyCAŋj9v4/oEL2Sz$3{눽2M(ת".@paIcbbǎ8p% q"dӽ| |3ž?oazuP] E-T ww(>Y\B-zyf%Z-J 7n`8EdȘu[Q!|tށ&W.vGAB3i$7:&kvKI88w$`DQUF@'rtŊ}ʶs%87l?[7jRj22_|2/P?5ފաÇʡ`LE>gAT 9axx\S/!˗U 4H<) f._9f ^YX#i2K%Cߊ?N14}FIYfjVTPͥ%4 = 6`/ȕsˍ t)@dyeg,a8 Btșc YCONI  Ŝ<*%KɧqaOA᷇ [<),nJ@ ˤX74@KR$@ ia&Df ǰ^OA/A @Ta㊐3ca^\?mdye,T}Z 6/P ߬0ĩR<Ѣ"- H fd h%X&5-R:SJU712Ƌ>AIJ(Ne/À`C٦p@i`nO)`Rf D IOx"څمW/v"fa 1.{/RB r7/lVChq_ʭwBvh N=Zlo48Z^Ej Ez?-[H}E 6(­@D9zq{ofm8`}i bT0Yl"[R+ bܰe\eM,$y]wˑ%t"^hx鲥׬Zsѯ3r؏)S~РigLQs@)RU*TFW/p}B\G ?iPɓ'7;D.Kٺ}kk /KluB'jaO>݈Y&cdf/^h"8q[mS@/i,(:uq'O+Q/_IN_>_d6ɓ ;qmڨ ;}4y!UUgdC 6m.]̑-{ >bJ̀/a$ -ܶTH %V^[eq{6PZo}Z恣ꦷH}ZhN:}0-q)%{RXmd dTx@y%M'$$"G-%Ѱ0hy..~-i"-)Mb& ZpT/yK;4?9i!Ge'BTi* P\w2+ >[ILmZt5lضM۾6msO:d=H;\[<GkߡL\i)jfCP_KҮ-Z׷owHVP p~jrS) d2 &O"eqM4iNS_Ӕމ>lįc{f| @ ;ğD#3FٳoO\9Z4k|&۵fse}5Lg5V%)2,Q Rׯ6Wjƍw)SysQ ?$sސ& N T%(aJĉ}W+А0֔&2ZXVƲ.F]pH='fʅ2q"~+?>ERA}d-`R+עd$OůbfZt=MeNya/Bl~NW#ߤESdM,biZo+,DL3&oLb0hAQK;O JXN5Md |Va .J ,-^ѢyhKTJ&B&ռt,u`caGAƴv#!1/M9Z ѣ%ݵ+!A@+ O` >u-D0@RCh3/.% f :rDdd,-Z>Cz/R' Zh]GѢ̴99z h---\E*1ʆ"EuIH%r͋07/FH˓#Th;ㆢy bɹT^Ea 4h 6F9IaH9qZz#Ĕ; 5mvz$|]xOk7r0agYtQt a2NC*u H`E {~76O;sTD>E}i#oΛ;ȱc]2ҵWR=߂RB+#Je ?ᡢǏyEPWu[$vTΌH]}$Gx|K]jjL`D(}# l/c^VJWYK܍Ek0wBIh'Ot`cURlݴ,0^B6fH֝X;O&M&s1%!1U|˂ sdu(]0)"V,mJ&܄r'xj3n ܺGZґFZ(4ZtYQ2:A5fB"ZJJlq!-|ɘ@ن9Y )2C)ӷrh7;Q>x^ЪfLG Dc qhSZ4fŧ?Gih T-B^0*Jc[tB}瞳-A T2[Cipx iq ͋ 4kۼ$ jEH0ɹ' Z_CTg.Kf^Of'1믿~ҫG˶QԒݺ<Dnظm6{y:S&?s͛qgd7Kd0JG{ :Q Tg qvGBF7x3EٲgC 断[7ĉ;" p%mZkN.} 6ooQȒc'O~aʯ[~箝Hu_-("ɱqz J}'4z7PzƍVZke˗Qɠ+ZH2HXWUik/^WUtLxC{3\M^°HEc,Z܀*2~'V;mjY^5#F“Bi39Zud-@(O@rUnb8 a]KH(e`B}B nh8UJP dH|ѢkѢh-H-&Dɲ7Z40M80]Ei͋N OT; D;ZhQE,L앚yդ ǧc, 䲊V0;/OQ6qiwAJU&Ticf0 /۸ѢNh`{h~Nڼ؃i[h%Ea)Ɛ0-|Z_T%"Q"y/RB&[&>/R 6w[RJFě0#6d7W^uut>Zt%s,2ЎK/]x4O=Aq{I46z@c#o8s 304o<5pB]XttL)Fd0K؍7 8W._AX'twYW%$ "UBu ݗI#C`>w<\Te(qs=w>qtҡY49~'z&cW?1j! .>5j֜]IDAT.p2ap!M^ĸ[9{ ə5۽oWDҤvYqtq*G rL@ڴiݷp/{}ŸPbؠҕ+I  m4a2N:bo#&` 3sb Kgvs sxeZeCW.' ū=f!Un;.rUZ? LP  -4݉Jb+zԋ--\v=H`sŮu+l_ɘhAbFd,-lZ}`a~cԩ'ؒEj9H2j{?tRY;"?͉P w3Q5@n l ̆xL|;ɝPϓ!v:bvӥ9lI-TGΪL%"&jEKa2#;R8tbP|qceu ˦Ey=vOuSB-|YὗI7c’rTY"PT,]h7uJZD*XHdad R!EeBHF 3˙!X@@ N0 `Z,?iB DzLVh!&ܼh!DDhNч, Qq |(-B b A.&yѕiO 6.\ 6-BZ'-Hk4 "ծNDgϜA âbYU>$OJcrg]`hѼtYАVbǮW:~ۦ 6\:-o\qvm[j%/z˗4=tP&/6]Z -$ޕnvLk+y:4@G4<rcE^ج|-ržNkD3zAN ln^Gb[B3S:e^y)KjMZ ENbDb\O> 5NU~5Ԏj}b vܼP\ @n-4B, O  CkKj.Yhܸ_-_P/`&f#[vWTP??|HG]L|"_ǭ^߿oW,_BB]F5wbiyMԼY__eq]<&[nP=l]' 8X<:aj؂w}D lڰIZEkт,Wahp4<1Gws4)R|sC& VSZLBiiD=cqi!@&ZDB!Sb{;M?/|r-R4N&}NhzE$qiQ;AƙxUET )Z4wRX,m܁*ߞqN FY/((~MomБ# =vi,B>>瑓.UDl)Xm ^3w {}ێL?,!!Kx7t?~}iҴ π"UV3gNeev1N0/+V_u}Ҕ/V{ ҽgOJϊl$_i8XOa&( .W,2B\3]xZw)SLK'^P9^;*2t,nm+a< +t3{ \gxfSLLg907]}f/|娃špf)c$ *-C7ha Sa"YѡBՔhhߧEM௣EE9xR?Ki^I ԧ7@b GN\:HrW~;DŽh4l b-b$ F h`0 4/0@dJ0xl㮢fAIp|2?b@I0hQ5`su 6^Z{!=Di0@TP:/RG-7/AZn&@-]JG^DH PfaZ Yr) EI `óf9s^xr;1B_3c#Q+!{Sñ^K$X U p8x^ jYp@eG4$-<s0?M6ȧ#Z\x.BX@Ѣf9%Zp!R}-&d%-sPuˣ?8L YLEZ#-A chahB޼<V`"Z$ء&؂5P#$MP7c^?`QJ1:aK-bEhao00P$rn^ 6 vHO1dL Z(ؔ"-Rl] -RE0{-L:J`"FB-bIG"h#!(hvٲDW7[F{{:|b 7UwwCx}+K]S:s~wY|5k6eZEV?vA'wP S&F$ ʘ:͗,]Zz'ig^diݺu5m:c ӑ(f͚+V\ry&?˚5_B&… \x) ۣ܉*ʈD'NӋ.-[h~{KDbk vԡ~z_lRCXw!U4WxXf'B co 3CsLi"ŵ(ւ9tT]QCeS| lT|+*REXNEH%q@K@&䆧[j>Uooer]D&0]mD 4\!bB@Ze2ĂH0U n( hW-(eBreUF7BthA-`Ҭ.8k&kHeBmԹRN8Ftp`+(DE? syᗴ`A i!c 9#AYSXQi1Ҙ,h(``GҳUjPГk_&*ġOE1BWY@lC0ĝ`ZYՋl_`@48yl0&@HʧEMF 6ՒbuNH}E ?"5HI[E , ~"iq;"5)s)zm8Ejm׵JVI9̚v(ZqU iqM7޽K9Q$sժIU5/]H(3 ǔXI-y;8ctY@Lc%DbCtSf["&'5dzAX#ɲ^nGᦍmEѹ֍w@|"{r2ʣf Al`w%BI,V2©5AZICzb(ϨB3--V6N ۦRI+{v^e~Y$n(T(b#p\JC*L(o"Еլ TD~^,&,{1,(|o^_xۀʓJ>QG&wF =SJ?JfkifuIdY @SvT"Yk@K; ^VZ3(r:TeetpPdh:P,$ t-cI23k4Q47Uـ1!3 YI 8Mhx,zO cb;[ H{T$RrY UPČ)0g udL=^-egPtm(02nE* ʲE+Ú0(,hXŰ`RO*薏7/) 8%؎^ކ,l +$P0pA X)TTp#Ub^t%dlHr2fF@*ZH=ZpeO 9B ()J#1 8/i,<d U<@U)%-$(Wp\ZG$[>.5`rq'c\v"~2z5JXy?Uaէ%HZX G3Uݍ˜`>YpĚ"AX~%.-yQ /qpk wcbC fF#k1@4(q%v J3` KHi{ Ր^qϱ0oabދ&X^61S)-܋f{1!.HiuNt(UhػHM 4lݨQ,fy䡆Qy"3WÈƿVYBP)E)K%Ő Mܥ5&#F[.oћ㍋FRY/b/p$^Ca񆅋-kBgn$HPuY  <5WU!lan[ @~;03 .< !^Flj{xd0t˗./7Pky)U͋M{hEtMxܰ/ׅ6'B#p,s0Q5KA^Db&{%jځ+̀lѫN|u;38cEUƁ a$_zW)0U-e x$_,2%K^i\ֆ\Td%TA9Ov^TCҥn>9J +LV%j\Rd{"3nqDͣif`s"b3S+U/}iZMttĪTթyQ&cѢ+Ѣo8ZO A-HHkV2w-cF LԂhqiQE iDP yCEEYH/ R @euz~h"3ЉŒ4Py3#>7kWOo^1cƬ 6BQo>a,eLi~{%zHIਏp+m>;?E@_14Im!z7G E/pG!* #d"8K^r a/)_{=T`]-DI}4jJ%|wbH8#/)F>;QAa?^DxA3.&N2yzFh 1be"#cHS$x/< !ߋBDC.]O gWT@nzʷm wl†BӊK5Mq h)k;1qBPf-(hONa""O6ܷΞ9ְNF֑I$硅W&VzfM=ؓ(Z acFYML"lp_v@k0n^pI _Ǘ9/"~H 8{!I /1ZqcE-f2b&D )P8`Jm'XQ5_%iX;Ƶ^(u c+I( Hy}|YD94&WAW^TXA~'#%LV%l%OÇ`O$7Yaq0<] &T2uFë@ g|嚕 ֋yЂaM?EwEeQFݹxh[54XbJ"JP0-\-pg -,C ,!Z E 4\0‰i)EA'>-bOevZyo08Hd 65HP@͋т仈+  M *(ZfRpuh-r(P=8$7`mos9t49CTg!xS#/G@%nw(-\E 27ϣG14Q≓'ș}ԉ[m'xHÊ+jqI'~ڷ?l",QjJdh G2v ^nݱF /V)>J(XgLhObs0i& M4ÆE_lwnG#sGb[Y4z*tpcKƔr/F|˔)S⠅yGIr_7F3j$Kx>B#6l\?jia+ǧ5KJ8|ˎ-'O5{zAgN% غ}ˎ]ۇrRhblrH#4ˇ&M#Gi'/XcH1coƌھk;I3^Hȴi ,XTTS/Tqŗ_ W^͛ވnٺT67lJFUⰓNJ]  o۶칳<Y?O?q=˗((wXHjxZ46o^ihɢ韬T"`(0h蠜9skkN4K0fի֭.VX Q 2`i@7-/W^xbatE+WZc(Qb)'dO lh;ACۘT_+C˯! غ2pgCK\3A]eeN}Bc sn/3j(՜s;0*g]/8t@fn2b(#tL X>-Ӎb9xi30L)hA`ZIhaE*MO w Z2T4<$Z:}LuNCbJЃii!9$ |G }lUeFY.xax,6|O d 9$׬T74H#D^<@cb B !BH&ٽ/-_q&CW6AYZ ݙпUL+VbV:n{K4b)R ř+w̪woO2 i7nܔ9sR +V@۽OP(fsW\UZu6b  .\}~d9H:,BP唷kڬ{6yŷ%k+W2i3mƥw9:hz=S&OyGSLoΝoM*) 6<""/6Æeϖ+eTll͒5;qR>Tm9C;~tƌ uZjfL-[YS%vV]'=?=kesB?[F)"%E#/(P藟G>{L*T_">|3ylr+Wr嚮]O{ʞ=' (VW_|Өqؾ3#:kϳd Ǐ=kv|ڵ:V\biM)NƎU*Uy>ߪUk6:͝';6lވ}뿖%[Grav:Ⱥ٢uUkk֭^dj6~'ΤJHd|_=X*`p`̜1+kR~?e̘9<lh3&M fMO ,jL>۲{{ %]'2ֽcKbrĪM^`Q,١v2ʥ+ۓ6#|ag|ګK'L.\pvKѢׯ8yCa!-6*'6%Ko~ʔ)/_zq c7._JVpK8V.XaƮݺCؼo(Ӌ/G0ׯG3"umR appX+> usm3:X[>^c%JcchbX'"r-pzAUf$AyY*&Ԍ+0SGiA%-f:_@PaI P8Z3hwjb֩a@ G shp^1,5DY00o0Ѣo0@C [1cc!8L@| UPqWe}<"S3JjӐGɎSZC ]xQBDR}.{_ /?˔)oӧ3/b jT#saP[RTW96K#[uk׺z+ueeGodx*S&̩3ŋ_jŲeK̃2N,k|9SOq=nr%ލ͟;_kfϖ:Z~mkR͋.e޼y2[XTY-P.jJ<4뷙Fг 3\e^Z)Rhcnjy:5~>wƦnFao#nluxu3ACX\aaNiOR͝;vphd:۷K*Ww YဇܬYӆo=qJAFFel/ގf wʕ(:e$Oʖ+ A?w^Sqߺ':r7_…? ҪM&*,"yMonpί]nzo^BQBB֯6~ya%If"޵awĝ;'w,[ϣ1ѣ/"eqFI(`8`dj?.BX%|y fSC,@E赝fH%p¢h7-G |$$L ci ܣ60)IZLcPև BPGTBL uשG"ʌ7-H@G l*,<*kr1P()@ ,Z6/FϓaH2Y\/ 0%=ywZ( 6x.ˉIFpeS"Xa|S'#>a@~KBLpL wC'VXѿ!g[ 46k{;enݪ+#0} 8xr;7+œn)#FEOQ}ÓluxnVH)վC;lrU*W35n "gFa͛61d;#F8dЂ  Q77oo{}в{Na1LSz`s1ȡ͛6omB/^:<[t*7CF ?jv/caL (41cǍ+]̤1wTA|=_}MfՅ,y +l۱u? 9kfk!O# ֭{5 e{ď?6mٜ-8. wBbiaX2 ,U+s ""vb a -]~̉:HZHGR/0e9UfݫI,SD7i۸^?vX`Vd;I-_%^NXGl/zQc^ƍWli|煲eG b]^U^gɔR9 D)ACV Zجp0"EV:Hm"kl'hu*02vIk;-̣E`E[G ;O܆z5b hq;vN}Z(͋xnڼB=-F 1RGV G a`_т& +Z؆!٬/cF "h#  ѩG dZi}()op{P:+^s[XbރyU=p}+N#^ײ+V|k (BB[-K/[xbpe+0`డâqHxo֭r?7j^weϚ`# GJ|'Tr)ӧ% ĝIڴiCVXxvx<۰ܵk.Z5~}PTuk'Lj%KAigBySgN,Ta7,H$3$$䧟~'TRjҜn %RJ+4b coaϑ=c'1je—뛿@w/i+U#-nl]:v-1lKfЄ@ș5ץKWWxLrN­+YdUČ'7J,JA̬̋ ڡ߆ N:_Dɭ;dc=VYz W7qƫVZxs <}wnTdMcƍbb%ys >reM:qۮ{oN6J9M~ǯ#]J!1IӤ[AqzݼuPBe˔FZ5j>É'GTUYg+^,K,hocUT-W͑xL=e=GEAc@VNp>{u72~X?$l%Ka!ѹx /TI &7vTbEW,_QZe|E:*]4i:5P*ȭ>[ ?`$؂^R`1YBo-̔>.-e]7uæ0'L֋څZfg DC{ iͣ:EbѢ8.-v E4lߚѧ(-K?cWh"0S@ch :͋1Ъ;z "Z 5K:$*qE ^$ ASg' b TqhW3\JɗB[13y]?${l^buD IRH-^uH[EIV7N~'7ƆAs3)S)({U 4P[6Zla@)̅ߩKVRueҒ4`:F ¾ kQ@*zܞ5n47q3[y^HG3Z1zcmzܺ,A 3};<,xtd&=NZc_ M̚}, n,{^xI\gL_ Hힵa13!M:.ω^Gzt>aD+L1܋G34`0Ww4DH Rh;Fz&AA={X"yܸAИyLQ' H ޛdA`chr+ >r01wn$-R# I0 Z-ke`@ Ƞ^ng2M̀! ۱m&9|aYh;1WPY{|YICHD"L:c:b8A8~Q?Kd8Dvûa@háMKԅ _f̣i:D|M BBh HL5q2"H i}d7Gx`mFΑ ?3&JVC,;OAEZ0PDAE`1-Mţ҈:ZħEF 82У?u͋qLꖣ[s1%^kyY!t3MI4K [?x6¤0(m$ \V}'>-Ƞ)a-. / VD!Ν0e A^eÐ  ;1 tW]N<8j(4b8$2irvBqWEuD#cl14w-$X䘝 X!O,ռ͞=+1'}{'#}o-O ' ޒ/CW5xI>2 )~ /F.Z  D@`0M Cx s|Y©9E&B\E-"qed5#90lt"MwYN%:XBm zc;^HIX(k2É/xzue$? Y` 5_9~¤3#Ͳs׎'~oSOAV] t&:̈́$kv^Jwc9t]>n߾]ΪDQuK6xI#o|)3Qco!AiF:N۶{谡ƭEɓ f?B:>h"B.]ۧ4 JO8˵*W8ix|yԩYsd͘)_3 ̿tR4ժX^o%9HUo,p<</,߱SǯM;siҤI@~۩SEKSL*9Ȫ' % LѩSիz}ujϊU*һ}'? =`ߊIs/T*y30;LA :C+VuyC-S[7۶m3iUWx=;G D&jLSm^CR&jU}*ݴv#CbJ¼|#k9|yY2gI˽v-B@ #Iu6-ƌNWZ}yop ܞ6}*8dt՚UW/_ƙ'OPB-Ȏ!p˖-vG –M2)_<rV/~{O{B’ݱsÇ=PJwUgL06"Z,joYf:uJ1oؽ/IW1`őaNhcVl}ŋg> />u6AT慩MӔFX"f{e" >TZyƽK,0#5 )m6<.aY{ꎌ]Azwy Uf.D OscЕFeW6[-܁haprY2){y-iBuBt -``8<V8->=Znۼ>e%JV]%r[j"I+x^[NŌȥg*cV`Z4 ia^SPr9\T7pT]|hk׮zrMH@/՝5oܼNZnБ~9?r7.\^zAPi-SךzH@,[KW.{݆/`>sǍo^?]dreCjmrBԝhV?Ǔˣw~N8tٷ fa9t#%x2e'@HN-!uQHu2o~oM]׼CFDF]׭[lB~ub.\SkWo/u9M;qtc#bn!~f1P/clprTlt/`/mK v^b.i`DR;$J4/oGzAqz>Spc%őN`fN xh%IZ%lHQdB4b z!@7/7ctk;%-7ݼP@׼0<%X-6$'e~6=ٮot6:w?!UWkQgH1vb~ŗtwСI˖-[-lO=}oϜ9*KaȒ5ۥ qoyhD!3}Q?=Ӷ@uj` (l0PvcX&)-Ă߶*H!iTSnmrhA(YY޸$˯*$.Uœ Z9D3Fܡ$0qd%iZ8L--JBr0->O\ꢅ dA&W7r./uV ТhiAfOch: 2¡yHi!nEť-jղB;H Yئ_ N p?MDC 6)XU'l2H'yLT-bFj$$v=xỸ"scQKF BT 6lXoOȣ9XOxÎ>KU6~kۻ׳j,Y~c.ecHG._Ľ{S.],nI%OD~Ū0IމtҒ%K''}6+IZӂw DY_w>PVXU.ȱ+䉥۵yٲlӦN0$[,H2`|BލkF2f}ἅd1W8{^F}F4uG8ɕ-K8 Pܢd2̰_F[PܐVYt,L^B%M m E%>Or5Ʊ\s}NvAz_ؐϜ ;q1u):w߸[o✆-Gב5 iLiQti GHOBƟ1ʸujIUZ*d֭[G$\m~;^]l h<(!sÆ)bb5/` gTiGj- Vw6K9o4b^P9 &u}WV %]S_9kZ,TBx]3U׬fji{ *8@T݂h!UŲ [v!ѢL h͟8͟ x0-Jy(BȋT$<0/v©7mBť 0f$ %89ș (Ir ƒ]RZ 1Ha-\୷*R"#hPc`qn7xm ,S7|QΰFn {_qHȂ>cW5!{8x1m7[n@ 7dTȻ0|"S(Kuv3斿! b</mٿF@-+UE !&;B?G#ZU O=bj֤Y.h۸ys nj?Xyg6>,eW, iզK|LM|y'0W.ɓ7O+q:q~!׮^ݰy!W_e$ _2<>{)Yvm⼨}liӥ * YM4I0jӲ@cǍi߶]^~2e +UT":-[̋/f=>|MU7j k48aED:ڋUat=w̱&LONw## P?A<2أgmڢ 6a}(^f%/9և8hA:$Of1p?O}Y~" U $고K&p:e:|7`b kv`E#~ʕg2aN׬]%q6 :)W\-Z `ŽNܷ__L=֮W1%wx9rɓgebpSh yiӦÛx$XGY\̇aJ? -ժV?iGߘ1`}6~= _|Yfp̞5 gӉIm[wagDIBӥK AS-B0&CI 4Ztt;ZhQ3C"7y " Kx{h!RI0SCϤNH 9k-vXb|ZKth(@if dOaE.POp)I϶kDZ&Qnh!}SD-`(ntyFʼp0d< A27qػQmD8B-2aE zѷ YԂhhqܱ B!0 uE}CxWc=!1Ͱ^#1&ABVL{fD1!ѬŊ@6|ر #|rT* =/*!p>!Y3ZF &wg3=cKtG9e$1!D{\Adm,`i$ڈݾZU1ՓW652Å17ZbXp$K-x *hmO?Un}ĭC*Imf]ٯ__̞#'b02GvoK jfzƑyd)>T& '66R3j,A$. Y%6lq| _A QATAq^FC RW/Z#D9'[h, G-*1gbb2hʭ!7QRVR=e:S,9{b`PPc2BS%["D&n]&}ILALSQwpUyBbe ܱ)Ae\)T½W坙DEЬ=d|6/6JHRp O_bi!RY.hZ8s*CcN6[!8\q1 gU$Y,a? ~p Ug9[7zpmeeW-+H-lzIlG[ $G3%ƔG쁼_$+B/qBjV { VZHvyxFۂ;'aPB#*4-E ha>-2@ZD h`O-egЩ&c b2Ac1w 7AnEހ,33>}(C*lC;t2tOnz{]8_~Vr|K>j6E UQif>3Q*%?~80JFNn̜ٿ4Uxja`9 %q7|0S8qȑCșn> &> O N,0 %b^,{TOzXgQsAJc(6p O ! DDx%xCkÇ8ϱPP(sv vr̓<}~ޥA]v` Z82㭻z+O}( 8l?P,rzR-į |XBPf;׆ ASMA, *b( / 'h<|R(4ܰi#ƃ \j!Pr.#/?;vS5M-\!}<)I@^P={ 1:k7~|]9z69Uې$H:G8q}wT_:nz9XLX秽qwѢ%/M1IE4G :FDP6㿄e:\4jD%g~;Kȥ{BLyA67R*4E@ %]^<}Z'\LHto3n2f3p_ݙM[/:) XcOTÀ%ʦax[1NA@$B*]U"LJEj.LWa2~ LqEh0^q^Q1k q; ia_کzN# gEJa`Ȣ[q>Ь (B> /&x&5kѢ[8#]n.SȩcGH0xa2h1hH}Zhq 49ZCKZ(Zhg"M7&؎ĺ7/Fu @}aQz$c鴔HI`\ZE\Ɣ CeD#Jy&#Ys2%jѥƑHhJ_0O}B l1ҏd H40'*oya}QT`mZ*%rYۛ7-]VNߦ}sTT -5G[17Qeyѽrr|4bďq Pغu >af?g"!X7G󁤰 L7of.*":͛s h| g.^ZRD$G0;HѢӧNlW[n 6fp$՛넾_A;Μ9kҥ3Pt֬ yx-Z(AÓ-Y(ݣf2yH?h(&\p(ΟCul}O IrYd><0 B`FMɓ!DK?ZLIjyéE(;tLKy},V5)|(͙rOy|B(32U3{‘\ ;c7"`A?ᰬ ar`SS|  bpIYkV-T-9NKmF{Z.mܥBuZǿV<ы|]h1L5Ύ8r0 =7[{ 7kj BZwEs24v)mD0"Z H/nhq`Œ^,"DZ4x8˝QW\ p  7@' F4¹s2Fǡ3-&>-&-PO5O`)P`ZH "ռln͋E*AvOG Wix>-rq0-/Rc-1B,Siv\Ҽ">9 JaF|Aa#ކYȮ;+U?S+宔U~B5gpm$UÈp$jݶulz.Tq7#GW_[H`*U2V±yq,bz@Y^zĽ{fժU` 0GKO ɕ#K/ɋڳ8~z|5kV% zBq[|.߀M_Xzy`Z@%\#맟~\e]F2VJD`npGx+:D;x2"(ՠtZCIv7/>x')*s\]I3 Z؋hQoOG .mh8 % գEumN,FKx^ 'BƙhQѢ-Zh %aZGΛya/zgȾJUm[>F%r--l粠c؜`J?/ $lH 6wm!llV)A[Kf2Qм$He\q9ύ68I[&[6+ʻ)@Ŋc W,^}R؅gߖ-[WXYc+vk8H4MmoLvGj%p? -ZG? hȣ"s? K{5d&hƎ(7V1.\ Eq3w\<ZS-jh+bʊ+X/W^6u .ߧN.W3꧟S+  j-͛v:\]u\9;"r˖sӵ+ӓrO%Jp{w&ekK.yET*ŧ۷o˝77w^]L 8} e~73b"fzdɩ^1+B r%s1Hؙ+/Uu%ΊYp-@Կ׹c4槴i-Y_SI b?>ߊ(>,_@H·֐XE]lE)F<\r:~r+V-V:w,|JϘ9+UT ދun\aSo-j8CȩAv y2ptɤK!C6Rpӹsp2nAL֍P/:Wg6P@1WbjG=YPCANl%N;4 SGU0r9Zx@SGJ cB!@#I;h!.[ Xġ @ZJ 5U-(jN'@ 4uz4i^%EBʯL Y}-rXc@p8B?NM KxyqlBHY0-26—nY4AZyl' 5cX ;O 7`+6A7/apU^ %ZB쐊pY|뤋%H`v`)ؒ1-R_偂yy`N_ܿH&+S JѼ4Kߒl\ftн[lYq8Ffe`1I78ЏC^ĝ$ů"1C֬7vR@,hNO%b`>mf?E ֙EK[ #R b4*FU>BN;5Vu-ԓ7k f}V2NLDp4L)% PKIsz A=hlPY"`TsHf 0P1:oU;&XThp(C C0K ZlboRcQyq`t/Y͚Ƨb%Q6/8 wZKI19 Pj0=H" ;kOVl"wN,Z]m^H)v]?J-9Pi7窦pц'M4Ě*9#p߼ˆlt dqPZe$@rV7W㜋}ƯáqFvăJ Ŷn)eWU$=@`ÅC7(4mN8 5n]VDy:?Tt@772%Y/[K Eo`ONSn8%Y!O-4An/^޿M0_ڮmV{n6l}owlK1>ń ih6ZFz?IdP/9m5R ev*ײhqiNQ,ȡBi-,.vmsh1WT") 0E;+i";\Q-ut8b!iQG (īvZ`RŸĆ$O GAHaAHT \M p-ӢCW2fx-+/:OnDK\SXcn^LU5ZjH irh-xl *%!n)͆2`Xn k}E3Yf՚}cBC6}4FGJy ͚=Lj$IN`%Ϙ3Bwp?n߽XZgΞ^9M]Aِ7#T1kB􎸗˖̜3 <ΝgDaZ Zoh7%t;(ѕ8ӿ͘~5Zv߸yùs*AQNА&-C+/!nݻubzo!lj#J.]DzZ{ 3R8A1Ĝ̙s̩|9ss+{K$)=@Bg._|?/ZqfN?z(ڑs`"8;ȢRA]\96lc|.$)+VڵnD8}iS!I,sl۾ ~%o< D&[zEZ6dIHƄ &4K@X m=@C4mG=&nBc!ŴeqRJ<:2[,R=z"3K*.+AI*G>m($7; Eʎ@eF/̒!]Vh8#j.1) w'"wPlf:pجee|Qj؂$^ "(6lnwGɢ-Q D@d)wH +XHO#G.ի}ޛEFIyѕKfm1^7x /;LZ:rr/ze׏!O[@Fv.Z_;ugA?>~7oˣFp.^j Ǐ<~5zyF ZBӦMczQ]ON:rJ:wLxhXn ≓'!G<[ ޸xq /Z͛ݻ@!0؇>4jʕyaƴxc wi^Q'{PSeժկ7x?R~}^:ΞiaÆZXfcN>NF(BF'Jc=ܿKWv %+?0uԵ;xW._%C(i!%7b0 2'7*'=o܈D1A+3Ym۶i=9eW,[0̞;L8+l]?vܩ޽zoܸoڣ76m*:,@oKN})޹sH7v9 |,+\QcE '}V< }MC# b/j2WEJ26PeLBDZVL@jcPc! #ь`B A^(ranD?@ nN]2@Z,kڱz7MXChw0pІsqw-8zD`)Ďk"Zp^3тk t8 dAl^<%~bhl8"u6 Z#B8W<-)o6˴:a¼<t$Kqh, n^h(%@ 1Dl7/, G/D 6 7o^|ڼ]G^HhiM& Z.RZ7d?f.! ]bPсdаA 0 JUoڶپVZq,h6i썍u1Q̧wcnݹj:+FI<\{'BrŪ~'UBTr'eJAMGpzͪ&㝼2 ^:~Id(')f[w@ ܻu Y| -jaO[gߞv'F 3VL +Eڟ8s/t}V1ۅO'?i%HiѬyƙEs'ahO8BK|aOkX´P<-`?/i>fTl`rr{,ˊhXԙcg?}N9v3p;C=Գ U -H@[W8_w2At3$w% x6^=;vD_'_qmB +|ǝ> t޽ՅjGNT^`lQܽ*uvO!܄Gԍb^hՅ_݀o7n裏"S(-l>*ز܁J =?bhu_K5`X#ad >b=W|85q!Ν;7J("E@h+ӸwFX}ÓEU J4; UmC,r_z 8[}V !g6Z-eTt^l+!IA;VKbWP,vSgO0`з@GV9&H#dƏ7=|4DEHf_?ܻ[78QQjM(lC w~ǶmP2mYRy~?<]0a1.KXVq,!&le& PxX Fe^A`X_b7v~d)Xhn[\|\/tg$\#a7&fvS"5$Jyj4r0#שhah"-.-#£2`hf% i`ZhYi!B.hafUYi{-Wdra - iy1goS!jpB|@zEI20Hha*B,{yq0wX%,آ%a`?l/ش6ENP\КeT>s 2"tP0wCK;ə[Hϖ[|)xӄZTgI5Dž 4g8zM@Ԯ]>v*r$ʵY,^x떭3fK`[&ʕt?ؠGO}կϡÇ T+TBڀQ?OݷޱN;dȫf[yz13Fꔏ_F^#|^bj?,\ڕkd!M6Uք(D@O#PjG`FG@׳קݺv;GL'Irz'>nWL4g͙URo߿KCGy$G g6Hp~ꋻ|ӥy Qw # M~ēOlۺW^=kvp,/|a1U+WnӪ-@Xe͜??zxv 6301;i1 ֠4K 9H ;b0!)n_ jʲ@~tBQ-tyļ.Ա9[/ϧŋ0i!>ZDZ ̴N5"w-GbTţ.LNY|-~/ȹO ^ƟZ,G9Z}K0? tm}ԠB/tSF&0/v0.p7@'c`Z17x_zTp`vE h[־`ǣo^$lj lY]4Mw@V"B \Z>UsAQR/}hx@%@6b~9J R]mE'"<@W+!s7B C(XP݇Ę_{Ͼk\ {t`?S oeZLlho&OE7mh?әBu<7nxD1z9xؐwj׮[vH}U߯Z  EFZ,/Bs޼-jݺCcT <ԯWHb\pa *L_%qw]uyWgȀJ[5x-{jժTO<)"NGz,y~y<Z'OFw24۵{-F0/ eL]ʖ->KR$MK,~-22[OkG-q:lؔɓQ-ҥt+WrRsAȝB 7} B8qt1o =W8!3>]d,Y¥J|K88a3?ZL?k yM$i[,? w /44y⫯, Vd|:croDX/>JhNV[*YbM5L(2lfoQ0P $IOfy;c\ LJ%hwz\EIaxw&JR,H'O)芏(6^S"Qh녎R Ԛ BjB*hhiA2}uK6xy:mU;Z 4ib͋10μxhx,"O ( ^&MxpTtȟfgA& oj4q$ -h!N2FRz/B3śE`' 6NE[^d_ElU;MX02Z>`kW lizcT,XIeh%W 0/=l@{R չgZ^x$$&D y2fY ,L4wL3z1l>q8VՋe{uplb$3r);۹ʣwħ--V;Y̋A0+캗fA'%3d2D ^:>`F 6u4 6얺9'Ig00\bv͔$:`sK-'AY%aRfX2 aF.ZF;)=*LC,$B=34ѠX) bhD<^# -*|B[D[ׄiFp<0Wщ`G 7$o^s+pj'aibsx80m$ v j Mxd, Xz ҂ˌ>E(P`cQ l%@L0센 &` iXKhd&4 ؜{.eJ{BbU~=m4.nݺe͒U+l1没d #Zo qo0 c-Q9Ai ӼN^Tל>D~y|rKB9; )-M qQxMr4Jr*G<`""@3ݨ-#ƕ%K&GʟG>yy:~' sTC]F5e٢1 kmhRY/P8"Z࠭. n9q akBIppI:X7YjZ!'cl7u rAa`݁EUP%%UcSAIdK^.VG͋}N;(DÒPR>Qv<GNC}@@d\ 1UEًyccEͭ&2j#{ZMr UT,@7YkD9-~Z̷g*O }­g =))iQ=7-dn A *$ n&@ E[@G0/Lj$Z[{2&;3S0ph#n^EyC[/J `)a/gU;bƝɗOĸ-^Ȍ[ U5gf"]yjKy<⁃ U e%T4q,-BI,Nutq2JcACO?3AE]`yG!2)N;b hvnG 4Yx.)=*JkrgϠ$,!h[ak-Bc|)%n+ͪAmq{=rXGj7w .煳Jrf9wO@~~FW\"BƢ%Q$;倇<ԗ0H;%VBiH 3Ktl^4kdB%*1P;V!"@9džqm- 9*! ?b5}a -~-^[ `|ѢSEl 8ϋV ݶ_&%J,R^׃hN hH!T˘X,\s"G1phfؼA$&=ކ-%AZH1ݧt0Bv9[BZ-H%cyzhv 6+.R۱Sqv͓y1VlOݚ ̋ 6Bd‚"ueC8 'Kᬤ[.EǠo;,d#܋| ,|/D \ɋoq^. qhvSv捴oՊ-&Jc-୪ 7 [Pi1iTU $Q@Ac̵9rA z=}Zsj1T)#!AK32B͟0J[Ld h@cMіU6?abgFKrļh?>,<,11H)ug ڀ0~ gB]Typ_(*Q=Ybت lZ,H9DM) 51%5c_ Ty/KUe Ȣ]v 9~l:YtbUAYE_[묉˂9 jRVv 9bq@fꅺS1jج͕B5@X(r['#i2z)[ѕatr2~DY z6gB_*RkL!˶ 8QtmŪ`H6}CtDp0BRfŔ[Վ8{:rNzW.2~I8O+D(]r.m 1|ʌm4`")xؼpsv,8hsі4VL<E)AgAIE+fro>Vɴybv{B DipfP loVUÚ.xy3U\A{@#a=]FpdJJ=dj^%YYⱈRo<)1Rl+ lj2aht Inѣ`t;F&>% 8sR,ʼnX: ,&6YpJc  t oQ G;XməHcUl["ŶAjSaAJ;uPW5HM :j!\nQ R>q20$K{eГuzMYԀ)“*\ R c,D a/Ɣt M&1} eA@`7$SАe:fE*EH=3$&¡2~a /2H`Ŗ,!K`,*4X*6M+f`ŶRL=,)0 VA =謁I6Ar`k!&=9C M^c̽KP!̮ DJ'A،:"j$x/ɮ](O<(C*ger!3R}b>YVMYɒb) M]Ѓ PYG$BL=?bӞAh*+hazd1Z"qt)hdeYλ,eEЩle1@yT-0ٌ}Z&-4ՆOb+*e_\ɒbC{,53̱#8JFK-%$&q'TIP/\8S A0lK 6W@jvD O%6.k/?M 1gϝA`P(VKW.\&2<7_|>hjzql׏u&$\.ڞF̗y)\Fᙗ`5-Aj6;?,[3[gx4({-Ao#WSMߛo憙J4;A{XyKx RfG+JqDƂ0е*Ҟmp Ga+#c\vIh#sϜ ?sP!<lBV)P4YSضP4}nO=Bq`-D rYzz+E0.:cY|9ZJe˖c9s}5sLPkgM@ųuo]'ɾ﷯ɾ *mp)V/X/WbI&5k޼s86ilZLL 3 fu4nt$Գy>)wH:l&͚{C8 /!ۼN;xqc$};w^M۴m7edOؽ ]۷nֽ+gwގ=rީp~i[r+$PYT! !dюNϹS"k|5`,2HNڞ2PSE8BZfYOzH4b:)%T%Kb,j@)6}žN5gU[)v@ P,P5`n UA$Qlj*`'mrDmdPFEG^"9dOZ6M. ԅ[SN Z\ $Jvg'${xڥl=IOYT~+VN4V=z߷o  Jʓ'M8abk#: !LԮUs?T3lsM7ԩ#'O , 5I}yHvd&| ?};l%b9N84P{h!HF dȠ;FL*DZ\肿aDx4>7*č߆9Iރ[>6m PDn9'^q?޼d l dΜY2dA2AVIȎ;NBS]t}{ īd*\1P˗ұ2^3tl"뵄}{gdMqZ$?xtQ.'b1v8oS PVfY4LE>f_@prEIPAd؃ܶ4xdžZ$s:cNaB9c&I#_|ׂ ņ⋀Wl(ѿb'a!9nX/fNF wƐiDp?"(W A2 ?4HDdV Eދ}+qJz9V8X%Dڒu%\b&[p:625 H>y`&K~=gXQׯ 0 ` =a(J|ogN7ߨQ;mUKVT4U(Ct/_›tH@s?MRvu_QKy^QQQo.]vaQ ^lk֪ǿa>PժWڽӧ/{Ta:G+Uy e/Zi(<ÏcPpV k)6-G,X9b8yc_>s!к ɂᥟ(RȂ]DRXs.ee K W^'?4HEvSa7 mN^CS˱q.ްnòe+̝-D\jntxM|:p%\i&YOzH aH1DVeG";O: XbK;q'T#?I>iXΎU)sC:/XM}߹?:WM_Xs[fþ>ܹsEO{3ӤI-U}ر>Hvm{Wn͙wƇ%)>ߴa_j9P`裏 b/5~mk֮ f6'WUO".] '֯_豣N[f@u/()RAJQ Np'裍ݐr3P –׿-D3Q/swB1qҽ 1bécDm D 5ouT0XSl@I)6p:vCv$Sl\H>T&E& t#Р`H!{eAJ pB6aeyɜ9ʕmV㶇}8_' `z04Ү]30jH%%$7/^0.)u]|+Yxt OwЬ`\⇘|GEzΠvxոQv|v5e0٫9sh ׬Y{[hEtwUt;.)ȈȆ/68r+x,_ t w>,a_ha]-\tA|s)S <,T']`G<~亍.X8|ٿ(Pdϓ7OtO_g3 ΍Fg鋋Ld/A*zT 9SA׀:U5ˬ_@P إX_1t'sA9LL8aQP&3$}]@[SO RN !mT)*6(iG+Thj.X0𿖅UrE8|,DoElZyGB"[U8?}[Ӯ];ݓ;B>rsNǧ~:mLL@.pH _/5o\ Ȅ<~F/Dz -4Ɗ5+2Ï$OIX0i`⵸aRzHa`dm>3̚fŶ,uTᄑ;)ZTEmJx;ƣMZ:z5Tj5E寚k,Yoր 98Z "8֠JI7sJ܉&t%U!Ñ#ݎ > 8k,wHkzq;w|Z0oEDV&!Ox<ۗEi_ /]Xp״;iZ L@OLcuKQml阰Rynt*%vhmƾ^%3C+b ;wd݄WvJ RkmRu1n/}|IW-; x-[rf^Snܰ1> @H|j*|lW` ¦kj<Ѝ2ۄ>t F'C-OP(~u`iڹ4a6cmE >įĎ._8-]}#G9j-CiѼ%n_ƍ "kR-NK̝ӢĆ72ej…*MaMrÇ!iH(2PpRicٖ5SҮ(nx֭w!a'X+Q^qbEK-o3WPTɪիqO,^z`K-xR"~%Kz$:t|^}M{%vێmhedDT,^hB\JE*S% K GbRai[ Z˯%KΫ:dg?8eRB%m2kl4{N]۴lo}UjxZP;L'}~m.-^ojWU*W/ࡓ&O!{}Λ,6 v&,`{EI؂WwEKLr(a '8? L“=Ŀ eIVLu <"^6JwlYıҏLC x-Ҷ:,ayJo ,2o/ }D)BZC!CY:&톲q8 BW[ ^Ð+6M #an~b+[?9HoآebK>W Re!H$VFHH`K|Yȑ+?Tqg/}H-wX 6 D36& >(F VV-#};p{ό=dʚjֻݺ+K.Y8!>A{p={~0dO֛͟ofH~Պʖ[xIWðܯO@TriOڥmg͜I[ƏvvZسWכ,X`%@rht۶@=7N2YhYR- M:EgR̙w[lۼiS'ҥIC9v'q s_FEN;im۶_^hAҭ͐1=6cF0CmXJ&61W,߳GjD,+DNDa`=WT4rAZfACQ6[.=j[BuRPc@2i(E" /c>DmGV{0z0m HTGHd͌dQn|LH&`d!e 0 %ēErY“ɂvfHdl1)}!-['-K^ 4{~cpd97:+/F7kL*cgZ3q+5Z(+;s{Уmcq\B6noݨFw|Wΐ&#:_1ߗ^|i칏<ӗK (xOgR(U#+'Rb#v-5 YZps5OX#J ejTbE|[˿B-At豈p t,|d0RHͽkn䲰>Rea}k#S{Ino X H![Z۔A e"Mq<ϹХ@6o!zC |6u~4x;J2/2ɍjƍFc3ڠ L揓ۯ6o7_-]lZd L~LL{MVV;17\zÆٳȯF6md)oo5k~\Pa_~3dh٢ cgΚ@>g͚]`߹?>l٪e02TkWUn{/mzO_K-=rC}΍Q*;47xRmٶm#ׯ[6QE5}=W$sC>i*?]TRcFJ)iOwO6n|}RT~ʀO!}>mFXAJ0d[3sEZZ~}p٦MW^}[t .}_7lԐ5 KG=qp/XFE{2|gտDb%%V. ` mpdeO O359RI!*-'3} dB"<.YIb_dnRddJ, ђ|Ӄ&HX%ِORl8۾bŴпJMcaXM^X]wLhLdnkfZuj;7eƋ; q{9n1yڔ,ٳ}خ\q[r̞IS&g%G OeJWW'oxjR<5)_fΚ}r Ȉ#p~'WMy;B:s,*U,W|JUK) 6 Kbޒ#kl8Y{m̸1<(m4Y$3{C)j'bʑßN=̉:%( @T eAX}ٳ8n>Z֭Sg؈/c1F&%  hcǤI3yO3*&Ϙ1=>= t8&81swug̙P{r^oi]ha\VV|14Mh| k֬ %{-}ASyN{Ng;3kI:oqϵ&[-\p331P8\Zou"LP_ s!xq%$M6R_tvIsT?("X>P (:&óĽ>j\nRQ:YH:,FËP] `Z,m9Ybdm8AJ54dQpAJn/eW:PHv$xZ#jnš" مK(Y VL@ kT؃0}Ϝ'dr0fC x[dHcRG-X4OKsdgfMbq2f ^pv0DӴ){vwpy%1B`KXsc6Ux%!"D\ê`RۓP >ǸGg MC 07%xÏ?u*@4ȲiFK}qD4goy=-sVYfk }Ri{'a5 1`D p^&$iy!A Kd> MߌgA6i|۶]kU |mھO6o 飏=ZlB }7/+Qd)&!s'3eڔ7`*X` ƃw.ZXҥ>$JibBE ݸ?o^/.YxE ^iA=D!tgxSt%7~Te+USNE-P_uޭ۶ƊTy뭶8`d;6#YN?/J"Wg6L$0A8tꣿTL8>|ohU`CKm\\^%Z{˃-RN¥ ?DUEqe" A~ ʝ(e!i&:da=o(T D&kW[ rt-եbLC)+Kk^7HhJ MYB/KT"¡!(N>5RG@٨,9<'-sj2P6dzfnuuJ7k0 O8H ڦֳy.KqW!P7F8Ux/.,8u tp-BĤkÄ^{lN]}E["!C(U?S:9 +@U[l} WK.^xLwmwߝ{֍ŊULqj`"A?ްu+_2hVjOXhq̙VZ]|ŝ;wD39^xի͙W:ze.ڸ~|ƌ`wmѲ%WLJ={\didd+ڷmˌ3d\l9BwJ,7~Xduk=Iv}9LrhKYy_:q ނNطy>mErơ3{٪Zjd t9s]Kh I<!& KJ<_")Ib'ے.v_k0 ]|lK5.62 j*p?%ƒ* _'>sXX[] \Oc顏5zRK>!8&C׿ d4#8BZ0/n6r/CP>PM,{B nbo)62[piGR3B)&nd5\&e TDqxJ:<($?ҽ$ ZҿXi77xH|oFN$_a}A :JƋzQ:8O'ڽcVK<x zҹ8:˞!C~xS7c挻r'˖+S|{H\y| ä_Ou9exU"ŊUe#mERe0ז8LڃH{d.ҺXߥ2̧JJur,Pb Wt+E }' {0:?H|&<o&1VBYa ,%T~ahb6/|j"GP% w@&|'ЀDbGG8lwM bI#:n RyY4ξ RSb# Vl% bRbPVP'bC4*eC9A Sj9 AFIm': ]dd$"ǫ?$hd.=,1!r_s׎OGisOY(^olG Zpde^>#?̐>Ԟs0RAamڵfܹq,/^w+\A.f|cX#ҜCypbԭsnw:XL']p-E"0qgF.\"MmZnbP~cDp%U,;u|y&qFxǦ͛cc;>< TPaX,:u؃ncs{$rDڨ4QLJ:qi"KyoTOM p4Ep&UxiztŊHҸmq~hivi)Y6C]=1{%%L~1r!Y1#,TOK!Q ŕVDEڮp aD&:(Ns*&lJ> !&QŠi¹߶tǒW7bIU܃=<Y(/JQL甓-"8~B.O5 p -F˘ eM8<9*+pfHN>Wɮ=YŨz/ P@k@fϦw_*Pl !OT~x5o'؎WBAJ`/RA+t3wb,d  Ҕe ,bGO.Ep-Y|`Go .:)Z[$dWbw/蘳'Omf䨯zԻyfxˉxI7}Ӻ*VOm~뭷~@j XLM .u3(c>S[6ۃ)pݺooiN;!.;tx{Ĉ|F]:w]v!c;6oaӺ/G ۴iޤi%Zj޾}f͚m߹SXh4ԯo9sgۻSmZl ˜)ĉ?Mĉ՞=Wm?a!'Nʥ'Ϝƛǎxر^nt𑧫V‡]fz'gZЪuCG`ժe˶m=ǂCM4i׮ݪ+N|cE%F5/̙`/~¹/4lڤކN!/^'U-۶4ksm9P9h<$@z~ocjRG8as@hL=8M:AkpP}=V['h)Q<5%2!axRxXؠ(JDL_<ʮZ.b6f( 4l9G2"J-<%m#R-iE˕X S2s#k() ,L"BZeYdA 7:Ԁ< E4 Ȣ@|cʜYl1+jB=YȃLߊ5Nt2,:L&& m|g^dB~-X5Nx~&4d-n\YУ2+6EA@ %dM\)o?oē)]3b{b4Hi BU,9{҃{S},LdI դCo!|a}7Qx.5Pҵ(sja3-#wWb|^0VH-*X0Zs©nKv2wM6勗d͌XTd<}ٚ3T{%Gx!qk~6mZP!斜9N˗a>YSҧtr41~A f<.DkL` E߱g' I9oˑ&Mzb0aE"+Ǚg045kT;3eɾwߟ v asdps@W+HӥKg=Fǎ~@;O6&wK_!a zܹ( I}aPɕ.XvģP qaCXcbҤɘU6t3gwlY^xsߕ6MLߧO9~=(gOpA Ѩ^s"rp42ve@_ |t< 3)<+na O*uKdnli 1j'XmmS׀ʐ dRtx1G6App_Ÿ[&CkevM)1Ld _'# dqH6 j%8Ɗ+Mf2m28X qUlU S@7-s,|gY(gx:X4PQ,q0 Y(}Hl._n-e+e&Eh2bS E%e@I-m! <t2 R^چt ;ʀAtIcYQ@e ,T)/ g|ء(6 !-C,db RG'ؾG ;zmړ` GFXD&bw>v(a ڗԩ3e蝎fϙz yΛ;a"<| KԵkwqt``=ڊ/K,2r_C R &+F0u2_)5^tt%agz(gEM !7PX<>ѧLkX""4F 3!3u 8*_}ͷ_ Q@۷X‡k(Pn9;"XMmᄑQlͷ~3j, 0?f͝աcvOptEɀO`830ort7Zq IX>1؀ Yx' EfN%d`B2pH  $%͈E+!6;QO<': o&wBj ` Biރd Gbr4n:_'_of [aϟ{mk$nv۽{OH_[Obq3Vӷ~Kj*YHnD:QhJ0>">WlLↀp `%b,X5F3wbt0B7j(u# l%pѤݔuK~51 ՁJBevEn.d1z &3Y|; {IPHץkgHwK[.Ï1/c nܬ -ZuQ`$x%._hΒ%K>q|{>\eꂷ($L?d৸.Q8v hx&'Ѯ{;7Gq`xGJ)ɼJ7:* nٰiC"EN:{a4#]s~iӦ074"Mմ{5z̙S9r|^o^3YpxWVM6x,ۣr|ɓPEաCH0,/ְ <عsC˟1#>O6+Z bC{\T 4Q*b˜%~uک4F73щkFc=CjbŊ=۷oɢMGn L$ K2/ ȂU*(Ei2jӡm=vBPqt[Y^Bҋ3E@)\+=fvbp%:KBuv!<1Sl<1%*sM.L8)UNpjb[NrSlBBΓ[)6ot`RM]lA/iSfviykjRϗϽo/ eҥ 0G-am+GXDƍ7Zn%.~aa,ЬEIeʰeJ)?b퓲evuڕ]Vr=ޙK6m1,Vة}UNMBQ+$bl9wEVx+:R~7OJ?aܷF۝htBԞouxkmF/p',*C0 Cw%)V RPI˄&#$4nP_W1~=c!>ǰQJeX -4. ъ > E˨Z_1_U" )J+FOڕr2n/`|ǔFbcJL cn4yʀ+C22HKCt)6ҍdINX[F X5-=v艃G?|dc=cɟ~?u3b[GPˌcF[b%Eڌ-VP*9 "P~dEfc4xyF2jU2}ƪ+1O"'֨\ jQQ~ ?m7n]߲B6CqO9q- |<o'fX x3RdΒ@ѣ;k֪ҧOz0GF%KJf(&_IÓ^1|ӳW?8>-[0/}K䐫By 9SU2{lAbxM͟ /] %K]E=w $ci}o_|k.C;BW?fȐ_]O}҃x4i 2gʵO6%UǟdՀu;v4pf͚ؾ=mN ƤaN:7 %Wy 駩/<_z3gYOR=d̰|*8pȞòO$#ܟ"M:3L>c98ia>s AxZ!ɱE&.+90O Rp (ƙM+tGh2B.O_GӶ;ωq1wGc >,]iDSReK$(Ŷ%]xJ-Q fҏ=88+2e\D1x ` s-^T鳼а!v+>]q䷣vZ:.  '.Iz\Je ri =M65~ckݻ0ǦMo_ANeK?lnݺ?_c8Br3uİ{ ?]Zɘ1ckԨ^ZReJ}Ǚs{%T^-_LUTY~ l'!DUV=1Sr2=V>=9˴_`(nݲ57?>MV,X1ў|V`Ғ, !⮜K{ګ$Ed)2+(+ N F)%!@)GD,[z\YB+%,@IZ|6"؅ +YHDzeܹ,*:YdOp&_RN~4-zbQ,,T #aӹaQFu_\W@ ^Tr*ap;LҦXpݸa3U^&"O8>"6>"w vkg &e`d1AY< h%߂ftH@6*+hHO aB3t+9Ph,L%GU'J,/`|$eQ$Z,La E:h1E#/SŞ#`\=W*MHWf Rŗ%<2! Q=dm]H}'&H2$W.B)2ʠ,bFW`}p$"RBeSlO_=Y؜K+KbSO-rC&1Qoj8Ŧʩ_lE0rc2uSx򖻃? (ҥ Y2g׻t|=w&M7?y&$œ"u䊵+/KFrCl;ciӖ|ywSm$*ɑ-ZhfNh ϝżL;{.s̊uy-Ba|l|By ^In5OR.۵Bn&LA8{eLQ42 9y(u״Q֑O+5P,МV5yt'e9ä/Gj=Fr ѳoݹ1ﵬR8Q8=XDRrFM#! ./]. ><ؒYr:v֜7#QRTW}nckcQ$%bܤCLf0@Oɇ`F; RId0Nm׎|>Y~` KF g&bDpGL]sWHhhN)*SKm!ePdV B 1 XIDAT#]nKV`(ュd #,K75e,t0B7T\P ߀4x%A>w!YD1 s;",e7Y#JDh&[ ^^(o䔕F/x_)$33Y HYL˜Z+ 6m=YJUf|po+ 5Γ'slr-Jy~)6..c ޱѷRUZe߁}:p~㳧NkeawsB,#M5mA @Uǩ12:lTLt [$m@Tڈ/V Ԅ$`%0Ru0$Ooɒ]d$XhK;5 ,$>ETX4jhN䦃M7z!V+ve8TMq8fx%!mjwPmĜ`U C*8`ѧ0=W R=xO<Nq 1y/uͨ$=aV6:#߽kTp|QkW\%`kHFG{mF$H$:tUUQ?n8KW^Zr.8Z2וB?ziӖ}f|W֮[M2 X w3cH~N*q|hfN粄Qk;1*E7x8$"‚p"/a%bf)x85[U(*Îi9wvMߢf d-,b_<-FPll+v@brh RFI\d /DDiX制c>jT߶uUi-?mF/N>] `F/ԻҰTj\=9+U T.Qާ=w6[X1~[劕(dQ*gΒY[L3PjZdtШ]D*2ʂq克qk4-P &nXTtP1x*V_(5+_8/Gےp_nޢsg /2pЧ1/ι@!޳XbvE @Ry!j7~z PE݋+RDQ$Z ]Yh!lg٧X׬Y|/MTl lLW_FTq4"23)G~gp+8eY0(YgE6(1FXO+1N+Ţ"́^G0Y~e03)ϦKէ+Y9x/|7nͺfjaN[MdKس{CKVwne_t)"qe+ ϝlɲ & 0P mqTֲ>yF~f^DmH+|gu͊چ$[w"j@sfYjmWgȐ9B.?z h}1ņ/ajU8[''4ji1032_5nؘhu?wZ74pR8K%} Z?pB" ˢ+@ˤBuݸRr,"\2Y*Y|sǗzf,jz' \Z%5Αǎiب0`8Q^ڬ Ins1BrܗaaxQ$񀹑{h޲sꂴA 'LBvEΎxadl4{c7tDfD|yq\-\ؼUF/5Б :N.]]/_~S6/^1Ay.\=oT‹io{ѫݢ l@%Sml6] 2@-+L^sYɓ0:uk/4p 2%|Hx⒥Jb6Kv+RvMt0{lgpgR eG*'<={^Y:\; 8T9B]izjÃ4ńkH^5zB?ۦV* 3#3;QJ:[AbyLXlc)B3ۻqQ 2v !tU)N{_ YTʢB?, EvJTs6KIeQ;{jEG}X@k,nq hfF7&큒/n S7_8bƶ5w ʵ+Wj7f\7,L_[4~i@' 0:Փ`|J,V qMd@LbgD&Sl76^˗E{ɔHfYcA*Im.eբI," H]2Ϙ)cF!#6W"ل ˗+7eڴSf9"ج 0yG533 FԲ=w޺c+4-)f:|܄ wݚ晠RdS1=[6_L~=kL'oXJ=FW\ OC}K/"Zuj}6x;j뽰3dC^C7"<{t^6hv젌>"4.ThʥFo ,?a>ͩ@`ӧK%"- C ˪VӜm[!6b.g5>!m6vO\ ›8pp/7_+:p_ٓU̙2~(NhFy9vEKbqkI9#(m. ڨ_T¸E`Spr㇁RȢƴ] آrs*% "%JP~cC6$L-@^YA ǚ,Q{D!be2 {= ^ =,:85ے LpEEx HYLX:m5/K_8GEփyQb,6˱`VoCeq =Y`ʀ/da_o$پO5ЗE, 5em%X=YfBHŐʦؾ,C)w208@ 'ZSR=CC,M(J Rgl|KN(T%j"u".C .M^o7oh&Ư7^dyjmsghl|;/RHB6|lފKԱゅs|-V8Nr+Vi+G7.P rm[z|w>pB'{L2oDE0\,VJ]w[tSO=XٳT\ v[`#ĽiC+F`y[=ЍYe˚YSX2Bnh@ .0|V2O-kYȊЬ7Z7nm5lҤIۧǸ,\#>?ɑc̓zܡ_OiZSpe>2:PSׄ& 6F Gk(s(4NP&iRvp{l&+O'nAevBeqg +&S-˜Z *%bAh ~$O/0cD)ś^6(#1u7>1PpY͠c'~&_kO{1&4&b7d/ğDbOD+8nTd( C8P,u.?\z&.L$sǚ.jF$}|! c6PkF ȩ:$ʠO]D"ŒDtk ʐ–P܈)lh !dP)e!2Z*XE''Qb:kb] +pTN)ӥ;v"duSafdB=YBX,A5' %,B,cM#$,^W F"YЀsEEJe7 )!qɨ>rStL *2\~~QɄ{:rs'0K.gн EJM7>Cr+6q+)\!<ȏA&luK ̃z%{}ibb ~W,,'7X`d\fQW.+Z^7ۊKP(HTk׮*P ?~AdP)]e0Mi-wAnfkAx'WG^Fnh)6P Mp%sdj#GHb,ew6arwԷ˩ G4ԜK! >A<ZdMsTO'{AT18ɼkvDxx|lltt'_;8r rQR¸eR;`zǜNlܔ*C7>srngj[,8EJ40hW.K#\h &FAѠ$epF14P) =er+_vR%ˀACÇ@h]Ƞu=a&B 1^ly( @qmqbU@ЏԹ 2!*?<|}*+Dnf9@=0OQUUn*~…swqn]R(+ƽTo=9@b/aOD/|:^t@豮NXU42*k M86T[Y>4w(nSP?c 3,X9 b-daӘ,"D,*ӑ{pBƟ.AOYPde@5TנN48'K2 e`u0ehydQW 6Ekx.Mқ)Íe1epM,S#D/4G} 孳dB<=أ~߅c<,޽O>rc̥ٳ=jE_JjnÜRa't.j:uXi ɹciK"*5٢w( |A0ŰZa n%IGg NGYWk#xהgLg:EYUOIBPD :({y:v>b_Hs"_t@I^y!/-RtX cOyF%P =q~A*)K0sJSnķ f3^Xzb%1PB| r 0,V0+O4.n[hsa50 ,EIbĊ#*jPlYV^HZ&ጉT~?HuvDvzX*:=E.)=VSfQٝ89$dPGЛ0Mc`{/hP DWRqP$3Smo]bמ2u.ϟu1ά/6ptiS>vJn`Hl }{.QK`1[` V|&Ldz z*~6mوM |Akl޶勡Qm?@>CѶ@n7E4sMm0'sV/LK証REv;)^# mĎ,2iqfb      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklnopqrstuvwxyz{|}~eN:&z?OZ=ig98YX%VA-^ް$BaMnxM\)ȢI|\* H,dT\@J2;Y 5'߀&v B:t_<ЧYxb7ت/j eH&6ֶ!V#5;Q0eBk572gdQe!p,l3VW)Z̚PSJu*M |+t 3 C38M}qٺu"[n."8ҧ|j|QX k"zd-?͘iҤ1'&1cTJTR5&nVڼi3L/h f7La:rţpBYpR^LK.lZuT4xA2 Dn2e@(ܽpg"4Wԩ{OW2'_n?"dH޻Gs$U@h&tk(_ַ_J֩[Jh#ZlJ{~UbŧtdzqSGF:u+W܎mo\4\bMB:>"b ԩA&ܴic?t \=82kVuvÆMo&ҝEm1.I+==-ζڶo֐?{c>WJU4V35G|9 yaׄ,{oܱHѢ^>Bnظjի?StCsAGH$cgM4nxBG>]2>X˭۶ȑ+ÁۂT*[ .Zx>.˔)Sf<7x,k>[ ֮ ~J\8CEh@6rN:שSߢ~GP1y]ē{۲u93؋b/Lxk ڵjmܰƀ+WGXh6n0h{WVsTիּ‹ kjm !O_GCyHʫ/}7.$J$FXהS,]'7߈}ҎHnaBdQ! `:d-0_h cU枎)Wb,q UGv_AGp]$L/@]~\po=}UdƛA o,q+|h=eLWiY$!Q3_J%8.!jM^&Ăo;Zv'My*Lӧ؇*_J)J.U DŸZjzw~޺m%˗l .Mz7O>a߮Y'Vk\bMρ߲eˬٸv9/4x%˔oLg;g pӗ_y~ye{W~OⒹ}]g>[rk7|`т~̊]o&0b䗘Iu?R_ ^Syj<<ߔ`Hd{~܏8TeP7m~MX)HVeAW"IK>+DOR_+0W+^7k}莝:⓳`Yƛs"+ gێ-NnOW)^"gO˗/7oЪu+D4ai |b64)m6DԹO/oUYY"ĮZr˲ G(:+bJq Ă/Ǽ٪3?G3'OQ8~[ycVgC;BEoۺӷo?t: ޫRJhLC͐'`#٦.*ڹ gj \Axe{{7q Aq= #Al;dA)R8\PdeBRLt)ӣZxćR]tZJXj2)6'| >Ore(>+@Jax( TC>V]cETOჟŕY )(X=YbV\MtsY7 ӵ/JX/j$d(_(9 *%Hc` ^:$:+(dIAb eA|,5:JA>c P$9jQ=~}N:N!Hil7p;nlLUPHBpbu?H wQE?yeVqUZ?{ߎ7ć!;oñ 0T @)P3Fq?v'x80ƍ;n c3>]ZHF+gY+Tȟ?.9z S^=7ӕez3B ng$,wD1{{M^]C"ġ֪Y3ft;>wꞻxo͛U'Kwz'FB|R`v "uFn0 ɦT.eΘıGM틗ϙDp-l˗/_~}ŝt%OBw?={`tɗv sd5 RdmgfA%Ϙ>c)Wfx>ص@k'bp9yO?8{ص⭑Zmubi2e1Hc{; $Pcˑ{P(X* 9IiG]8dDa:FeB&dTʢq,vyCYPЃeaMd"~!/Qg^ h]DLA RKrYBȲ2cE B&e8{~!8 cPROZ|Yسo1@Up 4 (8ʗ*|۶}>4abJ?αX'.Z_zh޼y7n+="DwFmBbYgS _Yrߞ f%;c9Fosg4i'Y0wSpZ?0F͘YthA!Ӱ99~}g̚u!*(x X[6C/`л\F?Et3g!y lL4; l/΢  RYgגAuN}_tz‘Y*n3e˙=;;ubF.KV&[raCNl؆a^k!ÐA6_Wa$O&-~*Ucǎخ}_~0N#cKs'MeƯho(9[8x ]baO .\:7"6][!(J`0qF,|=9#Kc(&zT`d@zߎ"ъ 3>w+TJB7i~Dnb,D(.e @F)4X,tXC2YDeP2P5]B+-_  E}&/ep*ʠʢdNOOŽPCHF NqkYE<[zĦ ;2\ uΎxgZ׺uv]# "4j9o#N@0F]"Vrj Kugju&e~vw}6Adyl˦2Gcyۺi+?J*Y4θ*%t jh'P,xCe އl`@mp̊&8Y"SRo&?5))r5,p;$k4'fC H g @WȊ.7Y%窹b$NZʎ>36X(ɡ)CݡqUEFIQ\Y$MX%[jS 3Ea71HyMN'u4#ԯ%Vz|pU`<X*[(a o}oBR,z{˗j5k?9Q6UŨ()d{bCuBC-WGNn?ΘTv  Uv f;s0m괾^?*e•/>P(ſsAIGs`%#Ka&eFNdI$AAnl(p0A v"GTxʫ ɢ*,FqyN&m+,,z/SE0Y.Zߞ,b 6y\U Yvpd o,~{]CNCB^/PK Z(\~/BE`@vdIlcLS!^~!Apt`! N@/݂ 2.]6:⪒:z㖍>Y҄NeTQV//Vh\dIgI8tl݆|r0G9 0{l颪-)±)$ Y2XGZRL\LhG]t(Ye츈d3d%;ہB+\1p! p~@#ҭjݚ|0m4k1b 2ӦB#)'g-hIAqA2C<rqTxQ myVpr;jrz@B,T MC+>J>S\o<]"D19{܊XJSH@r8( NW֙D*E2\OZ {A۴Y,7rRϹQ).g %(ѥ;6'l<*`-Q|EKSa΋<7@Q060u>*WRYX(Cb'dA <70o6+d_'X] I{tv@mB/&K~I^ C/)yb8x * ewd rv(w2e0YKqd2pVn1@)bABYжוb(>HU /daRwe W)vJ1^nSÇe)ߝb[hH/%AL6k UNAbSuᦥh(TNPd4Xk&' Ӝ,r2c>@,e|xrP *Ð#wsM@*]X>}Ξ>h5jT+X`f%dRX 8ogYёi"ԥ#HKȡ!<`NsЪg.EPȈ*8r];9}G@-;Inۣ#Ҁvϟ{mߡO9]{X"/V{]x+Wrؾk'dÇ#7JI׶܎R5EU6{5(48?qsڳ{?=I wl۹C~DTaH( ZZMիQPyR0S!ax ; S+WlC?w}9KeEr\v7paonݺ 6-ҙ,P3rjJH i3ad^SL~Ffxc " tbg 47%-b7BO K| !!/0]/"\K^BqjWp3q8#B.# ]L[X1LC G P&k%B7 6JgG .%!,\>;R8L925 /:L0B8ETb=YT 5 @.9d.D"aIn2Xyɢe&Yn%U0Y(,N"O CXө /XKORTZpB3,̿ӓ@I7RlI.Yp~b,b[7QO=Y8Ӧ()x `N6Ybdrip?r)"Ѐ,b(֨$zU8&ЬB@W@ȚeΞ C~10u]X=LV̉s?h͏wd<LSiZJBp%FqCv&MH]ʖŋׇM^o%y^O[r?}&#O/5z>|>dرcbtȏ|gC[zݛ%˖߯]TI'oѬ%6 e.]k֪5{oR1\@b{/3~~%m al =aJ/<ڷ K/;q"L4aQx|XZsg7~ <hxsq/7  6;Yb.w;slŋ7oֵ븱cYJtshaĠgpyƯ|чE %}Л (/Ғ hߦ==y|H\ZC4.m۱rUsyDŏ G6NDL(ϔ6GX RBx Uf^``1㘲%[HIIV̞M+QYJ32lkƤ#s#aa+8PW 1 a$D5U| 0#EY8ؕˢ lKBYt2,dC i@)k@<hdN P< B xѝ,Dy dAUl yj8Č9 %X@/ YMr$F ɂ,l@6ўWvCe>aӯdA_Lq+H7B"d oԀ1J,biwT ͜aH@rG-TZ2iDGEF}=>xMڋNQR5i Ycr| hㄈ䛰p{8quS#&n@:kX]\ХFFŤMe.\īIb!˘ %Ĺ ȜϿ,ܥ4 I 8l]x'-H(DV V"-?ZlRiH&Ф 9N_4x-{[o٪hQ_D朒K &wl!pp ^`oeѺc5sfؙmڴi^FBqtGv UX G.J6K`-st@OgE`q.0qRǸ}ńT͖WityZ 8ЏΧY8Yc(RaFbWZUU q~DzM pH3n|V@PXʪ ģX2Y84(=Y8./ '%Ѐ&a) 55|Y,–eA bBSFU 'K]XiepLѾ2Lˢӫ(Xb[@B3eN=6H)Udbk\PˢBJ_y#·)ؾ, 3P?h~IQAN}3QM\cy*pK&&on-Qr#WIײdLgp߁vk\jb~$-"u;{ jXEE8@Nktx^.d˚Û6o[t2 Wll\2e*AVp1]h{ׅgc$ ToR -j;h lm+jǏ嗹 \3W cL'N |CU /, :+ʛI̝?qpyfB>5ßLS6/Zo2F^kئ dŰ?hl V8\ .^ʫ{oڤi:r Gʉ'`ǒ9GdI_¾']qXH1]0SL͔@|t٦M1rH#H0:(}tV dC\Y*-Ep\LM.͒QUZ F]nT҂UB0Μ`L&5]*L[=yB ,KUO1!E',XdѥVn6K,j`Yʮ=YԀ:kzYzjhFb]$Meڔ3%v3bH8~eߓ";8iܯ!bmy( f@#_a*/YXӗeNJ`+Itd1eǓōSlHa(6C',Tl15') 7)q:HA*l9AjIŖN!ISzqg FݹSg0h SzGEE/\_f܃gͥJ*S 'B4pR'~asG|~& 7 6W Eyży&$#+7bέ'|G?O(SL}Ҧq$3-_'?&F|uT'ط5!9oEwt2?P!Z7n횵f̜ٵ[4im?8r* @a*Q'xJ, AM4+go-s{=XW^S`apNఘ'۶m@eAf߾sLJ|/S %h{oPjW^{/ܖ_oҲEKX @?>CQgl[o=qLS^|Νѳ~5 oF*ZH-NƄ:; 6m6IU`pJ -yTWfR> -AKA4J#" tL*He!#yNF/u1N˶e(ZI0ȱ tPO+X"Eme#=eBT  %C,!,E! _REE7VԀP1B QE먓@[M{&&bBp $a~U*Uue!NTSLA$䘌<_ \1p]3м`_D6%:{"@\_V[sQDf !p̬FI⢔>;]:ګ_p'Z_ pYˇjTO2 4^ 8"9p6Mx@~n"\D1M$x3_nQ)bLcD`a9NN7!,.eJ-\dp-@WJb, (BO*յb5?с_)nE1!;E#%$UHʃ,+iApH"gĬ`4^Oш7GK+T\+hKN"WUcQO`>ȍCYQT.An߂'fR ' :'9 B>BP'5$KYd! ڦbdk@&Y)ؓ, /âT"Ydue(!j`z8d΀K4V! c'% 嚽O6& l̡-GP,p)/dM,9 %5p~1&y1F)6Tdٽ"SAjb)GN/#1k4hQi!p,O98b5og._1cpq'4Qx~+8i- 8 ̸1[8eF'@$_|eO!F$Xydwن9cϬXOUgkָlBXh Z 9Ըf GUęc͞&F7s-}a U7~ #V!l.|v!+&` ⰚUQ$Hݑhu0 f:\6k1 lCmU zໆ5cPR]L%L Kԝ>? WNzE),/$ck.ʂ, a!TX$!BWb'rd) :FvAعCYUR'>N_2MAd& aqJYARYxXWX(#|(ɂ,7EǗ +Y[Hn" ۄ'Y:=Y Yr#/lDy䟖f26 @T!œHkN_BEv Y8|˂Q!e1ei,_ȩIAʛ,HTW ~xS뗀bEs, ’PBߌ,P^,0pj/aMEs_~ ֨?N6}*xbޏɹN6ex[gCYA,#~S&رscN19c֌UVc۾ȅgnHe'tْ0Dg@'z˶-=;[ ukׯJmΚ͛r:xA2+W;wfܽ珄8n8ƌZG8kX/qdހ]\7SӦNu}+&bHy D1x4BHFthN,: `.yB@G yd'Nx Хwb+w\B7r؁ zWt; x{/0eL 7ĖHLlhp1(2 M(;9ACtbih?HX,* \|j"!A&+K#, hV5`rYFY/d^,`I'Mbe 7b-e5du# A`ɀUVPɢRq x,EO2$ea5s)_4܀Ѝ,4nЀ``LK. f2hs* GFP(:, Ej>J$e1} UPYt;/ c,\* ' dQdSl61H) o:H>ƨ H(o&<Bs Kh6ݼ^,vkΝ.fthm@/ +- ˫3d>eU ǡT'صsHT,8qrĩͷax._;<|iO O:>tr+[W#!YdQ{8Ѻ2o{fΜ T[Ѧys;ujSճW^8{,FXmlbȯF9s8XdJL\b=?@.O>jނA>y)A( Bd ]ZL r9L-[jKH,WLW!޻Cbdr0ȹpG8cd X)m~f:8& `Éed%8eYD=VK|>Kb K!ԗD/T*F8>8/^2<*h$ Bd!+yY(i 9=:F80QW˝*\x9NK;׼ye͚մ=D,b嫖̓'O̕.ӛ\&6ŋ`곧r C@X'4F\%+oZqڊzbK!Ç?m۴,Lu%˜lY͚%왳HLt-? !lI8̂R  :P,$gA"r: tG&&>4YALlbE&ݑAL4;ftcbP6'ҲVTb_,<+ | ShRm4dc ,bA~(F',RQȢj,f6Yh!u]OE|Yu łw {b0/e!m~1IE*ʽ[̓럯 ~Ad!u)iY_bB]pw=e!68ؒSd&R`Y ذ膏>;DaOS`YH; ˿4t8H9e bap^Ӻ%&OB" /u,b2C5n q^Y>|qܙvۂ~ȍ( bX%$S }10PEa:tx{0>[X'@ @zL'XMg̸I~S.<!Ȅ@sӄqs#L Xq(29c= Q=Go92 %,Ot B$T!b70d=E^Y$?t1 {A sLoV(eQE.69윻tX_5p-F鎲N&C,2j{ Uj-:ˈ" Kd1Y ea d'XHY(Z<l!zш͐~YvOZfw݅A:4o| &>Rߏgf,u|F"р}|?n7E :rs/<&}5bBثVtVMK Z^yTebg($JiB>Yr"0\Di'܋tXFr>>V,EԱ V(6D CDue#RXVJ ғ.YOzYHSfm z\!ݜ,]_6 r֊6e!W0ͽCʲPCœ0kdB% kE}+_Ȃ)H7VB-e!cu2@-U8u@EӾض( Wl_#f_arwe ( Y)ڿ4eo1HFG̫c#4%!d9й{&_hV ۚ1ј(6C}XVy,˝ Htb{U5c(͓?a ;  ÈI]j8qD tu"BI ~N/Oq%7v#<\[[)`5ı@K``RJ<][rU+pO>`8(#>6D8VS>9V 4gVGd?XMU5L֮\'?!]zBѮ}5+Y^ k5-wth%8XN4)uE ) /4IF/>S#míׂ_sB;Z\  %BDx:Y|ٜ7T,M{7EBk`_9M](5`@!b \:A@%+' GIm_Ȓ3Y /,/) QUK~ Ȣ2kj!uW`Y97Ԍ#% (5Sl<-qdD XbSkLg_'Sl=+dv?^r#&VAjA*6q8kg:>X@}/N.]410`SL|X5{fe9M /?q;(05~@>, 1Ѩ lw$'QnO>z8|İ~ X)X sdꕗ.__q<# ؾ}#GPPᄑcݺw~x1~x,{܍O~3+ fjlRG?q|||Y^E**U֬5xԟ Bim4hXL-㤈9tƔ)_`w ʔ/ϋ,̝=Tx3gܵk in4ih ?$U&aj K*dc@IѺuw߂lς8SL*%Ҝ޶ >;"Ćs6$+%<1 't;Jx*iFuS 3"oȆG;4qS{jE.H&a4EjVB*3*! Ed xh"\8Il%թ Gyd/?ĢիTGZ򢅊/]ܹ_Xɻ*زUK#go42nP.lK&.LwJљ8X:3}-7k"Ϲ/C{UGn{b4 2Esb`nR>b*쀥Cat Q@<": s%)$bB=¥Y e+A{<66_bpϝ9Tmw N˞lÙRv0<@ Xm&S*F! 6#ړE\H8[d1|,jb9ɅcP4 x$(ɓEg[KI%,,% es dT@9_fLf $Ww 4{ SE5fA%/A]/ 5P;}7`2YbSAP~FeK"d!4Id,))) E\Yb޷~ Vl11%Qp)d QY4H+),q* [([8b[.gēۤpQXC`تeL6k憵_Ӓ=޺}7ߌ'ׄbd I+W՟Mʅ[E=Ԡ^0׮[co%V ֜wb8ulMe˖O۷|ك0є/_vႅ&$(f2ᤤ3}w.\ڴn;nXf8lE$睵[5/nz=A3_?ÌNErW?!Oߧٳ_~Fp~YIY[UmqΙ[ASgϨL'"Z ȝMTzAƮHr-8*))dgnwEQXҴGV* G E%8nEGe`(@eQFF~ĻJ00 |& S\&? lƭHrG:| ].V(G2GrO 15k ES O6 X o?@8]?qȖ{o?ܾ8qdђ /XZ):,k<ɓ[3uɍuy(Ɉ9>W' K3ĕ6?IX!h<]vVh붭7b+V[n|ѢEΜ9ӥKreU\rwy{n\f- $<7$#A!n%eCdqٝd|Fr8HZeJ8*W6!U<ZqlJRS2kKXl]T%^`d%ԦpwXj$*vHӽp)ߛ Z-iH',X'<볉Pb[c,0 e1GZ,qvU׷͵KЖwO ww+P܃ ܋͕$>\ {}=k%s1 rS%a/3QXXgE;í%u`K,1DZl@5M*&\Zi\2fα`{"%$aaBc!6 w ̄!0¶$a$ >= spڛ_.؅q)a)NLmX.9\3,II`#c3Խ\˱䓴(عbٔ%$CB˱׬gZegzt؈Cg,Yתsӭ7ǮfY,j2\TY}g}9 rؙ+V kE3_[=z՗seʕĕKϪJI9[40}  %C*tFcQ<.\Jaù8T<EFW5amP_QMGϽKו>BBmFWxN*b`v !`.aILj| ͞P.6vv9+ bu0I}LbL88Q%,>x0G3u-9jH+SۏT(O$I<~nnjp$8,3F(?XX4%$'>j1W9 !^ڐZ+à݋TSZUAEYOT!YVb¥:eEeڻiV*U2MDTEPa:{Ʀ|*TM]ۭoϾt.RgH٨ݔa& 'ntс>!&ݵ*<&?{s%gVEVuR*BC |}RE'TwqoDwvo( :(@^墬P=H"7ʒPx-K hdhE3a*j+ IT1rW\v<:T2O=;ĹO++V֜tY+Gu.:L5ʕGœ@jrF]vDD _y,$ҋfRAJ3jntߖfd6WVϰTC('h]`m1[Q.GᆬI%a;\u5b1?AnO)ίm)X]Eހx].`wTd,Wji,:D`)E=扆HVw`bV-8'Z6.zX4k:fXBoA,Ir,ȸ% f.wQ9p +e2F6LCr%ΰ`,Y_[ 6L˱$SmNR8&Gv?a!rJ"C^7R1cFqz+*46w{!B;_ʉv'ɪ{ʉ*ųr[Iwo})':ؑt1q=8J=xоsI'8SO;%ïىXWK.<SO==c75Ux5?#nFa=k:*oG}LJ7x{凞O:Ixu7yǭDt;j*^~ŝwoPY?R8,={Cճ;Qӱ:T}H><.aGG5zd^:Zov: < UEUNm?=[k=k=wC֢~^BhaWl c=N=_xn(R5[KJʵw};ӸS^wu5յkO?"}k=z:C櫂vy[oY?U{xETj\]3k"[!vY'~[aG(Gҡzwo=>#k&}J%P j;UsAK'ǟz8IIf ޲°;zRyZ:di,d\}tXB^#3%CAF X!>Vȃh!  }TbS7duxaVّ[aiXHH g.%kB<0x[`!CH !bXShuʰ&,P9›j}?G" H1'j:YEJ 8kP+i\:@lJXuOb/a1#vK EE;%AA(i\}va ]}IRlOtLs,J!N{Ӯ`\s,bEs;p[opbl&xÐl\3f#N~P?곱qϽ>oq?榿W";6ƛlߍU~W{JS}|5b={o'z<` ) &NjN:YъGoTI(u~V&7y+yr,zڬQ6FuYҠ>e,t,gXcɲq5,tഖ̇I f @ q)u;P]q0h|}W2V5A_ij%XJ, ,e2V\rIU,nX炝;ǒ v`i[%G3,Ic[i{/8ӷ? ?ӰC No6tߣ K*ZTe91~p0ʔWQq~A& jM>k/6.ES;t [Vޚk uҥSnw4 %Z3\swܭ[u]:teֳHuA]U ?kN5u<lF-ܥ\jx=v}e]zj˿o: yx{Jg]dE>ʋ_zA=Z7ۮ;v7N]ȶ4E1uus= ۆ erV\u:tPEY43C}2+!UtXc5Z{s#7,Zm-f`& $_˦=8CC:VÑ%vǭ`[֤%vlW[ФRr}~.UϽ~ZȰD|TT]Xf%6u9GҏfMhq[?R`abqPNm`1(;Z`8.`f ’ `m N #d™4N!%8VAi{ENblk&Xm^%dLrNp>.,C$NAj,%.a;;%O-l&67$1N m`Md˱{"F7vfkHj<hj]a_]FZ<ɓz7&7(_|˿X3;Tk >EǔѰDy أm֫w?nް{wșg=t־̓HQ'\;uygu~Ǐ_yU|¸ܣC].žAlj-_z_Mܘjsʵ]<'DK;{h'Fܤ[ZDOGy=N9[:եW%dEMsEmIj\rCo@zo1yҤ9sm xۏ?E^H~/R2fL^J"o 0{ַg-s;7ߤÇd+QQc?kEF^cw%i]"'i;ՉoUVސ{{&_VaGH |l3/wy~x"Em8!v|c2bwЌٿLd)\+R &I0I3,>]c 5)M,4aqߔ:Pd6ͱxq$W |Q t`K,I_bϢ;PsX 㒄tqHL2 (]K. ;Òƅ x06O΃ w&R&` 6]q̖c`mLXh0F'S7QĮN=GϞ-x.bǖdJwmz՗bˤ_zE>S/zlD{>w~a D|R=->?W7~LGy#F/yoIݻ\N4SN>3~K2q+9fT|O?>GyxA?S=cyr(|_G ~U^ճGO ìcV\VJʖ/,"ofuUv7}VYee}Pپzgbܸq_y>~wG||qra>ƩjWC=O:ӿ;V!uDC#RnF ^s_pB .x=KNn&cG}ǕGx'K~J|Av>8>89U;j< |ɇ<;O'X/d-}[T=/Sq[Y/To9P$[mP8,](*'U7bL8G89A=OҝfmdVs0eHy ?$ ,e$]H[X"1Vz󸸓ݫYԔ˃С Egx=.N B(TX̧NaƋV졠qɰxHXJX;%G3EVXn1.oV 2K˺_b]os,O*KA3,!^L3,a,`{. -%"`gba;'iZBza5s Q3:uYgZguWu:}wm{tҥYs5WX|%XM7$2$K ~蘱c[g=9u^k/¾ ꫯ/bU+'4[+d~ݷ~s9g)6eWXv%Z<kfZA>Xr,e;ub=ݷ:u~ +h: /B -,h,^,\~~tmzc@K/be\nt^xSOڹ .sHJΥYK.  "ʫ(Zw޹edI].̒/yE=SW_^y){J+;SN7ap1|Y+.BJ4yr/wuM6˄;uW,VZt{o&N6 ,b /_r5V_}_[ݱZ'e{Ej amZc5f2fn)cƍ>l?Fl׿{2ojzyoG)Ziŕ$_oQfm6pM7 S&+vt(o1z}ϿstC =ݽn*wwZ?Ą >/LkYFnT++<=| EȘί+|i"JOgeD&)^K'Wuw"uO0mVܨ[ K"5yk 8`3aD E,GxFfͷ,{VFXN ,XK,BX%rEۄ5P X"î  bü9 5a08K a,bgXc+Kѭ0(bȁ0IBwNXuƑ$c `[2_&حƅ2Sΰ5Ǯl,`; ommNxLvS&:Уً>&}is]M])N]ze_9f4hGžZׅ'%:)ϟ抾執:\Z3eiH={P]]J{UJe]e.JIrg騢 :?aLT+7:5*kR+؈RԤE\J up-d[ PE'*jTT@]˫d}7o6jOvlVZ=V3Q69thyEGS$¨Ҏԃ)Rtdl6uH(AZ"4"Oޘw wѨ~ڍu nu6=4ǀ*psU]tR'8%e%`*X=n{r=~iDW\zե'{˂X&Deqjq|4S(*ѡyuФ$VS'5W4F*?l>LnodFmEӋ.@-FOLG{Dd;⻪&Bf;5SqLTBõkc *GO!LP~'tZ!M:P?Q˺BfQ-'V]dzݴq= n$m\eURC"jԊmNs%esj5|[Zqq'WiunJ!zS#hNa]bL*oIЫQ~ ZR.Ku 0,,07yzF9Dub78&aRjoڄ9bpo #*Xt0,ܖ-L*B?l DJA3!RsLmc()rDžY:]T"w69Fr`ͱpBE9# q hNsu:0qɄ|>ݎF1qALmaAV)},b)v/؁%XI[`a9nK[`i[@bОh?$a:VT+:v6lغsz}Sa\?*={mr^|={Qۼͯv ^~~s1WvmKKVޢZD**Ǝ;~᪫flEW^yiitGjʻv*U ]ou]=Vƛn曊: y{αg3|[1XŌ=fHЛ!F݀~ ntT:|Cs aICB>ڔkVgSꁇ0Ŗ$ `iLC,c!H!-Xi'iQZu# v\tZ2‚`$NXrN۴#|)Ò v%ؿIn%mBl@wt% .4{gx, B/b]FuװXGf,=N=o=@>\l>ûeETe?7k[n1⭾o=xҊUg%Ĺ{.=p`Xko:[> 7z1!/v^~vq?ާϠwޖ˂} 'yǝڮ>xy}{@nqW[c?~wO&M;I|!m[1dRӫɒcSiOUf`/.w.M&ۖӶ{ ,KFI $wSq u3ǒX/`a`V0R.w2]T 2,1E,)EȔa )E$/bvM K['UٞF% s%,~Ҹ$,(is, vTɌEH-ؑ5 + +\X[b ')hd?.!^RlcI?60dXf&g(Y>[$% (dX$4 ymUܘua6oAQf[1Mrz8:Bũ/>GeY馓NUGjׇw} ?(Q%j=Ó'y%5W^^eUw/o@gNK~W+A=`/?8յ5?DU~7~KǯRe\I|ŗ-oWjEЅ\<qgi"fo ͷ`o ʈQU}TJv\CK>o/Jp@I],.i0qGfUV^bnbNQ*fzT0ԔN3fUR^3Y}nC-(MT4jXμ`F^YI Q=,jTבHe")aFiiEt(!@낱08BBhTߺ4 d.CcKXt0n%n wö@qP1F1.1vN h@) "6ac*r,m;u.aa/bF2,0$ d2,Xa,f,%f:0"q a0tΡ`ɞ֒ $E,`YøXq0(򎩋~_קIƒ(>|M҂0M8ip*aI S.ƒ[\c6 e8.[6Ǣd&ʼn?N$'ZoYpSۢO3}ķ ʋHP=[G|ym,:.ҧOcFK)PMM{# eLEa}+<%g;>-2}]wݱ{un{F#% tXr#o]A=ĕ۹O6y>믽~C{%֏.w[gݫ1[3즜j[q/jKT&^6H*Gzū~&ňU"GcU?v"qa"(ʉ"ħ>r[zWyE=e9kŬԙPIzNapg-&7Ǽ;*n{a1)E'0FCF,zX>Z] 5՟͆:*ͰiGI ,Q+:ZiTv zb4 ztDTۜcMbzKIƙ ciLZb!pZŞ¢FFF1c*$D((b!r`aO ,xU MX% 78X=.䥖ȫhZaJsLN=֤R#,T'TB%ŷũ Xc\s,0yeadX_0qI(jq΂]ΦO@6;+90X`{lRZKQﷵ`XZ ovJ@J3񁟃)Pa[!֢'p<+RY[Ŵ[n7zGsg獴hs} ׊~+77qBXq5[Bc +<ĉvC ʮAT;siT$_ _~?9>3 Q]?w1'H SB\*# Ri@8b*Fu1IQ,"T^;XٵQ#eHʑB弌X#K&\ `as>e^ZGH'O8QjFM䴵@pq+Fz0urnV %͸p+o @S?mBVqCd[ A/{pKQ]ˍu a13+aB JX4Al zHjX,& 4l (`!;j)`\4DYxzF c {#p5ruP܄ s\ Xq NR ]d!rX\Bn`Mi y0$Ka&)4.E,"CE\E v`Idʰ0B#S8|aRA%l*`a`F&%rTq69 wN.$6wtPM}֮Xp\rc=vw]zIU2a'Cq, zfշQ \̯xAe[fe6tX!B9Is^睷[ R SBQ-୷*I{ ;rd=V}ӅYdmma6ۜs,Ӕ~eC6;m +uUbk]s=? 1nu鱅]'_`Ɇl_{}bZWZ}6L%seͷv{^MjԺ묩<(o9; n%Ude}S|v0##, m pBqc s1Dcڂnf@Bژ=M]2CDk%%&λ4+GJ7<88鉑#u_nR*Xvdp.Q7cA]=ÂE^;U|EIR8s9'gTHv+Xl;}gf`i @Rjn;@XhV:u`%:?qEb%.Kx#l%umK%,5cq%,[b N%{C;XNXބT|P*PKIM9Rc n9pIҸff9LmmKv>.MrF$b%¸'iaľ t v73I9ya%qHK"B$u̓zt-d)UJW:kN:(RP::)!3=?Ui-Evm1om}KM!Zvy5$?R`NtCR+oV)tʙC6!Iӿ2DʆAbcoi)D4c8TL WCġ*`t"pRiS";bԈ/>r6W|T܊K̗_}IxepDYOoǿ4LW8ڳ=ݟAΐ 7zSoh.RkG=,Vo!UL-.9*fɬFe/u Ewp2)p0 dU\%ʭ8;Ք8:|1(%8 k؍Pz]֨F<[q~'kŷf.U6Zg,XѨ]:i+gX,E "2:t}1ۥЁeXs, ,jHAj/~+,.ž2,/oEE;Њ!ljۂ]v n% ENn(`iG=S*LweԂ$u-T8j齃\^sι[UEqɾ_it$y\%(S8}{W_1Dxpˍ7z*jp-[|q5/]^v }̴~ CȣV 9tU@*eD!@mF,b:RYny 2.9%DhEI-dY[ 3FD?:JViu0˖`4suULQҒ2n:[q:AQq FU%T~ ?87[thTXH<|`c!Y ,4aa YbmX8X5)5a1U4\b!τlEt"翱@,JE3.[aq¸ `,a14a$ͱh,$v"^t TmXؤ3,dzα0X 0aŸXBÎRCK J v}Bʅ!*vޘbCk6frV<[ov vIX'drrGcِ(zin ~ e[s5^{A$%y* @~ꊚN< Tlp7jU|E>!Pl 5أYy] ]YH=`zšn&mKκ묿zl dOV\aE]:kИ*(B%.uϿ~R/G7W>#ջfGTlG*e~u9ܳ)O>v!y 7xozg{ύ6pWͷܤRKM]rqEs;P.@ͬkW_ex:N't~}$ay[ne e8 vT*!(a  46nvPp1J7DTia3( }nF4r~BZvV*%Vog9:G8P.۬ Xݐ=x'FVm,*nJNE,jγZ -cqׄ$2,Hʰ?S,~ (6BbX4.:4D`Sa[]1.z^o1.`.a @8* JRi\RYJ@ߧr9g5BQR ъe,Ζ`K&m` $>>%$ rP.eX8o``C-plͦ$mNRo8R}u^z{?/\G/nڭ#E[nuu7vV@}}7bK\|!O| ۑlֺlw?;匓 ݟ塬8>D?]pyaÔa_9>}m=KKe\ze:gsqH/J?A4GZ a輣[V*sG)%;l:'A&P׿ēN:ӕk|CU:nCvSU&J"pNT H.v 5'5ęZ$5 qaߖ&E뱣QB}z& A{ %2Ҋ4?6aӭ"$,QeX(wrXDI , X$SRb3(6ބE;e l:TE :V<&:P"k@ & K+hh1.=,6a0I N(Hi\BJ CK,ZaP1.(KEąУ˰0x\"_QJ]AƠU[l\K&vX KAϱ0Q< 6΅jd;ǂ`}ʶ[ڧ)L.M'X#FE7;kȆ z7֏lMUWx`AJJym+a}K%mOd߅⥯>YaUŤ$PV~ԼΐgyںE\!U۵\g؏?y(Td$UС)lͶf}I& =yʔYګ=a3vێrrKGyŗYk-7Ioi% [qfZ7vJdOc˱dr[lj\KX4]Jo4@,s,99aנ|u`XصyH7E,p ō2Zc$mKLfq0n\bp!ec*32qaa9R ?hCq`ai- ?l{a[KR`A$ MҐw$GD)|!$qr_󐃃iE3.w~^:8;PVf7g~s>w Lj.O+GA9rh>:~b$+gUk#;Y|v\ !~R!g~}.;}}9yp\kW_yKv8y/&xBҴA7kرUe^}Օ{3<{w;c']fcx)Du7x{t^=y/?%]xϽL_~E>3bקPpPy$,DH29?v)*I)8_NfB+!,&D c6`|FXs߶ z ٱU[bXX7a*LJb,K $(:5 B%':v"(Mɰi\ra@l,PĂ#(if',jŇ0dX̃QTEαdmC``36?ql:`KۂՋXL}Ƹ&)xHG g_TUfq^ēOU 2Ko^{HwR*{+-);V"V,bZN?|ƚ*dW.\Տ#G=%j,鿌7s*y+`6}zٻucve rDZc9jGg ʹ[,Kκ{yNۭk7Qj>lf%S'ֵ :*U%DTٺvS 馪H$p‹-0~_өv7qi *_TJ>ܨj*DUb!o. l]eԘ=ߧ}rup Q{_wߥq=d0'T+k8U@5je5x!j2a^Yxo%K&k"Yo( kJHņ gG4?AೳB""(5nPI"TLch=ބ;9 4%@~a!"HBld8â ZR Kjř!&,ɰd-aACΰT3ha5=,"rD+%,+_X+1Ҹ ZH֒u);S>.2aL"„raɢ%k%B+L\\%$ X2˰J0xdMn˴&YKc ? v6. S0=o LQiK. OlNRM.s㊱GPOЇr>v}ΔdMxUא5UKS2h5I<=7p 3.D QؓQ$6 1J*B+TMpmBa$8G YRzY"y9wCf6r,mu`Ӂ-ǥ},ltQm,Y`g~B޸cˬCX ,hT01td=X@"! v Qh&ؿOҴ7I%tF dFiC%>2W+ۏdBs,Pw?㶁as/?fQDi'{gzIG}5r0SNeeԱC)={WV=“=ѿo?n:r61~$ORJB{%y]AG?!Q(lFwS4ٟdvpmUFjhTJOܺv,bO.=dQ+뮿U!{GHiE-|]wڀ+bK@C\:KVK,ue`!5.t` X?lE,0.`!qNba@.)#q1G >‚aq0Rvd!2,ъp9;0 El`c0a1PL;`hNXX4OfSKknI78IIH~:\^|xgR75xSIo᫯Z]TTܺg.?ruÎ8[n wq?fu䦪I'x‰*jSg]/d:dM7뾹-ʚn0qγF)ࢋ-zTuR?nZUI}2"گ񊊐jTwSU*Uw7Ny_%km|Z%UΔmyļtV[sHae6:ջ1j/7T$ѺW\ue2W XeD.,o+6)S+*TM)q+[,6}t2ZD5JH(لaQS O #6Դ#{X}ZJ_莮O.:X;1JUc 4JjhT:ܸCU 1ӗ8c˃@AW2?2eϖrM`w̰pͰ0Yǰ8qށE 3Y6a9b%D :Pcgg- Ck RKQV! 0dXHjkCfL<.P}~c I` YE,F‰%!% #͢`RKlc) y(xCmjkɗƅ1sZO\KX|Y$=IY c GPsLJ6-& Uγ\!,񻔂ztAvV\}%D Z0b^reab.`}vmTʶxm?7xuheQYӇxHi'N7K.'+a!GDwO}w_a?tW?ģaz>YtȺ]gM_x9v`jTw(:cqX Cf~d&5,A)o| D AъUv1vw?8}~8[~aqm<ظvj )AfM%/V ҨN? t5$/8Jy-|AֿV4Zj̓(Ui譶|uQHu14`!4Vz[cGFX0&,RaQh ) pܔ{’|/`q|P"#áaIIX\;=:0htXÎz׫kj}YeXo_qم_m>'IL֦ϣF330;4+(6KH~¢pF uwvyeqkqф;^pUXSiSUaŸ¶C]t3Z!9rm%#բx.0'Lь ePVùgՆmg$\(C2`5{WԾ&"g)ÈXupV#-DhԚR&rQ KH"H]5 XH9'V2,nṉJX0W;axtl^պű؞ڠ,%,P*67Muy2,zrMz74. {,Âi!X豶@K+Cł`q`_ATȱX݊SzX2cɦOeXJM$ƂJ`CI+6\y7I*OYTM[;댷R"X'"v SC-^zi-T꘱#ە,6Qce#^T-v.uGuUrrLC}mP]g@zgZVޯPfE֤*.qVշ{}V[pÍO2[ץ^+Ȗ](lx饗wsUFkMؘ[oTڕT,=G^{}g>z7DAL*(ikI*g&ۅp#Ӑ7j¶\ylR#aWR"6TJAFc̋DI{r+мyҨ9tC*7 vi[[ׇ7xxg4F58!@ F)B&bv: Xг fX[OXyEy%: >XJ댁 ?:7âX|\S3DbkXNK =J( Cu6P;4ƥ5;~ Y Or, ͔`4.0x\l%)Ȥ52nKo!0"lZ ,~sI^ qR`>Io}~du[\B/ILvE͇aÆwy<6p(FFgD=e}W6t/2MqF3qai?X7Y" yQtM{k͵yTVN9o$QPz~%zq;pygo~l?G7V~]k^^%? {W>Ӟ:u?i%f)+.bM7Iz_~eMlV^yV\zdfgPʀx5ޛwj+?7$w WazӺ뭻6\N>\'; Ih,Tk\u\;ߵ+jdyz;3vZx(2V(a + %eʸ1eHdHb4$ %eyl0 <9Qlnk_.䂂\c4໳TEg*lBcMc#B\4ԁU@kDms?ƒŏ}k 0с`4.-E9k0dXH5UccFw& g>.OyLp YI6 C``0Ӹ$ax[rbLs,U[2,@ ȷ!)W팗` *K'CHDJ\s{]E}(;i8G<&io;?sVǷJx ,(J 5_?2 8Ca06CdUFF!4nEnިna~ QOyW]yUT_TV~-t묿 4Xk+, ZFJZ2ǔ 㓯>*U:SeSCgp[nJh-eװP ,-X@J1 v.l ^yw9YmcmC<Ҹ$;ӯ %``a󩡄{k,Cfd@V"Yr,HҎ0X=%I_2Ia8\[6a~fʛeN"jDgtxYgi{'5VtjT6+[nE]߆3.j5!⚫V[mEYL{IIمXj?Ђ 7h71nux ,ԒʳS&{NzhqZ Τ®ʋ,ΪQ^"1Y |<K56rahaÆaI=Z)"@Dq!N*s}pR /3#XLʚTL(vQ|U١~-RU9kvlll:3m]e󯼰ퟶywe~IA}UUU¨5QCiN,}RJeT(>hw&RU*YKjtX[wt\•jThBj{e]3Ғo}7.kxHO˯+WXc'v껙²X}-#F/^ʈnw]s=PÏQqǹVH>Nϰا QɠY #s,c J"ǁw`Q Kt |\R$ >e6\qԁ0%YƥŬ=jasL`G+mj&؞,!Côv0+Ut=xyhAJ5U:ڹؾ;U*_kd;j-xGyt9{V)7|C7L/n}^]YtMوdyp;sOnJRlZeUʚGxZYo&~h+ko*UJ%F(HwscjQ^bU{@g=IuMM:Oj;1 #:dn"[Qs/oLA+kH'tz_psRLbEvk TvgkPFyt)M)($|܇,uQX-\+uMӕFK55) _I*Nq7|VԨX\,!XȢY%\BDi B*+H.ʠ~ XlZ$Q:% iiYVmr,C%aЛ1L *&y`qd >ɷͱ:Fj',! ;e&c%I[}V’8.d]ĒN1q)'$اUI` YEM8%R<mMMMr 3\'v5/[D8GάD*Vcb7w?4S?0}UU ο7_ͶԕZ~RTz]ޚgyλ༹Sac$WU8[ReW,2o}k{Wg{tD ;MW麫rwAܛb#ұ5 "2%dtO *sM{mS`'S7gmj,~ 5:Ao!$Ǜ 7x1ߐU\|kQ ,AjԄY7ZĢ#ǂgékN 95B U%,сE, ֨X+u /*W‚%umd-,IX`HæQ>;`Xs8^V P“xr,*b ! X*%,ܦ`R¢.ؖR2,vm>iE3͂$D+^S(#*/oޖxOϗB~i*Wa:^{F {WP;10ԍ#&l/G c-VNkہ uxM9(,R1äu+Cv:9Jj뀧}=ODM,E$tV Xtv00 &%3>}y9SNIX?BafH`ݴ E 5OG($Čn _`*:- ҸX0,$ 33E!ز\ut)b0$,IEZA!7cPVoFܕœ4I7Iq'Ns xŜ8MEmje]k]ٺucM]?|=oO=Ԉ1#וyNr{Zpцi|5+;[q&qNs}ܻǮ{ćG^^k<^}m7Ч;Gy)wyw~'g;Jed}:թM|lGTR.V^y 2ur_{-J9*r@v[o/s> +~ {;m nj<6dgJ4xṄ֘z c?\EyVdu4(3*/hYrN4.d{u.VwarLIPurZ/_`V"+<'TDƲ$Qq'uEhE){UQQ./!6~q7Nm{| Z?9⓫nsSKo5H\[ow8i=٪N#*$+EOX`:=mק1SٗɦT8$)nˑ;YfCOdK,>w qfX=Jgh,$,`ϴ?R05.zKD0X%rqweNmcq=pw1 vl2+MX+τۖc}LR ')&N1rpXz`jhhҥKCoqv"u^wֶr,袸,jthV]cE^TA5IH"Zj-8jw7>Nި o[z;ugSQ= V (SJt7Z2(׃)*dR7)ԈG9T]Yu#OVTrBpU|nT' E&w}@aTs5V[omF)Kͳ̲vIH'/K-eA}ͧÄƚj A\}q<+'}666M9k?ndy^nv"lb~7FxZhXå5shh++L`$d8'g;YX 9~@ < CUJkFT2JVh)d-ڦh\u|t3?ҭtQ)Ni%YHXh+Af\a)ަ4ٔIJXp@`|`n:(hށ&F[`1U'Ķ)E,)vda!>ɐsa0B D+,=߈ɰ:$1o `g1.0y\0X+ȕX,3(nkS1˕ 6[~A춱8#miM K5 N9A8kJX*$̈́dBesQҘ3f׳3:R>;IȚ4S+}էJ fċ/cMeC?9R"Dd+θqꪪ\'VwrB駝D=T)|\p;O>ToZ\i˄R]U.Z &XRXn"nXc>W5Lm]CbGLhzt`GC<)E 99U?I2ĜɬWINGx3XԥSej{^+_z^~9nU=怣;֥&j" PP)E@ecuBg #i*_ujvk+" 7% Wc|,+)}VgSp*n8>/\-`Q?lmdmIJLN0ӛs5CsCwQa JBzEvTfu46^60+dX4"maCФ8r,@kʼnAb\RƸXHcD%a ,>B#tv477Jt2p:jq\ra<`a`} K2\چ/F:!c9a0KgWlk,:`sq`:"W+0a1))d}.aL+,& 6XHVIc_4Iə#YIeSQP̎b-N:o߅(+K%]v}k"M%?T}ٟoMQ +LEaGwQR0 *;Yǚ{{vc=wq~o u]Rއ|xug85gCUYy}wo~UWuqS&=h_l}>2s_vi?ogm{~w*+ufƌ; + 6C6ŧ\z~~+~o cu5upk#TWʰA7}J+,Ėv+UjѻWXaG}$2Za۩ZAdE#硄H4Bř@l3,j4ǢT ;%lB^1 ǥ BN3 ҚeXaլjaC:-a9UOTCH XqE/"z',xŋXi4 X0a* :i vR.rn j`ssvrN2`;\L)a|)lai%9֖bR\[X~:3:acP͑Sblr2Ŵ՗^?+q xq| fNif,آ|v+6xݍ'}(5o+%D+*z /@ԞxlD>?CzkG+b?4[o',ou_{}lM7WmKsݟ}#F ҋ/^sXH</[5\ޫpv:1ӗ]r_|_tKv7g'^2{K/XZ]=pcC/&?;ɆPT}TYg5hTQ9>{X=Q[cq.b#5zwuMGeMvMr{a "ܤxf~L ӺDa0 C%zmIV _˜cƂX,6D7*@[Xl/:G%,@E(> z`IfohT ͱXΜ$2B&,odq #Z'Cf\ha':ee3r+a0 ah`E,2ah i ,`aQ2,!HIJ,aic\+pdfE`9 vXl\Za}\p~C#hF,__T7B" (h:Ѕsfv5;L3bG:'Û.;p}82c}uأ5ܭd{+vl)QY6ZѿǍ_xEƍ;w.! !ZE, NJKS+,)X0RZ`XBrT(`A춱`'ZKX 9r -`Oϸ`Xk}&EKC"I:ĹP>IT{c뵗u;k?y6-Nv;ӟu򩽆s=Ԝ]hln~ 㠞~{ᆪhNl{_s%ƔX:9E4uCIwy^y;0qx Up TMG}7޼;εuP)Ho|Z"%`Ǝ&1J2,W;u馛jjR(A%IE_M7^ {B|ҏ=G1v<.Sa0P;2QF:-F$,ɴi&54qiַxlrZ[xH7ʇA"YQw QCxfXl68u>'C 9XBٵh%}aCB mRb(JށE,5',Qb!#X~|%;e` XFb6:0=DaQo;m?,6xiռ4]%a0X eL m`IъMa_q)2,-;_926MR8ZUB3,gۂmi}f ok`D0L L&9X`קX~Ç]wj''Kδ6{C{7 M6zUرwm}ڪNZuLvEtJGnjF{PY8+F)pN iɧ~"Y|}~饗Gk穧=M7*{g|~ ]wuJ)|N6a@7i׿7vp"*[ٻv6i=vcذak" G2C qN,G@㍒AEJ>Qb))I59hScgdJ}HgN5MJ),vq+,~ oK64a䊦@**K;I98xZ,$1r L"R$Z`IB)dTC.aAߢ[/bqzar+v',Q+׼u?$QNЅ!V`dJ<.yӸd2a $K q!kV|DZ`a*`ӕ;XnV`Kkα(L#;Ǣw-,Y&*ƅ><.q)t4[p~sܑ.[ HXRjV5hq P{]24{\q h$7Ivj:vR\ 咯^s5{=ń=[qjNkadu5\-oN;4uF}]{"j qnBj͵x! MS.V!V1bUA WB‡Kn;Qgz @o񇰸* Yq-73tzw+\bi:8A@j*Zkw}W=FԊX!OmZWE@UT}zcꌦՇy={ 2Q=R/D.,+D$^*Dzw|* ⫯[\iVēmj#2h.f!QdV+ZКxK!L;LJ %t f­'K1:v̂C tw7Zi]53()XM˰+]3â#o!L7.% %8Xh/w;XYс9ZqiŦT2QlG<~Btс-cE^!ǥ],"0([7a\Ol\  V1z|HT(͝$&ǂ+a0KIr.b[g\|ϑ, m *pxO&d,X'oy[Ԙ#`Xdv'O4ǜs ~iK-LtQm>`eXSδah3S}l. 4`u7T hdnQ2pbްk)ED-R%hbӏ;|$yOoЂxTYU 8`7T۵}# }ltZoE1]ydSyR5om'THRt*X (֡F /$MSB9_ip=r`5sX+uK=zovE^xmV_Y5pPH2(c/ kvbL;t>r .ƊVY/nd/_xmsW8͡uvXֲY1#b]I/ fwqM?ފuؖJ-3:OQ΢G!4Ԇ U4CX[cIE X৆U3hF ~4G7YYOO"mO%ps)= @X]43,>lVwyv?‚0caYJoi{X{F_VXl;BÕPBJgTd.`i[q) 6X8Q'Iۙ$:w(6Çl3Xlͦ; ]PgiÆ}J /1c鴭v5jGo]Md񫬶 wѵPH+rzG**x~+t }g'㏿O?믿RzŅJ?d #Gԭtǟ~c?VF{~k)YXaCP(Ey VSQĪV ?#ijl=jԗJGv軡TEs>O眖q9> 4+7pڙt޲{CI r 'o9-;C~omY|]x*aKLS_J\6ccGE,HKiR-q#iƑλiQr,X XLͱc)q;M7%BṲa u)X܁  0?KX9X \8ca1q6H8x2aqAdmfӸ/@ oXgm.a) 6ky67}6&$- #yDJr*;9rVI&7JI!rTr>>HӦn3SO!VP;TtIw'}|aGz>TZjz>>p]w7s+>^ȑ8+V۞{|Æ<ē}zAr?}-pÍ}#;ٶ[o{qǝvnVb[Y {|p*Ty{O]͐v%h,K/H=o_rpk>owV[GuA(owK`[Δh;#?gzO%'iN6{;o?.CŸY}YBь[UlO>&yOv"!Ӛr ODv ;mW ߡԊ7/֕q!ף{? ,\êj08o!Y眳9-vڬƏ˱4{3bj$, cALR}hs`2m?ndHXL7sŋ"l\̚ Z>tqߡLf% Q,"fgTt@ k~y\p. /}䑍6^檫葇Yiι:/kNDR[U6[?#]pѣ>&^8Y&L~j纮n'zm7v_ݍ/ݷ:c?ḭRrTC2yʤy/ D)Y>ԁ'w=O>AqIa21Dԟuj=#:瞋{!ȭL43?[\5&H'[Vt뵃/!,I?mCqhg+KtEǔȏKYl4o5[Rsin. 2eՉVPS I 2,idk,0a!qcІFm[`^h,y-[ ]i\`4yƂ KT_w14%& ,dd\, dmbɄ%ټq.d#,Q\I$d\46XBUliA[bAkn)i\,!c%@XE[n@!`y˱Ё%,$MRM$%rA^u t&`!3Cܵ*܃+^>+GZ㚂W\}un]Te/cNLzq"D ܳ׽ޣXOr;4WL;'tn2K7 zW #>OD6*ɱ!W1sqn>O8뮹^|뭻Y%答6l5x{S}Vÿrg-:d}OT[ʪ?3mz6&^+*䋮T֫)*q6";U(b^h~ +_q¸ɟTŝ;ulM;g h{̸ >ZqA?H;RA@}bTad)s.$ ,mLb4.t$,$'|ywP&nK?u4ՊQ9Փܶ1(ъChT>ޔP"3aRP;  X`d ,.@NB*YYɰ*\E:r,5gK@cqa`>XdKǥ],cb\Z~Qc Qa\ %=aIX_0組)Y,cn`e ,`i%ٸL2fa/JI`X S7>I GjX36XOEX[na=Im_vM1wV^ӏ?=3\O:ib:M2q~eD3֙iBOSۧ<տ#FŠu[7wأ=3'M#^5Ѥs&Q.FS|'7ٷ=yڛ}sM5~x-SNy7{o[mSs^q> *>vmL<9k~ʉK/u7\*+2~LZ%MϻtWOcx}ⓨFN_0ZԌKX.gĊNJ h(&77dO> }ݚo&g7I"j1yI˩ۣFf/L6 Ȕ+A7+e 1L˲\VuF\7jVXXb*XBNM(ena!&ԛZd#"ܡ~e"p`SR=s,@"a1'2%iwXV?(u` ,%τAXB `ٸXQO^>s,@% C7%"4~bd;o a1Pl}C=6 eXq)Ma* #BoS섥LK.aɅ!EIjYh b<'l'pZ̨Vjؼ;Xgu_{UWABCeOV6k+~꺆>N&Ir,|'nYY͏:Iv}W*7w m믵7܂~mmp췰ry9fz!޺zJ+tksO^x[ou5ʤ"[l#?O[o}KiaZ`6d6x]v//rE> /(О3K.Ï.GtGqo;yysyllȓ?28=f,sFcXbo;u'jRs_dpCs_} ^%xvȽG>+kg=qY+óX[L'2j;6w)3orQ/FM+vA6eE}Էp{087!h%8No IMRztD<Z2ˌbcoW%:3X|X1VN<3zwtrP^azAeg~VANԞTRqZc}=M9zZp۾yZkWzDUQ$ޭlr0mYMdmh>R[0*UKFE-*Dk O2{z%;(\U5J[kY;HԲJ6_l#v-kz€}x=ZTf?o㲋/>@cS{#S4Hӓķ#>SZIsUuM3}1D={<7?e[~h?bm7R+k?v|E4$qMYCk0t'R dʸ8!S ~"O95N3켚ƒZ}i)~(kō& D U%=aQJhXS}V+i9s,0P;,p ,t*;žXX"L)ϰdÔ 'Zqo|mahSfba(>g. &B#L䒌D.aab%ug , vq\Tډ[KkR |>&Ez>I "WÆٓ!y媪k'@.+ol3Wv]vU*.E) !/70^pꚫٗBu#$@ qvSNW֨yq~A+2k LMom:=_w߆ʇJlx3yn6=|îkv;},WpRgTon*yT.mz+#_򜪸n+z AKczznok*!jo#(&:*%P_-s M+.m x٧{+W+k-7_WZyW^xwo~G{Ï?x `ܪW_{bW[YС=C?ͷˀ>%ӗx 7ozo?~S*Y1ecFKtmj9#[B\54N;ՋrʤI;t 'k K}H~xSS1L0CXSUrAQlƌEkioe jk{CopOx-Bn9UK@j7s;~\0T] .vR0˥Rbx҉calQfG%Qb8t]&B aa Zw\/ C'$a[9 !IŰF m? g NyPN3~ 0J+ EIQm[9NǑD`Y`)eX ,z:=,t ba WF?zdqᭃ)8M0,H Y'[ca)+ Ǹd`,S8ĵܱ2aDžh_B5"L `&rX|*Kl\"0,?Ck,nCX , v9!ƥLq,S0lX$Lf\{q ,0@ǥILRr8@Fdcv+DVت$:xRI!/뎻8&3:u뮻^PGSj5m:cD |ݵUT׳Do}syqYk=wkl.uꫯqxE_8<6[}ivuP/p ҫGsz?og%6OwN ҸP<'4Fu<~zʐT1zA-oQGvTJ[^ut?'>É.U<{Υǎ2 eN#^yD! ÒNU[95<3,n$z%mL`᳄_8VbeC X #KU SRq^h^ZPGClhaܖ`Fcri[mfm_ĢKyVﯾG/2K.s嗭[o{..`C:>yoV[mue\{uo[ 6lu˭ Cn\뮷1i\L$ 9Aښ]ZR*Ur=oV=:3)TuӞݻo.:¾%ъ:STSJȡkߐS>-j5LI!DOb'G%=ЪXF(fC(]ろ$T>hd[qa OM2e7zX9q+cqXGE,j2 :Fk,0X>:z 6E,9Ѹh (}ͷrl\ʰgwh{{^q^ CK,\x=0-T~D!6CIX|}6frc;z,l2S,:|XB2,`v! Ƃ` 2,˱>I8IqGDTVc}_/ )tLozދ/D,.O}{3\~oêus>ŮE#L _{ RJ0 z9gr!ϿYiRjm!>m5ܡjޑ'iPIW0~  ;Ǣ2lJ?ɰؔ^%.=8 f hpAJ2,4BC >(6R.W. 1.%,I<.wh_-c%,1-,kGXl(\)ͦY 6#~e,v>I X\h*/[5$MV3;ӠWʳiRrfsԆn]qک, y pJ487I)+7˼ܱ*\Dbt5r|GA\\:t*vRfEFBIIT(CMcqaEXIkrҜQ]m.Z*L*bK%R8LK3twl-`B,d#9CU5a9d詨r  T֌;0y0`^X\~ЭJyc#KH{c!F WƸ(XXtPSUa̸Vg[䠀5,$, ,|DMr"ؗS謎w`Tb/,R}Jdra+SG! P5UəF;0\GH.BrȀ'i5jJYԻ9J1Rb^IvKɥsҸ@=p}uWb72Fb3KXh%ai).ɮh_s,8(%I9!)5KXZdGX䘤lU{x',$EJ;XJ{cQ"k 4⤻J;9r-؁eX$%]@D9Iఄ'+RiK6Is,I pY <}fEaSr-&hDž݂Ug}f4=OY% ChgiZ=ZD’/'i3LE{4k)cGxG9P2ul͖Li4Q2qWuk3H `V4Ai?:=Gc5{ךƚ6f@r3O@,5jFfQ>YHP&gPjrZK`s&&0uk]x"ȞMViE&cSH7RrEĂzV =МXMXh+a>I3h)^naCk,DVj NF=.$,t'r E{68Xol(4_Xs,a 'W jTsYwK}NZ"S6nc숎a#4M /b<p\]ӹHNut&Lh*@S ` ,5ubUWʪ*ފN*ԁ-BIF.b\(n"l{~)Oiθ`c;`(f&dLoCQh!:sh$IR$, `s[ORۓ4a!Æْ`%, KHu $8VXp6e3즭&)$m0IcMR\-&i ,^ 4I- 3Ǣȥlĵʈ`Jv哴4.!ƅM "ue+N3lK`',T*9l5xav#& A>0`NRe/Y*8G5itq-z߃Z ,߰BNѬ4rdopap'&>Qk WHKTcmJap+xaΊVڐ}P;.=NR+|Q862bܵ60[68Vl ddHe㊓;*ž9ppzCΣ{EEn KW01=݁#k;Xݐcѯg?'Ğ(fN^ȽGg[I˞ٶX t@c Yb:Ѿtִնծ`q)6\.&@I$HF$`vLd={ QBI N6I^p0\pVf}ao5&ͪ`gXj['ԻNJ#GhDxI$rfj/<2jKXuGG=+x*@7Z)z AuF2{!D@Z`,]kx`QsDҨ`"Xȓ$J7[Fogm<1GẘtBj:,aqЙ[a/7#4⢷2:.yq60*4JjsP E.FP9a1 spXH1"]MX|B@!hQ}b\t2G+G}nӴFĢ%"B[)yb%.X|fi Ly}:並kRp! q#G2Ԍ(Š Un\𼈥ݔMv@v9Fy">pIR ,ƅB 1o%ap0E& lFtaI`coS XX&ivKQ`',Ii vҞ` Rœ0M Nb{i_XYqyXp2a`(^ rcciWIq)3:]jfEYgMs3:uhVu1|I]ѓKqRF~`a#vcLËc KjuE,ޕ ,BפpX\ً==ZmށŵZ%S% ӕMD/4.mbAMiE-ѭ%aa08'C ,w;MqiKL6 KۂKk,Y2SNXX1„[IlGP*G'#HfҵCu"`"v6/%hQj ʰf4?؉s4t`3gĄVH(ZS ~od'gEeYPԢ:Yooh S1B* Awz@Χ&]%/[Q._(7- ceFw$Ir" C$hb$)0P 3wCo_|u>d椩uS]GᩲkZi= ͚YuXc$8,\0Ihέ۪KfP)F*bQԀБMmڦ>'3oN&EuhEgAT|Z$$JXx[eE'PX˱hʟ-(`1,-ip^'XR  o N VqaNXf>[b෪8]:P$2 qAJu9$Qs\! KC0h.JiK < _;YR6Ǒ\1䂭Vl , 6[E.X"rf2.'.Rl6'$Uq ~!KObV IyT}T)S'>JqU k.±'{bR;֨KTʉ+AoO&g4(mth3p$3L9ӢUU~ \W;%K*"M1/sѪg>#T\u'ᄑk?yng盖HK1f_PG(Ze&{nkQDʨ#G#ԴSr ed#2|U~r&MR`+zB+ǎe䈑jԴnUޫF(YQ3iD^_z>=QGQ@5l[r"l-10|Ad徶҆3= M8$|9pCz~S߃ r]0T!F͗l1IK%N9$ _4"l}5ı'v ɵ B{+,< ,7cf+b8E, Np}ìc%(!L\Dوe,'}ZD>.-˨YqI0i9.b~HiC$hK&e]n0^M%$ءe$X`E鰄łʷD/0Yų;4r+0Wܹv<S]m>O;ľ߈ZiuR,~&-F Q ,˯K/+UC@qb/hxqU~}-_o?o AZhi|p~}1ǝ> LByO  #%USN9Îڨ땇rmwkTK6`VUGSr<#׿ 'O|GT:_ ZDEt+ˣ AJWU}C<=jZ7ܘwjLp'VܐiuԵ%1}.~U .j]S' (}tM?Os0I@ ړ[6ib5 54%~5ZĒ7VLn4hheXxx>1i(dJG?tz2ѡK6EL{ ,!$ը!\Xx mKCoV6..}CZbI]Ic| K" `v.i򶘤qi9ICƄ8IA$\.D`r5%(j=`gda3Ri'O{{ϽtM706-.)P_*?|ClmdԋT`MZ6[U_p*/[y͸ /辻}>x{m޽ҀOʫveEX""T(~S~ar%u;HO"!YKqb`Q7t3j9Vq|hIbzp em0\LC]c"K'Tr[6I](t۴F-)Cp'Bs\(NJVJ0bӊ"ynHvbX҂V JcP6YJ2Wj%\i\A؆``h8,Z&߶Ƃ.+$3T K]X܁cqB't #̱$,zBq1|Db6o4l#;"ۢ> 6X/z~KV\K` αWZ'ZIX%'iA,m`)LR{#LDsBKPꑓLԦUTt‰_tAL X^^~<4,,E%q6u,ؠ39vw-XT+o1VΩ]m]:VP ͍LBu"_"jj'?M׶kg~Yl: d&6-qJxMmG.]U; {OtTVO NilVR'DRug]cew^*CYUGH|s/ Jl!zi e/sϟwU'̟a?\u%r!aS:l7ܨ=sN$⠉ Ni9g`{oIxu|J-9R?J yW'Nr t8 UY` {tVnT~a^Fbc,eVW5[I̘R)W3ıH>['#hToi(7$Ogԗt@Fc_`qGiAǮI[Xt?b?|`!& ,2d s `mis- N&4F&h lmI f ,Ȑhmbab0q a C;cA̰Xb\/%+WkҠZ=-,$SErq 6LЁ:g|/c˰ Ga/1턅hgF]GS'g$uWZj>.-Nʹj>u. ө%Oq-늊)SR 8ALW4}kGI5G>PrY]$=OfNo?m[j$\%;HZ^BZK0sZ-ͯ^HGhٽa筛n+NplǪoڥsݧS'xʫo;os?g}^=XY;j{qVzy=1cFpSO=zЍ7|Av>wy5{뭷ȕu_pn;_&~0uͻ8p7kpEKUmO%B Mp[83{nR'~26 FC?P% `LrtSl,Zb;,r"Vb3RWmQ71I̤i1Sbd =O3 m#'oߚkKYkSg044SȂsaYb8P!iV& (j93=7" Xԁ .T7FpɭKǂkm5Lf/2,g¢F "BLnC̣9 h Hɠ7ZBURzLX8α\Yp=QҢ X ӸJ㒯$9L_b6 v9d#EJz]`A=c_(O]ٸfTA &&.X]Ș:0 bfz!lmE#ja,1IvIIl_N?Hqds>v~Zl673Y裏z^IC%r F|uQH}=q**Ǝ?0)uΖX ;)B]/CR3v|CӞyݺT\]]޵f[w{裎zg?Zhי^xEC>$n৞~bZvE]gy)'{'?}y{>{Go^ȣy?ZhW=3EY(=pߏ3v˖]v1Y89:w Jld ^")SQ֪?pbjtf '.m:ÀQ0nA=8|(d;:ɆF1u[fp'#-R{ѣ~h_I5`ey9X u$J ߸mKXLuvk#B¤g;S4nPd0XBun `pv Яql#qvzL ,$wVoY=%dR"jcnLф~X52,5ɝ2Nԁ)!&-XK,yŠ1{̱X 6:sR:8rv 9Bpa :0|d>I%Z H˱>ClW߶D=Isa{o4!n6B˷??nBdtkK/kOG}v9kəu9'%ڕEJkR죪BQ1*Gocj6,!% g< qѩUHjm,-~=Kߴ6h3Zc+S~'g[d9놛n`]S̴Ɔ S7C?>"[F|{up*,ΙƝUnv/c8!Cޯ2E hEc9oJUL̒߾o}ޮW"TWj&]߇ ѨUlNJAp~FP`bϷ)AP{tNP[gth7q*(:P2W [w!Yn>aFĸ‡Yb ղf#574+DK(*5LϔC۷VzMu94Lk 㡜~{ߡk<]Qt%ڣ8JʎEih""mpd*UӧBaXtC# R&RM!I!k,TCFIɲɔ`8&;I,^NܠN%FIva^XBEqonKmDu[u`]u' D(CU)o}$6BkV QUK8 jDF4c'EQ/tsHQ-+'tu75 FNAyoM% ,?Jf(P8MAŸ*U-;k]+,eIqj}lyAwUǯo>hv̰H/iXv7|wUÇ 7_!HI*s{5:֢CoO=Am8-Ӻi0r5IMP.e$Fܨ9X:b 7LS2&|<`nO=L{Oij C"MB;c%v(΁Y'VުyktxqULi)[.ϯè1{뵾 M_xy-Z$_|og;BZFë(,KVO=weGPBF,|,MҎڷ^/jIfFk0q%u%Fsλ6lsnZ_G*w?}w{o4*E\ /5USY@huMS5Vw/fJ"NoIފ_}]W>}mW_}Ck7ni~.$`?᧡Muo׷IQ*f2~c,#kBS}Wz;ݷ*$}87ԟM5.ڇ4]H3yҤ>* vW|E;ZĉBZ3dȐqƱǐsS:E?<^>Xks97mU=w^rm!!0ߑnúc' 0  7#Odlnڶի=5k<E nO9C8 FboLt!lγLe; #b}gk\Jbp6̅EM56a/`52i·),,42Y#c JQbEs}b$/ R{ b hXh~68,÷b xЋqXXȃS0Cg8 CӀEIC=dwG`5uX 0zBoB3)Jui@{)q݄R._)2%42/˕+Wb 9 l7nXEΕ3h7o)\PEsʽ`l˂ ȑcgNw Ϝ3UZ,fI(WjUs5w-ܒܺqSuQ'8p7*~Vv<c֬kWѠCnܺ[@ 'cJ]6`h'е˷yFAͅ lkִ%@ulL*4^2y់۶l_pxtu'NbrEG~m@6HIdT!,3bâ:``_^ yb0 @a LXa`>V"a iX؂l@Ze}t6iye`9(kf-=wcKްQ}nܺDz,UC_`Û"E/mbE7E(N6!/UQݾ }j2ۤ?-#xovm.]RB^ۢ K4$Nfu˕7k=yiWPH}z)ox;On,ѫo/\8x⁁x-l}{O&u-r;e',yYȕ#Η,נ8q⁃޾{+_G 'ӳg˰ի7{'o^,6{ `fmӶc>kV #;v7p'*>9Oڵkixo![qT'0yO?߰ʖ#nݶeԘڶisFM_q ۵uf9kU_4h1O_>a0i%qLW'?9X5g⥋vmoܼ7۱{;\z >{O͍7~f+,:|(Pڏi|\zMx%ۧ m,ERfʑʚ-ۃZi V\>p.w`:Ǥ$M~{Yi3.ysۛ|[{A#:u+ܙ!  6,j&-1Zap/籒\F1ny+, a]vKo^yʍ;Woܸo޾znzTSN~hGF  _Cp@@Qxȓ-?j)Tg0[ z3c0g}v=N82f\m[ဈo;}i3[DM7N7XP!?)8(;g&Uɒ믿ݹ{⸉͛5:tϿNYhHWҥp:5kv֭%{WRL7a^IXq u;mXgP& Pدq6/-XQ7W,+^x&pC4-۷:A|DrEJ֣;*XpX'NhHXP,-5?advb@Š`Qrv(,۱m@bm m$/bق~Zw# rdb R,4<$/Bif(%ߗX|%,|*Jc_`2fXA#%݄BK%E\?âL", ̻U>y [ [ӫf7U3=kB#Y G!0U_Xup\\ex)5rjz-W/q;tY{<{jG:}B ?SNi T1zZÇ=ܳgo [8}_(m7nB)WLR8 6a/&My!nwsfu}.aOŇ2ʙ ѭg9l֭[[Z,Ku'fXpeVu?b2~#ƍ띿f>'Z&Nb x=1x!_k?h;FxYwR-v}){56ҫ ΑA|ԙ3۶nrɓbClX4 ?1kΜ%.X`Գ5qDX>o߾ۯfGfsϟ9s=fV|?-?"6zJᖥF[6mɓ=7_zF׬Y{ᅬN2pp8pZ 'Om߾Z,~0Ϛ9s) 9 MF\$N{͟7H͛} >ık?:|z__neKEW.kŋRwC&afCi Z)'NC1b԰?f͒߸۰}O;s:&}VCq/e g"-Lt`qe| ֘g[\,,W|bam],vK#vX1 =Xx֋EBȿ`qAX|q'}6/6zͳIGqԧd9;RvB_ b9؂%27$q'#&.u\,\ MHhߌ}Hq%8$ID 77~B"'H #6`7 S~дa)= 9|Ͽi,E 91H@`Nר窾Eɐct^0#&נ^҄xG4zLL> B3g\v.Tx؟>ÊUTZU|BG *C9rd_f5 r]vܼ}'ofܹs'+7?amEJ-[LܹP;OCB}} O;GT).^z=cP߸qJ IwN~Yfϙu]跱ؒsuCVOyg'<'ݦe[z!ϳ碥8 ARN}CS'NwߢRLŵD[„?{$iϞðOԮv']:x>UTÆ6}eVD61O\XDͅbqyGU&IOh'Nt.#o6]fǎo߹Qc=m]3~Νտr*sſgϑkΣnj W\k׭QO|ګOOfAT>ur!pxjjիE0.4mOPgj٢'_cGzǎBK.{,ٲe8k@q3Ix޸/ C+^pa܄=|1>SÇ\v񓰞7i8T"YăO,K9#O'/c 4r[SEu@ VdX X41XЪqO7}x?pV4,,¦3*htX#_؅ܹ eCxg$,0 ; qEn# tZEʘ(jY$aW,*X r= uɮ~5 CBhڲU}zaAe{?H /Ss򙓧$S`p`Qjqhk\  CKFh+`1XW:"0MzH:%mu`‰%:~'> I}w׫2ʠN}~괨˗N&Gn2} w0-38nd˩X҉'?ʘqdzk7oS"T:gOxg!Е?/nxqqĢf*MHH(_D3-?q0" X͙5;t}`l=|<'N`p0hXϟ;nwseύiLTX/D̙.޳=GǎN >܈.f~"u…c͎b6m؈2EG˝7oo\mvƏ3AϥNr$}' bp1}zxPK͝GFH9rK+T {KPF.+C7M""3dL D ,?rpp0(Wp Fm…2$G&HIA/]8uTwɓ+c-[ +kNh;'C3}Q/6m3On:>޽k|*?chw */~$A@qք66fi+:<|hq2rôbĢܓa06P60i٤6S:dA̝ .5H]{,A$#rh&vEv"8GȉN7Fۂ\hGC^ !wK,Wvu~ s_U+T(G5Vn {*9_ڍl4tkJiWhANӀ%Y0~.4W|\a;.*2ci?H<ѷErJ2݄(@ Fxdm$RɈD#/ n)9I E!aCNS}-sLGBT?fsaFozƞpNZ=2#]#c(Z9X$0* k9v)Qy}O)-*!Zzi5/V Xpi:m+s6f' hZB  X,y-=QL6a!xOJ.ߠHȪfPbQlDKc:F-4q)3툴vyt™pV;|nĂ@ s8XC= } 鵬(5 CW UZ o:X̼OFEO~y cLPyH?al#L/t$ R )mɒ1JKb`G(ҳP8wn. /N k`cqgAm޲e߾o\AlpGkӦu%Ka9s ̟;gpb *UAǀU჈Tddž*eFϝtBv~<E|J*Yfx+diӺ-Xpv*4lujm# 5 @,miXtQ=d$qMΆ6ybaK$g3؀>Xf ncM $f” >A=57>rX,>m 7(@,zeqpasEQ(Hp_юS(:Y}eGS,w&,Rky:3;‚ 703^ގ8X b4, fmX|)h4܅ƪ1M4mϿWcS Abъ˅^3|Uݵg'fAiLsnذѠ`54d0O-PxJB] ]N,Y0&b*\hY:OLRb<Vp l%~0|-[@?(SR%7mƴ)V$y]~͢% ᱃B/^|'o0ZL< ,XM4l\s>w?Xf5~գwި^ .6zWһ`E_h:{H"ErTuWϢ?a5~e[W-_}+1.L^?~E O81M_jq$Xeʜ~y@+ yu8ӦO|=I G`Q}bfw Pz߂:X"aJ슆ۀ+M,}XO` 8RLUOR$lN( ^,>m`i0HaX&'8l& z>kAB%̿.b۫l!w*[X˚%[jjԨse(VU* wNI)S,"MQ\q\_ޛ?_0*ej)@ǡCtݺí%ٻ 巃!Q`7`\cԮ]G7k̹3­~G b@>ĕJi#p2Ѝ|9v CDsgBV\YٳsOFM͝/Iݽԡӧiw=}C;vۻoú Ň߹}'>t3gλÏ-|c`AGko:~Ԉ_h;vbF"3gw 4Xf%o۶ ?@} ^Ǐ`ŊbŊ$I".A+5{v\|;&wn*ך#{vx68c$(K٤SM^<˰ I$VR3o­+6Oko3N&#ERqõ#'_c} #T9E)vJJg.h -H䞍*+Nؔ,ƼP>}h10_wFbLn 5/O<Ql@*O (p+[lIyV` +YԚ>̘Q 7#/fxXhǎ_ؾ[sd8 ȞcuH7䝤=ٻgيp\fUkuwߩ]Nٲev8Q L J,o쯥Ѝp΂㘇(l j(*u5c剈#ZJU=y-{V+9U5zS˖,{i;p.SٳKA$_N0mz\ 9Y#g5)!j@TFD-Kf)j.)t$Ӯ )FAd004[eYMQ!&JzL%K:Cy1*I@eh\*7Mk⹄ 9{ z.5dxT$u,|.0nJnjmtl6bCVH:;1 ƚS#S{XFtۃX[Z=XY ?BB RA)\Ҥe #Rxp+G!SV5{34NZu\je1b1cj''(A¢~-P]RW@"PʌmJ +8\u #r$Y[>-Lt(ԴδF>bEUVS ENTdIm@D3H=XłV Ȍ' jUg)*ԋwrˬAJUnt!_lnRoDg*ʻlbDŽ8>9ozp'ŸX$R w/rR*tepx6hV#:t4sLqИI-sX1P)\nA&_|%JE }6 4;"'$^xܢ\ZHĒ3<Ėn߹ бK_YvV|L>`Fۡc֬QA_Ըn:7oOč>-Ύp O=t+'/~Aq%HȖ`jIJ9r ڴyI^iӧѶB7}M7#Xy(e)q^~'d!(o?KMANk"Ifƍލy\1lggʽ ?M7;ͶK7A4YjR$@K3#oɒ8Au cdAˠDH,EI{0X刲BIW> łR8Du/fڵ7w?8b 4F6# fڤkmt5ܪR,7_{c%0UQ}dO,h1SVR^'UV(X ),r2 KbKQǽFUHU 7՚_C'b:y[XԀ*j?9x:k EO{mP(}Y0xHpRԀXza+$N9E,i.XEe(#4bQʰmBa$b4GE,,'bȂV[I vd, bq02~WtT,j@RgRfheb%P_|y\jM$K~-=V豣͚6A/+P5k4o,{;qm5z[W ƤlJKiKD,ytJ%}>Yr"vPCA)|,_3 W{ )1QAd?WN.<1?2QÆRvz]kK6ҊB#  ` tcIkFm- MPkЙEU5dJ;-BB{@R"vupRY <:fBʠ0#r ⋅`0@a5%P-H+zUaFL-XꑰHOmYb`1 e,ꗨXtоgaXb,ap9{ÀT)Rc@\ɤs;ip/<+qތˁ] y#6W yBXlQZ܀2Ԧ_Reָ܋Wj"YBOsh8 X8[%R5Q kH\k5w2Pæ/XS)Մ*ZL %Q\DjM5g:52Z%3nGw*EMl9eW-Ūs &{v!3HfK)w ƃŚ|`( O"͹u50e\QS#I,=MLRISW+%:,J?豘Zru;hpw g uFa|+g`W53c``-%2qLTQ" >$cvve 3t-f:&"玞@suR60y^B?LA΂ڲu~_LiDGBÇ2Y4eD/g,`%`{:_;rD0 " Mk"#b7@bB.j'((%%~ J+}`U0?޿҅y߀ ԬZ*v R zmbQ{.w~A`5>rh1Hњظci wT `WZ5`@4[^T%g EA l ]ϯ⏈åIgx:ZJ8,l-5 C3 B-T>$S UH p ("c!-X.6r?bq[̰䋅ىE{Y+Hbr,ēaI־5'ŋEFn {CNXPR8rAE|šL[pQ~لaLn, #3m^E**~b!e Ƣ9Diݸu3=c*~4ަ͗byVI)'`׆'N8&x=zvZ0iXQd…} QaӾѣ?Βy=w4h͛7mk.m/ ᣻wYvK1;۷ MڍJ.lT;v mۑ 9)M3{=z#޽{۵ekׯ-^Cʑ-]I՗Z5o>Fajr'Nة7Ԁh,0Y?^ -8 tLN,eF,Y$_e5rd/w]u[ QO?ʒ6UbKXVILjٲ>8vp R&K>m:BaJl˖Uǡ~ׯ-Qb`B[HzP2md\X)dްa#w%I$p͜cpXׯ߰rrAAx5TbȬ0k֬}O~Ŋ:x(G\SNΝ+ =5UCjU{~ys5 GV]tݻgx7ž{SHYH!c\3e4t/Ǔ?g֬K?iSYjΝ7|˕.=h EFdTZe+U-\V(p%d *~z1 7d.dRH y05 )oa=ap6Ia]ɢq\έ|c2u3W,r/ǧC:Xf`aw0z1qE #cQ7}'HXTKXP,*q-Dk5C;X0+ '8B{h",Eń{_谘0P~_qPb[Ba~DJ˭̋A`aXH`DHM,4[J],oEDh?"]"b`{x۰Xubqb<0[L A/JdgAx)W/viɚ(mc:sq" x6E{H W3,]bѱV0Z܂uyVٿw_t"i*-ضHA+W;n,.ѣ$O7Kڻiq:q${.@5}@ɑrF: 0D|__ƆBy?00hSƎff@iР8̝7DZ8ᄙ? )ǂ 炂yB,kƌiV;`]J[7jѣ{}åKQ;o##Uv ĥ/K^+m:5i djGJ dkƢBi; ǁ^Tw8]aphMG-[6#?|f$ iٶիZL "e횵_Ŋ3P>uwuժU%foƏ˓;7ܽ;n?i 'OlU^EAiW:w:G=&XdAr[.Z?} 4%Pb>}q/]>֚z(0_V*N.UZ&D[  %aD+HĸtTqWP LМˀu$.)BC)ҁFMJ1d  (T܈o~u.j;q8A^b\ ƑPH|P,U5kE#4>2td,AXx I' CtXOat_cAuI#_Yy( x 4BJaA7Ea!(E$cl"/+E/ A: tԔ0{t[>ł'`{@mX%,36s%h;2pT"&M 1CB1$L'e6Hyq'NLG9a鵡!TL +=K|8-!ʞ{:QD0q'8Ǝe&hـ-”[l7ٖ|IV#]}(xբ È/*IF˔vnpVO:0%LddɓooJ>?+d3[N ',RI]r WZi^3e-I#n\HᦌJ֯H6o3cvHXH$I 2ۻuHP !N$IoEqK:5Kcx=ls󥜎ڏqӉӫ{/MG5nESdbu&ܙ8AԩRؾI~d7>y tXB|SϠT'ӧN=ep@Ν>cә)[>yT7Cȡ# 7v|RGS/04պeY_NxhG8dȼ(M$l"&U˗.CN  >5ajr5}ĈK sTPBF-ΒD2VO\|htu<[B1j4"LwyGai> RըhbMcCa::7(ʈ7ch> 餷5X[{3X |âCX8!:'ⴑf'o,6,b!m Dz>,dnQuLbQDBaxK:bXH2,`B:*DT f,:@Eń0`Q&207D1Ϫ!6}I})/`}0*&hPg djt-:?3^F 2yr\ 7VAt +%| *Wf*__<~RUS^ !8!B/<:iRUّF#(1|mQGazusQ)]xf(gQ0 iʴ&ևUzn!<2?O޴(%/jö<} %1- vWZ=PFk'VQi*Kmm@_lil)aQ7Y*r5_bѯPm%.x7:9aS[ {ZWoZv57)X$AYuOqQ2&B d0Hrx;ZI ; Q_~{z5k҇.(V,:KLtuMGc[yںk5wNȶP(8s2|+q& '0-F"qd| sjbQ ϜyΜ6Hzڐ` `D +H01^%IZM $N n /0\YDGߡMlB[8pq`j๨W4spD)˴2 ČXh?TdA8Jfj鏄َD3%^4/lػL} 6ځ+L#'y6:b3sc,A^q% -UGA390t#i5pѠG^ ;`ZLpab!6 &ėʑ'`C"А k8)-pdD>#9M$la8iڄɮy<)5hJl耡k2X –w?4,rQLs[+' ,8T(K$D¢=4D@<}bР+e) m4NZgba!B)r>X-ܨX[QSJXxzًE4/.`Qp# Z¬nHt%c>X_Y|j `$>Lc0vh>CpEQ.4J y_P=2+ *.|q{+MhdhOI cV),^?یyD)h_n?P̀Ϟ[?AxluwIg$Я̩GwtpmYT:v(W܈QÀZW^gMcQA) }uV`~fRy{6L8]uQhF 8D9$KaRrP}ʔ⒎Tpg5Ò+" fRUp.#KN2 AB“23@;gb$$Z`w6l߈e=,# F"[Z);,R)2.P`oX챊CSJce"RP> H#P5۰(ܢݧ7X˰h*@#Ku@, O,NF5|R\,˜^,,SE-ɾcRYm`?k?@X/\n 5K",rU`qgG aqrH%`@,& \H`c4la6~MrWP<uoe" RBG>LLS//N`CӐgD"nC>[ë]Jp`$!4֬ZCi)/4e8㞗1㉌5&Ce}iVeb5̘W̝+WEZd" /)~X|r RG .1[ю!E#<ӧO-RFSD߶{gB$I7_^5b^],ۅkL̘eʖΓ/]?֨Xkа!70fO?kŲQcF[NΝ_,gΞpMr,VPmQz:' RF S\hc;n„v2OػwO=CTZC8; 9DqPzp9 GB#ȗ/scƄ:Ɏ4X%Gi}QCJիURvߍv2LB/ *0wom ZqcMq[l5iٲIkپH'g)Jcdϙhb¸Y{歹Zla,tP=qނ9L;xYf[Ԧu+šڇЉHO 2A-$Ht\Ν~XӪbSdBFz Cy!X=,De8`'4̵JX_[x7rLt,$.4,Gʪu?= UaRRI[n3k ]Hwe,g1' M!KtXHmI{JhqJh%OXX1_,H# e u2+z1H*'*8)p8A'+E˹~䙭a\8F3ZgJUC\)>-ͨ^) þ3g?ȐVt1;ٷo[6oEO|=G6n߶}@:lg/q1v+ҷoKZ|׎]ڴ ~'+N1e붉7$.]f?7jeKJPf2xޱn߽կ_?"ACV^nún|HS!J>}ZF];~۲uK{~ݾ}xH,"  ezJ8ɑ; cb8q|9s{6a ~^n!Ϟ]}zN<vexhhldž,YQㆫTJˬԚum?FaN_w<`0=S!qw U[2౨Lʓ7mt&qbP$`R3v|g!؃7v M50\^rۦE+\>|9 (j(h-g'|-7x(RqfxO U~+6!ا>TXX p逍˜ܗ:)- H*T$18ZfprJz*aăJâ{ {Uzi򫿉COfʰa˃EA#a<֎ 3ygXK6#c+:,>]&/`{E?~$(,T_X(4fjγbzS"հc#%控qa=O,XX$^,`{8K_H-[ۋE\8xA*[ lЙŎp]89b=2 !eXtUܿ_~}[5mG9:#'3l*q|]r@l͹T^kǘdx8V(T+3aX[%|,jsէwmW_ie>zj-ǧH͛ Zzu{聍;7p`[jbkXA2D'N23/Q^Ni݃cG ȋO]NHl@u%W=/^,ܿ: &`q5  ]/RfaT1+ e7g W_EɮAd#ؒ `G# #JI"2_a0b"ؒ&l  7, U&#ľSouQ"?䯉&h ̆歛fƑ?ݺs|.E`$8p3ŏ9d8'ꗊoӥرxx"&R-JJe)_ NA,'C謪2~8\N2m鷔j'*~eʔfx0el~M_׭j+W=bɓ& ֪Y칳 &_`.M$G>?Oi˳e϶gM /\-p Μ;CPýpƏ5\qvvʔ)0.X8vehpE>ƍt~3CHo$sƌ}&vp*\hZx}ӱ)$hlF7-='aЂu7:/m1c]O3+/Y#wH _o5kϿN4i?pl_W۷<_ӾXfU~!N'Cnd<nR m-~X`NݴvY﫛W/ 챖 #2G8 KͲ֫ʋXHpe6nG# ,^`qomӚDbclZ^-{tmX" )>~A|qڜEi'q6 cƍ-["nm]t\!oú jTKnQPs]jɿ⤐aDah̘z9 "Eh\E&>xLŜ:}.b#5h 3"%iV:8;ȑ^'ș3W4q"mݱOo:;n  @k7tҧϜA(N;cus.\T*T8``ːĉ%Dֽ|eJA5ܽg|QQ%H7N$pD.D.#p٦u$E$aÇpˆaprJ`6ѧb(,ضiۦryUTD%Bb \T2uK% N2Ltf4"1 p$ڑMF: -).S>'Z Y5P]T uӃY]YX@QlXP PE/,vVB*,/p  BZRwâzP5 D$B ʌ= I.6 Zƃ]IcP84 (Xpiˬ_,qLJ,<0 `1R C=, 00") Po(o)1Zv8M,G%y EVElN`GPVQIJdC*`S~" TAĢA5'):gtsVͿ-Sl*<(f@wQi5!: w@,dE*ҽHDXVU+V@PW00Cs=n數Qehgܹ< Ȉ2 l2e.C `Y`ᰡ'=}sի8BÈj t8fp/n3b%– )bCYwe8&'*i1||I1yJ yz uz[hdʔGBvH[$EU ΨAcC)vCQ>LdD-3Wd.&%vHW(tJ䳐+cLK.@<гῑ)βPo䲅R@G2 z(Ehv\,N_,<_x"b (T"&N#/ABj`ٞcRL|xdXH V,` E4^*`` -u_4} 6U_XLЩԪF 5݈3fSέb~?4N~.xѢI3^~aB*2}{f|T$ւFruXs~&uZ4/mCݕ'Y|pZBa)SH.}cLFK3VYҤIKr|^}ӬYRLōf ~)##qBw咱:InP ̢ <&s@Dz<%x#;|XYCUI7&[ɉ|ɽ2dƅ7beˏ!1"`R|$,e<[ %s"CHi!L?rbȉAr$Aq}P0[S\:|_Uj c8t@BZثPbBfy#p.6MTdUެY3e\ Ր~ >|r?U&HS ea£l$,q"2H4 @OT`JޠA&ɓǚ:dL<8RǎΛr@c8Lv5qymkJIƎ p~Ua{xŸ/E:(~sϿ#+^1c"y*6J;xe "/±gڷMU{J^&E=PgJYL 4ND0W9$5sҹ p;A "q F _îIL10+,sXwq+y"wD\YP+a vʋˈ0c*gn2K<ᐖ[p_Z: --[ U8b/>4Vf-WpNXy!#8E\2(OƍfΞʳh XZ&DAhLed&@L})[lϞЮȱW]As^pN cԀǎ|7q9`x+oP%C !vb/S~)*#qBpB*WD~%ĖࢪiSraU#"鉚B un$RJ>Ӵ%Ntll籲1OY9.I2v^XvD;yU>,)TXuYhfxZ $ `l"bŃM$ҏ9X4[ނXnXa݋E /".iJFi@_,Ѵ~Dǚ5`,]dKRSE"c7,,{q_ax /&؆U0o‚͈EFb,89pbqƋ/hHbX" [84,6Hhi~y U3RdkK}(y63)o8B _u@h:]  k9z (:e$ϙ;FlrjjQeCL"p"Sn5jA&Ԯ]cNXq=0 + g!vPO137m5RGk׬nw+}VFX9lpN՚ʀ ֬^gyϟԪS k*z]:w=9,9{w߹kz]r\t5jԪUֶP(֨,u+U':V-Y'ϟuVufMLUA='9sѻ_<Cڍ+!U]*U:u pK.^_4nҸ|h7b8p;'br:AJL۴i ˷:"`/=|H*U *Q  Nr/u#qđ]b@R=CUhq3fo&-_ws8~j*O?ճ ߃sп󷁾L{>r 4FDSONZdOb>(>fR\IiK PwE +Fg=Z):=h =X Fb)Sy3Sl(Y(\52mԄLCPPJ6`amn =8wE5@g8 V*_?6 xJ`1X*둃E5Q  X់`QM苬`3,6"-GQGY^,̧d4;ax ?PŤ¹tb`[HGlۀWܑ^ ۰xžjh˼ 6I^LA*,&T`GW,Rg3H`]Rb*o~0P'ŐG>iKJBwnGMx,̚6ϱc-R̘ ]FNZ~:uɳ˗-_hb@s_"yMM }tR gJ39XODU+Wʑhr^w`/9ί2?{Py1-D"E#DL-",_>m칳]obYfѣrhHެi.];!}#ٳ.s6ED؀0zv[tΝYjdX$$EK?` 7,Λ;?\htL#lݤMZ q؀Be y/M2]| G QqFYT?|*J] π>8'a8 -9̱aF3+Wc ԨQsSN$ԧYsYa :dHPyS83 FNocX&@&BRcK4M<8x(", 4&bPYc:P 501E( ҫ_5-E9ˤ cN1ĸ`XXa%Uf)ԁa BxIEDbdf<& Otxn"ۥRX,>PDdyqCEjq IH(T6-)MQy(/bU Xh$`QJ;_X7 F"|*#a_pW"cJbz\N3&llvcqba۰Ha`qf" n#_qćV{XȞ.u}`׭eԪkW,Y`[4X0jK3 )6hFӵҥS%H(˧̣[Ued E=w7.^Y+Z[BU؁T\k{'4%P}ҶP17o~k,<^I$5sU+^q=֑6HVlͧЇG8~yߊ\os̎B*)&c89A{ȝµ'9—dJ=c\Nl.=z\f'X(WR~i~s"qYTkׁ<\T,\UVvc|[hWZW~ U)RDaR%-[ u9ϙlٳVQmܙbZnիn޺87<4 A|'γg %2u0ᠨMį{?ڱɒq&$B.6V W9FM䯘 x!5\z{-[0^ɄŌ!y͉Oxǯ?e={ ߓGx&sWE>́|l2kׯ[7S^~0q39s"B L]+rӁTa8xe#VwX%ѹĬɈiP{z@N?OA4gg4a=ɮ?8qjTPcby C4 K@fȰs+O,i33ap ! V08 oJsAB'2LT`Q)p cktsY~u 3F-7X=Y 0}4l)!1R,Dj baM,'9k!_,4s4 G3q_AVj#a Ѻ~zB/Yršx q('9c!E`р [Øm@b` 1 р(лaC/0XЅ" [JXs c5So(?9rxܹeB牄_Hо@ӘJE("ވ#6nt…wոIl裧Xz_.vA(4 8:Z=۵8\ʍwAey+^e5 ݷ7jدw?<9UI&2\TaUW"?'͒6M:I?~Ȃjpo<ڍ=yG2WXyȠ!w.;_^9|h"Ⱦ,i޼O="qe¬ǧS1XYqt1RHH"4cюfTPjqu Ȣ"72ԯ@giHÔW°b`]}.z <⏒pǚ|,f g)E˚Be62bJ0D\@ORW"-p4 P6 €ʝ kBu p4wE&M 4fdK9~Ql.HFUwXu,Vn\[@3^)AACb``xAl,gbh HqI_XłG ߬Qt"OBP5Q(z.}{6YN=GqWYeXd,dD{R"v&^h v.~<@^"LF,VcҷJ,d{rpִYtnMXÀ(i^ÖH*MgP65p?J$ vKKaJ- 9́bqWH(yxB4Z O ca?9^{qU"n\dRF˝\4QI[-I:(o΅b3c1}bRMKA .  #>X\sc9#ctX` Rꧤs!س8Y#űkJO4A N`Çׄ}Q֭xҞfwD\@f_c9A6(_b¹4"?p BM1!^fڄtT=Gk`щԈO 113^bU&#W"0eM Zh~KJ XP%< )7~Ք34"x(EA#O?TK8t3/F+Up߱G?^.2?'=1źtB8x;Gpuaa |9p=y4"!O^`dG;ʟv1$F @~\FyѐI Q#ǎ#JcHs~࢕W]G>rn6O0yع:r| z[={'Os7H2'?;| qE"+( lBS:zr$6""4K-M&bDDk?ʕ;~>\^F? 78x)j}ay8IF_!i![4o?|ϡG)hĭް&X!Bh" 0<#K<΋h|8=a%85:aϮdr &£&T>l*%('1S&{lP`Cőw 'ٳIi⤿-Ǐ߽4.;.LD={+Zҥb4YKZ /͚aʦ_tgXd)GOvuESO~۸͙Ϯ]޹ %."4yig1z|.BR<=kvVokI=rş=}*Np1ܛ'=N(FhFaN8N XBu^ ŝxրNs Z)510ʮ]s-R02Wp^> շfϬUn ߟ`x +(BvJ-ye(6 )'ݞ={#Fˤsf銸@u}u։/nf'N}ȑAK?>rĮ;~؈oڀ7(hu6Ǐ_<oHeޠ~=y76:l( 7Al`*!!/CC.TO^۶o }]:jƔ(U={;o]O<ߧl$ϹsNH`o2ma"%/KF> Mɛ/}bՊ1MX3E ctI6Gz,eÑ g,/U|} :u뀆-=B}aˎxm|هR)wlW&Wa[zu< CZ>(^#CK0Ih[^/D} E&P {K9d),},% ,TU(oa)/ ,u0IcQ(zٷx,;>Eeb7x 1YZ̰``Ӏ)XwmXXu=X^y!*EƂ&䠛@q+a08Ӛ +ؐHX" >`STP e#b*$uʵKׯ_v[Woܹrz[^~}ZXn'7L:61nCQ\%$i{:Z~ v!y ɃsJ6iҼMNNr7ު+c♒VI% =y$e˙ lj ,kFbΘe];vI6 vCG xhXgό*ᓫW]|ɓ )Y~Zxg $Ìӧg ?y ݳa>ZM`T8tvYf?cs1N 5?c~VPRJAt`=T9eZYʫ< Ϝ;?0'ϠE{VCZW E"@^U,5NOw3>;Iփe.mZl=y;ED6o_(fS2ӵs7+ z^=x<3CylFc*4~9s@|^={C]ܫWo,~VRR(O_ gKDME!=Mżx&͖#hy:} >)#riw[n H=@b%}S9,_BS=yOA^&~7}\F ;QˋK&ul `~[p^KA>ƅR9ǨIHԬ"@cR35P2`[֛[y/eEi?ɤf|['ߢqB3E^ jROXq6*JAs3lc@e>WX'6Q,RiXv%HT(;N/ʼnEXOE d  1_Ԁo`qZL)IenrxeF:t ^X CT,6lap3ʶw8CJPO?Z> RhEla~lzq9f>0 $\yM&j9~(I9lsbTq wU1+a]%NԺyK[;ţw^PL= yb!y|4C Ι 1jU6K(` Ld˖7xyx1Ha4c9/q<&aV ҉K&K\^խˢŋ]\>'ӥ/Z("=MA1'60*X*VjjZVSMCcۿpmraP Zm[4Zb'c< (S2e·-sW÷K/H=c&R܇6b8JYtY~3fϘ3w^yD)T{^ 8yh(±M,$b̕ y֠9ra\Jm ,n:MH۞);fmԤI1c@cEQ|QXtq j۪ dzT㭔Ѣ8P7qH^N]6ME<~=CٳiONeB~Ku?6ʴP[XVX:e}6m'Iт~eVCYw]ۻkM[>F֬YXA*UKۃ>0Çd .[>ΐݗqR 6>)ZO~{vb: +*"[޽T *N/s}%ǘ$mgFJRJmT4$gGK䒤#Ei&r2$;eRLzء~}.Z_eΜ!d4Aش-[#G3Ox\x%ϝ=ޟ5}VY+=Gܹ|U̟dFP@x+\: (?V-[yLiO˖ݧoX+WNx=zAIA66fM;u=gv\yρO2cNJ廮hjN7q<3,C}~gba XV _b:[Qbdc'b0:?d|:.)oâǒIMEHap|~0,VH)ؑx],bsfl  d@T*~4#-mT=-[kv^Pga{!zv{'Qׄ]ĿRJ5c/ZO:1(9SL{̩)%\yBpsvW/#@.X""" p*`1j7<|?[(%;4-&c @.>>YN H\9i?F 6C4]~ mMKKgMR*[r|r>G)*WSz@m9|֜{P52\6?VSqQbYevyŧ+T̙MD@ċpw-4:.oKeƞLFp&dsb`lkҦL &tܚ Ϟ:&Gϗ'o9#v&ΝoYa 7u Km^f)pP }`R! o{h> i'ݓ:.È[b=@u2*9VÙ9U(jIPyJ4Qe1wX*Jp*mbQ4ca$´zE)D*`rtXd ΗU| :)5^7ί~-Ƭ FJ ZLk*mfvX'c EgZBrGL}Fe*15et璒b7.P)YٻwUiʴ?PGle+fpgoȏлn;v(Q3P7UPpo 7nں#Zx҅nѢ͍3hʕ+o%{؟T `+]hpeCܹsnݺ3wlzg9scܩK;Z7mJW~iAg)M@ΈCC!|M6(dP?qԌrνQF_pw> )PS?{cOk.[r)\[-/qLoҤC3T)Æ1WS#G>u,ߴjC %8#0/AܐP>aߨ xsa@EbթYO>&ϔ8_4KA${l\nܹٽ{dM2Մn@@7 za3zu,^l]ɒ%۷g?Rf͛{p{$<~M9<={*4 ^LR,<cO3عH;NTR*Cݶt?vV:8spQOʕϑd%>V˴eˢsgxP[XvD.#:p{xda;ǢBJ-$. 5,N)n3SU(ش&HXl0~`BωŚbN Ns֋E{r+'EoXQ[,8UMk@=i^5/~$E``QZL{,"a1a!șj~Ą/ր^,,' CXLHXHS)f)&Vt-72?OX~=|03{3f"R1q³p]]V"FY5Ay=~d by>ה?q&poՊg BռY:Z;+gy7¤B{^ҧ۽{/mZ)Q 4nHSz7hX2oܵkՅba]v]?k.qDm[]Æt!UTn˘:9v=_??n,MZ ķR=jծ5w܆_4n٢5\J@P9uzM@qBV^l. @T)R`Z~CVm1ɢb}?{ޭ>} |7 /|KU"})TɒujkղuyKTNzQJɑ{mTK4YŊ?x/=իf 4hEu'SV=4ffM2] oAsޣ#ɒ(a.Tx=Xre;5iܼ]vȡW O%K6j0cL,Z:F'5K3䋈 ?Oo4i*\)` BFMq%25נi(iҤټi3~ۤqS싫WX/h7gƍ _֩ Wz_dϑCuD S/@?XV}ysDa/B˕,Qq%F''x{0An      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnpqrstuvwxyz{|}~+})SFPv݉ZXq5/FDSxcG!ܿ?SV;A,U_4lp!Ѹ5k֯V!hwk %}GM(YKwxP%_jHN]2ʦQKO`iJr|vTZ7I*`a#p~t@[oFذpsi9kXtP7N{`Ŧ5aќg XQii@ yX2ĒM¢T^,4,(a)/l ɪAp"cyS_p: 62YXLcj`ˍ`qZ,0xHC!UfbmUv\<0`C(> hGq2?T,_h 4J?Oϝr20}4H(bn)9:7B^cYlF[vot^v.촍'0l$ܱ}׶m[sk֬Wev٣ umŷw8N͉g[}dƦ?{=``R|a㔇%${2Y'gշ={6mXu1/`K.:i԰uH8I"r 1 pȐwݛhunXe=73 1(Fڧݱc>}\{-2^ Plo~۬EPpȁ [p`םLCB W% 5mD: ­H۸Yd7cubW(J0QpX<.&IRD1-YK$cG~ɘi%!.^lPm^ =?-TbP׀m*wtLRre|vs9rW 67;!/8V믿®… dbWzu̝` Ί !Sn)fϫeN8|~پ}d˞ܹs#p&ǖzdyDW !,~M?wB(HA}k@lD)8Lf~ɐc!xIhXKH#12rX,{D4!ń`Xu`>EO,$ J⫠qT+ԃHbXҧ_Ԁ^,UةEdO],FUjm!$ ~ǚ0bQTH`b_񄳀ńs%G q F/|9x0TV M!)>@)w)[dL\ aÇ*TgˊG(;_ ֏'"BÉvut#4A&쵚 1u{n½za¯b s:atӦ]náKӶ0#1`Kǭ<:_%{n޹q Q\>[A&)YpYpAxU>|ddmCfw'm{:e粒@pMda6_ ެXJҵ3 ;vGa Cr7B&)SD/ 2bVC&7Þ3 ^Zv޵? Qu R^!$R<)qb5k6y:*2 nDl,ҥbJ{Fhb|u/N|`-;PCn$M 0?SN?aDc?x@LGcK}n{1,Hxd0 MS^|xaf-ƌcf`U[6n@;qy͛ۻfگo{>uk3q~EIK?oKz}fWe"!3 XJSKr.Φ֓coͻl:¢~>̘x߫W/fH! [l=x`zgؓI?{j7ͭ[m߾_4h0aYAh%ܲ߾1rdH/za?ѭw=Nzس34_)'oܨ1\( 耠4^$" '{.lDPWb#=[sl̷C[)g Tȼ4Se G,YQ͸䈠.$XE\ eL$.#Rss$❓-܋XrcD@J-Sڃ?ކTSAbQHgj U/$wE Hƍ-66arӀ‚Q]=B/_,j@onVppX# 0U[BJPoN`O+ ^,2:ue)42m&Ur4J+?EHrsK)S5ft2%lɢw?ҾWmZӷW0СS!cReK͘99v'>zWO̺8fL#ɓK+]t L>,YtD #a^WΉ'.YTa0z +E~j֮e ܠ!C*TXdΙ3jjp@ 'Dl^3VThM?QZzܙv_}aٴxe?/׭WBsz˕Ē%J%LDR7lPT nݻ U$J̀{ן׭۰~{%aE!Pj5k/6t*XwT\q.T 9QO8bԖm*^r\V< rڱgǨF /&JpBx_~mM. X:I y'y>^e˖A$䆍{3@E)QG8tNT**Ԩif],TpL, $-XPNdty2b2+ r#䍛۶kW2*U,XSoʕ >V3TB5g"_~Ϝ>`{A ŀ4i$L'@ReAXl:S6jdas*8.a#ʔ+!S22GQ}x/'B'06jY:r 5+*|U.p"b~W?0~ /r~`WY]$k*[훟~Jڳ[;W(? ӶuM-ǟ"p=XHDzpBl&Wg`0!+[8ojiƈ%R HЅxIqc㧟 p̢N27caW̜-!iw$<|<>P0Ӗ$ު=|h([8cQ1kX`QxnB]ꓰ(0yEf` 7,x,<\,͋bE2önH(ō )#l*4u%G\,/_$ \P b0;&Bl rA(8^nz?`aDDcb Eb0;c{B OpΑNXXH<_䱔%bLiDz'Jt?T<aM6L@܈7l]d>/V v__ex'N_~]:Y= A) *2j bc$7< x)"ʝ3 f(*W˛y˰P`p\Pb.tYͨ-ZY,M%c+~`oG J &`l֖,LC2qVF[jc8nG{)2 @ Pm;}.\̀9 U/\Bc8M*0ES﷾fEJLӂg?sv L>VxMm h)vGLQ.,N)<- RưX,w"BV TRk@?#c~b`y}nz~˿ H)'a@XY)B% r5apeFVax LYGl 6n\S..8G `z=g5k3oVJwFa성w*ʙ,7lfQTeec Ķ]%IOMe"jLl74e ;@+7RnHᒪPRL;g blur { _Lq }9md`gyj㉯ Hϧo)|kd=sΌR%K"tV /#:r.x,}f(&`|.9@b2'ٔ1X*Ad-Qr vc`.`2|W 1%Ҋ ԿW8!![g(̒;0>VLN#:)%.2dtBƌݶ9Yl_JR'eYknLEcpθ]n%#dXL~!H P Eq!yrسo 20X5.VDMńAq" 6LA2} h,y0ř0ō2=Ґ65\:3#0WR@ G08kL3APCbms) QA慑|:|tq3' <'̷RqA=22a<WH}pV%fD)"EÙk$VZH/:GG+W(VVZh$A>|\L妅j,D|,TpJ1^z3|qiYfYlNiXM{r>h6j;7Ν9ջܠMWaTiBb53wvP`c<}̹3F rA!y3QwXx?+L׷ܡߩ :TdQRK*TEtZ:b$*(zSڹu9CKB7RI#_sdH%.mã Bs;SpAzpi grc񼟅b@-p¨V`| nAVDnap)KZxMMk!/vA݂98B,t++N 3֣1˘FGbEE B,c'X,$3A%q" )e-TYmPlS)l"' WeqlF/X\6 {a9K V-\eË |*`fBj 95lF~,{hzU 7Hiqzz(9*},DeEM /X=E, >ܽFdL?b+T+ "9X$ o4b`aEb԰HE}Ca bpTn^3gXB[$__&փe+ 7a.ɂo-vxUZ>CԩR/_~|سgd01X sCl,28"%,d( تCZ5LVɁ{әis,'腛Vm؇6{߫ib*)}V/<Jm,rY~Yi=+s-{԰rZ1i<=# _0DR5T 6hJU*5jBޏO醛#c[iՠ~ꕪn۹Sh{ڳgzFumyY TS`cZuԨҴqka͛]te0lm.w,ZpĈcƌF/Pꕪٷΐ-|٥-ڷ0Ai ʕXj x *ĿXq~ f&zB/#gqc1~?ЌЃ! M/ǎC rTVё1&LtK/j޲yI_ /(R*))sٽgWReS5c֨)CilWj_}hҢu&_qy*_qe:kתZrc+Ub T#d %@RF(b1lxa!3q 6;ƻ/3Ձ3DI#wJJA*jB9x*)>}\Ms%|}Fy(lt'Gb>2'9SmDJUlQXxTC 98Xd,ȡƯp q%!ct`aM>CP81O;@z7 |U/*0@FcX aNc{1X8ȏaM^> *rbJHr%рKqb9-`bȰЦR3oTaL,μ1Ԭ|0l)XT =c;XX`q} a*rt@Xʝ\PٰAE~q,Ԣ"*i81]I/BBHKC@X|zY"GHp`bDj !\ρ ?|DYXs T,J̗ .hakHF%A<78C{ ,dzm3åt F>l\l#6-\,e1rViYL/kB'#; c5;x~Қ5.!9٨ʷ\s0y)Q;{75!Q[n&I2\Ĕ zinLG+ϷBnjdZ3x?SvF'DVv"g5)9 nww{7ԦՎqC9sU2)I&0g5a PjڏVNnǾ "jtL:?ʡ nMǯIWjGL堌*{աJa"7`i>ix0u, ҂xJc1?z{` C~",63@[9m "C"VhdDV|\DgU C\;-qF‚*|6ED@OY@J0;-̮?`q@Z,0S;@}ߠs_A,;EB-(X-J-avTĄ d½+E5XOK`ѻwxa` ~X"a!ba5HQZ* †C Ɛ^qb *pra1d iRZDZ౏H1CHD6;I]&8"=\R6⣚D- jMRBopwҪ"kC#wWFM"؅}ovڎlFJ=jb|AH067+۱s'C-޼pBc*}&%PwBI vڅ%&rDSRO7W4mVVK-]\EJ,K'O8yaxPN';<ءZV 4'|#Lba艚vvZQ7o@_-[[&ഔ#GC:|oF_Vt\Sj7n_s >gÇbKGf|_}Z=p+WZhJ+0C=z:$ӿkC ǟz/; =cioٲnd!?ŝhp2 {{?|sǎN=9/qo2M֭[%Km٪%ˑ#޹kǮ=l%JzUԠACny_阃6kO>y*Tz o~a-Z=;u'|"Fm# Tak-ޱc~iyt?LPyMD : 9e¤w*Ȧ@*yA Mض؇=6*JbP}J,}l.zjMWQD\NaR8žhrYjJ@ W%}dJ;Wl۶7-\AAIp'vDJ+UdJ0-Q-U@`Bj _)UE(٘-<ԽXVr^)>5|  'XΘ <3w/<[{ޢ|E&P9zBWn!C!X9$,sbBa10y "߽ ͟7E/ZEOy=%KUT o,~QLlٟ/B;͛7/S+F! mTҤIp8"#ǚ4m2󧙕*V^,`Z_R+e?kT蝄XhQժU1Z3G!_"ռԷ/,֛%ǁ 5ҩ PǏcǎ]c玙3gtsjlh7mzч<0|;֒Kab*e'cK@]ʻE t !&6z_PO?bhsstLTK,sM7+W.6&&8R(tr\ƜntEZcmdO3[ PbX9~Xpe^ddar>;Q4>֥h.~2J*ri$n_f:5m*htzpZ7nmiXݞK 2ca  S݋-΄o*?u/b  ߋ `q-2Fދ;,HX,'He@J!dpSg㘏H֌|U%cHU6_a lTf'-!#?7-lm_𓓛 "iV԰Y^Gyg8K YZtfMC5!XF++m GZ ȉ,[ς- Kז_6Ac5*N29R{8}Cl),#RP04fUE tvCdfeCcܐw8ꔌG9fc2`<J CKFfZ4vGD+bͲ'NNJoVG\@zEB|j1K|,a\Odx4t`TX2 ^x O o0 $T0/ 2i3B:lHJWɥ@kw'ă{>`*Q~\eǣwF#SPCGJ[xM]3G{xbF3xeG2sG6ft3g MY"aqY hl-#(w@3xln=m`Tp{jbPmV! n 7Bd Nf(GaS`*[[Py U7&~4v4dn?;鵟|6.]Vvn`|o{XNH>׬] MB)\1mU|+q= )IAk׭euXFZ]˹ v^2+w]ۧ蝾Gvbd+Kc T LPL+udӊzKdVS )1 >Vtf2Pl0uʔٳgC 7oG>Bu=w#$$`#!f?0'59{[nH7]#r£xD6h/5 RBdҩ|^tQ/֠!ov-cĔtK*Y*ao0O\t* N#:Mw?ゝ "KV_I C[*$_Q7K*l'>Ẹ -`xegxL_EѠ$aɞKujq!XtJpȄRW p^h"K@8<@]`Mf-( ^!Ӆ|8{_iG:@*BjbH{Q 5uP<,佨#*؅`9%@w}b Y1RٰcQGF"ƃEDn,["?ȏGr`RW- WE,_[#5}QwcQLa![tŋY zO3+nUnT* vV#hM'v7~5_oŋ% lOPg;[E}W*:ͷ4yۤ򄊳fk(%@r>%,e7⎾(,ʶ5EXaV;oq)kv8xy*UX%h .r!J\[X숼T%93v)c]n  BxֽȨu-=,qLJ:-S(!".6d }8fU.{x[Q;X|q#ēs]|ClK^r {L^^,2/LȀ`ܿ@G]h,X@ OJ%7*&e\ haޮV:>O|>LIK&3$|ނ7mF.]vj>bj t:&u.ԧ֭ڠ7Dˠ,=V>OԘ|e2<C'JW?u=0TROܷ/ Yۢ%+V[0 o|sw׻0Ŵl YUR4Vẖ!_ fIُ|,:gΜF>4N5R\| +euV($Co{fӦk'hܱY:.Emͺ$PBFm[,|`ћ|I/-?`N- ;2{ E E:U|"qcY:+m̪hܽ;6dg 5M_w/B;d02?,B`Ie uyݤz!wv@XvHDCXLao R*:~`)FbL"Ubb8pza ϙ8\QGxkǎ._}6'AxsϿL51X1Kc/͜8Ѡ +lxZj9)k/_:} t9q}]&Iӟ| Mi}; Z!.\?A9ˑCsC;6)9 4hljj?|0N;t2q⢥.^ȑ, 7ӶЯ~ȁ;.=|JW3gժUoĻɘx/diME~:N55-6lظp; M:]bSLIHBt (Ј^!(CDHPУJWHX)=Sa ee F3<<"@Joޙ`u,MMu/L>!c +#rC"BUǒv>XGF ocnQv'27,je[ kSXVYr]R $KɋZJ?p$s?32r˔/Y@!'P;ic >6c7nٹL;@=yt=kVӏ8lÿ6onԮnlْ/cڴKm߾gtT/-ݺo~| W^~ xo;+\Yjom)SGĎd܃>ϗg8(h;؞}{@jgWٛgFcD|ᔣ"b6l6YYl10ndG(3&>'avmEG6Ț;η8LʊJ'4g`F Pt" zُ,"Lba AxgJK-f" xk?Q"q *B0LaC)v*X&.YRX7 j$8EPtbZGk*E~6bӘ bj.ZB"V,=I`*8"Eva4uiz`QG=z RqDj`a" ipHjY(ɻ%PI޽pQ-[,t`^,BϤƏ^ؗ]d#N N (ࠕkmbCX eXJ݋BlX,% k=Ć d݋KFc>ClB} b`c \`NIDjhD*X "@@ {!1("Av+Dnt%D՟j0+j2qkpNCWFG+{ _Iv |z܋ Л@)BAwNS6dɊ+W Ijt -r"1 ]*>`m!6i_(؇PnH#x ]PNPVDPXa0kXó9P(&"4(/28Jkvhc'L.E9)8l/s5T81Oj= 6X`ijO>dy.m&''tY[oGHa}#= o0v^gMxݺ0WK {+UA(r!4CX0+%DVhr ȉQw9ڀLS.걊>O^i=Orab,`Wv%XpEEյ]Rу_1*K`3sFH m  El83?,(;K 2a1/^2(˘YQ EbCud0S9P$,·¤b ΋gۢ ѩ2"y`)/K#E I/QDJ2WkO6^~YВC8Liة91Q> *7y/觜,̴y?Nt9EѲ`3v<N_p[ B"n0}7m?H5kWMOIU7_(%)4Cot)(4:퐝+i4[{wS&WYzrz'0:d+ ` b*K4*|Ke*JT_*W0UEuF7EP* RbCF;dTF(g-rR-`!/+u.G=%XӄDR<փ)GظU[ aQiTHve  ;z(HݙX*,xp/% V,l"Wބ-*XxgBd`0,BO(Sۘ`ai9ȠPc2R U y h\X !"|`q Y4|4(` RQ DzbY )IeJԼk("JW:A%+GBAs~3m \EpE ˉÛQG/:Ʈ=a}Sﱘ}!V6K/uѯ\u5ZI$''䷩L$5*g}W.|^夯*OG}ێ#wt}xO:m[ܷ{޽mO|D޽{铷vˈFF\rŲ?8Fa:<+kC`,XlE#,̦`H°XRӅl5sp9T IpQr=֚IY` `aX`R}ea9,l-e. )@6X T1M@X!h&aa\Gڽkݽ+1J8jwO@@uΝbPK*5<3.]z7Na:o&+ޭKWc BO=Tʗ,k Gܱzٝ]0PDkW׮W;!>PrGgZhPmLA6zw)bbLI9<0xmcN X-:̱JA wV2yM6Yf-yպ0D+[VR^Lk_C +O^`/Ʊ`ˆMGLTSuㄌajbq1rN{Dq=?O =fh`*5g,KQnI4Hf;\b 凌ǧ3_B ]+ ԢHl8oQ ب @\T5Vq,lCXh k$?¨G ,!?DH9VDDj["daGaXիTTxp TKG7beC.[ +h]D2I{rZj S,:rNG ?}3fN1/X;qMSh+ q0~]tlSM;z谷ކLLLDhw]ƍykȻ#Ŭлݽ}|F~4Ñ1l۸qG5ZAJt;vy䈡o]dÇ Cۇ)_O22O3~kr,KXHN$Oўd+H05~_~hw$-6 GmSυ"eW)j J s<96(n1㳚:a9 wYBXVŒJ Q8 =XT 8XN4kfKlįX)i?k\$Pen5..D,o]&% l[%X9XC,UFwmQ>V z#4*8< vP E0aaQ*nS Bk^,J; 37 đgx>dz>Xt8cPCV5Pp|4KrXx7lX<ĦŇcpb>d(H Cl,!aq͸%"vC)S$Bk?NQqU?*Yd O<DcC)-Ɣ@~:j-Y\qffg0ȭ3&*Vلϫר޸Ichɣ2uϾ­okРAjLfYV8SV͋7UƸO20()*^9H\;u޽wWC-`b>sO{5mO&%׬Ug-Z\ڸif7C򠁃jתٽ{6~ԩc Ռ Hqb]ԴB6*W0K//Oť%ss0ʦXMmFGX'ߦW׬IZzmPfyF^ z5ozA Wdcq/c! 0Ԅ:z2S-EAеS\%llILIW蕣O4n]p x-9 XDǿY B:J"1W9zE \0,񖘖/X'[5" vςL)Wƿ^%1:@w/ׁك-:d ӲE*4,D w"%Hɦzo}4"] 0ա>}}^[V] ܨf8?5a\TDE~=e]wv栩}^؂wk[XsCѮSSFKfr{L." L8) ~T̮Q|¨f2e7]OfU:2)ECH"|Xh8ejhO ^UT@fi'WH趭[z.s0*n񒅍^PD霼<7NNTj Ew~>@; /L -D-o/)SSF04Nރi, =6ߢ,|y`[0,4yR4,HX (9,\w/ սuMӺXk*hXEh,z#Q:=,a) o͇ [(·br^VABl1Q9Jb !RCqUE߿mJ,5}Nn;q8Ϟ} _| ԇ{+knfu*$B%k.b L&D[X8 F3BT/9]`C``ygˏ^q5G# or6YRcܭ0љdq¨N,L' ظcl^Qhxb>6Id:*n氊 "0&3#YRVa7Cly1 /rRXhƭ>8 Hnj5+gz  ŧS(ݢ LCCBsKj,S:w`2 n޳|-*$Umˌh?,*N}ν$a/n,8@F9e`|t(Lrrv E` av[!sB@G䥑 C푏kT)$RκCv⡜و;"f1lĦHX@," Dl, R()l&,|GlG>"R"u{ȩP Ϝ9rh?xTRr'c04?tWb \ME XdGOaj.TdCPϨ:A/By0GL(8ԭ?' UEJ jL8uuf^vfJVx6dOgF`[I,*HnpyD(-p7<q.KcNP `~gUb6W!,k!ϕI|EM#U tli! #  wb2ٹ)ۅ %%1n?G_AZů˩o1[SfTYZ w,2Y")k* ZD@XuVI`YV j=n_ g*RhTmB׍K}R`:k~ $(/¢tX2w\ +yMF D` Da2a1C 2@X꜡ٰP,P;BŐ.Yr}+!6UK!Ls!1"qUD1&%YGǰH+^Fql2i@9#:D,M9_{jAp.9Lɐxp>9H̓ez0EdRWdBj- r ̨fQnUnV«@c?SVbKEB{X 4V5% o)\0?#(?7UͽB?`{Ur!b-ebvc`mİuQukbLY,?XK$ ̤iH\l b{iexw>X ʶ;XȘۑ4Sr!]wh0-[% 9*>Xr[AKW.M'd, 'a9|)Clb'{9,0]-"-yT""vaXD*IѬx] @l&>w/)?DHOn #{Dlᗧ,t;x =5'A +挊Wx𿈈(t4'P~;:^~}t!P xmF&$SMmAVcHcT:aShMW=A. a [s*eET\7WU*Ԏ*Y-d0x r40]y00lGs7D NH,\yPS/`=8!ij 5¦ꄣA: w^^5YQU򵹊FpA{ 'W鱊Ż i_e< [KDc]\ )Gztg'|ц2 ZM Zhk>4=h0DGJUh N,䃅'&Xx4ఊ)E PRSsA![@ &T<=74 ~*k6,*Rp9e(E>rN*>S HzbHXl?KDjH|HYCd8T$WC(觨P(|sH{{FFEr_q2_Zu%JguL^BJ:uhrF&v<cBĤZ,Jk+ǓBq?ޱ_8 brTNXd'(teTD"rb;dB:' acMwb:@J!Xb**b){Te"5H$kRڻU^0]CvN]x fbU8cdYOHOMAc'%V 45d! "f @j4YNФH|nv4{qP M%ӔϤu[JL%fWg9C62ߌ9j҉Fs,bnV`Js6XJ!X, ,t'op4c"퀰X71|.U&JX$[ ߉1HGE~M"`!BoY^d.diV*cNǯc 'aa X [i*|&|'&ɫE-M&! >a~ƫmQ=w6,b ]<1T/?걊N=M"=0衅^SWX|wqU =Xp^;dR`8Xx3Ǻ{F*(ap'ؘa{q'l~!$ <@ C,޽hWI1yķB}x,!qQabtKp,$yft8 qL28Xl5t2rb1ucQFFI?DC~"V+ǜqlw|K!QQQ,\tȑH ~I7 ]K9KYe۶5-XL2#KM]̋6rZ|e`]:YW\;S4z~rdXSy%3o}9L͗CrB.9|,L AՍE%vܤ9&:K*ъv\N#-`i4XABX Ud>2hSYmv/<)y?*]b,J;6 #Bb۽hr`5OmᘻjH3=`bdWA/9QΒ i>+n"HCczTq? oȨ 8tX>@Dq%7t+0\-U$9-/LRh IV)]!1% ;<ϻQ#6 U,H'(0(6'Ek.%l\E*=/\;^\, n&:)e3P $#P#Y,@J?d-JHPj` ?G-{DMBEX x!¢ ;`!h|W0KdE),<1F!] `+ |' X-hٽ(/K½F<[F#UAl7f2b) нZbcgdw{DS!91 S`1wȀ{Wا`aAP>~,WZ%x\!6ɋX TȠ)1Eb!9BlfAX*#1'SRs{,r;T?DCE7*`Uh@W֮]W\BUHJwDn[* EIjLYm,I<4?믉Kwz,%j4 GaNWِՃHޙRKdoUV!hkу_$2X> j|,NeK.*`ɘ,ٰ`\E#Hh{zpE&;@DXҝYZ3U6P"eEӖIXHnQ?,xŊe.)`W݋V1΍?@{+XDnx{Oxe{k|ȠA:SWFXxDU`lQkyd20W,^R0pLGl|{rJXܭX:@K2Ķ:ñ@qXB-H/ R|!"K"z!gss۶]66>75*רQr/P&)Js .@ fvlWY4)Gsvh8&i{z1sYpzגq9eX~bn ~^@*gZlXĽܸRL pǾ]~ƒ;@wDc[c*ޒZԧ:-oNÀ{Ի #;kPs۽_Eߒ+ Żnȉ$< ;j*ء!{@{2x7ݙM@T= l",hPη;b<pvv wN -foHkD*O%RE"y!?DJo!R }"W=:? T Q& wnmCђSc{aC>rOnpb91[!4$;3gܸO|3) uwٻZTub&t$:M9$f}Bn&:ѱ[/kFD1Q(>H q)Ɋ\Oòhȑ#@ "_*\RVA+=*EU4 ;DbgK:ѷئN˻ n=`aq^fr+˖?<-!(lMS""\UZB!*lXM2&'-pbёNA# MC&*p*;Iubl^K+YqOa!3D`p[%/'X$&C9"oD34t4j3X+1{A-3WAPGU" ]n.W}3r^@y9a2pA3ؼ0 S" ]^n6o_#R59H TX^?`iE @YPrQuLڏH WI% U@@՟:VMUAH3HYX/HyH4H՘."eƼFLͺ $y=V,sɍ℉"U1BlMDJX>"2񊠳1YjB0Gl[D+TC)6y&HKc\0 `!+PB,"5V\ӟDK[4*)!@HpԨ.?O;q[|%kK"8$djߣF:` ^ew{V1Xxj,afE}=4E1έ"{Qٹs]SaMD:΂[8&+[[b k:ͫw&R,">@8  pb]Dy)}D9>K֤!%bkE!b"ڈ-mlM ]uTԤ^Rƣ&N~( L"D^߉ITd*^{Q~ OqE5֔ ~<6ijQql 6/KZBO(;؊" `98' 3UU(/Hc^LdE HS"g`lr0Dgp\Ls{Oŝ#,OQqtIR7'1vy6Tx6->1EuGlT(MjyuR|vcTRAl٣Su5T GT# xRv/;FPVӬCB9X_fz Oe,=[ F L\E^e*xejTʻEdjW!hs`156C.xbW"$Q `X8*$kDj7gpL#RULr]ŎxCX|tnj|QNv N1.uX`J & d('0@"[ˆ4" s~2G>apVxЈ,^&Ry?;  4'|YiCS="uKߩx^&RI}?,K|@"B P94M.7-DA cDJ,B K#R.DΓ#Lf(ZkVӪLo7_񿴹|m@ O<^:=[FEfsd}Wvu_o2nK)ڃe+6+mI,zXy6h>W{گXc*"BdOL#k! 4k}/:@ (Q#񘛷JϑΪwv-=2xT)3::"J 3 5v 7r_7~j*r&2~^aã"żн  EUXZ "X!El俎R 38*M;*k d8WTDFEqz*` *\t)1N1Q]nJ)IHA01Oh!d3}Sp2w/z4%U<,8mѬ?&S&鞋~{9rP[qsG.Ipp W1r΢pX;+f1pB/Z F~Êr3GO%+CW.);ћgػ:?^n$>]w [mkvE'N dT*MW:<6@lJ8< _J3XН)o 2Q@S \P/y*F9}آN9$\J`1Dن>rFi) Yp7<|r 36E OlPJwS߽Ȼ$S>yuj.S&2Řu1Ժٴk܅q.ʍ6~B֗FD-Uʜ?T] uMn0D*O,ĭ2sEXzӦʕX",c ( څIR'Qa~B+ Wl츏۷"2:dyĂEG&Ry:^\x3sxbT_VX|lllʕtf,LncɇFA͘q>ʶ1ȬsɌ;Bˇ$~ eIH6#sp/ѱ?0Q Q%^ R<JQ蘚٭[={={6Q,>G   jp/Y%%i$fn\X ~>flŨ2HfK;?VۇVY Uũ9+t#ӭ$One*9tI:꾢Ju 8 3MX*SDHm ǢL5՜j,ZdGm16CaX#؏QѫWkueYHIOό G$qpX"Qple^M#jk@X aLb[TpQDhxLL Zj՚wm>)`DGG*?-=80 AZ-XxM|UBpf9s_L6tHxd8RRRҢBXBy\T$=FddޢSNZj&cd_ɤYav;tUz5vڡtdAa(QcZZCtae`&":=(Bh][CEoXyY7!cGXa, a*vtr]z ^i85l\V /_Zݻw!M֒*Hv!gc{kÂ'KaK~suO>Xr_fSP6i3YsjȠ2{QDTcFJϞl Qu HcM8,i {4,LdRLR^"(e9آK4䏈TUU[-{r!Eb m1ζj*{quƕkڳg,V Ŋ:t{,$K^/,L1엦:^?~ϋsܹĽO}~^6/8,?:Oe؜ti XWSl 륦&f!'] :=g@(1* ܜ0_XhV*5ꆤ/Rӏ! &rrJ*c)WEe> ۏ,+cg|oBxlذUqq7mFtcA9ه$-c/ՆlCs1ˎYÍOfd@9/oEߙ{ R-wa]N}0UUsqi_ۺ ѷ\ߋziS4FxeN" 5k֨PB⾽dDs~Aɳ'L&:**551ԯ*]M=:S$yK/_ĉHJwF*j0cPpDDK}_}8p ֡!LpoG!Yk>$fXrúuEa#Aa~ ={J^<ЬY3dGy$5-'3PCb7āp(%`tgI2hLQ[onLt[+s.ؑxڴA4ر ZŋѣG s2òb2KJnږN#9ɴ6cb"͝Ơ1M𩂇=PDlDTd!eX|tDxv:ҌCBTBֿ\R_mGzV:5?Δ*G6],=dajln8GiKRϻ 4jسk) 9=0Ŋ xK.oqiW^ń/K/8GfTTvOkTPmB]0*LfFj`ƯE\{qvO&mlɓs_-b!/E8-s7d>ͥKT:Au4,Zܲ%W&*=卮j{MtɔM<@)8rly~ޢy~y깞6 @8BԏiM^x)e|A< F(RV|2+F1rGZ5k_ ZXju^[Fׇf %* % X /^1dRu V l27aV?4 O=vbb-[Oh}g|l#`5B,Jn/uc4U)_Mgy?x؇'fx.Ǽ3vmKټqQD $OW  /kvDX,#==A^8qz7w~U\,hu >xn(`ó6T "uW;T= h!ptCa=PTBPQt9 nۇ*DJ>|Zwk!G/j88aC;L : ;g #g{r#"Q @="ePM2E[ 3œRάZwܡm\ֽe]5C[=[*rUv/ Rc  âbx|1U^\Ҡnu4jwLrЖo ELPOqyFlvPXʿ!ɩ)s zOpϸOޞ]Ԥ~mPT8\Gٹ9)Ǐ8|:%% #؉䱓iiix+)5SONO?!foeS( x>"5aK`f=2J@(ph pe+Fg~^rt'ݳiG׼CJy/oG~{W&X%ywƑgvlkƵ:$pa'֬1kozޟ9T2\&YsŸv> v~ڷbN?l&MZ_ѳϋICɾ8%_Vt(Z])֧-,"ٸJqpv/4ݟ"-x]|o8!ʧa֒3f{ԩ}yשߴF&! ~3;4(;wU5HI)pA7 ]u۶`Jvb0YZ[:ҁJ}R/:Kn \vŗvfn&?ApM+V7wLU92ɾt6f(8nʖ-׾CI)kwkW=&Z}:Xbbi|;yk'_iǟĽ ,Vk,KDj?`o|0!!~ӯg^=v |3mD]:ݽe;v,=sf͚ 7n{@$*Tk쮲jرsxg˦_\޽S˗_f͘:sgf_N XV\WS%D-ӎuGܴy릭kVvf,_1w?6nUru5S~AHI0F/<=falUѭYN1sm;,_>{?\>u50W^PD ד,\dɒ2ۯ'bjQuX| M[1%ݳ1**AhZ=f厔ԤϽw>{|k>~}̝3 VY.2TQFδco X[FTfM W^y'@ӹ+}_xh!0ál&g Ǎ۬ŭbOrUW-6/tґ jrf-UNzԩnwT?6/;ue$$ćlu)iNݽ{7 :t,#.>ۙmږp]+*V,^.Yb~r z{I}Sc^70*]2[stGD3ys8}'?Tjg-[tH|>ɕFvzɔ?8@18d^S ?RxH rlF$U&φOB4!G w5 "^BNܼ;ʕC={]`?UbPgԪUT{OzF'++ԩdcAf1ѱq1q>YQ,krv// RQwo/]{qjsS3_ۤiO _s&dhc_|̈́I+ˏI /p^2e4{Z.Үm{ty>[is*KYR_C\wx }\!3_uXCL[$[}EV Ԗu9Kj7pݽ{ݹ7(j Y $%c:p,9KH,ba3D?|{#GNv-;μ;֭K}ٟS7xre(yY~._ܠo/^j7T8љb9̺/'}en՚x;ÇSzՄ8YO%cB[$:3/#;f'AAU;ѵ-]}_ r͚֝O˷n^,!n%KxͷWRLe*U]N~Ke6H^ڰ9sv./w-7͞X07_ ԌMII&+9--$89]ǽmt tz-]ҽwvnW*m莍{}rmݲuE b %XR{i ] =R'\՝0A$h'R>ŋ8| Ͽ?NLB-1 }>$N4Ԗݙ,/h{ILk [ۘѣƼ9tXxٖʙ{QO$1!4"n0D,o̽~w+Zwޜ~k{AU+Vu{bbJ(xJL||10Y[<1qP󃖠1?2 pȀa5kAf8,GODd_-Wv)6m+UÏq,G?QMQC7.>AЮ%ĥ#'7}P2uk]*B$رckשܵkotwM*8} Nd6$=*iߟUHMO}oQw4Q Oؠup{׮=>/ s3~ڎ^}Szt5ٕ*VއM>5QSMS[ ݳq}&~\WW<;#oؑ#ph1+(8Bo\|yRT_'Oܸy|qŭvwQ:O)SzYAIʅ4b*=y`z/\u-[3se}ܖzw&'YN=̂Vov'= k^ R~ޚDf*4c昇_lEMŽoܸ*<*mvuyq-؏f%egBÑ~1^-:Fs[2JRAeeY*c-6'CddYmwcW-((fv_i֬Oe̻Ukj7_|С%==}РArT2TQ;8| CӒ,ݺյI+$F XKbV,_p":}z<|nᑇ|W/i~q{Q^']q=' J~3oAjgLY3_N%}Kjr꬟gWVem1p@0yJC۶e/&k!n'@;vFRĉi۷@bBZzDAPdPAMjm׫9k,hժU>r(+^Rt%-YݶT3n5%p57ׯ]bJ8#G}Zjw-Gs򫯼nР7vl;#|mx'LC%v0'.z_^{uoAM>n 2x+V9۷ٰn}ùkYQ@eTrH.X؎|aTzVfc2lꔓ5{Y׬\3dЛo1t˖-M\ӑ3K,y:a4kcy!GsKJ*vޢgo~4{En >fjV? 3e˾;Æ81i0"ԑMvQrJ.w: BDؗXB{ߔz<`{7mlUOGp=EV,SiWy-[̽IZyەhi6>V H>`DZK]"7 o%pTJ1D[CM0?-Q$Pb<19:3q=Dw6~ڤ Wt[!Lxi%Ϯ܌;V-4YG@ˎ+5{='rC}:eƦuOXkoǎEhN,,/k>/eёZXmX+WX\։A''FG5 }͟C&!WLBQt/'Ŀʴ"]!+l+F:pxd˯^ǗQ<iȵ zݷ?dgQS`n qѦ/5-Wm}:Gu ppY=D U8]=1ie ]QR` ]HhjA?!~)ld_(zr;kڨꊕʖ)߿{^rlG ߠ~kԸ/ uW@jZر4jTZˉ#Ț0WVy$%w6maڵ?fJ `|dB:¡ݧOV\^zWw2bcb%Я%aCW޳go|֛n֛[]CK ܶuj~F7'5s͛߿g5k~kݦU*ʕ/?t|;ű-Kh$. E ͢MFuTpPR 2ntW#S%tRzfnPd_zm"םߑw|Ͻ<]ZzLwbѠ%̢n~Qߌmy%O=?uY+WdѼ\4Ptǥ6U:Y?boPA5iHQ 4ݪ G+L-G%QjM= ֬f.g0^#/wp_59gd#IiX*p:=3#>>v`j0.?tB%fKVA8yͭ;< BpЪk:>nm젠!]AvvMqݺuA˗)G9r*^ye@|| ft^Y#H|DzBϟZ^_{BhʞAT ֙g3k>+ǎG4XgVN6sd ` (Lr䔯8zd 7^]gqAAHPž*O(Q 0;+QdL{L2 #t0E*|Ȩ/ߨQ>iv8b{H9s]{IIz/p9 ӏu'XW_΂/&K( ڮyG۴Ͽ@bqeH­9BxE\%<.U+ !s[kdIgϱȪ5kܖgrF|y8\n/%%(U| x *YT/⋚5j/H;GJc!HC & yQtry|)T.Љl9d42RTp`d?DHQSs;^َf?끾}lݲaï+֨>ihؤUY \L<&;7eԝqzŘ6eK(u5W]uհbkժyY'szg@D\L .rMs̥LL^AIH%g<֐t^y~B<=([[^]d+6mZZÆᴚ7xp^J9,hWH?m`!|0rm7_rq']uuoɍ:04+4=5ȑcCK~/ΆgH_,ے=EqIIEG7jo{k6LAw9ٯM~' iwnR=3o԰qË7u=5kU?|5.Ytįcc_b,:0eSceG^z<+ҟ| ˂_I 0~!a%]0DX+VZr~[^yw?dPNuԅVfIIugeu8ը#G?~-_VJ)'!$ DycrK ~u0&A3@d:LP52%a̘f+Oxq N2 yJr.mqEͯ|͞'O=~b)#/Җݲ9|K޾}kU+^֪E QlrJAPT^yNL[GLfvcj,jӦ}٘џOзG9νE~E5OFB{ ϼT ecG|ɨ/'M+_Ƚ|׭УgoMnj9䍷G?k{ܠt1i9sְכ6 Zb؏?;f ߼>h.KhsE^ T[>س<}ێy{L2.UWb3@Q$Ӗ-_J&3&3Ula7qEV|4^-Z\yzGjt]ɓ'ggVOTPPres9><&CDh{cöD%C[oy=?x]?{Ⱨ$4Ҕ4{PT^U&݄VTpL92GUC;'\Qm|I75޽*/_a*k֫y5m/Y;zkڃ!+V,OuQt!>UgNfcXRWreV)}ѥM*֪=tI$@ގo:_7W_wrs-/SF8"2LyٙժTD/X x}c۶miwF]d'}uv4|'bbʙbG/?J7#RU2)\uPʵb)g1JClaL+S钟[J%KuAC/޼Ej5Ѣ6#<7jgO5?QelxݺR԰@찤ӧa4yC>oz]%?5wqO3~sJK/~pwhpAj*H^g]gjB͛7LWy7/%3zdžO?BTSI+3UnzC͕k}>mx -Fg~ѐ;tZf f)2 >3Nzv)dx8@lQ^iDBC:%_^VCΚәuk8]V%CN J/8@kصfZ 2/3+<Ȍ UktizFcCo8oڵYGwaWO^ 2j~2{gTT >IN +Tt8ekrl bs=w;Cҝ~K?18{䮝k1eתfOogf%M,@w?rw@SIQoxus9=:IAۖ,LZNer1W*"mܲ%`VRBTLԢ'ʖs MG7i}-˧8G)"ɆzWЁ =p!u7f' g\ڞ=;W߿'n̄SR6(Qq#G=T#O8"#"SrB ྊʁ@ D/Hԓܵ 404"-,3 cy{7ow+j=ߺMؘxp`9=n= Fϊ$-mؘѹmի% vFĭseϞ'~}&%eeٲ7z+ #HHff9@ |%*:2#3)}@o8q9ټy۬?B\|'qևM X_].8B63`ƣ,%ɆF1.+;33:663#=,V)\81~UX0^tٖ- MV\\՜áeǻ'IrPI~dL,n"S`bu> Q=o}q|5l5\$$CD- B4Ʌ'iu˯|]x'\BH[QC[ض|̔LLBnKt4KB\,3;;]bYٶJV "?FO@8_{m-:'b!QyYB{ 8qúaT6غ5#3FxTZZ}A[vv G0\lv6<1{wUX3 VANAÊ@6.\'(^dq6WDfPdq>kذQDdQ%&ֽqwE|ARdW~kZ1/zexMXf`gj֬V~{֯xTT|&;+Q{nmqI?]ꢧY;O_mMBz66>*AreWZ9K9sLnʏ?DQC;2dW_ 'V6{)ӵT'osZzƩfe\ [_JhON:}2 VR{qM Ixt>s:%hbS;5Pf]Tf\A!/'@{_cǎ!tR|5kTX"fVi !y?@•+Vd)VsͿ\ʗʶq+ZwAAŊ' -*EJJ<&u+iS'E}kzvnzN$!857?vծv#e!6y|d67<"# "CD“ս˟U"<+{Zժ;f)qf(ƈ᪀j׆%4ep +S Z&U*\9ى_=T."2゙<12{zގ@ JX^9+/obUV{SA+,??ݏ>9X|lqU[&'Y/(,Ĥts$X*ޢ*ԃ{m`NO~ u@ q._>vsgFD9wC*P?T3w.jpjXN 7n_/V}{?,jժWND rzյg Hm>PG\fC7[tٺu~e;̡1E_v&P#sP>Vλw앚EvS\;\<.j갨sb}^@-(@5L-2h+!e)o!<7\}~:Ed8@$%-ULHAsW_[l&aa:7'2!a%̜>RҨW zB0BƐ }jKAߐVlY(vje!R~ŝp:e E|XP /Nx֭/ ]:.YQcL:}*<,2$W?;~b^Xpج` vsqHC˗/³Om ) ``/VN/mLF\GgnܴNG8t]F:(̈́oS*UoW /"ae/{ZO>gϹ]J*u|Ǖ+{|/ǤIw@"BA o=S* *~NjLR 4!'i`3cԱ!~A+") X^$;MNF8lK0D\wɈ7ʕ+:ԸIb1%JB87qxȏt]R#"(EpB}x  AZRy i6`/1`4K0xfSC<&GB~@}ڵ&`R9FOCa1޻3ۄRX _~-v@fVJu(${,(55Q/O54Ϝ0dv[h#~uK}P"d6M1z6#pw#1~##M! n̘q>̠2ʀRn4oD͇ dܙ#@R=T1U])v޻uG}fڳ].(L4xrƚ_쐠á0U\a d5Z$(҇+{CI.gyj If/>);%B+t^#!\eWg #V#_%.e&Z.SvwSPDL쵪U ly@{6AS!i'qV:l0?v >H}&O9O2!gw˝pȄ;j7=y|:ˏbcsrNriTdLx腨Iۓ^wSW/z 54GЅJEKF 4NGI.N+K0W53+BS}ڔCaZLW`ljO&ODzclmkKN8)\L23}΢,4im[w6|9`q؉?T9}.7;]&X&#Ak`OsNm3n=d:O?Glxk_ԆDV3UpC!CP0ܒn _}TqMp(a ظ4 bH^B@K~^o5,%ܞ6T/=5;X8Quf"q #F>0zǎE 꽷Cac8"6 +۷EH^}L6%^d58 P^xTӇ=d)j 1g%aڱ ε _Yr;& !=.޶t 2O;k&I^P PqL)YYlT.{]v)˰[8dh!/<6V/')ڴE&sR13nZq*cW󕶣 <:xQ^B$Q]NUj؅VA< a[Ś;á>Ӡb}g:-k""9ʩnzj8H^]!gfe~T:he{_"!Gn -{Sj=ܥrGk(m@:=쾏zgDh8HT{( +Y&%sљN)|/ƢDOgv1Lş4jwfw}os # <@JD!n<䅀5t1kF]M'w`[*=SBݻNahoQ"ٶAlŎMG{dbV"F}lXܾ"' CRKlvս;E,Fu/IyU/F-W\Dabvv|L# V姥f0Ü>q:ۜ1)fXRo c8ޗP"ifJ (ڷ+Ia6xIi[E2w+`B9Vg4uhDVqNݘ0BL>m5:g=wϩ"r7(ζj Gc~eg 8j<7ϣGGjtDU3IENDB`WDd $k0   # A  bxDh&ă2K nxDh&ă2KPNG  IHDRp5sRGB pHYs+IDATx^̽U6>34&Hw b " Xt ҈twlofy98OLj|2 |Ɍ=ɍcbcrsq\_//&6ߌcsrB1>>rܸ/4yy~㋋|7crB9rr5ظ\,scqILF¿ߏÂrcrrs켸|,;>Wau1_ $\)ˉcF.a9y(w0>ư1qq193`}>0 źc199XˏwqQFJ:b: a9Hb9!(bqd(PSB񉁼La~ b1Fa^G8(l`f?V.@X_fXL5/l3E\+?91~ s@@ C c@.J"Dt`8L9X[,IfLJy8,,l$CC4CЃI&2x\,"?>,1 rrrW|X!~ Ǝ@];76?uRp2NIWp=.yx8Xp˂<U9&d|@5;(e/ *&Nh@@I$*ǃQɖdx '[ur-/&hH5͕>bJ4S1H|<.A*0D30F590e HÀ q+x DpinL@U狇F$:0"j(`2D @'Epir( Rt<?TxBL aˡT!K2礴 !b`T'*D}$XR.x '??99)++3Sh"Y0&&bX0 ?lXޕQ*>wT邘@J^ޟ;cŃih* y/Ƅ,K2O2(fT+@A200#9YŊdIPP+9!M ,g2OZ ~O`#@[R] !3dbʹ ?b&uN48/G /s0$&0"OGDikYX|bF J6/F'Zs0#SƱ8褙v_7p &Kʜ⣿(v(Ȩ (*h?LxlR}hNN8%Q_'2R4[IE3Ou%aS:@8c|"~"%)%qA@` 9 ].ޤ%E%(Zy!ad'Z -bQtt(P2dQnB쐅/@]Q.O6ߑ`TO`'|:oC~nD2ղ'fC=s98N(si](II~"kA1P(:Fo)8PNkn^@/{Ljy@6%\xi-2F?1 E&^cE*)JZ#s )D| 6Kv#8D1H \R&ANdKŵ8!s"Oћ`HND[D#͞Q!_q4j,h|LF!as kꗠ[fkDTˌ͡ji' ,AS("dQL5bo^Qǂ+8#-Ob84La8D4h4*.|p:sfH=4tL¼h%$&}/Q=2dg&$> JI*+9\^o|pOvO0}^/b 5*^נJ[”=~H;5(,m*_CB-iX3ӏ<ƵB)K/ENrO tD -% 8)Zq,h8 !jNne?qt? {s2NR)1x3Qd姛;a?z⟬ԔԽ' eoH*5{{̌tmzYiGN[)%Q b~lH~1<szsZ1(B9P@,GG򨥡 gRVbző5bb?=vwB '^UP) ï)pq;JW%JO1 A,Cb"Zp2,1eTx2`@j†> P͌rH)h֝ B 1PM!F3Qe2RQ&BZ(C|N;)d``)܌9EA68+Q.'j!RqHG }]֎a_iF=/']0wta 0-4xD|H Ndk!';65i1D|(kqJ,%hiJSH"c-).S8udc}HHBjށi1Ϻ \$J!OKG@-)add>he4K =#"D"􃲄#F ܐ_. >9\?Mܒ0t֑IC@! އ%P,LN{S'ڸ eL{`?c87?7uboV`fz(+5,HɤЍ-W扃'O'&Nxg㚯/kvAvfBY9yꉓ~}Ǎm_;r4G}{&M Xw<7؞#`v^0-;`PfѽJnnW? 0Q(u(3NCWDm'[,c,"0$!hћ-c}S 0}@]ɾaZq&U]9Jr,pS@&H[*,GBԩԹE' CRh#ULXJa)# $u9FUY3&eo 1*0f2 , U 59Ҁ(̝PIh`NN.ȣ쨙<-z1GB}]9,dzѷq?W,I38 s=%i.C8oy6?L&TgM74KHR 20. EL߂i- YL*ɏ`8sҺI7.>+o6R-;?r+ dLlK5 &fԖLᦌhȕCA>9d+QBW.2DDCcs[W9-w@}EtIOr# "Jj?#{V|)pTX XΈ @ ?騘 |#Xld Ix/9s?kiEJO@0ƌCrcƌp̜*bU%_QW-l_u7\ϻw ۰1jKfL+333?q.mM{gCsNV aoϘ痸f?})d|`ƺ5Lʢ9\{yswG~m{0(&8 ɰ^mހwM߷ jSk߆uf6w%zv#S{MN;냣w|c?=xw+_)9jDql}E3kR?R2S0уF|59zvW<5s҇\͞z k0+UQ{nktы+0?آѹsq_vK?~/b]''>葜 ]Əz!Qtބq|a׊X$JK -"yShFBsz0 IƘxY07BHiC b}?Շ 88.u#;% ?s4{Hp (Xx?YLGE,+vٽ*!50)JŌ y<en}êars7f&&Qi?+]LV PWpu"Q'@)KR`+VadAC(2U"PI1>\0\@6"$j-.`ٌ"S0\{7 ]# O@zDvg\NNVSKH2Jx2Jabv;alt: EY5~mp6+L/BADҚ#ϐAEi1Hi3?z*c4pa_Rbv?<@V:| `ÌC=20@3 ?΁c~*{LLO"XTN221h#C>WΰHt1XW-„#o>?!,_m2EbBUV2n’=<Y Qܬ FtXaE\, DR0L}fIAbF!D` *N"pL(8e#(/!9?>Y1Qò! HM)=%F3֍-RYeݷ믹z0_E6[im۴ fe)d$愊f6r&I)'9;L;}} / 1d&e1Nu[jCCNe5ھu]պJpٙ5*kv;C[5ܰn^bLu؍'o~ЁuԱդ_Ə+/ɞ0oS mUBힷ޹ɧ/Udm.ywoUo-|WDo[?lٓ~2OS,'1.6]C]٥F =y?{廚ӡEwimE4+e_t=zEcu޾~J{oy+kVJXz4SNl۵{"w͞쵷GJGFLCe'X H8:e9RPT+o˯ X|_,W|C6|c91sjӃ4 fE e QgmК{3Z>`Zfh/egSb ynFT%ЉL9=mTinJi`7\ 6sh#l_^zYN.\OM B,$9iT-K@5QC3(sGJTj(E 2 챦 &1 P~^ /BņaKpØ>2JdNb-@0 0 XmF`.trdӔ5|hcZx^GBd|Bs<^rYSNVkadUeIȼnjI TEp}X([? hYS|1)lwD;3`,$ lVڞV&˲@JIc84`X AS8u_ o& MN41y'}z[Y ʨ`k,VXBŌlH#.3c]׊]'Y͞t|4-{߬[e?fd`_r[y؄.iBlI։6xУlhkT$cE :辺ujVq_lbI3x)=2k& @˔-i?T\(U ,@Z)!vǞ/1twVik2R,Q,ZSyf*JAԀїǕG"C!&,c%iGC7wWm)'$osez9Wy1 Q4[6ZXЉj-ʨ6s4 *|U OY(keΈR.s`CXeU5|8K&X sa/_՞y?ȏ(m侼6${Ԙ.p1B(|EZeDl ET,(dtE0 XU]5lmtrwve&a_Q5}"jLyApՎ19-bhgYBl%\ 'e:7)FaJz0?GX@+jXi_2 ̂UtI3QuM,`! 3?}cJ+}ĠXz?G%uOP݊Bs\Ndc6rJߩeduI" ?"&`._Fn FHV6<E_,;Խ>_k̦o1d 6C<``Iv[_uc{!nQISX_#n&+X}F[e LJk0AWWm3`2JLP$=hlRBAnHʇp^Xqri $1U' u ?eך(Lz[n(& =#{'ښS|2iA?1,>?a&L}vs2( 5ozjWر#dѣ߲eGj&O}.{,2 TΠbE3O3ٱz̽;W>(.>%mw6珮+o/YTK&Mr҂qz. z -Y١_7am0;8cvkWz~Ff&y\[=um^b硫d\5eG.Zsm^TZfd;nZ9ݗ똙 ZV0 P^2lb\2/Ïs/XXἳ&ސIE򘑽J"&s)s iA7mٺI(?֩]@@QSNă8%dNwF᧎O31lfR92mH}R(C .]:K)"gL鄀dY'EB4NOSiEwW~ ԆF^UpATA}/JdqA;JfrH.j{ۜ 2g\5e(Xt9eT$K(-?DPn;0z S|.=u 'Z dVGk 0-Ft*46nȃ2.Q7b )*ܵ|| dv&&tp(gM_;pUell(Q kjm8vKA+twt#0wKRX܅i`xUo‹nH$0(vwDFj?!MI$$8<>/<''3\{+d1ܢ"%NGޥHrB0# bN;HLʏ/Jߏs֎\T㎢e-HLII/{N'RSWP"\F-L|n_2!!9Ĥxs2S`+#+e*?QJRe.H,j؜!G1ƒ<_bqiJ1aIƓ"va1]ې֣T!T"$1; &3q *+(mfH:EQ!H-F!|d?tq'q!`+ts(H1RY'}Wp'? JG F~C-&u/*\RТkhZR7!̊( Ee?Bٮ(ˢ&PVz6!;SrRF~r ľ*9km/JI7Yٖ1ҷ  f`bו gv4 !&QĐTΐ{NyCApb_ܒQG*j宪;TbA2a0rא~ qj@X~DC`yJ}2$VM1{H%}jiq *C FT q/ܶiP-!Vd:K(V[MPj] 0&CyG7e6JL ,ѤRT1Ƃ$.G!ˇ$+-%\QzaҋR*1L# 0j:ō·i4mS*e$,3EG3^,P}q Yդu Go0juϩnmMmJR,*4Z7Th!L N[A-2WfjPIsf%b d=X #eJeKe0ŗ4@ QЗ<8J>X t"C7!ɪHpc9T  HxL;67;/>gy̟ȘdݚOD>u tIL,A,frΉl7 $*dD!)ĕr*oqtSʔ;i aӂ4B9?VWORY\Ò؟=[Ƞ˯r?ig*/\ E_68 JV!B ChTQXG'",)URzi+(vSNS~r$RM;KI1)Gjr*?Ѭ9 m) sd.nHmӠS1)#9%إPPInJ'CgAT*gn&Iq/Y8UŰI ؐf$1ǒNE#F/lʪR >_F7O>mTH'0F˗ 3 -'oj 5U0xQer,AeႬyL˴hfӄXH7v1J7whK)AJ& #C #cxw? -Y1uղ 6(X"&aSFK(x<<<tUiԼRxnr, 8?(^Z#@Q?`v{m i| n5Z`@E6dK26l[<7tgޮf0'f }Y:$Йf)ѧ~=AKtrKTz,$\'cq(\Jx$057 PRʬHTY˲%0@ be kf7βJu4V+0h(AA=u#1aݦq[' n*`=ƶ14|)횉b`O 9F0 %ԤCˌoa+ƻa#zuapXyq4QHhʈFh*> tXu EOHa q`Dyyxɽ! QpgM'.m$x"O[ۯCc` ֩QYv# SA&X!eC3EtYQ&88܎AF@QY8XmFfx腁5'aRUh0l,ʭ>dhώRsdz`a',V ƽ@ŃExcȐgS|Ak8NvJIf57a,@c4Z8rޤ\ɤ\) SИZ/ ´ ԈXIUam!Pk' *҂l')IM4Tv/!,歳XR,M*&%&ԡ`>h1Y^>bzflz Xܰ,c;$s@X~[f1f8.J*g1X,Eq6oXcMjffGf]2~SKxH4h(6-TF0fe \1Ø8d q$.L7RBtԸ4:V'>b Ʋ߶' ԏl[ E`̎d72̂:!#<02#פIMr^Mg FXDf!/C02U&Nf\nXy)p"c&1scQf"& 4sT8cYA84jC M~S= vU`rڵHKqh  hߘ`ݮ]FwAEKL@y A'q'3`"6y$_VfZt)d #d\)+<$KGp ٻ`)b+^h,ziU~YkcF71O]P䊢}8~eFI.ಬ~"_W8-OX @3㧘pfe]ls0?r,r]b5!8BFRVm?sΰm4hs=Y"uwqH b21d-dL֒@k7CoX4)yŗ5:E`8ӥp'e.oGL!1d/"C?J0$dsPR;ħܛ"M ~6s0mWGdl#h1C'>*XLO5!X3jЅd?yy0h lHrѰA 05qآg }jcŸPfXj wi̧ڱuF3I%)Exhi_,'5S ^t#;,/"eyo++$wOԬQD&L &PuaV۵sƢ`R;w& ?TWl踃x4<EÉ{hTmˌq "zÎ 1XJ30v)\ytak8&sf `k)hq]%wT\:$\ضx )9KF2Z|„4º);r^eb„4Z|E)h!URǹNI(U:]Z 3vX"B[ip:r k5vp*c;7'F0uv .JI99ᗉw.NΙ5/zUWy4H3؎; :mn]0`PFz οNJIIM.ܴiAo=rr{c5/\teǏ߻#\,r[#K4]\4X@CNL҇j[Ǣ4,LcF'c9c2:1? m,nTh16ضoX@ alG5 ɯdJ3D`ƜBt ,2a,,ޞzXdtH,Fd! tjNp)n2~wBjI3D1oNk!}rIO%.%a!1DY鮈qH]YH[%p e˓&H'/܋/'N={_U'(re9z `zgϛ׻oo똝&l2zzr[Q1b;cq?<׉ݻM:IC NOxGۻs6m^x Λr /{4؎aii)?Ȍ5c0<jժU}vmߩc5cFȓ%,9yݹ86 OEI/URv&O=8AZPN^,:NܱBm7,5w__Ba-[NH9*OE{s ֠<,{!,zA38X,ZwByѸH`-g L{xx0FN{N âDH<5<oRUi, OelEXcۤx 7G4"8,Ϻef.X\6EC5a!k ݲϠp[t:3Dх΄*dR!J|N,rp4!U>Bw|6*`a' "]Cu,X Cf!Kz dz>0fR4Ǝ0rT):3)u)Hˮ, dC'N8~X}뫭]-/f5ٲ/ܲy{ +ΟPmŊϝ3遲1¦ۉ'O?λ+ے{i]X>z^x[[,XFl[Pޞ⇟c)'O\ڶM~}׭|``l(dVd奪xHSVȥDFJr$E}W)Jo0bq԰z0ݒ>oI""_Sėu2I1l`R[¹՝gV +ۗ9&+M1C ih, >0F{X #hhICdTDc3.7aɭV.2VQzQ1X~ap˜(OL"]h5H n k5W b>- apMj !0LQ0cfl8N^ R~aBjMhToV`1W6-H)Fcz_Q]8 :.`oY|[f/7Flj f,r؈4E= O˹a= 6IzQ%h9ݞ,˿gl"!)kk"<5)uph 'ZHM@Nx''`*/_hR%JYFٽg=wEJ1N(Q-G jr}wO?ʫD''üi,t:Lrggg^s5?2a_}M }EDrʕ/wR9䣡۷mkwh?|]vi0MMKG8lٳ*$hR%ohݐ>n׶ (] KG-"`ʉvMi} {leq2YeuM(cGkd `!z‡mXʋ䱭>Gp9ޤY#Tޤ~,0:@hX?>(o(5SHG: -2 S-|:wC`c9vRC*=NC ˟@O<6fO/"8f0Q8,\S87(Y&jf9=ٟg0ØV8O&OּYl 3D )la/#\Ţ/zc"drnSF! ǔ,+O+79u ,&1))#= l >5~rͅM'VlPC{89&t@0Q+R(ΫegJFfvRb6kdee`P&)II iijMGU&?d &%%gg#/r?~'9saa'-3 ,>8p7o|lm$͢wj`N'т6Y$< dä+ xj.֌ ,l>|/?s8 RD Dg(%El!IuZcb{xG[%zlY؀Dqg,$ h%^x>-#Dbh>/Cv;{,$Za:ņ=ӣ>,.2 @^ݵ']` $b,n%OalEיqYj4 (s)@JP-4fp?. !tdY8 K4YvTxoK, y_a*>OPY8ѓ">%,l(lRKY a( [)tqMZK ,"附gh) g3 ӥOا,o؞3[tC״V-ԭ/).Ҟ23^sD7b!Z zN =7[+0"e ƼYT2N?ȝKP/wՎpߢfpum2rRu%Ȃ,Dž9kAĂc\uTY uv,l%Y[,Ɗۺh'|y,xXY5*CMGj\w*ЧXz@G=#8{5vY1'8 ;gW1VސƨQŽ*Aw+1c$j(jI|,c9vKEPw,1uUMTu& 5ք"y2Ń%.0fB:FlN|8*vQH k6dt4 Tu:Baab=m?,3¢9@ %">#z&@X#*'"w1F?2C4,OLVca*G._؃kw-x q "'lnd+c=dzkէ)y՗QXospv-+37eG\|<Q)>4FՅs2ݻ+_)5Z7p]]!; l{_Vb Zl,k+5MMqt KTrj̨\F`!(B,$'uѡas2*J'2+kT8 N* DM* "*{ks"IQYUaJd|47?"X`͛ gX2$3Sv!QM~Yܧbft4 alE"t90ؙa9KTX X(B:%*L81n'ϣ9X.E2yBJ-GM.6bJ)lg/8?{:ᢋ.Dm-r_lbbi3貴ŊQ+c2"Eurt0:m2 {pBÝ2]}j$Sѧ)E; ӇP 9,$L'3[-4vvf@#8/؂T63-19!4O9Ie\dJhMڎ\vV魲Go*BpuO\v1#i7,VhQ1xPo ʄ1IkްBԗTtΝ %K$Ӫ9e{ƩiJ ZWreԌEdu8 aIK-Vc+F65A &Eޘ\ǝHCc_>&I[c{a[?}REr129ð3&`q4!-K0*oaA %B0,B!X3W~hҰw\` 1 u߉p̠,dEV8DM?+.ϬuWl݄.dAʣrOF/c:}^x^կ: y̔iSVZ녗 4XJT{ҸIe,.)O+`3fN?rڴm]~9sg=dЖ6k:/kШU˱K`n6S|'+Wnպߗ~#d>Ͱh>zOvoGN򛯸G_f)3 Ǐ~8^N>F~?~/4;'+\}?&3]پc;|͗fLä[o=r('M;5]05+J.ռy8SO/a(7g5kqRzG5byArI쉐s2=eĈ8K̒K^|Zj^q͕*_ Ųqf(?IrŊ/mw)zLc6۶uOb|8Vqa#sp}{ |o5f#9{_|;XBYO?TV-*\tߍp.NJ?p4ܺ}ˑc75&M%Cd, c-sB! Cj s@&~gBP(Ey.?F{^6>,7;$"ćc@2@5i(Is0)i`v`\։?M ֤X9X6[<֓s , aݤF!0@B 5!tr @6aո,@FDa=f"G;y,NH)b` {3lc` 'N>,K}-ca)a.$BBn7d8w]wm߿o׮];ٱ{'N7 (5_^xn-[ex{G5"x3ywJ+\i3g6mVXyW{pq7~偄PT-ơ-׏n8?g.i1瞇~ࡳ*bu5̩WeŕW\sV>yHA3n-3)ta |%J"cqk^jgpY=&I.Th,Q?V)'Mg239s0a„Ą Nɳ]y/?dKFį8m9S&M9t'>i]dԥ .\VλQ=/e/pYg}ꩧfnݓ&s{ypF>H4?fNU],,\s?9<*H^*׌"(@XTiw!+I9 g  pfp:wðFJp:to~cbcƎU3ŸohrIS'gILf1kfW\'kZ;s;rwS.\upG;&M8rhd.̷kߞ[ot-`Qk:޹UpKE7x1{v6m*_T֛oV g萡/z*YwԭWӭ;tiٺݺUVlx6lҬ x)3}qcmۼy=S'QVx'%dG4Ɔ&&%GIPhq^5)O;aa=e1v- .PDOM]R`[ep v*&qufuO_`  HNUں4!]i~Hs0_RH]x̛fj黩\Eޓ?1v~g8#}/wHcBWecKp6! xqRyhG~wyzqݻo!uk>t+PO]~&MxQSzW^ۻo~$Gs5@D]l7rA v=գ{o"m^xKaQA2[vjU{O>_~)?VLt!Kf7[=XYe\~e~3ݟ D^.1wPTJ}9-١9^C}IdwȓMMmKW}O`(KnOKB I0H%?-T4!v|G ;:WRڟ""l8w׬F!{{fϛեK|sŲث >ρy3(e*TCCx,.7N1;^@>;D.b|bkT9B,f0*?7 +:bB>J\4ֹ-'kT TSD[~v,gu6 c2h@NA(Ί  zhJ8N_&s(g6 P:FB?f<BT!2S)ڨa6 B\1 Xhx]OlRƠ ܪrS`jn` ҅g,M  `Q44XzDY 8d΂x`1f ,6)L[/cd*c m \i:0 X1rOZ "Ehe9$% 0`cl֡AF aqt,tfSazq. RozBrBJN:p:ubouS~l™Q+'pWO/]w˔R#'ce5V]SAVmZgozW^y%ܴe3֛֯;aDݳ_o|Ys6kc.|󪫯jܴm3@Rb5۪m?G6s*>[n~_M7JN, 0{iiٲqq%DMʂFMa .ĺ˜}Vs* h/N~)5שWwiMO:uUV\s-$lMyo֯שD`M;Csu֌wyy=|[74B:+[tPqggvW_s3]+QuIN{~{5WϜ1kU}ޏ5|`NA=pvfO`|^ňk׭|Y"O;p,Ժm'x',_~[Yrŷߏ߽kWg{lli2Z@@ʅ@U ]fdl\B B|JMV2T6Am B< ȋg]7'/i⧘9BY?0>ȩ& cU.TX+a>*fe*$80f*fe ?Fxf::Un> `#PU&QXʋdP1F֤RE BFT \bFO,^=ayWMPqJh c67C sI$-\3뤪!E`!,dq&WkU`A, -7` 6b< ZgpC*(vRԏKNMt~\;IWGfnvR\B c yA$[,0P':ȗcn"Q۫ϯd? ;]fN0)>DX{7@soKPzz0;#w=1 c`An^@n=']lY(8ldN[(ZB c^ KƮOyF`baBzT\]$ɺ`# /1]}+7ycuD׎ҝQ n NI1 r7&yFlY!ȁk2HiaY0zd ̈58)a!<aIf(>?Sg>IΒmuId",c&< "g`i*Q-hy@>!N,T)WphgBdrYTVq F(A `.@:sqF격YɠȠc>2U'(J$10*TXCc@ߟ%FQPƒfZ.{rԖzɺ ]Lt1>xEw1E'.[2R 36x ,*'FabhBKV``BE$4C"8WFINy#BM|WYptޝ@gF&c'Jyo5l84cj\ Zi]dsʗr%?B1Bq#:k`˔х 8"Wa+ Z29AˠP5̀ F&GU}M] ~( {R~5Jr*誹z `fAT%%ZG,fPOrTZq*-E-o|A5ބsOK׃Ӹݩ繻[:HI+|[.[JP. HyvC]b c]jޘ[6UlXAAɌri WnhJ`_؁f1[;ZTIp:QzƸӭ(Ÿfܷo_g; х,>ȄYx+gU,O7,3XB-XᏉmɢea-s8ڻoLx8Zq=zA-^-ɘTUي8y9礤PSAJ*R(C 5k\p6R(@j񉛶l,[ }>urp?tQ8<6(1C !`{e͋e QƔ FmE,,~%L&9zb#_k+Ax,С(9΁V"0kÖ ʜ#ftw6"w~')Y9&{"]5iE}YGrn M@jYcÒL,lFgq6aq +--5ii!/;Dw$zڛ;vP5GlDn&N,kXgo  ;>5 /F\xLh{x^X,aP@8AXb;s'+jjgnԷ8"p+P0`ЅXnܼ`NFtr#y=q: ;(4,/'<@1{)T ?@`ԌH+ͣpkb9{@bqrfٵg'ZfŇdw8S(C!89͂IÄ={N~8{š03NR:R:EafJ2E )1,eXlQQE~C`̐Od}2M1\r k̆ O ) cn O8җa1˝w~k{ u))h(C .1ߖ,бC;?I^Wu#f+Q-)^ۊ9<|NᆖZΜ5Vv|'MDVEo̙;gZ .>Evmwًv|ٮF1"xUР!ŌY3+qxӍo; 2x_Bzj:fA ߘ5{R#PZiSƤy/> _cs%i_lg_ܚ, eȉwuU8 te׮[ݦen6ݞ톃K4rF /<~:= bUŒ3_u+V|gc^^;'1 o8u]hQgٳ+]TϮ=:z,i+ \D~ CgD_oڼ_AK^v u֮ݺ~_qcWzE /<լQH@"vb9sf)=2r8?#{W~I!c7mzt)RŤW,+zoR0i?yDq=rJ<'?ϙ;dݧs/cꎝ۟mժUOJerQRY8T_w]~9@۫W(A xվy }՗e˖,j'[b pa6l޲}KϠشiy3qP~͟%N.AH+i'IA^!(]_qо>}^3]z츟۝wkvjBO=0u{סD4C{@<Fhw~? /]~7cS_аAv/QUC|}ŧŒw9de+AVZDa1!qLv/gΞpoU ˡ 8k-睏vC m!.{޳g/~u=vbO`9 vۿ[A?o.&EEAJK+Tv׀ҥK`h!5͙7^/ K\W_|s{Ǧz\x%-/IM9 6HKI<`Ͼ=/ u>/ غb !Q3fa;?<χY3h!fT'd x<Ȅ#+t'Pvw>njXiRd}rP]lP+Vro4D/~=F3j1njϿ׬1!n\!,,C>2urC.7Q킿9_Xopvé'3[6K@1/o 6oܠ~ڵw'2ol>,W\q}@y@W^{%BWmPcO&Nu̸1x$lɶ߃(|sݟm9m\~uo4ͷU;vK ۤ 6nо}3TekH l=ЭkՒK 26o_lu 465j rr16oǟ| 47/lup;/޽ 0 [wmůP+;<_׮D}8OW}h9|r7tQpҷy{ނyR8'ܽv6ʫro +X'3Nسg8t *ic,c1>yTȣϘ5/G5dGkAśݺka3|)cWxu,Fo{iUW]X:wԵٛ}fSO؉#c{El۵Jt@C<С{t?7~/7^QGQ >l'#o뭷B ~_蕾pk֭+wہ7|ᄑc׎-'|uL_/6iek\-zPxcv6P2]{[3ienj\׺|sG4[o5#3_!(\q<K={nJy%K۽ogJډ5jFlOp>܂|oUc𥮽Z`C'SO\}6W\xb@5qx6l\7sE.p7_‹hƲ?7UZ|a޼yW^qf9td?"JW6r˥RRnd:xݾc{<WԯW0x AO96h{̲"b{2\*4CM[:vE.O5ow|c֭=Ԟ{.7^>=6/iO1uKor5LHb\ wc|?)dꊫ)?پs[ʠ 'SOv;ބ^BLf2NW_E=k'zбC&PKQH 9z8{>{|Ӗ -x!M[4as/>?zm0`q^̀.u:/0(iZi3~37h*.~pӆO4qXIMYI5Muڒ5)ާe޾s};6ls?7m^q3۶}ô:qkvNPYT=cvuN[[Sχ t(*'+\ú?*u{o/hժTPB'߹* 5 6._WR+ãz&<\\Ϟ]|;{CFŋk e+WAUDINx8ͷ.bV&SVU'W8sQJ ?rxW1sBOtX9RKmjU]jl]}G_ӧ^z 7xd_"uQ{nu6j WA5#^xa;8,O?S{W[NWW\+r__up<#+BOa#*^t 6M{Ckrx32=?G$睋 UkV8[nRa" >H"L lOJU^4s"0$$%@ӧs [!LU` U}SհO+ b/%ŌЊ;U;.;և;zɏ}M=f jJĶ.lR':MiUۼ,G6:,N*dgg߬,.ۃR n ǣY>5f2 ZGXGaBvl~ott;BU|~ hԶե4;=bfk)kU83J^i9h믿6mND$xӦC*+hX(•Az]XŸF0~ݨ:$Dl;|($61Cu&eѢ{1{F ^Gfo7Z\d\KOOŇu7`i3godĤ!BE '(jZzժ`_=4.6\odPњqun=sv׮] i)XM'Ȩ@%Bǩjł+nXFVQ6D^<^q=]i-|rS"0%Kddzfβ l$3d?\'uF_'LܿfqŃvr?66'6~<irkuK+WP6} k=Ѭz5kXSr"\QoO'آ]q'PjҮ#V%TSr<;~m|;S#Gl:h P+T΄HR"8L&6P ﮻ƍ Ġ틯<إTFد 5==555%x⁂;{Yp^`<ڇbBcߘ:ؗ]~{ò4믽|gu; *0MRtHX 2/zۭ7nFW}wZy^tEn'*}!dTݥhԾe&Dڵ Tt*qo pz-xyN99RC_}6h,;%;IC\0em95lZ쭷h;noڴmo=^oִi ˟]teAPu QO>C?/Xxmw@б>&h#)1qŊU@}Ӵs\9v3fL͚,%vZN/Xve|OZn۶MݺuS9k&/~}yӦMeb jQ/݁>#F1f 9c>Ï?t4-ےp,Q¼'%-z|nte*av@O<˖G 1Ȑ-]t]Oo|gvm$٤ !M`g/KtaK.i`16AvJ+_6k sJ.:C_Ƙ}cfwc`/Q@פI%RX<IJYfHN5zs4R>A1 }_ۿLrv(xqƤ䩮OalΜh9Y"_~mח_~iPkJ$|jᢃW^-UTuV_0 F͔˝Ǫl9yF_ӦN;gի[f,{VY(w%%''6)fA&͚BfgϝI+yVeM}K*V^0+׈OOu3?sCy~h!kgPЫF(5)%N3-eQ&I> `{[]w}~zAFٲ-Z>/5iڸ_WQƁgȇC>x(g|!p.{^RH[EWQ^Eo"G[?_֭{u*n磤з_KVT}<#GB^|݇B7m~ؑ4OٳgLM{>PIEq *w|3 !w-{\y' 1ˤA9Y2>ή%><鬏:%!KCYF}CѶ0 PY#9FzfX5,Ԑ~SKBaYs+VG2)F`;3|wHx."Ud̄mK/XR`;@uxawy\f)4aQF ;}NJ9^dR !:٤l} (,-_m,n_~6OrL,,̒<5"Q<SEf$y"YEh$ÎrpdOXpva+ν\YW,'@?S9`(S6x5!u~ЊwchdR7rxٹ8itAݶ:؅c@ :854fN67TOD}gNb(gȥØ77Kf4]*}<.Ci؍7кeh!6QC?5:) vM`lx7Eͽv73׷ 0]N!ZC 2 \ڃԥ;?tꁖ |` Edh :w#G%Qn~vA Aqê嫰н"@:4o4,aUS|8Q4#8KD#= P$I3v,rW{_xRP#3Bn^ ͉喎C- O9$:Vỳ.FǻOSVZ֬2v[Xdc G!Ti<{]!KO0%R`/xN0 B-glO*ya7.a-T(ڽ% mv6l8v9q˃ &E_`<ۆcݒ5o*+`1̠wf|`E͛DȒ-yIhrx8b7uD$ifI- >yV\Kfaqr0sYQR։ڟ,9P>:[2 5A\۴j A06AlPF=9u[[|C]3h҄^}^zP|hYX Km픫/,zB`1rLz9MJa1+1 XFau2gXHW]Ki?Y*T/:?rN:zX`o`ac# ct!"A[]԰ðhgb0 yW?.U=d a;  ic;Rl k|:֗",cWxq22̑,;Ʀh2'>I _362|doX%Bf/|T Q2?#!EۘcW\yŕWܳ`VO|7V"0v@QXHOrRZ&c)BfLJ)p*(c*aX<,;p @q;wsÇYcC}VpnĻOw}ˑϰS["~cd;G>y@\؉c)'Nk˖oa~"98ۚƅWY&[޷goRB"'*[9`3y,5 O,gA)jfؕw8]L iEMc7Ծ\򢈛a8;"E ©K˅-@uW[ >COu3Il*"ऌlJug[¢n9aP/2謇QIHgI+_|mP})TyJK&=eR˄T'OI(XZmEmC8Vðn.$&38gXZ'UE3vcfq&ѰpX,t<0c icӽ*YsU(U^'Bjbplvh+ÖBJT[[K'N3D>jaf!Vt9τ'eTBeh(.jӓ)`[QΝ{F vķSՒ#4G~l2"GÚM K7ܹUkW]:=yftQx7qFعz4^;ѩHr錣o'Ë/wlVp=P|zw绑Hw5.ਝ8hko3o7_P}~ϽٷnAG8. x}эF;mšb;%7uw F bM"&Ǫ#(Ò[j'tmHEWXXΝ]ӬFmn#NjSSUT<+ņz] gh@)\ ư{NO|4L@ h;]w)aQR`O.^D5KkTB°cj"r %|;/9d*4m!1͢;2XdM*n`yo c\,ƦȋT˜c."0,: 51wB[(XjG:!41#Ե@ oZe,ZSVH@CQE16i9kOBJhfnS|iMufg!埄2a b%-C}gƑ;.0OZ g%RBj}c.9P|H(n%CW"xl_ҲW_~>h[?B hZ հjK+CAX%4d) #]@0Za! UZZk( !2yL Y< Zژх$hPI3P16Qd,8YTý.!1z[I; 1K-cs c;Xx2cG`¢T-4Ui(:3cTFc^qe)iB*)h `[2uaton !O ǃw 39f/2jCHIyc;J&1) "4cQQI(K uPFD*;ŶˁomP]550o$lf-PēopBuq:b[W9Tp,wZVoͼ__z?*$9!133s\ਃӿs 튆];w%֨'VOp%愲~7Ү.g&+/qőM  v΁QVc9/d3`uAgQ~ӽؑkPի%;uSW͒6) ɁNFe/Y3vVWۇ$$ +Ʒ؍- [˥x"rȘ{ɘ`QZw[ l L:ڞ6OFP?K&:pgX~E;ˮ02躈DވNsZ$=[}qQJ TO(c"Z {$JPJrҙK_9 ^IAJIW{# lR`˲U2yTq32T!ȝDU2Es,֋ށ"0,*bꓥ%1lFzG69H ޘ8%O]ͲAۏ B*կٽ^]] ,@/хWS=X ᘁ\d:kDI=] )K`2&=4LYb 9dlQ[0t{a,J.uCh2"ʔ&N֛oݦ͚w݉@*}VR%qlreJT"kzs8 Vxa3ߑFoS-%4@oP~P5Pzd&]NTs ԅ5兄@R5%C#ʵ|PIB\rt};Oy1#KYV\;,f?EǪK4h`?=XMJXdxAeN"P+k`aŹ]QmQ?g 6[Twbh'y21bWf7fTnrƐaX0)TtF`Y"Ѓ3xI)aƦ0C. QD|b͜׃caXTiW73a1RPER XXZ"E@ [J+t-X 22O1cJm7t!(M718@bBJȯGxENH *m OD )v&p ifE7z=@̻\ijBueOBj8H=XBQZ/93?ZH ygr cf{ئp,R^^8S&>4b!rڱ^B덏?RrիzJ#ffϜLgLt_vgm,.8"| @%-jmdfkUJa:'Aݤ<*s2I t+.3sBGzH0gv~0!ʯZ(7"&ݥYbW\u3Uܠ.v/xmntGc%`2AAL`jKJywWr?W꜍ S~`ޛ]@x RA#GE xK]D}8<[&%XX?,IqIB6$]x iwc0aVØ`t+1+ztٞRqnVh`uDQU Wpn|=BXlbJT 36M;jlR,ɣ4 `܌ T=C.[ GdRRS&ԋ.r-+ؤT(0jXmkM@e .6~ͺ5(kצ36*!z j@jIx tck֬IIKr"m>-naC Ys:&f`~mLXĎԒk?y [do>2PZn8صo)ex{@(MDPmi[XYX#>g clG  6)yTT8nf#䐄րܭV6[԰BTdG)X oiJfͩd n;CwA=Dt1VMwhZ!݆ C M>6iwƺ9 ۲{.çRj+^FJ Eah4.QAqtR\9`Q"u-0iD\ATjcqv`ɔkVtM9 \tʕx8g7T5cekrl8@7)3YauN7mۺ"2tNޤ~\HළN[yN:ѣJ|~ rCiœND1lb,v-t"Z7DٻO/iPr&`.$!?06)a@W__mXE.Yy!ۿ2/|&cRCR'^yakX$4%r҈kna, .6tĩVZ:sjWTboܸnB;ĵ3x =K}>G<>E?w|:<΀3t߳w3pj!>.+{9h YpiُIa&Vֶm=S>Q,p+Zb֭t{ú ۶m2ڴi+WϤ)= ǃyXb̂T''{0\D\v{qCbR2.ZϘ5 23ޠA۶`@sĭ,>2\Tjwtzɟƌ¤=IqQ(f/UGC[$16Hҫ^I* 9iTA&Ťxywkoou7\kdB3$PΛ kZ7ؕsZ|:pл H{%:xBYR.%uk`d՚53fuhFfJZL\ c1,;.Clذ굫ܖ@ܬrAŖt\z.]̙?c)ӦM_x9q={w ` "}C}Ν7lbNwaunpMdy}^Kܹg7NGs '1,jjXn&!,n&WEMlE1a R\('2 x\4Bê #FbOؔw1sW ln+w]L ̼)cufqeW:UzpXEwjM FTA9hNl\$ԵӸ/3ru.% S\Y¥qc]RlkSnT4m_~&M/eK(w֭7ڣ?|?s M@bYsoܶBmOzmK~_|u 4s|Z*o'"LofѲe}܎C ]jO~2,Y , L[T4YA\xQ8YE鼴?>ygK.1,4I*ܣx'+;17 ^bL;za34K,x gpp&.{E~Jzdy'~b"yhX)O$,! %dda,Xc ?Jba 42XfLq(`q EQt] c2͑;b}pH ,Y b,e`Aw;7o߱a?\r͚?r֭_5eo-}*3H%>?0qʯJ76*~PUj^1/Beթ^;wcS'R.lРA(;YvY%3t \]GBB7=@`uAU܋(zK./22gH=ePM2n#\VGۡxٿm.m|J<ίsϫ듐3nƫVQ;!Hر2>ᖕ7?C)%7U h(n/f4oզez L 7wz߃]Vp9 %yWF){RT@xRx15hI÷/cۣgwذGY,Ȃ,߈9j48rH]3d~1!Fx$)(/xIkp7nbE[ǏUWipwui2g}FKɧ<7pzkssΩWڰB+ָ.Bŋ?tA,| qg&rɪ޽ d4$0d}%Y1?]yU `5yj|6@y2xB_ QT钆bEI6mZשUOp] UјUρq=.@811?JE@{.%=ҽR| @uh+v펧Ǜ-/iQzvmxQEV*o$,KH:СF͚H~!;.ٰa#7'T5[ zpM |ϾLy^pAF.x`p{tPl;;2U8gyXmk~LyR3S8jL=KxЌ'Tq1*$sZ " ER8WBc5 hF}xz) d%# Hg[3S"i,Jv>)O,`agU= 1DV=ŕ6nx^$h7mܺUkb]v5,G'X6zw+TE=A/{Vٲͯrqe :,ӪOD4ovóYE-:o` ./͘>i#S-γ7TQamb`*'!2XIS͝f%- EH}D'6PIqŝEa_wW_uURp%a 4`Yn5跅_ ׂ>P/|n7l؀haU-U⬛o{M62tȾ0 r+V-7gΚx;vᐵ7u vZc7+hFLvK"v¥{׵I&mZ]THfM1q?k׮A4h y _o'V+nkOJHb!qW, i&Bw\UW_UJ"IH`b#GHo9]ňFժUŮ64n=3:?=W\u9^;F>CvbU>.};;߅:؂]r6%4n2eȪt&̹yy ݁o~2!͎/|w=8;5q/h>6qxԩ}|{ݶy7b~ȑ,Ⱥz4H:]Q?׽A ɳ̪V ׷߰q#͈/.o}֩Sdm]z ׂj>Y|ez[n )TjCTykA~vZUV/V2M6A?!xs5KNw޵%ͰQ ]/`6ש]{Yi/Qd6KQ}o?t07NDH]kh'T3z *qRxkiЄc7RrsQ.ATk Ng\UV0܉䀪dh`hRT\S0[줟Jp<9lOKX],P`S?6m/.fj+:QCB [%󈦼st5! :o b [ zxs_,T'pb< &q:&aPH:IIMm?K61BQs%4|c,R6 a# s6.ҝOh}ʔt KX B|f^bUMrl:| >\4 w=Ç})Ů5c`EdO&ӈx oG[tS=N ,LWȹaą/Gz?mj6"#u\nj~,)aȗm,CwZn>(* c)&6Q'A`rqub 1!qnɋx '&,(HDw(cgøvq#0cE;䭜<;%WUĊWUKF0>qEh/]jk̙?,O2"l&ǛQf@P,I]-GOtt _q-`^’`~eA_6n 41"J 6jޤ假,3w:G,SxŎLӡUTx" kTN״ 'aG`A5"y vV\Ǖ͊%<]*XLH!;rJ.CHYL`տMt1ʓ" &܇%au16oq`aVF A`)(8TEVʝv^f4FhnKUuY ʪ(ݱ&T F!! ,d7ELT0'*1KMb\t!1䄙L:IbT7'#edAۃFMG@XSZCq?1o!øQ,/ř.CjwnRɌ]W4kE8 Bì ,%7|h[:kž;e| k X@ .E(좞 0tn t4cۦc'S'Vo˚R/  |x~dB] 4rX(C4rPu~5'm'ǐ7l\sU(h~vg!˳;Q'.R]83r뢋\By8rLg-TKh]Ocgy˖nܴ.3mۊ@>9d[;H53D:g_Q13fN y&/O9x [{0 x1&_} nT?\8c9j-+&NH L6 :7}X2z̝n_2貍s~9R $ )u {ܸ~o?%(T?YDO$7D2k4<,s&XX OLC]ƙ1 g͝a 6\qXVl ̂sIՁ 낱"Pfx$Rs}'a״ -(bȐr -Rꂅ cNނId e%*M %<ƍl:u dAVphxSB; 5EɒeP*}B{ϟhRKer"Aga5>9r4FuKIMC4 .O,]2@F&v"pyH-pgؠFC1׹R#μCu޾{p0F;p&S>4h`NN6|8ylퟫ@e8<ApڒeK>f}{wۋ{כl<>Ed>>yE:u2ߚ(ScSv]*[4]%6c]5̼.c[oUہQؿ]ps:N n = 6v믢v{hZϠ)kx+oUOY9JIy.ƭrNQ)(4oS45j(R4AoK2:M`u6ڶ5t4v@}>SbP tRV[۶ly8y|ם0:-˄Ii`녋cIJ=xWFφG)(K}6kբkf vk;|+O^z7@~FVt1aa('V: csƧ;~4oGVۨI#`w[W= FP3ܞ=kѦ?ڼ}#oҴyW5m-JU:=| wΙ7 M*׮5$''#K+'f^BQZ5Q"Nȑ?b?\ F5ϲ aQJ? l&cǶl~!b 㖭c@)KQ۽{O xWL+l7m~G7o`GA .}!6/ipo֧[PbQIo^}5^~)fArye%ض][.2, ܅NMTӻ~BB]1̬u7^׺mkhv=zƇaNAE[TR%$[P@AFaf`?ϳ>0wwwwzkg=R5iLzpDثׯϚ; .""7@jCܦޏ#2}c;sI>Βɓ9`K8Ap?a*xQ.^;:..E`wJyjh1:¯͑=|+V-*0F߮ݻڀO]:w%ܸv5m70`d ƍ57G-؄dž)W&OaHAsL7nG 3Zi ?汬>Ik(?{X8wI&UWo˗5m Xz8[54gN$a1;bRŪ@~ԭ[W:i㦯 ;j?cA&|×R\b Qmk=/N]}'~U2E*Ӧms<|Qd\&}SY"ቸk.73[߈- .Vz^7oܹ3.\8۴Yq/Z 5Nc8cwbg~ܬPQVU\t{2W e舡:zˏ?Z첽"@Ѐ?R0g@߿Utir^pтsf"u_|];u`vZIQwީ^ˉLŞ(|x%pbLaϼACl,^.զmO~Z~glUApUGmN2uH8!>C82{x>_Jϕ;ax(N:gΝA ޯZjoG.mCďƷ*]jUy~CdM2ج m۶| ={͓T.L*hµW}DŽcNvo}@ X]/_fi le̜gϙ5J᳀ٝ;rP7=zX/U|{13ѼW.MxS F8UgR5_Gȱ<2z~[ ޏ5b-,HӣǴoJ_T36lݾ^M4^q-8$xϾmڵƬ@m|x#_q ,]<&1|j`CGūk|Wfv ~΍ժbc}u|ix3h3']0e{ޫvb%z,gs?v݇q@؞<1f=vɅƹ g.ե=/˲Zؒ<}z;c^la"r9rg'Obɝ0i®];O>yСwo߮m`nPY`JU^I}k>yҔybGh-[VHqƧҫ/bjfh.bAl\%.9mƍgp|oJ`b}u=wx#F^:fY˴ ĉK N gEԩӱCk׮#>Uz ]Hm۶%O%Q%h"MC}]+2 -" ZHrK|N9'QF7hܯwS N9>^K_NfM߸,{֪kX  f]/"] {$W2E %ԶdGDf t+!d@ěk͈Ktٲ@,48ӧJc2V7j:wx:uj8a7 L&0NU>-4h"y lc._ S !MUcƠq|xns #}jLx)Э/ŷnz>5L:%?VUP!~aʼnUƝ&Nϱk,ZP믏8 KOa'Izߓ7n=`lyLz!郇a[w'/P v N 7~{9se?{44YakNwH:|'*/io'LJlVNu Xπ w\ @uԽvI&%[rQL4Q.ܯp >lx…`a`TLT˴!NA8#oKϞ>sWhNQ5l~ú9sԮU @;WU*Cߚl{UmZ!K  W_/[~LY2'J>7omwbڳl}+(;ŮXys;Vġ3BԨ'yufF8Y7o?zxޝ Tg!k Ĺv6XbR".i%A1X'@Cp@`r.LTHN\LcN[ރJaHI0Iۉ( { @=M13}6x,ce kl|:·Ѱ2S~9z\jVW2ձS*ժÓgO%K 4s+旦-5ksWh!Rn:ycLÞś?fPXXfzÝflyFncgϝD-_|UnΧ=1>aXfmLF ;l!;"Ue+|{!My Bbp9nx7`0UVw^,Sl:6 "M[mEqаE3̹yCƓ2ߖװwjٻⵋ>;n4:s<5/xw`Qf:+Vl^Pm5Ԫ]o2ˌϧ۴)R#xYW4\h ^t"ȎU;a .B ['SLoa޻Pzo+NJ];b64׬QFut".AWL9 hTǫL-Z(] t5)!Xoa[jrڳ ր'ޏ0ΞSAoܠe`5iım,E޵{[*T2|42~ݙ>g&UjӪJjV,uФoHx{.OmVObY JժVRXlٲLiÈ8~g'@tlM;tjFE8b7nߘx>ܽQv?_vVSx(?,^Q2SMTZujх73gx~~~-x"-]Ի_?X{g@njf̸*V"֜:w#*+KW,wx_0ό~eʖרa=fI`Gڄ޹ga 6!ydD7^*.W.ݴwP+1̓To1b`yN=^nԩ F bwnX#H Y0"_.Q R~[F͚Q[`P,S  h'AhU J/ 4W Ѩ9 4o0/&OX -S܍{&6I-gX!ɩ|~ʵhkjڂ,^/_b߁F՚`ߩ2s.Y5Wz5d%80 2ur#,&<&}Ff^:5yg!.ˆ c(x_X}Ÿ'>0 go;wkϒ*V-5ojoif͟+$Ur@.10Hy3fmo5n6`>[ڥ*Y PSrrO ݩ8h9,^I& *1%HQg܇NCA;*# Ȁ'ǎBh)(CV)n1^k ,A,CF |4Ï}XDˍEMlǏ,̂m BLak޸@ x8'F%+`^~@vj`@*l>234Dr7>H"W0fRF00tHM\aL+k Lf5@2$Zx556r 4SrtP+nU ^$y䘆ɓ:ϱ6tW/f RsY+OG ÓהUCQIWy@h2)Q%7 ®v7CET0iAvB |?d`ƧQb.E"g)KQERyCIJ ӿ/hSx N![ VR$* mO(v !׆TKnHG&  MݔR?"bE2`A'N;o< %c߿o?^îE݄ gZ Rjs )NBhUt8RUP6HkfAR&4BR|g7f^7Ҿ'4B·pL#*">R̍[6\~Tom!XTGlR:ġ ?i.YXǘrd1e/I}],z8e#Um.eL@ ~J*靼cKn3|已x)S gϝޝ{ Qzf02a\PXPk 0 `tw@k&Lf0APLrd!-[ӻ/KFAO"nLlbrΐ χ7+g31cdjѪE_Muةw^ԯs-Z۫s'o޼>pxUo_c6q¤\!b ` 3b+΅Q6A >KzƖO|m`#?L0gpa$al?ABϘaz }(,/LtD6@CA/GEân"hM)'2+c*cƦs.=:t$ጠD vT$J5Ve$R_k>jMMmO: l$bHwh\Ͷ9ɎSDA016v\LuePm$MpYT&g) erKOFY|͘jr!` 0~3#W|tqԎ(1 l5*tJl) 5Ql±Qj0!0a9!#B/Y~ߑ}s7!v"N!֭_^ǎoש]fm۷g>d Vx%TZHk Sdw!E  w;****oXE~M"YdGX)$~̱ǨrR=UPve*3$vqb]6 s0t,ҜP :92dG&,l?i!Pp/{\Yt1YtTmPDccҔsj`eԫVlaz%VOă,㬧` mY؀"*gD`k*#e2@Zwy^TbЊhSXjV 'h>_ S% e5ϕuǥ3Jɰ]u؀L) yjoʠdÖa4NT:0 J4Y,^ EcNʬ/bS'0_/l`spj?jD2PHAV_Ѐly:eM@j,e,_'|4P%h)mB䠈( Ry,NPP aUlRԌ e, \;-_v !oo,4ڊ^X÷Ah*B! &͞=(ƥƏ#Ǩ1G#]`U[6E1p{$nC{yhXv黡B}+V/XD?n0$j 8r (xbSys潉D(!Y ,!~O,9zĨ? W^}e֬95khױw^T0:ؾw>)0SysTv)6n.v%iV})I;ypneGR Oc" =NS+rD,2>L? - 4)鸆8):7G]i sqhFٛWe0Va=,S^NCEFp)33c?rӛؒ 4#Ă4D& ZIIT3y23 O1.)DNG=I(1nM0!G'c H(yPE1=G섈\M")J,Ȯ;,lGvέTX~a%ի/1!f&}]L!B>8k$87jH8|yHF ʕ+g?+6 dPB* \Rk1ᶥgO0`@?D=oHXct`6j0[D=hF3Iے* J̇\[X8d+5YQ E茆Q0zvd=v vA e T &NO$^3 FJqZLidIOOX:KO/؆p]] XbIP(pej&IN3-\`֞YÅ,jdyPQf Pr?)z7Εz'=8ЉKY]Y2l3q_\e`,DXNTq/2:auLE0e2P/M4PfPnG]GU(9KQ9aS3Tl!16f-f jm4Il ;RD( H$ 7 >sVBE(Q _8M9ː dǏOz-c)U Q~UIffI8d̂E>/Ү]{@1S Pd{8η}7obI<1W\2Uy|Z@i$Ӧ^hE "=k8㋔ĕE9p-oG mky,_Ϯ[OY= lJgIO.PLf8g^ϳh#9&L+csfϳv5:bDl\ر۶n~ZVZpi +Ҋ7m֬k+_ţΙxѢ?//>])E[dɢT>/LGTSposl%Up#;^I:&2ܠdx DګHÇ~fb}8^@d֦l].QO'cXCX4 Hy!LnZD#Ţ|}CW1>w/5> gC<=0cK9sf׮MڝUk֜%0SĿ?qY_zƛ)kwyg 3B6i|$=|:PBm YLMݝMbg Y%YLm$ Tf葅6Bh#YxϳT^>eQyEv>G@&abAs"u'.B?ZOCбC6~SJpG[A @0Ah:4'ލ*/L1ht|7Fq*T:4E -Nkumt,s&-g9豞R_ ' @ h :#ApbzCYr ŀYn/<-4;\rv3$6Wysv8"m1C ..I>9h:FS%8(n6hp>I^^U `L n)ԕUlW - ue&ҠsFʰd!YmJܐwnJ^Yĝ1&oC5>Lk@urS# ,bX iD |# K2zYj^<[w :P1Hqϝ0~)Mtr҂kYh^N/pS)q)4y߻n={Χi~((ŘJpX S'A0AaH7\:26HJ:', m7-1 J Gp 7id]lpD"8Œ䠸 wI|}Vk:,E@^kZ_@mA 6%rzax8 GWHP<k<2> ŤA>cC0#$oGIS(?cQ ʹYOG)A(R|K7e@su$1(2 =TtelEwBD" Etac`McNluN"Y񹚒:F > Ń4,ZhnH7Y0;`'1@zīǜGOX%v._Ο/_z 7md=v5WҟfSZQ@8V;i_D)G;ѣ;V0 4|t>K.iUS`c%$):|(1׌^bY?EIqrO"'9 |{yϯ7[FF^@N8/ȂR@PQg?F<  y]ce$ v %4s#22?^z9X܋TqAtJdICs˖ѳx:Mߘ=۱uYsGI.ֲEk"A: TC}WΣqOc6d9s37y_JX QHd!n8Wj X_d_#+1@Ay Aseц4.TH7T(S"FOSnC+ƴ8?E2 ,Zlj)S^`1;Ϟþ iבT1XǘKDvn65ЂJR@K'J7ƼRlk|X2K4 B=,E@{C@S^b*NR^[@tbőJO(<1Rlk"|[胔 RcpoAq0 UehMtWr`1 ղR8 %1ߘ}=:H) 6hx,ǘ˴+ K!Œe;ڪPh>̴@"~+aHl5_ Gk;5z!v8h6-[G%0n<>Ilkz֨Qvuֲچu~m옱͛6~l߶P֭wgEW;>tp5$:y׫dծz6% .MeLUY o YP l† Çȑ#Bo!߼~;סÇbG߿k_o&6g^D)ֲ\nhAB2#hFKtvʋH|,֠[4ץJ"%sPxdcj#@uV#"1 @*|'rbǕR`n ItD@9[>Dv썧yO L> tGF bQM931 %y0>!JA,SV& Fg]ߕ3 7B9s`_ΙV ̝o_4H) HȢB RRXi*tcku! & RqCi!"62eZw@=k3'.YxmEW"%'ro:<[sQCKN }ܾȍ/_>|< XTv݉e_zx)UyX}i›]wM= 9[jW <_swΣG$O;U( ^: s!Q`_#DxU%H:dP0Bq)qqiw! ) TE'&[VcгL#.4.&3Z,[x~>wR]' R[7J[שPZp6@|c~SÃkU"!), z$"xI/mV?Zv 8bC3H]vlTl#E!a+[W{R~{Mp*Ƌ}u4H9 ytºA,I>H j`bbQ/1d+YhQ3t~hv4Gl%44SZFbw:̝'_|!6 2uʡCM:}tbwLc'OcNQFC0LưnvPrÇGK kаUW^}︼..;nرxM?3fXri̙.^z׳gtHDv,f&* ^H>eʐe ˦}~OPypQ0pS:f&F˜$}CsɿM>p|a-=j,XP}U<_O6wޜŸק 9رce};*ZlȐa$5&AVUVyԘGN o'+KZ&_^~~ T aݤmstbV=hq[#HR9( )85)s8m$SH"z6ը*F)M5 0&r/Qu7&HS'd!%2@uJ!Y=i?Zb C@|RW5sJdH$ҞL ,<}[; z#>o]>& a[4r %I#zI :y rk,&<0gJqr`mQ=XBMJ!!l6ˑ J"_~W_K({XB':8iB%N4Ȳ\,ibDMwQ BҶ*0$cBy( ̶0Aӏ Oty䉸&7ҽ4-4xPPpܨ }e)s,>6uC 1?:?A@]2m <:@'L0-VkE;;Pnj 85"?֑=rO OCA䮷'ܜbXH/ʍი8. w0\.T~jRxIRŶԞRha<LWZ |ͦJ+^Yxc-+Tgl>s@Sh-pGhOAdЫ1H#*0Lx 7g%# *(MNdZP5Ha)@n4H53h*pOmYwGn,rlzeNZhF4+1j(hU%삒TSSoOŸF" ?i(1xޢ%$E|z 4#`]j>DvEKA@S8x*8|Hxo:B/Zn4pA4ʛcpUVp[ Ur֜Ξj٤U<e$BC'T8q8$vqÍD )AE+.,ŲӪ0s֍)X`+_Q(w.],c )P ^NIza]4Y-)"s (@8lrѱXG FA2@0]B[f yCt/]@3hB,Md(9:]b b %*qC><ȂB`7Ieb Q dnAeՄ_p4b, q {Y޽+wJr̹IL8މC&O|m,H4scњ>{Ξ=55rH<:|p \]QS&ND(!ؾyG@ˉ༌zE[ߦ" 0ZLOpDaDRet$p05qCw@Gc[H 4sYb0"@KAj*=@/  O@W/c5E͘>cc~<He#wd/Eq;|,Ӏ.ExYA& vs@ [M ;88GBP1WIpa $n\6m qoٓMEO#BB^p>K}ւ9 ؉ OU̢FnR((D , tA0q9`}\>͝px¡f9?K8fQiHC͡EKQ/ɮ\%[nٶKNX,< 9r3'sG 3%lM~hr8 9e#,<۶o[ C^iӧUX%7#HΝ5'nHEP'Owlp.+ ˧(=V#Dac˕+W|y>X(S l0S+^=5o "6n }Q?)W2|>des۽3o<ĕ0.kO ~Vh6ș#_|3gD)Tʙ+g Pk׭I֜sv);{\9 Ųk.'ٲY&g CYeٻw0Mx#vC3{EK[4)6m'E m޲%^xwtwISYA~1b)yѠL\`YBIAgB}tHh7]28 AV߲;/U&^JBXs?d)VQܜI,:'Qz,KC:p'a N8[N8 EiMA8 ȉtCe*EKs 4˻"r:7)v+[BJ zHǎѭ;m㇖XmMZ  5$:yˑ-5} LTb+th~Q_N'DM#]zٳVBP*=ЁC m?s Zoڴi  fŶnۖ*Kbk]wEz:sv^z۪W?pv|Q#)ߝ[wP]z*Vk|a-[n82N25aDv~mJ,;wܼqsn=ui&lڂxEK&JE:y lްy̙sF2ĝΞ9P«֮իVέ;uKKΝXyT۲e uG+V/i$wol9.~}Bl[Zy 1/;z㤂R r_,W@XʍD*[ 'WVF*P< 2QhD,l +PZ2[4s>k Qxda2O>l)N*Y`hMk^+ZQl36V\UlEoKu@:CyCLQl_-P4bAp1'j'F G($Jx'%q**y)QjfqnU(!^_N{Cr8V/~;&zK%rڵ*^s 1ВiG Y- =AI߷ J8)7QϾX8o RV(M6kV{Qaf.q})ҁ%H0Eh}{­èN6Vgo&9)w@IZhh)c{HRQs b1Ř_'Omʔ_zĔl:bYB2i!;*sgU5m=CrLx+V-[N4d;tZJGe-|Ų͛[NEx'Lbi y̹3W,[1`@{`GM*۷cѠ՝wBq&f{T87iִӄyq?ۻ;^EߦN]fM…gNOxҁÇFԯ^j>Lz!bP2+1p׉&W^gk&LЪ%\:9-I={!j5+^P/涍i<` )y̱tH8fYT$P61%),-1Ɫ=aW*u3WdpʓDNmqPOP2a^YP& VD9SMQY0ڏ㑅Ő_GcBGk@G-d3 da=D0Ա+  A$wţ 1 /ȆO*JG$e*d1e&ĝdOTʹ*ޮ20;Kjx'3mR,Ȼ+ =# EebS֎!3weQ8SdgR"i$LOGA?S  7ojrܘ{i}cc.?8E6v3-8dPaGm۾%p$(R/#(qo;ڢUsmٶmiۮͦM[:ة_~\ܾC;p k8vܘ~W֏:!c눡ðV 7 7nᣆ׮We@oP?WΜ?}֭G^^={vӳvԱeÆ 8Id3τy5۞:}`Zܹm`~?zz %>j`'Oslv-pf͚jbi^vx$`5C_tQF[ڳcwd$>qAx Y3֬\re8bկZ %du!F"?WYմ~zG:֦mݻ #%Nndr,[Ov"mG`[0D[l19/#o͠p14lJS΃[gOA#۟>Nr2%LCOH k'n„ ^KBۤL$2M4I'?y3|12*bd_#-Վե,bZYR^,å"q[Bk h,ó`j# 7aGE=,Bd hALY*vl:f=( [8D.G]3Ts9(RB5H%A,3H/, !0aZQ.^^Νp0)SgƎ?Dĩ]vۼ~GB#3x߁^`qr@" g(i˦\9r)'RQqٵk'YXq#dElǙgC_z)vX !zN4sʰ*)R*(2 ])#?sb")Ox*:K_"r>CiqKʒe%$pvcD`CT'TOjգ&D>((᧏}PKyli@h=/,fG%v#w=DDfne=W\<"P w<pOrKa z?V8MFj# VdlG%S #C#^V7*@(E?lkO[ 8lI/~w=PÎ慘4xO #@$ R[QyȨ-T]x:13*bTZ۬,P N8^XZ?Ԝ=ICϳPBYLFCjs 8u 2r@&)B,GXe cUźd1xZLgdVVwk[Op򟓅2gMXM'5dqB1AAŎ "bmP=j*+uǔEL]6䟫رb feX,0};YlDh/| U7(A@RH.;wo?| ӯQ8Y|ߦ傪ݿ]Wn\%K=5?w:[v%5F`2`Z%`/0< Աcg , ^ud,͝3\pɁrfm?^I_3ۨdLP!|e[s&7yfp2DсE 6e#XMa14ˡ<N1zIF^ܖ[(+E g͛M܉aD0w̹3 rj˶th df|NO@5VޭOX]I/`¥V\4c6RԹkm߽oaC{ . I?1VSz|;?-6@T.ZY[|T*[G#*!y6 ;3U2|X6#iʰ=C=6^Wǝx6p0ѣ2Ж      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnoprstuvwxyz{|}~ʫ|#0e=e/>\4ࠡp&Bڴk#1,)\kg5m!Q EIb5 Rf<h)ŷM nW CrSFJˁr/^o+3Ƒp3G/c"y=lEU\Q}dAP2W]P#8=#5(Y(d4 d%_( ,6+\J%:'6|@`B7 峀 $ON0'tGV  >02e~ \Ią-XԵpBqx.SnJ~_ "FHHJ-@[.^:?~7ӥ4doæ~ŤhժU:p[l;HPmǶa###C^bY>@칋nq~|0d`4 Z;X{*WR)7o^4h C;~ȷj*M7yf֬YҥK[lػ@mΒ%CP̙3ș [?QrP,Ԓy3h?0,׭[{NULZ\ o)BǶq%OMUTr߰iC/'~G[7ϖ훿,Ů;1X_[',:t ~rJ{I! yr 8àRp65̘ЇXNT r1G~bfczh!Xz9 ,;SN:,\Y|DI}d!~#FH[pRTdOj ,}d!n,-Y"l `i,䲕,7#diʗRq 6Q<,6CϒJF._*L$>h-L_BOff.:2X}!L tPlh ¶g4 .SN<8EYD EG;#'u+=*(4e/Y,Ȅbjʬ&B4C|{dGlD*YOOд,HB~AcB|.e)ǜX}eQHMzeMdRR1^Y,M<YD/-u2H2@1G/@Bhe_& +H[N]Z-E>.UEnټ-gV״SK/D<#Bt0a\.Pݵ;ݫi[6J-3Rz ]ɰ>ʪfh吱X[J ˙6 }ƍ)M | Ah;gLcSKN"-,^!~}_f͞04^a~nlz޷_hwoW~S<).ŏ8}#{.g J8iωaM 4С#ƎSf5{ƒ0ÍtucƬF}_:yS/~[@Ѳuĉx06w# u;rL?F ޽sW99C4knjYK6[lP AhvTbmڵnz>\VYo㳉l/(~ZkNaJ Lm LD%,3ycb+[#u):C-:Ͷ Ց`Q X $,$cQQ84RfRcւC+؂)+F}(QSh]0j1 ԰2ip_J\#/kP$#Ȣ(zb9kΡCGQ|>b{m苢_~UW^Nc&5^رo~u3-/4р0d]JՐ@]mV QJޛ0aB6 }[e˛7'3J3_#^}= ,8͞9Xb˗/4|0Ÿ q~ 0~""f@W)Lxdq.uaCVXPBO>!!&S\5C… #RP (iҤǍ?}TBqn֢)L*U>+ I%Pɓc'÷ǵ'cƌprX'M}'(R&K:V+i?ʐ%Jh޲ҽ]z b|оy 5נu'OY3֭_7ΜԱl*Uv9pqØc֭ۏ"}+Wװ>>5J|Sg8hLAG&ҧ/Amўízk8kBX qR%A;dq,/ w)sd4x @&O_޶[i_TRv]1t2;9PWAij[.^ J 6ju-<؁U*O`!Y+D#JG3dI^D-~Dj"`yt" ^5*jk-;', ZCbOzefF%5n}e6MH@m {ི8NM;"m̚A"XSX0_ɻ51Xeq+ t,#bۀ&)3 9WǨd2 ,A"G]s8NTl’=} `NjK/**I.plH`pڱ^̧?bO(X)F.4fq^<|/8TwEKQ)`Dqp\8*TIhcl+ڭ-) @\5QNQbn6=,ajJ&>-ėYMg;2x؉p6^h |DkјFNѢ\ <όGPc* E)>$ y%YD7eʒiϮ=,m CA #pм:4 Md~R0(0*ci"e(Neԏ`[ Mif`lZFBl}< & ЉGB#X>N"'Q<lq¡Pw@{҃o\a#/QWBg0Hl@QʒqϮQPl1[R-VLjՔ:S<h\xxys`?9H埳#: k3QܧP<# 湅%6Ek%$VD)N |dU:摅RgecEhCV/,8I]Ob% 88bbu&r]?Кԭ_|e jH 梨B/T O\ R!]uz H3`bI}qax,j3Stze*1+%^4!,րAEYDo" VQ9UBO TLJjB*^y9;lQUӦ%4S&J#ײH,<ھAR. s a eYd~M=~Y8˓ ~VsCYjp>3fD8xĩ>߃!-D2k[%-@ \бg韦GJ:fd#Vp K;Q <ƈDB{(nf"v#fuPXQKT4$#+6O_\Gz/O &6Hh]6~HLIo?vlODg(|- ~b:zes.H iP w*h"c 3`X #̊:\4/'bVOlZ,ET_Y L/% tB^Yb쑅3AtYس1eZQ2* c_Qe6G-fq/E Y0)A/hU6h/"f 3@9t_YLTqGY xV4Y/^YIC[@bB*# ƣGWYyW*#2U8 1v`4c-M (YQ  )6d2hkmb RM!5}qNF%ErW P2c Mgϓݲ7H1j6nbj:c֌b`!;ŷM5ٴy}TlZk3y %W8 tP qܰٲQ\ɓ,TEJ{p_]p`vdx(Nhc.XGVI"") OÑŖFωP9(ؐ/z%UD5鈲< ,; |R4U1G+{,1Rtca|ٔs#_ %4c%qaOQ= Nz,o1GgH(j`,IԳ@/r 3ص] (K,:'''w`_F@ ܨx yt[Z`|y 0jӪtR'EUɧF@~q۵k[TC2޳3~E֩4WKǫč[AYCvBCLݽwb8P uHs>B LL1M&$x00D$a@:)upy@ۑ Ὲ tHp,oJ?{C#o-bh `S4qܥ?%_,|: #O[i$T$rkPR $IKxs<(T![nB#l0 w 8~U$  )5[?wP1bj֨ѨQdj >|؂ TRSxɜ9rΓ(t-Y2gɗ??"z1۔YT #%ڥkvܝ+Wf?ۆ iC ھcK>ܹO??*UT`9ؽg(xQ N{XL+?>͟|!7(gE};=C@|PJ;.(Y'$kI&,2`Ԙ1:]b!7jng8x zL u֍jU JfO֮Y3{? F>FJF?d0s,X߾|]PJ~y䩓,4⒄0@Lw{fׯD%6d ݞr!xG($~q\6*.d&Y NvRbXhWilLBcdZfb8KᶟFr2c) jB9#片!knVL%r DVO+ o!Kk7+Fa܈z,$'3ɂX* v(nX#L) K5cEz9>/ S{t:iKKC2N>+ Ja{LK^Y. 6Y,hM\> _$Gu/΍eIR(&n\zeaA[Qcqaҳb_<-Gt<\Yh) %րv*Ul:/bKg:v*g1 %~fJ5HeAOG$9fz!hC9Ȼ ;_$PˢcCݷgg]hI*`EE e?AfQ&M\ly{Gv14MۨcGyG8̭׬^z箝׬C~V\ipqT I@ACX\b5L x1ܺq HסCW\uɟK)^8 "g;kp|x:  TH{Ӧ!yV-)mF x0̢EJX&MTA޵;s5ǨQc`=xW@uk޾u H+mC%*8u5j[Rv!{Nw%ʢ/7nk_@l3Φy^={ժ^w>7~(eZ edٳs/$8:D)OGޡРPe/cn.]q^Kz_/dyH9`EbqrƐ+̏dIѬ/rWZ-Ec {6irc9+v&k#sdZ` j{T]8A hCZ]Il0 ba8ڦV^cp{Rⶌ e*YSs_]AkB5 $ؑЕͨhRj@~EMW) +ۀ& 6 '@k@Y uJ!u᭝~,J CS,ReϪES9<aW_es]Yb4 e/R,Wn*aT=aB.Q wJW0P4M7To>w˗5T`F4?%F'8x2Ze9Ba4N9Xq#f8څ]K8XGK/c"0uV g: $5Dc !ԷV!foU|x2ΤRHH-bOCcP1I,@"3YRpU(,E3q)2ժ3!ɎUAcAd)9y Wڲ,Ql6 G0ᒅ9Kz|,l2 _=h|,Kda& [ /eҕ_OFL$:25e~1e4Y8,A*uudx/M11pr\;(4H?1&~ sQo\=L͑_?~썯_]n]jUҥ9bԴ?~%f*u =:<x4I{wx^~wud'O%J[B@ef:q Yl pn BQ g͝77nX}ʕ4iwbi:ymZ߸~xZ (8@$'W+jYoqƛvmڡ,cSxZ5mm:iq4U8z=={c{-'ꙓg-oUUTeJ#^]w+ݾ}=xHBCDtxSZ &A81չ* BOHξ\h'k@iP o3Kj$2Pd@=Pk61Y| c/"ĆHHBж,JMHX9 QRXpX eu"fBY4B4E1?NEpSʥU8v aȅ6Tpz*5KQdQ# ŀ(5 K|7 2č+X`dsAWRԄ_|fS/Xg|+:Z"(ޛ2qSdAJ 㑅 -'xGepeU, >M#G.]YB ^E ]YdV+ )SMhݔ,52A_eMm Af4@ R1Wwzd2pVpWDM4H}[Hɔ$5VW=u6n{~ڭժ Z4B[lܰ DE{)ejx3݃ɴn:8p[.w\njƉ1 S6݊*7k֬Ǐc]ޢB ȝ 0mgA%d,#?#U BPpՂNT/:96'a2u/{nXaZd>(O+lOszx苿--̪2f=z̕t"Hi/o^|[JULlY>wGբyK7G8 1-Ao[@̕n6ڮY:K, ݸa煋0R7#Q9\fx۶m`Mp_~V '|8MRLݹKMc3{_|Q0_ϝ9s[^7l\Rɵjʢ†#,: .*?9Ysʵ~z 7hj N-DZԩRÉT/;M-5c0r L^:0gʔi>E׭T S<@*6qǿgZ2##9cF_{( QӰ'8SB ۓ@JAGT 2DG&Зbs_v"*@Ry}| debM% GY&)3#%)IМ: ]ߧ޺uQF-[`[-`K>{&8!|)1B 9՘oXKjmNtl\NPThҲrdݭu+-Q3fBθt)=/qx,WY/geI ,uAV^ Uc.),<-=#R;߷_dj@d4 _mh׀#h&؎:ǪP00#l|,>6,euU!dxB-2 \ LEydCyT&V`'+f*aH҉(ED "šf͈eImyH믽 doBH ȐҼsG[0*E+i8cq^y%rnLI11IԥOR yM?_!1޻ɓ%>BD),CDC5uȂw:N<ܖRNњ/B0KƘᥬrDdC L( f,*V9B9 `˅l)?|JS>Jķ(3\Q% ; I[ユ9c&b9}EΛ4͝7 `; !~ɑB?jќ=;w:hqRE+&ˈQ纠U,a$6,-C 4қfĝl TH|#e<rvhQw Cxq"vB Djpg d< GӉӧJX9r7իAAոqO:(aqD{/HI#,5<%K2sO:⸣R3w$RPpc.SW'7>TAe9G m# e8K9ùh)@N\l€+e8a$㜒otǒY1<{+ˢ)ޡtK d\YB Yvz- Eh Ԁ-/{r@?1dJ>?-_!s lPB!L-gw2 8eU@ 4n`CGcsfϲQ% ($c7DQ@+ܞ1}KL?ihi{x2~qI^W/B&@x,3g,d<,Ǻ# F#$@;[98]/ր2HY@pBP c$t_Ԁ>P  ϗ4P:S"2m8'8Ax1۴n}nNYˉap$tHdɅd `(֩W߅cK<%VR%J!"a+7 xΘ0 H/ZE>+\F5Px)Z+>12wM*o޶ˢ_7oܻv,TuJ, `~ə198cV-p|-ѣ2eKJ 8K7jSҭkz?1DT~A[ᰜ=v\sA#(|߰p… lӾ  +~y7:lݶ >ԫ7)W`9p T &ek.8"xD3E9q ^H=r;wm7޳Y7n([Νs߾=hPh]&U `M6ȣG xN[/ y 6mZCǎCcJܡc;C@S g3L8(i$.Ẋ>rlwC0WzsD-Jɛ?Dj՗R dF*"-4W3g΄N߰qL^/4G6SXݼnjԸH )ܱK|M60^0,#%\~vرb2/(<5|B#^%Npv7E-n7eJݽw3R `hϝ9_ܽ{WCoǶU*T%$.Ra7]c׮mܼ!$nhZǎssfc ;wǬ6fɘ9Г*!ã"}tgL]Ka)}f 7UKQƥJhu~(2 oE^Iª%X ҝ6 w:Ia+c!c% >Q HGnDzR{Op˚"Y؀"DGIt]4d!1dY#}dQ#qi2g)j^u7V -ө- /l@֌ #KlMx0hG)qA-F O98*gn.seB&hGJ|dQl" O3? z|jaox7֬]ҕ~/(M | mT|yxZq.{7Kp+V; o/w@_^E(y),%xXc;4kN{ֺ]7;ݫW^;voeѯq_̶_vmJq vL^}~Ya{5SHFU(߶]g*UK[ +sg_O)uP7< a*TlղG/,yG?3.ۇyL{舕6D)8BS?CjР"臐i\|yAWYSݰ;AtMiFD Y@Go)mظܾe["h=!'"鳧ݸM9GEa=yE8X khOs~j@e3VQMy$ᣇh7@9t>ݫ굫&u,>g yA&:7ȝݾEڢna.S,;y K_''[oS7#5˺ kEDP194PZ#j҇:bT`۠·-& o#X U),BMB$k,?cƍ%8g4v*7gިcڵmÊtYj?$oBR]A%[T:I\dϣ:#:mGM{X6&EݏSBHpS&; UwU/^0ebz10 s܌He}U$X3jH7;o?LFFbgϞݹCgYŹCx.a4CADI$ )rRjM#2X`T><Jqt:_<+@Gq#wT5[5:|~['eW?z,5EO#$ pea=' =Ju7]Y(,+Yh/j@_]YbnL~~K 0% ze/*W%OJ 'OkKNYXqGˑEJ˙b:PoEWb|eRJPx;ӎ, HV,_V`ҽ5`$kvDmɓ^u[(y -ܼa\ѽb4i_={v+V,884";˖" o[aİ.q*ݰa/aI6&d8YX"` =o0kM؂wfdϜdH%[WxF"ne;~Ka_0o>Λ?WH  (E&f +T.P@N;;a3tPD6k 18. gb3"7S{ۿJ׮^E #fM~ zXϜ:K8P{eڕ8oXre@Aۿx_pv?n28vjPmQFФ k̘䬈~ݯ7^|4iC~}l\%kf|5k W'V@ֈ$J(,Iæx2_,T0WH҈OR8awʗRڷ+̟߼u Aa7k3oh{aC-[q.|=?3\?{O'S!mTK N5j ^.X$M˭[;g[2d̔+O.Rנ.#g'[ v6>3gɴ}rzݍ_{ϝһUH7tr  (9e؝KH/$N,eG͚R8G=[&Kw>z6m:,f\a fq¤IHNpمK,\ڵyv5Y3eǍ)KǴicK4aD1H@}(=~(<3믢Rx63L{ b;lO$Cfx8e%A#\9hp U3szsE ^K&]~RT'܎RI]Y02~LY8 j]*D^Y|T+4O&+_4bEƣ7 ϗFOpC` CqY},:_ǔ,tJe`:ݖ-Ye0_Dd2gXe9蘐ZP@gNmo:uC)+/K)oÆP8Sf$`e oJA>TصzCK1Aj4p^{tJM=-RiyY; XMw7P5)P!G ^<栘7ꃟܨ 1fFL$k8?O@q%ϱqBe!<|T;7*F&'Sy487{m]58 3e5  #2_zA5{L0g> Kk_Oc]b3bQ>gv1*O)k@3'TnF6n[uSz߷ .L wPCO3#Ȃ& pqq#NR,X`|E'(I?{PoM̟= n- ~sWl(z @# Β%K-/ W?xRF3טn d VӀD7Q >cfS$)U)xƵ .a:3֔yD0_ C{O*$V< VDIJe NݤZaB5w u+< K1r>Q;ȉMm ϥj1%Q ɞZС5Az,J/E+7#MtIy5`l0N4Yhʢr)}2 Y\eVg5 ϗE6aYtadq4e h;q]hQGo}(aɒ ֪]}vo}*w~9 9Vؚ41kw߾,2K:mt`%8w<">ggdJІtpE' D8AD")_ ㆊ{,z>K/~,LzojǷ, B+ZVJKYP2N h`Dp~׏86ާD/HqƝ/S0!YkV.P$B i8o@+N8:N׵{crW+7%wEDЙT;*'zm#!wB!4 O܉bˇ6m\jGt&H3RA.P@Oi,r)\]eTWVI3Bגlj[M{TZ!lʧA(C*{([SDs46 "Fgb)|љkㄺyBR]4`f-N:{&́yQUOO,\偊! {}VU& qFy)Yz+ iߩA干[$nFE:>+QdHb hYnKoPe7dSW:[8X~!2,$1Ye IЂ@V3heuXxx -8 ;wo{3{={?sSŐ?#RM,g~ /ֽkV10fmK1"P!97Μ|26}c}}!p <[n;ugΜxcGo:y$}QQN@#UHQC0ԡS;V\90IتuF+Vמ8c5Ah$Ma`D D#""8v)n Μ?{w/ 䍋N2hչh1Z4cɓRZh5 k2g]D7n(%8 d AqQm8#bTfECeށZenLL,EsK+υdd ^ˊi7y/{J@,S(ٕttqXR}7)5ErI, E%YUtٶDBc][9Eu B}k>b-ەE.^AOBS +t)M| Ra=- DM%AK.h#6HJe j'#ŚpFS)hAi]w&::8`#N'qPZ5d) +$ G :S>+ nX"ɂudA]^$M+ɭh0W*WM\YԀ/A,j@WgcmRU eGy8EE0V=# ,ţ ͑?5=4|FbF˦ b#WHApbxL)/X10sZ=\ڮIiJr~-B!/A|;?a@>dÖ L0}_߷׎]Z4} cŀ u-8~N%K_4 n) gEo9jtik?@Ci8-_oM?/" Kf +rjvlJ)D р! 358u4RݰBB޽}3C@6m[ءC*U9kּ.aCΉ <nۮEo0te+bk2ueKjٺkn}=w& E"d~hcG&o{{ێ`yto5 }jA0B S y߽{7KHK+4B"=w< ^@ܧ/aYiR'N;/)fcbbqbPN,Ÿɑ&. 1p` ~$EO,3|,2s;D!P!QC\T}(T`[_0b5Uhn&b)6 i(Iy0=x,+A"' U<~$6RxF3Z,dQOkh(`CT4F VA[h!/\w gu"BKgPPqu6[WX9KL*)[/(xnW.7d|"#& ?Ι#oݻVZUW>zG 'Nj7degĐVi۪ /z5E~ 4Qw%74J)Y%ˆ :jԈG>x7~!]ŪϞ^h#8n#zè| 6NLgcJ Q. ªF?NȖI˔. |gO: ׭VoZ1Cto qpSdݔ͙BI1-5PAW&HVO}>? V $Б~Q$ۀN)f#yj# % f@)[ S7Ss:0-tCpVM&qY<ˣ˜p' 'HL8EPa< 1ϻ 71v0Y)tP3cIYP=WڮY(uLd= '#-ԕfcJY @'V(#Gcbrj1%$ Aˎ, |Yl,V(=x[d(#9GTİ<#ǐՒ2C#0G)ئ ,^Y He[02<f8 #miORbag/ ?Uk4Zk}WgI 1YDrHiO!7oݼ~ ӻw, 'n쁿c#,9d04c9vO~ݻw,vc)62Fb x w}hZ, 0@h'oCݜˏ2~4)PCM/<iD%KC&܎? ^q Ek#K(i=[ǁ T/ժ{o97~&g?Ѭ\BnaNe\d>CXIKl<.dd&5fgP0k%-;DNGXE#$/x :3P"X)dq&yeq|k&=h±*VNY{:Ry,N_|d3h7Mq&5b( K3@lHZL#) ]YLYn26xū؎,60bE`ǟϓ'WWULV,rܝH_hD~yFkyp:+K,2p1DX貕 ]YNRl-G4%8)Ӳ: h| 9 '+%EIaS?sXR&ylo˗/A6aϯa{A*>;*#-n EZqr̙6]5k֚S|PX,$fRL:^aaa ˯ٲz$1Νc)^܇#o(r h8l0cv٩48X!0W^F*^܏2:kC$Hu}ja$cLX׬[SFu\{4޸A7xcߞp޼|So -Hݗ4QcF;`/^{ϝ; VC\fɔ^ 7T^A CE@#"FET6k~F!4$$FtiDIݬX\r\bߞ}I'>8#[K/?wРƎ=r DJj>-`V׌HK.+u=T2{dQPРgp"QN t.H<# 6%bs+bR)dQX[HZY,)ğESRD{|l|AtG}d2,d~)swӘrXb%n@L?7>(}!%v5 >oV^9xpays#GHDa}bȘ)C0'iӾ޳Ȉһ?} ˕.7gN;ŏ`ƌ9r(T yYԷ|+8 ܷXhq ;vH߾Jj!EfTPR?O>ɊժVF[aM%-Zܮ}x3@^?у$d흻w-I*UrYf GH4Ȱ/a~ȞsŪ ҰǏٻ__E% pY~˂ <,j=}&</8uަtf=\i2 poTk)S$ҨB%vXx;HH)#+U}XdoƁaw̄1/Jub\(PW>`v:grÒ1#V'Fv>PJX[GjS||">Ҩ Ҏ@PӢdK7i1mۡ-\_k{uΝbiאm1J䡋jM/$2oLo/ Y`Ӱ'= -AAh@'buxCv@D2?T~bP0lc!KXRz$zHh%sס1h }D(~. <)Ztt O3E0r6 Ǒ &IkťEڸ!lJkHe*BFUf!EƐC%WZ8Yb:yjZ_;5 GJ {da[2;@~2)%epɷ_<eMeP~ue(ı+ÿ1&P˸%#vdwꭕ_RGGlڜ ^vŦ-Z3"%J 'ڠ{UP%q„OΚXRa׆g~~MPC} Qqԥ ׸Ԑ$p|;GΏ?0+.·ʪ{SLb64Ғ)O41$f"RU~ JeW# .Xx0(6p s. +P0t۠HUu! ÄkȅtLBD7%KNd,:m =6KhAB4 ID1ud~Kk7.Z `pȃתի]Ը1Gzf,ƱK4%.`XM&..X<O~%,[ CA[tAl&ãm_9Q VS M(J% n1%`:},"b7,aFvd myPy13D8YAuІVi`T/ SKFVbxGs5IGgRP<.! .ʍPd~[E.Ya4,%YXG@+Tx_, Uʕ ]b.pedEaJzdQoՀ*/pdᖗŰC4r__Y3{3Eɂm$YR(u`\& Ŕ+ 5iAYkLeߕ/Rlb*,KbNJ6b;G5~QlG}dqGGݧ&bZWhGh&"ADx<yf` b>|b o,Iq p.2`5+qCO9y&2  $BC-X`ޕd"Xwގm}i 27ĸF8xPEYPhg>xxm2poQ8gϞK\pvKʫ_,^x%:FChQMRVzraJKw?Z&= y+&72Ӷ-EqFHߓ}zx( cQL04wKce0*T& 00XEtK*O `x'Ȃ\B!@иQ1d cBɂ;b,JNl@,BH,2:Mex,<2*-^dd![YW_\Y`F @Wx)7^Y*dόRh0[d1 /l@1;2U(datriHH<q)At??t̫D9?G U&1{"e+eG=x#j5T< }H!R82[oRVHc箁ܺu[~[BB@,P fIi쨚 4Qlۺ_~\0؏J,aǮz~"0 ԺM{^tɓgBҥ/_|Y\|':p…cǏݻM 'w,[sH;uԬY3߾m즫U~ƍYsݴ,T^ڵN+U*[d-7{w|Mp,%^{lٲ)^B 3>Qڙ]b IѯVR#@.ZE /Z:tЬI -U)| +Eskyv;ǾO3GV@U B:*V@:T]G|N<[V0d8&Lj52H/5 !Ff¸EHj M.hވ|gבmsmY,d|,J[*_(:p͖|d ",܏#VV%JFweW<"Y\eG"s~s/^Yt%IIcn"0,^Fź[ R ()g,,M ν:D(gz+3H_?&{6mrwB(r*7f^CGB]vI8!qle7ض1<2zX FPӱ.5hߦ=7#G  ry\"J-rqDB t]^>hc-Aw J4bt+ݢ Hb(]"]c̵{/W]SX1X(I>QHb Ra=vEcFW9%=۩%NWc1S,ա@D,(^Rx#O'.'\('s(9a1LR`9Lo$9dfZ X aLTS#s%uLPF0sLV($T`OBXPBE*{Rb Q05-+Ej2\Mߒ,alYX\􌰨Pf9aQpWX$ca3wX;6>KuZ-E[Xd @e vQY[Ͱ,q,S|,p%A" 6a |.f܋]EUDۅ6"cB8+.TvX Zde!V~g> koXT'9bjuRXBa1cm]'R߰%P20,>XNj 1NJM72hM6?ұ1^GNrK1_9(AGi~qs[8I[ 0GCap,/ v6G6{XʗW;oO]~%WV݁T ~N)[oᡅIL6O2^PE]tᥗ_!T?zUի7 jV݇o1kꨛoi5o\+$99rh{ӽkg}.l;>fJ> )ik9n&)?$={=b婵KV+E .IV._!P,FdQ+$ $xFό?@1Yf1dWThX9 L~ A]RlNd(*ܖɫCl˥$ı0DC/qY( % a1J"T`!B٤Q$+ V1"sAU;ۂ*v=ϿY(G餃q[X +h\HfX?Ń,,$2y­5"p򱘺e{㔥XX2X~cAk}VcGCĐ՘f;a *|ȫK hg,c1Iglcpfda[Dbˀq]1Xt.\+X#Xnh.|,MXL)) y<&tR*ʰñа_M!I ɰ;QANF:ETVNy7O dm|! fAŗ^RFR> K+W~SOϗ$-"]; zUsPux~n%TxG}%K׮3p©}~5Oin'c~2m6P&b}5j@If=O37t}+V>,q[hU-ZN4~UmQj orO]H"4W\_~9瞱Tna<ې*x5mC^scr-ۅh>2dM2FXX>pQ-|\HW/,SzIhYb3NtXҀy&;mUcDSi ŌB:@Y r1)),F! m a]o;a(cam3lru ^HXp,4N یoϰň22l]BaqwR߰yTXNuR63lt.hX(R)U]2AMfJLN2O>^ȇ駞,yg{Yp\#R#Ikn!_^Rɬ4*kf|_!ߴ8OJ:p谡\w_O}QNx'y46jcA@c@ҁ!-G*G^[8O2tx*rs=7p+BY>HɎ14CN8)q+"`Iߊ':mtd 7cgAN.ĨR7h>b]mįXlM$•n!^BBq۳c|^ɭ ClPȰ]7 [ko]Db9aNjPNh ی!&*&GLVq0]q xF33 R[0oJJ#@$eK.1B=4&7hP_=M_kwBvmJn_AɅʖ*YR> N_cr5D$04o ;R1q! D8vJc(;D8b&ƍҡ@to`]'*97Mt𹍸8.a0ƫtr]WO9;<R~X6H#ԀcFY>|ty StBl,:jSY$'N"_5k " 8Hcc?|7{=S_zG$'Ob f\ V#Wc  &~$ ܵ JC2B/)~}''$n/~>{섘DӱMo8AKn.vOM(޾mfڷgowᄃ*B۳攩_خwyT}{gź~6eCh 'HN `$u۹s"+KQrQDIm +CA'04UH|,oA(s$Oѫ+샔BXa`!Q D;"Ə\4 1,=Si&^) S1',$%ubcc;󑠎Ih [*f(FVń>sso>fd'UB" `Qm(pjvU-.@ byٓPka1BVUk9 ۅA$#Y=\*hF lXLeU+`t}yXa,r5l39gj3l Z XTJV ay9C?I# ;NͰ]'a9aXd 6l\'p pө gǁ6 v\Ҁ9mj\bE\gX,7"!92=cd1b1vƒR 2NMȰAJrvObq-BrN^cy+HJ-5W]SxuWPu7l=aaU\4 mJ;t꤂:v4%K\^Í͛b_QN+weСX Q-Z"\rɥHu 5lrMk.Ą->U+U|g+q ~ļVL"*P~K+_ڿ[n2x4]%k+^8oALm* e6.IUA2q9 LD&- nPV>C jy,vx({X)ʑ*D=84Ԥ-1 ODJ⒎[1F&@PvŒT^ÅfXHANiEqEQ>: .A4W$ K@U*%ɰEhW#% ev`5O$&f*[8$ bâH#%Q!4!iFhXa`XS 䯌oey tX$%.m;>&`*0iٰH(w6ZaaF`Q( ;.-rocA, lf]aa%%`:q@as{Q33 bNP%߰#PH,0d4>;)L 86TഉtJ8/3N^G,E%nփ-"vԎl&%~݆?F3dhH~@/Fvď3Xoj%m2E޻_3]! ye"w`U7kr}W!w" W6\[hqw[8-Gf\K|iyQw>`s p-+_Zv~Uފц-TT'&::Qq4ofmlLuji"W-R^ze}2i%R[=)?d"bmz@A:GVjBXdlBBXUdKutɠ Qڸ?D!*#/;*ӽRHN_{Zqjꬓ'z~Ŗ\)gl,W4K[>r3/KUX7HSُQ`aXxC%o d I Q3öθDd@/+]'nHأU g@*T{S)*D [MbdE"2vfXH8Népg Í! 3bqT5"zNXq2^as)H kUQ 6&a!X1݌A|,ȍl3ԳcQ'^aa0C۰ЀC5`uRvF 863R:·Iܷ[0X EK'9wܽ^=H eٷC}^}Uu0k7D1lW^{ذ9| {vC15OԹSB="hGz hm۶ܹw/W1;o?| /P;ސ*م*E< G Ff#7#BǂZs5@JbS8DJuBmNV[ qP\x .E[ku-lk>ohhGT"zx=֑|a O; vjuJYA,(,&FS -gc{ϩ&e!G |Z1D|°hr*,vxX\RL??x8:.]`S/Ye+|4eӖ`Æ#=Rd+6<眲 ^fe%:_|}1vX^z"j…U'%yxѠ~ڵ W^zoOJUeVfoX_D6DzbLY_#vZ'3brЦ+>&A B[#S_y:1\ + $IAݘJQ!7K8ȟ _>b&B3npUi.ph@@F5h9fM#x㍥˝k <^\I? +׃=  hEyϛďdsq: 8<8Ep-J5fT˫:yi =Ƕ%=te/Hgjo!Ϙ[3uV:Pz9`7p/sE=ŒM``mqy'ӈZ>YFAD3JNM_9xMD>42pnBA NȄ(TK*)*+54>,X<@)c簠SfXQt%9A o9r\<5\Ƚ OEZzqH\^h +/qk21B; 0c&k,` ࡄx L~*,@@%RBE<,f~f: 22(h>3lƜ .4lf1c1(^`&+ƀӰ}rߩ]:;%. uREJٵK7ȰiMHnngp'宀EE߻ ţpP =ر# )R= ܔ#.d6-Zqˋˑ)3{%(q ){9KJDNԌG8r@/G&Ps1ٔW!4.q`FZBl($`6dT{œI@7sm7GZjqx6 8JyXDoa*@@)~>"Q'bkzȪ,sUAX8:,j&VRwsNmNvQ VhJ67]IoY oȱK6h- V DR5+]IV^jX8'r,xx@I8 X RvpZ,~2Y:qcQ pXLU.ĨLREZ֨AbڅT/](J%')1rFaN\6G,Ac0E},>v 3laq3"up L1Ͱ},2fvSIge vO,@G/7xzLݻuKLʙo))t`^ռ%[;9kO=.ݺ8Sh"Ox8@=> LJ~۶(Ly{r?]uy晧0qdzf=4x@.]x_5'ݺwx<-syqcҥ3JK.XNQN޵k5?hRv/`&Ab)dIVw?Nl *lGq7$$Rx-daaQ U7 sЇ‡PXa_HrA,\!a!COG,,z|IA IIYA/',â dD0슿!E= ;irc 7J D+ߝڳСnoy렵+/mk7wq=Td;c/x7OI;>kL+*i?[m"T ;wo;r;n'e˹ ;rt<|W^ge"ە7o۸k:kC }h‡Q:qeB ciT?ڽwglیwӬ\7iq-mO;ۦg}(ݕ⚫7o2RPix{={*8EaZFZJq*o3RRM*pOKty"wRXfx)i,•²Phq+E,(O(4TXp*DV`5 V jޯf"P7Sf ERrj֧l`6d0RT1i<s5Ft&/ OE%`_`͇nXw- ϜNФۺm;6n߹i-;lٱsӶmg[w=(/v%B^#~4O>A0\+uEnOD+nƾzYSO>un .\hB +TTY$+K_pB ɓy2Çļw.IF9|tA"=q"#O<,[sY)Ep )S.[}˫jҴIɒ%ztOϛ@ .S@ŋGlklB9˓gMΏ;@$Cuw޽6Br`APiڵf͚]h,=d8K+[D=gמN; o~wa)[9Sܼ *Pb$Oe+\pхJ] +أ׿m{-[K/ŷ`V3nHF o-}.N-&Z_ھp2%N (.ZY;vSL[s1e5h@~]˟{尓Ö;_VTf?s"-cHr;Wa[%#s)RkiŜ-d!,Z^G=?CBQ Ӷ#y1kE`΁]dP\;z*t\K}WJQXX(doܰx5c+P'aXx `mW@ѳV9Kv,@2C"kPg:jlbLWlHcv `@? CrśF>%TBu3ޖD`SM CͰ#аO ۰]o ;%]X1x[f33azI5m٤&3Mdh5ahb Cyy6D qbwꘖK/}ݒ)G@Ym񒅋'Q^7yrgS6oVJeʧM,X-_j*_;v6~:Orm|@ 7h6ϳz#ceի8x Fu_Rl5#Nf͚Ξ5gႅzJ̗?r؜5#GcڍW_}52ЭXoXru[[Ì+@|셩AGl,2.PЃ=˟96?S.J9{z…7oqAg,M y[V8p /I}۶*]}5]?.Voyy -fN_O /1c{kd l,E[k]wމ>Ò-y^}boZ > B/O5+%]0R$V0{хHC󊮬|8-. ,vڐNHKHwYKxTɻ"HLġ|/R&b~4:+>B6%Msb 0,P#P! Ul <`rX1 ǜPP1Ey)Tib2b ,v#YXlr{Xjf+MOi .5 [b'SA `#E2tP|cUg ~J<,1&X2[g!,1 8 6vÂR`#Ga/餢IUyРTF&&=bSFaXa /vK KX믿.[l A~7<{-Utq8rx78 CD ﶝ.{!+Oqmk~q[lݶCzDM9|)'"F~vp߁=ݫq~;6r]3<{ncG_FX A Os۶m_N⡇R>mM ô3۳{Fm ;X{hz`J!ÆuyMkjWU|p.Đ/ysq*Y \v%??,=[?_;ϿHOO:nݺܹKW_ڭM_HEA ڿÆK/"5Vt) w,\DX@W_Ϩ_^n]aŜsyƏa|5mݺyOЬh>R^~_}Ff&u\p";:?[_9¦j1E7!Κ e|w6;HV q,N/Q M Ҍ_'d/lr1Hhokdt3&)G3lqɣ-"_*o)KL CknEjX0P¡BcѶ[\!,j\hjҝ #ñP]( aaK* :,} `B/b.7LNcZMc [#RH%Kewa+G °x@N٘3 ޽zk|c+?kBa\yX̰|b 咔a[ي3H,#!)MxKabމ|N:hUسXyOisb1b(1N@_PmRwd&pt&b$(D좆8@b9Q2m4PBXUeb'dpn7Y /q$r\/8 -F&V24聋ls\`Ԥ7d*.PMbQ 8&'e,߅(},baBEbiiaԓXâmE"XPw )Aa6 $@.[s@pTÿaj$cӃjӆ*Ģ4u$߹vǢc$[*.ApX$b4, >%`|3lZӽv!H6lEa1f_==Gv &.g`'v/}nMJj )pEhIU>X y2:Ps,F%9'9W˓ +a]"$ cGu$S,D}2[Pa$}!]| Fv+T="f#ǿlh|;Q:v1EZITxtBx;eA U.OqM%K@C"2bi]HN9RO<,lsLNKQ"3mPRP hP)'/۞( ;$ NWj}*K&G;CS (w0LK#y yLH#GBmyl{ELj  ʛ*č"'7,ScRV4)P/7,-T̠*7XONX*X.'<>2tQq@k}VQ#1k&kScҖMKHc"{1,PN?0lbXr7lt# _Ja.> Tc,stWzIW_0\RMV~v2Fu-[R/blIغ}xLv+8`?lw˗-,uVQ3J${w"S\T[ދyDڐ8TPܨD%ÌZ=KPz̦֨}y09@L,b6#}1i`,cxV1y6aX=بuA)xMN$/x寿\0J>-8Kw}O'ox[T zBLH!aNbtd0z:2a6 A:=%}{IRq; q.$()0$, YB Bh\z\3~Bm*VBwHlMD`6BveWjMQ{x@]RQ޹{5[ΦHg[)|*'J!y p6W)s 1>KFgDQjZv Bκx&c,Nq+;.$zl>;Cz? 6,Knwʮ@+B&̅|BLE:[ā |g-e=Zcbd6 wcuRHmt^zlqEKn߾c>_ &} 8.YVv͙5ww˚7jo>gT[[-Z1S64cikZ>CHZkn$p-Stn=]d۶ /D-J eC7it_:z4H'F E5Fڗ,` w9k7FՁK]@@x b6ܔ1";7=ΐD,P=@\J.IFкWCf9`i"\ٻDslT6:Kq hN0d*{_Y.Cdv)8.Ȧ]HD'N٘آy/m5WjwUT}3 p 0;G Y%.VQ{P|0|w n ; N l,h؆3lgBj6fo9چ *ɜNruRua4(@K'T7 I/}YWxaW_y!sig" ?( @a3 ǍidR'3r/? =2/ >CN85„?럭[a0) ;vʗ/=*&oP'8pWYqRX T) x{ܰdWjZʸq{"D (RZˤ&}{p-ZuI(HUFb6߉H1t!YCJ;{%@ *LS;sUӂCaĔY e8dgr` ַ 4,a++c&l݂9ۅ`CXd `qX(]avKƸv9-lT5,щv :>NJ+yIDATڅ꤆%X~' ;7,1xBuR]d g~'&# tJ±" &Tױյ79)'v 1us͚nfڗ2Ȅ?)tVBj=ݽoz8S.7 >S^%;ˆ+ ._Ǝ{m|j~‚RӾ%cKjVD|&/E ӽdt Çhkw-K XM졭Ʋ@ʪ]eAⲇwDڕr`Ç|{MiPJ x5, ,bae+# ;>L(MiLHg&N-$R-">AtA߰*5,I9cq' lWp( 뤧:)%`;)ӶI},9vRI9iT5ݶĔx x%O 96ݱ3g̜d$\6ێ3z&N[BHoT☍6!BkƎM/;19Jʽz> /㺓8!7r۟N v)qq%Zr*h"_vIR|9Էc 6=/~aشE[nmx 3;7Qc+P_?|~"k]>1dSU&MmE&+ +!) P/ܫb UwaZao&<\g%׼G2Js)r,sG &_J:-)7?t o Rcd羐)DžHI.4@ *=I#̎q#\3K%\|+TJ8_,f$BS,qjte3Z=0CT2׉7pXĶ%ߖꬖOca)LE,S|UzBae,I $, S*vѦÂd1Vl=,xaڅ%{* ^Bc v1,\R.Z8A)B,tE#2m X(8CyÇ6}*,asѰaNf’Ͱe &a|V'eT’ݰ;i$TCAX'R'd3SUVA!uO2/ޥ{ndLP%H1CrA..NpC]{yAn,82LGqK[ };;+kWtƥBq͉ bI٥۩QGQ ~ab{3`&f&It6b4&#"6iWh xUyPXqfT@t# H p7 ;/o,67%GݺPP-k_X\r%kFPG1vɪŊ_ay6Ԅb{8/Zx7:, ,AmF|pr#R1TWBg%5Z"BȨS9eâh O><,V:l?E2!@v)_) bϰf 9*Z#XKOW o Vm,.9`lLUDŰiFOs6&fE}E66[ha‚vN}TB:u?s箝V1͛hqiP}wԤ'?9zRMW^A66~.ݣǎJb0=N~[0kj1 7BB~c#8@s67Z)xx̍xJ̗(fSbc 愋, {eB~2̦=84KRGo*Yh)̦zH|S*.F[(VRB⚷hFeT;,>|$̹(xo'z5?6tQ?/Nq[ګQu`ELB :+/H=Ja;)jP39t-Oqz1uS"ECKWVuH#Y䊚`p#^bMD/[Z*nīLUcKp uFC;ʺSXcs,\cX 9CXh"EX4%aSa>V9Ԏa .U$[Q\vŰ03[ZeꔧlCR#>QX^f: t,ES"cԼWEZв솭ea1\]d 6L>"prBhaK g _X4g;IkcU ."dT/rرzsga8l85$1OkK̔UJL(\0ҡ`d|D|t?|>X2.1)UUmذa&Ο[v+4Ji*H+>ȱc*Ujܸ1(B ժU^][ ޳w~R ΫY$5j4m1o{ATLZRN_~Q$@/Ψ:<0bx=1Ҧbn%+WdD|HZ~jUƱ׮]kX7~'+$*Xr(|Δ `ahUdZFgn>{0on L`p] #7E #%i =AhPK(7fJނJ$>i{̂:nKu!m'2VcXrֆrD;h1BP*d_9]cXx_"!,R#ºIb2*0NٶVc|q\dbg ٱPc1ŞkB>WW`Po qQX*T/`a!׉4_`f LEV*V! 3#Xfj Ѹ Kb$g X~"+ baX~-\ﺳ J2|(RO*T,P!ԡ oϐgqRwË_$19ٶV޶sGP7 ].jl/YG=9̍%-cW_鄤-HJ^ZxPErN\P,EA-w8FI6L&%-A̲ 24HHۊDxL ݖ)H` UPK)7 ,%*+#fU+X4ñC,$ư CB1OXT>()}"O629;,R ^%JaaV%n./ru ꓙj|c0/Űp;Eڅr !s"8cPn1P;>ErMv0w<3lxMZIXNc D1F9;aRMf "s{?F_yH)SkHrZD嗟mܸa}NǸ|GS6b:dMxXhB~oE2<,z".2,@<6JqX(l`b pаF,!h څg\aBFBU2l TXag;idTL9pݡGp JP[7KD 8[Qx#FyJ/ߍyxƀבVNq>iԨmc8хNd"u|k ̬t$F/>p X v2@<=!Nj~>cH?u+T ̞ӬYsg9s)^>P@ĿA_'-XছnLKAV^ ޼MI ɗ'Or[O&&:qy5a!ևcyɧt<^{u C}Fv]jq(B$^j¡ج:̣c)0pCr Â)6gQ@sv[<*}TgթH:uq䝐J<ź$[VJ Z驰H&GIahXZXZk0 *Pըv*kV`{}l9K V=]!ba%3>mv m %`Lcam#% \ \XrZKv`8ji1l43lq(r5l^8,a9 8;clAt˹\@-VGl]rŌa7߾G{t1P~ԘMҀ1xЛÜڨi⅋vleo<1:&C_]‹/ЫOoJZy];@>~ԘշRJ۷piV1n_~m͚ճf}&T:~^9pp#GxN(S-rOuOvaQn2dVn}cP+P,T *Rh~wҩꓣnjj@G>ڭ{m;_8Y1^>w欙_}5݊3ڪB!,DGQ'=\F5I5rά@: KG\n$)C뮻yWzpSd 3wJ..sR7mB?u:J&QLdl*6O"]7VRCD w[E"¢Z5bbpra*VcyFgKU§߰&U`$a–ިSk]ÂjX KMj&xⰸ Upk.>qE+ĩy+ C-`@,8>8aƂX|Ö }f ۰, X#էƸwڅK,9gb'A@ͩTLkpÈSۤF*&ܘ:vl裏D ž{4R%JCx3,./\8/jԮzjPtnO^tY\v f&fP͛?^Jx Ѱ)]-`i"?(1&*J.'լUsUpɂyVW.VH0.IL,T$*nz˿[ `IQꕫPc8;Ycdjxlܼ@2޻Q7k7>dG*l&O>L=ֱ}Gp\XHНFM-^pYmW]ґ/fJ҃yCL?!:k_10d($n.P̤(_4jl,5,4?+EF:zT)7y>+߫ɑpI3&BFX8g', vX܋B0tiXȔmҖ aaMF ̎EiY( `|]°PN8 ss g TBq[r&"&c~Qrv37Pl内U 13yI-,ac¢`:N6F\ l,KMoc2ldnz- v3cgN8ңƑJCԉ)i/Ra3jTkԤх_T6fE0s-w.L<̟Uv)[zrKL/RH"E) hbT2 Ks9QfL%KpA<ɉ,ThEKbyaP;:J%5pŋ w>>x%1*OR"%hlN%U|yedbJHJJ>LYrJ]Dqhe_PƜgy؜y"_ĐJj񴘼*KJLF~,i1xpRUzy25VXp ~V.sBì@Bbҥ.Ar8+~Bh8?o dY9d=|Cѱ.mY 8J4m14^ q6녔sxdtF7LfrGiuk?eBxK[8bBuǴEJMYWrqrF)-騐RaaJY(aXx*"$Y XT""XE9?F0η!,'`lH =,uX-< J] &/.pV scw$!=B0u]"9q`2RDE9.Vd,M a+.g U 'XXk ”FDn .k2lam,;8f_ SH 54lDR;vX<a/_g;I̚)GvH {i) JVq#G۷__Pz4ƾ8)$1!.yڌiQ^zq2MI90}t\ur~Orf\gct$(͘eI\#h"Q(ȫ= E:]jDZ@n"4 ǟOD?D@}BCI soy-Ȑn"!2SI2s 3x`'J LH6{nx=JƎ=ޖb⑼A |̇|yŷ= 3zȗٲ7)Z2q۶cC!.DyϫXBFt' YP1䅦Lkޤ9NN=ҲЊ6S$~7eqR<=#%!U+uY`4(&f$@V.lɕL1#%Mqѣ109c ̵ af vͰ)22lZ a 6ŨS!,ᆭ.C)6PL7Sc Nz&wRs 3V{ EOLF;sd8j5C\~fl׳w#Gs#kР#hy +”~o7nj^1?!aF47wvzu+_~O#.TTzM)"e5jP]Fh‡WI&ժWCS.X4pHToG|tܶnz(E-W~ +4 Hnʢcڽ -L"w(Xoɓeaٶ}Gj6iXQ"W^aA[ EQ}`H|$fGntvsx((Js,K8% RkÇeVb%*t'uGf#*T0qZ%f'%r (ٵ|j-(*Ti+K'x&Ewm9]ӌPIK\ 6"&+4 ,-\p( y@@K,G<k{,OP,tXBg 2 =|0zESJ84i$<HgwN6 %8:clL PJG6Gܠ[,1%hؒ'jlXB}Zo:;) t$(1VPEy0WGpᩆ!QTWb|b͹ Uys^xEI<7X,.-۶zWR~K/{߽Z$ی&M!E-\ԼEK$u9sIҶm[\}WVZz52"zt괩 ,q͏]r)>ɧo4uSn32e+Hgږqe׬Zc]`կz=1!i玝Vx e#\"tw]5?W*޷R@]?VthP܂6hH!<ҳKd~,WwAnB+\D7Um/Ekw[~EcR8+1O1=(TIY:n5uXBE{,fXA,thUJ!:X<,[lk_O Q L<ۜŕU~|,aQHae3FZa!R-[Vj‚F8!/fc!ÖK?d9`~7l},b҄f2l/Nj3ɨP6T'T a)Id,C_Щ?BQ޽ ⷊIgGY8ֳI67_|e߃4s7RfMWkZ=G9]J׻sf?~!dPOd7@P~/g|an 6<ػCe[o1˗C_ٻ2j*Wxj H۷m߶mMc(2٬CML IJi.;Io," hbdS>t{Iy99)g 5wDO/}bupBն Ia*u].csAEUR1Hu7lH1݆|L8cqiJ0ln:gc0 62.ĠڰNj !>IN C`.DjGp|"`0"J\ˢT۷k7vؤ$_FJSBTX~];gּoMIz 87p3TdǮx?f "ܜ i@̅%nJ>&xx|rJIj;Fү@?KD["-&+G "Rٽ%Ô::1BOB5.< )V9q( 7E/#-<ΥV貉qtV S'Ģca*uIXTTrp햇eɨZHVh]"d  v 1X ISDa1V uXxJĂKfEdBR)аR\r@Sv 7l>o9`Qi= ٘AXhΰ_a!vRJ,ia6G:IN (/%E$@NK\lXnHٳs7/Rn!k_ۍ~|sͻѕ%2AA &۶<3>M7߈R/$lyCʻꪫ}5)I| H[^õ5WKl#wCsS *>|ӖM͚6E~?@< xmPJ{Yf{͛ov%%5':;RWB,!!:g*UXaH\| 0Zs] ,__JB QqN7p}c{+ ]p$ESue_OC<&Uvq-h\/㬖78$箑BRtr|K-@/G1e4$X 4\pLR0BH+wxee<c[.bH$QdɆ@RAҚ@o a[X@ps)b)ɪmƹqsXcn"P-E_=,TPb!0o 0‚{,VŖ",lw.QD H IWpz,@ 1KXrŰsh1߰°a.aMBÖFYam٘ l'=;ctx2a<|^nU}dtt젩cp/a?F\zXXC\ a\<,pqٱP _X's".2{1Hz&>kXD0y'7;b.8Tΰ"rf١v.°=,2ÖuKnEN@1 jl'3RLls*wܡE"0RI=D|B.ũ ,Z,SmO˕+NB% )J˕=Svra!no)S4Imh)U+$eUqSUvGfmXURMP d@YXokOea `V-aE2+EP"RƇBz&?ѠŊsLK/\R0bJ,qK9v*v1_YDzlTZXH!ԑ#@#;ˆW/^GVNrkp,q 8ۅx͔ 6K)j1K<,f?ٍ*ٰI} ,2lLt.!,YSI -+c)aklg NzvR9gќ%c?vl5tkmt'|[n9w' w`ef9:|nی-,.V!!&i漙7Mڴmq646cwK1%`P3C(Ę$¡,|2Ahb#K$3MR7!: 4;$>V<yM1IAc|<>ޅ{ j.5M79J(sΙ33c}c/ULKq܋ޏ6,x8Yb]٘/>'K}Tέۇ8TS>G8;W©mz+8|K6(pr452+@\!p+L t F^B_N0,E$ aQ\i;oð:4â*ְ(L8[_bKaHE~ i/lD` -x),2Â/7N~4\3pcp,b"!,f,G9bхX8X<7̰"%°5X62hTI_RM,a{6K@/RhؖYZGTB!$2@ }ͯ !uʕ7k8$Sn3h?i =2dWFThƍΟ0SĴ4i;oOc]3fDWQ`m(bNBaǎmRl|TSO*\.;~ \Ĩ8p#DՓ@pѷp&G^_~,v^p'R!tx̦'B@- б򰃟{,TU+ *TnɟOƪ& oռ އV naQ3EҢVX,2xώE6K3z5F޸.Bjbt!|Nc0^aj)]H}ryYtڀ-׿rwa90vX̰ "*Fx,$%dҵ6M+EvƁ1dخ;)̰gԙ-)CqDuP#H2~嗄dlF97\iI\w hk /_0G vF~K%؂ =>r):8&a~Ch͚#̴A6idf/ ugBB+ƀ OEQ{`ҤI^X=vg[lpҫ]uY'c[^R%+e8>~5x<fZ0EzYYEpq`uepxL WXw87]x8,Z Z}s؛y${mccF 3;AH[%HJ++n)dG&ӷiǦP $ѭ/_V sIЫ*a)a gdԖ-6P+ft!ut!NٰPaa>0,d`)eX=8;'}&-`\0-Յ* 0]ث 03é mΪ)yp C;ƩJN΀aD' T<+¥X\U(#ױ-=[<<*,*԰03Y‚+԰Y #E*E|V ć!,g# f*wX0dǢ1հ.T_˭kV`.X\jwd H> g mJznj6h| ,l5Wyt d AEsB.b9,7liDDl,ܰR6ʰr%,%`اrٝT! r+Xxq>{Sg۶ש[_ܱSUuшoΝ:x9YH@7pvn1bUWlڢ)5߈i4mb:zJyn8:bOU}w=sj}>qǝw;_{g}m3hHk)S>{իۨqU`O9 ;᯦͛6A;nsѾbZv-6orK%-k.U9E|B 5FDm:A3E *'>>>ďy M <Åsnl$i\xr1ŸBI\U[y[>c<}I%$GVP hF>Bi ` pSbzX{EBfâ#z.YEX$bBG` dU aCUF m k,Qp~A)9éPN|J>m3٘W8cP1ñcڰ7Ka [.z}æ(2lvdKð zSX:)Ri5:rFOTtzؠCۦ]FdJŀO*wP-&:>\[nuPa o3h  6ܹZ|+"FPT6d:ykVNL!Rғb2!rD2 z+3d:琌Cug 9P,kysV:2؇Z޸5Ѐe{cAJ}[nzK0ᶌX)V_Pc m(kp㯿2lѣX)|>ulh'Pz-DŽ%rkt"7 , XPF#^a @HVxbNi 9`!9 T Sfا Nc KKU&a9c 'xXP p!pNjY )awN (nVx?~`.*W6_pa3N ..3%%9pGYNHpXr%K.>ՠCL+T̓,VʼnqC6Yj IUQB'1&q=YKtGH-!Cg R0!h_SA@P Z2%ԿU cn/E:.aƐWo 5 ، b1 7p,F2,-+)JFKXh y K1s"z!Tc`Q2lCaˈCv-Ұs"3TI6%ǐc)wDӍD~NSINfi]r"F.^};L'{֗^y1.]ڶÕTf޴> ӿ2 鄶Y+ܥQ_~%i#īPi"@2NCT|1x3Lu^*}`bxKp;t8*I =Rtx1]5tԧ[TX(Ka Ă3>ljXX}.; XU,VA,J¢5dů@>Qm% +0 a" $0aQ yxL,x,.mdz=O2BX m5Fj3'G,ů@v Sv.Xac El%d9b.8_sc\Xv3R[3 U.K^ᓦRSnPLݻg_xI0c˫e?pwݱr*v̗%P<~MkG[T"諯jŪ M> &E&/8qp-pM ,k1;#ï["jt&9eļaouYoXJXd9|2qU-뚶h Kꪫڲu;UzE]DPo oYy}9ILۣƨi18Q7rJW[:tHkFw@a\[o /} T!yay'Q<\'0y8^Ӓ*,&yKߎvPn*#.=q[ t: A5L>j#/MyEjP1D; k< #pꄟMoѢŢ?W_}U\擳gϜ1fM͞=9ѣG}{g~esf1ysf9ܹU֊ς !!x,;"PÇ Çy+]{Ǖ(Q"1QzRaْE .jw^s5_~ezj}{) +wjkx M6gOw5`'iy93Si>iQ{b|>9Udh EkA·q1ι-l\qIϏPC1nh9|C o: ÑKOW(Bc 逷'X ɶhmĊ2aa_:BW(1hZ;bnːV /tXצ:|k)>{^|饕?IM%6DmyWعnۺu |&6ni01:z(@9e9Cw 65-jUbs甅RSS]P,үhbwȰXEة$WvwwϚ5 ݒJ+Z5B*^ k6k:bH'W +ӎ Lm7Hď0ͼf錌mU8bM^&/y$b8UE $;XSЋͅv!-+."OJ!h[Na JcÂզj VjjjXvH= iOŌ3>+]xXB+T h1 FG\bs$m:@bCd]$6JT0%̰},rbHNCnvæ"h2lչB}: ヰ9 8g`'Wwco9H6ohyO9?ƀC/ ͗'%$uU])-f| ?*]~lAHJB7YqzB(͐Ωt6r5ktܸw-,9>|2F,ͦަM`uV՛y]%[iJvӿޡC' ,EGf5p|"M+Pu(D,zgkcNi-i+V)@h%"0T-Z\nɄdVKHNB"FIt2bcE!xaQbv*NEܓ[j{0UFA e{q~˹0P°±<,Dv @AN/Hӳ2{۝Qٱ+MF5 td*d95Ɓ{``2~rv,wl"jajnV {t1Wl80,D0gc1J $bmff,Mm0Ö<'Wj/RCˆ%hdT:)uR.@MU#|C)KɴELwԮ]70$lc\P2ZjѢEevԡhosۯ'e\pAM6kL\^o_}k֬jyu Dhb{σuE~Ӕ. 8^H'5fkԬ?{/t'[¼m]ʺڦ*rMLL#'* N;b}z4J~ _ػg=mϿ}&ut㄃QD,DsO@锚S|abN!^EI1P8(c]CHS,$tehBCS7y(|TK8RB"WLYaU^%c3.XFZcK$c[aQ xM+ }i@|,\6Kz1,X xJ,,dqJ]ꄀD1Rb{ UBWa2h #WV[vb9,t! 8H)kg Fv81i?aќPKa+oاb-bX4T|vX`آ9,fcmXNz&wR:Us%.!ԩeq~W\P}r5eICfAJ9#h4>~'kԪz*eV/SYrg~ _M-$˖.ېZB~eJ\ţ I5jW_b "y$'@Wa<@Hh ?rKe>9CQ? 8ٽax*a)&Cט$#OŪv֥w_Z!u٤ћ4NkCLZ?Y?SR;<)D`WZ=3r'Qqol9^ *=` 8lgZĪscen_ZbV%"+֦Ti4teAL, deєK5%͡긢S5iqB)!n7k+Ea p'_$ 3!A,l b13qlfǂUU SU]. 4XXch>+rÒIGNX|c$!,[2f)ƚ0,L!c"~11k&aSD3dcҰM3lk ¥\ݰ,95_vN8+&vHUgn*pT!Og<KMK-/C~H* /r|atR 8|0_8SiWD5t%eJz-FA1K <3t`k0Z̲IU+E)i9rB`ZV&f/r< dY)O_(HbsBn9!ָLfQ ȝ U UVj @nDbX&cY*T鲲e1ѱs:iX7@qU/t"KӭkWl)f}СZ9Pa#Xh .8?oako(] b_`܊* sκ&0P"0(߈Rs+G?*I$8DXKm"y\JkM]~A5D\3FV(1$^ҊPT8#lk$˄23VrrdM bq抅)X(Jar_G"ij},lJ @B} <%]rƢ tjxL+i|LS80 ]Jdt`mi aZX_ X$i "t  ="O [r aJ31j3dְMG6æ¾U S!Vٰhɡ:dg;i19}7",9| vy|@' -|4}wPXW_{mJk=z $@eo\\#GTN9f#fe>3Vni3 oD/d2KɢcݟG[߸Dyr$~-YYKR߿d{b ??3jL\᯿Z:D xiR!c#_Yȼu616~۶?Jbl }`y~- 8\e ˷}s ރYQn(vnλ@;[`٨.b9tp?m s΁}#Y=qbL%+,}K,25$1OshXV,vzluLNATݖ`#1a@a>ȕBZlC$yH;},N2`Ԉ,Fj&RYc0,z4Â3YaU$srqHс{O =%@]j&|kXXY>*;1XpL;= cBÌA[IC6,Im9C:FOab…"SD=ni董8|՗ء?ʛ'ԑb'ٺsC=D'"Ma燢V>Bɣ<ї^~ iԺu 091ɢ*1= ^dƉ昱c.wƽGe&~s{j}1c9d=gq1֬9|939YcygCz wk޴98+Oƌw=&Mb[[߆:s˕G.~e3b n۲χW R,Vc+0* 73vs/>R=8bİJB5,W_u5ŗ_^b9J"VbUdV]hЂFE1B F%))Z$%PR7D422T.T( uJF~J%x9ְXUV baB-:Lf `QX"&9bQS6oWݖnaC]*PN֘vS A,V Cۅn( a1̫H,ڝꑬhŸbzcQ{X$UɉG* HcfXxǠaTXsXŌ!;aOа},b;- l'tRC8*[ʓ7y_|鮷RD/ۅ*28>G(%A=Kl[TYqtL4"I!x*GNb* y%.2)B Kd^quH,,X(#lَLɰSM"G+pX+cAݘD[XxlR@âRbĢ4_>] *dyhj&ж3 .V:v!dâRTZB .¶p+1h}vbHAsXt`$HcpXv^d4.4l٘kgaX1 aq*"Oyfʆ|8@]uc!4Gn3\uRv.2g;gN?;5ypU)RVȽ kCnDON2~㿷`u CSX$,?C&| [0?ޯyWʌ/,]:}47( <|B7}r5B-G Ğ=z6joӳgwFk~nz$3&MרY}9Tfir Rzwζ\wc(Ė 4"^6=V헠x'/\}6Ј[ۇłKd?+?ַJo bwĤMwL<kJh)Qc8i78y9ɕHY$1_=l'=%;]|21 R+M(Rӑ`9v~qMz?c.ll^)8̢&AſGŋ胏p-K3g#M-uA.Xz՚fM5 Bٻ[Æٔ۷'Wh vʴ/Vرc>`evJ,ք(hasT7J,T ҤKѲʴر9sO5q_;h(#._ =cYAJnȟb!;TB;ԼD[e[(~N3JvmK^Ƃr_.-.*y \ڼۊ*P+vDp aZ'T|e\vBH 2ĸSF3UcAzg<<C)[`|@29U6,H,^mewj.ck:E* *%B,B*7v9%+ZH Mڅ*1B7e VvQhcȄP%&1fcf ۅqr e nk`PyBBˆa:d=zƄ%hS.bakvѷ̰Qk' vX' Ka:i4dاy>y~OtٰI0a&bqK *;|ᢇ?蜙=هڵYʋ/" FU-T]IEi#$$=?Ƥ(/{ZrS0"kdIDq GwaXp1*TXX()!JlUD,l!6d E) dXTaXt[­.AL3@*R1 9c6jM*@ +4XU0H9ˎ%TEb-A,van@PxP?4YW(B ͂1U E0ua0EL~.|kUDRXeز1a 6? gbq24lSÌͰy'߰-ȵKNNQ& uRqdXwXvIQ\³69*9hm=h㊚ĸx&a?~疷x26:{HL}R %(̜烐Et=tEVV YעV HX4r2"|oJ9=r_Tio'C/HBE [ 8Nn4 |BV zer[-FBNtsb\Ξm7JֈWVa`]s:@aFyXXvq jk8sjWFũs"1ܖ{\A'X.p*,9W p^ [nv 7}*,7l7qaqbbYŸVB=)1@1ҳRl2_:t6+* {5t4:ow`v^̓i:vlL;f̚&ar.l1Ï?Ŀ gDeehHC.t1\4vCJU Fx& *$&:=+$,4+SRnTٔ#& ljd?l4U<6yM_}=}[oW߯h2g\ PAAT ~%2/Oݼy]2drڗG[:rpѢ"޽jB UO?ZNlz vfP nK|i&¡#>4Y$H0._ {VgΘ2 șwRh:ÆR3;'(T:4RT L%^y-lx*%p-#mGKw[v $hg| MHG" %c+&wRHnR(R[_p~%Y"P8$faaE8Fʝo6,@1\p`^аpDFv  9RvXf튒&)aMhبOtuzp{'I--!ۅ%UZW01w1غc`0K},^k|KczW Dio-V()c` B'g%xZ8}!V)A,< aa:aqy'C+wh^MU^.Xo9H(?2ɓM#mc DfBvbADJJV*^k_;p`6˗-]޵scb>Iu5-%};zTΚ{M7e JWӦqI\Bbo/)nrE}vOy-f 6lDJJ:ND'%Z0bcZjSSR $ JW xf|X%@N`Nr ' % e Bm)G HTK4ᇤ,iCt/P2{3'V]mOV#JZ .J;9,S1 :/=,L K`tXD `!0_9E3sbJ!,Üjj9QxƼv!qPZ[XrE!, aڅ£0.1Xp۠V)-,Q e, Ph EB #4lð(Cа},-I)1pEr nfA,Acp2d v8Yhʠard줤1$k;i{Xp3>ܡ[0]z=r/MهbzwKnlc+yݺ}s5y ~,> Y\샨_s 6L?,_.V_>rwqG:uJHz7#?h t-Gl۽:bŊC\}v7nճ7 IZKt2i~!R̞st@);tY~UAءS}Ezj}D/Jʗ0o\dEݼyu'[k.T`. x}?Vl]0rҮ];<ȑŜ5k .ɛ/WZ`-s.~/|}E15?vǟ. UzY.9l*[qv֥F\5}e2߭ʔ-Ώ?8*zL4bWTzE3`m(Acɫ%ܨ0 +P Ǔ bAvkL]ΰ@rXH b'-'9TT29 X#97wX$c U Qb@ ۅ- }$:]} 䁻"p 4,:> a X_De/,%6 ;;p<{*W|cLYei-2Yh=һOs|@K?MKKkum GrgLr*T{P|btbNԞ={gf׎GFZ}:wzA{ݩOKOݽs< Bo5xlwmܙTo9:uֽǡ:fbݫ{; ƫXZ_ꩶC)ߒeJ.J_4'-sCI7SJbdes\9,d?£8!T0, P.aQ)}*,c\FDpջ-Ja3Ivs1la9}'u; GBœ _M`Tpi|ḧ3sqݨ)ʀE8>yӢ?ti )34hv孷݊ϛ`-ǥ5aZ>`ƾqEFO uK/=s,+.H*Ŕ_~|3>Eńد'uܙ/-j>lPhBW^j߾1!S%lGORk֮Qn{.Y+$DcǀXdr>kWJʛpI1}F!ʕqQ3FxʈN\U{N'I_ν8*U|) #:qR"YێĻ- X&5tecǴ0>¢BB|0lXdרa0,ixaA:X x XRXw%w/Er }CD-k[{aXd >Cƴo֔a -h؆%]̂mv~z,t6&cbQY 7ls' b)ԫ@a ;Iso:Ao:&6;٘ ۆ462٣ Ԣ#X4:q` e_Rfu32Qʕ{{~gIQmj%NcΦM\*wL% +Y]|yZ6v+/[ַʠ<}iqF5kր3C֭nFPn+f}3{F0XQE!_^v+V`> ֺ5yV淵ƿ;,]$BKsqyW65vܘ.(W";tڳ{=4oܺu"@_B/NPW6leVq~É Rs4 "hJl]2^tz? 7nؿ' j,矽Wԭ3b~Q^IB-L I3(t)剣:kIOc!pTCIK_PDGeR0PQl>'OM)J1!2'_ѩK> }V*dQ(X;Kٰp>#aPŷ<R_ O배aYpXTṌ  r> CbO,Fa,a kZaX3k)(X֤@ "DpNY3A9.3 !,<чONjvqXxNxt:,{Иb:E-,ΰ8gaQ+6W-`ҳv"1;)\|P 03 {C1@>:2}| *{0{*X0?[8e%%dƃF׾CwǍGJ|\ AgH߯A[pINf$F򉞽z,YnU&CVsL`#4""[2SDFaD.UNd+#)x !33]*EP:N:v:b吏@ WIaܹL~)xUK:A\\h` 1vC{aN8Σݴ 5,{6xOՈ<7AJVCq^ y~,.Z?(^x 3ȲH8Bryu#s$OϖDO`e#+ǜ`&W-KC)NcI/grDho Cy&@Fݖ*厅"L8\(kBkv,ʲgX00,:;%z-E".Ԫ2xV%L`dL),p,<Sr`XohBo fc!c`j 32iVbR֌ Z uX|qrs%Dаð~ ۫ ⟇*"g, z;Ön j\A " Wj,̣G@Oašr SRF*d_Ԁ&.:+x4mT*o!uZ驙i d̦/U.1¾k>{8 tE녉o ܃dlvO'$[ dc\l #)>LOR)͠C''oPLm|(RTGO4x <h1j*ܵ_`ۇAJBJS_ &̲xKE7X'4@aHÿPopOT[ z9CFO{p wQ-NO8jh"KMc)x<3ɉ2眃 TZU[PaI=jh ۏ'M`MFE?p"Ak'jJݻv)]*!JLʍ^1ff-A$CL[+عwhN8r6>lXM;w 4mRv핫VvӻDHN Ú&1e ղ0_8wѷ0.^h/hՏZb-LOK#FKf5S*2.p#g#U?tz)"innw.S#m`}RܩmY[Xe^8Pis\ݖt!4{bGG1+G/ ϖt*,>9fb(>Xh2Q$ q^'3tS{X3%wLދXXc\@XQRJIr%W # !],wzUchvщ%},| 7"O/ӧlL&1` $;1vZ$V9GzX̰Dagâx;WUcf3lSO667 ;̰XZ\V뭯'OoK 뵒im gq[nn}kkT͸qq6'Z QL'>vhJ*'b7mwo6ٖ o_8rl5i_LQ>7v}|¨}{,W`ɝ1Yh#,56rbQpXM1ss(B1-h`unoe(;$ܐML*Q5h}⒰8h,%QGOJ8[t>~ݙ!qƊMƀWq͏Fg0N;]xVbrB7>K+nZN,us /O? }}INZbNX::\r%eltm+_=N:J-gzn0S:瞷]QCFh_:}#u掺N#Ba8+T0q768' jSDr&1x#Lqjx!cE=/muPZ y[lDӹp5-z)XLBX̴:Tuv,y@S E"pB=(47,p8] !O‚X d^;, 6cECI hO31p AXLNJk6dcBo (y". 3l  l,̰L^n]ߒ,FKd7laqM g-A6,vX{gfJb+:(=<{@EV\9u_|N7'BŗOo$}SL:R gX3getYؿd@8}mpo6_{+W!R LJLgʞ՗ "0j; KuTN{ Izb :`Ӳp`ʆ{|~0<[VDc?,53E))P_O1%Yi)i)Yf*~Onˢ4GYϥ4mSqT fAJjF~Ѫ_OD]z(Vdl|<ϟ??yDBt"v~qbn l*_<Wx;m6nΈW]#S=QQnjΗ (`ϰzj69hZz ^  /jfTĦ;nDETiC1HFa>Νa@{{=ϳg?{(Ѳw`m Tv\D0OQ8\mgXD fX|CODn NVIeTO (d*,E8 9S u4FcJ\r h'oX{u&Xh`Ccy YY.,,J/bI]7BTx BŞ+ ҷF ؀j4$ab ۇE P>2݀c%a~B1` X&c`Sy6Q`yQK%ؼh,&n 7i:xEUDШ3ub'Ycf#@fpe ׷6!(gfZdkc}|Z@+PeEƺVxfa(fɊobu7F|c`h?.9meRW詜dr44 a@ yzƹ?A}J 7$| QMeJsb%KgΜ(t1q:l=V+J=sw*/Ӽ/8vh"V@MLYdƋWEIT&y A?8q(=S dNTD'|啧x7!qwfҎPh) K#"LdXBcb!ʼnۀu-AXAc15 L^N^B݀|.=9!b5e2sPxqaqutbX:2F3xWc1a -VRd # .`q6*ջ_;[ XlɃHI/` /70<[v lj{-hlqP;wܼY"JYFMos^FfTm5 $:&%oWOm_|k'`=F@6&RPuj@,&c,^DR1Jax4)Qvr=)?>OOpW԰t#+,0952RruAL=Z $dQY(73Q+o95Q&8{p,Giwo0bXN?zڶo %Ɗg3رc֭(K];K $aD$I#~xxd2[G{{+QTV-+vֶvq5u~PMBSAN,wed&(5xc,"xaHƦe_B9'˃RV UJmnRA6Q)슸9Ot<x RҩQRB\sE q`g %XԀXXQb1~Y¼4,R"^(^SyH֖4NSB'r H.}9/$"3ڴ',cv8Ic`nrx /`X09)hNʘ 1cIDÂ$=P&z[Ke3|>vx-x Rm㌅Qi&ymb)&zY] y.XTo,:pPFcb/bqZ+pŖ&,LgFaq u06:{?&WmXf#ؒ" 㠆V-*"Jv sm hB7d@8_" X$ ރH#A*,q RqߥPLiB(AqtXSًȈre.Yw۷1B:@{U,o I;b3L]u\0$vHF&xi ;^GQnK gpᴼ:# G"ivTY[Elڻ8l%eI'T  aUDhAHD"iאtL;XКDĢxO"I%#CUʔ"1&g,$P3p'` 5 5(A|XWڙӧXEyfϑۇv$)~o8aܟf'NKlr-X'gN,#37gX#'M;fʓ;/~;j3b~!,ۼ JV ӧK*PT1ŷ-ֈʃ%KR96(Mj:X R b@#s5>ƢB$]( XQCg(*JQ$Ѥi(^rO8q)ɈAls ?ϐyOeszf⒒!& [])9=6 ' ,)X̊I5rŭLH;:l #$8n8GU1'3bNr_)I`ΦBJPEi5Q(dLXh,i^XQꅅINaa|Qg4bt uT ߩBϛ*YH􋄁7oaRx6F/Y))n:1( \2bE-gh,*$+A=O ~Be& ᄩNʨ'gN '洣*v̇:`'o3 \~2\IKٳI?(_ A_adJ>[Ǝ׷gΤ:Z*⠆^W ͏ga3Ms{T΢rGG"' g|v⨅Bg44`֮kQ{cAz 9pfGQj mp_CT#^q+@oY>9T(LD\ո)|x HPnʬ UBDv(T2qVҰX+BUAa+h=kfZUٹV0 G B]KM9H6{+0.8 ~ޅrb%yR4jX|\'PSAK{aBCXi5O8Z  zB>Lri a> <./X|ԩx̀pXh( 9XHX4 rӊ)VdD ~x "{?", (g {>ENPLM{iB5Z,11)׾@;7θKfmއ̣Ѐx4;^q >S_y惴N"Ij ;Q7ݹ{!WJ& uxi?@Vܣw5).\T)+Nx)%`ypo`2guɍC7Nb}9&V]JBzԟHFS([.ułTpb,AB=Xi5ȃo,ijD#-x?cF%.,Z* u%B택~EX5u  %t2FNjB XXԿtVadU{:aQ+E%I~ ""M;ue۷q Q^vM$L^L+}law1B7JB)sNHM* |xIdKrraXx>o@z7oʍX1!B |4;e|X"0[FA5/g f ׳#e @>(vs<Hرc7n\W4 /у!A_~APo'O4ˌ o+g"˰̓K[wn,1EUپcBvޱc>{.:۵oשKVBXDB!|ҢeάZÇ ;.ڇGdEA_̟fz~|ᙐoAz.r*/t!T{ocǍBqƏ{m;Ὲpԉ%:w8{,*Py?{T*ȧ$ *P0sլYrJpZ}٧ =RH%~).ǎ7sP Y(-^qcl28. eN:)U !gK@0ɜ)#G_jݺ5۟9w+p %bۯOt@%wӡ}Yg-۶|x~:x[o4 VTB I1G(iC#ԮfѬ_ a˗/Og={+kV={|۬EK.MΝnܺQha){~X .x~Ҫ^Dg%JPҥˬ۰oܹs]vM=WCoߵo<yҼe>)UP0x(#Gu ?/Xbق7l\w蟃Vz'dU /Х=VOë$!J:!_g̔t}rAC4(;^y~,I#P`H[/1o޺7e˕OϜ;ծ][;~x]c`+u >7,RJ%08HA㲂`ٶ{/V>R탇ޟ9wsԠQwnt!s]AW>W6nؤIcPYPy yGH}*(QKh1o[- ɑ1|aO14R v ٰǺ]hssMz[՝ cGF[W8%:<>}?(>%N(|' O>m~ĨϜ~!LC57i1c|7P0MgOcZ2K9C&|ɩ_9~A8 ,8e29XmА6bFE%L8ɓ&jo0d#~(pñ3pA;o/sS$WsRH,QaoUP)uYҳ2$E?H~hkFܹsUt6`ۧLS8X{bszsZI73 x19rjժ8]eyZP . Q돎9O"V(_Gm7nڈFM=zuV?q?qXVmpe=[jM4U)S'JySmPHѳgϮkU:u7ha7oބv = %c"wU[5kcǖ<<'nQ|R UUqFk޵w Eh }|98rEnߺu~A\~}۰QcL(؍ծS^LX=zQ9 >|ݷǎ$|=b޾}G*7n\bE>!iV-[f̘Ⱦ5=j4}zne CJ|Ls0S^_ J օHC͏,cxעܫccI-ReL(H@Md21L KQtFBe;a(pxhGGիBpBgX8Xvy%+Jt: )c_E>)PX0>J/[Baq6,l@66;yXg˃k@br0"+#i]aDcq M Ba` 2.R8hOcv̢&HIYdIӫV1=֙9q_xi]vlܭIB &=u⅝v.,Kv޹cxYCoΜ9ך6nހt4xXg̚k˯+ԾWgמݻwb]Gxަ7dsf4r 9cl7o>yd\s=*ߏS'mڼ 'O;}j&4ZYun8~}?G,׭I"o+7Y6U4k Бڳ"G>?w=XT9sdښ?*Y_n߲C߬^ߦ͚I&ϟK%:&k31LF#-H!y.ASy%jLɟEXcdLk#آj؄ÅͱBqgH*8$ cMl3(7GY. -.[IT9 }9Hbր?y\,Nh,`ZX؜Vh4:__)&zRW8u i/#D cSBhvG/^3,b0߄A&;"  !/ϣ,Og2"j'輸¦Э{׫׮ڱƭ!PtܾugӦ͟eVd= s!Ϟ9if,lBB/547XȽ,8yXT;!RPڹsq8j!:= >|r'O|s-PϋAsu%3w7aDcS,ri&6RgoÆzuϐ^\ tAO&6kY7i]1 ET#vgN:q FN4u6m8e(?HK75s]a~O6m)Λ{ʕonذiIT鐯WG=O_ jg˞.M '4Api^˚ ʥ 6oބ*E&2KɎ&~P:~?Ws?7ot&ItͺR(X@ݑBgӖ-۴L軡G< RL:U˗ۻoxO}pXg TwކԮW  X[th?9| lD *oQql|6n1B5kjq- ENݷיgvu6ɿ[H(lTʕ+'K,o;vh5kj~÷;\၃Κ1 Աm{w l{J )xrA4FNTZ=\2eJ(UhW3*pW 5K&>Ĩ'뇶\QA3sM*5N*@*.ܻeq&O-*>RPGaBϦ\:m=XxTrk\K[c*,*ՂXPmQf04,:??1,XCo,&i8FzNx[/V &@ȳ*,j@.<ó[ KAG,PVa_b`q.1BCݢ,%zX̔ v#7vGm?ko5PȠ_~; @)1)QFg͛E9`2i$yZ) YTBɒ2pϞygb/_طpٓƻю&HsE#L-Yi1H#Hc)+)Sz'% ~Bkta=/ rv_hc<[ qR8-76C׿// xȰh^6yAAv_:AjwB1T^$O+5,ʃ˃[,]}|kbh /dƒFÇ꩞!H<@6;ٍ\Ѷ씣8wLV&6:-Vtt'#q<֙le$ZQ5_GcQā%BBy%K2SvxW,P/bF7%b1W- / W UUى!p@'&q881䱺@DL< ΓLR?]:o߹s.]Ȓ)p҅{nϏ5lh@TM)CFEEaf&%K_HEua)S W37~K``LHb)B~S'Z#}PEF2,^x e;zW iFUDD\9DOI蘫*02Bw,QX YODV!7X4 a 9eJ Sr|1ezvĂd7)Dk%g +Ńd mh1,j.7Krͺ yơoRz=h`qG) bhg[$g>GH-&p(KĂbٜj@gQJasb'.,Zl@_(hL99Dݹ>xT%otu5jT/S=v۷PJ534_Kh/:{Bi°Fb+SL2eòC@zwCYu)I{ٳ ;u Q3&M9-T{u)$^qɓu1¬c߀#J/^lx&MԪU@ O' ,\_Mz)2vX0SƌG*Th۶-\R5XXT"Jj:r-{n:~ $~u XmڰI,o/oX]q~e_nK8=% 09LН Io? bִ61tI5nke Ʊ!2M#]kV͈N]2cbOOa)JLk D.P|Q+|-YJM8P(XLL:&O}+EeH&-( )*1"bA:0;:r.dQcE!)*!N aIaa)DgFca) Ġs."00f( M =@Od1D p3QXzP"r_IaQeb MML~,h ĜXL,0  !n,/:Nў!C3g;Ev䥜<%qb.LtaCEP%FQW|uV϶6y 1U~ Cz -[^XQ|;Y߾̟9OC740C97k'^_ 85Լu^-ہ'$y+.Y@Z$e+WU `jҨyG!w)_ž}G…\lW^UFu|G۶^w~ϟK޽^uٳ7|9h𗃾ěknعV< 4bKlݲ D|Mrʉ߮XNjG㷨OǶ$XXA>^h:1ChBsdճGwG?׻9MG5'v:2&ZLr IwlpT('{8 Ajϕ'Uv!^ad)i #R+PlX|fDjjtA{x,Pig)XZa*IiT2An&!6!q-E !\ l caE.tQwhߐSE #X*7(ـSʋ",C"jgwR #6q8/\jxb//G<:Un=RLѨA#x?ydHR +x._Y[̬>2'o}b,ZmΝ'7Բ01%Ԯ/_~oE>/Q|L޹[BʃZuk/{x بq#=%^z\-ZlR&ǘNJBʊh'iaƖn`qh8 5(wVTWǚ ^UQtV>vPg'J*&jkp1[9PS%̠IGY-/,8K-s\,tE4YQ)*T Ecb#+TWGG닋J`QB>9[4~~!{,?3Rw8X 2ƒ4ak@*$qc!ăqx Cl,T6xcQIbl"`;XD/qlM 2D ɘ#Tjܴ_\DDw_T/`z-n(яbA9HcN8ujS(\ *Uy-C]n:HPvnHIM {az=e8ے)fH2ءM$][6 .Nv%bg4 EQL]  \T%  ?O 6BL~ui#HJN&T -_Hj&3;_5#GDx\9sF_l௹`[/"[hP3Fo-7f۷ns5x֮]m{kig l̘1ÆXW"\&MPp ǐO2MI_!PѢEׯ]7hЗ{' ^a':% :4XRe('G 4M*Z?>."[cc+D4ĊOYY(MؠƤ 4,SƌBk[ ;DUL8!$iI,9ł"/k#z[({M 79؃iƢd"H셔X%XR 4q|,z)S'ËcXO9=}Ç͞ӂE v D$iOW,D;as~P>2cLh={wC|gSOr2bd˖m&N4jHٺ}+wn٠aÓO\ruY&MXl Raao[wnFDF^~mȷC`C:6(}UVۻw䉈3aIN8{[ȉ=idt}cExx4r„ x TOg/Y;ȰX=_ w$]9{ `S?>{&L1kUl`19DaH?}N|*K!'.u=c*_2l4[ .Sh2340>,L"maH4q+J*3Sӊpy341)#{L,F9xc1;ipJeҒ4ڧZ % #,TZ钼X E u0\uNhb8J~Ob_X(5'ND~qzb@-OYxc4Wf?Œ%YbZlfK_I1Q~,L8:x˘#hX&$P԰PI}rjt"Űblm 5y jXē?\A`Pbׄ]*p(|qy>p^^-8|HbZ0c9I7g0^TH5?CY$M/+U60eJBR'I.` y۷ _6`rɜ93<#;{.3rrHqڻ+A„NXx\j֩xɒ%͐!GZnցfd)#ZnҦO1}z2MsaTsVP{'IYկ_/~0O=X+֯Y)iɓ%kبAɨo#+9+KpqϳZߙln^hɓPRXᄉ)SJW_oФ! 9r yf)gGeJN ]!ɒ%ժTE@tdI> d`ɓ+LuK2Ly_LɴF44@~}ěM2->aЭGRf kU+W]7Tz *1// Jd5zه 8ŋ&ۅ.YH$AjsxckmxT\O"VJs 7IedL/,Z)|pT$C㒼fP4qZqXh1laccinPŒ];Xȷҩ86#H,ZY ρ XBZ.cO MFBkĂ-,~EK/b/X0 B< q`B cRrY"AY ̳K6BIQՀBMlk @{rmlT-Z<||XT /2;/1XСX'tH;j2=e+O,§3 K)ݟ5;>>KN1E؋gbk ͸j:闙6"a5(UsAxFgX%8ZO&#qGoS+ G4G1;`)`}LhtjZև~{<ŧN LŁF9@#a4`$ {O?AlxSq%gBV:Qp BLPhņ fV@pIpj1s'KL> l-$o3Ob!OgΞ3 QPgܳdْc~1|;qℕ,7W֍>vɴSs!CCvuOsadƊm`gGX#L!!k83\ h qHᡇY4|Dd*Jzm6Hœ#QhQD4ǰ%^ΰ( !'q`A <'01,ݺQ<ąwy5BъAE1~')iz^BXV/BFu10۪k1%0PbST/08X8HXWwJqG^/ $0-:tq fh0 jܵkG7s YfS~E ͗-~ )V 8ђVpAeQ޽{!֙sgUhaGdm%KD28+j`]wѕiBa"ŊCl냳aߣ&W|LHU@sΡ?W/>G͓// \=އ,K/c /ի9á~ܵˌ`6VRNݡ}Gl2d-琾݈4l>|kWs_ -pu0Q{Jr= 7cL W_F!]^[WwI1C~sݓH>|/?O< bQeXX u ݻ) -\^vZǚUX8N1f\%ɒ'Cܻ,y2lhPBhCG7mڀjkvh{睷!K.k޵w7?7Q4mt_~3(q›n瘻p#- $dr9pe̜'MFeD61BճW9r$O?_g*^i'1[g0Hjf_z ʰmdJ-.žK}2̨q$ϜApo#q5uj_%C %UVp+V)KW2,wZZ=Hi0ЈEs[K a=gbcVGjb;O3ȨJb7( 2$ZC^1q`aUGPX$/TX U2]4uXE٭5Ƣs.9koʘ/j#ycBEpflb*LL`l_EFAja.s[֩h,/z;b*VX^1H \JՀ䔋a%w !aO7g[Ӷ/AȧTzyĬax߇RGT [c|c(xեK9nXjE=rΝo9Yvc$m[l˙34it*}T Wf͚.*up_Ǩcmt̠%"]pNgߗ._m6E80)c+&='Loq oKaeӶZ M5o!uB&iw$\˂wAkZo.@;RX[qc:fȘ2dӧAܳb&F#8gg``O0,MuMBkŦBSʼ:Lӫw?W7OG?{M^|=AYg8; >7vU"W0̜9{nԧ~EzOCƈb߸Cǎȁ D Trn&w_!*zM(*ͫ > +5S bu`9Xvҥʖc>HPHnQb%%NԹK)&'KvJUJ@([Ik2oh'c edN0"X:D3#pE9Q1H5V+KMB8.݂郞R)FƖ՜H&+y4ta1aa Ngx+hU",:XBCkX ۚg"bsÖ %渱 pN=R`cտNXXHDO|+ʹ5Ez C4߄Bs\X8`u% E35%Xd) E5#BW 80QYh\@/т561[Nq.Dnz0~qA,037 LY}^% e\r]L=ar,PZQkwl)l]G.r}wt(` 1k ԛ FR{T< 9ya90`'Sh^.+'"RYgPVTaǖTq%SAuXT[-riQɪh&-?GMxg_݋?%wp:XBb?DՁ7sm~ڶms}H`DFP*iUꂈ˖.T-5/mw>4]$98~2iğ}I {Ʒiz,M~{w]z)qDPH@$-~#}!0-htRwN$pMjEQvahE*0CݔQň3.-١(K"P3b`'RImpPFE 3W+6pgB$=R7|n<0UXFգݻkvmȝ3;w{' @8bGcͤIq*Wl Zʟlj.0v.]:)[6Ei[V 9s:q)_ Թ\FVB=8BBLbwCOcƍAMʟAXpʍ3:4 3W̝3oロ6m~w@]2u#;:zp"!Uj Zi@*\|6I&? cSO۰N{6nt/]ԹcgjŗV1$;?N:>$ko&qp"Rew^eʗٸnL$I5m>mڈHNgπTؽWZf=hG;@Ԫ_l2g xfώ kQp\" IS`Ft1ARRa#^x9<,ǝsʳ~}݇M2L[(zy)n*f|[n_wPo3iܾsk"%`T=SN C@d2):rqH@*ؒgkCiJdE?,3euVjH2Y1R(\S&UZ WI!?O rso T riD> 1IDATK?ܤ5sm>JiIG>.[bt ٪i2|D0bTaEP{23+г=Q2b&gZ;XB7siuF=2)㊑iVa)( KC+/XgCG#aroܮh)Ԗ!ٕ^W.}xiXT4'١P 4U3oFZ*1*Np0D03fs%Y4ud8g 0BbON-ce!pkff"BM .VrúK29(@FBHx9g0(ω~Myl隺Gg>,esD_L)S %?3y} 2iXIܘRɨ4,T3G'pGUX._c5?rHl.+T-/,J PS,h)XxY7&n/Ѐq5D"1bcOp?x 3X1~qAX ޏ/QhtT/+2-1Eyǵa!\-ca-"5JVqHM AjA'|s5ni"SOځAH&J*P9+f}:l(k3!p;p)Td0e˗b1iR8yf~ϡ!1 O9j$KC)۶n A`f ΁ iN_ Gl99# DI(^8 @ YٻoϞ=SA[g|.b7, ![ƳgA+܍$%NH1ϖp#Y3gc!Ŋd 's!YSvUxÑƏvA\V I &`E)~h,o6^7-@vF)̂<(F#j6#19nF@܎8R9:zU-y>4f}{ڽxӁVx!CK(V) ՉSǐitj$po];`*=ިG*6L8V8'-^N& ϟ5gukPOXi~;t֝;=ݷw{z|I~Hw `Ae*(Es{ ( ~$V*԰hKGc\x"XΑ=mbc˒!mڷzg;)l"`JCPc>FJL鐸_TàR%bepTsNOZ΄bI%e:P 9lgB{&7 :XQLWd  Ѽc$3o#獅[m&PtF=1,V;H|rX5 OX膬7b8ߪ_v,r8XЃ BJڋXLh^0X/1`³5+ 67,?H`1_ȹ! 4/\,=9)1;,EE-c&" Aj2rbٍ9< yшh "g޼y=آC9BϯcS@HC 'k|֭oxhRQW6a|FǷU0 K,uuAApXdE !@J*̠ 60r \!*bBrO5Ix%KS= * B( ڢe[r &meɓ…sOž>ȊX~DwʥfD=RJ+YģǏ0tdP(2!fڜrv  2ydk/R0V}\~1x*ap0q‘G'L GFqF͓'x%;#A0 ܆ uՅv-cdɌwXNHlٲ(w1'NDU,9 1 +\M/ Jఐ(' CIY:q],tDp@|RF0C%ʛ/,fbk6y~>ə+Տn`ar+Vhٲ߫V,X8,|v܁^(oݾt@~֞Xͫ <ljɒ%a;0o8|w2KF6kOvc\nظt2&MPC_֭VQCCC_ϟ8~xvIÔ"Gԗ.# t:1[Btȃlu[$4%VGh̐׈ǣø#b+=dZka"B[nzfb;\RhmѴE,zA 2L,"9T"QĚH%nX3KC B A@;JÂeƂ= u_B,9qbTj;dGE2EV' KbXREX4HWWba*^# "arbAK~1,G< B>N{^XԀXb#<߷tl@ѣEVT黂MI!HGȗ ڕ 6#njb%o`nwlV"X%l;wBD{֔'O{ }psqƀ`ܸIcl@XR"ELo * V-Z!0F[WvnYPaqۦU*VDgd͘#ߣ^ͺ0?V,pسpI &ǡ6ebD,]BhsX{wZiyx|N;#/xaۼa1 ;^>GzΛG~[lO0h:ŠFn0v)6n&SDC6>o/wށ{ $~%K@{t_5Gρ iݴy?ǎ5i#8MP%H;twz X),Eeu]T0@AE)NY,EYF=*X0 b+2 2{R314pR1CK?#dTL)ʡ} %Q+wQ`F0=c)-4["з]&O)B$%҃Œ3C~Xy`V qgF7E45 &l@徎j 0G],:kی M0_4uE hX ^Xx2=|,8^›3R4F`e-rbcabLz & nX( +Nb#s"_Eҕ1Gh,h@ (#rR6lGc llb!`lb!3#,ރCl//o"e*bbEr8?*Vϑ^{Ca^dӫlvs%k+Tw=#h"F &77I Rl^)S_2+LA^IF7N/˜ <8JcILfv2_:K>۶I۶[;6ِ}|[l5n8>[lSIQ|E ?i_;vf_vرH,<;@%Jؓ-$a4}]XhL.i;i,Yp6/#&Y2? ضl&A2;i⤃ yţڴmAճ|4^OG,S GEFe3{z֭"KW#$L7/!8-v)- ֶ8XwQLN,6aO2eq(WLɲeJ/!s&O4A2pko gҥKUPھmwC}CdIf˒937 b{ Lx 5D2? Rgţ7gG&^P>n'Z 23O_̦* @FYBx@ɶJJ/cKU[1?$is'u- m Yp+TX8>P c=XTxF1R0xEb`*(BE9%B_bHU)X9 H ȃm8(5+EńGmjZza0g@h,"%#}lLL估 E H`^XXv*M}0(EWh(ү0wMK)1)1dX4/)1Qq*Ђi&/ba{;8ic|~] *}x] 4̌Ѭ^r\PꌟfƊX-~rʟ<{ZpH*ur!*MѿճO?Gxn,)JPYoQyPU+!B"##,\U떇KJW1mTx޻,C|J/]h+nRK(.E+m MWXr#26^ .|2hq׮ʉ#; 4LA]TVAQBE@0<%'7[( Ɯ+5(}mP7` 'VmRu[G""̺[BEbR,7y)_Er Xa-bQM5.RN~4-bQ3~1)= ȃ/nx_\,.%ZXp8nR8;V ɢN yoa@=_C.MvNtN=2J,^ՋXL yG`{c!N)Ģ`[G[L/ RgBdd[E*Ua݈~60{~ D'FM&Mjt|Fҕa<͟.0Ԇ8 6,PL6 )KsgjF8󋤷 O8 ې F!)מ86وؐ;)%L^!"aKٳע<վQnM3 1Ā: }0?o tFQ jrΔ"[.x .-9rV+ lPL l`qH!Oî2Ѝ FPs2 AEL.2;R,&E YC2avuV1,\z_ U_/,\/"&,r=GaѸ/<A轱B&i8yaa)bB :",[oO>XDlAo,a , h>(X(ra0򾙫a\XDC$ sPb̀%_@9ax 6K[PX4|Vx + ?~ ulC{'먀|?~c?_"NMXr w̘)%D m&my3e$ucg'(vӧMO=7|Q.EZ_{ "J;lLKQQyɘ!6bi.JAᅴ)}FJ&JTS ˸Th/G ~=\>Iza`NF,Q&kkJ=!K‚9E@CV3d.H,)Y WyPpV(JӸ#?P6YDY vft@ӤP 2~iCYc `ť\/0Q|i%ndM/X|/3G!!ZEMmi}LfJW[e_kFU*8ba}Aiyp+aCxnG ih`iji}(,;DG uxQ92BtJ8F! n8(M]Ur%͜.DcR^t sU3_<<8'Vթ6T1X"b/1,: դ*k?[X̯XDI1L._4 $ wQq ,b!G-Fz( s?alGa0ޖ0u c-",Xr( s /Jf09  CBMl_#c=@)/Lb4~ v"yc-}tX)P i{cP-%+Fmϟi ƱY3lmPkݿsW )'7TO8`=G  sG} kj<Qj%Hb28TG_O+I :w5Z~\viY*wC8*|ǙNx,UH E;C;x6bR0鬉*`rN8ѕS;BFBhcq 1_ B"j|d(Rw_VV',O~˚(9 :5A xf0~tl@K* T)KlY/]b09"F`Wс{?E#R`A'AԽHFGfxES'ծSrJBBtw9|}^Zr*+3"<p, bm(Faj=ztGpr[Ijժ-Y7f:pq@{p2dy7 ~dKAX/epԠK 9r=Rec0.}5HLXzJQ,B'"ω,$"?q} Jv~(Y 嘡XÃ(6T8[BWYNlbca¢DϱbqXOx-1вXc=P_sӀ,TPȟ,މ x\,L.Jhc 7:S\reQ0Nި2T\*+_BBwÖmZ #%`@E=Ǐ򏕣nj\erj1SE-VعgqmTRtu7?G"%"9+Vڃ\h &ڳs}ݻOBԭ]l8x5R#xZ𞽻 *3ǃ 1{gX,uT.yUV" ϖ-ZAi:pymԬ BLtieZI/˸,ERp?>cʕ+W^u)eF1TUH٘FՀi8PC-DA x0 r?5J pĴ ̈,Qbr„GF0 JR sG^kTGiFQiB- jsrR2J^QkR+*ccc=XH\?r JQu,[\XXH܍Xd842Ap֭Yov$N'O"ܾz#<< lfM[`ZjQl]D^D$/cێ[=U?e`<͞3-siS۷0b*ժ"aέ;C$&$5 y]:vA..߮]{ o$KߨFC~ݻwoX!2w} w;rLtsr/>.p[oW{I񙐕\j.^H".K*%|&O9*7x وr-XBn:\al @̙3ECB6ʑ I`9"b!1m"X< ia xŵ6d(O;*D7vZr>V%:fhX-i`co;oPmIYEq6X {$9rYaSX^e,.EcEBttI }Ȥm@ۀEL,2 ;XX,ba5-/# X+k@|eAfn$?_Wa0Pa0# qzdL?`1 Xtpټ3~['XŤѲǮ2 _'xΧv-n#?a?`-,d߮߸$ؚGhԧf-jR ;IUVYj vtһ29H@aOqَ;oXKjrbaUAQʜd]Ě;SF h=[4of=p0ŽK`3ϔ1#͛6uSyƍ0: 7o$dW{9d]e>z"΂8W%M~)ˆHz<(A˗Xʾ% oG3"Ej< /X$ر`+)hP@EO[1bf,?: ;BW:˯Oq?>h/-Z3L_K,s& j0fb)0K$ 7>! r}|9x02f1&ײe?xhp1eI X-HŲrs=ðO9wμg޼E7nD[kժT%?~ȑ-6wNz9Ƿ6>y4=D!YRRP4xi`/|w9~_Y<w4# اoqsӫ,d9ϑ4,O;w0/ȯB &2o6}d&LŦwZ|uM5m)Sh#}1|AA7ntx$ȡ+B2cy %lAJRdlV)#-X$\c EI5H퇔R,j"MM irvtT٧W۶,T`YXNfQm۴ݺuL_kVO"MܶdӾCeJ#T)N˙~hO>}R-QlЗ_@lyTxRXcg"agRe6jrɎ#|jQ8_N0S8"QYjfJP͟Ø7m޴a㨑? AĉKJ2Bz$G()pǤM$I׭]$0t +RP>W!|J*XM7 mwr…-ܣW'EAk7| G-Z[n du0+Q|-ps1)k70 -VZX'H)T`ii% ¢~BJ4kVݣ[J*!pȓ&9R%O.UQpUB7!)r>8A|{ K(8eʖ;̻_\,@9P$^Hv~\,ls}S=$4, 3EXS1y0_q2IAXb/1`NQńAE4p<3YA**YL,`Ç`jE"YwAӰHymX.whp!H0WrqkJuNK?\5ndp-~#|"zˇyJOh8Lf/$dRqgS.4~ Ks3 +}M / W 8ϯBnP)eÆ@ts^ n\7h(#2E)N-A4G$-8ΆlCW}J'y6)He8asvVA5&d'o=G wЫZd7 IKQJ9:tx; w\x_? v 0S5 tـCq\FL҄ h4f'Xt=+b K./!SoiA4cЉQU9 6Da5 4jR@$zW"/\Ȥ'\e+6 mDCRüԎ01 g28-T\_&#CKfB]18LqT(cbxs*uK$N1]P!XyFhNb@!vcBPyA 50FNrZL@\Y]e$ecDALG(&FI$IΖh3V.G # X<Ҏ P ,  BX ,^Rrǩ%      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrtuvwxyz{|}~#뱱r[ĉ-bA@q@;#  c&WpH*- S;5crAW~5Jr~q0`bQnvgOBP释PJ72V ~3뙳di L4`6˝L`Bl*p.̗ ン>}F$@x~Ӧk&O~8[ٮ(i"ϕ;gLB Z{'CLx2j8A~3e-r 3r1}ʶ@Rާ-#bj#h!b) PO/9W<,|1ġiF-}4m(PK۴Yx94<~IvKzĉfGqowJ8rvwJ+yp:C!pX~˽ =|k֪(ABvd$v1Jwrbqt#M~&<{I'˗(8(>2 'OL,F :s8bl1svUlxL]1}2A ^8eesf?y䴩3A@r$S8 WWfE29l!,\"ӂ_98`s'sb8ANb9?mK?WL6mpR (9^fP| z?,.l;z$+Z]dU)N_d@cBf.$tB0{ qк`yDɴoc Ѥ︵ocok8#2~2(Sn>oq/;zܻo':3+!䒥1*U9R5'ܵS O#O =4U{񯋑k? # P4)HzC`5eo} <QosXe*5X >#>mt)n[&l̓J4w);>FV!8r qkh17Eqd qbJuh4,:Lnoh,'ƃP}Fp""+bXNE%16 >X/ckL",b-,J]8X$ ^XtxаFĉ'h+|_M% (ּ! ),\)*Zu@m[V j[-fMqDh3J>Ǐwmߞ3fhѲ3| aBރ;pqPn0=;uh~z #c]Z?rh欙0AH7ΛS>^Q$IԫנjժwP`?DJ-Bw%">ũ1T``.k"Wf]D=pp [L*U>_ 0g*m8ԯ߰RK2pF Mc\nn>>wQb%8mݾm_6kw\qQHPBǎ!#cz=tY5ҦK={F%GY*X6onWA& m=w6T3׭_wPLfx.] &O|ْVv:ڨP?b8~Ko ׬YfM7W^*T߯?#/5?$#ӫw_~[z7j׮S\'O}l2eݹs1Fs ڶe[ժqkÆ(ůIfrj!_}vG.f׬F:uuq̯}1 YYh`8FF,q dX"+ӥFQ;7kdKX ;t4ܢūP|6m6měr{O=$`MDEN: 2n7QGAZl>wт7oRBE1RV-;ذ|W:%#N@.X82Sr,bQ,9j&KX%&]R͹!fYDjdlIɍ'Sǚ2l^cZm%v4bDoģ @GW#v uhۦGc!10Uh,|&B ǰH/ŝB hI݁E,skh,'PXMBW\i@V,j@诂&gSJ=dz)2~_蹫TXP~ b1(ĴńP.\,Zba.=,yH$saɕfXL5=`2`y`{a`;22֔eXSQtc%8N5WrœN*FaevY~}D?sۚ5F87nX}{|ͯ-:mʡ#uSD’ QQcǏeɯvV=˯<_o&8~J駟\Z (eauGcA5k7o߰'T\(HT,D?{-Z}g;v!*xՁߚk!*>Gh{A,_`_뷯Ԧ+~(4=qWr̸1m?7nBÄZvs͋HK`͗}~>&6ƶ ;n}3 Ok$`vC|SDQ,ScǍݴm3ޣ <ߠQUG(; L1Nxlu*<ɓ'2  g'OMfhfE(fs$r  n.4 u|,~Jxdž9 ,|l E%BßN|RXy .CBJ,7XPy,P1=y iya Xj&aޟyߴ Z[ >ǍL\cu4Q+9~$lqsnPPhQ)2q3f$?sb'`V#aL%L#Nzҥ˯eJ^|58 S''v8߯}`vB*+n˚5=֭YUYxқٲ[«W}߆߹{X￿u@G9e:Lf yY&~_Czr˖-H+gΐ<1KY&#e !qʪA%ٻ(g /# P71zdi\ҡ -D\9|ӦN /ʔ)SCP#^<FR eDCa-83蚔|OwC(w\KDmg Z;O-[RI-J*3Nc>ZDqjx{O7!:`ZCB~ჳog)oe-A቗zB m1 "0bhxr^F!^&fw!1-ƐLZ1F)ЃHNg(D!)Szfy^vlߎdR+V7{TQcᢅNK& m[.UOF*so$n@O&2CQ$jC,@Cxc$j͛O=>R >F͚I$E|hZZmb 5sdBH i{ :eZAwȑD ' 7&"TO,gG0c+RI[!c֍s$NԪUf-AN{X7(f@Ŋo<+DiŞCږ@%Y)G^įi]8>ymwuj!Û6oٻo_-yD)iO0 k͛79Vf΀_P+޹pB%p1cfݵkg:t#q2x'YPΚ=vx~ "7(§%B'sj`S42,6W0+w+m% }fF2!kИn]a l RJPKD.Y8Ҳ@С*@!?!+ F"˰aw:e8P',V)~値h|ԮXHgE6V)H!$`aـXE㓲Y 2,,Tн],ly(/\ 7h,L `qł0bbA@cIF~Q2oK aP\kHSs $9* 0,ha 4*# %"qw-،bXԀRO9츰`ՇQÇzc_JLr,a ~7d,Zxʕ `.1F'I\Sֆu֬^Ӷ})RP#RO%.\O#_ o%`gɗg:*zϓSNP,S`Q>z:7mи>ERD "gpgTC "`j6`X+4rtKѼ:w0a*\LlekQ3fa~ӆZ5j-[J-`7|#ϒߗ<yo:w(Tp̄(ٳ b"ahT:/0^ĉ{7gmpϘ>]-bw`XtHzoK_zpN1хRJHOбKGO,Q˖/ocɱaqREi&zŋVmZI+V̕'B%5Ha) Pxm#l68um@gc'w]6yr+X`OϕLٲ|;93jڑ'K`a7 r܇eS5iƿhhba4F!O#CiNtJR[ S-)?'>ȧPdѸ|KFq/˙K&]gxVPEZhPf35\(8*V2~'І.\C^6,PmE"~33`= Gcjw' 燰yš-1gy>DS &t#'B (l817wvm|e A?/Qtr~$Jb޴w2>΢1{B3=p.g!2:_& FbAˤ o5@:aoIA)eEfSqQRL].*#~*Tr:!\驸>"+ljC{`QC8,4HTR5l nGɧHVr30NE֕Fwyaa!$&bUJaĶԢ%+*n'PDU.,B`X:wvB4B&/"h_b1Ƶ5dE*,nJ0^h@r,1HcE(iH_^Sǘ %Hl?aVŁ. _׮_պ *=!Ep lJˇsUȇ՘J+ٳfb^SH+t Λ+S̈ՠ?,;y+wCcKq&]od > dSc-]"0"D=nݾuiҡPҷ*Aك"C)8 )7ݗ5Bn.TZlQ ?XYsb1rahqRN)1(ج3*$/P:t˳ k[pkX4r0~(m\X8 cb37 ؚ-^{-KanYDB/xCحX*^4/=_qЂ[9M,rz $+@c9+B OXPA*΂*w(,@c#?7JGNYZȹ&Z4: JyF]ہ6~9~QD`^ca{.]uAu4r7CF,u:k"~̇L\~=q `Y TUh K>|}O=3mTp>u'Gt(Eqb)@ p"9v8^@|vG_^G=|dLx zSXa'ڱcGܽī qıNroލ7 )Xzas]v$EkAݸ}ݶ7} |@[B]8f@#ܾs'syXL? wuc`|b#AF1?5!@XuZrE,Wo\:#?Krٺ W8}K;wa~AR}$$$z 6v- } \b\v|Xv?z1,ֿnCxOǯ^|tӓrBjX0s8PH˅՝>'!CN>q?Zt6<8ͧM'Μ|ǏjW 1Dݬ_z2~/n)Wia? pbbŊ#̚2fǏBT?Ͻ]@͘<d sy@c |9P-^@6.،""hBA"t &Z_ :m_Ԏ;ǯ|,ϛ7^Μ⊍ٳg_O-=*E=EtY>/hyӧ̘7w1.\ӌʕ.ݷC'Q怪U?{=sx&Թ]',Ӧe۩?7S.]8-6cnV/G3v,Bȑ?LSiG?ҫW3~ѵ;717nxSV,ȧiæg̘2a .Dyn"|G>M|+ ~R7^{w0ݷߝ3{'عCC|1r>(e ^ڣY-yߧoM45Sz}Q3k'Ncl=oӜm[=vl( ߔ(QyTa>u##[Jվ}<.i]*_'c/02yo1}*T? zam}1hڴisFԪQ{L6zh!̟`OYxԯ }H(ڴjŸgLe6$;s9i}{"2-dɔ}S&:m~\>6" r+\l㋐ uƯ~  (Qן~1sa״I410oE~3&B۷%p ;3 58y`B`yS#Yh`@l ʰЍtTflB) ͥx2c؂@Chp:^u O?-PǏ۴YS\_`Ԩ[vnG|a:=13?jmо'⁞g;vJ+5o ${ٸi'{\:YN;R)]p"N!x_4ۇoJ+U(<5\5MЯqy/b-+ DBƧCeU˖)c_3ш#5lT6rh?T\+U7o1OɝGwo޿L>Xha? ;|AX"7u΅klt)|7bhqڕW>i:7y _$7?`r'-WH!Q[~]@%{أ3-^nayf7oc\6~k7[-n96mJX;|+psF(S̹ gȭz`iѺ+|[| >z~xt#>agv>h=| LMsxx۷/^6-F6b GXOVRTgR)QR޻Ju:%@!̑! Lh 9\Q]!ɓPD鲂L4h(*^R%eVPi p+:yҤ fGeʔ)&.}1.ǏڰƢw,O0>Aw #H Jup4 8+%jO ɎңYgP[hdg RB%m`ЙgAGA^a-# w,X𛯇ݺw-Rh%.OvH\w US>PO48M4W I7XOwQbnࣜDڤڜEġeTI>LN҆qг{t&"E#OQ,4r:!S 8CߪP BY K0p"4G@)#jr,O QBX\h,b@1D(,ɀŞXJ|)!cP\h/ 7)Ȁ&,l@/"0EX,ve,,:¬_$ E7G*Ow Z\,iH1p{AGƬYt8EpV3^T"}Ͽ,Js{%cyv:ݻv?xt(6D1 WXPYq$ɓ/_}8p/A#%Z'?e/BɷfZ7ۻ{{ G!@}֯SxD:pS/< Rٳ^Lzu=F90H~̙n޼|pz5eXNZP#FD*ZhNFI1mv1~A"GB$LW}JB#?O~ I֥ìX(Ͽ[#-KE ޼i3"+W.ބ#[ U?LˊASz".c{u!iyQs.6cҵSv հta9gV\\3fnC*ݚJXS2P MJLD<ط& dlOk1QKlg]iGS_ ,⤠DEz\¢dcwy$ >uX؂6* i\X^sP{вb):m1D7e !~.E7kcX<  "t!6 /"J0k+8Y4:ZVSsÅ6*8<X=;uԸq ?o0 %Ӓ?g%K4ioM89VO/ SOesŒ8?@/ײyKh,Td=ǘcsU$2B$Æ hupNq,IC| }";?V)?>!7-_\FB ^1~2c}ݷC;t࢟-QUQ.  blC<\Hpa\0oAlM9\ mwe/3[T{/ ?ЪjtJAKw" ` HH7tt" J7\nsc{?QgZ{5W9_ RJ9V%,U:d(ja (W,ڴn *,$%H}#>4oU+(VXb0S _x{'pUR Z*ȠEZ6lrN Q2"4; xyl԰x@EU\| ; 72FK`އQڀb7oޫ;|>ԓCCEEEgqYq~#+Rڵp gjB*\0@[ w#"AK/mGmL#|8lٲ{Ȉth=# ">!(*\YfB=/ni nCp\y׮]@۞=s-Z(YT=Z4DJ,jլ!P:hZxu"6˱UxVX]p(iܩ 2󷂷s:ʐwIuW8Tl$=a'Gx$2N|LA/7BbL 0TQpur GI*,+ (,9(nWBp,P.p+Rɢ3U*_W\yd{m@J9ђ-f>Y(imGB`Q yewF-,R %Um:FY ѱ)5`2YZ82$EtQl%Ԣ9ܙò1ڌ E|}}`ckx&ŃWsN˒9 63Z ?Vi X{~7R~TnpJ0e*GOyZ`t#. zK^حR2Q@J‹?#\n`C/H yYDi\B05&y&B2C*-4\LB"l$UN.O n!n(aLbG(Dƃy \C (D^"ù{XF+}^q8y4P YCHg tڱ (sy=8P0W4kIB"bfOLZaehb_0 vG/7й^m1b@9 L b ·@Ta[%"Gq/ SkV,;0Oa5Ad֚|B nQ&)Ӧ3vfU'TCcҪUa#ϔU*Y^p6oFa|1<{nV+"}XDd1[&҃&OHMD`6;o ot](LmDvħ`$[g NmKW98c$ 3n 8qVPl҉F7'҆bJZ@Xރ.qE07)OX{0-s)`,-:BkH%$ ̡_>P_ʂZD)h@A<0 _qʂ} e@4 VdQ& VQMmb7,X $2<К~2AS; a_L3Y+9Ǣn>~:X.]Y̐WXKrFu\Bk/]8+JZm12Zd̢8T;ᇜCSjҥJGDk<[=v7YzI X~qڪ_a#Vy$B9)c @ x>M~/Xf} a4#Bď:K߄Й5Xl/LB@2n/,2jC7i*1&DaXa^|1YZ4NY6qM8yZ)yԕ}XCNR`{0JJs,YZ@X[O WLYAUI 2m;a&}=<oZz)> 2H2W*l1NˠFdXh6|0G\f̚ u߁Lwy`ƧĈ l}Jq_|<hͥ͞IAy"G ?!ET :pHp`vO_Ѱ0͙2I$1@2ǟF`TZ*PO]zRqP4 }ӓ,:W"Z( /G8'hՁS:9HA:'!lX~AZn I1לְ6fYGc*ȻFg-陶"T.Jn-ZβѬBi[,)rVdQ"ހeuЕީ_HfL +M*OClR?d.6횞{ϱYQwJ8SA+ 1b\0KoRXr={J'2r$PK9b`wdK.Z.q㾺z:~5m0WvуS?pU.W? Dq|a9Ct8@5ird[tvuְDW }3gΙi/͘50y?Jp#3oa;y>_x-[Ij˟LfX| ~={V%K/_ Ů_5Ƶȼ6g z$0V?w ϝ?{Hh7!bg!ڼyϟc#p(zD0ա cE87^mhK[80 w{^v g;vh֬Vk{Y"Fk…aMi &z_lڪ(j=m[kw9}v3X-&F&M | ępԨSㆍ!x`ӧ.;`hYsf9v e.B:u?v,:%K8$ݷhe+zx7zBSehZ38O6_*4>Gv|Jvd3xRtxj t$˜LyI<\сccmoo*hIl0^iĒ\)% &p*Ճqx%He#;)ֹA, tA87 XR9 ` YDZIHbj͉A򌪉h:+YYHT0ckČ h~-UDw^V U6ڲʴ'YnBR,Xe @e!M eUWK|dA1G}er&W&NQyUx̜,zN ,b{dXVdўG4^,`~q_ ;Z2?YLcA/& )Nj)_ ,9:f0s8e0!2^~{:8M YH,eH. 7\xxԎ;38Kb48(J oE߼ծ[lGƅ+M%三ǟ6mٖ'+goi#G %t43AS8 1I9h1b$lu[pEf ׺ULȱմYkQ/_;iڴj~'` Ux8&6 Y:~?;BBB/_$;vn?{%,M4vQ)!%?Qm TB)SΌ,4 A-_}sgϟ:ÐAPi0z1-[XϚ vhƽ{lڰoEp'y(rٴoOg&|!SFa|7~/ԴI38iӧmޢȰi,-iMhc4Z:9zO>b87oBݍ엀G;7F:DK2"-}d# )*BW`T8pwv NshNDyG$a1xK$<\f%eq@2D݈jղp.߳w_R/ 4 +..zԍe˖,F(F9= ( )$Jl1zYX~ٍ6ɐ1#ҘyR@UjT{ŹaٳKG8^*8ÿwءEˏ^ChٔFВѬόH8cߋQ|9xuK..bf U*D @etZnF\'!2FfVcHxEBɵHg\_"+ #YP)e r"+6D8,4dm# 2@ܕEـEd-Ȃ& "dk@=m'#+9G[2H ; 4 P/:IGTxdq5#옓JGfP_H@#20׍c>]Y\ ,t d&KI!Y *v~qdj(Ērgţخ,TlT(]/T %Nԝ 8'=&PvAI=SZ|$3E͖-[߷iTvay>p™}q_evAtyB0 57yy-fGo.:r8>92"<[VKP2y%(S%'/_MH݌[$MU zAD3n"qBR$NQ fmrr| k68ٴHtGŽ&\8Vڱ)adoߕmD\zY%Л;|0 @P,[nٳ>͸KD7_GkzPnrT e+,AYHV[>XM cRP` pຄ$j([98#ed_0\@KpۺUkoWZ9ɹd^(^7e85U ! a&X_{5~Ξ;# /~I.P/~b#s i`fȂKYPGBzz~a!hO" bWVjOIY_wƕm@@ueqGGM|d1fksx*/~m6AְHBuEsɀAbZȁoܦ88O1k\M_ J<!+; zeԌXGܥ43lB}5j. 2i݌&B ׯ_oD4L̷c;4p͑;G?3B% xǎsyfaKL*K?yOoWaT$BcVh՜={ժh #EZ>`b[oAy _ )e T7\?yozݷqek֬ݲekn=Il  w~w _rB@h3S̀nӪd2et7lX߰cjk֬y!d4ӷ/.dZJ su}VY!=;e4|>Zk} r?Nޗ!> l1,zzupJG`ktݛj@2Λ#.h1ڐګo߾]u X *O-Z cJR4ipoӶ͵רăc%Cp3&]D"S|g%ڙPsr~]<0u9-x^@ "qtDF"skX3DnhB#J n~[Ÿ4=p"YN[BWUɞHZ,F e- 0xk' !VY,Nļq+ MxxR3S(add/_ uY0صx/,WK2Y]L2B4*)eENvmxAX~ ݬ,6yؔ9MY\F@OWE0H_]Y V+)Ӏ~/ ;l{YI%Yd;!X 2w/D{eϞ6yT%暖lC7T9s,] -OYBΞ!ׂˊ6rAaxC| jŌ3$׮m[ۆl|Ȑ"k@h7qv@'LVoђ/wm:fUU{Nf*W.C4dAZ:0!)_бCJF,/6@@m>o7lҘE5mڶMq_f \"\Nֵ;f@$ se ̎N.}ʕ[Be$C}ڶ{iYvݺu 9 z=u%PP1p~<:`Zys'? OܙzCV *[,x`1<%Xi1 A+ e#yc=8d չpCr20-LS %`ua`qT;d3H~Cp9y Tt)X5tNeh܄fEYܦ4' n=ʈB[T// k`^YuiDuIE&Հ5,`bL\Y8T؄>\+ yd!dndFɔ_HZAev@-Y,{W6hvr_*eQpG|ŕQCZepe6Y\ŖrmP$'E9AfqūX]YL=d[L?YxEfB ORj||JG4PAE~Bsj`L>}ai:uΒ%zѡz`LHr:abBOL}27 X̭f(vܙj*:"RP14Cڟ~GVz9y7X;z/ aH `)UrP`2bC3eHY-npK'`&bL\Z4БC_Wܹ=.!˱B#H)ߖh# @|UN J{"OkyX:b=Ѻhj=[IKbJQNMN*+Fv3b3saGU|E@YmnYjip) FC"4 p 3F`b&Vmd R"k^*Q+ dbuVc'PE! ls(eP;J<|rYdL雏ekBM%3I]D2YG`Ƙq334GNJO)bYZt/G0.⳴Bd_nSB\)6 ZQYbS 5,\|e(G(|}Y|\~QWGV# 5t)VR& EDi""f54xb8 duj`rJH|‘Z6qۮ(g^l;c w;hF$ <3̙2ߓ-;1+4 ьX gӏ`e|b@c`TĽ `bmÌ-t9s(2åD` JPP"ÙGcW_K 582@.= EbHʃ[c- 0/cC=p5˳O_?UYNq&CDg/ -7R({6yI)>`#D@V:`Z 6nИ[ RZ-bS[[:sh@dE_A%I,_|{AumEa+&C`RN /!,BG)  U,Hqc+3·?ou/V1jhAt[ %Sl]::ML_(d1 srY0(nE::o)_ʢ> R Ȣn;E~y ?Y/ـN,:war8zC8_:P12d9jlիW;pWdć0ۖ5,a,s0)GBE )S9^8oqO )2[Aj~ E.O&YVƎ3x'c}i0s, 歛}ѠO>Zv5+t7d}>4b0ഊ;[z^ 6X>)KPKap,6F閭:OPS޼ `Xԑn><っ1{lYAa>]<… /]-x͞5-Re胳q۹sPRۀ$!0/2p]aC`vć֯8"4 k;o-"ՐUUpH@ (?ATҎʈ.BBM@61Jd"[j%@^QNr\rCt2%kS:b0(IbDD%ڲB+0`>*CZLydFc36]AlY2Щdg mwDw륯[5YuRY7XJx%8Yyt&}>7a\ G&APp)ɏbs_ȡGRUgvƯbTk F?vdTjGYMf9>h&#d/Y0Ȣ c #i.c&xes+M BEe!?zpEL42i©%[${|)zbO?4C$+Md4!ZfM{sØD*gJ~﮽6m6 0"}RX&~ot3ޠFoZzRed˜v:?Rf-j{СOVZe"-[.YLtΌ{o,ׯZ_(~ĥco}GE1 :ϐ&`a7ƍG G}`z啗iv5@+U.Ull>k{[|:$>Hʕ+|Zܱ2a z#ՕZW6mz:A~NF:3lx}6xHaD -}͎^QU@0A2rŶJw:G7v"21vyG+[%i&ABh'jb7 =DZ pU3/|@k!MZ-dp!(-Q;|n|bD)$yhRrwdh7PdҹsaO}]ZLdЌ 8(/Bt8e!i%+ZQ1m+Ց;H}YJ28"2`z>T/ +udQd'P]xBni 6G+h*lKTgu,㑅c8]Y% g%ڴ@="B##ET'3XgQ:,B0[؀Ǎճ\hbٽo_լPG7F 㓎 iS_}՟Xbٲ*V2WŞ(^Ob#2|5Tu.b[UF{fX<~ED. 52gƤ\:E mߦ#>Ƿ7ւƍu7zK>r~4c=f RԫGoT|5ɓ9c+*X0lJ*lr[P-`i̛@M(y3K=-׀MNT b k rFZ1tEcɽv`¹R@ 8lC/ܳ-| vrjPN`02!R7D.@pbhvgkAh2uưn-b =Ql.~F* Q,J~F'/rÏ~ ^tEF75o&e: u`{'pe񟢑ڧn-`1J_-®0cIᨐ::Fjcg(8W5%V ;Hq[Fx?H 'pe,ajكdATzYԀAJ84e>r bM8&߄C12ͱmBjVG@[7ΓwH͍ oS:ҐaWL˖+ -]Mjm=&~;@|L@ikd-UH^zڵɚKYݷLs s5̅3|~'N/zb|˚`x9wĉcʻn: g'|^>';{cQ7oΟ?{Q8zcb̗7_8p s` xɢ3mƌoշOSǟWjӶ5.\ AaozqTzfL\'4u>j4R?~ x Cx\СE>YW{ADݼټi'NFl6[f&b{! wwƩ6x[ `^Jq Uv^Up\.[V ^/T]JX5b-T+Bsj2ndOT-d QŊ7R,rJZ|tzp(I<-m_f͕Lc'+ƥ :2.A(~^JZA#sT"30 Gv2_w Ǻ2LBr±[g&v6K1=- 8֨VmE}z{K{_@|Μ9}Zjc9SN[͐ч{{`9;#"#{~d!d:fڴi~4ծ~8ݘH(Ԉ SWB^wygGXLR <={`q7qZ_pe8F[{}_neʔ)tْ\sbE/puƪc5i{`YgϜq|V[ G/_"\ *DNyԀ\ *]PS&MjFae=H͛7v dA K)>G+Ÿs=)NYQRe.K8J-og6x DJ%\G UX쨩Jp|7ö%4*."P^%_${VBenܑŊI#Pf)bXYxIDMKiɎ2\t<+@|:vM* :*O:H pVM84L8q'Nk_ G†&8b{mbN6\%iu[ȇڮoym7Iӆྦྷ+2BLB}%dNLv:^fKe/ ;YriLJ+ 'ERegSq's`20g qeL FFL oDX(bf Ap l |xp̔Da҄U̙(>IWk=6`wvx.bXz0X_8~gIÝ;wnCqYڠh 2$b-{rb$ fF4ɺp*a50TZ"ґY{~]̮׹䋄EH2ޡ(`REeӢ.C, 9Y F,GeKɫ؂3\UlNr8i:p[eؚSTA پ> f1sO8O\t ٢=`L"Xʤ [>TJ\Cq:4LXM0\`95 B3:< YdI0>Eo@S`m=9ޫ 6^X8lRx%āk. AV\hXh,!XMu#<siBwxhܔxr$+v)(X |=<216޿h+XDW7Ύq`Zۄj">!pjJX>֭ uK 5GS6WXM)e˗"o1ezj3h ##k΅re I+a4atYJAრ]- I $ B7D=r͖ytB  *,%qk!VECo$O ~mQGߩ``C"B#h^b C$:߂&|`lyĿVOP `Jr3E8/)W;g G1}& r"q'ZnpOt&N !hTy9WԲNYCbl\7>3gգW׮[oB|SX>VР7vz˛[oDKtk/̩r֯_SjϞ=g̜Ȑ#Ǐ>4j4=L%H؂,.ln٢śog-n^Z9"^F.\ܹa!-ZbJ`tӦ  a3;kҤ1I4'_>4wlk7/_\s>fz-ܐ5՚6i { ~dVTaڔ#> g"njt/|ѭ{WZ0֨UP,~x?l;xs[G\rbbM<ҵG20&z (˔)=r(LDEp_$&ƽҩc֭"t-#FQճf6b0d{Qˮ@re25)&Db4>QiqFhٺoAKlZ0~sΩeuEK,&XR ʅVR*JVZCud8ӄ,XyZ'% $H[Kq:6L0by"H bD+̥gϪKH.b!A,wxNHe, YF1\[E:&+w:lMrd읐T`B# ]I ajJm `rzp'*'g.΄r)N8Ÿ( gs'NpY@P #( ӊ&D)-7^\<2߯-SN{;&1)ZDf[@EѦ#3ٚ>}ߚ0;XMiF͐1CDXd{:$T7cիרQ#E7߯=k_tY=r42MD?}97f"WZ?o>ƍCf~?\_|{2e}Swz͜)ߟ.}: ee͞)S&cS$z~q̙ |P$#tրl矫Vz-R\,i M?sܗ#mD:},ԏ*ntZkayN}upiBʇ#+7J3_ 9,](1B鍔a[&Dch 'Xxtg q ]jST,܎Uq,ln,+,(v|$`Ymc3P}@ rE7]irwRMT) Rp,8HN8u&phphٲ G~8MX6k^5`nYwIϝ=P xK1g8){֬J4њjJy;!toqŷ{K(kta$V}ێkߡ=-d͜f6#ɡÇnDE=7o߶Llp<T+^ 4YzP3W\wrWcӱ}ǩӨ2e 'Ė)Wvmؚ,H-m\:kң [oٶe c}i|%y*;{oޜy;'t@,:+Vړ@beȏhBs+ThZIrJyE3$ׂ@c!e `g|.=lS(Ef )'XLU!|RQeCIg-$դ,meZ,z2K,|/eq#=&-RAB& UVA*5v GT% kM8zLAʻI^>K)&,YH&Yd9RWba;"R P)3g*Wsp:y]^jEKzטh>|uy[Lܟ۽.D'T9(Ǝ#swSù erγj!*OۡゟV] Ű[ʞnYbJD$ ͽ<;r+ ~lKa &a;-A)i{ŵuҩY.)ӭբ$qb!ŭI$;tՎM(LOаC="|tL0F[,6K_Y/@S@=S[/"ƋfKit6|k T3޹ǀ&MNh2u RϨ?H? _?j sу9HM̙pYכF.~dRr.e&؇@_*l+׋>ޫqtq!`Xа} wst76F 3/l"1`\96nt,HZ3#?q֬^oM <[ Gel|lN^)nɃ>رߛF5k~ '8}zȱ߳rud\ׯ#Y3f%1T3GW:u}xr]{̻c7Ժ^(X;q@~ffJ8uxbXLd@B݀~ස+V,2q am[($cJK.]rw(Sz,6Y֢#W(ZFPl (6}CrNQP2[C1AH:T,t<:բ$(xЁ>oaaBLԑ9_q%)C,bt  bbmᭅoVw d!+7 ,kbz:ҋWj {[N xjnBuIؚ _dLAJjѨeAj, q O-a)T*_]61ZJQ eF@EHcIb (_NU6ښjy 9y";>0j}}ȓ5)&1>"8 0ZujHK!@Gf\Ǘ:$\cY*$B>s:PN M[7ϘLȖ% .D Rrj񥗱2et 8)t?vE(OS<||. )xqD"`D(cA:L$J&p|^7YrIb*Yd' $ee2$[Np%%NJL *ƕRCN>\cFPnh{B[" RWrwKLB*SHY-2װ`4Wd̆Jl:U@26 C[`Z$:1bT %9 r;ā+sn 4.h1!ly+i$fsw2MG%# ctRW  UmW5H1)TǦj!aҟyb RnY ֦sT \ }N΄c&LZ)O RNvpJT>_YSTpWY b3L8p) €{8r‰4&mڴkaxhG׮]mچ۵k'<P# X/x-C]zAq. iϜZVĥ]?~9t-**Mvu!Tk_b 9+CH{8,!Y.xX4>)NXSF[jf :ƒ#,{Vʻl9UKA(."= \reJA[Ն ȞLHՔ85$Hpd:jA/jVK)_ Rޕ_ӆ"B"baX!M 4-^= AHY {L $B0ƒLC( `ql☛(;8pmШZ Μ?ݷo4.YT0ڱSG$ZXNPv<U\iN 9gS׫-5 "rHi'OsN\‘pC(qpCe˖߰{`xQ|@ȩӧXeO|勗_&[#&"ETRjj˗/+VиYc=;Xک|/]oƟ9{bE(4B^4\a?RC)[O|Z|*UYSi%K a @8h TӦM_vc'V\B m۵ʼnsu*"M!o?jUWvw'8Qfu6ڟ'*U5 Kf(Yl^&3~:#pN<`o ZJ*K߹kkTC<ÿWV=\rd_'lҴ?.[ XBn=$<'C> I@/^ho}+,(뭷·Z*jߊ(Vr! P%t \%ۢXxժTVp-$ĵ$4JwLc>.&U>Srt%[jbM/;/ST:5 ,Ur ߞoFrY]rCDn|OsGm 3Cr OG7;9&-#'xEN#f)Y1M1L8N6VO'@.W (楶N[.]ܴyS{gO%x GxxH.YotMUXQ:oވBzxm_mٶ~`y<7W =XKE}hx8~7 O~'7_fOZrINUTEq7^߶}U˿;FGl۱>5mƴ?d_G$m8d-r/h'>Ջ^|^?Wp.aU} K{3B6o!y5ؿ~ݚY~iSz7(؛ 6<7|}(vz+ފ7|Iն[`F ]8ӢEK|ޔ(Ydz/eRrE 鏟<9?=-O { />_țO? Z:TԒx̟mڷq7mtMh)AX&6ot|4qQ  T*Tɔ>F T>DTТ[qpcyt,Gi/N:f٥bMnA;j己QZpSk,bKŶZx{ZY+ &o{ϳ'NoN97G~632b Qd&iɢݺvu|[YY^{5 ^CwXl ǏG25ֱ~$-Yp[6 kt @JP$.ιC^zB*Ӈ ǟ:wzvđ^~o-| 6Ԭ]j*Y2glW^~d~ϐ_ڹsK(VT NM:!+\&MxᰈCG~Z7;81ccY!MxX89T av]dҥKhPHxĨ#Anz^tڍ堗j!j8;^-4bu`N8+2.htu,0eH0e zl\PVb0t)ɼ蘂am 'Vspt f-,WBC`o3 #ѥPl6`~dZŽ'c)#bKٌHLW>r 7EYIXOYn5`d2!kaYe>=nGs~dmҞ3(eJxB,58*{Vi(sq̐&=2Cb5tsM 4/N'"e(ѹ {}xLm_j]pa ħ Ѽ6iVGVj|Pn%58f[ȈM7)\_kj 1+Dʕ*]vfΙa)b3ի-[lЄh凡gPn"#֮]ͷ!tx+Veϖ}邋7a6!!-Z4qƑ'|7Ꮣ'&O2g\܀ٽkSO?4W 0dU?/4iҚ5`.^dѪUȋ<׮\L.- 7W&(SN/)X-N#mV0πC(*W`E LQJ2s TgDxFżӤF 1.tBG&n>6IcC;U`` z&^5(vpH((l @!+K D&vۑUl.Z^Y[udd# sbp>gMsJpWrBVQȢTnRJAJYdOF]YЀxZ xGRWWRҘ,]]# >$ ħUM"1QN̙k֪_ٺ}SP/) R:hlӧMʸzcԫ~<{NwÆi]7] :>fܘÇ!7!.~9_СGzj^~aA8ڜΝ>1 Xe OI"H;/?+@s qr^8vvEW:6h^WZ&dٳg̚1l5m <~Iޟ}鳧\*4NK `lJɏH"x!a: S_t;O|g1ihH F$Zc1z`xvHd 瘎((h \adnLc.NjmY tnAWIrb#]_6YP,D?^Yue!%8\YO~0:d!$pb0Aqx;a,4QqV,3HՀ uu@V)^)EI7Js#ΥƧt|2.UZ|5a$ľHC3r6}qXxއ#6o|Ȑ{XOc=q$Xj֩12ݕknF{}ܢ"yiGK;~7{Ltt١u*A{W0;-}=m6(O>s3u`gx≢x!CF\|L R}0R Jgćzx;7cD5#h5pϯ{$G{8#w߾0]w-R . 6op?AXC{ݼ|Pb} kRre/[,>>{ܹs) cxO{}=1\|]a\/߳owByYf":VTm1(CP}1yҥJc)U3&aCA /0(\fWj $k8M&0BEXmZg*P}1Sd$1(ΑC<:<ŒSG͓̚b)3K@*Smm"Ȕ:x,W>@˼JVȢ<;>Uh E+>:ŷy&-WZɂ_8f/E"pW㖀O:'l 3%&bX18SetH1>o=Q3,W0] a%JD0`a,+V?=s 1(ΐxIn]qјC Lz`tis̍5j*))+8)W[|5<ܩ%1[=|DHF ɕA„KHOs0lciQ E+rc@4!~Kʨ ԁtσ?!jn@Q,;v _ud 4CʟV tY6dQ-2,'D h/)\hm?D$wPdŊtha$5w_/ <b ܐ4  F!tZ)RH NP{#w;(l-#nk7lS$~X(ZπG3`gΙ|ݺ8`Z&NEl1,:Z-S&hr~yglcPi`@xOTpR[ Y D(n1(PL|t:@ig1/fo1no!2\E4r45l#aܬ&\IS ПLioST|jE:LȂY,82oB|eU{E۔-O*ea #Kբ$,֡ `~LkgmӀoi"K]B?&2M6CE?oܺq̘Ӱv]&OnܴƔ4|pW͛7G1$ע PJ8v8 \"++ 7a=xVB H܃=$Lj-L q)׊uKPD/3WSrpeH0FvA"K/ǑIz25zJ!{[Ņ)S'b5z~/Sj%ѱeA [,8 մ.azrgg!X=zvC8NB|l0j҄! `ۤx ;00,+sقNދttsH,dT46 L'J/΁Yb1IqI?B(j8`X gSI}TK͛a%ͼ֭2[tnZT RFR(6gvzqaBCyAJQa%M>z  D?ҕMRuQ*.5&.*6hԄåKi#A kᙒ1pgboWN d1bGB0e"G6-,JP28XўޱR\aqA˳ Ld! H&m_/y4 &gJ1 DzyX(ʕCM Ňq`5G+#_@qLL4*URK.ULJ*6jJ _iRW|u… WRx`npY"zjXko8}4h<ֶ76M6+V?GU,UƛoTh2KWP?qc!;nh.YhIlH`eJ]8y' Ir/VCG#x$;j.YKʘVyJiah,-f(%j63l; R&-g<Ӄ"4ALMxT  *%BInXWHg8"m/6 t0·vL~=yo~2x𒥋|`P bBb8/]ܼi -Xh~k!@à?Njwl:jCZB@& %b:ŠaXqq%&711/4Ayqgo}' _xN=_V5-L90'-W+AA+tѣ?U=0ا{ѢOۯ]f5>^[EcPgّQq t]83׫L~YFTpA T[*8OU$4OrFZ-}⵲2PSbq$3쪄y=-~@zTC# #ʢpFd E.fӑ,Td`Wj }AJ^qAO.RҏC<&<;hM8te0x)QQ GS~eREQϞ= -K,'Nf'+N8t6F- } Wn xA,֞t?p"=}D_r)s,H0ÇgʘͨxnW2I /kf.h(a1_}3LRln+]:uj)`?V H(۹[b,kORDqdp %fN 9=Y#Ͽh| ӮM;_60T3" ",YD1i1w"B*O z%ԃ11|HVc\A0_f<=~"Q)e |У)BMV0$(D~ $@p510f#ݕ U(T-άlXdO Rn7I`&5Onyo͂ȵAJ %g #lڄQ9#Sũ& cgqӂd 뛲Izf9wq¡,A8iL8\&#`8G 0"Ā(h< g^2j9ufoyz8cy|<Fxl0۰6-Q7\*v[H1:H)Oa/OR׎?Y`aF)Γ+ν|ɔ@z6% UcV',9ȜL<fP@PlSrX6.=2Ir=E?4rDl()QDdYVbw7E?+KY%?樘·& ) 9U#?HuPm193gfApjUs 'J2ZV3p,֘.hPZw)])cAU/kڼ˹kpgH!Khn=SO={@Ȇ^,2*D+#r&47읝;0 tj]ϝ?kGZV6:)QEɓL3v-ɳDHif`dGj`*%!Ah;X TgPvjDI$^0pNl\ŒG"@/sB [X T,`{e˜.2>nCz0dM^P1C@JɃ 6HPN;l]/^tBTp9D/~c5-S4:\RVpA&a%I(G6 ks}5fKID{+nK~%/rN( Pa&@$.c(pƱX_X)>g\YQA!Q^|B}•1K$M,)W[Z.}_֭͛9YwnSObeݾ}[B;xs-#6B]dYvm;M부~6xH6Q+~<.8nj3Ro/]?捛p\bp_zN~r1PM߿ߠ5^N2Ï싅 FW6mvdv0J(VQaYӑ׽|Vze-8H5-Y2ʬdV-XARʢשT-&Yx+ vdȟܑE|"vV-ԩk RDcco!En n1q)H{zʛr\` DMd奾UO^ܜ_odbR{$!jAPo?[ R 1:Sg¡#͙p;7(O&'pD+ ̠JN8*Mpt:I&/葏j, HjW(gsX;ׯ[ HZqoz4$5!!( ̖M[ ,`N,ִNxQC}'\8c <Mз0Wl4ҦCG(;f_{E\>7_ڴiׯ[{˫zڕQQ6]F:O>Ξ6bعg(0glsl/ٺu7WT~YېpE ḼXS(qm6m2k'%ĂS풤j1'M7ߌq?ZA8= dC&ͧC?=kV՝Z,G}Aդߤ_P8JG?kdP93$ri5*x F>IY 5Mi6\yJ8DҨFh ?_KrGrd^ 6+&hs*5Y$5WTlk+mQ(6aJob!8@t}QliLUF&SAjg*kpȣkτ#F]!\<;z' jёM8:L */Ch9L K;x@'[eS'OGvC,Z)k֨8ԋΑF8 # /؉@rc^,R,ZYfyHxe8K>1H4mШ!55.UۢUs` JBV,_xѢ[koٺ-cL='`aE"zKFZƒy1g^{'+Y"3 |)SƴfT:uʴ˗8ZyƔ$&Lk-!>t'NQjN#ݾP5^|E5n>)XR^͈ߑTULkdOƌ\".)@ے+vd#,<vy7*_j铆[2w3ZijTбhQd*C}DËEaRIE02sCGteA_(ݱqY-`-ϛ_Jg#b[Qlj+[G#Ŗab[BASiAJZƾӀlig±wA1g!v5لL2bMN00GP S9( ];U:76O2dx9})0.[RYd7! yץS~RyHU+.C[nUBO,`J4 RPțoYzZk/V̞Z6-:t ̚9[]^v|Xjv/3f̡Cpћ/:v~ O>$^#MC'DѾ T|}%>c:RXun"S,ȼz=_uͨ2fA P1{nrV[7z(|*5,uE!C2 [X  Lby-qO+h{d!Gf">)P:)Pis#Aܸb x+\deBS_Wlw)TQllI94cȸ-aH :XBM-0u0HE;t3τCmap83g])' M8/]N4EtP&aX_gh1}[߾}~( (la%V E Hw,}6P,|!&0\E [L`{o-Xs䗣rwz !"L ,m(^-3':'D~[ {؀d…iB v2I XAs>bB[2 Z ?!$.gfz=>Fĩ5͢T˕/ᗍ4½ Zd[(jBË{b׎ ޙi:?z/mL=>u5@ط*W\fj-Vt׎]Z!epO"JF_XW6<+@"@MYgtl Ky.TrfR%>LbY(LjC~`=XJY\'eYV$U'[`z?Y Dg̈́C؄ggKiRmatӧO4yZReTBAVo .^Xf&:"yr?@dPJ>_ -Z(Wk"F-UU'=9KPk$W4 ,V*W[S(}oiię@ʘAJ_F4gy[%Ɋ%z̩RaT)+v"wER_+JmN(KƓ;(gf=7bSs)3^x?bR G@^g4+c&CAM8Z ̈wpn \tδQ7s&aS'$b㛴i|7uӮC[pt`z)/(l̘ 6:wWAQ7kԪQ'NcOPlſ{I$-v*,Cʼnm5gu7pM<YU(L$DJPebTf[c-;,82 Z A(g5>q'C? g`~0"a(ϼ [-00 )?'CowߧM0& BFM,\ E4i,y% 5J/Ǘ!ayo߷WZݫG/V8԰5kV.S.LV,+_ժ6n˧H/]iJuȄ̗ڽo{ Y`Νh> |A|;̙jժa4e" {,~ZGaqP'aB@@ƌl֦D?j="`+Zb?w+ad0bORbO>Y2fȬbޠ"Ԁt' xqtvd="'^cCoL?'N̐rw`B I 2{+' Mp7l:SPU>diQ)6^)M:ad$fuZ ;ַYX)ղ( `_fPgFtXG$$WgF#|ަ0FB` B X-W,b-JUBeLb9jA~J>-?GRwm8Z{,:aeau^YJ"őԯ_88dI­=Ul(3UlGe6n?((Hޫ OxHIM8% Bޝpoio‘58# τF2M8<HjF]g *<%$Bs;nwT"8i8s.AT $~@-`#L a<:pWʕPdwy񐑁n v͛6+n5eC*V\5m4'e@Wko4~,PP7_˨7-_B'S&M_|&Ӹ>uz_jbX?x0.YKUݼE9su=<,e@47AB}l[~?ooK*j# 0֯tzyݺu3f֠6Q:rOH -7iDjx~hVRNDR%hFRjcLH* ,yEpc;X&LܪtJl+%/ H4/ p83IDATD7|r-('jzȭTؘ{O\|#{?,$AQӷ 2;`ATʢLʓf1*15_Wۧ_LEpYM. $,MAd:H~D=ϸL`d7W5h59eE}l{w} ;%.\ؼYS dt#8,UٸQiSqN EY)pZvͶ۲eͺxb~\z|F׭]߼Ef-:r]H ;uz ֌+۪K/k޲χ[SYZGcP;nu|_<~}͛7oҴ<>/QD{AV;2w!bQVpBҶڎ3q&vc4?qCYNکs:O=Ol5*1j;e`6~FEK -s-- /? #&B0,iy$p:LScZ~X/Zf6)U0s34 QMt;ZX,d2XNrlL~ ց;2ڤSᖢɯn) Jav"B%k1<)Y`2{eq;3%.͊,$aܕE,$Nb,$QBd>sJX+=N&YbMRBePyE@Âcf`n~n?Y`T`,X7"A2YdCB=S*6*b;Md3Ql,HYŖ,|]YTNj 9rЬ=ƹ㸰yj)5jViOg/cy,;u6}zsÇǠBO ̺I'M8IC,B+]YIRLBs>۬ycSJ4V "azر_i:`:O1l3fPL)S'[$=f7nQy/f=כ7kuBBY,Z:tx[+!΃j)Y"@6uji׶ mֺa" $'aTI |irreyZ 9rG;0 d&w!G.[-Z%-w fay+-d䔤J9#,D`&T0h+NYaU謣+ RDR?YPdDEBNKD1 #^YqwYh 4 }Ԫ# ZՀMŲ7GY(΢=/BiɊ\eb/ PYp(5cL@x,RkO)W( +|eAE,UFNw_2sc Vqe1_(xb3ؔE1AYWA5HV ؜ %h0r;sM?3nEYeJM2@g߾K֮[lEݺu͚]e:6]ئϞ_ժ]Zjj5o =V̕UAP ٚc:tqm̒CC+UۡÇ9q $ .0oKJʐ1C4ҥO)HsǎŋrW"#ر= ,Y_ ~aCR%| 9pKpy!S2K@>m@9Θ>aÆ:%W4;؍4,UOBv Q-l@pJ'Kn ó\$rkq In8 NU*CCYwhIS=#KGb6}R~)ĹIHGg,j:i!%N*,8jz*5Y,HWQ ZLhjWр,VK4SN=# ]YԀwHuطgdaBb(5,l(_ˢuE*db:fb<1)?eYy,T:Y7LuiKE)kQl3S$ū~QA_?Hm*%#Shmf:d}uXC=0"D3Ά}aE0XoC*}Yš&Hw1P ?Aaa$!`PYX'xEąYd,nFsQ ݻ@;ԖM,eʖٴqp׾]_?jIq'C>T4 Q@ZbВKnݼ5R0~aE K QGKJĽr042%k`%XYKMo/yJJ{-WPxj2ƩXo +i*ۮhGN-Rx=SD"<\m.VPWIjǻbL> ETVnzXm~Aj@9,oSŧ|!~HMڐ2pU[e"*~E:39w)"L=mwPld' bSRG4,+,=w%u Rfv [OϞ;}I +mVC .@ʒ9ͫi0s_OSMbErm)pp`p)Z~ľI(5Wf/{|G!8二vԬ\XSKBA%DbIo gW֕+)RX=vFPV71sķreʔ9t0cHآ|Lv8JX&k҅l܀5 #R Ն*h9M\KԀ@ 8BϪ")V02 |2P5؉c?dle/C ٰcGIt N6/Dr p I> E QFj_,]䧹?e\!HE0#[ xi|Y,'̺:~B+FԻ^SI!O U,,Wpi#7 D˄$w鼂, ,=p=$'z)V Y( bex^Yh瑙:VjLđa'WOAe4Ȃ$# PHY4_:E~q# 9,԰IhB&6p 5DM7ԡSh-T6_a߲ECbXݼyf횈7=}~uk皵\֩VA_|ō6A anZT*,T@qsO=r7mbŪU<(dZvmdc&b3{,,d4 gvO h nd-g̐3q`覍[3eTAa#eVpD:bgx-qn E@mqŭJD3 { .ƒR*Т3% GcZ)8"ǩlZZ`5JJb K@2.xZ“#r0* |qA# $,DgU*,ܾ!mCtWT hTƎ,jЦ~!W1YQrQ~a_'ZYd! 6A^Y B)Ì2Y+ ,q  )ZoGz}eQ`+!Qda7y#m(؄y;Y8b )Qln *cJP/4,/~ YnSl,(ԫةԫyfѣads q1xn'SAz K OQRXQڑ̘pbsG_G}@┋AVGƓjWUR|KQ^XIIț)%.M:&ҎbF]$V,T4(L j,JnT疓WLg,ڔdqX`&Dʢ9,\xwdQu\YEAf%&"c9$ɐ٥> HD­q bFH<jE~qALӀ^zdaf۔A[SeQ:z?0b.ƪpwMxl7|G=.C\ΤVZzm۷WR w(D$Y{ Nz!L}UlRy:CPOK `3g)dC?~hX ЎrpN*|U tjqDZT@XhdV [S¿v#>; Ѯ,j8FI), ,_W 4Q-'j!Ih,GqeBuda\ϲ_0$V-N' L Ԍ ='HXdp0 yyW' ߁Cg )-U Ň= bQ)jqK`*bQ+eJ#T o|eJ) DORF)b@bZ\٦caȁbG9xa_*GZRi  p%W!$N9@pDTs9Ge]{?v45K^Hw=?<܅ƫghan%5m䧹?eN).!|j)&h7iJYU;o;r6ZO@{ ě} ik4uJF y;]>`}guW^Ok3e䬥6di)0DUX4nSvM?Y&އwȞbv4 ȑcՊU.^b%:֍?! ?QBޡ']hmf&Zk'0ĈVK ͷ^óPN'(G,\BYt@J2oO+&-e'4z ݣ6'UjJFtR,TȨyC$,*uecs^ux|l!(Ʀ);Y j/fteCR dO"X#w=pj:g[K)#G/1j/ۿ_ۥV؆rۣ RlGkP/+$zbs᣾KIoN5H5Hq]g88Q>EFiӦϝ7THi/E&V˖._p˯t̞ T Iڵkj!w)ĉ @.k2fs"L޽G7o_=0)7`…E^EPᅴп'Nܱ}~>sE ;0VTppR漹Urr oPV*0So~bOŊSg?Y,E!R7#_4T_YLI%ŁT*nNHf(({Ƀȑ 񑺲5MnGKC#0쑿t̔n< HIc'QL-[O\]&U .b3,Gtfq1ԝp).6H=S CxL1j.Y^j߶w߷y?5p:lٳǑ$;aq1Ԇ/Q| 10WlBlHHX|l -Z(&iGcAa\9r/bLRtD 7N`Zp"8o{ח0OrRQ&$мbdp'5bcnEú%Eڴnѣ@ZVoDc"a%JضmHl8!{}|HlKmڡD z-%^%R)`:/gp,qOr|7hx4Q6ѢT,}\q1ӑ{2(jS3W=^R>G@S%.><'xBI'aO|LA^'bjp E*[Α),|FHJSl};p+*MvH?ņilIS +ǝp0I]paa`F*IQoXPq&TrLYl2A8aMA=H94 K,M.c]X\9B˳8\@ +6{tL`ʑA>T&L(R݁I2"EΕl'};B(*+'Y$*Ӎa4cH06wt}"8)*x|3HNWj|Z&4(YM,1g\<]CZn&aI$e+ N\hB/^HA ]~ H &Km* ަ ş.YzT<BHͣ'䳄4v*QK#{bHJs!)IFRԐd_%BD_Y<25CC"637ZkI3g/eqgb/O6/\RVl!aMec.*vX /#m)6?bsM،ƂɫBkx;uz?k dA׮]3xQҤ219,j@PȴYT'~JLc +F?sNav̨J,jHwZhZDmHhjZ~ReKۛ*?q/0AsϮ_wǏ߿СC}Uba._(Dp۷9@} ?< }oa0]xe{|yǒgz~+i׮Qxc'ARsڵĄ8|x4$vQTx 8x.9 x`4( b1Y W.D6ց߹{'DԌ'N|t$Q/_xbv'/]ܻwϱ )[AAhH.W엾}նHiGUvB)f5i%6$eᷜur洂m1+?L.w*[ Y,+ C%uJQ$e|eq*JfXe֊~בs&\o\(I) LGEڥ-[ ߪe+LиK+48?xgϜ~k gܳk7~-9‴i-]:#Y閍[po9g͚6uwS&!h괩f4Ղ;u!d|kڴ)r73oo޼io,yܸ_rOsujՙ^#b:jR D/h%>-!T<*[/VmjKJۥzjm?BvYH`hrW-p=jEQp#JBܛ,rZCaTE o:BIIEB˴bۗZ8$-2(vŶ~*6tzmjIV bRqLUbSacA4ϒfZvdbR_( Fԯ!/ ٣KP=%is6Okײ/hTX7O:KN6Ra3.*K(ڍ& Rg̜?}ygן?5jE(񇟔/Wv@~~S}XGQs4>. #>,_<=p|\/9|ĨfNjY~᧟ 9sܓ1sF+&<$VZ3g͚ ^\~} [Z|Et7a85?y_꓏?=j}_Z={|VMfa{vl߁̬ٳewZVJMNV+6>7_#7$_tN$uav"LC h>xZOLF'ZhWe:YeHA0_>LKgSuT+RtbJ"LL.+DbQ0+8q1CR߸:VeS}e!1Y=Le 2,I_B$d,KDLL&Bɢ8,V-#0_EgXAI^emO6B+*6u6vEm:UlnhIG' jqj)(V$;6oQ_Y8A*4 RF.Yܫb E!)]EMÕ|uV- |3;Qx:bD i -tED:_p #thqҤ൧܄,)?0w} O :z?xpEرk欙 0%s M(35SWTTE|7?4`=eJ!-?J Tjŋ/]Zj {UH@+^nժM'k[ 7k,M3bH#Y GΘ}[}2glFr@+;2dz ,g󌊴q1J`xw-:B ZLr؁ ۔JY>GbمIJA(X iEL7) G@Hcωub[cg>v>\mKYb^208TSe>Hx,7f~]%jamK^Z$0z1pd VG,S), P#?6to!"Ʉ}EZa H88Ǧء ;%K>uĐ=[m4|WreK*9zϗx{xC'ʘ)UkTZLq_-X?%^8,\`x6{$Y^Y bL7D>PR__uhBoܸvzXdI|@_rOٵg'Ξ9cF}s +G& mBbRS e Ho8b$0t)Ux`c^sۼR߾ơbXWw}睷A"q%4V,AO? `e4/V.aaKЮ'%DB(no?SLHc@%ᰠpD.kbZ|X) ,ǓcX#g1,.@z+I߆v&bp av,ժ%tK-{ QXV-_{+F VfUVY(qp:o|2g̩q -ZlSY6h`!m1}9iИ>R'c-!E#\q%6vJL2I}a)o6xFĮ<HYqA'TW.S#PCO-(AXdQ~!S/w|ea 2R>O, , "+m =G"PŝLYD^Xʲg|e1(?'M+`?[Ϫ2A˗L)c~4!ޒ)*WǼ*(8/I:%YF P?|{gZ)5w{4r~b*^0$M5}KPRY=@FKCV6[+"($]t?8Z.$-dJ N>},DEDߟ#G1ws"pqiS TE&kr0n[OYCTܼ$f*ePqF[2'^yZzI<%SI7 f%Q#!g>-'[`+5 W\"rjӪ-au&Ǹծu;JW!R/kզt."vW-C2ȴM2}8Ri3E$\"Q2=@J+)hkQVzGD@UkWgL.Q|5m Vbn ×S2J!h $jU/?f]bSB$[++p{>,g`@N !dY|}d|nPLose!|Krdde)&of9R]I#R,x0/rJDSz߯_+u]e&_)tUj &~GG(/YeQ+WPUl9cM/tLGr؂ WM>),*$Sl{,5H9F4}Ai*Pr~X)#-߂Wo%Uֹ4~׮qtkN⠦ ˀPnD)RTRr[ F0'W׮?W9p~sHsv'psw;9:uYӗ._{Ə?[t1@?͟.[ͨ ~ _d⥋<|*8/_2}ƴ9sg]Kμ>T{l2b0~@MbXUtG Ov=v~4D&t-2MڨK׮-Z_FT-AA@v'׬YUy wO0!6:fm4*&ĄSN1 I,[6ZgK[h}=*ʠ:tD.\ob<Ç_ ╂~mA8c{waFf4TOzwW^b&&3O>̰Ara" 6\NPǀ+BE}O_Z1WyjdmoQ7)TsVVXo@HC3/od{ xP"pϟ;G!"Ǻe&qR+1YQF D]ƄaĢBR8rY⪀ȃbW} b"iY 2ג+OpPfzlI!V\8ypreOe#|e2 :ed1fckc6 eqN#%GX~,hd.#:XcS~᥂)MdM`&C),d]Y~eGW$ r"옟2~aD4(f\3rh/>*Ìd3.j&,,wRlY /~ G> a\Tl_LWSτ?:G,JoգZ/2;qv ß+] Vc=K×OBϋ.^ S=z_!!h>P& ߤQF >ϫL 6 < Ng{&gΜeM7VK\`{iƏ>Kh߾çFAKfIH3flkרuu<";5n6|Mwz{}Gٱu{LTt  4VzS7W#kNQ3v~0n8zZYYb׿\r-ZS+Wux^=^r̙bw.of-Vҭ;wneN)Alي+%VAܚl hV`gzG&h cotD#𣀄ȴz/~)p[N]^ɝ'ϱ ``p„[@ۖYcG]_?x0 ]{ϞΝ_{+tuq\~*ҭKǎFvAD.32n,!#>hР?I.X矫j.ZUaNܳ2RᗬEA  he@`z+/ SHW3@B[ d{o)!|1l@sWT"תV)`d8'E'LYV#_i M& q:@䑅RK,m,<;:%HyY,|$Y4؀].GWeabpb|ϻB#)E$^eN*sSdQʢ~qdA H+ n;{e0YfK*V @2,WrūB٪_RPd~_7-bK,÷˒L}K _ RqW%iWHiZx 9huV,H lpslMᬳyӧ/4I{|ݿ;5E  lزmK%g)cka]a|jPpE\q]vpΞxM/^o`m۾-ɛ/=LsE|UkT3w-i鴛q]|>f4G#5.e'w<={AcƏ:֮)Z((/%W"! dO;|p%0҆ϓ/F}SO; =FhA"yh&.1)`OYbar~KN^N& (@OCpe0@żfmLnOAS|  JU%f#Z\GP|ӞY X3cŧIi,Z< IA zd1WN&U\H}YIAaL> nӀ& }ZsXX&(%Y؀ũZ_LE[#FY9w!,z:ʢƙPf ѭEf_epeI å|J:~(+4YԨe*67b\|,Tl/MR6?ط˒:HGT~}:}8s%DSMmz *^нfǕ+WzTR կXB}[t 3sA~zv܅2{ދ}W_YoƃqHϚ>tuÑzp n\>i G\zeJjש]Z-6:v|r5k2x' `5k!?`y1!y8ˠD;dG$%K +[L) rܱ!Diϡ4H&P'OTJeI)]hN7'ănEZFD[#".MIr`§\͸vC* xsgKti}qj&`IX)IH*PmIAl(e> .-EiKLM+J8.QX~G!Yڔ ,րnjg#։|Ɓҫ;,,كvɐ-F˹E c*,&&~5/Yд@YdWB< FdMH& ] km88"Yc:FBSlRܛb1W `%ت宲C,r,ŶHt?Ŗ,TlȢ,RR 0TCEl~jz\%O>?Ϯ,|AΝ2gϳ M@pT;~8FY8 ~"y 6!!ders2+\* HF=Bh6ed%K$GxSQ1@\B<0Ryĥ\ f%Y$!F%2&B b8QmY8:pnJ!ɕy]i l#/6iИC ~gC BBulL"Ԭyɓ&HF*L͚7کZO>W߿{V QëרQ@AAB^28pBʕp2FY)kPr g9&'w^:n *YAatZGH!SLq*b񸩧PSVPX- )a$ȢP )cϪrjq> #&}2_އBݙsmj (R0 n#e (P'B^2p"9/x^֬Y?Cќ!(@A8zb dXM1I XM\ŔK!1=1c-A7Xt+"* Hb74 6"tR "t1\{}}|}^}cj1Lg1-ft%_ ЗPBJ̦7PvXj ̦&w`/"VQ(҆ڶ)pi(NS. +dfReF6&ߜN³/"xn<0xf˖l*ly/"1_i>]yUMY'lcns 0_@{g܀&*4>Vϥ,M,ہ6S**K‡h Q0SLیO#T :#2~ʴ/E Eb"n EY^HŮD2EyBA s*≴X7ezWР6:/a^y$LRq) đ}`-Oke)Q QeJI$-[Dam<53)QUln[v RZ3P6  #=;5>ǂ B{XL.e $ Ź<,MUq˯?D;k7H=-_nE`V4vfD *L7רޫwϸDn, ), >ܰeD}}71DI\lёow1qޣۈxW2G#Ft#Gp=zR&MqN+8~f;vtr;7y_Ln h~#5nܴt9G#ƷQ1?+Y`y6hOr 1 s̭XbΟAnzC5鵮U=ݳ]@^zГkoS{=6n{J/s-7 ^ y׸Io72MߨP† eVvڽ{7EG"Dc^Č__&?_~/ g7lؾ7T쐡Cm嫖"92u?Fզ7@?  o#pD{C(1pJC@&|UN"Pj (':ΈC׸6)ʱ@ٚLk'mF;İ8T3mRX2CtdT5GxJmɊasq`#5 7ⲰrFfĕ#l?iʎbcX8-zX 幪p@,l’R|,JX/EpR<,4yy[8.~ K`XeH#c'd.5ed`aL4*axX.hv!O!J %EX٘bHrlbbv9`I3la 6,!cpX;)d3fG?ߞIFW$+ouGAYg?|GwOKD)S!xȭv͵в*W1X[׼)cj1mlQլiys}H Ehڤɓ- >]ݳO? RwovA~ X|6i"o6m:wQܨI#̵[6n^lŚkU0"+={YsA"$hǟWZow8rHmxrVm _^ T͚JF[#u%?3P>鉓gO};uK[,'_b%}=s)#&?XcHbb d2 fSll޼9_& g;+v~~lY&ɗF-X yM#aVͷZM!B;%,Ӣ©Z a!Qʿm%!Ut$X]Qۅc%gaB9cM,xfU%-'>aX\찰Uv;oa!-Z@8,՝1dhW2ǢAaD 1âSfF1vqƠ+1H23lr29e Β)9|6X\ o.̰a԰3 NX!yfl.-8?hvrw䓝9dj;ˣբ~3.۷c>>DD#q7䐖,ZN W:'_}(2S#FRdM:urA#Itħ%߷t~i3~{c(j? C i  =|ZMvڍ?uϽw/\_{͵?Q-^ +*ϋĉu$⤤YKbIkVr"5Ul٭۶.YmP-={BzS~Fxf=a͛7ռ)/i! dJ7ګgznq !M-S,! JݝS}%&2љm)dأ NVY: mITu^l.Y=RC[H8a*:BxM5.\5lsnJogE-",T7T 0Z ]Q4R|UE(/ z0uX XeR(]ܤM:,\χa0,@|<>no l'i!c+]6$o댁+$٘aY(3,VXLa]ͳa0vⰈw'A1.4_԰_-,@fѰXe_"XasqFNH0oq4pҒ@*!^+n*,{Ͽr?Wrgz(I׊ Qn7 k:K9JeX^qݽ{џnѲ/?Q3^`i~txA#({mߺc{͞#;.}!9kaغ~ڒ3gPqQ(~1ѡH"g&mlOO>Q5~q箝[ؕ'N ?D_πwtHŷl޲l25>3G8O@bǿw[@o~syZlپ]#'%F׷~Ï>lߡ=֫Wz/Ⱑ~qv}蓧@s^֭9ѣFshռc +I-ڴ\zyʕ1:?.RZl"//^xTr֭ ='[zc۔I8žsPW˺sx@ 7A*)WP!Snn2Y{y1qݦx 8J`]@ЮCQQi_"{M)$>W4'BV9Sh_& <ɝ΀B9s*a}°@żh ɟ\ A,$YX-,5DRj3NWm},ܖcG6[.vqXDu LEb΅:v1Ջr*%'$)ۅ>WBOqXx[h?,\10]K o‚S7ژ ,aǗ’< ;E8|`qvl0lU ZMX.n"7n uR~4vΜ:ӵky38Iri3f@*Pݺw~-kO@>,^:œ/>w x g"S_(,|),/Abr, I\Va;HX4-Ap,\Y^"[['a baP ~ŌBv;5h4:X0N)t<b"a?}cԈCXpnfcKaKȰ.qv:,T/faX|Æ% [rX:eF r$(tG̤I,?y-LdG[bW#{%ONG̖#5B$||T\ݻ RXQs燌SσDU1>… ̛rJCU>=L"(&c"@8xrYFދ+lZxۈ璑CxE@T$nބx/xdz2)PrCe"^2 ".%0Z_V2K濒/{MK _^-bx䟓U'H D xh?~"X<<*Np !I[4 tËϧ$D=m95E7ΕKg.ɐw6 L>*ǩvTܶW`N!F^D^^39ksyI9A^srAW$0(B:8 0Uv 'rXЅ1 y5P*yjcJ* M8ġ5!XԠf:6?X2#U{,sXatŜRɄX~e85]aX wƀbUġ@--~K!©i viX;j縹g ~f 4l62l ӫ@EaQQ [(/B1^g~)ΰI q'UR'рHf,YX>T6 >tz8BRI?'gOSD\rG۷A].0 k}cI41D4p fV>2@דsߣ`nCL' ݐbQ(X/l22@Qea wDx?/[Tst)ωzEODam*ouA/8Q)OjG,6j6b1&%XxC 2{ ml:2 F9NzX N b*$ 4n2m[ha5Eh b刵>n73b!4n(XEc(緋Շ3}k6f-'_b$&2%A Kz, BX dcf 4F*h f؎!`6j1J$qQ,fخ7yb$xaPj,ΰ}K;sqK#u6gPS/a "O /> KW.uq'.'c>o7YHO>T^T+V[̈7W$w}}FSBÆ ڶkhvk׮n֢ /غm^} pw߭W)p|ͬ-7kSukm, vzF` |D@FYN1 7ALԈ]o<6FƏ[~}=k昱{qQ kd6j-[hҢ5+۰0?CQʗS'15*vH'ӧN1kaF/uxNX }vx$P#Vݺulq7S~ٺ oQ Br[lѮã փ~w-߸}^S)`Ѧ b8LTG6VRdTiM&oć7XIB4 H\A_S*).5Pn^\Hr,&Tp1rc#~BUvϥϹӘ*FзV)|9,0,nm[Sֶ@I͹ Q Xʸ̡RXsX 馪j )!:,$<,C&Xt" 0, !gBPϵ źvaQ9yU , 4VZXM R|Z10׍k%` E0ݐq6Ko$\ܰbۘ|l>P1~am;agv3NVcUXZqqU5Znk09w̙3M7$3!f&$Yۿ@|yէDlY~1Q< >%;G \q8,4&M~ -x^{9aXpfӅ#*R $D(XBM؍7݄ iX7"b振iTG˘cWG1 L2}׳p?:e:믿MV;vD]>Oǎ:|Ġʔ-W|֭[ţuo9nOWeԩS{9M6V!xmˋ-A|HCGѣgͽdJBf$Tvӑ̥l#g̑&)[8kU\ c(^6#E-ρle<2ޯY7޴jBeX]tmJ )?mī> V!4dXѺwY ]~ LϕARkH ʦBX춬@1[mܸ73,=;(̰C֘n²s9JW(]U `p dUârN,1c R<,2Kf`+BA?v@2+},簒5 91ᶕ9ϰe,f>n%-_ =,ܧEXd 䠅.{>(ϰ3酪c:)G}߰XToT LՕKKа=,ݝ8S["lf7ךּ5Fc~ _V_g-^ĉ+q('-d!XF}='fSe[cDFSnLc! /߀~GB 3WNlXI!ؕxA^?| qp$daGwnb ]~0[y̙ %@ /_vc񉉏<\w?P!Ў[wGwupa#5o+{'&B?(pu9kfΜ9-㍉s0/*kZ#w`(TC ClB>3lQlaVvX $þ(+%]<!Â\2:E[T Ua{_I)K5kPFneg>фLB:"h^E lZʡcw׺tYpS'0j:4{$&Y.8 ?4x ƓΥԬ^޽{@>N1T0+M X yց!іv4~iuc 2;CǍWr5W"!3 A '4kPKLjtqt˅-+ob`~cԁѭ$~eJ=3]\9 m4aORx(ė[q#68N4A GˈsP`,w`^-a%S  iINKNYhPx7zъmOzަXP(R(=paZSMńʂLI@ N5,@DcBrw)nLEQ4w4p,eaIŲcAS~mԴ>766_b6sWK/9߼sO<rB֬Y=kLj9)E!vx_M깧/qfЪ+/^W0ys[_zD$K3wvϞ=qȕV^{vt fRK#;[>l` 6|h/REsnذǟ7۳gN<{$MH1BN;J[WлȈӧΖ?,Xm#>})ci֢cɎwϕR^MG4?IAC%3KdQ<&" BXp :,6p) % v``5*#yZ*B%H$d 86KXHnb]d  6}[hc\16ؔXh xׄvJҡ9523"Ö|FfXbϰvrd4;7;)̆+Z(Ђ:iP*MQgϞ#G6c'Sy/z5|ذoKJ";n]jȑ2]5QI?%KB#LOBbGb -* \h67(ρoʕla˯[>u#8twǎ].9r}{l˂ 5xɟʖ+Wܟզ]k\'φ hBzsu--?lݾJ9v+H w\K/fI̲mBMܣ቗,,8|A>t "^)N^8NxǏT"ѱHWҧȍ1ɹyX:亀H.5nފvΉMv+aHǮPE_C-n %]ШgD1(4zZU4nWX$nu1,FD\HyXx~*nkS4BtOmv̞ +P"9eRy0 U%!cNTE1 )j/!1L:FXƐ [dn_ǵoؒfY5ZQ  ;} ,2l>7;;)Cc̲u4raK'g6 GiۺK.X H]- %1:AV?%)6Dtl\t,_~RϧkŋȘ5kWʝpT>* !mn聕z8Fb4`(;Tiʁqy0PBl"O^Fp(ꝦOKN@FR i-SFDWkV 1fϬV9 Gm۴KFv9զU[\o4Co}S|jcTGȴOND)(䔕h&$W pRࡅ#,[Y0o.aPm-F*VEZt ũa,RĂs /)KbaFV.(ńdX 2ѿl)J*uq,6 W<͡G2ĞΦS~9zB!+VP M6!&[LTrGl%Kxqt4t ² ~i_N ǏՁ`$.=J҇"b QXzPqaHoѲJ<NKRj$DO E)]V೐"RȷSBu!y,sN䑚M*4'!,,Ի- :I:<,|n n:,bY$ql3`@EX eaQ%X -'\KaalY]<,`XT(׺a]I,bCܼOXhERfSVƏ&n2"cR )I RQ"@#C2pXH]HІ 1!VSU ۷1d<"öB=vX.2lް [+ӧD^^&X9C;)7XeuRGJ6NCGi@)"bwce_/쓳Ů`^NQT|^=;h,m~ÿmXp6=q|IڅCEF% [lH-ܓYpǕ) v뼅 z衇n^Q``{ᕗb"M(Ü:y猙wݍxμٛ܂5nF2e` RJ(ǐߴy nd:=H;_|N|b* [޽guiD񓯿=QxrF:޽{o ~;siXlqK nVg6hQCKZ-oۉbP[P7^N9-Mc;Xݳg?@>-ӏSfLGB<0cʉ`)yD8voAo! -I=Èx rF&&Cf?1?Ҹ`T݀RP(=3P>j~m`y@Sp[#ݖa< %D jopca{ 98R(Ű`SPۂXG,tC*aaR 9O|,0"%aa yB5?na _%T|K**ǒڅXء ǂ#>]f 8.aJ֢vGK7© jc }c hg,\ԀZI,|0ΈKaC TаI JcP,RȰX<æ.r ;|,hKb38R4dvcQ9af^^&GăM.Mum]_j}8sE̛7/g<}DF$s3Y ew_F<+Ā(-]dڵXݺcǏX3eYqW^iش҃cT?v|.^@)ӧq6ھ:ovjԴ+-_pcGkXy՗_~pf};JYx T/u8rp|{tO'u}C+(qFMdDΝ;kuρ{om.~b5סt`3URXr#"6haN2x,`d2 w}m+WBV5ȘKt[-I^t)ȚiPR50(@at)6I"%'&e[aG:XJ%@%Z%{CMyHv,v(C:Ԩ-y/,tjͮeg{X1bRX3zP#>w&K DBq0:"kar1a11[Z0Ű*&+,\ũR8tʡZNr6sYXǛ@ U ;q 脆-.[] Xf1)oĂ$1H/( #vqX,P  ľ'IgdBTjb4څۃ ]|V؉}Ȱyca"aXBX.I},AάJ@;) _'uNJ1&UjE%ΡiaN>c!G , 'I,: >< {=pb8Jripbz (I.F~k2'wĢ"-^Zp2e6mD%\~+_S\ʞ 4j˩SG.]J7B]>r 5EƇſPx^=qU7߄p'M|5jV-[M7ވЮU[]H1$$ ҫw߃;ݧ||"F2LRkPw^HvWοKnݻ?LmݓxUɃ$`[P$(& ߙbQ0FRq& /7ʔa I_tw*轧BOѐÈ2@R?SP Z|>(jXH&JyInұ*%pBvF"83,:ҴൃRV pajZ܊LH[VY'aXHo!ەT$-OX0aT,X*lfÒ2`!+f(0.4VKcHZ;upcv a1 aXHR*Pa ;h 4l>l#3,ґwX6 ; [K3b 3lY@3uҿE~P'H,2lgc˝4da'58) ÓTlnɤ$݇ F(On݇?٥H{x野gU?!O&\'%hrzr Fk ,O6rm1c4lP#e|c̗B*M6\uՕyի7m_l-[-09$ H)I8)Q 1?zX|)Sq,?O$fXq7~?nh[vT& PGnN8ͼYLJxŠ!F}qlKY>\:V Yu>TBv ^fg&ۿw߿y4VZ%舡ڼy˟~y#O؟%k&N,[rsC M76lh{#3pe|"S)YFTE-],ESq,X,1â.$e2MLQ QJBv  ))FMR+EM#*iXq *ǂ8.b8,XNK*MV"XYہvK&#cn K1.,a(>US\Ç*0s,&>*P>] Z{Xp ]6GvbA6F\)1 a;c%-h7-c0Q,0.(ICl3d l&uR=XH^0:c0,33bV uRKfTX.e>a.IUptR4ϺzT$r&'1q$\汒ZLicW_S}v$PdJQB"C#bX'HP@x(}PP/98KWɊ0`oe)&ڵpFIm)'JRDA0`=*4)0.̬񁮌 q؉rO}R-,XP X)͊v9h1ju +ZDo(_!,|FCj҃|^zAEP< @sC.k%$,"p@go$.UX:BMao٭t4Rp_ n1 XԔ d}V{f pB|(a׮]xva8^'6#vb| vX%uy&'cP *&tXl*,JH5k; [4qBXh ~' Nl9;c0_Nc 浪@ ʰA԰aeuR߰aã vN ;I-:;i4δj!"%Y4|CšH2oW"v|\xk$A 09 }]x 99"T9}V-[U[-V[W.tq2ߩM yd^cVPJsn܇1Q#( 1#]f fP>MHY<1OcMց8;GN4HD7Rۣ~ ]Xqͱ\| f|ybϧLjXa*TDmA08q& a@׍gMicDΫ1~sJrJReA\Rxyr]VD1-8p IBu4#H5WDtJfRl^' dl- ;l[XrIh$@S,c:XH8F))[ܹ丧ώ0^ޓ|!BM'CĢWJێNa*ec~$)H+ s18Sh&YiTB OPŐ f<`Onšb(\'ÿ1>uB9H.X 5S!7}$=KN'h.8.^'!UioGW,Y/= u#R!T>XɘkmߚnKyK)J0!2C-ڶO,߈MIjHͱh@nI}rFOD֙8o(ת=晩t8[_-܀|KdQ#}.{ũ9JY]& kx[θ4\"܁. X:G) Iz0jwXT$AX`a8,XTg@NbueEA_E7Ecq¢v35wӷK $$M"c1cܲ‡Ŷ 7ba{lX8?(hNq:`>3l5G XhvBih &(\ڰAH˰٧A;uۙbTF+ͥi9)B $%%xov2 >W}镗#Bm,˟Dmڶu( " GsSN+_[o̭ZjR!\tzͷTǷ7VQn߱TRJk"*U۞}zW-vرPL7Wyk͛kܼhBR-֬H=\<*џP rH͚5Rhe6mܴlɲ%־㮵k֢eKM|r ઽwW,[ +Wk~ˏ?.xԹ/|Qo ,4'Oʝ+7EB+V.]oRe]d/[كmۺ1+^l˦-;w쀎x7u֫Ml˕-;ص{=njǎW^y$zV*s׾n`f>ݷ߭ZAC?O?['O޳*n޲ȩq*mҴ⥋N8]˗/1ʼX !+Pc͛XjM֬Y/]1l7co-o6uի^x9$9Ǥۤi^| |>[Κub%`eοZ?BиcN>4D@-Vb iX(,^xͪ5* K Ԅ'ys`]mo|9'eSW,PD}cm3M7Ũ)q$c0R#Lut#]m ޖ6K `:*z? _debɛ{Hdz0 xcJyIo Fh1,?*3,Vw\bobba]J(,l 5B7U`&XHw(6l&bUh>BR;z" v 1\XTZixXD;M,*X yx4 o37xyMX| ;C N. E\ b6g >f'%!FV ^ɪg˰݆F'|zq qز虈v/\'tжHcpЂ~a~& Gt7hѢ7װ9l◭?#=u-4A^)HG2QĈ̻_zђ'ǎML|JR u| ڷ 9ڦϘ oth _;[sg׹Kz?7_YȆ39V ~Ǎoa*=9 â-ɵ ϼ]Kh6X SOHxog`̙^$R{o8[Ffϑ31khh]ϟ?%>!ȸgNe˖Q&__}ԁrY:tWhpoG_|ccڦ;jot{˞%рZ2$knV*8n`V}ر9>Q꫑رcItt9f˙#h/Bn歛c %dA B;{={[`=a„%K־S[+~)9vNb`OH_Wf˞UxYZ6e`\9ψZ3.._7mD?L͕aW?Dҥ+TCG ph(u͉vi<+KCB5Kተ_8MXY0 XĢ ̴](s+ kXDej,f ]oRIm1`w"cqXd5}i,,G*{X෋g j}] [X\"}aəh-]XІꍜ/mNRQɴP#ciMK@E)|lnfwh?g"p A}m5) yzk69se|}s}kpǐlŒ6mWX N|/+l=z5Z'eureΝ3gw֮[~wO?G~<~ؘ}wX-j9V"Ӻ>Z)=잿mߎ  zȟ}{~ͻv7wcÏqdر= 3O} ߞ9uꮻj7kM:5m4^9ޑW^5k޺o>qm][9"hXO=e3դiO޽ԯ__@Ќl֬ysPʼ׬^ԓ1'|E=ªU+;tAS^l; ąŏ?`޼?VFz/xp]w{3ܵfN[˛#O>[XsE/ bOI+#0.4@"nB͇sJ!XRwBK"&Ezf)dHӖg,koD`0,V@㸣P\R$L"6"o aB:c0Â}$Xb5ܧPǂ/0 `!)33,â dy|%kaQ%GHR+Pԣ̰#9f yxa! )%)[nψEvQ;K83pS"XDI.^ 1xX.<`'3a0f@a}(ñX2?" NVDo2ĕÔN<>BsS-SA"l^@șDPlҼKA9O:GPrE1\{~GW]u:g ƍ'O"Y)X2#"*^G%Gp#{vn1 TZ:eXca3'-$\]S'.,v"v!959[lhH| %AЀ:g܇B)GF\~y&9q&[l׀9@Gr;}#^}-˓_by;,}ۍYl#RR-z dێy͝37lkgtW>gˆ̲ Zwú -)?wyOX9ݿF9<É'P?XW>'2bwO{NdC @a>=3kN|= l[lRQ? wYXLGO*Bl&̍D3$#ǻ@##kkԌpl<#X݃>@)}9_ 2НM44/g XZL&0h¢@)_C"@]yH4a)R+{X)CUBK\vVYdE+C>\31,X.i ֐r:J>.nc _a*;,%8Uf|0DMѝP1ria3SGF4db|B<+lۮ Ů)fpW&Se#:P@' YNL 1,Z)(d>:6qo, <7ulhx`?ֹӓOw>x2iCL?_w aZpԬY_#6T#u̔ӑ(1 e$IyJDguVr7𡾍S FaBA xfg &xb@ Q?eΈ唄:LbN8/{`z <7Q?Pb6mס?Fz+#0*q>ΰ C4X.(C,JzxxdCP'q+!fNȜnSSs[eTxKx IKR1Pݸ*YZ$eXJ0$IKNmNE yPkQJJZ2!YQ&a6ŹPuMxZ\_ x+?c۞OMmtllb,cA)12&6,T<@+)A^A). 膑U~aX'a -%61&*D%]dJvG"˧hWGL6WHS gwapmE9+E^r N(-| Dyag7@- . W~v!)2,RV0S Xx vICؿ\'V1R[)lj?` >hmEOeW)973ĢD`frV,dA[f.z=vLf(v a"*!,2@ 6vj?>30,$X1d0N3T*0!5m"6OTvco`LYeCoצ;~(/}] 5Fpk 64E{`Yf?UdB,df[=d$nVH6jȞ!u0a2{+7mQڼ{xo֊+.]dgn(ub7˕+ێN=Sqytwk "m[4x࣏-\0Vyի߄By%ÑXW\^[TlU{5^ _A/__yFzT6m㏷xCېlM6}kV^xiVmVZhG}PXmyC—1PBYo2{8 r1,p5mәt؃,r",xH=,he߰0#xf4CXxʲP" 3 c?}XtJQ( lXz),<#4`cNsz,h?GXbuO"%0,2OB'kXP( Fߊ}3l Kb+(ncǢN)gز1^'̀:) ATUt?] 'Za[' $Po r æf0u<*d0n'FlKcZtr/^ Dg<4#̸C̆WY'{!Hq":"F+.n jvWZuq^y*^RE< s+p\7_*ز+\6}1rfɒg^={2O,@"&dw`#usWƍ$>,ĶvI-Ot6M׮=r ^}lk jԨުUˇ˷iiRäƉc'wgϜɕ;m[۞3wࡃqR 7Z؋LMP4*ќg~[ͯgt(6¯4qCo=?I̒Qk~{E-;N&|*BfVross/6S-֞R2t=G(@WRXUwT@ %ӷ;}YSCœ%R;r s]m"RrEʜ E"ϊ=nkhp))5 EI+҉ T6LBcѷ*KbB9Py80&5D@շrp Map/*,jN[VST-=JɅkۺ-OcB3`!9T#cи < یիvya\'.1P.6=:;ofc>$!Ō] a Ű\°v :)G,0I/b>f'u@'Y2gK-aVQYSM\9sש֭[[; `hEKV?o4c oJv;aRJ]XA=v3q`Kl@)/bnug->\|Z`>SeUfOǎ!C;w~YfV.;tD+Tꢗ_v=5nZuy˶[ۧOwu`Ou?o>Nja&r s/>A4nS^Uhf$b3'O?ըaCtL %{&{\iϵ"CR\= qoJ"re.6{U%bW,|f<ݜFowuK+9t^Y3hNti${z~iĦgX@ ř܅40 `amxAԊs(Fia*_j̜f Aj֠HooZT"zSpX4j>%+T>ErD⦜{Y^'X։OU!D,2l Y3VJ1@C֯"ZȰ[.Vka:){EE@*  °u X(Paa;iF,aM?".IeZZ*̰2`GuR3TI 2KeNsf Hw9Q*kڢ\V DKLrMbFl}oմN'hi|ڃԝlFb4 Fpaġ*!K.1ҷa-.8T\ɐ L  p8Y&0#Pab2^)2~NI "bF}!z3㘧uxx:u~Ώ.qrFE[zLb]#EfRCvgcRڵ~T]RsYxٜR ,<~d*m\ Jt,gζ"mmFokkT7Y]usG֤#*rmXT^x$x$=ʭCj`Q $W!2z])H]C+E{qJr[$K3}*8=nXiXWX,bXU[JtB]QF `z`Q}]9,V'fPCV %a @Ifؗlg <[X ;1d.1X]Z-b?3lΰ K^°NG1EX:_bHB :[ORYLIϓGW4O|6f  b_){-uFYEƀtET,s#IFD-W0J͚ e:Ϩ ^{ݵY$JG\ 2D'Sh _.cqZB`hV oR*rXdo&?bԩ8pPN]Ҵ,'1&d͚?Zi~:r9 #.9 Үxc㎝8Y8#5'W_{w OۢfΜbrje8Ql|q[FǡD>`Otb*xZVF2)1nUDP $[\ dLP=Ja8LNŘ25eJ& Aeeϒ @?o9u+| D[6Q_ Ab["l9AȃRcZp`Q]7e V\pP)"7Jʀ8"7D 0:-V7I{X-SLoSD>BzX@b؃*0sqXX `aJ;2 =*JKcXa 1.&$fR] +J7 R X ]YR.ZKEyCz:Ac{ ]2bzX;fm1K,j7bİvEmX<6,,7X\I!#lWa̰ 3`[TK;N ްŜΟ),\ktŽ8[=4ڷ0{nݺ@SHO􂔤&ϝ=FJQ#;ʼpuu13'& Λs/$ :ilq GrRvr[9Uq3Bp۠aXIr;q~ǝw >\}"5`N}@)Sǎ.zExb˗YHSQe #\6@/TR}G1bΘ K)';>؟ƶw3gᆱ6f.~: _ՏF 7U-|ZJcʞե w <<"򋌭'cm.D#  ?nu;@El9t%,4ʂ}'PkrHnnٍQڸNw |+^ 7 &I =̎^r9JI g14 EQE5ɒxg)SéIz1;*4;.K,HpyX P<--,,E1X,'ca1W PaѷXX,ܘY'KZ‚VlxXvѣ3!IU *"Xz-=P#86>ŰpY2.Z.\BB&XTp y Hd6Kfx͹?S&W-,i4l՘ot8cah4;?S'd< Vuыjuf,;މ9u5XΘ6s7 S&!//Jg;x[7&Z*Wv֬]p/+ ,܇ЬB*9 u Y1Pa1>,Ia9Rc7QfX hLfcۦ v[ vaQCXĂbq/57TH8.¢M);jfXrP)*WoX_r,ÌAaW]2 =XXtc٘Cv&X@Hΰ8cpƞ0,< o؎閩az"fgz 7I ܰ4O 9aI9T':txDh4zmm7GOE7$|#bgϞ &MqMsviv閩[#Oh3˄zCreȘmMۆ4H14kެyVΰ *C|OG}Ҷ}f-ѵ[>=ٲfT{˕:|-'j@@7z+J}m۵ݶmTV\U|%paFAYck7o0>,fT;LٷRxٲSHUJs D5 ҿ 7R`?)}gf-5R&PcZ>F p=%p8b6.5%QrqH?O+ԢA֖FBZrT/Jˇ:MaH!,XPaA<)i$5cN4a!?b b*PIǬ]XT"t8W>kj*аլ].T..ĢgrH1pט g[ke4`¿C@ 1g!,|Jxl7lzc RXlaak ; /z NdĸS&4%48ˏgcݤe/|1ua#4F죋?~ ؁C.v5<_?5ji6ZHJcrGe;p?n1>DS; >%9F}8j ɝۮZ We~Z=D|;C\ *P F7mkݺI͐7x[gͅɃ%Pm[{~>FAi{vqg97 şp|4HZ D([زR?Ap$7+|+O+M VNyX|kϬmhGZH^vQ ;QD%&dz c'AҲܕ&gЧF aXN7zXLmQ 5,Hzl>>a34cΏ!,p,z{),W(+ aUW\S =No:,VXV"~قrv1,A"["=Pr//E?A,j/u86@ 0,2 <,3lV_zf9,&3뷋AFQ=,t-gEHmBDQ K am>0ܰNXses$L)]8qeʖ4 W`-JAn [o-yhGęOl1cj׾Z| aAcjӪÇLkG[\`HdNmնw`AJڭk7+OI9kjĨy>hv>9O>Qݑ%$ EvL]|ī/}qFڸa#N9jk/1lgM6%aˤ@[)ej!ѣ߁^ Ts38O- zL;p+Ɍм#RߑW#ۍY~a␁[BEy Tl(pϠ=XowVJTN3#XqǙblW2& 5gKRBcBX-I X5bZ&gQe >oKXbcvWX҇1]d5A4.]|c0;)SZ'XQ<,09bʌB} dx]º-U@v1bf b˰\ܰCX`c ®Ja%aWI.N*bt&vRChv# 7IJmmRW]}?ă=|ԐϟxU'0J!r -J[l'}xIiI`ۺo%Caذa>T+/Xȁw`VDXo=uh*:N/a*q0]\) ѱ^ |! L@9@P}Q NAJlt,rybՃoKWcml f-w[V^ x@ֲe|fT X&] F 1bȤsI ~:?j X&+UV#E+Fe-S&\Tx[Z18_m ؈se @J-ZQآ5C7Ӥ &ƚAX]xB9Aߖg|@IEGؽKa4RL4ܣF`?KΌXH.!#&cdf0XE:4CKP* "GaQ*аPv_}aXW*B%D)5CKbA|pucIv>7*XQQ-Qx|tvdRʖevc(=d2RFѤij ;rb~:!ݙx(l";+W0WoxnPqd[MIC82vN7@LnkOR|l*S`P uzCXdmz.%AA,jXh*ĢqX!7HZuXjXfk&y,(X(Ҥm9<Ģ۲+,vmsXƠfY4.kA31 aqu1dlaÒH55^a+'3,|߰m8 3X2v8P6i؆6 ?̰݃IwR'?Nq#*3Τtڱ.Q>R} -b"GezTdf"¾`P1s8yL2F1ՙ_.]Y."8# _T}z(iW3f"*wA&Ƨb;53Pp!6G|;xYW@̜?9ϧ2QLжG.{P+Tlx =, \!e&4@e>̢RR< `sDۑfwsࡌ59go ⇩)#myy`ְ~EurJ*VD?ڮ}(gaCq-",5dr'$53 Ytzf᎝jr+ NiVQB pM@[OxΤIpT`JF]Z+Ayݖibbaͅ(!*vaJ)#J_yL<@ӚNMTa.V"hŢ?+ح *P į@ piv{`LV͸100ذ-.̛bj%ۆ!#9l-K3 \tJ°},iؙ`h,FۅqڌkF9V\԰`&ovLӝT16pC!O+(:IՍ$N8.>}O;i֢)|IBB9|H 7oݳdaRK9ڼi35l{~ʾϦO?nya*W*&mִyf-@!^bu1n',ʇs\_m߾jGE{U"Iu:m*gňX돘6Ч-[nH÷ 7n{Ŝ:y^qͯwyђeρم-A" b7uyҗ7kڬe˖<  &fa,bY/D(Cѣ?Et|#Ka3mOѠȼ*oJ[·JvqMPڮ27)#ڈ~2C譖660+q,K rJS~7VRCD*eH6Ss3#XpbQC[aQv*ShT"Z§6^^X aX\Ha1O!CXX:1sBmnXP}UEtSA4+WU.lk7c`4.>Ͱ 1ka[(JѯY)Ū{f٣_b-5n:uȺMw?HN%ǜAMJz՗&>y9fn7oSRҾz7wAOF}kϮ7uMHV~zÏ6fϘ>cxNAw|=kּEF%"ԯ#CG?$*ܧgϞ(7o|&jRSEsi^eƌڷ눳[ˆJ`0uRl8Daku`N&GyZ}-IOr3mF+`hB6emaE3I ߢ6,Efx,43#.!c`)|Ѽ1JZC%Tca!Uq-1 [XXcaIas;-]'HQ:6,F `QT4%ܰj A>vY+pK =p7, nEϝ;g?.Nǎ͒=wmM*Oԡ{AX"H9~﮻Z)񇜏95F6tU+WIIGAՁ,/Ăa0Kxmi>qjYMEUțmwV_bcG^qGEwϛ;Ͼ?= C\TV۫U @7*2W\֬jJ)omz@(У]KP:r X7l&vÇx r6CH35lJ*XfaXwREI/褖z ӕn6iT+hD91.~ɒnGC=(^yD>0k?O6-8b|>Wo}s׮u9S!"LWs>qV qmlj="˫ 0Jbz~FP#Ny_L A~B ~#Srժ޽zɛn{{ʝ/o(rB yu<޽| (y'T fs#yD;e{atyZ~C~K(<-9ּo\j+ۡj~otLO-V$%Ʊ)d5U8)"va{`b䦆[y'4ʑqѕJZQc@\V*&p}@ J煰pЌXfd t GR@b_aX.AݖXcv>< t@b v#k}, 2,Ac %4bq`9icᢇ!̀Ɛ 鰰h/gm JK:c\Ko\P-gasO*3lY̰A:*И:@uC%؁+پdٺmkCP*.ڤy,T@>.zB%\Z있wD>?2U]sfN9-Dsw(re꥝K%Z!+R*Xq{ؖrMz!JZHRsbF'O4K^',ؒ|0LlCr*i$JyaAZƪkWE8i\tGwQZ:w>Ux7T8,-Ez$W2w19|$1M yDa J4%C)\OPToVd0\Xw8OқɅ:ne%WdsX($5@"VǻF9hBD'V%f-hX0,<~a Z bĢ dBe9|,%|cӄ*XPAq%8Vݹ 0C:,a@, ; Ocof@f_c \U)\GO*P~p25ԫkq33lzla^Kv,eر8˿44tRE!5(cy'GL0bd-KIMILH̗x۾{*NU-HÃR9/FA6\BlVW|#eΦds),VHDc^̼gc-cj[4&&'&nMՠmD<061)rS[<bbܖ{LwZrr^3vskAW Ai<8aswϟM>wוH9# !)[M9w.1;$x<- &9<͞=Ebuc7r0%%y׮%dLQ#oѫaT.J^;+!C!B$7F'+ąߊs \mcKP{V 튌?2Q(2ǹ#sȧvr-e݌BE,l  IR>lyҜ2 [ƐVDa!SǖkBN:,2Xva5/ DH="õKz,vT@l&XȈLâꥱ*&㵋NMa{!,L9R.7ic٘һp5_İC `2lZ /u0U=o6, ˿Hc@g8Z/m$`(8h4:|Hʕ <|Wc]aT:= 'O>d}z{lشqXh@5,hǫp_4z&Jٹc!ClX‡˖,[xF#ãh_C&"隦j??< 6bt ? `ۅ#Rp0Ha-U0tr54qUmp:ނ2SBu[@¶ ?<6,>ŝ#ފDڈ=[B兰V>xe 0R`RBXt[!,K kyߏ+AWd;Ȼ[[PH;?eʖ2m&oW͙3Fu߮Qe 5{V (3gڭǮݿcNkӫ|ٕnd6i6m]^bh"=A:>kۮ(\hѤ3UoVXD]x_à`9CoLšeJ/P64d>Ǫe ' U)(% > בU% -m*<2Rt!>˰`Bл>lI# q"%q̕ Bf>]c;XDocB E^yXՍO*g8اlaQ LaAc*VgEi_g .>p_cQJ׌!]2Ǣp bX`r!ö 3%̰P_h\ N_ISOMöڣ ryV?4r2mzwF´kPSEpXv3>=<}1h8Ґ+TZ'Mʛ'g;#^y5kܧwre Bot}^L=wWUV)>l)'9o7Ok>05n{._bagA7hT^.[4̕An[2 V>իnΐ>`/\XHIX-%Jt}+lތv+KYWQ]R}]"Vf@^^&J(J+?2v*8 tCQ"DP )EA*61"+6RSLM rIGͧ b!iGnȟL,$׆a!of(X pXJ*PKW‡g(v8QEv!A킡8-.3k2 30&=NbiYt :>`X[db .aXnCmX TKv&XL^caaa+ΈAFf tR4ܰ?}G{Z"Ҹ[a.8R%Oc? H y \adVZq\TYtÇL`Eȕ/揇z1e8/X\ |*d?L:f&sI!v0"O>4~qix5& W$k/>9ITMtUHCSwj\ZؕP6]),g QT _oPWJ@<:25ΐr_s>>K!1g+ XT8ET0{谠CV॰[r3 IJ0~FXj֌aXL Zl& (]v\3] %CR.\8lχ'[1d]3"cz:apiæ.Ēް=,2l]42;Abɰ3b1Xm\*\;iaIɝ1i(mmf԰4HE]|b"Tsա-s\R"TZ|㍮>{{oz!5%pjR0H޻*>h۶j)qV];szIDAT=P';?խ wxҊF{@eVSٽ<́?4h[R|b׿K8 B 7.*\qh.Bs,_-k 1IIM;mR%5eЍ7:[}QPE AБC v7Yf֭#QuRakWoE;[A ȢyX(};BюLq޻Sy`8wоK FXaaJj*EQp˟b 5v bi7]V Spֳf]XTf}),1fi .yF,7f ^4H& tΕ903raƐ]:Qf 6ŠdrJvl:&߰"TXؑ}f4P'0zyBö`*,J5%J3(9:`-w/>E ffVjo6t^~嬉mf|(8N>SL++dќò3gN/W.\j3Cyi(?{#ʙ$;P))I;u޻g 7z{߾oBhA;̙/V 6̝;{ o~-.SK|ي{ނen^l#Ξ9[fjժ *[ z ,xuk"_i!Xjx >^n;v̸޽&\u*D,uqsvWiOj&EtO*0ViDEE)vKk&A-ݘZiRF wtUA29t?9AsmA+EϷDMYS &S"p'<,-; <ŃXdnA,`%\9,@b xWmEf ¹بO>EI4R>?â _EIm6*"Xd>3A/j.<ޚ}]) q(1(Ip 0]m9YdCQ ,^).T dZ a1֢. -nHa!,!Ö5ȰP)d䠹RTkk ەB uR>I/fvr' kqf"RFl鲥JCw.WO#c>*C(j̰ |1 %KA GTgڣrU+r;… #I7Q if$n?RJ EHSGXb5r͚gbvxpP9Y: +G_A4#h)q "wcŢXs Sh{vʢLAF<6/LO;yiG ?ZcۺR¼r򓮓a 6!Y6.6%%WGgraX4=,?D ˕+>PNǛNXX`p%A:,4 b1 J;!v1n O\cHS$hELdX赋a!# k¢pg <-`ؔ c鶬 cű8æ9ΰ$ KȰ܌6`vP'쇐Y'/iz$ae2zheѨcc>7ly2<B7u|c,]a&d,Q'K|k>_L,R0$'O梓`"=qėSⳉ˿nwңs\s/&M1-6:'6nS|9~x sĉ)[b <6qѢ~C) a3Jk~'a: GT h$K:VBL #EJ299θ<#/ .hp[%B'ecos[B9D'~?MLm Tn NEY!nq#x8P rA' v@{aA9 e3`aA]EcC5ۅx,y XAEnGk +:1L/u 1D=E(xnB9V `.!3, U ¹̮ec 2lp:3o3l6a0"NOSJ{N~ysu{߁O:y PnwS|sێ "0?r51 >w>{P%Xj<=2A< ~zR%nXx1>֗%O?=[VO< Bhժ5:ӧlrb9>=!|7+WbLIN:~?pێ֬>K;:Azk5f̜Ճ`ZY)[_KSF_[WfQeq<dܪ\`x׬G :p[NR-NK8mGjIY Y)W8bB=,LSĢ((GmYh,*X%e**0O4/*U},x`GxF,)}gbX\BE ?d4Kca@.U iA,mk Y>| Kyvefsv&킞/fb_ʰP ; KȰ},7eźgڔc?jַ 7]<iK4lv1,@:~},֧M=,߰ݷ ۰Ȱi_Bc1Æ] uR_wR3;L}h<]ؔLbZ}gex۫{=zhqH/&x;g{oڣ>Lv'N37Q;XDYbF֞7خx}x,@K`pdquz~-]t.@4g{YϞ9z%_nǕtK/>q=ǰwzjMIGYhq'lO3էEjBVL=)x !]wvZp#GRN-H"rsi\sƔT%sɸ5JG)ZW-͐*B:3l<L.])DO&RPRz<5RRW"t:W$$Q* $Iq6jxgA&'cg 7S瞻ﻧeWjҴI+yQ:iS]>36-[K71{ܹ{1OkF6lnza"v_jq5JPpbůϚзo#;Q* n@t!܅RߔP)*Tt!21ZaD} ?tYTL2iN,P k V2Զ% KJہe: /sD(R"&zRE dsů@ % JF3sX]X ]W<4Iv!S 0T@R&XH DzA]B+-\©M28JQZd͔ 2x3Sg 3c.FCX7l"vXh䌒f& :$jv6GVKaa6f&\l}kL7INê>1fF)se?%)h\o8hy˯Rb}KF>oةC\yRp.XЉ!!*G<*}pk׮C*P셕d/S[zͤs)xk_a188R:?Q~ vvmdbsIsBHM.ex/t>m߂3NvQa}Dk>+IG5 NPq;&O嗺!1ki)U +~3SFL$(SiNTrzY%G2Nd|;t=Ab7oyNo0%ҋ9J }T;Vѹ25T"ó"gyŷF=c](QMlS&|ɝ_9\| -@at߲rt#/|seA)9`ʏ璐dG :s/ XbH@)B&uku/;3x@_,`H0i tyfSu78 hQ̦Hjp=b6cE;l҄{vC,*[zcV[CI g x*y7jAD`8&bҔI;~0$Y7$O<=x UioBaSXMF\C @n_JFb:cj&pmj 1wP!;8p鶒#I+CEdӓ 'B "RâEX31Vh*ڎEu,f] odXBu@cgzƵ7o1Dfjv9OJ11xB3Z{ 7b1 dљ3m ̛S[3qc8=[qʖ+[Č%f…)_Lŷ]ع*TpB}m[Ӕoh]_f-{}=RdW_8{g=nٍ4:8sǎ= 8vȑEKпO>׬!`^=gϛ5ysIꆍ1a޻O︨3g,^NݺGcߤ+]FqrSu)ѳ[g͙|ƌO&v:tr^ /BD,]Ϟ97nxAXk:?g<v*ĸcEC Dx|xH3VmT1cq"Mj3E?|"Ib1wxE^oal@b(ͅA,&"&K>H\#㠋 cDO,Jiٯ@Z _.B*)+=kL3!jXI,+Yn]\)c9X4` dym%hopE8 @w3lV$V v fؒlȈas.ölx aa]_a's&kp,vN kv8.ӪN3_/ r)Ld@ɓzo~7_Fpf! aqӆeV\V[ZQ,irfω9r劕.`||!6[l֭hWv׫[5 /PC P*+k}p"g1?s cغukk3ɓ&=\uKN{n}m$IFz ӯU불#*Y.Y֪u{ᆱ@A-E'ȡYsNb)G'l1l┊Or,N?ot޶msݵt &~il,'5vyRʏ4hxb,+6qزâxq 6ig+K%^zP% G]cI H<:غ1Ayz;%]]:,  aP>.ERRFJb@r*ͩd0hu*] IDJOH'S,K t Ѕ@ӏvqhtkz°8z%d aт~BY.1)x\=~dZİP3lxEqsX"6XA7F]E,2;?:)ZsSIAKsH+7uju@޽E YZ׻=l--K@oD$sK4Lܪgm~!'whشIG xkΛů(R VJ.`6n$lG?pB,W|+VZŪV _ +TX!oܧϞ8aB{ƍ_[ʢW/S>{Bj;zJ*|SR%K={bJռJ_z ;w~}Qȑ#:?8‡4w<+WP/UnZRXZE[e:~Ó'&f˞+G-HHQH {W-V(W+Qn{C kѬeC%$ྋN#uD ͆6o|-[HWP[Tf}25P3խWi|{$Ӥl.kU@8A'2~ak_zb>g{jIpi 3/ñ7 vTt˷1TOVĆ#-`S9~궸NN,EGcOQPaO9ax QJoަ|FqaQm IX/98)OG\ #xk_\E2Dwxc\9M0ϡ "m?d@B)w SgNC4-͹ܷ[q 9SDnħ-:tbH]~qV_?O ^ؾ뷓N/&Oڱ}dz__z} H1է ɷ\'O1T6:s*WC3nиaǴՀi_v<>#΂0LLTrIxpM^ɚ/PQF['ag+q4^ҕY4CA&RWTa}ѫB4OZEl3>E)ðPp(,8W.0,j}eq]pñ`e+,OgkA,aa<*Pca)Ov1,{1]>FH~E<؀1dĂœ.:/U@.-cU( aa1c'JېLf]|æ@_EgAflgئ`93l>o b kv:,4;NJm{fCêY٤ òTPD vr{=;|䠱o(/G5o :8`cM3nA_~ʟbQ56$2x .3/wu/H:_#p %Pr' /`u 7^c;H 1*iI 0vS{s8}c0[Y]u=Cw H-b"bw` IHH 03|};sf_w]u<^{+#$~|=33:tpAoԙÆ]vyɳgbDz2FEؾ}{^z oS >N˽Ʊ<)LruFzUw QeeK;ھ}}{^}O5% hük׎'*^CBqثޱ#VlVMBYӣAO&?4'x}Q${Afj hvE%ɸ_~RͧMJuWw/xyRd tչ[8a{`ZYr"EK4ڠ '%,:|M2(H?b;za ,47X8`nRRQs6΅m`XY CXCs`!> Xx`, aaE@li\/\Rm60,:<łUd7|>|ӧ)\w|;fm<9 fYG^+]wd~х wÆ ?IP'AFu7yҤW}&q?MU?2h5kּpknݳ764SxiT=JFLFJ 97w.4СCu9巩ln߹eې5klh޽j,6 ~UDf1@1 `Fq&JH&1( M-H1a``geB%B8N]K Tb!ljrΣCѰb)%ΈΙ#قXM KXJҠXa!*ѧ,qCyHj@('RHj,fݼ Cl߰Tl@.OUiҶé'X5- (,V- π\.PKiHvtz (`KBPIk%$oՅ)s#Y E>Ezabw.?d0XKbZ81`2(&Ő!H 8?X\4rhz,\._w.>dClClY"C3SĖ$5i@|kbz$F^. Ê[/B2480 pJC>J 0#+Ewl_~; Y.7NbTO+ ;A$04ŬLDO>INv6JL5/`aB1 `%TOGSvnoR&̐3ǾO' x1SPq+Jx1=%˅lhD2M|Fi1;7 *g$.{ X0*)/jGŋ( GO=}[      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstvwxyz{|}~4uU9$))i!r@ dB&#1-ށ-R)2QQ2s2P)8^zp<ӫODX$x:>Eމ shjW̓ w޽;Dw՗_}gSۧ=0^C4B [B!7߄7_uؑ_@jJ0t@fD@3UP.>"4Vd,12$@{3U+Wc6>È 

ƤVxŗ[KHtءcՐct;6J P_L} Њi>{\YbYn8h%qW;xv'=~(=3-B*]d\H9{2+;ş\pCgΝ3 =&=|G2R*#Dh,Yjp'H,>*rͻUb,Þ L* E=R7A\"=mdxI#jjqX~RٝQTXסV #_@QS$V9)Pr S% pɃQ9>XhQŕ, qYSR꿁`ae1Y_}a@Xp԰a:X|w.>X|h,1u䛅aAH.x.EP;?28Xc`aKd04UlE,T;d,>ֹ#jcJh b{!!6],ud%,sq"eୈW,ҋ$tu/SV ?fѥs`90 3`zCE?3?SiE J_QXeYVO[JUʊݳqm>z]l믽ګ8?$17@M h'l篽W^xy~Cl+P)ֻ=7{%&OhzJ$̙׿>d&ۣw>zWw#Ԥ\Qw8_0IVF֎YrTdo8?#:sŠ$Cl E0E‘ ,`fVdkEhr G15 FfXvVõ{ I:PEBhAL\?y͆! b?,(JN ƕQ(»ڹd*A=&9V@ e`` Ȣ2B0`kUOUFWs, I( [`n\(a޹@  չ  m # 4H`]!6M<?X(  T"`$, l?C?Xo>Xb,71N@l[9bý$bI!5?@DJ6VBg[cF2hA-…iQfcڸ~; guw'LqOrr'QYWm.SU* @ԌyK(Xx`?B΄I?DGZZr6lZYy{X?Lr7aUħ^XX ,va7z?^Mӳ{ߍnղժ+.!q1O=qWƭ >>X_أvm)RǍ~7_2P1h ={7{_fԷP2 QQn~wܹvs.=uD 4*Л*y /J]Pyi)j2,[YüjX<[Z|9,~#G>~ äTI[WcWN"X3K¢yvVXP?,\E(eY@B |ؓŽ` $,S/=<c80\T`Н _`):.2Z6&D&߹xȠ $,YeZ5;'\+/(|_&m$%&s/6;п=:)f~~iDED;Ptz/sk;ow}=nN{ l 4C{=c'PTrƍvhҥ_uCnHNJSW^řd- %X۔U\RY Uok2Gʖ})l)b O*xGfF`4їyƟZMRbzRG {X%IL5Bs[lyS~`1=mE 4XL;KrM|y碟pyñ8EŤb`Zp"|`uō-bsjbaAyHaa~}fL6rЫTA!OyͭX~Gl[bszG;E8V ),>vWܪCla "Uy$1њ \'15#tέQj_k0Mxޭ{W^{}  F4om]IYZ?͡Vب}ï],Mnt(F]#a"EzH] ?17|x77Ke n׬]s׍9MfL=p1AO4qOճ.]oEn۾TϜs4V5>e Py5>uҥ+V9w oa~b ț#ܹlU>cؙ9:}Uփ?ũTc.+xݑ>ܩD[1,̤֨ P2 B:y?x-ǎ^C?y13i9{TPoܱej<,_(ԩW9r|!Z~Se:i?BQEyf gr=90XԪw.`8p!r9XRR~X$cĖ,; Ib>f_tfI?Ķ݆Lb{!,C:XHW}0(xYDޢU~hRru{46ΜֲUluqnF?)ȤRay!6헩} 4 2\ }51q5kP/>{722P-'8'< !_a:f.8c@WҒdIGg=~h ֹU2ȓix Auedp5b%8vbۘ 6)3},4u?[sݼIX+/re A8;bAF2/7WJT`4g Șn -D @?L,#B1\ %EI ڱ0q2ҍ_NqIVPdO1+) ùP: 4ah5k`ASvNa :dX@x`(=+ (XW~U&gԉIU8yE7oR9ENٹ k"&'X!?`e7P1 c>XTs%/}.rm qŸ/a( [ hb@`OLpٹ$,$~GC󐁰0Mt uh7 :q\VN]([0hwy .[bCV-_9Xb&¿R~PRs/C=}綰pbTjb0};rhZnwQJWV6 9(9oe -]$\"Gs&_F:Mb%ND-9Y,c&u|9oמ*ya,O M¥>Cpeoڲa9k֭wlk4oF4G鞾:[nwpBr$Kr?Ķ`w.M߆[`O0e -Xvj&m߾wo߁Oqω'"y)Afge9Gٽkad6s$$Yh-驩 ,ZlӄeA 9mG]pѢ?B "IPrrꕫm]wnߩe˖-s铧Vܼ,X DF!'Qm[Q B=rg:g-u&&%.^K4} b c -_,<>E%Q yUbXz#>̝N#32 5lI1G VZnVt8 ^ X;o\MVYyiHSl"&Ё SvեҴM6rfT F`˾+ OXq[OЦ%X GeXBI]=W6ܼa%)͈ Ũ2k`X\V)7L⹨7|9X۔烅n`, % ,%7)Rpjyz %)=:ڽ_0˼~0ٖ"߹hy.j7`AOs1dw Cln=1ֹP\iʃ)jQk:&5X9Sa%viXrE^NJDFLSw#{j==Qq`:xu.\qVi]qڴy{& Od Կ'|if =sIIvGϰYueuխs!P,/(5E\>AOlHC1o n&kZ`e0 HL԰዗,޵k'flj<4@^bٖm['N4h8kkq"Q'CؐφG%"uڵ-t䉋O@Eu=/"FV! eʲ>d={`iS>|?}΅2殻נޏ?I126oբ otCz Mے۸6<0tE6ngO?s B?ў[|#!9蔪"C}n:YpOٻoӖxY&L~ߏR'{g^R9$8Wwى=3$f̘/?qXgٶmpiDkSVD۾/}zvg͚>s:`Aw k׮wᄄ)-.xБA._ x h֬Æ}}\|ЧիsTV{grr/_cΗ^z r+RY1G=uLuPs_p.+V.oڼ)r7(tҏ{ 7"[l' a "Ғ腜Ţ.S=% m]e*r f P"gqcL˭@[7epr"X]`Q ETF,ϰ1O(,1'}{5H.Үht(X͸Jvr,n s2 Z=/Tx SY|-(gė3K-L(@ 3{/&)?Oc'E!@/|yDc<}|BB|'f3&O?i瞝L[~ܘ?M睞t1V[//xҴYSɰO5ofx ځ%i\6XnO>Oҳ?xGl6wBCy CCG *uםM6]v5>ѫG -7lW֭Zu^֭[#ҊK?";{yre cP1ߡ4?hX~{7|՜9@NLx5ܜĤN<ݩӓgϦ>{E%z@wZA>s\5xuh{9n<̑1 cz7>} oGNeLDŽ \[OVF@% 'C6*L9_}aV.1{RN_GVn6}Z:?lþ>Ck[.ּj{&pmk8,|#Fh/#|;Ok]W۞,6沯FP <ѱ=EV"\.A۫vky-?G= ݧx}s왟ԮSީUOfv:>oh5Q 1lڶgxJL7^;xeKc9)~ʗ|PpF 2I/xi -+ՑO.?-V(hwR30`X]8 >^jZY0KfIӁؠn1Ma5)Gƿ\&5>Ya E8情frqӧ_ D>2 w;#7땗^7oލMnG{%R7˗/1lO<9`'#FXzU\sZ`1eAȯG͟;WI*,$Ë e} Ro"^W fB/?gH-Wc큥q'NH ŭ_QzlLLV-:vL`';~4&::45:kkV~zM>{| Ȩ(SOaDD'B91 1tڎpmx?p-(w]W^z&~хyf3τ$հO m&sE ਊ0kf6:3+Rhbo7TtYd"\kìM z 9D E#2;Eej]3OXhYg"zWCΕ&*Iv!ݨ_NnT MRHw#QGbE`ab:ks P=rtekׯY|)AkNI駟{9[\ 7Kam}y۶N?Bk4'zXs[璜B*>Vj}VG 7ChId_y6L9R/ d tfd~ZXYo 1 q*XLy,z z+=#R3M J.%չ+U,,s֤ 8M6Ss, %&e`*vL H4\4 Ͼ,EkPoQ?XXV` @'*  bg$n2aaĞ}5g p#Aˇ 1 Į`]-}pRZOؑ-?,HPx>Jv/0VJL'ۻ=t߃zYN [QF5PQK%OY9 f9-p!v@z0Cѫ9Ll)Wƾ }]mwx6+8vx bad{qÛ4q2nX˳>a{=\͝!t<|*O16aN?wMl.G_>:IIh#M;)0 P4c#O:ַBNfdL:bi'(L`~:ss)vյ`;0)]VO‚l=Ys!,yeَiHMe\?f͘5kʴax 1|9s$''0~\U a⠩rƒ8_ۿ_8 gٰ&`ҬGF>0 /$/`ۗשSϘiW~.8woS|#0ӦMOB%z;>iԨoA%CKT̶YΝ,XT׃HbRyhƆ6bIŨoݹ0Nߤ, S8K,^sڤPJ󃅮IXp1X0Èİ J20bdŌEVȠ$RrB d), 5cQ+UR(Ɩ+WRʗ+\p4(E=Esi oO$)Ui|rÆ#F T::Oi/}yuAT)F*zb]GQ2χ:oKr0ӥ!֭[?۵{xϒpACTR;~*VX];v?JୟTsUzJډs=P fHN8Oԩ=s̕V۵]@O\$Vo>?=zX׮]7dx0-¾uz ޻#2: v<՗jtYfg)Tplݻ/4e/DGtSo6޹聝B:{L۞]-VaC5l.*Yr@ǎnNO<Bqf!Bt,\(^<33n:&N޶y;ژK>}P%JDf쓁XkФq箝U[,.\ @ "z6nԠa#lبoSo\b 5PO>1nY3f:plr*͞.߰C_+߽ 5h'͛7C> Ma•W^uۭoê.?JʵxC'xy}6<<ew/_}φ-YZ<Pbb~#wv0K.ָ: #|UKWZa&Wq7Q{} y&O@n;nоk̚W(w܍}_ZJ^=|6mjԸ7o,))yO~8oA> >;n_k׮o߾i;v8H osoNYhq"@N8'n&zXFG}fi 2A"!) 1a }YigPbb{FjuE ̸Md!~_,j#,U!ܚU; QӛbY0(bX`5b2p~X^̢H,,a1F\B-B;>VM  ` V as7x 4XTq7hZ%#E߳Wfs!,ȃ Ksaw.l iD cAbaa U+MJU!SK{~h d)Wy aAɅb_}}{IluL`GuC}{c6i4pknAeJ9pKELyCY׮YWYx>60r ӲY3gn0F!#b+mHճ{ 6 HJMSxWנBw4ƽÕV7m;x׬*U*/]IfUP!A.^Fu`-f5gfXh8|]U*h0^QJ k;z ]F]vqe+BAZCUߴycZ0 T0VVL҉4\`BC`$%[6mѠzJ.QAE?.UOC7lpb7f-/ZY}vmuuk]p0<>T\W]C{cQ,^jgO-SLk;qt+++Nh*SPj9!7oDVݰmuW!i 9pMnl46:heփ{zǭ@M[֝>~\Cï~EϫF4 !/%%BV ^cb@d:cDpϜ Q-/9? qg'Oڲm $w5 9}Mb%A( Z(ȟAyu͊*$]j]DdX<[bƆ̀9'#<87J-uMk1_vmK/=𯾂w` "蘨 =L0lڂѧU2{qэpDN m'd\`H ߾kGAu*Y4UV&ҨqȰsA FWf-329{ 58uז-Sk@_^uLL jjZrI!OUܼq34""bڐcaVaܔ=ւ4q(!'vK˥R'UPIȸ]ː1[ل 0 &aimfT [4aiKe- hQ/ 7B \~X(H`{s=, k%?=&@953Lz^\ ⷁ`q睋)sb!AERK>X)i XJ!yo`EVw :qҏGtpBWjרPZ7Ξ;MbxvO)CGn^ƾfTj;Θ}b}lNa=58dͨEWjL `NÆcbP z /.A ? HİMϗû/oɊnr8D&K{xF+-+jx6y£>^@:Sx1uN<:X TF3bO,[蔟6 昋.\q( ͜s1VFǞ`Cc w36n,ǰxUU,C),Tnit 5a*y GqD q=YRx5^UɘӲ De|hR-^.|XէEL' H6{+=,vҰ op[s!4~E;okp,ZXG>XlTbh8 q.p ,8  wMw71lxHp:uj۶miNa9]Zr̬4 [}eY@{Y[V8AA6YnUUWD9Qz:!32XӏR,ߵ;V[f=K>5q1#ghᠱwe6-;LyG2@}t=Xwv9fbijwU(p<j aOFl$2b4-F 55&boJmRsW0)Lʤc42YB1A0xkJidήҚv#hCA .`OC"l J.".$bmrs‚á2@Aь$)ւYh!`fM}C,/]H臓 Xv k쌟PaAi2!f<=hf!s@GXMF(Ⱥl.F`)X%u`[Ҏ1B@ {q#]XXM22 T hT6s&)LORIn)b)Hx[,>ؕ09D*r ҏ,"O7 %{FG4ÃHr>d]? JA{1ы6'DbeD7LC/1lMm`(cktQsV?\T/Y4?,be', H` ` B ,V`a9Ll`~X(>\ Ȑ!6)=l;Q=. 7rb(r120iVNJEjd`cD|t.zZx pd`20oo 6x 9šXSıi9c&*ٜb+ T*4a5g;Vwl"e $%`#ƸlVJe5xp1 qRJLűt;c$@{t+)E^i$my]h;M(y2yYpw&w/{PÕ"W)H2koS+"@Z2i>S7|5 [L |¼f2T-^A]p-`Xm])#t9BrVuŤ=Yg!3s~,4%eS2HM 㰣ga:# vYعM=i>C(DgQ'5Le mJ\WYpX*3TPlE`a)bYyBW-!Lb38gE4[=YՓab8*Z@`1:B]\0+\w?;C9}T΅H>@ "lCz!2-_^Z| ' o*u ~febCB?,,=X `!=XD@{,n|\0Űh Ŏ"[۹`\g -H̃bds&X,?V@X ܫ CQ,] % Q`'i]!J/bG_R5HuQ5$TdC^WirlH^(/1Ɂh,{Hfce!{cvi!]y'1]I}J,ZZ\jR^l'MJ7 '7 u? ]ƃś DtjPTys܀ 4hmE%>tCvuuL4nn`,T;FnB5˦BgH}?ÂYffhD cdn\̴BED߱`j%2a&C!ΒoI7ig_ hi]a #.1.&s񛅐ƛ.Dlo 61I.SMGdłOwe͂Y}"P Hi0Qv~! ;D `a7s2혛2D*CܥusIr\x>3lDjWcr~@mDi:G۱<"K y LjTS7l!%c璬@qF\o."RJyur>"1Kč6i>VY`0\<rQ G΋A3/2e@}8;ȇ|ʫ*HEt% Qa_ M@w#ԀxmHڊR{hf(pi ̝ gA%{ *Kc$8i%)vl4 7 ~ß{,:^LIg0܇͂{ս U<׭ M͂+4G #" L/D2p,({b8W4.tΏ7l'@nJw,mdڰ*ff)fɃ=h*7K&k:&q s PxS^oXW%V91 (U_`lKK`fdq ]sYOB r );&Xxnv? R&hDDPX ))|) ܹco,,̤$,RpiaۂP|?̻E> ;@b#U4C-#!%aY)k'RHN}"U)/G,"u}"eLHE>M"]||,'ȼ$-tqR/,;گ_NOv `Yy1Jʅ 1<-R0mBxfa@'Nk+i^2W~ bTD?_*&dVemmIt6_JW0TSH1;.– 1,%ĝZfAҎ6]5Xx6XEd: b?X4@,CjeUIx-MtE"4-,(n~p_a Z { w.ރ'=̮X^H{sR("lYSUK*dBa;*ns/`|n Ӫk碵\B} bC 1󂅇BqS/b_[uH)m e9 ؼBz퐁 aKCl;7K>Xb,HEӉ'c8É*RK rDJoH "'YEDP(SjSuMۮUQ оCQ^3ZE|ZsgRQk˖dH86==$d/fҒT'VށԾy9wٜ <Ω ;b6qP —U ܥtՠh|zNOs^rhם72L8X8'qh|X@hM|fP=awO*VPdv/^lE0a8?W@M5D1u)O^^&'? !I(&2<6f| _l̸w xLx1V41]z\*@.. |{VJ¬ kVHjrۺLŴr2ljX˻ȃEf ;&A]'_?FiX9>mHC",%,4 `jH<%Zf`i+stuSx.>X~mXE ΅+,NdlvDQيCyb'չso``E@\\ VW%bs&^VmFia'5!6 ŪR9 YKeʐbV!6<3[7&5ꡛDuKDGCc˼#=#"z 8nvuI\&"R#+bIVC](`)KXs^'j2ьl{?Ҽ&{iY迦R>D=$"ȑym\a KfF)-iGW57[!{8@8,퐺oqR] $&zƲ&kYMameðIM`, nrp@bB #ȖMc/%,+x:µؖ$)gȁd7O3`1F,.FmuŵSJ)qL2”< (X)|470nK!č,{1 uypt.@ia5t.<|ٕl3qj}8΅`b+x~\7bdGA+9Q΂ xi>?N_"HEiczT~?#{T #ǎMRMx0eTK+N aFBJ N'^L\TuTI*%3<$zԣ\(6BP锕ie,lTT4?X6>vQ_֎@-ïcX'f0f"2c9l6X5"&}DMBEX8 x!`"|`py >, R+]Li֤2Ĕ* XPw] %t^-n=X`{=ճq8骴j(|J2]9 淁r{#Ȑ Qt.0`1 |0*,?QpHcC僅b(炟$E-Uov֊x0_ QfGE&WbM"2Ƞ:)1Iba!F?>Cl&fAXm,~;]R(k,2;TD/K$R-.jH5 Z@ZS!Pԑk i[ۓڶ+Xk>TUhc[bݤKIg]iH:y,JVη>7RJ]fCVπ뱅Ư(gqT<]2K&Saura9]RW ˠS]%'d ,X!Her2s(ФxIE@iYqgFiVjtrXHnľ,66ЂllTgp8O> \6ќDDcH%Rc8N2^jѢy6o^M}j jTNGy'x)0H=PT`=mJ//Ɏ#9R,_ 瑸~h_,~'MoH˜[ؿ&֧Ĭ˰ rrZځ)|Sf@=ip=j!RiW-H=2:dH:GTMd'_`G=Ht]kډk-95!z=B |hN#4f35%<C'CMq|s~j^޹=X4+%` WxZ~P˳a_Q|N*@PԕT朗JvxH*3R76 +Rd:} >)qȇby& H, bX`liJd,9Y%ֱ - \U,#>d!'`1ř=Xtn#ሁGX$%ݎy-v)^0Z QD8o/"RHer2#GD >"u`#FeԁF1*Uvf]΂ΣM^fz:*4E DLB?pQ̺( N@f6BfdX7@E+c(< Dߐ0l5hR=6gbDkWf:D"q# K}Pb${k\y1儈-ib"Bn^ :+ue@C4V trtFZXM{rpL5q% ,ٙj0vކq` cZm)8.Q_s,p ck5K=,/TF*Q>p 4;+6QYJF> a~q Kw-QdŞegeը'"U=Vʚ4 =8nA[X-  R8є*Њ;&2)>"5\%t,,TpYV:TcDXAff#6#RGLIlK `ErB@ ;$/cs eaɳ̬#RD#R!jJ&> )eT-"~JHJF`40\+ $BV?XDjEQ"Rr4*(.@HpT-|DJ#[5rԪUk[~<4) '$%Q1=,= [tde_!4rl^ x1al`(Ҧ0RVuM+QwN>-l8zI/9n\9 Mɥ(6@ilvIm( a0dk_nRŗبfe ,@‚Nff;5Xcn|; r/YLV8TkO[,n>ҼpyDP%dvkNqݬdJ^Z-V3W,3MǏm sq+ZY_b\yQ-; T1╶}S?}w+[< 䐁f =V; *s24:ߣ`x4nBf1X!fvGls|1av u?{"ӀTonZ+U,\h_bV@X ہHw?&Dq('tO2Cly,a vv >aɚT9ģKK!n`"[[ٚf,:*K3O'1э;} C~Od&H$jd*^sQw~E5攉XZ/s oA:9CaI0qPXXZ3ԏ5.])qWR b"7,nESb"LSE1Q*=xANnH!br4IU!Y[ MPqX3 / \8kxRUmkALd?^+3Ks7 7`d}. Y*C ((4xKEa/qx+ZlLLE`r1+$c SQ,\.67 f2ꗪ5=.^* o:uiDz\.dTvLH`m[w ;]B6Luљ^ q|,D!0Zz)R! Sv.;$ 43. 1j6-aS zr8W]mu(a7 F EVY w.` V˪=H1 w =Lfd*🅠!..٨QQt"͏4$rR8zŽ"$Y#R;Ҿc"nyh|Pb-v $$bCtǟh .`1ƥvl+`/ы#RY%Y:X,ZFFGbk4\bG>h#0B,* YwLԵcȇe r $E\c{D갗S!Ŭ ?J{3F> Rp>V/n0&4ɇ eOW^,H9K0YG:a Rܠ{Vezx=QgOKIt6}GnMx4""ͫa9D$<"f8MNRFMe+he&|ŊzK%uM_mXcʘ,"|dwLmɑ5%@  (Q#~ 񘋷JqeEn^<DFF@DP~aoBFخ͡z | >85*U ?XvYc4_'oDY܎DEF8E/bܡ#~^L>ytYLpt~0{ͷWZ-\\̊HҰ;""aoT?Csf񱂈0fHC|Դ/qL GlB0Lt4?[#PohAAQVonj_D>w~LOc\ yp)MjA űjv4.QEIAjUnظTtꧻe.ۗkNGvG<3)&v3SJ'W_v;v{gΜ=/6'MG:m6Ov&L&a'臘t|9tE`Bb31c+F #t{EfZ~}*k\zL+T2dV.CGQPe˱k,b5Y1#ҷXcrt3[Wvy< B ŃEGv}FKEq*^W'_pXhpVEYm</MV \,Ⱦ[[V}n +U>n&MY!hB=P@Ʊr.`+[;K3eV,T!|+WYҏ}s<%۳w_|q trlpn2P ^Slaf]e9gmpf"`HnDxZ؟ 9Q,;G゚ )82`o-3vY4G#=NEߠaD*y1͎\ncoJOCLJJZdDhdt,<ł*\"2Y5ja,pv3A:,QIQQ_|9⚫nҤAŊUݥuRVR Wj@X J ,bŊ=zp쉪6VI~{g!0Pܞ[J`hDjPDZWoRv[c!Eb 8a1b wuUTۿ/1eR\Bǎcd녅M1KSP׭ݰtw{wΜ>C_qŷ~{SV9ܾ)ps>?3T;I)Dz/[2MMr9=Ĉ0mxPfj/$8RjCЗd!!I)'qELO"RJAzl[->ؼykƍbbl݆*GFł33͝MrV ŵ@/;Ohx|55Mꍙ+DW#F]Snh #`ʬ?1)I={um4IsM%[g[.` ?(M@b !@ 0:Ăs R 0[t">s6@UT6o];//b8}0/p-YֲY3DAN: ȈV:4Ys_K>GZhHzvTZzhbq!Q= 0탵|lrTsf|2sg'%'=: >U yB!SfZo6cwy)"hS"w6Pk7o| yH;!{DW͔@mXFR*SF%Ѡ4H9[P7jpcM[?-\"(xCq(,ޯP9@YrDo0iiʁA6tÑ#yC_>{ź'BBVP gmN }>?/R|*b~آƍ'u7ֺ-QgrG&ĩU9 CBFZ[n] p&FQ?Un2K)kf ^C饲ƖXy N;qjSŊѷrU \qDw׬3&]=jW~#GG4Q8Spc8=!5CHkHBRbZJc>1O.4g^9_?篿Dttԙs !;RN9gOMJMNNHGIgϜ;p>%1|r1{T/—Di [ 4qp(#?d6R1Zz0ڶu 􋶓~yN>q2:-Gs{v_ѽZu͛Ẇ<; wHLNjǎWOpwϜ_vn7;;lb%Kpq\/*\xVժcW|lGC#sC :ƛIoڼ{|X8. (bKED`ʊYPrрg3Oq/`•; J;.@(н1WMW&*8ôp44hgT kx {Z%`+vg'XIVkۧ\*ëu˔)d'4aOgΞ2eZxX$H ֯ :s$S}4(FX#G¤wj~-Ku<֯ry+YpR<8x-RQKRolȡ#RP]s掮quU*A ѡY%nPfbb?E;v|soW%ŕ(rA/)0ͧ)4 9bYߩJn஠okw0#|&w/gt8CIP2U6w0q;|TdVO ٰo{??ܺvuw:t8u7mڴu`6wAH%B/j"5ѵ07;qS׼Lգ[yИ)ScM0hE۷޳{._y˖m0rxj3'".SRݺ,S=7w==~[ڳ}J.~~O:tx?&kM0ya_w$"݂ve>m;Xv m8}9[w,߲mfUpLfLx bDJJi 4z0scNb ޹Ufoٲ|媟6lZo=|~"E`&ME=zɿLpöae'VAG &7'1*5Nއ>h_3 ܸ'584aƩAgddM2ȑgΞ# J( 1$rxFr~ CO824"w NiQ~C"+ $FFo@ܺu;<&P{fR%@;HmڻCpܝw}!x}{o7f>tcp`*E 7"vlа|sB@J 0۬I+sQ#RӾ*^xh!79?bM(/Θ1 GnM"6bi[7Tvތ{V ?w:K<=qT~uz3/ .|*E֏:~율ۏg/SF3#W޲ݰwxlR:F};9.p_ix)UT>PhM<ԧ~m!>.5_yXCLG$[D-],=v/3=:}!'gR(jp _ư'acb;w,9KHMba3D):@Ce .z?2[ڸв+'OfRJ.Rhێ3g*]T>.\o~ʕT19 yb?{}-Y麡#3hʕ+~\,fQёߎ}Q~G^ii13#P{!Kc΂}ؾcO;vYpsbEPR%XrٲʕWGd'2J/ڐ?G| 2>m$ߪ_6˝;wڪj0LLX\Z_! Ը~vQ̡P2zدOyz]eKоӌg+['`ѬюX!Iڐ[6:~0~O?R٩O9xz hkNU+Vhݺ8{m۾s͋/^D3fw=iû^MU,Z)RzNظq?fe4ө2T,0k,=P/j skb3F<|B{,w;$-kCЮzwP 37|߳_5= >=' 4NĔoiгl,2' @5˴TZt 3g~ۢukvҀ̪UZ~kۙ31&o>n͟ %%w޽={.Ydu*ԉIJ>G`Sg7mrk2fRPիVp!.:u~Р~wy =~ԫgpHOOS쨒xx6hٕq/qSfOخ3gˎ΍ןKHBfWTa}|ܳGO0!?P|wn1(Q11p[K3TJH#(ܤ䲭ZyP\rJXn@x@nV<}ۮC+Wm{{׾?ضx'Ùf K13uB0W% >pCއ|Lgoڤ djBWY3kZ5ۼqS``QεnQ@ETrH.X+9Aa)ie#+ʰSfVzj!u|ׯY߷w?}:uTĻ1Ԃ%˴N9X^`Ʉ"!gF= _G1֯_瞙;g+?xА%K~:hȠz 4ej줔(A&wrN>xRwfS:cniRODp=…-Qn℉Ou|zOK,"â0b^hv%[cJg0"KyIn"5KQz+YJ|jjx*%b:bEKTVVp}@cǎCDY=bto%ʧCL6.88|7fUoznvI;w߼[|ڹsz#%6o6bİm7zݸiӺ a ő 㤶zՄ Թ)-xlƁ܄MiF=4#YZF[oٲU {Ö[~ :fϞ [O=fg{cu=|+;)Nj+7R`}WMxa%sn7T,dY!e3Y<}uw޻~G4#i/}G{E##U(0W80L3'c>qm@5(Fk2 t%8ER.zA|WW+_mժz̒%Jw>w٭O׾s!Wռ;oժ]{>IaAHJNauj8*VahDY*NDS#2fґzM6o_Zg6U^ QH, {sז)_棏|ч? |QfT886Lzu;Vqםmw4l[ZU!C_y奙3fo߶^Qá=8~N  [/M-!ɰVO13*O^,_}87pRذQw~aϟ;ױcwyڵ߿o pK(Mm1! !N9𫨖dl?.7#\w8ĤzgΜ5E q+Ujݺoe]>kj]NC 3 Z`ٷ'2E2J/!{_v͒EK=>iO 4t S ! :<(Tcb?8@TeK)T414,!lg*WN[Rv O ?/#F~xva͚XTz7 2PT/I  $=VS!:ɝ̏1Qc8f91c8֒M@ƦG*]z۶.޶m=zIpɒ`YU]96UVa6Im2 :z,a]Zzjӧ͛?w\U*_hҥ;ɛn9y;\[UB iVuWa8 Ie>ݩGnA@iG ۺmsnֽ5W_;eo#dLJmm /!&_}m۷ u~Kk֨okڬI J.oS>űx42Pg,;~x3\5mBL 2Gz%jl3g<Ǭ?~K|G Kg)phgE|EMFvT`@BrS۴}BTI86YWVgsvFGddd }ulƾVݬ'&_4h ]b_7nൗx##lLW PrjX*nσ4>{Uȭ$ %9YȀM*HKlS0GPIuZ@@P5=3n+^xo`Bzdf{`rij'$'%aP)i=zSo+RknQmfi*,HWߺ3g|;koؘmz>t쀀!a]A>ߍ 9rTUV-E'O: |#66fӧB㱓f@o0uuw˔TA` Qi)RJH@Q.[6X uh)xSoX! \(\0&:|lPؙ?x;Nv 01Mݲ \)Io9[_F]鬉k\Y#)9 R8Ngf2;#+==sK( p پ}/NN*`Z%aLF}а<qE/R]C>P#0420b@rg+k^8(=cbbC-5$*"bvů:ׅ=qt6עK E)] FDE y5cj*xr`O50!cE+4 m W~!Tщ,9d42Rppd1>涽;h֮\gv}oC鎻?>"Jw%gB@ ,V:M2W KyddaƍޯyŸo[?OܙEnfbUzC9g3 =(Uݶushq[1<5_|~GP@Q,:;<@? @Q$^_qevh⥗^]xkʕ*8U^ix5A,%1}ٽ_|liuF>\H-[k5tލR:fdMm^[vzꉪ*?~|,7nBdtX_Ilu쌰KN[b[o֣{ uDRfh1SWrq3!6^wMD♫Z7izW2okp2 J#'===:ts /KQd2x%o}W {s…n/VC0Aˬ*,2bx'PpR`_̛lGҰѣkqgl8}fCi22|͚uK,kժillTvv-T~Gy|Ų74iTLi$!Tb*W@lS1SfK֍غQ#1|2_Vι%i9vϜY}w{Wl -R XϾdgty{:vۛ5q}?sfoA=Ȑ̔\X{]w]?}=r#ƌcwYxz5Tk*T,uW=Ko_0yXDT\EL[tI* +HP9z5uw0|[W^UQ1p;>_Qtቧ&N26p\l Ԡ ˛).Qws {Q>pYXPlO{Oڵeߌ^_!ޫBp2&8L2h~dr"E"6+)m^iLw ܷ*.]Z5˔- y^qeַ_nO:y[Z!˖- Kuet!>gFfc\7׺UKV(~}:e $:==yب_ֻ{7j۶Q5U)[;R(^4;#Rq76!@;yԑGO<}v{n-)>ȢߪU bŋ5ΫڳG-Zlݼe׮@a_/Z+/ִYZ5}WdG/>J7=R2)\uƀb)%!x6꒓UBKi{ߪwֻo…5jT =r5ogGwRS:k4+\Ul :,y\UA OZD2A/Z?oi~>sXyuR ^.Ժa9 Eȷm8͛K?g"T* v۠"Į`z} t5rY6oֺz+~뽍7.\xj5=YK?wλرݹ}ٳ22Ds  5ZlÆU?v_ܸഩ'&-_& _??G:H*0V3(^n劂@+S(`l\~%KyΜy(pa 'c˖qB?fl臭JXK;VRof(~sgq.c~ygG#!\bQqYD۹#A)Isѣy4xCـ.>vͦIZz\AgCu3f٣G3v'k'#j[aZu-a Bqƍm]B2Q15nZ7]USϝ xlWM6^ȭ"̀zWЁs=PU7oj^u%8{ k&- J5 ? LL\H.iFZ Pe>a LII\ L*22,-="-5I/"Ogǎwp@$O}dž yj_˖-:aܚ4o*:*lδc`|U~✃7p F͊x-1Q=z}`6+$ DFŬYcǧrrK\)~}!1qMɒtINJ鑊{V.$ R$--YB ~>7 8̬dl۶sY]{'&3BCOa|Bß:uDMl!\)ɸE",)ÌF2+#--2::-5%$Rsc?v7bcbW`x%7j0ef>Pg~ ȁ#P @z2'ʵ\%9Q(! ]|M_|K>gnd bU|ճ99YHCD-BK̂%iU"V[ﻳ <, V:؎);W\Rm{yfd@L4Q==f,!8]8#fXiy`m䖛^y-6Ed# e^' "ӻǑټ{ǎԴ*Ub䔃5kn߽5@}Œxf2@t>սQqwc.^/(%qb]K?Q .pHAG.\Y氇'wĠd: eԨ﮽VXxaCxQF U3><K+0 \x]pDn^~ϖPu 3UV('w]?V8""VC{N^YsOߨAĔب/^_Z=oA5 tkn_~ϿN6m~葾}|͐0b5kϟJah;]y/ =YSRϝ9/;ݱsIիWt}˔A+`2E2x|bk6J]L)BC媕}-桲RRժU> 0ɧ::u-&:||oR<=vrr2 &"W^qW߆U`C&"6[1xL7]7}wTbLWa7U ծ CKxfӭJ%6omԨ!\MH b9 Tj33M\lXR ([PVTtNOJNL gjJ%($A([ތ򫯯 *:pIGSO=DhAj\ދc8HmXYi\}Bڿ p"|Gƒbƍn⓭cR9 }ʼ7R9- y>ٶ_\LU1qؙQNܹC]B98ƱaYz礆~򎹨e(BϟojѝIv=zkX{IR8 qJ5BzJ*VvHrrzՕg LMI-P#;Ӣ-YbƍϿlɒO;\ء}^D]V"P32>VG))&2rjXv.Uϥ82:R@HY[ -UQǟӹ ~HTxY;3~kݴYyCAÁ 5/1u_$&S z3B }rKAVdI(v*eBDŽ!"<+p:e y|S /NhMo */Za_#b'\hHxPX S|=f\vH0Y77w?.f.]7_C]UW]>j1=0>!9F76ltLfeYnɓ'8w-ѶPцpjy^BP8d2U6l}o N7oqѨ+V>nA9sa,͒D$2/:*'`>uO0" `fvm/OPmXքABYDJ*?xܴyU+jΝ;*qu)(0ƿ^KVxV};W~i7-k>pd5u}o?}QDwz\R+`|Ǒ+zt/GIAj"! х*?3)*4x`e2J4@\*"@ECm;nY |fJiӖ͛Yȱc.UH1s KjT0D3>վR^ӡvhqZnxD@į֬yU&*T4o|D@&$^mqC z i&r044/ۤMּ*,Tܝ:eJ^=w>d*•:6[~Ti~iXLA)n ?0FdVrk1&P#p_`8Gq126阾Ѽ!$0HB8_ ve!y'˦|G%h .#Fk(Vr+-ށ"j>d 0m`_I ;c_|jg.X"<e9ϯ[opFP`\\~ 3iHAÆ}5d`J TE 3VIHM2zy.ȏ_ tCV^ fdo-r6[ -a$Z/Q_'##WꡥݾlgeBBcO]pȄ`3wM77=qGљٙT94"<*4$fdHl;-#Ν=\t!%"h?C<,{8Ezf̌\ON6)Y8w *ZDGARb"U1S(g$CC ӥ(${O`1F}f"im"{`Úoe\QkM[⚘9ht֦VD"=v:Y?q +ڵo[nԉ"F{)[|\XXW` sf`W\(b^) C!"؆OLVp,뚞W';jcƄUg6,y'| 21uʢ,4iڝ;Ի.lX9`qԙ|>}J,f8gʿW6-H;J=ؗa~m=b="ɚy^hqKQQUU'wi>dYom޴y¤I S1 @{ś-ma{ A-;A001\l2T/=5;XظQu򮉌Q`5Pn( 6>i~UQ`!v)XS]u-H1Cv=` ~Bq}z͂V)OAs[G;*ThW7\^w]mq ̟PJ߹ .5g'pv)&ӈb!wuEAaDRtjtN. {p.Fl\Zj<,NKxQ6+Y =j yk? T@bP,E-ȗٷ< Ww2v\aU c8f`dk1pF͂ÐSm[WL[:'Mʎɴ+Iv@2吇űM)㙼^,T Kk]PaRz#Lcz[[b4 h&ONݚvLĈhƮpv8 "R8![Y `,AeWZ,;A䠐bEۡ,\CP+8 sȡZ&Pl] ,~lĤ %,q<^]a?HfdOQ$H~eC(9TkpA@~ڴǓt̃EIVJd[ f pcۦC{ŘmwAAXܺ#'C# lvս "Pz˝Ԡ^$U{rKXqI; G21kXJ'OdclqhۭŮ Y~#[7JZI]QFD"Ϗc!UV8=ˇeDE{`t>n{1)- m?[-$P,cDz(`ʿ<w n܉I V(Е/6;ݹ)Fj-țԏ (I6/zp*Rk@- 6|ww݁w;[;;P`?v)IENDB`0Dd C20  # A"^g4}*I/$! @=^g4}*I/$ $c#~NxԽE?K^D=T3! f;yz&Ev'oH3aF]6N ˆM]]S=3;ޝ-jTzUJ8n.zq=cq9wδs\׫yY߃nwץq1NՋ[QOn0$_?'3$ʿӔ>C) '׋4L K de-3!?3! !1f#򳥐?BRDrB 's!C<7ŸanG& |`L!s6͖a>2L#G& <ȯ >2LBo)9Wφ̆gC ِ |>f?>f\Ula6lp>flW) '!RPKRc)X |,/-qSK!xX uX |,>KKR7n٘'&>pN73>x;'0, P~"'d8Y<xp<@]`q \2| X< 4[CDԀ| | @B CCDH΄38袋sSLnVyjrofnܦM N$n\}}=.? %@GAAo?I /eƆLZ?Ǡpv\ 8n.¿?w瀬zT4n!~<-ܒ^O7ߒwW i` 0搷vޗp(9]ǗY,Mwjv;nύI([mڅ2ݡ\$|vQKˉ/JymzDOguX /F>psO?X7#FXRoI,0Dk_e<9I<.oH\efҔf*?ᬍejIj8fkGc/0oג#\_!+e)swGJRYO,}SOy0rq-H*ySǻ1%Jzݣ7܁JOW r.! KOx$ߪwJi^}ka#R*"4J䞜'vwoQC"wU~a9FV}O~ǻR$SW#U7ƺœT:.gFO}0hFix_%$!Am0o$=7e֍9U(5- %!\Si~m1Xϰrؖb#DWI6-hD?];n_nL}iهpRiGV!9{9|l;v"rD>Qu̜>ƙn^oIӦΊ|7͊OPYfި)$SΚa(2ߖs<k%PV:@e>Q}8!M,PYA3 !_Y =^ S>^{=˧<&fm+OaWEOm0z5AڅA&Y>rκ(? f\@'ozd$i V>USR._G?d\f[+'>R7̘Fz6c08ϥ\C?'̺1.?SOD~w*Sz԰V6('lTvp?bI$f--+; 0L5uMuDn)cfv<35)j,)O#m6"! 9ߊ:-$DQk3+>N>GnlkJNm4G+i/VOP'cЫC4 [(}sGC[|]}Bng1Q> Hs+jcߋIK.cYJVoL6-[u%.x|Bwȭ7?>??s:^X9Opӹ^αgf+O1HJe+z(A;slIC>Y衏(~JweY-lciR{BzS|d̙N՞kn9 7_ÏnKCNn[WiSɘ # <?ryi="vS>sh/s"򬔟M._~/ܻj dv^X2xy塪PiYMiIr98XR^kK

펩fH~@'40f;/̤Ȯ$ȓ'=?nWu{MY B\}$^QP&^Mښiu80^qNmq= \]Ȥcsv|Д^o ]~6޽:~]ښjHÝMз5-!*H&oIXTJ]~R7+1Gve _JfR~;^;뛐HS?&]]֏v4HԿnL^{ATi7-mZ8%)HJP~t|TSqJ[,)v"5#-k?U׺;,%TCC5o|y7{q}|c>oc$.{~3GOX1G.r+SJ#=)=ܓOrR1B\QMI_MI;_!EwCZ p =`,tK^:/8%VP | }\뫃!Fug~OZ{sS7[1΀1z{y.m܂.4Fx.7L#!Xi,MgfQٰ"MDΌΰ)f$WF_~\F:׻/Jezz`eĖ+)XQ,Y[`qTT( K`iP**|bc$m טMc VVevHi,̦69jsPu]aٶް߹[zz/wiN㽩pwy]49]@@t_51{ӂ+̦KMYcQ&eɔi5O΂nʚ`@!ODN^'+H8=&e?ND[nuӧQ$/KF097 VC8XoZ ɉ/O佢92sSIi,ysn&@K՚Om$ =?W?ezgNj[X3 Tܾ_󚦽ԞhRaҵAtH8M/T+3܏s?/}d̜y }d䏙3_Ȅ3 wljjzԱHso'OXN{r_>jtRfH&MViWx$|5w[~Sx A(>RO( K4$z Y]H$x/ %ۀ(el>fp``ȗKbе6sQ?@C_1Wk4"qQHYX7ᣞڰ :4N-cak++I aaa)N1hՊ[n*c3砮@`@H*|ك^~x97-]r9V俻쵕KZ7g?|cu{r  ݶY`mg+^Zm_.|}P{b աl9d^PO˱ ʷʱķ@ ?!10.f~C?Ɲq 01cWeO7zRX5%M̿Gƣ7$ՖWڑi|v _ٰ w`~օ7?8 d(sw_ޜLR{(~PJϚ!}bP%{IN{HzȘ_ATWq}~%@JȎ,35Ur~xϦjA9B0i9vhN'wёHj8:C5Юhn.v?xAOb k&Ab9Kߢio6SۻZ>hʗdK/_ǧI>$ lʸ_GU&P8 aEjJw%I|øU|{!k7#[E] ^ϥ4;F=(tC|\~ >IDZbW ,rs?z9r\^궄2û½L .ң l`ibm Jy0~L|ɘғ+Y9~eB*0* 3q@x З‚֒XYY 1Zi^!^ _1|J@^P,e+Ac+njgU1u۫|{Y /CXwD78+pV-o6~uU7>)bA7lZ//__\~D?zt_.Ϋ2qδXBh B xwZm`u:a' ڄзk=aZ]o ^ճgOXwipNOj}.z v VCYW6zvQlh*oʾl/P'TKuoؾO ڸ=IO^-o+]h!1yL9 UE??NڏGzXԣBGZMx|W̾ZOX,m/l8N-;*F'5xTh_+4 =ҫ66jזU|ckו|[~z{E܆3.x$Dr r"+cWXXHl8DWUyGO7 goWv^8A3(|d2NLx9|As~rʓM[,(*nWٟo$OiGGE4|ϝpI񩍍Y+?S]QA;V\p,&L2) *@7%%=Y3g qˏ3ƍXh (Xb%z U4TG7rV"ճ񕎫3ir=z .6;c*Dm,x(w!Un 2N'[׽5aq-H܍˓p3MVn5sAxPMş|I}g q7U/"=G 7zƇrU]JT4qk ϲ[J*Cu }4ae5] sX!! 氌ȱ}]b5-(}\ůy2Wo.e.KoO>3vc*w{-%QDB(Nʺܒ5B 4esmH#lֳkj{&dgM2gWS] 1xx}wyKp!Iddq%K M>ƄrN-$lEzGo?<ӧ,2LK@K^>vاW̃%'C O$4PsOE#+:kBKG$V,I$1R=d?5h oi b|r1>[[9=ɤ<£ H218<zY$^sY_Sc&}b}uq :#9A?)  >epusMky7<"%6ai^IA~?1}i9 `)+/-:?7] Af@;yG-&=*t8":/aˤrzp:]W j|3=9˅@Uv$Dnu:eȋ':Cq㸇 ABٓoɁ}rF"R#h+|E.Wq2Qb 6c5L%sH9ޖj]PeKh@K3w.-'Z#s{Y_}gܱТ ¢>~9=?=F7P V1_%PX~@^~qv?8{wfN˳b3"7%ae|сYSǢF ~]S7͛eU_p}{nWaPa.9 ϺvqR EWWX/3-iWwWȢc/Y.0X̦ V&HNw'}|LZE\55O~Nq/,òd\ljZ',o쳔owJbp]n>2mGPKO^oU RqI1wဩy9bl ZJi}X&VeRzȓ35- i_}%s{ݳmхmW6oIgyFOa N͘3A~4z9ZT=ss`6y.-‚m0Rۃp!OE2`{K'W.`q} RK}V"%BqȕIFu#+U>So+N#{:ltlߏ&)O̯"(F#*>K-Rnmj*N'RYΛ#<6FYI6tˆ5_cF8c@Rlazk[Ќꬬ ˿;׋WX7z {oqn\" %q#̶}iz/X|BG[l}Ƴ9/?}wܳ/W*# 'x $q$X:|[ڹ^HSpX,;qA^ZgWedU'"&+T@Cpa<>P"B"J]BCv¡kOQ5 ,` :S"WսC g+O&h[$>}:~.H5aeԫb?yة,yY,?=,v6/%~gX<n\ F_sc"-g|{߹K\һIrm(~yߞ/g_mpvck! ^3k;u"_mi6nƙY(/8}~"OkOR-FǠb>qCd5Ζog1ؠC ( qx:ʜU4Y`YB,gYτkγ.d d&vӼ?wB "-B/w1+#9CQ θL|j^4D޼ *҃I‰C.۠DR%4IOQ$}iXdIKJwyF&ћ1ai?iGqEIg8"T3KXw]o;1 .:ʓ&#m_P0M%_bXzҔ$Zk?(k{5 "ZL>u|SN搽x.^$m3*HqWu)UW Q0y9תzHCN;i]=736;lO3?z7Ubή~呡'y\g(P p{q}6pUrB (т[M]w*w09W-yէ^7_bͶ:o w=x[ mz.'2x򱣧EvfG5yx M=X?⸎,ޢjIDU$7@&(>It&Os46Gxe›JidTuz:Oa2ޢ7鼦>>C{| <.9a8?o2||Qm>x2OH|Qe)ZiXOV:*++\&e"Mplsxk a1QdV=·F| c:Ю\45\͗o,}ˌ̺p?}s. . 9F=s׸irr34/_̷\h#1ٶ`-ki欩֬Ui5eZ{/9a,g1`%iI8pӲ%m_UK._ܒ|;ϿR^zxFˡq8ݡ19N 8tyJ;!ts+_aɾ2kAW]JЧYk[5L>Wiǖ=e} ~qSN4f:"- D<ۊlt1VW*(y ŖB,cf8T6-Lb)Hb{nnO|7QE<3ȭQޘ4VN;?DT|,:ߩjxfT76Vo;D<b,JӾ\Up1$;Nn݊|*Dbu~mfF0iwQN^]?^tE?~ĥ.r#~P/~bC]h?ߞ/I{}*jcg/J/[Yzs$3?V]Dh z_W>Sm|z֞{QkV| "c-ԍ{:_${QPUKAwZ ݆ 6e/A%?vWzM]U+@M 3׷ϸ^曎_G(2 _"?Ee-epw> >|*s銇߃muزf(ˠbm5_mes[ܠA\n-M[XkddiLu:>Kw@E>}".;FӍz-Jn+k2Ҙ+^Ml|xK1;: u~ GW׌IˏBI&?.)~/:X4\%/Ԇ [>ѧ?#;w78esp?׿81 L]BE;uVbT0NbEcgrƙ0$?EC֖]VΥف@} ]_*^Hl `/ uxFnQm+L,xuLc\-s5/NU].7qe\Kss- smS-&P}DPgھ 1XЊ5.[h{y9K=jgn=sʏ5C^K`qO(?@Vv8;{~rB]`4,`B@cjCx/[ҰTpi=HbU,KxM394kQIX_6^ϢeR 'X@N`d|~1@Nw<ѿߦ쬦m30h5em 8Hq~bzha݄4f4dCD@1fUN(5IQhvQ>SU8ۢy}+ӹAEWzU%+ZsߣO[wVٺz[wK=>~7tz7lǍXpK+ JTj$agQ}1jJ5$D+)+.RQbG.~\ -%?(@}Ќ=Z?ToBX#2hapK>K*o]o*YF{=hOG?>֋>9owPULCVie>ŻE~FΖbڽ4S %@T3DNԕe_%<]tFY͹˸w bv{GgakOE~wx>]aUyCNcOn˛w/Tn(\@p!tu6 Dj`QtmVeϙ5iDzXqjUyW[k˖D/'^@cGhuښV~Kz<-'jw~]__:^x{xZG_{AS~7[f67O,lק;^Xf9NOS%eCBP\s_vOmXf8&x#1ٶ`:£*1OqRdN9i0\q5Z#:ZwE}k[{2xKe]zbb+J&~RFp%ZΝGknN~b'Kut"?lcz[Ap˖llyjIu\?caG3'<]o Vb+PMcx1[aB^}dHأi%%? (hg#@h{{//}4EAG$RjO#Bbx4Ng'H~|gz*VN%>Eʥ^Тڊ575avM$$ǖg;8¢‚hkđ GqYÆ>tgߗ{~*yC>0^eֵ܄ܤarwEw=wbg} dحyU}oRӨDesOqJ~tk)**kV43UM py ws]rS1Χ4ܪV~d(fkihi"^.رg]Z\wF_$ ݊16{MڅؚH&AXWS;6t>fy葍Mʺ’]v>0ܴ4t2y],37Ŷ& bkʺJ7EA;~x%[lqŊ,ÖCy^yVc5?'>2EGFȦ+2vt_ԤKS+:YZ*) vbNOp,ƞ@'/E XD+2;#w3KFRLD=+>bi$AH6Og ˂O5i' >s wk0=Wޛr޽ѴN- zy+,N^T:9|V}nL-kZpmzzU"G.*n((X 0O}ԱMHp/:Q,=+$K[D}L&q@t>j?&xGNy [Q_}סqf (Ḣ'>t蹗BsWP,@ Պޮg  (|QJO6?C_y._ {MfXJ`k?2?_U>e7?BO{U"i'+_$7TIUrW%qke|QA,s.HpCkWO opwXe5A+i1k '\9{x1l3b߉O0) ɺpjǤW\-}ԉ.^+ﮙ6Հ~Kݏ͙ȟǜٗ c|WS#"?7.n>{/󶯚~gg}Uy$a5!tV{@Jsh a9 q)׊//{ ߗ J?7DDњfF͞*'קgX5VxȺvinoy /7'=&gYе?G(s!lk^ y~ kh-x#K#*o^A0x]lzDKaqBLꩂ|_3FCWG&V*>[?޸x4ܷoԸqӸ t[q1(WұlYf g"zQD—Tx@sc@1^H.ւSͶ qDb>ׯϞbS+XM4NշּԪ|6E;:vD:|ݢ*nɂ%J!P_bg{O<(~;OF)Ӧ>uPR^1йU h\Fe,@YKZ}U;>.VߥJ.ζigO}:L~/CMM|oO7*15GB&;g' _휽P[и9Zek x|9ka8"tI°dؖf;K7hlEѡiIE{Iþ|a4wӹ5!]]=2y?yd,E~Ӏ8Ք5 Ё|N^\RD,&+a;tpzz_m)gdٝ m7fA|_ 9vtD[[z9l\Aýp;˽ima3[?~'(w0TmvDZZ#2Ip_u_ 'a˱fZH/7ZSRtg.t1^tX˿&JT}*~ºxSb >]i~U4E_Y/)p\OyD2;>5J?qF`}4bD%QT5obacOunGWFz 7_4w}?a{t/h]n=e%@^?1$GON#Wn\S^~ˎW~{/uk߶|X?4Ͼ"\kG}q9xtr@0$B('BJ-!ie]ͬeKC[Q=ᇗX27w{!B+Z vUw?UI\&]%%){%K< o;=K_.$;Vbbw//#,T>m!9?496Aiquq@a ~6_ n+~jDZAʱεpa;IĠ>nvO|*~ED{ 8(}#o,'?rCqx(vP}SgP=a }Ì fgsi}&;fe/RT%dN+Ԥt9 ҧ?$qTi'Gf+Kmq=TRP]BM*K1$ܣZ}jZ5U#(..VWۧX"i|3E3ڣgEmjo|\\-wam(-P!Q[Gg+Ӎ9O?C`HsۋVlnªZo &_e'u++zAP?Igm SqFzKN ϲ !Ij^jt q1onRoۤqf:!|o_u\G_ԣȮ(,>DW'_я{9_rJ?N+F *n^,^T4koáog>TڙY=ZaWYׇd A_f99MgYyRˁay3Ha@/].98WT++LU%Wm\K[hw.~Xh lS1$.S%_HҪ`TM `9B7XqK ,Y#mrDsm֩V|O’=1[жw7u,tU 1|/cgR,rEqԂ&K>24R k) 's~/56aRQ4Pk= O tP\%XxJqj=,9 2ɧr<> b9aX>9{x7ugʧ9X̞Ȟ6{~ro#n{u~J2i$gbP's+5zkt9*SFbR R -Kut8ǝRq=UrȞseY=ӸԶ;ߍKKޑ;W7VgOd>)߫tG ]Cu;OuhAtAG?a׀w| >/۽ A㻷%z~=dsx7E=B4LgrlNu ~Dm-MOef>(vDбtqܵ{=rg%[CBFP;~oTҜ|T7pL|_.|aa^AEWe]dܜ@iTTͲ$TP՗7OsU =r.e|П,x}ў_?뇵EZmPt o7.sˇVmw4DP ?8Ľ1'DO[v95̍߹,,OAhLn>#uHS@t8`5Ar0qǛ_S y Sł-:*ڢ oߘ,w?:/V7ׯfS_of9E{=_|y^Utal䥐/m++\Q5__}O=aolܰH\h(ደkۀ[A}/r`B[F|3"8a9+WJ(BȄ%Ǩ}V#/km㝷>= [ÁPz ąS6GW֞KڅZ Ųʖ|p`܂WFYMڀw:{N^szw3_IO帀a}8O߀=[xnɟ+?U)b=LTH/Gz4x$?bd RN~URXMiwUV'+>m}ʖ幻[;?2xڵx @}^H~}'bקM 3ˏO9q'7үc@| x(I𩟯U_T7/stgلL|9|dã5G<<\%yl1}d#۱s^o(ܮb`1&_t47w}Ӄ`)hio5<>WJz̿Jc0>o_5?(++klohDGag CGЎ]h8*~l:ixß0lޟ08~#ƀ"L6ba$V3Xs)4q'2Ǎ_5Zw}~tw;M`St6ʢ/O9"W3)Xޠ#ҚЏ?~/.\;i{&m揕.A 5nҒ5>{>gZO˱qdM2Ϳ*i7:~ $΢˗\lK=7A9 V-.4Q\n3B#u2@Ct$~_mrӂ-YL,Cl!X8;{5:[[%4_-NnGe~U|'>n=ʿƮ(x}o'>2nTnAKуXMe 4(WX:~Fޑ4L*r.{ ז/$quW+xHNJXn-?1W"_`7#oÄUi;^;m*А(Ot"KzHu~ oTP8'*փ;;?]oz"Q>¨yvwuyvsߟ)}⽹pdlL|K歚7%5 M,^ Oink5b9|S^ VwbQO^}~]~GXřSG ֲ횓cdMAy0:t 2qYwaIrw$UV2r^^x5dbTZѶg|6$n!醬y g5L_>WUibm~s_=ֶ`n缓FmusP=n=a5Մp?ʃzt\z KA\0F;6/kikoXy]m L6?!$L"Tʯ4'_YQ02iQq%!>qbQU%}3g̫(SE|>X])- UKa@=A9&9<$!To{$]c /=b+jݕ+>G kMٙ6mI+lfPk-lfPtK68z ƧWE搴)U TD0 擸WXPC\TI4x[].*DI@Ϛ?J -汦,NYPaYlj&4r,w )?<'᧫u\q#4$ՈϢ;;ㆫ?|_:~q) 0nƽ$؈6xSc2SJrUI #M8Ur K@Yte\=Q|;ҳ>F=ݑ3YD+ 9,I1Xat:OɮpFng"=d8}M3!3 yWUD MP}ί U5 E'7" =9w^CHD>I*KI_b^vd峤|[U:3o}8+VG:ZÂpHσ{A#fvh/Q5%I>g9yGW.!ѷ= z/L ZMi{Ԅ?'5P̃VA=6W<{`7~ )Y$eM?~r䋻+U|yH8s|VO$Y;9o_g[[!]~&\Gqh+b-7[wMq'z$( R'r1AAJǒM8*wH>``ȧu?} 5Uܶ?%U8FUHr+[ oӁPH0\7{}H#ƞ@Yz'_g%6<'bȡ,o'2 ] g5|ϒ薿]SǥRiRۙJ:N`ԉ!HYuK@_Fx31+[S/q-d^HE4>Sڑ qFN]xVMtv4_tG1MNMNۡon{[s[^~Hkk[ZxDO3'v`p'*un/,;a~\VRqHc!ry=O?b9^hث_O&h$'$fVr׮?7-%+!w*3K_PW_h?{ʒ~R=}X=5XTW`$Y]YK XaϲͺQ$)G\RɰN֗#֭h!o zeZq(IB C@qC$]XW%0HO_轴]6[C\Z~pU("@eP"MK.oqO|C</z=|bwPc##L\ ]*V\x=Z=_ 'R?o!yzIya˧}$nX=K.?;^Q(c|oR@Iʳi߄<'$z3܇vj+ϴfSvLE<Ҹ\yw _Qyϝ'뿱N6vy93p1kV.w՜cwi9N4Ny9,]KC:ePdS'_M@q PY3>)=WBQ"1` XSvzWzUv;Z |r,8?8?_zXce/(Ox>2W+ƱP_'==ArnxwO{o{GIDWz+_=9R&:KvU,wWO$υ{7?=o0Or?rZyFl fX4F:ڕHSgX崜ߡc>%}.W(UzDUNtStr lb<^U%jj1ѫ4!ڨuc% X$5Osgg"yhCrz]~]z|6wqzl]d4F[[;h/>v&m.bҖ%[eYb+׌i[-Ѱa4h@tlddf\,|t~bc#Oc7\oœm?|JL>^C,\?peF9E٩YyRnCޗKg~)玿}v^yU?O拸(w=#:t_z3?b>KB-G`P{R|?D]ʾ'<ߞߣg4:;}={wj"禞ٙʧ_Nߞ9ߝ>7?ïvFNߞ['sv㡿YJtS~UW?/Tr5Eȿxοh.;mv(8eS;OW?v\iS|n_dF+V7[7.U'6nxz#2{jū3I̟jMۑqM~ɵô|nyM~B/l)?ZrZn+=TjR8kwKu긻 ,xۗm_?__:w_s~ۥp̳1ΒvV>^ri]w7|yaсl1 0=p9GSVn^ *oךW7[+[UT z\ٴ6Dj,nyvu~,ڷ)\Vw-yxO jWyݲSߒ3fJo;Ͽzx閞kRTl?]k0p?nqwĕk2nNŸ9;6[.a*3S.TDjAgĩ.Hln)6i<+y-sz);nw# ^3Վ[uo__"sAWϿQ/Wu;#7M;U|Etvyά5~dee];襎|v^J*9ǭ:O}~x=\r6׭uOqg=[}r}zF~N[~-3籫ή[ǧ^T/ga6ޟ PUju*Podzqx tuoų寄]sۯR nsݾqg-{7^|l~v[i.*?9Zs}z<$_ksmymKy ䷼~vQ+pM;bK?s]>U~ f9;k= e9u^EZ߱8i9׃ogDx[|.JkFnm~x=2zvR{Pzދ[G+x+Vzռm{(3_=zyPCUY[~~Xs^|oRqO.UHKٮGUqh2W4 g_w|r/gϥ]۷ (.Oe߾NR_]IqJKv2ǁ#rlq=/ώ/wdܴQ-uq:T^vqˠ?|2Xvwtِm_zQ_WNn>b+ϡgc;կ"qG͙kVsus?/W뮫yԾ{ E7pssn|;먮[oyu|qvw_'>~|n<|ɻ->/k.Nz97hu^W_@cs?+NdhM8;Lzqs.^ЃF_{Nft_!jpw;K[-~7Fq?%H??3_ʝׄ/ޥt6l-mMy??T/d6ޭnWgEYjܞz~_$ߚյ1(̅R|n<<}/k˾7?-^'ϋ}7}~vr#+>DN]qKܡk1l\ug|^֟=qtO5E4b.UqT1OLD=WjoNDv"骅75wVnS{ӝ[{78_]| ߌW|+*3_خP3t.kwř뵯(c"|JzWk+Љ=_zBSy>и՞SyZ˱* O俩_N(3EAɣn=pK9nų|#+۳[JV#XEŕ_6)9>"h_Qw*/uh5g^Q#kU~nY/VվN3Slk }5 }ӟ8=(OȂ7)VSRuiYqshXZAK36YekD|#k{ZK?卫6 =[ke?02sv iï#^bq=)^g&yMYtj4iiȭ}ح}jG88/W!|7k"\5μ?y\|XT\g >#;@w[R7C>|#sk_爥nK< 558/[â樇?=š94Ziz[o\;~/8~wyG/{L'|#oO?Rˮc3c4r :DkfeO %坅Rlt</r>z _]Kk"K=#&UڏԑbG(".+L;o2uR/s+#8B/}gk? T?uxZO=3WOrv+~3z<7?b5祿v&n?X1eV䔾gPjx48D%J[v̯ίΞ?Tke?[^W+jl6L;5xbz#J0>>9VL;&G(ic;#8#/_/~V :Uݟn/ .jѵVtu~ͺY?o;}ky';^f7Q?CF_固pF#8]⓬m|j aOW奊Xqߋ8uVIϺȧ>g浚^lL_O8ϝࡸZ]}{!キ"Y vӕ|/"ki_@e/Nߢ//8sv腊n;ZȖ>q[!|#G_=_jߊ}m| Nveߚ@qG5OJ;I9 W~գݠ?xƚ3ϗĴoEy佺(^X[˫yQY?'7n/닋|#G_=󞡶t{g˪]u6Ƴ<֫[nkܱ}o}Ӿp3<~_Zz=vUUߢkPklr@+gR"lg?||RGLv&;)@>|#;wcъwwVwھtmhZg➵` ~j0^n ihם}s7_?7qs{BfQ,YQ'cZ,NrS/D< ҎSI?yLD'ډbyY;ڗ:o̗gO.Z)[* j]wȗ;_s~#GK՟|ۏ1Z}Xəy]r%K-x=DiLʷ;ps<yQ7Y_}s? gIa fTu^$U?8&gsU-2d܀i9}Q.鱮,V/_@wKsJ_iDd]Ӿ[]KYo6S+xl׿R5ZkR8M{E9(Q܏^JKoZ#=we%J?zn:. G%9ed7\oSiVe}nխռzU\EYfIkV2dvrj 6TkwQnaiXeihNjIm!2GOu.y_%o0hi+{4J^+N*XU;v-:kMZSݷ4 G>o|5x-W{Sgߎv+&į~Sg8(~e)#r~6#̣8W4>J'5;1^p/&{fahu:g>x"OD4ub=O,\-]j_Rځ k2.tkٚ(R;ALĹXQ}ATdݎSēe,l"qY~U;Dk^=^NdK hͻ9ؓQV-Ph?oV_O.hpRsƃD SC>M|oӏ]|D)bsLa3kֲ߇7P~|]/|+q>˥aV.9A":?iqR|.{zwy/zyz~.}A.u AF]:K\{y!EW:pw'xʺղ7zOΙS }˺I{ ؊s>R(0u;>0Q"#vv<\DQ1DŽ8b; }|}>Ž}s|,ɑ%mWtplM3ErKMD\Cq;ê\G>>(ϧWͫyLVڈg@,)WLӃ?:KrY}~baPd[Pjc_採lDdYSjB<[^vs,w[#K{i_%egs0%nǼegZSNcߛx~Z~#1^y>D)9R~ʑ8T^knzSqGsϢ/rV?SVOǐJpofcYoguM>}Zm7.U%#9`UWX5#bX!gz=׻m(#7L2ηW P$T$a(nR#(S*𣈟E7"5|"vr"^wq|w…wvw4n IGz嫂sγaZN68Uǜ+N|{;J(Q4?ow&s|u1sd GSOxR{ Iu<8;fޗO~7|wr(#Nӷ]ΩX1ޙEޫgݱӑH4jt]?X~2H~j_GÜ!ϊ[TCbu<ÿ\%A~A#Z2Պa8<~ Ee,ybnȵi]V,8CSډ/,q'Gy.x2 iv9N4T{/8_N֬\'e\*}FC05lhtZ8:n5{G>_7'8{هT{oWq:{|!?|ϵ5o~k_z4y }eTu}9D(߇nI8OPgmyʜXnfBIǬ&;LwUxN'os֢s˶?'>׳%4h"2JbWoI}_޹Hz탺b1}7DԨOj8g}8xwZ2CCZd6lqG*;P}2qYRF+Cv=j-'Puoj嬻'j?N>"$f\c# ٺ(z-l"em!~ [V3jGsZz5 _$Z|*Vmb^vZ$پ@߬%t"Q`2L >~CKkֺy?qIG>mb>OO`*~>6S{wڴ7 0Zb&+1^ ?|sRuO aHKM8Gc;@%_@g[;+VX35Io;ϻQqd3iIKO>"s&z?Uw-Jj_$o '9lkE;R#\}ge=1Uվl~|J~U3{nhJkP?~^{~zܴs@/@3㉡#}F~_ qԷ6KG>__a?53WڙbkY|>#gY07G9Y=S.@'Bb\}r< vB}O?MwF?8%~Q2eNf^ɮ(-]ʉӮoBSNG@%.37߫or^={|DSރ~]~4) .W&n#4-+~|>ܾ qЀ^[, {K{iޥwhCs蹁/?&5Uq l_+;m{=εݪ͚{Y K}vtMJ(QdiX4{oZ'㼝qe,f4'z@݊ޔ?^Y\4qznG.GzԴE%Cߒ3{pgשX`m|׳Q!ԌųA:wy߹~㑞C ,yZ`n 3WcZPig?)g(kYC0ho+׃_S '=ovZ3R<׾g&d1wm ]x9|_khdZqG%Iji#{}|\J]&/1;LO#?߽mFdZ S}ҒK*OGǓ.'c0yC8ӃrcYo_R'8/htSL셎7dM#e;fuټjP_/d˗ Wi_|]z٬LEqjPǕDjK?hS 3u/#qWe!_erIBUl5://Lolov*xf몝M72?vT~eکOTxq+GqxJ҇=UuC;T@+2ߑe\)l_O9  ORnUx=G#0oOOޞQߝ?KL*ŤZõfagf[F$ʍe^s. krd;w7zҺnӾ zdxͱ/ԗ/wrumQl_n 7}{vqǹoSu"+~1nxU_;[K~TUl0Js.&eCOvTEr<~}ߎU֨jmW/Ë~5s|; ?~ǟI77;L}L{꽫l2IycFn%7XF$8I5ɬw?~??kc3=tͦ\+ꌆ՟ƣV:" xHPvj?R9;z~0OMm g|o>~?lZYi2/`K.]{L:S_or7ޒȢT?? yݾށ7s>6j9]i~?X$\2—3~fo]̿#wJ~^[&GWYɿ|9F)~?TuڣKT^;m;ŷe?d<}>ˈLk?.-7m5v |`ohu<?~UQ"OVպ@GmaqfKuX;$u91{UM3vasFd4Nb;YZ8[{|*|-?~?&Pp#t8`X]Jm\#Z/ԝjH87:VyIN?-l-S m͒\~?`ܽk\+'һtes` g}%l FC7?]UK}M_;B.(q~?=gd:eڥj?D'7k?F;8,Wi^;xޚ@?~{//`p#5fwa:_.O5YFQx{9?~?FA"ۏڡWw&WsKg0y>iHǞP;\DžHчLt1efA!z/TODDԟ h?/YCI݂?~_Kۡ}0g<5Ǧe;3OvEƧEҔũ.#&~!fNs{/}wMQlw;~?^P^38/*gVK,ROUӷ4n?_rtbYԛMqw S<7/^Ҽx򴜅?~~?lbo<~!`hgBz/awm"5Q3ۿ44HŮgVyZRrreDNjyF|Fjh9` yDs|~?#sѾ@鹑ny,geD]}/9NL>o֕~5E5YT/ 9Zy3Zh&ޚ*|)Y?~?_qMm3j_PwJwPꗚR/_ Ԕ##GqR%9r*ϴ_Uh~?CgDa/v׽wNk4N_?~?g?? )i4{-?i##T:(.@? iQ.mԃ?~L5oek??{!ODŕYOrR9Z1=/*_=4~?_l?i:t @z8S?EdLe{/LP7Jb?~htοX3hͿˆoʽL~?mz|Z_$?~gp=l_ hnTb;`K@\;x^+*_Oc1?Jb_U#/~?o~_8ij$d{gﵓqv#jȟ͌=r5KӲTƯW#9j~??~k_OZnO?.`9aZp4ӊӘEڣ8 2_bE]p<?~ev]H!=#Oޔ{C/o~j6:m*ۿ/h5(qYOOWU_헻[zS8?ޘ9t>dv~?G[ї|*rgo#ߔ/U~wn8p<. X$4NfEZd+1?YZ?~?7Y0dw|&uWLfVIѿ.fɮui}~?}o]3 g>٥8Սo(yb_ p)g> |WţXJZ*_Ηsq^m}}w?~7qT?&թ }%o6[_&N}xTKCTOG;yp\?ko0JgaY%$qXkJG~6np?~7 S=|Jрb[2S7^t-:I}ow8{h(d݂X)-A}ʗq~?<*.f\p0z*9N.?O|3T _ T?{z/dMT_͂oA=\_?~Gw.f'C.MW5JדZc\n?7zOu``y[ڤ&jww7{KS`hE?~?Uf q sM0*]j޾F))A oIX 4z"75158N 1$:W_R-Si&F~?~ ɟs @u{w=VxusoOIQ?;K}kf3T"5/r׊y_,5NbD_ r5\?~`ri7k&Dt$f{wFC`hL'B_X@w2eYJS\>(&_j^5T4Z2x~?~$).]S@b7vhS ٮ>{+@?RGH2SYŬ bA6_׎Pz?~{u6߬}z^7?]-/']X'๞Z;%_A tM̷5ZٸX^~?~_1Xiɰ;Cޛf-{zwδ_۷7{M0/pO1B*rvM}0W~?'yt ;y [^@/B9n5tbll{g"oW?~/ܚ\_v53)l.Vڹf{EqH_X[~?~'vIo;W_Nߊ ravRx`n4(?5bcGfD6Sߩ~MĹ|O뛯_??~?_-krsJW? o*#SU&n)3VaSP26ӀkZʫrԽ:>/?~o3dk3F j_Oh `D_gE\F?W'Ho ~?~_ |݉_.@ Hvz>F鍆&^tZI F4˷W?~Gßˡ7tvowZx/}A80!BOy.YƓr?qԳRA~??]:`ϯo4{_< uGÞ79?/47& iaF.Z$jvF;\>_ ?~?Z~vz}X-PQߝ xRGhhc7G!_ ?~?N~SŽ[73C>-I[AQ+|-UfWe?~??rkixAZ눅t2*_ }Whebf?7ZCe?~?? ´'/P ?9^0 D?JkD-gQiRidA8OM5 5̶~?~6ŵ=7O_jFJ%RF\$,jXkr>&Ζ<)!uSZD/f~?cyߢ?[x||?,FqY4rV1 e/a3r@?~M<_EU;?y+COF<|GIiRdiy~>z)У`/kSZez1!~?@5ܮإ3]ghh+h(Nܑ;@)WPqrT`F?~T/:]CV):C?O,Cd}J ʿT>\~<?~s]U[_ROIľr!sZ#ʤJfh|P yZ!5WUZ,*~?~?I-KYJ~R#dsFC/PDhXkCQIMz-fHU?~GIH,-)N zV;,MtSLOl-9bsD\^~?GL^~N-yJ/d:Áë_G>Em_*-JT4fzv Wa~? u?S5B< _NrgqydHތ8S,%qOu_j ,I~?l`<-L;jQ_\ VZo5BFW}F>z`WFV~h|S9.hX?~1s;ŵ=/B?7?q7A >JGgW8~?$SlڧFq?Սg/oW+t{|ױV/ =xUf1 eKwSR{7FEg?~? kߞ/߾/hh?CԍWK}J*XuOiɞ?~?.AKsY V~v5EyNT/˲uզ}|*_BqzPVo>S9cS~?Csؾחߝa`?uN=g?\VӉqJ¡?ҵ|^eLzx,8խ,GI|;Nϵ4ZU!?~??Zf@q;򝩜/Ќz:ё/FroMj5E/SV)UqH~?faY"nV$Qf#zy(,.M4(Q<??)Jnhu!MS_;xĜʬuW%~?<>v/;F}/#v7h",j|MzYj,O=/t~`SW=?~!2eesm"ۧh?]O );H2GO>חKSWkFD?~GCKoxZ4[wg=W/7(MQ/kWֈ3rRG-j_,Ù݂_?~?_)?\R$y~Ӊq?FYYd뗸zY(-Sώ:GlῺJ?~qsݾy]3VT:7~OY/ p]FbuM&ъ)UϫG3P_)?qj;JN~?~qYv;vl7g:q&CB_;*Ĭ5A@ڤD\i$~-?~?Y0Ox_VPy/x>Yv=_|/ PG92MTnJz~H?~Sgŵԟ7]?D)Uh3CtD75[kTKF-Oη}SD?~?&\Oq:_?^7w'Ͽ P;FZ?Z!FC, S4?>y'_kT_?~?);O7l=?3z#5jx vRz~ ߵtDv,M M;ix㢖iC5یJ~?CW/0Oo]}8ӉIT(t]Ox濯Z#;E*4KIXe xFKhr_oj?~P0`~;5Z'IWw|G?+7}>,h@IkL{˷wUERήo>oj?~BM?2eQNz㫄57F7j.WB벸?~}E?+v[ߓj^^@'5x& \wBY$Mgi2xJvM=Zᝥ?~3iݾYPU!p=_3:HHy~ vW?~܎~k_o#]lfvJ^/?ZoJgrO#bS~EU?~x$^uyUSv=;T}MMW~?史U{~I!Ij4[$sxSD3ni(^?~?_\SDm)t"5BJ;d44Pɘr|y_ؚ"Y8@jL^ٯyy43~?WY0O`>y@ҵF}}u_@S惼# ESVΟ%?SgrR~?~ X>kz_ƓZij"4pYY$H) T$5N|@”GEVCWN[~?~V *鉎oP>{S5i-w|9 cUq_}?~?vzgs:d4BX/sq7w(_544P46 ixE󌲴zkӸ_/ל3 ?~Go`;|{yxR5T, 6Iʟe㪛u D\^Fe+?~رج P>y)ThX,iʳqH4GREU?~.@"P疮z S?g2鏍OZ׳0qΗס~R#)g|4n* ~?~?omͿq;򝩜O6E$YS| C!:GJQUYxS #y(EqTG_~?c句W?3?pi=s*/ZUմbJ4lPsn7wwz0qS퇝Nw}{ ~?~2߹Q_y9Ǫ~Ҹ7VcZRSia2 sηKN?~?,6%' X!s\'fs\N,*xMT+?~֌ϫjj7O ~]Ïq[qYC/zˢ@hKE8;'gV `<?~;S ?7'Ck4yg]*f˔*-U?~hnYSE|o aPF_{S|,ڿTܘޤj49Z[^4BZEE=˺z_ .*?~3{{ d=şNFHjO?Lz 0Q#S;# |_1Q޿Thf>x`Q{ȗ#&)Zk?~vzP`>9(jBc=; .a?Z9+xu (Bd8YI_oF^ERmήo>v"?~> zNRh:hpYX#pR|46ɬP摋5[(juS!/CZ?~aC9oڷW7n{1/wM9b_< fN/'A Vu|_Qjk?~k x濨K=|= Tj 5E^]Ld\ۣO)kii|?UO?~?ܚl;bϲЧ6vv_(O]/j̝3?Y)OK悯kҊG ~?~δ/.w.=77eI ?TǼ^c%k ijjtMfZ`Q{Wt~?~NI~iY_ NBo6zS|G`fvg>,Xo|M] wjx^^`F_~?/#a7湥d?5O/7`퐓zJbeJCgzZ&nMk?~?o痮`g:[oZݩ7z?/TCb_Tq\:k3e,| &~:?8)7#?~bY0W?3/W|?<q,#OK{!# ~D,~)7.GI1/L|dtgZ ?~?~LۏeϼJ~&?=O% l|j^/[eEIuxSE Vsվwono?T89z{6~?#俽}ʢ/o}/\}X;4>K.*>ɸ1:M/rv>cIdI;(b?~?̯eڷیV_R?;)M9߳Be]}=o>Jhrot R(r}]\y ~?~?̮5=?ũO5Bc+sG /R"o$JeOgLTLor(;~?__JX*gfp͉mosRe{JTh WOZ6˝u<?~yGSg:q&[#D=|g5JS4 Ϳ\8jӐ$krw?~7Y07k|T#40:rߌ&!ڛGSG?Z:@\~D3CaZx}?~??5_\ |r24J5Ouw$ȝNvXyzw i f)[ ȷGa&_ ?~?6\YjkΏ&?~sv ?(V=."&.fZJ͒x<҉WίZ/:AΗ?~#^ [sKwzNO=|]׬Nt]m ȂYgKOe,_d=[׆??~??S8P٥~Ty=.*Ww=鿺6nW.?~ϭ{_:KcvQ՛MJڤi޿tm]ݍ ~?~O;KsngvՂBE8] Zz.T׃e(VI=/,Q`6~?}GU/+N߶f}?/?RyjPd?6x_K*)޺jӀݗ[z#׷T|{Cuz-?诙8d9?~er(N?ϫjl5;]'_*t|4$)ԕ %U9ȗc+r} ~?~,EL})NꮟzOFB54)sKYD$\myc:K?~uVSIOwJ!)#[1΢4`=kx4ۿTE_8Vl;?~Bv$^opFOheo4E/" ;ZkqO/M* m9M?~˿\? ӂkky>uź/}/7']@4EGjum;?~P~!7wܬ&iy(?~_dϽnZ?ϽwfW @9B3x{n?/BehF.Iw.i$I>Oֶe/5s,|hwZQW`^c Up"3Kݦ`v^6'2"HC]ϳ zf:%Y$h!:_sڧ8IZ4M\DMi$xzIߌ?~u|&Q $I~ ({o?/>x^qow&_./i/8%s[WoM߯.5n~Cvpss`Ws{~6א^~?~̿aXOq\Y5?wǩܠn?+|7YgӕsU?~TeK+]v 7ؓWꅔ*tDT,7ߩg /SnyleU9:}?~_&#|6͔F(9<tFq`k"郚7UI\G_;9?~)gEL6+}J.3m|~Hvʚ/ gԽ?Q(;"3b?~~:Ѯ+ͻcQ64B=#V @tʢjS-Ow:_~+?~N|^y`Yɣ-ga_#!ug()I_S]4K+R/j^@/e-F@i"z?~்?w]>7}ۧ2|>ɟȧ*iHpuiVie7KC/q~?~mhk )5P,?luuvyl{Fo(MLkd像~I,o4nޡq:D>REE\~?v ;ݱ-x?鳕ڜ_vwo6tJDzUj_:y~?=kW/!7?gWq;_V%BCDs]TJ<*4k+V?~?V]`Ww*}P3OK.lhs3^g&m>5~ y~Y?~T#-lR14B)Χw=(_SA5g_ZW/O2VmW;4Z?~U"|o]vKO#gHןA,**Cj?7"|p^9\?~'¯`_lεb۶+羧N)d#x-K{|Pyݒ>^_?~iӶ_Ӯ{٦}^GGnBe/G+ %~T\ e]J3]Ze >/jX\%_V?~'ÿG]WS~!/S}~:m|:vT|[Ytۢ[Yl*?__忺OS$\7Ej?~?m]Twƶߒ'ߟ^esGxgj\tTQѬ*~KymWCJW~?O6+>cO+YcvRnq-W4uWe}f?~N~s2]2mΜl{A%@/9?/[mqIMR>LTԒKU_M6i{?~uQ*q=ߒX5[TggMџPD}st'[^{J>Ipi֜S$`Y~?_'~w/B&cgMCBOuQ[>'x,މ6SR~)U[Ţ_}7G ?~௓_)3]' &,,}2 Q`{)JYv+K2*j4ܣq:DREJ}A]<?~+vw [g5BT vhUYM$m Uqz|g춵_aUk?~?>j}* JOƞT%N総o:uP>Lg*n;U+eEy揺+?~E3u(zl6پhO9sرq9q?H&Q<ÄGНKoꤦ?~+)Nu+X(]I4T>QinZJVrJ22c-_DJY?~?_ʧQe<Ízve[{η(#BݼE\~%NG1 {w=%?nq0?7;?~}G/&Uãm93_羕)+,7|LM|PU|>WƏ IW~?S.#4B 0mUWGgC"ko:Y?Jʧ4_z" |e?~O8؞.vJ޾Hv.)(E:sx e¤TƩ:K9zֿ ޤ?~dvqoopWUx}c;/bѶ s(ͽOңR&u~?~G7d뱩zTK]J·R~iZg_5]˂j#4QudJ&~?Rqq}{ҝϡ϶c{Y0OF]MS$q,?}R?quU?~ wl×7>/UC| `ioQĈIMAuJ ie%#M~?~?k ?yc(iG^OHߵFU"]4KQ:(i(9_i??~?O?_[}f͕x.녩˒! 4E W~>iA㛘݇#0?~?Mdbړw&sy;>Iqp?|:vNi;K|?/?~?-~}Fע%S/4SW_7Ye\IJ [%뗸15Naĺ*y~?Mu_ϋ͹?lKlG4x)~YVzhПX**y:T>3һ?~?4ßUV{_K;o>zQM!C"gh8/Jqg:jiyUZ&lf$] sU?~g:y-eS+C?J{[uo߾xn6TQ~uYTiWw?~x;E]f?|?~(w2+&3SSp)sz|wWı:N8MDW!dQt`yۿ;}N?~W}Cڇ ߼ 0_ß5B f΢*G*E&-7}N/Js?~?]v\[?? Hö#T/R+ͿT)5}YŏPG=V~,5ZA,X?~'&AX XUS/le/xSl yjtOW?~OěgY~g[_ɿ<Y?-"7i~M>qVwu?~o;@>7 5w{M_'|h67nK|, :(_ʕNx>tY_u?~j] @ _V{j.?cd[~qI?}C UL8E ~?~J =NJXtiѲiʶ];P_t*uZ/-w;JU?~F_gXeyzl])vޫV_#}}-QKոRՊP>wL?~jʹ^Oq_wdeQ@YYڤkĵjQ_?~?ů,}}O={b(3v=_e nw[g5rdw<qؿ~?(2#/+yy$/,GRG$4E*)e/(˪eA 镮@I%Nz|9MN _ܿ9~?l(4/yNpg]g:S:/M*h%ϯoQuݼEؽ CvpssD^?hnnA?~&fwo]l[R/OwtQ;֕j8GƩ?VT%<?~ljJޥ+O{BG7QYӜCR\鯂 ~?7 HYMuϟkJgҵCE/H4٤eM*;$qET\sUm ?~௓?ޤ;֧y$z\'?<{'CmE`\qw#M;xk(* ,~BQТgЊ?G z*n{=~?zOi)@"^JcǢ v5wx#,IOY}Jê8ͅi J?~=SYiB@P`{ỏ0.\G4sw#1E(ZA^!B5TIYoد_?~ߵbϛvu>p0mU)Ր65Li6sOo v^]qR w:lv o}O|?~1#uwj}u5L? \|?5?tYUW~?ן2/O |_Ov\yZG'o;B׿TnL/+ްO” ?~?%Rb=7wW!{ӫMk\!qfsuG@XT(뤤Y2ԙVңUۿdq?~HyϒAYS3g:k4ٚHyn< lNwjȗް_ٿ?~?:#@h+K*;mH{G6E*iXzUv?~?=j,}`%*y/]WP;s, + ljqvXdxc~?67#ߙ !'סM>k (o=G-hx8EQ|-g7Ty5?~tUt/iWjH],eUYZK5tPRDULV|yU!d5X?~'O8J؜kOJ(SM:,RHإW즳WqeV_!}?~Irq8l/w>}p~_i]l|D%sI˴Kt|b?~?w,(ϛ֫fxLr:U2Bֈ=K6!0YZ%8яxۿ'~?~Wʧo8;߻g_.B) }*әfk45KCGί_?~?O `ߞoW>c{{3w'΢7h ?_5\EKp~? Ov{ʴC[Q[M\/MEܥ:t?h:PA ~?~_/`:z.PhgǎU\' m8ʟ8j.@:(-ޥ'f֗ŵU槚Q 7Q<?~FA"׏~wƶPDXMTq,J2&8MgZ&bI T՟Osg UN0?~Of|M{(2.>궯:ߚ[<^ũ@sbVhvZ`xG/1cx?5? y?~?#2GCīni#MAO-7 XSǝ&En/^Ud.R]~?~?uK}~ZQlvH;̷e~ДI頸)h|š_?~5??9++bs oeR?2nTdf_bdZ&kv|#up++~?osrسM]_$Qaqg>GK칿bUfZJ˴Kt|b ?~I?˧.+)W;#< 3~th#A*-ʨnĻ(*~?|M.[{&Ľr|IRIJRM;%%W[c?~zMbg?:O)k_<@>_}45.S8Y믶O1~?wt2uFh4BTݣeә3t)L=mX8?TUh$1~?J:?/ze}߼ T:mk:zA'F@_sK._Coዙ%1fc?~'87ͻcTW v/|V]2wE,UC+?U3Fj ?~்_XGtMޱ+n]|^b/F}aFY.W:[b0H|Mwkz*V?'~?~֧ރ`DOc{p6TP[߯.il7)q9/Ŀf5Ӝ ߿~p;E/C *.rOK?~?OC>ږ%O<<ج(Xk.3q,;ӜJo_(N#hdOm?~?s!G;Fsr|G#V?ɕE&։_JYtv?~?; 9;Cwv"E_^Wj>֥8߶ A<?~KsVs?ϣ!*l{/tmՋ>"LA"~wJ 7,Vŵj_!% +~?_'|'g+G3}W̛OqKG=R_?~?,z_8w-*hŁPSw6aϳ$_ZK5W)nP5=^_-?~'O @ PF#|iyn;^8Z]cQ~)j(u73Kez|S7)WO_)~?]*4=/%Nۧ|}Jeovp=s'/:&巡Kt28ՙe5?~DKw .| G۲>Uuuvy '8ϷQ_P]?~`Ӧ_OqZ?T<#BƾsubCUL˴J-VђaM ~?~_+wx?Wc?~e*STb /kGA~?~R]zd6c3q:{*Hv`JkrѵI4K%]SFk~?7ͻt5Bnw,O?#Fq=5RTň g>"-0?W+W?~{ͻi7nT|IV7ԙ*+U^ ?~்y-rՐyx?\rҫFnIאE|)CEm*?~ێZ;P>;Ϭ5ʽIb\Ui:N҈* ? x^AI&Q~?~, (+?ڷe޺|ko]v5;eo7EUq[߻lݛ!soD4lyO^揇?~?sMcǢužB5\5$F&љ,5/@EI:%V+ EM\G~˚5W_5? ~?~o|Vx+ph7nD_OT 55,j%M^A+5HW )Js?~xf/f~S`z@[z/G,_JS4~ ]o*US*v?~#md5LCw&syd\#T:Wcc?i*z}Pk_?~?O5]kQ @}c)ߞV42Qst~z|"dc~?ckT\{ Pz~[^~/'g67((_;Z&v:-k? DEckWV~?~C؛nGB-OR/|~3#J5&SWi8EMT(e~?~2| ]%Uu%4GgT:Ww5FC|ֈ T`92TkĻ3iW?~#Л)N{9w4odQz4KvG@<NGWK?~I{ 7 z._[|@f:eusYUT2xJՒJ ~?~ AD%=,/iۏOIo?LO?S=D?眺~?tEL6+N^s7?24B=5z|[Yt?/T<S*W\aq?~_oێ|V۹RHBbyAYUn}P{쏺2LrS}Y1T_~?~?jdzuŸj;lOcYe1=ew&% 4|/k|Ϻ?P?~?OOM~ow;?5Bj7.>/jE,"_PpqZ!ZAui|(R]+f7cz 9Ǐo.y~?ɿǎEevKAsnH 2[ںynwZ^w&{5痚QuN ?~GyoP,R?muPu@ՄL"ıq$r1i*M9#_MF>G?~99\]`[zK_.\ۑҠĖ>?Jgz/jqf)zul~Ie*j~OS*i_F ?~?%Vhd.5Ͽr |+P#xgTPd%Y>ZhW/aٗU_ ~?#;p/:iYO3yJ)hf,W,_tkk(M5.cŕoj(ӨW4 ~?~]9מRHy_gޡ&2nv (^G)%]-?~ ?_.h8hShlN|&Y_șΨ05K4FJ+U&!5WX4 ?~?5~ZV:rQ/\o?BSd]y_q>UT\2Ѩ.#uU~?~$"^Oq+:='sߚybO=-EB/ )&,Q5kMTG~nBOi&~?_J&_Y?ڥ2t47)vLeQ+\hIjR*_C Y&WaЏ?~_'Oe!3{:{5EHJ4ʂ^]&[}TAqO|5_u*~?lEL6+N^Uw-]_K{(Fݓ>_DvEgĚ"ۡO=Niz_C/7₆ ~?~c}^߼ 0?WWgPޡ,R}P#YԘ>_o3gMy~?~j}ZĞVpKwRJ "AP7|J_ HB\`jjWJE?~(a1?0QaW_ۧv_vH5GvE-WTl?}_:;Y=j^O*^*L[?~?squ; * E%ҕ>rK/wG,/WHu;+iz|No4dfJ_M6)~?:>rv7S `S-0 kF_ WHS]C4[RJTͳչ//E?~',H43Ut~6)@wW${F rƮChWyjG5L5cWP?~g=^Oqw)t:k{vOYK~N3]#ĕ{B?q_LxZ#_.RM*4Kۛ%-Sć߯R~?v `]o*T)/HO8-~ %*MTL+uJM?~O>7ͻcQ]7៶t:E/-i-OC뾩u"O?~?)R: ?٤5?~?I/Gb~g P^;(vBDe~JQ ~UTSџPD?~?:/`KcǢϲV)'|>{N'HU|F/UZ& xZC~* U1?~WOԚ&8Vx&g"4ƈVKsr|SIEn9QKZ) ?~??AXj=Xl @Eo_il7ij54߯.9.#f[׫˻puw?Cz,~?9}lGZ>~?̦rq;<.>Ok9c9Nlv]?6|# Wo3GDηqZ Ygq[;WM)~<_EQ~?S'pZ#W]yh;!VW'tЫ_')W+?~T;++B=[_+TCn/>E*O=CdžFK?~?6?{ǻפ&S/eo>vh` ?F㝊~?ig~|9\BYO4U?~HyU_gXۥ~^U+>g>ϵC](x 7wR$Hb=&?_J՛-~?\Rw>gJP˟zkQW  S?>-y֓k?~?~SwMBWƮ]G77FYಲ(x "IZ[Z:j,AA%?~wX&Q_9}ęt5 kSq@w7hk8%!)STYJZ W5--u.3jRvvh)%z":u'(534KQWT[UmIuVo~~?_ǗFwƶwg2uD3k*ЬJo=뚥uE 7U馘6Jt \?~uWs|֫JQWo:;Xw{;ZC0R[R, HÂi>ZC+ԋQ5U?~^@_?oFrǞ ͿiJk4?W=/M:+}YT ~?~ɿ@qwuO<>l])_$@6Z#* |辦1\fu击[4x.?~}?v,ZSWڡ.7Q gC6xVU*]5U?~X?%O[|h[Y D٨4Klx^Y,5KgcxVM5GYIjm<?~crGcm߀!a~?~_%1mK(}5s)W?4|g2eeټlﭫvuő}fEqΤVͿ|k]]1zs>/{?nAQp0݁?~uWZw'b ]_8c.}+_SWl4RYtjrU}@rי/hyE?~I;٘dz6i_w)F~8NWjA1^s~y-GiHsW~?W๩ܽ>SϞg%?I?&wT2僚lҸMB_ٯ_?~?O?H]gX֫V)O_zO[سe`xJQWާ%RuY5)? 79__S~?4MsMg.E;Q>W4}M/՜W?~=_*?U k;wiS,3u:Y9\㘚:󗚆+?~杂$z_;?8Ja =q>g?'y_. 鹨}*j3kZٯUŹ2ZK?~T"X&Z'XhOnwLg?v+:yMEGGC j8Z?~?V'y`l;eM#NRD;gepzP,- fIj)GUQCWI[~?~߈UyoU5 ? ?~׀~RWw}gFHnkx)eܟ7ʴF⎀AMjz~?;ǎEkSg&MQ* fqquJf抓*4 Q ?~?"r[_ֺ/svȵteMVYs]a,6?鋪J_?~?O$.Yv.](?,w>=w4/*#_",#CSTSU?~%uk#ߙv,Wq("BBT4Hg]ss{&я)_q:`~I+? jT'~?c,M_87vǎhwV46ם|T,uUʧRVkA8{Ӌ&90 ?~5+JÑ-~Ǒ#ےqɵZ>Gl]qdĜӨa1 KCYJ/?~?.kFʯ_w>}w c-۞β8k"Ѷ8Xη-g:jViZ;yj:H|s~?\}h5֫vuvy_<#V}(RʟdAY_S/,/sMw4'Aa~?~Y_`r&:5];s-GJY]mbYi0Ŭ{D8=Z?~s*W_h?mݑOlv3}cuP5Q<ޤY4Y,5/dWjMr}Jq r~?~ %Iޠ?~Nq3]#ħbaOgL.@;]k_.٘_*z|Y1(_\[?~Ջ9)/L;ĶiϷY#sGO% yG%Ϳ4S"L~?_U^r\DRm.z|?~?A@'B_7N^<>3.)x߰5"AJ$uC+k2ՔBOCm~?_{WuJ=~HI/xGh^w~I>$AmL+E:^>h޿(m ~?~yOM~_ۧN_?|(M8/iOiLR=דqlR?~(QNAqBMY9fXg>Ov?vE_`u3Zãڤʻfv.n7מ) ??~_7h&cg+_(pWٔy l.)J퓸˜W1j GS,WݿArVf?:%MZU;4\GvWX)#ME??(eA%KV~}Ԛ'osk9˿~Jej5Rg~?7/Vᨨ.%/Ѷ[ôgP/)ƾJD6N2]Iy^Z|#^C~J曽y~ڑ' %K~4lsuFq&ÁW~Ň?~&_y'sr [0w-2thͯƑHnZ3U{4P5(_ͮ_yğ_II#Eeпv<0~7E)`T |k"&XqTs2om!uo^wZ-ZʊvW[ݶs]5F|GovZNݤbOާMJq ~ԌKSx/߻ɟbӐ:y~~mܮ˝.kOJg [η[yu&F癴ם&U8}|j`O,ߕ(OEN7^ζ+(-DZ]|u;[nkn=~7w7пb>~sws?z?~ h_߷N/TY6}5Ey)Ɲ9/H9|&\\'/ɹZ+ _V[&b,zO~QsJ~to F>dLp<Q~?M>A[__3Z'?U֫VQvhZiGkZ#?8Q6"x}{it?Xf.ҨOu(^¹F?kx׀{H6NK~c˼*nG8c["SƬwMh{YWu?r(i "i5?~_ϯ_'gȟw~ s_e;|cH?5ZW )NYypsR&~%ެ7zdսK7'-XDzS!~2uOGl2)0wlΚ"dqCSĕkhBqt4H5>̾I)>٣c4`>ksW/hZ7x?7g\l?]W??`=)Og875̬!gQ-`vi|;S?m=uJw=}8Wco=~u_ExE|j?~{\?ݧێBg'S*s?Uoϫq&UyzVS|+h%BI/i; ߛS/}n?:Rn/Ѳ錶Ϝ /5ҳcL}& Ѣ*_C+{|(ߟd4~?+X__dsՙ[N;Gy)=QT^4||g}**ƻ:~rgE?kL`QB/BVC--|~?M]˛ǎEݣgr>WFI_T??u>cͿCnoɜ=Mim?쭤oA'x>3\+(onaS?ο+ڥW*xC휫v9}sz(r}[s~Mjޕ zݺ?߼cry__y9_P;(Ⱥ^u$u7W_/y~y~޺u_F޲ =ꥴJS4h?9Of.i\IQW~f}+ϟͷ>ӽkY_\_͚myw# ~_qGm}}η~O\Ӥz*񨐿pO#~?w嫻{OoL+J-:{8vlv.H-]qj,5H#]>껴?4#O>35ey~޽N;F;/@_U}pvޯ*|#V N?~Q~~Y#-d|*C|:q|gK|"p><<5?շ Ti$,u-_YӘ?~?̩Or6b"h^u IQL4Y1sʡx?mS_hѱWvdP?Wq(%5P=z*O-?[<?~r^KTwF>v"}JSMVF/boW&9(%?Y۵KMfUJ$sǸ.IܥD K&%Qm/; ȓ$+qpek騿F+ek_g#z4=;/hszy\}?|~_N:q6x.^/G ~/ wpp+@?ɐ#,1zźq|j?~rߧ:N{k``ilMuE@bt[/ۀG ~/Q™?gjN\_=Sv䘏c`?1zu O|J|C΢g7>Jh<>ߠ/9>8rP3\>蟁n9oc:ZyI<_ ~/ை8Vlow *K|xoPe_y?25qΕ%9 rGŻCwñ Ͽ^~ݣ*ϫ^Fc>v|ϳ{;Zn'8 Ѝx_ ~ >y6'Go~}_{gAIwWރ!PJ_o{-ǭ&!\3*> ?cvs?\_e_g=ϛ3 2(_`=?Rr{FbR~Wyj<_ ~/G{$fq?G{8Ol'wr]/']/,o^NݦgW1l#\,#z/6+=Z5~e7~]VȮW NUQϫO__@W8p8sh<_Z}zck<5/_c_kI'=<`ǕByj(3 uCNxCB 1 *ȊޱQF=b¼*&Ep#]+~aogOOdRh[\#v'2//_V3'~e-B]ߒtSS6</_n|yj;pe4 u=~ Ե:h/81Xӟ'cs_#_ ?u '7ꖫI ]X[n8)2l*,:c;-npV^T{`"ZNQc~b44έ'] r}C;ݵ{SNwc /Lʀ-Ep͸K[ӟ og)o7."c1?6iL8q0 W")P@";v\r}z>WH]oDj-í1N`W1Q;@ߟR!E-OFiwzƇ S鴷anj .sC2 f}Dv9`W=۵{i?b`'j?k0[\QعsF=37|x z #y._'P A|]Ӌ3.πG ~/!*v@{zO{U*3Ӊ_-[͠F:˲erSV)CU#8AEtcx-g9@Yt2uo2O'#_ & ܻ'>p=|R@jrȉMpI_ .4 Y1\lC*~r~H5WvdSF:9oэњ0@M)lj X f MȸcZ}Q Ϩc2\U̹樓' qdq<铯_ T)nz[j _ ~/Gw\; }tWήT6mmɎz免B5 FziK5: 9v5)eu20c[@/9eԱFPL;9ҍ ]w gu.'0^"yrg+-:h~B#08zM\Pi=|ݡt.lq/c?qbsZǩp)(iS] 1E?>U.囹?Tr+$w~h|/_og7ǫC]G5!?q]t`qg~LzT/1+C;̼tꨞ*"f*gr)seaJQ?"'nntL N cacx~G4][ΐB Z@[aSy}N: !zJeV8]ʿ.|O;D-ϣ3 o~?üA5?~Uf V?J/D ~/Q`v/ KݼncEW;RܖWV? p;Vo?T'Jc} qrKZ0 bVMnSBı8hr gk.tiR@f~z5B~!'jb{zOQ|>? OE\>zt?1'ܾ)r~BS_ ~/r1cʮt!Oÿ>}T㾶٣>^=;Sk_,o;E?Bo?˃^y5as_t`ײHVϟL>dߠ?qOϾ>?/_W ǙK\j&nÙ8tL_]6K%N{ӣWT.JJ8>h1겑b:#dOiƏkq7 |w9̞#Vs[{>/G ~/T!ydvj? n*rz֞_ )M8?n1){^y/ɳq;[e*)F^c`}msCn<_ ~/oa1m'㓣wGw 9[f&)8:~\Yj9Hqv :]?T@vGCcڹ?:Ka 0tpƞ6o$N/RQ_9yҾ󹎿)>0*anW U}Q?h{<_ ~/_د79X?H;ROT:+7ZG=uۏcwUq.x{õC&o{l<_ú:Uv_gu}I7*uC=u]:ra9_ ~/ǙVŏN1c\zRZ tI?2{׺n*WwFr*<O= 7Sf^>>mGsX|O\Ox]z Lxlx_ ~֎qw4J]殫+uP_yp=~}heƧɳ|;1W*Wn9~x9>>p]Cx "9q OG ~/!Ŭ`?{sP_o~+%@Gz{?? vF|.z;Wdb-zUu]Ə?~<*8D;I O<<~fq239nԿڎ?Pgq|><_ ~/Og?U րϨ{_nU}Uo[5 7j9?k{xZ7Eu=\ܣw>yu{.Mǁ}^aAuػ/n# o?h-g+bo> 8%?F ٿPcx6<_ ~/6 okZ;y{xr6gzZW@㰇PBz<}ͽ竔1N?>k}@JuwlcRoY R^ݗ7H8FTmTݯ_!9:1#z//cpf'gy.'P8~%}cs?<+/_W_T3_ZwT51&zjqp-CvVZgWZSnڝի391չw+,Lp}:wmvw4:27nO;̮ɮ@չ lozn~k|.=_^~;]NP?_ ~/*XL{sۇg8BjX6r)g˹|eYTNDyݨ;!)p;öa 6deWEaW{2SPa±8 ϻl.]y ۱~! >w>j1b|4"9IFl?>'l1n ^7O[?|SQ</_𯃟*0x6Q8ҫYE<$O-wZYpn+uQpW! e>0_Y~o0Pj+Ư~/\XS[t/_%Ӿ?(W<`R# <5~I+eG gqap)Cw7X'zcjL_(_ ~/}p'(G& T@9)|USص6 O~Hnp]15nyȁyCAx^ ;Y^=r-@4 .EOluZePUMػ]1ϑPHA;b@~D_w.pX8oZ(Sw@=5 e0u Czh{t7jᆠP+w]5~A#ןsSހb1N/G ~/|-eWC9<>V+ʲw?*7s~D>s|U?dGSZCw*RmO F+*S ŦT 0g1 X.[I2x1 ,AOuzqŅz}rq#>޹zmRN/_ ~/Ks'8GvJs!?ܰMɮ'fGNIz~n9O^+s`|{ Sߗw5/2D>TjBq{%pMZOa{yOf3\1asYy9ԏdx_ ~:b qOV"{|؛/=wP#ص^0ʝz*=ړ0&ث &Š2AHԶ8 ӟOܗ7ΑϷTsݣqp55gO2Z=Oxޯk ??%^/oc8}<_ ~/ைuS~ȁnN yp?_@l< +~'Mty|g5_f"KIJw0 =??|ޭ,ӳGY _ ~/x NT?t@9<Qs=Vꥯ{GQfU#"p*U0^AsY}d_kp???GLm&_ ~/_) "8ǣY}}z*PjPۭV@ONWEig#0`$4a;>O1XP+z:ët25[yKG_WyAsQ?؏9~/? c5k=|ïfhG] }v9o墧5o7ӟ.7>pN>on;}NAj<#?cZC}l!'ya+C=ܿpB.G3[<̿+T3-x_ ~wrjbyøٚ]bRxZݽ_r]}qj^ֆKwuT\ny^JO@7_{ [8bOA6aWE_o}X7Y8tbo#t9xWF˳_ ~/?*xrS?@msNiRoCYe2}Ԝ1b>lS+{ǯ{_O/aEQww(P7av1v ExN/Φ~/?PnPlQ?û0=V*+ G|_ 'Ga!zE-+U{_&E0}n夆3 3.wg\x_ ~\J^Y=yR0sr PKWsÁw8~;=2}0 Qo?a?k78Zƣ}#3ɯּ?ꈵacn0je ~rU |x_ ~{̵/{?ľT:o? {ud Q>=QSv%W?'l!<7DHi_,3Wea1^xqtr+ 7ˊgϭ>[~Z;f o+w,'UzvϹz'q|{~y #_ n!/EFJwrQQ3s8R%W?v\GY;Жxϑq;fz|<*gW|\x      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvxyz{|}~_ ~__9xs(?ڞ|6b߮PoNZ*rwm7{L^NnY^nOIfqrǧޕ|q_'U??ύܨ hl2%mg#_ >_- N/79B O/^O[rpcqЮ@=V7>c\Nlm}~m's4Ğj?eāq,ޯW|n { $xu&|_?_ ~/~o?[^]"eWa&YB>hSQ?/( Uk;}3}>{=:jq`A(Lg::WyOi'e0_oYo^X:* _hLg~/:NO#{o>q`JPT[>qgx~1TRWonwUs2V {#AcB|~nc^_u_Uʮ|d?bob;:<:9UoWczgi<]~_ߗ?__ ~/|?<3 =k9Қ=(8:QtF@9Dk߫mD}ږӞ~ROڭPWϿkA0}jj.Cnu`A-[8+ \z#zfz?xrc_,Pj~/>Sߚo#tU^OM~h HwKAeE+xEg9sFoss-)q'vF^E/o\=9,%~/Gu}>ܞZlx_ ~_GY~ev~:sȎfۜω5q_ٱv-BtMe3Ck|:pxԽ۟#Πj#9z]6O=N]`/)ڧ}qKaA~/?A fi?碗~ngFyNK]$˲B v%FN>Z~]2EimYE/r5(6ԵbZ\akr|cu3Y~x ;5az|jyJg:_ ~/<>7{3LO緿h~D_s)!='E٧3Np,C]ː]WmQ=Q;,'戻62xBN^}Ӿﶒ~ uSuߗS{4;F:b]}'S_굸߬?<_ ~/vm꽨Ql0L~P/Jb>?FS 1q1?;6krsʿ7Z=W[r*.@k YڄKo7UXM@ ws A+)vs+g}:>뛱 Ӌ)$/_8s@-E?k]мPU>dcy%?_ZyŁw4[?7U= ʊw)"TVϓ,Paݏ03~/5lkh z_77x9ќd M34\Ep'">?/_76>ν9j~K_{I0Z̖_'_KߌStůQLxFϘOtqMy{Wk*x$!2@]]M݉K Fjۏ}~T #ïښs]58>Ok t=1p_A0;Ff Z.6z~NjSv~xP7=_ ~/C9aϵ.q1 y˒O yݪ`񍚊Hsuu^eze6sj'?{,6ªhTwx⠆#r#@h7];HrWkQs%ڮ3Rf@ͽOQH}og7%+ܿJR(?_ ~/8~ߖZHTy.ʾPd6%ލsqJ\}W!z5dhqU3%ʹbb_0 >ϧ.}1ĸSx9ҧ=]oVrk_WrqG?m>O&0OSώu꿐<xYsF_ ~/yL~/ݣet^MGLJzs-9;xF^]\>fVAHFNp~iWC@=G=fA~SNeC۞!ڄ2Oݾ N_7O?Eϙ?Ю~X~V<_ ~/o?`  ܫp~Wv5]?-2 GLUkK gJ']2힝sfmW^=}(J1_L3ׂ"<ðt2g#_ O+6xR'zӾaU%+ٽQ/f;UύCu GρG ~/L{}kP#?l:^.qrv-8yӉkjj**Nr~T]<3O^_[eO=oxn;ս''幣`Bx_ ~x|W-s}P}5QQ{~O,t|VG9FU'{8BJB+׿nGC zy/G_ ~/_(j6r{Diig)%׽q{ُɭ/R  N~vʥc?8lnU}cU5㩻߇۩6n/OB١ ~ܾxN翮_ ~/C; ,jA7?dy|_yn9r_}rHEȍo7?sN~Q5wP;g؛wGcx=6]/_Uq6X۵ WEW^;D;}ul  9nQ}wVvT_Qx uK')p.ǠKyN<_ ~/lK\?>99EOw +ϵ^ HeWqN\w3!Iٓu/ФkUXw~]^A+,?Rx_ ~˻xը{ _ CY\A$6˫u]<{^znLv緽tka9_u_hWHPCץfA{hpE /@׍ߗo?NClQ$v_ ~/iǓ8kwTL~r?۶-3޸U:_ŜooVx꯭]c;t=G4 G~n5|~3.7UȧJA]`Q-FvI8ш0kB]=rPkߘ4x_ ~ |xrd{WVYsݝmy2u:A ?.8r¹|ҏr7o~7?x3#_ &9ů76Ww>\P1ң+>Ez'.f!w ~Yj ͍QL7Nqp/ê pG&]k7/]Zf#wzg]L+_, 3\_>~#}`ώ:Ϊ)]acx_ ~ܮ,QlF9hsk_nT;1 |WoT 0o÷7˓S-Nd޼QgwVMhP9<9Dߎ Bʭ^+Yjx׼@ cm{Tp~*MKTE~/*kc]MHknѺ\wV-w?ϊd`ƖOmV=χ8nj6q7A(QBDŽ|ǡk!;U}ӒNy__׮i-O9\ Ο=#_ ҟm !d }Lt oGupBO@wcN-pe8X@?+zD}Ǥ}qĕ;u:G* 2y&F<~<_ ~/'YC}O긆?tz!orT+IF'wڌYD"ҫtC{f1ݢA j7v_ ^wPZv[Sd,8՘CL^;~F+\ľԧ?7jzG s69//_7_V ČZQ|r_r,>'LiB5(Q}H#ql-䷇4jvY߁C_`5?Ys/bߐ]?yNj^/}xjdKjnϏG ~/及pv_\e)C'\Zn퍥|m ;۠eܗ{Xך n@Eq2x? :/hŠ ;ȻN=^ON}x_ ~c}f`:%' ;yz݁lI?fkmff#ݤ\zR?5^D8z0 hՐÚNrϬfsMtQekh?ryz~>a{<_ ~/?x /_VccfsQcwxtu~z/Q~>&hϯ;Xu UVD8{N5Dl_7S/خb7NىӋ(i~/WTspIz9.CNPSfA)!Gz u,dG ڄMb'X;r^a> G)lq8jJ_:X{Ú~Uzoy}ȹ3%/.Oq_ ~/]Sŧ~7W3P3UgJ,tr擞myFoH-t,wB 7Lދ]=|W2=nG}byIVrW^i_pwleg߬zT{Wm>gw`MgjMqN`gkQ!\nj[>\}~l|/_o?vPW k?VXvzg,tYdGC]ZG=*BRe]T"K =PhWnXWޅW!K؛ 1 YǷCo,2 '1amTM?Ɵr|ҏr' ?~v= ?6_ ~/ ?ePsnLOLͦ^W䯊L{$_0$Jw%],Wc콫OWɯz}l.7̿'ss^UWG %f[Of v_}goض{=nŀw+f߸?fN/-JV3|6<_ ~/=5P?2aGLJzsι͌[_uOI@I@?{ELej*CfNqi{Aٿb﷝MDb48V1u3w5ξُ s0x}]yj  ~͚s#F-qWo_=W;8@?oQrVa[bscF<_ ~/;?/b}BeW=O9( CZ_t3hWWsoQ#8ry_clط_VxTMlc`Z `vv];`Jh;Y]{Tr_I{` ^7,GQ`+g>/_yh|djחwb[NW>A~j':O̓|~>igYaɧ{ |80E]S݁`yc5{`Xk0>x#6/Lo3q(~?_oP.狻;6/G ~/UKG `-g[NtfG*WWwLV| U8@g W㘚ۿ{/[&Hq[@/Z4z]ǝ/  u/a/'_Q7~vqsܘx&<_ ~/# `mh61)fr=/q;Yਂ^'r%ܤK|P>G]r8+O_saZ [cM*wʜӌx_Oz*OBy[Dk1o ¯`^r ?2LǷ_ωG ~/ŏ8?QsEO_?<<8<>;87~s{GxNvLEs&Zh|H (aח}RoVq`ZTUnj7hOѡ.Ͽ^^|8?0o]~sҳ믍.B # ~/)H4>S[Uu@w-Sg;X4͆vx1;26*#;h1o^CC{_"\c+(_yOZ^1e:G] W~ΏɃW?&d-_ ~/C5o=yz@\tV p3KXNw9N_߭q0 [!p-ZJ8K5 ?ZaqIwn~q,q]bOG ~/gf0z|37+VZrP vRuG{rڣA/G8u,'gҁoW]?̿® noX(w]NQWsx;"soUq '?+x;}1ZMWN_ ~/'G?O9]Wϟ:sԤeoaARY|x=1F# k%eAOAO}#2^t}۩ Y# #_ 5௎(oarsVROl_olǕlz~] *T85 z*V_ЏUOT>v<3>:c;<}P?㘦s_ ~/,J4Gl7tꆳ9d?`GzAZ{OU߁v;x]}~z#QZ,98>%Un|; ң:P^)JؾEot|δZU,qB܄wS'Oy~/u| &j{d+}]qk8O~$DߵGՑS'j]oG[pzsW?__ ~/k.K;OQV#2o|rkHnuU{fixE.:ocOKu Z̻p#Y nh5u ~va(5cybQ_H?G?̧>W΍2@`ߘ?(l~R"#_ KtzY/o~==]s9@R??PqڳPMt>8*!Vμ.a{?4p_j,pfAMP麨qLMĐ8W#Pq4V#pv_`!gx?03Ft|/_o?H~ނeW=/sWyqHOkJn_唥L #P =ջZ;lE n#g\CQ|W`v 6AgˍO5(&fkw"*]3l|uɎh{َ3,{]PY :Q{=FJ{B s_eZJKp9_ ~/ ~dj\Oo-ɘΣ쨖 Z;P}2CÐW3Xj+?)w{ 1k#],GFL.hyj3)ցhɠ0ް>&O-з7Q1n ~9c/G ~/^K#[c-z>vѪstC;὿BֽHX[8?oPQ5VyxĮqrOgu)&wzY{T]{Z*>)}(v u}k | (d>= x2$zuu] rfD6O-?~c8x*~&o #H];[\)p㛿hk 0N׎C^ TޅMx|*$[ qM?u?Tqwڧy؏~/`-2pji߼S=VNwRhi5ݲߵWPϿZG=';fMi2_u^bWլ֎:&<_]>OpfgI9 C4U2ۏ:2|EE@k h# gf$h9#RnwUʑ^~@<WI7ky(R nlğuّGXNg#_ ~d:^@٪NVQlK?w%*B*'I<;A&tO`ug)6~k'{6{_򚘅s}Ὓh ypA {1]{kjc6Z=z5Ѣi~3Ҙr;?]s~Ã~Fɟl9Sc܏ Re8I(a!/&/zϏrzU訇v=#\&Է'՝&#c-w,>DRӌkn/_W^1^K_ջOCϏjF{' Kꨳk%H|T~[mѰF}.띣Vossa|6<_ ~/?wOCj~SZߎ ^`f|7Ix댁k'0+#_ 9Ja!cyC*H (+ Od di/ tVޯ2zOø~f<_ ~/ொ_?p?L̬;-pA~8Əx_^ũ6h</ެrf>xr{J-#_ wzYDFJKjg1nw+t՚eNo J ^o^ Df-/TM#_ ~O?w3jx9UCzۯb]Gi1_Sk]98{s07~UqE طwcs5Y{?S!3_ ~/C9O'l:^.ildyw3wz3JN3˸ZK]/fOЮA⮫O~dopC8]<ҟ[lϊG ~/ ?r9~yx$7"w8B~Y5M]E}l V%?ҬPʅ"vo]o -`;Y+^h0?F~UЯP]0&<)/_GW/'o|xwoq :i"Oq'wrp_MڂGe?O}ڏ*/wly}?k 6]?:\~2<_ ~/_ ~IvuD{9{8?<>;0+K_܀^tws*iQ/R1KtTb^{;KyЮN_s~U]W8{[ `Xk>.'c(z}]ݼ?> OGc%QWOx=v2]\\] χG ~/џP_*F/o~FFG{' GZ`rgaCOGCO_Z^.vo]׼0{U >vv?ۋ0|_9 =?<⍻vZRpj~Q>RMumVkdkw}4d|߅ݩv|zu񣝈7׳i;sy?|?*PYӝ 澺,oiU,U\_p;k0wYgn+|ovl.F(rsu9Y({gA vO?|*W;@xB5F#epنukf_ކH2נ;jB#!O$W*}7{ǽo/̝l?cݨoq{G1<陇yZq+㛨JNY\yqʵZ[!' [tS?W2-{TUP;E?"©9x^[7kۃ; W| 8ꯦj~?c|5_? ߅No/~;=-vYx~U̘s~?-!ۯcͯ b:?m$FUOο??pKEbφt߅}b7wk{Ƿ![{^v.2{S5;Bms~x8o<[x\zN>#903jseV_K[?$Z@se U腡2א'{i8_O^#>Ҝռ`mˆL hCiWǿ mw1 ۈ?v{'+לyx>;ېUS *=1;n\Pcy,*GoC~J]F1J˭B?jPU} ()OccϾ;{hNj;=d[0~KÏlWjOXZ YPYյzVw٪<]U uq7_n>/etZ;!O{ߟ_|/۬s?I27ayaq2X['?KRMga`J"r!BA4GE}~'Wu *8pSK?n'yysᏲ5o[?b^#O=] 2vꊴ\1_Weϑ&h&EclȟY]~?7o6Н Mޝ=͐}XQYNFIbv>N_qp^mvԲW<goȸ*aO^Zio|7+}jOCa:2OڜQG~N\n_?|#ۖv aJ-4.O QQH~jw[ KB_gHqKV3+ݿ?忿?6O0rp{O9X칶d?FkuΫQmՉ=tRrkn*}h aF=e҉Wl\׫/!dϳ~s^=G r)cqrkU ?̻> ~x_Is#Cۂ3p*g3v}V]^k{Vox=tz;FV6c,G9r gW#ծ6.C݊8"N? ~uql_'B{ .Qȷ9*koy5ߎ'¿QGݙlXrlF?7of˹znXfrd;vϗ˶7K5u=N*|UW ]ǯ>_*#)O,2ۇޮ^WIM+Yo_77qFO " [|MoV  6/5^Rչ _??Y\}/zpn7.?9Q߱ߟy%~Og޿_~xݛ>_߿{7B7֮˻7Mayhj_ygM$;3Ѭ]Xb_  laS/y=6l9Dwuހf3s&@HR[f5jVc 2|Gcy3; ]߸q#?zYl!tTwL:$wn<wIRv.rC;i68|mw _#ȑ+~vlNCxW߅k?y"%_:Γ7r؛M[qU!MD[[ cck&QOi^{}__3vCkkk+Vg}u:R^[Z1t0f` /1Zn .bӞD}N.30\Tw)^{}Ri$뫭vgw߽ҺUqBXbr~fjp'*H=1Պ2 (IEL}AsTz_mO#%Fgސ}V-fnj,?/ dY^{}W/v6}4*no9ΒɓGGm޿Vigw^^^^[%'>WOFRL.,)L7@.U%@0fi:Lav +nkpx;Y'w$-:,?0ҏuԺ~^^^^>Ͽwuluz%V+T-[)ʚEN8%$iixWiPiJLKo6N:Li1WO/k'6cƘ,q^{}GKu]+++ku Z5lV#Sziws{%]d@C,-Ⱥ?~fz_ i6^]p|^<4X@?6B>σmǘ 6V={}^ߢ,@WFh1BmEK $}ȱ8[Pӧx4=Cz_DjI2\LUybgwykO.Oq%4TaV$ϥvbUzHCLy}b ߑ6gk ^{}=hs}2h}ށGB@$o]$;DW ֖|wkY/G?cT:},QSt2+#y 䌤\k~yD"*$d{bi-`BfiZX1h32 Cq^{}UqaR߅k ylACCH?֑c?FfvbQⷋvv>x*cHdnFw"O}Q ~JOB#:+N>|ŸϿ'!#sv 6a?_k yrk^{}Of ?7S?`+?9`W:VrQbi?~|F9zyѣpc?z["NSV4{>{0^YX *!v//:䔿P}ClH0#Č<o50^{}_T۱7d/B[ԃZL;:Rڿooinۻ#?΢KRNcS->UAG b_{n4^gm``vx_ V&'` .fW܊@"s*_;1=)k=hcp^{}KI8"8 cCw!J>77{,ٹ/}OHQC<|##O .3W6Up> i?X S[XWҊ"DmNvVat9u=҅^{} "|51{=]gNzF9s̙uixHhi[Y|Xs{&k$-~ |A@y?>!;ftW9g^{};bGŕ#Y&YIv ?UKK{v=)Lψu,J${5y߁pIGgjն~ 8=$^{}߼񉱉ɑzjjtb IzOL~J9$9qέw)-u pNA Ty^{}~?Ɩ_M"|JsrMBX?$e&r-Ot-%cN.Lw{m)cK?"Lsm케tԌaQ8;b^^{}#i#J)zvFa~{joRйر\^^^^@)n]/RhZѩIy&5X/^{}PZXZܨflPB#Lu$^}j硪FE>B䁪o&?^{}~8j)eI1쟔Xh@%7]`8R3[-˽2!xJFNNSPt//^{}߇~ctzDYdrw?UZ8.iLҸZ fM/SvR [r/lrqJ"'}$٭wD͚?>O}S^G&ƫj<ÈL]O~ T\e9V2YH|ɎOw+kK,j7ڝ%,oZT.$^;GN5jMOVy{{{{vȫ]Ʌ8߾̰C1Gi\+?&K?'ONlQ0O|O(?#(M"ς>~bL 2r 8^_:)t.䱉Q\G(F`f c b^{}+A-|idR  ,}ꮻ>r,>OMIr 9N>y:#˽|'QˀR?M (. ׎s lr^{b X˅d$Pa#&$\YEG8k>\ivK`v&s{{{{$&?5$=twau:Wpy各eYs~v*ѯQZ^佘ucݪaf'ConO}Sԧ>ݪ4h4oBL?ONTZXasqa 97tuċ^_˽gC_f$Z? dZ N ^{} 7kp)(!wO a`>5^<^W|8/'=p x}vk* ZkdO=A%%$ɟzỏLgTkaKmb+ ٯHS 5S^4i4׆O}ӞiWa svB+Pۃ_"RRy+Jw?B5r=wu"Az6kNx}}~ =C׏׿aWzb7֒&[ Y*[M.ko+_竏Iv7F5*Irg/%- |zc!Ҙtr+cJ,g{R_ 0e1!ٴ\WeUo\#v@y$O>09y,$”J@L=$WENwtjq}򳓈/sco'^r=&$}3^+󎓋ZkmUQ{` jmwoq$l@H1!;(!X<׫O/o*D#㯘2[5T<{/w{ 0{;6'S^ +>&[YFqJG@/$*=%Hb&d91}{MsXKGNP2OЧ ͆ť_Uǁm-<Svq/~BEJi[n羽z<ɭ޾Kڅ^[ M7V|5Owe8G +Ilkj"“O??UEH8LWdyXγRAZKoPKy CC /;3y/Myvwvx{ ״so|\]/qF2<>166=u|b\#c  $4C!X%_CvF> XrY/!쉱I5~_V^"etKDDUu.oxlט=+Va䔯+tEwxɇ{&O(%N[Yk  )D7 H!в=̧j+F}FAZ"w?}ԛ_9=\[!q)'?g8vSUKZyjz2n4%6L`4= KS|$yP1/+gV6>rzS ~oy> s]K9)O®q`bzruQm-MO!P?C?d/oyɅttjFAz_m#n6km~z 3ZT񡮌cbH|?ڑ_vkSr6NN~d)}lh9hy?U7h/c?)Ur"5J;f/)o_.;jP`*n߳G'ƨ7~pqe񉱕Ukdrl1h'F+%=w`3L7 j=/x[ު lOӅq sUe'~fOO_xzO~5ypr/{_/>şe>E'}{ˮxwMef/4k"-(5 eijL>wmhɧi$eagPr&/09ͮ2ИQ˓.xqZ[ ֬a}buAv(y}.OƱ '#M_ƪ[,]%Bn϶IfкHM{RۋTP;d*H$I߷I=Z+uU"#)=\\UN~Un_[Y#\~}| wj][+/gvZmw8}1Yb2hG!/B+c|,,;\? \ ZFXf%1pą(5~*;j{ǻoA?(9:zح?=県qXln=WC/On`((&~EƹK1ρ)yL~zX-y4T,5ˆw"z>\K{ov>̪UhoG|Yˇ߽/n^:-~k"'>nX[^=rݍ߀Ưnƞ=?zM_̚V~O˜;[q//U)o-?^uLoa]_h/|QxD W4y6!UYzʥkyX$Fʳ]'3Uy&*/tWV-a*kͮV-lB="v-۱7W~KO-=A?$_/}?|s\wj~>+ _5wL d̑Ջ9׭6 Li*`%@n>dAcǽ;J#A#6^Xdd6,UGbݭ i)*P9~#\_+WqVB:ۣA^YC/`@&?ZhLO-U\rlcܧVw 3wy@'s+iG-~KOHzϣ牜H_ySʘsS[Q3_\?~ {g>ӝlw3纟{% 9Ih̆Akc=iaeb鼥u||_};Z`FtcVmݥ={K{ߞݳak"7sAxQF8 `Cyaav6R`oĺk`WvbBQ7xTX_M$4P XaGVEY~%]`Ĕ3HB~ Q?QU?as"Eb2Lxkeu}b!, Nw14 _u5~rn& ǘ5Al/3S+1&?Y~NΠ5;_;c|"a?^8A.Ҿ; j@`ss0am_f<^BvHzS,.&/{<ݚlro*hzU§3[^ܲ9EmXֹ|/iЏ ltjB)Ž?r1A_{}p\̹giiЇ?5''HJ?`4-~#c(0Ps7^ ~f338_^xJW vA;s+s|);K^jt|W[sanF>qdy9wGקdgǎ~#=ґ!K$C L]3lda,%fOتl$|yjy||91a) zO /螏=gH'X]݇B4;2ƹ37`%1 Y!>ݽϿ ׿bċFGnћ& ytё_9װb`q*_ NAı ?_2!̈́X ൐u9@N$%Q5 \%+|FI^A7ߤ /Tt|N$Kwp,%E=B.-`x)3tKsJ8mH1XysqIJW^o%&cZb̿W7c~EX}ťPQa_F$w}/}/v|;g!?l.< DAVy"-aV Q#NDdEKݎƴtkq 8(ÌhPClV6*n:ˀZU$FZI~" 0#bX#A}51VZ=}>䢪ϡ/asXwCx<:1 *E`r)icĔ hWG33g8b>Ts h|u|tMq".c拖gcQϙNqV伴k3W쀆]GSkiY&_bϟL5[e_kvl0Xcvq%VbǎG7*f4Y<=ulU>rG~J*Ms\wHVbd>!_d`\X1^. CcP"PL{'p"LUa)`xb\!b 'w=!fK!?G cdH#X,uL!ys]s'95bϧ K`y Pgc%19cL_үu0f^Z]6Գ #y)9 OZ>pz\d,E+< 64y5L,ݬ5jρ1ܭ vȐ^ttΎiocqa3CދG$s$\@ =보߭!6[`,o?@5BdK"j')s6-OIXpbt C}:7I*)߳烻^Yl&s^|n1qd,dg!)Bw&Gf?E gX*=tç~fdڷg-Og'R'Kݿw{>[-RlW?vdU/#t5u" 27'Sa:;_i-]ڳ!Sn2]~9jCy`*I]-|y^< sƥcIRw3 K9cHCbu{?&(|ŎOBOy`y$)?vc##Dj-t? ,dèx ? [F<打5B tW[K>\;O2?n[ky,EJt>?!E|w5e?Cx37m.b6?`gSEG.=_G(c!M51Tʧ'v8~${(i;CU{R;|_G^h8d|)XP &'mt> ?ryGI*B/(}׆iryVj+(Ҟ=gww~ C|% 3_ h0 °!Ɗ5$Ƈw4S*͝~|#JpJǾt;xdsd'J=Ey[Ĥ oӝ==svݻ磏v{Ν5J= dkb>XCpS!ɇWw't ?v?wȢ/[{?nT>؜1+P}ϰCқ+B۟ /_Fmڌ , :vc"A 9:N@HgǘɈ),2ICbi TZq]i6 {Z D4z1b, vX8yFrcya;cL6S38ἀ+T_'Fkt i҆-[$OmYe<9 GP{,p&ԷOce 륏+^ q>`^`wz݈tAa? sxC-*ρrW=.z `IZ⺡9>YJKW?!D`U߯"%0};je) % iwί5Z>Wx5&jdGOoBJ('8J(fN}nHpehm|MϦ!lslHdp)<ɻ۬a6X"7(f҅Q 9u<VcbH)2@0%3X침?Jl\;pAI14Kly;u϶30^ow-W{W:X?n(1&synuf?t䔝al.]/ ;bw*pG+/(/bB);J-FRO`S ҂b 9l?8&/W2 s 2F 2J{h&33/ ~ty{b6+a֓nTf-N8!0\/,1q<[}p.͋Cެ׆,jO.URΨF}7# Zm)O?olGG y>Kx2/=.3 㔹2,+kϔ=(߮mO _e ֌b1f{87y㵨ga6s&/_c<[YInA N?,s!:LTus~{=0.;Wmt0A<+mЧQ4yhɤd sB/.Փ1WzI.*`g*qYwqvSEƳ4s}; ,6Λ/"ׁk6#rШ6%#["fK{Өњ_7UR]UbO7`1/:8f挊[ߚCN#Gy H z@ {ex?`5X{HZPPζ MGNce[jB3?ۢ#?T  ;_1>Jؕ3%__v)$jdȯkɫIį[jUBUZ$Wy{~yEwވ3S{AŮ}(rJK6}a+$vR{Gp\1;]Y xO/$CA;w2KJuiqBRbsِT5v7jccLnecl*gͬVlk+'^䏰gv ![>[{gg7;}3ovMm)q;ż. Zհ_d(X`ʯ'\. -w"Y<<;VϜ n,xbۗ`fXn1>_k O>w:ϹX?ٹ'*^a%BZn/,ӑY=%kqn}5=oeX%+N@ :& Cwa) >`AqaT,В?+O4wa+O_}}o{?} ߁>&R)-_jytWPO4Wy\LV}|+f~&%A}P ﭯi]MELo[Mf7DoYe^M Bu\Ǽ˝vEjQ;絯~^_hK[?フ3d}ZOٜ_WخۋWqt`rXX1zWܪ-`z{Ahm0jGleȖYD?"Vz?Ol E=MN#w,6(Ǹ=Ni{EHHb$4ѿo>\ 7 (W˧JQul]上g}G@aZ&efAٸͮt z~RCSFrg5`CiӟpUr^Zro{e4GlVa-`[l>֢_fٖ<\uƨ־6`_ϜZi''Ǧ'W%Jұɑ ?9=2tFG><:zZ[]"C;)re# \3/yzewٽ/\_\We>}$[' [T>Xy8_`KeWyKSy|ѽ5;Yl?p/yk)ן>1?Z>'M}"?w<'S'&Icjyd,Oz;@y~?كI~<^#Wq׾W\]C&{brjo.}u<ޮdgǃ>VeOM^5:5SOQƦO,8>6'E(G^AF/2m%$^GZ0BD6}(\3D=Xү>Ǫe\NU3,O5 ͕#jrS?#N-/?hW~hI"7a-1[_ N X|SNY<=g/})ػ=Cͩ:d lp>:=EҲD|MOJ)[K=̌ZN+%e'C"dދsSL>R ;`Dk.M^'_Zv^}xS{OѳUN-.Rfyl 4(~nmm-eb{^~~/o_y|ٛr_nk74ZW#Ls.y Q 5"@pgrx{=s!xˁwtjrNvf_7#c9;o(e!B<,Ǽ!Tr |AɃ]_3sVIZ>rE&~exiE>`7cyg䧵iyM/{y9,Yz浍WWrܗAϭӆ4 K fyڎפs(||_I=T),;2})r:9<$[O^пLyY9cfz;+gw؏}ǸHx6qlڨgqC5qzklWɞm߻+Lx:H2KDR#M^ɟl3!M~^py X!1U9͟cSa8/.& iNLO̞==7]33dv_lhS@NU( ZUI1-qvd;_@Y+Sj\sy(3xS]|t%?|*b _H,Y-p<'xb18>x=C渞F@:Ïj'}? 珽e;~j51$u<ٖh;gy*qd`q|TD^v }.yh57=x/?݊B/%ü5se `jJn v4lSd{ZX# L.]-Y{.hϫYP>w|z-=^[%>O^\miLQO#C+Vdpiφ inGyao,|}$Ox > 敍U'}tup~ox;Dx*~)rk=S]n/͕W&p@ Q=Ò$Hciy0P_0lRе`n: \IJOE>&\dXe晄|p>U\@ܲb%YaRGd:0|O_?M|1 wal'n6J?ꍷ z:"Al5!1҇{'fo!;Qo@bs =lca }EVĘv܈>Wd90;#{aXP\b:%Ol: 8m7(/lM/1 \`1<0}<7n4yI`BĆ$(fk#8iGe(Mg'Wz{կ>{R{M.o!kV'X@B29G1<!@K26s!ʿlH1'w,6F儽x)ȉ?>Sӧ3ݹnt |{ KG2?5w:ӒJv4;OZC^`EKjH qsa*,eӦ2 WF9q }i=K3k} /&ױ*A-ZٳS=zD`/y-:b VѾt( D rw,Oyn?^R n?DTHJ5~nrn?5o>N4[_;hos}[X[ԾV&[oz}M3 S΋ax-V/foNogmf.콗MqYclE-S3sȏRz_) LZQk6kdаVٍU)|j{:+S 9! [0ZYl7AlO$*+3׉Uz\\^տsWUP$7BnV]3c,v/TU tYH5(B9PqED8b'b\FqY6#@Q/?{Տ^ے&V*}`=ounN+O};A[l1tfl;9_/w싉fF/(yK( K C I9EJd18g7g^W?ng5W^g*xJ)9Ųc,< BK%O'BfLtk-nx.0<@dX}l=a3>X^7&̙Q.1r߄k" ecŴA!g CZekF],dHTv@ֳd0uiVNrc.{>ng~}e&wbq4`ɍ$J2K(1,^1 EUjTޗ'}El.}I4 Dh wYH9D{_yd~GX&XAb&=G.䟷(<?~ry_Vlixy gr.GE<c\{åO6^y+/f@=wmKb߅6'=l}ey?xy۞{|3ګQ>mؾa`m﫵}q}B<$:~i7[u2/MuLH φf X6'Y|wIDrk{{ԍ~o~Gsћ7ӝw|)wf̩ӭWg0OfH%ʊ/Z ˤ`%&_cju&fLb|5V"ʵKb- C {_ =p(RaQ5ngO00oLS,iyvFƄx9/gyMpq:UЪ86HZc*C W{/Ԛcz`^z[qsx񘅊a-<@YV0YJpjKJUFL얢{U,فL c(` !;,$w]cfPb 9¢vT)y٧~ߋWMk;(#[TW 1;y R=11z=8xzʘ Izs #혽W5X"v*?~_2;b1L>@k~\vb0"}a&ˍ_w߬98}/7/곁w+ߌ~ -&җ}cQz_W{-$y6//ҿV?zE]<|[;Rjg^O\3 y/ H,h]z8Cg_>x>p~uwzuCc x5901t-#YD:HxS&RBTJe>gM=҆>{|˥>ۄ{<ȏU.\"]<_q=h>g%ԟc{@=(TO-V{g[$/;0}S|-gG}&渴x KڿZ~m;0UʽƍmGk_z3{ϼW3F yOX? 0/;58QP%OR91_1J¹# =SS'~wI^lN> 0?N:!mE_b>4Ő?8f39e `(W) aQS0B>Yw7$]RxY8aod'+5Z\YEj =NhSvB uA{ Cޱ/}NVPZYԓ>VgzƈPOMm 3o猊(W] bzUW |j/)֯0A-1,< s#O4 &ʂ&X&7#cSGG8&ɩ1`cD:ybr]S0IwSK|$ #=څ-Ϗ576!'{ bsKl! ânzpa%܁z4O;= ڕY8w/{ XWS׬gkLDBJN{e?^sӤ/Lo*ӞC-}vωwyBm!w1_=cv63@i?qxb$+v+^}8}}x_<.sI¬]и\1Xc =ͫ_$k ={|z 556gX}syJ˾{,pN ΫR A2>\'0F(<`k*H/) kzX}V%Zp9lb>W;p^\_QR'u/,$ %_zs|k־:&M|KWx3([c'q'^۱Uo}-ِh7\u<1ʙ ֎G]p=S+C-'Ѣ_UVLBcؽ RA3~R5v!%72&m/9Mڿ|ߜzFyYnm?90w8k #yG}VQֳRZOsRDQZ}ŞBמQ`ԫ\7IiG}|_j}ZkAp8渤IqOE_}kx.KЅEZYoIW6(Zie-1KX_kei XՍ5*v'IR!c6luEi9 }Pυ{W >/W~"yZ{b嘱^.؉V[SmXh_Ҏڋrt.I铿Bit-9Xك,_2ORxZ%mJ䲽ް}Jۻ{[wˡ{/:v`.үWcG9z9"%)gLJ .}I!]vk/w0R8ٳ]CnbM;tiwCnowM o/fJyP>ݺZZs+]-s<>|bVؼT,}u~>wwzS?=Rfj٤~✸q6YxkcG9@ HT>H2XmNSܣ<+>ORO%㱢o!i׏Բ| %e?YrQe37Dj>ΐʉZA?ژ4SYCHhur}/s}[g$%ދX!L#jrp:/s}Ikƽ:$-[I\5ˀ#uԃS;Q?Ev$}8WLVr`r]Қ- o\ɻX9r}$TM|D] CyϜMߒ"ks|2b2+,glA_,}-$mzn*RYϚ|55g1܃rd>n5R9+ڼ&Q^ebW<2'B}b}59Fz7'C=47(a3=tnS,y j um!,Ǒ?Q8Ӟi`sbC_h}|[ƏF{̘~G4X Jb0~{y'hCg8V!{qJ3.O*_qe xh7쌋U\W$PqŎtxgCrP"/~sE^UK6*]UlEAUɁI>U5+kRkK`)xZ"KW'+g8.0Yٴ*{e3#ץ6gD!^*ܔ٘q=™̈0`8 OݭY1 6g#5;o^-XUioˉ۲&o_HcvՑ;%`#μĭ1vxm[sy Oߙp[N[_v,ڞ3o{ "È)Z8aWaeX_hҥ_z$K-Iw_x^?a,]~eV/^e+T0>RІGWL=V&p2>(]~zՑʕGSppU58իc'qv:xm&GÕGyďV:\v6d*5Yxtvf ~*'9i͙6fcոD!tuJ!X}&XgrgoSٌ̅"u維ל9M[p8M;qi{9vÎ/޼9Ӻ.,8B5NXow^SriG%Ta|`}%M pio%w%M~xň:X~K8N`ɵ}>9RqX%o(L~Ɓr|cՈq^Oat-~Sdg'?Wj>;UU_d OT7bDZπQຯNoϜL-S TWg7̝s 8V_i;6ݹNӖkr^ls.ny|a36sq *]4߃׃?|Fﺚ|3:>2#bzE|zk- 1K#L 6i8x` aaG 6 ҼM{(|?oXE$_Dq&CcTpu>8vx80?Mx`{L)VuctQpMGAd]7q;u;0x(pm]vEd}]uȮWMEqf}tL3vPDnqv;JvY6"n t_'ɱ.{pK^ x 7X:}8#$ ]1P 83wHxFX+E|HDZ"8X ƛ5k633&3AB$mIx󴱦3KcjYXc~O:з'677^5bdˌɖxO$􉄱VMbz,\3:}Ut댩g =c@kȞF;6S93+g^;c`;ٮ5g2 Z3kZgD<iG ; \vnސYvžv`eDٝr:bΙcns8yC̱wF|gr9s?XpWG# ]k:qXQy856}Th` FdϱEnȺù a|0 D ?Yȱ˜9' ciAa`u?.J+8yb}ܱ#yшO"E*#"8#1Nj[.GTI?=S`Xr\X?_/q4?-Ml\zzlXHO?StiE竗p?_ ث5U'1\r* 8>yXׇ ylJh#%phSi+y|̣S=ZtŃo-~t %ߣU _ytz7gi,{z*qxrљJğ]|șgj~T,qVU+{~~B5{_}vŚM_|3o~xhsyng5Aϛj_\wV?IAl?.Fd2K}}Lp(B#\XهzX0ɫL?7V &/p(0>p6a&m-ځSHC[~*@E<ܼ X:G##>>a&Gk䜸6m;');?ak:,OE ]bl:v#:3)ƋC'݉ ~}J?ry|DPDiX{X~5BO҃#Aa`G Yq>w`s ۭmT_خ=hc#x 2;ׁ#ؙSDK5;~eZA;:h?9R|wGP}) \$cE_IA{. 2ȼ2q͈(ڽGrcK]H 6McLiG x`: 8 ;ރ@ƙI Ȕory&4Ÿ.l2.b&uQ`錫#gcE$HXͮ}7&AU9nN}̍Πߍ v,D %qX=;ƠH71 $rHv,B|s+R+6%y ڿ Jt` >n\5;R,E,4^;%'K/V0g1&baEH eYq0sUj_~rK5q+38?^v&I+ #òKu+Օz*|U76__~}s*Q}ӫ 7!X<3^ݔ,Q0/0v$lS|5 0"De{-'\A?ەC)웻bwds;|3՗q8@>2 Lp `qCy_\|}zps(YӃ iDB`>숯JM12|uP3 |/aLJA28vJ~d O#`5qN% |ᬒJ|s;UP^p^80?5Oo.4Λ4xDǙh<>SYSk#EA/O0 K9-s'!qbmxwfXyQ`ՂۺtoRWM{W`v5߂L.0[~ei"&Ģ ?H~i &mڇY hA[u0oHGbjHU{G,Dl6Ȳ="n6Ժe-)g"[w )06;E 芏 hv>}ܠJ@%ھWqK}Ϩ ;XtPę(^8^=cu7.f7ĉHcq {/q]kdXo)giqe$1^>҈+IiSJ __?΄;J$?)?oX5j8SP_VrIڿJ|QWӬ?՚?j~\W+&}zS W;ʞiV\_dK~\Y29s쵘A7 M;l!)WӇa8+q |yL#KbSpR#$"EQU,T>W%To _zs׀#O8Q?C *Ř*K`$zߘ S׀+ᚿ$q/jCD T~s1X8<%J%ʦd_ߒN|Mֶ,m")J`{?vH)Bwv&g'g>ߟskwh+5~8|Y'oayE+u&2 +L}Å/:iȱ0y!G9"'Lٝ7Հo~OTE{9j5j?c^I^ "k@<>WJ=*kㄯ=\ 5/l]ZƪtNi)22j̘3pj󓩫7Hk}L?+ZT`߆o?4?If~&uw>=z{ =(/ګ<ҫۻso7x]o `߈{0ù=-;#7ijnymt0mo}fQjnni'Wˮxi6lJˎ|naEgg.]2Xw5n9,ݢy{/n=hwǙ9Vds6l{[ Ӧmo15m˺[M.xfk8`o;C_n>]=d@VvOԍ;.#ic>̷8aFw7r4_ha'wqQqCFCzG7j6 ̾OqApCŌ@>H @/BI}އ$Q_1@VW0F"3cq+eL_`i6Jʿ1Qʿs=DA )δY+J H~`zĹ>"{cq uE8KiI#D>$Q8/=C)dmq`9ζ8 2/϶˙=s1,%~A|j?.T$~p_+ bOۨuڏāR\u/zC<z\;g6 )0^]s F1uR"HdD.SwL?}6M**tt2jL(~#&p/\(@)eTxe$)UMF.|:ˁd?uTƟVO~pL 1jG.iՈGΤ}1y{5Kb|}w j8Qp.܉[ҁq?6j&p4Q|G\GgM [G @Aߺu8C].SGB+}o)Vb;S|S~4aw/wL ;MOqB+o/rG7ӼA/ g3ޟr D;3? x 9 ~$F+G TADjy{WsG@V:.qHE)a!^pd!:UK<Q8ITeg_ORAYsl1>"58W bM~zǛ*^Y~YIS8 DvڕO I-%_ 𕺕^y>"HO GĕJ~C|R/էqt.iH?u6xkqtRon˖k>ޑB##A3u]AT㝙P*(ZT83{ο+*%\gAP`g _ 4*s|w v%j|zDG>:p`r="GK/El_Vy @L)OWr'ytzCJ P"YDSVg*p?:_3|Q~q2Dkkz|٥/>3xk=Y7n}|M?dJL5~ϯ^הW)$_A_սtEMK7=HF/F?GCpa@A>vE6~>6Qmdnh۹;~bA7{oỮmu=T_3o:u??tI8f.HTuIϏu~y:۬"u<ѽVӹ]uBR@_b g8lMU}w+<(ºw@_~Gon]t?=I]=-;_y|j`wz۫"D}ρ0^ϳG 4w_wy hۋgWO 7FRo?{C_ݫǺ 3ף {oGqC.nԺگ 5Y^ }^ +kT_npn?NQ=9q@HSDރZ";2 PE|*w v?WA|^|{i#'˾~+s|,:BO)sDA-tEZʈgK5:X'yO z(>`I )<xP0#PkD@ԩϳ.1}?gXO1 *9  Ӭ&?xr?IO,@TV۰Gu)ngf|F@3 0X7N1 Qn;{Zh@i MP (ЋyQ5\!_}_U3&Ѿ& h~s]PmDTu~^>cG5J_?kxYm^u'?Kzgd`0yW^LE B^6Mj"f: @XQ3MY U}mig,lql˓< uMTRc]?A#bed@("EK=:[›R/+v!sw{m_q<ROYVsDjy=bݝdzxi> :5$_V#MR/r 'v,)ޟ)d?"Mj.%BHDRt)Yd@dEG(ϝPDTY\b]Q#p(T&OBV/p钘XϚc1'Ji(L,@"Pϖ-B =;_/ #`P.OAEauwL.wu??jմG6݃vFz?h;RG@R01W8ޒ  '~\)СOz˟:Xүqyy=,r`os4*/j@\R*Y<F-D@?FGF 8F\/z8KUOr f? hɕHZ$ʌ4; B7`L_4P~s ! Rv'[׊ɂq)Nc?% B*I|XO]ѹ.C@R/{%!`icY_3|̕^f{UAS4ug`K4FQE`#D5EO}ۙ+4^|];JVV .@k¸/"txM`U?W? ¸ ]ZwxQcL ,أ9JGRƈȋ:z{=+ '"+sBs'Lcx.B? #vd/$>.`PBTZ,{HjjF/zb r}JSr~z?o@!`,4#)vyʿp⚿v @owG%d<#PFI<ݾZ̳1 8h A ${h@:8Ww?_j3O)P}x|sEAL}|=G Ÿ#JD@:?r QrypQ 8@bSwl{Jm_p{R/&gMUϔ=?T?_)~_ڄxգY۫sW@R]Ǚ eWkn hMSGï?[z_zMvem+tﰸW~EpY $ӷH&/3-si ݋GVV_]A";!wtw1fgowu/qA;bѯ>ƴ+Uo_m30$?=ƁF| G ?cif; 'OGeWvh@TOwGʿbhZOW$+?$4\g?7\t!H_?˸X8djex` cO38ٶ9vkl9w l?O73tט ?V\G8k9Sgr9"6cvF^\'ZA(U PQ@4 5HX{)Y0?jʿ&yY*K`}U@rB\ yRI?`*'ׅOg(#`?8WMBprTgr.bc3g';\J;i{"fsa}k ^CI| 'Jٟq<9luYNŭb NpGJ xiDw%5:F1_@x16.Ť di/33Ze) pgdQ:cOPq1@CCd_ Hvysa_~|* 3f'~_K=H_vD!G "P6qm+e_`GG$Gr# ?(Gd~+],8[xT8@i8B/jиj?O |R ?pSRHebuy\Z8濂\Wb #Uj] kxoJ.3x .U\76SOoJeSPkBqHckY[8~USgxq_1̏ds Bf#Jc:H#ǁVIbHhIDbWgBl@H'T/t2v-B,|.XO#Q}++E:pp]!Ew add1dEToj_\R_| ]x(>? H'*):D]#,C2rNUOn_E *7Q-|XO/@3b@)_jġT7<3uŒ/4_ad[tG>?3I\>u<z3_@jKg# ;:L; mwp6 _9[tŬ=0L(|~vEXt߯s~y?ݪ'[tUgG7mc;EcߓOt?=r3JW/=F_pЋ>>Aߺ[_clY?s`_Pzb{D 04 |XFcQ)>$es_X/J,0C_jd3XpR^@!_zK,47 @zYc.?2OiY{LuWDrV/e$\Aj?yսGVt H? W,=A>SKOw^? t#Dn$4Rb]+n"O#_Te@s_`kekm`?y:u%/FsOUU ?<yR}?OBîGrD#kA?K12 eOWΟ/1Alɕ/y|ZT+T'*㦚*if^\Uk/ ׯZ}K?< >%6|^/~E_L\e2J>ޙ\2}wTm=C@ +}@8ү83 7x_T)*ϧ0cui$L^7v>Vibl?sͲ3O|F󹯞ͳa֖F_}UwO|,ړn_yϼ;XuEsS=/t޿{Z«]{YG?[T),_h%(.@-@e_+ `_po'W/=I?g/{`?$Z{p^K4?wzaߚ!4-Qصw )@ UC/IݓC?3@.@o~Sϳs('U/ȋ?MhGD)wU @k`?{Qr v jϓr.x{s<=?_Z}dH)?K.t EKٕC=DjW!4{M`kWnݸɭK7?f\QFM՛7,s_h4AJV*-cr&#DM0j#"?~~6ٰ2F-0icxJW^< >1mc>m=ڻvt1'v>Ǣ3Hy22O ~fXfمceO<gwpo=᧿E/n;Bwmӝ|m:yfźOA{`hBHI)w bB`CA}]~/7s0 vb` 1?O\wBq^zt;pxv7'N~))T 3}\`Ey+IxCtkD2gR*!ߩG^Zl.JG@+@?2kKCLJ`(mkkPkgI_;5o^EhIx&) =C[3:|KYQoKRnMrǷ8Y  ~W?#{ ]xg#,wZJ*V,ljIT}#N.LAVGr# N2+'X2@^"' NdzϚX_vjي%I>H @V羀Җˑ冔 V= ʦd а?gf7(]2;t4%3O/<y\xؗn:|ϿG'+:Pw |_ cb T<;~H/kAE_RrMׯIֻR7_~|2) ^z]F^Sj@|^?T ?. ; EH2?;/{HFͶT7} nlta[Q9EW>h&tWهqmL?$op6X8`?PGI4Su5Ĝ?*DXa&_`Q",@uA-?La9bP@HmB}n16|ǏH^/"av+ ޶=Acm{Dhȷ;t_hr# C/-'k>xh}ࡽk$U˳_c_/WK1 G>_i \gJ *^7G郰r4ϙ;o~hU:k|kgm?=R}r]R) ?R?/tj/q ;GoFkT_?MlT6 1 1d#.g?H3#OCx~{koVW?I%,~-8Pfr.@/k_Yb.)L$YqཙA)'r uQ{Cof0?@k?&1Q'aO^4+H_1?!k~?;Ͽ:ƫǭYzOB~+;Z,_kVJ TO~('j>J?d?3Z_nL"iGEjl*AqƖ̖:Hn4/+K_Ԁk nBA}o#ʿ.C2<Yh-0p"r_ңsL)k?oO)J팀&Q>?BUz2?FW  m%7Ow@ )qf@otOz۠ 3ˠ?kFeIw}Lۺ~lÿD;5}5#Ucޖ@ݱG ՇXmuQkS8?нz1Ep8o݁Fu hۿ<{hn"ڴ31 k݁|u'#LcvXd-x`wݯ4&MAFx{ lo:+x~Kz& ȡHb$:t37:O$ 㽎ipaƋQ_k=9xc¤7RBۿr$ ?W?U1$@$c]&L@HRǙ_ _,}Jz?UM_5k[˚3fWd|-#/_6\_=|~4e@ V %?`R3/0:hRq/5kj 2xrs'#hώ@l344 |9qz{qa:H4X/ݑ$ҝʿL^5Rw >OoPxo3RW/fUaZ&:÷_ {]] hr NJ?^$f4Z_)LQ/N{9.@{T-_\kX).k*J}Oq2 [+6T^7e?=UgZ Q)HKPfwhj5-U?Nu} ?s'W/mY=_vDѲGJ[HU xT{'Hj?ȿҾQ!_D5B,A+ri_,pQ_9y* _4]H!yG ;u=z{Hw=ݝGa@w| d7x'BM 'e<=c'o~{Qm$ƎG(@`ϼe`NAV/@XÙ lԿcabl:$vd1'ui8 >",@A]ȀQv]m oIxN$Eu#ܶ{}H=cwMp)_:'1a=b  Lp4D֐~>}tc$ !jo\Ms0? iOm:QoBTwj=7]!>oo2e:@g'+pvo7_!/ `IkY&RE^cA[^8WZcI=AěJ~MToz#.Ǒ]qow[v-B+ɳqc<߽—\wxnOx? e'_z_Ro:i?uKlb"Mu 'PgIN #p,?i @s4&濕"zg8?gA[7U'iN'6?_yjjϳZ pfJ-?ؾo>/e4Wn?7d^mĸͿf'OE &pO.\MUف\.@_iPGˁ>_~}5}Vw{h=忨bZEOs""--73&/XH7_,e%rW3?O?3M%?9L eX6;7|p7FY}뀤ѮJdQIoR~0yf~$*a8="ac!RH~\W)5`lWF.@e~W"an߅#uuԾ^ckI ?a/+-Y:?{S/5yhw-y"`_v,}kj[xȗZ9P3Y? ~b!9cB珽?OLh?s_8#=5=_Xy>zۯ,wM@u)FO+u~]J|7_ߖI]Z.@z{>;,ׇ Y?3AefTWWase/^ 9b?TGVz{vG\7j7~S_Wn>_Εq@Fq폺_7SyAۋt}?ws>b^ϼjD~nG q3BEsyjn}vxfd|y&lH~_'ÅGq2DM2a>v^GTe @X@|u;@ |D8)@(Ex .d 祝`\k|ȕ%.ohpWx0|ox0 JZ?7P}POJ?S6x<=6* (&* ⣚"IcUC[|QTPC|0AyJ [ , PE(J"h ZRsgvv>rיmr_>_1|k6vJ_@o14uԑMHg|{/Z,>  @(qLo[R/?);^q_7hp!P5ǽm]o>Re?^ Bv7Jd޻޵]O5y cR2/[O\O/Z'O7]ƶr ϝllRg:wY=M?t6+3۳_qVq <~Q]M`T"'.mwkι#3|9y K;\ߕ癛)?'՟7\LYO}fH<ϼPl#&xՋggde {ܡe0K/6C3$=Ͼ /{͗a\0sȥ90(۟{6#9î( GG0?'7C B92(]krW-ȿ>s,VIZإ^ɣP qF W?bהp/#"Q#\ϨLS?*3r /lw?t;0X\/3x9ON$5epQ7}o aBc*A%f]}r°Bb,]I?~fD !O7ْON+` 97kL!Oy#_HhQT۟'4Ф?|g#'[kcBY}}?zL;d]o1R_Z )0y.MgiL׹R/+l?KZx8ϳo hz "6~C-&y^`ƃ%@:Gؿm֤4["w?!uxf/+j7 @6g]f$/3ߴ#/ʳ^) "^ `t^@geYIC+˧H~^>/.3X[_/S30(-l?a2gJ Ο4|HS濦ؓ? r8/tibCK_p~|?X(Cy1`@U)(+ ƈ HͿoc8Kl? @4Q˝ ? aѭA?u*8} ^_6W¦V&Mihxs%}2%O\wV|?euzjOJؽ{ jYzZ\O,5.Surw5>"2Zwߚ cȰ233*,,p8lYVѨhZֱcǬx?@ABCDEFGHIJKLMNOPQRSTUVWYZg\]^_`abcdefXhijklmnopqrstuvwxyz{}~'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4u$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l      <0'5y555!55+4p<kd(%$$Iflֈ  o &y!+      <0'4 lap<$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4u$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l      <0'5y555!55+4p<kdT>%$$Iflֈ  o &y!+      <0'4 lap<$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4u$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l      <0'5y555!55+4p<kdU%$$Iflֈ  o &y!+      <0'4 lap<$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5y555!55+#vy#v#v#v!#v#v+:V l0'5y555!55+4$$If!vh5 5#v #v:V P4  %%5 5/  / 44 Pf4p%%z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4z$$If!vh5 5#v #v:V P45 5/ 44 Pf4u$$If!vh555555S#v#v#v#v#v#vS:V l( <%%%%%%555555S/ /  / 4ap<%%%%%%$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  / / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/ /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  / / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/ /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  / / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/ /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  / / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/ /  / 4au$$If!vh555555S#v#v#v#v#v#vS:V l( <%%%%%%555555S/ /  / 4ap<%%%%%%$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/ /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  / / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/ /  / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/  / / 4a$$If!vh555555S#v#v#v#v#v#vS:V l(555555S/ /  / 4a$$If!vh5L5L#vL:V l   0    5L/  / 4p$$If!vh5L5L#vL:V l0    5L/ 4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l   0    5L/  / 4p$$If!vh5L5L#vL:V l0    5L/ 4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l   0    5L/  / 4p$$If!vh5L5L#vL:V l0    5L/ 4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l   0    5L/  4p$$If!vh5L5L#vL:V l0    5L/  4$$If!vh5L5L#vL:V l0    5L/  4$$If!vh5L5L#vL:V l0    5L/  4$$If!vh5L5L#vL:V l   0    5L/  4p$$If!vh5L5L#vL:V l0    5L/  4$$If!vh5L5L#vL:V l0    5L/  4$$If!vh5L5L#vL:V l0    5L/  4$$If!vh5L5L#vL:V l   0    5L/  / 4p$$If!vh5L5L#vL:V l0    5L/ 4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L/ 4$$If!vh5L5L#vL:V l0    5L/ / /  / 4$$If!vh5L5L#vL:V l0    5L/ 4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$If!vh5L5L#vL:V l0    5L4$$IfZ!vh55#v#v:V l   06554aZp$$IfZ!vh55#v#v:V l06554aZ$$IfZ!vh55#v#v:V l06554aZ$$IfZ!vh55#v#v:V l06554aZ$$If!vh55#v#v:V l   06554ap$$If!vh55#v#v:V l06554a$$If!vh55#v#v:V l06554a$$If!vh55#v#v:V l06554a$$If!vh55#v#v:V l06554a$$If!vh55#v#v:V l06554a$$If!vh55#v#v:V l06554a$$If!vh55#v#v:V l06554a]$$If!vh55#v:V l5/ 4]$$If!vh55#v:V l5/ 4]$$If!vh55#v:V l5/ 4DyK yK http://vaww/DyK yK :http://www.va.gov/hepatitiscDyK yK Dhttp://www.regenstrief.org/loinc/DyK yK http://vista.med.va.gov/softserv/clin_nar.row/lab/loinc/loinchm.htmk$$If!vh55#v#v:V l55/ 4k$$If!vh55#v#v:V l55/ 4k$$If!vh55#v#v:V l55/ 4$$If!vh5t55#vt#v#v:V lV%5t55/ 4$$If!vh5t55#vt#v#v:V lV%5t55/ 4DdX  C &AmsoA8B"@@bP @]p8Uw1%nP @]p8UwPNG  IHDR exsRGBPLTE';bRQxx,+yy;bqpbbuvZZLLxwjjNNA@zzmm^_ywyxxwRR,*++X6 cmPPJCmp0712tRNS0JIDAT]= PԘc FF??!*pkjjp $i( w?ѹ|L Յ{Qd:$~9lwVİCSLQE|18RK篽CPגZd?۵*$`IENDB`"&#'#(#R####$/$Z$$$(')'*'x'y'z'(((~((((V))))+*+R++.,,,,,,,-- .~.....///$0%0G0000000K112`22D33@445j55 6V667_7889::;z;;X<<b==i>>A??@$A}AATBBCoCCDDD0EEEmFFVGGHiHHII JcJJ K^KKLdLLM]MMNHNNN2OOOOPPPAQQQ7RRSuSSTTT)UuUU V{VVWxWWXeXXY[YYZfZZ[j[['\\\0]]]>^^_m_``9aaUbbKccFddieeDff>ggYhhwiiujj$kkk\llHmmRnnFoodppyqq~rrrssUttXuuv wsww\xx?yy6zz{{{[||M}}%~~~~N5'dĄ9!!hy7NҌ{ȍxofecޓ5Wu֖9ԗTjܙB\Var/РѠҠӠՠ֠נ٠CD6[\ƮǮjkbc'(kOPѵҵ:;ǹȹɹghi/T@T zNormal $@ CJOJQJ_HaJmH sH tH N@N S Heading 1@&^` CJ$OJQJ@@@  Heading 2@&5CJPJ\D@D  Heading 3 $@&>*CJF@F  Heading 4  @&5CJaJh>@> Heading 5 @&`>*>@> M Heading 6 ^>*CJ:@: M Heading 7 ^CJ@@@ M Heading 8 ^ 6>*CJD @D M Heading 9 @&^ 5>*CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k(No List POP j Char Char1!5CJPJ\_HhmH sH tH HOH  Char Char>*CJ_HaJmH sH tH @@ TOC 7 $(^(CJaJ@@@ TOC 5 $p^pCJaJ@@@ TOC 4 $^CJaJ@@@ qDTOC 3 $^CJaJB@B TOC 2 $x^5\H@H TOC 1 $x56CJ\]aJRR Index 7 x8^x`8CJOJQJkHRR Index 6 8^`8CJOJQJkHRR Index 5 8^`8CJOJQJkHR R Index 4  8^ `8CJOJQJkHR R Index 3 X8^X`8CJOJQJkHR R Index 2 8^`8CJOJQJkHR R Index 1 8^`8CJOJQJkHL @L Footer" H0]0^`CJ@@ TOC 9 $^CJaJ>)@> M Page NumberCJOJQJaJbOb Inside Cover 24 Hel!5B*CJ0OJQJ\^Jph@@ TOC 6" $L^LCJaJ@@ TOC 8# $^CJaJRR Index 8$ @8^@`8CJOJQJkHRR Index 9% 8^`8CJOJQJkHFV@aF FollowedHyperlink >*B* ph6U@q6 Hyperlink >*B*phH+@H  Endnote Text(^`CJ4@4 Header ) $CJJOJlN?@KL"#${| I y z |!!!""%&ɽʽCͿοr123 G89:wxHcdecdBb012yL+jkl8IJ*+c"fghGH!H $%F#$CDnJwbcWX YZ[l xy-gh>YZOPLMNghOPQR'() M 2lmP Q _             u v   GHItuv I!"{|lmno+,>z*+012>&'Mop)*EklmnqrUs'}~     !@!e!!!! " """"""""##.####U$%%%]%%%%%%%%&&&''5'''''';(<(=(L(M( ) ))-)@)P)))*<*_*`*o*p****+V++++7,n,,-S------.H.].^._.l.m.///U/// 0>0w000I1y11111-2.2N2O2;3<3M3N3e3f3/404n4p444555566R6T6|667757~778X88888 9c999):I:c:d:::::;.;\;;;(<C<<<<<<==t==== >Q>>>>>> ? ?)?*?@@@@AAoAAAFBBB$CoCCCCCCDDDDDD`EaEjEkEEEEFKFFFF2GfGGGHH H HHHHHjIkItIuIIIIJ^JJJK K KK K/K0KQKRKKKK`LaLbLsLtLLLLLL0M3M`MbMdMMM*NmNNN3OvOOOPZPPPQFQ}QQQ!RXRRRR4SkSSSSSSSSSSTTTTTRUSUTUUUUUVVVaVbVcVVVVKWLWMWWWWXX'XRXlXmXYZZvZwZZZ-[.[/[\[][^[[[[[ \ \D\\\\]/]?]g]]]]]]^^"^#^$^V^^^^^^^^?____`*`+`N`O`P`Q`s````````'a)avaxaaa b bbDbFbgbibzbbcc+c-c@cecgccccccccdd d(dvddeQeReSeTefegeheiejeeeIfJfKfofpfff6g7g8g^g_ggggg%hChDhhhhhii4iZiiiijj5jIjcjdjjjjjDkEkkkl4l5lWlXlwllllllLmnnnnonpnnnnnnnno*o@ogooooooopTpUprppppppp qqGqHqIqqqqq;r[\  RS<=>c(ǺȺFGHIz|~˻a-z,oվaп\)jkF;<ab1Hf]^qrs  `8EFGHI89:OPQy%IJ "9Pg~ 4K$@A-mnp*]NBlN9#q [E/}gQ[\9Y():;<=>Z[/STU"Bop012~Y]^__acJ PTcdg@hiNO!"ijz{|<=>TU()_`tuQRSabc    ()Q~!"de<=EF !VZ[fghiMNV~/012FGvx`aE)v23B    8      F G    X Y Z [    P*+qrO_r .A]p5Ul &'D~YZn(KMh23qz3qz"`iu#0<IVdl}23LYZ ;[-Py{} /RT}   & , 2 8 > u w         !!!$!1!F!|!!!!!""!"7"n""""""",#o#x#########$M$O$$$$$$$$$%%&&&X&Y&Z&&&&'1'2'3'''''''((J(z((()>)a)))) *?*n****+;+p+++0,^,},,,+-w----.3.H.p......//m/////$0Y0000191111122F2223.303N3333.4C4k444445f5h555$6b666667W7y7777-8B8j8888889T99999 :@:::: ;;;^;;;;;;;<d<<<=&=X====>;>m>>>>>>>>?`???@@#@U@@@@@ AA/A?A[AlAAAAAA=B{BBBBB)CpCCCCCD+D=DoDDDDBEEEEEF7FlFFFFFF&G6GGG[GmGGG*HhHHHHHI\IrIIIIIIII J JAJJJK.K0KNKKKKLL;LNLLLLM?M@MuMMM;NbNdNNNN0ObOwOOOP#P5PgPPPP QHQQQQQQ4R{RRRRSPSrSSSSSSTYTTTTULUUUUV7VNVOVtVVVV&WWWWWW)XIXwXyXXXX Y"Y=Y]Y_YYYYZEZxZZZZZ%[e[[[=\\\^\`\\\\\\0]_]]]]]^^7^T^|^^^^^^_9______"`3`W`h`{````,aJakaaaaa bb0b}bbbbbc*cNcacqccccccccd!dEdWdgdzdddddddde*eveeeeeff'f8fIfmf{ffffffff gg0g@gOgagpgggggg h,hShphhhhh-iKi[iiiiiij^j|jjjjj k-k@kAkkkllltlulvlllll m m)omonopoqoooSpTpVpWpppqqqYrZr[r]r^rrrssssCtDtttt~uuuuuuuv v"v#vvv.w/w0wxxxxxxx(y)y*yyyyyJzKzzzz { { {H{I{{{{||||||||}/}[}\}}}}~~~ ~g~h~~~()*mnoFGƀǀ -._āԁՁց57mւ ;<˄)gڅCd./0opڎێ܎ d;<SToՐ֐#$VWXijk!"01 :;<=ijN~ǔȔ۔3BCDEFv/MNOPQh'Z[\]^}ٗڗۗܗݗE[\]^_~ŘƘǘȘɘ6789:ߙLMS֚Cܛ )*WXb;<Q՞*;ß Ơ>?p34Kdۢ 1bcyԤ4fgp=>Gئ٦CWpq}ΧaQRթ&;<Fmnx 0\]rstuJKLM0129:|}   "NO_wμ 3Fؽ ()Wp|о^ݿ,><=6789 !"# ABWX ,PQR%23Fc#?[iz34`b>?>?"#hBXl;CRS3PQfghi/^,x12x'/|=>?de<=_34LMi*+st #$Lyde/OZs '5FQj68z{PXY  UV2|}Gst 34~ XOTU de89  V9:PQl-.r/0X()op  :Ze~2@Q\u  DF !bjk !klB"MN XY5Nvw   U V    4 5       W X      . { |       - {     =UVW_`%Rt=>\(3Li|*C[tHI-5 56d .Lh~IQ  [ \    ! !O!!!!!<""""###F#G####$$i$j$}$$$$3%4%d%e%f%%%%=&>&&&&&&&&8'R'S''''''**L-M-H/{/|/}///// 0%0G0g0000000!1`1m1n111111122/2K2^2z2222222 3353N3n3o3333304~44455p5q5r5556(6)6w6x6y6z6667U7V777788[8c8888'9)9r9s99 : :;:<:::::D;E;F;;;<<\<]<<<< =$=%=q=r=s===>P>Q>>>>>>>?V?p?q???? @!@tBuBBBBBB CBC]CCCCC D D)DXDDDDDDDEE6EIESEfEEEEEEEEF(FAFQFlFFFFFF#G$GjGGGH HHFHHHHHIIPIQIqIrIsItIIIIGJHJJJJJ!KIKJKKKKKK#LqLrLLLLMPMxMyMMMMM N NQNNNNN1O2OFOOOOOOOOCPDPPPPQQ\Q]QsQtQQQQQFRGRwRRRRTTTTUUUUU(W)W*W+WFX|X}XXXXX Y%YGYgYYYYYYY!Z`ZmZnZZZZZZZ[[/[K[^[z[[[[[[[ \\5\N\n\o\\\\\&]r]s]]]]^@^H^^^^ _ ___U_V____/`F`G````aNavawaaaaa b bQbbbbbbcbcccccc#d$dkddddeJeKe^eeeeffffYfZffff4g5gvgwggggghh_h`hhhhhjjjjkk;khkkkkk l lRlSlqlllllmm=mHmam~mmmmmmmn#n4n?nXnpnnnnnnnoooYoZoooo1p9p:pspppp4q\q]qqqqqqq:rrrrrrssZssssssttttttu@uuuuvvvLvMvvvv)w*wtwuwwwww=x>x?x@xAxxxxyy\y]yyyyyyz8z9zzzzzzz}}}}~~~~̀΀πЀ^_`ւ%@b ;z؄,6Iexυڅ $4OhBۇ.6CDՉ։BJ  OPI̍DEGюab '(tuvwMNґӑSlmefijcde34IJr۝AB֞"#6Ss~ǟџ/KYjuϠ#$YZlnGHޥ,zȦ`9ALMߩ%-.t|ɪ@ABʫGHw !oqIJޮ߮@Z[1~ðİ8EFPwxڷ۷ܷ¸øĸŸƸTUʺ4Vv/n{|̼׼  *=Ylýν(C\|}J0#tefklmHI2Z[1~\_;<OIJ !bcyzABstMNlm:Uw!P.AK^z 9Id},-rJ-.78bcLtu  P1~=>bcv*+,-qrIJ %&klBd,-Kz 9Vis 0HaqUV2e%&lNVbc'(WQS,-rs89_`f   Y Z         5 W w      0 o | }       ! + > Z m         ) D ] } ~     22hp5678|}#B`~7XV^!#fg)*^  WXYZ/0st9:`aj$%567LMu ! E F     !&!'!:!W!w!!!!!!!""3"O"]"n"y""""""#'#(#S#U####.$/$t$|$}$$$/%m%%%'&_&g&&&&,'-'.'/'q'r'' ( (V(^(_((((")#)r)s)t)u))))I*J*y*z****++S+U++++(,),n,o,,,,-.-/-{-|-}-~--- .X.Y......./`/y/z/////00)3*3W3X3Y3n3o33334#4C4g4h44444;5H5I5\5y5555555 6&696U6q666666667)7I7J7o7q7777G8H8888889F9o9999:=:p:x::::9;:;;;{;|;;<<Z<b<c<<<<&='=w=x=y=z====I>x>y>>>&?N?O?????&@o@p@@@AAAA8A9AAAAAAABaBBBBBBBCfCCCCCDDEDFDGGHGIGJGHHHHIIJIKIIIIIIJ2JMJoJJJJJJKHKKKKKKKK L'L:LDLWLsLLLLLLLMM2MBM]MvMMMMMMNNYNNNNNN'O/O~OOOOO>P?P@PAPPPPQ[QqQ|QQRRR SS;Syǫ:;̬ͬ`a̭ܭ)QR,-s¯`bvİ78ɱʱ^_fٳABIJKLɶʶ˶̶efgh   jkl׺6Vz{»O\]pѼ :MiȽ $=]^׾ؾjkHpqK%^$Ew D} !"i{?ADEtghijAB8RSY)*@A\BTUVW~'Tv>?] *5Nk~!,E]v]^9ACv~@A"pqImo45n/0|~]_)QR89 !opEF'uv2?KLM    rst4567D/012UVWde 8QRzJx4?Ngz78KL0Gq-:Op+V+FfFAl)e+Ww7h Z%Z1h DyS- . d e f        ` a       % C D E S    %`WXij4|F~D)*+>1s![23Pfz{J7LM,xM12yz{NajFi./uC    !!*!i!j!!!!!!!""" "(""""""#(#)#*#,#K#Y#Z#[#]#j#k#z################## $ $$$$$J$K$L$N$T$d$e$f$i$r$$$$$$$$$$$$$$$$$$$0%1%5%7%O%c%&&&&-&E&F&G&I&[&&&&&&&&&&''r's'{''''''''''''' (%(&('()(=(Q(e(f(j(l(((U)V)W)Y)h)w)x)y){))))))))))))))))))*** *********+*,*-*7*A*B*F*H*O*_*++++#+H+I+U,V,,,.-/-7->-Q-c-d-e-f-g-....m/n/r/t///c0d0e0g0q000000000000000000001#11111111112%2&2'2)242?2@2A2C2N2Y2Z2[2]2i2222222222222222 3 3 3333)3*3,3-3.3/3J3K333333444`5a5b5c5x5y5n7o77777::: > >.?/?@@AA[D\D]DzD{DFIIKKMMOORRSRSSTTVTWTfT|T}T~TTT&X'XQYRYSYnYoYZZZZ\\\\\\\]]^^__``abbcccgeheeeeee=fGfffg*g+gagbgggg=h>h_h`hhhhhi*i+i{iiijRjSjjj*kzkkkklSlTllll8momqmmmmm n n[ngninnnooRoo/p0pppppp0q1qqqqq9rGrHrrrrrVtWtttttJuuvv5v6vvv{y|y}y~yy{{f{g{<|=||||}}}}7~A~r~~~PQ?ʈˈT89׌$rɎ.|}ߑ.=IJKD͔1yzTUtu_`Ƨǧȧ  ЪѪ۫lկ89 Z[˵nиѸV4lWhiLS!#U%')q @0l$defaIKM#q [E/} n XB,zdfhD56RTz>@BBDpXO 5I5J4[\<=>Z\FGH>?l 2n"^N>z;./0*v  _,.];=?"[gi#tu`b!rt-/~?AaJLNz|~R (j"d Z          8 z    &      S T   2rsa6} R'nC_4{   rsP5z_D+w^DE   +!x!!"""c"""0#1#W#{$|$}$$%W%%%F&&&)'2''''&(~(((9):)))*h**+Q+++E,,,6-x--..1....E/////0h0j00001\1^11112P2Q22222$3`3334P4445@5|55506l6m6n66677F7777708l888 9\999:L:::;<;h;j;;;;J<K<L<w<<<<2=4=a===>Q>>>?A?}???1@m@@@AXAYAZAAB[B]BBBB CGCCCC7DsDDD'EcEEEECFDFFFFF(GsGtGGGGGG@HHHHH3I JJJYJJJKKBKKKKK8LtLLL(MdMMMNTNUNVNNNN6OrOOOOOO6PaPPPP#Q%QQQQQRAR}RRR1SmSSS!T]TTTUVUUUU9V;ViVVVWYWWWW9X:XvXXX*YfYYYZVZWZZZZ9[u[[[)\e\\\]U]]] ^E^v^^^*_f___`V``` aFaaaa6b7bbbb cGcccc7dsdtddd(edeeefffcfkfff8g:glgEhFhrhshhiPiiiijjjjJkKkkk(lhljllZm\m^mmmnTnVnnnno@o|ooo0plppp q\q]qqqr@rBrorrrs sMsNsssstWttt uGuuuu7vsvtvuvvv&w(wWwwww xHxxxx8ytyyy(zdzezzzC{{{{[|]|^|||}Q}|}}}}$~&~S~~~CI)rɁ2n"^ރ G7sST̆DHoq݈4\ԉLĊDEF MӎYZÏ CDfܐRȑ>y*eۓQǔ=xʕ˕̕1qZЗ()*ژ2V}~˛3t7x;|?BUVW{ݠXijkҡӡXڢ\ޣ_ `st¥DABè@AêEūFȬHɭۭBCDkҮT֯WٰZ۱;|?{>z P_TUVl\89cڼ'()W78uv+HIMd!67;H&HIMcv HIVar)QRVi9$%)5x HIM]sQab0bcgx  !k,-1G9:GRcqr}~^ l $%&'(,;r? %34?@ABCLMNOPTj%&*@VPQUj/cdhuR12z{G 67;R'J`aep?@%&H XYs ,Px$Ht5Mf0CXp+Lu !>Vw7`%Md|,Ys7QpCh&E\!@_~>]|4Tt'Gg3Z},HjCi 6c3Wo2Sq#A[t!<Vr%Jg7Qr4Uo1Om/BUr(?^s3J`v$Ce&EXt2Lcz2Ja)Df|4Rl @ g       # ; U t       0 H j       & = U n       & H t     8Wt4Og ,Lj(Jaw&E\{ 'B[+Cd;Us#@]t1Ib{@^|6Zs,Tk0Jr4Oh";\/\v:Pp , T v      !2!D!n!!!!!!"-"D"b"y"""""##7#O#i#####$$A$Y$~$$$$$%&%D%Y%y%%%%%&$&:&U&l&&&&&'='`'''''(%(F([(w((((()<)Q)q)))))*0*Y*s***** +#+<+V+r++++++,1,J,t,,,,,-2-V-p-----$.>.\.u...../!/?/[/y/////0#0A0[0y00000 1+1@1_1t111112242M2i2222223303G3\3v333333 4$4F4]4y4444445+5R5r55555 6&6?6[6u6666667C7]7x777778)8R8o8888889)9>9V9q999999:,:G:p::::: ;#;P;l;;;;;;<.<F<b<}<<<<<=0=S=t=====>+>G>g>>>>>??8?T?q??????@9@V@m@@@@@A)AMAeAAAAAAB-BBBeB|BBBBBC$CDCcCCCCCCD0DNDhDDDDDD E,ELEdEEEEEEF8FQFwFFFFFFG-GGG_GGGGGGH2HTHqHHHHHI&IBI]IIIIIIJJ@JZJqJJJJKK?KZKsKKKKKKL,LCL^LvLLLLL M!M9MQMgMMMMMMMN0NRNiNNNNNNO!O:OQOlOOOOOOP4PPPhPPPPPPQQ1QKQdQ}QQQQQ R3RRRjRRRRRSS6SVSoSSSSST4TOThTTTTTU!U4U\UUUUUUV2VJVeVVVVVVW?WcWWWWW X)XQXrXXXXXY.Y[YtYYYYZ&ZDZbZZZZZ [G[m[[[[\\9\`\}\\\\\"]B]a]]]]]^6^X^t^^^^_>_i______,`Y`t`````a+aFajaaaaaab;bWbnbbbbbbc3cNcpcccccd8ded|dddd e1e^exeeeeef=fjffffff gg?g`ggggggh:hbhxhhhhhi,iUimiiiiij-jKj_jjjjjjk,kNkikkkkkkl0lJlfllllllm1mOmmmmmmmmn0nLnhnnnnnnoGo\o|oooopp7pTplpppppqBqoqqqq r:rYrrrrrrs1sQsqssssst7t_t{tttttu,uKuxuuuuvCvfvvvvvw4wRwswwwwwwx3xUxuxxxxxy8yTyoyyyyyz)zJzczyzzzzz{4{P{q{{{{|'|C|_|~||||}$}:}^}v}}}}} ~%~K~q~~~~ 2Kx(Lf؀=Wq6P{΂'Qkރ,YЄ9Tmׅ/Hd~<ToՇ4]~6Tn؉2T}ˊAnԋ'?Wtnjߌ>e=\wƎ *?Yt̏!=]-CXvƑ5Lnђ<_˓ 'DYnΔ.F^vؕ #<UoӖCg͗0W~ -Jaԙ.UnК(F\xӛ2ZȜ;Roٝ$Qwʞ2Onӟ #;Wu͠3Lkáۡ!>g7Rd|ң$CbѤ">`xȥߥ8]ܦ3Jgڧ #8Stè٨1JiƩ6Xzݪ0Moի:cƬ,Vz٭  <TŮ0U~ܯ7Wİ)Dhɱ;T|Ȳ3Spϳ0Pjܴ .Gc~Ե 9Un۶7Oe}ŷ=bx޸ ":[sع<^yź7[sͻ4_zμFgӽ*S~9Vpۿ'Rx$@a9Ol2OjBo?X{-F_}Em<c2R~'Tn"Dh/Ts +Dd~"Ot@m!=`'?Wr&@ZvD[Gr9b(T+X/Hs :]|-Z">Yy-Vr2Ld$Jo'Fc.Ki,MrBXv7Ys@b?Wx'Kx0\Ab4Ru $>Ys 8Sl~-?Wp9Sw ;Mbw%>Xr;^}*Pk2Rr&Db;f%@W:Z} 9f<Xt :g Eo/["Op4MgHu/Ts #IoAj'Jc!>Xz4`>b8Rm >W{%Eb  = c       - K h      , E ^      3 X o      = g     !>[} ,If0Lf.Np$Ef@l9UqB^Ce7c 4a=i'BW=^;W}&S{HmJr I p     !+!O!t!!!! "1"U""""""#$#:#`####$2$X$$$$$%E%h%%%%%&A&c&&&&'''N'y''''(C(n(((()))R)~))))%*P*{****+5+W+t++++ ,*,S,,,,,-I-r-----&.Q.q..../9/_/////0:0[0|00001*1L1n111112D2\2p2222222233(3:3P3b3u333333334%494M4`4s44444444 5515D5W5j5}555555566)6=6Q6e6x666666677*7>7R7f7z777777788&898M8`8t88888889,9C9Y9n99999999 : :3:F:Y:l:::::::: ;;/;C;V;i;|;;;;;;;<<)<<<O<c<w<<<<<<<==0=D=Y=m=======>+>@>U>j>>>>>>?6?J?_?~????? @)@D@g@@@@@@A1A[A}AAAAB)BFBmBBBBC'CDC_CCCCCDD:DcD~DDDDE5ETEsEEEEEF8FcFFFFG-GZG{GGGG*HLHsHHHHI5IbIIII J2JNJiJJJJJKu^uuuuuv'vDvavvvvv#wIwqwwwwwx5xTxsxxxxx&yFycy}yyyyzz7z\zzzzz!{N{r{{{{{|4|X|||||}2}T}z}}}}~-~Q~v~~~~/Ci(U|Ā#BfɁ1Sz˂ 8Tp҃ $Kk˄ -Oxم<Yv҆<Zs؇7Smވ7a׉8^yЊ>Z{֋4Pnٌ)Mg/IeҎ +Gh -Fh!Lhڑ(@Vqߒ(Je͓#@cӔ'Ozĕ=XrіGn 1X˘=iܙ3Ktњ#?a| -MnŜ/QuƝ!7Pq 4Ysӟ.Ml֠6Nqԡ3IdzϢ 2Yѣ@Tuڤ$Lr1\}ߦ2Opݧ@]}֨$Qw֩*Wz˪.[{<YtƬ>`ѭAhޮ .Fj/Yt$Kb=eDz!:W{ɳ:Xrд-Jgѵ9ayͶEnDh/W~йEbyۺ)Kj» +AYtȼ=e½*Vw7_ֿ%Rz;a B`&Cl&Ga!Jl#Co1T} 0Wy9Z ,Wy+Q{;e-Jg6\wAd|.Lj9W&R}+V1X{1Lo /Pl*Mq =[HdEq6Y'Rm@m>h?` Hg,Ja~,Y)S}:Pr +Wv?]3\yA_=]AmAYtAn9Ll &?Xj ,Ou8b (E`3[ 7dFo=b.Id&Su4Vr6S} +Nj)Gbz1\-Ok'Ro+Gi @ d  : U w     . K m      / D Z y      @ ]     ( S     0 T x      # E d       8 X z     5 V w  B h  & F f  ) O m  7 ]  5 H [ x      7 U q       1 F a {      ( A \ x        / F ^ z     ' B X r      1 ^      D g      : a |     $ < `       L n      > a       1 I t      ' F d       1 L o       ; Y w     ) V       & A \      ' Q x ! >! _! ! ! ! ! " 8" ^" s" " " " " %# K# h# # # # $ C$ o$ $ $ $ $ % F% m% % % % % & 8& X& & & & ' %' L' s' ' ' ' ( -( W( ( ( ( ( ( ) 9) Y) x) ) ) ) * * +* @* ^* * * * * + + -+ J+ g+ + + + + + , ', G, g, , , , , , - - 3- E- Z- o- - - - - . :. g. . . . . / 1/ D/ q/ / / / 0 0 ;0 W0 s0 0 0 0 0 0 '1 O1 u1 1 1 1 2 <2 i2 2 2 2 2 3 63 [3 y3 3 3 3 3 4 D4 ^4 4 4 4 4 4 5 45 V5 v5 5 5 5 5 &6 C6 `6 }6 6 6 6 7 &7 K7 g7 7 7 7 7 8 %8 R8 v8 8 8 8 9 -9 L9 k9 9 9 9 : $: D: i: : : : ; 3; J; k; ; ; ; ; < =< X< s< < < < < = = 3= H= m= = = = = > 4> P> q> > > > > ? C? k? ? ? ? @ $@ 8@ a@ @ @ @ @ A 2A JA mA A A A A B 3B NB {B B B B C #C @C ZC C C C C C D +D UD {D D D D E E @E bE E E E E F 6F ^F zF F F F G BG kG G G G H 9H ^H ~H H H H I /I AI jI I I I I J @J lJ J J J J %K >K XK wK K K K K L 'L CL kL L L L L M ,M TM iM M M M M M N +N AN mN N N N O (O BO eO O O O O P 'P ?P _P zP P P P P Q Q 1Q EQ aQ Q Q Q Q R .R DR [R zR R R R R S 'S DS `S S S S S S T 'T CT \T sT T T T T T U -U AU ]U U U U U V )V LV kV V V V W =W dW W W W W W X 8X eX X X X X X X X X X X Y Y !Y "Y #Y %Y &Y 'Y (Y JY KY ]Z ^Z _Z yZ zZ Z @[ A[ b[ U\ V\ b\ \ \ \ \ \ &] '] 4] E] F] J] T] U] Y] f] g] k] z] {] ] ] ] ] ] ] ] ] ] ] ] ] ] ] ] ] ^ ^ ^ "^ #^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ _ _ $_ (_ )_ *_ ,_ 2_ t_ x_ y_ z_ |_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ ` ` ` ` ` !` #` *` ;` ?` @` A` C` J` `` d` e` f` h` o` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` a a a a a a a "a -a 1a 2a 6a 8a =a `a da ea fa ha oa a a a a a a a b b b b b Fb Wb Xb Yb \b cb b b b b b b b b b b b b b b b c c c c c c c c c c #c 3c 7c 8c 9c ;c Bc }c c c c c c c c c c c c c c c c c c c c c c c c Rd Vd Wd Xd Yd Zd [d \d ]d ^d _d `d ad bd cd dd fd ld sd wd xd d d d d d d d d d d d d d d d d d d d d d +e /e 0e 4e 6e ;e Oe Se Te Ue We ]e ve ze {e e e e e e e e e e e e e e e e e e e e e e e e e f f f f %f &f 'f *f 1f _f cf df tf wf |f f f f f f f f f f f f f f f f f f f f f f f f f f f f g g g g g g g g .g 1g 7g Dg Hg Ig Jg Mg Sg mg g g g g g g g g g g g h h h 2h 3h 4h 7h i ?i Ai Gi _i di ei fi hi mi yi ~i i i i i i i i i i i i i i i i i i i i i i i i j j j j ^j _j `j lk mk k k l l jm m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m n n n n n n "n /n 0n 1n ;n ?n Cn Fn Sn Tn Un en in mn pn }n ~n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n o o o (o ,o 0o 3o @o Ao Bo Ko Oo So Vo co do eo qo uo yo {o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o p p p p p p p !p %p (p 5p 6p 7p Ap Ep Ip Kp Xp Yp Zp ap ep ip kp xp yp zp p p p p p p p p p p p p p p p p p p p p p p p p p q q q q q %q +q /q 6q Aq Bq Cq Oq Pq Qq Rq Sq Tq Uq \q _q bq dq qq rq sq q q q q q q q q q q q q q q q q q q q q q r r r r r r r 0r 4r 8r ;r Hr Ir Jr `r dr hr kr xr yr zr r r r r r r r r r r r r r r r r r r r r r r r r r s s s s s $s &s 3s 4s 5s t Bt Et Rt St Tt _t `t kt qt ut |t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t u u u u u u #u $u %u 4u 8u { E{ I{ M{ Q{ ^{ _{ `{ { { { :| ;| T| l| m| } } &} '} M} a} x} } } } } } } ~ ~ !~ "~ m~ ~ ~ . J t     V  P E ۂ  < z ڃ ۃ ܃      + , . 9 : < H I K c d f r s u ń Ƅ Ȅ ߄    3 4 6 M N P j k m Ѕ х Ӆ      7 8 : T U W h i k Æ ݆ ކ    A B P ] k x ć Ӈ ׇ ۇ ߇   " # ' 1 5 = B N O T _ d s w ~  ƈ ֈ ڈ ߈   ! / 0 5 B E U Y _ ` d i n v z lj ȉ ̉ ։ ډ    % 7 ; I N U V Z i m y ~ ʊ ˊ ϊ ܊    ( . > ? C R V ] b y z ~ ȋ ̋ Ջ ֋ ۋ   0 1 5 ? D I N _ ` nj Ռ     ( , 2 5 ; < A W \ m q  ƍ ߍ  ! & 8 = D H P Q U _ c n r ~  Ŏ Ǝ ˎ ׎ ێ      , 1 6 7 ; H L a e k l p t x | ŏ ӏ ԏ ؏      ! % T U Z b c d e f g { ܐ ݐ  + , 7 j k v / 0 ; R S ^ В ђ ܒ  > i j u z { ғ ӓ ړ   4 5 < B C ^ Ɣ ǔ Ҕ ה ؔ    ! F G R y z      5 p   ! " # $ 5 6 < H I K R S U Z [ ] c d ڗ ۗ ޗ    * + - 7 8 : G H K ` a d s t u v Ř ǘ Ș ՘ ט ؘ ٘ ژ     9 ; < V X Y v x y י ٙ ڙ W X Y f }    & = > ] ^ _ u     ! h i      < = f g V W u v Ѵ Ҵ 7 κ Ϻ к Ѻ  % & ' 5 9 L M N S    # $ d  ۼ ܼ    - . < = \ ] } ~ ڽ ۽   % & D E _ ` { |   / 0 E F Q R ] ^ i j v w ſ ƿ ǿ ȿ # $ R S u v    ! " * 9 B C L M V W ` a j k t u ~   ! " # + 3 ? @ H T c d l | }    1 c d e f g h i j k n 000000!0!0!00000!00000!00000!00000000000000000000000000000 00 00 00 00 00000000000606060606000000000000000000000006000000000606060@0@0@ 0@ 0@ 0@0@0@060$0$0$0$0$0$0$0$0$0$0$0$060|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!060*'0*'0*'0*'0*'0*'0*'0*'0*'0*'060V)0V)0V)0V)0V)0V)0V)0V)0V)0V)060,0,0,0,0,0,(0,060.0.0.0.0.0.0.0.0.0.00000000000000000000000000000000000                          ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q s t u v w x y z { | } ~  0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000٠0٠0٠000000 00 00 00 00 00 00 00 00 00 0 0 0 0 0 0 0 0 0 00 00 0000000000000000000000000000000(00800ʽ0ʽ800ο0ο0ο0ο0ο0ο(00800 0 0 (0(080w0x0x80w0(0(0(00e80e0000000000000H0000H0020202H0000H00000000H000(08(080J0J0J 0J 0J 0J 0J 0J 0J 0J 0J 0J(080f(080h0h0h 0h 0h 0h 0h 0h 0h0h(0800000(00(0(000(000(00%(0(00(0(0000000 0 0 0 0 0 00(0(0000(0000000(00c0c(000(000(000(00X0X0X0X000000000[0[0[00 0 0 0 0 0 0 0 0 0 0 00>0>0>0>0>0>00N(0N0h0h0h0h0h0h0h0h(0N0R0R0R0000000000000800H000H00008000000000800(0800 0 80008000800m0m8000800Q (080 0 (080 0  0  0  0 0 80 0 0 00v 0v 0v 0v 0v 0I0I0I0I0I0I0I0I0I0I0I0I0I0I0I0I0v 0o(0o00(0o0,0, 0, 0,(0o0z0z 0z0z(0o0000v 020202 02 02 02 0202 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02020v 0n0n0v 0r0v 0U0U0v 00v 0v 00v 0v 000v 0~0~0v 000v 00v 0000000000000v 0 "0 "0 "0 "0 "0 "0 "0v 0v 0#0#0v 0#0#0#0v 0%0v 0]%0]%0]%0]%(0]%0%0%0%0%0%0%0%0%0%(0]%(0]%0'0'0'0'(0]%0=(0=(0=(0=(0=(0=(0=(0=(0=(0=(0=(0=(0=((0]%0`*0`*0`*0`*0`*0`*0`*0`*0`*0`*0`*0`*0`*0`*0`*0`*0`*0`*0`*0`*0`*0`*0`*0`*(0]%0_.0_.0_.0_.0_.0_.0_.0_.0_.0_.0_.0_.0_.0_.0_.0_.0v 010101(010.20.20.280.20<3H0<30N30N30N30N30N30N30N30N30N30N30N30N30N30N30N30N30N30N30N30N30N30N30N30N30N30N30N3 0N3 0N3 0N3 0 N3 0 N3 0 N3H0<30I:0I:0I:0I:0I:0I:0I:0I:0I:0I:0I:0I:0I:H0<30<H0<30<0<0<0<0<0<0<0<0<0<0<0<0<0<80.2H0>H0>0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?H0>0C0C0C0C0C0C0C0C0C0C0C0C0C0C0C0C0C0C0C0C0CH0>0G0G0G0G0G0G0G0G0G0G0G0G0G0G0G0G0G0G0G0G0G(010 K80 K0 KH0 K00K00K00K00K00K00K00K(010bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL0bL00S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[00je0je0je0je0je0Kf(0Kf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf0pf(0Kf0l0l80l0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n80l0q0q0q0q(0Kf0r0r0r0r0r0r0r0r80r0v0v0v0v0v0v0v0v0v0v0v0v0v0v0v0v(0Kf0y0y0y80y000000000000000(0Kf0ف0ف0ف0ف0ف0ف0ف0ف0ف0ف0ف0ف0ف0ف0ف0ف0ف0ف0ف0ف0ف0ف0ف0ف(0Kf0s0s0s0s0s0s80s0ʈ0ʈ0ʈ0ʈ0ʈ0ʈ0ʈ0ʈ0ʈ0ʈ0ʈ0ʈ0ʈ0ʈH0ʈ0000000000000je00000000(0000 0  0  0 0 0 0(00?0?0?0?0?0?0?0?0?0?0?0?0je0J(0J0L0L0L0L0L0je00000000(00͝0͝0͝ 0͝ 0͝ 0͝ 0͝ 0͝ 0͝0͝(00+0+0+0+0+0+0+0+0+0+0+0je0C0C0C0C0C0C0C0C0C0C0C0C0C0C0C0C0C0C0C0je00000000000000!0000000000000c0c0c0c0c0c0c 0c 0c 0c0c0c0c0ò0ò0ò 0ò 0ò0ò0ò0ò0ò0ò 0ò0ò0ò0ò0ò0ò0ò0c0c0>0>0> 0>0> 0>0> 0>0> 0>0> 0>0> 0>0?0?0d0?0d00d000d0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ(0ɺ0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 80 000000000000000000000000000000000000000080 0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J(0ɺ000(0ɺ80000000000000080000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000H00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000800 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 800$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$ !0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$800Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk0Bk800 {0 {0 {0 {0 {0 {0 {0 {0 {0 {0 {0 {0 {0 {0 {0 {0 {0 {0 {0 {0 {0 {0 {800!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~0!~80000000000000000000000800101010101010101010101010101010101010101010101010101800g0g0g0g0g0g0g0g0g0g0g0g0g0g0g0g0g0g0g0g0g0g0g800L0L0d0]0]0]0] 0] 0] 0] 0]0] 0] 0] 0] 0] 0] 0]0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0]0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0]0] 0] 0] 0] 0] 0]0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0] 0d00 0 0 0 0 0 0 0 0 0 000 0 0 0 0 0 0 0 0 0000000 0 0 0 0 0 0 0 0 0 0 0d00 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0000 0 0 0 0 0 00 0 0 000 0 0 000 0 0 0000 0 0d00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0d0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ0ƭ(0ƭ0 0 (0ƭ0000 00 0 0 0 0 0 00000000 0 0 000 0 0 000 0 0 000 0 0 000000000 0 0 00 0 (0ƭ0*0*0*0*0*0*0*0*0*0*80*0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000(0ƭ000000000000800000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000(0ƭ0000000000800000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000(0ƭ0L0L0L0L0L0L0L0L80L000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000(0ƭ0'0'0'0'0'0'80'0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/0W/(0ƭ0?0?0?80?0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B(0ƭ0R0R0R0R0R0R0R0R0R0R0R0R0R0R0R0R80R0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX0UX(0ƭ0h0h0h80h0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j(0ƭ0z0z0z0z0z0z0z0z0z0z0z0z0z0z0z0z0z0z0z0z0z80z0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o!!!!!!!! ! ! ! ! !!!!!!!!!!!!!!!!!!! !!!"!#!$!%!&!'!(!)!*!+!,!-!.!/!0!1!2!3!4!5!6!7!8!9!:!;!!?!@!A!B!C!D!E!F!G!H!I!J!K!L!M!N!O!P!Q!R!S!T!U!V!W!X!Y!Z![!\!]!^!_!`!a!b!c!d!e!f!g!h!i!j!k!l!m!n!o!q!r!s!t!u!v!w!x!y!z!{!|!}!~!!!0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o(0ƭ0000000000000800000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000(0ƭ0.0.0.0.0. 0. 0. 0. 0.0.0.0.0.0.0.0.0.0.0.0.80.0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d0d(0ƭ00000000000000800|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|(0ƭ0000000008000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000(0ƭ0000000800i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i 0i (0ƭ000800000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000(0ƭ0 00 00 080 0093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093093(0ƭ(0ƭ0TD0TD0TD0TD0TD0TD0TD0TD0TD0TD0TD80TD0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI0ZI(0ƭ0]0]0]80]0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`(0ƭ0@q0@q0@q80@q0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u(0ƭ0Є0Є0Є0Є0Є0Є0Є0Є0Є0Є0Є0Є80Є0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U0U(0ƭ(0ƭ0^0^0^0^0^0^80^00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000(0ƭ000000000000000000800000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000(0ƭ0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q80Q00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000N0N0N0N0N0N0N0N0N0N0N0N0N0N0N0N0N0N0N!0N!0N0N0N0N0N0N0N0000000000000000f(0f00000000000000000000000000000000000(0f000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!"00(0f0000000000000000000000000800T 0T 0T 0T 0T 0T 0T 0T 0T 0T 0T 0T 800g0g0g0g0g0g0g0g0g0g0g0g0g0g0g0g0g0g0g0g0g800:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:(0f00000000000000000000000000000000000000000000000000000000000000000000000000800y!0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y!0y! 0y! 0y! 0y! 0y! 0y!0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y!0y! 0y!0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y!0y! 0y! 0y! 0y! 0y! 0y!0y! 0y! 0y! 0y! 0y!0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y!0y! 0y!0y! 0y! 0y! 0y! 0y!0y! 0y! 0y! 0y! 0y! 0y! (0y!(0y! 0y! 0y! 0y! (0y! (0y! 0y! 0y! 0y! 0y! 0y!0y!0y! 0y! 0y! 0y! 0y! 0y!0y!0y! 0y! 0y!0y!0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y!0y! 0y! 0y! 0y! 0y! 0y!0y! 0y! 0y! 0y! 0y! (0y!(0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y!0y! 0y! 0y! 0y! 0y! (0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! (0y!(0y! 0y! 0y! 0y! 0y! 0y!0y!0y!0y!0y! 0y! 0y!0y!0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y!0y!0y!0y!0y! 0y! 0y! 0y! 0y! (0y!(0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! (0y!(0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! 0y! (0y! 0y! 0y! 0y! 0y! (0y! 0y! 0y! 0y! 0y! (0y! 0y! 0y! 0y!0y!0y!!0y!!0y!0y!0y!0y!0y!000>30>30>30>30>30303030303030303(030r50r50r5 0r5 0r5 0r50r50r5(030:0:0:0:0:0:0:0:0:0:0>30>30>30lD0lD0lD0lD0lD0lD0lD0lD0lD0lD0lD0lD0lD0lD0>30S0S0S 0S 0S0S0S0S0S0S0S0S0S(0S(0S0bY0bY0bY(0S0Z0Z0Z0Z0Z0Z0>30\0\0\0\0\0\0\0\0\0\0\0\0\0>30c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0>30r0r0r0r0r0r0r0r0r0r0r0r0r0>30Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0Ev0>30ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0ק0>30%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0>30n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0>30f0f0f0f0f0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f0f0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f0f0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f0f0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f0f0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f"""""""" " " " " """"""""""""""""""" "!"""#"$"%"&"'"(")"*"+","-"."/"0"1"2"3"4"5"6"7"8"9":";"<"=">"?"@"A"B"C"D"E"F"G"H"I"J"K"L"M"N"O"P"Q"R"S"T"U"V"W"X"Y"Z"["\"]"^"_"`"a"b"c"d"e"f"g"h"i"j"k"l"m"o"p"q"r"s"t"u"v"w"x"y"z"{"|"}"~""" 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f0f0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f 0f0>30)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""#0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)######## # # # # ################### #!#"###$#%#&#'#(#)#*#+#,#-#.#/#0#1#2#3#4#5#6#7#8#9#:#;#<#=#>#?#@#A#B#C#D#E#F#G#H#I#J#K#L#M#N#O#P#Q#R#S#T#U#V#W#X#Y#Z#[#\#]#^#_#`#a#b#c#d#e#f#g#h#i#j#k#m#n#o#p#q#r#s#t#u#v#w#x#y#z#{#|#}#~###0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)0)!0)!0)0)0)0)0)0)0)0)0)007Y 07Y 07Y 07Y 07Y 0nZ 0nZ 0nZ 0nZ 0nZ 0nZ 0nZ 0nZ 0nZ 0nZ 0nZ 0nZ 0nZ 0nZ 0nZ 0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ 0nZ 0nZ 0nZ 0nZ 0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ 0nZ 0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 (0nZ 8 0nZ 8 0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 (0nZ 8 0nZ 8 0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ 0nZ 0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ  0nZ  (0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ 0nZ 0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  (0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 8 0nZ 8 0nZ  0nZ  0nZ 8 0nZ 8 0nZ 80nZ 8 0nZ 8 0nZ  0nZ 0nZ (0nZ (0nZ 0nZ 0nZ 0nZ 0nZ 0nZ 0nZ 0nZ 07Y 0ym 0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym 8 0ym 8 0ym 8 0ym 8 0ym 8 0ym  0ym  0ym  0ym 8 0ym 8 0ym 8 0ym 8 0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym 8 0ym 8 0ym 8 0ym 8 0ym 8 0ym  0ym  0ym  0ym 8 0ym 8 0ym 8 0ym 8 0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym 0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym 8 0ym 8 0ym 8 0ym 8 0ym 8 0ym  0ym  0ym  0ym 8 0ym 8 0ym 8 0ym 8 0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym 0ym 0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym 8 0ym 8 0ym 8 0ym 8 0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym 0ym 0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym 8 0ym 8 0ym 8 0ym 8 0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  (0ym  0ym  0ym 8 0ym 8 0ym 8 0ym 8 0ym  0ym  0ym  (0ym  0ym  0ym  0ym  0ym  0ym 0ym 0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  (0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym 8 0ym 8 0ym 8 0ym 8 0ym 8 0ym  0ym  0ym  0ym 8 0ym 8 0ym 8 0ym 8 0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  0ym  (0ym 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 0o{ 80o{ 0ȃ 0ȃ 0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ  0ȃ 80o{ 0 0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  80o{ 0o 0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o  0o 8 0o 8 0o 8 0o  80o{ 0v 0v 0v 0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v  0v 0v 80o{ 0 0 0 0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  80o{ 0R 0R 0R 0R  0R  0R  0R  0R  0R  0R  0R  0R  0R  0R  0R  0R  0R  0R  0R  0R  0R  0R  0R  0R  0R  0R 0R  0R  0R 0R 80o{ 0+ 0+ 0+ 0+  0+  0+  0+  0+  0+  0+  0+  0+  0+  0+  0+  0+ 0+ 80o{ 03 03  03  03  03  03  03  03  03  03  03  03  03  80o{ 0s 0s  0s  0s  0s  0s  0s  0s  0s  0s  0s  0s  0s ##############################################################################################################################$ 0s  0s  0s  0s  0s  0s  0s  0s  0s  0s  0s  0s  0s  0s  0s  0s  0s  0s  0s  0s  0s  0s 80o{ 80o{ 0 0  0  0  0  0  0  0  0  0  0  0  0  0 0 80o{ 0 0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0 0 0 0 0 0 !0 !0 !0 !0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 0 0  0  0  0  0  0  0  0  0  000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 @ 0  0  0 @ 0  0  0 @ 0  0 0  0  0  0  0  0  0  0  0 @0y00@0y00@0y00@0y00@0@0@0@0@0@0@0@)0@0@0@0@0@0@0@0@0@)0@0@)0@0@)0@0@)0@0@0@0@0@0@0@0@)0@0@0@0@0@0@0@0@)0@0@0@0@)0@0@)0@0@0@0@)0@0@)0@0@)0@0@)0@0@)0@0@)0@0@)0@0@0@0@)0@0@)0@0@)0@0@)0@0@)0@0@)0@0@)0@0@)0@0@)0@0@)0@0@)0@)0@)0@0y00X 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000Lfghij{|}~/0+,Z[# $ D E 6BC67vwab,-NOxy>?@KL"#${| I y z |!!!"""&#'#(#R####$/$Z$$$(')'*'x'y'z'(((~((((V))))+*+R++.,,,,,,,-- .~.....///$0%0G0000000K112`22D33@445j55 6V667_7889::;z;;X<<b==i>>A??@$A}AATBBCoCCDDD0EEEmFFVGGHiHHII JcJJ K^KKLdLLM]MMNHNNN2OOOOPPPAQQQ7RRSuSSTTT)UuUU V{VVWxWWXeXXY[YYZfZZ[j[['\\\0]]]>^^_m_``9aaUbbKccFddieeDff>ggYhhwiiujj$kkk\llHmmRnnFoodppyqq~rrrssUttXuuv wsww\xx?yy6zz{{{[||M}}%~~~~N5'dĄ9!!hy7NҌ{ȍxofecޓ5Wu֖9ԗTjܙB\Var/РѠҠӠՠ֠נ٠CD6[\ƮǮjkbc'(kOPѵҵ:;ǹȹɹghi%&ɽʽCͿοr123 G89:wxHcdecdBb012yL+jkl8IJ*+c"fghGH!H $%F#$CDnJwbcWX YZ[l xy-gh>YZOPLMNghOPQR'() M 2lmP Q _             u v   GHItuv I!"{|lmno+,>z*+012>&'Mop)*EklmnqrUs'}~     !@!e!!!! " """"""""##.####U$%%%]%%%%%%%%&&&''5'''''';(<(=(L(M( ) ))-)@)P)))*<*_*`*o*p****+V++++7,n,,-S------.H.].^._.l.m.///U/// 0>0w000I1y11111-2.2N2O2;3<3M3N3e3f3/404n4p444555566R6T6|667757~778X88888 9c999):I:c:d:::::;.;\;;;(<C<<<<<<==t==== >Q>>>>>> ? ?)?*?@@@@AAoAAAFBBB$CoCCCCCCDDDDDD`EaEjEkEEEEFKFFFF2GfGGGHH H HHHHHjIkItIuIIIIJ^JJJK K KK K/K0KQKRKKKK`LaLbLsLtLLLLLL0M3M`MbMdMMM*NmNNN3OvOOOPZPPPQFQ}QQQ!RXRRRR4SkSSSSSSSSSSTTTTTRUSUTUUUUUVVVaVbVcVVVVKWLWMWWWWXX'XRXlXmXYZZvZwZZZ-[.[/[\[][^[[[[[ \ \D\\\\]/]?]g]]]]]]^^"^#^$^V^^^^^^^^?____`*`+`N`O`P`Q`s````````'a)avaxaaa b bbDbFbgbibzbbcc+c-c@cecgccccccccdd d(dvddeQeReSeTefegeheiejeeeIfJfKfofpfff6g7g8g^g_ggggg%hChDhhhhhii4iZiiiijj5jIjcjdjjjjjDkEkkkl4l5lWlXlwllllllLmnnnnonpnnnnnnnno*o@ogooooooopTpUprppppppp qqGqHqIqqqqq;r[\  RS<=>c(ǺȺFGHIz|~˻a-z,oվaп\)jkF;<ab1Hf]^qrs  `8EFGHI89:OPQy%IJ "9Pg~ 4K$@A-mnp*]NBlN9#q [E/}gQ[\9Y():;<=>Z[/STU"Bop012~Y]^__acJ PTcdg@hiNO!"ijz{|<=>TU()_`tuQRSabc    ()Q~!"de<=EF !VZ[fghiMNV~/012FGvx`aE)v23B    8      F G    X Y Z [    P*+qrO_r .A]p5Ul &'D~YZn(KMh23qz3qz"`iu#0<IVdl}23LYZ ;[-Py{} /RT}   & , 2 8 > u w         !!!$!1!F!|!!!!!""!"7"n""""""",#o#x#########$M$O$$$$$$$$$%%&&&X&Y&Z&&&&'1'2'3'''''''((J(z((()>)a)))) *?*n****+;+p+++0,^,},,,+-w----.3.H.p......//m/////$0Y0000191111122F2223.303N3333.4C4k444445f5h555$6b666667W7y7777-8B8j8888889T99999 :@:::: ;;;^;;;;;;;<d<<<=&=X====>;>m>>>>>>>>?`???@@#@U@@@@@ AA/A?A[AlAAAAAA=B{BBBBB)CpCCCCCD+D=DoDDDDBEEEEEF7FlFFFFFF&G6GGG[GmGGG*HhHHHHHI\IrIIIIIIII J JAJJJK.K0KNKKKKLL;LNLLLLM?M@MuMMM;NbNdNNNN0ObOwOOOP#P5PgPPPP QHQQQQQQ4R{RRRRSPSrSSSSSSTYTTTTULUUUUV7VNVOVtVVVV&WWWWWW)XIXwXyXXXX Y"Y=Y]Y_YYYYZEZxZZZZZ%[e[[[=\\\^\`\\\\\\0]_]]]]]^^7^T^|^^^^^^_9______"`3`W`h`{````,aJakaaaaa bb0b}bbbbbc*cNcacqccccccccd!dEdWdgdzdddddddde*eveeeeeff'f8fIfmf{ffffffff gg0g@gOgagpgggggg h,hShphhhhh-iKi[iiiiiij^j|jjjjj k-k@kAkkkllltlulvlllll m m)omonopoqoooSpTpVpWpppqqqYrZr[r]r^rrrssssCtDtttt~uuuuuuuv v"v#vvv.w/w0wxxxxxxx(y)y*yyyyyJzKzzzz { { {H{I{{{{||||||||}/}[}\}}}}~~~ ~g~h~~~()*mnoFGƀǀ -._āԁՁց57mւ ;<˄)gڅCd./0opڎێ܎ d;<SToՐ֐#$VWXijk!"01:;<=ijN~ǔȔ۔3BCDEFv/MNOPQh'Z[\]^}ٗڗۗܗݗE[\]^_~ŘƘǘȘɘ6789:ߙLMS֚Cܛ )*WXb;<Q՞*;ß Ơ>?p34Kdۢ 1bcyԤ4fgp=>Gئ٦CWpq}ΧaQRթ&;<Fmnx 0\]rstuJKLM0129:|}   "NO_wμ 3Fؽ ()Wp|о^ݿ,><=6789 !"# ABWX ,PQR%23Fc#?[iz34`b>?>?"#hBXl;CRS3PQfghi/^,x12x'/|=>?de<=_34LMi*+st #$Lyde/OZs '5FQj68z{PXY  UV2|}Gst 34~ XOTU de89  V9:PQl-.r/0X()op  :Ze~2@Q\u  DF !bjk !klB"MN XY5Nvw   U V    4 5       W X      . { |       - {     =UVW_`%Rt=>\(3Li|*C[tHI-5 56d .Lh~IQ  [ \    ! !O!!!!!<""""###F#G####$$i$j$}$$$$3%4%d%e%f%%%%=&>&&&&&&&&8'R'S''''''**L-M-H/{/|/}///// 0%0G0g0000000!1`1m1n111111122/2K2^2z2222222 3353N3n3o3333304~44455p5q5r5556(6)6w6x6y6z6667U7V777788[8c8888'9)9r9s99 : :;:<:::::D;E;F;;;<<\<]<<<< =$=%=q=r=s===>P>Q>>>>>>>?V?p?q???? @!@tBuBBBBBB CBC]CCCCC D D)DXDDDDDDDEE6EIESEfEEEEEEEEF(FAFQFlFFFFFF#G$GjGGGH HHFHHHHHIIPIQIqIrIsItIIIIGJHJJJJJ!KIKJKKKKKK#LqLrLLLLMPMxMyMMMMM N NQNNNNN1O2OFOOOOOOOOCPDPPPPQQ\Q]QsQtQQQQQFRGRwRRRRTTTTUUUUU(W)W*W+WFX|X}XXXXX Y%YGYgYYYYYYY!Z`ZmZnZZZZZZZ[[/[K[^[z[[[[[[[ \\5\N\n\o\\\\\&]r]s]]]]^@^H^^^^ _ ___U_V____/`F`G````aNavawaaaaa b bQbbbbbbcbcccccc#d$dkddddeJeKe^eeeeffffYfZffff4g5gvgwggggghh_h`hhhhhjjjjkk;khkkkkk l lRlSlqlllllmm=mHmam~mmmmmmmn#n4n?nXnpnnnnnnnoooYoZoooo1p9p:pspppp4q\q]qqqqqqq:rrrrrrssZssssssttttttu@uuuuvvvLvMvvvv)w*wtwuwwwww=x>x?x@xAxxxxyy\y]yyyyyyz8z9zzzzzzz}}}}~~~~̀΀πЀ^_`ւ%@b ;z؄,6Iexυڅ $4OhBۇ.6CDՉ։BJ  OPI̍DEGюab '(tuvwMNґӑSlmefijcde34IJr۝AB֞"#6Ss~ǟџ/KYjuϠ#$YZlnGHޥ,zȦ`9ALMߩ%-.t|ɪ@ABʫGHw !oqIJޮ߮@Z[1~ðİ8EFPwxڷ۷ܷ¸øĸŸƸTUʺ4Vv/n{|̼׼  *=Ylýν(C\|}J0#tefklmHI2Z[1~\_;<OIJ !bcyzABstMNlm:Uw!P.AK^z 9Id},-rJ-.78bcLtu  P1~=>bcv*+,-qrIJ %&klBd,-Kz 9Vis 0HaqUV2e%&lNVbc'(WQS,-rs89_`f   Y Z         5 W w      0 o | }       ! + > Z m         ) D ] } ~     22hp5678|}#B`~7XV^!#fg)*^  WXYZ/0st9:`aj$%567LMu ! E F     !&!'!:!W!w!!!!!!!""3"O"]"n"y""""""#'#(#S#U####.$/$t$|$}$$$/%m%%%'&_&g&&&&,'-'.'/'q'r'' ( (V(^(_((((")#)r)s)t)u))))I*J*y*z****++S+U++++(,),n,o,,,,-.-/-{-|-}-~--- .X.Y......./`/y/z/////00)3*3W3X3Y3n3o33334#4C4g4h44444;5H5I5\5y5555555 6&696U6q666666667)7I7J7o7q7777G8H8888889F9o9999:=:p:x::::9;:;;;{;|;;<<Z<b<c<<<<&='=w=x=y=z====I>x>y>>>&?N?O?????&@o@p@@@AAAA8A9AAAAAAABaBBBBBBBCfCCCCCDDEDFDGGHGIGJGHHHHIIJIKIIIIIIJ2JMJoJJJJJJKHKKKKKKKK L'L:LDLWLsLLLLLLLMM2MBM]MvMMMMMMNNYNNNNNN'O/O~OOOOO>P?P@PAPPPPQ[QqQ|QQRRR SS;Syǫ:;̬ͬ`a̭ܭ)QR,-s¯`bvİ78ɱʱ^_fٳABIJKLɶʶ˶̶efgh   jkl׺6Vz{»O\]pѼ :MiȽ $=]^׾ؾjkHpqK%^$Ew D} !"i{?ADEtghijAB8RSY)*@A\BTUVW~'Tv>?] *5Nk~!,E]v]^9ACv~@A"pqImo45n/0|~]_)QR89 !opEF'uv2?KLM    rst4567D/012UVWde 8QRzJx4?Ngz78KL0Gq-:Op+V+FfFAl)e+Ww7h Z%Z1h DyS- . d e f        ` a       % C D E S    %`WXij4|F~D)*+>1s![23Pfz{J7LM,xM12yz{NajFi./uC    !!*!i!j!!!!!!!""" "(""""""#(#)#*#,#K#Y#Z#[#]#j#k#z################## $ $$$$$J$K$L$N$T$d$e$f$i$r$$$$$$$$$$$$$$$$$$$0%1%5%7%O%c%&&&&-&E&F&G&I&[&&&&&&&&&&''r's'{''''''''''''' (%(&('()(=(Q(e(f(j(l(((U)V)W)Y)h)w)x)y){))))))))))))))))))*** *********+*,*-*7*A*B*F*H*O*_*++++#+H+I+U,V,,,.-/-7->-Q-c-d-e-f-g-....m/n/r/t///c0d0e0g0q000000000000000000001#11111111112%2&2'2)242?2@2A2C2N2Y2Z2[2]2i2222222222222222 3 3 3333)3*3,3-3.3/3J3K333333444`5a5b5c5x5y5n7o77777::: > >.?/?@@AA[D\D]DzD{DFIIKKMMOORRSRSSTTVTWTfT|T}T~TTT&X'XQYRYSYnYoYZZZZ\\\\\\\]]^^__``abbcccgeheeeeee=fGfffg*g+gagbgggg=h>h_h`hhhhhi*i+i{iiijRjSjjj*kzkkkklSlTllll8momqmmmmm n n[ngninnnooRoo/p0pppppp0q1qqqqq9rGrHrrrrrVtWtttttJuuvv5v6vvv{y|y}y~yy{{f{g{<|=||||}}}}7~A~r~~~PQ?ʈˈT89׌$rɎ.|}ߑ.=IJKD͔1yzTUtu_`Ƨǧȧ  ЪѪ۫lկ89 Z[˵nиѸV4lWhiLS!#U%')q @0l$defaIKM#q [E/} n XB,zdfhD56RTz>@BBDpXO 5I5J4[\<=>Z\FGH>?l 2n"^N>z;./0*v  _,.];=?"[gi#tu`b!rt-/~?AaJLNz|~R (j"d Z          8 z    &      S T   2rsa6} R'nC_4{   rsP5z_D+w^DE   +!x!!"""c"""0#1#W#{$|$}$$%W%%%F&&&)'2''''&(~(((9):)))*h**+Q+++E,,,6-x--..1....E/////0h0j00001\1^11112P2Q22222$3`3334P4445@5|55506l6m6n66677F7777708l888 9\999:L:::;<;h;j;;;;J<K<L<w<<<<2=4=a===>Q>>>?A?}???1@m@@@AXAYAZAAB[B]BBBB CGCCCC7DsDDD'EcEEEECFDFFFFF(GsGtGGGGGG@HHHHH3I JJJYJJJKKBKKKKK8LtLLL(MdMMMNTNUNVNNNN6OrOOOOOO6PaPPPP#Q%QQQQQRAR}RRR1SmSSS!T]TTTUVUUUU9V;ViVVVWYWWWW9X:XvXXX*YfYYYZVZWZZZZ9[u[[[)\e\\\]U]]] ^E^v^^^*_f___`V``` aFaaaa6b7bbbb cGcccc7dsdtddd(edeeefffcfkfff8g:glgEhFhrhshhiPiiiijjjjJkKkkk(lhljllZm\m^mmmnTnVnnnno@o|ooo0plppp q\q]qqqr@rBrorrrs sMsNsssstWttt uGuuuu7vsvtvuvvv&w(wWwwww xHxxxx8ytyyy(zdzezzzC{{{{[|]|^|||}Q}|}}}}$~&~S~~~CI)rɁ2n"^ރ G7sST̆DHoq݈4\ԉLĊDEF MӎYZÏ CDfܐRȑ>y*eۓQǔ=xʕ˕̕1qZЗ()*ژ2V}~˛3t7x;|?BUVW{ݠXijkҡӡXڢ\ޣ_ `st¥DABè@AêEūFȬHɭۭBCDkҮT֯WٰZ۱;|?{>z P_TUVl\89cڼ'()W78uv+HIMd!67;H&HIMcv HIVar)QRVi9$%)5x HIM]sQab0bcgx  !k,-1G9:GRcqr}~^ l $%&'(,;r? %34?@ABCLMNOPTj%&*@VPQUj/cdhuR12z{G 67;R'J`aep?@%&H XYs ,Px$Ht5Mf0CXp+Lu !>Vw7`%Md|,Ys7QpCh&E\!@_~>]|4Tt'Gg3Z},HjCi 6c3Wo2Sq#A[t!<Vr%Jg7Qr4Uo1Om/BUr(?^s3J`v$Ce&EXt2Lcz2Ja)Df|4Rl @ g       # ; U t       0 H j       & = U n       & H t     8Wt4Og ,Lj(Jaw&E\{ 'B[+Cd;Us#@]t1Ib{@^|6Zs,Tk0Jr4Oh";\/\v:Pp , T v      !2!D!n!!!!!!"-"D"b"y"""""##7#O#i#####$$A$Y$~$$$$$%&%D%Y%y%%%%%&$&:&U&l&&&&&'='`'''''(%(F([(w((((()<)Q)q)))))*0*Y*s***** +#+<+V+r++++++,1,J,t,,,,,-2-V-p-----$.>.\.u...../!/?/[/y/////0#0A0[0y00000 1+1@1_1t111112242M2i2222223303G3\3v333333 4$4F4]4y4444445+5R5r55555 6&6?6[6u6666667C7]7x777778)8R8o8888889)9>9V9q999999:,:G:p::::: ;#;P;l;;;;;;<.<F<b<}<<<<<=0=S=t=====>+>G>g>>>>>??8?T?q??????@9@V@m@@@@@A)AMAeAAAAAAB-BBBeB|BBBBBC$CDCcCCCCCCD0DNDhDDDDDD E,ELEdEEEEEEF8FQFwFFFFFFG-GGG_GGGGGGH2HTHqHHHHHI&IBI]IIIIIIJJ@JZJqJJJJKK?KZKsKKKKKKL,LCL^LvLLLLL M!M9MQMgMMMMMMMN0NRNiNNNNNNO!O:OQOlOOOOOOP4PPPhPPPPPPQQ1QKQdQ}QQQQQ R3RRRjRRRRRSS6SVSoSSSSST4TOThTTTTTU!U4U\UUUUUUV2VJVeVVVVVVW?WcWWWWW X)XQXrXXXXXY.Y[YtYYYYZ&ZDZbZZZZZ [G[m[[[[\\9\`\}\\\\\"]B]a]]]]]^6^X^t^^^^_>_i______,`Y`t`````a+aFajaaaaaab;bWbnbbbbbbc3cNcpcccccd8ded|dddd e1e^exeeeeef=fjffffff gg?g`ggggggh:hbhxhhhhhi,iUimiiiiij-jKj_jjjjjjk,kNkikkkkkkl0lJlfllllllm1mOmmmmmmmmn0nLnhnnnnnnoGo\o|oooopp7pTplpppppqBqoqqqq r:rYrrrrrrs1sQsqssssst7t_t{tttttu,uKuxuuuuvCvfvvvvvw4wRwswwwwwwx3xUxuxxxxxy8yTyoyyyyyz)zJzczyzzzzz{4{P{q{{{{|'|C|_|~||||}$}:}^}v}}}}} ~%~K~q~~~~ 2Kx(Lf؀=Wq6P{΂'Qkރ,YЄ9Tmׅ/Hd~<ToՇ4]~6Tn؉2T}ˊAnԋ'?Wtnjߌ>e=\wƎ *?Yt̏!=]-CXvƑ5Lnђ<_˓ 'DYnΔ.F^vؕ #<UoӖCg͗0W~ -Jaԙ.UnК(F\xӛ2ZȜ;Roٝ$Qwʞ2Onӟ #;Wu͠3Lkáۡ!>g7Rd|ң$CbѤ">`xȥߥ8]ܦ3Jgڧ #8Stè٨1JiƩ6Xzݪ0Moի:cƬ,Vz٭  <TŮ0U~ܯ7Wİ)Dhɱ;T|Ȳ3Spϳ0Pjܴ .Gc~Ե 9Un۶7Oe}ŷ=bx޸ ":[sع<^yź7[sͻ4_zμFgӽ*S~9Vpۿ'Rx$@a9Ol2OjBo?X{-F_}Em<c2R~'Tn"Dh/Ts +Dd~"Ot@m!=`'?Wr&@ZvD[Gr9b(T+X/Hs :]|-Z">Yy-Vr2Ld$Jo'Fc.Ki,MrBXv7Ys@b?Wx'Kx0\Ab4Ru $>Ys 8Sl~-?Wp9Sw ;Mbw%>Xr;^}*Pk2Rr&Db;f%@W:Z} 9f<Xt :g Eo/["Op4MgHu/Ts #IoAj'Jc!>Xz4`>b8Rm >W{%Eb  = c       - K h      , E ^      3 X o      = g     !>[} ,If0Lf.Np$Ef@l9UqB^Ce7c 4a=i'BW=^;W}&S{HmJr I p     !+!O!t!!!! "1"U""""""#$#:#`####$2$X$$$$$%E%h%%%%%&A&c&&&&'''N'y''''(C(n(((()))R)~))))%*P*{****+5+W+t++++ ,*,S,,,,,-I-r-----&.Q.q..../9/_/////0:0[0|00001*1L1n111112D2\2p2222222233(3:3P3b3u333333334%494M4`4s44444444 5515D5W5j5}555555566)6=6Q6e6x666666677*7>7R7f7z777777788&898M8`8t88888889,9C9Y9n99999999 : :3:F:Y:l:::::::: ;;/;C;V;i;|;;;;;;;<<)<<<O<c<w<<<<<<<==0=D=Y=m=======>+>@>U>j>>>>>>?6?J?_?~????? @)@D@g@@@@@@A1A[A}AAAAB)BFBmBBBBC'CDC_CCCCCDD:DcD~DDDDE5ETEsEEEEEF8FcFFFFG-GZG{GGGG*HLHsHHHHI5IbIIII J2JNJiJJJJJKu^uuuuuv'vDvavvvvv#wIwqwwwwwx5xTxsxxxxx&yFycy}yyyyzz7z\zzzzz!{N{r{{{{{|4|X|||||}2}T}z}}}}~-~Q~v~~~~/Ci(U|Ā#BfɁ1Sz˂ 8Tp҃ $Kk˄ -Oxم<Yv҆<Zs؇7Smވ7a׉8^yЊ>Z{֋4Pnٌ)Mg/IeҎ +Gh -Fh!Lhڑ(@Vqߒ(Je͓#@cӔ'Ozĕ=XrіGn 1X˘=iܙ3Ktњ#?a| -MnŜ/QuƝ!7Pq 4Ysӟ.Ml֠6Nqԡ3IdzϢ 2Yѣ@Tuڤ$Lr1\}ߦ2Opݧ@]}֨$Qw֩*Wz˪.[{<YtƬ>`ѭAhޮ .Fj/Yt$Kb=eDz!:W{ɳ:Xrд-Jgѵ9ayͶEnDh/W~йEbyۺ)Kj» +AYtȼ=e½*Vw7_ֿ%Rz;a B`&Cl&Ga!Jl#Co1T} 0Wy9Z ,Wy+Q{;e-Jg6\wAd|.Lj9W&R}+V1X{1Lo /Pl*Mq =[HdEq6Y'Rm@m>h?` Hg,Ja~,Y)S}:Pr +Wv?]3\yA_=]AmAYtAn9Ll &?Xj ,Ou8b (E`3[ 7dFo=b.Id&Su4Vr6S} +Nj)Gbz1\-Ok'Ro+Gi @ d  : U w     . K m      / D Z y      @ ]     ( S     0 T x      # E d       8 X z     5 V w  B h  & F f  ) O m  7 ]  5 H [ x      7 U q       1 F a {      ( A \ x        / F ^ z     ' B X r      1 ^      D g      : a |     $ < `       L n      > a       1 I t      ' F d       1 L o       ; Y w     ) V       & A \      ' Q x ! >! _! ! ! ! ! " 8" ^" s" " " " " %# K# h# # # # $ C$ o$ $ $ $ $ % F% m% % % % % & 8& X& & & & ' %' L' s' ' ' ' ( -( W( ( ( ( ( ( ) 9) Y) x) ) ) ) * * +* @* ^* * * * * + + -+ J+ g+ + + + + + , ', G, g, , , , , , - - 3- E- Z- o- - - - - . :. g. . . . . / 1/ D/ q/ / / / 0 0 ;0 W0 s0 0 0 0 0 0 '1 O1 u1 1 1 1 2 <2 i2 2 2 2 2 3 63 [3 y3 3 3 3 3 4 D4 ^4 4 4 4 4 4 5 45 V5 v5 5 5 5 5 &6 C6 `6 }6 6 6 6 7 &7 K7 g7 7 7 7 7 8 %8 R8 v8 8 8 8 9 -9 L9 k9 9 9 9 : $: D: i: : : : ; 3; J; k; ; ; ; ; < =< X< s< < < < < = = 3= H= m= = = = = > 4> P> q> > > > > ? C? k? ? ? ? @ $@ 8@ a@ @ @ @ @ A 2A JA mA A A A A B 3B NB {B B B B C #C @C ZC C C C C C D +D UD {D D D D E E @E bE E E E E F 6F ^F zF F F F G BG kG G G G H 9H ^H ~H H H H I /I AI jI I I I I J @J lJ J J J J %K >K XK wK K K K K L 'L CL kL L L L L M ,M TM iM M M M M M N +N AN mN N N N O (O BO eO O O O O P 'P ?P _P zP P P P P Q Q 1Q EQ aQ Q Q Q Q R .R DR [R zR R R R R S 'S DS `S S S S S S T 'T CT \T sT T T T T T U -U AU ]U U U U U V )V LV kV V V V W =W dW W W W W W X 8X eX X X X X X X X X X X Y Y !Y "Y #Y %Y &Y 'Y (Y JY KY ]Z ^Z _Z yZ zZ Z @[ A[ b[ U\ V\ b\ \ \ \ \ \ &] '] 4] E] F] J] T] U] Y] f] g] k] z] {] ] ] ] ] ] ] ] ] ] ] ] ] ] ] ] ] ^ ^ ^ "^ #^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ _ _ $_ (_ )_ *_ ,_ 2_ t_ x_ y_ z_ |_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ ` ` ` ` ` !` #` *` ;` ?` @` A` C` J` `` d` e` f` h` o` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` a a a a a a a "a -a 1a 2a 6a 8a =a `a da ea fa ha oa a a a a a a a b b b b b Fb Wb Xb Yb \b cb b b b b b b b b b b b b b b b c c c c c c c c c c #c 3c 7c 8c 9c ;c Bc }c c c c c c c c c c c c c c c c c c c c c c c c Rd Vd Wd Xd Yd Zd [d \d ]d ^d _d `d ad bd cd dd fd ld sd wd xd d d d d d d d d d d d d d d d d d d d d d +e /e 0e 4e 6e ;e Oe Se Te Ue We ]e ve ze {e e e e e e e e e e e e e e e e e e e e e e e e e f f f f %f &f 'f *f 1f _f cf df tf wf |f f f f f f f f f f f f f f f f f f f f f f f f f f f f g g g g g g g g .g 1g 7g Dg Hg Ig Jg Mg Sg mg g g g g g g g g g g g h h h 2h 3h 4h 7h i ?i Ai Gi _i di ei fi hi mi yi ~i i i i i i i i i i i i i i i i i i i i i i i i j j j j ^j _j `j lk mk k k l l jm m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m n n n n n n "n /n 0n 1n ;n ?n Cn Fn Sn Tn Un en in mn pn }n ~n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n o o o (o ,o 0o 3o @o Ao Bo Ko Oo So Vo co do eo qo uo yo {o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o p p p p p p p !p %p (p 5p 6p 7p Ap Ep Ip Kp Xp Yp Zp ap ep ip kp xp yp zp p p p p p p p p p p p p p p p p p p p p p p p p p q q q q q %q +q /q 6q Aq Bq Cq Oq Pq Qq Rq Sq Tq Uq \q _q bq dq qq rq sq q q q q q q q q q q q q q q q q q q q q q r r r r r r r 0r 4r 8r ;r Hr Ir Jr `r dr hr kr xr yr zr r r r r r r r r r r r r r r r r r r r r r r r r r s s s s s $s &s 3s 4s 5s t Bt Et Rt St Tt _t `t kt qt ut |t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t u u u u u u #u $u %u 4u 8u { E{ I{ M{ Q{ ^{ _{ `{ { { { :| ;| T| l| m| } } &} '} M} a} x} } } } } } } ~ ~ !~ "~ m~ ~ ~ . J t     V  P E ۂ  < z ڃ ۃ ܃      + , . 9 : < H I K c d f r s u ń Ƅ Ȅ ߄    3 4 6 M N P j k m $$$$$$$$ $ $ $ $ $$$$$$$$$$$$$$$$$$$ $!$"$#$$$%$&$'$($)$*$+$,$-$.$/$0$1$2$3$4$5$6$7$8$9$:$;$<$=$>$?$@$A$B$C$D$E$F$G$H$I$J$K$L$M$N$O$P$Q$R$S$T$U$V$W$X$Y$Z$[$\$]$^$_$`$a$b$c$d$e$f$g$h$i$k$l$m$n$o$p$q$r$s$t$u$v$w$x$y$z${$|$}$~$$$ Ѕ х Ӆ      7 8 : T U W h i k Æ ݆ ކ    A B P ] k x ć Ӈ ׇ ۇ ߇   " # ' 1 5 = B N O T _ d s w ~  ƈ ֈ ڈ ߈   ! / 0 5 B E U Y _ ` d i n v z lj ȉ ̉ ։ ډ    % 7 ; I N U V Z i m y ~ ʊ ˊ ϊ ܊    ( . > ? C R V ] b y z ~ ȋ ̋ Ջ ֋ ۋ   0 1 5 ? D I N _ ` nj Ռ     ( , 2 5 ; < A W \ m q  ƍ ߍ  ! & 8 = D H P Q U _ c n r ~  Ŏ Ǝ ˎ ׎ ێ      , 1 6 7 ; H L a e k l p t x | ŏ ӏ ԏ ؏      ! % T U Z b c d e f g { ܐ ݐ  + , 7 j k v / 0 ; R S ^ В ђ ܒ  > i j u z { ғ ӓ ړ   4 5 < B C ^ Ɣ ǔ Ҕ ה ؔ    ! F G R y z      5 p   ! " # $ 5 6 < H I K R S U Z [ ] c d ڗ ۗ ޗ    * + - 7 8 : G H K ` a d s t u v Ř ǘ Ș ՘ ט ؘ ٘ ژ     9 ; < V X Y v x y י ٙ ڙ W X Y f }    & = > ] ^ _ u     ! h i      < = f g V W u v Ѵ Ҵ 7 κ Ϻ к Ѻ  % & ' 5 9 L M N S    # $ d  ۼ ܼ    - . < = \ ] } ~ ڽ ۽   % & D E _ ` { |   / 0 E F Q R ] ^ i j v w ſ ƿ ǿ ȿ # $ R S u v    ! " * 9 B C L M V W ` a j k t u ~   ! " # + 3 ? @ H T c d l | }    1 c d e f g h i j k n 000000!0!0!00000!00000!00000!00000000000000000000000000000 00 00 00 00 00000000000606060606000000000000000000000006000000000606060@0@0@ 0@ 0@ 0@0@0@060$0$0$0$0$0$0$0$0$0$0$0$060|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!0|!060*'0*'0*'0*'0*'0*'0*'0*'0*'0*'060V)0V)0V)0V)0V)0V)0V)0V)0V)0V)060,0,0,0,0,0,(0,060.0.0.0.0.0.0.0.0.0.000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000٠0٠0٠000000 00 00 00 00 00 00 00 00 00 0 0 0 0 0 0 0 0 0 00 00 0000000000000000000000000000000(00800ʽ0ʽ800ο0ο0ο0ο0ο0ο(00800 0 0 (0(080w0x0x80w0(0(0(00e80e0000000000000H0000H0020202H0000H00000000H000(08(080J0J0J 0J 0J 0J 0J 0J 0J 0J 0J 0J(080f(080h0h0h 0h 0h 0h 0h 0h 0h0h(0800000(00(0(000(000(00&(0(00(0(0000000 0 0 0 0 0 00(0(0000(0000000(00d0d(000(000(000(00Y0Y0Y0Y000000000\0\0\00 0 0 0 0 0 0 0 0 0 0 00?0?0?0?0?0?00O(0O0i0i0i0i0i0i0i0i(0O0S0S0S0000000000000800H000H00008000000000800(080 0!0!80 0080 0080 0n0n80 0080 0R (080 0 (080 0  0  0  0 0 80 0 0 00w 0w 0w 0w 0w 0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0w 0p(0p00(0p0-0- 0- 0-(0p0{0{ 0{0{(0p0000w 03030303030303030303030303030303030303030303030303030w 0o0o0w 0s0w 0V0V0w 00w 0w 00w 0w 000w 000w 000w 00w 0000000000000w 0"0"0"0"0"0"0"0w 0w 0#0#0w 0#0#0#0w 0%0w 0^%0^%0^%0^%(0^%0%0%0%0%0%0%0%0%0%(0^%(0^%0'0'0'0'(0^%0>(0>(0>(0>(0>(0>(0>(0>(0>(0>(0>(0>(0>((0^%0a*0a*0a*0a*0a*0a*0a*0a*0a*0a*0a*0a*0a*0a*0a*0a*0a*0a*0a*0a*0a*0a*0a*0a*(0^%0`.0`.0`.0`.0`.0`.0`.0`.0`.0`.0`.0`.0`.0`.0`.0`.0w 010101(010/20/20/280/20=3H0=30O30O30O30O30O30O30O30O30O30O30O30O30O30O30O30O30O30O30O30O30O30O30O30O30O30O30O3 0O3 0O3 0O3 0 O3 0 O3 0 O3H0=30J:0J:0J:0J:0J:0J:0J:0J:0J:0J:0J:0J:0J:H0=30<H0=30<0<0<0<0<0<0<0<0<0<0<0<0<0<80/2H0>H0>0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?0 ?H0>0C0C0C0C0C0C0C0C0C0C0C0C0C0C0C0C0C0C0C0C0CH0>0G0G0G0G0G0G0G0G0G0G0G0G0G0G0G0G0G0G0G0G0G(010 K80 K0!KH0!K01K01K01K01K01K01K01K(010cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL0cL00S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0S0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[0[00ke0ke0ke0ke0ke0Lf(0Lf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf0qf(0Lf0l0l80l0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n0n80l0q0q0q0q(0Lf0r0r0r0r0r0r0r0r80r0v0v0v0v0v0v0v0v0v0v0v0v0v0v0v0v(0Lf0y0y0y80y000000000000000(0Lf0ځ0ځ0ځ0ځ0ځ0ځ0ځ0ځ0ځ0ځ0ځ0ځ0ځ0ځ0ځ0ځ0ځ0ځ0ځ0ځ0ځ0ځ0ځ0ځ(0Lf0t0t0t0t0t0t80t0ˈ0ˈ0ˈ0ˈ0ˈ0ˈ0ˈ0ˈ0ˈ0ˈ0ˈ0ˈ0ˈ0ˈH0ˈ0000000000000ke00000000(0000 0  0  0 0 0 0(00@0@0@0@0@0@0@0@0@0@0@0@0ke0K(0K0M0M0M0M0M0ke00000000(00Ν0Ν0Ν 0Ν 0Ν 0Ν 0Ν 0Ν 0Ν0Ν(00,0,0,0,0,0,0,0,0,0,0,0ke0D0D0D0D0D0D0D0D0D0D0D0D0D0D0D0D0D0D0D0ke00000000000000!0000000000000d0d0d0d0d0d0d 0d 0d 0d0d0d0d0IJ0IJ0IJ 0IJ 0IJ0IJ0IJ0IJ0IJ0IJ 0IJ0IJ0IJ0IJ0IJ0IJ0IJ0d0d0?0?0? 0?0? 0?0? 0?0? 0?0? 0?0? 0?0?0?0d0?0d00d000d0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ0ɺ(0ɺ0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 80 000000000000000000000000000000000000000080 0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$%J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J0J(0ɺ000(0ɺ80000000000000080000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000H00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000800 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 800$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$800Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk0Yk800${0${0${0${0${0${0${0${0${0${0${0${0${0${0${0${0${0${0${0${0${0${0${8008~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~08~80000000000000000000000800H0H0H0H0H0H0H0H0H0H0H0H0H0H0H0H0H0H0H0H0H0H0H0H0H0H800~0~0~0~0~0~0~0~0~0~0~0~0~0~0~0~0~0~0~0~0~0~0~800c0c0d0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0t0d000000 0 0 0 0 0 00000000000000000000000000000d00000000000000000000000000000000000000000000000000d00000000000000000000000000000d0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ0ݭ(0ݭ0$0$(0ݭ0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.(0ݭ0A0A0A0A0A0A0A0A0A0A80A01010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101(0ݭ000000000000800000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000(0ݭ0000000000800000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000(0ݭ0c0c0c0c0c0c0c0c80c000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000(0ݭ0'0'0'0'0'0'80'0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/0n/(0ݭ0@0@0@80@0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B(0ݭ0R0R0R0R0R0R0R0R0R0R0R0R0R0R0R0R80R0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX%%%%%%%% % % % % %%%%%%%%%%%%%%%%%%% %!%"%#%$%%%&%'%(%)%*%+%,%-%.%/%0%1%2%3%4%5%6%7%8%9%:%;%<%=%>%?%@%A%B%C%D%E%F%G%H%I%J%K%L%M%N%O%P%Q%R%S%T%U%V%W%X%Y%Z%[%\%]%^%_%`%a%b%c%d%e%f%g%i%j%k%l%m%n%o%p%q%r%s%t%u%v%w%x%y%z%{%|%}%~%%%0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX0lX(0ݭ0h0h0h80h0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j0j(0ݭ0z0z0z0z0z0z0z0z0z0z0z0z0z0z0z0z0z0z0z0z0z80z00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000(0ݭ0000000000000800000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000(0ݭ0E0E0E0E0E 0E 0E 0E 0E0E0E0E0E0E0E0E0E0E0E0E80E0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{0{(0ݭ0000000000000080000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000(0ݭ0000000008000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000(0ݭ0000000800 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0ݭ0+0+0+80+0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0(0((0ݭ0 00 00 080 00P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P30P3(0ݭ(0ݭ0kD0kD0kD0kD0kD0kD0kD0kD0kD0kD0kD80kD0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI0qI(0ݭ0]0]0]80]0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`0`(0ݭ0Wq0Wq0Wq80Wq0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u0 u(0ݭ000000000000800l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%&l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l0l(0ݭ(0ݭ0u0u0u0u0u0u80u00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000(0ݭ0000000000000000008003030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303030303(0ݭ0h0h0h0h0h0h0h0h0h0h0h80h00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000e0e0e0e0e0e0e0e0e0e0e0e0e0e0e0e0e0e0e!0e!0e0e0e0e0e0e0e0000000000000000}(0}00000000000000000000000000000000000(0}0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&0&(0}0000000000000000000000000800k 0k 0k 0k 0k 0k 0k 0k 0k 0k 0k 0k 800~0~0~0~0~0~0~0~0~0~0~0~0~0~0~0~0~0~0~0~0~800Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q(0}00000000000000000000000000000000000000000000000000000000000000000000000000800!0!0!0!0!0!0! 0! 0! 0!0! 0! 0! 0! 0! 0!0! 0! 0! 0! 0! 0! 0! 0! 0! 0!0! 0!0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0!0! 0! 0! 0! 0! 0!0! 0! 0! 0! 0!0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0!0! 0!0! 0! 0! 0! 0!0! 0! 0! 0! 0! 0! (0!(0! 0! 0! 0! (0! (0! 0! 0! 0! 0! 0!0!0! 0! 0! 0! 0! 0!0!0! 0! 0!0!0! 0! 0! 0! 0!0! 0! 0! 0! 0! 0! 0! 0! 0!0! 0! 0! 0! 0! 0!0! 0! 0! 0! 0! (0!(0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0!0! 0! 0! 0! 0! (0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! (0!(0! 0! 0! 0! 0! 0!0!0!0!0! 0! 0!0!0! 0! 0! 0! 0!0! 0! 0! 0!0!0!0!0! 0! 0! 0! 0! (0!(0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! (0!(0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! 0! (0! 0! 0! 0! 0! (0! 0! 0! 0! 0! (0! 0! 0! 0!0!0!!0!!0!0!0!0!0!000U30U30U30U30U30303030303030303(03050505 05 05 050505(030:0:0:0:0:0:0:0:0:0:0U30U30U30D0D0D0D0D0D0D0D0D0D0D0D0D0D0U30S0S0S 0S 0S0S0S0S0S0S0S0S0S(0S(0S0yY0yY0yY(0S0Z0Z0Z0Z0Z0Z0U30\0\0\0\0\0\0\0\0\0\0\0\0\0U30c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0c0U30r0r0r0r0r0r0r0r0r0r0r0r0r0U30\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0\v0U3000000000000000000000000000000000000000000000000000000000000000000U30<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0U3000000000000000000000000000000U300000&&&&&&&& & & & & &&&&&&&&&&&&&&&&&&& &!&"&#&$&%&&&'&(&)&*&+&,&-&.&/&0&1&2&3&4&5&6&7&8&9&:&;&<&=&>&?&@&A&B&C&D&E&F&G&H&I&J&K&L&M&N&O&P&Q&R&S&T&U&V&W&X&Y&Z&[&\&]&^&_&`&a&b&c&d&e&g&h&i&j&k&l&m&n&o&p&q&r&s&t&u&v&w&x&y&z&{&|&}&~&&&0 000000000 0 0000 0 000000000000000000000000000000000000000000000000000000000000000 0 000000000000000000 0 0 0000 0 0000 0 0000000000000000000000000000000000000000000000 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 00 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 00 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 00 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00U300000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&'00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000'''''''' ' ' ' ' ''''''''''''''''''' '!'"'#'$'%'&'''(')'*'+','-'.'/'0'1'2'3'4'5'6'7'8'9':';'<'='>'?'@'A'B'C'D'E'F'G'H'I'J'K'L'M'N'O'P'Q'R'S'T'U'V'W'X'Y'Z'['\']'^'_'`'a'b'c'e'f'g'h'i'j'k'l'm'n'o'p'q'r's't'u'v'w'x'y'z'{'|'}'~'''00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000!0!00000000000Y 0Y 0Y 0Y 0Y 0[ 0[ 0[ 0[ 0[ 0[ 0[ 0[ 0[ 0[ 0[ 0[ 0[ 0[ 0[ 0[  0[  0[ 0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[  0[ 0[ 0[ 0[ 0[ 0[  0[  0[  0[  0[  0[ 0[  0[  0[  0[  0[  0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[  0[  0[  0[  0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[  0[  0[  0[  0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[  0[  0[  0[  0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[ 0[ 0[  0[  0[  0[  0[  0[ 0[  0[  0[  0[  0[  0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[  0[  0[  0[  0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[  0[  0[  0[  0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[  0[  0[  0[  0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[  0[  0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 (0[ 8 0[ 8 0[  0[  0[  0[  0[  0[  0[  0[  0[ 8 0[ 8 (0[ 8 0[ 8 0[  0[  0[  0[  0[  0[  0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[  0[  0[  0[  0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[  0[  0[  0[  0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[ 0[ 0[  0[  0[  0[  0[  0[ 0[  0[  0[  0[  0[  0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[  0[  0[  0[  0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[  0[  (0[  0[  0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[ 0[ 0[ 8 0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[  0[  0[  0[  0[  0[  0[ 8 0[ 8 0[ 8 0[ 8 0[  0[  0[ 80[ 80[ 80[ 80[  (0[  0[  0[  0[  0[  0[  0[  0[ 80[ 80[ 80[ 80[  0[  0[ 80[ 80[ 80[ 80[  0[  0[ 80[ 80[ 80[ 80[  0[  0[ 80[ 80[ 80[ 80[  0[  0[ 80[ 80[ 80[ 80[  0[  0[ 80[ 80[ 80[ 80[ 80[  0[ 0[ (0[ (0[ 0[ 0[ 0[ 0[ 0[ 0[ 0[ 0Y 0n 0n  0n  0n  0n  0n  0n  0n 0n  0n 80n 80n 80n 80n 80n  0n  0n  0n 80n 80n 80n 80n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n 80n 80n 80n 80n 80n  0n  0n  0n 80n 80n 80n 80n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n 0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n 80n 80n 80n 80n 80n  0n  0n  0n 80n 80n 80n 80n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n 0n 0n  0n  0n  0n  0n  0n  0n 0n  0n  0n 80n 80n 80n 80n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n 0n 0n  0n  0n  0n  0n  0n  0n 0n  0n  0n  0n  0n  0n  0n  0n  0n  0n 80n 80n 80n 80n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  (0n  0n  0n 80n 80n 80n 80n  0n  0n  (0n  0n  0n  0n  0n  0n 0n 0n  0n  0n  0n  0n  0n  0n 0n  0n  0n  (0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n 80n 80''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''(n 80n 80n 80n  0n  0n  0n 80n 80n 80n 80n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  0n  (0n 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 80 | 0X 0X 0X  0X  0X 0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X  0X 80 | 0 0  0  0  0  0  0  0 0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  80 | 0 0  0  0  0  0  0  0 0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0 80 80 80  80 | 0 0 0 0  0  0 0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0 0 80 | 0 0 0 0  0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 80 | 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 80 | 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 80 | 0× 0× 0× 0× 0× 0× 0× 0× 0× 0× 0× 0× 0× 80 | 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 80 | 80 | 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 80 | 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y !0y !0y !0y !0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 0y 00 0 0 0 0 0 0 0 0 0 0 000$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ @0$ 0$ 0$ @0$ 0$ 0$ 0$ 0$ 0$ 0$ 0$ @0$ @0$ 0@0@0@0@0@0@0@0@0@0@0@0@)0@0@0@0@0@0@0@0@0@)0@0@)0@0@)0@0@)0@0@0@0@0@0@0@0@)0@0@0@0@0@0@0@0@)0@0@0@0@)0@0@)0@0@0@0@)0@0@)0@0@)0@0@)0@0@)0@0@)0@0@)0@0@0@0@)0@0@)0@0@)0@0@)0@0@)0@0@)0@0@)0@0@)0@0@)0@0@)0@0@)0@)0@)0@0 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000HM P]kkkkk~ OOOOOe|||||#WWWWW:::<<jjjjjj      1111147M!$m&+3B56U89\::t;<<=>!??@@EBFCJD#EFFGHIJ)ѢkVG,qh X(u [ $#')*D-g2<4E^gm{yz}{iʉh^_ՠIjTuO?*b a'sV#m'e.3.6? CDwG MPEV Y\_(dqjGmMquvK}@АW՟ $eɼO=81~A  w 0$(*C/z267;1>CFJMO0RY\_dfHiks=wzC~ԛ;&uh`4 xZ  d!#&+/.5P9@EG\0irtA}B;͕qƭܿM$0e  &$*?.58EfU#b{B@Y »X^@_^1 h cm { u < j ;      !"$%&'()*+,-./013456789:;<=>?@BCDEFGHIJKLMNOPRSTUVWXYZ[\]^_abcdefghijklmnoqrstuvwxyz{|}~   "$%*+.037;>AFHIKNQSUX[]ckorxz{}  "$&)*.0347:<>@BEGHKMOQTVXZ\^acegjlopstvx{~  .=LRTVXY]_abdeghjkmoprtvy{|   " % o R  6 G J V X ^ ` e i l  D- h&+527=IRT]e6r~؊\0 7@8oPs j<0!!!"W"""|'X+-215w9=CFIlNpRrUVQZM^`eYhjlspuwzc}R US:X{ReADfGR{+*BH   P!$%(*+,.02=57<?CG_K OQT Xy[_cehIleo5rQtu yz~bÒuɠ{~14,/ۥޥorƧbuX(S6a>S[3]Fh  FJ!$&'A-/36>@COFI&MQSUW[]1`ce+hnjEmo\rt6yv{J}HyАԒ|F&m˷-tAv48  EJZ$&#*p-/1g57h;3>BD+GJLqO:RW}Z\z^|cXf8L8c8z8P9:;;=>>?,?@,@^@x@@@@ADAgAER[gktx"|"o *  I|"(d/k5;@@DI.N$S)Va[^cgkpty|{aɜ ۮ=L7p%8do1,#]7Q$Der'0<AP`4ly^+8*joN Q;pZ`|k:   .qI"$U'Q*W-/2N5P8;=@BE7HJM{P'SUXB[]%`be iJloRrXu=xz}" ܕÞuΦį6@Ol&2I}<>)$LB;5S  "D&)V-0347;>sADCEFHJLjOR VY\`[cfLjmp*suxW{N~bʇ#C@7 WֹNJ}H\I y szCa  7 `    @ n  ! $ ( * - 0 q4 7 : ?= u@ C F J L (P >S V Y \ _ `b Oe Zg _k k k k l Ml l l m m 3m 4m em m m n 5n Xn xn n n n n o 5o Qo jo o p 9p p p p q 9q ;q Pq Uq q q r r r r r r r r 's hs s s s s t 6t ^t t t t t u u >u @u Uu gu u u Wv v v v v 3w `w vw w w w w x Bx x { { { { | 8| Y| x| | | | | | | } $} e} } } } } } ~ ~ 8~ O~ o~ ~ ~ ~ ~  % F h      ; U Ԁ  . G m с ! : c  8 O u à ݃ 7 Y Ԅ  H d ͅ ؅ M z ۆ  U q ˇ  ' H N _ o ڈ  / J l Z 1 P r  Q & S  5 ̕ ѕ  [ . h З * X ˘  6 w ݙ  2 i  ! k , Y ; o ȝ < & E d & h   ,  ; m {  / N   R ; Z ͥ  0 V c p  R t Ч  + h D " ؼ  Elĩ>h1#2AQ`p   !#&'(),-/1245689:<=?@BCDEGJLMOPRTVWYZ\^_`abdefghijlmnpqstuvwy|~    !#%'(+,-/125689;=?ACDFIJLNPRSUWY[]_`bdfhikmnqruwyz|}    !"#$%&'()*+,-/0123456789:;<>?@ABCDEFGHIJKMNOPQSUWZ[\^`cfilnqsuwxz}~                        ! # $ & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n p q r s t u v w x y z { | } ~                            ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~                           ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 7 8 9 : ; < = > ? @ A B C D E F H I W Y Z [ \ ] _ a f g h j k m `+++++,B,m,,//"0G0m000000000001+1F1H1I1K1j1w11111112 2 22.2?2Z2]2^2`22222222#3>3A3B3D3c3333333 4;4=4>4@4_44444444555555I5d5g5h5j5555555556 6 6 6+656P6S6T6V6u666666666777$7>7Y7\7]7_7~77888888888889a9|999999999: :^:y:|:}::::;;;;&;Y;t;w;x;z;;;;;;;<7<R<U<V<X<w<<<<<<<A=\=_=`=b======= >H>c>f>g>i>>>>>>>? ?;?>???A?`??????@@@@@@@AA!A"A$ACA\AwAzA{A}AAAAAAAB3BNBQBRBTBsBBBBBBBBCCCC8CNCiClCmCoCCCCCCCCCDDDD>DcD~DDDDDDDDDDEE*E-E.E0EOEnEEEEEEEEEEEFLFgFjFkFmFFFFFFFG5GPGSGTGVGuGGGGGGGGHHHH5HHHcHfHgHiHHHHHHHHHIIII=ImIIIIIIIJ J J J,JBJ]J`JaJcJJJJJJJJJK K K K,K=KXK[K\K^K}KKKKKKKKLLLL&LCL^LaLbLdLLLLLLLLLMMMM&MQ?QAQ`Q{QQQQQQQQQQQ RR1R4R5R7RVRRRRRRRRSSSS6STSoSrSsSuSSSSSSSSSTTTT=T`T{T~TTTTTTTTTTU#U&U'U)UHUTUoUrUsUuUUUUUUUUUVVV V?VZVuVxVyV{VVVVVVVVV W W WW.WWWrWuWvWxWWWWWWWWWXXXX4XDX_XbXcXeXXXXXXXXXXXYY!Y:YUYXYYY[YzYYYYYYYYZ Z ZZ-ZEZ`ZcZdZfZZZZZZZZZ[[[[<[I[d[g[h[j[[[[[[[[\!\$\%\'\F\i\\\\\\\\\\\\]*]-].]0]O]q]]]]]]]]]]]^^8^;^<^>^]^t^^^^^^^____'_L_g_j_k_m___````&`y``````a3a6a7a9aXaaaaaab4bObRbSbUbtbbbbbbb*cEcHcIcKcjccccccc%d@dCdDdFdedddddd eHecefegeieeeeeeef#f>fAfBfDfcfffffffg8g;gg]ggggggg8hShVhWhYhxhhhhhhiViqitiuiwiiiiiiijTjojrjsjujjjjjjjjkk!k"k$kCk`k{k~kkkkkkkkkl;lVlYlZl\l{lllllll'mBmEmFmHmgmmmmmmm1nLnOnPnRnqnnnnnnn%o@oCoDoFoeoooooooCp^papbpdpppppppqXqsqvqwqyqqqqqqqr\rwr{r|r~rrrrrrrsPsksospsrssssssst3tNtRtStUttttttttt6uQuUuVuXuwuuuuuuvrvvvvvvvw w w w,wQwlwpwqwswwwwwwwx:xUxYxZx\x{xxxxxxxy8ynߜ 4OSTVuɝ%?Z^_aӞ 1Pkoprٟݟޟ (,-/Nɠ͠Πנ̸ϸ=rrr΂Fɶ :"Stu-u~&~5~@O׷#Hn ˯ K u  3 c m XXXXX X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%̕:_CXXXXXXXXXXXXXXLSV(/24!t!t!8<=@P0<( $ N  9'0 ;#  s"*?` : c $X99? 9'0   <"HNHN̙ '$  "~   6!HNHN̙L G !  B HNHN̙    BHNHN̙r   <HNHN̙r E   BHNHN̙L[%   BHNHN̙p}   BHNHN̙}!   BHNHN̙"%   BHNHN̙ z $ l  0G`HF I`[f  s *GH4Ir  BHNHN̙@ ' )   BHNHN̙7')   BHNHN̙')   BHNHN̙')   BHNHN̙y')   BHNHN̙q'!)   BHNHN̙h"'%)   BHNHN̙;),    BHNHN̙)k,  ! BHNHN̙)_, ZB " S Dq<%qj'TB # C D@ ~,K%~,f" $ s *G**HI."T$ % <HNHN̙9E ZB & S D..pZB ' S D..ZB ( S DQX!R"ZB ) S DYZZB * S DYZ~ + 6 HNHN̙L    - B HNHN̙\   . B HNHN̙   / B HNHN̙   0 BHNHN̙ @JT  1 BHNHN̙" >!R"  2 BHNHN̙X##$  3 BHNHN̙7I /0 ZB 4 S D__ 5 BHNHN̙I ] ~ 6 6HNHN̙ -@l0  7 BHNHN̙v-/ ZB 8 S D / / 9 BHNHN̙<%#=' B S  ??`$͸m ;}$2t _Toc425818978 _Toc76869005 _Toc422544862 _Toc422643711 _Toc423227157 _Toc76869006 _Toc76869007 _Toc65978720 _Toc76869008 _Toc65978721 _Toc76869009 _Toc76869010 _Toc76869011 _Toc76869012 _Toc76869013 _Toc76869014 _Hlt72302554 _Hlt72302555 _Hlt72302751 _Hlt74023660 _Hlt72302789 _Toc76869015 _Toc527340372 _Toc76869016 _Hlt73405351 _Hlt72302725 _Hlt72302726 _Hlt62540914 _Hlt73405424 _Hlt73405425 _Hlt42063318 _Hlt42063319 _Hlt62540924 _Hlt72302740 _Toc38350713 _Toc48621291 _Toc49325339 _Toc62559263 _Toc63757668 _Toc65027244 _Toc66016468 _Toc66242688 _Toc67190332 _Toc68574076 _Toc70232411 _Toc71618936 _Toc72217700 _Toc72302935 _Toc72817229 _Toc73857808 _Toc74038833 _Toc74039089 _Toc74464636 _Toc74622235 _Toc74628896 _Toc76869017 _Toc355590655 _Toc355590835 _Toc355590938 _Toc355591009 _Toc355591128 _Toc355591501 _Toc355591538 _Toc355592146 _Toc425208706 _Toc425638399 _Toc425818980 _Toc425819627 _Toc76869018 _Toc76869019 _Toc76869020 _Toc76869021 _Toc76869022 _Toc65978731 _Toc76869023 _Toc76869024 _Toc76869025 _Toc76869026 _Toc76869027 _Toc76869028 _Toc76869029 _Toc76869030 _Toc76869031 _Toc76869032 _Toc76869033 _Toc76869034 _Toc76869035 _Toc76869036 _Toc76869037 _Toc76869038 _Toc76869039 _Toc65978749 _Toc67190355 _Toc76869040 _Toc65978751 _Toc76869041 _Toc65978752 _Toc76869042 _Toc65978753 _Toc76869043 _Toc65978754 _Toc76869044 _Toc65978756 _Toc67190361 _Toc76869045 _Toc65978757 _Toc76869046 _Toc65978758 _Toc76869047 _Toc65978759 _Toc76869048 _Toc65978760 _Toc67190365 _Toc76869049 _Toc76869050 _Toc76869051 _Toc76869052 _Toc76869053 _Toc76869054 _Toc76869055 _Toc76869056 _Toc425208785 _Toc425638483 _Toc425819066 _Toc425819697 _Toc76869057 _Toc364667807 _Toc425208748 _Toc425638441 _Toc425819022 _Toc425819655 _Toc65978769 _Toc67190374 _Toc76869058 _Toc65978770 _Toc76869059 _Toc65978771 _Toc76869060 _Toc65978772 _Toc76869061 _Toc65978773 _Toc76869062 _Toc65978774 _Toc67190379 _Toc76869063 _Toc76869064 _Toc36275317 _Toc76869065 _Toc36275318 _Toc76869066 _Toc36275319 _Toc76869067 _Toc76869068 _Toc76869069 _Toc36275323 _Toc76869070 _Toc36275324 _Toc76869071 _Toc36275325 _Toc76869072 _Toc36275328 _Toc76869073 _Toc36275329 _Toc76869074 _Toc36275331 _Toc76869075 _Toc36275333 _Toc36275332 _Toc67190393 _Toc76869076 _Toc76869077 _Toc36275336 _Toc76869078 _Toc36275337 _Toc76869079 _Toc36275338 _Toc76869080 _Toc76869081 _Toc76869082 _Toc76869083 _Toc425208756 _Toc425638449 _Toc425819030 _Toc425819663 _Toc76869084 _Toc425208757 _Toc425638450 _Toc425819031 _Toc425819664 _Toc67190400 _Toc76869085 _Toc67190401 _Toc76869086 _Toc76869087 _Toc76869088 OLE_LINK1 _Toc425208749 _Toc425638442 _Toc425819023 _Toc425819656 _Toc76869089 _Toc425208750 _Toc425638443 _Toc425819024 _Toc425819657 _Toc76869090 _Toc425208752 _Toc425638445 _Toc425819026 _Toc425819659 _Toc76869091 _Toc10952682 _Toc76869092 _Toc425208753 _Toc425638446 _Toc425819027 _Toc425819660 _Toc76869093 _Toc425208754 _Toc425638447 _Toc425819028 _Toc425819661 _Toc76869094 _Toc76869095 _Toc425208759 _Toc425638453 _Toc425819034 _Toc425819667 _Toc76869096 _Toc425208762 _Toc425638456 _Toc425819037 _Toc425819670 _Toc76869097 _Toc425208764 _Toc425638458 _Toc425819039 _Toc425819672 _Toc76869098 _Toc425208765 _Toc425638459 _Toc425819040 _Toc425819673 _Toc76869099 _Toc425208766 _Toc425638460 _Toc425819041 _Toc425819674 _Toc76869100 _Toc76869101 _Toc76869102 _Toc425208761 _Toc425638455 _Toc425819036 _Toc425819669 _Toc76869103 _Toc76869104 _Toc76869105 _Toc76869106 _Toc76869107 _Toc76869108 _Toc76869109 _Toc76869110 _Toc76869111 _Toc76869112 _Toc76869113 _Toc76869114 _Toc76869115 _Toc76869116 _Toc76869117 _Toc76869118 _Toc76869119 _Toc76869120 _Toc76869121 _Toc76869122 _Toc76869123 _Toc76869124 _Toc425208777 _Toc425638471 _Toc425819052 _Toc425819685 _Toc76869125 _Toc76869126 _Toc76869127 _Toc76869128 _Toc76869129 _Toc76869130 _Toc76869131 _Toc76869132 _Toc76869133 _Toc76869134 _Toc67190442 _Toc76869135 _Hlt492192008 _Hlt492192009 _Toc65978841 _Toc67190443 _Toc76869136 _Toc67190444 _Toc76869137 _Toc67190445 _Toc76869138 _Toc67190446 _Toc76869139 _Toc67190447 _Toc76869140 _Toc76869141 _Toc76869142 _Hlt67209917 _Hlt74617900 _Toc65978855 _Toc67190449 _Toc76869143 _Toc65978856 _Toc67190450 _Toc76869144 _Toc67190451 _Toc76869145 _Toc76869146 _Toc76869147 _Toc65978867 _Toc67190452 _Toc76869148 _Toc67190453 _Toc76869149 _Toc76869150 _Toc65978868 _Toc67190455 _Toc76869151 _Toc76869152 _Toc76869153 _Toc76869154 _Toc76869155 _Toc67190462 _Toc76869156 _Toc76869157 _Toc76869158 _Toc76869159 _Toc65978915 _Toc65978916 _Toc65978917 _Toc65978918 _Toc65978919 _Toc65978920 _Toc65978921 _Toc65978922 _Toc65978923 _Toc65978924 _Toc65978925 _Toc65978926 _Toc65978927 _Toc65978928 _Toc65978929 _Toc65978930 _Toc65978931 _Toc65978932 _Toc65978933 _Toc65978934 _Toc65978935 _Toc65978936 _Toc65978937 _Toc65978938 _Toc65978939 _Toc65978940 _Toc65978941 _Toc65978942 _Toc65978943 _Toc65978944 _Toc65978945 _Toc65978946 _Toc65978947 _Toc65978948 _Toc65978949 _Toc65978950 _Toc65978951 _Toc65978952 _Toc65978953 _Toc65978954 _Toc65978955 _Toc65978956 _Toc65978957 _Toc65978958 _Toc65978959 _Toc65978960 _Toc65978961 _Toc65978962 _Toc65978963 _Toc65978964 _Toc65978965 _Toc65978966 _Toc76869160 _Toc67190466 _Toc70214671 _Toc76869161 _Toc70214672 _Toc76869162 _Toc70214673 _Toc70214674 _Toc76869163 _Toc76869164 _Toc76869165 _Toc76869166 _Toc76869167 _Toc76869168 _Toc76869169 _Toc425208788 _Toc425638486 _Toc425819069 _Toc425819700 _Toc425208771 _Toc425638465 _Toc425819046 _Toc425819679 _Toc76869170 _Toc425208772 _Toc425638466 _Toc425819047 _Toc425819680 _Toc76869171 _Toc76869172 _Toc76869173 _Toc76869174 _Toc76869175 _Toc67190478 _Toc76869176 _Toc76869177 _Toc67190481 _Toc76869178 _Toc76869179 _Toc425208791 _Toc425638489 _Toc425819072 _Toc425819703 _Toc67190483 _Toc76869180 _Toc76869181 _Toc76869182 _Toc76869183 _Toc425208792 _Toc425638490 _Toc425819073 _Toc425819704 _Toc76869184 _Toc76869185 _Toc425208793 _Toc425638491 _Toc425819074 _Toc425819705 _Toc76869186 _Toc76869187 _Toc425208794 _Toc425638492 _Toc425819075 _Toc425819706 _Toc76869188 _Toc76869189 _Toc425208795 _Toc425638493 _Toc425819076 _Toc425819707 _Toc76869190 _Toc76869191 _Toc425208796 _Toc425638494 _Toc425819077 _Toc425819708 _Toc76869192 _Toc76869193 _Toc425208797 _Toc425638495 _Toc425819078 _Toc425819709 _Toc76869194 _Toc76869195 _Toc76869196 _Toc76869197 _Toc76869198 _Toc76869199 _Toc76869200 _Toc76869201 _Toc425208798 _Toc425638496 _Toc425819079 _Toc425819710 _Toc76869202 _Toc76869203 _Toc425208799 _Toc425638497 _Toc425819080 _Toc425819711 _Toc76869204 _Toc76869205 _Toc425208800 _Toc425638498 _Toc425819081 _Toc425819712 _Toc76869206 _Toc76869207 _Toc425208801 _Toc425638499 _Toc425819082 _Toc425819713 _Toc67190511 _Toc76869208 _Toc76869209 _Toc76869210 _Toc76869211 _Toc425208802 _Toc425638500 _Toc425819083 _Toc425819714 _Toc67190515 _Toc76869212 _Toc76869213 _Toc425208803 _Toc425638501 _Toc425819084 _Toc425819715 _Toc76869214 _Toc76869215 _Toc67190519 _Toc76869216 _Toc76869217 _Toc425208804 _Toc425638502 _Toc425819085 _Toc425819716 _Toc76869218 _Toc76869219 _Toc425208805 _Toc425638503 _Toc425819086 _Toc425819717 _Toc671(((((((( ( ( ( ( ((((((((((((((((((( (!("(#($(%(&('((()(*(+(,(-(.(/(0(1(2(3(4(5(6(7(8(9(:(;(<(=(>(?(@(A(B(C(D(E(F(G(H(I(J(K(L(M(N(O(P(Q(R(S(T(U(V(W(X(Y(Z([(\(](^(_(`(a(c(d(e(f(g(h(i(j(k(l(m(n(o(p(q(r(s(t(u(v(w(x(y(z({(|(}(~(((90523 _Toc76869220 _Toc76869221 _Toc65979040 _Toc67190525 _Toc76869222 _Toc425208839 _Toc425638544 _Toc425819127 _Toc425819751 _Toc76869223 _Toc76869224 _Hlt64941738 _Hlt64941739 _Hlt64941854 _Hlt64941855 _Hlt64941856 _Toc76869225 _Toc425208840 _Toc425638545 _Toc425208841 _Toc425638546 _Toc425819128 _Toc425819752 _Toc76869226 _Toc425208842 _Toc425638547 _Toc425819129 _Toc425819753 _Toc76869227 _Toc76869228 _Toc425638548 _Toc425819130 _Toc425819754 _Toc425638549 _Toc425819131 _Toc76869229 _Toc425638550 _Toc425819132 _Toc76869230 _Toc425638551 _Toc425819133 _Toc76869231 _Toc425208843 _Toc425638552 _Toc425819134 _Toc425819755 _Toc76869232 _Toc425208844 _Toc425638553 _Toc425819135 _Toc425819756 _Toc76869233 _Toc425208845 _Toc425638554 _Toc425819136 _Toc425819757 _Toc76869234 _Toc425208806 _Toc425638504 _Toc425819087 _Toc425819718 _Toc76869235 _Toc425208807 _Toc425638505 _Toc425819088 _Toc425819719 _Toc76869236 _Toc76869237 _Toc76869238 _Toc425208808 _Toc425638506 _Toc425819089 _Toc425819720 _Toc67190543 _Toc76869239 _Toc425208812 _Toc425638510 _Toc425819093 _Toc425819724 _Toc65979059 _Toc76869240 _Toc76869241 _Toc76869242 _Toc67190548 _Toc76869243 _Toc425208817 _Toc425638515 _Toc425819098 _Toc425819729 _Toc76869244 _Toc76869245 _Hlt64969416 _Toc425208818 _Toc425638516 _Toc425819099 _Toc425819730 _Toc76869246 _Toc76869247 _Hlt73230892 _Toc67190552 _Toc76869248 OLE_LINK2 OLE_LINK3 _Toc76869249 _Toc76869250 _Toc76869251 _Hlt73405548 _Hlt73405549 _Toc425208780 _Toc425638474 _Toc425819055 _Toc425819688 _Toc31184976 _Toc76869252 _Toc31184977 _Toc76869253 _Toc425819056 _Toc31184978 _Toc76869254 _Toc31184979 _Toc76869255 _Toc31184980 _Toc76869256 _Toc67190561 _Toc76869257 _Toc76869258 _Toc31184982 _Toc76869259 _Toc76869260 _Toc76869261 _Toc76869262 _Toc31184983 _Toc76869263 _Toc31184984 _Toc76869264 _Toc31184985 _Toc76869265 _Toc31184986 _Toc76869266 _Toc76869267 _Toc76869268_PictureBullets6@$}!*'W)`+`+ ,B,z,,..0 0 00y0y0{0{0{0{0000000000000000000000000000000٠٠٠٠٠ʽʽο :xe29Jh%%%cX [[[ ??NNhhRRR mmQ       v Io,,,,,,z{2>llllnqqqqrUUUUV~ " " " " "######%]%]%]%]%^%%'=(a*_.1.2<3N3J:<> ?CG K K0KcLS[jejejejejeKfpflnqrvyځځtttʈʈ@L͝͝͝+,Dcccòò?<>>ɺ FJ F#[wNV@1GxaE)vB  8    $$$BkBklro {!~1Y=Oǔǔǔǔҙҙҙҙ  uussssss>'''''I/?????uBxRxRxRxRxRGXhhhhhjzzzzza Vun[ /////*3DDDDDDLI]`2q2q2q2q2q2qt„„„„„G|ڳڳڳڳڳCCCCCC@@@--;;;X8 8 8 E E E XXY+++j!j!j!j!k!/3/3/3/3/333333c5:[D[D[D[D[D]DSSSSSSSYZ\\cccccr u6v6v6v6v7vɧE,E,`X(Y (Y (Y (Y (Y (Y _Z _Z \ km km a{ a{   a h h D  $ $ d e u v ژ ژ n  ! @@@@@@@@@@@@@@@"#$%&'()*+,-./0123456789:;<=>?BCDE@AFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"%&#@$@'()*+,-./01234@5@6789:;<=>?D@ABCEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     "#$%@@@ @!@&'()*+,-/012.3456789:;<=>?@ABCDEFGHIKLMNJPQRSOTUVWXYZ[\]^_`abcdefghijklmnopq@yz{|rst@uvwx}~@@.AJz!w')++ ,{,,,..0 0 00z0z0|0|0|0|00000000000000000000000000٠٠٠٠٠٠٠٠$ȽBBqFvGxK*H EEE"" kkkXXff&  11^ ^             s<<<<===|qqqqr%%%%&     """"",#,#,#,#-##%^%^%^%^%%%'K(n*k.1M2L3d3b:<?(?DHK.KPKrLS[eeeeenffKmmn:rrwy?څڅڅHH!!99rۚۚ###ppq>vv۲۲?Zbbb'9DUeLU}Eu|_D$u1A  3    E $$$kkloG{f~nh}ҙҙҙҙޙޙޙޙޙ=P!M;;@ SSSST'''''z/@@@@@BRRRRR{Xhhhhhjzzzzz2D #####400000V3DDDDI]]]]]`UqUqUqUqVqVq4u}NNi@@@@JJJ..<<<6c c c J J R ``h55=!3333I3333333333w5:xDxDxDxDyDyDSSSSTTmYZ\\cccccr!uvPgg],],____>IY IY IY IY IY IY xZ xZ \ m m { { ك ك @ @ y z  ] 4 4 4    n _^_D^_^_]_D]_\_D\_[_D[_$__d__d__$__$__$__$__$__d__d________\_______\____\_____5_T4_4_3_4_T3_3_2_3_T2_2_1_2_1_T1_1_D<_;_,;_:_,:_9_l9_,9_8_l8``91`` `T``" `@ `A  `İ `1  `@  `,P  `L#`,F5`d`D@ `$` `? `L `L`= `= `< `4< `4; `: `4: `49 ` `DA  `*!`L+5"`E #`DE $`G5%`LY &`<4'`" (`|1)`4*`+`I#,`-`O.`T1/` #0`B 1`t 2`.3`J#4`Dd5`6`ԗ7`48`dM9`E:`?;`<`d=`>` ?` @`? A` B`,!C`l1D`1E`47 F`G` H`I`DJ`K`| L`M` 2N`O`̤P`7 Q`7 R`48 S`4T`tU`V` 1W`1X`txY`xZ`z[`z\`']`\'^`d~ _`~ ``~a` b` c`L d`t,e`,f` g` p`D? q`4r`4s`<4t`#u`#v`#w`x`,y`0z`T0{`0|`0}`,~``Z`T[`[`[`4p4`tp4`p4````lz`z`z`,{`{`w`x`Dx`x`C`TC`C`TD`L ` ` ` `L ` ``l``,`l```4``4`t```N`O`O`P`\P`P`P`Q`T`Ԡ`T`ԡ``T``1`1`1`1`T1`1`1`1`1`J` K`LK`K`K` L`LL`L`L` M`LM`M`M` N`_`_`_`D````Da`a`Db`b`5`5`6`T6`6`6`7`T7`7`7`8`T8`8`8`9`T9`9`9`:`T:`:`:`;`T;`;`;`<`T<`<`<`=`T=`ԥ``T``Ԧ`T`ԧ`aTaaԨaaTaaԩaaT a aԪ a aT aaԫaaTaaԬaaTaaԭaaTaaԮaaTaaԯa aT!a"aԠ#a$aT%a&aԡ'a(aT)a*aԢ+a,aT-a.aԣ/aT0aԤ1a2aT3aԥ4aT5aԦ6aT7a8aԧ9a:aT;aԨaT?aD% @a% Aa& Ba& Ca' Da' Ea( Fa( Ga$) Ha) IaD* Ja* Kad+ La+ Ma+ Nat, Oa- Pa- Qa- Ra. Sa. Ta4/ Uat/ Va/ WaD0 XaT Ya ZaT![a!\a"]aT"^a"_at#`a$aa$ba$%ca%daD&ea&fad'ga'ha'iat(ja)ka)la$*ma*naD+oa+pad,qa,ra-sa.ta.ua4/va/waT0xa0yat1za2{a2|a$3}a3~aD4a4ad5a5a6a7a7aa\aalaaaaa<a|aaLaaa\aa,alaaaaa<aa\aa,alaaaaa<aa aLaalaaaaa<aa\aa|a aa,alaa<a|aaa<a|aaԱ a aT a aԲ a aT a aԳ a aT a aԴ a aT a aԵ a aT a aԶ a aT a aԷ a aT a aԸ a aT a aԹ a aT a aԺ a aT a aԻ a aT a aԼ a aT a aԽ a aT a aԾ a aT a aԿ a aT a a a aT a b b bT b b b bT b b  b  bT  b  b  b bT b b b bT b b b bT b b b bT b b b bT b  b !b "bT #b $b %b &bT 'b (b )b *bT +b ,b -b .bT /b 0b 1b 2bT 3b 4b 5b 6bT 7b 8b 9b :bT ;b bT ?b @b Ab BbT Cb Db Eb FbT Gb Hb Ib JbT Kb Lb Mb NbT Ob Pb Qb RbT Sb Tb Ub VbT Wb Xb Yb ZbT [b \b ]bT ^b _b$ `bd ab bb cb$ dbd eb fb gb$ hbd ib jb kb$ lbd mb nb ob$ pbd qb rb sb$ tbd ub vb wb$ xbd yb zb {b$ |bd }b ~b b$ bd b b4 bt b bD b bd b b b$ b bD b bd b b4 bt b b| b b b< b| b b b< b| b b b< b b b bT 8  ]!!"2#C#\#l####### $$9$K$d$t$*'*'1'<''R+R+.,.,%0EE  R]''**1&&''!(!(((3(++O+O++N/N////q1q14N;=aAFJ#M`l*lxՊՊ #3Pb{ө+;"Ob<<%%>>@&&+,%,,,,,-/////002{222U3U3]3c35D6W6666679t999999S;P<<<-=-=5=;=L???*@*@2@8@A]BpBBBBBD.EEE F FFFGJH]HHHHHvJJJUKUK]KcK4MMN0NNNNNPhQ{QQQQQCTTT!U!U)U/UVV,X,X}}Z Ԥap}-'.:S:Si<<00/Ic006:?llrv{&&&<_<_C_N_____``````aabbb$bbbbbffggiiijjjjlllllooqqqt>{2E22``ffy4GDLLt P\<O?!H<iI5G!4t    Tgr#%#--E0-27AABHHHHJJhK Vg-griiJl]lmmnBrrr/ssvvw(w}wwe{x{~OdqÈ<$\\__e&jjJJ;;]]O """"$$$$$$4%4%?%%%%2F2F:Waaddييߊ""++((  00HHU]]K K   "%%TETENMNMqq7u7u:uGGגג_ˡĭĭ8zzTT44 ' ) 6 k; k; 9D 9D >D ID PD D [ R_ hf hf of |f |f f |m |m { f f 2 2 ē ē _ _ k o u .  n  6 B S S Y  0 ~ ~    * n       !"#$%&'()+*,-./0123456789;:<=>?A@BCDEFGHIJKLMNOPQRSTUVWXY[Z\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123458679:=;<>?B@ACDGEFHIJKLMNPOQRTSUVXWYZ\[]^`_abdcefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~= 2o!!"A#Q#i#~######$$.$H$Y$q$$0';'B'B''X+X+<,<,*0HH *Z  1o%11/33&&'''(2(9(9(++U+U++T/T////w1w14Z;=mAFJ/M`)l2lx   ؊؊§0E_pȩ 8H  'Yl??(( AA'J&&+,/,,,,,.%///00002223\3b3k3k35N6a666667 9~999999];Z<<<4=:=C=C=V???1@7@@@@@AgBzBBBBBD8EEEFF"F"FGTHgHHHHHJJK\KbKkKkK>MM'N:NNNNNPrQQQQQQNTTT(U.U7U7UVV/X/X}}ƒf%ߤly-,.CSCS"iHH004Ih  59>HHquz&&&B_M_T_T_____````aaaab#b*b*bbbcc$f$fggiii"j"jjjlllllooqqqtE{  <O"<<jj  pp>QNSS~ZfFYI+R FsS?Q +>~    ^q|#/#-.O0727AABHHHHJJrKV$g7g|iiTlglmmnLrrr9ssvv%w2wwwo{{ ~Yn{͈ F#**bbdhh+rrRR##BBddS """"$$$$$$>%C%C%%%%6F6F>Waaddފ**--//88TYYeeP P ==B B #%%hEhEUMUMqq9u=u=uNNޒޒ''bϡʭʭ@#""\\<< ' ) 6 ; ; =D HD OD TD TD D $[ U_ nf sf sf f f f m m { m m 4 4 ʓ ʓ i m t t  ;  {  H ̺ K W [ [ 5 Ž Ž  ) 0 0 n   !"#$%&'()+*,-./0123456789;:<=>?A@BCDEFGHIJKLMNOPQRSTUVWXY[Z\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123457869:<=;>?AB@CDFGEHIJKLMNPOQRTSUVXWYZ\[]^`_abdcefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~ >$*urn:schemas-microsoft-com:office:smarttags PostalCode:*urn:schemas-microsoft-com:office:smarttagsStreetBY*urn:schemas-microsoft-com:office:smarttagscountry-region8*urn:schemas-microsoft-com:office:smarttagstime8*urn:schemas-microsoft-com:office:smarttagsdate;*urn:schemas-microsoft-com:office:smarttagsaddress=*urn:schemas-microsoft-com:office:smarttags PlaceType=*urn:schemas-microsoft-com:office:smarttags PlaceName9*urn:schemas-microsoft-com:office:smarttagsState8*urn:schemas-microsoft-com:office:smarttagsCity9*urn:schemas-microsoft-com:office:smarttagsplace L.0110111213141516171819195019571994199519972202000200120022003200420062122232425273303145526789DayHourMinuteMonthYear*+*+*+*+*+,)-,%)-,&)"-,)-,)!-,")-,() -,)-,)!-,")-,() -,)-,)!-,")-,() -,)-,)!-,")-,%)-,&)"-,)&-*+*+*+*+*+*+*+*+*+,#)-,)-,#)-,)-,%) -,)%-,()(-,)-,)-,()-,#)-,&)-*'+$,')-,')-,)-,%)-,&)"-,)-,)!-,")-,() -,)-,)!-,")-,() -,)-,)!-,")-,() -,)-,)!-,")-,%)-,&)"-* +,)-,)!-Y,)-,)-,)!-,)-,)!-,)-,)!-,)'-,)-,)!-,#)'-,)'-,)-,)!-,)-,)'-,)-,)!-,)'-,)-,)!-,#)-,)'-,)-,)!-,)-,)'-,)-,)!-,)'-,)-,)!-,)'-,)-,)!-,%) -,)'-,)-,)!-,)'-,)-,)!-,)'-,)-,)!-,)&-,)'-,)-,)!-,)'-,)-,)!-,)'-,)-,)!-,)&-,)&-,)- ,)- ,)- ,)- ,)- ,)- ,)- Y,') -*+*+* +,")-,") -,")-,") -,)-,)!-,)-,)!-,)-,)!-,)-,)-,)!-,)-,)!-,)-,)!-,)"-,)#-Y,)"-,)"-,)#-Y,)-,)!-Y,#)-,)-,)-,)-,)!-Y,)-,) -,) -,)-,)#-,)-,)!-,)-,)!-Y,)-,)-,)-,)-,)-,) -,) -,)-,) -,) -,) -,) -,)-,)-,)-,)!-,)-,)!-,)-,)!-,)-,)!-,)-,)!-,)-,)!-,)-,)!-,)-,)!-,)-,)!-,)-,)!-,)-,)-,)"-Y,)-,)-,)!-Y,)-,) -,)-,)!-,)-,)!-,)-,)!-Y,)-,)-,)-,)-,)-,)-Y,)-,)-,)-,)-,)-,)!-,)-,)-,)-,)-,)-,)-,)-,)-*+ YYYYYY,#)-,#)-Y$,%)-Y,%) -,%) -,&)-,() -,)!-,()--) ,%-),%-),%8=# 7<ty(((())++*+/+`+++++++,,-,.,2,B,,,,,,,-..%0*0#gl U_Ѹָ&+W]ny)./2\f{         6;tyM`BGei*/ AF  l#q#%%%%%%++003066+737 99 9+9E9K9c9w9x999999999999::-:8:M!MWM_MMMTTZZ[\__wn~nnnnnnnnnooMoUoVo]ohooooooo:pAp_pippppppp>qFqPqWqtqq*1YlՐߐ8B!;AYmn|ђ֒גڒ#.atʞ#- &,DXYgw ŠIN"'x}ej 4:Sghv̸ѸҸո  +BLԹ޹~LM<A|,CIfk}9<.$1$<$@$X'['a(e(((((((()%)/)V*^*77:;==2DJ389< %+CWXfv 3=CMXd ,6ƽ;E$<ABE +ALcn8C5@ QXZaivw  tzv|{bhtt|'1 EQ7Ay%$''*(3(4(?((((((() )@)L)))**j*s***r,{,--444444 55557777778$8%83888k@q@3H9HxJ~JJJJJRRRRiTuTTUeUsUXX]]"`(`r`~`````i j`pfprrrrrrzzzzzz{{   {~,/36ty;C&,.;<JĿɿV^(*IQily{&)$4>[e'1 #+%2'4$$&&&&I(O(_(l(m({(0"0j2x288M<S<c<p<q<<D D'D-DFDQDVD_DzDDGG?GEG%H+HIHTHYHbH/I4IOONQTQQQSSSSSSS TTTTT]]^^1_;___`%```>fDf8h>h iii)ippqqrrttzz||||||Մބ ѐא!347ޙ)/QZݚbk֛ œ ڞmv՟ޟ#0נܠݠpv$*4;nxڳ'3Q]̶ֶ2<GR[dɷշ%*16<AKP]3=HT !.;<DJVW]gtu|#-9:DNZ[fjv /;<CMYZaiuv|CWXfv=Cjpchci(.+2cm },3MT$*:BmpW_NV(3^k'1nX`:Fpzy    H%N%Y)b)h)q)))))L+W+++++++++ ,,Y,e,f,v,j-u---!.,.m.{../:/J///000001b2h233C4L455667 7o7z777777748=888899999B;K;(<1<<<{==4?9?k?t? @)@@@@@AAAA BBfBoBgCpC}CCCCOO RRcceeeett}}:DirυՅ'-/3lrtxˆІֆچMXˈψDHɞ՞%z~npţѣ ѪժT`±˱˵ϵ߶>CIM˷"5?<Hhr3=HT./jk#^c?Ipylm !\]LM<=xyJa %   *.0..."3#3^3_3333344N4O4444455>5?5z5{55555.6/6j6k66677.8/8j8k8888899Z9[99999::J:K::::::::;;;<;F;====>>O>P>>>>>????@?{?|???(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((()??/@0@k@l@@@@@ECFCCCCCCC5D6DqDrDDDDD%E&EaEbEEEEE~FFFFFFIIIIIIJJJJJJKK6L7LrLsLLLLL&M'MbMcMMMMMNNRNSNNN4O5OpOqOOO6P?PaPjPPPQQQQRR?R@R{R|RRRRR/S0SkSlSSSSST T[T\TTTTTVVVVWWWWXWWWWWtXuXXXXX(Y)YdYeYYYYYZZTZUZZZZZ7[8[s[t[[[[['\(\c\d\\\\\]]S]T]]]]]^^C^D^^^^^(_)_d_e_____``T`U`````a aDaEaaaaaaa4b5b c cEcFccccccc5d6dqdrddddd&e'ebeceeeeeffegkgggggii)j3j>jGjlllm>o?ozo{ooooo.p/pjpkpppppqqZq[qqqrr)r2rttUtVttttt u uEuFuuuuuuu5v6vqvrv x xFxGxxxxxxx6y7yrysyyyyy&z'zbzcz{{{|Q}Z}|}}}}~~~~AB}~01lm !\]؃݃EF56qrʆˆBC~҉ӉJKŠÊ>CƐА <Fw(2cmْOYœϓ ;Ev'1blΖؖ DNė *akeo=G~ɢ AKãͣ DNƤϤ)3js&0gp(1hr*4fp'0gq*4kt,5lv.7nx9Czů<F}Ȱ @Iak$.eo#-dnVZhl eh&+gn swVa*1CL[btfo~*Zh /4LUdq,6EY$3<[cr{%+gr &'6EP_hio~v489=S[py/348NRSWmqrv26QUpt '+GKgk+5Q[ek@Iaj/5u}_k(- 'aj cqMXfs+1@K`b&1@Ioxy&7CT` )3BK`kz    + 9 : ? N X [ f     1 : f j   , / > G V i x           % K T c m |          V e     .BN]fw:FZix'6CX`ov4>S[jq&=Ait%&*9BQ]KTcl18NU*3NWlu *5DYhr +:Ebj %/>IXghq ]g!0:NVCKT[ju HO~  # + : I b q           !!&!1!@!C!^!h!!!!!!";"C"""""##E#N#]#h#w########$$$$$$$$$%4%>%g%q%%%%%%%%&&&&#&&&&&&& ''#'-'.'8'n'x'y'''''(((3(@(T(Z(i(v(((((((_)p))))))))))))))))))*******%*/*>*H*R*T*U*X*g*r*********+ ++"+J+U+++++++,,&,0,?,I,X,k,l,s,,,,,,,,,(-1-d-o---------..2.=.L.[.j.t......./ ///>/M/Z/i/s//////////000O0W0i0x0000000011*1N1^1111111111222)232B2L2[2h2w2~222222222222333(3/3>3F3U3[3j3u33333333333333 44#424E4T4\4k4x44444444444 555*5555546>6M6Z6i6t66666 77k7w777778(8J8Q8`8h8888888999(9L9U9d9p9999999 ::#:+:::F:U:]:^:b:c:o:::::::::::;";1;>;C;O;^;k;;;;;;;;;p<|<<<"=/=a=m=========>>>*>U>_>`>f>y>|>>>>>>>>>??2?7?F?S??????? @@-@8@@@@@AAA(A7AAACAKA[AdAsA}AAAB BBCC#C2C8CRC]CqCzC}CCCCCCCCCCDD!D/D>DMDvDDDDDDDDDDZEcEEEEEEEF(FFFFFFFFF G,G;GFGUG^GmGxGGGGGGGHH$H-H@HMHbHkHHHHHHHHHHI"I%I4IAIXI\IkI~IIIIIIIJJNJWJhJpJJJJJJJJJJKKK3K9KMKYKhKrKKKKKKKKKKKLL:LBLQL]LlLuLLLLLLLLLLLLMM M/M8MGMPMuM~MMMMMMMMMMM NN#N/N>NGNHNQNwNNNNNNNNNOO O/O9OHOPOOOOOOOOO'P3PBPJP^PgPPPPPPPQQ?QJQYQcQQQQQQQQRR"R#R-RARIRJRQR`RiR~RRRRRRRRRRRSSS,S5SDSUSdSiSjSnSSSSSSSSSSSTTBTNTvTTTTTTTUU U~ ~ - .  ػ $ /   k n  R+`+++++,-,.,B,,,?-A- &&'')')A)J)o)q))))) *#*++-,6,,, --V-X-------../ ///00<0p0t00011L1S111`3c344644444556666%7+7U7X7773858y8}8_:a:::;;<<<<J=L=@>F>>>$?'?@@AA:A=ABBfBmBBBDCLCCCCC(D*DDDEERGWGGGHH5H7HHHIIII~JJJKLLMMyMMFZJZ'\1\<^F^l`q`cceeSgVgzggggggh$hDhLhMhPhchfh i iXjbjdjljmjpjjjpppqwwww}xxJNǀɀ(.jlFHDFܳ߳(0030?#/TXIMy}W[_c  #'  ?CJN$*'+kug m p!t!`"f"#$#$$9&B&X'`'9(B(++++H,V,,,,,----".2.:.G.\.o.w.. /%///J0X0]0e00011*1011122A2C22233334-454B4W4j4r444444 555555z66777777778,848A8V8i8q8~888889 9991:?:D:L:O;U;;;;;;;;;<<U<Z<<=~====\>l>>>>>??Q?V??@{@@@@AAAABBC(C-C5CCCDD3E8EEE]FkFpFxFFFG%GGGGGHHIII!IIIJ{JJK-KKKKK MM0M6MpMrMMMSNaNNNNNQOaOiOvOOOOOVPfP{PPPPQQ%R3R8R@RRRRRRRRSSSSS T TTTrUUUUUUVV#V6V>VMVXXYY[[B\F\\\\\@nDnnnNW]^kl&)kk49ac$'˹ι#CG.2",tz!Uadhx{ ;?X\W[  s y         .2ksQTko  """"##.$4$q$u$%%)%Z%\%B&G&''''((+1+0 000P1T1 6 6h6l68899::5;9;<(<l<r<<<????? @!@:@9CACD!DDD(G4GHHAIEI*K.KKKYM]MMMOOPPQQTQ8RB)3x~fh~cf̢ТЫԫw{26֮ڮͰѰswosջػ>BQU04X\HR8:muRU  dfmq2604nq.6>N!DLowV\vWZSW dm58jm  3OkR`_ a --GUIU^^Ta[aiil%lqqrr0u2uuu>||Q~U~i~m~6ՂނŌɌLil x{ao 1R@A#W\WHv  -6`iy. 7 z  !!$$&&22 7777U;Z;JJJJNPSPoPtPK^P^bbnorr!r&ri}n}}}ɕv'8cy&<g}ž.ƟGTܠ]herέڭ  küƼ$wlsr'3IDe " ))+F2F"I%Iddhhmiiiix2x3xTxUxtx_|}|}}Pz'CxқZȜnu.03;tw<?ruGq'0[z|(3T_ :?glXy/ 2 ,/HK'*K^/8""*$*t*v*D2T2??PDTD(E*EsEEFF5IaIIIIIJJMMSS4S7STSWS~SS4[6[^^4_Q_______``[prpwwwwwwwxx2x5xQxTxpxsxxxxxx y!yyy?B Ttkv 9D+ !$yq        # !# ;$ >$ ( ( 2 3 E ?E Q Q R S S "S DS _S `S {S ]U ~U Bb Eb j j   > F C R Ų ̳ ö 6 ػ $ /    * / 9 A C K M U W _ a i k s u }   3 9 H O T U l r    k n 3333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333$`+++,B,,00+1I1w111 2?2^222#3B333 4>44445I5h5555 656T66667>7]77888a9999^:}::;Y;x;;;7<V<<<A=`===H>g>>> ?????@@A"A\A{AAA3BRBBBBCNCmCCCCDcDDDDE.EnEEEELFkFFF5GTGGGGHHHgHHHHImIII JBJaJJJJ K=K\KKKKLCLbLLLLMxxkkȔ/'ݗE_:MS֚C*Xb<QYß Kۢg 1cygpG٦e}թFnx 0]rؽ о^! """*#k#####$$L$$$$%O%&[&&&&'s'=(f((W)))O*+#+/-g-n/t/e0q00112'2i222o77WTT~((**,.-E//66O6P[=xЗx@ Hٰz+Id!H&Iv IRi%5ax 2]0cx !kGt: ;[rj@Ajd7Rp@'] #^ ^ 2_ t_ =a `a oa a b Fb Bc }c c c c Rd d +e 1f _f ^h h h h i #i i j j jm y y jz z { % U { ݐ 7 k v 0 ^ ђ  j ӓ 5 ^ ǔ ! G R z  9 < V Y v y י S    " ܼ   , / ; = [ ^ | ~ ٽ ۽   $ ' C E ^ a z |  . 1 D F P R \ ^ h k u w Ŀ S t v  " A C K M U W _ a i k s u }  ! # > @ H d { }   b n `+++,B,,kkP n ֔ .T.x0BW| Zo20ұ""*2K56&l5t:lx?0CBl<I}E<|5 H@{_dXQHyjdR 4j _Ίd`>N`gsq$ ^`OJQJo(hH^`OJQJ^Jo(hHopp^p`OJ QJ o(hH@ @ ^@ `OJQJo(hH^`OJQJ^Jo(hHo^`OJ QJ o(hH^`OJQJo(hH^`OJQJ^Jo(hHoPP^P`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh88^8`OJQJo(hHh^`OJQJ^Jo(hHoh  ^ `OJ QJ o(hHh  ^ `OJQJo(hHhxx^x`OJQJ^Jo(hHohHH^H`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hH^`OJQJo(hH^`OJQJ^Jo(hHopp^p`OJ QJ o(hH@ @ ^@ `OJQJo(hH^`OJQJ^Jo(hHo^`OJ QJ o(hH^`OJQJo(hH^`OJQJ^Jo(hHoPP^P`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh ^`o(hH.h^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hH 20I}E0"*2` 0j _dR`` 0K56d`l5t:.T?0C Hsq_dXQ00                                                                                                                                                   xM0,s~<Microsoft Office Word@@<(xc@lE9@{sG  FMicrosoft Office Word Document MSWordDocWord.Document.89q     Department Of Veterans Affairs Title[   _Toc768692197  _Toc768692187   _Toc768692177  _Toc768692167  _Toc768692157  _Toc768692147  _Toc768692137  _Toc768692127  _Toc768692117  _Toc768692106  _Toc768692096  _Toc768692086  _Toc768692076  _Toc768692066  _Toc768692056  _Toc768692046  _Toc768692036  _Toc768692026  _Toc768692016  _Toc76869200?  _Toc76869199?  _Toc76869198?  _Toc76869197?  _Toc76869196?  _Toc76869195?  _Toc76869194?y  _Toc76869193?s  _Toc76869192?m  _Toc76869191?g  _Toc76869190>a  _Toc76869189>[  _Toc76869188>U  _Toc76869187>O  _Toc76869186>I  _Toc76869185>C  _Toc76869184>=  _Toc76869183>7  _Toc76869182>1  _Toc76869181>+  _Toc768691801%  _Toc768691791  _Toc768691781  _Toc768691771  _Toc768691761   _Toc768691751  _Toc768691741  _Toc768691731  _Toc768691721  _Toc768691711  _Toc768691700  _Toc768691690 ՜.+,D՜.+,p,x     Department Of Veterans Affairs Title[ 8@ _PID_HLINKSA[*_rDhttp://vista.med.va.gov/softserv/clin_nar.row/lab/loinc/loinchm.htm FEo"http://www.regenstrief.org/loinc/ KTlhttp://www.va.gov/hepatitisc i http://vaww/ :xfhttp://www.va.gov/vdl/ Qc1http://vista.med.va.gov/ClinicalSpecialties/lab/ `@`$mailto:POSTMASTER@FOC-AUSTIN.VA.GOV ]7]mailto:05/19/04@22:18 ]4Zmailto:05/19/04@23:35 `@W$mailto:POSTMASTER@FOC-AUSTIN.VA.GOV QT1http://vista.med.va.gov/ClinicalSpecialties/lab/ QQ1http://vista.med.va.gov/ClinicalSpecialties/lab/ ON-http://www.va.gov/vdl/Clinical.asp?appID=119 L!Kmailto:XXX@Q-EPI.MED.VA.GOV 0;  _Toc7686926805  _Toc768692670/  _Toc768692660)  _Toc768692650#  _Toc768692640  _Toc768692630  _Toc768692620  _Toc768692610   _Toc768692603  _Toc768692593  _Toc768692583  _Toc768692573  _Toc768692563  _Toc768692553  _Toc768692543  _Toc768692533  _Toc768692523  _Toc768692513  _Toc768692502  _Toc768692492  _Toc768692482  _Toc768692472  _Toc768692462  _Toc768692452  _Toc768692442  _Toc768692432  _Toc768692422  _Toc768692412  _Toc768692405  _Toc768692395  _Toc768692385  _Toc768692375{  _Toc768692365u  _Toc768692355o  _Toc768692345i  _Toc768692335c  _Toc768692325]  _Toc768692315W  _Toc768692304Q  _Toc768692294K  _Toc768692284E  _Toc768692274?  _Toc7686922649  _Toc7686922543  _Toc768692244-  _Toc768692234'  _Toc768692224!  _Toc768692214  _Toc768692207 _Toc768691680  _Toc768691670  _Toc768691660  _Toc768691650  _Toc768691640  _Toc768691630  _Toc768691620  _Toc768691610  _Toc768691603  _Toc768691593  _Toc768691583  _Toc768691573  _Toc768691563  _Toc768691553  _Toc768691543  _Toc768691533  _Toc768691523}  _Toc768691513w  _Toc768691502q  _Toc768691492k  _Toc768691482e  _Toc768691472_  _Toc768691462Y  _Toc768691452S  _Toc768691442M  _Toc768691432G  _Toc768691422A  _Toc768691412;  _Toc7686914055  _Toc768691395/  _Toc768691385)  _Toc768691375#  _Toc768691365  _Toc768691355  _Toc768691345  _Toc768691335   _Toc768691325  _Toc768691315  _Toc768691304  _Toc768691294  _Toc768691284  _Toc768691274  _Toc768691264  _Toc768691254  _Toc768691244  _Toc768691234  _Toc768691224  _Toc768691214  _Toc768691207  _Toc768691197  _Toc768691187  _Toc768691177  _Toc768691167  _Toc768691157  _Toc768691147  _Toc768691137  _Toc768691127  _Toc768691117  _Toc768691106  _Toc768691096{  _Toc768691086u  _Toc768691076o  _Toc768691066i  _Toc768691056c  _Toc768691046]  _Toc768691036W  _Toc768691026Q  _Toc768691016K  _Toc76869100?E  _Toc76869099??  _Toc76869098?9  _Toc76869097?3  _Toc76869096?-  _Toc76869095?'  _Toc76869094?!  _Toc76869093?  _Toc76869092?  _Toc76869091?  _Toc76869090>   _Toc76869089>  _Toc76869088>  _Toc76869087>  _Toc76869086>  _Toc76869085>  _Toc76869084>  _Toc76869083>  _Toc76869082>  _Toc76869081>  _Toc768690801  _Toc768690791  _Toc768690781  _Toc768690771  _Toc768690761  _Toc768690751  _Toc768690741  _Toc768690731  _Toc768690721  _Toc768690711  _Toc768690700  _Toc768690690  _Toc768690680  _Toc768690670  _Toc768690660y  _Toc768690650s  _Toc768690640m  _Toc768690630g  _Toc768690620a  _Toc768690610[  _Toc768690603U  _Toc768690593O  _Toc768690583I  _Toc768690573C  _Toc768690563=  _Toc7686905537  _Toc7686905431  _Toc768690533+  _Toc768690523%  _Toc768690513  _Toc768690502  _Toc768690492  _Toc768690482   _Toc768690472  _Toc768690462  _Toc768690452  _Toc768690442  _Toc768690432  _Toc768690422  _Toc768690412  _Toc768690405  _Toc768690395  _Toc768690385  _Toc768690375  _Toc768690365  _Toc768690355  _Toc768690345  _Toc768690335  _Toc768690325  _Toc768690315  _Toc768690304  _Toc768690294  _Toc768690284  _Toc768690274  _Toc768690264  _Toc768690254  _Toc768690244}  _Toc768690234w  _Toc768690224q  _Toc768690214k  _Toc768690207e  _Toc768690197_  _Toc768690187Y  _Toc768690177S  _Toc768690167M  _Toc768690157G  _Toc768690147A  _Toc768690137;  _Toc7686901275  _Toc768690117/  _Toc768690106)  _Toc768690096#  _Toc768690086  _Toc768690076  _Toc768690066  _Toc76869005:x http://www.va.gov/vdl/ Q 1http://vista.med.va.gov/ClinicalSpecialties/lab/ Uftp://ftp.fo-slc.med.va.gov/ }0ftp://ftp.fo-hines.med.va.gov/ ., ftp://ftp.fo-albany.med.va.gov/ )))))))) ) ) ) ) ))))))))))))))))))) )!)")#)$)%)&)')()))*)+),)-).)/)0)1)2)3)4)5)RAaw'"YHi6Iw [ F %Y 'u M< m wnh 7 B":J}UBf@r|v Z?W&|GT \- #FB3_L"!"L;#U#X#!#O$?=%$q'q'k#'{)O)1*^Z*J,I.r|N/C0e0|2.2s244mt5e66F6R@7$9~g<AY<N>Uz @.'B!B$CYdFDAD5KF6FFaRFoGRG8fkH1! Iz,L,AN|+O.XO0&P|Q7RLRf?S#SrOTU}UOPU Vs6WlX@Y!Z3Z&]N^$9@_(_,agbq"bUg dd^d e'pfgUg^h)@hAh3j@jLkb`k kPm\nuq'rYvLVv5wq"b ddlwy zkzl {Bi{ ){|r|/|~g< dd ~  xP Nj67YOPQVblm;p- $)*4?NR%advQs$PE'IJ\jxc2(-33M5_NxW{;&,8Tzr  k04MS_`dz#.<8=>cTY\a&ddt l@\]PaIcg.jm ~! ) - 3 5 @ KJ nL QP w | k}   _ ! H M Y @^ j fn > $ / = G c k % r; X Ae x `}   l% I2 `\ kc q  eo#<Navkqo u{r| ?DBqI Qwphtv@J}~hy-(/DN?XQ\enoq|p3ye.rx ;#$9c]] 74=gAeWtuyi O&QV#[]o]_imo*yL|.s"(@MPlQ?\TvWxq0T8BCEqZcq5uB&3p34;;E_dG d#(96BJN U bom%4L>pxpa@TAP_# P6IqY\_nf 03D^Vnxn '_6:ADZJCM3[]]f R  . a n ;p p t  !q;!G!K!O!Z!l!!"I "v"7!"B"N"/R"t}"#/#J#+#,E#(J#P# i#]w#x##{#$$ $a@$@$L$TP$S$V$\X$h$%+%+%0%7%7%M<%Q=%F%[%g%H &&&( &#&@&K&w&W''''''*'3'F;'I'y'{'( (! (((4(?(#F(_L(V(dr()P\)i)p)r)*y*w*p(* )*H,*R.*0*2*6*I*K*n*_w*+C+0 ++5*+S+ Y+UY+Z+fr+|+b,K,+F,W,Z,} -WE-5L-X-Y-?]-oe-h-- . .:..}A.nB. R.GU.a.c.sd..g.n./ /Q//Y/=Z/'\/ak/~/0"0n.0250F0L0d0}091B1O1 Y1Cm1Hm1v1222+2 242wQ2[2zk2An2P3)!3X)3-313E3}M3U34>4"4GF4\4o_4}4555555W55t:5S>5@S5m5n5g669*6306,2656:6T6c6 6D 77777\G7U7_7}g7|7%8"858B8~H8+U8s8999:695=9;O9W9[92_9d9Gh9n9r9,:':B:CJ:sg:jn:r:y:z:U;;;;<;XE;H;J;|T;pX;2Z;j;~;<d'<j'<5<r></O<SW<i<9u< ===="=))=C=p=>M!>2>!>>#M>~>?^?O?iP?V?jc?j?bz?4@k9@@@@@#Q@Y@\@^@c@-AAAA5AAAbAfAfAf~A6!B %B$HBk[BwB}Bd~BC'C4C9CNRVReRkR6|RR}RSSS4SFSGSoS6TT3TEXTwTyT UU.U.UX3Ut=UMU`OUPUWUFlU}UnV V"V2VOVIVV`VgV[W Ws*WX?WKWOWsWXX&Xf:XsFXraXaX#cX>XYYJY%Y=5YOYZYoYuY Z}Z.ZLZTZWZv\Z_ZtZ[@[A[KJ[b[d[i[Hw[y[}[\V\\3/\0\J\p\6y\z\~\]]0!]']N]^]4a]^^#^g0^p6^9^?^V^W^__ __#_20_8_@_F_G_rt_zw_`~`!`"`&`{,`2``<`=`T`[`u`*a]*a3aAeDeHeJenfff(fNpGL_3c7cs&0222UFJ6MXZ(sNQ'6,@5;qx 8(:<$KCK:GVee{rsZZ$*(=78BFYex06MF2Yo;@*NT\Q`c dv;FZGuzx|="O022MQrz}!l0l7gHNb\wzT#,!2 E)Uw, 04=GuX@\ho,G=dUnUo8uCuVuZ{?pO\\r*$;369zl)/RNFU*^h`bL8:9ZS\uV ,697agkq=J.2356G{MQCVk]aqo qrgtv $%1J,_v.wjz3EJbK?"$cnt})"8%'Y,-.58@DL}c193>L_gmAvz7Zl?IKdWFcek"8JRLZ dmc!(4BNSu[x`= 7@y#RguO M 1->EJt\\oMu39 0)1KQTX)Z`ojbk|k} 1w1KW[guwRu5ST}UU=!$z):J:cpjmne> @3JPy({T7CO(z_{X39;m=5FJVX^r`jos|!<"'-ACWZAf sxKU,jy}Wb~)3{?eEG-KN'UZpy`$!&$z'.a{l2}>&ERBasrD{~'!,z1R57KTs H-]-B@LW'js1*a #*:Yat - -&I@NSl{>}9"A0#C@Ygos%%8=NYZg t!#(8BU|v/VB?v:xxy:p>BLEmOwU&i~~w p.89C{EU{ayWF#13@MNP\T=XbffMils2~: ":\w3G7Pi{||J \/0<HO#U|h! b !-X\Gkl>s} )b 6&p12c;Cbd{3".DX`abm +@5<JRW3e7XHh}!i=VVma#)a7;A0C[`$b{}&(d6CCYKLU `'g)3+.00ES{~ (t.}BHZv5nH-@[q~5N[0dADGQ]antRN 0p6;=IQV[\f *^lwzu~Q)HK[e%iXmHx3 p&*8:@U3``9vL!( u1 BPCXOtP 26,.4:=J.^jlu 1 a >RGS]T  r1=1PShh}lo\p !Yt},D?AFPq  +45m69>\BUgj!>I ZawyfE &'Mop)*EklȔ۔BCDEFv/MNOPQh'Z[\]^}ٗڗۗܗݗ[\]^_ŘƘǘȘɘ6789:LMSWXb;<Qß Ơ?p34Kۢ 1bcyfgp=>Gئ٦pq}Rթ&;<Fmnx 0\]r_ؽ()Wо^!!!!!""" """"""(#)#*#,#K#Y#Z#[#]#k################ $ $$$$J$K$L$N$T$d$e$f$i$r$$$$$$$$$$$$$$$$0%1%5%7%O%&&&&-&E&F&G&I&[&&&&&&''s'{'''''''''''''%(&('()(=(e(f(j(l((U)V)W)Y)h)w)x)y){)))))))))))))))))*** *********+*,*-*7*A*B*F*H*O*++++#+,,/-7->-Q-c-d-e-f-g-m/n/r/t//c0d0e0g0q0000000000000000000011111111112%2&2'2)242?2@2A2C2N2Y2Z2[2]2i2222222222222222 3 3uv+HIMd!67;H&HIMcv HIVar)QRVi9$%)5x HIM]sQb0bcgx  !k,-1G9:GRcqr}~^ l $%&'(,;r? %34?@ABCLMNOPTj%&*@VPQUj/cdhuR12{G 67;R'J`aepX '] 4] E] F] J] T] U] Y] f] g] k] z] {] ] ] ] ] ] ] ] ] ] ] ] ] ] ] ] ] ^ ^ #^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ _ _ $_ (_ )_ *_ ,_ 2_ t_ x_ y_ z_ |_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ ` ` ` ` ` !` #` *` ;` ?` @` A` C` J` `` d` e` f` h` o` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` a a a a a a a "a -a 1a 2a 6a 8a =a `a da ea fa ha oa a a a a a a a b b b b b Fb Wb Xb Yb \b cb b b b b b b b b b b b b b b b c c c c c c c c c c #c 3c 7c 8c 9c ;c Bc }c c c c c c c c c c c c c c c c c c c c c c c c Rd Vd Wd Xd Yd Zd [d \d ]d ^d _d `d ad bd cd dd fd ld sd wd xd d d d d d d d d d d d d d d d d d d d d d +e /e 0e 4e 6e ;e Oe Se Te Ue We ]e ve ze {e e e e e e e e e e e e e e e e e e e e e e e e e f f f f %f &f 'f *f 1f _f cf df tf wf |f f f f f f f f f f f f f f f f f f f f f f f f f f f f g g g g g g g g .g 1g 7g Dg Hg Ig Jg Mg Sg mg g g g g g g g g g g g h h h 4h 7h i ?i Ai Gi _i di ei fi hi mi yi ~i i i i i i i i i i i i i i i i i i i i i i i j j j m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m n n n n n n "n /n 0n 1n ;n ?n Cn Fn Sn Tn Un en in mn pn }n ~n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n o o (o ,o 0o 3o @o Ao Bo Ko Oo So Vo co do eo qo uo yo {o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o p p p p p p p !p %p (p 5p 6p 7p Ap Ep Ip Kp Xp Yp Zp ap ep ip kp xp yp zp p p p p p p p p p p p p p p p p p p p p p p p p p q q q q %q +q /q 6q Aq Bq Cq Oq Pq Qq Rq Sq Tq Uq \q _q bq dq qq rq sq q q q q q q q q q q q q q q q q q q q q q r r r r r r r 0r 4r 8r ;r Hr Ir Jr `r dr hr kr xr yr zr r r r r r r r r r r r r r r r r r r r r r r r r r s s s s s $s &s 3s 4s 5s t Bt Et Rt St Tt `t kt qt ut |t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t u u u u u u #u $u %u 4u 8u { E{ I{ M{ Q{ ^{ _{ `{ ܃      + , . 9 : < H I K c d f r s u ń Ƅ Ȅ ߄    3 4 6 M N P j k m Ѕ х Ӆ      7 8 : T U W h i k Æ ݆ ކ   B P ] k x ć Ӈ ׇ ۇ ߇   " # ' 1 5 = B N O T _ d s w ~  ƈ ֈ ڈ ߈   ! / 0 5 B E U Y _ ` d i n v z lj ȉ ̉ ։ ډ    % 7 ; I N U V Z i m y ~ ʊ ˊ ϊ ܊    ( . > ? C R V ] b y z ~ ȋ ̋ Ջ ֋ ۋ   0 1 5 ? D I N _ ` nj Ռ     ( , 2 5 ; < A W \ m q  ƍ ߍ  ! & 8 = D H P Q U _ c n r ~  Ŏ Ǝ ˎ ׎ ێ      , 1 6 7 ; H L a e k l p t x | ŏ ӏ ԏ ؏      ! % T U Z b c d e f g ݐ  + , 7 j k v / 0 ; R S ^ В ђ ܒ j u z { ғ ӓ ړ   4 5 < B C ǔ Ҕ ה ؔ    ! F G R y z     ! " 6 < H I K R S U Z [ ] c d ڗ ۗ ޗ    * + - 7 8 : G H K ` a d s t Ř ǘ Ș ՘ ט ؘ    9 ; < V X Y v x y י ٙ ڙ  & = > ] ^ _ u к Ѻ  % & ' 5 9 L M N S d n ^^^^^@cd@IccbceӚ ӛ Ӝ Ǟ ǟ 9 9 9 9 f f f ݽ m `@`"`H@``X@`n`p`@` ` `\@` `d@` `l@` `t@` ` ` ` `@` ` `0-@```````L-@`-@Unknown Gz Times New Roman5Symbol3& z Arial?5 z Courier NewG5  hMS Mincho-3 fgoNewCenturySchlbkCentury SchoolbookO1 CourierCourier New7Tms Rmn5& zaTahoma;Wingdings#) hjF f2F sGsG!4d  2qPQS}6Department Of Veterans AffairsL           CompObjq